Citrus Sinensis ID: 015041
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 414 | 2.2.26 [Sep-21-2011] | |||||||
| P42158 | 450 | Casein kinase I isoform d | no | no | 0.753 | 0.693 | 0.735 | 1e-143 | |
| Q5ZLL1 | 416 | Casein kinase I isoform e | yes | no | 0.736 | 0.733 | 0.681 | 1e-128 | |
| Q5BP74 | 415 | Casein kinase I isoform d | N/A | no | 0.712 | 0.710 | 0.698 | 1e-128 | |
| Q9JMK2 | 416 | Casein kinase I isoform e | yes | no | 0.736 | 0.733 | 0.678 | 1e-128 | |
| Q6P647 | 415 | Casein kinase I isoform d | no | no | 0.712 | 0.710 | 0.698 | 1e-128 | |
| Q7T2E3 | 403 | Casein kinase I isoform d | yes | no | 0.712 | 0.732 | 0.701 | 1e-128 | |
| P49674 | 416 | Casein kinase I isoform e | yes | no | 0.736 | 0.733 | 0.678 | 1e-128 | |
| Q6P3K7 | 409 | Casein kinase I isoform d | no | no | 0.712 | 0.721 | 0.698 | 1e-128 | |
| Q06486 | 415 | Casein kinase I isoform d | no | no | 0.712 | 0.710 | 0.694 | 1e-128 | |
| Q9DC28 | 415 | Casein kinase I isoform d | no | no | 0.712 | 0.710 | 0.694 | 1e-128 |
| >sp|P42158|KC1D_ARATH Casein kinase I isoform delta-like OS=Arabidopsis thaliana GN=At4g26100 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 509 bits (1310), Expect = e-143, Method: Compositional matrix adjust.
Identities = 233/317 (73%), Positives = 277/317 (87%), Gaps = 5/317 (1%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G K++LGRKIGSGSFGEI+L +++ TNE +A+K+EN TKHPQLLYE+K+Y+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIHTNEELAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG+G+PN+KW+GV+G+ NVLV+DLLGPSLEDLF +C RK SLK+VLMLADQMI R+E+ H
Sbjct: 61 GGTGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFFH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ FLHRD+KPDNFLMGLGR+ANQVYIIDFGLAKKYRD TT++HIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGY+L+YFL+GSLPWQGLKA TKKQKY++I EKKVST IE L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEAL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
C+ +P+EFASYFHYC+SL FD +PDY +LKR+F DLF REG+ FD+VFDWTILKYQQ+Q
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 TKSQDLLPASRVTNSRV 317
T P SR N V
Sbjct: 301 TA-----PPSRALNPAV 312
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. It can phosphorylate a large number of proteins. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q5ZLL1|KC1E_CHICK Casein kinase I isoform epsilon OS=Gallus gallus GN=CSNK1E PE=2 SV=2 | Back alignment and function description |
|---|
Score = 459 bits (1182), Expect = e-128, Method: Compositional matrix adjust.
Identities = 208/305 (68%), Positives = 261/305 (85%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G KY+LGRKIGSGSFG+I+L +++ T E VA+K+E TKHPQL E+K YK++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIATGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP+IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CK +P+EF++Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+ +
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAARN 300
Query: 301 TKSQD 305
+ D
Sbjct: 301 PEDMD 305
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5BP74|KC1D_XENLA Casein kinase I isoform delta OS=Xenopus laevis GN=csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 459 bits (1180), Expect = e-128, Method: Compositional matrix adjust.
Identities = 206/295 (69%), Positives = 257/295 (87%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + +E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAASEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKY 295
CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Isoform 1 can phosphorylate a large number of proteins. Isoform 2 has no kinase activity. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9JMK2|KC1E_MOUSE Casein kinase I isoform epsilon OS=Mus musculus GN=Csnk1e PE=1 SV=2 | Back alignment and function description |
|---|
Score = 458 bits (1179), Expect = e-128, Method: Compositional matrix adjust.
Identities = 207/305 (67%), Positives = 261/305 (85%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G KY+LGRKIGSGSFG+I+L +++ + E VA+K+E TKHPQL E+K YK++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP+IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CK +P+EF++Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+ +
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAARN 300
Query: 301 TKSQD 305
+ D
Sbjct: 301 PEDVD 305
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Inhibits cytokine-induced granuloytic differentiation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P647|KC1D_XENTR Casein kinase I isoform delta OS=Xenopus tropicalis GN=csnk1d PE=2 SV=1 | Back alignment and function description |
|---|
Score = 458 bits (1178), Expect = e-128, Method: Compositional matrix adjust.
Identities = 206/295 (69%), Positives = 256/295 (86%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAAEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKY 295
CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T2E3|KC1DA_DANRE Casein kinase I isoform delta-A OS=Danio rerio GN=csnk1da PE=2 SV=1 | Back alignment and function description |
|---|
Score = 457 bits (1177), Expect = e-128, Method: Compositional matrix adjust.
Identities = 207/295 (70%), Positives = 257/295 (87%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + T E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDITTGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKY 295
CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P49674|KC1E_HUMAN Casein kinase I isoform epsilon OS=Homo sapiens GN=CSNK1E PE=1 SV=1 | Back alignment and function description |
|---|
Score = 457 bits (1176), Expect = e-128, Method: Compositional matrix adjust.
Identities = 207/305 (67%), Positives = 261/305 (85%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G KY+LGRKIGSGSFG+I+L +++ + E VA+K+E TKHPQL E+K YK++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP+IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CK +P+EF++Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+ +
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAARN 300
Query: 301 TKSQD 305
+ D
Sbjct: 301 PEDVD 305
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Inhibits cytokine-induced granuloytic differentiation. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P3K7|KC1DB_DANRE Casein kinase I isoform delta-B OS=Danio rerio GN=csnk1db PE=2 SV=1 | Back alignment and function description |
|---|
Score = 457 bits (1175), Expect = e-128, Method: Compositional matrix adjust.
Identities = 206/295 (69%), Positives = 256/295 (86%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDISVGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKY 295
CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06486|KC1D_RAT Casein kinase I isoform delta OS=Rattus norvegicus GN=Csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 457 bits (1175), Expect = e-128, Method: Compositional matrix adjust.
Identities = 205/295 (69%), Positives = 256/295 (86%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP I+W G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKY 295
CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q9DC28|KC1D_MOUSE Casein kinase I isoform delta OS=Mus musculus GN=Csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 457 bits (1175), Expect = e-128, Method: Compositional matrix adjust.
Identities = 205/295 (69%), Positives = 256/295 (86%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP I+W G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKY 295
CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 414 | ||||||
| 224092300 | 431 | predicted protein [Populus trichocarpa] | 0.995 | 0.955 | 0.762 | 0.0 | |
| 359484562 | 433 | PREDICTED: casein kinase I isoform delta | 0.995 | 0.951 | 0.735 | 1e-178 | |
| 356523722 | 430 | PREDICTED: casein kinase I isoform delta | 0.995 | 0.958 | 0.740 | 1e-178 | |
| 388495184 | 431 | unknown [Lotus japonicus] | 0.992 | 0.953 | 0.734 | 1e-178 | |
| 356513159 | 430 | PREDICTED: casein kinase I isoform delta | 0.995 | 0.958 | 0.740 | 1e-177 | |
| 356531301 | 426 | PREDICTED: casein kinase I isoform delta | 0.995 | 0.967 | 0.740 | 1e-175 | |
| 224142173 | 424 | predicted protein [Populus trichocarpa] | 0.978 | 0.955 | 0.736 | 1e-175 | |
| 357500563 | 424 | Casein kinase I isoform delta-like prote | 0.992 | 0.969 | 0.730 | 1e-174 | |
| 356495220 | 662 | PREDICTED: casein kinase I isoform delta | 0.966 | 0.604 | 0.738 | 1e-173 | |
| 357520927 | 430 | Casein kinase I isoform delta-like prote | 0.995 | 0.958 | 0.714 | 1e-172 |
| >gi|224092300|ref|XP_002309549.1| predicted protein [Populus trichocarpa] gi|222855525|gb|EEE93072.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 661 bits (1706), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 324/425 (76%), Positives = 357/425 (84%), Gaps = 13/425 (3%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERIIG KYKLGRKIGSGSFGEIFLA+H+ + EIVAVKIEN TKHPQLLYEAK+YKIL
Sbjct: 1 MERIIGEKYKLGRKIGSGSFGEIFLATHIHSGEIVAVKIENRSTKHPQLLYEAKLYKILG 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGI NIKW GVDGEDNVLV+DLLGPSLEDLFVYC RKFSLKTVLMLADQMIARIEY+H
Sbjct: 61 GGSGIANIKWCGVDGEDNVLVIDLLGPSLEDLFVYCGRKFSLKTVLMLADQMIARIEYMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
+GFLHRDIKPDNFLMGLGRKA+QVY+IDFGLAK+YRDPTT++HI YRENKNLTGTARYA
Sbjct: 121 VKGFLHRDIKPDNFLMGLGRKASQVYVIDFGLAKRYRDPTTHQHITYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLES+GYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESIGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKLSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+REG++FDFVFDWTILKY+QTQ+
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFTREGFEFDFVFDWTILKYKQTQR 300
Query: 301 TKSQ----DLLPASRVTNSRVMPMRTDKLK---------EVLECRGSYNRTRPDADMQHR 347
K Q DL P SRVT+SR M M +K K EV + RGS RPD MQ
Sbjct: 301 PKPQPQSSDLQPNSRVTSSRAMAMDLNKDKGVNGASYSAEVADHRGSNKVARPDTHMQLG 360
Query: 348 PSVAEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIGRGHGNKTGA 407
S + +++D+ KH+M NAS+PS SFV PS R+F K +G +A NIGRG GN+ GA
Sbjct: 361 SSFSRNVTADNPLDKHNMNNASMPSTSFVPPSASRRDFMKLDGSTDAVNIGRGLGNRAGA 420
Query: 408 SSSWM 412
SS M
Sbjct: 421 SSRLM 425
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484562|ref|XP_002284044.2| PREDICTED: casein kinase I isoform delta-like [Vitis vinifera] gi|297738784|emb|CBI28029.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 631 bits (1628), Expect = e-178, Method: Compositional matrix adjust.
Identities = 311/423 (73%), Positives = 343/423 (81%), Gaps = 11/423 (2%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERI+G KYKLGRKIGSGSFGEI+LA+HVDT EIVAVKIENS TKHPQLLYEAK+Y +LQ
Sbjct: 1 MERIVGGKYKLGRKIGSGSFGEIYLATHVDTFEIVAVKIENSKTKHPQLLYEAKLYNLLQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP I+W G+DG+DN+LVLDLLGPSLEDLFVYC RKFSLKTVLMLADQMI RIEYVH
Sbjct: 61 GGSGIPGIRWSGIDGDDNILVLDLLGPSLEDLFVYCGRKFSLKTVLMLADQMITRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDSTTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKLSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+REGY+FD++FDWTILKYQQTQK
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFTREGYEFDYIFDWTILKYQQTQK 300
Query: 301 TKSQ-DLLPASRVTNSRVMPMRTDKLK---------EVLECRGSYNRTRPDADMQHRPSV 350
+++Q L PA+ ++SR M M D+ + E E S N S
Sbjct: 301 SRTQPQLSPAAGGSSSRAMAMDVDRHQGGINASYSAEATERIRSSNAAASSGIRMQFKST 360
Query: 351 AEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIG-RGHGNKTGASS 409
+ +SS+ K+ + +A +PS SF L RN KP P E N GH NK G SS
Sbjct: 361 GKNLSSESPAEKNIVSDAHMPSTSFSLAGFSKRNAPKPMLPTETTNTAHHGHTNKIGPSS 420
Query: 410 SWM 412
SW+
Sbjct: 421 SWI 423
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356523722|ref|XP_003530484.1| PREDICTED: casein kinase I isoform delta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 630 bits (1625), Expect = e-178, Method: Compositional matrix adjust.
Identities = 311/420 (74%), Positives = 342/420 (81%), Gaps = 8/420 (1%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERI+G KYKLGRKIGSGSFGEI+LA+H+DT EIVAVKIENS TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIVGGKYKLGRKIGSGSFGEIYLATHIDTFEIVAVKIENSKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIPNIKW G+DGEDNVLV+DLLGPSLEDLFVYC RKFSLKTVL+LADQMI RIEYVH
Sbjct: 61 GGSGIPNIKWSGIDGEDNVLVIDLLGPSLEDLFVYCGRKFSLKTVLLLADQMITRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDSTTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC+KK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICQKKLSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+REGYDFD+VFDWTILKYQQ+QK
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFAREGYDFDYVFDWTILKYQQSQK 300
Query: 301 -TKSQDLLPASRVTNSRVMPMRTDKLKEVLECRG-------SYNRTRPDADMQHRPSVAE 352
L P +NSR P+ D + + G + + T +Q + V +
Sbjct: 301 NVMLPPLSPVPGASNSRATPIDVDSHQGLNAYSGHVKERIRAGDATGSGVKIQFKSPVGK 360
Query: 353 KMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIGRGHGNKTGASSSWM 412
+S ++ K+ G A+IPS SF ST RN K EA+N G G+K G SSSWM
Sbjct: 361 NLSYENPLDKNIFGEANIPSTSFSPASTSKRNSLKQSLSAEASNPGHAQGSKMGPSSSWM 420
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388495184|gb|AFK35658.1| unknown [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 630 bits (1624), Expect = e-178, Method: Compositional matrix adjust.
Identities = 310/422 (73%), Positives = 343/422 (81%), Gaps = 11/422 (2%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERI+G KYKLGRKIGSGSFGEI+LA+H+DT EIVAVKIENS TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIVGGKYKLGRKIGSGSFGEIYLATHIDTFEIVAVKIENSKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP +W GVDGEDNVLVLDLLGPSLEDLFVYC RKFSLKTVLMLADQMI RIEY H
Sbjct: 61 GGSGIPGTRWSGVDGEDNVLVLDLLGPSLEDLFVYCGRKFSLKTVLMLADQMITRIEYAH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD +TNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDSSTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC+KK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICQKKLSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+REGYDFD+VFDWTILKYQQ+QK
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFAREGYDFDYVFDWTILKYQQSQK 300
Query: 301 TKSQ---DLLPASRVTNSRVMPMRTDKLKEVLECRG-------SYNRTRPDADMQHRPSV 350
Q L P +NSRV+PM D + + G S N +Q + V
Sbjct: 301 NAVQPSLSLQPVPVASNSRVIPMDADNHQGLNAYSGHVKERIRSGNAATSGVKIQLKSPV 360
Query: 351 AEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIGRGHGNKTGASSS 410
+SS++ K+ G +++PS S+ ++ NR KP EA+N G+G G+K SSS
Sbjct: 361 GRNLSSENPLDKNIFGESNMPSTSYPAGAS-NRTSLKPAFSAEASNPGQGQGSKIAPSSS 419
Query: 411 WM 412
WM
Sbjct: 420 WM 421
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356513159|ref|XP_003525281.1| PREDICTED: casein kinase I isoform delta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 628 bits (1619), Expect = e-177, Method: Compositional matrix adjust.
Identities = 311/420 (74%), Positives = 341/420 (81%), Gaps = 8/420 (1%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERI+G KYKLGRKIGSGSFGEI+LA+H+DT EIVAVKIENS TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIVGGKYKLGRKIGSGSFGEIYLATHIDTFEIVAVKIENSKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIPNIKW G+DGEDNVLV+DLLGPSLEDLFVYC RKFSLKTVLMLADQMI RIEYVH
Sbjct: 61 GGSGIPNIKWSGIDGEDNVLVIDLLGPSLEDLFVYCGRKFSLKTVLMLADQMITRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDSTTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC+KK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICQKKLSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+R+GYDFD+VFDWTILKYQQ+QK
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFARDGYDFDYVFDWTILKYQQSQK 300
Query: 301 -TKSQDLLPASRVTNSRVMPMRTDKLKEVLECRG-------SYNRTRPDADMQHRPSVAE 352
L P +NSR +PM D + + G + + T +Q + V +
Sbjct: 301 NVMLPPLSPVPGASNSRAIPMDIDNHQGLNSYSGHVKERIRAGDATGSGVKIQFKSPVGK 360
Query: 353 KMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIGRGHGNKTGASSSWM 412
+S + K+ G A+IPS SF ST RN K EA+N G G+K G SSS M
Sbjct: 361 NLSYEKPLDKNIFGEANIPSTSFSPASTSQRNSLKQSLSAEASNPGHAQGSKIGPSSSLM 420
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356531301|ref|XP_003534216.1| PREDICTED: casein kinase I isoform delta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 622 bits (1604), Expect = e-175, Method: Compositional matrix adjust.
Identities = 308/416 (74%), Positives = 338/416 (81%), Gaps = 4/416 (0%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERIIG KYKLGRKIGSGSFGEI+LA+H+DT EIVAVKIEN TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIIGAKYKLGRKIGSGSFGEIYLATHIDTFEIVAVKIENGKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP+IKW GVDGEDNVLV+DLLGPSLEDLFVYC RKFSLK+VLMLADQM+ RIEYVH
Sbjct: 61 GGSGIPSIKWCGVDGEDNVLVMDLLGPSLEDLFVYCGRKFSLKSVLMLADQMMTRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDSTTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ LKAATKKQKYDKICEKKVSTPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQNLKAATKKQKYDKICEKKVSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+REGY+FD+VFDWTILKY+Q QK
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFTREGYEFDYVFDWTILKYKQAQK 300
Query: 301 TKSQDLLPASRVTNSR-VMPMRTDKLKEVLECR--GSYNRTRPDADMQHRPSVAEKMSSD 357
+ Q + T+S MPM D + + S N T +Q + V + + S+
Sbjct: 301 NRVQPHISTVPGTSSSPAMPMDVDNHRGDVSAERIKSGNVTGSGVKIQFKSPVGKILGSE 360
Query: 358 HHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIGRGHG-NKTGASSSWM 412
K+ G ++IPS S+ + T RN KP EA G G G NK G SSSW+
Sbjct: 361 KPLDKNIFGESNIPSTSYSIAGTSRRNTMKPALSTEAPKPGHGQGSNKIGPSSSWI 416
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224142173|ref|XP_002324433.1| predicted protein [Populus trichocarpa] gi|222865867|gb|EEF02998.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 620 bits (1599), Expect = e-175, Method: Compositional matrix adjust.
Identities = 310/421 (73%), Positives = 342/421 (81%), Gaps = 16/421 (3%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERIIG KYKLGRKIGSGSFGEI+LA+H+DT EIVA+KIENS TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIIGGKYKLGRKIGSGSFGEIYLATHIDTFEIVAIKIENSKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP+IKW GVDGEDN LVLDLLGPSLEDLFVYC RKFSLKTVLMLADQMI RIEYVH
Sbjct: 61 GGSGIPSIKWSGVDGEDNALVLDLLGPSLEDLFVYCGRKFSLKTVLMLADQMITRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDATTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKLSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CKSHP EFASY HYC SLTFDQRPDYGFLKRLF DLFS GY+FD+VFDWTI+KYQQ QK
Sbjct: 241 CKSHPVEFASYMHYCHSLTFDQRPDYGFLKRLFRDLFSHGGYEFDYVFDWTIIKYQQAQK 300
Query: 301 TKSQDLLPASRVTNSRVMPMRTDKLKEVLECRGSYN---------RTRPDADMQHRPSVA 351
+SQ + +S ++TD + +GS+N T P MQ + +
Sbjct: 301 NRSQPRSSPNPACSSHA--VQTD----MENHQGSHNACYSSEIMRSTGPGIRMQSKSGLG 354
Query: 352 EKMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIGRGHGNKTGASSSW 411
+ + SD H K ++ + IPS SF + T R+ KP P+E+AN GH NK G SSSW
Sbjct: 355 KNLISDIHADK-NIVSQHIPSTSFQVGGTSKRHASKPVLPNESANPAHGHNNKIGPSSSW 413
Query: 412 M 412
+
Sbjct: 414 I 414
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357500563|ref|XP_003620570.1| Casein kinase I isoform delta-like protein [Medicago truncatula] gi|357500745|ref|XP_003620661.1| Casein kinase I isoform delta-like protein [Medicago truncatula] gi|355495585|gb|AES76788.1| Casein kinase I isoform delta-like protein [Medicago truncatula] gi|355495676|gb|AES76879.1| Casein kinase I isoform delta-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 617 bits (1590), Expect = e-174, Method: Compositional matrix adjust.
Identities = 304/416 (73%), Positives = 341/416 (81%), Gaps = 5/416 (1%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
M+RIIG K+KLGRKIGSGSFGEI+LA+H+DT EIVAVKIE TKHPQLLYEAK+Y ILQ
Sbjct: 1 MDRIIGDKFKLGRKIGSGSFGEIYLATHIDTFEIVAVKIETGKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP+I+W GVDGEDNVLV+DLLGPSLEDLFVYC RKFSLKTVLMLADQM+ RIEYVH
Sbjct: 61 GGSGIPSIRWSGVDGEDNVLVMDLLGPSLEDLFVYCGRKFSLKTVLMLADQMMTRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKAN VY+IDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANLVYVIDFGLAKRYRDSTTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ LKAATKKQKYDKICEKKVSTPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQNLKAATKKQKYDKICEKKVSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CKSHP EFASYFHYC SLTFDQRPDYGFL+RLF +LF+REGY FD+VFDWTILKYQQ+QK
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLRRLFRELFAREGYKFDYVFDWTILKYQQSQK 300
Query: 301 TKSQ-DLLPASRVTNSRVMPMRTDKLKEVLECRG--SYNRTRPDADMQHRPSVAEKMSSD 357
+++Q + P +N+R MPM D + + S N T Q + S + ++S+
Sbjct: 301 SRAQPHISPVPVASNNRAMPMDIDNQQGNVSAEQIRSDNATSSGVKFQFKSSGGKNLASE 360
Query: 358 HHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIGRGHG-NKTGASSSWM 412
+ GK+ G A+IPS S ++ RN KP EAAN G G +K G SSS M
Sbjct: 361 NPLGKNIFGEATIPSTSHSFEAS-RRNSLKPSASTEAANHRHGQGSSKIGPSSSRM 415
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356495220|ref|XP_003516477.1| PREDICTED: casein kinase I isoform delta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 612 bits (1578), Expect = e-173, Method: Compositional matrix adjust.
Identities = 302/409 (73%), Positives = 330/409 (80%), Gaps = 9/409 (2%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERII KYKLGRKIGSGSFGEI+LA+++DT EIVAVKIEN TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIICAKYKLGRKIGSGSFGEIYLATNIDTFEIVAVKIENGKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIPNIKW GVDGEDNVLV+DLLGPSLEDLFVYC RKFSLK+VLMLADQM+ RIEYVH
Sbjct: 61 GGSGIPNIKWCGVDGEDNVLVMDLLGPSLEDLFVYCGRKFSLKSVLMLADQMMTRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD +TNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDSSTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ LKAATKKQKYDKICEKKVSTPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQNLKAATKKQKYDKICEKKVSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+REGY+FD+VFDWTILKYQQ QK
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFAREGYEFDYVFDWTILKYQQAQK 300
Query: 301 TKSQDLLPASRVTNSR-VMPMRTDKLKEVLECRG--------SYNRTRPDADMQHRPSVA 351
+ Q + T+S MPM D + + G S N T +Q + V
Sbjct: 301 NRVQSRISTVPGTSSSPAMPMDVDNHRGINAYSGDVTAERIKSGNVTGSGVKIQFKSPVG 360
Query: 352 EKMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIGRG 400
+ + S+ K+ G A+IPS S+ + T RN KP EA N G G
Sbjct: 361 KNLGSEKPLDKNIFGEANIPSTSYSVAGTSRRNTLKPALSTEAPNPGHG 409
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357520927|ref|XP_003630752.1| Casein kinase I isoform delta-like protein [Medicago truncatula] gi|355524774|gb|AET05228.1| Casein kinase I isoform delta-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 610 bits (1572), Expect = e-172, Method: Compositional matrix adjust.
Identities = 300/420 (71%), Positives = 335/420 (79%), Gaps = 8/420 (1%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERI+G YKLGRKIGSGSFGEI+LA+H+DT EIVAVKIENS TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIVGGSYKLGRKIGSGSFGEIYLATHIDTFEIVAVKIENSKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP +KW+G+D EDNVL +DLLGPSLEDLFVYC RKFSLKTVLMLADQMI RIEYVH
Sbjct: 61 GGSGIPGLKWFGIDREDNVLAIDLLGPSLEDLFVYCGRKFSLKTVLMLADQMITRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+G+LHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YR+ TTNRHIPYRENK+LTGTARYA
Sbjct: 121 SKGYLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRESTTNRHIPYRENKSLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL+AATKKQKY+KIC+KKVSTPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLRAATKKQKYEKICQKKVSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+REG++FDFVFDWTILKYQQ+QK
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFAREGHEFDFVFDWTILKYQQSQK 300
Query: 301 TKSQ-DLLPASRVTNSRVMPMRTDKLKEVLECRG-------SYNRTRPDADMQHRPSVAE 352
Q L P +N + M D ++ G S N T +Q +
Sbjct: 301 NLVQPSLSPVPGASNRHAVAMDVDNHQDFHAYPGHGEERIRSGNATGSGVKVQFKSPAGR 360
Query: 353 KMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIGRGHGNKTGASSSWM 412
+SSD+ K+ G A++ SAS+ T RN P E +N G G +K G SSSWM
Sbjct: 361 NLSSDNPRDKNIFGEANMASASYSPAGTSKRNPLNPALSAEPSNTGHGQASKIGPSSSWM 420
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 414 | ||||||
| TAIR|locus:2117778 | 415 | ckl3 "casein kinase I-like 3" | 0.968 | 0.966 | 0.706 | 7.2e-155 | |
| TAIR|locus:2117843 | 414 | ckl4 "casein kinase I-like 4" | 0.966 | 0.966 | 0.709 | 1.1e-153 | |
| TAIR|locus:504954933 | 435 | ckl12 "casein kinase I-like 12 | 0.893 | 0.850 | 0.654 | 9.1e-132 | |
| TAIR|locus:2120765 | 450 | CK1 "casein kinase 1" [Arabido | 0.765 | 0.704 | 0.732 | 1.7e-130 | |
| TAIR|locus:2024147 | 471 | ADK1 "dual specificity kinase | 0.949 | 0.834 | 0.615 | 4.5e-130 | |
| TAIR|locus:2167634 | 476 | ckl7 "casein kinase I-like 7" | 0.903 | 0.785 | 0.633 | 1.9e-129 | |
| TAIR|locus:2030170 | 465 | CKL2 "casein kinase 1-like pro | 0.719 | 0.640 | 0.765 | 8.4e-129 | |
| TAIR|locus:2050409 | 433 | ckl5 "casein kinase I-like 5" | 0.826 | 0.789 | 0.671 | 4.6e-128 | |
| TAIR|locus:2090875 | 442 | ckl10 "casein kinase I-like 10 | 0.719 | 0.674 | 0.761 | 1.2e-127 | |
| TAIR|locus:2121338 | 479 | CKL6 "casein kinase I-like 6" | 0.719 | 0.622 | 0.765 | 2e-127 |
| TAIR|locus:2117778 ckl3 "casein kinase I-like 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1510 (536.6 bits), Expect = 7.2e-155, P = 7.2e-155
Identities = 298/422 (70%), Positives = 334/422 (79%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERIIG KYKLGRKIG GSFGEIFLA+HVDT EIVAVKIENS TKHPQLLYEAK+Y+IL+
Sbjct: 1 MERIIGGKYKLGRKIGGGSFGEIFLATHVDTFEIVAVKIENSKTKHPQLLYEAKLYRILE 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP IKW+GVDG +N LV+DLLGPSLEDLFVYC RKFS KTVLMLADQM+ RIE+VH
Sbjct: 61 GGSGIPRIKWFGVDGTENALVMDLLGPSLEDLFVYCGRKFSPKTVLMLADQMLTRIEFVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+G+LHRDIKPDNFLMGLGRKANQVY+IDFGLAK+YRD TNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGYLHRDIKPDNFLMGLGRKANQVYLIDFGLAKRYRDANTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA KKQKYDKICEKK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAVDKKQKYDKICEKKISTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CK+HP EFASYFHYC +LTFDQRPDYGFLKRLF DLFSREGY+FD++FDWTI+KYQQ QK
Sbjct: 241 CKNHPVEFASYFHYCHTLTFDQRPDYGFLKRLFRDLFSREGYEFDYIFDWTIIKYQQAQK 300
Query: 301 TKSQD-LLPASRVTNSRVMPMRTDKLK---------EVLECRGSYNRTRPDADMQHRPSV 350
+++Q +P S +N R MP+ T + E E S N P + + +
Sbjct: 301 SRNQSQAVPGS--SNPRAMPVDTSNHRGGPNISYEAEASERVRSANAIGPSPQINNNTAA 358
Query: 351 AEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIGRGHGNKTGASSS 410
DH K N ++PS S T RN GP E +N G G GN+TG +SS
Sbjct: 359 GRTPGFDHPVHK----NMNMPSTSLSPAGTSKRNV----GP-ETSNSGYGSGNRTGWTSS 409
Query: 411 WM 412
+M
Sbjct: 410 FM 411
|
|
| TAIR|locus:2117843 ckl4 "casein kinase I-like 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1499 (532.7 bits), Expect = 1.1e-153, P = 1.1e-153
Identities = 296/417 (70%), Positives = 337/417 (80%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERIIG KYKLGRKIG GSFGEIFLA+H+DT EIVAVKIENS TKHPQLLYEAK+Y+ L+
Sbjct: 1 MERIIGGKYKLGRKIGGGSFGEIFLATHIDTFEIVAVKIENSKTKHPQLLYEAKLYRTLE 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP I+W+GVDG +N LV+DLLGPSLEDLFVYC RKFS KTVLMLADQM+ RIEYVH
Sbjct: 61 GGSGIPRIRWFGVDGTENALVMDLLGPSLEDLFVYCGRKFSPKTVLMLADQMLTRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+G+LHRDIKPDNFLMGLGRKANQVY+IDFGLAK+YRD TNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGYLHRDIKPDNFLMGLGRKANQVYLIDFGLAKRYRDANTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQ RRDDLESLGYVLLYFLRGSLPWQGLKA KKQKYDKICEKK+STPIEVL
Sbjct: 181 SCNTHLGIEQGRRDDLESLGYVLLYFLRGSLPWQGLKAVDKKQKYDKICEKKISTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CKSHP EFASYFHYC +LTFDQRPDYGFLKRLF DLFSREGY+FD+++DWTI+KYQQ+QK
Sbjct: 241 CKSHPVEFASYFHYCHTLTFDQRPDYGFLKRLFRDLFSREGYEFDYIYDWTIIKYQQSQK 300
Query: 301 TKSQD-LLPASRVTNSRVMPMRTDK----LKEVLECRGSYNRTRPDADMQHRPSVAEKMS 355
T+SQ +P S +N+R +PM T K E + S +R RP P + +
Sbjct: 301 TRSQSQAVPGS--SNARAIPMDTSNHRGGTKISHEAQVS-DRVRPANASGPSPQINTAVG 357
Query: 356 SDHHFGK-HSMGNASIPSASFVLPS-TFNRNFQKPEGPDEAANIGRGHGNKTGASSS 410
F + H N ++PS++ + P+ T RN +PE +N G G GNKTG +S
Sbjct: 358 RSLGFDQVHK--NMNMPSSTSLSPAGTSKRNV-RPE----TSNSGFGSGNKTGGWTS 407
|
|
| TAIR|locus:504954933 ckl12 "casein kinase I-like 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1292 (459.9 bits), Expect = 9.1e-132, P = 9.1e-132
Identities = 250/382 (65%), Positives = 301/382 (78%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G KY+LGRKIGSGSFGEI+L +H+ TNE VA+K+EN TKHPQLLYE+K+Y+ILQ
Sbjct: 1 MEPRVGNKYRLGRKIGSGSFGEIYLGTHIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG+G+PNIKW+GV+G+ N LV+DLLGPSLEDLF +C RK SLK+VLMLADQMI R+EY H
Sbjct: 61 GGTGVPNIKWFGVEGDYNTLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEYFH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ FLHRD+KPDNFLMGLGR+ANQV+IIDFGLAKKYRD TT++HIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVHIIDFGLAKKYRDNTTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGY+L+YFL+GSLPWQGLKA TKKQKY++I EKKVST IE L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIESL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
C+ +P+EFASYFHYC+SL FD +PDYG+LKR+F DLF REG+ FD+VFDWTILKYQQ+Q
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYGYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 TK--SQDLLPASRVTNSRVMPMRTDKLKEVLECRGSYNRTRPDADMQHRPSVAEKMSSD- 357
T S+ L+ + T++ + P L + G RP D R +MS
Sbjct: 301 TAPPSRGLVSPAVGTSAGLPP----GLTSIDRYGGEEEGGRPPMDSSRR-----RMSGAL 351
Query: 358 HHFGKHSMGNASIPSASFVLPS 379
+ G S +PS+S S
Sbjct: 352 ENSGNLSSRGPMMPSSSLFAQS 373
|
|
| TAIR|locus:2120765 CK1 "casein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1280 (455.6 bits), Expect = 1.7e-130, P = 1.7e-130
Identities = 235/321 (73%), Positives = 281/321 (87%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G K++LGRKIGSGSFGEI+L +++ TNE +A+K+EN TKHPQLLYE+K+Y+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIHTNEELAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG+G+PN+KW+GV+G+ NVLV+DLLGPSLEDLF +C RK SLK+VLMLADQMI R+E+ H
Sbjct: 61 GGTGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFFH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ FLHRD+KPDNFLMGLGR+ANQVYIIDFGLAKKYRD TT++HIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGY+L+YFL+GSLPWQGLKA TKKQKY++I EKKVST IE L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEAL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
C+ +P+EFASYFHYC+SL FD +PDY +LKR+F DLF REG+ FD+VFDWTILKYQQ+Q
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 TK--SQDLLPASRVTNSRVMP 319
T S+ L PA V S +P
Sbjct: 301 TAPPSRALNPA--VGTSAALP 319
|
|
| TAIR|locus:2024147 ADK1 "dual specificity kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1276 (454.2 bits), Expect = 4.5e-130, P = 4.5e-130
Identities = 250/406 (61%), Positives = 302/406 (74%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
M+ +IG K+KLGRKIGSGSFGE++L +V T E VAVK+E+ TKHPQL YE+K+Y +LQ
Sbjct: 1 MDLVIGGKFKLGRKIGSGSFGELYLGINVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG+G+PN+KWYGV+G+ NV+V+DLLGPSLEDLF YC RK SLKTVLMLADQ+I R+E++H
Sbjct: 61 GGTGVPNLKWYGVEGDYNVMVIDLLGPSLEDLFNYCNRKLSLKTVLMLADQLINRVEFMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
+RGFLHRDIKPDNFLMGLGRKANQVYIIDFGL KKYRD T+RHIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLG+EQSRRDDLE+LGYVL+YFL+GSLPWQGLKA TKKQKYD+I EKKV+TPIEVL
Sbjct: 181 SVNTHLGVEQSRRDDLEALGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVATPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CK+ P+EF SYF YC+SL FD +PDY +LKRLF DLF REGY FD+VFDWT+LKY Q
Sbjct: 241 CKNQPSEFVSYFRYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQIGS 300
Query: 301 TKSQDLLPASRVTNSRVMPM-----RTDKL--KEVLECRGS-----YNRTRPDADMQHRP 348
+ + T + + + +++ KE E R S ++R P A R
Sbjct: 301 SSGSSSRTRNHTTANPGLTAGASLEKQERIAGKETRENRFSGAVEAFSRRHP-ATSTTRD 359
Query: 349 SVAEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEA 394
A + S D KH G++ P +S S+ R P A
Sbjct: 360 RSASRNSVDGPLSKHPPGDSERPRSSSRYGSSSRRAIPSSSRPSSA 405
|
|
| TAIR|locus:2167634 ckl7 "casein kinase I-like 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1270 (452.1 bits), Expect = 1.9e-129, P = 1.9e-129
Identities = 244/385 (63%), Positives = 296/385 (76%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
M+ +IG K+KLG+KIGSGSFGE++L +V T E VAVK+EN TKHPQL YE+K+Y +LQ
Sbjct: 1 MDLVIGGKFKLGKKIGSGSFGELYLGVNVQTGEEVAVKLENVKTKHPQLHYESKLYMLLQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIPNIKW+GV+G+ +V+V+DLLGPSLEDLF YC RK +LKTVLMLADQ++ R+E++H
Sbjct: 61 GGSGIPNIKWFGVEGDYSVMVIDLLGPSLEDLFNYCNRKLTLKTVLMLADQLLNRVEFMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
+RGFLHRDIKPDNFLMGLGRKANQVYIIDFGL KKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLG+EQSRRDDLESLGYVL+YFL+GSLPWQGLKA TKKQKYD+I EKKVSTPIEVL
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CK+ P+EF SYFHYC+SL FD +PDY +LKRLF DLF REGY FD+VFDWT+LKY Q
Sbjct: 241 CKNQPSEFVSYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQIGS 300
Query: 301 TKSQDLLPASRVTNS---RVMPM-RTDKL--KEVLECR--GS---YNRTRPDADMQHRPS 349
+ T P+ R +++ KE + G+ ++R P R
Sbjct: 301 SSGSSSRTRHHTTAKPGFNADPIERQERILGKETTRYKIPGAVEAFSRRHPTTTSSPRDR 360
Query: 350 VAEKMSSDHHFGKHSMGNASIPSAS 374
+ S D F K + G++ ++S
Sbjct: 361 SRSRNSDDGPFSKQTHGDSERANSS 385
|
|
| TAIR|locus:2030170 CKL2 "casein kinase 1-like protein 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1264 (450.0 bits), Expect = 8.4e-129, P = 8.4e-129
Identities = 229/299 (76%), Positives = 268/299 (89%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G K++LGRKIG GSFGEI+L +++ TNE VA+K+EN TKHPQLLYE+K+YK+LQ
Sbjct: 1 MEPRVGNKFRLGRKIGGGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYKVLQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG+G+PN+KWYGV+G+ NVLV+DLLGPSLEDLF +C RK SLKTVLMLADQMI RIE+VH
Sbjct: 61 GGTGVPNVKWYGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRIEFVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
+ FLHRDIKPDNFLMGLGR+ANQVY+IDFGLAKKYRD + ++HIPYRENKNLTGTARYA
Sbjct: 121 QKSFLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRD-SNHQHIPYRENKNLTGTARYA 179
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLG+VL+YFL+GSLPWQGLKA KKQKY+KI EKKVST IE L
Sbjct: 180 SMNTHLGIEQSRRDDLESLGFVLMYFLKGSLPWQGLKAGNKKQKYEKISEKKVSTSIEAL 239
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQ 299
C+ +P+EFASYFHYC+SL FD +PDY +LKRLF DLF REG+ FD+VFDWTILKYQQ+Q
Sbjct: 240 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 298
|
|
| TAIR|locus:2050409 ckl5 "casein kinase I-like 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1257 (447.5 bits), Expect = 4.6e-128, P = 4.6e-128
Identities = 235/350 (67%), Positives = 285/350 (81%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G K++LGRKIGSGSFGEI+L + V TNE VA+K+E+ T HPQL YE+++Y++LQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTDVQTNEEVAIKLESVKTAHPQLSYESRIYRVLQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG+GIPN+KWYGV+G+ NVLV+DLLGPSLEDLF YC+R+FSLKTVLMLADQMI R+E++H
Sbjct: 61 GGTGIPNMKWYGVEGDYNVLVMDLLGPSLEDLFSYCKRQFSLKTVLMLADQMINRLEFIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ +LHRDIKPDNFLMGLGR+ANQVYIID+GLAKKYRD +T+RHIPYRENK+L GT RYA
Sbjct: 121 SKSYLHRDIKPDNFLMGLGRRANQVYIIDYGLAKKYRDSSTHRHIPYRENKSLIGTPRYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDD+ESLGY+L+YFL+GSLPWQGLKA KKQKYDKI EKKVST IE L
Sbjct: 181 SLNTHLGIEQSRRDDIESLGYILMYFLKGSLPWQGLKAGNKKQKYDKISEKKVSTSIETL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
C+ HP EFASYFHYC+SL FD +PDY +LKRLF +LF REG+ FDFVFDWT+ KYQQ+Q
Sbjct: 241 CRGHPTEFASYFHYCRSLRFDDKPDYAYLKRLFRNLFIREGFQFDFVFDWTVYKYQQSQS 300
Query: 301 TKSQDLLPASRV-TNSRVMPM--RTDKLKEVLECRGSYNRTRPDADMQHR 347
Q V T+S + P ++K +V RT PD ++ +
Sbjct: 301 GNPQPRPHDGGVGTSSGLNPAVGNSEKRPDVPN-----QRTNPDFTLKQK 345
|
|
| TAIR|locus:2090875 ckl10 "casein kinase I-like 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1253 (446.1 bits), Expect = 1.2e-127, P = 1.2e-127
Identities = 227/298 (76%), Positives = 264/298 (88%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
M+ +IG K+KLGRKIGSGSFGE+++ +V T E VA+K+E TKHPQL YE+KVY +LQ
Sbjct: 1 MDHVIGGKFKLGRKIGSGSFGELYIGINVQTGEEVALKLEPVKTKHPQLHYESKVYMLLQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG+G+P+IKW+GV+G N + +DLLGPSLEDLF YC R FSLKTVLMLADQ+I R+EY+H
Sbjct: 61 GGTGVPHIKWFGVEGNYNCMAIDLLGPSLEDLFNYCTRSFSLKTVLMLADQLINRVEYMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
SRGFLHRDIKPDNFLMGLGRKANQVYIID+GLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF+RGSLPWQGLKA TKKQKY+KI EKK+ TP+EVL
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFIRGSLPWQGLKAGTKKQKYEKISEKKMLTPVEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQT 298
CKS+P+EF SYFHYC+SL F+ +PDY +LKRLF DLF REGY FD+VFDWTILKY Q+
Sbjct: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQS 298
|
|
| TAIR|locus:2121338 CKL6 "casein kinase I-like 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1251 (445.4 bits), Expect = 2.0e-127, P = 2.0e-127
Identities = 228/298 (76%), Positives = 262/298 (87%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
M+ +IG K+KLGRKIG GSFGE+FLA + T E AVK+E + TKHPQL YE+K+Y +LQ
Sbjct: 5 MDNVIGGKFKLGRKIGGGSFGELFLAVSLQTGEEAAVKLEPAKTKHPQLHYESKIYMLLQ 64
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP++KW+GV G+ N +V+DLLGPSLEDLF YC R+ +LK VLMLADQ+I+R+EY+H
Sbjct: 65 GGSGIPSLKWFGVQGDYNAMVIDLLGPSLEDLFNYCNRRLTLKAVLMLADQLISRVEYMH 124
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD T+RHIPYRENKNLTGTARYA
Sbjct: 125 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDLQTHRHIPYRENKNLTGTARYA 184
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLG+EQSRRDDLESLGYVL+YFLRGSLPWQGLKA TKKQKYD+I EKKVSTPIEVL
Sbjct: 185 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDRISEKKVSTPIEVL 244
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQT 298
CKS+P EF SYF YC+SL F+ +PDY +LKRLF DLF REGY FD+VFDWT LK+ Q+
Sbjct: 245 CKSYPPEFVSYFQYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTALKHPQS 302
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q556Y4 | KC1_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.6428 | 0.7101 | 0.6901 | yes | no |
| P49674 | KC1E_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.6786 | 0.7367 | 0.7331 | yes | no |
| P35508 | KC1D_BOVIN | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6949 | 0.7125 | 0.7108 | yes | no |
| Q7T2E3 | KC1DA_DANRE | 2, ., 7, ., 1, 1, ., 1 | 0.7016 | 0.7125 | 0.7320 | yes | no |
| P42168 | KC1A_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.6360 | 0.7608 | 0.9237 | yes | no |
| Q5RC72 | KC1D_PONAB | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6881 | 0.7125 | 0.7108 | yes | no |
| P29295 | HRR25_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.6254 | 0.7415 | 0.6214 | yes | no |
| P40235 | HHP1_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.6979 | 0.6956 | 0.7890 | yes | no |
| O76324 | DCO_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.6779 | 0.7125 | 0.6704 | yes | no |
| Q8IHZ9 | KC1_PLAF7 | 2, ., 7, ., 1, 1, ., 1 | 0.6523 | 0.7294 | 0.9349 | yes | no |
| Q5ZLL1 | KC1E_CHICK | 2, ., 7, ., 1, 1, ., 1 | 0.6819 | 0.7367 | 0.7331 | yes | no |
| Q9JMK2 | KC1E_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.6786 | 0.7367 | 0.7331 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 414 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-48 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-35 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-35 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-31 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-24 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-22 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-22 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-19 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-19 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-18 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-16 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-15 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-15 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-15 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-13 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-13 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-13 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-12 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-12 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-10 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-10 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-10 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-10 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-08 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-08 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-08 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 8e-08 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-07 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-07 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-07 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-06 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-06 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-06 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-06 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-06 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-06 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-06 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-06 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-05 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-05 | |
| COG2112 | 201 | COG2112, COG2112, Predicted Ser/Thr protein kinase | 2e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-05 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-05 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-05 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-05 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-05 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-05 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-04 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-04 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 3e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 4e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-04 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-04 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 9e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 0.001 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 0.001 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 0.001 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 0.001 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 0.001 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 0.002 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.002 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 0.002 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.002 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.002 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 0.002 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 0.002 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.003 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.003 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 0.004 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 6e-48
Identities = 77/266 (28%), Positives = 110/266 (41%), Gaps = 27/266 (10%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSG 64
Y+L RK+GSGSFG ++ A H T +IVAVKI K E ++ + L
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSH--- 57
Query: 65 IPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYV 119
PNI + + + LV++ DLF Y R S +A Q++ +EY+
Sbjct: 58 -PNIVRLIDAFEDKDHLYLVMEYCEGG--DLFDYLSRGGPLSEDEAKKIALQILRGLEYL 114
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
HS G +HRD+KP+N L+ + V I DFGLAKK GT Y
Sbjct: 115 HSNGIIHRDLKPENILLD---ENGVVKIADFGLAKK-------LLKSSSSLTTFVGTPWY 164
Query: 180 ASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
+ L G + D+ SLG +L L G P+ G + Q +I +
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEP 224
Query: 239 VLCKSHPAEFASYFHYCQSLTFDQRP 264
S E C + +RP
Sbjct: 225 KWS-SGSEEAKDLIKKCLNKDPSKRP 249
|
Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 1e-35
Identities = 90/315 (28%), Positives = 138/315 (43%), Gaps = 23/315 (7%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
Y++ RK+G GSFGE++LA ++VA+K+ E+ + + L E ++ L
Sbjct: 1 SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 63 SGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
I + + D LV++ + G SLEDL R S L + Q+++ +EY+
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
HS+G +HRDIKP+N L L R V +IDFGLAK DP + IP + ++ GT Y
Sbjct: 118 HSKGIIHRDIKPENIL--LDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV-GTPGY 174
Query: 180 ASCNTHLGIEQ---SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK-YDKICEKKVST 235
+ LG+ S D+ SLG L L G P++G K ++ + I E +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 236 PIEVLCKSHPAEFASYFH--YCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 293
L S+P + + L D + L HDL + D + L
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL---KLKESDLSDL 291
Query: 294 KYQQTQKTKSQDLLP 308
L P
Sbjct: 292 LKPDDSAPLRLSLPP 306
|
Length = 384 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 8e-35
Identities = 68/200 (34%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIPNI-KW 70
+G G FG ++LA T + VA+KI E+S + +LL E ++ K L PNI K
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH----PNIVKL 56
Query: 71 YGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 127
YGV D LV++ G SL+DL K S +L + Q++ +EY+HS G +HR
Sbjct: 57 YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
D+KP+N L L +V + DFGL+K K + GT Y + LG
Sbjct: 117 DLKPENIL--LDSDNGKVKLADFGLSKLLTSDK-------SLLKTIVGTPAYMAPEVLLG 167
Query: 188 I-EQSRRDDLESLGYVLLYF 206
S + D+ SLG +L
Sbjct: 168 KGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 73/246 (29%), Positives = 115/246 (46%), Gaps = 27/246 (10%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGI 65
Y++ K+G GSFG+++LA T ++VA+K+ + ++L E K+ K L+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKH---- 56
Query: 66 PNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
PNI + Y V D + LV++ G L DL R + S Q+++ +EY+HS
Sbjct: 57 PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHS 115
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
+G +HRD+KP+N L+ + V + DFGLA++ GT Y +
Sbjct: 116 KGIVHRDLKPENILLD---EDGHVKLADFGLARQLDPGEK--------LTTFVGTPEYMA 164
Query: 182 CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
LG + D+ SLG V+LY L G P+ G + + KI + K P
Sbjct: 165 PEVLLGKGYGKAVDIWSLG-VILYELLTGKPPFPG--DDQLLELFKKIGKPKPPFPPPEW 221
Query: 241 CKSHPA 246
S A
Sbjct: 222 DISPEA 227
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 5e-24
Identities = 68/221 (30%), Positives = 112/221 (50%), Gaps = 24/221 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTK-HPQLLYEAKVYKILQGGS 63
+++ G KIG G+FG+++ A ++DT E++AVK I+++ K ++ E KV ++L+
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH-- 58
Query: 64 GIPNI-KWYGVDGEDN-VLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
PN+ K+YGV+ V + G +LE+L + R + + Q++ + Y+
Sbjct: 59 --PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYL 115
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN-KNLTGTAR 178
HS G +HRDIKP N + + + DFG A K ++ TT E ++L GT
Sbjct: 116 HSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNTT----TMGEEVQSLAGTPA 168
Query: 179 YASCNTHLGIEQS---RRDDLESLGYVLLYFLRGSLPWQGL 216
Y + G + R D+ SLG V+L G PW L
Sbjct: 169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 9e-23
Identities = 56/216 (25%), Positives = 89/216 (41%), Gaps = 31/216 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGS 63
+YK+ +IG G+ G +F A +T E VA+K Q L E K + Q
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQH-- 58
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
P + K V G VLV++ + L ++ R V ++ + Y+H
Sbjct: 59 --PYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP------YRENKNLT 174
+ G +HRD+KP N L+ + I DFGLA+ + + + YR + L
Sbjct: 117 ANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173
Query: 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 210
G +Y G+ DL ++G + L GS
Sbjct: 174 GARKYDP-----GV------DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 1e-22
Identities = 67/233 (28%), Positives = 101/233 (43%), Gaps = 37/233 (15%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKILQ 60
+K G+ IG GSF + LA +TN+ A+KI E K + E +V L
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEK---KVKYVKIEKEVLTRLN 59
Query: 61 GGSGIPNIKWYGV--DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
G GI IK Y D E+N+ VL+ G L+ ++ K A +++
Sbjct: 60 GHPGI--IKLYYTFQD-EENLYFVLEYAPNGELLQ--YIRKYGSLDEKCTRFYAAEILLA 114
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-------------TN 162
+EY+HS+G +HRD+KP+N L+ K + I DFG AK + +
Sbjct: 115 LEYLHSKGIIHRDLKPENILLD---KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
R + GTA Y S + DL +LG ++ L G P++G
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 1e-22
Identities = 85/304 (27%), Positives = 141/304 (46%), Gaps = 53/304 (17%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLAS----HVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL 59
I G ++K+ + IG G FG ++ H N+ VA KIEN ++ ++ E VY +
Sbjct: 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVA-KIEN--LENETIVMETLVYNNI 65
Query: 60 QGGSGIPNIKWYGVDGEDNV--------------------LVLDLLGPSLEDLF--VYCR 97
I W + D++ ++L+ L + +++F + C+
Sbjct: 66 YDIDKIAL--WKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCK 123
Query: 98 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
K +K ++ M+ +EY+H G H DIKP+N +M G N+ YIID+G+A +
Sbjct: 124 NKKLIKNIMK---DMLTTLEYIHEHGISHGDIKPEN-IMVDGN--NRGYIIDYGIASHF- 176
Query: 158 DPTTNRHIPY-RENKNL-TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
+HI Y +E K+L GT YA + H G +RR DLESLGY +L + LPW+G
Sbjct: 177 -IIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG 235
Query: 216 LKA------ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269
A K ++ E K+ K+ + L+++++PDY L
Sbjct: 236 FGHNGNLIHAAKCDFIKRLHEGKIKI------KNANKFIYDFIECVTKLSYEEKPDYDAL 289
Query: 270 KRLF 273
++F
Sbjct: 290 IKIF 293
|
Length = 294 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 4e-21
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKH-PQLLYEAKVYKILQGGS 63
++ G +G GSFG ++LA DT E++AVK + + L E ++ LQ
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQH-- 58
Query: 64 GIPNI-KWYGVDGEDNVLVLDLL-----GPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
PNI ++YG + ++ L++ G SL L + K + Q++ +
Sbjct: 59 --PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSL-LKKFGKLPEPVIRKYTRQILEGLA 115
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
Y+HS G +HRDIK N L+ V + DFG AK+ D T ++ GT
Sbjct: 116 YLHSNGIVHRDIKGANILVDSDG---VVKLADFGCAKRLGDIETG-----EGTGSVRGTP 167
Query: 178 RYAS---CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
+ + G E R D+ SLG ++ G PW
Sbjct: 168 YWMAPEVIR---GEEYGRAADIWSLGCTVIEMATGKPPW 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 33/173 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTK---HPQLLYEAKVYKILQ 60
+Y+ G+K+G G++ ++ A +T IVA+K E K + L E K+ + L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 61 GGSGIPNI----KWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD----- 110
PNI +G N+ LV + + LE + + K VL AD
Sbjct: 61 H----PNIIGLLDVFGHK--SNINLVFEFMETDLEKVI---KDK---SIVLTPADIKSYM 108
Query: 111 QMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
M R +EY+HS LHRD+KP+N L+ + + DFGLA+ + P
Sbjct: 109 LMTLRGLEYLHSNWILHRDLKPNNLLIA---SDGVLKLADFGLARSFGSPNRK 158
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 6e-19
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
+++ KIG G FGE++ A H T + VA+K+ S K +++ E ++ K +
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKH---- 56
Query: 66 PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
PNI K+YG + ++ +V++ G SL+DL + + + + +++ +EY+HS
Sbjct: 57 PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
G +HRDIK N L+ +V +IDFGL+ + D + + GT + +
Sbjct: 117 NGIIHRDIKAANILL--TSDG-EVKLIDFGLSAQLSDT--------KARNTMVGTPYWMA 165
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
G + D+ SLG + G P
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (207), Expect = 3e-18
Identities = 66/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSG--IPNIKW 70
+G GSFG++ L DT ++ A+K+ K ++ + IL + I + +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 71 YGVDGEDNVLVLDLL--GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
E LVL+ G +LF + + +FS + A +++ +EY+HS G ++
Sbjct: 61 AFQTEEKLYLVLEYAPGG----ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIY 116
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPTTNRHIPYRENKNLTGTARYASCNT 184
RD+KP+N L L + + + DFGLAK+ TN GT Y +
Sbjct: 117 RDLKPENIL--LDADGH-IKLTDFGLAKELSSEGSRTN---------TFCGTPEYLAPEV 164
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP-------- 236
LG + D SLG +L L G P+ A +K+ Y+KI + + P
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPPFY---AEDRKEIYEKILKDPLRFPEFLSPEAR 221
Query: 237 --IEVLCKSHPAE 247
I L + P +
Sbjct: 222 DLISGLLQKDPTK 234
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 2e-16
Identities = 54/175 (30%), Positives = 83/175 (47%), Gaps = 24/175 (13%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKI--ENSGTKHPQLLY-EAKVYKILQGG 62
LG+K+G G+FGE++ VAVK E++ + + EA++ + L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH- 60
Query: 63 SGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IE 117
PN+ K GV + E +V++ + G L R K SL +L A Q IAR +E
Sbjct: 61 ---PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQ-IARGME 116
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYR 168
Y+ S+ F+HRD+ N L+G + V I DFGL++ D +P R
Sbjct: 117 YLESKNFIHRDLAARNCLVG---ENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR 168
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 77/271 (28%), Positives = 115/271 (42%), Gaps = 61/271 (22%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK------IENSGTKHPQLLYEAK------- 54
+Y + R IG G GE++LA + VA+K EN + L EAK
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENP-LLKKRFLREAKIAADLIH 61
Query: 55 -----VYKILQGGSGI----PNIKWYGVDG-EDNVLVLDLLGPSLEDLFVYCRRKFSLKT 104
VY I G + P I+ Y + +V + L L + K S+
Sbjct: 62 PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAE-------KTSVGA 114
Query: 105 VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK---------- 154
L + ++ A IEYVHS+G LHRD+KPDN L+GL +V I+D+G A
Sbjct: 115 FLSIFHKICATIEYVHSKGVLHRDLKPDNILLGL---FGEVVILDWGAAIFKKLEEEDLL 171
Query: 155 --KYRDPTTNRH---IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG 209
+ IP + + GT Y + LG+ S D+ +LG +L L
Sbjct: 172 DIDVDERNICYSSMTIPGK----IVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTL 227
Query: 210 SLPWQGLKAATKKQKYDKICEK-KVSTPIEV 239
S P+ +++K KI + + +PIEV
Sbjct: 228 SFPY-------RRKKGRKISYRDVILSPIEV 251
|
Length = 932 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 1e-15
Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGSGI 65
YK+ +++G G+FG ++LA + +T E+VA+K + L E K + L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEH--- 57
Query: 66 PNI-KWYGVDGEDNVL--VLDLLGPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHS 121
PNI K V E++ L V + + +L L + FS + + Q++ + ++H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 122 RGFLHRDIKPDNFL-MGLGRKANQVYIIDFGLAKKYR 157
GF HRD+KP+N L G V I DFGLA++ R
Sbjct: 118 HGFFHRDLKPENLLVSGPEV----VKIADFGLAREIR 150
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (186), Expect = 2e-15
Identities = 53/157 (33%), Positives = 77/157 (49%), Gaps = 20/157 (12%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGG 62
+LG+K+G G+FGE++ T VAVK G + L EA + K L
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH- 60
Query: 63 SGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IE 117
PNI + GV GE +V + + G L D K +LK +L +A Q IA+ +E
Sbjct: 61 ---PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQ-IAKGME 116
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Y+ S+ F+HRD+ N L + V I DFGL++
Sbjct: 117 YLESKNFVHRDLAARNCL--VTEN-LVVKISDFGLSR 150
|
Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (187), Expect = 2e-15
Identities = 47/161 (29%), Positives = 72/161 (44%), Gaps = 20/161 (12%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQ-LLYEAKVYKILQGGSG 64
Y+ K+G G++G ++ A T EIVA+K ++N P L E + K L+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKH--- 57
Query: 65 IPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEY 118
PNI K V + LV + DL Y S + + Q++ + Y
Sbjct: 58 -PNIVKLLDVIHTERKLYLVFEYCD---MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
HS LHRD+KP N L+ + + + DFGLA+ + P
Sbjct: 114 CHSHRILHRDLKPQNILIN---RDGVLKLADFGLARAFGIP 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 5e-15
Identities = 49/161 (30%), Positives = 74/161 (45%), Gaps = 20/161 (12%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKH-PQLLYEAKVYKILQGGS 63
KY++ ++IG GSFG+++L ++ +K + N K L E K+ K L
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNH-- 58
Query: 64 GIPNI-KWYGVDGEDNVL--VLDLL-GPSLEDLF---VYCRRKFSLKTVLMLADQMIARI 116
PNI K+Y E L V++ G L + F + +L Q+ +
Sbjct: 59 --PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 117 EYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKY 156
+Y+HSR LHRDIKP N FL V + DFG++K
Sbjct: 117 KYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFGISKVL 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 6e-15
Identities = 66/216 (30%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYK---ILQGGSG- 64
++L R IG G+FG++ + DT ++ A+K N K + V ILQ +
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ-KCVEKGSVRNVLNERRILQELNHP 60
Query: 65 -IPNIKWYGV-DGEDNVLVLDLLGPSLEDLFVYC--RRKFSLKTVLMLADQMIARIEYVH 120
+ N+ WY D E+ LV+DLL DL + + KFS + V +++ +EY+H
Sbjct: 61 FLVNL-WYSFQDEENMYLVVDLLLGG--DLRYHLSQKVKFSEEQVKFWICEIVLALEYLH 117
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT-GTARY 179
S+G +HRDIKPDN L+ + V+I DF +A + T GT Y
Sbjct: 118 SKGIIHRDIKPDNILLD---EQGHVHITDFNIA---------TKVTPDTLTTSTSGTPGY 165
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
+ S D SLG LRG P++G
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 6e-15
Identities = 56/176 (31%), Positives = 84/176 (47%), Gaps = 25/176 (14%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKI--ENSGTKHPQLLY-EAKVYKILQGG 62
LG+K+G G+FGE++ VAVK E++ + + EA++ + L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH- 60
Query: 63 SGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKF-SLKTVLMLADQMIAR-I 116
PNI K GV + E ++V++ + G L D R K SL +L A Q IAR +
Sbjct: 61 ---PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQ-IARGM 116
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYR 168
EY+ S+ F+HRD+ N L+G V I DFGL++ D +P R
Sbjct: 117 EYLESKNFIHRDLAARNCLVGEN---LVVKISDFGLSRDLYDDDYYKVKGGKLPIR 169
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 14/158 (8%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQLLYEAKVYKILQGGSG 64
Y+ KIG G++G ++ A T EIVA+K S L E K+ K L
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNH--- 57
Query: 65 IPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
PNI K V D LV + + L L +R + Q++ + + HS
Sbjct: 58 -PNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
G LHRD+KP+N L+ + + DFGLA+ + P
Sbjct: 117 HGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSP 151
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 71/246 (28%), Positives = 110/246 (44%), Gaps = 30/246 (12%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIEN-SGTKHPQLLYEAKVYK-ILQGGSGIPNIK-WY 71
I G++G +FLA T +I A+K+ + + + + IL +K +Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 72 GVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQM----IARI----EYVHS 121
G+ N+ LV++ L G L L L+ V L + + IA I EY+HS
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASL---------LENVGSLDEDVARIYIAEIVLALEYLHS 111
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YRDPTTNRHIPYRENKNLTGTARYA 180
G +HRD+KPDN L+ + + DFGL+K N + +E+K + GT Y
Sbjct: 112 NGIIHRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
+ LG S+ D SLG +L FL G P+ G T ++ + I K+ E +
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG---ETPEEIFQNILNGKIE-WPEDV 224
Query: 241 CKSHPA 246
S A
Sbjct: 225 EVSDEA 230
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 4e-14
Identities = 66/237 (27%), Positives = 111/237 (46%), Gaps = 36/237 (15%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQL-LYEAKVYKILQGGSG 64
Y+ +IG G++G+++ A + T E+VA+K +EN P + E K+ + L+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR---- 56
Query: 65 IPNI-KWYGV---DGEDNV-LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
PNI + + G+ ++ +V + + L L KF+ + Q++ ++Y+
Sbjct: 57 HPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL 116
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY----RDPTTNRHIP--YRENKNL 173
HS G LHRDIK N L + + + DFGLA+ Y TNR I YR + L
Sbjct: 117 HSNGILHRDIKGSNIL--INNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 174 TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230
G RY + D+ S+G +L G +QG +T+ ++ +KI E
Sbjct: 174 LGATRYGP-----EV------DMWSVGCILAELFLGKPIFQG---STELEQLEKIFE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 9e-14
Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 30/206 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHP-QLLYEAKVYKILQGGS 63
K+ + +IG G++G+++ A DT E+VA V+++N P + E K+ + L +
Sbjct: 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRN 67
Query: 64 GIPNIKWYGVDGEDNV----------LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI 113
I N+K D +D + LV + + L L FS + Q++
Sbjct: 68 -IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL 126
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY----RDPTTNRHIP--Y 167
+ Y H + FLHRDIK N L+ Q+ + DFGLA+ Y P TN+ I Y
Sbjct: 127 EGLNYCHKKNFLHRDIKCSNILLN---NKGQIKLADFGLARLYNSEESRPYTNKVITLWY 183
Query: 168 RENKNLTGTARYA------SCNTHLG 187
R + L G RY SC LG
Sbjct: 184 RPPELLLGEERYGPAIDVWSCGCILG 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 66/247 (26%), Positives = 108/247 (43%), Gaps = 52/247 (21%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL--------QGGSG 64
+ I G+FG ++LA T + A+K+ K ++ + +V + QG S
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKV----LKKSDMIAKNQVTNVKAERAIMMIQGES- 56
Query: 65 IPNIK--WYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR----- 115
P + +Y +D + LV++ L G L +KT+ L + +
Sbjct: 57 -PYVAKLYYSFQSKDYLYLVMEYLNGGDCASL---------IKTLGGLPEDWAKQYIAEV 106
Query: 116 ---IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
+E +H RG +HRDIKP+N L+ + + + DFGL++ ENK
Sbjct: 107 VLGVEDLHQRGIIHRDIKPENLLID---QTGHLKLTDFGLSRN-----------GLENKK 152
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
GT Y + T LG+ + D SLG V+ FL G P+ A T +D I ++
Sbjct: 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH---AETPDAVFDNILSRR 209
Query: 233 VSTPIEV 239
++ P EV
Sbjct: 210 INWPEEV 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 40/242 (16%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP--------QLLYEAKVYKILQ 60
++ + +G+GSFG + L H + + A+KI + K +L E ++ + ++
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILS---KAKIVKLKQVEHVLNEKRILQSIR 59
Query: 61 GGSGIPNI-KWYGVDGEDNVL--VLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIAR 115
P + YG +D+ L V++ + +LF + R+ +F A Q++
Sbjct: 60 H----PFLVNLYGSFQDDSNLYLVMEYVPGG--ELFSHLRKSGRFPEPVARFYAAQVVLA 113
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
+EY+HS ++RD+KP+N L+ + I DFG AK+ + T L G
Sbjct: 114 LEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGRT----------YTLCG 160
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVS 234
T Y + L + D +LG +L+Y L G P+ Q Y+KI E KV
Sbjct: 161 TPEYLAPEIILSKGYGKAVDWWALG-ILIYEMLAGYPPF---FDDNPIQIYEKILEGKVR 216
Query: 235 TP 236
P
Sbjct: 217 FP 218
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 44/226 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHP----QLLYEAKVYKILQ 60
+++ G +GSGSFG ++ ++D + AVK + + G QL E + LQ
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 61 GGSGIPNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRKF-SLKTVL--MLADQMI 113
PNI ++ G + E++ L L+L+ G SL L +K+ S + + Q++
Sbjct: 61 H----PNIVQYLGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQIL 112
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
+EY+H R +HRDIK N L+ V + DFG+AK+ + + K+
Sbjct: 113 LGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQV--------VEFSFAKSF 161
Query: 174 TGTARY------ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
G+ + A + D+ SLG +L G PW
Sbjct: 162 KGSPYWMAPEVIAQQGGY-----GLAADIWSLGCTVLEMATGKPPW 202
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 8e-13
Identities = 50/164 (30%), Positives = 73/164 (44%), Gaps = 38/164 (23%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY-EAKVYKILQGGSGIP 66
YK KIG G+ GE++ A+ T + VA+K ++ +L+ E + K + P
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKH----P 75
Query: 67 NIKWYGVDGEDNVLVLDLL--------GPSLEDLFVYCRRKFSLKTVLMLADQMIARI-- 116
NI VD D+ LV D L G SL D+ + + + IA +
Sbjct: 76 NI----VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR--------MNEPQIAYVCR 123
Query: 117 ------EYVHSRGFLHRDIKPDNFLMGL-GRKANQVYIIDFGLA 153
EY+HS+ +HRDIK DN L+ G V + DFG A
Sbjct: 124 EVLQGLEYLHSQNVIHRDIKSDNILLSKDGS----VKLADFGFA 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 8e-13
Identities = 62/224 (27%), Positives = 93/224 (41%), Gaps = 23/224 (10%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNI-K 69
+G GS G ++ H T +I A+K + QLL E K + S P + K
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKT--LRSCES--PYVVK 63
Query: 70 WYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFL 125
YG + +VL+ + G SL DL K + +A Q++ ++Y+H+ R +
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHII 122
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH 185
HRDIKP N L+ +V I DFG++K + + GT Y S
Sbjct: 123 HRDIKPSNLLIN---SKGEVKIADFGISKVLENTLDQCN-------TFVGTVTYMSPERI 172
Query: 186 LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229
G S D+ SLG LL G P+ + + IC
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC 216
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 76/282 (26%), Positives = 120/282 (42%), Gaps = 45/282 (15%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IE---NSGTKHPQLLY--------EAK 54
K+ G IG G++G ++LA +V T E++AVK +E +H E +
Sbjct: 1 FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60
Query: 55 VYKILQGGSGIPNIKWY-GVDGEDNVLVLDL---LGPSLEDLFVYCRR--KFSLKTVLML 108
K L NI Y G + + L + L G S+ R +F + V
Sbjct: 61 TLKDLDH----LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFF 113
Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
+Q++ + Y+HS+G LHRD+K DN L+ I DFG++KK D N
Sbjct: 114 TEQVLEGLAYLHSKGILHRDLKADNLLVDADGICK---ISDFGISKKSDDIYDN-----D 165
Query: 169 ENKNLTGT----ARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK 224
+N ++ G+ A + G S + D+ SLG V+L G PW +A
Sbjct: 166 QNMSMQGSVFWMAPEVIHSYSQGY--SAKVDIWSLGCVVLEMFAGRRPWSDEEAI---AA 220
Query: 225 YDKICEKKVSTPI--EVLCKSHPAEFASYFHYCQSLTFDQRP 264
K+ K+ + PI +V P + + C ++ D RP
Sbjct: 221 MFKLGNKRSAPPIPPDVSMNLSPVA-LDFLNACFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 3e-12
Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 26/170 (15%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTK---HPQLLYEAKVYKILQGGS 63
Y+LG IG G+FG ++ +++T + VA+K I K ++ E + K L+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKH-- 58
Query: 64 GIPNI-KWYGVDGEDNVL--VLDL-LGPSLEDLFVYCRRKF-----SLKTVLMLADQMIA 114
PNI K+ G + L +L+ SL + +KF SL V + Q++
Sbjct: 59 --PNIVKYIGSIETSDSLYIILEYAENGSLRQII----KKFGPFPESLVAVYVY--QVLQ 110
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
+ Y+H +G +HRDIK N L K V + DFG+A K D + +
Sbjct: 111 GLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLNDVSKDDA 157
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 51/180 (28%), Positives = 77/180 (42%), Gaps = 25/180 (13%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGI 65
Y+L IG G+ ++ A + NE VA+K E T +L E +
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNH---- 58
Query: 66 PNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRK-----FSLKTVLMLADQMIARI 116
PN+ K+Y + L V+ L G SL D+ + + TVL +++ +
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL---KEVLKGL 115
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
EY+HS G +HRDIK N L+G + V I DFG++ D + K GT
Sbjct: 116 EYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLADGGDRTR---KVRKTFVGT 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 71/245 (28%), Positives = 103/245 (42%), Gaps = 53/245 (21%)
Query: 13 RKIGSGSFGEIFLA---SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGSGIP 66
+K+G G+FGE++ VAVK + L EA+V K L G P
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL----GHP 56
Query: 67 NI-KWYGV--DGEDNVLVL------DLLG---PSLEDLFVYCRRKFSLKTVLMLADQMIA 114
N+ + GV + E LVL DLL S + SLK +L A Q IA
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ-IA 115
Query: 115 R-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP-----TTNRHIPYR 168
+ +EY+ S+ F+HRD+ N L+G + V I DFGL++ D T +P R
Sbjct: 116 KGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
Query: 169 ----ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKK 222
E + + + +S D+ S G VLL+ F G+ P+ GL
Sbjct: 173 WMAPE------SLKDGIFTS-----KS---DVWSFG-VLLWEIFTLGATPYPGLSNEEVL 217
Query: 223 QKYDK 227
+ K
Sbjct: 218 EYLRK 222
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 44/175 (25%), Positives = 71/175 (40%), Gaps = 30/175 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQLLYEAKVYKILQGGS 63
KY++ +G G++G + + T EIVA+K E+ L E KV + L+
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRH-- 59
Query: 64 GIPNI-----------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQM 112
NI + Y LV + + +L +L V Q+
Sbjct: 60 --ENIVNLKEAFRRKGRLY--------LVFEYVERTLLELLEASPGGLPPDAVRSYIWQL 109
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167
+ I Y HS +HRDIKP+N L+ ++ + + DFG A+ R + Y
Sbjct: 110 LQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDY 161
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 49/185 (26%), Positives = 77/185 (41%), Gaps = 19/185 (10%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTK---HPQLLYEAKVYKILQGGSG 64
Y++ K+G G+FGE++ A + T +VA+K I K L E K+ K L+ +
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV 69
Query: 65 IPNIKWYGVDGEDNV-------LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
+P I + + +V + L L K + + Q++ I
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGIN 129
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
Y+H LHRDIK N L+ + I DFGLA+ Y P P + GT
Sbjct: 130 YLHENHILHRDIKAANILID---NQGILKIADFGLARPYDGP-----PPNPKGGGGGGTR 181
Query: 178 RYASC 182
+Y +
Sbjct: 182 KYTNL 186
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 10/155 (6%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHP-QLLYEAKVYKILQGGSGIPNIK 69
+I G++G ++ A T EIVA +K+E P L E + LQ + I +K
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN-IVTVK 70
Query: 70 WYGV-DGEDNV-LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 127
V D + +V++ + L+ L ++ F V L Q+++ + ++H LHR
Sbjct: 71 EVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHR 130
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
D+K N L+ + I DFGLA++Y P
Sbjct: 131 DLKTSNLLL---NNRGILKICDFGLAREYGSPLKP 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 73/278 (26%), Positives = 125/278 (44%), Gaps = 38/278 (13%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPN- 67
KL RK+G+G FGE+++ + T + VAVK GT P+ L EA++ K L+
Sbjct: 9 KLERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRH----DKL 63
Query: 68 IKWYGV--DGEDNVLVLDLLGP-SLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVH 120
++ Y V + E +V + + SL D + + +K L ++ +A Q+ + Y+
Sbjct: 64 VQLYAVCSEEEPIYIVTEYMSKGSLLD---FLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARY 179
SR ++HRD+ N L+G I DFGLA+ D + + K + TA
Sbjct: 121 SRNYIHRDLAARNILVGEN---LVCKIADFGLARLIED---DEYTAREGAKFPIKWTAPE 174
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
A+ I + D+ S G +LL G +P+ G+ T ++ +++ E+ P
Sbjct: 175 AANYGRFTI----KSDVWSFG-ILLTEIVTYGRVPYPGM---TNREVLEQV-ERGYRMPR 225
Query: 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275
C P E C ++RP + +L+ D
Sbjct: 226 PPNC---PEELYDLMLQCWDKDPEERPTFEYLQSFLED 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 6e-11
Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 30/167 (17%)
Query: 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-GTKHPQLLYEAKVYKILQGGSG 64
++L IG G++G+++ A H T ++VA+KI + + ++ E Y IL+ S
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEE---YNILRKYSN 61
Query: 65 IPNI-KWYGV-------DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
PNI +YG +D + LV++L G S+ DL K K L ++ IA
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWIA 116
Query: 115 RI--------EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
I Y+H +HRDIK N L+ K +V ++DFG++
Sbjct: 117 YILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 74/275 (26%), Positives = 119/275 (43%), Gaps = 28/275 (10%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQ-LLYEAKVYKILQGGS 63
+++ +KIG G F E++ A+ + + VA+K E K Q + E + K L +
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGP-SLEDLFVYCRRKFSL---KTVLMLADQMIARIEYV 119
I + + D E N+ VL+L L + Y +++ L +TV Q+ + +E++
Sbjct: 64 VIKYLDSFIEDNELNI-VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 120 HSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
HSR +HRDIKP N F+ G V + D GL + + TT H +L GT
Sbjct: 123 HSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAH-------SLVGTPY 171
Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
Y S + + D+ SLG +L P+ G K +C+K
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-----DKMNLFSLCQKIEQCDYP 226
Query: 239 VLCKSHPAE-FASYFHYCQSLTFDQRPDYGFLKRL 272
L H +E C DQRPD G++ ++
Sbjct: 227 PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 7e-11
Identities = 51/174 (29%), Positives = 77/174 (44%), Gaps = 21/174 (12%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHP-QLLYEAKVYKILQGGS 63
KY+ KIG G+FGE+F A H T +IVA+K +EN P L E K+ ++L+ +
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHEN 72
Query: 64 GIPNI-------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
+ I Y LV + L L KF+L + + ++ +
Sbjct: 73 VVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGL 132
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-------TNR 163
Y+H LHRD+K N L+ K + + DFGLA+ + TNR
Sbjct: 133 YYIHRNKILHRDMKAANILI---TKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 7e-11
Identities = 49/151 (32%), Positives = 79/151 (52%), Gaps = 14/151 (9%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPN- 67
+L RK+G+G FGE++ +T VAVK GT P+ L EA++ K L+ P
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLAEAQIMKKLRH----PKL 63
Query: 68 IKWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
I+ Y V E +V +L+ G LE L R L ++ +A Q+ + + Y+ ++
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN 123
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
++HRD+ N L+G + N + DFGLA+
Sbjct: 124 YIHRDLAARNVLVG---ENNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (153), Expect = 7e-11
Identities = 48/177 (27%), Positives = 76/177 (42%), Gaps = 56/177 (31%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQL----LYEAKVYKILQGG 62
+Y+L + IGSG++G + A T VA+K I N L E K+ + L+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-FDDLIDAKRILREIKLLRHLR-- 57
Query: 63 SGIPNIKWYGVDGEDNVL-VLDLLGPSLEDLF--VYCRRKFSLKTVLMLAD--------- 110
+N++ +LD+L P + F VY + T LM D
Sbjct: 58 -------------HENIIGLLDILRPPSPEDFNDVY------IVTELMETDLHKVIKSPQ 98
Query: 111 ------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK 154
Q++ ++Y+HS +HRD+KP N L+ +N + I DFGLA+
Sbjct: 99 PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV----NSNCDLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 8e-11
Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 23/200 (11%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGSGIPNI 68
R +G G+FGE L + + +V K N S + L E + +LQ PNI
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH----PNI 61
Query: 69 -KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRG 123
+Y +DN L++++ G +L D V + + F + VL Q+++ + Y+H G
Sbjct: 62 IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG 121
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
LHRDIK N + KA + + DFG++K Y + + GT Y S
Sbjct: 122 ILHRDIKTLNIFL---TKAGLIKLGDFGISKILGS-------EYSMAETVVGTPYYMSPE 171
Query: 184 THLGIEQSRRDDLESLGYVL 203
G++ + + D+ +LG VL
Sbjct: 172 LCQGVKYNFKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 9e-11
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 27/207 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQ-LLYEAKVYKILQGGS 63
KY+ R +G G+FG + L ++V +K +E E +V K+L
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSH-- 58
Query: 64 GIPN-IKWYGVDGEDNVLVLDLL---GPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEY 118
PN I++Y ED L++ + G +L + C T+L Q++ + +
Sbjct: 59 --PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHH 116
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--GT 176
VH++ LHRD+K N L+ + V I DFG++K I ++K T GT
Sbjct: 117 VHTKLILHRDLKTQNILL--DKHKMVVKIGDFGISK----------ILSSKSKAYTVVGT 164
Query: 177 ARYASCNTHLGIEQSRRDDLESLGYVL 203
Y S G +++ D+ +LG VL
Sbjct: 165 PCYISPELCEGKPYNQKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 30/231 (12%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIEN-------SGTKHPQLLYEAKVYKILQGGSGIPN 67
+G+G+FG + L + A+K+ +H E +V K + I
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVH--NEKRVLKEVSH-PFIIR 65
Query: 68 IKWYGVDGEDNVLVLDLLGPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFL 125
+ W D ++++ + P E LF Y R +FS T L A +++ +EY+HS+ +
Sbjct: 66 LFWTEHDQRFLYMLMEYV-PGGE-LFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIV 123
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH 185
+RD+KP+N L+ K + + DFG AKK RD T L GT Y +
Sbjct: 124 YRDLKPENILLD---KEGHIKLTDFGFAKKLRDRTW----------TLCGTPEYLAPEVI 170
Query: 186 LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
++ D +LG ++ L G P+ Y+KI K+ P
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPPFFD---DNPFGIYEKILAGKLEFP 218
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 24/164 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK----------IENSGTKHPQLLYEAKVYK 57
KY+ KIG G++G +F A + +T+EIVA+K + +S + LL E K
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 58 ILQGGSGIPNIKWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
I ++ Y V D LV + L+ F C + V Q++
Sbjct: 61 I---------VRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKG 111
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
+ + HS LHRD+KP N L+ K ++ + DFGLA+ + P
Sbjct: 112 LAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIP 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 37/230 (16%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP-------QLLYEAKVYKIL 59
++ G+ +G G+FG ++L VDT +AVK P L E ++ K L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 60 QGGSGIPNI-KWYGVDGEDNVLVL---DLLGPSLED-LFVY------CRRKFSLKTVLML 108
Q I ++YG +D L + + G S++D L Y RK++
Sbjct: 62 QH----ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR------ 111
Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
Q++ +EY+HS +HRDIK N L A V + DFG +K R T
Sbjct: 112 --QILEGVEYLHSNMIVHRDIKGANILRDS---AGNVKLGDFGASK--RLQTICSSGTGM 164
Query: 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218
K++TGT + S G R+ D+ S+G ++ L PW +A
Sbjct: 165 --KSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 44/164 (26%), Positives = 78/164 (47%), Gaps = 37/164 (22%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI-- 65
Y+L ++IGSG++G+++ A + T E+VA+K+ L ++I+Q +
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIK--------LEPGDDFEIIQQEISMLK 55
Query: 66 ----PNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI- 116
PNI ++G + L V++ G SL+D++ R L++ IA +
Sbjct: 56 ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP--------LSELQIAYVC 107
Query: 117 -------EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
Y+H G +HRDIK N L+ + V + DFG++
Sbjct: 108 RETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 33/116 (28%), Positives = 47/116 (40%), Gaps = 26/116 (22%)
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD------------- 158
++ ++ VH GF+HRDIKPDN L + + + + DFGL KK
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNIL--IDADGH-IKLADFGLCKKMNKAKDREYYLNDSHN 166
Query: 159 --PTTNRHIPYRENKNLT-------GTARYASCNTHLGIEQSRRDDLESLGYVLLY 205
N + R++K GT Y + G D SLG V+LY
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLG-VILY 221
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 62/260 (23%), Positives = 97/260 (37%), Gaps = 50/260 (19%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSGIPN 67
+G G FG + L N A+K +E +H E ++ + P
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS--EKEILEECNH----PF 54
Query: 68 I-KWYG--VDGEDNVLVLDL-LGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHS 121
I K Y D + ++++ LG +L+ R F T ++ EY+H+
Sbjct: 55 IVKLYRTFKDKKYIYMLMEYCLG---GELWTILRDRGLFDEYTARFYIACVVLAFEYLHN 111
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--GTARY 179
RG ++RD+KP+N L+ V ++DFG AKK K T GT Y
Sbjct: 112 RGIIYRDLKPENLLLD---SNGYVKLVDFGFAKKL----------KSGQKTWTFCGTPEY 158
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKA-----------ATKKQKYDK 227
+ L D SLG +LLY L G P+ K ++
Sbjct: 159 VAPEIILNKGYDFSVDYWSLG-ILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN 217
Query: 228 ICEKKVSTPIEVLCKSHPAE 247
+K I+ L + +P E
Sbjct: 218 YIDKAAKDLIKQLLRRNPEE 237
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 40/242 (16%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
+++G +G+GSFG + +A H T E A+K K ++L +V + Q S + +
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKC----LKKREILKMKQVQHVAQEKSILMEL 75
Query: 69 K-------WYGVDGEDNVLVLDLLGPSLE-----DLFVYCRR--KFSLKTVLMLADQMIA 114
E+ V L LE +LF + R+ +F +++
Sbjct: 76 SHPFIVNMMCSFQDENRVYFL------LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL 129
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
EY+HS+ ++RD+KP+N L L K + V + DFG AKK D T L
Sbjct: 130 AFEYLHSKDIIYRDLKPENLL--LDNKGH-VKVTDFGFAKKVPDRTF----------TLC 176
Query: 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234
GT Y + + D ++G +L F+ G P+ T + Y+KI ++
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD---DTPFRIYEKILAGRLK 233
Query: 235 TP 236
P
Sbjct: 234 FP 235
|
Length = 329 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 48/209 (22%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSGIPNI- 68
++G+G+ G + H T +I+AVK +E + Q+L E + P I
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILH----KCNSPYIV 62
Query: 69 KWYG---VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGF 124
+YG +G+ ++ + + G SL+ + + + + + +A ++ + Y+H
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI 122
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
+HRD+KP N L+ Q+ + DFG++ + + K GT+ Y +
Sbjct: 123 IHRDVKPSNILVN---SRGQIKLCDFGVSGQLVNSLA---------KTFVGTSSYMAPER 170
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
G + S + D+ SLG L+ G P+
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 57/190 (30%), Positives = 90/190 (47%), Gaps = 25/190 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQL-LYEAKVYKILQGGS 63
+Y+ KIG G++G ++ A TNE +A+K +E P + E + K +Q G
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG- 61
Query: 64 GIPNI-KWYGVDGEDNVL-----VLDL-LGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
NI + V + L LDL L ++ + + +KT L Q++ I
Sbjct: 62 ---NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLY---QILRGI 115
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENK 171
Y HS LHRD+KP N L + R+ N + + DFGLA+ + P T H + YR +
Sbjct: 116 AYCHSHRVLHRDLKPQNLL--IDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPE 173
Query: 172 NLTGTARYAS 181
L G+ Y++
Sbjct: 174 ILLGSRHYST 183
|
Length = 294 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 25/165 (15%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHP---QLLYEAKVYKIL 59
+G +YK IGSG++G + A + + VA+K I ++ + L E K+ +
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF 61
Query: 60 QGGSGIPNI-------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQM 112
+ NI + G D +D +V+DL+ L + ++ + + + + Q+
Sbjct: 62 KH----DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHI-IHSDQPLTEEHIRYFLYQL 116
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ---VYIIDFGLAK 154
+ ++Y+HS +HRD+KP N L+ N+ + I DFG+A+
Sbjct: 117 LRGLKYIHSANVIHRDLKPSNLLV------NEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 6e-10
Identities = 39/144 (27%), Positives = 73/144 (50%), Gaps = 11/144 (7%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI-KWYG 72
K+G GS+G ++ A H +T ++VA+K+ +++ E + K P I K+YG
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDS----PYIVKYYG 65
Query: 73 VDGEDNVL--VLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129
++ L V++ G S+ D+ + + + + + Q + +EY+HS +HRDI
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDI 125
Query: 130 KPDNFLMGLGRKANQVYIIDFGLA 153
K N L+ + Q + DFG++
Sbjct: 126 KAGNILLN---EEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 7e-10
Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 34/226 (15%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-------ENSGTKHPQLL----YEAKVY 56
K+ G IGSGSFG ++L + + E++AVK +S + +L E +
Sbjct: 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60
Query: 57 KILQGGSGIPNIKWY---GVDGEDNVLVLDLL-GPSLEDLF-VYCRRKFSLKTVLMLADQ 111
K LQ NI Y +D + + L+ + G S+ L Y F V Q
Sbjct: 61 KELQH----ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQ 114
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR----DPTTNRHIPY 167
++ + Y+H+RG +HRDIK N L+ + I DFG++KK TN P
Sbjct: 115 ILKGLNYLHNRGIIHRDIKGANILVD---NKGGIKISDFGISKKLEANSLSTKTNGARP- 170
Query: 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
+L G+ + + +R+ D+ SLG +++ L G P+
Sbjct: 171 ----SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 7e-10
Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSG 64
+ L IG GSFGE++ A TN++VA+K+ E + + + E + +
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR---- 57
Query: 65 IPNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
P I K+YG + G ++++ G S DL K + + +++ +EY+H
Sbjct: 58 SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH 115
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
G +HRDIK N L+ + V + DFG++ + + R+
Sbjct: 116 EEGKIHRDIKAANILLS---EEGDVKLADFGVSGQLTSTMSKRN 156
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 9e-10
Identities = 66/276 (23%), Positives = 119/276 (43%), Gaps = 42/276 (15%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
+ L RK+GSG FGE++ + VA+KI + K E + K L+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKH--- 63
Query: 67 NIKWYGV--DGEDNVLVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVH 120
I + V GE ++ +L+ L + R + + +++ +A Q+ + Y+
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKG--SLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP---TTNRHIPYRENKNLTGTA 177
+ +HRD+ N L+G + DFGLA+ ++ ++++ IPY+ TA
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCK---VADFGLARLIKEDVYLSSDKKIPYK------WTA 172
Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEK-KVS 234
A+ + S + D+ S G +LLY F G +P+ G + YD+I ++
Sbjct: 173 PEAASHGTF----STKSDVWSFG-ILLYEMFTYGQVPYPG---MNNHEVYDQITAGYRMP 224
Query: 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270
P + C P E C + + RP + L+
Sbjct: 225 CPAK--C---PQEIYKIMLECWAAEPEDRPSFKALR 255
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 69/276 (25%), Positives = 122/276 (44%), Gaps = 29/276 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
+L K+G G FGE+++ + T VA+K GT P+ L EA+V K L+ +
Sbjct: 9 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK---LV 64
Query: 69 KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
+ Y V E+ + ++ G L+ L + L ++ +A Q+ + + YV ++
Sbjct: 65 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 124
Query: 126 HRDIKPDNFLMGLGRKANQV-YIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCN 183
HRD++ N L+G N V + DFGLA+ D N + + K + TA A+
Sbjct: 125 HRDLRAANILVG----ENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALY 177
Query: 184 THLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
I + D+ S G +L +G +P+ G+ ++ D++ E+ P C
Sbjct: 178 GRFTI----KSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC- 228
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
P C ++RP + +L+ D F+
Sbjct: 229 --PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 262
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 71/265 (26%), Positives = 112/265 (42%), Gaps = 53/265 (20%)
Query: 12 GRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
+IGSG+ G ++ H T + A+K+ + T Q+ E + IL+ + PN+
Sbjct: 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIE---ILRDVNH-PNV 134
Query: 69 ----KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
+ +GE VL+ + G SLE + + + +A Q+++ I Y+H R
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQILSGIAYLHRRHI 189
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAK---KYRDPTTNRHIPYRENKNLTGTARYAS 181
+HRDIKP N L+ + V I DFG+++ + DP + GT Y S
Sbjct: 190 VHRDIKPSNLLINSAK---NVKIADFGVSRILAQTMDPCNSS----------VGTIAYMS 236
Query: 182 ---CNTHLGIEQSRRD----DLESLGYVLLYFLRGSLPW----QGLKAATKKQKYDKICE 230
NT L D D+ SLG +L F G P+ QG A+ +C
Sbjct: 237 PERINTDL--NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL-------MCA 287
Query: 231 KKVSTPIEVLCKSHPAEFASYFHYC 255
+S P E + EF + C
Sbjct: 288 ICMSQPPEAPATASR-EFRHFISCC 311
|
Length = 353 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 29/210 (13%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQ-LLYEAKVYKILQGGS 63
+K+ +KIG G F ++ A + +VA+K E K Q L E + K L
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH-- 61
Query: 64 GIPN-IKWYGVDGEDNVLVLDLLGPSLEDL------FVYCRRKFSLKTVLMLADQMIARI 116
PN IK+ E+N L + L DL F +R +T+ Q+ + +
Sbjct: 62 --PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
E++HS+ +HRDIKP N + A V + D GL + + TT H +L G
Sbjct: 120 EHMHSKRIMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTTAAH-------SLVG 168
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLY 205
T Y S + + D+ SLG LLY
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLG-CLLY 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 48/171 (28%), Positives = 75/171 (43%), Gaps = 37/171 (21%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQ-LLYEAKVYKILQGGSG 64
Y+ +IG G++G ++ A ++T VA+K + S P L E + K L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLES-FE 59
Query: 65 IPNIKWYGVDGEDNVLVLD-LLGPSLE--------------DLFVYCRR----KFSLKTV 105
PNI V +LD GP + DL Y + +T+
Sbjct: 60 HPNI----------VRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETI 109
Query: 106 LMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
L Q++ ++++HS +HRD+KP N L+ QV I DFGLA+ Y
Sbjct: 110 KDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG---QVKIADFGLARIY 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 42/165 (25%), Positives = 81/165 (49%), Gaps = 37/165 (22%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEA-KVYKILQGGSGIPN 67
+++ ++G G +G++FLA DT EIVA+K LL++ +V +L +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKK-----SLLFKLNEVRHVLTERDILTT 57
Query: 68 IK--WYGVDGEDNVLVLDLLGPSLEDLFVYCRRKF----SLKTVL----MLAD------- 110
K W ++ LL +D ++Y ++ +T+L +L++
Sbjct: 58 TKSEW----------LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYM 107
Query: 111 -QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+M ++ +H G++HRD+KP+NFL+ + + + DFGL+K
Sbjct: 108 AEMFEAVDALHELGYIHRDLKPENFLID---ASGHIKLTDFGLSK 149
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 46/173 (26%), Positives = 76/173 (43%), Gaps = 28/173 (16%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQL--LYEAKVYKILQGGSGI 65
YK+ KIG G+F E+ A T + A+K ++ Q+ L E + + L S
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRL---SPH 57
Query: 66 PNIKWYGVDGEDNV---------LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
PNI + + + LV +L+ +L +L +R K V Q++ +
Sbjct: 58 PNI----LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSL 113
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
+++H G HRDIKP+N L+ K + + + DFG + PY E
Sbjct: 114 DHMHRNGIFHRDIKPENILI----KDDILKLADFGSCR-----GIYSKPPYTE 157
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 52/162 (32%), Positives = 75/162 (46%), Gaps = 33/162 (20%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQ----LLYEA------KV 55
+ IG G+FGE+ L VDTN + A+K + + H + +L EA K+
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 56 YKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
Y Q + + Y + G D + +L LG EDL +F + L A
Sbjct: 67 YYSFQDKDNLYFVMDY-IPGGDMMSLLIRLGIFEEDL-----ARFYIAE-LTCA------ 113
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
IE VH GF+HRDIKPDN L+ + + + DFGL +R
Sbjct: 114 IESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFR 152
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 73/275 (26%), Positives = 111/275 (40%), Gaps = 34/275 (12%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGTKHPQLLYEAKVYKILQGGS 63
+++ +KIG G F E++ A+ + VA+K + E + K L
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH-- 61
Query: 64 GIPN-IKWYGVDGEDNVLVLDLLGPSLEDL------FVYCRRKFSLKTVLMLADQMIARI 116
PN IK+Y EDN L + L DL F +R KTV Q+ + +
Sbjct: 62 --PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 117 EYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
E++HSR +HRDIKP N F+ G V + D GL + + TT H +L G
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAH-------SLVG 168
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
T Y S + + D+ SLG +L P+ G K +C+K
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-----DKMNLYSLCKKIEQC 223
Query: 236 PIEVLCKSH-PAEFASYFHYCQSLTFDQRPDYGFL 269
L H E + C + ++RPD ++
Sbjct: 224 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 37/169 (21%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHP-QLLYEAKVYKILQGGSGI 65
KL R IG G++G ++ A + EIVA V+++N P L E + L+
Sbjct: 11 KLNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRH---- 65
Query: 66 PNIKWYGVDGEDNVLVLDLL-GPSLEDLFV---YCR-----------RKFSLKTVLMLAD 110
PNI V + +++ G L+ +F+ YC FS V L
Sbjct: 66 PNI----------VELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLML 115
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
Q++ ++Y+H +HRD+K N L+ + I DFGLA+ Y P
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYGLP 161
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAV-KIENSGT----KHPQLLYEAKVYKILQGGSGIPN- 67
+IG GSFG ++ A++ TNE+VAV K+ SG K ++ E K + L+ PN
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH----PNT 83
Query: 68 IKWYGVDGEDNV--LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
I++ G +++ LV++ S DL ++ + + + + Y+HS +
Sbjct: 84 IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167
HRDIK N L+ + QV + DFG A K + PY
Sbjct: 144 HRDIKAGNILL---TEPGQVKLADFGSASKSSPANSFVGTPY 182
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 1e-08
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 18/210 (8%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGSG 64
KY KIG G+ G +F A V T + VA+K N K P+ ++ E V K L+ +
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINL-QKQPKKELIINEILVMKELKNPNI 78
Query: 65 IPNIKWYGVDGEDNVLVLDLLGPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHSRG 123
+ + + V E V++ L G SL D+ C + + V + + +E++H+
Sbjct: 79 VNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRECLQALEFLHANQ 135
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
+HRDIK DN L+G+ V + DFG + + R + GT + +
Sbjct: 136 VIHRDIKSDNVLLGM---DGSVKLTDFGFCAQITPEQSKR-------STMVGTPYWMAPE 185
Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
+ D+ SLG + + + G P+
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 70/273 (25%), Positives = 124/273 (45%), Gaps = 29/273 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
+L K+G G FGE+++ + T + VA+K GT P+ L EA++ K L+ +P
Sbjct: 9 RLDVKLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVP-- 65
Query: 69 KWYGVDGEDNV-LVLDLLGP-SLEDLFVYCRRKF-SLKTVLMLADQMIARIEYVHSRGFL 125
Y V E+ + +V + +G SL D K+ L ++ +A Q+ + Y+ ++
Sbjct: 66 -LYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYI 124
Query: 126 HRDIKPDNFLMGLGRKANQV-YIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCN 183
HRD++ N L+G N V I DFGLA+ D N + + K + TA A+
Sbjct: 125 HRDLRAANILVG----DNLVCKIADFGLARLIED---NEYTARQGAKFPIKWTAPEAALY 177
Query: 184 THLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
I + D+ S G +L + +G +P+ G+ ++ +++ E+ P C
Sbjct: 178 GRFTI----KSDVWSFGILLTELVTKGRVPYPGM---VNREVLEQV-ERGYRMPCPQGC- 228
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275
P C D+RP + +++ D
Sbjct: 229 --PESLHELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 12/168 (7%)
Query: 10 KLGRKIGSGSFGEIFL----ASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI 65
K R +G G FG++ L ++ T E+VAVK K IL+
Sbjct: 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66
Query: 66 PNIKWYGV--DGEDNVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSR 122
+K+ G + L L + L L Y + K +L +L+ A Q+ + Y+HS+
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
++HRD+ N L+ V I DFGLAK P + + RE+
Sbjct: 127 HYIHRDLAARNVLL---DNDRLVKIGDFGLAKAV--PEGHEYYRVRED 169
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 42/147 (28%), Positives = 68/147 (46%), Gaps = 7/147 (4%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
KY KIG G+ G ++ A V T + VA+K N K ++ E V + + + +
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79
Query: 66 PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
+ Y V E V++ L G SL D+ + + + + +E++HS +
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVI 137
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGL 152
HRDIK DN L+G+ V + DFG
Sbjct: 138 HRDIKSDNILLGMD---GSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 61/246 (24%), Positives = 99/246 (40%), Gaps = 37/246 (15%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGS 63
Y++ IG GSFG + +I+ K + G + QL+ E + + L+
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKH-- 58
Query: 64 GIPNI-KWYG--VDGEDNVLVLDL---LGPSLEDLFVYCRRKFSL---KTVLMLADQMIA 114
PNI ++Y +D + L + + G L L C+++ + + + Q++
Sbjct: 59 --PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 115 RIEYVHSRG-----FLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
+ H+R LHRD+KP N FL N V + DFGLAK ++
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDA----NNNVKLGDFGLAKILGHDSS------- 165
Query: 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228
K GT Y S + + D+ SLG ++ S P+ A + Q KI
Sbjct: 166 FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT---ARNQLQLASKI 222
Query: 229 CEKKVS 234
E K
Sbjct: 223 KEGKFR 228
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 68/272 (25%), Positives = 123/272 (45%), Gaps = 27/272 (9%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
+L +K+G+G FGE+++ + + N VAVK GT P+ L EA++ K L+ +
Sbjct: 9 QLIKKLGNGQFGEVWMGTW-NGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDK---LV 64
Query: 69 KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
+ Y V E+ + ++ G L+ L R L ++ +A Q+ A + Y+ ++
Sbjct: 65 QLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 124
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
HRD++ N L+G G I DFGLA+ D N + + K + TA A+
Sbjct: 125 HRDLRSANILVGDGLVCK---IADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYG 178
Query: 185 HLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
I + D+ S G +L + +G +P+ G+ ++ +++ E+ P C
Sbjct: 179 RFTI----KSDVWSFGILLTELVTKGRVPYPGM---NNREVLEQV-ERGYRMPCPQDC-- 228
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275
P C ++RP + +L+ D
Sbjct: 229 -PISLHELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 15/149 (10%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGGSGIPN 67
R+IG GSFG ++ A V TNE+VA+K + S K ++ E K + ++ PN
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH----PN 86
Query: 68 -IKWYGVDGEDNV--LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
I++ G ++ LV++ S DL ++ + + + + Y+HS
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
+HRDIK N L+ + QV + DFG A
Sbjct: 147 IHRDIKAGNILL---TEPGQVKLADFGSA 172
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 58/227 (25%), Positives = 93/227 (40%), Gaps = 49/227 (21%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT---------KHPQLLYEAKVYKILQGGSGI 65
IG G++G ++ HV T +VA+KI N T + LL + + S
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ-------SQP 61
Query: 66 PNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLM---LADQMIARI----- 116
PNI K+YG L GP L + Y S++T++ +A++ I+ I
Sbjct: 62 PNITKYYGS---------YLKGPRLWIIMEYAEGG-SVRTLMKAGPIAEKYISVIIREVL 111
Query: 117 ---EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
+Y+H G +HRDIK N L+ V + DFG+A ++ R
Sbjct: 112 VALKYIHKVGVIHRDIKAANILV---TNTGNVKLCDFGVAALLNQNSSKR-------STF 161
Query: 174 TGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219
GT + + G + D+ SLG + G+ P+ + A
Sbjct: 162 VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF 208
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 43/135 (31%), Positives = 62/135 (45%), Gaps = 39/135 (28%)
Query: 77 DNVL-VLDLLGPSLEDLFVYCRRKFSLKTVLMLAD---------------------QMIA 114
DNVL LD+L P D F + + T LM +D Q++
Sbjct: 59 DNVLSALDILQPPHIDPF----EEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILR 114
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTNRHIP------- 166
++Y+HS G LHRDIKP N L+ +N + I DFGLA+ +P ++H+
Sbjct: 115 GLKYLHSAGILHRDIKPGNLLV----NSNCVLKICDFGLARV-EEPDESKHMTQEVVTQY 169
Query: 167 YRENKNLTGTARYAS 181
YR + L G+ Y S
Sbjct: 170 YRAPEILMGSRHYTS 184
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 5e-08
Identities = 42/167 (25%), Positives = 82/167 (49%), Gaps = 25/167 (14%)
Query: 9 YKLGRKIGSGSFGEIF-LASHVDTNEIVAVKIENSGTKHPQLLYEAK-----VYKILQGG 62
Y + +GSG+FG ++ + + ++A+K N +P + + + I+
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEIN--VHNPAFGKDKRERDKSIGDIVSEV 59
Query: 63 SGI------PNIKWYG---VDGEDNVLVLDLL-GPSLEDLFVYCRRK---FSLKTVLMLA 109
+ I PNI Y ++ + +V+DL+ G L + F + K F+ + + +
Sbjct: 60 TIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119
Query: 110 DQMIARIEYVHSRGFL-HRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
QM+ + Y+H + HRD+ P+N ++G + ++V I DFGLAK+
Sbjct: 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLG---EDDKVTITDFGLAKQ 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 45/165 (27%), Positives = 81/165 (49%), Gaps = 18/165 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL-------- 59
+Y+ +GSG++G + A + VAVK L++ + Y+ L
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVK--KLSRPFQSLIHARRTYRELRLLKHMKH 73
Query: 60 QGGSGIPNIKWYGVDGED---NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
+ G+ ++ E+ LV +L+G L ++ V C+ K S + V L Q++ +
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNI-VKCQ-KLSDEHVQFLIYQLLRGL 131
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
+Y+HS G +HRD+KP N + + ++ I+DFGLA++ D T
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVN---EDCELRILDFGLARQADDEMT 173
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 23/206 (11%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG- 72
+IG GSFGE+F T ++VA+KI + ++ + +L K+YG
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 73 -VDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129
+ G ++++ L G +L+ L +F + T+L +++ ++Y+HS +HRDI
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATML---KEILKGLDYLHSEKKIHRDI 127
Query: 130 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE 189
K N L+ + V + DFG+A + D R GT + + I+
Sbjct: 128 KAANVLLS---EQGDVKLADFGVAGQLTDTQIKR-------NTFVGTPFWMAPEV---IQ 174
Query: 190 QSRRD---DLESLGYVLLYFLRGSLP 212
QS D D+ SLG + +G P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 8e-08
Identities = 47/152 (30%), Positives = 72/152 (47%), Gaps = 25/152 (16%)
Query: 73 VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 132
V+G D +L +G L V R + +TVL L EY+H+ G +HRD+KPD
Sbjct: 83 VEGGDCATLLKNIGA----LPVDMARMYFAETVLAL--------EYLHNYGIVHRDLKPD 130
Query: 133 NFLM-GLGRKANQVYIIDFGLAK-KYRDPTTNRHIPYRE-------NKNLTGTARYASCN 183
N L+ +G + + DFGL+K TTN + + E +K + GT Y +
Sbjct: 131 NLLITSMG----HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE 186
Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
L + D ++G +L FL G +P+ G
Sbjct: 187 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 8e-08
Identities = 24/146 (16%), Positives = 57/146 (39%), Gaps = 12/146 (8%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWY 71
+ + G ++L +E +KI S K E + ++L +P +
Sbjct: 4 KLLKGGLTNRVYLLG--TKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 72 GVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 130
G + L+++ + G +L+++ + + + +++A++ + H D+
Sbjct: 62 GESDGWSYLLMEWIEGETLDEV-----SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLH 116
Query: 131 PDNFLMGLGRKANQVYIIDFGLAKKY 156
P N L+ + IID+ A
Sbjct: 117 PGNILV---DDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 9e-08
Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 37/213 (17%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV 73
KIG GSFGE+F T ++VA+KI + ++ + +L K+YG
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 74 DGEDNVL-----------VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
+D L LDLL P D + + T+L +++ ++Y+HS
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILR---EILKGLDYLHSE 120
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
+HRDIK N L+ + +V + DFG+A + D R+ GT + +
Sbjct: 121 KKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMAP 170
Query: 183 NTHLGIEQSRRD---DLESLGYVLLYFLRGSLP 212
I+QS D D+ SLG + +G P
Sbjct: 171 EV---IKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIEN-SGTKHPQLLY-EAKVYKILQGGSGIPNIKWY 71
KIG GS G + +A + VAVK+ + + +LL+ E + + Q + + K Y
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 72 GVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 131
V E VL+ L G +L D+ R + + + + + ++ + Y+HS+G +HRDIK
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145
Query: 132 DNFLMGL-GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ 190
D+ L+ L GR V + DFG + ++ +P R K+L GT + +
Sbjct: 146 DSILLTLDGR----VKLSDFGFCAQ-----ISKDVPKR--KSLVGTPYWMAPEVISRTPY 194
Query: 191 SRRDDLESLGYVLLYFLRGSLPW 213
D+ SLG +++ + G P+
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 52/191 (27%), Positives = 85/191 (44%), Gaps = 33/191 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQ--LLYEAKVYKILQGGS 63
KY+ +G GS+G + H +T +IVA+K +E+ K + + E ++ K L+ +
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 64 GIPNI-------KWYGVDGEDNVLVLDLLGPS-LEDLFVYCRRKFSLKTVLMLADQMIAR 115
+ I + Y LV + + + L+DL Y V Q++
Sbjct: 62 LVNLIEVFRRKKRLY--------LVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRG 112
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-------YRDPTTNRHIPYR 168
IE+ HS +HRDIKP+N L+ ++ V + DFG A+ Y D R YR
Sbjct: 113 IEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYTDYVATRW--YR 167
Query: 169 ENKNLTGTARY 179
+ L G +Y
Sbjct: 168 APELLVGDTKY 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 73/277 (26%), Positives = 117/277 (42%), Gaps = 56/277 (20%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI-----PN 67
KIG G+FG+++ + N VAVK T L + K K LQ + PN
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVK-----TCRSTLPPDLKR-KFLQEAEILKQYDHPN 53
Query: 68 I-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRK---FSLKTVLMLADQMIARIEYVHS 121
I K GV + +V++L+ L + R+K ++K +L ++ A +EY+ S
Sbjct: 54 IVKLIGVCVQKQPIYIVMELV--PGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES 111
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-----YRDPTTNRHIPYR----ENKN 172
+ +HRD+ N L+G N + I DFG++++ Y + IP + E N
Sbjct: 112 KNCIHRDLAARNCLVGEN---NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN 168
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICE 230
RY S D+ S G +LL+ F G P+ G+ + +Q ++I E
Sbjct: 169 ---YGRYTS-----------ESDVWSYG-ILLWETFSLGDTPYPGM---SNQQTRERI-E 209
Query: 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 267
P LC P E C + + RP +
Sbjct: 210 SGYRMPAPQLC---PEEIYRLMLQCWAYDPENRPSFS 243
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 45/150 (30%), Positives = 72/150 (48%), Gaps = 9/150 (6%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNIK- 69
+ +G G+FGE+ LA VDT+ + A+K + Q+ + IL +K
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 70 WYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHR 127
+Y +DN+ V+D + P + + + R + F ++ IE VH GF+HR
Sbjct: 67 YYSFQDKDNLYFVMDYI-PGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR 125
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
DIKPDN L+ L + + DFGL +R
Sbjct: 126 DIKPDNILIDLD---GHIKLTDFGLCTGFR 152
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 69/272 (25%), Positives = 112/272 (41%), Gaps = 47/272 (17%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL----LYEAKVYKILQGGSGIPNI- 68
+IG G+FGE+F N VAVK T P L L EA++ K PNI
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVK-SCRETLPPDLKAKFLQEARILKQYSH----PNIV 56
Query: 69 KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRR---KFSLKTVLMLADQMIARIEYVHSRG 123
+ GV + +V++L+ D + R + +K ++ + + A +EY+ S+
Sbjct: 57 RLIGVCTQKQPIYIVMELVQGG--DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH 114
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN-----RHIPYR-ENKNLTGTA 177
+HRD+ N L+ + N + I DFG++++ D + IP +
Sbjct: 115 CIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEKKVST 235
RY+S D+ S G +LL+ F G++P+ A Q+ + E+ V
Sbjct: 172 RYSS-----------ESDVWSFG-ILLWEAFSLGAVPY----ANLSNQQTREAIEQGVRL 215
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 267
P LC P C QRP +
Sbjct: 216 PCPELC---PDAVYRLMERCWEYDPGQRPSFS 244
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 29/238 (12%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSG-----IPN 67
IG G+FG+++ DT I A+K+ + ++ + IL I
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 68 IKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFL 125
+K+ D LV D + S +LF + ++ +FS +++ +E++H +
Sbjct: 61 LKFSFQTDSDLYLVTDYM--SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPTTNRHIPYRENKNLTGTARYASCN 183
+RD+KP+N L+ + + DFGL+K + TTN GT Y +
Sbjct: 119 YRDLKPENILLD---ATGHIALCDFGLSKANLTDNKTTN---------TFCGTTEYLAPE 166
Query: 184 THLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
L + ++ D SLG ++ G W A +Q Y I KV P VL
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCG---WSPFYAEDTQQMYRNIAFGKVRFPKNVL 221
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 48/164 (29%), Positives = 68/164 (41%), Gaps = 45/164 (27%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQL-LYEAKVYKILQGGSGIPNI- 68
KIG G++G ++ A T EIVA+K +E P + E + K L PNI
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNH----PNIV 61
Query: 69 KWYGVDGEDNVLVL-------DL-----------LGPSLEDLFVYCRRKFSLKTVLMLAD 110
+ V +N L L DL L P L ++Y
Sbjct: 62 RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLY--------------- 106
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Q++ I Y HS LHRD+KP N L+ + + + DFGLA+
Sbjct: 107 QLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 51/221 (23%), Positives = 101/221 (45%), Gaps = 30/221 (13%)
Query: 9 YKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT--------KHPQLLYEAKVYK 57
++L R +G+G++G++FL V D ++ A+K+ T +H + E +V +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRT--ERQVLE 59
Query: 58 ILQGGSGIPNIKW-YGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLMLADQMIA 114
++ + + + + D + + L+LD + +LF +Y R F+ V + +++
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLH-LILDYVNGG--ELFTHLYQREHFTESEVRVYIAEIVL 116
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
++++H G ++RDIK +N L+ V + DFGL+K++ R +
Sbjct: 117 ALDHLHQLGIIYRDIKLENILLD---SEGHVVLTDFGLSKEFLAEEEERAYSF------C 167
Query: 175 GTARYASCNTHLGIEQSRRD--DLESLGYVLLYFLRGSLPW 213
GT Y + G D SLG + L G+ P+
Sbjct: 168 GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 70/237 (29%), Positives = 101/237 (42%), Gaps = 22/237 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEA-KVYKILQGGSGIP 66
+Y++ +KIG GSFG+I+LA +E +K E TK P EA K IL P
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIK-EIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 67 NI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK----FSLKTVLMLADQMIARIEYVHS 121
NI ++ E+ L + + DL R+ FS +L Q+ ++++H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 122 RGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
R LHRDIK N FL G A + DFG+A++ D GT Y
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAK---LGDFGIARQLNDSM-------ELAYTCVGTPYYL 169
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
S + + D+ SLG VL P++G Q KIC+ + PI
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG---NNLHQLVLKICQGYFA-PI 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 16/209 (7%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
KY KIG G+ G ++ A V T + VA++ N K ++ E V + + + +
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 66 PNIKWYGVDGEDNVLVLDLLGPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
+ Y V E V++ L G SL D+ C + + V + + +E++HS
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALEFLHSNQV 137
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
+HRDIK DN L+G+ V + DFG + + R + GT + +
Sbjct: 138 IHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKR-------STMVGTPYWMAPEV 187
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
+ D+ SLG + + + G P+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 40/149 (26%), Positives = 70/149 (46%), Gaps = 15/149 (10%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGGSGIPN 67
R+IG GSFG ++ A V +E+VA+K + S K ++ E + + L+ PN
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH----PN 76
Query: 68 -IKWYGVDGEDNV--LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
I++ G ++ LV++ S DL ++ + + + + Y+HS
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
+HRD+K N L+ + V + DFG A
Sbjct: 137 IHRDVKAGNILL---SEPGLVKLGDFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 20/159 (12%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
YKLG IG+GSFG ++ A +DT+E VA+K + PQ Y+ + I++ + I I
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIK---KVLQDPQ--YKNRELLIMKNLNHINII 122
Query: 69 ---KWYGVD----GEDNV---LVLDLLGPSLEDLF-VYCRRKFSLKTVL--MLADQMIAR 115
+Y + E N+ +V++ + ++ Y R +L L + + Q+
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+ Y+HS+ HRD+KP N L + + + + DFG AK
Sbjct: 183 LAYIHSKFICHRDLKPQNLL--IDPNTHTLKLCDFGSAK 219
|
Length = 440 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 46/145 (31%), Positives = 72/145 (49%), Gaps = 13/145 (8%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNIK-WY 71
IG G+FGE+ L DT I A+KI + + Q+ + IL G +K +Y
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68
Query: 72 GVDGEDNV-LVLDLLGPSLEDLFVYCRRKFSL---KTVLMLADQMIARIEYVHSRGFLHR 127
+ N+ L+++ L D+ +K +L T +A+ ++A I+ +H GF+HR
Sbjct: 69 SFQDKRNLYLIMEFLPGG--DMMTLLMKKDTLSEEATQFYIAETVLA-IDAIHQLGFIHR 125
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGL 152
DIKPDN L+ V + DFGL
Sbjct: 126 DIKPDNLLLD---AKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 12/155 (7%)
Query: 13 RKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
R +G G FG++ L + +T E VAVK + + K +IL+ +
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 69 KWYGVDGEDN----VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
K+ G+ ED L+++ L SL++ + K +LK L A Q+ ++Y+ SR
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
++HRD+ N L+ +QV I DFGL K
Sbjct: 130 YVHRDLAARNVLV---ESEHQVKIGDFGLTKAIET 161
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 9/150 (6%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNIK- 69
+ +G G+FGE+ LA VDT + A+K + Q+ + IL ++
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 70 WYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHR 127
+Y +DN+ V+D + P + + + R F ++ +E VH GF+HR
Sbjct: 67 YYSFQDKDNLYFVMDYI-PGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
DIKPDN L+ + + + DFGL +R
Sbjct: 126 DIKPDNILID---RDGHIKLTDFGLCTGFR 152
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 20/158 (12%)
Query: 10 KLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGG 62
K +++G G FG++ L + +T E VAVK N + E ++ + L
Sbjct: 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDH- 65
Query: 63 SGIPNI-KWYGV---DGEDNV-LVLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARI 116
NI K+ GV G ++ L+++ L SL D R + +LK +L+ + Q+ +
Sbjct: 66 ---ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+Y+ S+ ++HRD+ N L+ + V I DFGLAK
Sbjct: 123 DYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 48/176 (27%), Positives = 71/176 (40%), Gaps = 58/176 (32%)
Query: 8 KY-KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL----LYEAKVYKILQGG 62
KY KL KIG GS+G +F + +T +IVA+K P + L E ++ K L+
Sbjct: 2 KYEKLS-KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH- 59
Query: 63 SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD------------ 110
PN LV +L ++F RRK L V D
Sbjct: 60 ---PN------------LV------NLIEVF---RRKRKLHLVFEYCDHTVLNELEKNPR 95
Query: 111 ------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Q + + + H +HRD+KP+N L+ K Q+ + DFG A+
Sbjct: 96 GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 51/153 (33%), Positives = 81/153 (52%), Gaps = 21/153 (13%)
Query: 15 IGSGSFGEIFLASHV----DTNEIVAVK-IENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
+G G+FG + L + +T E+VAVK +++S +H + E ++ K LQ NI
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQH----DNI 67
Query: 69 -KWYGV---DGEDNV-LVLDLLGP--SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
K+ GV G N+ LV++ L P SL D R + + +L+ A Q+ +EY+ S
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYL-PYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+ ++HRD+ N L+ N+V I DFGL K
Sbjct: 127 KRYVHRDLATRNILV---ESENRVKIGDFGLTK 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 6e-07
Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 15/152 (9%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPN- 67
KLG IG G FG++ L + + VAVK +++ T L EA V L+ PN
Sbjct: 9 KLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRH----PNL 62
Query: 68 IKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK----FSLKTVLMLADQMIARIEYVHSRG 123
++ GV + N L + + L Y R + +L L A + +EY+ +
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
F+HRD+ N L+ + + DFGLAK+
Sbjct: 123 FVHRDLAARNVLVS---EDLVAKVSDFGLAKE 151
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 67/287 (23%), Positives = 113/287 (39%), Gaps = 64/287 (22%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSGIPNI-KW 70
IG G+FG + H + I+AVK + +LL + V S P I K+
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVM---RSSDCPYIVKF 68
Query: 71 YGV---DGEDNVLVLDLLGPSLEDL--FVYCRRKFSLKTVLMLADQMIARIEYVHSRGF- 124
YG +G D + ++L+ SL+ +VY K ++ ++++ +I +
Sbjct: 69 YGALFREG-DCWICMELMDISLDKFYKYVYEVLK------SVIPEEILGKIAVATVKALN 121
Query: 125 --------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
+HRD+KP N L L R N + + DFG++ + D
Sbjct: 122 YLKEELKIIHRDVKPSNIL--LDRNGN-IKLCDFGISGQLVDSIAK-------------- 164
Query: 177 ARYASCNTHLG---IEQSRRD------DLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227
R A C ++ I+ S RD D+ SLG L G P+ + +D+
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-----FDQ 219
Query: 228 ICEKKVSTPIEVLCKSHPAEFA----SYFHYCQSLTFDQRPDYGFLK 270
+ + V +L S EF+ ++ + C +RP Y L
Sbjct: 220 LTQ-VVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELL 265
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 6e-07
Identities = 39/149 (26%), Positives = 77/149 (51%), Gaps = 11/149 (7%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
KL +K+G+G FGE+++ + + + VA+K G+ P+ L EA + K LQ +
Sbjct: 9 KLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPR---LV 64
Query: 69 KWYGVDGEDNVLVLD--LLGPSLED-LFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
+ Y V ++ + ++ + SL D L K ++ ++ +A Q+ + ++ + ++
Sbjct: 65 RLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI 124
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
HRD++ N L+ + I DFGLA+
Sbjct: 125 HRDLRAANILVS---ETLCCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 23/212 (10%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----LLYEAKVYKILQGGSGIPN 67
+ +G GSFG++FLA TN+ A+K + E +V + + +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 68 IKWYGVDGEDNVLVLDLLGPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFL 125
+ E+ V++ L DL + + KF L A ++I ++++HS+G +
Sbjct: 61 LYCTFQTKENLFFVMEYLNGG--DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPTTNRHIPYRENKNLTGTARYASCN 183
+RD+K DN L+ + I DFG+ K+ D T GT Y +
Sbjct: 119 YRDLKLDNILLD---TDGHIKIADFGMCKENMLGDAKTC---------TFCGTPDYIAPE 166
Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
LG + + D S G +L L G P+ G
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 59/232 (25%), Positives = 104/232 (44%), Gaps = 27/232 (11%)
Query: 15 IGSGSFGEIFLASHV---DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIK-- 69
+G GSFG++FL + D ++ A+K+ T + K+ + + P I
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 70 WYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFLH 126
Y E + L+LD L DLF ++ F+ + V ++ ++++HS G ++
Sbjct: 64 HYAFQTEGKLYLILDFLRGG--DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK--NLTGTARYASCNT 184
RD+KP+N L+ + + + DFGL+K+ D E K + GT Y +
Sbjct: 122 RDLKPENILLD---EEGHIKLTDFGLSKESID---------HEKKAYSFCGTVEYMAPEV 169
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
++ D S G ++ L GSLP+QG +K+ I + K+ P
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTGSLPFQG---KDRKETMTMILKAKLGMP 218
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 8e-07
Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 35/157 (22%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
IG G+FGE+ L DT +I A+K +++ K QL + K + + S P W
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAH-VKAERDVLAESDSP---W-- 62
Query: 73 VDGEDNVLVLDLLGPSLEDLFVYCRRKF----SLKTVLMLAD------------QMIARI 116
V+ L + ++Y +F L T+L+ D + + I
Sbjct: 63 --------VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAI 114
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
E VH GF+HRDIKPDN L+ + + + DFGL+
Sbjct: 115 EAVHKLGFIHRDIKPDNILID---RGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 8e-07
Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 16/209 (7%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
KY KIG G+ G ++ A + T + VA+K N K ++ E V + + + +
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79
Query: 66 PNIKWYGVDGEDNVLVLDLLGPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
+ Y V E V++ L G SL D+ C + + V + + ++++HS
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALDFLHSNQV 136
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
+HRDIK DN L+G+ V + DFG + + R + GT + +
Sbjct: 137 IHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKR-------STMVGTPYWMAPEV 186
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
+ D+ SLG + + + G P+
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 8e-07
Identities = 46/167 (27%), Positives = 73/167 (43%), Gaps = 39/167 (23%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYK---------- 57
KY++ +K+G G++G ++ A T E+VA+K K++
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALK---------------KIFDAFRNATDAQR 52
Query: 58 ------ILQGGSGIPNI-KWYGVDGEDNVLVLDLLGPSLE-DLFVYCRRKFSLKTVLM-- 107
LQ PNI K V +N + L+ +E DL R L+ V
Sbjct: 53 TFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANI-LEDVHKRY 111
Query: 108 LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+ Q++ ++Y+HS +HRD+KP N L L V + DFGLA+
Sbjct: 112 IMYQLLKALKYIHSGNVIHRDLKPSNIL--LNSDCR-VKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 21/50 (42%), Positives = 30/50 (60%), Gaps = 1/50 (2%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDP 159
Q++ + Y+HS LHRD+KP N +MG G + V I D GLA+ + P
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 9e-07
Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 28/159 (17%)
Query: 11 LGRKIGSGSFGEIFLASHVD-TNEIVAV-----KIENSGTKHPQLLYEAKVYKILQGGSG 64
LGR IG G FG+++ ++ NE +AV K S + + L EA + +
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH--- 66
Query: 65 IPNI-KWYGVDGEDNV-LVLDL-----LGPSLEDLFVYCRRKFSLK--TVLMLADQMIAR 115
P+I K GV E+ V +V++L L L+ K+SL ++++ + Q+
Sbjct: 67 -PHIVKLIGVITENPVWIVMELAPLGELRSYLQ------VNKYSLDLASLILYSYQLSTA 119
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+ Y+ S+ F+HRDI N L+ + V + DFGL++
Sbjct: 120 LAYLESKRFVHRDIAARNVLVS---SPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 9e-07
Identities = 47/169 (27%), Positives = 82/169 (48%), Gaps = 22/169 (13%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIEN-SGTKHPQLLY-EAKVYKILQGGSGIPNI--- 68
KIG GS G + +A+ T VAVK + + +LL+ E + + Q PNI
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQH----PNIVEM 81
Query: 69 -KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 127
Y V E V++ L G +L D+ + R + + + + ++ + ++H++G +HR
Sbjct: 82 YSSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLHAQGVIHR 139
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
DIK D+ L+ +V + DFG + ++ +P R K+L GT
Sbjct: 140 DIKSDSILL---TSDGRVKLSDFGFCAQ-----VSKEVPRR--KSLVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 41/149 (27%), Positives = 70/149 (46%), Gaps = 15/149 (10%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----LLYEAKVYKILQGGSGIPN 67
R+IG GSFG ++ A V TNE+VA+K + K ++ E + + L+ PN
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH----PN 76
Query: 68 -IKWYGVDGEDNV--LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
I++ G ++ LV++ S D+ ++ + + + + Y+HS
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
+HRDIK N L+ + V + DFG A
Sbjct: 137 IHRDIKAGNILL---TEPGTVKLADFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 13 RKIGSGSFGEIFLASHVDTN-EIVAVK-IENSGT-KHPQLLYEAKVYKILQGGSGIPNIK 69
R +G+GSFG + LA++ + + VA+K E S K Q+ + KIL + +
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 70 WYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHR 127
YG +++ L L L + F + RR +F A Q++ EY+ S ++R
Sbjct: 96 LYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYR 155
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
D+KP+N L+ K + + DFG AK + L GT Y + L
Sbjct: 156 DLKPENLLLD---KDGFIKMTDFGFAK----------VVDTRTYTLCGTPEYIAPEILLN 202
Query: 188 IEQSRRDDLESLGYVLLYFLRGSLPW 213
+ + D +LG + L G P+
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 23/154 (14%)
Query: 11 LGRKIGSGSFGEIFLA---SHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIP 66
+++GSG FG + L +D VA+K+ G + EAKV L P
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKID----VAIKMIREGAMSEDDFIEEAKVMMKLSH----P 59
Query: 67 N-IKWYGVDGEDN--VLVLDLLGPSLEDLFVYCRR---KFSLKTVLMLADQMIARIEYVH 120
N ++ YGV + +V + + + L Y R K + +L + + +EY+
Sbjct: 60 NLVQLYGVCTKQRPIFIVTEYM--ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
S GF+HRD+ N L+G + N V + DFGLA+
Sbjct: 118 SNGFIHRDLAARNCLVG---EDNVVKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 24/217 (11%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQ---LLYEAKVYKILQGGSGIPNI-- 68
IG G FGE++ DT ++ A+K ++ K Q L ++ L P I
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 69 KWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFL 125
Y D + +LDL+ DL + + FS + A ++I +E++H+R +
Sbjct: 62 MSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT- 184
+RD+KP N L+ + V I D GLA + ++ P+ GT Y +
Sbjct: 120 YRDLKPANILLD---EHGHVRISDLGLACDF-----SKKKPHAS----VGTHGYMAPEVL 167
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK 221
G+ D SLG +L LRG P++ K K
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 55/235 (23%), Positives = 88/235 (37%), Gaps = 73/235 (31%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-----------------IENS----GTKHPQLL--- 50
+G GSFG++ LA TNE A+K +E +HP L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 51 --YEAK-----VYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLK 103
++ K V + L GG + +I+ G +F
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHIQSSG--------------------------RFDEA 96
Query: 104 TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPTT 161
A ++I ++++H +G ++RD+K DN L+ K + I DFG+ K+ +
Sbjct: 97 RARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD---KDGHIKIADFGMCKENMNGEGKA 153
Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQG 215
+ GT Y + G + + D S G VLLY L G P+ G
Sbjct: 154 S---------TFCGTPDYIAPEILKGQKYNESVDWWSFG-VLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 70/288 (24%), Positives = 123/288 (42%), Gaps = 48/288 (16%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG 64
+ +Y+ +GSG++G + + DT + V ++ +++ + Y+ L+
Sbjct: 15 VPERYQNLSPVGSGAYGSV--CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL--- 69
Query: 65 IPNIKWYGVDG--------------EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD 110
+ ++K V G D LV L+G L ++ V C+ K + V L
Sbjct: 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIY 127
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
Q++ ++Y+HS +HRD+KP N + + ++ I+DFGLA+ D T
Sbjct: 128 QILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT--------- 175
Query: 171 KNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229
T Y + L + ++ D+ S+G ++ L G + G T K+
Sbjct: 176 -GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLI 230
Query: 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277
+ V TP L K +E A +Y QSLT Q P K F ++F
Sbjct: 231 LRLVGTPGAELLKKISSESAR--NYIQSLT--QMP-----KMNFANVF 269
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 41/163 (25%), Positives = 68/163 (41%), Gaps = 45/163 (27%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD 74
IG G+FGE+ L DT I A+K + ++L + +V V
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKK----LRKSEMLEKEQVAH---------------VR 49
Query: 75 GEDNVL-------VLDLLGPSLEDLFVYCRRKF----SLKTVLMLAD------------Q 111
E ++L V+ L ++ ++Y ++ + T+LM D +
Sbjct: 50 AERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAE 109
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
I I+ +H G++HRDIKPDN L+ + + DFGL
Sbjct: 110 TILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 51/203 (25%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLY-EAKVYKILQGGSGIPNIKWY 71
KIG GS G + +A+ T + VAVK ++ + +LL+ E + + + + Y
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 72 GVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 130
V E V++ L G +L D+ + R + + TV + ++ + Y+H++G +HRDIK
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCL---SVLRALSYLHNQGVIHRDIK 145
Query: 131 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ 190
D+ L+ ++ + DFG + ++ +P R K+L GT + + +
Sbjct: 146 SDSILL---TSDGRIKLSDFGFCAQ-----VSKEVPKR--KSLVGTPYWMAPEVISRLPY 195
Query: 191 SRRDDLESLGYVLLYFLRGSLPW 213
D+ SLG +++ + G P+
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 39/218 (17%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKV-------YKILQGGS 63
+IG GSFGE++ T E+VA+KI E + + + E V Y GS
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 64 GIPNIK-WYGVDGEDNVLVLDLLGPS-LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
+ K W ++ LDLL P LE+ ++ T+L +++ ++Y+HS
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLKPGPLEETYI--------ATILR---EILKGLDYLHS 119
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
+HRDIK N L+ + V + DFG+A + D R+ GT + +
Sbjct: 120 ERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMA 169
Query: 182 CNTHLGIEQSRRD---DLESLGYVLLYFLRGSLPWQGL 216
I+QS D D+ SLG + +G P L
Sbjct: 170 PEV---IKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 50/214 (23%), Positives = 94/214 (43%), Gaps = 16/214 (7%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQLLYEAKVYKILQGGSG 64
+ G+++G+G+F + A V T ++AVK + N+ ++ +++ + L
Sbjct: 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61
Query: 65 IPNI-KWYGVDGED---NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
P+I + G ED N+ V + G S+ L + F ++ +Q++ + Y+H
Sbjct: 62 HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHL-LSKYGAFKEAVIINYTEQLLRGLSYLH 120
Query: 121 SRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
+HRD+K N L+ G++ + I DFG A + T L GT +
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQR---LRIADFGAAARLAAKGTGAG---EFQGQLLGTIAF 174
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
+ G + R D+ S+G V++ PW
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 51/185 (27%), Positives = 85/185 (45%), Gaps = 29/185 (15%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQL-LYEAKVYKILQGGSGIPNIK 69
KIG G++G ++ + T +IVA+K +E+ P + E + K LQ PNI
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH----PNI- 61
Query: 70 WYGVDGEDNV-------LVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIARIEYVH 120
V +D + L+ + L L+ + + L+ + Q++ I + H
Sbjct: 62 ---VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT---TNRHIP--YRENKNLTG 175
SR LHRD+KP N L+ + + DFGLA+ + P T+ + YR + L G
Sbjct: 119 SRRVLHRDLKPQNLLID---NKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLG 175
Query: 176 TARYA 180
+ RY+
Sbjct: 176 SPRYS 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 64/274 (23%), Positives = 112/274 (40%), Gaps = 38/274 (13%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY----KILQGG 62
+ ++ G+ +G G+FG ++L VDT +A K + P+ E ++L+
Sbjct: 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 63 SGIPNIKWYGV---DGEDNVLVLD--LLGPSLED-------LFVYCRRKFSLKTVLMLAD 110
+++YG E + + + G S++D L RK++
Sbjct: 62 QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYT--------R 113
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
Q++ + Y+HS +HRDIK N L A V + DFG +K+ + +
Sbjct: 114 QILEGMSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRLQTICMSG----TGI 166
Query: 171 KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230
+++TGT + S G R+ D+ SLG ++ L PW +A KI
Sbjct: 167 RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA---AIFKIAT 223
Query: 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
+ + + SH +E A F C + RP
Sbjct: 224 QPTNPQL----PSHISEHARDFLGCIFVEARHRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 25/225 (11%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKIL 59
V ++LG+ +G G+FGE++L DT +AVK + + + L E ++ K L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 60 QGGSGIPNIKWYGV--DGED---NVLVLDLLGPSLED-LFVYCRRKFSLKTVLMLADQMI 113
+ +++YG D E+ ++ V + G S++D L Y + Q++
Sbjct: 62 RHDR---IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQIL 116
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
+ Y+HS +HRDIK N L A V + DFG +K+ + + K++
Sbjct: 117 QGVSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRIQ----TICMSGTGIKSV 169
Query: 174 TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218
TGT + S G R+ D+ S+ ++ L PW +A
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 58/229 (25%), Positives = 88/229 (38%), Gaps = 22/229 (9%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIK 69
IG GSFG++ LA AVK+ T + ++ E V + +
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 70 WYGVDGEDNVLVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFLHR 127
+ E VLD + +LF + +R+ F A ++ + I Y+HS ++R
Sbjct: 63 YSFQTAEKLYFVLDYVNGG--ELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
D+KP+N L+ V + DFGL K+ +P GT Y +
Sbjct: 121 DLKPENILLD---SQGHVVLTDFGLCKEGVEPEET-------TSTFCGTPEYLAPEVLRK 170
Query: 188 IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
R D LG VL L G P+ + Q YD I K + P
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYDNILHKPLQLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 51/202 (25%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLY-EAKVYKILQGGSGIPNIKWY 71
KIG GS G + +A+ + ++VAVK ++ + +LL+ E + + Q + + Y
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 72 GVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 131
V E V++ L G +L D+ + R + LA ++ + +H++G +HRDIK
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA--VLKALSVLHAQGVIHRDIKS 144
Query: 132 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQS 191
D+ L+ +V + DFG + ++ +P R K+L GT + + +
Sbjct: 145 DSILL---THDGRVKLSDFGFCAQ-----VSKEVPRR--KSLVGTPYWMAPELISRLPYG 194
Query: 192 RRDDLESLGYVLLYFLRGSLPW 213
D+ SLG +++ + G P+
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 47/171 (27%), Positives = 82/171 (47%), Gaps = 18/171 (10%)
Query: 1 MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKI 58
MER I +K+KLG G +GE++ + VAVK ++ + + L EA V K
Sbjct: 3 MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 58
Query: 59 LQGGSGIPN-IKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLML--ADQMI 113
++ PN ++ GV + + + +L Y R + + V++L A Q+
Sbjct: 59 IKH----PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 114
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
+ +EY+ + F+HRD+ N L+G + + V + DFGL++ T H
Sbjct: 115 SAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 162
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 13/106 (12%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI-PYRE 169
QM+ I+++HS G +HRD+KP N ++ + + I+DFGLA R TN + PY
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA---RTACTNFMMTPY-- 182
Query: 170 NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
T Y + LG+ D+ S+G ++ ++GS+ +QG
Sbjct: 183 ----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY------KILQGGSG--IP 66
+G G FGE+ + T +I A+K+ K LL + V IL + IP
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKV----MKKSVLLAQETVSFFEEERDILSISNSPWIP 64
Query: 67 NIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
+++ D ++ LV++ G L L +F +++ I VH G++
Sbjct: 65 QLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYV 124
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKY-RDPTTNRHIP 166
HRDIKP+N L+ + + + DFG A + + N +P
Sbjct: 125 HRDIKPENVLID---RTGHIKLADFGSAARLTANKMVNSKLP 163
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 11/153 (7%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
KL +K+G+G FGE+++A++ + + VAVK G+ + L EA V K LQ +
Sbjct: 9 KLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDK---LV 64
Query: 69 KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
K + V ++ + ++ G L+ L K L ++ + Q+ + ++ R ++
Sbjct: 65 KLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 124
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
HRD++ N L+ + I DFGLA+ D
Sbjct: 125 HRDLRAANILVS---ASLVCKIADFGLARVIED 154
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 13/145 (8%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIK-WY 71
IG G+FGE+ L DT + A+KI + Q+ + IL + +K +Y
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68
Query: 72 GVDGEDNV-LVLDLLGPSLEDLFVYCRRKFSL---KTVLMLADQMIARIEYVHSRGFLHR 127
+ N+ L+++ L D+ +K +L +T +A+ ++A I+ +H GF+HR
Sbjct: 69 SFQDKLNLYLIMEFLPGG--DMMTLLMKKDTLTEEETQFYIAETVLA-IDSIHQLGFIHR 125
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGL 152
DIKPDN L+ V + DFGL
Sbjct: 126 DIKPDNLLLD---SKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 45/151 (29%), Positives = 66/151 (43%), Gaps = 17/151 (11%)
Query: 14 KIGSGSFGEIFLA-SHVDTNEI--VAVKIENSG--TKHPQ-LLYEAKVYKILQGGSGIPN 67
K+G GSFG + ++ VAVK S + L EA + L N
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDH----EN 57
Query: 68 -IKWYGVDGEDNV-LVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
I+ YGV + +V +L LG L+ L F + T+ A Q+ + Y+ S+
Sbjct: 58 LIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
F+HRD+ N L+ K V I DFGL +
Sbjct: 118 FIHRDLAARNILLASDDK---VKIGDFGLMR 145
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 32/107 (29%), Positives = 51/107 (47%), Gaps = 8/107 (7%)
Query: 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 139
LV + L L+ C S+ V + Q++ + Y H R LHRD+KP N L+
Sbjct: 80 LVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN-- 137
Query: 140 RKANQVYIIDFGLAKKYRDPT---TNRHIP--YRENKNLTGTARYAS 181
+ ++ + DFGLA+ PT +N + YR L G+ Y++
Sbjct: 138 -EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 28/212 (13%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNI- 68
++G G+ G + +T I A+K + Q+L E ++ K + P I
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKS----PYIV 62
Query: 69 KWYGV-----DGEDNVLVLDLLGPSLEDLFVYCRRK---FSLKTVLMLADQMIARIEYVH 120
K+YG + + G SL+ ++ +++ K + +A+ ++ + Y+H
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
SR +HRDIKP N L+ + QV + DFG++ + + TGT+ Y
Sbjct: 123 SRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVNSLA---------GTFTGTSFYM 170
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
+ G S D+ SLG LL + P
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 64/273 (23%), Positives = 117/273 (42%), Gaps = 34/273 (12%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
+++ IG G++G++F + AVKI + + + EA+ Y IL+ S PN+
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEI-EAE-YNILKALSDHPNV 77
Query: 69 -KWYG-------VDGEDNVLVLDLL-GPSLEDL---FVYCRRKFSLKTVLMLADQMIARI 116
K+YG +G+ LVL+L G S+ DL F+ + + + + + +
Sbjct: 78 VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
+++H +HRD+K +N L+ V ++DFG++ + T+ R R N ++ GT
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQL---TSTRL---RRNTSV-GT 187
Query: 177 ARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231
+ +C L R D+ SLG + G P L K +
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP 247
Query: 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
+ P + EF + C + +++RP
Sbjct: 248 TLHQP-----ELWSNEFNDFIRKCLTKDYEKRP 275
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 12/176 (6%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSGIPNIKW 70
K+G G++ +F T +VA+K +E+ + E + K L+ + +
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 71 YGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 130
D + LV + L L+ C S+ V + Q++ + Y H R LHRD+K
Sbjct: 73 VHTD-KSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLK 131
Query: 131 PDNFLMGLGRKANQVYIIDFGLAKKYRDPT---TNRHIP--YRENKNLTGTARYAS 181
P N L+ + ++ + DFGLA+ PT +N + YR L G++ Y++
Sbjct: 132 PQNLLIN---ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 49/178 (27%), Positives = 77/178 (43%), Gaps = 52/178 (29%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKH---PQLLYEAKVYKILQ 60
+ KY + IG G++G + A + +TNE VA+K I N+ + L E K+ + L
Sbjct: 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL- 61
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLMLAD-------- 110
D E+ + + D++ P + F VY + LM D
Sbjct: 62 -------------DHENVIAIKDIMPPPHREAFNDVY------IVYELMDTDLHQIIRSS 102
Query: 111 -------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK 154
Q++ ++Y+HS LHRD+KP N L+ AN + I DFGLA+
Sbjct: 103 QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL----NANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 19/220 (8%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY----KILQGGSG 64
++LG+ +G G+FG ++L DT +AVK + P+ E ++L+
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 65 IPNIKWYGV--DGEDNVLVL---DLLGPSLED-LFVYCRRKFSLKTVLMLADQMIARIEY 118
+++YG D + L + + G S++D L Y + Q++ + Y
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSY 121
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
+HS +HRDIK N L V + DFG +K+ + + K++TGT
Sbjct: 122 LHSNMIVHRDIKGANILRD---SVGNVKLGDFGASKRLQTIC----LSGTGMKSVTGTPY 174
Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218
+ S G R+ D+ S+G ++ L PW +A
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 40/168 (23%), Positives = 74/168 (44%), Gaps = 21/168 (12%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
Y+ KIG G++G+++ A +T ++VA+K ++ G P L E + ++L
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIP-PTALREISLLQMLSES 60
Query: 63 SGIPNIKWYGVDGEDN-------VLVLDLLGPSLEDLFVYCRRKFS----LKTVLMLADQ 111
I ++ V+ + LV + L L+ R KT+ Q
Sbjct: 61 IYI--VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
++ + + H G +HRD+KP N L + ++ + I D GL + + P
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLL--VDKQKGLLKIADLGLGRAFSIP 164
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 47/198 (23%), Positives = 86/198 (43%), Gaps = 24/198 (12%)
Query: 1 MERIIGVKYK-LGRKIGSGSFGEIFLASHVDTNEIVAVK------IENSGTKHPQL---- 49
M I +Y G +G G++G++ A T +IVA+K I N TK QL
Sbjct: 2 MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMC 61
Query: 50 ------LYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLK 103
L E K+ ++ + + + Y V+G+ LV+D++ L+ + + + +
Sbjct: 62 GIHFTTLRELKIMNEIKHENIMGLVDVY-VEGDFINLVMDIMASDLKKVV-DRKIRLTES 119
Query: 104 TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163
V + Q++ + +H F+HRD+ P N + I DFGLA++Y P +
Sbjct: 120 QVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN---SKGICKIADFGLARRYGYPPYSD 176
Query: 164 HIPYRENKNLTGTARYAS 181
+++ + S
Sbjct: 177 --TLSKDETMQRREEMTS 192
|
Length = 335 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 58/252 (23%), Positives = 91/252 (36%), Gaps = 64/252 (25%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
+ +G GSFG++ LA T+E+ AVK+ ILQ +++
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDV-------------ILQDD----DVECTM 43
Query: 73 VDGEDNVLVLDLLGPSLEDLFV-------------YCR-----------RKFSLKTVLML 108
E VL L P L L Y +F
Sbjct: 44 T--EKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY 101
Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTTNRHI 165
A +++ ++++H RG ++RD+K DN L+ + I DFG+ K+ T
Sbjct: 102 AAEIVLGLQFLHERGIIYRDLKLDNVLLD---SEGHIKIADFGMCKEGILGGVTT----- 153
Query: 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQK 224
GT Y + D +LG VLLY L G P++G + +
Sbjct: 154 -----STFCGTPDYIAPEILSYQPYGPAVDWWALG-VLLYEMLAGQSPFEG---DDEDEL 204
Query: 225 YDKICEKKVSTP 236
+ I E +V P
Sbjct: 205 FQSILEDEVRYP 216
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 5e-06
Identities = 59/238 (24%), Positives = 97/238 (40%), Gaps = 30/238 (12%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIP 66
+++ + IG G+FGE+ + + +++ A+KI N K + + +L G
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN-- 60
Query: 67 NIKW-----YGVDGEDNV-LVLDL-LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
+W Y E+N+ LV+D +G L L + +M+ I+ V
Sbjct: 61 --QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
H ++HRDIKPDN LM + + + DFG K + T ++ GT Y
Sbjct: 119 HQLHYVHRDIKPDNILMDMN---GHIRLADFGSCLKLMEDGT------VQSSVAVGTPDY 169
Query: 180 ASCNTHLGIEQSR-----RDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
S +E + D SLG + L G P+ A + + Y KI K
Sbjct: 170 ISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYGKIMNHK 224
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 45/171 (26%), Positives = 77/171 (45%), Gaps = 40/171 (23%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL----LYEAKVYKILQ 60
+G +Y+ IG G++G + A+H T VA+K + S +H L E K+ + +
Sbjct: 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK-KISPFEHQTFCQRTLREIKILRRFK 61
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGP-SLEDL----FVYCRRKFSLKTVL---MLAD-- 110
E+ + +LD++ P S E V + L ++ L++
Sbjct: 62 H--------------ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDH 107
Query: 111 ------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK 154
Q++ ++Y+HS LHRD+KP N L+ N + I DFGLA+
Sbjct: 108 IQYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTNCDLKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 40/151 (26%), Positives = 79/151 (52%), Gaps = 10/151 (6%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
Y+L +++GSG++G+++ A ++ T E+ AVKI L + +++ + + NI
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHC--NI 68
Query: 69 -KWYG--VDGEDNVLVLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
++G + E + ++ G SL+D++ + S + + + + + Y+HS+G
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
+HRDIK N L+ V + DFG+A K
Sbjct: 128 MHRDIKGANILL---TDNGDVKLADFGVAAK 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 41/154 (26%), Positives = 73/154 (47%), Gaps = 16/154 (10%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS 63
+ G+ + + R + GS G +F +SH D + V VK + ++EA++ + L +
Sbjct: 166 VAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVK----AGWYASSVHEARLLRRLSHPA 221
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGPSLE-DLFVYCRRK---FSLKTVLMLADQMIARIEYV 119
+ + V G + L+ P DL+ Y + L V +A Q+++ I+Y+
Sbjct: 222 VLALLDVRVVGG-----LTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYI 276
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
H G +HRDIK +N L+ + + DFG A
Sbjct: 277 HGEGIIHRDIKTENVLVN---GPEDICLGDFGAA 307
|
Length = 461 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 49/221 (22%), Positives = 106/221 (47%), Gaps = 30/221 (13%)
Query: 9 YKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT--------KHPQLLYEAKVYK 57
++L + +G+G++G++FL V D+ ++ A+K+ T +H + E +V +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRT--ERQVLE 59
Query: 58 ILQGGSGIPNIKWYGVDGEDNV-LVLDLLGPSLEDLFVYC--RRKFSLKTVLMLADQMIA 114
++ + + Y + + L+LD + +LF + R +F + V + + +++
Sbjct: 60 HIRQSPFLVTLH-YAFQTDTKLHLILDYINGG--ELFTHLSQRERFKEQEVQIYSGEIVL 116
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
+E++H G ++RDIK +N L+ V + DFGL+K++ + R +
Sbjct: 117 ALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFHEDEVERAY------SFC 167
Query: 175 GTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPW 213
GT Y + + G + + D S+G ++ L G+ P+
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 46/152 (30%), Positives = 78/152 (51%), Gaps = 19/152 (12%)
Query: 13 RKIGSGSFGEIFLASHVDTN--EI-VAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIP 66
+++G G+FG + ++ + E+ VAVK E+ + L EA V L P
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDH----P 56
Query: 67 NI-KWYGV-DGEDNVLVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
I + GV GE +LV++L LGP L+ ++ RR+ + + LA Q+ + Y+ S+
Sbjct: 57 CIVRLIGVCKGEPLMLVMELAPLGPLLK--YLKKRREIPVSDLKELAHQVAMGMAYLESK 114
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
F+HRD+ N L+ +Q I DFG+++
Sbjct: 115 HFVHRDLAARNVLL---VNRHQAKISDFGMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 57/262 (21%), Positives = 108/262 (41%), Gaps = 27/262 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
+Y + R +G GSFG L HV++++ A+K E K + +++ +L PN
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMK-EIRLPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 68 IKWY--GVDGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
I + + + ++ +V++ G ++ + + + F T+L QM ++++H +
Sbjct: 60 IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
LHRDIK N + + +V + DFG A+ P GT Y
Sbjct: 120 RVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGAYAC-------TYVGTPYYVPP 169
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
+ + + D+ SLG +L P+Q A + K K+C+ P+
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHPFQ---ANSWKNLILKVCQGSYK-PL----- 220
Query: 243 SHPAEFASYFHYCQSLTFDQRP 264
P+ ++ F + P
Sbjct: 221 --PSHYSYELRSLIKQMFKRNP 240
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 68/272 (25%), Positives = 115/272 (42%), Gaps = 47/272 (17%)
Query: 14 KIGSGSFGEIF--LASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIPN 67
++GSG+FG + + + + VAVKI + P +LL EA V + L P
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDN----PY 57
Query: 68 I-KWYGV-DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
I + G+ + E +LV++L + F+ + + K + L Q+ ++Y+ F+
Sbjct: 58 IVRMIGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFV 117
Query: 126 HRDIKPDNFLMGLGRKANQVY--IIDFGLAK------KYRDPTTNRHIPYRENKNLTGTA 177
HRD+ N L+ Q Y I DFGL+K Y T+ P +
Sbjct: 118 HRDLAARNVLL-----VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK--------- 163
Query: 178 RYA-SCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEKKVS 234
YA C + S + D+ S G VL++ F G P++G+K Q + +++
Sbjct: 164 WYAPECMNYYKF--SSKSDVWSFG-VLMWEAFSYGQKPYKGMKGNEVTQMIES--GERME 218
Query: 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266
P + P E C + D+RP +
Sbjct: 219 CP-----QRCPPEMYDLMKLCWTYGVDERPGF 245
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 36/157 (22%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKI 58
R+ Y++ + IG G+FGE+ L H T ++ A+K+ E +E +
Sbjct: 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 59 LQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
+ + + D +V++ + P + + + K +++ ++
Sbjct: 99 FANSPWVVQLFYAFQDDRYLYMVMEYM-PGGDLVNLMSNYDVPEKWARFYTAEVVLALDA 157
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
+HS GF+HRD+KPDN L+ K+ + + DFG K
Sbjct: 158 IHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMK 191
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 7e-06
Identities = 44/151 (29%), Positives = 69/151 (45%), Gaps = 9/151 (5%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGS 63
+Y + +G G+FG + A T + VA+K P + E K+ K L+ +
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHEN 70
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
I + ED V +LLG L L R + + Q++ ++YVHS G
Sbjct: 71 IISLSDIFISPLEDIYFVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAG 128
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+HRD+KP N L+ + + I DFGLA+
Sbjct: 129 VVHRDLKPSNILIN---ENCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 8e-06
Identities = 37/151 (24%), Positives = 79/151 (52%), Gaps = 10/151 (6%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
++L ++IGSG++G+++ A +V+T E+ A+K+ + + ++ I+ NI
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEI--IMMKDCKHSNI 68
Query: 69 -KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
++G + L + + G SL+D++ + S + ++ + + + Y+HS+G
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIY-HVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
+HRDIK N L+ V + DFG++ +
Sbjct: 128 MHRDIKGANILL---TDNGHVKLADFGVSAQ 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 9e-06
Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 11 LGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQLL------YEAKVYKIL 59
L R++G G+FG++FLA S +VAVK K P L EA++ L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVK----ALKDPTLAARKDFQREAELLTNL 64
Query: 60 QGGSGIPNIKWYGV--DGEDNVLVLDLL------------GPSLEDLF----VYCRRKFS 101
Q +K+YGV DG+ ++V + + GP L + +
Sbjct: 65 QHEH---IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
L +L +A Q+ + + Y+ S+ F+HRD+ N L+G V I DFG++ RD +
Sbjct: 122 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL---LVKIGDFGMS---RDVYS 175
Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL-YFLRGSLPW 213
+ YR + R+ + + + + D+ S G +L F G PW
Sbjct: 176 TDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 56/227 (24%), Positives = 91/227 (40%), Gaps = 28/227 (12%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKW---- 70
IG GSFG++ LA H + AVK+ K L + + + + + + N+K
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQ---KKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 71 ---YGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGF 124
+ D + VLD + +LF + +R+ F A ++ + + Y+HS
Sbjct: 60 GLHFSFQTADKLYFVLDYINGG--ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNI 117
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
++RD+KP+N L+ + + DFGL K+ + GT Y +
Sbjct: 118 VYRDLKPENILLD---SQGHIVLTDFGLCKENIEHNGT-------TSTFCGTPEYLAPEV 167
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231
R D LG VL L G P+ A + YD I K
Sbjct: 168 LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDNILNK 211
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 58/219 (26%), Positives = 92/219 (42%), Gaps = 24/219 (10%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQ---LLYEAKVYKILQGGSGIPNI-- 68
IG G FGE++ DT ++ A+K ++ K Q L ++ L P I
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 69 KWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFL 125
Y D + +LDL+ DL + + FS K + A ++I +E++H+R +
Sbjct: 62 MTYAFHTPDKLCFILDLMNGG--DLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT- 184
+RD+KP N L+ + V I D GLA + + + GT Y +
Sbjct: 120 YRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGYMAPEVL 167
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ 223
G D SLG +L LRG P++ K K +
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 44/155 (28%), Positives = 67/155 (43%), Gaps = 14/155 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
KY +KIG GSFG+ L + + +K N P+ E++ + PN
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 68 IKWYGVDGEDN---VLVLDLLGPSLEDLFVYCRRK----FSLKTVLMLADQMIARIEYVH 120
I Y E+N +V+D DL+ + F +L Q+ +++VH
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGG--DLYKKINAQRGVLFPEDQILDWFVQICLALKHVH 118
Query: 121 SRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAK 154
R LHRDIK N FL K + + DFG+A+
Sbjct: 119 DRKILHRDIKSQNIFLT----KDGTIKLGDFGIAR 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 30/112 (26%), Positives = 54/112 (48%), Gaps = 19/112 (16%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT---TNRHIP- 166
Q++ + Y+H R LHRD+KP N L+ ++ + DFGLA+ P+ +N +
Sbjct: 111 QLLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARAKSVPSHTYSNEVVTL 167
Query: 167 -YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 217
YR L G+ Y++C D+ +G + + ++G + G+K
Sbjct: 168 WYRPPDVLLGSTEYSTCL-----------DMWGVGCIFVEMIQGVAAFPGMK 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 18/202 (8%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
K+++ +G G++G + H +T EIVA+K EN K L E K+ + L+
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTL-RELKMLRTLKQE 60
Query: 63 SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
+ + + + G+ LV + + ++ +L + V Q+I I + H
Sbjct: 61 NIVELKEAFRRRGK-LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119
Query: 123 GFLHRDIKPDNFLMGLGRKANQVY-IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
+HRDIKP+N L+ N V + DFG A+ + + + Y T Y S
Sbjct: 120 DIVHRDIKPENLLI----SHNDVLKLCDFGFARNLSEGSNANYTEY------VATRWYRS 169
Query: 182 CNTHLGIEQSRRDDLESLGYVL 203
LG + D+ S+G +L
Sbjct: 170 PELLLGAPYGKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 52/169 (30%), Positives = 74/169 (43%), Gaps = 29/169 (17%)
Query: 11 LGRKIGSGSFGEIF--LASHVDTNEI---VAVKI---ENSGTKHPQLLYEAKVYKILQGG 62
L R +G G+FGE++ L D + + VAVK S L EA ++
Sbjct: 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEA----LIMSK 65
Query: 63 SGIPNI-KWYGVDGEDN--VLVLDLL-GPSLEDLFVYCR----RKFSL--KTVLMLADQM 112
NI + GV E ++L+L+ G L+ R R SL K +L A +
Sbjct: 66 FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125
Query: 113 IARIEYVHSRGFLHRDIKPDNFLM---GLGRKANQVYIIDFGLAKK-YR 157
+Y+ F+HRDI N L+ G GR A I DFG+A+ YR
Sbjct: 126 AKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK---IADFGMARDIYR 171
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 61/229 (26%), Positives = 93/229 (40%), Gaps = 32/229 (13%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKW---- 70
IG GSFG++ LA H + AVK+ K E K + + + + N+K
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQK--KAILKKKEQK-HIMAERNVLLKNVKHPFLV 59
Query: 71 ---YGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGF 124
Y D + VLD + +LF + +R+ F A ++ + + Y+HS
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGG--ELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNI 117
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP--TTNRHIPYRENKNLTGTARYASC 182
++RD+KP+N L+ V + DFGL K+ + TT+ GT Y +
Sbjct: 118 IYRDLKPENILLD---SQGHVVLTDFGLCKEGIEHSKTTS---------TFCGTPEYLAP 165
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231
R D LG VL L G P+ A + YD I K
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA---EMYDNILNK 211
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|225023 COG2112, COG2112, Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 42/192 (21%), Positives = 72/192 (37%), Gaps = 38/192 (19%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
+++ G+ ++L VA+K+ + L EAK+ +IL G P + +Y
Sbjct: 28 KELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY- 84
Query: 73 VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTV--LMLADQMIARIEYVHSRGFLHRDI- 129
GED + + + G L L + RK L+ + D++ G H ++
Sbjct: 85 --GEDFIRMEYIDGRPLGKLEIGGDRKHLLRVLEKAYKLDRL----------GIEHGELS 132
Query: 130 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE 189
+P ++ VYIIDF A + P +N+T L E
Sbjct: 133 RPWKNVLV---NDRDVYIIDFDSATFKKKP-----------RNVTQALSL------LFRE 172
Query: 190 QSRRDDLESLGY 201
R + GY
Sbjct: 173 GLRIEKTILRGY 184
|
Length = 201 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 66/278 (23%), Positives = 109/278 (39%), Gaps = 81/278 (29%)
Query: 13 RKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT---------------------KHP- 47
+ +G G +G++F V DT +I A+K+ T KHP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 48 --QLLY----EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK-- 99
L+Y K+Y IL+ SG GE LF++ R+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSG----------GE---------------LFMHLEREGI 96
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
F T ++ +E++H +G ++RD+KP+N L+ V + DFGL K+
Sbjct: 97 FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD---AQGHVKLTDFGLCKESIHE 153
Query: 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219
T H GT Y + + + D SLG ++ L G+ P+ A
Sbjct: 154 GTVTH-------TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT---AE 203
Query: 220 TKKQKYDKICEKKVSTP----------IEVLCKSHPAE 247
+K+ DKI + K++ P ++ L K +P+
Sbjct: 204 NRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSS 241
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 57/238 (23%), Positives = 100/238 (42%), Gaps = 36/238 (15%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEA-KVYKILQGGSGIPN 67
+K+ +K+G GS+G ++ + N+ A+K + G+ + +A +IL + PN
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNH-PN 60
Query: 68 IKWYG---VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI-------- 116
I Y +DG N L + + DL ++ + ++ +Q I RI
Sbjct: 61 IISYKEAFLDG--NKLCIVMEYAPFGDLSKAISKRKKKRK--LIPEQEIWRIFIQLLRGL 116
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYII-DFGLAKKYRDPTTNRHIPYRENKNLTG 175
+ +H + LHRD+K N L AN + I D G++K + I G
Sbjct: 117 QALHEQKILHRDLKSANIL----LVANDLVKIGDLGISKVLKKNMAKTQI---------G 163
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG-----LKAATKKQKYDKI 228
T Y + G S + D+ SLG +L + P++ L+ ++ KY I
Sbjct: 164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI 221
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 45/165 (27%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHP-QLLYEAKVYKILQGGS 63
+Y+ +IG G++G ++ A + VA V+++ + P + E + K L+
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 64 GIPNI-KWYGV------DGEDNV-LVLDLLGPSLEDLFVYCRR----KFSLKTVLMLADQ 111
PNI + V D E V LV + + +DL Y + +T+ L Q
Sbjct: 61 H-PNIVRLMDVCATSRTDRETKVTLVFEHVD---QDLRTYLDKVPPPGLPAETIKDLMRQ 116
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
+ ++++H+ +HRD+KP+N L+ G QV + DFGLA+ Y
Sbjct: 117 FLRGLDFLHANCIVHRDLKPENILVTSG---GQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 44/165 (26%), Positives = 79/165 (47%), Gaps = 28/165 (16%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTN--EIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGI 65
Y+L +++G G++G + A + +T+ E VA+K I N +K + K+L+ G
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 66 PNIKWYGVDGEDNVLVLDLLGPS-LEDLFVY-----CRRKFSLKTVLMLAD--------Q 111
NI D +D++ P +L++Y +++ L D Q
Sbjct: 62 KNITCL-YD-------MDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQ 113
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
++ ++Y+HS LHRD+KP N L+ ++ I DFGLA+ +
Sbjct: 114 ILCGLKYIHSANVLHRDLKPGNLLVNAD---CELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 39/159 (24%), Positives = 74/159 (46%), Gaps = 18/159 (11%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
+Y+ +++GSG++G + S +D V I+ L+ + Y+ L+ + +
Sbjct: 16 RYRDLKQVGSGAYGTV--CSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKH 73
Query: 68 IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
G+ D LV+ +G L L + K S + L QM+ +
Sbjct: 74 ENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGL 131
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
+Y+H+ G +HRD+KP N + + ++ I+DFGLA++
Sbjct: 132 KYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQ 167
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 44/169 (26%), Positives = 71/169 (42%), Gaps = 35/169 (20%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGSG 64
+K K+G G++ ++ + T EIVA+K + GT + E + K L+
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-REISLMKELKH--- 57
Query: 65 IPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYC-------------RRKFSLKTVLMLAD 110
NI + + V +N L+L +F Y R TV
Sbjct: 58 -ENIVRLHDVIHTENKLML---------VFEYMDKDLKKYMDTHGVRGALDPNTVKSFTY 107
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
Q++ I + H LHRD+KP N L+ K ++ + DFGLA+ + P
Sbjct: 108 QLLKGIAFCHENRVLHRDLKPQNLLIN---KRGELKLADFGLARAFGIP 153
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 46/179 (25%), Positives = 78/179 (43%), Gaps = 56/179 (31%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLY-EAKVYKILQ 60
+Y+ +GSG++G++ A T VA+K ++ H + Y E ++ K +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYRELRLLKHMD 72
Query: 61 GGSGIPNIKWYGVDGEDNVL-VLDLLGP--SLEDLFVYCRRKFSLKTVLMLAD------- 110
+NV+ +LD+ P SLED + L T LM AD
Sbjct: 73 ---------------HENVIGLLDVFTPASSLEDF-----QDVYLVTHLMGADLNNIVKC 112
Query: 111 -------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKK 155
Q++ ++Y+HS G +HRD+KP N + + ++ I+DFGLA+
Sbjct: 113 QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSN----IAVNEDCELKILDFGLARH 167
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 47/171 (27%), Positives = 77/171 (45%), Gaps = 44/171 (25%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGS 63
+YK+ IG GS+G + A T E VA+K N +H ++L E K+ ++L+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRH-- 58
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGPS----LEDLFVYCRRKFS-LKTVLMLAD-------- 110
P+I V + ++ P +D++V S L V+ D
Sbjct: 59 --PDI----------VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQ 106
Query: 111 ----QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN---QVYIIDFGLAK 154
Q++ ++Y+H+ HRD+KP N L AN ++ I DFGLA+
Sbjct: 107 FFLYQLLRALKYIHTANVFHRDLKPKNIL------ANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 3e-05
Identities = 48/220 (21%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-SGTKHPQLLYEAKVYKILQGGSGIPN 67
++L +G+G++G+++ HV T ++ A+K+ + +G + ++ E + K I
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 68 IKWYGV------DGEDNV--LVLDLLGP-SLEDLFVYCR-RKFSLKTVLMLADQMIARIE 117
+YG G D+ LV++ G S+ DL + + + + +++ +
Sbjct: 68 --YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
++H +HRDIK N L+ + +V ++DFG++ + D T R GT
Sbjct: 126 HLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQL-DRTVGRR------NTFIGTP 175
Query: 178 RYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
+ +C+ + + DL SLG + G+ P
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 21/56 (37%), Positives = 33/56 (58%), Gaps = 3/56 (5%)
Query: 99 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
S V L QM+ ++Y+HS G +HRD+KP N + + ++ I+DFGLA+
Sbjct: 113 PLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN---EDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 31/107 (28%), Positives = 51/107 (47%), Gaps = 8/107 (7%)
Query: 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 139
LV + L L+ C ++ V + Q++ + Y H R LHRD+KP N L+
Sbjct: 81 LVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN-- 138
Query: 140 RKANQVYIIDFGLAKKYRDPT---TNRHIP--YRENKNLTGTARYAS 181
+ ++ + DFGLA+ PT +N + YR L G+ Y++
Sbjct: 139 -ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 50/188 (26%), Positives = 82/188 (43%), Gaps = 34/188 (18%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK----------IENSGTKHPQLLYEAKVYKILQGGS 63
KIG G++G ++ A + T E+VA+K + ++ + LL E
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-------- 58
Query: 64 GIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIARIEY 118
PNI K V +N LV + L L+ F+ + L+ + Q++ + +
Sbjct: 59 --PNIVKLLDVIHTENKLYLVFEFLHQDLKK-FMDASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNL 173
HS LHRD+KP N L+ + + DFGLA+ + P T H + YR + L
Sbjct: 116 CHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 172
Query: 174 TGTARYAS 181
G Y++
Sbjct: 173 LGCKYYST 180
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 24/75 (32%), Positives = 38/75 (50%), Gaps = 18/75 (24%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--------------- 155
QM+ I+++HS G +HRD+KP N ++ + + I+DFGLA+
Sbjct: 126 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRY 182
Query: 156 YRDPTTNRHIPYREN 170
YR P + Y+EN
Sbjct: 183 YRAPEVILGMGYKEN 197
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 51/214 (23%), Positives = 90/214 (42%), Gaps = 31/214 (14%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLL---------YEAKVYKILQGGSGI 65
+G GSFG++ LA E AVK K +L E +V + +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVK----ALKKDVVLIDDDVECTMVEKRVLALAWENPFL 58
Query: 66 PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRG 123
++ E V++ L DL + + K F L A +++ ++++HS+G
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGG--DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG 116
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--GTARYAS 181
++RD+K DN ++ + + I DFG+ K+ + +N+ T GT Y +
Sbjct: 117 IIYRDLKLDNVMLD---RDGHIKIADFGMCKEN---------VFGDNRASTFCGTPDYIA 164
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
G++ + D S G +L L G P+ G
Sbjct: 165 PEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 49/182 (26%), Positives = 72/182 (39%), Gaps = 53/182 (29%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGG 62
+G +Y R +G GS G +F A D ++ VAVK + L E K+ + L
Sbjct: 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLD-- 60
Query: 63 SGIPNIKWYGVDGEDNVL-VLDLLGPSLEDLFVYCRRKFSLKTV-----LMLAD------ 110
DN++ V ++LGPS DL L +V M D
Sbjct: 61 -------------HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE 107
Query: 111 --------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ----VYIIDFGL 152
Q++ ++Y+HS LHRD+KP N + N + I DFGL
Sbjct: 108 QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFI------NTEDLVLKIGDFGL 161
Query: 153 AK 154
A+
Sbjct: 162 AR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 12/154 (7%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
KL +K+G+G FGE+++ + ++ + VAVK GT Q L EA + K LQ +
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTLQHDK---LV 64
Query: 69 KWYGV-DGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
+ Y V E+ + ++ G L+ L K L ++ + Q+ + Y+ + +
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+HRD++ N L+ ++ I DFGLA+ D
Sbjct: 125 IHRDLRAANVLVS---ESLMCKIADFGLARVIED 155
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 29/209 (13%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSGIPN 67
IG GSFG++ DT I A+K + S H L E V + +P
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHT--LAERTVLAQVNCPFIVP- 57
Query: 68 IKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFL 125
+K+ E LVL + +LF + +R +F L +++ +E +H +
Sbjct: 58 LKFSFQSPEKLYLVLAFINGG--ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVI 115
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAK--KYRDPTTNRHIPYRENKNLTGTARYASCN 183
+RD+KP+N L+ + + DFGL K D TN GT Y +
Sbjct: 116 YRDLKPENILLDY---QGHIALCDFGLCKLNMKDDDKTN---------TFCGTPEYLAPE 163
Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLP 212
LG ++ D +LG VLLY + LP
Sbjct: 164 LLLGHGYTKAVDWWTLG-VLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 51/227 (22%), Positives = 84/227 (37%), Gaps = 32/227 (14%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTK-HPQLLYEAKVYKILQGGSG 64
+++ KIG GSFG +F + A+K + + + + EA+V L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 65 IPNIKWYGVDGEDNVLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
I + + G+ N+++ L L + R V Q++ + ++HS+
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK----------------YRDPTTNRHIPY 167
LHRDIK N + + V I D G+AK Y P PY
Sbjct: 122 ILHRDIKSLNLFLD---AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPY 178
Query: 168 RENKNL--TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
E ++ G Y C D + G ++L +RG P
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPF------DANNQGALILKIIRGVFP 219
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 51/219 (23%), Positives = 89/219 (40%), Gaps = 17/219 (7%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPNI--KWY 71
+G G FGE+ T ++ A K ++ K + A K + I Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 72 GVDGEDNV-LVLDLL-GPSLE-DLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
+ +D++ LV+ L+ G L+ ++ F + A Q+I +E++H R ++RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 129 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 188
+KP+N L+ V I D GLA + + K GT Y + G
Sbjct: 121 LKPENVLLD---DHGNVRISDLGLAVELKGGKK--------IKGRAGTPGYMAPEVLQGE 169
Query: 189 EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227
D +LG L + G P++ K +K++ +
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 32/154 (20%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKV------YKILQGGSGIPNI 68
IG G+FGE+ + +T ++ A+KI N ++L A+ +L G +
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKW----EMLKRAETACFREERDVLVNG----DR 60
Query: 69 KW-----YGVDGEDNV-LVLDL-LGPSLEDLFVYCRRKFSLKTVLMLAD----QMIARIE 117
+W Y E+N+ LV+D +G L L KF + +A +M+ I+
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLL----SKFEDRLPEDMARFYLAEMVLAID 116
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151
VH G++HRDIKPDN L+ K + + DFG
Sbjct: 117 SVHQLGYVHRDIKPDNVLLD---KNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 42/149 (28%), Positives = 69/149 (46%), Gaps = 11/149 (7%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIK 69
L ++IGSG FG ++L ++ ++ I + EA+V L S ++
Sbjct: 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKL---SHPKLVQ 63
Query: 70 WYGVDGEDN--VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 126
YGV E + LV + + L D R KFS +T+L + + + Y+ S +H
Sbjct: 64 LYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIH 123
Query: 127 RDIKPDNFLMGLGRKANQVY-IIDFGLAK 154
RD+ N L+G NQV + DFG+ +
Sbjct: 124 RDLAARNCLVG----ENQVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 6e-05
Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 34/229 (14%)
Query: 11 LGRKIGSGSFGEIFLASHVD-----TNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGS 63
L R++G G+FG++FLA + +VAVK + S EA++ LQ
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR---------------RKFSLKTVLML 108
+K+YGV E + L++ DL + R + + +L +
Sbjct: 69 ---IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
A Q+ A + Y+ S+ F+HRD+ N L+G + V I DFG++ RD + + YR
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMS---RDVYSTDY--YR 177
Query: 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL-YFLRGSLPWQGL 216
+ R+ + + + + D+ SLG VL F G PW L
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 6e-05
Identities = 51/220 (23%), Positives = 90/220 (40%), Gaps = 51/220 (23%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK---------IENSGTKHPQLLYEAKVYKILQGGSG 64
++G+G+ G +F SH + I+A K I N + Q+L+E I
Sbjct: 12 ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI------ 65
Query: 65 IPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
+ +YG DGE ++ + + G SL+ + LK + +Q++ ++
Sbjct: 66 ---VGFYGAFYSDGEISICMEHMDGGSLDQV---------LKKAGRIPEQILGKVSIAVI 113
Query: 122 RGF---------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
+G +HRD+KP N L+ ++ + DFG++ + D N +
Sbjct: 114 KGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMAN---------S 161
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
GT Y S G S + D+ S+G L+ G P
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 8e-05
Identities = 20/67 (29%), Positives = 34/67 (50%), Gaps = 5/67 (7%)
Query: 91 DLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148
DLF Y R L+ + + +++ + Y+H RG +HRD+K +N + + +
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD---EPENAVLG 227
Query: 149 DFGLAKK 155
DFG A K
Sbjct: 228 DFGAACK 234
|
Length = 392 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 8e-05
Identities = 36/146 (24%), Positives = 75/146 (51%), Gaps = 9/146 (6%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKV-YKILQGGSGIPNIKWYG 72
++G G+FG+++ A + +T + A K+ TK + L + V +IL + +K G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 73 V---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129
DG+ +++ G +++ + + R + + ++ QM+ ++Y+HS +HRD+
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDL 136
Query: 130 KPDNFLMGLGRKANQVYIIDFGLAKK 155
K N L+ L + + DFG++ K
Sbjct: 137 KAGNVLLTLD---GDIKLADFGVSAK 159
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 9e-05
Identities = 42/170 (24%), Positives = 72/170 (42%), Gaps = 41/170 (24%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----EN------------SGTKHPQL--LYEAKV 55
+G G+FG+++ A H +T A KI E S KHP + LYEA
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 56 YKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
Y+ N W ++++ G +L+ + + R + + + QM+
Sbjct: 73 YE---------NKLW---------ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE 114
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
+ ++HS +HRD+K N L+ L V + DFG++ K + R
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTL---DGDVKLADFGVSAKNKSTLQKRD 161
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 9e-05
Identities = 52/221 (23%), Positives = 105/221 (47%), Gaps = 30/221 (13%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
++L +G+G++G+++ HV T ++ A+K+ + T+ + + ++ +L+ S NI
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TEDEEEEIKLEI-NMLKKYSHHRNI 75
Query: 69 -KWYGV------DGEDNV--LVLDLLGP-SLEDLFVYCRRKFSLKT--VLMLADQMIARI 116
+YG G D+ LV++ G S+ DL V + +LK + + +++ +
Sbjct: 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDL-VKNTKGNALKEDWIAYICREILRGL 134
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
++H+ +HRDIK N L+ + +V ++DFG++ + D T R GT
Sbjct: 135 AHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQL-DRTVGRR------NTFIGT 184
Query: 177 ARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
+ +C+ + R D+ SLG + G+ P
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 31/221 (14%)
Query: 9 YKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKHPQLLYEAKVYK-------I 58
++L + +G+G++G++FL V DT ++ A+K+ + L+ +AK + +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKV----LQKAALVQKAKTVEHTRTERNV 57
Query: 59 LQGGSGIPNIK--WYGVDGEDNV-LVLDLLGPSLEDLF--VYCRRKFSLKTVLMLADQMI 113
L+ P + Y E + L+LD + S ++F +Y R FS V + ++I
Sbjct: 58 LEHVRQSPFLVTLHYAFQTEAKLHLILDYV--SGGEMFTHLYQRDNFSEDEVRFYSGEII 115
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
+E++H G ++RDIK +N L+ V + DFGL+K++ R +
Sbjct: 116 LALEHLHKLGIVYRDIKLENILLD---SEGHVVLTDFGLSKEFLSEEKERTYSF------ 166
Query: 174 TGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPW 213
GT Y + G + D SLG ++ L G+ P+
Sbjct: 167 CGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 50/189 (26%), Positives = 77/189 (40%), Gaps = 37/189 (19%)
Query: 8 KYKLGRKIGSGSFGEIF--LASHVDTNEI---VAVKIEN---SGTKHPQLLYEAKVYKIL 59
K L R++G GSFG ++ LA V E VA+K N S + + L EA V K
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF 66
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCR------RKFSLKTVLMLAD 110
++ + GV G+ ++V++L+ DL Y R L
Sbjct: 67 N----CHHVVRLLGVVSTGQPTLVVMELMA--KGDLKSYLRSRRPEAENNPGLGPPTLQK 120
Query: 111 --QMIARI----EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-----KYRDP 159
QM A I Y+ ++ F+HRD+ N ++ + V I DFG+ + Y
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMTRDIYETDYYRK 177
Query: 160 TTNRHIPYR 168
+P R
Sbjct: 178 GGKGLLPVR 186
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 50/211 (23%), Positives = 85/211 (40%), Gaps = 31/211 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS---GTKHPQLLYEAKVYKILQGGSG 64
+Y L +++G GSFG ++L +K+ G +P +A L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 65 IPNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIE 117
P I K++ ++ + ++ + G L+ + + S V Q++ +
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR---DPTTNRHIPYRENKNLT 174
Y+H R LHRD+K N + K N + I DFG+++ D T T
Sbjct: 121 YMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLAT----------TFT 166
Query: 175 GTARYASCN--THLGIEQSRRDDLESLGYVL 203
GT Y S H G + + D+ SLG +L
Sbjct: 167 GTPYYMSPEALKHQGYDS--KSDIWSLGCIL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 63/241 (26%), Positives = 102/241 (42%), Gaps = 51/241 (21%)
Query: 11 LGRKIGSGSFGEIFLASHV-----DTNEI--VAVKIENSGTKH---PQLLYEAKVYKILQ 60
LG+ +G G FG++ +A + N + VAVK+ S L+ E ++ K++
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 81
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK------------------FSL 102
I N+ G +D L + + S +L Y R + S
Sbjct: 82 KHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-----KYR 157
K ++ A Q+ +EY+ S+ +HRD+ N L+ + N + I DFGLA+ Y
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYY 196
Query: 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQG 215
TTN +P K + A + TH + D+ S G VLL+ F G P+ G
Sbjct: 197 KKTTNGRLPV---KWMAPEALFDRIYTH-------QSDVWSFG-VLLWEIFTLGGSPYPG 245
Query: 216 L 216
+
Sbjct: 246 V 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 36/228 (15%)
Query: 14 KIGSGSFGEIFLA--SHVDTNE---IVAVKIENSGTKHPQLLY--EAKVYKILQGGSGIP 66
++G G+FG++FLA ++ + +VAVK ++ + + EA++ +LQ
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH--- 68
Query: 67 NIKWYGV--DGEDNVLVLDLL------------GPS---LEDLFVYCRRKFSLKTVLMLA 109
+++YGV +G ++V + + GP L + +L +L +A
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 110 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
Q+ + + Y+ S F+HRD+ N L+G G V I DFG++ RD + + YR
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGL---VVKIGDFGMS---RDIYSTDY--YRV 180
Query: 170 NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL-YFLRGSLPWQGL 216
R+ + L + + D+ S G VL F G PW L
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 59/242 (24%), Positives = 103/242 (42%), Gaps = 47/242 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVK-IENSGTKH--PQLLYEAKVYK 57
+ LG+ +G G FG++ +A + ++ VAVK +++ T L+ E ++ K
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMK 72
Query: 58 ILQGGSGIPNIKW-------------YGVDGEDNVLVLDLLGPSLEDLFVYCR---RKFS 101
++ I N+ Y G + P ++ F C+ + +
Sbjct: 73 MIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-----KY 156
K ++ A Q+ +EY+ S+ +HRD+ N L+ + N + I DFGLA+ Y
Sbjct: 133 FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV---TEDNVMKIADFGLARDVHNIDY 189
Query: 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQ 214
TTN +P K + A + TH + D+ S G VLL+ F G P+
Sbjct: 190 YKKTTNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-VLLWEIFTLGGSPYP 238
Query: 215 GL 216
G+
Sbjct: 239 GI 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 40/154 (25%), Positives = 80/154 (51%), Gaps = 27/154 (17%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIK----- 69
I G+FG+++L + +++ AVK+ K ++ + V+++ + K
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKV----VKKADMINKNMVHQVQAERDALALSKSPFIV 67
Query: 70 --WYGVDGEDNV-LVLD-LLG---PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
+Y + +NV LV++ L+G SL ++ Y + ++K + ++ ++Y+H
Sbjct: 68 HLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYI----SEVALALDYLHRH 123
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYI--IDFGLAK 154
G +HRD+KPDN L+ +N+ +I DFGL+K
Sbjct: 124 GIIHRDLKPDNMLI-----SNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 41/162 (25%), Positives = 70/162 (43%), Gaps = 16/162 (9%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN- 67
+++ + IG G+FGE+ + T I A+KI N ++L A+ + + + N
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW----EMLKRAETACFREERNVLVNG 58
Query: 68 -IKW-----YGVDGEDNV-LVLDL-LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
+W Y E+ + LV+D +G L L + +M+ I +
Sbjct: 59 DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
H ++HRDIKPDN L+ + + + DFG K T
Sbjct: 119 HQLHYVHRDIKPDNVLLDMN---GHIRLADFGSCLKMNQDGT 157
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 2e-04
Identities = 56/245 (22%), Positives = 107/245 (43%), Gaps = 42/245 (17%)
Query: 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
+D LV++L+ +L + + + + + L QM+ I+++HS G +HRD+KP N +
Sbjct: 95 QDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151
Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 195
+ + + I+DFGLA+ T+ PY T Y + LG+ D
Sbjct: 152 V---KSDCTLKILDFGLART--AGTSFMMTPY------VVTRYYRAPEVILGMGYKENVD 200
Query: 196 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC 255
+ S+G ++ +R + + G +++K+ E ++ TP K +Y
Sbjct: 201 IWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIE-QLGTPCPEFMKKLQPTVRNY---- 252
Query: 256 QSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLL-------P 308
+ RP Y L F LF + D ++ + + ++++DLL P
Sbjct: 253 ----VENRPKYAGLT--FPKLFPDSLFPADS-------EHNKLKASQARDLLSKMLVIDP 299
Query: 309 ASRVT 313
A R++
Sbjct: 300 AKRIS 304
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 47/204 (23%), Positives = 90/204 (44%), Gaps = 29/204 (14%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIK---- 69
++G G+FG+++ A + +T + A K+ + TK + L + V + PNI
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVID--TKSEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 70 --WYGVDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
+Y E+N+ +L G +++ + + R + + ++ Q + + Y+H +
Sbjct: 70 AFYY----ENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKII 125
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS---- 181
HRD+K N L L + + DFG++ K R I R+ + GT + +
Sbjct: 126 HRDLKAGNILFTLD---GDIKLADFGVSAK-----NTRTIQRRD--SFIGTPYWMAPEVV 175
Query: 182 -CNTHLGIEQSRRDDLESLGYVLL 204
C T + D+ SLG L+
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLI 199
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 24/78 (30%), Positives = 40/78 (51%), Gaps = 18/78 (23%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--------------- 155
QM+ I+++HS G +HRD+KP N ++ + + I+DFGLA+
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 156 YRDPTTNRHIPYRENKNL 173
YR P + Y+EN ++
Sbjct: 191 YRAPEVILGMGYKENVDI 208
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 33/110 (30%), Positives = 53/110 (48%), Gaps = 10/110 (9%)
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165
+L Q++ ++ VHSR +HRD+K N FLM G + + DFG +K+Y D +
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG----IIKLGDFGFSKQYSDS-----V 223
Query: 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
+ GT Y + S++ D+ SLG +L L P++G
Sbjct: 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 64/203 (31%)
Query: 11 LGRKIGSGSFGEIFLASHVDTNE-----IVAVKI--ENSGTKH-PQLLYEAKVYKILQGG 62
LG+ +G G+FG++ A V + VAVK+ +++ K L+ E ++ K++
Sbjct: 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI--- 72
Query: 63 SGIPNIKWYGVDGEDNVLVLDLLGPSLED--LFV---YCRR------------------- 98
G+ + +++LLG ++ L+V Y
Sbjct: 73 ------------GK-HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASP 119
Query: 99 --------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 150
+ K ++ A Q+ +E++ S+ +HRD+ N L+ + + I DF
Sbjct: 120 DDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED---HVMKIADF 176
Query: 151 GLAK-----KYRDPTTNRHIPYR 168
GLA+ Y TTN +P +
Sbjct: 177 GLARDIHHIDYYRKTTNGRLPVK 199
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 45/174 (25%), Positives = 68/174 (39%), Gaps = 40/174 (22%)
Query: 12 GRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGT--------------KHPQLLYEAK 54
G K+G G++G ++ A D E +IE +G KHP ++ K
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65
Query: 55 VYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
V+ S W L+ D L + + R + K + L M+
Sbjct: 66 VFL-----SHSDRKVW---------LLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVK 111
Query: 115 R--------IEYVHSRGFLHRDIKPDNFL-MGLGRKANQVYIIDFGLAKKYRDP 159
I Y+H+ LHRD+KP N L MG G + +V I D G A+ + P
Sbjct: 112 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 59/223 (26%), Positives = 88/223 (39%), Gaps = 40/223 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----------ENSGTKHPQLLYEAKVYK 57
KY + R +GSG+ G + A V E AVK+ +N L +
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFS 92
Query: 58 ILQGGSGIPNIKWYGVDGEDNV----LVLDLLGPSLEDLFVYCR------RKFSLKTVLM 107
I++ + +NV LVLD DL + R F +
Sbjct: 93 IVKCHE---DFAKKDPRNPENVLMIALVLDYANAG--DLRQEIKSRAKTNRTFREHEAGL 147
Query: 108 LADQMIARIEYVHSRGFLHRDIKPDNFLM---GLGRKANQVYIIDFGLAKKYRDPTTNRH 164
L Q++ + +VHS+ +HRDIK N L+ GL V + DFG +K Y ++
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL------VKLGDFGFSKMYAATVSD-- 199
Query: 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 207
+ GT Y + S++ D+ SLG VLLY L
Sbjct: 200 ---DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLG-VLLYEL 238
|
Length = 496 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 49/178 (27%), Positives = 86/178 (48%), Gaps = 31/178 (17%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEA-KVYKILQGGSGIPNI-KWY 71
+G G++G ++ A + T +A+K I +++ Q L+E ++ L+ NI ++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR----NIVQYL 71
Query: 72 GVDGEDN---VLVLDLLGPSLEDLFVYCRRKFS-LK----TVLMLADQMIARIEYVHSRG 123
G D E+ + + + G SL L R K+ LK T++ Q++ ++Y+H
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR--DPTTNRHIPYRENKNLTGTARY 179
+HRDIK DN L + + V I DFG +K+ +P T + TGT +Y
Sbjct: 129 IVHRDIKGDNVL--VNTYSGVVKISDFGTSKRLAGINPCT---------ETFTGTLQY 175
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 28/107 (26%), Positives = 54/107 (50%), Gaps = 21/107 (19%)
Query: 49 LLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLM 107
LL EA+ +G+P Y VD E+ +V++ + G L+D+ ++
Sbjct: 389 LLSEAR-------RAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLEG------NPELVR 435
Query: 108 LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+++A++ H G +H D+ NF++ + +++Y+IDFGL K
Sbjct: 436 KVGEIVAKL---HKAGIVHGDLTTSNFIV----RDDRLYLIDFGLGK 475
|
Length = 535 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 26/205 (12%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIPNIKWY 71
+G G+ G ++ A H+ T I+AVK+ + + Q++ E +IL I +Y
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSE---LEILYKCDSPYIIGFY 65
Query: 72 G---VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
G V+ ++ + G SL+ VY RK + +A ++ + Y+ S LHRD
Sbjct: 66 GAFFVENRISICTEFMDGGSLD---VY--RKIPEHVLGRIAVAVVKGLTYLWSLKILHRD 120
Query: 129 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 188
+KP N L+ QV + DFG++ + + K GT Y + G
Sbjct: 121 VKPSNMLVN---TRGQVKLCDFGVSTQLVNSIA---------KTYVGTNAYMAPERISGE 168
Query: 189 EQSRRDDLESLGYVLLYFLRGSLPW 213
+ D+ SLG + G P+
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 21/50 (42%), Positives = 30/50 (60%), Gaps = 1/50 (2%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFL-MGLGRKANQVYIIDFGLAKKYRDP 159
Q++ I Y+H+ LHRD+KP N L MG G + +V I D G A+ + P
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 16/150 (10%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
Y + + + GS G +F+A+ + V +KI GT L EA + + + S I +
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTT----LIEAMLLQNVNHPSVI-RM 122
Query: 69 KWYGVDGEDNVLVLDLLGPSLE-DLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGF 124
K V G +VL P DL+ Y R + L++ Q++ + Y+H++
Sbjct: 123 KDTLVSGAITCMVL----PHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRI 178
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+HRD+K +N + +QV I D G A+
Sbjct: 179 IHRDVKTENIFI---NDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 4e-04
Identities = 27/110 (24%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 52 EAKV-YKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLA 109
EA++ + + G +P + Y VD E+ ++V++ + G L+DL +
Sbjct: 49 EARIMSRARKAGVNVPAV--YFVDPENFIIVMEYIEGEPLKDLIN--SNGMEELELSREI 104
Query: 110 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
+++ ++ HS G +H D+ N ++ ++Y+IDFGLA+ +D
Sbjct: 105 GRLVGKL---HSAGIIHGDLTTSNMIL----SGGKIYLIDFGLAEFSKDL 147
|
Length = 211 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 68/285 (23%), Positives = 116/285 (40%), Gaps = 41/285 (14%)
Query: 11 LGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENS---GTKHPQLLYEAKVYKILQGG 62
G+ +G+G+FG++ A S D VAVK+ ++ L+ E K+ L
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 63 SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK----FSLKTVLMLADQMIARIEY 118
I N+ G +++ + DL + RRK +L+ +L + Q+ + +
Sbjct: 99 ENIVNLLGACTIGGPILVITEYC--CYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
+ S+ +HRD+ N L+ G+ I DFGLA R I N + G AR
Sbjct: 157 LASKNCIHRDLAARNVLLTHGKIVK---ICDFGLA---------RDIMNDSNYVVKGNAR 204
Query: 179 ----YASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEK- 231
+ + + + D+ S G +LL+ F GS P+ G+ +K Y I E
Sbjct: 205 LPVKWMAPESIFNCVYTFESDVWSYG-ILLWEIFSLGSNPYPGMPVDSK--FYKLIKEGY 261
Query: 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276
+++ P PAE C +RP + + +L
Sbjct: 262 RMAQPEHA-----PAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 21/152 (13%)
Query: 14 KIGSGSFGEI------FLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
++GSG+FG + +D I +K EN + +++ EA++ L P
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDV-AIKVLKNENEKSVRDEMMREAEIMHQLDN----PY 56
Query: 68 I-KWYGV-DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
I + GV + E +LV+++ G L + + ++ V+ L Q+ ++Y+ + F
Sbjct: 57 IVRMIGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 125 LHRDIKPDNFLMGLGRKANQVY--IIDFGLAK 154
+HRD+ N L+ NQ Y I DFGL+K
Sbjct: 117 VHRDLAARNVLL-----VNQHYAKISDFGLSK 143
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 46/163 (28%), Positives = 68/163 (41%), Gaps = 29/163 (17%)
Query: 15 IGSGSFGEIFLASHVD-----TNEI-VAVKIENSGT---KHPQLLYEAKVYKILQGGSGI 65
+GSG+FGE++ + D + I VAVK G + + L EA L
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAH----LMSNFNH 58
Query: 66 PNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRK---------FSLKTVLMLADQMI 113
PNI K GV E ++++L+ DL Y R +LK +L + +
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGG--DLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGL--GRKANQVYIIDFGLAK 154
Y+ F+HRD+ N L+ V I DFGLA+
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 6e-04
Identities = 39/147 (26%), Positives = 71/147 (48%), Gaps = 17/147 (11%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN-IKWYG 72
K+ G FG++ + H T ++ KI + K+ + E V+++++ PN IK Y
Sbjct: 23 KLIDGKFGKVSVLKHKPTQKLFVQKIIKA--KNFNAI-EPMVHQLMKDN---PNFIKLYY 76
Query: 73 VDG--EDNVLVLDLL-GPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHR 127
+ +VL++D + DLF + K S V + Q++ + +H +H
Sbjct: 77 SVTTLKGHVLIMDYIKDG---DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHN 133
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAK 154
DIK +N L R +++Y+ D+GL K
Sbjct: 134 DIKLENVL--YDRAKDRIYLCDYGLCK 158
|
Length = 267 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 26/83 (31%), Positives = 41/83 (49%), Gaps = 10/83 (12%)
Query: 105 VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG-LGRKANQVYIIDFGLAKKYRDPTTNR 163
V + Q++ + Y+H + LHRD+KP N L+ LG ++ + DFGLA+ P+
Sbjct: 105 VRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG----ELKLADFGLARAKSIPSQTY 160
Query: 164 H-----IPYRENKNLTGTARYAS 181
+ YR L G Y+S
Sbjct: 161 SSEVVTLWYRPPDVLLGATDYSS 183
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 32/129 (24%), Positives = 57/129 (44%), Gaps = 13/129 (10%)
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
F + L A +++ +E +H ++RD+KP+N L+ + I D GLA K
Sbjct: 99 FEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD---DYGHIRISDLGLAVK---- 151
Query: 160 TTNRHIPYREN-KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218
IP E+ + GT Y + + D LG ++ + G P++G K
Sbjct: 152 -----IPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
Query: 219 ATKKQKYDK 227
K+++ D+
Sbjct: 207 KVKREEVDR 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 14/126 (11%)
Query: 91 DLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148
+LF + R+ F+ + ++++ +EY+HSR ++RDIK +N ++ K + I
Sbjct: 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKIT 137
Query: 149 DFGLAKK-YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 207
DFGL K+ D T + GT Y + + R D LG V+ +
Sbjct: 138 DFGLCKEGISDGATMK--------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189
Query: 208 RGSLPW 213
G LP+
Sbjct: 190 CGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 8e-04
Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 27/158 (17%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI-KWYGV 73
IG G++G+++ ++ + AVKI + + + + EA+ Y ILQ PN+ K+YG+
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEI-EAE-YNILQSLPNHPNVVKFYGM 87
Query: 74 -------DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY------- 118
G LVL+L G S+ +L K L L + MI+ I Y
Sbjct: 88 FYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQRLDEAMISYILYGALLGLQ 142
Query: 119 -VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
+H+ +HRD+K +N L+ V ++DFG++ +
Sbjct: 143 HLHNNRIIHRDVKGNNILL---TTEGGVKLVDFGVSAQ 177
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 8e-04
Identities = 53/225 (23%), Positives = 91/225 (40%), Gaps = 44/225 (19%)
Query: 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI------ 65
G +G G++G ++ + +++AVK T + L E K Y+ LQ +
Sbjct: 5 GEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSN-VLAAE-KEYEKLQEEVDLLKSLKH 61
Query: 66 PNIKWY-GVDGEDNVL--------------VLDLLGPSLEDLFVYCRRKFSLKTVLMLAD 110
NI Y G +DN + +L+ GP E V+C+
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPE--PVFCK----------YTK 109
Query: 111 QMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
Q++ + Y+H+ +HRDIK +N LM G + +IDFG A++ H +
Sbjct: 110 QILDGVAYLHNNCVVHRDIKGNNVMLMPNG----IIKLIDFGCARRL--AWVGLHGTHSN 163
Query: 170 N-KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
K++ GT + + R+ D+ S+G + G P
Sbjct: 164 MLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 8e-04
Identities = 60/244 (24%), Positives = 105/244 (43%), Gaps = 51/244 (20%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVKI--ENSGTKH-PQLLYEAKVYK 57
K LG+ +G G FG++ +A + ++ VAVK+ +++ K L+ E ++ K
Sbjct: 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 75
Query: 58 ILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK------------------ 99
++ I N+ G +D L + + S +L Y R +
Sbjct: 76 MIGKHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK----- 154
+ K ++ Q+ +EY+ S+ +HRD+ N L+ + N + I DFGLA+
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDVNNI 190
Query: 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLP 212
Y TTN +P K + A + TH + D+ S G VL++ F G P
Sbjct: 191 DYYKKTTNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-VLMWEIFTLGGSP 239
Query: 213 WQGL 216
+ G+
Sbjct: 240 YPGI 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 8e-04
Identities = 65/242 (26%), Positives = 106/242 (43%), Gaps = 53/242 (21%)
Query: 11 LGRKIGSGSFGEIFLA-------SHVDTNEIVAVKI--ENSGTKH-PQLLYEAKVYKILQ 60
LG+ +G G FG++ A S D VAVK+ +N+ K L+ E ++ K++
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG 75
Query: 61 GGSGIPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRR----------------KFS 101
I N+ GV +G V+V +L + F+ RR + S
Sbjct: 76 KHKNIINL--LGVCTQEGPLYVIVEYAAKGNLRE-FLRARRPPGPDYTFDITKVPEEQLS 132
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-----KY 156
K ++ A Q+ +EY+ SR +HRD+ N L+ + N + I DFGLA+ Y
Sbjct: 133 FKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT---EDNVMKIADFGLARGVHDIDY 189
Query: 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQ 214
T+N +P K + A + TH + D+ S G +L++ F G P+
Sbjct: 190 YKKTSNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-ILMWEIFTLGGSPYP 238
Query: 215 GL 216
G+
Sbjct: 239 GI 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 9e-04
Identities = 39/157 (24%), Positives = 69/157 (43%), Gaps = 21/157 (13%)
Query: 10 KLGRKIGSGSFGEIFLASHV---DTNEI-VAVKI--ENSGTKHPQ-LLYEAKVYKILQGG 62
+ + +GSG+FG ++ + + +I VA+K+ E + K + +L EA V
Sbjct: 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYV----MAS 65
Query: 63 SGIPNI-KWYGVD-GEDNVLVLDLLGPSLEDLFVYCRR---KFSLKTVLMLADQMIARIE 117
P++ + G+ L+ L+ L L Y R + +L Q+ +
Sbjct: 66 VDHPHVVRLLGICLSSQVQLITQLM--PLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Y+ + +HRD+ N L+ + V I DFGLAK
Sbjct: 124 YLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 9e-04
Identities = 12/48 (25%), Positives = 25/48 (52%), Gaps = 7/48 (14%)
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
++ ++ H G +H D+ N ++ +++Y+IDFGL K +
Sbjct: 102 LVGKL---HKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYSDEI 142
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 65/273 (23%), Positives = 112/273 (41%), Gaps = 45/273 (16%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----LLYEAKVYKILQGGSGIPNI- 68
+G G+FGE+F + D VAVK PQ L EA++ K PNI
Sbjct: 3 LGKGNFGEVFKGTLKDKTP-VAVK--TCKEDLPQELKIKFLSEARILKQYDH----PNIV 55
Query: 69 KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK---FSLKTVLMLADQMIARIEYVHSRGFL 125
K GV + + + + D + R+K K ++ A A + Y+ S+ +
Sbjct: 56 KLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCI 115
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN----RHIPYR-ENKNLTGTARYA 180
HRD+ N L+G + N + I DFG++++ D + + IP + RY+
Sbjct: 116 HRDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
S D+ S G +LL+ F G P+ G+ +++ +K ++S P
Sbjct: 173 S-----------ESDVWSYG-ILLWETFSLGVCPYPGMTNQQAREQVEK--GYRMSCP-- 216
Query: 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271
+ P + C + RP + L++
Sbjct: 217 ---QKCPDDVYKVMQRCWDYKPENRPKFSELQK 246
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 58/232 (25%), Positives = 91/232 (39%), Gaps = 34/232 (14%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKW---- 70
IG GSFG++ LA + AVK+ K L + + + + + + N+K
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQ---KKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 71 ---YGVDGEDNV-LVLDLLGPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGF 124
Y + + VLD + +LF + + R F A ++ + + Y+HS
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGG--ELFFHLQRERSFPEPRARFYAAEIASALGYLHSINI 117
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTTNRHIPYRENKNLTGTARYAS 181
++RD+KP+N L+ V + DFGL K+ D TT GT Y +
Sbjct: 118 VYRDLKPENILLD---SQGHVVLTDFGLCKEGIAQSDTTT----------TFCGTPEYLA 164
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233
D LG VL L G P+ A + YD I K +
Sbjct: 165 PEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---EMYDNILHKPL 213
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 48/177 (27%), Positives = 75/177 (42%), Gaps = 35/177 (19%)
Query: 11 LGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGG 62
L R++G G+FG++FL + E+VAVK EA++ Q
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH- 67
Query: 63 SGIPNI-KWYGV--DGEDNVLVLDLL------------GPSLEDLFVYCRRKFSLKTVLM 107
NI K+YGV +G+ ++V + + GP L L +
Sbjct: 68 ---ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 108 L--ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
L A Q+ + + Y+ S+ F+HRD+ N L+G V I DFG++ RD T
Sbjct: 125 LQIAVQIASGMVYLASQHFVHRDLATRNCLVG---YDLVVKIGDFGMS---RDVYTT 175
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 36/128 (28%), Positives = 58/128 (45%), Gaps = 13/128 (10%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
Q+I+ +E++H R ++RD+KP+N L+ V I D GLA + +D + +
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLD---NDGNVRISDLGLAVELKDGQS-------KT 154
Query: 171 KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL--RGSLPWQGLKAATKKQKYDKI 228
K GT + + G E D +LG L + RG +G K K+ K +I
Sbjct: 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK-QRI 213
Query: 229 CEKKVSTP 236
V+ P
Sbjct: 214 LNDSVTYP 221
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 17/46 (36%), Positives = 29/46 (63%), Gaps = 3/46 (6%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
Q++ ++++HS +HRD+KP N L+ Q+ + DFGLA+ Y
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 19/43 (44%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
Q++ + +H G +HRDIKP+N L+ + QV IIDFG A
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVD---GQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 24/71 (33%), Positives = 41/71 (57%), Gaps = 7/71 (9%)
Query: 90 EDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149
EDL ++ +L+ ++ + Q+ +E++ SR +HRD+ N L+ + N V I D
Sbjct: 169 EDL---YKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICD 222
Query: 150 FGLAKK-YRDP 159
FGLA+ Y+DP
Sbjct: 223 FGLARDIYKDP 233
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 40/164 (24%), Positives = 69/164 (42%), Gaps = 11/164 (6%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
K LG IG G FG + + T + VAVK L E V L + +
Sbjct: 7 KLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRL 64
Query: 68 IKWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRKF--SLKTVLMLADQMIARIEYVHSRGF 124
+ GV + + +V++L+ F+ R + S+ +L + + +EY+ S+
Sbjct: 65 L---GVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKL 121
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
+HRD+ N L+ + + DFGLA+ N +P +
Sbjct: 122 VHRDLAARNILVS---EDGVAKVSDFGLARVGSMGVDNSKLPVK 162
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 42/180 (23%), Positives = 69/180 (38%), Gaps = 60/180 (33%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-------IEN----------------SGTKHPQLL- 50
+G G FG++ LA + T E+ A+K I + +HP L+
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 51 ------YEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT 104
E V +++ +G G DL+ D+F R F
Sbjct: 67 LFACFQTEDHVCFVMEYAAG----------G-------DLMMHIHTDVFSEPRAVFYAAC 109
Query: 105 VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTT 161
V++ ++Y+H ++RD+K DN L+ V I DFGL K+ + D T+
Sbjct: 110 VVL-------GLQYLHENKIVYRDLKLDNLLLDT---EGFVKIADFGLCKEGMGFGDRTS 159
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 33/151 (21%), Positives = 65/151 (43%), Gaps = 8/151 (5%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSG 64
Y + + IG G+FGE+ L H + ++ A+K+ E +E +
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 65 IPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
+ + D + +V++ + P + + + K +++ ++ +HS G
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYM-PGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGL 163
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
+HRD+KPDN L+ K + + DFG K
Sbjct: 164 IHRDVKPDNMLLD---KHGHLKLADFGTCMK 191
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 48/220 (21%), Positives = 88/220 (40%), Gaps = 51/220 (23%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK---------IENSGTKHPQLLYEAKVYKILQGGSG 64
++G+G+ G + H + I+A K I N + Q+L+E I
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI------ 65
Query: 65 IPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
+ +YG DGE ++ + + G SL+ + +R + ++++ ++
Sbjct: 66 ---VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR---------IPEEILGKVSIAVL 113
Query: 122 RGF---------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
RG +HRD+KP N L+ ++ + DFG++ + D N +
Sbjct: 114 RGLAYLREKHQIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMAN---------S 161
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
GT Y S G S + D+ S+G L+ G P
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 45/152 (29%), Positives = 60/152 (39%), Gaps = 33/152 (21%)
Query: 11 LGRKIGSGSFGE--IFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGSG 64
L IG + LA H TN +VAVK N S L E + LQ
Sbjct: 2 LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQH--- 58
Query: 65 IPNIKWYG---VDGEDNVLVLDLLG-PSLEDLFVYCRRKFSLKTVLM--LADQMIARI-- 116
PNI Y + + +V L+ S EDL LKT L + IA I
Sbjct: 59 -PNILPYVTSFIVDSELYVVSPLMAYGSCEDL---------LKTHFPEGLPELAIAFILK 108
Query: 117 ------EYVHSRGFLHRDIKPDNFLMGLGRKA 142
+Y+HS+GF+HR +K + L+ K
Sbjct: 109 DVLNALDYIHSKGFIHRSVKASHILLSGDGKV 140
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 24/77 (31%), Positives = 40/77 (51%), Gaps = 8/77 (10%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----I 165
Q++ + Y H R LHRD+KP N L+ + ++ + DFGLA+ P+ T + +
Sbjct: 111 QLLRGLAYCHQRRVLHRDLKPQNLLIS---ERGELKLADFGLARAKSVPSKTYSNEVVTL 167
Query: 166 PYRENKNLTGTARYASC 182
YR L G+ Y++
Sbjct: 168 WYRPPDVLLGSTEYSTS 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 29/169 (17%)
Query: 9 YKLGRKIGSGSFG---EIFLASHVDTNEIVAVKIE----NSGTKHPQLLYEAKVYKILQG 61
+ LGR +G G FG E L S + + VAVK+ S + + L EA K
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 62 GSGIPNI-KWYGVD----GEDNVLVLDLLGPSLE--DL--FVYCRR------KFSLKTVL 106
PN+ K GV + + + ++ P ++ DL F+ R L+T++
Sbjct: 61 ----PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV 116
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
+ + +EY+ S+ F+HRD+ N ++ + V + DFGL+KK
Sbjct: 117 RFMIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVADFGLSKK 162
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 48/210 (22%), Positives = 89/210 (42%), Gaps = 28/210 (13%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKW---- 70
+G G+FG++ L + + A+KI K ++ + +V L + N +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKI----LKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58
Query: 71 ---YGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGF 124
Y +D + V++ + +LF + R+ FS ++++ ++Y+HS
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGG--ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKI 116
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YRDPTTNRHIPYRENKNLTGTARYASCN 183
++RD+K +N ++ K + I DFGL K+ D T K GT Y +
Sbjct: 117 VYRDLKLENLMLD---KDGHIKITDFGLCKEGITDAAT--------MKTFCGTPEYLAPE 165
Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
+ R D LG V+ + G LP+
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 16/36 (44%), Positives = 25/36 (69%), Gaps = 3/36 (8%)
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151
++ +HS GF+HRD+KPDN L+ K+ + + DFG
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.003
Identities = 19/75 (25%), Positives = 39/75 (52%), Gaps = 7/75 (9%)
Query: 91 DLFVYCRRK----FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 146
+LF +R+ S + A +++ +EY+H G ++RD+KP+N L+ ++ +
Sbjct: 87 ELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIM 143
Query: 147 IIDFGLAKKYRDPTT 161
+ DF L+K+
Sbjct: 144 LSDFDLSKQSDVEPP 158
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 39/150 (26%), Positives = 79/150 (52%), Gaps = 14/150 (9%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVK-IENS--GTKHPQLLYEAKVYKILQGGSGIPNIK 69
++G G++G + HV T I+AVK I + + +LL + + ++ +
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDIS--MRSVDCPYTVT 64
Query: 70 WYG-VDGEDNVLV-LDLLGPSLEDLF--VYCRRKFSLKTVL-MLADQMIARIEYVHSR-G 123
+YG + E +V + ++++ SL+ + VY + + +L +A ++ +EY+HS+
Sbjct: 65 FYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
+HRD+KP N L+ + QV + DFG++
Sbjct: 125 VIHRDVKPSNVLIN---RNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 23/159 (14%)
Query: 9 YKLGRKIGSGSFGEIFLASH-VDTNEIVAVKI--ENSGTKHPQLL-YEAKVYKILQGGSG 64
Y R +G GS+GE+ L H D + V K+ N+ + + EA++ L+
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKH--- 58
Query: 65 IPNIKWY--GVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI-------AR 115
PNI Y +GED +L + + DL+ + K L+ +Q++
Sbjct: 59 -PNIVAYRESWEGEDGLLYIVMGFCEGGDLY---HKLKEQKGKLLPENQVVEWFVQIAMA 114
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
++Y+H + LHRD+K N + + N + + D G+A+
Sbjct: 115 LQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIAR 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 414 | |||
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.58 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.45 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.38 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.37 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.31 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.26 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.21 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.1 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.06 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.05 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.81 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.8 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.78 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.68 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.68 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.65 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.62 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.6 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.55 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.53 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.44 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.36 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.36 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.07 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.02 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.02 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.98 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.92 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.88 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.86 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.58 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.56 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.56 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.55 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.51 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.5 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.5 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.47 | |
| PLN02236 | 344 | choline kinase | 97.28 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.24 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.23 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.11 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.07 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.99 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.9 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.78 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.62 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.37 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.3 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.23 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.12 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.1 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.91 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.86 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.68 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.42 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.14 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.07 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.02 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.67 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.86 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.74 |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-60 Score=425.95 Aligned_cols=291 Identities=58% Similarity=1.011 Sum_probs=283.3
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
|||-.|+++++||+|+||++++|+...+++.||||.+....+.+++..|.+.++.|.+..+||.+++|+.++.++.||+|
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEcc--CCCCCeEEEeeecceeeecCCCC
Q 015041 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL--GRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 84 ~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~--~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
++|.+|+|+|..|+++|+.++++.++.|++..++|+|++.+|+|||||+||||+. ..+...|.|+|||+|+.++++.+
T Consensus 105 LLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 105 LLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred hhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 9999999999999999999999999999999999999999999999999999984 23456789999999999999999
Q ss_pred CccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhh
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~ 241 (414)
..|+||++.+.+.||++||+.++++|.++++++|+.|||-++++++.|.+||+|+++.+.++++.+|.+++...|++++|
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc 264 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLC 264 (449)
T ss_pred cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCccccccccc
Q 015041 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK 294 (414)
Q Consensus 242 ~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l~ 294 (414)
.++|++|..++.+...+++++-|+|+.+..+|.+++.+.|+.+|..|||..+.
T Consensus 265 ~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln 317 (449)
T KOG1165|consen 265 EGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN 317 (449)
T ss_pred hcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 99999999999999999999999999999999999999999999999997654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-61 Score=413.96 Aligned_cols=297 Identities=68% Similarity=1.184 Sum_probs=289.7
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
.+++++|+++++||+|+||.+|+|....+|+.||||++++...++++..|.+++..|++..++|.+.+++.+..+.++||
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 47899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 83 e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
+++|.+|++++..|.+.|+.++++.++.|++..++|+|.+++|||||||+|+|++.+.....+.|+|||+|+.+.+..+.
T Consensus 91 dLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 91 DLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred eccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhh
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~ 242 (414)
.|+||++.+..+||++|++...+.+.++++++|+.|+|++|.++..|.+||+++.+.+..+++.+|.+.+...+++.+|+
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~ 250 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCK 250 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCccccccccccchhh
Q 015041 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQ 299 (414)
Q Consensus 243 ~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l~~~~~~ 299 (414)
++|.+|.-++++|..+.+++.|+|..|.++|+-++...++..++.|||.+++.+..+
T Consensus 251 G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk~~q 307 (341)
T KOG1163|consen 251 GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQKSQQ 307 (341)
T ss_pred CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHHhhc
Confidence 999999999999999999999999999999999999999999999999998855433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-50 Score=377.66 Aligned_cols=265 Identities=26% Similarity=0.372 Sum_probs=228.0
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
.+|.+++.||.|+|++|++|+++.++..||||++.+.. +.+-+..|-.+|.+|.+|++|..+++.+.+...+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 68999999999999999999999999999999876542 3344678889999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
+||+ +|+|.+++.+ -+.|++.++++++.||+.||+|||++|||||||||+|||+ +++++++|+|||.|+.+....
T Consensus 153 Le~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCChhh
Confidence 9999 9999999987 4679999999999999999999999999999999999999 799999999999999876543
Q ss_pred CCccccc----cC--CCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC
Q 015041 161 TNRHIPY----RE--NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 161 ~~~~~~~----~~--~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
.....+. .. ...++||+.|.+||++.+...++.+|||+||||+|.|+.|.+||.+.++. ..+++|+...+.
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney---liFqkI~~l~y~ 305 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY---LIFQKIQALDYE 305 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH---HHHHHHHHhccc
Confidence 3311111 11 25799999999999999999999999999999999999999999986544 556667776666
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcccccccc
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 293 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l 293 (414)
+| +++|+...+|+.++|..||.+|++..+|.+ +.|...+||.-+
T Consensus 306 fp-----~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~----------HpFF~~Vdw~nl 349 (604)
T KOG0592|consen 306 FP-----EGFPEDARDLIKKLLVRDPSDRLTSQQIKA----------HPFFEGVDWENL 349 (604)
T ss_pred CC-----CCCCHHHHHHHHHHHccCccccccHHHHhh----------CcccccCChhhh
Confidence 66 677999999999999999999999987755 245556677553
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=354.93 Aligned_cols=247 Identities=23% Similarity=0.318 Sum_probs=202.6
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
++|.+.++||.|+||+||+|++..++..||||.+..... .+.+..|+.+|+.++| ++|+.+..+....+..++||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H-~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKH-PNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCC-cceeeEEEEEecCCeEEEEE
Confidence 789999999999999999999999999999998776642 2346889999999985 78888989999999999999
Q ss_pred ecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCC---CeEEEeeecceeeecC
Q 015041 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA---NQVYIIDFGLAKKYRD 158 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~---~~vkL~DFG~a~~~~~ 158 (414)
||| ||+|.+++.. .+.+++.+++.++.||+.||++||+++||||||||+|||++..... -.+||+|||+|+....
T Consensus 89 EyC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred EeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 999 8999999886 5589999999999999999999999999999999999999754233 5789999999997664
Q ss_pred CCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
.. ...+++|++.|||||++..+.|+.|+|+||+|+|+|++++|+.||...+..+ .+..+.......|.
T Consensus 168 ~~--------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e---L~~~~~k~~~~~~~- 235 (429)
T KOG0595|consen 168 GS--------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE---LLLYIKKGNEIVPV- 235 (429)
T ss_pred hh--------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH---HHHHHhccccccCc-
Confidence 33 2358899999999999999999999999999999999999999999755433 33222222222221
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~ 268 (414)
..........+++-..+..++.+|-.+..
T Consensus 236 -~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~ 264 (429)
T KOG0595|consen 236 -LPAELSNPLRELLISLLQRNPKDRISFED 264 (429)
T ss_pred -hhhhccCchhhhhhHHHhcCccccCchHH
Confidence 11222345567888888888888877653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=360.73 Aligned_cols=262 Identities=25% Similarity=0.333 Sum_probs=219.0
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
-..|++++.||+|+||+||+++...+++.+|+|++++.. .......|..++..++| +.|+.+.+-+.+....|+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~h-PFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKH-PFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCC-CcEeeeEEecccCCeEEE
Confidence 468999999999999999999999999999999887653 23457789999999764 788888888889999999
Q ss_pred EEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 81 v~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
|+||+ ||.|...+.. .+.|++..++.++.+|+.||.|||++|||||||||+|||+ +..|+++|+|||+++.....
T Consensus 103 Vld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhcccC
Confidence 99999 8899888876 6679999999999999999999999999999999999999 69999999999999876554
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
... ..+++||+.|||||++.+..|+..+|+||||+++|||++|.+||.+. +..+.+.+|...+...+..
T Consensus 179 ~~~-------t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~---~~~~~~~~I~~~k~~~~p~- 247 (357)
T KOG0598|consen 179 GDA-------TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE---DVKKMYDKILKGKLPLPPG- 247 (357)
T ss_pred CCc-------cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc---cHHHHHHHHhcCcCCCCCc-
Confidence 432 24789999999999999999999999999999999999999999974 3456677777777554432
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCccccccc
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTI 292 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 292 (414)
.++.+..++++..+..+|.+|.... .+..+-..+.+....+|+.
T Consensus 248 ---~ls~~ardll~~LL~rdp~~RLg~~------~d~~~ik~HpfF~~inW~~ 291 (357)
T KOG0598|consen 248 ---YLSEEARDLLKKLLKRDPRQRLGGP------GDAEEIKRHPFFKGINWEK 291 (357)
T ss_pred ---cCCHHHHHHHHHHhccCHHHhcCCC------CChHHhhcCcccccCCHHH
Confidence 2468999999999999999996410 1111123446666677854
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=373.57 Aligned_cols=249 Identities=29% Similarity=0.411 Sum_probs=221.1
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
.+|+.++.||+|+|+.||.+++..+|+.||+|++.+. .....+.+|+++.+.|.| ++|+.++.++.+..+.|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~H-pnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKH-PNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCC-CcEEeeeeEeecCCceEEE
Confidence 5799999999999999999999999999999987753 334568899999999986 7888999999999999999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
+|+| .++|..+++ .++.+++.+++++++||+.||.|||+.+|||||||..|+|+ +++.+|||+|||+|.....++
T Consensus 97 LELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 97 LELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCcc
Confidence 9999 778877777 47889999999999999999999999999999999999999 689999999999998877553
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
.. ..+.|||+.|.|||++.....+..+||||+|||||-|+.|++||+.. ...+.+.+|....+..|.
T Consensus 173 Er-------k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk---~vkety~~Ik~~~Y~~P~--- 239 (592)
T KOG0575|consen 173 ER-------KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK---TVKETYNKIKLNEYSMPS--- 239 (592)
T ss_pred cc-------cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc---hHHHHHHHHHhcCccccc---
Confidence 32 35899999999999999999999999999999999999999999963 456788888888888774
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~ 277 (414)
.++.+.++||..+|+.+|.+||+.+++.. +..+
T Consensus 240 --~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~--h~Ff 272 (592)
T KOG0575|consen 240 --HLSAEAKDLIRKLLRPNPSERPSLDEVLD--HPFF 272 (592)
T ss_pred --ccCHHHHHHHHHHhcCCcccCCCHHHHhc--CHhh
Confidence 45789999999999999999999887755 4444
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-49 Score=357.82 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=211.5
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCC-eeEEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE-DNVLVL 82 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~-~~~lv~ 82 (414)
.+.+.++.||+|+.|+||+|+++.|++.+|+|++.... ...++.+|+++++.. .+++|+.++..+.... ...|+|
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceEEeeh
Confidence 46778899999999999999999999999999884433 345789999999998 4588888888887777 599999
Q ss_pred ecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||| +|+|.+++.. .+++++.....|+.++++||.|||+ .+||||||||+|||+ +..+.|||||||.++...+..
T Consensus 158 EYMDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS~ 233 (364)
T KOG0581|consen 158 EYMDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNSI 233 (364)
T ss_pred hhcCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhhh
Confidence 999 8999998876 3679999999999999999999995 899999999999999 699999999999998776552
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC--hhhchHHHHHHHHhhccCCchH
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL--KAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~--~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
..+++||..|||||.+.+..|+.++||||||++++|+++|+.||... ......+.+..|+.... +
T Consensus 234 ---------a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp----P 300 (364)
T KOG0581|consen 234 ---------ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP----P 300 (364)
T ss_pred ---------cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC----C
Confidence 24899999999999999999999999999999999999999999863 22345566666665332 3
Q ss_pred Hhhhc-ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 239 VLCKS-HPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 239 ~~~~~-~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.++.+ ++++|++|+..|+++||.+||++.+|.+
T Consensus 301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 33343 7899999999999999999999988755
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=362.13 Aligned_cols=253 Identities=26% Similarity=0.340 Sum_probs=212.1
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---------chhHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---------HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 74 (414)
-+.+.|-+.+.||+|+||.|-+|....||+.||||++++... .....+|+++|++|+| ++|+.+..++..
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~H-P~IV~~~d~f~~ 247 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSH-PNIVRIKDFFEV 247 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCC-CCEEEEeeeeec
Confidence 467889999999999999999999999999999999875421 1235799999999976 788889888888
Q ss_pred CCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
.+..||||||+ ||.|.+.+.. .+.+.+...+.++.||+.||.|||++||+||||||+|||+...+++..+||+|||+|
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred CCceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 89999999999 8889888875 456788888999999999999999999999999999999987667789999999999
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHh
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE---QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~ 230 (414)
+...... ..+++|||+.|.|||++.+.. +..++||||+||+||-+++|.+||.+..... .....|..
T Consensus 327 K~~g~~s--------fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI~~ 396 (475)
T KOG0615|consen 327 KVSGEGS--------FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQILK 396 (475)
T ss_pred hccccce--------ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHHhc
Confidence 8764322 235899999999999998775 3458899999999999999999998754332 23344555
Q ss_pred hccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 231 ~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
.++.+- +..+...+++..++++.+|..||+.||+.++.
T Consensus 397 G~y~f~-p~~w~~Iseea~dlI~~mL~VdP~~R~s~~ea 434 (475)
T KOG0615|consen 397 GRYAFG-PLQWDRISEEALDLINWMLVVDPENRPSADEA 434 (475)
T ss_pred Cccccc-ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHH
Confidence 555543 34556778999999999999999999997753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=344.83 Aligned_cols=254 Identities=22% Similarity=0.310 Sum_probs=209.2
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCch----hHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
.+|+.+.++|+|+||.||+|+++.||+.||||.+....+.+ -.++|+++|+.|.| ++++.+...+......++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH-~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKH-ENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhccc-chHHHHHHHHHhcceeEEEe
Confidence 47889999999999999999999999999999887766543 36899999999987 55556656666777899999
Q ss_pred eccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 83 e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
|||..++.+.+......++...+..++.|++.|+.|+|+++||||||||+|||++ ..+.+||||||+|+....+..
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit---~~gvvKLCDFGFAR~L~~pgd- 156 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT---QNGVVKLCDFGFARTLSAPGD- 156 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe---cCCcEEeccchhhHhhcCCcc-
Confidence 9999999999998788899999999999999999999999999999999999995 899999999999998775433
Q ss_pred ccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC-------
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS------- 234 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~------- 234 (414)
....++.|.+|+|||.+.| -.|+..+||||+||++.||++|.+.|.|.++.+..-.+.+.+....+
T Consensus 157 ------~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 157 ------NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred ------hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 2236788999999999998 56999999999999999999999999997765544433332211111
Q ss_pred ---------Cc-------hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 235 ---------TP-------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 235 ---------~p-------~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.| .+.-......-+.+|++.|+..||++|++.+++..
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 01 11111233456889999999999999999988765
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-48 Score=360.98 Aligned_cols=254 Identities=26% Similarity=0.369 Sum_probs=208.6
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc-h--hHHHHHHHHHHHcCCCCCCeeEEeeeeCC-eeE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-P--QLLYEAKVYKILQGGSGIPNIKWYGVDGE-DNV 79 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~--~~~~E~~~l~~l~~~~~i~~l~~~~~~~~-~~~ 79 (414)
++-.+|+++++||.|+||.||+|+.+.+++.||||.++..... + --++|++.|++|..|++|..+.....+.+ ..+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 4567999999999999999999999999999999977655322 2 24789999999996677777765555555 899
Q ss_pred EEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 80 lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
+|||||..+|..+++..++.|++..+..|+.||++||+|+|.+|+.||||||+|||+. ....+||+|||+||.....
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~---~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS---GNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec---ccceeEecccccccccccC
Confidence 9999999999999998788899999999999999999999999999999999999994 5889999999999976543
Q ss_pred CCCccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC---
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST--- 235 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~--- 235 (414)
. || ..++.|.+|+|||+++.. .|+.+.||||+|||++|+.+-++.|.|.++.+. +.+||+-...+
T Consensus 164 p-----PY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq---i~KIc~VLGtP~~~ 232 (538)
T KOG0661|consen 164 P-----PY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ---IYKICEVLGTPDKD 232 (538)
T ss_pred C-----Cc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH---HHHHHHHhCCCccc
Confidence 3 23 266789999999998755 599999999999999999999999999765543 34444322222
Q ss_pred ----------------------chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 236 ----------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 236 ----------------------p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
++..+..+++.++.+++..|+.+||++||++.+..+
T Consensus 233 ~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 233 SWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred cchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 233344456778888888888888888888876654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-48 Score=362.28 Aligned_cols=217 Identities=27% Similarity=0.366 Sum_probs=185.8
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCch----hHHHHHHHHHHHcCCCCCCeeEEeeee-CCeeEE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIPNIKWYGVD-GEDNVL 80 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~E~~~l~~l~~~~~i~~l~~~~~~-~~~~~l 80 (414)
...|+.+++||+|+||.||+|++..+|+.||+|.+..+.... -..+||.+|++|.|.+.+......... ....||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 356888999999999999999999999999999877665433 257999999999885544443333333 578999
Q ss_pred EEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 81 v~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|+|||..+|.-++....-+|+..++..++.||+.||+|||++||+|||||.+|||| |.++.+||+|||+|+.+....
T Consensus 196 VFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 196 VFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccceeeccCCC
Confidence 99999999999988766689999999999999999999999999999999999999 699999999999999876654
Q ss_pred CCccccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~ 231 (414)
... ....+-|.+|+|||+++|.. |+..+|+||+||||.||++|++.|+|.++.++.+.+.++|..
T Consensus 273 ~~~------~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGS 338 (560)
T KOG0600|consen 273 SAP------YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGS 338 (560)
T ss_pred Ccc------cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCC
Confidence 322 23567799999999999885 999999999999999999999999998887777777777653
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=371.87 Aligned_cols=299 Identities=21% Similarity=0.300 Sum_probs=223.2
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcC-----CCCCCeeEEeeeeC
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQG-----GSGIPNIKWYGVDG 75 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~-----~~~i~~l~~~~~~~ 75 (414)
++.++.+|.+++.||+|+||+|.+|.+.+|++.||||+++.... ..+...|+.+|..|+. ..+++.++.++...
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 56778899999999999999999999999999999999987643 4567889999999982 24567778889999
Q ss_pred CeeEEEEeccCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 76 EDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 76 ~~~~lv~e~~~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
.+.|||+|++..+|.++++.+. ..++...++.|+.||+.||.+||+.+|||+||||+|||+... ....|||+|||+|+
T Consensus 261 ~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~-~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 261 NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP-KRSRIKVIDFGSSC 339 (586)
T ss_pred cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC-CcCceeEEeccccc
Confidence 9999999999999999999654 569999999999999999999999999999999999999533 34489999999998
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
...... ..++.+..|+|||+++|.+|+.+.||||||||++||++|.+.|.|.++.+ .+..|++....
T Consensus 340 ~~~q~v----------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D---Ql~~I~e~lG~ 406 (586)
T KOG0667|consen 340 FESQRV----------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD---QLARIIEVLGL 406 (586)
T ss_pred ccCCcc----------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH---HHHHHHHHhCC
Confidence 543322 15677899999999999999999999999999999999999999976654 44455555544
Q ss_pred CchHHhhhcChHHHHHHHHH-------HhcCCCCCCCChHHHHHHHHHHHHh----------------cCCCCCcccccc
Q 015041 235 TPIEVLCKSHPAEFASYFHY-------CQSLTFDQRPDYGFLKRLFHDLFSR----------------EGYDFDFVFDWT 291 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~-------c~~~~p~~RP~~~~l~~~l~~~~~~----------------~~~~~~~~~dw~ 291 (414)
+|...+- .... ...++.. |...+-.+-....+.++.+...... .+......|.-.
T Consensus 407 Pp~~mL~-~~~~-~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~ 484 (586)
T KOG0667|consen 407 PPPKMLD-TAKK-AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKR 484 (586)
T ss_pred CCHHHHH-hccc-cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHH
Confidence 4433322 1111 1222222 3333311111111222222211111 111111123337
Q ss_pred ccccchhhhccccccCCCCccccCC
Q 015041 292 ILKYQQTQKTKSQDLLPASRVTNSR 316 (414)
Q Consensus 292 ~l~~~~~~~~~~~~~l~~~~~~~~~ 316 (414)
+|+++|.+|+++.++|.|||+....
T Consensus 485 ~L~~dP~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 485 CLEWDPAERITPAQALNHPFLTGTS 509 (586)
T ss_pred HhccCchhcCCHHHHhcCccccccc
Confidence 8999999999999999999998443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=362.85 Aligned_cols=255 Identities=25% Similarity=0.374 Sum_probs=216.6
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (414)
..++++++||+|.||+||+|.+.. ...||+|.++.... ...+.+|++++++|+| ++++.++.++..+..++|||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H-~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRH-EKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcc-cCeEEEEEEEecCCceEEEEEec
Confidence 456778999999999999999964 34799998887554 4678899999999987 66778888888878999999999
Q ss_pred -CCCHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 86 -GPSLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 86 -~~sL~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
.|+|.++++. .+..+...+.+.++.|||.||+||+++++|||||.++|||| +++..+||+|||+|+...+....
T Consensus 284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d~~Y~- 359 (468)
T KOG0197|consen 284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARLIGDDEYT- 359 (468)
T ss_pred ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEcccccccccCCCcee-
Confidence 8999999986 56679999999999999999999999999999999999999 58889999999999943333221
Q ss_pred cccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhhh
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~ 242 (414)
......-.+.|.|||.+....++.++||||||++||||+| |+.||.+++..+..+ .++...+.|.+..|
T Consensus 360 -----~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~----~le~GyRlp~P~~C- 429 (468)
T KOG0197|consen 360 -----ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLE----LLERGYRLPRPEGC- 429 (468)
T ss_pred -----ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHH----HHhccCcCCCCCCC-
Confidence 1122233678999999999999999999999999999999 999999987754443 45667777777555
Q ss_pred cChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 243 ~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
|+++.++|..||+.+|++||+|+.+...|++++..
T Consensus 430 --P~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 430 --PDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred --CHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 99999999999999999999999999998887654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=354.11 Aligned_cols=256 Identities=25% Similarity=0.363 Sum_probs=212.0
Q ss_pred CCceEEecceeecCceeEEEEEECCCCce-EEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCC-eeE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEI-VAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE-DNV 79 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~-vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~-~~~ 79 (414)
.....+.+.||.|+||+||+|.+. |.. ||||++..... ...+.+|+.++.+|+| ++|..+.+.+.... ..+
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~H-pNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRH-PNIVQFYGACTSPPGSLC 116 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCC-CCeeeEEEEEcCCCCceE
Confidence 345667788999999999999985 555 99999876542 2368999999999987 55656666666555 689
Q ss_pred EEEecc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC-eeccccCCCceEEccCCCCC-eEEEeeecceee
Q 015041 80 LVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRG-FLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKK 155 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~-iiHrDLkp~Nili~~~~~~~-~vkL~DFG~a~~ 155 (414)
|||||+ +|+|.+++... ...+++..++.|+.||+.||+|||+++ ||||||||+|||+ +... ++||+|||+++.
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGLSRE 193 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCcccee
Confidence 999999 99999999873 678999999999999999999999999 9999999999999 5775 999999999987
Q ss_pred ecCCCCCccccccCCCCCccCcCcccccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHL--GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
...... ......||..|||||++. ...|+.|+||||||+++|||+||+.||.++.. .+....++....
T Consensus 194 ~~~~~~-------~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~~~~v~~~~~ 263 (362)
T KOG0192|consen 194 KVISKT-------SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQVASAVVVGGL 263 (362)
T ss_pred eccccc-------cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcCC
Confidence 654321 112478999999999999 55899999999999999999999999999765 344445555555
Q ss_pred CCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 234 ~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
+.+++. .+|+.+..++..||..+|..||+|.++...|+.+....
T Consensus 264 Rp~~p~---~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 264 RPPIPK---ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred CCCCCc---cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 555443 35899999999999999999999999999999887643
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=341.53 Aligned_cols=282 Identities=24% Similarity=0.365 Sum_probs=221.8
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCch----hHHHHHHHHHHHcCCCCCCeeE--EeeeeCCeeEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIPNIK--WYGVDGEDNVL 80 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~E~~~l~~l~~~~~i~~l~--~~~~~~~~~~l 80 (414)
..|..+.+|++|+||.||+|++..|++.||+|.++.+.... ..++||.+|.+++| ++|+.+. ..|..-+..||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H-~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARH-PNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCC-CCeeeeEEEEeccccceeee
Confidence 46888999999999999999999999999999887765332 35899999999985 7777774 44556677999
Q ss_pred EEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 81 v~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||||..+|..++.....+|...++..++.|++.||+|||...|+|||||++|+|+ ...|.+||+|||+|+.+..+.
T Consensus 155 VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm---~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 155 VMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL---SHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee---ccCCcEEecccchhhhhcCCc
Confidence 99999999999999888899999999999999999999999999999999999999 489999999999999887763
Q ss_pred CCccccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
. .....+-|.+|+|||++++.. |++.+|+||+|||+.||+++++.|.|..+.++..++.+++ ..|.+.
T Consensus 232 k-------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ll----GtPte~ 300 (419)
T KOG0663|consen 232 K-------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLL----GTPSEA 300 (419)
T ss_pred c-------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHh----CCCccc
Confidence 2 223667799999999999886 9999999999999999999999999977665555544433 344444
Q ss_pred hhhcChHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHH-HHhcCCCCCccccccccccchhhhccccccCCCCcccc
Q 015041 240 LCKSHPAEFASYFHYCQ-SLTFDQRPDYGFLKRLFHDL-FSREGYDFDFVFDWTILKYQQTQKTKSQDLLPASRVTN 314 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~-~~~p~~RP~~~~l~~~l~~~-~~~~~~~~~~~~dw~~l~~~~~~~~~~~~~l~~~~~~~ 314 (414)
.++++..- . .+ ..+..+-| +..+...|..+ +...|++ +-..+|.|+|.+|.+|.+.|.|+||..
T Consensus 301 iwpg~~~l--p----~~k~~~f~~~p-yn~lr~kF~~~~lse~g~~----Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 301 IWPGYSEL--P----AVKKMTFSEHP-YNNLRKKFGALSLSEQGFD----LLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred cCCCcccc--c----hhhccccCCCC-chhhhhhccccccchhHHH----HHHHHhccCccccccHHHhhccccccc
Confidence 44333210 0 11 12222222 34455554433 2233322 223779999999999999999999975
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=335.10 Aligned_cols=244 Identities=25% Similarity=0.314 Sum_probs=199.9
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeE-EeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIK-WYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~-~~~~~~~~~~lv 81 (414)
..|+|+++||.|.||+||++....+|..||.|.+.-+.. .+....|+.+|+.|+|+|.+.... .+..+..-.+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 358999999999999999999999999999997664322 234789999999999855443333 233344448999
Q ss_pred Eecc-CCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh--cC--eeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 82 LDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHS--RG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~--~~--iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
|||| .|+|...+... ++.+++.++++++.|++.||..+|+ .. |+||||||+||++ +.+|.|||+|||++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDFGLG 175 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceeeccchhH
Confidence 9999 89998888743 4569999999999999999999999 45 9999999999999 58999999999999
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
+.+....+. ...++||+.||+||.+.+.+|++++||||+||++|||+.-+.||.|.+ ..+.-.+|.+...
T Consensus 176 r~l~s~~tf-------A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n---~~~L~~KI~qgd~ 245 (375)
T KOG0591|consen 176 RFLSSKTTF-------AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN---LLSLCKKIEQGDY 245 (375)
T ss_pred hHhcchhHH-------HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc---HHHHHHHHHcCCC
Confidence 988766553 347899999999999999999999999999999999999999999863 3334445555444
Q ss_pred CCchHHhhhcChHHHHHHHHHHhcCCCCCCCCh
Q 015041 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 234 ~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~ 266 (414)
++-+. .-++.++..|++.|+..|++.||+.
T Consensus 246 ~~~p~---~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 246 PPLPD---EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred CCCcH---HHhhhHHHHHHHHHccCCcccCCCc
Confidence 32221 2346899999999999999999984
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=326.01 Aligned_cols=287 Identities=21% Similarity=0.265 Sum_probs=216.4
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
.+|..+++||+|.||.||+|++.++|+.||||.++.... ....++|++.|+.++| ++|..+.+.+.......+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h-~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKH-PNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccC-cchhhhhhhccCCCceEEEE
Confidence 579999999999999999999999999999998876543 3458899999999986 56666666666777899999
Q ss_pred eccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 83 e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
||+..+|+..++.....++...+..++.+++.||+|||++.|+||||||.|+|++ .++.+||+|||+|+.+..+...
T Consensus 81 Efm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis---~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 81 EFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS---SDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred EeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc---CCCcEEeecccchhccCCCCcc
Confidence 9999999999987777899999999999999999999999999999999999994 8999999999999988776543
Q ss_pred ccccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhh
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~ 241 (414)
.. ..+-|.+|+|||.+.|.. |+..+||||.|||+.||+.|.+.|.|.++-++... |...... |.+..+
T Consensus 158 ~~-------~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~---If~~LGT-P~~~~W 226 (318)
T KOG0659|consen 158 QT-------HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSK---IFRALGT-PTPDQW 226 (318)
T ss_pred cc-------cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHH---HHHHcCC-CCcccC
Confidence 21 226799999999999875 99999999999999999999999999766544444 4333322 323222
Q ss_pred hcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCccccccccccchhhhccccccCCCCccccCCCcccc
Q 015041 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLLPASRVTNSRVMPMR 321 (414)
Q Consensus 242 ~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 321 (414)
+++. .+-++.+.-.-..|..+ .++.....+. ..+--.++.|+|.+|.+++++|.|+||.. .+.|..
T Consensus 227 P~~~-~lpdY~~~~~~P~~~~~-----------~lf~aas~d~-ldLl~~m~~ynP~~Rita~qaL~~~yf~~-~P~pt~ 292 (318)
T KOG0659|consen 227 PEMT-SLPDYVKIQQFPKPPLN-----------NLFPAASSDA-LDLLSKMLTYNPKKRITASQALKHPYFKS-LPLPTP 292 (318)
T ss_pred cccc-ccccHHHHhcCCCCccc-----------cccccccHHH-HHHHHhhhccCchhcccHHHHhcchhhhc-CCCCCC
Confidence 1110 12222222111111111 1222111111 01111789999999999999999999985 444444
Q ss_pred c
Q 015041 322 T 322 (414)
Q Consensus 322 ~ 322 (414)
.
T Consensus 293 ~ 293 (318)
T KOG0659|consen 293 P 293 (318)
T ss_pred h
Confidence 3
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=327.27 Aligned_cols=234 Identities=23% Similarity=0.349 Sum_probs=210.5
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
.+|.+++.||.|+||.|-+++++.+|..+|+|++++... .+...+|..+|+.+. ++.+..+...+.+....+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeEEEE
Confidence 578999999999999999999999999999999887642 234678999999988 47777788888899999999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||. ||.|..++++ .++|+++.++.++.||+.||+|||+++|++|||||+|||+ |..|.+||+|||+|+......
T Consensus 123 meyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~rT 198 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSGRT 198 (355)
T ss_pred EeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEecCcE
Confidence 9999 8888888877 4579999999999999999999999999999999999999 699999999999999876543
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
.+.|||+.|+|||++...+|++.+|+||||+++|||+.|.+||...+. .+.+.+|++.++.+|
T Consensus 199 ----------~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~iY~KI~~~~v~fP---- 261 (355)
T KOG0616|consen 199 ----------WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQIYEKILEGKVKFP---- 261 (355)
T ss_pred ----------EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHHHHHHHhCcccCC----
Confidence 388999999999999999999999999999999999999999997554 688999999999988
Q ss_pred hhcChHHHHHHHHHHhcCCCCCC
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQR 263 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~R 263 (414)
..+..++++|+..+++.|-.+|
T Consensus 262 -~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 262 -SYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -cccCHHHHHHHHHHHhhhhHhh
Confidence 4557899999999999998888
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=344.01 Aligned_cols=270 Identities=24% Similarity=0.316 Sum_probs=215.9
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
--++|.++++||+|+||+||+|+-..||+.+|+|++++..- -..+..|-.+|.. ...+.++.+++.+.+..++|
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~-~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAE-VDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhh-cCCCcEEEEEEEecCCCeeE
Confidence 34789999999999999999999999999999999887642 2346678888877 55688999999999999999
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
|||||+ ||++..++.. ...+++..++.++.+++.|++.||..|+|||||||+|+|| |..|++||+||||+.....
T Consensus 218 LiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchhhh
Confidence 999999 9999999886 5679999999999999999999999999999999999999 7999999999999863321
Q ss_pred CCCC--------------c----ccc-----cc-----------------CCCCCccCcCccccccccCCCCCchhhHHH
Q 015041 159 PTTN--------------R----HIP-----YR-----------------ENKNLTGTARYASCNTHLGIEQSRRDDLES 198 (414)
Q Consensus 159 ~~~~--------------~----~~~-----~~-----------------~~~~~~gt~~y~aPE~~~~~~~s~~~DiwS 198 (414)
.+.. . ..+ .. .....+||+-|+|||++++..|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0000 0 000 00 012468999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc--cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 199 LGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK--VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 199 lG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~--~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
||||+|||+.|-+||.+.+.. +.+.+|+.-+ +..|.+.-+ .++..+||.+|+. ||+.|....-+.+
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~---~T~rkI~nwr~~l~fP~~~~~---s~eA~DLI~rll~-d~~~RLG~~G~~E----- 441 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQ---ETYRKIVNWRETLKFPEEVDL---SDEAKDLITRLLC-DPENRLGSKGAEE----- 441 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhhhccCCCcCcc---cHHHHHHHHHHhc-CHHHhcCcccHHH-----
Confidence 999999999999999986554 5555665544 566655433 5899999999998 9999986322211
Q ss_pred HHhcCCCCCcccccccc
Q 015041 277 FSREGYDFDFVFDWTIL 293 (414)
Q Consensus 277 ~~~~~~~~~~~~dw~~l 293 (414)
-..+.+...+||.-+
T Consensus 442 --IK~HPfF~~v~W~~l 456 (550)
T KOG0605|consen 442 --IKKHPFFKGVDWDHL 456 (550)
T ss_pred --HhcCCccccCCcchh
Confidence 123456666777543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=343.68 Aligned_cols=248 Identities=27% Similarity=0.354 Sum_probs=212.4
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-------CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-------TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
...++|.+++.||+|+||.|++|.+..+++.||+|+++.. .....+.+|+.+++.+.+|++|..+..+.....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4568999999999999999999999999999999987664 123456689999999997788888888887777
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCC-CeEEEeeeccee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA-NQVYIIDFGLAK 154 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~-~~vkL~DFG~a~ 154 (414)
..++||||+ +|.|.+.+.. .+++.+..+..++.|++.|++|||++||+||||||+|||+ +.+ +.+||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill---d~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL---DGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe---cCCCCCEEEecccccc
Confidence 899999999 7799999988 7889999999999999999999999999999999999999 466 999999999998
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccCCC-CC-chhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QS-RRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (414)
....... ...+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|..||...+ ....+.+|....
T Consensus 170 ~~~~~~~-------~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~---~~~l~~ki~~~~ 239 (370)
T KOG0583|consen 170 ISPGEDG-------LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN---VPNLYRKIRKGE 239 (370)
T ss_pred ccCCCCC-------cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc---HHHHHHHHhcCC
Confidence 7631111 235889999999999999987 85 88999999999999999999999743 334555566666
Q ss_pred cCCchHHhhhcC-hHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 233 VSTPIEVLCKSH-PAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 233 ~~~p~~~~~~~~-p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
...|. .+ +.++..++..|+..+|.+|+++.+|.
T Consensus 240 ~~~p~-----~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 240 FKIPS-----YLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ccCCC-----CcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 66553 33 78999999999999999999998876
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=335.66 Aligned_cols=252 Identities=26% Similarity=0.377 Sum_probs=201.3
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCC--eeEEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE--DNVLVL 82 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~--~~~lv~ 82 (414)
.+|..++.||+|+||.||++.+.++|...|||.+..... ...+.+|+.+|..|+ +++|+..+....... .++++|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLN-HPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCC-CCCEEeeCCccccccCeeeEeee
Confidence 458889999999999999999999999999997665421 345889999999999 466655544322222 689999
Q ss_pred ecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCC-CCeEEEeeecceeeecCCC
Q 015041 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK-ANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~-~~~vkL~DFG~a~~~~~~~ 160 (414)
||+ +|+|.+++...+..+++..++.+..||+.||+|||++|||||||||+|||+. . ++.+||+|||+++......
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~---~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD---PSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe---CCCCeEEeccCcccccccccc
Confidence 999 9999999997666899999999999999999999999999999999999994 5 6899999999998665311
Q ss_pred CCccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
. .......+.||+.|||||++..+ ...+++|||||||++.||+||+.||... ....+.+..+......+ .
T Consensus 173 ~----~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~~~P---~ 243 (313)
T KOG0198|consen 173 T----KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGREDSLP---E 243 (313)
T ss_pred c----cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccCCCC---C
Confidence 1 11223468899999999999953 3456999999999999999999999874 22223334444333222 4
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+...++++.++|+.+|+..+|++||++.+|.+
T Consensus 244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~ 275 (313)
T KOG0198|consen 244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE 275 (313)
T ss_pred CCcccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 44567899999999999999999999987755
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=346.92 Aligned_cols=243 Identities=23% Similarity=0.341 Sum_probs=210.6
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
+--.+|++++.||+|+||.|++|..+.+++.+|||+++++.. -+....|.+++.....|+.+..+..++....+.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 334689999999999999999999999999999999887642 245778999998888889999999999999999
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
++||||+ ||++... .....|++..+..++..|+.||.|||++||||||||.+|||+ |..|.+||+|||+++...
T Consensus 445 ~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccC
Confidence 9999999 5552222 224679999999999999999999999999999999999999 799999999999999766
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
.... ...+++||+.|||||++.+..|+..+|+|||||+||||+.|+.||.|.++. +.+..|+......|
T Consensus 520 ~~g~-------~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---e~FdsI~~d~~~yP- 588 (694)
T KOG0694|consen 520 GQGD-------RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---EVFDSIVNDEVRYP- 588 (694)
T ss_pred CCCC-------ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHhcCCCCCC-
Confidence 4332 235899999999999999999999999999999999999999999986543 56667777666666
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCCh
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~ 266 (414)
..++.+...+|+.++..+|++|..+
T Consensus 589 ----~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 589 ----RFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----CcccHHHHHHHHHHhccCcccccCC
Confidence 3447899999999999999999876
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=323.66 Aligned_cols=287 Identities=21% Similarity=0.251 Sum_probs=208.5
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeeEEeee----eCC
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGV----DGE 76 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~----~~~ 76 (414)
+..+|..++.||.|+||.|+.|.+..+|+.||||.+... ...++..+|+++++.++|.+.+..+..+.. ...
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 457788889999999999999999999999999976532 334567899999999997555554444444 346
Q ss_pred eeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 77 DNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 77 ~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
..|+|+|+++.+|..+++. ++.++...+..++.||++||.|+|+.+|+||||||.|+|+ +.+..+||+|||+|+..
T Consensus 100 DvYiV~elMetDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 100 DVYLVFELMETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKICDFGLARYL 175 (359)
T ss_pred eeEEehhHHhhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheee---ccCCCEEeccccceeec
Confidence 6899999999999988875 4559999999999999999999999999999999999999 68889999999999987
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
....... ....++.|.+|+|||+++.. .|+..+||||+|||+.||++|++.|.|.+... .+..|.+....+
T Consensus 176 ~~~~~~~-----~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~---Ql~lI~~~lGtP 247 (359)
T KOG0660|consen 176 DKFFEDG-----FMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVH---QLQLILELLGTP 247 (359)
T ss_pred cccCccc-----chhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHH---HHHHHHHhcCCC
Confidence 5431111 12467789999999998754 69999999999999999999999999965543 344444443343
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCccccccccccchhhhccccccCCCCcccc
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLLPASRVTN 314 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l~~~~~~~~~~~~~l~~~~~~~ 314 (414)
+.+.+..--++....+++.+-. ..|-++..+.. ..+...-+.+ -+||.++|.+|+++.++|.||+++.
T Consensus 248 ~~e~l~~i~s~~ar~yi~slp~---~p~~~f~~~fp-------~a~p~AidLl-ekmL~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 248 SEEDLQKIRSEKARPYIKSLPQ---IPKQPFSSIFP-------NANPLAIDLL-EKMLVFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred CHHHHHHhccHHHHHHHHhCCC---CCCCCHHHHcC-------CCCHHHHHHH-HHHhccCccccCCHHHHhcChhhhh
Confidence 3333322223444454443321 22222222211 1111110111 1677888888888888888888754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=333.28 Aligned_cols=304 Identities=20% Similarity=0.297 Sum_probs=241.2
Q ss_pred CCcccC-CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc-hhHHHHHHHHHHHcCCC-------CCCeeEE-
Q 015041 1 MERIIG-VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGS-------GIPNIKW- 70 (414)
Q Consensus 1 ~~~i~~-~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~E~~~l~~l~~~~-------~i~~l~~- 70 (414)
+|+++. +||.+.++||.|.|++||+|.+..+.+.||+|+.++.... +..+.||++|+.++.+. .|+.+..
T Consensus 71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 467777 9999999999999999999999999999999999887543 44788999999987432 3444433
Q ss_pred ---eeeeCCeeEEEEeccCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhc-CeeccccCCCceEEccCCCC---
Q 015041 71 ---YGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKA--- 142 (414)
Q Consensus 71 ---~~~~~~~~~lv~e~~~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDLkp~Nili~~~~~~--- 142 (414)
-+..+.+.|||+|++|.+|+.++.+.. +.++...++.|+.||+.||.|||.+ ||||.||||+|||+...+..
T Consensus 151 FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~ 230 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAK 230 (590)
T ss_pred ceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhh
Confidence 345788999999999999999999764 6799999999999999999999964 99999999999999321000
Q ss_pred --------------------------------------------------------------------------------
Q 015041 143 -------------------------------------------------------------------------------- 142 (414)
Q Consensus 143 -------------------------------------------------------------------------------- 142 (414)
T Consensus 231 ~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n 310 (590)
T KOG1290|consen 231 DAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRIN 310 (590)
T ss_pred hhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCC
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 015041 143 -------------------------------------------------------------------------------- 142 (414)
Q Consensus 143 -------------------------------------------------------------------------------- 142 (414)
T Consensus 311 ~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~d 390 (590)
T KOG1290|consen 311 GNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECD 390 (590)
T ss_pred ccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccc
Confidence
Q ss_pred CeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC---Chhh
Q 015041 143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG---LKAA 219 (414)
Q Consensus 143 ~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~---~~~~ 219 (414)
.+|||+|||.|......-+ .-+.|..|+|||+++|..|++.+||||++|++|||+||...|.. ....
T Consensus 391 i~vKIaDlGNACW~~khFT----------~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~ 460 (590)
T KOG1290|consen 391 IRVKIADLGNACWVHKHFT----------EDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYS 460 (590)
T ss_pred eeEEEeeccchhhhhhhhc----------hhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCC
Confidence 0356666666665433322 33568999999999999999999999999999999999999964 3334
Q ss_pred chHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCccccc--cccccch
Q 015041 220 TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDW--TILKYQQ 297 (414)
Q Consensus 220 ~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw--~~l~~~~ 297 (414)
.+...+..|++.....|...+..+ ..-++|+++--.+.--.|..+..|.+.|.+.|.-...+...+-|+ .||+++|
T Consensus 461 rDEDHiA~i~ELLG~iPr~ia~~G--k~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~P 538 (590)
T KOG1290|consen 461 RDEDHIALIMELLGKIPRKIALGG--KYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDP 538 (590)
T ss_pred ccHHHHHHHHHHHhhccHHHHhcC--cchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCc
Confidence 566778888888888887665543 345688888888888888888888888887775443333333333 8999999
Q ss_pred hhhccccccCCCCccccCC
Q 015041 298 TQKTKSQDLLPASRVTNSR 316 (414)
Q Consensus 298 ~~~~~~~~~l~~~~~~~~~ 316 (414)
.+|++|.+.|.|||++...
T Consensus 539 eKR~tA~~cl~hPwLn~~~ 557 (590)
T KOG1290|consen 539 EKRPTAAQCLKHPWLNPVA 557 (590)
T ss_pred cccccHHHHhcCccccCCC
Confidence 9999999999999998554
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=324.47 Aligned_cols=285 Identities=21% Similarity=0.276 Sum_probs=212.1
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCC------e
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE------D 77 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~------~ 77 (414)
.|..+++||+|+||+||+|+...+|+.||+|.++.... .....+|+.+++.|+|.++++.+..+..... .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 47778899999999999999999999999998776544 2346899999999999776777766665554 7
Q ss_pred eEEEEeccCCCHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 78 NVLVLDLLGPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 78 ~~lv~e~~~~sL~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
.++|+||+..+|.+++.... ..++...++.++.||+.||+|||+++|+||||||+|||| ++.+.+||+|||+|+
T Consensus 92 l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 92 LYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI---SSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE---CCCCcEeeeccchHH
Confidence 88999999999999999876 468888999999999999999999999999999999999 479999999999999
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
.+..+. +.....++|.+|+|||++++. .|+..+||||+|||++||++++..|.+..+.+... .|.+...
T Consensus 169 a~~ip~-------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~---~If~~lG 238 (323)
T KOG0594|consen 169 AFSIPM-------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF---RIFRLLG 238 (323)
T ss_pred HhcCCc-------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH---HHHHHcC
Confidence 654332 233467889999999999998 69999999999999999999999999987754443 4433332
Q ss_pred CCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCccccccccccchhhhccccccCCCCccc
Q 015041 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLLPASRVT 313 (414)
Q Consensus 234 ~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l~~~~~~~~~~~~~l~~~~~~ 313 (414)
.|.+..+++ ...+-. +...+.+++....+...+... ..+..+.+ -++|+|+|.+|.+|..++.||+|.
T Consensus 239 -tP~e~~Wp~----v~~~~~--~k~~f~~~~~~~~l~~~~~~~----~~~~~dll-~~~L~y~p~~R~Sa~~al~h~yf~ 306 (323)
T KOG0594|consen 239 -TPNEKDWPG----VSSLPD--YKAPFPKWPGPKDLSSILPKL----DPDGIELL-SKLLQYDPAKRISAKGALTHPYFS 306 (323)
T ss_pred -CCCccCCCC----cccccc--ccccCcCCCCccchHHhcccc----CccHHHHH-HHHhccCcccCcCHHHHhcChhhc
Confidence 232222211 111100 111222222222222222111 00111111 167999999999999999999997
Q ss_pred cCCC
Q 015041 314 NSRV 317 (414)
Q Consensus 314 ~~~~ 317 (414)
....
T Consensus 307 ~~~~ 310 (323)
T KOG0594|consen 307 ELPE 310 (323)
T ss_pred cccc
Confidence 6543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=339.48 Aligned_cols=247 Identities=22% Similarity=0.364 Sum_probs=203.8
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
..|+..++||+|+.|.||.|+...+++.||||.+.... ..+-+++|+.+++.++|.+.+..+..|... +..++||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-DELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-ceeEEEEee
Confidence 57899999999999999999999999999999876543 444588999999999875555555444433 789999999
Q ss_pred c-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 85 ~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
+ |++|.|+... ..+++.++..|+++++.||+|||.+||||||||.+|||++ .++.+||+|||++..+.....
T Consensus 352 m~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~---~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 352 MEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT---MDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred cCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec---cCCcEEEeeeeeeeccccccC--
Confidence 9 8888888774 3489999999999999999999999999999999999995 888999999999987766544
Q ss_pred cccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhc
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~ 243 (414)
...+.+||+.|||||++....|++++||||||+|++||+.|++||-..+.. +.+..|. ....+.+ .....
T Consensus 425 -----KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl---rAlyLIa-~ng~P~l-k~~~k 494 (550)
T KOG0578|consen 425 -----KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---RALYLIA-TNGTPKL-KNPEK 494 (550)
T ss_pred -----ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH---HHHHHHh-hcCCCCc-CCccc
Confidence 235899999999999999999999999999999999999999999874432 2222222 2222221 12245
Q ss_pred ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 244 HPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 244 ~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
++..|++|+.+||..|+++|+++.+|++
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 6789999999999999999999987755
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=339.74 Aligned_cols=244 Identities=23% Similarity=0.334 Sum_probs=214.4
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
+-|++++-||.|+-|.|.+|++..||+.+|||++.+... ...+.+|+.+|+.+.| +++..++....+..++|+|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~H-pnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEH-PNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcC-CCeeeeeeeeccCceEEEE
Confidence 679999999999999999999999999999999876632 3347899999999887 5566777777888999999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
.||+ +|.|.+++.. .+++++.++.++++||+.|+.|+|..+|+||||||+|+|+ |..+++||+|||+|.......
T Consensus 91 lEyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred EEecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecccCCc
Confidence 9999 8899998887 6789999999999999999999999999999999999999 577779999999997543322
Q ss_pred CCccccccCCCCCccCcCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
.-.+.||++.|+|||++.|.+| +.++||||+|||||.++||++||.+ .+....+.+++...+..|
T Consensus 167 --------lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD---dNir~LLlKV~~G~f~MP--- 232 (786)
T KOG0588|consen 167 --------LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD---DNIRVLLLKVQRGVFEMP--- 232 (786)
T ss_pred --------cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC---ccHHHHHHHHHcCcccCC---
Confidence 2357899999999999999997 6899999999999999999999995 445677788888888877
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+++.+..+|+.+++..||..|.+.++|.+
T Consensus 233 --s~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 233 --SNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred --CcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 667899999999999999999999888766
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=334.24 Aligned_cols=262 Identities=19% Similarity=0.319 Sum_probs=203.6
Q ss_pred cccCCceEEecceeecCceeEEEEEEC-----CCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeee-
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGV- 73 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~- 73 (414)
++-.++|++.++||+|+||.||+|.+. .++..||||++..... ...+.+|+.++..+.+|++|+.+..++.
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 455789999999999999999999753 3456899998875432 2357889999999966677777665444
Q ss_pred eCCeeEEEEecc-CCCHHHHHHHhC-------------------------------------------------------
Q 015041 74 DGEDNVLVLDLL-GPSLEDLFVYCR------------------------------------------------------- 97 (414)
Q Consensus 74 ~~~~~~lv~e~~-~~sL~~~~~~~~------------------------------------------------------- 97 (414)
.....+++|||+ +++|.+++....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 445689999999 889998886431
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccccccCCC
Q 015041 98 ------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171 (414)
Q Consensus 98 ------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~ 171 (414)
..+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++........ ....
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~~-----~~~~ 234 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDY-----VRKG 234 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcch-----hccc
Confidence 237788899999999999999999999999999999999 57889999999999764322111 1112
Q ss_pred CCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHH
Q 015041 172 NLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFAS 250 (414)
Q Consensus 172 ~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~ 250 (414)
...++..|+|||++.+..++.++|||||||++|||++ |..||.+..... .+...+....... .....++.+.+
T Consensus 235 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~---~~~~~~~~~~~~~---~~~~~~~~l~~ 308 (338)
T cd05102 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE---EFCQRLKDGTRMR---APENATPEIYR 308 (338)
T ss_pred CCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH---HHHHHHhcCCCCC---CCCCCCHHHHH
Confidence 3456788999999999999999999999999999997 999998754321 1222222211111 12355789999
Q ss_pred HHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 251 YFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 251 l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
++..||..+|++||++.+|.+.|++++.
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=319.55 Aligned_cols=258 Identities=20% Similarity=0.289 Sum_probs=211.5
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
+..+.|++.+.||.|.-++||+|+...+++.||||+++.+... ..+.+|+..+..+.| +||...+..+..+...|+
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~H-PNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDH-PNIVTYHCSFVVDSELWV 101 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCC-CCcceEEEEEEecceeEE
Confidence 4568999999999999999999999999999999998865433 457899998887765 777777788888899999
Q ss_pred EEecc-CCCHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 81 VLDLL-GPSLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 81 v~e~~-~~sL~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
||.|| +|++.+++.. ....+++..+..|+++++.||.|||.+|.||||||+.|||| +.+|.|||+|||.+.....
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSASLFD 178 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeeeecc
Confidence 99999 9999999884 35679999999999999999999999999999999999999 5999999999998876665
Q ss_pred CCCCccccccCCCCCccCcCccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC--
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS-- 234 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~-- 234 (414)
.... ..++. .+++||+.|||||++... .|+.|+||||||++..|+++|..||..+.+.. -.+.++ +...+
T Consensus 179 ~G~R--~~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--vLl~tL-qn~pp~~ 252 (516)
T KOG0582|consen 179 SGDR--QVTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--VLLLTL-QNDPPTL 252 (516)
T ss_pred cCce--eeEee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--HHHHHh-cCCCCCc
Confidence 4422 22333 788999999999996543 59999999999999999999999999876542 122222 21111
Q ss_pred ---CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 235 ---TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 235 ---~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.......+.++..|.+++..|+..||.+||++..|.+
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0112233456778999999999999999999988766
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=331.34 Aligned_cols=245 Identities=23% Similarity=0.319 Sum_probs=208.3
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCch----hHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..+.+ .+.+|++++..|+|++ |..+...+....+.++|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpn-iv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPN-IVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcc-hhhHHHhhcccceEEEEe
Confidence 57999999999999999999999999999999887654432 4789999999999854 555555556778899999
Q ss_pred eccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 83 e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
||+-|+|..++.. ..+++++.+..|+.|++.||.|||+.+|+|||+||.|||+ ++.+.+|+||||+|+.......
T Consensus 81 e~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~- 155 (808)
T KOG0597|consen 81 EYAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTS- 155 (808)
T ss_pred hhhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCce-
Confidence 9998899998887 6689999999999999999999999999999999999999 5999999999999987654221
Q ss_pred ccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhh
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~ 242 (414)
......||+.|||||+..+.+|+..+|+||||||+||+++|++||.. ....+.+..|.......|.
T Consensus 156 ------vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a---~si~~Lv~~I~~d~v~~p~----- 221 (808)
T KOG0597|consen 156 ------VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA---RSITQLVKSILKDPVKPPS----- 221 (808)
T ss_pred ------eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH---HHHHHHHHHHhcCCCCCcc-----
Confidence 12356899999999999999999999999999999999999999985 3344555566555555553
Q ss_pred cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 243 ~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+..|..|+...+.+||.+|.+..+|..
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 45689999999999999999999877655
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=326.24 Aligned_cols=254 Identities=22% Similarity=0.325 Sum_probs=208.1
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
....|+.++.||+|+||.||+|.+..+++.||+|++...... ..++.|+.++..+++ ++|...+.....+...+++
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~-~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDS-PNITEYYGSYLKGTKLWII 89 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCc-chHHhhhhheeecccHHHH
Confidence 346789999999999999999999999999999998876543 347889999998876 5555555555677889999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||| ||++.+++.. ...+.+..+.-++++++.||.|||+++.+|||||++|||+. ..+.+||+|||.+.......
T Consensus 90 Mey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s---~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS---ESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---ccCcEEEEecceeeeeechh
Confidence 9999 8999999875 33448888889999999999999999999999999999995 66999999999998766544
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
.. ..+++||+.|||||++.+..|+.|+||||||++.+||++|.+||..+.+.... -++.+. +++.+
T Consensus 166 ~r-------r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl----flIpk~---~PP~L 231 (467)
T KOG0201|consen 166 KR-------RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL----FLIPKS---APPRL 231 (467)
T ss_pred hc-------cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE----EeccCC---CCCcc
Confidence 32 25899999999999999889999999999999999999999999987653211 111221 12233
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
-..+++.|++|+..|+.++|+.||++.+|.+ ++++++
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK--h~FIk~ 268 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLK--HKFIKR 268 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHHhh--hHHHHh
Confidence 3467889999999999999999999988876 344443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=337.89 Aligned_cols=260 Identities=22% Similarity=0.297 Sum_probs=207.4
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
+|..+...++..||+|.||+||+|.|-+ .||||+++..... +.|.+|+.+|++-+| .||..+-+++.....
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH-~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRH-ENILLFMGACMNPPL- 462 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcch-hhheeeehhhcCCce-
Confidence 3556778899999999999999999943 4999999876543 348899999999987 445555555555554
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
.||..+| |.+|..++...+.+|...+.+.|+.||++||.|||.++|||||||..||++ .++++|||+|||++..-.
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKT 539 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccceeeee
Confidence 9999999 778998888777889999999999999999999999999999999999999 477999999999986432
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
.-... .......|...|||||++... +|++.+|||||||++|||++|.+||..... .+.+..+....+.
T Consensus 540 ~w~g~-----~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~---dqIifmVGrG~l~ 611 (678)
T KOG0193|consen 540 RWSGE-----QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR---DQIIFMVGRGYLM 611 (678)
T ss_pred eeccc-----cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh---hheEEEecccccC
Confidence 21111 122356788999999999744 589999999999999999999999994322 2333333333333
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
+.......++|.++++|+..||..++++||.|.+|...|+.++.
T Consensus 612 pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 612 PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 44444556789999999999999999999999999998877654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=329.45 Aligned_cols=300 Identities=18% Similarity=0.261 Sum_probs=228.1
Q ss_pred CCcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCC-----CCCCeeEEeeee
Q 015041 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGG-----SGIPNIKWYGVD 74 (414)
Q Consensus 1 ~~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~-----~~i~~l~~~~~~ 74 (414)
+++++.++|.+...+|+|+||.|-.+.+.+++..||||+++.-.. .+...-|+++++++.+. .-+..+..++..
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 468889999999999999999999999999999999999876543 34467899999999543 223444566778
Q ss_pred CCeeEEEEeccCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCC-------------
Q 015041 75 GEDNVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR------------- 140 (414)
Q Consensus 75 ~~~~~lv~e~~~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~------------- 140 (414)
.++.|||+|.+|.++.+++..+ -.+|+...++.|+.|++.+++|||+.+++|.||||+|||+...+
T Consensus 163 rghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 163 RGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred cCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 8899999999999999999864 35699999999999999999999999999999999999995211
Q ss_pred ----CCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 015041 141 ----KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 216 (414)
Q Consensus 141 ----~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~ 216 (414)
+...|+|+|||.|......+ ...+.|..|+|||++++..|+.++||||+||||+|+++|...|++.
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h----------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH----------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc----------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 13468999999998655443 3678899999999999999999999999999999999999999998
Q ss_pred hhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhc--CCCCCC--CChHHHHHHHHHHHHhcCCCCCccccc--
Q 015041 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQS--LTFDQR--PDYGFLKRLFHDLFSREGYDFDFVFDW-- 290 (414)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~--~~p~~R--P~~~~l~~~l~~~~~~~~~~~~~~~dw-- 290 (414)
.+.+..+.+.+|++ +.|.....+.. .-+.+-+.+++ .....| -...+..+.|+..+...+.+....||.
T Consensus 313 en~EHLaMMerIlG---p~P~~mi~r~~--~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 313 ENLEHLAMMERILG---PIPSRMIKKTR--KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred CcHHHHHHHHHhhC---CCcHHHhhhhh--hHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 87766666666655 44444333221 11122222222 112222 111112223444555555555555554
Q ss_pred cccccchhhhccccccCCCCccccC
Q 015041 291 TILKYQQTQKTKSQDLLPASRVTNS 315 (414)
Q Consensus 291 ~~l~~~~~~~~~~~~~l~~~~~~~~ 315 (414)
.||.|||++|+++.++|.||+|...
T Consensus 388 ~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred HHHccCccccccHHHHhcCHHhhcC
Confidence 8999999999999999999999753
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=318.61 Aligned_cols=249 Identities=23% Similarity=0.303 Sum_probs=193.2
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEE-eeee-CC---eeE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKW-YGVD-GE---DNV 79 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~-~~~~-~~---~~~ 79 (414)
..-.|+-.+.+|.|+||.||.|....+++.||||..-.+.+.. .+|++++..+.| ++|+.+.+ |... +. ...
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k--nrEl~im~~l~H-pNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK--NRELQIMRKLDH-PNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC--cHHHHHHHhcCC-cCeeeEEEEEEecCCCchhHHH
Confidence 3446899999999999999999999999999999776655433 479999998877 45555544 4332 22 456
Q ss_pred EEEeccCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 80 LVLDLLGPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 80 lv~e~~~~sL~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
+||||+..+|...++.. +..++...++-++.||++||.|||+.||+||||||.|+|++ .+.+.+||||||.|+..
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEeccCCcceee
Confidence 99999999999998843 56788999999999999999999999999999999999996 56699999999999987
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
...+.+ ..+..|..|+|||.+.|.. |+.+.||||.||++.||+.|++.|.|.+..++...+.++++ .+
T Consensus 177 ~~~epn--------iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG---~P 245 (364)
T KOG0658|consen 177 VKGEPN--------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLG---TP 245 (364)
T ss_pred ccCCCc--------eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhC---CC
Confidence 655443 3667799999999999885 99999999999999999999999999766554444444332 22
Q ss_pred chHH------------------------hhhcChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 236 PIEV------------------------LCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 236 p~~~------------------------~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
..+. ..+..+++..+|+.+++..+|.+|.+..++
T Consensus 246 t~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~ 303 (364)
T KOG0658|consen 246 TREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEA 303 (364)
T ss_pred CHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHH
Confidence 2111 223345566666666666666666665444
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=320.45 Aligned_cols=263 Identities=26% Similarity=0.461 Sum_probs=192.7
Q ss_pred CCcccCCceEEecceeecCceeEEEEEECCC---CceEEEEEecCCCCchhH----------HHHHHHHHHHc--CCCCC
Q 015041 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTKHPQL----------LYEAKVYKILQ--GGSGI 65 (414)
Q Consensus 1 ~~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~----------~~E~~~l~~l~--~~~~i 65 (414)
++++.+++|++.++||+|+||+||+|.+..+ +..+|+|+.......... ..++..+..+. .+.++
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i 85 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI 85 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence 4678899999999999999999999998877 667888865443321100 01112222221 23556
Q ss_pred CeeEEeeeeCC----eeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCC
Q 015041 66 PNIKWYGVDGE----DNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (414)
Q Consensus 66 ~~l~~~~~~~~----~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~ 141 (414)
+.+..++.... ..+++++++..++.+++.. ...++...++.++.|++.||+|||+++|+||||||+|||+ +.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---~~ 161 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---DG 161 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cC
Confidence 66665544332 4578889888888888765 3346788899999999999999999999999999999999 57
Q ss_pred CCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhch
Q 015041 142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK 221 (414)
Q Consensus 142 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~ 221 (414)
++.++|+|||+|+.+..................||..|+|||++.+..++.++|||||||++|||++|..||.+......
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 88999999999987653221111111112345799999999999999999999999999999999999999987633221
Q ss_pred HH------HHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 015041 222 KQ------KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (414)
Q Consensus 222 ~~------~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l 273 (414)
.. .+..+...+ ......|+++.+++..||..+|++||+|++|.+.|
T Consensus 242 ~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 LIHAAKCDFIKRLHEGK------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHhHHHHHHHhhhhh------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11 111111111 12245588999999999999999999999998875
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=345.23 Aligned_cols=295 Identities=20% Similarity=0.276 Sum_probs=204.5
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCC-----CCCeeEEe-eeeCCe
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGS-----GIPNIKWY-GVDGED 77 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~-----~i~~l~~~-~~~~~~ 77 (414)
..++|+++++||+|+||+||+|.+..+++.||||+++.... ......|+.+++.+++.+ ++..+..+ .....+
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence 35789999999999999999999999999999999865322 234567888888887543 23444433 334567
Q ss_pred eEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeccccCCCceEEccCC-------------CCC
Q 015041 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGR-------------KAN 143 (414)
Q Consensus 78 ~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDLkp~Nili~~~~-------------~~~ 143 (414)
.|+||++++++|.+++.. ...+++..+..|+.||+.||+|||+ .|||||||||+|||+...+ +..
T Consensus 207 ~~iv~~~~g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 207 MCIVMPKYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred EEEEEeccCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 899999999999988875 4579999999999999999999998 5999999999999995221 122
Q ss_pred eEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHH
Q 015041 144 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ 223 (414)
Q Consensus 144 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~ 223 (414)
.+||+|||.+...... ....+||..|+|||++.+..|+.++|||||||++|||++|+.||.+........
T Consensus 286 ~vkl~DfG~~~~~~~~----------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 286 RVRICDLGGCCDERHS----------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred eEEECCCCccccCccc----------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 5999999987532211 235689999999999999999999999999999999999999998765433222
Q ss_pred HHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc--CCCCCccccccccccchhhhc
Q 015041 224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE--GYDFDFVFDWTILKYQQTQKT 301 (414)
Q Consensus 224 ~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~--~~~~~~~~dw~~l~~~~~~~~ 301 (414)
.+.......|..........+..+++.......+...|.. +........... .......+-..+|+++|.+|+
T Consensus 356 ---~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 356 ---LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKH--LARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred ---HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHH--HHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 2333333333222111112233344443333333322221 111110000000 000011233588999999999
Q ss_pred cccccCCCCccccC
Q 015041 302 KSQDLLPASRVTNS 315 (414)
Q Consensus 302 ~~~~~l~~~~~~~~ 315 (414)
++.++|.|||+...
T Consensus 431 ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 431 NARQMTTHPYVLKY 444 (467)
T ss_pred CHHHHhcCcccccc
Confidence 99999999999753
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=318.54 Aligned_cols=271 Identities=21% Similarity=0.335 Sum_probs=220.6
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
+.|++++.||+|.-|+||+|+...++..+|+|++.+.. +..+...|.+||+.+.| +.+|.++..+...+..|+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDH-PFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDH-PFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCC-CccchhhheeeccceeEEE
Confidence 56889999999999999999999999999999987653 23456778889998875 8899999999999999999
Q ss_pred Eecc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC-
Q 015041 82 LDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD- 158 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~- 158 (414)
|||| ||+|..++++.. +.|++..++.++.+++.||+|||-.|||+|||||+|||| .++|+|.|+||.++.....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccCCCC
Confidence 9999 999999888653 569999999999999999999999999999999999999 6999999999999753211
Q ss_pred CC------------------------------CCcc-----------------ccc-cCCCCCccCcCccccccccCCCC
Q 015041 159 PT------------------------------TNRH-----------------IPY-RENKNLTGTARYASCNTHLGIEQ 190 (414)
Q Consensus 159 ~~------------------------------~~~~-----------------~~~-~~~~~~~gt~~y~aPE~~~~~~~ 190 (414)
+. .... -|. .....++||-.|.|||++.|..-
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 00 0000 000 01235789999999999999999
Q ss_pred CchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 191 SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 191 s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
+.++|+|+||+++|||+.|..||.|.+ ..+.+..|+.+.+.+|-.. ..+..+++||+.+|.+||.+|..+..
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~---~~~Tl~NIv~~~l~Fp~~~---~vs~~akDLIr~LLvKdP~kRlg~~r-- 384 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSN---NKETLRNIVGQPLKFPEEP---EVSSAAKDLIRKLLVKDPSKRLGSKR-- 384 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCC---chhhHHHHhcCCCcCCCCC---cchhHHHHHHHHHhccChhhhhcccc--
Confidence 999999999999999999999999864 3467778888887777542 34578999999999999999988431
Q ss_pred HHHHHHHHhcCCCCCcccccccc
Q 015041 271 RLFHDLFSREGYDFDFVFDWTIL 293 (414)
Q Consensus 271 ~~l~~~~~~~~~~~~~~~dw~~l 293 (414)
-..+-..+.|..-++|..+
T Consensus 385 ----GA~eIK~HpFF~gVnWaLi 403 (459)
T KOG0610|consen 385 ----GAAEIKRHPFFEGVNWALI 403 (459)
T ss_pred ----chHHhhcCccccCCChhhe
Confidence 1122234567777888654
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=326.07 Aligned_cols=240 Identities=22% Similarity=0.303 Sum_probs=200.2
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
+|++++.||+|+||.||+|++..+++.||||++.... ....+..|+.++..+.++++++.+..++......++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5899999999999999999999999999999876432 22346778888988888888888888888888999999
Q ss_pred ecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCC
Confidence 999 7888887765 4568999999999999999999999999999999999999 5788999999999875332211
Q ss_pred CccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhh
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~ 241 (414)
......||..|+|||++.+..++.++|||||||++|+|++|+.||.+.... +.+..+.......|
T Consensus 157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i~~~~~~~~----- 221 (324)
T cd05587 157 -------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQSIMEHNVSYP----- 221 (324)
T ss_pred -------ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCCCC-----
Confidence 123567899999999999999999999999999999999999999875433 34444444443333
Q ss_pred hcChHHHHHHHHHHhcCCCCCCCCh
Q 015041 242 KSHPAEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 242 ~~~p~~~~~l~~~c~~~~p~~RP~~ 266 (414)
...+.++.+++..||..+|.+|++.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 222 KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 3457899999999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=318.37 Aligned_cols=202 Identities=25% Similarity=0.355 Sum_probs=171.6
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
++|++.++||.|+||.||+|.+..++..||+|++.... ....+.+|+.+++.+.| +++..+..++......++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKH-ANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCC-CCEeeEEEEEcCCCeEEEEEe
Confidence 57999999999999999999999999999999876432 23457789999999976 566677777777778999999
Q ss_pred ccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 84 ~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
|+.++|.+++......++...+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 84 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~~-- 158 (288)
T cd07871 84 YLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPTK-- 158 (288)
T ss_pred CCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeeccCCCc--
Confidence 99889999887766678999999999999999999999999999999999999 5788999999999976433221
Q ss_pred cccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhh
Q 015041 164 HIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~ 219 (414)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+....
T Consensus 159 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~ 210 (288)
T cd07871 159 -----TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK 210 (288)
T ss_pred -----cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 1124567899999999876 46899999999999999999999999875543
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=326.36 Aligned_cols=249 Identities=21% Similarity=0.312 Sum_probs=201.3
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|+++++||+|+||.||+|++..+++.||||++.... ....+..|+.++..+.| ++++.+...+......++|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS-EWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCC-CCCccEEEEEEcCCEEEEE
Confidence 57999999999999999999999999999999886432 22347789999998874 6777777777788899999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 80 ~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~~- 154 (333)
T cd05600 80 MEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVTY- 154 (333)
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCcccccc-
Confidence 9999 8899998865 4568999999999999999999999999999999999999 57889999999999755431
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHH-
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV- 239 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~- 239 (414)
.....||..|+|||++.+..++.++|||||||++|||++|..||.+.........+... ......|...
T Consensus 155 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~ 224 (333)
T cd05600 155 ---------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW-KETLQRPVYDD 224 (333)
T ss_pred ---------cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc-cccccCCCCCc
Confidence 12567899999999999999999999999999999999999999875443322222111 1111111110
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
....+++++.+++..||..+|++||++.++.+
T Consensus 225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred cccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence 01245789999999999999999999877755
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=327.02 Aligned_cols=244 Identities=21% Similarity=0.319 Sum_probs=195.1
Q ss_pred ceEEecceeecCceeEEEEEEC---CCCceEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 8 KYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~---~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
+|+++++||+|+||.||+|++. .++..||+|++.... ....+..|+.++..+.+++++..+..++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 478899999876421 1234678999999998888898888888888889
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
++||||+ +++|.+.+.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCcccc
Confidence 9999999 7788888765 5678999999999999999999999999999999999999 578899999999997653
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHH-HHHHhhccCC
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY-DKICEKKVST 235 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~-~~i~~~~~~~ 235 (414)
..... .....+||..|+|||++.+.. ++.++|||||||++|||++|..||...........+ ..+.......
T Consensus 157 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (332)
T cd05614 157 SEEKE------RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF 230 (332)
T ss_pred ccCCC------ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 32211 112457999999999998754 889999999999999999999999754332222222 2232222221
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCCh
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~ 266 (414)
....+..+.+++..||..+|++||+.
T Consensus 231 -----~~~~~~~~~~li~~~l~~dp~~R~~~ 256 (332)
T cd05614 231 -----PSFIGPEAQDLLHKLLRKDPKKRLGA 256 (332)
T ss_pred -----CCCCCHHHHHHHHHHcCCCHHHcCCC
Confidence 23457899999999999999999954
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=322.82 Aligned_cols=236 Identities=24% Similarity=0.350 Sum_probs=197.3
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
.+|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.+++.+.| +++..+.....+....++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH-PFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCC-CcHhhhHhhhccCCeEEEE
Confidence 47999999999999999999999999999999876432 22347789999999976 5666666666777889999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 80 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 80 MEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhccCCc
Confidence 9998 7889888875 4578999999999999999999999999999999999999 578899999999987653321
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
....||..|+|||++.+..++.++|||||||++|+|++|..||.+.... ..+..+.......|
T Consensus 156 ----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~---- 218 (291)
T cd05612 156 ----------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---GIYEKILAGKLEFP---- 218 (291)
T ss_pred ----------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCcCCC----
Confidence 2457899999999999999999999999999999999999999875432 33444444444433
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCC
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPD 265 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~ 265 (414)
...+..+.+++.+||..||.+||+
T Consensus 219 -~~~~~~~~~li~~~l~~dp~~R~~ 242 (291)
T cd05612 219 -RHLDLYAKDLIKKLLVVDRTRRLG 242 (291)
T ss_pred -ccCCHHHHHHHHHHcCCCHHHccC
Confidence 344788999999999999999996
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=317.89 Aligned_cols=201 Identities=24% Similarity=0.348 Sum_probs=171.7
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
..+|++.++||.|+||.||+|++..+++.||||++..... ...+.+|+.+++.+.| +++..+..++......++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKH-ANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCC-CCcCeEEEEEecCCeEEEEE
Confidence 4689999999999999999999998999999998865432 2346789999999976 56777777777788899999
Q ss_pred eccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 83 e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
||+.++|.+++......++...+..++.||+.||+|||++||+||||||+|||+ +..+.+||+|||+++.......
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~- 158 (303)
T cd07869 83 EYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVPSH- 158 (303)
T ss_pred ECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceeccCCCc-
Confidence 999999998888766678999999999999999999999999999999999999 5788999999999875432211
Q ss_pred ccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCh
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLK 217 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~ 217 (414)
......||..|+|||++.+. .++.++|||||||++|+|++|..||.+..
T Consensus 159 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 159 ------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred ------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 11245679999999998764 58999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=326.81 Aligned_cols=237 Identities=23% Similarity=0.346 Sum_probs=199.1
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
-++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.+.| +++..+...+......++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH-PFIVNMMCSFQDENRVYF 95 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC-CCCCcEEEEEEcCCEEEE
Confidence 378999999999999999999999999999999876432 22457889999999976 667677777778889999
Q ss_pred EEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 81 v~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
||||+ +++|.+.+.. ...++...+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 96 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 96 LLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcCCC
Confidence 99998 7889888875 4578999999999999999999999999999999999999 58889999999999865432
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
. ....||..|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+.......|
T Consensus 172 ~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~~p--- 235 (329)
T PTZ00263 172 T----------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP---FRIYEKILAGRLKFP--- 235 (329)
T ss_pred c----------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH---HHHHHHHhcCCcCCC---
Confidence 1 245789999999999999999999999999999999999999987543 234444444444333
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCC
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPD 265 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~ 265 (414)
..++..+.+++..||..||.+||+
T Consensus 236 --~~~~~~~~~li~~~L~~dP~~R~~ 259 (329)
T PTZ00263 236 --NWFDGRARDLVKGLLQTDHTKRLG 259 (329)
T ss_pred --CCCCHHHHHHHHHHhhcCHHHcCC
Confidence 335788999999999999999997
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=319.44 Aligned_cols=243 Identities=19% Similarity=0.275 Sum_probs=194.4
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
.|++.+.||+|+||+||+|.+..+++.||+|.+.... ....+.+|+.++..+.| +++..+...+......++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~-~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNS-RFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCC-CcEEEEEEEEccCCeEEEEE
Confidence 4889999999999999999999999999999876432 12346789999999976 45556666666777899999
Q ss_pred ecc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 83 e~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||+ +++|.+.+... ...+++..++.++.|++.||+|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCC
Confidence 999 77887776543 3468999999999999999999999999999999999999 578899999999997653321
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
. .....||..|+|||++.+..++.++|||||||++|||++|+.||.+.......+.+...+. ......
T Consensus 157 ~--------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~----~~~~~~ 224 (285)
T cd05631 157 T--------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK----EDQEEY 224 (285)
T ss_pred e--------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh----cccccC
Confidence 1 1245789999999999999999999999999999999999999987554332222222211 111223
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCCh
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~ 266 (414)
...++.++.+|+++||..+|.+||+.
T Consensus 225 ~~~~s~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05631 225 SEKFSEDAKSICRMLLTKNPKERLGC 250 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHhcCC
Confidence 34568899999999999999999973
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=325.52 Aligned_cols=240 Identities=21% Similarity=0.308 Sum_probs=199.7
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
+|++++.||+|+||.||+|.+..+++.||||++.... .......|..++..+.++++++.+..++......++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5899999999999999999999999999999877542 11235667778887778888888888888888999999
Q ss_pred ecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
||+ +++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCCCCC
Confidence 999 7888877765 4568999999999999999999999999999999999999 5888999999999875432211
Q ss_pred CccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhh
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~ 241 (414)
.....+||..|+|||++.+..++.++|||||||++|||++|+.||.+.... ..+..+.......|
T Consensus 157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i~~~~~~~p----- 221 (323)
T cd05616 157 -------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSIMEHNVAYP----- 221 (323)
T ss_pred -------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-----
Confidence 123567899999999999999999999999999999999999999875433 34444555444333
Q ss_pred hcChHHHHHHHHHHhcCCCCCCCCh
Q 015041 242 KSHPAEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 242 ~~~p~~~~~l~~~c~~~~p~~RP~~ 266 (414)
...+.++.+++..|+..+|.+|++.
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 3457899999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=345.41 Aligned_cols=261 Identities=23% Similarity=0.331 Sum_probs=219.0
Q ss_pred ccCCceEEecceeecCceeEEEEEEC-----CCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 75 (414)
+-..+.++.+.||+|.||+||+|+.. .....||||.++..... .+|.+|++++..|+| ++|+.+.+.+..+
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H-~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQH-PNIVRLLGVCREG 561 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccC-CCeEEEEEEEccC
Confidence 34566788999999999999999864 34568999998877654 469999999999986 7788888999999
Q ss_pred CeeEEEEecc-CCCHHHHHHHhCC---------C----CCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCC
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYCRR---------K----FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~~~---------~----~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~ 141 (414)
+..|||+||+ .|+|..++..... . ++..+.+.|+.|||.||+||-++.+|||||..+|+||+ +
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg---e 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG---E 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec---c
Confidence 9999999999 8999999986421 2 77889999999999999999999999999999999995 8
Q ss_pred CCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhc
Q 015041 142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT 220 (414)
Q Consensus 142 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~ 220 (414)
...|||+|||+++.....+..+ ....-.-.++||+||.|+..+|++++|||||||+|||+++ |..||.++.+++
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk-----~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E 713 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYK-----VRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE 713 (774)
T ss_pred ceEEEecccccchhhhhhhhhc-----ccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH
Confidence 9999999999999776655422 2223334789999999999999999999999999999998 999999988764
Q ss_pred hHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 221 ~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
..+ .|...++ .+.+ .++|.++..||..||+.+|.+||+|.+|...|+......
T Consensus 714 VIe---~i~~g~l-L~~P---e~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 714 VIE---CIRAGQL-LSCP---ENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHH---HHHcCCc-ccCC---CCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 443 3334333 3333 566999999999999999999999999999999876543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=320.26 Aligned_cols=262 Identities=19% Similarity=0.277 Sum_probs=200.8
Q ss_pred ccCCceEEecceeecCceeEEEEEECC----------------CCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVD----------------TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSG 64 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~ 64 (414)
+..++|++.++||+|+||.||+|.+.. ++..||+|++...... ..+.+|+.++..+.| ++
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~n 80 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKD-PN 80 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCC-CC
Confidence 456899999999999999999998632 3447999988764322 357889999999976 66
Q ss_pred CCeeEEeeeeCCeeEEEEecc-CCCHHHHHHHhC------------------CCCCHHHHHHHHHHHHHHHHHHHhcCee
Q 015041 65 IPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR------------------RKFSLKTVLMLADQMIARIEYVHSRGFL 125 (414)
Q Consensus 65 i~~l~~~~~~~~~~~lv~e~~-~~sL~~~~~~~~------------------~~~~~~~~~~i~~qi~~aL~~LH~~~ii 125 (414)
+..+..++......++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 777777777778899999999 889998876421 2367788999999999999999999999
Q ss_pred ccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHH
Q 015041 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY 205 (414)
Q Consensus 126 HrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~e 205 (414)
||||||+|||+ +.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++||
T Consensus 161 H~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 232 (304)
T cd05096 161 HRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYY-----RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWE 232 (304)
T ss_pred ccCcchhheEE---cCCccEEECCCccceecccCcee-----EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHH
Confidence 99999999999 47889999999999765432211 11123455788999999998899999999999999999
Q ss_pred HHc--CCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 206 FLR--GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 206 l~t--G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
|++ +..||.+............................+|..+.+++.+||..+|++||++.+|.+.|+
T Consensus 233 l~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 233 ILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 986 678898765443332222211111110001111345789999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=317.46 Aligned_cols=251 Identities=21% Similarity=0.267 Sum_probs=194.9
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.++| +++..+..++......++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQ-ENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCC-ccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999998765432 2457789999999976 55656666666778899999
Q ss_pred eccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 83 e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
||+.+++.+.+......+++..++.++.|++.||.|||+.+|+||||||+||++ +.++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCcccccccccc
Confidence 999777777766556679999999999999999999999999999999999999 57889999999999765332211
Q ss_pred ccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchH----
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE---- 238 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~---- 238 (414)
......||..|+|||++.+..++.++|||||||++|||++|+.||.+.........+..+. ...+..
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~ 227 (287)
T cd07848 157 ------NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVL---GPLPAEQMKL 227 (287)
T ss_pred ------cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh---CCCCHHHHHh
Confidence 1124578999999999999899999999999999999999999998765433222222111 111100
Q ss_pred -----------------------HhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 239 -----------------------VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 239 -----------------------~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
.....++.++.+++.+||..+|++||+++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l 282 (287)
T cd07848 228 FYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCL 282 (287)
T ss_pred hhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 01112456677888888888888888876553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=314.43 Aligned_cols=250 Identities=20% Similarity=0.268 Sum_probs=192.1
Q ss_pred CceEEecceeecCceeEEEEEECC-CCceEEEEEecCCCC----chhHHHHHHHHHHHc--CCCCCCeeEEeee-----e
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGTK----HPQLLYEAKVYKILQ--GGSGIPNIKWYGV-----D 74 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~--~~~~i~~l~~~~~-----~ 74 (414)
.+|++.+.||+|+||+||+|++.. ++..||+|.+..... ...+.+|+.+++.+. .|++++.+..++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999864 468899998765432 234667888888775 3466666655442 3
Q ss_pred CCeeEEEEeccCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 75 GEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 75 ~~~~~lv~e~~~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
....++||||+.++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEccccce
Confidence 45689999999999999887543 458999999999999999999999999999999999999 57889999999999
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
+...... ......||..|+|||++.+..++.++|||||||++|||++|..||.+..... .+.++.....
T Consensus 158 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~ 226 (290)
T cd07862 158 RIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIG 226 (290)
T ss_pred EeccCCc--------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhC
Confidence 7654321 1235578999999999999899999999999999999999999998765433 2333322111
Q ss_pred ----------------------CCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 234 ----------------------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 234 ----------------------~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
..+.+......++.+.+++..||..+|++||++.++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 285 (290)
T cd07862 227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285 (290)
T ss_pred CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHh
Confidence 1112222234566778888888888888888876654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=322.84 Aligned_cols=255 Identities=22% Similarity=0.287 Sum_probs=193.5
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeee-----eCCee
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV-----DGEDN 78 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~-----~~~~~ 78 (414)
+|++.++||+|+||.||+|.+..++..||||.+.... ....+.+|+.+++.++|+ ++..+..+.. .....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHP-DIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCC-CEeeecceEeccCCCCCceE
Confidence 6999999999999999999999999999999876432 223578899999999864 4544433332 12357
Q ss_pred EEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 79 ~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
++||||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 80 ~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 80 YVVFELMESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEEecCCCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCcccccccc
Confidence 99999999999888875 4568999999999999999999999999999999999999 5889999999999976433
Q ss_pred CCCCccccccCCCCCccCcCccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHH--------
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI-------- 228 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i-------- 228 (414)
..... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+...
T Consensus 156 ~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 156 DTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231 (338)
T ss_pred ccCcc----ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 22111 01134678999999999876 57899999999999999999999999875432211111110
Q ss_pred ---------------HhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 229 ---------------CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 229 ---------------~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+......+........++.+.+++.+||..+|++||+++++.+
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 1111222222233345677888999999999999998876654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=328.65 Aligned_cols=258 Identities=20% Similarity=0.328 Sum_probs=204.4
Q ss_pred CCceEEecceeecCceeEEEEEECCC-----CceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
.++|++++.||+|+||.||+|.+... +..||||++...... ..+.+|+.+++.+..|++++.+...+.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 45799999999999999999986543 357999998754332 3477899999999666888888888888889
Q ss_pred eEEEEecc-CCCHHHHHHHhC-----------------------------------------------------------
Q 015041 78 NVLVLDLL-GPSLEDLFVYCR----------------------------------------------------------- 97 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~----------------------------------------------------------- 97 (414)
.++||||+ +++|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999 889998876421
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccccc
Q 015041 98 ----------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167 (414)
Q Consensus 98 ----------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 167 (414)
..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++........
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL~DfGla~~~~~~~~~----- 268 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNY----- 268 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEEeeceeeeeccCCcce-----
Confidence 236788899999999999999999999999999999999 47889999999999765433211
Q ss_pred cCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChH
Q 015041 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (414)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~ 246 (414)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||...... ..+.++.......+.+ ...|.
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~---~~~~~~~~~~~~~~~~---~~~~~ 342 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN---SKFYKMVKRGYQMSRP---DFAPP 342 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc---HHHHHHHHcccCccCC---CCCCH
Confidence 11123345678999999999899999999999999999997 99999875432 2222333322222211 23478
Q ss_pred HHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 015041 247 EFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (414)
Q Consensus 247 ~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~ 277 (414)
++.+++.+||..+|++||++.++.+.|++++
T Consensus 343 ~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 343 EIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=324.45 Aligned_cols=233 Identities=22% Similarity=0.317 Sum_probs=190.8
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-C
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 86 (414)
+.||+|+||.||+|++..+|+.||||++.... ....+..|+.+++.+.| +++..+...+......++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRH-PFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC-CCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999886532 12346788999999876 56777777777888999999999 7
Q ss_pred CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcccc
Q 015041 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (414)
Q Consensus 87 ~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~ 166 (414)
++|.+.+.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~----- 150 (323)
T cd05571 80 GELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGA----- 150 (323)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCC-----
Confidence 788877765 4578999999999999999999999999999999999999 5788999999999875332211
Q ss_pred ccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChH
Q 015041 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (414)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~ 246 (414)
.....+||..|+|||++.+..++.++|||||||++|||++|..||.+... ...+..+.......| ..+++
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~~~~~~~~~p-----~~~~~ 220 (323)
T cd05571 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEEIRFP-----RTLSP 220 (323)
T ss_pred --cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHHHHHHcCCCCCC-----CCCCH
Confidence 12356799999999999999999999999999999999999999986432 233333333333333 45678
Q ss_pred HHHHHHHHHhcCCCCCCCC
Q 015041 247 EFASYFHYCQSLTFDQRPD 265 (414)
Q Consensus 247 ~~~~l~~~c~~~~p~~RP~ 265 (414)
++.+++..||..||++||+
T Consensus 221 ~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05571 221 EAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred HHHHHHHHHccCCHHHcCC
Confidence 9999999999999999993
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=315.13 Aligned_cols=255 Identities=22% Similarity=0.275 Sum_probs=202.9
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----------------chhHHHHHHHHHHHcCCCCCC
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------------HPQLLYEAKVYKILQGGSGIP 66 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------------~~~~~~E~~~l~~l~~~~~i~ 66 (414)
+..-++|++++.||+|.||.|-+|++..+++.||||++.+... .+...+|+.++++|.| ++++
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H-~nVV 171 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH-PNVV 171 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC-cCee
Confidence 4455899999999999999999999999999999999765431 1357899999999987 6666
Q ss_pred eeEEeee--eCCeeEEEEecc-CCCHHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCC
Q 015041 67 NIKWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 142 (414)
Q Consensus 67 ~l~~~~~--~~~~~~lv~e~~-~~sL~~~~~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~ 142 (414)
.+..+.. .....|||+||| .|.+... .+... +++.+++.++++++.||+|||.+|||||||||+|+|++ ..
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~--p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~---~~ 246 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWC--PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS---SD 246 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccC--CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc---CC
Confidence 6655543 456789999999 4433211 11233 89999999999999999999999999999999999995 78
Q ss_pred CeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCChh
Q 015041 143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE----QSRRDDLESLGYVLLYFLRGSLPWQGLKA 218 (414)
Q Consensus 143 ~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DiwSlG~il~el~tG~~Pf~~~~~ 218 (414)
++|||+|||.+..+........ -.+...-+||+.|+|||...++. .+++.||||+||+||.|+.|++||.+..
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~--d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~- 323 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGS--DDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF- 323 (576)
T ss_pred CcEEeeccceeeecccCCcccc--HHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch-
Confidence 9999999999986633211110 00112468999999999988743 4678999999999999999999998743
Q ss_pred hchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 219 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 219 ~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+.+.+|+...+.+|... ...+.+++++.++|.+||++|.+..+|..
T Consensus 324 --~~~l~~KIvn~pL~fP~~p---e~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 324 --ELELFDKIVNDPLEFPENP---EINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred --HHHHHHHHhcCcccCCCcc---cccHHHHHHHHHHhhcChhheeehhhhee
Confidence 4577888888888877542 23578999999999999999999877654
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=332.18 Aligned_cols=257 Identities=22% Similarity=0.263 Sum_probs=194.4
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeee-------eC
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV-------DG 75 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~-------~~ 75 (414)
+...++|+++++||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++|.+.+.....+.. ..
T Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 345678999999999999999999999999999999875443 234579999999987554443333221 11
Q ss_pred CeeEEEEeccCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecc
Q 015041 76 EDNVLVLDLLGPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (414)
Q Consensus 76 ~~~~lv~e~~~~sL~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~ 152 (414)
...++||||+++++.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++ ...+.+||+|||+
T Consensus 140 ~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~--~~~~~vkL~DFGl 217 (440)
T PTZ00036 140 IFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGS 217 (440)
T ss_pred eEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEc--CCCCceeeecccc
Confidence 246799999999988877642 45689999999999999999999999999999999999994 2345799999999
Q ss_pred eeeecCCCCCccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhh
Q 015041 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (414)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~ 231 (414)
|+....... .....||..|+|||++.+. .++.++|||||||++|||++|.+||.+.........+.++...
T Consensus 218 a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 289 (440)
T PTZ00036 218 AKNLLAGQR--------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT 289 (440)
T ss_pred chhccCCCC--------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 986543221 1245789999999998765 6899999999999999999999999886544322222221110
Q ss_pred c--------------cCCc-------hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 232 K--------------VSTP-------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 232 ~--------------~~~p-------~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
. ...| ...+....|+++.+|+.+||..+|.+||++.++..
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0 0000 01122345788999999999999999999988765
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=311.47 Aligned_cols=256 Identities=15% Similarity=0.243 Sum_probs=204.4
Q ss_pred ccCCceEEecceeecCceeEEEEEEC---CCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
+-.++|++.+.||+|+||.||+|.+. ..+..||+|.++..... ..+.+|+.++..+.| ++++.+..++.....
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDH-SNIVRLEGVITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCC-CCcCeEEEEEecCCC
Confidence 45678999999999999999999875 45678999988765432 347789999988865 677778777778888
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
.++||||+ +++|.+++......+++..++.++.||+.||+|||++|++||||||+|||+ +.++.++|+|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQED 157 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCcccccc
Confidence 99999999 678888877655678999999999999999999999999999999999999 57889999999987543
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
..... .......++..|+|||++.+..++.++|||||||++||+++ |..||.+..... .+..+ ......
T Consensus 158 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~~-~~~~~~ 227 (266)
T cd05064 158 KSEAI------YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKAV-EDGFRL 227 (266)
T ss_pred cccch------hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH-HCCCCC
Confidence 22111 01113345678999999999999999999999999999775 999998765432 22222 222222
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
+. ...+|..+.+++.+||..+|++||++.+|.+.|.++
T Consensus 228 ~~---~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 PA---PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CC---CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 32 245688999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=336.44 Aligned_cols=262 Identities=19% Similarity=0.248 Sum_probs=207.7
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEE-eee-----e-CC
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKW-YGV-----D-GE 76 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~-~~~-----~-~~ 76 (414)
+.+++|.+.|.+|||+.||+|++...+..||+|.+-.... -..+.+|+.+++.|.+|++|+.+.+ ... . ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 4578999999999999999999988878999997655422 2347899999999999998887755 211 2 24
Q ss_pred eeEEEEecc-CCCHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeccccCCCceEEccCCCCCeEEEeeecc
Q 015041 77 DNVLVLDLL-GPSLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDLkp~Nili~~~~~~~~vkL~DFG~ 152 (414)
+++|.|||| +++|.|++.. ....|++.++++|+.|++.|+.+||... |||||||-+||||+ .++..||||||.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls---~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS---ADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc---CCCCEEeCcccc
Confidence 578999999 5899999983 3456999999999999999999999987 99999999999994 888999999999
Q ss_pred eeeec-CCCCCcccc-ccCCCCCccCcCcccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHH
Q 015041 153 AKKYR-DPTTNRHIP-YRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (414)
Q Consensus 153 a~~~~-~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~ 227 (414)
|..-. .+.....+. ..+.-....|+.|+|||++. +.+.++|+|||+|||+||-||....||++.. -..
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-------~la 265 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-------KLA 265 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-------cee
Confidence 86432 221111110 11112345699999999874 6679999999999999999999999998642 134
Q ss_pred HHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 228 i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
|+..++.+|.. ..++..|++||..||+.+|++||+..++...+-.+....
T Consensus 266 Ilng~Y~~P~~---p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 266 ILNGNYSFPPF---PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred EEeccccCCCC---ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 67778887764 355789999999999999999999877777666665443
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=326.69 Aligned_cols=283 Identities=18% Similarity=0.198 Sum_probs=209.1
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
+..++|++++.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+++.|+| ++|+.+..++......++|+|
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~----~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR----GGTATEAHILRAINH-PSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh----hhhHHHHHHHHhCCC-CCCCCEeEEEEECCeeEEEEe
Confidence 345789999999999999999999999999999996432 356889999999986 667677777777888999999
Q ss_pred ccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 84 ~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
++.++|..++.. ...+++.+++.++.||+.||+|||++|||||||||+|||+ +..+.+||+|||+|+........
T Consensus 164 ~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~~~- 238 (391)
T PHA03212 164 RYKTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPVDINAN- 238 (391)
T ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCccccccccccc-
Confidence 999998888765 4568999999999999999999999999999999999999 57889999999999753322111
Q ss_pred cccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhh----chHHHHHHHHhhccCCchHH
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA----TKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~----~~~~~~~~i~~~~~~~p~~~ 239 (414)
......||..|+|||++.+..++.++|||||||++|||++|..||...... .....+..++......|..
T Consensus 239 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~- 312 (391)
T PHA03212 239 -----KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE- 312 (391)
T ss_pred -----ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh-
Confidence 112567999999999999999999999999999999999999887643211 1122333333333222211
Q ss_pred hhhcChHHHHHH---HHHHhcCCCCCCCChHHHHH---HHHHHHHhcCCCCCccccccccccchhhhccccccCCCCccc
Q 015041 240 LCKSHPAEFASY---FHYCQSLTFDQRPDYGFLKR---LFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLLPASRVT 313 (414)
Q Consensus 240 ~~~~~p~~~~~l---~~~c~~~~p~~RP~~~~l~~---~l~~~~~~~~~~~~~~~dw~~l~~~~~~~~~~~~~l~~~~~~ 313 (414)
+.......+..+ ........|..||....+.. .+.+++. .||.++|.+|+++.++|.|||+.
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~------------~mL~~dP~~Rpta~elL~hp~f~ 380 (391)
T PHA03212 313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLIC------------KMLAFDAHHRPSAEALLDFAAFQ 380 (391)
T ss_pred cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHH------------HHhcCChhhCCCHHHHhcChhhc
Confidence 110001112222 12334455667776554332 2222222 67888899999999999999985
Q ss_pred c
Q 015041 314 N 314 (414)
Q Consensus 314 ~ 314 (414)
.
T Consensus 381 ~ 381 (391)
T PHA03212 381 D 381 (391)
T ss_pred c
Confidence 4
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=320.80 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=215.4
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
+...|.+.+.||.|.||.||+|+...+|+.+|+|++.+... ...+.+|+.+++.+.+|+++..+..........+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 55789999999999999999999999999999998876543 2468899999999997888999988888888999
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCC-CCeEEEeeecceeeec
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK-ANQVYIIDFGLAKKYR 157 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~-~~~vkL~DFG~a~~~~ 157 (414)
+|||++ |+.|.+.+... .+++..+..++.|++.++.|||+.||+||||||+|+|+...+. .+.+|++|||+|....
T Consensus 113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 999999 89999988865 4999999999999999999999999999999999999975433 4589999999998776
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
... .....+||+.|+|||++.+..|+..+||||+|+++|.|++|..||.+.... ....+|......++.
T Consensus 191 ~~~--------~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~---~~~~~i~~~~~~f~~ 259 (382)
T KOG0032|consen 191 PGE--------RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF---EIFLAILRGDFDFTS 259 (382)
T ss_pred CCc--------eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh---HHHHHHHcCCCCCCC
Confidence 521 124789999999999999999999999999999999999999999986543 344466666665543
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
+ .+...++..++++..++..||..|+++.++.
T Consensus 260 ~-~w~~is~~akd~i~~ll~~dp~~R~ta~~~L 291 (382)
T KOG0032|consen 260 E-PWDDISESAKDFIRKLLEFDPRKRLTAAQAL 291 (382)
T ss_pred C-CccccCHHHHHHHHHhcccCcccCCCHHHHh
Confidence 3 3456678899999999999999999987653
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=329.55 Aligned_cols=238 Identities=21% Similarity=0.317 Sum_probs=201.4
Q ss_pred EecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-CCCH
Q 015041 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSL 89 (414)
Q Consensus 11 i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~~sL 89 (414)
-+++||+|+.|.||+|+. .++.||||.++.- -..+|+-|++|+| ++|..|..++....-+||||||| .|.|
T Consensus 128 ELeWlGSGaQGAVF~Grl--~netVAVKKV~el-----kETdIKHLRkLkH-~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL--HNETVAVKKVREL-----KETDIKHLRKLKH-PNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeec--cCceehhHHHhhh-----hhhhHHHHHhccC-cceeeEeeeecCCceeEEeeeccccccH
Confidence 357899999999999987 5788999965432 2457888999987 56667888888888899999999 8889
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccccccC
Q 015041 90 EDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169 (414)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~ 169 (414)
..+++. ++.++......+..+|+.||.|||.+.|||||||.-||||+ .+..|||+|||.++...+..+.
T Consensus 200 ~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs---~~d~VKIsDFGTS~e~~~~STk------- 268 (904)
T KOG4721|consen 200 YEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS---YDDVVKISDFGTSKELSDKSTK------- 268 (904)
T ss_pred HHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee---ccceEEeccccchHhhhhhhhh-------
Confidence 888876 67899999999999999999999999999999999999995 7789999999999887665442
Q ss_pred CCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHH
Q 015041 170 NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFA 249 (414)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~ 249 (414)
-.++||..|||||+|...+.+.|+|||||||+||||+||..||.+.+.. ..+..+....+..|.+ ..+|+-|+
T Consensus 269 -MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---AIIwGVGsNsL~LpvP---stcP~Gfk 341 (904)
T KOG4721|consen 269 -MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---AIIWGVGSNSLHLPVP---STCPDGFK 341 (904)
T ss_pred -hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---eeEEeccCCcccccCc---ccCchHHH
Confidence 2789999999999999999999999999999999999999999874332 3333334445555555 45599999
Q ss_pred HHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 250 SYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 250 ~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
-|+++||...|-.||+|.+|+..|.
T Consensus 342 lL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 342 LLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred HHHHHHHhcCCCCCccHHHHHHHHh
Confidence 9999999999999999999987665
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=294.19 Aligned_cols=245 Identities=24% Similarity=0.331 Sum_probs=213.4
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
-++|.+++.||.|-||.||+|+..+++-.||+|++.+.. ...++.+|+++...|+| ++|-.++.++.+....|+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~h-pnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRH-PNILRLYGYFHDSKRIYL 99 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCC-ccHHhhhhheeccceeEE
Confidence 368999999999999999999999999999999866542 34568899999999986 667778888889999999
Q ss_pred EEecc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 81 VLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 81 v~e~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
++||. .|.+...+... ...+++.....++.|++.||.|+|.++||||||||+|+|++ ..+.+||+|||.+.....
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg---~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG---SAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC---CCCCeeccCCCceeecCC
Confidence 99999 77787777633 45699999999999999999999999999999999999995 889999999999875431
Q ss_pred CCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
....+++||.-|.+||+..+...+..+|+|++|++.||++.|.+||.... ..+.+.+|.......|
T Consensus 177 ---------~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~~~~~p-- 242 (281)
T KOG0580|consen 177 ---------NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKVDLKFP-- 242 (281)
T ss_pred ---------CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHccccCC--
Confidence 13358999999999999999999999999999999999999999999754 5677888888777777
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...+...+++|.+|+.++|.+|....++.+
T Consensus 243 ---~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 243 ---STISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ---cccChhHHHHHHHHhccCccccccHHHHhh
Confidence 556889999999999999999998776644
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=319.22 Aligned_cols=241 Identities=22% Similarity=0.318 Sum_probs=200.4
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
+|++.+.||+|+||+||+|++..+++.||+|++.... ....+..|..++..+.|+++++.+..++......++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999886432 22346678888888888888888888888888899999
Q ss_pred ecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCCCCc
Confidence 999 7888887765 4569999999999999999999999999999999999999 5788999999999875432221
Q ss_pred CccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhh
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~ 241 (414)
......||..|+|||++.+..++.++|||||||++|+|++|..||.+.... ..+..+.......|
T Consensus 157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i~~~~~~~p----- 221 (323)
T cd05615 157 -------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQSIMEHNVSYP----- 221 (323)
T ss_pred -------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-----
Confidence 123567899999999999999999999999999999999999999875432 34444544444333
Q ss_pred hcChHHHHHHHHHHhcCCCCCCCChH
Q 015041 242 KSHPAEFASYFHYCQSLTFDQRPDYG 267 (414)
Q Consensus 242 ~~~p~~~~~l~~~c~~~~p~~RP~~~ 267 (414)
..++.++.+++..||..+|.+|++..
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 222 KSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 34578999999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=324.54 Aligned_cols=254 Identities=22% Similarity=0.305 Sum_probs=206.9
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEec-CCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-SGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~-~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
|-+..|+++++||+||.+.||++...+.+ .||+|.+. ...+. ..+.+|+..|.+|+++..|..+++|...+...|
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 55789999999999999999999875544 45555433 33222 347899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 80 lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
||||+-..+|..++......++...++.+..||+.|+.++|..||||.||||+|||+ -.|.+||+|||.|......
T Consensus 437 mvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl----VkG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 437 MVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL----VKGRLKLIDFGIANAIQPD 512 (677)
T ss_pred EEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE----EeeeEEeeeechhcccCcc
Confidence 999999999999998766666666899999999999999999999999999999999 7899999999999988776
Q ss_pred CCCccccccCCCCCccCcCccccccccCCC-----------CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIE-----------QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i 228 (414)
.+... ...-+||..|||||.+.... .++++||||||||||+|+.|+.||.... +...++..|
T Consensus 513 TTsI~-----kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI 585 (677)
T KOG0596|consen 513 TTSIV-----KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAI 585 (677)
T ss_pred cccee-----eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhh
Confidence 65432 23568999999999997443 4689999999999999999999998643 344556666
Q ss_pred HhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 229 ~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+-...++.+...+ +.++.++|+.||..||++||+..+|++
T Consensus 586 ~~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 586 TDPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred cCCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 55544444333332 234899999999999999999887654
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=317.19 Aligned_cols=248 Identities=23% Similarity=0.286 Sum_probs=193.2
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|++++.||+|+||+||+|++..+++.||+|++... .....+..|+.++..+. +++++.+..++......++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD-RRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCceEEEEecCCeEEEE
Confidence 4799999999999999999999999999999987642 12234677888888775 47777887778888899999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCC
Confidence 9998 889999987666779999999999999999999999999999999999999 588899999999997654332
Q ss_pred CCccccccCCCCCccCcCccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
.. ......||..|+|||++.. ..++.++|||||||++|+|++|+.||.+.... +.+.++.......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~---~~~~~i~~~~~~~ 227 (331)
T cd05597 157 TV------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHKEHF 227 (331)
T ss_pred Cc------cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH---HHHHHHHcCCCcc
Confidence 21 1123468999999999873 45788999999999999999999999875432 3333443332222
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCC---CCChHH
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQ---RPDYGF 268 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~---RP~~~~ 268 (414)
..+.....+++.+.+++..|+.. +.+ |+++++
T Consensus 228 ~~~~~~~~~~~~~~~li~~ll~~-~~~r~~r~~~~~ 262 (331)
T cd05597 228 QFPPDVTDVSEEAKDLIRRLICS-PETRLGRNGLQD 262 (331)
T ss_pred cCCCccCCCCHHHHHHHHHHccC-cccccCCCCHHH
Confidence 22222234678899999988764 333 445443
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=325.21 Aligned_cols=256 Identities=21% Similarity=0.330 Sum_probs=202.2
Q ss_pred CCceEEecceeecCceeEEEEEE-----CCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
.++|+++++||+|+||.||+|++ ..++..||||+++.... ...+.+|+.++..+.+|++++.+..++..+..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45899999999999999999975 34567899998865432 23578899999999667888888888888889
Q ss_pred eEEEEecc-CCCHHHHHHHhC-----------------------------------------------------------
Q 015041 78 NVLVLDLL-GPSLEDLFVYCR----------------------------------------------------------- 97 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~----------------------------------------------------------- 97 (414)
.++||||+ +++|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999999 889988886421
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 98 ---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 98 ---------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
..+++..++.++.||+.||+|||++||+||||||+|||+ +..+.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE---ECCCcEEEecCccceeccCcccc
Confidence 136778899999999999999999999999999999999 47788999999999865432211
Q ss_pred ccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhh
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~ 241 (414)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+..... .+.+.+........+
T Consensus 271 -----~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~---~~~~~~~~~~~~~~~--- 339 (375)
T cd05104 271 -----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS---KFYKMIKEGYRMLSP--- 339 (375)
T ss_pred -----cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH---HHHHHHHhCccCCCC---
Confidence 01122345678999999999999999999999999999998 899998754322 222222222222211
Q ss_pred hcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 015041 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (414)
Q Consensus 242 ~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~ 275 (414)
...|.++.+++..||..+|++||++.++.+.|++
T Consensus 340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 2347899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=316.90 Aligned_cols=236 Identities=22% Similarity=0.324 Sum_probs=192.7
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-C
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 86 (414)
+.||+|+||.||+|++..+++.||||++.... .......|..++..+.+|++++.+...+......++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999876532 22335567777776667788888887777888999999999 8
Q ss_pred CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcccc
Q 015041 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (414)
Q Consensus 87 ~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~ 166 (414)
++|.+++.. ...++...+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~----- 151 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEG----- 151 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCC-----
Confidence 888887765 4578999999999999999999999999999999999999 5788999999999976433221
Q ss_pred ccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChH
Q 015041 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (414)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~ 246 (414)
.....+||..|+|||++.+..++.++|||||||++|||++|..||.+.... +.+..+.......| ..++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~~~i~~~~~~~~-----~~~~~ 221 (316)
T cd05592 152 --KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELFDSILNDRPHFP-----RWISK 221 (316)
T ss_pred --ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCCCC-----CCCCH
Confidence 123567899999999999999999999999999999999999999875432 33333433322222 34578
Q ss_pred HHHHHHHHHhcCCCCCCCChH
Q 015041 247 EFASYFHYCQSLTFDQRPDYG 267 (414)
Q Consensus 247 ~~~~l~~~c~~~~p~~RP~~~ 267 (414)
++.+++..||..+|.+||+..
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~ 242 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVD 242 (316)
T ss_pred HHHHHHHHHccCCHHHcCCCh
Confidence 999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=317.69 Aligned_cols=272 Identities=21% Similarity=0.301 Sum_probs=208.7
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
++..++|++.++||.|+||.||+|.+..++..||+|++...... ..+.+|+++++.+.| ++++.+..++......+
T Consensus 1 ~l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEIS 79 (333)
T ss_pred CcchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCC-CcccceeEEEEECCEEE
Confidence 45678999999999999999999999999999999987754322 457899999999975 66777777777788999
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
+||||+ +++|.+++.. ...++...+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++....
T Consensus 80 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 80 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchhhh
Confidence 999999 7899998875 45689999999999999999999985 79999999999999 577889999999987553
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHH-----------
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD----------- 226 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~----------- 226 (414)
.... ....||..|+|||++.+..++.++|||||||++|+|++|+.||...........+.
T Consensus 156 ~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (333)
T cd06650 156 DSMA---------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESE 226 (333)
T ss_pred hhcc---------ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccc
Confidence 3211 24578999999999999899999999999999999999999997643221111000
Q ss_pred --------------------------HHHhhccCCchHHh-hhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 227 --------------------------KICEKKVSTPIEVL-CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 227 --------------------------~i~~~~~~~p~~~~-~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
.+.......+.+.. ...++.++.+|+.+||..||++||++.++.. +.++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~--h~~~~~ 304 (333)
T cd06650 227 TSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV--HAFIKR 304 (333)
T ss_pred cCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh--CHHHhc
Confidence 00000000000000 1134678999999999999999999988754 455544
Q ss_pred cCCCCCccccc
Q 015041 280 EGYDFDFVFDW 290 (414)
Q Consensus 280 ~~~~~~~~~dw 290 (414)
...+..+...|
T Consensus 305 ~~~~~~~~~~~ 315 (333)
T cd06650 305 SEAEEVDFAGW 315 (333)
T ss_pred CccccccHHHH
Confidence 43344444455
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=320.47 Aligned_cols=238 Identities=24% Similarity=0.330 Sum_probs=196.5
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCC-ceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTN-EIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~-~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
+.-++|++.++||.|+||.||+|.+..++ ..||+|.+... .....+..|+.+++.+.| ++++.+..++.....
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH-PFCVNLYGSFKDESY 105 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC-CCCcceEEEEEeCCE
Confidence 34568999999999999999999876554 68999987542 223457789999999975 667777777788889
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
.++||||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeec
Confidence 99999999 7889888875 4578999999999999999999999999999999999999 57899999999999765
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCc
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p 236 (414)
.... ....||..|+|||++.+..++.++|||||||++|||++|..||.+.... ..+..+.......|
T Consensus 182 ~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~~~i~~~~~~~p 248 (340)
T PTZ00426 182 DTRT----------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---LIYQKILEGIIYFP 248 (340)
T ss_pred CCCc----------ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---HHHHHHhcCCCCCC
Confidence 3211 2567899999999999989999999999999999999999999875432 33444444433333
Q ss_pred hHHhhhcChHHHHHHHHHHhcCCCCCCC
Q 015041 237 IEVLCKSHPAEFASYFHYCQSLTFDQRP 264 (414)
Q Consensus 237 ~~~~~~~~p~~~~~l~~~c~~~~p~~RP 264 (414)
..++..+.+++.+|+..+|.+|+
T Consensus 249 -----~~~~~~~~~li~~~l~~dp~~R~ 271 (340)
T PTZ00426 249 -----KFLDNNCKHLMKKLLSHDLTKRY 271 (340)
T ss_pred -----CCCCHHHHHHHHHHcccCHHHcC
Confidence 34578899999999999999996
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=315.39 Aligned_cols=254 Identities=19% Similarity=0.299 Sum_probs=198.2
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
+..++|++++.||+|+||.||+|++..++..||+|++..... ...+.+|+++++.++| +++..+..++......++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCC-CCCCeEEEEEEECCEEEE
Confidence 556899999999999999999999999999999998875432 2458899999999976 567677677777788999
Q ss_pred EEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 81 v~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
||||+ +++|.+++.. ...++...+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 81 CMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred EeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCcccccccc
Confidence 99999 7799888875 45689999999999999999999986 69999999999999 5788999999999876543
Q ss_pred CCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHH-----------
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK----------- 227 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~----------- 227 (414)
... ....||..|+|||++.+..++.++|||||||++|||++|+.||...........+..
T Consensus 157 ~~~---------~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (331)
T cd06649 157 SMA---------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPH 227 (331)
T ss_pred ccc---------ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCcc
Confidence 221 245789999999999999999999999999999999999999975433211111000
Q ss_pred ----------------------------HHhhccCC-chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 228 ----------------------------ICEKKVST-PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 228 ----------------------------i~~~~~~~-p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
........ +.......++.++.+|+.+||..||++||++++|.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~ 300 (331)
T cd06649 228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN 300 (331)
T ss_pred ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 000001134678889999999999999999887644
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=316.92 Aligned_cols=239 Identities=22% Similarity=0.321 Sum_probs=193.5
Q ss_pred eEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHc--CCCCCCeeEEeeeeCCeeEEE
Q 015041 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~--~~~~i~~l~~~~~~~~~~~lv 81 (414)
|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|++++..+. .|+++..+..++......++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 789999999999999999999999999999886432 1234666777665443 357777777777888899999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|...+. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCC
Confidence 9999 777776654 4579999999999999999999999999999999999999 588999999999987533221
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
. .....+||..|+|||++.+..++.++|||||||++|||++|..||.+.... +.+..+.......|
T Consensus 156 ~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~~~~~i~~~~~~~p---- 221 (324)
T cd05589 156 D-------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---EVFDSIVNDEVRYP---- 221 (324)
T ss_pred C-------cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC----
Confidence 1 123567999999999999999999999999999999999999999875433 33334444333333
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChH
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYG 267 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~ 267 (414)
..++..+.+++.+||..+|.+||+..
T Consensus 222 -~~~~~~~~~li~~~L~~dP~~R~~~~ 247 (324)
T cd05589 222 -RFLSREAISIMRRLLRRNPERRLGSG 247 (324)
T ss_pred -CCCCHHHHHHHHHHhhcCHhHcCCCC
Confidence 34578999999999999999999653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=317.82 Aligned_cols=235 Identities=20% Similarity=0.291 Sum_probs=194.0
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-C
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 86 (414)
+.||+|+||+||+|++..+++.||||++.... ....+..|.+++..+.+|+++..+..++......++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 47999999999999999999999999876532 22346678888887777888988888888888999999999 7
Q ss_pred CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcccc
Q 015041 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (414)
Q Consensus 87 ~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~ 166 (414)
++|.+.+.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~----- 151 (321)
T cd05591 81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGV----- 151 (321)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCc-----
Confidence 788877765 4578999999999999999999999999999999999999 5888999999999875433221
Q ss_pred ccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChH
Q 015041 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (414)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~ 246 (414)
......||..|+|||++.+..++.++|||||||++|||++|+.||.+.... ..+..+.......| ..++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~~~i~~~~~~~p-----~~~~~ 221 (321)
T cd05591 152 --TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFESILHDDVLYP-----VWLSK 221 (321)
T ss_pred --cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCCCCC-----CCCCH
Confidence 123567899999999999999999999999999999999999999875433 34444444433333 23478
Q ss_pred HHHHHHHHHhcCCCCCCCCh
Q 015041 247 EFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 247 ~~~~l~~~c~~~~p~~RP~~ 266 (414)
++.+++..||..+|++||+.
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~ 241 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGC 241 (321)
T ss_pred HHHHHHHHHhccCHHHcCCC
Confidence 99999999999999999953
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=318.58 Aligned_cols=237 Identities=24% Similarity=0.333 Sum_probs=192.3
Q ss_pred eeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-CCC
Q 015041 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (414)
Q Consensus 15 iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~~s 88 (414)
||+|+||.||+|++..+++.||+|++.... ....+..|+.+++.+.| ++++.+...+......++||||+ +++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNC-PFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 799999999999999999999999876421 22346789999999875 55666666666778899999999 888
Q ss_pred HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcccccc
Q 015041 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168 (414)
Q Consensus 89 L~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 168 (414)
|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~------- 148 (312)
T cd05585 80 LFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDD------- 148 (312)
T ss_pred HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCC-------
Confidence 9888865 4578999999999999999999999999999999999999 5888999999999875332211
Q ss_pred CCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHH
Q 015041 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEF 248 (414)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~ 248 (414)
.....+||..|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+.......+ ..+++++
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~---~~~~~~~~~~~~~~~-----~~~~~~~ 220 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV---NEMYRKILQEPLRFP-----DGFDRDA 220 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH---HHHHHHHHcCCCCCC-----CcCCHHH
Confidence 12356789999999999999999999999999999999999999987543 233444444433333 4567899
Q ss_pred HHHHHHHhcCCCCCCCChHHHHH
Q 015041 249 ASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 249 ~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+++..||..+|.+||++..+.+
T Consensus 221 ~~li~~~L~~dp~~R~~~~~~~e 243 (312)
T cd05585 221 KDLLIGLLSRDPTRRLGYNGAQE 243 (312)
T ss_pred HHHHHHHcCCCHHHcCCCCCHHH
Confidence 99999999999999998644433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=317.74 Aligned_cols=232 Identities=22% Similarity=0.329 Sum_probs=189.5
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-C
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 86 (414)
+.||+|+||.||+|++..+|..||+|++.... ....+..|+.+++.+.| +++..+...+......++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC-CCCcceeeEEecCCEEEEEEeCCCC
Confidence 47999999999999999999999999876432 22345678999998876 56777777777788899999999 7
Q ss_pred CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcccc
Q 015041 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (414)
Q Consensus 87 ~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~ 166 (414)
++|...+.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~----- 150 (323)
T cd05595 80 GELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA----- 150 (323)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCC-----
Confidence 788777654 4578999999999999999999999999999999999999 5788999999999875332211
Q ss_pred ccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChH
Q 015041 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (414)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~ 246 (414)
......||..|+|||++.+..++.++|||||||++|||++|+.||.+.+.. ..+..+.......| ..+++
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~~~~~~~~~~p-----~~~~~ 220 (323)
T cd05595 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELILMEEIRFP-----RTLSP 220 (323)
T ss_pred --ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHhcCCCCCC-----CCCCH
Confidence 113467899999999999999999999999999999999999999864432 33333333333333 35678
Q ss_pred HHHHHHHHHhcCCCCCCC
Q 015041 247 EFASYFHYCQSLTFDQRP 264 (414)
Q Consensus 247 ~~~~l~~~c~~~~p~~RP 264 (414)
++.+++..||..+|.+|+
T Consensus 221 ~~~~li~~~L~~dP~~R~ 238 (323)
T cd05595 221 EAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred HHHHHHHHHccCCHHHhC
Confidence 999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=322.68 Aligned_cols=252 Identities=21% Similarity=0.337 Sum_probs=192.9
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|+++++||+|+||+||+|.+..+++.||||++.... ....+..|+.++..+.| ++++.+...+.+....++|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~-~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS-LWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCC-CCcceEEEEEecCCeEEEE
Confidence 47999999999999999999999999999999986532 12346778899988865 6677777777788889999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 80 MEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCcccccccc
Confidence 9999 7889888875 4679999999999999999999999999999999999999 578899999999987543211
Q ss_pred CCc-------ccc---------------------ccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 015041 161 TNR-------HIP---------------------YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212 (414)
Q Consensus 161 ~~~-------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~P 212 (414)
... ..+ .......+||..|+|||++.+..++.++|||||||++|||++|..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 000 000 0001245799999999999999999999999999999999999999
Q ss_pred CCCChhhchHHHHHHHHhhc--cCCchHHhhhcChHHHHHHHHHHhcCCCC---CCCChHHHH
Q 015041 213 WQGLKAATKKQKYDKICEKK--VSTPIEVLCKSHPAEFASYFHYCQSLTFD---QRPDYGFLK 270 (414)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~--~~~p~~~~~~~~p~~~~~l~~~c~~~~p~---~RP~~~~l~ 270 (414)
|.+.... +.+.++...+ ...|.. ..+++++.+++.+++. ++. .||++++|.
T Consensus 236 f~~~~~~---~~~~~i~~~~~~~~~p~~---~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~ 291 (363)
T cd05628 236 FCSETPQ---ETYKKVMNWKETLIFPPE---VPISEKAKDLILRFCC-EWEHRIGAPGVEEIK 291 (363)
T ss_pred CCCCCHH---HHHHHHHcCcCcccCCCc---CCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence 9875433 3344444322 222211 1245778888887543 344 456766553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=308.09 Aligned_cols=252 Identities=19% Similarity=0.244 Sum_probs=194.2
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHc--CCCCCCeeEEeeee-----CC
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQ--GGSGIPNIKWYGVD-----GE 76 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~--~~~~i~~l~~~~~~-----~~ 76 (414)
+|++.+.||+|+||+||+|++..+++.||+|.+..... .....+|+.+++.+. .|+++..+..++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 69999999999999999999999999999998765322 234667888888775 34666665544332 34
Q ss_pred eeEEEEeccCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 77 DNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 77 ~~~lv~e~~~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
..+++||++.++|.+++.... ..++...++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccCcccc
Confidence 579999999889988887543 458999999999999999999999999999999999999 5788999999999976
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhh----
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK---- 231 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~---- 231 (414)
...... .....||..|+|||++.+..++.++|||||||++|+|++|..||.+.........+......
T Consensus 158 ~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07863 158 YSCQMA--------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 229 (288)
T ss_pred ccCccc--------CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChh
Confidence 543211 12456789999999999999999999999999999999999999875443333222221110
Q ss_pred ---------------ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 232 ---------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 232 ---------------~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
....+.......+++.+.+++.+|+..||++||++.++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l 283 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHh
Confidence 001111223345677888999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=325.51 Aligned_cols=246 Identities=23% Similarity=0.333 Sum_probs=191.2
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|+++++||+|+||+||+|.+..+++.||||++.... ....+.+|+++++.+.| ++++.+..++.+....++|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS-PWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCC-CCcceEEEEEEcCCeeEEE
Confidence 47999999999999999999999999999999875432 12346789999988865 6777787777888899999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 80 ~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 80 MEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeeccccccccccc
Confidence 9999 8899888865 4578999999999999999999999999999999999999 578899999999996432211
Q ss_pred CCcc----------c-c------------------------c-----cCCCCCccCcCccccccccCCCCCchhhHHHHH
Q 015041 161 TNRH----------I-P------------------------Y-----RENKNLTGTARYASCNTHLGIEQSRRDDLESLG 200 (414)
Q Consensus 161 ~~~~----------~-~------------------------~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG 200 (414)
.... . + + ......+||..|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 0000 0 0 0 000135799999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCChhhchHHHHHHHHhhc--cCCchHHhhhcChHHHHHHHHHHhcCCCCCCC
Q 015041 201 YVLLYFLRGSLPWQGLKAATKKQKYDKICEKK--VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 264 (414)
Q Consensus 201 ~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~--~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP 264 (414)
|++|||++|..||.+.... +.+..+.... ...|.. ..++.++.+++.+|+. +|.+|+
T Consensus 236 vil~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~~p~~---~~~s~~~~dli~~lL~-~~~~r~ 294 (377)
T cd05629 236 AIMFECLIGWPPFCSENSH---ETYRKIINWRETLYFPDD---IHLSVEAEDLIRRLIT-NAENRL 294 (377)
T ss_pred hhhhhhhcCCCCCCCCCHH---HHHHHHHccCCccCCCCC---CCCCHHHHHHHHHHhc-CHhhcC
Confidence 9999999999999875432 3333333221 221211 1346788999999996 777764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=314.93 Aligned_cols=236 Identities=21% Similarity=0.309 Sum_probs=191.5
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-C
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 86 (414)
+.||+|+||.||+|++..+++.||+|++... ........|..++..+.+++++..+..++......++||||+ +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999988653 222346677778777667788888888888888999999999 7
Q ss_pred CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcccc
Q 015041 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (414)
Q Consensus 87 ~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~ 166 (414)
++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||+++.......
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDN----- 151 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCC-----
Confidence 788887765 4568999999999999999999999999999999999999 5788999999999874322111
Q ss_pred ccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChH
Q 015041 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (414)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~ 246 (414)
.....+||..|+|||++.+..++.++|||||||++|||++|..||.+.... +.+..+.......| ..++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~~~~~~~~~~-----~~~~~ 221 (316)
T cd05620 152 --RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFESIRVDTPHYP-----RWITK 221 (316)
T ss_pred --ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-----CCCCH
Confidence 123567899999999999999999999999999999999999999875433 22222222221111 34578
Q ss_pred HHHHHHHHHhcCCCCCCCChH
Q 015041 247 EFASYFHYCQSLTFDQRPDYG 267 (414)
Q Consensus 247 ~~~~l~~~c~~~~p~~RP~~~ 267 (414)
++.+++..||..+|.+||+..
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~ 242 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVV 242 (316)
T ss_pred HHHHHHHHHccCCHHHcCCCh
Confidence 999999999999999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=316.16 Aligned_cols=237 Identities=18% Similarity=0.278 Sum_probs=194.3
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-C
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 86 (414)
+.||+|+||+||+|++..+++.||||++.... ....+..|..++..+.+|++++.+..++......++||||+ +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999876431 22345678888887777788888888888888999999999 7
Q ss_pred CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcccc
Q 015041 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (414)
Q Consensus 87 ~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~ 166 (414)
++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~----- 151 (320)
T cd05590 81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGK----- 151 (320)
T ss_pred chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCC-----
Confidence 788877765 4579999999999999999999999999999999999999 5788999999999875332211
Q ss_pred ccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChH
Q 015041 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (414)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~ 246 (414)
......||..|+|||++.+..++.++|||||||++|+|++|..||.+.... +.+..+.......| ...+.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~~~i~~~~~~~~-----~~~~~ 221 (320)
T cd05590 152 --TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DLFEAILNDEVVYP-----TWLSQ 221 (320)
T ss_pred --cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHHHhcCCCCCC-----CCCCH
Confidence 123567899999999999999999999999999999999999999875433 33444444333322 34578
Q ss_pred HHHHHHHHHhcCCCCCCCChHH
Q 015041 247 EFASYFHYCQSLTFDQRPDYGF 268 (414)
Q Consensus 247 ~~~~l~~~c~~~~p~~RP~~~~ 268 (414)
++.+++..||..+|.+||+..+
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred HHHHHHHHHcccCHHHCCCCCC
Confidence 9999999999999999998743
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=311.59 Aligned_cols=203 Identities=25% Similarity=0.360 Sum_probs=171.6
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
.+|++.++||+|+||.||+|++..+++.||+|.+.... ....+.+|+.+++.++| +++..+..++......++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKH-ANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCC-CCcceEEEEEeeCCeEEEEEe
Confidence 67999999999999999999999999999999876432 22356789999999976 566677777777888999999
Q ss_pred ccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 84 ~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
|+.++|.+.+......++...+..++.||+.||+|||++||+||||||+|||+ +..+.+||+|||+++.......
T Consensus 85 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~-- 159 (309)
T cd07872 85 YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPTK-- 159 (309)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceecCCCcc--
Confidence 99889998887766678999999999999999999999999999999999999 5788999999999976433221
Q ss_pred cccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhc
Q 015041 164 HIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT 220 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~ 220 (414)
......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 160 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 212 (309)
T cd07872 160 -----TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED 212 (309)
T ss_pred -----ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 1124467899999999875 458999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=317.46 Aligned_cols=232 Identities=22% Similarity=0.326 Sum_probs=188.1
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-C
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 86 (414)
+.||+|+||.||+|++..++..||+|++.... ....+..|++++..+.| ++++.+..++......++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~h-p~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH-PFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999886532 12345678888888765 67777777777888999999999 7
Q ss_pred CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccc
Q 015041 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (414)
Q Consensus 87 ~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 165 (414)
++|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~---- 151 (325)
T cd05594 80 GELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGA---- 151 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCc----
Confidence 788776654 4578999999999999999999997 799999999999999 5888999999999875432221
Q ss_pred cccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcCh
Q 015041 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (414)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p 245 (414)
......||..|+|||++.+..++.++|||||||++|||++|..||.+.... .....+.......| ..++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~~~i~~~~~~~p-----~~~~ 220 (325)
T cd05594 152 ---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILMEEIRFP-----RTLS 220 (325)
T ss_pred ---ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHHHHHhcCCCCCC-----CCCC
Confidence 112457999999999999999999999999999999999999999874432 23333333333322 3457
Q ss_pred HHHHHHHHHHhcCCCCCCC
Q 015041 246 AEFASYFHYCQSLTFDQRP 264 (414)
Q Consensus 246 ~~~~~l~~~c~~~~p~~RP 264 (414)
+++.+++..||..+|.+|+
T Consensus 221 ~~~~~li~~~L~~dP~~R~ 239 (325)
T cd05594 221 PEAKSLLSGLLKKDPKQRL 239 (325)
T ss_pred HHHHHHHHHHhhcCHHHhC
Confidence 8999999999999999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=324.08 Aligned_cols=253 Identities=23% Similarity=0.302 Sum_probs=193.7
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|+++++||+|+||+||+|++..+++.||||++... .....+.+|+.++..+.| ++++.+...+......++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN-EWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCC-CCcceEEEEEEcCCEEEEE
Confidence 4799999999999999999999999999999987642 123447789999999976 5666777777778899999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++.. ...++...+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|..+....
T Consensus 80 ~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 80 MDYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCccccccc
Confidence 9999 8899998875 4568999999999999999999999999999999999999 588899999999985332110
Q ss_pred CCcc------------------------------------ccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHH
Q 015041 161 TNRH------------------------------------IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL 204 (414)
Q Consensus 161 ~~~~------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~ 204 (414)
.... .........+||..|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0000 0000112457999999999999999999999999999999
Q ss_pred HHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCC---ChHHH
Q 015041 205 YFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP---DYGFL 269 (414)
Q Consensus 205 el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP---~~~~l 269 (414)
||++|+.||.+..... ....+.........+ ....++.++.+++.+|+ .+|.+|+ ++.++
T Consensus 236 ell~G~~Pf~~~~~~~---~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 236 EMLVGQPPFLADTPAE---TQLKVINWETTLHIP-SQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred ehhhCCCCCCCCCHHH---HHHHHhccCccccCC-CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 9999999998754332 222222211111111 11245678888888876 5899998 54444
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=313.26 Aligned_cols=236 Identities=23% Similarity=0.329 Sum_probs=191.7
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-C
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 86 (414)
+.||+|+||+||+|++..+++.||||++... ........|..++..+.+|++++.+..++......++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999987653 222345677777777666788888888888888999999999 7
Q ss_pred CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcccc
Q 015041 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (414)
Q Consensus 87 ~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~ 166 (414)
++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDA----- 151 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCC-----
Confidence 899888875 4568999999999999999999999999999999999999 5788999999999875332211
Q ss_pred ccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChH
Q 015041 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (414)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~ 246 (414)
......||..|+|||++.+..++.++|||||||++|||++|..||.+.... +.+..+.......| ..++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i~~~~~~~~-----~~~~~ 221 (316)
T cd05619 152 --KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSIRMDNPCYP-----RWLTR 221 (316)
T ss_pred --ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-----ccCCH
Confidence 113567899999999999999999999999999999999999999875433 22333322222212 33578
Q ss_pred HHHHHHHHHhcCCCCCCCChH
Q 015041 247 EFASYFHYCQSLTFDQRPDYG 267 (414)
Q Consensus 247 ~~~~l~~~c~~~~p~~RP~~~ 267 (414)
++.+++.+||..+|.+||++.
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~ 242 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVK 242 (316)
T ss_pred HHHHHHHHHhccCHhhcCCCh
Confidence 899999999999999999985
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=317.31 Aligned_cols=232 Identities=22% Similarity=0.332 Sum_probs=189.1
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-C
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 86 (414)
+.||+|+||.||+|++..++..||+|++.... ....+.+|+.+++.+.| ++++.+..++......++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRH-PFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCcceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999886532 22346788899988876 66777777777888999999999 7
Q ss_pred CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcccc
Q 015041 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (414)
Q Consensus 87 ~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~ 166 (414)
++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~----- 150 (328)
T cd05593 80 GELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAA----- 150 (328)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccc-----
Confidence 788777654 4578999999999999999999999999999999999999 5788999999999875332211
Q ss_pred ccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChH
Q 015041 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (414)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~ 246 (414)
.....+||..|+|||++.+..++.++|||||||++|+|++|..||.+.+.. +....+.......| ..++.
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~~~~~~~~~~~p-----~~~~~ 220 (328)
T cd05593 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILMEDIKFP-----RTLSA 220 (328)
T ss_pred --ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HHHHHhccCCccCC-----CCCCH
Confidence 113467899999999999999999999999999999999999999864432 22333333222222 45678
Q ss_pred HHHHHHHHHhcCCCCCCC
Q 015041 247 EFASYFHYCQSLTFDQRP 264 (414)
Q Consensus 247 ~~~~l~~~c~~~~p~~RP 264 (414)
++.+++..||..+|.+|+
T Consensus 221 ~~~~li~~~L~~dP~~R~ 238 (328)
T cd05593 221 DAKSLLSGLLIKDPNKRL 238 (328)
T ss_pred HHHHHHHHHcCCCHHHcC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=323.26 Aligned_cols=249 Identities=22% Similarity=0.329 Sum_probs=195.5
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|++++.||.|+||+||+|++..+++.||||++.... ....+..|+.++..+.| ++++.+...+......++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN-PWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCcceEEEEEcCCeEEEE
Confidence 47999999999999999999999999999999886432 12346789999999874 7777777777888899999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 80 ~E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 80 MEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred ECCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceeccccc
Confidence 9999 7888888765 4569999999999999999999999999999999999999 588999999999987643221
Q ss_pred CCccc-----------------c---------cc-----CCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcC
Q 015041 161 TNRHI-----------------P---------YR-----ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG 209 (414)
Q Consensus 161 ~~~~~-----------------~---------~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG 209 (414)
..... + +. .....+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 10000 0 00 01135799999999999999999999999999999999999
Q ss_pred CCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCC
Q 015041 210 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265 (414)
Q Consensus 210 ~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~ 265 (414)
..||.+.... +.+..+.........+. ...+++++.+++.+|+. +|.+|++
T Consensus 236 ~~Pf~~~~~~---~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~ 286 (364)
T cd05599 236 YPPFCSDNPQ---ETYRKIINWKETLQFPD-EVPLSPEAKDLIKRLCC-EAERRLG 286 (364)
T ss_pred CCCCCCCCHH---HHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-CHhhcCC
Confidence 9999875433 33333333222111111 12357889999999986 8999987
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=320.96 Aligned_cols=260 Identities=19% Similarity=0.254 Sum_probs=205.6
Q ss_pred cCCceEEecceeecCceeEEEEEECCC-----CceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
-.++|++++.||.|+||.||+|.+... +..||||++..... ...+.+|+++++.+..|++++.+..++....
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 367888999999999999999987433 34699998865433 2357889999999976688888888888888
Q ss_pred eeEEEEecc-CCCHHHHHHHhC----------------------------------------------------------
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCR---------------------------------------------------------- 97 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~---------------------------------------------------------- 97 (414)
..++||||+ +++|.+++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 899999999 889988876421
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCC
Q 015041 98 -------------------------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 140 (414)
Q Consensus 98 -------------------------------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~ 140 (414)
..+++..++.++.||+.||+|||+++|+||||||+|||+ +
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill---~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL---A 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE---e
Confidence 236778889999999999999999999999999999999 4
Q ss_pred CCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhh
Q 015041 141 KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAA 219 (414)
Q Consensus 141 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~ 219 (414)
.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNY-----VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred CCCEEEEEeCCcceeccccccc-----cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 7888999999999865432211 11223456788999999999999999999999999999997 99999875332
Q ss_pred chHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 220 TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 220 ~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
. .+...+......+. ...+|.++.+++.+||..+|++||++.+|.+.|+.+++
T Consensus 347 ~---~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 347 S---TFYNKIKSGYRMAK---PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred H---HHHHHHhcCCCCCC---CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1 11122222222222 13558899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=296.56 Aligned_cols=251 Identities=25% Similarity=0.309 Sum_probs=209.6
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
.+...|.+.+.||+|.|+.||++.+..+|+.+|+|+++.. ...+.+.+|+.+-..|+| ++|+.+..........+
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqH-P~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESFHY 86 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCC-CcEeehhhhhcccceeE
Confidence 4667899999999999999999999999999999987643 345678899999988886 66777766666777889
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
||+|++ |+.|..-+.. +.-+++..+..+++||+.||.|+|.+||||||+||+|+++...+....+||+|||+|....+
T Consensus 87 lvFe~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred EEEecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 999999 6666555543 34578899999999999999999999999999999999998777778899999999988763
Q ss_pred CCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
.. ....++||+.|||||++...+|+..+|||+.|+|||-++.|.+||.+.+ ....+..|....+..+.+
T Consensus 166 g~--------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~---~~rlye~I~~g~yd~~~~ 234 (355)
T KOG0033|consen 166 GE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYEQIKAGAYDYPSP 234 (355)
T ss_pred cc--------ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc---HHHHHHHHhccccCCCCc
Confidence 22 2347899999999999999999999999999999999999999999843 345677787888777754
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~ 268 (414)
. +.+..++.++|+++++..||.+|.++.+
T Consensus 235 ~-w~~is~~Ak~LvrrML~~dP~kRIta~E 263 (355)
T KOG0033|consen 235 E-WDTVTPEAKSLIRRMLTVNPKKRITADE 263 (355)
T ss_pred c-cCcCCHHHHHHHHHHhccChhhhccHHH
Confidence 3 3566788888888888888888877543
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=312.94 Aligned_cols=235 Identities=22% Similarity=0.311 Sum_probs=194.0
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-C
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 86 (414)
+.||+|+||+||+|.+..+++.||||++.... ....+..|..++..+.+|++++.+..+.......++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999887432 22346678888888877788888888888888999999999 7
Q ss_pred CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcccc
Q 015041 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (414)
Q Consensus 87 ~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~ 166 (414)
++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (318)
T cd05570 81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGV----- 151 (318)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCC-----
Confidence 888877765 4579999999999999999999999999999999999999 5788999999999875322211
Q ss_pred ccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChH
Q 015041 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (414)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~ 246 (414)
.....+||..|+|||++.+..++.++|||||||++|+|++|..||.+.... ..+..+.......| ..+++
T Consensus 152 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~~~i~~~~~~~~-----~~~~~ 221 (318)
T cd05570 152 --TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELFQSILEDEVRYP-----RWLSK 221 (318)
T ss_pred --cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHHHHHHcCCCCCC-----CcCCH
Confidence 112457899999999999999999999999999999999999999875432 33334444333332 34578
Q ss_pred HHHHHHHHHhcCCCCCCCCh
Q 015041 247 EFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 247 ~~~~l~~~c~~~~p~~RP~~ 266 (414)
++.+++..||..+|.+||++
T Consensus 222 ~~~~li~~~l~~dP~~R~s~ 241 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGC 241 (318)
T ss_pred HHHHHHHHHccCCHHHcCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=312.24 Aligned_cols=233 Identities=23% Similarity=0.336 Sum_probs=188.3
Q ss_pred ecceeecCceeEEEEEEC---CCCceEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 12 GRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~---~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
+++||+|+||.||+|++. .+++.||||++.... ....+..|+.+++.+.| +++..+...+......++||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKH-PFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCC-CchhceeeEEecCCeEEEEE
Confidence 468999999999999864 468899999876421 12346789999999976 56666666666778899999
Q ss_pred ecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
||+ +++|.+.+.. ...++...+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 80 EYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred eCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCC
Confidence 999 7788887765 4568889999999999999999999999999999999999 5788999999999875432221
Q ss_pred CccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhh
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~ 241 (414)
......||..|+|||++.+..++.++|||||||++|||++|+.||.+.... +.+..+.......|
T Consensus 156 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~---~~~~~~~~~~~~~~----- 220 (323)
T cd05584 156 -------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK---KTIDKILKGKLNLP----- 220 (323)
T ss_pred -------cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCCCCC-----
Confidence 112457899999999999989999999999999999999999999875432 33444444433333
Q ss_pred hcChHHHHHHHHHHhcCCCCCCC
Q 015041 242 KSHPAEFASYFHYCQSLTFDQRP 264 (414)
Q Consensus 242 ~~~p~~~~~l~~~c~~~~p~~RP 264 (414)
..+++++.+++..||..+|++||
T Consensus 221 ~~~~~~~~~li~~~l~~~p~~R~ 243 (323)
T cd05584 221 PYLTPEARDLLKKLLKRNPSSRL 243 (323)
T ss_pred CCCCHHHHHHHHHHcccCHhHcC
Confidence 34578999999999999999999
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=322.80 Aligned_cols=253 Identities=24% Similarity=0.364 Sum_probs=201.8
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|++.+.||+|+||+||+|++..+++.||||++.... ....+..|+.++..+.| ++++.+...+.+....++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS-PWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCC-CCccchhhheecCCeEEEE
Confidence 47999999999999999999999999999999886432 22347788999988875 6676776677778889999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++... ..++...++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 80 MEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCcccC
Confidence 9999 88999988763 679999999999999999999999999999999999999 588999999999997654332
Q ss_pred CCc----------------------cccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChh
Q 015041 161 TNR----------------------HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218 (414)
Q Consensus 161 ~~~----------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~ 218 (414)
... ...........||..|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 000 0000112345789999999999999999999999999999999999999987553
Q ss_pred hchHHHHHHHHh--hccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCC-hHHHHH
Q 015041 219 ATKKQKYDKICE--KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD-YGFLKR 271 (414)
Q Consensus 219 ~~~~~~~~~i~~--~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~-~~~l~~ 271 (414)
. ..+.++.. .....|.. ..+++++.+++..|+. +|.+||+ ++++.+
T Consensus 236 ~---~~~~~i~~~~~~~~~p~~---~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 236 Q---ETYNKIINWKESLRFPPD---PPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred H---HHHHHHhccCCcccCCCC---CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 3 33334433 22222221 2257899999999997 9999999 776643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=314.86 Aligned_cols=238 Identities=20% Similarity=0.306 Sum_probs=193.0
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-C
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 86 (414)
+.||+|+||.||+|++..+++.||||++.... ....+..|..++..+.+|++++.+..++......++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999999999999999887532 12346788899998877888888888888888999999999 7
Q ss_pred CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcccc
Q 015041 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (414)
Q Consensus 87 ~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~ 166 (414)
++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~----- 151 (329)
T cd05588 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGD----- 151 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCC-----
Confidence 788877754 4679999999999999999999999999999999999999 5788999999999874322211
Q ss_pred ccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhh------chHHHHHHHHhhccCCchHHh
Q 015041 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA------TKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~------~~~~~~~~i~~~~~~~p~~~~ 240 (414)
.....+||..|+|||++.+..++.++|||||||++|+|++|+.||...... ........+.......|
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p---- 225 (329)
T cd05588 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP---- 225 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----
Confidence 123567899999999999999999999999999999999999999642211 11122233333333333
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCCh
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~ 266 (414)
..++.++.+++..||..+|.+|++.
T Consensus 226 -~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 226 -RSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred -CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 3457889999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=321.10 Aligned_cols=215 Identities=19% Similarity=0.266 Sum_probs=176.5
Q ss_pred cccCCceEEecceeecCceeEEEEEEC--CCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
.++..+|.++++||.|+||.||+|... .++..||+|.+... ....+|+++++.++| ++++.+..++......++
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---~~~~~E~~il~~l~h-~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---KTPGREIDILKTISH-RAIINLIHAYRWKSTVCM 163 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---ccHHHHHHHHHhcCC-CCccceeeeEeeCCEEEE
Confidence 356778999999999999999999764 45678999987653 245689999999986 556666666667788999
Q ss_pred EEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 81 v~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||+ +..+.++|+|||+++......
T Consensus 164 v~e~~~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 164 VMPKYKCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EehhcCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCccccccCccc
Confidence 999999999888843 5679999999999999999999999999999999999999 588899999999997654332
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~ 230 (414)
.. .......||..|+|||++.+..++.++|||||||++|||++|+.||.+.........+..++.
T Consensus 240 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~ 304 (392)
T PHA03207 240 DT-----PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304 (392)
T ss_pred cc-----ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH
Confidence 21 112356799999999999999999999999999999999999999987655444444444444
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=333.42 Aligned_cols=255 Identities=23% Similarity=0.317 Sum_probs=197.3
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEee-eeCC
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYG-VDGE 76 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~-~~~~ 76 (414)
+++.-++|+++++||.|+||+||+|++..++..||+|++..... ...+..|+.++..|.|++.+..+..+. ....
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 45666899999999999999999999999999999998765432 235788999999998755444444333 3345
Q ss_pred eeEEEEecc-CCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc-------CeeccccCCCceEEccC------
Q 015041 77 DNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSR-------GFLHRDIKPDNFLMGLG------ 139 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-------~iiHrDLkp~Nili~~~------ 139 (414)
..+|||||+ +++|.+++... ...+++..++.|+.||+.||.|||+. +||||||||+||||...
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 689999999 78999988753 24689999999999999999999984 49999999999999521
Q ss_pred --------CCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccC--CCCCchhhHHHHHHHHHHHHcC
Q 015041 140 --------RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRG 209 (414)
Q Consensus 140 --------~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DiwSlG~il~el~tG 209 (414)
+....+||+|||++........ .....||+.|+|||++.+ ..++.++||||||||||||++|
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--------~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESM--------AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred ccccccccCCCCceEEccCCcccccccccc--------ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence 1234589999999976533221 124578999999999865 3588999999999999999999
Q ss_pred CCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 210 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 210 ~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..||...... .+ +...+......+. ...+.++.+||..||..+|.+||++.++..
T Consensus 240 k~PF~~~~~~--~q-li~~lk~~p~lpi----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 240 KTPFHKANNF--SQ-LISELKRGPDLPI----KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCCCcCCcH--HH-HHHHHhcCCCCCc----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 9999864322 12 2222222222221 345789999999999999999999988764
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=329.93 Aligned_cols=254 Identities=24% Similarity=0.255 Sum_probs=197.4
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeee----
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVD---- 74 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~---- 74 (414)
+..+++|++.+.||+|+||+||+|++..+++.||||++...... ..+.+|+.++..+.|.+.+.....+...
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34678999999999999999999999999999999988654322 2356788877777654333222222111
Q ss_pred ---CCeeEEEEecc-CCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEE
Q 015041 75 ---GEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 147 (414)
Q Consensus 75 ---~~~~~lv~e~~-~~sL~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL 147 (414)
....++||||+ +++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|||+ +.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEEE
Confidence 11367999999 78999888643 2468999999999999999999999999999999999999 47889999
Q ss_pred eeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHH
Q 015041 148 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (414)
Q Consensus 148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~ 227 (414)
+|||+++.+....... .....+||..|+|||++.+..++.++|||||||++|||++|+.||.+.... +.+..
T Consensus 185 ~DFGls~~~~~~~~~~-----~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~---~~~~~ 256 (496)
T PTZ00283 185 GDFGFSKMYAATVSDD-----VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME---EVMHK 256 (496)
T ss_pred EecccCeecccccccc-----ccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHH
Confidence 9999998654322111 123567999999999999999999999999999999999999999875432 23333
Q ss_pred HHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 228 i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+...... + +...+++++.+++..||..+|.+||++.++.+
T Consensus 257 ~~~~~~~-~---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 257 TLAGRYD-P---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred HhcCCCC-C---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 3332221 1 23456889999999999999999999998765
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=313.27 Aligned_cols=242 Identities=22% Similarity=0.283 Sum_probs=191.5
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|++.++||+|+||+||++++..+++.||+|++.... ....+..|+.++..+.| +++..+..++......++|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN-QWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCC-CCEeeEEEEEecCCEEEEE
Confidence 47999999999999999999999999999999875421 12236677778777654 6677777777788899999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecccCC
Confidence 9998 889999998766779999999999999999999999999999999999999 588899999999987654322
Q ss_pred CCccccccCCCCCccCcCcccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
.. .....+||..|+|||++. ...++.++|||||||++|||++|+.||.+... .+.+.++.......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~---~~~~~~i~~~~~~~ 227 (332)
T cd05623 157 TV------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGKIMNHKERF 227 (332)
T ss_pred cc------eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH---HHHHHHHhCCCccc
Confidence 11 112457899999999986 34588999999999999999999999987543 34444554443333
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCC
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFD 261 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~ 261 (414)
+.+..+..+++++.+++.+|+..+++
T Consensus 228 ~~p~~~~~~s~~~~~li~~ll~~~~~ 253 (332)
T cd05623 228 QFPAQVTDVSEDAKDLIRRLICSREH 253 (332)
T ss_pred cCCCccccCCHHHHHHHHHHccChhh
Confidence 33333345678899999998865443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=319.96 Aligned_cols=243 Identities=22% Similarity=0.283 Sum_probs=200.5
Q ss_pred ceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-CCCHH
Q 015041 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLE 90 (414)
Q Consensus 14 ~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~~sL~ 90 (414)
.||+|+||+||-|++..++..+|||.+..... -+-+..|+.+.+.|+|.+ |+...+.+..+.+.-|+||-. ||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkN-IVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKN-IVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHh-HHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 59999999999999999999999997655432 234889999999999855 444444455666888999988 99999
Q ss_pred HHHHHhCCCC--CHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcccccc
Q 015041 91 DLFVYCRRKF--SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168 (414)
Q Consensus 91 ~~~~~~~~~~--~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 168 (414)
++++...+++ ++.++-++.+||+.||.|||+..|||||||-+|+|+. .-.|.+||+|||.+++...-..
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP------- 731 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINP------- 731 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCc-------
Confidence 9999877777 8999999999999999999999999999999999996 5678999999999987543211
Q ss_pred CCCCCccCcCccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChH
Q 015041 169 ENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (414)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~--~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~ 246 (414)
...+++||..|||||++..++ |+.++|||||||++.||.||++||..+... ...+.++.--+..+|++. .++.
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp--qAAMFkVGmyKvHP~iPe---elsa 806 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP--QAAMFKVGMYKVHPPIPE---ELSA 806 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh--hHhhhhhcceecCCCCcH---HHHH
Confidence 225899999999999998764 999999999999999999999999876443 234445555566666654 3378
Q ss_pred HHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 247 EFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 247 ~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+.+.|+.+|+..+|.+||++.+|..
T Consensus 807 eak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 807 EAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHcCCCcccCccHHHhcc
Confidence 9999999999999999999876543
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=321.96 Aligned_cols=254 Identities=22% Similarity=0.300 Sum_probs=194.6
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
..|++++.||+|+||+||+|++..+++.||||++.... ....+..|+.+++.+.| ++++.+..++.+....++|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~l~~~~~~~~~~~lv 79 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN-EWVVKLYYSFQDKDNLYFV 79 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCC-CCeeeeEEEEecCCEEEEE
Confidence 36999999999999999999999999999999886532 12346789999998875 6777777777788899999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +..+.+||+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 80 MDYIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCccccccc
Confidence 9999 7889888765 4568999999999999999999999999999999999999 578899999999986432111
Q ss_pred CCccc----------------------------------------cccCCCCCccCcCccccccccCCCCCchhhHHHHH
Q 015041 161 TNRHI----------------------------------------PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLG 200 (414)
Q Consensus 161 ~~~~~----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG 200 (414)
..... ........+||..|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 00000 00001246799999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCChhhchHHHHHHHHhh--ccCCchHHhhhcChHHHHHHHHHH--hcCCCCCCCChHHHHH
Q 015041 201 YVLLYFLRGSLPWQGLKAATKKQKYDKICEK--KVSTPIEVLCKSHPAEFASYFHYC--QSLTFDQRPDYGFLKR 271 (414)
Q Consensus 201 ~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~--~~~~p~~~~~~~~p~~~~~l~~~c--~~~~p~~RP~~~~l~~ 271 (414)
|++|||++|..||...... +...++... ....|.. ..+++++.+++.++ +..++..|+++.++..
T Consensus 236 ~il~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~---~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPT---ETQLKVINWENTLHIPPQ---VKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred hHHHHHHhCCCCCcCCCHH---HHHHHHHccccccCCCCC---CCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 9999999999999875432 222233221 1222211 23567889999884 4445556888876643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=307.61 Aligned_cols=243 Identities=19% Similarity=0.264 Sum_probs=194.0
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
.|++.+.||+|+||+||++.+..+++.||||++.... ....+.+|+.+++.++| ++++.+...+......++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-RFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCC-CCEeeeeeeecCCCeEEEEE
Confidence 4899999999999999999999899999999876432 12346779999999976 55666666666777899999
Q ss_pred ecc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 83 e~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||+ +++|.+++... ...+++..+..++.|++.||+|||++||+||||||+||++ ++.+.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecCCCC
Confidence 999 78888777643 3468999999999999999999999999999999999999 578899999999987653221
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
. .....|+..|+|||++.+..++.++|||||||++|||++|..||.+.......+.+...+.... ...
T Consensus 157 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~ 224 (285)
T cd05605 157 T--------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ----EEY 224 (285)
T ss_pred c--------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc----ccc
Confidence 1 1245789999999999998999999999999999999999999987554332222222222111 112
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCCh
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~ 266 (414)
...++..+.+++..||..||.+||+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLGC 250 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcCC
Confidence 24467899999999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=314.37 Aligned_cols=238 Identities=21% Similarity=0.315 Sum_probs=192.0
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-C
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 86 (414)
+.||+|+||.||+|++..+++.||+|++.... ....+..|+.++..+.+|++++.+..++......++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999887532 12336678888888877788888888888888999999999 7
Q ss_pred CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcccc
Q 015041 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (414)
Q Consensus 87 ~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~ 166 (414)
++|...+.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~----- 151 (329)
T cd05618 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGD----- 151 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCC-----
Confidence 788777654 4579999999999999999999999999999999999999 5888999999999875332211
Q ss_pred ccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhh------chHHHHHHHHhhccCCchHHh
Q 015041 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA------TKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~------~~~~~~~~i~~~~~~~p~~~~ 240 (414)
......||..|+|||++.+..++.++|||||||++|||++|..||...... ........+.......|
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p---- 225 (329)
T cd05618 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP---- 225 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----
Confidence 123567899999999999999999999999999999999999999632111 11122233334333333
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCCh
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~ 266 (414)
...+.++.+++.+||..+|.+||+.
T Consensus 226 -~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 226 -RSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 3457889999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=306.13 Aligned_cols=242 Identities=21% Similarity=0.205 Sum_probs=196.0
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeeEEeeee----CCeeEEEEe
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVD----GEDNVLVLD 83 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~l~~~~~~----~~~~~lv~e 83 (414)
..||+|+++.||+|.+ +|+.||||.+...... ..+.+|+.++.+++|+ ++..+..++.+ ....++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSN-NILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCC-CEEEEeeeEEecccCCCceEEEEE
Confidence 5789999999999998 6889999988754322 3456999999999875 66666555444 356899999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
|+ +++|.+++.. ...+++...+.++.|++.||.|||+. +++||||||+|||+ +.++.+||+|||+++......
T Consensus 103 y~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 103 YCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred eCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcccc-
Confidence 99 7889998875 45789999999999999999999985 99999999999999 578999999999987543322
Q ss_pred CccccccCCCCCccCcCccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
....|+..|+|||++.+ ..++.++|||||||++|||++|..||.+.+.. +.+..+.......+.+
T Consensus 178 ---------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~~~i~~~~~~~~~~- 244 (283)
T PHA02988 178 ---------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIYDLIINKNNSLKLP- 244 (283)
T ss_pred ---------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhcCCCCCCC-
Confidence 13467899999999976 67999999999999999999999999876432 3334443333333322
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~ 277 (414)
..+|+++.+++.+||+.+|++||++.++.+.|+.+.
T Consensus 245 --~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 245 --LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred --CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 245889999999999999999999999999988764
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=310.81 Aligned_cols=235 Identities=23% Similarity=0.330 Sum_probs=188.2
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHH-HHHHcCCCCCCeeEEeeeeCCeeEEEEecc-
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKV-YKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~-l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (414)
+.||+|+||+||+|.+..+++.||||++.... ....+..|... ++.+. |++++.+...+......++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC-CCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 47999999999999999999999999876432 12234455544 44554 467777777777788899999999
Q ss_pred CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccc
Q 015041 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (414)
Q Consensus 86 ~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 165 (414)
+++|.+.+.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~---- 151 (323)
T cd05575 80 GGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSK---- 151 (323)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCC----
Confidence 7788877765 5578999999999999999999999999999999999999 5788999999999875332211
Q ss_pred cccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcCh
Q 015041 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (414)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p 245 (414)
.....+||..|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+.......+ ...+
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~-----~~~~ 220 (323)
T cd05575 152 ---TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT---AEMYDNILNKPLRLK-----PNIS 220 (323)
T ss_pred ---ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH---HHHHHHHHcCCCCCC-----CCCC
Confidence 12356789999999999999999999999999999999999999987543 233444444333322 3457
Q ss_pred HHHHHHHHHHhcCCCCCCCChH
Q 015041 246 AEFASYFHYCQSLTFDQRPDYG 267 (414)
Q Consensus 246 ~~~~~l~~~c~~~~p~~RP~~~ 267 (414)
..+.+++..||..+|.+||+..
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 221 VSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHHHhhcCHHhCCCCC
Confidence 8999999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=318.21 Aligned_cols=250 Identities=22% Similarity=0.278 Sum_probs=210.7
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
..+|.+++++|.|+||.+++++++.++..||+|.+..... .....+|+.+++++.|++.|-....+..++...+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 3689999999999999999999999999999998765432 234789999999988755444445555566669999
Q ss_pred Eecc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 82 LDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
|+|| ||++.+.+...+ ..|+++.+..++.||+.||.|||+++|+|||||+.|||++ +++.|+|+|||+|+....+
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt---k~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT---KDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc---ccCceeecchhhhhhcCCc
Confidence 9999 999999998655 5699999999999999999999999999999999999995 8888899999999987665
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
.. ...+++||+.||+||++.+.+|+.|+|||||||++|||++-+.+|...+ ....+.+|+..... |++
T Consensus 160 ~~-------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~---m~~Li~ki~~~~~~-Plp- 227 (426)
T KOG0589|consen 160 DS-------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN---MSELILKINRGLYS-PLP- 227 (426)
T ss_pred hh-------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc---hHHHHHHHhhccCC-CCC-
Confidence 42 2357899999999999999999999999999999999999999998744 34556666665532 333
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~ 272 (414)
..+..++..+|+.|+..+|..||++.+|...
T Consensus 228 --~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 228 --SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 3457899999999999999999999988774
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=315.64 Aligned_cols=239 Identities=20% Similarity=0.296 Sum_probs=193.8
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-C
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 86 (414)
+.||+|+||+||+|++..+++.||+|++..... ...+..|+.++..+.+++++..+..++......++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999875421 2346788889989888888888888888888999999999 7
Q ss_pred CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcccc
Q 015041 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (414)
Q Consensus 87 ~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~ 166 (414)
++|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (327)
T cd05617 81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGD----- 151 (327)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCC-----
Confidence 888877764 4579999999999999999999999999999999999999 5788999999999875332211
Q ss_pred ccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhh----chHHHHHHHHhhccCCchHHhhh
Q 015041 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA----TKKQKYDKICEKKVSTPIEVLCK 242 (414)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~----~~~~~~~~i~~~~~~~p~~~~~~ 242 (414)
.....+||..|+|||++.+..++.++|||||||++|||++|..||...... ........+.......| .
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p-----~ 224 (327)
T cd05617 152 --TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP-----R 224 (327)
T ss_pred --ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC-----C
Confidence 113567999999999999999999999999999999999999999643221 11122233333322222 3
Q ss_pred cChHHHHHHHHHHhcCCCCCCCChH
Q 015041 243 SHPAEFASYFHYCQSLTFDQRPDYG 267 (414)
Q Consensus 243 ~~p~~~~~l~~~c~~~~p~~RP~~~ 267 (414)
..+..+.+++..||..+|.+|++..
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCC
Confidence 4578899999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=317.42 Aligned_cols=200 Identities=25% Similarity=0.302 Sum_probs=164.9
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeee-----
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVD----- 74 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~----- 74 (414)
.+-++|++.+.||+|+||.||+|.+..++..||||++.... ....+.+|+.+++.+.|. ++..+..++..
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK-NIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCC-CEeeeeeeeccCCCcc
Confidence 35589999999999999999999999999999999886432 234577899999999764 44444433322
Q ss_pred -CCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 75 -GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 75 -~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
....++||||+++++...+. ..++...+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 97 ~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~a 170 (359)
T cd07876 97 EFQDVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA 170 (359)
T ss_pred ccceeEEEEeCCCcCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEecCCCc
Confidence 23579999999888877664 358889999999999999999999999999999999999 57899999999999
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChh
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~ 218 (414)
+....... .....||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 171 ~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~ 227 (359)
T cd07876 171 RTACTNFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH 227 (359)
T ss_pred cccccCcc--------CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 75432111 1245789999999999999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=314.17 Aligned_cols=261 Identities=21% Similarity=0.320 Sum_probs=202.0
Q ss_pred ccCCceEEecceeecCceeEEEEEECC-----CCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEe-eee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWY-GVD 74 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~-~~~ 74 (414)
+-+++|++.+.||.|+||.||+|.+.. +++.||+|++...... ..+..|+.++..+.+|+++..+..+ ...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 446799999999999999999997543 4578999988754332 3467899999999666666666544 445
Q ss_pred CCeeEEEEecc-CCCHHHHHHHhC--------------------------------------------------------
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYCR-------------------------------------------------------- 97 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~~-------------------------------------------------------- 97 (414)
+...+++|||+ +++|.+++....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 56788999999 888988875421
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccccccCCCCC
Q 015041 98 ----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173 (414)
Q Consensus 98 ----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~ 173 (414)
..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||+++........ ......
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~~~vkL~DfG~a~~~~~~~~~-----~~~~~~ 235 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDY-----VRKGDA 235 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCCCcEEEeccccchhcccCcch-----hhccCC
Confidence 257889999999999999999999999999999999999 47889999999999865332111 011234
Q ss_pred ccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHH
Q 015041 174 TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYF 252 (414)
Q Consensus 174 ~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~ 252 (414)
.++..|+|||++.+..++.++|||||||++|||++ |..||.+....+ .+............ ....++++.+++
T Consensus 236 ~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~~l~ 309 (337)
T cd05054 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---EFCRRLKEGTRMRA---PEYATPEIYSIM 309 (337)
T ss_pred CCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---HHHHHHhccCCCCC---CccCCHHHHHHH
Confidence 55778999999999999999999999999999997 999998643221 12222222222111 134568899999
Q ss_pred HHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 253 HYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 253 ~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
..||..+|++||++.++.+.|++++.
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=323.22 Aligned_cols=257 Identities=27% Similarity=0.382 Sum_probs=212.2
Q ss_pred CceEEecceeecCceeEEEEEECCCC---ce-EEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTN---EI-VAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~---~~-vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
.+-.+.++||+|+||+||+|+....+ .. ||||..+... ...++.+|.++++.++| ++|+.++++......
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H-~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNH-PNVVRFYGVAVLEEP 235 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEcCCCc
Confidence 45567799999999999999987432 23 8999877522 23458899999999876 778889899999999
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
+++|||+| ||+|.+++......++..+...++.+.+.||+|||++++|||||..+|+|++ ..+.+||+|||+++..
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~---~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS---KKGVVKISDFGLSRAG 312 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec---CCCeEEeCccccccCC
Confidence 99999999 8999999998777799999999999999999999999999999999999994 6677899999998754
Q ss_pred cCCCCCccccccCCC-CCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccC
Q 015041 157 RDPTTNRHIPYRENK-NLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
..... .. ...-..+|+|||++....|+.++|||||||++||+++ |..||.++...+.. .+|.....+
T Consensus 313 ~~~~~--------~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~---~kI~~~~~r 381 (474)
T KOG0194|consen 313 SQYVM--------KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK---AKIVKNGYR 381 (474)
T ss_pred cceee--------ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH---HHHHhcCcc
Confidence 31111 11 1123679999999999999999999999999999999 88999998766433 344444555
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~ 281 (414)
.+.+. ..|.++..++..||..+|++||+|.++.+.|+.+.....
T Consensus 382 ~~~~~---~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 382 MPIPS---KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred CCCCC---CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 55443 458999999999999999999999999999998876543
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=301.44 Aligned_cols=256 Identities=20% Similarity=0.330 Sum_probs=205.9
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
+....|.+.++||.|+||.||+|.+..+++.||+|+...... ...+.+|+++++.+.| +++..+..++......+++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCC-CChhheEEEEcCCCCcEEEE
Confidence 455789999999999999999999999999999998775432 3457889999999976 55666666666777889999
Q ss_pred ecc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||+ +++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||++ +.++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCccccccccce
Confidence 998 789999887543 458999999999999999999999999999999999999 478899999999997654332
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
.. ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+..... ....+ .......
T Consensus 159 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~-~~~~~~~--- 225 (263)
T cd05052 159 YT------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELL-EKGYRME--- 225 (263)
T ss_pred ee------ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH-HCCCCCC---
Confidence 11 1112234668999999999999999999999999999998 999998754322 22222 2222221
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
.....|.++.+++.+||..+|++||++.++.+.|+.+
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 2245689999999999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=301.69 Aligned_cols=260 Identities=21% Similarity=0.289 Sum_probs=203.4
Q ss_pred CCcccCCceEEecceeecCceeEEEEEECCCCc----eEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeee
Q 015041 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGV 73 (414)
Q Consensus 1 ~~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~ 73 (414)
|+-+...+|+++++||.|+||+||+|++..++. .||+|++..... ...+.+|+.++..+.| +++..+..++.
T Consensus 1 ~~~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~ 79 (279)
T cd05109 1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS-PYVCRLLGICL 79 (279)
T ss_pred CcccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCC-CCCceEEEEEc
Confidence 567788999999999999999999999876666 489998765433 2346788888888865 55666655554
Q ss_pred eCCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecc
Q 015041 74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (414)
Q Consensus 74 ~~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~ 152 (414)
. ...+++++++ +++|.+++......+++..++.++.|++.||+|||+++|+||||||+|||+ +.++.+||+|||+
T Consensus 80 ~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~---~~~~~~kL~dfG~ 155 (279)
T cd05109 80 T-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV---KSPNHVKITDFGL 155 (279)
T ss_pred C-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCCCc
Confidence 3 3467889888 889998887655679999999999999999999999999999999999999 4778899999999
Q ss_pred eeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhh
Q 015041 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEK 231 (414)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~ 231 (414)
++.......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||....... +...+..
T Consensus 156 ~~~~~~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~~~~ 226 (279)
T cd05109 156 ARLLDIDETEYH-----ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE----IPDLLEK 226 (279)
T ss_pred eeecccccceee-----cCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHHC
Confidence 987643322110 112234678999999999899999999999999999998 999998754332 2222333
Q ss_pred ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 015041 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (414)
Q Consensus 232 ~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~ 277 (414)
....+.+ ..++.++.+++..||..+|+.||++.++.+.|+++.
T Consensus 227 ~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 227 GERLPQP---PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred CCcCCCC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 3222222 345789999999999999999999999988877664
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=339.57 Aligned_cols=259 Identities=20% Similarity=0.290 Sum_probs=210.3
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCC-----ceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTN-----EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 75 (414)
+-....++.+.||+|+||+||.|...... ..||||.+...... ..|++|..+++.+.| +||..+.+.+...
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~H-pNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDH-PNIVSLIGVCLDS 767 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCC-cceeeEEEeecCC
Confidence 34567889999999999999999876332 34899987766443 458999999999987 5555665555568
Q ss_pred CeeEEEEecc-CCCHHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEe
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYC------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~ 148 (414)
...+|++||| +|+|..+++.. ...++..+.+.++.|||.|++||+++++|||||.++|+|+ +....|||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL---DERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee---cccCcEEEc
Confidence 8899999999 99999999987 4568999999999999999999999999999999999999 477999999
Q ss_pred eecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHH
Q 015041 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDK 227 (414)
Q Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~ 227 (414)
|||+|+...+... |+....-.-..+|||||.+....++.|+|||||||++||+++ |..||.+.++.+....+.+
T Consensus 845 DFGlArDiy~~~y-----yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ 919 (1025)
T KOG1095|consen 845 DFGLARDIYDKDY-----YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE 919 (1025)
T ss_pred ccchhHhhhhchh-----eeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh
Confidence 9999995544443 222222233579999999999999999999999999999999 9999998776544433322
Q ss_pred HHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 228 i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
+.++ +.+ ..+|+.+.++|..||+.+|++||+|..|.+.+..+..
T Consensus 920 --ggRL--~~P---~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 920 --GGRL--DPP---SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred --CCcc--CCC---CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 2333 333 4559999999999999999999999999987776654
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=304.01 Aligned_cols=255 Identities=21% Similarity=0.294 Sum_probs=202.9
Q ss_pred cCCceEEecceeecCceeEEEEEECCCC-----ceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTN-----EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
--++|++.+.||+|+||.||+|.+...+ ..||+|.+..... ...+.+|+.++..+.| +++..+..++....
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h-~~i~~~~~~~~~~~ 81 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH-PNIVCLLGVCTKEQ 81 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCC-cccceEEEEEcCCC
Confidence 3468999999999999999999876554 6799998765433 2347789999999876 56666666666777
Q ss_pred eeEEEEecc-CCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCC
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 140 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~ 140 (414)
..+++|||+ +++|.+++.... ..++...++.++.|++.||.|||++||+|+||||+||++ +
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~ 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---G 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---c
Confidence 889999999 789998887532 347889999999999999999999999999999999999 4
Q ss_pred CCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhh
Q 015041 141 KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAA 219 (414)
Q Consensus 141 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~ 219 (414)
.++.++|+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~ 233 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYY-----RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ 233 (283)
T ss_pred CCCcEEECCCcceeeccccccc-----cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 7889999999999765432211 11224456788999999998899999999999999999998 99999876543
Q ss_pred chHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 015041 220 TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (414)
Q Consensus 220 ~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~ 275 (414)
+ ....+.. ....+ ....+|.++.+++..||..+|.+||++.+|.+.|+.
T Consensus 234 ~---~~~~i~~-~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 E---VIEMIRS-RQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred H---HHHHHHc-CCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 2 2222222 22222 224568999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=316.15 Aligned_cols=245 Identities=22% Similarity=0.304 Sum_probs=190.6
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
.+|+++++||+|+||.||+|++..+++.||||++..... ...+.+|+++++.+.| ++|..+..++......++|||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNH-PNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCC-CCcceeeeEeccCCeEEEEEe
Confidence 578899999999999999999999999999999865433 2457889999999976 666677777777888999999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
|+ +++|.+ ........+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 153 ~~~~~~L~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 153 FMDGGSLEG-----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred cCCCCcccc-----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceecccccc-
Confidence 99 666643 2335677888999999999999999999999999999999 5788999999999986543211
Q ss_pred ccccccCCCCCccCcCccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
......||..|+|||++.. ...+.++|||||||++|||++|+.||..............+.... .
T Consensus 224 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~--- 293 (353)
T PLN00034 224 ------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ-P--- 293 (353)
T ss_pred ------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-C---
Confidence 1134578999999998743 234678999999999999999999998433322222222222111 1
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
......++.++.+++..||..+|++||++.++.+
T Consensus 294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112355789999999999999999999887643
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=317.41 Aligned_cols=251 Identities=22% Similarity=0.282 Sum_probs=199.1
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
-..+|++.++||+|+||.||+|++..++..||+|++... .....+..|+.+++.+.| ++++.+..++......+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h-~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS-EWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC-CCcceEEEEEecCCEEE
Confidence 346899999999999999999999999999999987642 122346688999988865 66777777777888899
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
+||||+ +++|.+++.. ..++...+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 120 lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeeccC
Confidence 999999 8899888764 458899999999999999999999999999999999999 5889999999999986543
Q ss_pred CCCCccccccCCCCCccCcCccccccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGI----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
.... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.... ..+.++......
T Consensus 195 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~~~~~~ 265 (370)
T cd05596 195 NGMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIMDHKNS 265 (370)
T ss_pred CCcc------cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH---HHHHHHHcCCCc
Confidence 2211 11356799999999998754 3789999999999999999999999875432 344444443222
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCC--CCChHHHHH
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKR 271 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~--RP~~~~l~~ 271 (414)
...+. ....+.++.+++..|+..+|++ |++++++.+
T Consensus 266 ~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 266 LTFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CCCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 11111 1235789999999999988887 888876644
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=307.63 Aligned_cols=258 Identities=21% Similarity=0.298 Sum_probs=202.6
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCce----EEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEI----VAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~----vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
+-..+|++.+.||+|+||.||+|.+..+++. ||+|++..... ...+..|+.+++.+.| +++..+..++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~g~~~~~- 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN-PHVCRLLGICLTS- 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEcCC-
Confidence 3457899999999999999999998766554 89998765432 2457789999999876 5555565555443
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
..+++++|+ +++|.+++......++...++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 158 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEcccccccc
Confidence 466888887 889999988766678999999999999999999999999999999999999 4788999999999986
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccC
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
........ ......++..|+|||++.+..++.++|||||||++|||++ |..||.+..... +..++.....
T Consensus 159 ~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~----~~~~~~~~~~ 229 (316)
T cd05108 159 LGADEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEKGER 229 (316)
T ss_pred ccCCCcce-----eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHhCCCC
Confidence 54332210 0112334678999999999999999999999999999997 999998754332 2333444433
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
.+.+ ..++.++.+++..||..+|++||++.++...|..+..
T Consensus 230 ~~~~---~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 230 LPQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 3332 2347889999999999999999999999998877653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=311.80 Aligned_cols=235 Identities=24% Similarity=0.300 Sum_probs=186.9
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHH-HHHHcCCCCCCeeEEeeeeCCeeEEEEecc-
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKV-YKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~-l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (414)
+.||+|+||+||+|++..+|+.||+|++.... ....+..|..+ ++.+. |+++..+...+......++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCC-CCCCccEEEEEecCCEEEEEEcCCC
Confidence 47999999999999999999999999876432 12234555554 44454 567777777777788999999999
Q ss_pred CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccc
Q 015041 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (414)
Q Consensus 86 ~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 165 (414)
+++|...+.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~---- 151 (325)
T cd05604 80 GGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSD---- 151 (325)
T ss_pred CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCC----
Confidence 7788777654 5678999999999999999999999999999999999999 5788999999999875322211
Q ss_pred cccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcCh
Q 015041 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (414)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p 245 (414)
.....+||..|+|||++.+..++.++|||||||++|||++|..||.+.+.. +.+..+.......+ ...+
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~~~~~~~~~~-----~~~~ 220 (325)
T cd05604 152 ---TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---EMYDNILHKPLVLR-----PGAS 220 (325)
T ss_pred ---CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH---HHHHHHHcCCccCC-----CCCC
Confidence 123567899999999999999999999999999999999999999875432 33334433332222 3457
Q ss_pred HHHHHHHHHHhcCCCCCCCChH
Q 015041 246 AEFASYFHYCQSLTFDQRPDYG 267 (414)
Q Consensus 246 ~~~~~l~~~c~~~~p~~RP~~~ 267 (414)
..+.+++..|+..+|.+||++.
T Consensus 221 ~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 221 LTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred HHHHHHHHHHhccCHHhcCCCC
Confidence 8899999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=296.19 Aligned_cols=296 Identities=21% Similarity=0.314 Sum_probs=212.4
Q ss_pred CceEEecceeecCceeEEEEEECCCCc----eEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~----~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
..|+++++||+|+||.||+|....++. .+|||.++... ......+|+.+++.++|.+.+..+..+.......
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 469999999999999999996554433 68999877652 3456789999999999877666666666667889
Q ss_pred EEEEeccCCCHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEc-cCCCCCeEEEeeecce
Q 015041 79 VLVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG-LGRKANQVYIIDFGLA 153 (414)
Q Consensus 79 ~lv~e~~~~sL~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~-~~~~~~~vkL~DFG~a 153 (414)
++++||...+|..++...+ +.++...+..|++||+.|+.|||++-|+||||||+|||+. .+.+.|.|||+|||+|
T Consensus 104 ~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 104 WLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred EEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 9999999999999998543 3588999999999999999999999999999999999995 2345699999999999
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCChhhc------hHHHHH
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAAT------KKQKYD 226 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~------~~~~~~ 226 (414)
+.+.++-. |......++.|.+|+|||+++|.. |+.+.||||.|||+.||++-++.|.+..+.. ....+.
T Consensus 184 R~~~~plk----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 184 RLFNNPLK----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred HHhhcccc----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99877643 344456778899999999999875 9999999999999999999999998743211 122333
Q ss_pred HHHhhccCCchHHhh---hcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcccc--ccccccchhhhc
Q 015041 227 KICEKKVSTPIEVLC---KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFD--WTILKYQQTQKT 301 (414)
Q Consensus 227 ~i~~~~~~~p~~~~~---~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~d--w~~l~~~~~~~~ 301 (414)
+|.+.... |...-+ +++|+ ...++...-. + .+.. -.|...+..-+......+| -++|.|||.+|+
T Consensus 260 rIf~vLG~-Pt~~~Wp~lkk~Pe-~q~~ls~f~~-----~-~~~n--~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRI 329 (438)
T KOG0666|consen 260 RIFEVLGT-PTDKDWPDLKKMPE-YQTLLSDFRR-----H-YYDN--VSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRI 329 (438)
T ss_pred HHHHHcCC-CccccchhhhhCcc-hHHHHHHhHH-----h-hcCc--chHHHHHHHhcCCCchHHHHHHHHhccCchhhc
Confidence 33332222 211111 11121 1111111110 0 0100 0123333333322222333 388999999999
Q ss_pred cccccCCCCccccCC
Q 015041 302 KSQDLLPASRVTNSR 316 (414)
Q Consensus 302 ~~~~~l~~~~~~~~~ 316 (414)
++.+++.|++|....
T Consensus 330 ta~qAleh~yF~~d~ 344 (438)
T KOG0666|consen 330 TAEQALEHPYFTEDP 344 (438)
T ss_pred cHHHHhcccccccCC
Confidence 999999999987654
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=310.11 Aligned_cols=234 Identities=26% Similarity=0.345 Sum_probs=187.1
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHH-HHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAK-VYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~-~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (414)
+.||+|+||.||+|++..+++.||+|++.... ....+..|.. +++.+. |++++.+...+......++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCEEEEEEcCCC
Confidence 47999999999999999999999999876432 1223445554 455555 467777777777888999999999
Q ss_pred CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccc
Q 015041 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (414)
Q Consensus 86 ~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 165 (414)
+++|...+.. ...++...+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~---- 151 (321)
T cd05603 80 GGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEE---- 151 (321)
T ss_pred CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCC----
Confidence 7788776654 5678999999999999999999999999999999999999 5788999999999875332221
Q ss_pred cccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcCh
Q 015041 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (414)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p 245 (414)
......||..|+|||++.+..++.++|||||||++|||++|..||.+.+. .+.+..+.......| ...+
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~-----~~~~ 220 (321)
T cd05603 152 ---TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---SQMYDNILHKPLQLP-----GGKT 220 (321)
T ss_pred ---ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---HHHHHHHhcCCCCCC-----CCCC
Confidence 12356789999999999998999999999999999999999999987543 233444444433333 3457
Q ss_pred HHHHHHHHHHhcCCCCCCCCh
Q 015041 246 AEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 246 ~~~~~l~~~c~~~~p~~RP~~ 266 (414)
..+.+++..|++.+|.+||+.
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~ 241 (321)
T cd05603 221 VAACDLLVGLLHKDQRRRLGA 241 (321)
T ss_pred HHHHHHHHHHccCCHhhcCCC
Confidence 889999999999999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=320.36 Aligned_cols=249 Identities=22% Similarity=0.304 Sum_probs=191.8
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
.+|+++++||+|+||+||+|++..+++.||+|++.... ....+..|+.+++.+.| ++++.+...+.+....++|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h-~~iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN-EWVVRLYYSFQDKDNLYFV 79 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCC-CcCCeEEEEEEeCCEEEEE
Confidence 36999999999999999999999999999999876532 12346789999999875 6677777777788899999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++.. ...++...+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+....
T Consensus 80 ~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 80 MDYIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCccccccc
Confidence 9999 7889888765 4568999999999999999999999999999999999999 588999999999985432110
Q ss_pred CCcc----------------------------------------ccccCCCCCccCcCccccccccCCCCCchhhHHHHH
Q 015041 161 TNRH----------------------------------------IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLG 200 (414)
Q Consensus 161 ~~~~----------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG 200 (414)
.... .........+||..|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0000 000001245799999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCC
Q 015041 201 YVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265 (414)
Q Consensus 201 ~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~ 265 (414)
|++|||++|+.||.+.... +...++.........+. ....++++.+++.+++ .+|.+|++
T Consensus 236 vil~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~-~~p~~R~~ 295 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPL---ETQMKVINWQTSLHIPP-QAKLSPEASDLIIKLC-RGPEDRLG 295 (382)
T ss_pred HHHHHHHhCCCCCCCCCHH---HHHHHHHccCCCcCCCC-cccCCHHHHHHHHHHc-cCHhHcCC
Confidence 9999999999999875432 22333332221111111 1234678888887765 58999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=317.48 Aligned_cols=243 Identities=22% Similarity=0.321 Sum_probs=202.8
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
.|.-++.||.|+||.||-|++..+.+.||||..+-.. +...++.|+..|..|.|++ ...+.+|.....-.++||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPn-tieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPN-TIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCC-cccccceeeccchHHHHH
Confidence 4666789999999999999999999999999876543 3356889999999999854 445555555566679999
Q ss_pred eccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 83 e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
|||-|+..|++....+++.+-++.-|+.+.+.||.|||+.+.||||||..|||++ +.+.|||+|||.|......
T Consensus 106 EYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs---e~g~VKLaDFGSAsi~~PA--- 179 (948)
T KOG0577|consen 106 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS---EPGLVKLADFGSASIMAPA--- 179 (948)
T ss_pred HHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec---CCCeeeeccccchhhcCch---
Confidence 9999999999998889999999999999999999999999999999999999995 9999999999998754322
Q ss_pred ccccccCCCCCccCcCccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
..++||+.|||||+|+. +.|+-++||||||+++.|+...++|+.++++....-. |....-+. .
T Consensus 180 --------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH---IAQNesPt---L 245 (948)
T KOG0577|consen 180 --------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---IAQNESPT---L 245 (948)
T ss_pred --------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH---HHhcCCCC---C
Confidence 37899999999999974 4599999999999999999999999999877543322 22222111 1
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
....+++.|..|+..|+.+-|.+||+.+++.+
T Consensus 246 qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 246 QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 12455789999999999999999999887654
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=289.18 Aligned_cols=267 Identities=19% Similarity=0.217 Sum_probs=205.1
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEee----eeCC
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYG----VDGE 76 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~----~~~~ 76 (414)
.|.++||++.+.||.|||+-||+++...++..+|+|.+.-.. ..+...+|++..+++++++.++.+.... ....
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 367899999999999999999999999999999999765443 4456889999999999855554442211 1234
Q ss_pred eeEEEEecc-CCCHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhcC--eeccccCCCceEEccCCCCCeEEEeee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDF 150 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDLkp~Nili~~~~~~~~vkL~DF 150 (414)
..|+++.|+ .|+|.+.+..+. ..+++.+++.|+.+|+.||++||+.. +.||||||+|||++ +.+.++|.||
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~vl~D~ 173 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---DSGLPVLMDL 173 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec---CCCceEEEec
Confidence 579999998 889999988653 35899999999999999999999998 99999999999995 6899999999
Q ss_pred cceeeecCCCCC--ccccccCCCCCccCcCcccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHH
Q 015041 151 GLAKKYRDPTTN--RHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY 225 (414)
Q Consensus 151 G~a~~~~~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~ 225 (414)
|.+........+ ......++..-..|..|+|||.+. +...+.++|||||||+||+|+.|.-||...-.. .....
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-GgSla 252 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-GGSLA 252 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-CCeEE
Confidence 998754432211 112222333445689999999986 445789999999999999999999999742110 00011
Q ss_pred HHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 226 DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 226 ~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
..++...+..|.. ..+++.+.++++.|++.||.+||+..+|...++++
T Consensus 253 LAv~n~q~s~P~~---~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 253 LAVQNAQISIPNS---SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred EeeeccccccCCC---CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1233334444433 23689999999999999999999999998877765
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=303.95 Aligned_cols=284 Identities=43% Similarity=0.698 Sum_probs=237.7
Q ss_pred ceEEecceeecCceeEEEEEECCCC-ceEEEEEecCCCCc--hhHHHHHHHHHHHc---CCCCCCeeEEee-eeCCeeEE
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTN-EIVAVKIENSGTKH--PQLLYEAKVYKILQ---GGSGIPNIKWYG-VDGEDNVL 80 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~--~~~~~E~~~l~~l~---~~~~i~~l~~~~-~~~~~~~l 80 (414)
+|++.++||+|+||.||+|.+..++ ..+|+|++...... ..+..|+.++..+. +..+++.+...+ ......+|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 8999999999999999999987664 68999988765332 36889999999998 456899999999 57888999
Q ss_pred EEeccCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCC--CCCeEEEeeeccee--e
Q 015041 81 VLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR--KANQVYIIDFGLAK--K 155 (414)
Q Consensus 81 v~e~~~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~--~~~~vkL~DFG~a~--~ 155 (414)
||+++|.+|.++..... +.|+..++++|+.|++.+|++||+.|+|||||||+|++++... ....++|.|||+|+ .
T Consensus 99 VM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~ 178 (322)
T KOG1164|consen 99 VMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFK 178 (322)
T ss_pred EEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcccc
Confidence 99999999999997655 7899999999999999999999999999999999999998543 22679999999999 4
Q ss_pred ecCCCCCccccccC-CCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC
Q 015041 156 YRDPTTNRHIPYRE-NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 156 ~~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
+.........+.+. ...+.||.+|++++++.+.+.++++|+||+++++.|++.|.+||.+.........+.+.......
T Consensus 179 ~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~ 258 (322)
T KOG1164|consen 179 YVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLT 258 (322)
T ss_pred ccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhcc
Confidence 44333322344444 34677999999999999999999999999999999999999999987765555555554444433
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCccccccccc
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK 294 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l~ 294 (414)
.. .+...|.++.+++..+-..++.++|+|..+...|.+.+...+......+||....
T Consensus 259 ~~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~~~ 315 (322)
T KOG1164|consen 259 DR---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEVKL 315 (322)
T ss_pred cc---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCcccccc
Confidence 32 3344578999999999999999999999999999999999999999999997543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=305.27 Aligned_cols=246 Identities=22% Similarity=0.355 Sum_probs=211.2
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
..+|.+.+.||+|+||.|-+|.....|..||||.++++... -.+.+|++++..|+| ++|..|+..+.+....+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNH-PhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNH-PHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCC-CceeehhhhhcCCceEEE
Confidence 46899999999999999999999899999999988766432 237899999999987 566677777778888999
Q ss_pred EEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 81 v~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
||||. +|.|.|++.. .+.+++.+++++++||+.|+.|+|.++++|||||.+|||+ |.++++||+|||++-.+.+.
T Consensus 131 vMEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 131 VMEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhhhhccc
Confidence 99999 9999999987 5579999999999999999999999999999999999999 79999999999999776554
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
.. ..++||++-|.+||++.|.+| ++.+|-||||++||.++.|.+||.|.+ .+..+.+|....+..|.
T Consensus 207 kf--------LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---hk~lvrQIs~GaYrEP~- 274 (668)
T KOG0611|consen 207 KF--------LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---HKRLVRQISRGAYREPE- 274 (668)
T ss_pred cH--------HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch---HHHHHHHhhcccccCCC-
Confidence 32 348999999999999999997 688999999999999999999999854 44555555555555442
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l 273 (414)
-|.....||+.+|..||++|.+.++|...+
T Consensus 275 -----~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 275 -----TPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -----CCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 267888999999999999999988887643
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=315.41 Aligned_cols=247 Identities=22% Similarity=0.337 Sum_probs=198.5
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|++.+.||+|+||+||+|.+..+++.||+|+++.... ...+..|+.+++.+. +++++.+..++.+....++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCeEEEE
Confidence 479999999999999999999999999999998875422 234667888887765 47777777777778889999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++......+++..+..++.||+.||+|||+++|+||||||+|||+ +..+.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECCCCC
Confidence 9999 889999988766789999999999999999999999999999999999999 588999999999998654322
Q ss_pred CCccccccCCCCCccCcCcccccccc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc--
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHL------GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK-- 232 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~-- 232 (414)
.. ......||..|+|||++. +..++.++|||||||++|||++|..||...... ..+.++....
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~~~i~~~~~~ 227 (330)
T cd05601 157 MV------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA---KTYNNIMNFQRF 227 (330)
T ss_pred ce------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH---HHHHHHHcCCCc
Confidence 11 112457899999999987 456889999999999999999999999875433 2333333322
Q ss_pred cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 233 ~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
...|.. ...+.++.+++..|+. +|.+||+++++.
T Consensus 228 ~~~~~~---~~~~~~~~~li~~ll~-~p~~R~t~~~l~ 261 (330)
T cd05601 228 LKFPED---PKVSSDFLDLIQSLLC-GQKERLGYEGLC 261 (330)
T ss_pred cCCCCC---CCCCHHHHHHHHHHcc-ChhhCCCHHHHh
Confidence 111211 2457889999999997 999999987653
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=313.08 Aligned_cols=244 Identities=23% Similarity=0.265 Sum_probs=193.1
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|++.++||+|+||+||+|++..+++.||+|++.... ....+..|+.++..+. ++++..+..++......++|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEE
Confidence 47999999999999999999999999999999876421 1223566777777665 47787888888888899999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++......+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeeccCCC
Confidence 9999 899999998766779999999999999999999999999999999999999 578899999999997654332
Q ss_pred CCccccccCCCCCccCcCccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
.. ......||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.... +.+.++.......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~ 227 (331)
T cd05624 157 TV------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHEERF 227 (331)
T ss_pred ce------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH---HHHHHHHcCCCcc
Confidence 21 1124578999999999876 45789999999999999999999999865432 3344444333222
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCC
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRP 264 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP 264 (414)
+.+......++++.+++.+|+...+ +|+
T Consensus 228 ~~p~~~~~~~~~~~~li~~ll~~~~-~~~ 255 (331)
T cd05624 228 QFPSHITDVSEEAKDLIQRLICSRE-RRL 255 (331)
T ss_pred cCCCccccCCHHHHHHHHHHccCch-hhc
Confidence 2222234567899999999987544 444
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=311.68 Aligned_cols=236 Identities=23% Similarity=0.320 Sum_probs=188.0
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHH-HHHHcCCCCCCeeEEeeeeCCeeEEEEecc-
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKV-YKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~-l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (414)
+.||+|+||+||+|++..+++.||+|++.... ....+..|... ++.+. |++++.+...+......++||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCC-CCCCCceeEEEEcCCeEEEEEeCCC
Confidence 47999999999999999999999999876432 11234444443 44454 467777877777888899999999
Q ss_pred CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccc
Q 015041 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (414)
Q Consensus 86 ~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 165 (414)
+++|.+++.. ...++...++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~---- 151 (325)
T cd05602 80 GGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNG---- 151 (325)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCC----
Confidence 7788877765 5568899999999999999999999999999999999999 5788999999999875432221
Q ss_pred cccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcCh
Q 015041 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (414)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p 245 (414)
.....+||..|+|||++.+..++.++|||||||++|+|++|..||.+.... +.+..+.......+ ..++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~-----~~~~ 220 (325)
T cd05602 152 ---TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDNILNKPLQLK-----PNIT 220 (325)
T ss_pred ---CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHHHHHhCCcCCC-----CCCC
Confidence 123567999999999999999999999999999999999999999875433 33334433332222 3567
Q ss_pred HHHHHHHHHHhcCCCCCCCChHH
Q 015041 246 AEFASYFHYCQSLTFDQRPDYGF 268 (414)
Q Consensus 246 ~~~~~l~~~c~~~~p~~RP~~~~ 268 (414)
..+.+++..|+..+|.+||+..+
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 221 NSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred HHHHHHHHHHcccCHHHCCCCCC
Confidence 89999999999999999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=313.89 Aligned_cols=200 Identities=23% Similarity=0.317 Sum_probs=165.5
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeee-----eC
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV-----DG 75 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~-----~~ 75 (414)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.|.+.+..+..+.. ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4589999999999999999999999999999999886532 22457789999999977554443333322 22
Q ss_pred CeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 76 ~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
...++||||++++|.+.+. ..++...+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 102 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 175 (364)
T ss_pred CeEEEEEeCCCCCHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEeCCCccc
Confidence 4579999999988887764 357889999999999999999999999999999999999 5788999999999975
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChh
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~ 218 (414)
...... .....||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 176 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 230 (364)
T cd07875 176 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 230 (364)
T ss_pred cCCCCc--------ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH
Confidence 432211 1245789999999999999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=315.29 Aligned_cols=249 Identities=20% Similarity=0.253 Sum_probs=186.9
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCC-----ee
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE-----DN 78 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~-----~~ 78 (414)
+|.++++||+|+||.||+|.+..+++.||||.+.... ....+.+|+.+++.++|. ++..+..+..... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHD-NVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCC-CcCCHhheecCCCccccceE
Confidence 4789999999999999999999999999999876432 124578899999999864 4544544443333 68
Q ss_pred EEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 79 ~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
++|+||+.++|.+.+.. ...++...++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 80 ~lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 80 YVVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccceeeccc
Confidence 99999999888887754 4578999999999999999999999999999999999999 5788999999999986543
Q ss_pred CCCCccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
.... ......+|..|+|||++.+. .++.++|||||||++|||++|+.||.+.+....... +.......+.
T Consensus 156 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~~~g~~~~ 226 (372)
T cd07853 156 DESK------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL---ITDLLGTPSL 226 (372)
T ss_pred Cccc------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHH---HHHHcCCCCH
Confidence 2211 11234678999999999875 489999999999999999999999987654433222 2221111111
Q ss_pred HH---------------------------hhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 238 EV---------------------------LCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 238 ~~---------------------------~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
.. .....++++.+++.+||..||.+||++.++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 286 (372)
T cd07853 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286 (372)
T ss_pred HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHh
Confidence 11 1122345666777777777777777766543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=314.80 Aligned_cols=234 Identities=22% Similarity=0.293 Sum_probs=186.2
Q ss_pred eeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHc--CCCCCCeeEEeeeeCCeeEEEEecc-C
Q 015041 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (414)
Q Consensus 15 iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~--~~~~i~~l~~~~~~~~~~~lv~e~~-~ 86 (414)
||+|+||+||+|++..+++.||||++..... ......|..++..+. ++++++.+...+......++||||+ +
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999999999999998764321 122345666665554 6788888888888888999999999 7
Q ss_pred CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcccc
Q 015041 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (414)
Q Consensus 87 ~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~ 166 (414)
++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||+++.......
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~----- 151 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNK----- 151 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCC-----
Confidence 788877765 5678999999999999999999999999999999999999 5788999999999875322211
Q ss_pred ccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcCh
Q 015041 167 YRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (414)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p 245 (414)
.....+||..|+|||++.+. .++.++|||||||++|+|++|..||.+... .+.+..+.......+. ..++
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~----~~~~ 222 (330)
T cd05586 152 --TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT---QQMYRNIAFGKVRFPK----NVLS 222 (330)
T ss_pred --CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH---HHHHHHHHcCCCCCCC----ccCC
Confidence 12356799999999998765 489999999999999999999999987433 2334444443333332 2357
Q ss_pred HHHHHHHHHHhcCCCCCCCCh
Q 015041 246 AEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 246 ~~~~~l~~~c~~~~p~~RP~~ 266 (414)
+++.+++..||..+|.+||+.
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCC
Confidence 899999999999999999954
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=300.73 Aligned_cols=255 Identities=20% Similarity=0.277 Sum_probs=200.4
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
.+...++|++.++||+|+||.||+|.+..+++.||+|+...... ...+.+|+.+++.+.| +++..+...+......+
T Consensus 4 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h-~~ii~~~~~~~~~~~~~ 82 (267)
T cd06646 4 RRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKH-CNIVAYFGSYLSREKLW 82 (267)
T ss_pred ccCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCC-CCeeeeeEEEEeCCEEE
Confidence 45567889999999999999999999999999999998865432 2346789999998877 45556666666778899
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
+||||+ +++|.+++.. ...++...+..++.|++.||+|||+.||+||||||+||++ +.++.++|+|||++.....
T Consensus 83 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 83 ICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITA 158 (267)
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceeecc
Confidence 999999 6788888765 4578999999999999999999999999999999999999 5788899999999986543
Q ss_pred CCCCccccccCCCCCccCcCcccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
... ......|+..|+|||.+. ...++.++|||||||++|||++|..||....... ....+.......
T Consensus 159 ~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~---~~~~~~~~~~~~ 228 (267)
T cd06646 159 TIA-------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---ALFLMSKSNFQP 228 (267)
T ss_pred ccc-------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh---hheeeecCCCCC
Confidence 221 112456889999999885 3447889999999999999999999997643321 111111222222
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+.......++..+.+++..||..+|++||+++++.+
T Consensus 229 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 264 (267)
T cd06646 229 PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLT 264 (267)
T ss_pred CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhc
Confidence 222222356789999999999999999999988765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=301.11 Aligned_cols=244 Identities=21% Similarity=0.295 Sum_probs=194.2
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
.|+..+.||.|+||+||+|.+..+++.||+|.+..... ...+.+|+.+++.++| ++++.+...+..+...+++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~-~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNS-QFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCC-cCceeEEEEEecCCEEEEEE
Confidence 48889999999999999999999999999998765321 2336789999999976 55556666666778899999
Q ss_pred ecc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||++ +..+.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecCCCC
Confidence 999 678887775433 469999999999999999999999999999999999999 477899999999987643221
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
. .....|+..|+|||++.+..++.++|+|||||++|+|++|..||.+.......+........ .....
T Consensus 157 ~--------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~----~~~~~ 224 (285)
T cd05632 157 S--------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLE----TEEVY 224 (285)
T ss_pred c--------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhc----ccccc
Confidence 1 12457899999999999999999999999999999999999999875443322222221111 11122
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChH
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYG 267 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~ 267 (414)
...++.++.+++..||..+|++||+..
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 225 SAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred CccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 345678999999999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=297.09 Aligned_cols=255 Identities=23% Similarity=0.375 Sum_probs=201.7
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
+..++|+++++||+|+||.||+|.+..++ .||+|++..... ...+.+|+.+++.+.| +++..+..+. .....++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l~~-~~i~~~~~~~-~~~~~~lv~ 79 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRH-EKLVQLYAVV-SEEPIYIVT 79 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhCCC-CCcceEEEEE-CCCCcEEEE
Confidence 55689999999999999999999986654 599998875433 4568899999999976 5555555444 345678999
Q ss_pred ecc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 83 e~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||+ +++|.+++... ...+++..++.++.|++.||+|||+++|+|+||||+||++ +.++.++|+|||.++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE---cCCCcEEeccCCceeeccccc
Confidence 999 67999888753 3457899999999999999999999999999999999999 478889999999997654322
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
.. ......++..|+|||+..+..++.++|||||||++|+|++ |..||.+.... +.+..+ ......+.
T Consensus 157 ~~------~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~~~~-~~~~~~~~-- 224 (262)
T cd05071 157 YT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQV-ERGYRMPC-- 224 (262)
T ss_pred cc------cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHHHHH-hcCCCCCC--
Confidence 11 1123345678999999998899999999999999999999 89999875433 222222 22222222
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~ 277 (414)
....|..+.+++..||..+|++||++.++.+.|++++
T Consensus 225 -~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 225 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred -ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 2345789999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=302.08 Aligned_cols=236 Identities=21% Similarity=0.291 Sum_probs=187.0
Q ss_pred eeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-CCC
Q 015041 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (414)
Q Consensus 15 iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~~s 88 (414)
||+|+||+||+|.+..+++.||+|.+..... ...+..|+.+++.+.| +++..+..++......++||||+ +++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHS-RFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCC-CcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 7999999999999999999999998764321 1345679999998855 66767766677778899999999 788
Q ss_pred HHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccc
Q 015041 89 LEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (414)
Q Consensus 89 L~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 165 (414)
|.+.+... ...+++..++.++.||+.||+|||+++|+||||||+||++ +.++.++|+|||++........
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~---- 152 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQS---- 152 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCc----
Confidence 87776432 3458999999999999999999999999999999999999 5788999999999976543221
Q ss_pred cccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchH-HHHHHHHhhccCCchHHhhhcC
Q 015041 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK-QKYDKICEKKVSTPIEVLCKSH 244 (414)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~-~~~~~i~~~~~~~p~~~~~~~~ 244 (414)
......||..|+|||++.+..++.++|||||||++|||++|+.||......... .....+..... .....+
T Consensus 153 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 224 (280)
T cd05608 153 ---KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV-----TYPDKF 224 (280)
T ss_pred ---cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC-----CCcccC
Confidence 112457899999999999999999999999999999999999999864332211 11222222111 122456
Q ss_pred hHHHHHHHHHHhcCCCCCCCCh
Q 015041 245 PAEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 245 p~~~~~l~~~c~~~~p~~RP~~ 266 (414)
+..+.+++..||..+|++||++
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~ 246 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGF 246 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCC
Confidence 8899999999999999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=302.63 Aligned_cols=256 Identities=18% Similarity=0.241 Sum_probs=202.9
Q ss_pred CceEEecceeecCceeEEEEEECCCCc--eEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNE--IVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~--~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|++.+.||+|+||.||+|.+..++. .+++|.++.... ...+..|+.++.++.+|+++..+..++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 579999999999999999999876654 468887764322 235788999999997778888887777777889999
Q ss_pred Eecc-CCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeE
Q 015041 82 LDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 145 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~v 145 (414)
+||+ +++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCCeE
Confidence 9998 789999886532 247889999999999999999999999999999999999 478899
Q ss_pred EEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHH
Q 015041 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQK 224 (414)
Q Consensus 146 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~ 224 (414)
||+|||++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||.+..... .
T Consensus 159 kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~ 227 (297)
T cd05089 159 KIADFGLSRGEEVYVK--------KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---L 227 (297)
T ss_pred EECCcCCCccccceec--------cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H
Confidence 9999999863221100 112233567999999999899999999999999999997 999998754432 2
Q ss_pred HHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 225 ~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
+.++.. ....+. ...++..+.+++.+||..+|.+||+++++.+.|+.++...
T Consensus 228 ~~~~~~-~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 228 YEKLPQ-GYRMEK---PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHHhc-CCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 222222 222211 1345789999999999999999999999999998887644
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=311.97 Aligned_cols=198 Identities=24% Similarity=0.384 Sum_probs=164.9
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeee------e
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV------D 74 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~------~ 74 (414)
+.++|++++.||.|+||+||+|.+..++..||||.+..... ...+.+|+.+++.+.|.+ +..+..+.. .
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN-VIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCc-hhhhhhhhcccccccc
Confidence 56899999999999999999999999999999998765422 234678999999998754 444432221 2
Q ss_pred CCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 75 ~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
....++++++++++|.+++. ...++...+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 92 ~~~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 92 FNEVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGLAR 166 (343)
T ss_pred cCcEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCEEEcCCccce
Confidence 24578999999999988775 4569999999999999999999999999999999999999 578899999999998
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChh
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~ 218 (414)
...... ....||..|+|||++.+ ..++.++|||||||++|+|++|..||.+...
T Consensus 167 ~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 221 (343)
T cd07878 167 QADDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY 221 (343)
T ss_pred ecCCCc----------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 654321 24578999999999987 4689999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=315.84 Aligned_cols=250 Identities=21% Similarity=0.274 Sum_probs=193.8
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
+..++|++.+.||+|+||.||+|++..+++.||+|++... .....+..|+.+++.+.| ++++.+..++..+...
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~h-p~iv~~~~~~~~~~~~ 118 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCEE
Confidence 3457899999999999999999999999999999987642 122346678888888765 6677777777788899
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
++||||+ +++|.+++.. ..++...+..++.||+.||+|||++||+||||||+|||+ +..+.+||+|||+|....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEecccceecc
Confidence 9999999 8899988864 458999999999999999999999999999999999999 588999999999998654
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIE----QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
..... .....+||..|+|||++.+.. ++.++|||||||++|||++|..||.+... ...+.++.....
T Consensus 194 ~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~---~~~~~~i~~~~~ 264 (370)
T cd05621 194 ETGMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL---VGTYSKIMDHKN 264 (370)
T ss_pred cCCce------ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCc
Confidence 32211 123567999999999997643 78999999999999999999999987543 234444544332
Q ss_pred CCchHHhhhcChHHHHHHHHHHhcCCCCC--CCChHHH
Q 015041 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFL 269 (414)
Q Consensus 234 ~~p~~~~~~~~p~~~~~l~~~c~~~~p~~--RP~~~~l 269 (414)
....+. ....+..+.+++..|+..++.+ |+++.++
T Consensus 265 ~~~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~ 301 (370)
T cd05621 265 SLNFPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEI 301 (370)
T ss_pred ccCCCC-cccCCHHHHHHHHHHccCchhccCCCCHHHH
Confidence 221111 0134678889999988744332 5565544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=297.15 Aligned_cols=248 Identities=21% Similarity=0.292 Sum_probs=198.0
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (414)
..+|++.+.||+|+||.||+|.. .+..||+|..........+.+|+.+++.+.|.+.+..+..+.......+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46899999999999999999976 4778999998776666678899999999987544444434444556789999999
Q ss_pred -CCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 86 -GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 86 -~~sL~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
+++|.+++..... .+++..++.++.|++.||+|||++||+||||||+||++ +.++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~-- 157 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCccceeccccCC--
Confidence 6799998875433 48899999999999999999999999999999999999 5788999999999875443221
Q ss_pred cccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhhh
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~ 242 (414)
...++..|+|||++.+..++.++|||||||++|+|++ |+.||....... ....+ ....... ...
T Consensus 158 --------~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~-~~~~~~~---~~~ 222 (256)
T cd05082 158 --------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV-EKGYKMD---APD 222 (256)
T ss_pred --------CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH-hcCCCCC---CCC
Confidence 2334568999999998889999999999999999997 999998643322 22222 2222211 124
Q ss_pred cChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 015041 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (414)
Q Consensus 243 ~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~ 275 (414)
.+|..+.+++.+||..+|++||++.++.+.|++
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 568899999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=295.26 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=204.9
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++..++|++.+.||+|+||.||+|.+. ++..||+|.+.... ....+.+|+.+++.++| +++..+..++......+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRH-PKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCC-CCccceeEEEecCCCeeee
Confidence 456789999999999999999999875 45679999887543 33568889999999986 5666777777777889999
Q ss_pred Eecc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 82 LDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
|||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+||++ +.++.++|+|||+++.....
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARVIKED 156 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEEccCC
Confidence 9999 899999987543 468999999999999999999999999999999999999 47889999999999876532
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
... .......+..|+|||++.+..++.++|||||||++|||++ |+.||.+..... .+..+ ......+.+
T Consensus 157 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~-~~~~~~~~~ 226 (261)
T cd05068 157 IYE------AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQQV-DQGYRMPCP 226 (261)
T ss_pred ccc------ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH-HcCCCCCCC
Confidence 211 0112223467999999999899999999999999999999 999998764332 22222 222222222
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~ 275 (414)
...++.+.+++.+||..+|++||++.+|.+.|++
T Consensus 227 ---~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 227 ---PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ---CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 3457899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=311.30 Aligned_cols=199 Identities=23% Similarity=0.316 Sum_probs=164.6
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeee-----C
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVD-----G 75 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~-----~ 75 (414)
+-++|++.+.||+|+||.||+|.+..+++.||||.+..... ...+.+|+.+++.+.|.+.+..+..+... .
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 45899999999999999999999998999999998865422 23467899999999875444444333221 2
Q ss_pred CeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 76 ~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
...++||||+.+++.+.+. ..++...+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 95 ~~~~lv~e~~~~~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 168 (355)
T ss_pred ceeEEEhhhhcccHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEeeCccccc
Confidence 3579999999888877664 358899999999999999999999999999999999999 5788999999999975
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCh
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 217 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~ 217 (414)
...... .....||..|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus 169 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 169 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred CCCccc--------cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 433211 124578999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=312.38 Aligned_cols=261 Identities=21% Similarity=0.339 Sum_probs=222.9
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc-hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
-..+.++..+||.|-||+||.|.|++....||||.++.+... .+|+.|..+++.+.| ++++.+...|......|||+|
T Consensus 265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikH-pNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcC-ccHHHHhhhhccCCCeEEEEe
Confidence 345677889999999999999999999999999998887644 569999999999976 667777777888889999999
Q ss_pred cc-CCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 84 LL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
|| .|+|.++++.|.+ .++.-..++++-||..||+||..+++|||||..+|+|++ ++..||++|||+++.+.....
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg---EnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc---ccceEEeeccchhhhhcCCce
Confidence 98 9999999998865 467778899999999999999999999999999999996 889999999999998876654
Q ss_pred CccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
..| ....-.+.|.|||-+....++.|+|||+|||+||||.| |.-||.|.+-. .+..++++.++..-+
T Consensus 421 TAH------AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS----qVY~LLEkgyRM~~P-- 488 (1157)
T KOG4278|consen 421 TAH------AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYGLLEKGYRMDGP-- 488 (1157)
T ss_pred ecc------cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH----HHHHHHhccccccCC--
Confidence 332 23334678999999999999999999999999999998 99999986443 344556666665554
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCC
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY 282 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~ 282 (414)
.++|+.+.+||..||+.+|.+||+|.++-+.|+.++.....
T Consensus 489 -eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSi 529 (1157)
T KOG4278|consen 489 -EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSI 529 (1157)
T ss_pred -CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccc
Confidence 45699999999999999999999999999999999865543
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=314.28 Aligned_cols=260 Identities=22% Similarity=0.303 Sum_probs=204.8
Q ss_pred ccCCceEEecceeecCceeEEEEEEC-----CCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 75 (414)
+-.++|.++++||+|+||.||+|++. .++..||||+++..... ..+..|++++..+..|++++.+...+...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34567899999999999999999864 34568999998765332 35778999999998567888887777777
Q ss_pred CeeEEEEecc-CCCHHHHHHHhC---------------------------------------------------------
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYCR--------------------------------------------------------- 97 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~~--------------------------------------------------------- 97 (414)
...++||||+ +++|.+++...+
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 8899999999 889999886432
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEc
Q 015041 98 ----------------------------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137 (414)
Q Consensus 98 ----------------------------------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~ 137 (414)
..+++..++.++.||+.||+|||+++|+||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl- 272 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI- 272 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE-
Confidence 125677788999999999999999999999999999999
Q ss_pred cCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 015041 138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 216 (414)
Q Consensus 138 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~ 216 (414)
++.+.++|+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 273 --~~~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 273 --CEGKLVKICDFGLARDIMRDSNY-----ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred --eCCCEEEEEecCcceeccccccc-----ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 47889999999999865332211 01123456789999999999889999999999999999998 89999765
Q ss_pred hhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 015041 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (414)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~ 277 (414)
... +............+.+ ..++.++.+++.+||..+|.+||++.+|.+.|+.++
T Consensus 346 ~~~---~~~~~~~~~~~~~~~p---~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 346 PMN---EQFYNAIKRGYRMAKP---AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred Cch---HHHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 322 2222222222222221 345789999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=307.14 Aligned_cols=248 Identities=25% Similarity=0.325 Sum_probs=217.3
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
|++=|.+.+.||+|.|+.|-+|++.-||+.||||++.+... ...+..|+++++.++| ++|+.++.........|+
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQH-pNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQH-PNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcC-cCeeeeeehhcccceEEE
Confidence 45789999999999999999999999999999999887543 3458899999998876 677788877778888999
Q ss_pred EEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 81 v~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
|+|+- +|+|.|++.+....+++..+.+++.||+.|+.|+|...+|||||||+|+++- .+-|.|||.|||++-.+...
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeeccccccCCCc
Confidence 99998 7799999998888899999999999999999999999999999999999875 68899999999998655432
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQS-RRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
....+.+|+..|.|||+++|..|+ +.+||||||||||-+++|++||+..++ -+.+..|++-++..|..
T Consensus 173 --------~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND---SETLTmImDCKYtvPsh 241 (864)
T KOG4717|consen 173 --------KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND---SETLTMIMDCKYTVPSH 241 (864)
T ss_pred --------chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc---hhhhhhhhcccccCchh
Confidence 234588999999999999999986 568999999999999999999997544 46677788888888855
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+ +.++++||..+|..+|.+|.+.++|..
T Consensus 242 v-----S~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 242 V-----SKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred h-----hHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 4 679999999999999999999888765
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=303.05 Aligned_cols=262 Identities=20% Similarity=0.309 Sum_probs=205.7
Q ss_pred ccCCceEEecceeecCceeEEEEEECC-------CCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV 73 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~ 73 (414)
+..++|.++++||+|+||.||+|++.. +...||+|++...... ..+..|+.+++.+..|+++..+..++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 445789999999999999999998643 2346999988754322 347789999999966678888877777
Q ss_pred eCCeeEEEEecc-CCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEc
Q 015041 74 DGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137 (414)
Q Consensus 74 ~~~~~~lv~e~~-~~sL~~~~~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~ 137 (414)
.....++||||+ +++|.+++.... ..+++.+++.++.|++.||+|||++|++||||||+||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill- 173 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV- 173 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE-
Confidence 788899999999 779999987532 247889999999999999999999999999999999999
Q ss_pred cCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 015041 138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 216 (414)
Q Consensus 138 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~ 216 (414)
+.++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 174 --~~~~~~kL~dfg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 174 --TEDNVMKIADFGLARDIHHIDYYK-----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred --cCCCcEEECCCcccccccccchhh-----ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 477899999999987553321110 0112234568999999999899999999999999999998 89999764
Q ss_pred hhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
... + +.+.+......+ .....+.++.+++..||..+|++||++.++.+.|++++...
T Consensus 247 ~~~---~-~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 247 PVE---E-LFKLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred CHH---H-HHHHHHcCCCCC---CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 332 2 222222222211 12345789999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=313.80 Aligned_cols=252 Identities=23% Similarity=0.313 Sum_probs=196.4
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
++..++|++.+.||+|+||.||+|++..+++.||+|++.... ....+..|+.+++.+.| ++++.+...+.....
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~h-p~iv~~~~~~~~~~~ 117 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQLFYAFQDDRY 117 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEcCCE
Confidence 345689999999999999999999999999999999875421 12335678888887765 677777777778889
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
.++||||+ +++|.+++.. ..++...+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKM 192 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCceeEc
Confidence 99999999 7889888764 458999999999999999999999999999999999999 57899999999999865
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIE----QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (414)
...... .....+||..|+|||++.+.. ++.++|||||||++|||++|..||.+.+. ...+.++....
T Consensus 193 ~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~ 263 (371)
T cd05622 193 NKEGMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMNHK 263 (371)
T ss_pred CcCCcc------cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH---HHHHHHHHcCC
Confidence 432211 123567999999999997643 78999999999999999999999987543 23444554433
Q ss_pred cCCchHHhhhcChHHHHHHHHHHhcCCCCC---CCChHHHHH
Q 015041 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQ---RPDYGFLKR 271 (414)
Q Consensus 233 ~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~---RP~~~~l~~ 271 (414)
.....+. ...++.++.+++..|+. ++.. |++++++.+
T Consensus 264 ~~~~~~~-~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~~ 303 (371)
T cd05622 264 NSLTFPD-DNDISKEAKNLICAFLT-DREVRLGRNGVEEIKR 303 (371)
T ss_pred CcccCCC-cCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHhc
Confidence 2211111 13457899999999997 5555 556555443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=316.08 Aligned_cols=249 Identities=22% Similarity=0.328 Sum_probs=193.7
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|++++.||+|+||+||+|.+..+++.||||++... .....+..|+.++..+.| ++++.+...+......++|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG-AWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCEEEEE
Confidence 4799999999999999999999999999999988642 122346778889988865 5666676777788889999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++.. ...++...++.++.|++.||+|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 80 MEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCccccccc
Confidence 9999 7889888865 4568999999999999999999999999999999999999 578999999999987543211
Q ss_pred CCcc----------------------------ccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 015041 161 TNRH----------------------------IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212 (414)
Q Consensus 161 ~~~~----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~P 212 (414)
.... .........+||..|+|||++.+..++.++|||||||++|||++|..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 1000 000001245799999999999999999999999999999999999999
Q ss_pred CCCChhhchHHHHHHHHhhc--cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChH
Q 015041 213 WQGLKAATKKQKYDKICEKK--VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 267 (414)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~--~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~ 267 (414)
|.+.... ..+.++...+ ...|.. ...++++.+++.+++ .+|.+|++..
T Consensus 236 f~~~~~~---~~~~~i~~~~~~~~~p~~---~~~s~~~~~li~~l~-~~p~~R~~~~ 285 (360)
T cd05627 236 FCSETPQ---ETYRKVMNWKETLVFPPE---VPISEKAKDLILRFC-TDSENRIGSN 285 (360)
T ss_pred CCCCCHH---HHHHHHHcCCCceecCCC---CCCCHHHHHHHHHhc-cChhhcCCCC
Confidence 9875443 3333343322 222211 124678899998876 4999998743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=321.65 Aligned_cols=250 Identities=20% Similarity=0.224 Sum_probs=201.7
Q ss_pred CCceEEecceeecCceeEEEEEECCC-CceEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDT-NEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
...|.+.+.||.|+||.||+|....+ ++.||+|........ ..+..|+.+++.+.| ++++.+..++......++||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~H-pniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDH-FGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEEECCEEEEEE
Confidence 34599999999999999999998877 788999976544322 346779999999875 67777777778888999999
Q ss_pred ecc-CCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 83 DLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 83 e~~-~~sL~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
||+ +++|.+.+... ...++...+..++.||+.||+|||+++|+||||||+|||+ +..+.+||+|||+++....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCceecCC
Confidence 999 88998877532 3458899999999999999999999999999999999999 5788999999999987643
Q ss_pred CCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
.... ......+||..|+|||++.+..++.++|||||||++|||++|..||.+.... +.+..+...... +.
T Consensus 222 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~~~~~~~~~~~-~~- 291 (478)
T PTZ00267 222 SVSL-----DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EIMQQVLYGKYD-PF- 291 (478)
T ss_pred cccc-----ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCC-CC-
Confidence 3211 1123567999999999999999999999999999999999999999875432 333333333222 11
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...++.++.+++..||..+|++||++.++..
T Consensus 292 --~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 --PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1345789999999999999999999988754
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=295.66 Aligned_cols=255 Identities=24% Similarity=0.337 Sum_probs=201.8
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|++.+.||.|+||.||+|++..+++.||||.+..... ...+.+|+.+++.+.| +++..+..++......+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH-PNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCC-cceeeeeeeEEECCeEEEE
Confidence 689999999999999999999999999999997654221 2346789999999976 5566666666677889999
Q ss_pred Eecc-CCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 82 LDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
+||+ +++|.+++... ...++...++.++.|++.||+|||+++|+|+||||+||++ +.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE---cCCCCEEECccccceecc
Confidence 9999 67898887642 3447899999999999999999999999999999999999 478889999999987654
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
..... .....|+..|+|||.+.+..++.++|+||||+++|||++|..||...... ....... +......+.
T Consensus 158 ~~~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~-~~~~~~~~~ 228 (267)
T cd08228 158 SKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQK-IEQCDYPPL 228 (267)
T ss_pred chhHH-------HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHH-HhcCCCCCC
Confidence 32211 12456788999999999888999999999999999999999999764321 1222222 222222221
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
.....+..+.+++.+||..+|++||++.++.+.|+.+
T Consensus 229 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 --PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1234578899999999999999999999999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=273.48 Aligned_cols=283 Identities=22% Similarity=0.291 Sum_probs=215.9
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
+|.-.++||+|.||+||+|+...+++.||+|.++.+... ...++|+-+++.|.| .+|+.++.....++...+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkh-knivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhh-cceeehhhhhccCceeEEeHH
Confidence 577789999999999999999999999999987765433 458999999999987 567777777777788999999
Q ss_pred ccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 84 ~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
+|..+|..++..+.+.+..+.++.++.|++.||.|+|+.+++||||||.|.|| +.++.+||+|||+|+.+..+
T Consensus 82 ~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgip---- 154 (292)
T KOG0662|consen 82 FCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIP---- 154 (292)
T ss_pred HhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCCc----
Confidence 99999999999999999999999999999999999999999999999999999 69999999999999876443
Q ss_pred cccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhh
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~ 241 (414)
.+....-+.|.+|++|.++.|.. |++..|+||.|||+.|+.. |++.|.|.+..+...++..++. .|.+..+
T Consensus 155 ---vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg----~p~ed~w 227 (292)
T KOG0662|consen 155 ---VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG----TPTEDQW 227 (292)
T ss_pred ---eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhC----CCccccC
Confidence 33444567799999999999886 8999999999999999997 8899998765554444444333 2222222
Q ss_pred hcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCccccccccccchhhhccccccCCCCccccCCC
Q 015041 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLLPASRVTNSRV 317 (414)
Q Consensus 242 ~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l~~~~~~~~~~~~~l~~~~~~~~~~ 317 (414)
++.. --.|...-|.|-... .+..+..+.+..-.+ +--+.++++|.+|++|..++.||+|++.++
T Consensus 228 ps~t----------~lpdyk~yp~ypatt-swsqivp~lns~grd-llqkll~cnp~qrisaeaalqhpyf~d~s~ 291 (292)
T KOG0662|consen 228 PSMT----------KLPDYKPYPIYPATT-SWSQIVPKLNSTGRD-LLQKLLKCNPAQRISAEAALQHPYFSDFSP 291 (292)
T ss_pred Cccc----------cCCCCcccCCccccc-hHHHHhhhhcchhHH-HHHHHhccCcccccCHHHHhcCccccccCC
Confidence 1110 011222233332211 112222222211111 112678999999999999999999987653
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=300.44 Aligned_cols=253 Identities=22% Similarity=0.327 Sum_probs=202.5
Q ss_pred CCceEEecceeecCceeEEEEEEC-----CCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
.++|.+.+.||+|+||.||+|.+. .++..||||.+...... ..+.+|+++++.+.| +++..+..++.....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH-ENIVKFYGVCTEGDP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCC-CCchheeeEEecCCC
Confidence 567999999999999999999874 33578999998765443 468899999999976 566677777777788
Q ss_pred eEEEEecc-CCCHHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCC
Q 015041 78 NVLVLDLL-GPSLEDLFVYCR-------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN 143 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~-------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~ 143 (414)
.++||||+ +++|.+++...+ ..+++..+..++.|++.||.|||++|++||||||+||++ +.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cCCC
Confidence 99999999 889999887532 247888999999999999999999999999999999999 5789
Q ss_pred eEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchH
Q 015041 144 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKK 222 (414)
Q Consensus 144 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~ 222 (414)
.++|+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.+.....
T Consensus 160 ~~kl~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-- 232 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-- 232 (280)
T ss_pred eEEECCcccceecccCcce-----ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--
Confidence 9999999999764332211 11123445788999999999999999999999999999998 999998754432
Q ss_pred HHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 223 QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 223 ~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
.+..+.......+ ....+..+.+++..||..+|++||++.++.+.|+
T Consensus 233 -~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 233 -VIECITQGRLLQR----PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -HHHHHHcCCcCCC----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 2333332222222 1356789999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=316.72 Aligned_cols=199 Identities=25% Similarity=0.299 Sum_probs=169.5
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
+.+..|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+++++.|.| ++|+.+..++..+...++||+
T Consensus 166 ~~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----~~~~~~E~~iL~~L~H-pnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 166 VAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW----YASSVHEARLLRRLSH-PAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc----ccCHHHHHHHHHHCCC-CCCCcEEEEEEECCEEEEEEE
Confidence 34678999999999999999999999999999999632 2346789999999976 667677777777888999999
Q ss_pred ccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 84 ~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
++.++|.+++......+++..++.|+.||+.||.|||++|||||||||+|||+ +..+.+||+|||+++.........
T Consensus 241 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 241 KYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceecccccccc
Confidence 99999998887655679999999999999999999999999999999999999 478899999999998654322110
Q ss_pred cccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~ 215 (414)
......||..|+|||++.+..++.++|||||||++|||++|..++..
T Consensus 318 -----~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~ 364 (461)
T PHA03211 318 -----FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS 364 (461)
T ss_pred -----cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence 11246799999999999999999999999999999999998766543
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=296.73 Aligned_cols=254 Identities=22% Similarity=0.360 Sum_probs=202.5
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
+-.++|+++++||+|+||.||+|.+. ++..||+|.+.... ....+..|+.+++.++| +++..+..........+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQH-DKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCC-CCeeeEEEEEcCCCCcEEEE
Confidence 34578999999999999999999864 55679999876543 33567889999999976 55666666666777889999
Q ss_pred ecc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 83 e~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||+ +++|.+++... ...+++..++.++.|++.||+|||+.+++||||||+||++ +.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCccceecCCCc
Confidence 998 78999988753 3568899999999999999999999999999999999999 578899999999998654322
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
.. ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+..... ....+. .....+..
T Consensus 158 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~-~~~~~~~~- 226 (261)
T cd05072 158 YT------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQ-RGYRMPRM- 226 (261)
T ss_pred ee------ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHH-cCCCCCCC-
Confidence 11 1113345678999999998889999999999999999998 999998754332 222222 22222211
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~ 275 (414)
..+|.++.+++.+||..+|++||+++++.+.|++
T Consensus 227 --~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 --ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 3468899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=301.09 Aligned_cols=252 Identities=20% Similarity=0.267 Sum_probs=192.4
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
++|++.++||.|+||.||+|.+..+++.||+|.+..... ...+.+|+.+++.+.| +++..+..++......++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH-ANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCC-CCcceEEEEEecCCeEEEEEe
Confidence 579999999999999999999999999999998764322 2356789999999976 566677777777788999999
Q ss_pred ccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 84 ~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
|+.++|.+++......++...+..++.||+.||+|||+.||+|+||||+|||+ +.++.++|+|||++........
T Consensus 85 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~-- 159 (301)
T cd07873 85 YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTK-- 159 (301)
T ss_pred ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccCCCCC--
Confidence 99989998887766678999999999999999999999999999999999999 5788999999999875432221
Q ss_pred cccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC--------
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS-------- 234 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~-------- 234 (414)
......++..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+..+......
T Consensus 160 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 160 -----TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred -----cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence 11234568899999998764 4889999999999999999999999876543322222221110000
Q ss_pred --------Cc------hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 235 --------TP------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 235 --------~p------~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
.+ .......++.++.+++.+|+..+|.+||++.++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ei 283 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEA 283 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 00 011112345666777777777777777776554
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=312.50 Aligned_cols=237 Identities=24% Similarity=0.363 Sum_probs=193.1
Q ss_pred ecceeecCceeEEEEEEC---CCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 12 GRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
++.||+|+||.||++++. .+|..||+|++.... ....+..|+++++.+.| ++++.+...+......++||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNH-PFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCC-CCcccEEEEEEcCCEEEEEEcC
Confidence 368999999999999863 578999999886532 22346779999999976 6677777777778889999999
Q ss_pred c-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 85 ~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
+ +++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 80 LRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCC--
Confidence 9 7888887764 4568999999999999999999999999999999999999 5788999999999875433211
Q ss_pred cccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhc
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~ 243 (414)
......||..|+|||++.+..++.++|||||||++|||++|+.||.+... .+.+..+.......| ..
T Consensus 154 -----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~~~~~~i~~~~~~~p-----~~ 220 (318)
T cd05582 154 -----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---KETMTMILKAKLGMP-----QF 220 (318)
T ss_pred -----ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH---HHHHHHHHcCCCCCC-----CC
Confidence 12256789999999999998899999999999999999999999987543 233444444444333 34
Q ss_pred ChHHHHHHHHHHhcCCCCCCCChHH
Q 015041 244 HPAEFASYFHYCQSLTFDQRPDYGF 268 (414)
Q Consensus 244 ~p~~~~~l~~~c~~~~p~~RP~~~~ 268 (414)
+++++.+++..||..+|++||++.+
T Consensus 221 ~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 221 LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 5789999999999999999999765
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=310.25 Aligned_cols=192 Identities=23% Similarity=0.328 Sum_probs=164.5
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (414)
..+|++++.||+|+||.||+|.+..++..||+|+.... ....|+.+++.++| ++++.+..++......++|||++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----TTLIEAMLLQNVNH-PSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----ccHHHHHHHHhCCC-CCCcChhheEEeCCeeEEEEEcc
Confidence 45799999999999999999999999999999975433 34579999999986 56777777777788899999999
Q ss_pred CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccc
Q 015041 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (414)
Q Consensus 86 ~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 165 (414)
.++|.+++......+++..++.|+.||+.||.|||++|||||||||+|||+ +..+.+||+|||+++......
T Consensus 140 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~----- 211 (357)
T PHA03209 140 SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAP----- 211 (357)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCccccccccCc-----
Confidence 999999887766789999999999999999999999999999999999999 578899999999987432211
Q ss_pred cccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 015041 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213 (414)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf 213 (414)
......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 212 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 ---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 112457899999999999999999999999999999999854444
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=298.60 Aligned_cols=258 Identities=20% Similarity=0.294 Sum_probs=201.3
Q ss_pred ccCCceEEecceeecCceeEEEEEECC-----CCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 75 (414)
+-+++|++.+.||+|+||.||+|.+.. ++..||+|....... ...+..|+.+++.+.| +++..+..++...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~ 81 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH-QNIVRLIGVSFER 81 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEccC
Confidence 456889999999999999999999976 778899998765432 2347889999999976 5666676666677
Q ss_pred CeeEEEEecc-CCCHHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEe
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYCRR------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~ 148 (414)
...++||||+ +++|.+++...+. .+++..++.++.||+.||+|||+++++||||||+||++........+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 7889999999 8899999876432 48899999999999999999999999999999999999533334578999
Q ss_pred eecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHH
Q 015041 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDK 227 (414)
Q Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~ 227 (414)
|||+++........ ........+..|+|||++.+..++.++|||||||++|||++ |..||.+..... ....
T Consensus 162 dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~~ 233 (277)
T cd05036 162 DFGMARDIYRASYY-----RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VMEF 233 (277)
T ss_pred cCccccccCCccce-----ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence 99999865322111 01112233568999999999999999999999999999997 999998754332 2222
Q ss_pred HHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 228 i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
+ ....... ....+|..+.+++..||..+|++||++.++.+.|.
T Consensus 234 ~-~~~~~~~---~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 V-TGGGRLD---PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred H-HcCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 2 2111111 12456889999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=299.21 Aligned_cols=256 Identities=20% Similarity=0.299 Sum_probs=199.8
Q ss_pred cccCCceEEecceeecCceeEEEEEEC-----CCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 74 (414)
++.+++|++.+.||+|+||.||+|.+. .++..||+|.+..... ...+.+|+.+++.+.| +++..+..++..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~-~~iv~~~~~~~~ 80 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC-HHVVRLLGVVSQ 80 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEcC
Confidence 367889999999999999999999864 2356799998764332 2347789999998876 566667666777
Q ss_pred CCeeEEEEecc-CCCHHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCe
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYCRR---------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 144 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~ 144 (414)
+...++||||+ +++|.+++..... .+++..+..++.|++.||+|||+.|++|+||||+||++ +.++.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~---~~~~~ 157 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFT 157 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE---cCCCC
Confidence 78899999998 7899988865322 35778899999999999999999999999999999999 47889
Q ss_pred EEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHH
Q 015041 145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQ 223 (414)
Q Consensus 145 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~ 223 (414)
++|+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.+.... +
T Consensus 158 ~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~ 229 (277)
T cd05062 158 VKIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---Q 229 (277)
T ss_pred EEECCCCCccccCCccee-----ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence 999999998754332211 11123355788999999999899999999999999999999 78999875443 2
Q ss_pred HHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 224 ~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
.+..+...... + .....+..+.+++.+||..+|++||++.++.+.|+
T Consensus 230 ~~~~~~~~~~~-~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 230 VLRFVMEGGLL-D---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHcCCcC-C---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 22222222221 1 12345789999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=301.73 Aligned_cols=201 Identities=22% Similarity=0.299 Sum_probs=161.5
Q ss_pred ecceeecCceeEEEEEEC--CCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEee-eeCCeeEEEEeccCCC
Q 015041 12 GRKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG-VDGEDNVLVLDLLGPS 88 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~-~~~~~~~lv~e~~~~s 88 (414)
+++||+|+||+||+|++. .++..||+|.+........+.+|+.+++.+.|.+.+..+..+. ......+++|||++++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD 85 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCC
Confidence 578999999999999965 4678999998877665567889999999998755444443333 2345689999999999
Q ss_pred HHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccC-CCCCeEEEeeecceeeecCC
Q 015041 89 LEDLFVYCR--------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG-RKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 89 L~~~~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~-~~~~~vkL~DFG~a~~~~~~ 159 (414)
|.+++.... ..++...++.++.||+.||+|||++||+||||||+|||+... +..+.+||+|||+|+.....
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07868 86 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCC
Confidence 988876431 248899999999999999999999999999999999999432 35678999999999865432
Q ss_pred CCCccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGL 216 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~ 216 (414)
.. +........||..|+|||++.+. .++.++|||||||++|+|++|+.||.+.
T Consensus 166 ~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 166 LK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred Cc----cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 21 11122356789999999999875 5899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=299.88 Aligned_cols=243 Identities=20% Similarity=0.274 Sum_probs=192.5
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
.|++.+.||+|+||+||+|.+..+++.||||.+..... ...+..|+.+++.++|. ++..+...+......++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~-~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR-FVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCC-CeeeeeEEEecCCEEEEEE
Confidence 47889999999999999999999999999998764321 13466799999999764 4555555566677899999
Q ss_pred ecc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||+ +++|.+++.... ..++...++.++.|++.||.|||+++|+||||||+||++ +..+.++|+|||++.......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecCCCc
Confidence 998 788988875433 458999999999999999999999999999999999999 578889999999987543221
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
. .....|+..|+|||++.+..++.++|||||||++|+|++|..||..............+.... ....
T Consensus 157 ~--------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~----~~~~ 224 (285)
T cd05630 157 T--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----QEEY 224 (285)
T ss_pred c--------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh----hhhc
Confidence 1 123478999999999999999999999999999999999999998754322222222222111 1122
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCCh
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~ 266 (414)
...++.++.+++..||..+|++||++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~R~s~ 250 (285)
T cd05630 225 SEKFSPDARSLCKMLLCKDPKERLGC 250 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHccCC
Confidence 34567889999999999999999983
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=293.88 Aligned_cols=249 Identities=19% Similarity=0.270 Sum_probs=198.6
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (414)
++|++.+.||+|+||.||+|.+. .+..+|+|.+.... ....+.+|+.+++.+.| +++..+..++......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSH-PKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCC-CCceeEEEEEccCCCEEEEEEcC
Confidence 57999999999999999999875 45679999876543 34568889999999976 56666766777778899999999
Q ss_pred -CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcc
Q 015041 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (414)
Q Consensus 86 -~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~ 164 (414)
+++|.+++......+++..++.++.|++.||+|||++||+||||||+||++ +.++.+||+|||.++........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~~~-- 156 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDEYT-- 156 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccCCCcee--
Confidence 789998887655568999999999999999999999999999999999999 57889999999998754332211
Q ss_pred ccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhhhc
Q 015041 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (414)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~ 243 (414)
......++..|+|||++.+..++.++|||||||++|||++ |+.||...... +.+..+.... ....+ ..
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~~i~~~~-~~~~~---~~ 225 (256)
T cd05114 157 ----SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVEMISRGF-RLYRP---KL 225 (256)
T ss_pred ----ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHCCC-CCCCC---CC
Confidence 1113345678999999998899999999999999999999 99999875433 2233332221 11111 23
Q ss_pred ChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 015041 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (414)
Q Consensus 244 ~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l 273 (414)
.+..+.+++..||..+|++||+++++.+.|
T Consensus 226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 468899999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=295.13 Aligned_cols=250 Identities=27% Similarity=0.439 Sum_probs=200.5
Q ss_pred eEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchh----HHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
|++++.||+|+||+||+|.+..+++.||+|++........ ...|+.+++.+. ++++..+..+.......++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLR-HPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHT-BTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccc-ccccccccccccccccccccccc
Confidence 8999999999999999999999999999999887754332 245889999995 57777787777788899999999
Q ss_pred cCC-CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 85 LGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 85 ~~~-sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
+.+ +|.+++.. ...++...++.++.||+.||++||+++|+|+||||+||++ +.++.++|+|||.+........
T Consensus 80 ~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~-- 153 (260)
T PF00069_consen 80 CPGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENNE-- 153 (260)
T ss_dssp ETTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTTS--
T ss_pred cccccccccccc-cccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccc--
Confidence 955 99988873 5678999999999999999999999999999999999999 5889999999999876411111
Q ss_pred cccccCCCCCccCcCcccccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhh
Q 015041 164 HIPYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~ 242 (414)
......++..|+|||++. +..++.++||||||+++|+|++|..||...........+.+........... ...
T Consensus 154 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 227 (260)
T PF00069_consen 154 -----NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-QSR 227 (260)
T ss_dssp -----EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-SHT
T ss_pred -----ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-ccc
Confidence 123567899999999998 7889999999999999999999999999863333333333332221111100 001
Q ss_pred cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 243 ~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+.++.+++..||+.+|++||++.++.+
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12479999999999999999999887654
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=296.32 Aligned_cols=256 Identities=18% Similarity=0.215 Sum_probs=199.3
Q ss_pred CCceEEecceeecCceeEEEEEECCCCc----eEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
.++|++++.||.|+||+||+|.+..+++ .|++|.+...... ..+..|+..+..+.| +++..+..++. +...
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h-~~iv~~~~~~~-~~~~ 83 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDH-AYIVRLLGICP-GASL 83 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCC-CCcceEEEEEC-CCcc
Confidence 4689999999999999999999977766 4777776543322 235556666777766 45666655543 3456
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
++++||+ +++|.+++......+++..++.++.||+.||+|||+++++||||||+|||+ +.++.+||+|||+++...
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCccceecc
Confidence 7888887 899999998766779999999999999999999999999999999999999 578899999999998654
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCc
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTP 236 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p 236 (414)
...... ......++..|+|||.+.+..++.++|||||||++||+++ |..||.+.... .+..++......+
T Consensus 161 ~~~~~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~~~~~~~~~~~~ 231 (279)
T cd05111 161 PDDKKY-----FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH----EVPDLLEKGERLA 231 (279)
T ss_pred CCCccc-----ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHCCCcCC
Confidence 322111 1123456788999999998899999999999999999998 99999876432 2233334333333
Q ss_pred hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 237 ~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
.+. .++..+.+++..||..+|++||++.++.+.|..+..
T Consensus 232 ~~~---~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 QPQ---ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 222 347789999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=304.09 Aligned_cols=263 Identities=19% Similarity=0.312 Sum_probs=206.6
Q ss_pred ccCCceEEecceeecCceeEEEEEECC-------CCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV 73 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~ 73 (414)
+...+|++++.||+|+||.||+|.+.. .+..||+|++...... ..+..|+.+++.+.+|+++..+..++.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 456789999999999999999998643 2236899987754332 357889999999966678888877777
Q ss_pred eCCeeEEEEecc-CCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEc
Q 015041 74 DGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137 (414)
Q Consensus 74 ~~~~~~lv~e~~-~~sL~~~~~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~ 137 (414)
.....++++||+ +++|.+++.... ..+++.+++.++.|++.||.|||++||+||||||+|||+
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill- 167 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV- 167 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE-
Confidence 778899999999 779998887522 247788999999999999999999999999999999999
Q ss_pred cCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 015041 138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 216 (414)
Q Consensus 138 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~ 216 (414)
+.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 168 --~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 168 --TEDNVMKIADFGLARDVHNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred --cCCCcEEECCcccceeccccccc-----ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 47889999999999865432211 01122334568999999999999999999999999999998 89999875
Q ss_pred hhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 015041 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (414)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~ 281 (414)
.... .+..+.. ....+. ....+.++.+++..||..+|++||++.++.+.|+.++....
T Consensus 241 ~~~~---~~~~~~~-~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 241 PVEE---LFKLLKE-GHRMDK---PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred CHHH---HHHHHHc-CCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 4322 2222222 222221 13457899999999999999999999999999998876554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=300.45 Aligned_cols=259 Identities=21% Similarity=0.308 Sum_probs=204.6
Q ss_pred ccCCceEEecceeecCceeEEEEEEC-----CCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 75 (414)
+..++|.+.+.||+|+||.||+|.+. .++..||||.+..... ...+..|+.+++.+.+|+++..+..++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 44568999999999999999999852 3456899998765432 234778999999996567888887777778
Q ss_pred CeeEEEEecc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
...+++|||+ +++|.+++.... ..+++.+++.++.|++.||+|||+++|+|+||||+|||+ +.++.++|+|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCCccc
Confidence 8899999998 789998887533 238999999999999999999999999999999999999 47889999999998
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhc
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKK 232 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~ 232 (414)
+........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+..... .+.+.....
T Consensus 189 ~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~---~~~~~~~~~ 260 (302)
T cd05055 189 RDIMNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS---KFYKLIKEG 260 (302)
T ss_pred ccccCCCce-----eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---HHHHHHHcC
Confidence 765432211 01123345778999999999999999999999999999998 999998754322 222222222
Q ss_pred cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 233 ~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
...+ .....++++.+++.+||..+|++||++.++.+.|.++
T Consensus 261 ~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 YRMA---QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CcCC---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 2221 1134578999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=307.50 Aligned_cols=260 Identities=22% Similarity=0.321 Sum_probs=201.0
Q ss_pred cCCceEEecceeecCceeEEEEEEC-----CCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEE-eeeeC
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKW-YGVDG 75 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~-~~~~~ 75 (414)
-.++|++++.||.|+||.||+|.+. .+++.||||++...... ..+.+|+.++..+.+|++++.+.. +...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 3578999999999999999999853 45778999998754332 347789999999977777766654 44455
Q ss_pred CeeEEEEecc-CCCHHHHHHHhC---------------------------------------------------------
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYCR--------------------------------------------------------- 97 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~~--------------------------------------------------------- 97 (414)
...+++|||+ +++|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 6789999999 889988876421
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcccccc
Q 015041 98 ---------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168 (414)
Q Consensus 98 ---------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 168 (414)
..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++......... .
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~-----~ 236 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDY-----V 236 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcch-----h
Confidence 236778889999999999999999999999999999999 47889999999998765322110 1
Q ss_pred CCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHH
Q 015041 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE 247 (414)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~ 247 (414)
......++..|+|||++.+..++.++|||||||++|+|++ |..||.+..... .+..........+.+ ...+++
T Consensus 237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~---~~~~~~ 310 (343)
T cd05103 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFCRRLKEGTRMRAP---DYTTPE 310 (343)
T ss_pred hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH---HHHHHHhccCCCCCC---CCCCHH
Confidence 1123345678999999999899999999999999999996 999998753321 112222222222222 234678
Q ss_pred HHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 248 FASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 248 ~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
+.+++..||..+|++||++.+|.+.|+.++.
T Consensus 311 ~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 311 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=302.62 Aligned_cols=256 Identities=19% Similarity=0.241 Sum_probs=202.0
Q ss_pred CceEEecceeecCceeEEEEEECCCCce--EEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEI--VAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~--vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|++.+.||+|+||.||+|.+..++.. +|+|....... ...+.+|+.++..+.+|++++.+..++......++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 5799999999999999999998777654 56666553221 235778999999997678888888888888889999
Q ss_pred Eecc-CCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeE
Q 015041 82 LDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 145 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~v 145 (414)
|||+ +++|.+++.... ..++..+++.++.||+.||+|||++||+||||||+|||+ +.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---cCCCcE
Confidence 9999 789999887532 247899999999999999999999999999999999999 578899
Q ss_pred EEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHH
Q 015041 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQK 224 (414)
Q Consensus 146 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~ 224 (414)
||+|||+++...... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+..... .
T Consensus 164 kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~ 232 (303)
T cd05088 164 KIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---L 232 (303)
T ss_pred EeCccccCcccchhh--------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---H
Confidence 999999986321110 1112234667999999988889999999999999999998 999998754432 2
Q ss_pred HHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 225 ~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
...+ ....... .....+.++.+++.+||..+|++||+++++...|..++...
T Consensus 233 ~~~~-~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 233 YEKL-PQGYRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HHHH-hcCCcCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 2222 2111111 11345789999999999999999999999999988876554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=300.97 Aligned_cols=261 Identities=18% Similarity=0.282 Sum_probs=198.9
Q ss_pred cCCceEEecceeecCceeEEEEEECCC--------------CceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCe
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDT--------------NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPN 67 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~--------------~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~ 67 (414)
-.++|++.++||+|+||.||+|++..+ ...||+|.+...... ..+.+|+++++.+.| +++..
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h-~~i~~ 81 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKN-PNIIR 81 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CCcCe
Confidence 357899999999999999999987543 235899988754322 347889999999986 56777
Q ss_pred eEEeeeeCCeeEEEEecc-CCCHHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceE
Q 015041 68 IKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-----------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135 (414)
Q Consensus 68 l~~~~~~~~~~~lv~e~~-~~sL~~~~~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nil 135 (414)
+..++......++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++|++|+||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 777777778899999999 789988886421 13678899999999999999999999999999999999
Q ss_pred EccCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc--CCCCC
Q 015041 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR--GSLPW 213 (414)
Q Consensus 136 i~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t--G~~Pf 213 (414)
+ +.++.+||+|||++......... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||
T Consensus 162 l---~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~ 233 (295)
T cd05097 162 V---GNHYTIKIADFGMSRNLYSGDYY-----RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233 (295)
T ss_pred E---cCCCcEEecccccccccccCcce-----eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 9 47788999999998765332211 11123445778999999998899999999999999999988 67888
Q ss_pred CCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 214 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 214 ~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
.............+.................|+.+.+++.+||..+|++||+++++.+.|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 234 SLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred cccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 8755433222222211111111001112345789999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=297.78 Aligned_cols=260 Identities=23% Similarity=0.327 Sum_probs=207.1
Q ss_pred ccCCceEEecceeecCceeEEEEEEC-----CCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
|-+.+|.+.+.||.|+||.||+|.+. .++..||+|.+..... ...+.+|+.+++.+.| +++..+..++....
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 80 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQH-EHIVKFYGVCVEGD 80 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEecCC
Confidence 34578999999999999999999852 3456789998765432 2357889999999976 67777777777888
Q ss_pred eeEEEEecc-CCCHHHHHHHhC------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCC
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCR------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN 143 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~ 143 (414)
..++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+|||+ ++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccCC
Confidence 899999999 789988886432 248999999999999999999999999999999999999 5788
Q ss_pred eEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchH
Q 015041 144 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKK 222 (414)
Q Consensus 144 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~ 222 (414)
.++|+|||+++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 158 ~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--- 229 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--- 229 (288)
T ss_pred cEEeccCCccccccCCcee-----ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 9999999998754332211 11223445778999999999899999999999999999998 99999875433
Q ss_pred HHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 223 QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 223 ~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
..+..+....... .....+.++.+++.+||..+|.+||++.++...|+++...
T Consensus 230 ~~~~~i~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 230 EVIECITQGRVLQ----RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHHHcCCcCC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 2333333322211 1234578999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=297.70 Aligned_cols=252 Identities=19% Similarity=0.281 Sum_probs=198.7
Q ss_pred CceEEecceeecCceeEEEEEEC----CCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
..|++.++||+|+||.||+|.+. .++..|++|.+...... ..+.+|+.+++.+.| ++++.+..+...+...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHH-PNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCC-CCeeeEEEEEecCCceE
Confidence 57899999999999999999853 45678999987653322 347789999999976 56666766677778899
Q ss_pred EEEecc-CCCHHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCC
Q 015041 80 LVLDLL-GPSLEDLFVYCR----------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 142 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~ 142 (414)
+||||+ +++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||+ +.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---GEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---cCC
Confidence 999999 778988875321 236788899999999999999999999999999999999 477
Q ss_pred CeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhch
Q 015041 143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATK 221 (414)
Q Consensus 143 ~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~ 221 (414)
+.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.....
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~- 234 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYR-----VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE- 234 (283)
T ss_pred CcEEeccccccccccCCccee-----cccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-
Confidence 889999999997654322111 1123445778999999998889999999999999999998 999998754322
Q ss_pred HHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 222 ~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
+.+.+......+ ....+++.+.+++.+||..+|.+||++.+|.+.|+
T Consensus 235 ---~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 235 ---VIEMVRKRQLLP---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred ---HHHHHHcCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 222222222222 23456889999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=306.16 Aligned_cols=247 Identities=21% Similarity=0.280 Sum_probs=205.2
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
+-.+.|+.-+.||+|+||+||-++...||+.+|+|.+.+. ....-.++|-.++.++.. +.|+.+.+.....+..
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s-~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSS-PFIVSLAYAFETKDAL 260 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhcc-CcEEEEeeeecCCCce
Confidence 3457789999999999999999999999999999965443 333447889999998875 5777777777788899
Q ss_pred EEEEecc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 79 VLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
|+|+.+| ||+|...+-..+ ..|++..++.++.+|+.||++||..+||+|||||+|||+ |+.|+++|+|+|+|..+
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEEec
Confidence 9999999 777765554333 469999999999999999999999999999999999999 79999999999999987
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCc
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p 236 (414)
...... ...+||.+|||||++.++.|+...|+|||||++|||+.|+.||...+.....+.+.+ .....
T Consensus 338 ~~g~~~--------~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr----r~~~~ 405 (591)
T KOG0986|consen 338 PEGKPI--------RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR----RTLED 405 (591)
T ss_pred CCCCcc--------ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH----HHhcc
Confidence 654332 245999999999999999999999999999999999999999997655444433332 22233
Q ss_pred hHHhhhcChHHHHHHHHHHhcCCCCCCCCh
Q 015041 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 237 ~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~ 266 (414)
...+...++++.++|.+..|..||.+|...
T Consensus 406 ~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 406 PEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 345557889999999999999999999864
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=294.40 Aligned_cols=254 Identities=21% Similarity=0.360 Sum_probs=202.0
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
+|....|+++++||+|+||.||+|... +++.||+|.+..... ...+.+|+.+++.++| +++..+..+. .....+++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~-~~~~~~~v 78 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH-PRLVRLYAVV-TQEPIYII 78 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCC-cCeeeEEEEE-ccCCcEEE
Confidence 467889999999999999999999864 567899998776443 3468899999999976 4555554443 34568999
Q ss_pred Eecc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 82 LDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
||++ +++|.+++... ...++..+++.++.|++.||+|||+.|++|+||||+||++ +.++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCcceeecCCC
Confidence 9999 78999887643 3468999999999999999999999999999999999999 57889999999999765422
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
... ......++..|+|||++.+..++.++|||||||++||+++ |..||.+......... +......+.
T Consensus 156 ~~~------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~----~~~~~~~~~- 224 (260)
T cd05067 156 EYT------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN----LERGYRMPR- 224 (260)
T ss_pred Ccc------cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH----HHcCCCCCC-
Confidence 211 1123345678999999998899999999999999999999 9999987654322222 222222222
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~ 275 (414)
....|.++.+++.+||..+|++||+++++...|++
T Consensus 225 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 --PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 23457899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=294.32 Aligned_cols=248 Identities=20% Similarity=0.322 Sum_probs=192.3
Q ss_pred ceeecCceeEEEEEEC--CCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-CC
Q 015041 14 KIGSGSFGEIFLASHV--DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GP 87 (414)
Q Consensus 14 ~iG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 87 (414)
.||+|+||.||+|.+. .++..||+|+...... ...+.+|+.+++.+.|. ++..+..++ .....++||||+ ++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~-~ii~~~~~~-~~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNP-YIVRMIGVC-EAEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCC-CeEEEEEEE-cCCCeEEEEEeCCCC
Confidence 4899999999999775 4456799998876543 23478899999999764 454454443 345679999999 78
Q ss_pred CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccccc
Q 015041 88 SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167 (414)
Q Consensus 88 sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 167 (414)
+|.+++......+++..++.++.|++.||+|||++|++||||||+|||+ +.++.+||+|||+++........ +
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~----~ 152 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSY----Y 152 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCccc----e
Confidence 8988887656679999999999999999999999999999999999999 47889999999998754332211 0
Q ss_pred cCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChH
Q 015041 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (414)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~ 246 (414)
.......++..|+|||++.+..++.++|||||||++||+++ |..||.+...... ...+ ......+. ....++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~-~~~~~~~~---~~~~~~ 225 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV---MSFI-EQGKRLDC---PAECPP 225 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHH-HCCCCCCC---CCCCCH
Confidence 11112233578999999998889999999999999999996 9999987654322 2222 22222222 234578
Q ss_pred HHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 015041 247 EFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (414)
Q Consensus 247 ~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~ 277 (414)
++.+++..||..+|++||++.++.+.|+.++
T Consensus 226 ~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 226 EMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 9999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=291.59 Aligned_cols=246 Identities=21% Similarity=0.326 Sum_probs=194.9
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-CCC
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~~s 88 (414)
++||+|+||.||+|.+..+++.||+|....... ...+.+|+++++.+.| +++..+..++......++||||+ +++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSH-PNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 479999999999999998999999998764432 2457889999999975 66777777777778899999998 788
Q ss_pred HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcccccc
Q 015041 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168 (414)
Q Consensus 89 L~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 168 (414)
|.+++......+++.+++.++.|++.||+|||++||+|+||||+|||+ +.++.+||+|||++..........
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~----- 151 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYAS----- 151 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccccc-----
Confidence 988887655568999999999999999999999999999999999999 477889999999987543211100
Q ss_pred CCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHH
Q 015041 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE 247 (414)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~ 247 (414)
......++..|+|||.+.+..++.++|||||||++|||++ |..||........ ...+......+. ....|..
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~----~~~~~~~~~~~~---~~~~~~~ 224 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT----REAIEQGVRLPC---PELCPDA 224 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH----HHHHHcCCCCCC---cccCCHH
Confidence 0111223457999999999899999999999999999997 9999986544322 222222222222 2345789
Q ss_pred HHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 248 FASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 248 ~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
+.+++.+||..+|++||++.++.+.|+
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=300.10 Aligned_cols=259 Identities=19% Similarity=0.306 Sum_probs=198.7
Q ss_pred ccCCceEEecceeecCceeEEEEEECC----------------CCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVD----------------TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSG 64 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~ 64 (414)
+..++|++.++||+|+||.||+|.+.. ++..||+|++..... ...+..|+.+++.+.| ++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~-~~ 80 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKD-PN 80 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CC
Confidence 345789999999999999999986432 345799998875432 2357889999999976 66
Q ss_pred CCeeEEeeeeCCeeEEEEecc-CCCHHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCc
Q 015041 65 IPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR----------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 133 (414)
Q Consensus 65 i~~l~~~~~~~~~~~lv~e~~-~~sL~~~~~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~N 133 (414)
+..+..++......+++|||+ +++|.+++.... ..+++.+++.++.|++.||+|||++||+|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 767777777778899999999 789998887532 236778899999999999999999999999999999
Q ss_pred eEEccCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc--CCC
Q 015041 134 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR--GSL 211 (414)
Q Consensus 134 ili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t--G~~ 211 (414)
||+ +.++.++|+|||+++........ .......++..|++||+..+..++.++|||||||++|||++ |..
T Consensus 161 ili---~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~ 232 (296)
T cd05095 161 CLV---GKNYTIKIADFGMSRNLYSGDYY-----RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQ 232 (296)
T ss_pred EEE---cCCCCEEeccCcccccccCCcce-----eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCC
Confidence 999 47889999999998765332211 11122344678999999988899999999999999999998 789
Q ss_pred CCCCChhhchHHHHHHHHhh---ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 212 PWQGLKAATKKQKYDKICEK---KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 212 Pf~~~~~~~~~~~~~~i~~~---~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
||.................. ....+.+ ..+|+.+.+++..||..+|++||++.+|.+.|+
T Consensus 233 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 233 PYSQLSDEQVIENTGEFFRDQGRQVYLPKP---ALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred CccccChHHHHHHHHHHHhhccccccCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 99865443322222111111 1111111 345789999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=293.50 Aligned_cols=255 Identities=16% Similarity=0.278 Sum_probs=203.7
Q ss_pred CCceEEecceeecCceeEEEEEECCC---CceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
.++|++.+.||+|+||.||+|.+..+ ...||||++...... ..+..|+.++..+.| +++..+..+.......+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDH-PNIIRLEGVVTKSRPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCC-CCcceEeEEEecCCceE
Confidence 46899999999999999999998643 467999988755432 347789999999976 56667766677778899
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
++|||+ +++|.+++......+++..++.++.|++.||+|||+++|+|+||||+||++ +.++.++|+|||+++....
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhcccc
Confidence 999999 779999987666679999999999999999999999999999999999999 5788999999999987642
Q ss_pred CCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
..... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ....+.. ....+.
T Consensus 159 ~~~~~-----~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~-~~~~~~ 229 (266)
T cd05033 159 SEATY-----TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAVED-GYRLPP 229 (266)
T ss_pred cccce-----eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHHHc-CCCCCC
Confidence 21110 0112334678999999998899999999999999999998 999997654332 2222222 222222
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
+ ...|+.+.+++..||..+|++||++.++.+.|.++
T Consensus 230 ~---~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 P---MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred C---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 2 34578999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=293.03 Aligned_cols=253 Identities=23% Similarity=0.392 Sum_probs=198.6
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
+..++|.+.++||.|+||.||+|.+..+ ..||+|.+..... ...+.+|+.+++.+.|.+.++ +..+. .....+++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~-~~~~~-~~~~~~~v~ 79 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVP-LYAVV-SEEPIYIVT 79 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeee-EEEEE-cCCCcEEEE
Confidence 5568899999999999999999987654 4589998765433 345788999999998766554 43333 345678999
Q ss_pred ecc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||+ +++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||||+||++ ++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceEccCCc
Confidence 999 679999887533 348899999999999999999999999999999999999 578899999999997653322
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
.. ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+...... ...+ ......+.
T Consensus 157 ~~------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~-~~~~~~~~-- 224 (260)
T cd05069 157 YT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQV-ERGYRMPC-- 224 (260)
T ss_pred cc------ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH-HcCCCCCC--
Confidence 11 1123345678999999998899999999999999999999 9999987654322 2222 22222221
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~ 275 (414)
....|..+.+++.+||..+|++||+++++.+.|++
T Consensus 225 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 -PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 23568899999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=327.55 Aligned_cols=263 Identities=27% Similarity=0.373 Sum_probs=204.3
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|++.++||+|+||.||+|.+..+++.||||++..... ...+.+|+++++.+.| ++++.+..++.+....++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~H-PNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH-PGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCC-cCcCeEEEEEeeCCEEEEE
Confidence 689999999999999999999999999999998865422 2357889999999986 6666777777778889999
Q ss_pred Eecc-CCCHHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeee
Q 015041 82 LDLL-GPSLEDLFVYCR----------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 150 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DF 150 (414)
|||+ +++|.+++.... ...+...++.++.||+.||+|||++||+||||||+|||+ +.++.++|+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEEEec
Confidence 9999 889998886421 235667889999999999999999999999999999999 57889999999
Q ss_pred cceeeecCCCCCc-----------cccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhh
Q 015041 151 GLAKKYRDPTTNR-----------HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219 (414)
Q Consensus 151 G~a~~~~~~~~~~-----------~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~ 219 (414)
|+++......... ..........+||..|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9998652111000 00011123467999999999999999999999999999999999999999864322
Q ss_pred chHHHHHHHHhhccCCchHH-hhhcChHHHHHHHHHHhcCCCCCCC-ChHHHHHHHHHHHHh
Q 015041 220 TKKQKYDKICEKKVSTPIEV-LCKSHPAEFASYFHYCQSLTFDQRP-DYGFLKRLFHDLFSR 279 (414)
Q Consensus 220 ~~~~~~~~i~~~~~~~p~~~-~~~~~p~~~~~l~~~c~~~~p~~RP-~~~~l~~~l~~~~~~ 279 (414)
.. .. ......|... .....|+.+.+++.+|+..+|++|| +++++.+.|+..+..
T Consensus 238 ki--~~----~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 238 KI--SY----RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hh--hh----hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 11 11 1111112111 1235688999999999999999996 567777777777653
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=297.83 Aligned_cols=256 Identities=18% Similarity=0.304 Sum_probs=201.5
Q ss_pred ceEEecceeecCceeEEEEEECC-----CCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
+|++.+.||+|+||.||+|.+.. ....|++|.+..... ...+.+|+.+++.+.| +++..+...+......+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNH-PHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCC-CCEeeEEEEEecCCCcE
Confidence 58899999999999999998753 235688998765443 2357789999999976 55666666666777889
Q ss_pred EEEecc-CCCHHHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceE
Q 015041 80 LVLDLL-GPSLEDLFVYCR-----------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~-----------------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nil 135 (414)
+++||+ +++|.+++.... ..+++..++.++.|++.||+|||+.+|+||||||+|||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 999999 789988876421 24788899999999999999999999999999999999
Q ss_pred EccCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 015041 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQ 214 (414)
Q Consensus 136 i~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~ 214 (414)
+ ++++.++|+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 160 l---~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 160 V---AEGRKMKISDFGLSRDVYEEDSY-----VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred E---cCCCcEEeccccccccccCccch-----hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 9 47889999999999765332211 11123345678999999998899999999999999999998 999998
Q ss_pred CChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 215 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 215 ~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
+.... .+..........+.+ ...+.++.+++..||..+|++||++.++.+.|++++.+
T Consensus 232 ~~~~~----~~~~~~~~~~~~~~~---~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 232 GIAPE----RLFNLLKTGYRMERP---ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred CCCHH----HHHHHHhCCCCCCCC---CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 75432 222333333222222 34578999999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=293.61 Aligned_cols=250 Identities=17% Similarity=0.271 Sum_probs=199.9
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
.++|++++.||+|+||.||+|.+.. +..||||.+.... ....+.+|+.+++.+.| +++..+..++......+++|||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSH-EKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCC-CCeeeEEEEEccCCCcEEEEEc
Confidence 4679999999999999999998754 4469999876543 24568899999999975 6777777777777788999999
Q ss_pred c-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 85 ~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
+ +++|.+++......+++..++.++.||+.||.|||++||+|+||||+||++ +.++.+||+|||.++........
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecCCCcee-
Confidence 9 778999887655678999999999999999999999999999999999999 47889999999998765432211
Q ss_pred cccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhhh
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~ 242 (414)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ....+..... .+.. .
T Consensus 157 -----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~~~-~~~~---~ 224 (256)
T cd05113 157 -----SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKVSQGLR-LYRP---H 224 (256)
T ss_pred -----ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHhcCCC-CCCC---C
Confidence 1112345678999999998889999999999999999998 999998755432 2223333222 1111 2
Q ss_pred cChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 015041 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (414)
Q Consensus 243 ~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l 273 (414)
..++.+.+++..||..+|++||++.+|.+.+
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 3478999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=299.11 Aligned_cols=261 Identities=18% Similarity=0.306 Sum_probs=206.2
Q ss_pred ccCCceEEecceeecCceeEEEEEEC-------CCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHV-------DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGV 73 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~ 73 (414)
+...+|.+++.||+|+||.||+|++. .++..||+|....... ...+..|+.+++.+.+|+++..+..++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 45678999999999999999999753 2345799998765432 2457889999999966678888877777
Q ss_pred eCCeeEEEEecc-CCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEc
Q 015041 74 DGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137 (414)
Q Consensus 74 ~~~~~~lv~e~~-~~sL~~~~~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~ 137 (414)
.....+++|||+ +++|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+||++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili- 170 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV- 170 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE-
Confidence 778899999999 779998887532 247788899999999999999999999999999999999
Q ss_pred cCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 015041 138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 216 (414)
Q Consensus 138 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~ 216 (414)
+.++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 171 --~~~~~~kl~D~g~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 171 --TENNVMKIADFGLARDVNNIDYYK-----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred --cCCCcEEECCCccceecccccccc-----cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 478899999999998664322211 1123345678999999999889999999999999999998 88999875
Q ss_pred hhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
... +....+ ........ ...++.++.+++..||..+|++||++.++.+.|++++..
T Consensus 244 ~~~---~~~~~~-~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 244 PVE---ELFKLL-KEGHRMDK---PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred CHH---HHHHHH-HcCCcCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 433 222222 22222111 134578999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=292.12 Aligned_cols=248 Identities=22% Similarity=0.354 Sum_probs=192.4
Q ss_pred cceeecCceeEEEEEE--CCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-
Q 015041 13 RKIGSGSFGEIFLASH--VDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (414)
++||+|+||.||+|.+ ..++..||+|++...... ..+..|+.+++.+.| +++..+..+. .....++||||+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~-~~~~~~lv~e~~~ 78 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDN-PYIVRMIGIC-EAESWMLVMELAE 78 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCC-CCcceEEEEE-cCCCcEEEEecCC
Confidence 3699999999999965 467789999988655432 357788999999876 5565555544 345678999999
Q ss_pred CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccc
Q 015041 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (414)
Q Consensus 86 ~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 165 (414)
+++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||++ +.++.+||+|||+++........
T Consensus 79 ~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~--- 151 (257)
T cd05116 79 LGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENY--- 151 (257)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCe---
Confidence 6788888765 4578999999999999999999999999999999999999 47788999999999765432211
Q ss_pred cccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcC
Q 015041 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (414)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 244 (414)
+.......++..|+|||.+....++.++|||||||++|||++ |..||....... ....+ ......+. ...+
T Consensus 152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~i-~~~~~~~~---~~~~ 223 (257)
T cd05116 152 -YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQMI-ESGERMEC---PQRC 223 (257)
T ss_pred -eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH-HCCCCCCC---CCCC
Confidence 011112234678999999988889999999999999999998 999998754432 22222 22222222 2356
Q ss_pred hHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 015041 245 PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (414)
Q Consensus 245 p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~ 277 (414)
|+++.+++.+||..+|++||++..|.+.|++.+
T Consensus 224 ~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05116 224 PPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256 (257)
T ss_pred CHHHHHHHHHHhccCchhCcCHHHHHHHHhccc
Confidence 889999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=294.32 Aligned_cols=252 Identities=21% Similarity=0.372 Sum_probs=195.3
Q ss_pred eEEecceeecCceeEEEEEECC---CCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCC-----
Q 015041 9 YKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGE----- 76 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~----- 76 (414)
|++++.||+|+||.||+|.+.. ++..||+|++...... ..+..|+.+++.+.|. ++..+..+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHP-NVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCC-CeeeEEeeeccCCccccC
Confidence 6789999999999999998754 3478999988754322 3577899999998764 5555544433322
Q ss_pred -eeEEEEecc-CCCHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEee
Q 015041 77 -DNVLVLDLL-GPSLEDLFVYCR-----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149 (414)
Q Consensus 77 -~~~lv~e~~-~~sL~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~D 149 (414)
..++++||+ +++|..++.... ..+++..++.++.|++.||+|||+++|+||||||+||++ ++++.+||+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEECC
Confidence 368999998 788888875431 358999999999999999999999999999999999999 5788999999
Q ss_pred ecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHH
Q 015041 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKI 228 (414)
Q Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i 228 (414)
||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.+.... +.+..+
T Consensus 157 fg~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~ 228 (273)
T cd05035 157 FGLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYL 228 (273)
T ss_pred ccceeeccccccc-----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH
Confidence 9999876543321 11122344678999999988899999999999999999999 99999875433 223332
Q ss_pred HhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 229 ~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
.... ... ....++.++.+++.+||..+|++||++.++.+.|+++
T Consensus 229 ~~~~-~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 RHGN-RLK---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HcCC-CCC---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2221 111 1245688999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=295.08 Aligned_cols=251 Identities=19% Similarity=0.310 Sum_probs=197.3
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeee------CCe
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVD------GED 77 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~------~~~ 77 (414)
.++.|++.+.||.|+||+||+|.+..+++.||+|+...... ...+..|+.++..+.+|+++..+..++.. ...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 46789999999999999999999999999999998865433 34578899999998766777776555432 245
Q ss_pred eEEEEecc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 78 NVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
.+++|||+ +++|.+++... ...+++..++.++.|++.||.|||+++|+|+||||+||++ +.++.++|+|||++..
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEccCCCcee
Confidence 78999999 67898888753 3468999999999999999999999999999999999999 5788999999999876
Q ss_pred ecCCCCCccccccCCCCCccCcCcccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHh
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~ 230 (414)
...... ......|+..|+|||++. +..++.++|||||||++|||++|..||......... ..+..
T Consensus 161 ~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~---~~~~~ 230 (272)
T cd06637 161 LDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---FLIPR 230 (272)
T ss_pred cccccc-------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH---HHHhc
Confidence 433211 123567899999999986 345888999999999999999999999765432211 11111
Q ss_pred hccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 231 ~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.... ......++.++.+++..||..+|.+||++.++.+
T Consensus 231 ~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 NPAP---RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCC---CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1111 1112345789999999999999999999887643
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=294.74 Aligned_cols=253 Identities=21% Similarity=0.234 Sum_probs=195.6
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
+|++.+.||+|+||.||+|.+..+++.||||.+..... ...+.+|+.+++.+.| +++..+..+...+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH-PNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCC-CCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999998999999998764322 2457889999999985 667777777777888999999
Q ss_pred ccCCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 84 LLGPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 84 ~~~~sL~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
|+.++|.+++.... ..++...++.++.||+.||+|||++||+|+||||+||++ +.++.++|+|||++........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 80 FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred cCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeecCCCcc
Confidence 99889988876543 468999999999999999999999999999999999999 5788999999999875432211
Q ss_pred CccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHh----------
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE---------- 230 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~---------- 230 (414)
......++..|+|||++.+. .++.++|||||||++|+|++|+.||.+...............
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
T cd07861 157 -------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV 229 (285)
T ss_pred -------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence 11234568899999998764 478999999999999999999999987543221111111000
Q ss_pred -----------hccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 231 -----------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 231 -----------~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.............+++++.+++.+||..||.+||++.++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000011112345788899999999999999999887643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=294.94 Aligned_cols=259 Identities=22% Similarity=0.313 Sum_probs=202.7
Q ss_pred ccCCceEEecceeecCceeEEEEEECC----CCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEe-eeeC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVD----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWY-GVDG 75 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~----~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~-~~~~ 75 (414)
+-+++|++.+.||+|+||.||+|.+.. ++..|++|.+..... ...+.+|+.+++.+.|. ++..+..+ ...+
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~-ni~~~~~~~~~~~ 81 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQ-NILPILHVCIEDG 81 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCC-CCCeEEEEEecCC
Confidence 557899999999999999999999875 367899998765433 23467899999999764 45455444 4445
Q ss_pred CeeEEEEecc-CCCHHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEE
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYCR-------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 147 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL 147 (414)
...+++++|+ +++|.+++.... ..+++..++.++.|++.||+|||+++++|+||||+||++ ++++.+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE---cCCCcEEE
Confidence 6788999998 689988886532 358899999999999999999999999999999999999 47799999
Q ss_pred eeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHH
Q 015041 148 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYD 226 (414)
Q Consensus 148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~ 226 (414)
+|||+++.+....... ......++..|+|||++.+..++.++|||||||++||+++ |+.||....... +.
T Consensus 159 ~d~g~~~~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~ 229 (280)
T cd05043 159 TDNALSRDLFPMDYHC-----LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE----MA 229 (280)
T ss_pred CCCCCcccccCCceEE-----eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH----HH
Confidence 9999997654322110 0113345778999999998899999999999999999999 999998754432 22
Q ss_pred HHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 227 KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 227 ~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
.........+.. ..+|+++.+++.+||..+|++||++.++...|+++.+
T Consensus 230 ~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 230 AYLKDGYRLAQP---INCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HHHHcCCCCCCC---CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 222222222221 2457899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=298.14 Aligned_cols=252 Identities=17% Similarity=0.290 Sum_probs=197.9
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
..++.|+++++||.|+||.||+|++..++..|++|++..... ...+..|+.+++.+.| +++..+...+......++|
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNH-PYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCC-CcEeeeEEEEEeCCeEEEE
Confidence 345789999999999999999999999999999999875542 2347789999999886 5666666666677789999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|..++......+++..++.++.|++.||.|||+.+|+||||||+||++ +.++.++|+|||++.......
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceeccccc
Confidence 9999 677777766556678999999999999999999999999999999999999 478899999999987543221
Q ss_pred CCccccccCCCCCccCcCcccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
. ......++..|+|||++. ...++.++|||||||++|||++|..||...... +.+.++.... .
T Consensus 165 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~--~ 232 (292)
T cd06644 165 Q-------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKSE--P 232 (292)
T ss_pred c-------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH---HHHHHHhcCC--C
Confidence 1 122456788999999985 345788999999999999999999999865432 2222222211 1
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+.......++.++.+++.+||..+|++||+++++.+
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111112345678999999999999999999887643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=296.26 Aligned_cols=240 Identities=20% Similarity=0.259 Sum_probs=189.4
Q ss_pred eeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-CCC
Q 015041 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (414)
Q Consensus 15 iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~~s 88 (414)
||+|+||+||++++..+|+.||+|.+.... ....+..|+++++.+.| +++..+...+......++||||+ +++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCC-CcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 799999999999999999999999875422 22345669999999965 56666666667778899999999 788
Q ss_pred HHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccccc
Q 015041 89 LEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167 (414)
Q Consensus 89 L~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 167 (414)
|.+++... ...+++..+..++.|++.||+|||++||+||||||+||++ +.++.++|+|||++........
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~------ 150 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKT------ 150 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCce------
Confidence 88777543 3458899999999999999999999999999999999999 5788999999999876543221
Q ss_pred cCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhc-hHHHHHHHHhhccCCchHHhhhcChH
Q 015041 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT-KKQKYDKICEKKVSTPIEVLCKSHPA 246 (414)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~-~~~~~~~i~~~~~~~p~~~~~~~~p~ 246 (414)
.....|+..|+|||++.+..++.++|||||||++|||++|..||.+..... ..+....+....... ....+++
T Consensus 151 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 224 (277)
T cd05607 151 --ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF----EHQNFTE 224 (277)
T ss_pred --eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc----ccccCCH
Confidence 123468999999999999899999999999999999999999998643321 122222222222211 1135678
Q ss_pred HHHHHHHHHhcCCCCCCCChHHHH
Q 015041 247 EFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 247 ~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
++.+++.+||..+|++||++.++.
T Consensus 225 ~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 225 ESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred HHHHHHHHHhccCHhhCCCCccch
Confidence 999999999999999999986653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=307.20 Aligned_cols=255 Identities=22% Similarity=0.311 Sum_probs=200.4
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCC-eeEEEEe
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE-DNVLVLD 83 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~-~~~lv~e 83 (414)
++|.-...||+|+||.||+|... ++..||||.+..... ..+|.+|+.++.+++ |+|+..+.+|+.+.. ..++|+|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~-H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLR-HPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred hCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCC-CcCcccEEEEEecCCceEEEEEE
Confidence 46667789999999999999864 448899998877655 467999999999998 577778888888777 5999999
Q ss_pred cc-CCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcC---eeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 84 LL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRG---FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
|+ .|+|.+.+..... .++|..+++|+.++|.||+|||+.. |||||||++|||+ |++..+||+|||+|+....
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCEEccCccCcccCCc
Confidence 99 7899999886555 8899999999999999999999853 9999999999999 6999999999999965543
Q ss_pred -CCCCccccccCCCCC-ccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCh---hhchHH---------H
Q 015041 159 -PTTNRHIPYRENKNL-TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK---AATKKQ---------K 224 (414)
Q Consensus 159 -~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~---~~~~~~---------~ 224 (414)
.... ... .||..|+|||++..+..+.|+||||||++++|+++|+.+..... .....+ .
T Consensus 230 ~~~~~--------~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~ 301 (361)
T KOG1187|consen 230 GDTSV--------STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGK 301 (361)
T ss_pred cccce--------eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcc
Confidence 2110 112 78999999999999999999999999999999999998887432 111111 2
Q ss_pred HHHHHhhccC-CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 225 YDKICEKKVS-TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 225 ~~~i~~~~~~-~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
+.++++.++. ...... ..-..+..+...|++.++..||++.++.+.|+.+
T Consensus 302 ~~eiiD~~l~~~~~~~~--~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 302 LREIVDPRLKEGEYPDE--KEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred hhheeCCCccCCCCChH--HHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 2333333322 111000 0123477888999999999999999988877544
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=295.06 Aligned_cols=248 Identities=25% Similarity=0.435 Sum_probs=193.5
Q ss_pred EEecceeecCceeEEEEEEC----CCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 10 KLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 10 ~i~~~iG~G~~g~V~~~~~~----~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
++.+.||.|.||.||+|.+. ..+..|+||+++.... ...+.+|++.++.++ |+++..+..++......++|+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLR-HPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHS-BTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccc-ccccccccccccccccccccc
Confidence 57889999999999999987 4467899999966443 346889999999995 577777877777777799999
Q ss_pred ecc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 83 e~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||+ +++|.+++... ...+++..+..|+.||+.||.|||+++|+|+||+++||++ +.++.+||+|||++.......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccc
Confidence 999 68999999876 5679999999999999999999999999999999999999 478899999999998652221
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
.. ...........|+|||.+.+..++.++||||||+++|||++ |+.||.+..... ....+.+... .+.
T Consensus 158 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~~~~~~~~~-~~~-- 226 (259)
T PF07714_consen 158 KY-----KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---IIEKLKQGQR-LPI-- 226 (259)
T ss_dssp SE-----EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HHHHHHTTEE-TTS--
T ss_pred cc-----cccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccc-cee--
Confidence 11 11234456789999999999889999999999999999999 789998764433 2233322222 221
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l 273 (414)
...+|..+.+++..||..+|++||++.+|.+.|
T Consensus 227 -~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 -PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 234689999999999999999999999987764
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=298.22 Aligned_cols=259 Identities=20% Similarity=0.314 Sum_probs=203.7
Q ss_pred ccCCceEEecceeecCceeEEEEEECCC-----CceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 75 (414)
+-.++|++.+.||+|+||.||+|.+... ...||+|........ ..+.+|+.+++.+..|+++..+..++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 4457899999999999999999987643 378999987754332 34778999999996567777777777777
Q ss_pred CeeEEEEecc-CCCHHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccC
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYC---------------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 139 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~---------------~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~ 139 (414)
...+++|||+ +++|.+++... ...+++..++.++.|++.||.|||+++|+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~--- 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--- 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE---
Confidence 7899999998 88999888642 2458899999999999999999999999999999999999
Q ss_pred CCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChh
Q 015041 140 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKA 218 (414)
Q Consensus 140 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~ 218 (414)
+.++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++||+++ |..||.+...
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYR-----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred cCCCeEEeCcccccccccccccee-----ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 478899999999998654332111 1112334678999999998899999999999999999997 9999987543
Q ss_pred hchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 015041 219 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (414)
Q Consensus 219 ~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~ 277 (414)
.. ....+ ........ ....+..+.+++..||..+|++||++.++.+.|++++
T Consensus 241 ~~---~~~~~-~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 EE---LFKLL-KEGYRMEK---PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HH---HHHHH-HcCCcCCC---CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 22 22222 22221111 1345789999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=293.32 Aligned_cols=252 Identities=19% Similarity=0.349 Sum_probs=192.9
Q ss_pred eEEecceeecCceeEEEEEECCCCc--eEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeee------eCC
Q 015041 9 YKLGRKIGSGSFGEIFLASHVDTNE--IVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV------DGE 76 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~~~~~--~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~------~~~ 76 (414)
|.++++||+|+||.||+|.+..++. .||+|.++... ....+..|+.+++.++| +++..+..++. ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDH-PNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEccCCcccCCC
Confidence 4578999999999999999876665 58999876542 12347789999999976 45555543321 123
Q ss_pred eeEEEEecc-CCCHHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYC-----RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 150 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DF 150 (414)
..+++|||+ +++|.+++... ...+++..+..++.||+.||+|||+++|+||||||+|||+ +.++.++|+||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEECCC
Confidence 468999999 78888877532 2347899999999999999999999999999999999999 57889999999
Q ss_pred cceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHH
Q 015041 151 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKIC 229 (414)
Q Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~ 229 (414)
|+++....... +.......++..|+|||++.+..++.++|||||||++|||++ |..||.+.... +.+..+.
T Consensus 157 g~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~ 228 (272)
T cd05075 157 GLSKKIYNGDY-----YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYDYLR 228 (272)
T ss_pred CcccccCcccc-----eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH
Confidence 99986543221 111223345778999999999999999999999999999999 89999875432 2222222
Q ss_pred hhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 230 ~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
... ..+ ....++..+.+++.+||..+|++||++.+|.+.|+++
T Consensus 229 ~~~-~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 229 QGN-RLK---QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred cCC-CCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 211 111 1235678999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=299.69 Aligned_cols=262 Identities=20% Similarity=0.312 Sum_probs=205.0
Q ss_pred ccCCceEEecceeecCceeEEEEEECC-------CCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV 73 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~ 73 (414)
+-..+|.++++||+|+||.||+|++.. ....||+|.+...... ..+..|+.+++.+.+|+++..+..++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 345789999999999999999998642 3457999987754332 346789999999976688888877777
Q ss_pred eCCeeEEEEecc-CCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEc
Q 015041 74 DGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137 (414)
Q Consensus 74 ~~~~~~lv~e~~-~~sL~~~~~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~ 137 (414)
.....+++|||+ +++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill- 167 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV- 167 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE-
Confidence 778899999999 789999886532 347889999999999999999999999999999999999
Q ss_pred cCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 015041 138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 216 (414)
Q Consensus 138 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~ 216 (414)
+.++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 168 --~~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 168 --TEDNVMKIADFGLARGVHDIDYYK-----KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred --cCCCcEEEcccccccccccccccc-----ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 478899999999997654322110 1112234567999999999899999999999999999999 89999875
Q ss_pred hhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
.... .+..+.. ..... ....++.++.+++..||..+|++||++.++.+.|..+....
T Consensus 241 ~~~~---~~~~~~~-~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 241 PVEE---LFKLLRE-GHRMD---KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred CHHH---HHHHHHc-CCCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 4322 2222222 21111 12355789999999999999999999999999998886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=298.58 Aligned_cols=260 Identities=20% Similarity=0.280 Sum_probs=202.0
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCc----eEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 75 (414)
.+-..+|+..+.||+|+||.||+|.+..++. .||+|.+...... ..+.+|+.+++.+.| +++..+..++..
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-~niv~~~~~~~~- 80 (303)
T cd05110 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH-PHLVRLLGVCLS- 80 (303)
T ss_pred ccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCcccEEEEEcC-
Confidence 3556789999999999999999999877776 4688887654432 246788899998876 555555554433
Q ss_pred CeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
...+++++|+ +++|.+++......++...++.++.|++.||+|||+++|+||||||+||++ +.++.+||+|||+++
T Consensus 81 ~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill---~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 81 PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLAR 157 (303)
T ss_pred CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---cCCCceEEccccccc
Confidence 3467889998 788999887655578999999999999999999999999999999999999 477889999999998
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhcc
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.+..... +..+.....
T Consensus 158 ~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~----~~~~~~~~~ 228 (303)
T cd05110 158 LLEGDEKE-----YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE----IPDLLEKGE 228 (303)
T ss_pred cccCcccc-----cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHCCC
Confidence 65432211 01113345678999999999999999999999999999997 999998754322 222333333
Q ss_pred CCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 234 ~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
..+.+ ..++..+.+++..||..+|++||++.++.+.|+.+...
T Consensus 229 ~~~~~---~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 229 RLPQP---PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 33322 23468899999999999999999999999988877543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=292.43 Aligned_cols=250 Identities=20% Similarity=0.298 Sum_probs=198.8
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
..+|++.+.||+|+||.||+|.+. ++..+|+|++..... ...+..|+.+++.+.| +++..+..++......++||||
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSH-PNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCC-CCEEEEEEEEcCCCceEEEEec
Confidence 357999999999999999999875 466799998765433 3467889999999976 5666676667777889999999
Q ss_pred c-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 85 ~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
+ +++|.+++......+++..++.++.|++.||+|||++||+||||||+||++ +.++.+||+|||+++...+....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~~~- 156 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQYT- 156 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceeccccccc-
Confidence 9 788999887655578999999999999999999999999999999999999 57889999999998765432211
Q ss_pred cccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhhh
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~ 242 (414)
......++..|+|||.+.+..++.++|||||||++|++++ |..||....... ....+ ......+.+ .
T Consensus 157 -----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~-~~~~~~~~~---~ 224 (256)
T cd05059 157 -----SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVESV-SAGYRLYRP---K 224 (256)
T ss_pred -----ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHHHH-HcCCcCCCC---C
Confidence 0112223568999999999899999999999999999999 899998754432 22222 222222211 3
Q ss_pred cChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 015041 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (414)
Q Consensus 243 ~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l 273 (414)
..|.++.+++.+||..+|++||++.++.+.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 4588999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=293.22 Aligned_cols=254 Identities=24% Similarity=0.397 Sum_probs=199.2
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++..++|++.++||.|+||.||+|.+. ++..||+|.+..... ...+.+|+.+++.+.|. ++..+..+. .....+++
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~-~i~~~~~~~-~~~~~~lv 78 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHD-KLVQLYAVV-SEEPIYIV 78 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCC-ceEEEEeEE-CCCCcEEE
Confidence 356789999999999999999999875 556799998876433 34688999999999875 444444443 34557899
Q ss_pred Eecc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 82 LDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
|||+ +++|.+++... ...+++..++.++.|++.||.|||+.+|+||||||+||+++ .++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~---~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe---CCceEEeCCceeeeeccCc
Confidence 9999 78999888753 34589999999999999999999999999999999999994 7789999999999765432
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+..... ....+ ......+.+
T Consensus 156 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~-~~~~~~~~~ 225 (260)
T cd05070 156 EYT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQV-ERGYRMPCP 225 (260)
T ss_pred ccc------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH-HcCCCCCCC
Confidence 211 1112345678999999998889999999999999999999 999998754332 22222 222222222
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~ 275 (414)
...+..+.+++.+||..+|++||++.++.+.|++
T Consensus 226 ---~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 226 ---QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 3557899999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=298.65 Aligned_cols=261 Identities=18% Similarity=0.284 Sum_probs=200.3
Q ss_pred cCCceEEecceeecCceeEEEEEECCCC----------------ceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCC
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTN----------------EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGI 65 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i 65 (414)
-.++|++++.||+|+||.||+|.+...+ ..||+|.+..... ...+..|+++++.+.| +++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSD-PNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCC-CCE
Confidence 3578999999999999999999876543 4589998876543 2357789999999976 556
Q ss_pred CeeEEeeeeCCeeEEEEecc-CCCHHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCce
Q 015041 66 PNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR----------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 134 (414)
Q Consensus 66 ~~l~~~~~~~~~~~lv~e~~-~~sL~~~~~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Ni 134 (414)
..+..++......+++||++ +++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 66666666778899999998 788998887543 2589999999999999999999999999999999999
Q ss_pred EEccCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc--CCCC
Q 015041 135 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR--GSLP 212 (414)
Q Consensus 135 li~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t--G~~P 212 (414)
++ +.++.++|+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 162 li---~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 233 (296)
T cd05051 162 LV---GKNYTIKIADFGMSRNLYSSDYY-----RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233 (296)
T ss_pred ee---cCCCceEEccccceeecccCcce-----eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCC
Confidence 99 47789999999999765433211 11224456788999999998889999999999999999998 7788
Q ss_pred CCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 213 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
|..............................+|.++.+++..||..+|++||++.+|.+.|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 234 YEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 87654433222222111100111111112345789999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=295.93 Aligned_cols=257 Identities=25% Similarity=0.318 Sum_probs=195.4
Q ss_pred Cce-EEecceeecCceeEEEEEE----CCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeee--CC
Q 015041 7 VKY-KLGRKIGSGSFGEIFLASH----VDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD--GE 76 (414)
Q Consensus 7 ~~y-~i~~~iG~G~~g~V~~~~~----~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~--~~ 76 (414)
++| ++.+.||+|+||+||++.. ..++..||+|++..... ...+.+|+++++.+.| +++..+..++.. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYH-ENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCCc
Confidence 455 9999999999999988653 35678899998876432 3457789999999976 555555554433 34
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
..+++|||+ +++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||+ +.++.++|+|||+++.
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKA 156 (283)
T ss_pred eEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeecccccc
Confidence 578999999 7888888764 459999999999999999999999999999999999999 4778999999999976
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhc-----------hHHH
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT-----------KKQK 224 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~-----------~~~~ 224 (414)
....... +.......++..|+|||.+.+..++.++|||||||++|||++|..||....... ....
T Consensus 157 ~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05080 157 VPEGHEY----YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR 232 (283)
T ss_pred cCCcchh----hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhh
Confidence 5432211 111123345677999999998889999999999999999999999986532110 0011
Q ss_pred HHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 225 ~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
+...+......+. ...+|.++.+++..||..+|++||+++++.+.|+++
T Consensus 233 ~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 233 LIELLERGMRLPC---PKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhhhcCCCCCC---CCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 1111111122111 234578999999999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=293.13 Aligned_cols=260 Identities=19% Similarity=0.281 Sum_probs=204.9
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCc----eEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 74 (414)
-.+...+|++++.||+|+||.||+|.+..++. .||+|........ ..+.+|+.+++.+.| +++..+..++..
T Consensus 2 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~ 80 (279)
T cd05057 2 RILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH-PHVVRLLGICLS 80 (279)
T ss_pred cccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEec
Confidence 45667899999999999999999999876654 5899987665432 357789999999976 455555554444
Q ss_pred CCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
...++|+||+ +++|.+++......+++..++.++.||+.||+|||+.+|+||||||+||++ +.++.+||+|||++
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~~ 156 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLA 156 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCccc
Confidence 6789999998 889999988766679999999999999999999999999999999999999 57889999999999
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhc
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKK 232 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~ 232 (414)
+......... ......++..|+|||.+....++.++|+|||||++||+++ |..||.+.......+ .+ ...
T Consensus 157 ~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~~-~~~ 227 (279)
T cd05057 157 KLLDVDEKEY-----HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD---LL-EKG 227 (279)
T ss_pred ccccCcccce-----ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH---HH-hCC
Confidence 8654322110 0112223568999999988889999999999999999998 999998765432222 22 222
Q ss_pred cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 233 ~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
...+.+ ...+..+.+++.+||..+|.+||++.++.+.|.++..
T Consensus 228 ~~~~~~---~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 228 ERLPQP---PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCCC---CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 222222 2346789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=299.56 Aligned_cols=254 Identities=19% Similarity=0.230 Sum_probs=199.3
Q ss_pred CCceEEecceeecCceeEEEEEECCC-----CceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
..+|++.++||+|+||.||+|.+..+ +..||+|++...... ..+..|+.++..+.| +++..+..++.....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-~~iv~~~~~~~~~~~ 82 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQH-PNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCC-CCcCeEEEEEcCCCc
Confidence 35688999999999999999987543 578999998765432 346788888888876 566667677777778
Q ss_pred eEEEEecc-CCCHHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCC
Q 015041 78 NVLVLDLL-GPSLEDLFVYC---------------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~---------------~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~ 141 (414)
.++++||+ +++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||+ ++
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~~ 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV---FD 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---cC
Confidence 89999998 77888887531 1247888899999999999999999999999999999999 47
Q ss_pred CCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhc
Q 015041 142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT 220 (414)
Q Consensus 142 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~ 220 (414)
++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~- 233 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYY-----KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ- 233 (283)
T ss_pred CCceEecccccccccccchhe-----eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence 788999999998765332211 11123445778999999998889999999999999999998 88999875443
Q ss_pred hHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 015041 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (414)
Q Consensus 221 ~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~ 275 (414)
+.+..+...... + ....+|..+.+++..||+.+|++||++.+|...|+.
T Consensus 234 --~~~~~i~~~~~~-~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 --DVIEMIRNRQVL-P---CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred --HHHHHHHcCCcC-C---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 333333332221 2 224568999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=296.33 Aligned_cols=259 Identities=23% Similarity=0.306 Sum_probs=206.5
Q ss_pred cCCceEEecceeecCceeEEEEEEC-----CCCceEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
-.++|.+.+.||+|+||.||+|++. .++..|++|.+...... ..+.+|+.++..+.| +++..+..++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~ 81 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH-EHIVKFYGVCGDGDP 81 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCC-CCcceEEEEEccCCc
Confidence 3568999999999999999999864 34567899987655432 457889999999876 667777777778888
Q ss_pred eEEEEecc-CCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCC
Q 015041 78 NVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~ 141 (414)
.++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~---~~ 158 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---GA 158 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---cc
Confidence 99999999 899999886532 237899999999999999999999999999999999999 57
Q ss_pred CCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhc
Q 015041 142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT 220 (414)
Q Consensus 142 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~ 220 (414)
++.++|+|||++......... .......++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 233 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 233 (291)
T ss_pred CCcEEECCCCcccccCCCcee-----ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 889999999998754332211 11224456788999999999999999999999999999998 999998754432
Q ss_pred hHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 221 ~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
.+..+....... .....|..+.+++.+||..+|++||++.++.+.|+++...
T Consensus 234 ---~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 234 ---VIECITQGRVLE----RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred ---HHHHHhCCCCCC----CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 222222222111 1234578999999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=295.65 Aligned_cols=251 Identities=22% Similarity=0.261 Sum_probs=193.9
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
+|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+..|+.+++.+.| +++..+..+..+....++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCC-CCeeeHHHHhccCCceEEEEe
Confidence 69999999999999999999999999999998764322 2346789999999976 556666566667788999999
Q ss_pred ccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 84 ~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
|++++|.+.+......+++..++.++.||+.||.|||++||+||||||+||++ +.++.++|+|||+++.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~-- 154 (284)
T cd07839 80 YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVR-- 154 (284)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCCCCC--
Confidence 99999998887656679999999999999999999999999999999999999 5788999999999875432211
Q ss_pred cccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCc------
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP------ 236 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p------ 236 (414)
......++..|+|||++.+.. ++.++|||||||++|+|++|..||..... ..+.+..+.......+
T Consensus 155 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07839 155 -----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEESWPG 227 (284)
T ss_pred -----CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC--HHHHHHHHHHHhCCCChHHhHH
Confidence 112345688999999987754 79999999999999999999888643222 1122222211110000
Q ss_pred ------------------hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 237 ------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 237 ------------------~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.......+++++.+++.+||..+|.+||+++++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 01112245678899999999999999999877643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=294.70 Aligned_cols=252 Identities=19% Similarity=0.274 Sum_probs=198.0
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
..++|++.++||+|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.+.| +++..+..........++||
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h-~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH-SNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCC-CCeeeEEEEEEeCCEEEEEE
Confidence 356899999999999999999999999999999987655322 346788888888865 56666666667778899999
Q ss_pred ecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
||+ +++|.+++.. ...+++.+++.++.|++.||+|||+.||+|+||||+||++ +..+.++|+|||++........
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 86 EFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred eccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEccCccc
Confidence 999 6789888765 4578999999999999999999999999999999999999 5788999999999876543211
Q ss_pred CccccccCCCCCccCcCcccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
......|+..|+|||++. ...++.++|||||||++|+|++|..||....... .+..........+..
T Consensus 162 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~ 231 (267)
T cd06645 162 -------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---ALFLMTKSNFQPPKL 231 (267)
T ss_pred -------ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh---hHHhhhccCCCCCcc
Confidence 123557899999999974 4458899999999999999999999997644321 111222222222211
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.....++..+.+++.+||..+|++||++++|.+
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 111245788999999999999999999887654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=284.78 Aligned_cols=249 Identities=21% Similarity=0.352 Sum_probs=206.0
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
+.+++.-||.|+.|+||+++...+|..+|||........ ++++..+.+..+-..++.|+.-.+++..+...++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 345677899999999999999999999999987665443 34666777766655578888778888888889999999
Q ss_pred cCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 85 LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 85 ~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
+...++.++....+++++.-+-++...++.||.||.++ ||||||+||+|||+ |+.|++||||||.+....+...
T Consensus 173 Ms~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkA-- 247 (391)
T KOG0983|consen 173 MSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKA-- 247 (391)
T ss_pred HHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeecccc--
Confidence 98889999988888899999999999999999999976 89999999999999 7999999999999987765433
Q ss_pred cccccCCCCCccCcCccccccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
...-.|.+.|||||.+.-. .|+.++||||||++++|+.||+.||.+.+ ...+.+.++.+. .+ |.-..
T Consensus 248 ------htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~--tdFe~ltkvln~-eP-P~L~~ 317 (391)
T KOG0983|consen 248 ------HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK--TDFEVLTKVLNE-EP-PLLPG 317 (391)
T ss_pred ------cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC--ccHHHHHHHHhc-CC-CCCCc
Confidence 2356789999999998644 58999999999999999999999999853 234556666662 22 22222
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..++++.|.+|+..||.+|+.+||.|.+|.+
T Consensus 318 ~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 318 HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 2458899999999999999999999998765
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=292.58 Aligned_cols=256 Identities=18% Similarity=0.291 Sum_probs=203.4
Q ss_pred CCceEEecceeecCceeEEEEEECCCC---ceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
..+|++.+.||+|+||.||+|.+..++ ..||+|.+..... ...+..|+.+++.+.| +++..+..++......+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH-PNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEecCCccE
Confidence 468999999999999999999886443 3799998765432 2357889999999875 66777777777778899
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
+||||+ +++|.+++......+++.+++.++.|++.||.|||+++++||||||+|||+ +.++.++|+|||+++....
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCccccccc
Confidence 999999 788999987656678999999999999999999999999999999999999 5788999999999986543
Q ss_pred CCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
..... .......++..|+|||++.+..++.++|+|||||++||+++ |..||.+..... ....+.+ ....+.
T Consensus 159 ~~~~~----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~~-~~~~~~ 230 (267)
T cd05066 159 DPEAA----YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIEE-GYRLPA 230 (267)
T ss_pred cccee----eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHhC-CCcCCC
Confidence 22110 01112233568999999999899999999999999999886 999998765432 2222222 222222
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
. ...|+.+.+++.+||..+|.+||++.++.+.|.++
T Consensus 231 ~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 231 P---MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred C---CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 2 34578999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=293.96 Aligned_cols=256 Identities=20% Similarity=0.302 Sum_probs=201.9
Q ss_pred cccCCceEEecceeecCceeEEEEEECCC-----CceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 74 (414)
++..++|++.+.||+|+||.||+|.+... +..||+|....... ...+.+|+.+++.+.| +++..+..++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~ 80 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNC-HHVVRLLGVVST 80 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCC-CceeEEEEEEcC
Confidence 35568999999999999999999988643 47899998765533 2347788999998875 567777777777
Q ss_pred CCeeEEEEecc-CCCHHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCe
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYCR---------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 144 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~ 144 (414)
....++||||+ +++|.+++.... ..+++..++.++.|++.||.|||+.+|+||||||+|||+ +.++.
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~~ 157 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDLT 157 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCCC
Confidence 78899999999 789999886432 236788999999999999999999999999999999999 57899
Q ss_pred EEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHH
Q 015041 145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQ 223 (414)
Q Consensus 145 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~ 223 (414)
+||+|||+++....... +.......++..|+|||.+.+..++.++|||||||++||+++ |..||.+.....
T Consensus 158 ~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--- 229 (277)
T cd05032 158 VKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--- 229 (277)
T ss_pred EEECCcccchhhccCcc-----cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---
Confidence 99999999875543221 111234456789999999998889999999999999999998 999998754332
Q ss_pred HHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 224 ~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
....+. .....+. ...++.++.+++..||..+|++||++.++...|+
T Consensus 230 ~~~~~~-~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 230 VLKFVI-DGGHLDL---PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHHh-cCCCCCC---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 222222 2211111 1345889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=296.36 Aligned_cols=249 Identities=21% Similarity=0.343 Sum_probs=195.8
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
++|++.+.||+|+||.||+|.+..+|..||+|.+..... ...+..|+.+..+..+++++..+..++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 479999999999999999999999999999998875432 23456677665556667778777777777888999999
Q ss_pred ccCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc-CeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 84 LLGPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 84 ~~~~sL~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
|+.++|.+++... ...+++..++.++.||+.||+|||++ +++||||||+||++ +.++.+||+|||++......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecccccccccc
Confidence 9999998887653 24589999999999999999999997 99999999999999 57889999999998765332
Q ss_pred CCCccccccCCCCCccCcCccccccccC----CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLG----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
.. .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||..... ..+.+..+... ...
T Consensus 158 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~-~~~ 226 (283)
T cd06617 158 VA--------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQLKQVVEE-PSP 226 (283)
T ss_pred cc--------cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHHHHHHhc-CCC
Confidence 11 123467889999998865 4578999999999999999999999975322 11222222221 111
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.. ....+|+++.+++..||..+|++||+++++..
T Consensus 227 ~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 227 QL--PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CC--CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 11246789999999999999999999988765
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=290.07 Aligned_cols=252 Identities=21% Similarity=0.309 Sum_probs=202.3
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
.++|++.+.||.|+||.||+|.+..++..+++|++.... ....+..|+.+++.++| +++..+..+.......+++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRH-PNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCC-CChhceEEEEEeCCEEEEEEe
Confidence 468999999999999999999998889999999877543 23468889999999976 566667677777888999999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
|+ +++|.+++......++...+..++.|++.||.|||+.+|+|+||||+||++ +.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhhhhhhh-
Confidence 99 678888887655779999999999999999999999999999999999999 5788999999999875443211
Q ss_pred ccccccCCCCCccCcCccccccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
......++..|+|||.+.+. .++.++|+|||||++|+|++|..||.+...... ...+.......+...
T Consensus 157 ------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~ 227 (262)
T cd06613 157 ------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA---LFLISKSNFPPPKLK 227 (262)
T ss_pred ------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhccCCCcccc
Confidence 12345788899999999877 789999999999999999999999987543322 222222222222212
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.....+.++.+++.+||..+|..||++.++..
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 22345788999999999999999999987754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=293.88 Aligned_cols=259 Identities=21% Similarity=0.306 Sum_probs=201.5
Q ss_pred cccCCceEEecceeecCceeEEEEEEC-----CCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 74 (414)
++...+|++.++||+|+||.||+|.+. ..+..||+|.+...... ..+.+|+.+++.+.| +++..+...+..
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~ 80 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC-HHVVRLLGVVSK 80 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEcC
Confidence 356789999999999999999999764 23458999987654432 236678888988875 567777777777
Q ss_pred CCeeEEEEecc-CCCHHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCe
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYCR---------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 144 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~ 144 (414)
....++||||+ +++|.+++.... ..++...+..++.|++.||.|||+++|+||||||+||++ +.++.
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili---~~~~~ 157 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV---AHDFT 157 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE---cCCCc
Confidence 78899999999 889999987532 234677889999999999999999999999999999999 47889
Q ss_pred EEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHH
Q 015041 145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQ 223 (414)
Q Consensus 145 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~ 223 (414)
++|+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.... +
T Consensus 158 ~~L~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~ 229 (288)
T cd05061 158 VKIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---Q 229 (288)
T ss_pred EEECcCCccccccccccc-----cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---H
Confidence 999999998754332211 11123345678999999999899999999999999999998 78999875432 2
Q ss_pred HHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 015041 224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (414)
Q Consensus 224 ~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~ 277 (414)
....+...... + .....++.+.+++..||..+|++||++.++.+.|++.+
T Consensus 230 ~~~~~~~~~~~-~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 230 VLKFVMDGGYL-D---QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHHHHcCCCC-C---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 22223222111 1 12345789999999999999999999999988887654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=287.78 Aligned_cols=246 Identities=25% Similarity=0.316 Sum_probs=200.0
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
+|.+.+.||+|+||.||+|.+..+++.|++|.+.... ....+..|+++++.+.| +++..+..++......++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS-SYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCC-CCeehheeeeccCCEEEEEEE
Confidence 5889999999999999999999999999999876432 23457789999999876 556666666667788999999
Q ss_pred cc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 84 LL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 84 ~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
|+ +++|.+++... ...++...+..++.|++.||.|||++||+|+||||+||++ +.++.++|+|||+++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---eCCCCEEEcccccceeccCccc
Confidence 98 88999988764 4568999999999999999999999999999999999999 4778999999999886543321
Q ss_pred CccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhh
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~ 241 (414)
......|+..|+|||++.+..++.++|+|||||++|+|++|+.||...... .....+...... +..
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~-~~~--- 222 (256)
T cd08529 157 -------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALILKIIRGVFP-PVS--- 222 (256)
T ss_pred -------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCC-CCc---
Confidence 112456889999999999999999999999999999999999999875432 233333332222 111
Q ss_pred hcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 242 ~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..++..+.+++.+||..+|++||++.++.+
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 245789999999999999999999987754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=289.00 Aligned_cols=255 Identities=23% Similarity=0.313 Sum_probs=202.9
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+|+++++.+.| .++..+..++......++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~-~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH-PNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCC-CCeeeeeeeeecCCeEEEE
Confidence 68999999999999999999999899999999775321 23457889999999976 5566666666667788999
Q ss_pred Eecc-CCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 82 LDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
|||+ +++|.+++... ...++...++.++.|++.||.|||+.||+|+||+|+||++ +.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceeeecc
Confidence 9999 78999888643 3458999999999999999999999999999999999999 578899999999987654
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
..... .....++..|+|||.+.+..++.++|||||||++|+|++|..||..... ...+....+.. ....+.
T Consensus 158 ~~~~~-------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~-~~~~~~ 228 (267)
T cd08224 158 SKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEK-CDYPPL 228 (267)
T ss_pred CCCcc-------cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-cHHHHHhhhhc-CCCCCC
Confidence 32211 1245678899999999988899999999999999999999999975431 11122222211 112221
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
+ ...++..+.+++.+||..+|++||++.+|.+.|+++
T Consensus 229 ~--~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 229 P--ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred C--hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1 125578999999999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=289.78 Aligned_cols=246 Identities=22% Similarity=0.278 Sum_probs=199.5
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
+|++.++||.|+||.||++.+..++..||+|.++... ....+..|+.+++.+.| +++..+...+......+++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKH-PNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCC-CCcceEEEEEEECCEEEEEEee
Confidence 5899999999999999999999999999999875432 23456788899988876 5677777777788899999999
Q ss_pred c-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 85 L-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 85 ~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
+ +++|.+++... ...++...++.++.|++.||.|||++||+|+||||+||++ ++++.++|+|||++........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeeccccc-
Confidence 9 78898887643 3458999999999999999999999999999999999999 5788999999999976544322
Q ss_pred ccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhh
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~ 242 (414)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||...... ..+..+...... +. ..
T Consensus 156 ------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~-~~---~~ 222 (255)
T cd08219 156 ------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK---NLILKVCQGSYK-PL---PS 222 (255)
T ss_pred ------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH---HHHHHHhcCCCC-CC---Cc
Confidence 112456889999999999988999999999999999999999999864332 222333222221 11 13
Q ss_pred cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 243 ~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.++..+.+++..||..+|++||++.++..
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 45788999999999999999999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=294.23 Aligned_cols=255 Identities=20% Similarity=0.252 Sum_probs=195.5
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe-----
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED----- 77 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~----- 77 (414)
++|++.+.||+|+||.||+|.+..+++.||||....... ...+.+|+.+++.+.++++++.+..++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 479999999999999999999999999999998765432 24578899999999887888877766654444
Q ss_pred eEEEEeccCCCHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 78 NVLVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 78 ~~lv~e~~~~sL~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
.+++|||+.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++ +.++.+||+|||++
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl~dfg~~ 158 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLG 158 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe--cCCCeEEEeecccc
Confidence 79999999889988876532 3489999999999999999999999999999999999994 22789999999998
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (414)
+.+..... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.......
T Consensus 159 ~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 231 (295)
T cd07837 159 RAFSIPVK-------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP 231 (295)
T ss_pred eecCCCcc-------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 76533211 1113356788999998865 457999999999999999999999998754433222221111000
Q ss_pred --------------------cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 233 --------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 233 --------------------~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
............+.++.+++.+||..+|.+||++.++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil 289 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL 289 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHh
Confidence 00011112234678899999999999999999987654
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=293.93 Aligned_cols=251 Identities=21% Similarity=0.334 Sum_probs=203.8
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
..+|+++++||.|+||.||+|.+.. +..|++|++..... ...+..|+.+++.++| +++..+..++......++|||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRH-KHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCC-cchhheeeeEecCCCeEEEEe
Confidence 4679999999999999999999877 88899998876543 4567889999999975 666667677777888999999
Q ss_pred cc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 84 LL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 84 ~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
|+ +++|.+++... ...+++..+..++.||+.||.|||+.||+|+||||+||++ +.++.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhhcCCccc
Confidence 99 77999988753 3458999999999999999999999999999999999999 4788999999999976543211
Q ss_pred CccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
. .....++..|++||++.+..++.++|||||||++|+|++ |+.||.+.... +.+..+.. ....+.+
T Consensus 160 ~-------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~-~~~~~~~-- 226 (261)
T cd05148 160 L-------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQITA-GYRMPCP-- 226 (261)
T ss_pred c-------ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHHh-CCcCCCC--
Confidence 1 113345678999999998899999999999999999998 89999875533 23333322 2222222
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~ 275 (414)
..+++.+.+++.+||..+|++||++.+|.+.|+.
T Consensus 227 -~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 227 -AKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 3557899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=290.80 Aligned_cols=258 Identities=18% Similarity=0.270 Sum_probs=203.2
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCc---eEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
|...+|+..+.||+|+||.||+|.+..++. .||+|.+..... ...+..|+++++.+.| +++..+..++.....
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH-HNIIRLEGVVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCC-CCeeEEEEEEccCCC
Confidence 556789999999999999999999875554 799998765432 2357789999998876 466667777777788
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
.++||||+ +++|.+++......+++..+..++.|++.||+|||+.|++|+||||+||++ +.++.++|+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVL 157 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceec
Confidence 99999999 678888887655678999999999999999999999999999999999999 47889999999998765
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
........ .......+..|+|||++.+..++.++|||||||++||+++ |..||...... +....+. .....
T Consensus 158 ~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~~~~~i~-~~~~~ 229 (268)
T cd05063 158 EDDPEGTY----TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---EVMKAIN-DGFRL 229 (268)
T ss_pred ccccccce----eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHHHHHh-cCCCC
Confidence 43221110 0111223457999999998889999999999999999997 99999765432 2222222 22222
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
+.. ...|..+.+++.+||..+|++||++.++.+.|+++
T Consensus 230 ~~~---~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 PAP---MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 222 24578999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=291.55 Aligned_cols=254 Identities=22% Similarity=0.302 Sum_probs=197.1
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+..|+.+++.+.| +++..+..++......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH-PNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCC-CCEeeeeeEEeeCCEEEEEE
Confidence 47999999999999999999999899999999875432 22346789999999986 55666666667778899999
Q ss_pred eccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 83 e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
||+.+++.+.+......+++..++.++.||+.||+|||+.||+|+||||+||++ +.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecCCCcc-
Confidence 999666655554445579999999999999999999999999999999999999 4778999999999986544321
Q ss_pred ccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc---------
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK--------- 232 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (414)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+....+............
T Consensus 156 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 156 ------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred ------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc
Confidence 1123457889999999876 458899999999999999999999998765433222222111100
Q ss_pred --------------cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 233 --------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 233 --------------~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...+........+..+.+++.+||..+|++||++.++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 001112223456788999999999999999999887643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=291.22 Aligned_cols=258 Identities=18% Similarity=0.305 Sum_probs=202.0
Q ss_pred CCceEEecceeecCceeEEEEEECCCCc---eEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
.+.|++.+.||+|+||.||+|.+..++. .||||.+..... ...+..|+.+++.+.| +++..+..++..+...+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH-PNIIHLEGVVTKSRPVM 81 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC-cCcceEEEEECCCCceE
Confidence 3579999999999999999999876654 599998875432 2357889999999876 56777777777778899
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
+||||+ +++|.+++......+++.+++.++.|++.||+|||++|++|+||||+||++ +.++.++|+|||+++....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCcccccccc
Confidence 999999 678988887656678999999999999999999999999999999999999 5788999999999875433
Q ss_pred CCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
..... .+........+..|+|||.+.+..++.++|||||||++||+++ |..||........ ...+ ......+.
T Consensus 159 ~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~---~~~i-~~~~~~~~ 232 (269)
T cd05065 159 DTSDP--TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---INAI-EQDYRLPP 232 (269)
T ss_pred Ccccc--ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH---HHHH-HcCCcCCC
Confidence 22110 0000011112457999999999999999999999999999886 9999987554322 2222 22222222
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
. ..+|..+.+++..||..+|++||+++++...|+.+
T Consensus 233 ~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 233 P---MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred c---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2 34578999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=293.92 Aligned_cols=255 Identities=22% Similarity=0.323 Sum_probs=200.7
Q ss_pred ccCCceEEecceeecCceeEEEEEEC-----CCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
+-..+|.+.++||+|+||.||+|... .++..||+|.+..... ...+.+|+++++.+.| +++..+..++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 80 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQH-QHIVRFYGVCTEGR 80 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCC-CCCceEEEEEecCC
Confidence 45678999999999999999999743 3566899998765432 2458889999999976 56666767777778
Q ss_pred eeEEEEecc-CCCHHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCC
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCR--------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~--------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~ 141 (414)
..+++|||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ ++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~---~~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---GQ 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE---cC
Confidence 899999999 789998887532 247889999999999999999999999999999999999 47
Q ss_pred CCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhc
Q 015041 142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT 220 (414)
Q Consensus 142 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~ 220 (414)
++.++|+|||+++....... +.......++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 232 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE 232 (280)
T ss_pred CCCEEECCCCceeEcCCCce-----eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH
Confidence 88999999999976543221 111223445788999999999999999999999999999998 999997654332
Q ss_pred hHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 221 ~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
.+..+.... ... ....+|+.+.+++.+||..+|.+||++++|.+.|+
T Consensus 233 ---~~~~~~~~~-~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 233 ---AIECITQGR-ELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ---HHHHHHcCc-cCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 233322221 111 11356789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=281.51 Aligned_cols=249 Identities=22% Similarity=0.232 Sum_probs=209.5
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC------c----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK------H----PQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
.+|.-.+.||.|..+.|.++.+..++..+|+|++..... . +.-..|+.+|+++.+|++|..+..+.....
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 457778899999999999999999999999998753321 1 224678999999999999998888877788
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
..++|+|++ .|.|.|++.. .-.++++....|++|++.|++|||.++||||||||+|||+ +++.++||+|||+|..
T Consensus 97 F~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEeccceeec
Confidence 899999999 8888888875 4568999999999999999999999999999999999999 6999999999999987
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccC------CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHH
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~ 229 (414)
...... -..+|||+.|.|||++.- ..|+..+|+||+|+|+|.++.|.+||..-+ ..-.+.-|+
T Consensus 173 l~~Gek--------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk---QmlMLR~Im 241 (411)
T KOG0599|consen 173 LEPGEK--------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK---QMLMLRMIM 241 (411)
T ss_pred cCCchh--------HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---HHHHHHHHH
Confidence 654332 247899999999999862 358999999999999999999999998632 334455677
Q ss_pred hhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 230 ~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+.++.+..+. +...+...++|+.+|+..||.+|.+.++...
T Consensus 242 eGkyqF~spe-Wadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 242 EGKYQFRSPE-WADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred hcccccCCcc-hhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 7777776554 3566788999999999999999999887655
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=294.04 Aligned_cols=244 Identities=22% Similarity=0.312 Sum_probs=191.4
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+++++.+.| +++..+..++......++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS-PYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCC-CCeeeEEEEEEECCEEEEEEe
Confidence 468899999999999999999999999999998765432 2347789999998876 566666666677788899999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
|+ +++|..+ ..+++..+..++.|++.||+|||+.||+|+||||+|||+ +.++.++|+|||++........
T Consensus 80 ~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~~~- 150 (279)
T cd06619 80 FMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNSIA- 150 (279)
T ss_pred cCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceecccccc-
Confidence 99 5555322 347888999999999999999999999999999999999 5788999999999976543221
Q ss_pred ccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhch----HHHHHHHHhhccCCchH
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK----KQKYDKICEKKVSTPIE 238 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~----~~~~~~i~~~~~~~p~~ 238 (414)
....||..|+|||++.+..++.++|||||||++|+|++|..||........ ......+.... +..
T Consensus 151 --------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~ 219 (279)
T cd06619 151 --------KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED---PPV 219 (279)
T ss_pred --------cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC---CCC
Confidence 245789999999999999999999999999999999999999975332111 11111111111 111
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
......++++.+++.+||..+|++||+++++.+
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 112335678999999999999999999887644
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=291.76 Aligned_cols=251 Identities=22% Similarity=0.247 Sum_probs=195.0
Q ss_pred eEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeC--CeeEEEEe
Q 015041 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG--EDNVLVLD 83 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~--~~~~lv~e 83 (414)
|++.++||+|+||.||+|.+..++..||+|.+..... ......|+.++..+.+|+++..+..++.+. ...++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 7889999999999999999999999999998765422 223457888888887667777777666665 78899999
Q ss_pred ccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 84 ~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
|+.+++.+.+......+++.+++.++.|++.||+|||++||+||||||+||++. . +.+||+|||+++........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~~~~~~- 155 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---D-DILKLADFGSCRGIYSKPPY- 155 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---C-CCeEEEecccccccccCCCc-
Confidence 998899888876556789999999999999999999999999999999999994 5 99999999999765432211
Q ss_pred cccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhh-----------
Q 015041 164 HIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK----------- 231 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~----------- 231 (414)
....++..|+|||++.. ..++.++|||||||++|||++|..||.+.+..+...........
T Consensus 156 -------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 156 -------TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred -------CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence 23457889999997654 45789999999999999999999999875443222222111100
Q ss_pred ----ccCC------chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 232 ----KVST------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 232 ----~~~~------p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.... .+..+....+.++.+++.+||..+|++||+++++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000 011222356789999999999999999999887644
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=294.61 Aligned_cols=247 Identities=17% Similarity=0.307 Sum_probs=194.3
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (414)
-|++.++||.|+||.||+|.+..++..+++|.+..... ...+.+|+++++.+.| +++..+..++......++|+||+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDH-PNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCC-CCeeeEEEEEeeCCEEEEEEEec
Confidence 46889999999999999999999999999998865432 2347789999999976 55666666666778899999999
Q ss_pred -CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcc
Q 015041 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (414)
Q Consensus 86 -~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~ 164 (414)
+++|..++......+++..+..++.|++.||.|||+.||+||||||+|||+ +.++.++|+|||++........
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~--- 158 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQ--- 158 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEcccccccccccccc---
Confidence 677777666545679999999999999999999999999999999999999 5788999999999875432211
Q ss_pred ccccCCCCCccCcCcccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 165 IPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
......++..|+|||++. +..++.++|||||||++|||++|..||...... +.+..+..... +...
T Consensus 159 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~~~~~~--~~~~ 229 (282)
T cd06643 159 ----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKSEP--PTLA 229 (282)
T ss_pred ----ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH---HHHHHHhhcCC--CCCC
Confidence 112456899999999984 445788999999999999999999999875432 22222222111 1111
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
....++.++.+++.+||..+|++||+++++.
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 260 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLL 260 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 1234578999999999999999999987653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=291.65 Aligned_cols=255 Identities=24% Similarity=0.315 Sum_probs=202.2
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
.+|++.+.||.|+||.||+|.+..++..||||.+.... ....+.+|+.+++.+.| ++++.+..++......+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH-PNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccC-CchhhhhheeEeCCeEEEE
Confidence 47899999999999999999998899999999765422 12357789999999865 5666666666677789999
Q ss_pred Eecc-CCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 82 LDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
|||+ +++|.+++... ...+++..++.++.||+.||.|||++|++|+||||+||++ +.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhhccc
Confidence 9999 67998887642 3458999999999999999999999999999999999999 578899999999987654
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
..... .....|+..|+|||++.+..++.++|+||||+++|+|++|..||.+.... .......+.... ..+.
T Consensus 158 ~~~~~-------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~-~~~~ 228 (267)
T cd08229 158 SKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQCD-YPPL 228 (267)
T ss_pred cCCcc-------cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhhhcCC-CCCC
Confidence 32211 12456889999999999888999999999999999999999999764321 112222221111 1111
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
.....++++.+++.+||..+|++||++.++.+.++++
T Consensus 229 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 --PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred --CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1134578999999999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=292.67 Aligned_cols=241 Identities=21% Similarity=0.315 Sum_probs=202.8
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
--++|..++.||+|.||.|-+++-+.+++.+|+|++++.... ..-+.|-++|+..+| +.+..+.+.+....+.|
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~H-PFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRH-PFLTSLKYSFQTQDRLC 244 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccC-cHHHHhhhhhccCceEE
Confidence 346788999999999999999999999999999998876421 224567788887765 66666777788889999
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
+||||. ||.|.-.+.. .+.|++...+.+-.+|+.||.|||+++||+||||.+|.|+ |++|++||+|||+++....
T Consensus 245 FVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhccc
Confidence 999999 7777766665 4579999999999999999999999999999999999999 7999999999999986544
Q ss_pred CCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
... ..+++|||+.|.|||++....|++.+|+|.+|+++|||++|++||...+ ....+.-|+-..+.+|
T Consensus 321 ~g~-------t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d---h~kLFeLIl~ed~kFP-- 388 (516)
T KOG0690|consen 321 YGD-------TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD---HEKLFELILMEDLKFP-- 388 (516)
T ss_pred ccc-------eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc---hhHHHHHHHhhhccCC--
Confidence 332 2468999999999999999999999999999999999999999998643 3344444555555555
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCC
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPD 265 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~ 265 (414)
..+.++.+.|+..++..+|.+|..
T Consensus 389 ---r~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 389 ---RTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred ---ccCCHHHHHHHHHHhhcChHhhcC
Confidence 455789999999999999999973
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=288.34 Aligned_cols=247 Identities=19% Similarity=0.246 Sum_probs=195.5
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
.|++++.||.|+||.||+|.+..+++.||+|.+..... ...+.+|+++++.+.|.+.+..+..+.......+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 59999999999999999999998899999998764332 23477888999999765444333333334456789999
Q ss_pred cc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 84 LL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 84 ~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
|+ +++|.+.+... ...+++.+++.++.|++.||++||++||+|+||||+||++ +..+.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEecccCC
Confidence 99 68898888753 3458999999999999999999999999999999999999 4788999999999987643322
Q ss_pred CccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhh
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~ 241 (414)
......++..|+|||++.+..++.++|||||||++|++++|+.||...... .....+....... ..
T Consensus 158 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~----~~ 223 (257)
T cd08223 158 -------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---SLVYRIIEGKLPP----MP 223 (257)
T ss_pred -------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHhcCCCC----Cc
Confidence 123557889999999999999999999999999999999999999864322 2222333322211 12
Q ss_pred hcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 242 ~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...++++.+++.+||..+|++||++.++.+
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 456789999999999999999999887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=297.15 Aligned_cols=245 Identities=19% Similarity=0.307 Sum_probs=203.3
Q ss_pred eEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-CC
Q 015041 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GP 87 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 87 (414)
|.++.+||+|+||.||+|.+..+|+.||||.+..+.+-+++..|+.+++.+.. +.++.++..-......+|||||| .|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S-~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKS-KYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCC-chhhhhhhhhccCCceEeehhhcCCC
Confidence 66789999999999999999999999999999888888889999999988865 44544433333556789999999 78
Q ss_pred CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccccc
Q 015041 88 SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167 (414)
Q Consensus 88 sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 167 (414)
++.|+++..++++++.++..+++..+.||+|||...-||||||..|||+ +.++..||+|||.|....+.-..
T Consensus 114 SiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTMAK----- 185 (502)
T KOG0574|consen 114 SISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTMAK----- 185 (502)
T ss_pred cHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhhhhHHh-----
Confidence 9999999888899999999999999999999999999999999999999 68999999999999776554332
Q ss_pred cCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh--hhcCh
Q 015041 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL--CKSHP 245 (414)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~--~~~~p 245 (414)
..++.||+.|||||++....|+.++||||||++..||..|++||.+..+. ..|.-.... |.+.+ +..++
T Consensus 186 --RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM------RAIFMIPT~-PPPTF~KPE~WS 256 (502)
T KOG0574|consen 186 --RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM------RAIFMIPTK-PPPTFKKPEEWS 256 (502)
T ss_pred --hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc------ceeEeccCC-CCCCCCChHhhh
Confidence 24789999999999999999999999999999999999999999875432 111111111 11111 12347
Q ss_pred HHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 246 AEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 246 ~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+|.+|++.|+-++|++|.++.+|.+
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 88999999999999999999876654
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=297.34 Aligned_cols=251 Identities=20% Similarity=0.299 Sum_probs=195.8
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
++|++.++||+|+||.||+|.+..++..||+|.+...... .++.+|+++++.+.| +++..+..++......++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNS-PYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEeeCCEEEEEee
Confidence 4799999999999999999999999999999987654332 347789999999976 567777777778889999999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
|+ +++|.+++.. ...++...+..++.|++.||.|||+ .+|+|+||||+|||+ +.++.++|+|||++........
T Consensus 80 y~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~ 155 (308)
T cd06615 80 HMDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSMA 155 (308)
T ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE---ecCCcEEEccCCCccccccccc
Confidence 99 7799988875 3668999999999999999999998 589999999999999 4778899999999875433211
Q ss_pred CccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHH--------------
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK-------------- 227 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~-------------- 227 (414)
....|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+..
T Consensus 156 ---------~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 156 ---------NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred ---------ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence 245789999999999888899999999999999999999999975432211111100
Q ss_pred ---------------HHhhccCC-chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 228 ---------------ICEKKVST-PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 228 ---------------i~~~~~~~-p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+.+..... +.......++.++.+++.+||..+|++||++.++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 286 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK 286 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000 000000124678999999999999999999887755
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=294.85 Aligned_cols=248 Identities=23% Similarity=0.333 Sum_probs=197.7
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
.++|++.+.||.|+||.||+|.+..++..|++|.+..... ...+.+|+.+++.+.| +++..+...+..+...++|||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h-~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCC-CCEeeEEEEEEeCCEEEEeec
Confidence 4799999999999999999999988999999998765432 3457789999998876 556666666667788999999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
|+ +++|.+++. ...++..++..++.|++.||+|||++||+|+||||+|||+ +.++.++|+|||++........
T Consensus 98 ~~~~~~L~~~~~--~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 98 YLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred ccCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccchhcccccc-
Confidence 99 788988875 3458999999999999999999999999999999999999 4788999999999875432211
Q ss_pred ccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhh
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~ 242 (414)
......|+..|+|||.+.+..++.++|||||||++|+|++|..||....... ... .+.... .+......
T Consensus 172 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~-~~~~~~--~~~~~~~~ 240 (296)
T cd06654 172 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALY-LIATNG--TPELQNPE 240 (296)
T ss_pred ------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHH-HHhcCC--CCCCCCcc
Confidence 1124568899999999998889999999999999999999999998654321 111 111111 11111123
Q ss_pred cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 243 ~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+..+.+++.+||..+|++||++.++..
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 45788999999999999999999887765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=290.21 Aligned_cols=249 Identities=21% Similarity=0.336 Sum_probs=202.1
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (414)
++|++.++||.|+||.||+|.+..++..|++|.+........+.+|+++++.+.| +++..+..++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDS-PYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCC-CcEeeeeeeeecCCcEEEEEecCC
Confidence 6899999999999999999999888999999988766545678899999999955 66666766677778899999999
Q ss_pred CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccc
Q 015041 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (414)
Q Consensus 86 ~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 165 (414)
+++|.+++......+++..+..++.|++.||.|||+.+|+|+||+|+||++ +.++.++|+|||++........
T Consensus 82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~~---- 154 (256)
T cd06612 82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMA---- 154 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---CCCCcEEEcccccchhcccCcc----
Confidence 678999887666789999999999999999999999999999999999999 4788999999999876543321
Q ss_pred cccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcCh
Q 015041 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (414)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p 245 (414)
......++..|+|||++.+..++.++|||||||++|+|++|+.||......... ..+.. . ..+.......++
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~---~~~~~-~-~~~~~~~~~~~~ 226 (256)
T cd06612 155 ---KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI---FMIPN-K-PPPTLSDPEKWS 226 (256)
T ss_pred ---ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh---hhhcc-C-CCCCCCchhhcC
Confidence 112456788999999999989999999999999999999999999875433211 11111 1 111111123456
Q ss_pred HHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 246 AEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 246 ~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.++.+++..||..+|++||++.++..
T Consensus 227 ~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 227 PEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 78999999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=288.92 Aligned_cols=255 Identities=24% Similarity=0.388 Sum_probs=204.1
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++...+|++.++||.|+||.||+|.+. ++..||||.+.... ....+..|+.+++.+.| +++..+..++......++|
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v 79 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRH-DKLVQLYAVCSEEEPIYIV 79 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCC-CCEeeeeeeeecCCceEEE
Confidence 366789999999999999999999975 45779999887543 34568899999999986 5666676666777789999
Q ss_pred Eecc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 82 LDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
||++ +++|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+||++ +.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECccccceeccch
Confidence 9998 789998887533 468999999999999999999999999999999999999 47899999999998765432
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
... ......++..|+|||.+.+..++.++|||||||++|++++ |+.||.+.... ..+.++. .....+.+
T Consensus 157 ~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~-~~~~~~~~ 226 (261)
T cd05034 157 EYT------AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQVE-RGYRMPRP 226 (261)
T ss_pred hhh------hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH-cCCCCCCC
Confidence 110 1112334578999999998899999999999999999998 99999875433 2333332 22222222
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~ 275 (414)
...|.++.+++.+||..+|++||+++++.+.|+.
T Consensus 227 ---~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 ---PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 3347899999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=294.56 Aligned_cols=251 Identities=18% Similarity=0.325 Sum_probs=198.1
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeee------eCCe
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGV------DGED 77 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~------~~~~ 77 (414)
..+.|++.+.||.|+||.||+|.+..+++.||+|+..... ....+..|+.+++.+.+|+++..+..++. ....
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 4578999999999999999999999999999999876543 33457789999999977777777765543 2456
Q ss_pred eEEEEecc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
.+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||||+||++ +.++.++|+|||++..
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCcchhh
Confidence 89999999 668988887533 458888899999999999999999999999999999999 4788899999999875
Q ss_pred ecCCCCCccccccCCCCCccCcCcccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHh
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~ 230 (414)
...... ......|+..|+|||.+. +..++.++|||||||++|||++|..||...... ..+..+..
T Consensus 171 ~~~~~~-------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~---~~~~~~~~ 240 (282)
T cd06636 171 LDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM---RALFLIPR 240 (282)
T ss_pred hhcccc-------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH---hhhhhHhh
Confidence 432211 123567899999999986 346888999999999999999999999765432 22222211
Q ss_pred hccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 231 ~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
. .+.......++.++.+++.+||..+|.+||++.+|.+
T Consensus 241 ~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 241 N---PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred C---CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 1 1112223456889999999999999999999987643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=299.27 Aligned_cols=257 Identities=21% Similarity=0.230 Sum_probs=194.2
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeee-----eCC
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGV-----DGE 76 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~-----~~~ 76 (414)
++++|++.++||+|+||.||+|.+..+++.||||.+.... ....+..|+.+++.++|. ++..+..+.. ...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHE-NIIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCC-CcCchhheeecccccccc
Confidence 5689999999999999999999999999999999876432 223467899999999864 4544433322 224
Q ss_pred eeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 77 DNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 77 ~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
..++++||+++++.+++. ...+++..+..++.|++.||+|||+.||+||||||+|||+ +..+.+||+|||++...
T Consensus 82 ~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 82 DVYIVQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLARIA 156 (336)
T ss_pred eEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECcccceeec
Confidence 579999999988887765 4579999999999999999999999999999999999999 57889999999999865
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHh-----
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE----- 230 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~----- 230 (414)
....... .......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+..+..
T Consensus 157 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 157 DPEHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccc----CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 4322211 11234578999999998765 4689999999999999999999999976432221111111100
Q ss_pred ------------------hccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 231 ------------------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 231 ------------------~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.....+........+.++.+++.+||..+|++||++.++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~ 291 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00111112223345678999999999999999999887755
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=295.74 Aligned_cols=252 Identities=20% Similarity=0.292 Sum_probs=197.6
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
.+|...++||+|+||+||++.+..+++.||+|.+..... ...+..|+.++.++..+++++.+..++......+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 467788999999999999999999999999998765432 23577899999998756778777777777788899999
Q ss_pred ccCCCHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 84 LLGPSLEDLFVY----CRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 84 ~~~~sL~~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
|++.++.++... ....+++..+..++.|++.||+|||+. +|+||||||+||++ +..+.++|+|||+++....
T Consensus 84 ~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHHhcc
Confidence 998888776543 235689999999999999999999975 99999999999999 4788999999999875443
Q ss_pred CCCCccccccCCCCCccCcCccccccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
... .....|+..|+|||++.+. .++.++|||||||++|+|++|+.||.... ...+.+.++.......
T Consensus 161 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~ 230 (288)
T cd06616 161 SIA--------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPI 230 (288)
T ss_pred CCc--------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCc
Confidence 221 1234678899999999876 68999999999999999999999998643 1222222222211111
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
........++.++.+|+..||..+|++||+++++.+
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111346789999999999999999999988766
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=287.26 Aligned_cols=250 Identities=25% Similarity=0.333 Sum_probs=199.0
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-------chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
+.|.+.+.||+|+||.||+|.+..++..||+|.+..... ...+.+|+.+++.+.| +++..+..++......+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH-ERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCC-CCeeeeEEEEccCCeEE
Confidence 579999999999999999999988999999998764321 1346789999999875 56667777777778999
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
+|+||+ +++|.+++.. ...++...+..++.|++.||.|||+.||+|+||+|+||++ +.++.++|+|||+++....
T Consensus 81 ~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 81 IFMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceeccc
Confidence 999999 7788888765 4568999999999999999999999999999999999999 4778999999999876533
Q ss_pred CCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ..+..+.......
T Consensus 157 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~--- 226 (263)
T cd06625 157 ICSSG----TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---AAIFKIATQPTNP--- 226 (263)
T ss_pred ccccc----ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---HHHHHHhccCCCC---
Confidence 21110 0112456788999999999999999999999999999999999999864332 2222222222221
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.....++..+.+++.+||..+|++||++.++.+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 227 QLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 122456789999999999999999999887754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=291.88 Aligned_cols=252 Identities=20% Similarity=0.300 Sum_probs=196.0
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEee-----eeCCee
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYG-----VDGEDN 78 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~-----~~~~~~ 78 (414)
..++|++.+.||+|+||.||+|.+..++..||+|+...... ...+..|+.++..+..|+++..+..++ ..+...
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 45799999999999999999999999999999998765332 345788999999996566777665544 234568
Q ss_pred EEEEecc-CCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 79 VLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
++||||+ +++|.+++... ...+++..+..++.|++.||.|||+.+|+||||||+||++ +.++.++|+|||+++
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~ 172 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL---TTEGGVKLVDFGVSA 172 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEE---CCCCCEEEccCCcee
Confidence 9999999 88898877532 3468889999999999999999999999999999999999 477889999999987
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHH
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~ 229 (414)
....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.||....... .+.++.
T Consensus 173 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~---~~~~~~ 242 (286)
T cd06638 173 QLTSTRL-------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR---ALFKIP 242 (286)
T ss_pred ecccCCC-------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH---HHhhcc
Confidence 6543221 1124468999999999853 457899999999999999999999998754322 121111
Q ss_pred hhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 230 ~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.. ..+.......++.++.+++.+||..+|++||++.++.+
T Consensus 243 ~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 243 RN--PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred cc--CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11 11111112334678999999999999999999988765
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=287.76 Aligned_cols=254 Identities=22% Similarity=0.378 Sum_probs=199.7
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++.+++|++.++||+|+||.||+|.+. .+..||+|.+..... ...+.+|+.+++.+.|. ++..+..+... ...+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD-KLVKLHAVVTK-EPIYII 78 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCC-CcceEEEEEcC-CCeEEE
Confidence 467899999999999999999999864 455699998765433 34578899999999764 45555444444 678999
Q ss_pred Eecc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 82 LDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
|||+ +++|.+++... ...+++..++.++.|++.||.|||+.|++|+||||+||++ +..+.++|+|||.+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCcceeeccCC
Confidence 9999 68999998753 3457888999999999999999999999999999999999 57889999999999765432
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
... ......++..|+|||++.+..++.++|+|||||++|++++ |..||.+.+...... .+ ......+.
T Consensus 156 ~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~---~~-~~~~~~~~- 224 (260)
T cd05073 156 EYT------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR---AL-ERGYRMPR- 224 (260)
T ss_pred Ccc------cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH---HH-hCCCCCCC-
Confidence 211 1123345678999999998889999999999999999998 999998765432222 22 22222221
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~ 275 (414)
....|.++.+++.+||..+|++||++.++.+.|+.
T Consensus 225 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 --PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 14567899999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=294.60 Aligned_cols=201 Identities=21% Similarity=0.290 Sum_probs=160.2
Q ss_pred ecceeecCceeEEEEEEC--CCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEee-eeCCeeEEEEeccCCC
Q 015041 12 GRKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG-VDGEDNVLVLDLLGPS 88 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~-~~~~~~~lv~e~~~~s 88 (414)
+.+||+|+||+||+|++. .++..||+|.+........+.+|+.+++.+.|++.+..+..+. ......++||||++++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHD 85 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence 468999999999999965 3568899998877665567889999999998755444333333 2456789999999999
Q ss_pred HHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccC-CCCCeEEEeeecceeeecCC
Q 015041 89 LEDLFVYCR--------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG-RKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 89 L~~~~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~-~~~~~vkL~DFG~a~~~~~~ 159 (414)
|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||+... +..+.+||+|||+++.....
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCC
Confidence 988876321 247889999999999999999999999999999999999422 35678999999999865443
Q ss_pred CCCccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGL 216 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~ 216 (414)
... ........||..|+|||++.+. .++.++|||||||++|||++|..||...
T Consensus 166 ~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 166 LKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccc----ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 221 1122356789999999999874 5899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=288.64 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=199.4
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc-----------hhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----------PQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
+|.+.+.||.|+||.||+|.+..++..||+|.+...... ..+.+|+.+++.+.| +++..+..++....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH-ENIVQYLGSSLDAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEeCC
Confidence 588899999999999999999888999999977644221 246788999999976 66777777777788
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
..+++|||+ +++|.+++.. ...++...+..++.|++.||+|||++|++||||+|+||++ +.++.++|+|||.++.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISKK 155 (267)
T ss_pred ccEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCCCcc
Confidence 899999999 7788888865 4568899999999999999999999999999999999999 5888999999999886
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
........ ..........|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+.... ..+.++.... .
T Consensus 156 ~~~~~~~~-~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~-~- 229 (267)
T cd06628 156 LEANSLST-KTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---QAIFKIGENA-S- 229 (267)
T ss_pred cccccccC-CccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---HHHHHHhccC-C-
Confidence 64321111 0111122456889999999999888999999999999999999999999875332 2222322211 1
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+......+..+.+++.+||+.+|.+||++.++.+
T Consensus 230 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 230 --PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1122456889999999999999999999887754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=291.08 Aligned_cols=247 Identities=19% Similarity=0.244 Sum_probs=194.3
Q ss_pred cceeecCceeEEEEEECCCCc--eEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-C
Q 015041 13 RKIGSGSFGEIFLASHVDTNE--IVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~--~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 86 (414)
+.||+|+||.||+|.+..++. .+++|....... ...+..|+.++..+.+|+++..+..++......++||||+ +
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999887765 468887764322 2357789999999977788888877777778899999999 7
Q ss_pred CCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeec
Q 015041 87 PSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (414)
Q Consensus 87 ~sL~~~~~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG 151 (414)
++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||++ +.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECCCC
Confidence 89999887532 247889999999999999999999999999999999999 588899999999
Q ss_pred ceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHh
Q 015041 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICE 230 (414)
Q Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~ 230 (414)
++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||.+..... .+..+ .
T Consensus 158 l~~~~~~~~--------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~-~ 225 (270)
T cd05047 158 LSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKL-P 225 (270)
T ss_pred Cccccchhh--------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHHH-h
Confidence 985322110 1112233567999999988889999999999999999997 999998754332 22222 1
Q ss_pred hccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 015041 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (414)
Q Consensus 231 ~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~ 277 (414)
....... ....+.++.+++.+||..+|.+||++.++...|+.++
T Consensus 226 ~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 226 QGYRLEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCCCC---CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1111111 1245788999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=284.98 Aligned_cols=256 Identities=22% Similarity=0.294 Sum_probs=210.9
Q ss_pred ecceeecCceeEEEEEECCCCceEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-CCC
Q 015041 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~~s 88 (414)
.+.||+|+|+.|--+....++..+|||++.+...+ .+..+|++++...++|.+|..+..|+.++...|+|||-+ ||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 35799999999999999999999999999887654 458899999999999999999999999999999999999 999
Q ss_pred HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcccccc
Q 015041 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168 (414)
Q Consensus 89 L~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 168 (414)
|...+.. +..|++.++.++..+|+.||.|||.+||.||||||+|||-...+.-.-||||||.++........-.....-
T Consensus 163 lLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP 241 (463)
T KOG0607|consen 163 LLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP 241 (463)
T ss_pred HHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence 9988876 667999999999999999999999999999999999999976666667899999987643221111111111
Q ss_pred CCCCCccCcCcccccccc---C--CCCCchhhHHHHHHHHHHHHcCCCCCCCChhh------------chHHHHHHHHhh
Q 015041 169 ENKNLTGTARYASCNTHL---G--IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA------------TKKQKYDKICEK 231 (414)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~---~--~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~------------~~~~~~~~i~~~ 231 (414)
+-.+.+|++.|||||+.. + -.|+.++|+||||+|+|-|+.|.+||.|+-.. -....+..|.+.
T Consensus 242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEG 321 (463)
T KOG0607|consen 242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG 321 (463)
T ss_pred cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhcc
Confidence 334778999999999864 2 24899999999999999999999999875432 145566778888
Q ss_pred ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 232 ~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
++.+|... +..++.+.++++..++..++.+|..+..+
T Consensus 322 kYeFPdkd-WahIS~eakdlisnLlvrda~~rlsa~~v 358 (463)
T KOG0607|consen 322 KYEFPDKD-WAHISSEAKDLISNLLVRDAKQRLSAAQV 358 (463)
T ss_pred CCcCChhh-hHHhhHHHHHHHHHHHhccHHhhhhhhhc
Confidence 88888554 45667889999999999888888776544
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=288.63 Aligned_cols=245 Identities=21% Similarity=0.285 Sum_probs=195.5
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (414)
-++|++.+.||+|+||.||+|.. +++.||+|..........+.+|+.++..++|++ +..+..++.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~-i~~~~~~~~~-~~~~~v~e~~ 80 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKN-LVRLLGVILH-NGLYIVMELM 80 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCC-cCeEEEEEcC-CCcEEEEECC
Confidence 36899999999999999999874 678899999876655567889999999998754 4445444433 3478999999
Q ss_pred -CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 86 -GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 86 -~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
+++|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||++ +.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~~~-- 155 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMGVD-- 155 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceeccccCC--
Confidence 789999987543 358999999999999999999999999999999999999 4788999999999875432211
Q ss_pred cccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhhh
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~ 242 (414)
....+..|+|||.+.+..++.++|+|||||++|+|++ |..||......... .. ......... ..
T Consensus 156 --------~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~---~~-~~~~~~~~~---~~ 220 (254)
T cd05083 156 --------NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK---EC-VEKGYRMEP---PE 220 (254)
T ss_pred --------CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH---HH-HhCCCCCCC---CC
Confidence 2233567999999998899999999999999999997 99999876543222 22 222222211 24
Q ss_pred cChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 243 ~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
.+|+.+.+++..||..+|+.||++++|.+.|+
T Consensus 221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 56889999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=292.15 Aligned_cols=247 Identities=23% Similarity=0.334 Sum_probs=198.2
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
.+|++.+.||.|+||.||+|.+..+++.||+|.+.... ....+.+|+.+++.++| ++++.+..++......++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKN-PNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCC-CceeeeeeeEecCceEEEEEEe
Confidence 67999999999999999999999999999999876543 23457789999999976 5566666666777889999999
Q ss_pred c-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 85 ~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
+ +++|..++.. ..+++.+++.++.|++.||+|||+.|++|+||||+||++ +.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~~~-- 170 (296)
T cd06655 98 LAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQS-- 170 (296)
T ss_pred cCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhcccccc--
Confidence 9 7888887763 468999999999999999999999999999999999999 4788999999999875432211
Q ss_pred cccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhc
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~ 243 (414)
......++..|+|||.+.+..++.++|||||||++|+|++|..||.+...... ...+.... .+.......
T Consensus 171 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~---~~~~~~~~--~~~~~~~~~ 240 (296)
T cd06655 171 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLIATNG--TPELQNPEK 240 (296)
T ss_pred -----cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhcC--CcccCCccc
Confidence 11245688999999999988899999999999999999999999987543222 11221111 111112245
Q ss_pred ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 244 HPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 244 ~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
++..+.+++.+||..+|.+||++.++..
T Consensus 241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 241 LSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 6789999999999999999999987755
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=293.92 Aligned_cols=251 Identities=18% Similarity=0.310 Sum_probs=199.3
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
-..+|++.++||+|+||+||+|.+..++..||+|+...... ...+.+|++++..++| +++..+..++......++|
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRS-PYIVSFYGAFLNENNICMC 81 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCC-CCcceEeeeEecCCEEEEE
Confidence 34789999999999999999999998999999998765432 3457889999999865 6677777777777899999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
|||+ +++|.+++.. ...+++..+..++.|++.||.|||+ .+|+|+||||+||++ +.++.++|+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 82 MEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccchhhh
Confidence 9999 6788777765 4568999999999999999999997 589999999999999 57889999999998654322
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhc----h----HHHHHHHHhh
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT----K----KQKYDKICEK 231 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~----~----~~~~~~i~~~ 231 (414)
.. ....|+..|+|||++.+..++.++|||||||++|++++|..||....... . ...+..+...
T Consensus 158 ~~---------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd06620 158 IA---------DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE 228 (284)
T ss_pred cc---------CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc
Confidence 21 24578999999999998899999999999999999999999998654321 1 1112222211
Q ss_pred ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHH
Q 015041 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (414)
Q Consensus 232 ~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~ 272 (414)
.... .....+|.++.+++.+||..+|++||++.++.+.
T Consensus 229 ~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 229 PPPR---LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred cCCC---CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1111 0111257889999999999999999999887663
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=291.31 Aligned_cols=236 Identities=24% Similarity=0.375 Sum_probs=197.3
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+++++.+.| ++++.+..++..+...++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH-PFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCccceeeEEEcCCeEEEE
Confidence 47999999999999999999999999999999876432 23457789999999984 6777777777788889999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++.. ...++...+..++.||+.||+|||++||+|+||+|+||++ +.++.+||+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 80 MEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC-
Confidence 9999 8999988876 4678999999999999999999999999999999999999 57889999999998765433
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||..... .+....+.......|
T Consensus 155 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~---- 218 (290)
T cd05580 155 ---------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---IQIYEKILEGKVRFP---- 218 (290)
T ss_pred ---------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCccCC----
Confidence 1245788999999999988899999999999999999999999986542 233334433333222
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCC
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPD 265 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~ 265 (414)
...+..+.+++.+||..+|.+|++
T Consensus 219 -~~~~~~l~~li~~~l~~~p~~R~~ 242 (290)
T cd05580 219 -SFFSPDAKDLIRNLLQVDLTKRLG 242 (290)
T ss_pred -ccCCHHHHHHHHHHccCCHHHccC
Confidence 345789999999999999999983
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=320.52 Aligned_cols=292 Identities=19% Similarity=0.237 Sum_probs=197.6
Q ss_pred ccCCceEEecceeecCceeEEEEEECCC-CceEEEE------------------EecCC-CCchhHHHHHHHHHHHcCCC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT-NEIVAVK------------------IENSG-TKHPQLLYEAKVYKILQGGS 63 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~-~~~vavK------------------~~~~~-~~~~~~~~E~~~l~~l~~~~ 63 (414)
.+.++|+++++||+|+||+||+|..... +..+++| ..... .....+.+|+.+++.+.| +
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H-p 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH-E 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC-C
Confidence 3457899999999999999999876432 2222222 11111 112346789999999976 6
Q ss_pred CCCeeEEeeeeCCeeEEEEeccCCCHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccC
Q 015041 64 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 139 (414)
Q Consensus 64 ~i~~l~~~~~~~~~~~lv~e~~~~sL~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~ 139 (414)
+|+.+..++......++|+++++++|..++.... .......++.|+.||+.||+|||++|||||||||+|||+
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl--- 300 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL--- 300 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---
Confidence 6777777777888899999999888887765321 224467788999999999999999999999999999999
Q ss_pred CCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhh
Q 015041 140 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219 (414)
Q Consensus 140 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~ 219 (414)
+.++.+||+|||+++.+...... .....+||..|+|||++.+..++.++|||||||++|||++|..++.+....
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~ 374 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA------FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG 374 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc------ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC
Confidence 57889999999999876543221 112467999999999999999999999999999999999987644332222
Q ss_pred chHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCccc-cccccccchh
Q 015041 220 TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVF-DWTILKYQQT 298 (414)
Q Consensus 220 ~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~-dw~~l~~~~~ 298 (414)
.....+.+++.... ... ..+|+...+++...........+. .+..++...+...+... --.||.++|.
T Consensus 375 ~~~~~~~~~~~~~~-~~~----~~~p~~~~~~~~~i~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~kmL~~DP~ 443 (501)
T PHA03210 375 KPGKQLLKIIDSLS-VCD----EEFPDPPCKLFDYIDSAEIDHAGH------SVPPLIRNLGLPADFEYPLVKMLTFDWH 443 (501)
T ss_pred CHHHHHHHHHHhcc-cCh----hhcCCcHHHHHHHhhhhhcccCcc------chhhHHHhcCCChHHHHHHHHHhccCcc
Confidence 22333333333221 111 122333334444443333333332 11222222222221111 1168999999
Q ss_pred hhccccccCCCCccccCC
Q 015041 299 QKTKSQDLLPASRVTNSR 316 (414)
Q Consensus 299 ~~~~~~~~l~~~~~~~~~ 316 (414)
+|+++.+++.||||....
T Consensus 444 ~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 444 LRPGAAELLALPLFSAEE 461 (501)
T ss_pred cCcCHHHHhhChhhhcCC
Confidence 999999999999997643
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=294.29 Aligned_cols=250 Identities=19% Similarity=0.320 Sum_probs=199.5
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
.++|++.++||.|+||.||+|.+..++..||+|+...... ...+..|+.+++.+.| +++..+...+......++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH-PNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCC-CceeEEEEEEecCCeEEEEee
Confidence 3579999999999999999999988899999998765432 2357789999999984 677777777777888999999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
|+ +++|.+++......+++..++.++.|++.||.|||++||+|+||||+||++ +.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhhccccc-
Confidence 99 778888887766779999999999999999999999999999999999999 5788999999998865432211
Q ss_pred ccccccCCCCCccCcCcccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 163 RHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
......++..|+|||.+. +..++.++|||||||++|+|++|..||...... +.+.++.... .+.
T Consensus 159 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~--~~~ 227 (280)
T cd06611 159 ------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM---RVLLKILKSE--PPT 227 (280)
T ss_pred ------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH---HHHHHHhcCC--CCC
Confidence 112456889999999975 345788999999999999999999999875432 2222222211 111
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
......++.++.+++..||..+|.+||++.++.+
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 1112345789999999999999999999887644
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=286.41 Aligned_cols=253 Identities=19% Similarity=0.267 Sum_probs=191.1
Q ss_pred cceeecCceeEEEEEECC---CCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-
Q 015041 13 RKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (414)
+.||+|+||.||+|.+.. .+..||+|.+..... ...+..|+.+++.+.|.+.+..+..+...+...+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998753 345799998754332 2356788889988876544444443444555678999998
Q ss_pred CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccc
Q 015041 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (414)
Q Consensus 86 ~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 165 (414)
+++|.+++......+++..++.++.|++.||.|||+.+|+||||||+|||+ +.++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~~-- 155 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYS-- 155 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCccee--
Confidence 789999987655567888899999999999999999999999999999999 478899999999997654322111
Q ss_pred cccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcC
Q 015041 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (414)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 244 (414)
........++..|+|||.+.+..++.++|||||||++|||++ |.+||...+... ....+ ......+.+ ...
T Consensus 156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~-~~~~~~~~~---~~~ 227 (262)
T cd05058 156 -VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYL-LQGRRLLQP---EYC 227 (262)
T ss_pred -ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH-hcCCCCCCC---CcC
Confidence 111123456778999999998899999999999999999999 567777644322 22222 222122211 345
Q ss_pred hHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 245 PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 245 p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
|+.+.+++..||..+|++||++.++.+.|++++.
T Consensus 228 ~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 228 PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 7899999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=288.79 Aligned_cols=254 Identities=22% Similarity=0.285 Sum_probs=197.6
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
+|++.+.||.|+||.||+|.+..++..||+|++..... ...+.+|+.+++.+.| +++..+..++..+...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQH-PYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCC-CCCcceeeEEecCCeeEEEec
Confidence 69999999999999999999998999999998765432 3457889999999975 667777777777888999999
Q ss_pred ccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 84 ~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
|++++|.+++......+++..++.++.||+.||+|||+.||+|+||||+||++ +..+.++|+|||++........
T Consensus 80 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~-- 154 (286)
T cd07832 80 YMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEP-- 154 (286)
T ss_pred ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCC--
Confidence 99999999987666779999999999999999999999999999999999999 4788999999999876544321
Q ss_pred cccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc----------
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK---------- 232 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~---------- 232 (414)
+......|+..|+|||++.+.. ++.++|||||||++|||++|.+||.+.................
T Consensus 155 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 ----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred ----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence 1122456889999999987654 6899999999999999999998887654332222111111000
Q ss_pred ------------cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 233 ------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 233 ------------~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...+........+..+.+++..|+..+|.+||+++++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000111222345677888888888888888888776543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=292.56 Aligned_cols=248 Identities=17% Similarity=0.254 Sum_probs=196.2
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
.+|++++.||+|+||.||+|.+..++..||+|.+..... ...+.+|+.+++.+.| +++..+...+......++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVS-PYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCC-CcHHhhhhheecCCeEEEEEe
Confidence 478999999999999999999998999999998765422 2457789999999876 566666666667788999999
Q ss_pred cc-CCCHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHh-cCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 84 LL-GPSLEDLFVYC--RRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 84 ~~-~~sL~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
|+ +++|..++... ...+++..+..++.|++.||.|||+ .+|+|+||||+||+++ .++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN---GNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC---CCCCEEEeecCCcccccCC
Confidence 99 77887777643 2368999999999999999999997 5999999999999994 6889999999998765332
Q ss_pred CCCccccccCCCCCccCcCccccccccCC------CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGI------EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
.. ....++..|+|||.+.+. .++.++|||||||++|+|++|..||...........+..+.....
T Consensus 157 ~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd06622 157 LA---------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP 227 (286)
T ss_pred cc---------ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC
Confidence 21 244678899999998554 358899999999999999999999976543333333333332221
Q ss_pred CCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 234 ~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
......+++++.+++..||..+|++||+++++..
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 ----PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ----CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1122346789999999999999999999988765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=298.41 Aligned_cols=254 Identities=18% Similarity=0.217 Sum_probs=188.9
Q ss_pred Eecceeec--CceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 11 LGRKIGSG--SFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 11 i~~~iG~G--~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
++++||+| +|++||++.+..+|+.||+|.+..... ...+..|+.+++.+.| +++..+..++......++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNH-PNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEECCEEEEEEec
Confidence 57889999 789999999999999999998875432 2346678899988876 6677777777788889999999
Q ss_pred c-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 85 L-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 85 ~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
+ +++|.+++... ...+++..++.++.|++.||+|||+++|+||||||+|||+ +.++.++++||+.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE---ecCCcEEEcccchhhcccccccc
Confidence 9 78999988653 3458999999999999999999999999999999999999 47889999999876543322111
Q ss_pred ccccccCCCCCccCcCccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC------
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS------ 234 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~------ 234 (414)
............++..|+|||++.+ ..++.++|||||||++|||++|..||........ .........+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~ 234 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LLEKLNGTVPCLLDTT 234 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH---HHHHhcCCcccccccc
Confidence 1100011123456788999999976 4589999999999999999999999986543221 1111110000
Q ss_pred -Cch----------------------------------HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 235 -TPI----------------------------------EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 235 -~p~----------------------------------~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+. ......+++.+.+++..||..||++||+++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000 0011234567889999999999999999887654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=286.46 Aligned_cols=249 Identities=23% Similarity=0.313 Sum_probs=200.5
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
+-.++|++.+.||.|+||.||+|.. .++.||+|.+..... ..++..|+.+++.+.| +++..+..+.......++||
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRH-PNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCC-cceeeeEEEEcCCCCeEEEE
Confidence 3467899999999999999999987 478899998876654 4568899999999986 55556666666678899999
Q ss_pred ecc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|++ +++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||++ +.++.++|+|||.++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEccccccccccccc
Confidence 999 579999887543 268999999999999999999999999999999999999 578899999999997653221
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
. ....+..|+|||.+.+..++.++|||||||++|++++ |..||....... +...+.......
T Consensus 157 ~----------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~~~~~~~~--- 219 (256)
T cd05039 157 D----------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPHVEKGYRME--- 219 (256)
T ss_pred c----------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH----HHHHHhcCCCCC---
Confidence 1 2234568999999998889999999999999999997 999998654322 112222222211
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~ 275 (414)
.....|+.+.+++..||..+|++||++.++.+.|+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 123558899999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=285.47 Aligned_cols=248 Identities=24% Similarity=0.304 Sum_probs=193.4
Q ss_pred cceeecCceeEEEEEECCCC---ceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-
Q 015041 13 RKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (414)
++||+|+||.||+|.+..++ ..||+|.+..... ...+..|+.+++.+.| +++..+..+.. ....++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDH-PCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCC-CCeeeEEEEEc-CCceEEEEEeCC
Confidence 57999999999999876544 7899998876543 3457889999999876 55555554443 45679999998
Q ss_pred CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccc
Q 015041 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (414)
Q Consensus 86 ~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 165 (414)
+++|.+++.. ...+++..++.++.|++.||+|||+.+++|+||||+|||+ +.++.+||+|||+++........
T Consensus 79 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~--- 151 (257)
T cd05060 79 LGPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDY--- 151 (257)
T ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCcc---
Confidence 7899998875 3478999999999999999999999999999999999999 57889999999999865432211
Q ss_pred cccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcC
Q 015041 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (414)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 244 (414)
+.......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ....+ ......+. ...+
T Consensus 152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~-~~~~~~~~---~~~~ 223 (257)
T cd05060 152 -YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAML-ESGERLPR---PEEC 223 (257)
T ss_pred -cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHH-HcCCcCCC---CCCC
Confidence 111122234568999999998899999999999999999998 999998754432 22222 22222221 1345
Q ss_pred hHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 015041 245 PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (414)
Q Consensus 245 p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~ 277 (414)
+..+.+++.+||..+|++||++.++.+.|+.+.
T Consensus 224 ~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 224 PQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 789999999999999999999999999888653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=290.32 Aligned_cols=260 Identities=24% Similarity=0.268 Sum_probs=197.2
Q ss_pred CCceEEecceeecCceeEEEEEE----CCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEee--eeCCe
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASH----VDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYG--VDGED 77 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~----~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~--~~~~~ 77 (414)
..+|++.+.||+|+||.||+|.. ..++..||+|.+..... ...+.+|++++..+.| ++++.+..++ .....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQH-DNIVKYKGVCYSAGRRN 81 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCC-CCeeEEEEEEccCCCCc
Confidence 46899999999999999999974 45788999998765543 2357889999999976 5555554433 23456
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
.++|+||+ +++|.+++......+++..++.++.|++.||+|||++||+||||||+||++ +.++.++|+|||+++..
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTKVL 158 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCcccccc
Confidence 88999999 889999987655678999999999999999999999999999999999999 57889999999999865
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhc------------hHHH
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT------------KKQK 224 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~------------~~~~ 224 (414)
....... .......++..|+|||++.+..++.++|||||||++|||++|..++....... ....
T Consensus 159 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 159 PQDKEYY----KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH 234 (284)
T ss_pred cCCCcce----eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence 4322110 01112233456999999998899999999999999999999877765322110 0011
Q ss_pred HHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 225 ~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
+..++......+. ...++.++.+++..||..+|++||++.++.+.|+.+
T Consensus 235 ~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 LIELLKNNGRLPA---PPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHhcCCcCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1112222222221 134578999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=290.89 Aligned_cols=253 Identities=21% Similarity=0.265 Sum_probs=194.4
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc-------hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-------PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
+|++++.||.|+||.||+|.+..+++.||||.+...... ..+..|+++++.+.| +++..+..++......++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH-PNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCC-CCChhhhheeecCCEEEE
Confidence 589999999999999999999989999999988654322 345679999999985 556666666666788999
Q ss_pred EEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 81 v~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||||++++|.+++......+++..++.++.||+.||.|||++||+|+||||+||++ +.++.++|+|||+++......
T Consensus 80 v~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 80 VFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred EEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE---cCCCCEEEccceeeeeccCCC
Confidence 99999999999887544469999999999999999999999999999999999999 478899999999998765432
Q ss_pred CCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhh--------
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK-------- 231 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~-------- 231 (414)
.. .....++..|+|||.+.+ ..++.++|||||||++|||++|.+||.+................
T Consensus 157 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 157 RK-------MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred cc-------ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhh
Confidence 11 123356788999999865 45789999999999999999998888765433222221111100
Q ss_pred ------------ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 232 ------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 232 ------------~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
....+........+.++.+++..||..+|++||++.++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0011111222344678889999999999999999877644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=289.11 Aligned_cols=200 Identities=26% Similarity=0.365 Sum_probs=168.8
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
++|++.+.||.|+||.||+|.+..+++.||||.+..... ...+.+|+.+++.++| +++..+..++......++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKH-ANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCC-cceeeEEEEEecCCeEEEEEe
Confidence 689999999999999999999988899999998764332 2346789999999976 567777777778889999999
Q ss_pred ccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 84 ~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
|+.++|.+++......+++..++.++.|++.||.|||+++|+||||||+||++ +.++.+||+|||+++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~-- 158 (291)
T cd07844 84 YLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVPSK-- 158 (291)
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECccccccccCCCCc--
Confidence 99889999887766678999999999999999999999999999999999999 5788999999999865322111
Q ss_pred cccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCh
Q 015041 164 HIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLK 217 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~ 217 (414)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus 159 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 159 -----TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred -----cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 1123346789999999876 458999999999999999999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=285.23 Aligned_cols=245 Identities=26% Similarity=0.383 Sum_probs=199.7
Q ss_pred cceeecCceeEEEEEECCC---CceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-
Q 015041 13 RKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (414)
+.||.|+||.||+|.+... +..|++|++..... ...+..|++++..+. ++++..+..+.......+++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEecc
Confidence 5799999999999999865 88999999876654 346788999999998 566777766666788899999999
Q ss_pred CCCHHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 86 GPSLEDLFVYC--------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 86 ~~sL~~~~~~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
+++|.+++... ...+++..++.++.|++.||+|||+++|+|+||||+||++ +.++.++|+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccccc
Confidence 99999998865 3678999999999999999999999999999999999999 477999999999998765
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCc
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTP 236 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p 236 (414)
.... +.......++..|+|||.+....++.++|||||||++|+|++ |..||........ ...+.. ....+
T Consensus 157 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~~-~~~~~ 227 (262)
T cd00192 157 DDDY-----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV---LEYLRK-GYRLP 227 (262)
T ss_pred cccc-----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHHc-CCCCC
Confidence 4321 112234567889999999998899999999999999999999 6999988644322 222222 11222
Q ss_pred hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 015041 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (414)
Q Consensus 237 ~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l 273 (414)
. ...+|.++.+++..||..+|++||++.++.+.|
T Consensus 228 ~---~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 228 K---PEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred C---CccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1 234578999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=289.96 Aligned_cols=254 Identities=22% Similarity=0.283 Sum_probs=195.3
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
++|++.++||+|+||.||+|.+..+++.||+|.+..... ...+.+|+++++.+.| +++..+..++......++|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRH-ENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCC-cchhhHHHhcccCCeEEEEE
Confidence 479999999999999999999988899999998654332 2357789999999876 56666766667788899999
Q ss_pred eccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 83 e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
||+.+.+.+.+......+++..++.++.||+.||.|||+.||+|+||+|+||++ +.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGE- 155 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCcc-
Confidence 999655544444434568999999999999999999999999999999999999 5788999999999876543321
Q ss_pred ccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc---------
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK--------- 232 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (414)
......++..|+|||++.+. .++.++|||||||++|||++|..||.+....+....+..+....
T Consensus 156 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 156 ------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred ------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhc
Confidence 11245678899999998764 47889999999999999999999998654322222211111100
Q ss_pred --------------cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 233 --------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 233 --------------~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...+.....+.++..+.+++..||..+|++||++.++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 001111223456788999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=288.17 Aligned_cols=251 Identities=22% Similarity=0.340 Sum_probs=197.5
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeee------CCee
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVD------GEDN 78 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~------~~~~ 78 (414)
.++|++.+.||.|+||.||+|.+..+++.|++|++..... ...+..|+.+++.+..|++++.+..++.. +...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 5899999999999999999999988899999998876543 34578899999999766777777666543 3458
Q ss_pred EEEEecc-CCCHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 79 VLVLDLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
++||||+ +++|.+++.... ..++...+..++.|++.||+|||+.+++|+||+|+||++ +.++.++|+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d~~~~~ 161 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---ccCCeEEECCCccce
Confidence 9999999 678888876533 568999999999999999999999999999999999999 478899999999987
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHH
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~ 229 (414)
....... ......|+..|+|||++.. ..++.++|||||||++|+|++|..||...... ..+.++.
T Consensus 162 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~ 231 (275)
T cd06608 162 QLDSTLG-------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---RALFKIP 231 (275)
T ss_pred ecccchh-------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---HHHHHhh
Confidence 6543221 1224568899999998754 34678999999999999999999999864332 2222222
Q ss_pred hhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 230 ~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...... . .....+++.+.+++..||..+|++||++.++.+
T Consensus 232 ~~~~~~-~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RNPPPT-L-KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccCCCC-C-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 211111 0 111235778999999999999999999987754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=328.83 Aligned_cols=261 Identities=26% Similarity=0.351 Sum_probs=213.1
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
++-..+|.+++.||+|+||+|.+++++.+++.||+|++++- .....|..|-.++..- ...=|..+.+.+.+..+
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERY 149 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccc
Confidence 35567899999999999999999999999999999998762 2233466666666432 23446667778889999
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
.|+||||+ ||+|..++.... ++++..+++++..|+.||.-||+.|+|||||||+|||+ |..|++||+|||.+-.+
T Consensus 150 LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKM 225 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhc
Confidence 99999999 999999998766 89999999999999999999999999999999999999 69999999999998777
Q ss_pred cCCCCCccccccCCCCCccCcCcccccccc----C-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhh
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHL----G-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~ 231 (414)
...+... ....+||+-|.|||++. + +.|++.+|+||+||++|||+.|..||.. ....+.|.+|+..
T Consensus 226 ~~dG~V~------s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa---dslveTY~KIm~h 296 (1317)
T KOG0612|consen 226 DADGTVR------SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA---DSLVETYGKIMNH 296 (1317)
T ss_pred CCCCcEE------eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH---HHHHHHHHHHhch
Confidence 6544432 23678999999999986 3 5699999999999999999999999985 3455778888776
Q ss_pred --ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCC---hHHHHHHHHHHHHhcCCCCCcccccc
Q 015041 232 --KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD---YGFLKRLFHDLFSREGYDFDFVFDWT 291 (414)
Q Consensus 232 --~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~---~~~l~~~l~~~~~~~~~~~~~~~dw~ 291 (414)
.+.+|... ..+++.++||...+ .+++.|.. ++++. .+.|+...||.
T Consensus 297 k~~l~FP~~~---~VSeeakdLI~~ll-~~~e~RLgrngiedik----------~HpFF~g~~W~ 347 (1317)
T KOG0612|consen 297 KESLSFPDET---DVSEEAKDLIEALL-CDREVRLGRNGIEDIK----------NHPFFEGIDWD 347 (1317)
T ss_pred hhhcCCCccc---ccCHHHHHHHHHHh-cChhhhcccccHHHHH----------hCccccCCChh
Confidence 55556222 26899999999988 47899987 44443 34566667784
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=287.81 Aligned_cols=250 Identities=22% Similarity=0.288 Sum_probs=188.6
Q ss_pred cceeecCceeEEEEEEC--CCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-C
Q 015041 13 RKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 86 (414)
+.||+|+||.||+|.+. .++..+|+|.+...... ..+.+|+.+++.++| +++..+..++......++||||+ +
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQH-SNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCC-CCEeeEEEEEcCCCCcEEEEECCCC
Confidence 46999999999999864 34567999987654322 357789999999976 55666666666777889999999 7
Q ss_pred CCHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 87 PSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 87 ~sL~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
++|.+++.... ..++...++.++.|++.||+|||+++++||||||+||++ +..+.++|+|||+++.......
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~- 155 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKEDY- 155 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEECCccccccccCcce-
Confidence 89998886532 235677888999999999999999999999999999999 4788999999999864332211
Q ss_pred ccccccCCCCCccCcCccccccccCC-------CCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccC
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGI-------EQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
+.......++..|+|||++.+. .++.++|||||||++|||++ |..||......... ...+......
T Consensus 156 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~--~~~~~~~~~~ 229 (269)
T cd05087 156 ----YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL--TYTVREQQLK 229 (269)
T ss_pred ----eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH--HHHhhcccCC
Confidence 1112245678899999998643 35889999999999999996 99999875443221 1222233333
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
.+.+......++.+.+++.+|| .+|++||++++|...|.
T Consensus 230 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 3333333456788999999999 68999999999987653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=286.95 Aligned_cols=200 Identities=23% Similarity=0.342 Sum_probs=168.2
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
++|++.+.||+|+||.||+|.+..++..||+|++...... ..+.+|+.+++.+.| +++..+..++......++|||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH-ANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCC-CCEeEEEEEEecCCeEEEEEe
Confidence 6899999999999999999999989999999987654322 246789999999976 567777777777888999999
Q ss_pred ccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 84 ~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
|+.+++.+.+......++...+..++.|++.||.|||+.||+|+||||+|||+ +.++.++|+|||+++.......
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~-- 158 (291)
T cd07870 84 YMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAKSIPSQ-- 158 (291)
T ss_pred cccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEeccccccccCCCCC--
Confidence 99988888776545567888999999999999999999999999999999999 4788999999999875433211
Q ss_pred cccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCh
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLK 217 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~ 217 (414)
......++..|+|||.+.+. .++.++|||||||++|+|++|..||.+..
T Consensus 159 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 159 -----TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred -----CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 11234568899999998764 58899999999999999999999998654
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=289.91 Aligned_cols=255 Identities=22% Similarity=0.326 Sum_probs=200.6
Q ss_pred ccCCceEEecceeecCceeEEEEEEC-----CCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 75 (414)
+-.++|++.++||.|+||.||+|.+. .++..||+|++..... ...+.+|+.+++.+.| +++..+..++..+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h-~~iv~~~~~~~~~ 80 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDH-PNIVKLLGVCAVG 80 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCC-CchheEEEEEcCC
Confidence 34578999999999999999999874 3678899998875543 2457789999999976 6677777777777
Q ss_pred CeeEEEEecc-CCCHHHHHHHhC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCc
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYCR---------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 133 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~~---------------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~N 133 (414)
...+++|||+ +++|.+++.... ..+++..++.++.|++.||+|||+++++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 8899999999 679988886421 236788899999999999999999999999999999
Q ss_pred eEEccCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCC
Q 015041 134 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLP 212 (414)
Q Consensus 134 ili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~P 212 (414)
|++ +.++.++|+|||+++....... +........+..|+|||.+.+..++.++|||||||++|||++ |..|
T Consensus 161 il~---~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p 232 (288)
T cd05050 161 CLV---GENMVVKIADFGLSRNIYSADY-----YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232 (288)
T ss_pred eEe---cCCCceEECccccceecccCcc-----ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 999 5788999999999875432211 011122334678999999998899999999999999999997 8889
Q ss_pred CCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 213 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
|.+.... +....+...... + .....|.++.+++.+||..+|++||++.++.+.|+
T Consensus 233 ~~~~~~~---~~~~~~~~~~~~-~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 233 YYGMAHE---EVIYYVRDGNVL-S---CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCCCHH---HHHHHHhcCCCC-C---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 9875443 233333222221 1 12355789999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=291.15 Aligned_cols=255 Identities=20% Similarity=0.229 Sum_probs=193.2
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeee--CCeeE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVD--GEDNV 79 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~--~~~~~ 79 (414)
-.+|++.+.||.|+||.||+|.+..+|+.||+|.+..... .....+|+.+++.++|.+ +..+..+... ....+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN-IVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCC-CcceEEEEecCCCCeEE
Confidence 3689999999999999999999999999999998764332 223568999999998754 5555444432 35689
Q ss_pred EEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 80 lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
+||||+.++|.+++......+++.+++.++.||+.||+|||+.|++||||||+||++ +..+.+||+|||++......
T Consensus 85 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceeeecCCc
Confidence 999999989999988766779999999999999999999999999999999999999 57889999999999876543
Q ss_pred CCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc-----
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV----- 233 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~----- 233 (414)
... .....++..|+|||++.+ ..++.++|||||||++|||++|..||.+.+.......+........
T Consensus 162 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 162 AKP-------MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred cCC-------CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhch
Confidence 211 112345788999999876 4589999999999999999999999987654433322222111000
Q ss_pred -----------CC---c---hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 234 -----------ST---P---IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 234 -----------~~---p---~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.. + ........++++.+++.+|+..||++||+++++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 0 00001123667788888888888888888776643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=291.45 Aligned_cols=259 Identities=23% Similarity=0.286 Sum_probs=196.6
Q ss_pred CceEEecceeecCceeEEEEEE----CCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeee--CCe
Q 015041 7 VKYKLGRKIGSGSFGEIFLASH----VDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD--GED 77 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~----~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~--~~~ 77 (414)
+-|+++++||+|+||.||+|+. ..++..||+|.+..... ...+.+|+.+++.+.| +++..+..++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH-ENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCC-CCeeeeeeEEecCCCCc
Confidence 4579999999999999999985 35688999998764432 2357889999999977 445555444433 356
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
.++||||+ +++|.+++......+++.+++.++.|++.||+|||++||+||||||+||++ +.++.++|+|||+++..
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAI 159 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE---cCCCCEEECCCcccccc
Confidence 78999999 899999887655568999999999999999999999999999999999999 47888999999999865
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCh-----------hhchHHHH
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK-----------AATKKQKY 225 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~-----------~~~~~~~~ 225 (414)
...... ........++..|+|||++.+..++.++|||||||++|||+++..|+.... ........
T Consensus 160 ~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 160 ETDKEY----YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred ccCccc----eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 433221 111224556788999999998889999999999999999999876653210 00001111
Q ss_pred HHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 226 DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 226 ~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
.+........+. ...++..+.+++.+||..+|++||++.++.+.|+.+
T Consensus 236 ~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 236 VRVLEEGKRLPR---PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHcCccCCC---CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111222222221 234678999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=287.31 Aligned_cols=254 Identities=21% Similarity=0.305 Sum_probs=198.1
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCC--------CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
+|+.++.||+|+||.||+|.+..+++.||+|++.... ....+..|+++++.++| ++++.+..++......+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH-PHIIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCC-CceehhhceeccCCeEE
Confidence 5889999999999999999999999999999876433 12457889999999976 55556656666777889
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
+|+||+ +++|.+++.. ...+++..++.++.||+.||.|||++|++|+||+|+||++. .....++|+|||.+.....
T Consensus 80 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~--~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 80 LFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID--STGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccccccccccc
Confidence 999998 7889888865 45689999999999999999999999999999999999994 2334699999999876654
Q ss_pred CCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
....... ......++..|+|||.+.+..++.++|||||||++|+|++|..||.............++.......
T Consensus 157 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--- 230 (268)
T cd06630 157 KGTGAGE---FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP--- 230 (268)
T ss_pred ccccCCc---cccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCC---
Confidence 3221110 1224568899999999998889999999999999999999999997544333233332222222221
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
......+.++.+++.+||..+|++||++.++.+
T Consensus 231 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 122345788999999999999999999887653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=284.86 Aligned_cols=258 Identities=22% Similarity=0.325 Sum_probs=201.8
Q ss_pred ccCCceEEecceeecCceeEEEEEECCC---CceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
+-..+|++.++||+|+||.||+|.+... ...||||....... ...+.+|+.+++.+.| +++..+..++.+ ..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~-~~ 80 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH-PHIVKLIGVITE-NP 80 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCC-CchhceeEEEcC-CC
Confidence 4567899999999999999999987543 34689998765542 2357889999999986 455555554443 45
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
.++||||+ +++|.+++......+++..++.++.|++.||+|||+.|++|+||||+||++ +..+.++|+|||+++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV---SSPDCVKLGDFGLSRYL 157 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE---ecCCCeEEccCceeeec
Confidence 78999999 789999987655668999999999999999999999999999999999999 47789999999999765
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
...... ......++..|+|||.+....++.++|||||||++||+++ |..||.+..... ....+.. ....
T Consensus 158 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~~~-~~~~ 227 (270)
T cd05056 158 EDESYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VIGRIEN-GERL 227 (270)
T ss_pred ccccce------ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHc-CCcC
Confidence 443211 1112234568999999988889999999999999999986 999998765432 2222221 1111
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
+. ...+|..+.+++.+||..+|++||++.++...|.++...
T Consensus 228 ~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 PM---PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred CC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 21 245688999999999999999999999999998877543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=291.29 Aligned_cols=260 Identities=23% Similarity=0.312 Sum_probs=203.3
Q ss_pred CCceEEecceeecCceeEEEEEEC----CCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeee--CC
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD--GE 76 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~----~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~--~~ 76 (414)
.+.|++.+.||+|+||.||+|.+. .++..||||++..... ...+.+|+++++.+.| +++..+..++.. ..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~-~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDH-ENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCC-CChheEEeeeecCCCC
Confidence 467899999999999999999864 3478999998876654 3568899999999976 556666555554 55
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
..+++|||+ +++|.+++......+++..++.++.|++.||+|||++||+|+||||+||++ +.++.++|+|||++..
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKV 158 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccccccc
Confidence 789999999 789999988655579999999999999999999999999999999999999 4779999999999986
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhc-----------hHHH
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT-----------KKQK 224 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~-----------~~~~ 224 (414)
....... +.......++..|++||.+.+..++.++|||||||++|||++|..||....... ....
T Consensus 159 ~~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05038 159 LPEDKDY----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234 (284)
T ss_pred cccCCcc----eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence 6532211 111112344567999999998899999999999999999999999987532221 1122
Q ss_pred HHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 225 ~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
+...+......+.+ ..+|.++.+++.+||..+|++||++.++.+.|+.+
T Consensus 235 ~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 LLELLKEGERLPRP---PSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHcCCcCCCC---ccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 22222322222222 34578999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=281.95 Aligned_cols=246 Identities=24% Similarity=0.304 Sum_probs=202.0
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
+|++++.||.|+||.||.+++..+++.|++|.+.... ....+.+|+.+++.+.| +++..+..++......+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH-PNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCC-CCeeEEEeEEecCCeEEEEEE
Confidence 6999999999999999999999999999999866432 22457889999999965 667777777777888999999
Q ss_pred cc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 84 LL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 84 ~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
|+ +++|.+++... ...++...+..++.|++.||.|||+.|++|+||+|+||++ +.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE---eCCCCEEECcCcceEEcccccc
Confidence 99 78999988754 3568999999999999999999999999999999999999 4788899999999986644331
Q ss_pred CccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhh
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~ 241 (414)
......|+..|+|||++.+..++.++|||||||++|+|++|..||..... .+....+........ .
T Consensus 157 -------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~~----~ 222 (256)
T cd08221 157 -------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---LNLVVKIVQGNYTPV----V 222 (256)
T ss_pred -------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHcCCCCCC----c
Confidence 11245689999999999988899999999999999999999999986432 233334433332221 1
Q ss_pred hcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 242 ~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...+.++.+++.+||..+|++||++.++.+
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 223 SVYSSELISLVHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhh
Confidence 455789999999999999999999987765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=297.20 Aligned_cols=200 Identities=24% Similarity=0.341 Sum_probs=165.3
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeee-----e
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV-----D 74 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~-----~ 74 (414)
.+.++|++.+.||+|+||.||+|.+..+++.||||.+.... ....+.+|+.+++.+.|.+.+..+..+.. .
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 46789999999999999999999999999999999876432 22346789999999987544443333322 2
Q ss_pred CCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 75 ~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
....++||||+.++|.+.+.. .++...+..++.|++.||+|||++||+||||||+||++ +.++.+||+|||+++
T Consensus 93 ~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 93 FQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 166 (353)
T ss_pred cCcEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCccce
Confidence 235799999999898887753 28999999999999999999999999999999999999 578899999999998
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCh
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 217 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~ 217 (414)
....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+
T Consensus 167 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 167 TAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred eCCCCCC--------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 6533211 123467889999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=287.68 Aligned_cols=246 Identities=22% Similarity=0.333 Sum_probs=199.3
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
++|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.+.| +++..+..++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRS-PYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCC-CCeeeeeEEEEECCeEEEEEE
Confidence 479999999999999999999999999999998865432 2347789999999986 556566666667788999999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
|+ +++|.+++... .+++..++.++.|++.||.|||+++|+|+||+|+||++ +.++.++|+|||+++.......
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 80 YCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred eeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeeccccc-
Confidence 99 77898888743 78999999999999999999999999999999999999 5788999999999987654321
Q ss_pred ccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhh
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~ 242 (414)
......++..|+|||++.+..++.++|||||||++|+|++|..||...... .....+.... ..... ..
T Consensus 154 ------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~-~~~~~--~~ 221 (274)
T cd06609 154 ------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM---RVLFLIPKNN-PPSLE--GN 221 (274)
T ss_pred ------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH---HHHHHhhhcC-CCCCc--cc
Confidence 123456788999999999989999999999999999999999999865432 2222222221 11111 12
Q ss_pred cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 243 ~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.++..+.+++.+||..+|++||+++++.+
T Consensus 222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 26889999999999999999999887754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=284.68 Aligned_cols=322 Identities=22% Similarity=0.255 Sum_probs=225.6
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecC---CCC-chhHHHHHHHHHHHcCCCCCCeeEEeee-------
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS---GTK-HPQLLYEAKVYKILQGGSGIPNIKWYGV------- 73 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~------- 73 (414)
..+.|.-..+||+|.||+||+|+...+|+.||+|++-. .+. ....++|++++..|.|.+.+..+..+..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 34678888999999999999999999999999995332 222 2346899999999988655444432221
Q ss_pred eCCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 74 DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 74 ~~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
+....++||.+|..+|..++.....+++..++..++.+++.||.|+|...|+|||+|++|+|| +.++.+||+|||+|
T Consensus 95 ~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilklADFGla 171 (376)
T KOG0669|consen 95 DRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILKLADFGLA 171 (376)
T ss_pred ccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEEeeccccc
Confidence 223479999999999999988656789999999999999999999999999999999999999 58899999999999
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (414)
+.+.......... ....+.|.+|++||.++|.. |+++.|||..|||+.||++|++.|++.++....+.+..+|...
T Consensus 172 r~fs~~~n~~kpr---ytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 172 RAFSTSKNVVKPR---YTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred cceecccccCCCC---cccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 8876554332221 23456699999999999874 9999999999999999999999999988776666666555533
Q ss_pred cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCccccc--cccccchhhhccccccCCCC
Q 015041 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDW--TILKYQQTQKTKSQDLLPAS 310 (414)
Q Consensus 233 ~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw--~~l~~~~~~~~~~~~~l~~~ 310 (414)
.. ++.+ ++ +-..++.. +...|--.-.+..+.+.++.+ .. .++..|. .++++||++|+.+.+++.|.
T Consensus 249 tk---evWP-~~--d~lpL~~s-ie~ePl~~~~~rkv~n~~kp~----~k-d~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 249 TK---EVWP-NV--DNLPLYQS-IELEPLPKGQKRKVKNRLKPY----VK-DDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred Cc---ccCC-Cc--ccchHHHh-ccCCCCCcchhhhhhhhcccc----cC-ChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 22 1111 00 00112221 222332222233333333311 11 1112221 77999999999999999999
Q ss_pred ccccCCCcc-ccchh-----hhhhHHhhccCCCCCCCcccc
Q 015041 311 RVTNSRVMP-MRTDK-----LKEVLECRGSYNRTRPDADMQ 345 (414)
Q Consensus 311 ~~~~~~~~~-~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 345 (414)
||-. .++| .+... .+...|.++.+++.+.....|
T Consensus 317 ~F~k-dp~pqanl~~ml~t~~~s~fey~~~~~~~~~~~~~q 356 (376)
T KOG0669|consen 317 FFWK-DPMPQANLQDMLSTHLQSMFEYLAQPRRSNQMRNYQ 356 (376)
T ss_pred hhhc-CCcchhhHHHHHHHhHHHHHHHhcCcchhhhhhhHH
Confidence 8753 3333 33222 234677777766655544433
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=291.91 Aligned_cols=248 Identities=22% Similarity=0.319 Sum_probs=197.3
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
.++|++.+.||.|+||.||+|.+..+++.||+|.+..... ...+..|+.+++.+.| +++..+..++......++|||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCEEEEeec
Confidence 3789999999999999999999988999999998765432 3456788898888865 566666666677788999999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
|+ +++|.+++.. ..++...+..++.|++.||.|||+.||+||||||+|||+ +.++.++|+|||++........
T Consensus 97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~~~~~- 170 (297)
T cd06656 97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS- 170 (297)
T ss_pred ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccceEccCCcc-
Confidence 99 7888888753 458899999999999999999999999999999999999 5788999999999876433221
Q ss_pred ccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhh
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~ 242 (414)
......++..|+|||.+.+..++.++|+|||||++|++++|..||.+..... ....+... ..+......
T Consensus 171 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~---~~~~~~~~--~~~~~~~~~ 239 (297)
T cd06656 171 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYLIATN--GTPELQNPE 239 (297)
T ss_pred ------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch---heeeeccC--CCCCCCCcc
Confidence 1124567889999999999889999999999999999999999997643321 11111111 111111123
Q ss_pred cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 243 ~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+..+.+++.+||..+|++||++.++.+
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 45788999999999999999999887654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=293.06 Aligned_cols=245 Identities=22% Similarity=0.303 Sum_probs=210.1
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
+|-..+|.++..||+|+||.|.+|....+.+.+|||+++++... +--..|-++|.....++.+..+..++..-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 45567899999999999999999999999999999998876422 1234566777666667777777888888899
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
+|+||||+ ||+|-..+.. -++|.+..+..++.+|+-||-+||++|||+||||.+|||+ +..+++||+|||+++..
T Consensus 425 LyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeeccccccc
Confidence 99999999 8888777665 4678999999999999999999999999999999999999 69999999999999865
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCc
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p 236 (414)
.-... ..++++||+-|+|||++...+|+..+|+||+|++||||+.|++||.|.++ .+.+..|.+.+...|
T Consensus 501 i~~~~-------TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE---~elF~aI~ehnvsyP 570 (683)
T KOG0696|consen 501 IFDGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQAIMEHNVSYP 570 (683)
T ss_pred ccCCc-------ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHccCcCc
Confidence 43322 23589999999999999999999999999999999999999999999654 466777888888877
Q ss_pred hHHhhhcChHHHHHHHHHHhcCCCCCCCCh
Q 015041 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 237 ~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~ 266 (414)
++++.+...++...+...|.+|...
T Consensus 571 -----KslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 571 -----KSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred -----ccccHHHHHHHHHHhhcCCccccCC
Confidence 5668899999999999999999753
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=291.69 Aligned_cols=250 Identities=21% Similarity=0.308 Sum_probs=199.0
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+..|+++++.+.| ++++.+...+......+++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH-PFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCC-CCchhheeeeecCCEEEEE
Confidence 4799999999999999999999989999999988765322 347789999999985 6677777777788889999
Q ss_pred Eecc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 82 LDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
|||+ +++|.+++... ...+++..++.++.|++.||+|||+.|++|+||||+||++ +.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE---cCCCCEEEeecchhhccccc
Confidence 9998 78999988753 3568999999999999999999999999999999999999 47889999999998754322
Q ss_pred CCCccc----------------------cccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCh
Q 015041 160 TTNRHI----------------------PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 217 (414)
Q Consensus 160 ~~~~~~----------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~ 217 (414)
...... .-.......||..|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110000 0001124578999999999999999999999999999999999999998754
Q ss_pred hhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCCh
Q 015041 218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~ 266 (414)
.. ..+.++.......+.. ...++.+.+++.+||..+|++||+.
T Consensus 237 ~~---~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~s~ 279 (316)
T cd05574 237 RD---ETFSNILKKEVTFPGS---PPVSSSARDLIRKLLVKDPSKRLGS 279 (316)
T ss_pred hH---HHHHHHhcCCccCCCc---cccCHHHHHHHHHHccCCHhHCCCc
Confidence 32 3344444433333321 1257899999999999999999993
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=290.14 Aligned_cols=206 Identities=22% Similarity=0.313 Sum_probs=167.6
Q ss_pred ceEEecceeecCceeEEEEEECC--CCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeC--Cee
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVD--TNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDG--EDN 78 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~--~~~ 78 (414)
+|++.++||+|+||.||+|.+.. ++..||+|.+... .....+.+|+.+++.+.| +++..+..++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH-ENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCC-CCccceEEEEeCCCCceE
Confidence 58999999999999999999987 8899999988763 233457789999999986 5566665555555 779
Q ss_pred EEEEeccCCCHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEcc-CCCCCeEEEeeecce
Q 015041 79 VLVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL-GRKANQVYIIDFGLA 153 (414)
Q Consensus 79 ~lv~e~~~~sL~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~-~~~~~~vkL~DFG~a 153 (414)
++||||+++++.+++.... ..++...++.++.||+.||.|||+++|+||||||+|||++. ++..+.+||+|||++
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999999989988876432 25889999999999999999999999999999999999952 112889999999999
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChh
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~ 218 (414)
......... ........++..|+|||++.+. .++.++|||||||++|+|++|..||.+...
T Consensus 160 ~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 160 RLFNAPLKP----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred cccCCCccc----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 865433221 1122355778999999988764 589999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=281.26 Aligned_cols=244 Identities=20% Similarity=0.319 Sum_probs=192.1
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-CCC
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~~s 88 (414)
++||+|+||.||+|.. .++..||+|++...... ..+.+|+.+++.+.| +++..+..++......++||||+ +++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDH-PNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCC-CCcCeEEEEEecCCccEEEEECCCCCc
Confidence 4789999999999985 46788999987765432 347789999999865 66666766677777899999998 888
Q ss_pred HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcccccc
Q 015041 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168 (414)
Q Consensus 89 L~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 168 (414)
|.+++......+++..++.++.|++.||.|||++|++|+||||+||++ +.++.++|+|||++.........
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~------ 149 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYS------ 149 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceeccccccc------
Confidence 988877655668999999999999999999999999999999999999 47889999999998753322110
Q ss_pred CCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHH
Q 015041 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE 247 (414)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~ 247 (414)
......++..|+|||++.+..++.++|||||||++|++++ |..||.+........ .+ ....... ....+|..
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~---~~-~~~~~~~---~~~~~~~~ 222 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE---QV-EKGYRMS---CPQKCPDD 222 (250)
T ss_pred cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH---HH-HcCCCCC---CCCCCCHH
Confidence 1112234567999999998889999999999999999998 999998764432222 22 2221111 12345789
Q ss_pred HHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 248 FASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 248 ~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
+.+++.+||..+|++||++.++.+.|.
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=281.64 Aligned_cols=252 Identities=18% Similarity=0.199 Sum_probs=204.8
Q ss_pred CCceEEe-cceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeee----eCCeeEE
Q 015041 6 GVKYKLG-RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV----DGEDNVL 80 (414)
Q Consensus 6 ~~~y~i~-~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~----~~~~~~l 80 (414)
-.+|++- ++||-|-.|.|..+.++.||+.+|+|++.... ...+|+++.-....|++|+.+..... ..+...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~---KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi 136 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP---KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI 136 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH---HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence 3566665 47999999999999999999999999876543 46789988877888888887754332 3345689
Q ss_pred EEecc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 81 VLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 81 v~e~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
|||.+ ||.|...+...+ ..|++.++..|+.||+.|+.|||+.+|.||||||+|+|.+....+..+||+|||+|+....
T Consensus 137 VmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 137 VMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred eeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 99999 888888887644 4599999999999999999999999999999999999998777788899999999987553
Q ss_pred CCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhch-HHHHHHHHhhccCCch
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK-KQKYDKICEKKVSTPI 237 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~-~~~~~~i~~~~~~~p~ 237 (414)
+.. ..+.+-|+.|.|||++....|+..+|+||+||++|-|++|.+||........ ...-.+|....+.+|.
T Consensus 217 ~~~--------L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~ 288 (400)
T KOG0604|consen 217 PGD--------LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE 288 (400)
T ss_pred Ccc--------ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence 322 2366779999999999999999999999999999999999999986543221 1223455566667775
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
++ +...++..+++|+.+|..+|.+|.+.+++
T Consensus 289 pE-Ws~VSe~aKdlIR~LLkt~PteRlTI~~~ 319 (400)
T KOG0604|consen 289 PE-WSCVSEAAKDLIRKLLKTEPTERLTIEEV 319 (400)
T ss_pred hh-HhHHHHHHHHHHHHHhcCCchhheeHHHh
Confidence 54 35668899999999999999999997655
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=291.25 Aligned_cols=253 Identities=21% Similarity=0.336 Sum_probs=200.8
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
+-.++|++.+.||+|+||+||+|.+..+++.||||.+..... ...+..|+.++..+..+++++.+..++......++
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 345789999999999999999999988899999999875432 23456677777777667888888888888889999
Q ss_pred EEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 81 v~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
+|||+++++.+++......+++..+..++.|++.||.|||+ .||+||||+|+||++ +.++.++|+|||++......
T Consensus 92 v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 92 CMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred EeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchhccCC
Confidence 99999988988887766789999999999999999999997 599999999999999 57889999999998765432
Q ss_pred CCCccccccCCCCCccCcCccccccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIE----QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
... ....++..|+|||.+.+.. ++.++|||||||++|+|++|+.||..... ..+.+..+.......
T Consensus 169 ~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~ 238 (296)
T cd06618 169 KAK--------TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT--EFEVLTKILQEEPPS 238 (296)
T ss_pred Ccc--------cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh--HHHHHHHHhcCCCCC
Confidence 211 1335678899999987654 78999999999999999999999976322 122333333322111
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
. + ....+++++.+++.+||..+|++||+++++.+
T Consensus 239 ~-~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 239 L-P-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred C-C-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 1 11245789999999999999999999988765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=301.10 Aligned_cols=256 Identities=22% Similarity=0.332 Sum_probs=209.0
Q ss_pred CceEEecceeecCceeEEEEEECC--C--CceEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVD--T--NEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~--~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
...++.++||.|-||.||+|.... . .--||||.-+.+. ..+.|+.|..+++.+.| ++|..+.+.+. ....+
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdH-phIikLIGv~~-e~P~W 466 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDH-PHIIKLIGVCV-EQPMW 466 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCC-cchhheeeeee-cccee
Confidence 344567789999999999998752 2 3358889877654 34568999999999987 55555655553 35689
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
||||++ .|.|..++......++......++.||+.||.|||++++|||||..+|||+. ....|||+|||+++...+
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs---Sp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS---SPQCVKLADFGLSRYLED 543 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec---Ccceeeecccchhhhccc
Confidence 999999 8889999988778899999999999999999999999999999999999995 788999999999997766
Q ss_pred CCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
.... ......-.+.|||||-+.-..++.++|||-|||++||++. |..||++.++.+..-.+ +..-+.|.
T Consensus 544 ~~yY------kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i----EnGeRlP~ 613 (974)
T KOG4257|consen 544 DAYY------KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI----ENGERLPC 613 (974)
T ss_pred cchh------hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe----cCCCCCCC
Confidence 5432 2223344678999999999999999999999999999997 99999998765433332 34444454
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
+ .++|+.+..++.+||..+|.+||.|.+|+..|.+++..+
T Consensus 614 P---~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 614 P---PNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred C---CCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 4 456999999999999999999999999999999998743
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=289.93 Aligned_cols=266 Identities=26% Similarity=0.321 Sum_probs=211.3
Q ss_pred CCcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHH--HcCCCCCCeeEEeeee----
Q 015041 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKI--LQGGSGIPNIKWYGVD---- 74 (414)
Q Consensus 1 ~~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~--l~~~~~i~~l~~~~~~---- 74 (414)
++|.|+++.++.+.||+|.||+||+|.| .|+.||||++.+.. +..+.+|.++++. |+| ++|-.+......
T Consensus 205 VQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd-E~SWfrEtEIYqTvmLRH-ENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 205 VQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD-ERSWFRETEIYQTVMLRH-ENILGFIAADNKDNGS 280 (513)
T ss_pred hHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc-hhhhhhHHHHHHHHHhcc-chhhhhhhccccCCCc
Confidence 4688999999999999999999999999 58889999998754 4567778777764 556 444444322221
Q ss_pred CCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-----c---CeeccccCCCceEEccCCCCCeE
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-----R---GFLHRDIKPDNFLMGLGRKANQV 145 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-----~---~iiHrDLkp~Nili~~~~~~~~v 145 (414)
-...++|.+|. .|+|.|++.. ..++....++++..++.||++||. + .|.|||||..|||+ .+++.+
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C 355 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTC 355 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCcE
Confidence 24579999998 8999999984 679999999999999999999994 2 49999999999999 599999
Q ss_pred EEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCC-----C-CchhhHHHHHHHHHHHHcC----------
Q 015041 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-----Q-SRRDDLESLGYVLLYFLRG---------- 209 (414)
Q Consensus 146 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~-s~~~DiwSlG~il~el~tG---------- 209 (414)
.|+|+|+|...........++ ....+||.+|||||++...- . =..+||||||.++||++..
T Consensus 356 ~IADLGLAv~h~~~t~~idi~---~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDTDTIDIP---PNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred EEeeceeeEEecccCCcccCC---CCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 999999998876654333232 23678999999999986431 1 2468999999999999863
Q ss_pred CCCCCCChh--hchHHHHHHHHhhccCCchHHhhhcCh--HHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 210 SLPWQGLKA--ATKKQKYDKICEKKVSTPIEVLCKSHP--AEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 210 ~~Pf~~~~~--~~~~~~~~~i~~~~~~~p~~~~~~~~p--~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
++||.+..+ ...++...-++..+++++++..+++.| ..+.++|+.||..+|..|.++-.|++.|.++.+
T Consensus 433 ~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 433 QLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 688887532 234445555677888888877777666 468999999999999999999999999988764
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=285.41 Aligned_cols=248 Identities=18% Similarity=0.258 Sum_probs=186.2
Q ss_pred cceeecCceeEEEEEECC--CCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-C
Q 015041 13 RKIGSGSFGEIFLASHVD--TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 86 (414)
++||+|+||.||+|.... ....+|+|.+..... ...+.+|+.+++.+.| +++..+...+......++||||+ +
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h-~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNH-PNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCC-CCcceEEEEECCCCceEEEEEeCCC
Confidence 469999999999997532 345788887654332 2346789999988875 56666666666778899999999 7
Q ss_pred CCHHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 87 PSLEDLFVYCRR----KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 87 ~sL~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
++|.+++..... .+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccchhe
Confidence 899998875432 24677889999999999999999999999999999999 57889999999998653221110
Q ss_pred ccccccCCCCCccCcCcccccccc-------CCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHH-HHhhcc
Q 015041 163 RHIPYRENKNLTGTARYASCNTHL-------GIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDK-ICEKKV 233 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~-i~~~~~ 233 (414)
.......++..|+|||++. ...++.++|||||||++|||++ |..||....... .+.. +.....
T Consensus 157 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~~~~~~~~ 228 (269)
T cd05042 157 -----ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VLKQVVREQDI 228 (269)
T ss_pred -----eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHHhhccCc
Confidence 0112334577899999874 3457889999999999999999 889998754332 2222 222233
Q ss_pred CCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 015041 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (414)
Q Consensus 234 ~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l 273 (414)
..+.+.....+++.+.+++..|| .+|++||+++++.+.|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 229 KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 33334444567889999999999 5999999999988765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=287.39 Aligned_cols=251 Identities=19% Similarity=0.301 Sum_probs=195.0
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeee-----CCeeE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVD-----GEDNV 79 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~-----~~~~~ 79 (414)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+..|+.++..+.+|+++..+..++.. ....+
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 478999999999999999999999999999999886543 234577899999998666777777655442 24589
Q ss_pred EEEecc-CCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 80 LVLDLL-GPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
+||||+ +++|.+++.. ....+++..++.++.|++.||+|||+.+|+|+||||+||++ +.++.++|+|||++..
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili---~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL---TTEGGVKLVDFGVSAQ 177 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEeecccchh
Confidence 999999 7799888763 24568999999999999999999999999999999999999 4788899999999875
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHh
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~ 230 (414)
....... .....|+..|+|||++... .++.++|||||||++|||++|+.||...... ..+.++..
T Consensus 178 ~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~---~~~~~~~~ 247 (291)
T cd06639 178 LTSTRLR-------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV---KTLFKIPR 247 (291)
T ss_pred ccccccc-------ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH---HHHHHHhc
Confidence 4332211 1234678999999997643 3689999999999999999999999875432 22222222
Q ss_pred hccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 231 ~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.... .. ......+..+.+++.+||..+|++||++.++..
T Consensus 248 ~~~~-~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 248 NPPP-TL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCC-CC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111 00 011234578999999999999999999887754
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=286.19 Aligned_cols=255 Identities=21% Similarity=0.246 Sum_probs=195.3
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
++|++.+.||.|++|+||+|.+..+++.||+|.+..... ...+.+|+++++.+.| +++..+..++......++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH-GNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccC-CCEeeEEEEEecCCeEEEEE
Confidence 579999999999999999999998999999998764322 2457789999999976 66777777777888999999
Q ss_pred eccCCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 83 DLLGPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 83 e~~~~sL~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
||++++|.+.+..... .++...+..++.||+.||+|||+++|+|+||+|+||+++ ...+.+||+|||++........
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~--~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 81 EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID--RRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred ecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE--CCCCEEEEcccccccccCCCcc
Confidence 9998888888765332 367888999999999999999999999999999999994 2456799999999975432211
Q ss_pred CccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc--------
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK-------- 232 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~-------- 232 (414)
......++..|+|||++.+. .++.++|||||||++|+|++|..||...................
T Consensus 159 -------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 159 -------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred -------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccc
Confidence 11234568899999998764 57899999999999999999999998754432222111110000
Q ss_pred -------------cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 233 -------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 233 -------------~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
............++++.+++.+|+..+|++||++.++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000111122345788999999999999999999887654
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=287.27 Aligned_cols=255 Identities=22% Similarity=0.300 Sum_probs=199.1
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
++|++.++||+|+||.||+|.+..+++.||+|.+.... ....+..|+++++.+.| +++..+..++......+++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRH-ENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCC-CCeeehhheEEECCEEEEEE
Confidence 47999999999999999999999999999999876432 23467899999999985 56666666666788899999
Q ss_pred eccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 83 e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
||+.+++.+.+......++...+..++.||+.||.|||+.+|+|+||+|+||++ ++++.++|+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccCCCccc
Confidence 999777777666555679999999999999999999999999999999999999 57899999999998765543321
Q ss_pred ccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhh----------
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK---------- 231 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~---------- 231 (414)
......++..|+|||++.+. .++.++||||||+++|+|++|..||.+....+.......+...
T Consensus 157 ------~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 157 ------PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred ------cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence 11245678899999999888 7899999999999999999999999875433222221111100
Q ss_pred --------ccCCc-----hH-HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 232 --------KVSTP-----IE-VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 232 --------~~~~p-----~~-~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
....+ .+ .....++.++.+++..||..+|++||++.++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 00 111223788999999999999999999887643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=282.68 Aligned_cols=246 Identities=21% Similarity=0.289 Sum_probs=198.2
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+..|+++++.+.| +++..+..........++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSH-PNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCC-CchhheeeeEecCCEEEEEEe
Confidence 6999999999999999999999999999999876542 23457889999999976 556666666667788999999
Q ss_pred cc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 84 LL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
|+ +++|.+++.... ..+++..++.++.|++.||+|||++||+|+||||+||+++ +..+.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCcc
Confidence 99 779999887543 4589999999999999999999999999999999999995 3456789999999986543321
Q ss_pred CccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhh
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~ 241 (414)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||.+.... .....+...... + ..
T Consensus 158 --------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~-~---~~ 222 (256)
T cd08220 158 --------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVLKIMSGTFA-P---IS 222 (256)
T ss_pred --------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHHHHHhcCCC-C---CC
Confidence 12456788999999999888999999999999999999999999875432 222232222111 1 12
Q ss_pred hcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 242 ~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..++.++.+++..||..+|++||++.++..
T Consensus 223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 345789999999999999999999987754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=301.86 Aligned_cols=283 Identities=23% Similarity=0.300 Sum_probs=217.5
Q ss_pred CCcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCC-----CCCCeeEEeeee
Q 015041 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGG-----SGIPNIKWYGVD 74 (414)
Q Consensus 1 ~~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~-----~~i~~l~~~~~~ 74 (414)
+|+++.++|.+....|+|-|++|..|.+..-|..|||||+.... .++.-+.|+++|++|+.. .++..+.-.+..
T Consensus 426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 47899999999999999999999999999999999999988764 344567899999999743 233344444557
Q ss_pred CCeeEEEEeccCCCHHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecc
Q 015041 75 GEDNVLVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (414)
Q Consensus 75 ~~~~~lv~e~~~~sL~~~~~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~ 152 (414)
.+++|||+|.+..+|.+++...+.. +....+..++.|+..||..|-.+||+|+||||+||||. .....+||||||.
T Consensus 506 knHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~k~iLKLCDfGS 583 (752)
T KOG0670|consen 506 KNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ESKNILKLCDFGS 583 (752)
T ss_pred cceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cCcceeeeccCcc
Confidence 7899999999999999999976654 78899999999999999999999999999999999995 4566789999999
Q ss_pred eeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc
Q 015041 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (414)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (414)
|........ . .+..+..|+|||+++|.+|+...|+||+||+|||+.||+..|.|.++. +.+.-.++.+
T Consensus 584 A~~~~enei---t------PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN---~MLrl~me~K 651 (752)
T KOG0670|consen 584 ASFASENEI---T------PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN---QMLRLFMELK 651 (752)
T ss_pred ccccccccc---c------HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH---HHHHHHHHhc
Confidence 976544332 2 334477899999999999999999999999999999999999996554 3344444556
Q ss_pred cCCchHHhhhcC---------------------------------h-HHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 233 VSTPIEVLCKSH---------------------------------P-AEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 233 ~~~p~~~~~~~~---------------------------------p-~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
..+|...+.++. | ..+...+..|-.+ |++-|. ++..|++++.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~-~deq~~---~~~~~rdLLd 727 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRL-PDEQPK---IVQQLRDLLD 727 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCC-CchhHH---HHHHHHHHHH
Confidence 666644443221 2 2333333333222 222222 2333444432
Q ss_pred hcCCCCCccccccccccchhhhccccccCCCCccc
Q 015041 279 REGYDFDFVFDWTILKYQQTQKTKSQDLLPASRVT 313 (414)
Q Consensus 279 ~~~~~~~~~~dw~~l~~~~~~~~~~~~~l~~~~~~ 313 (414)
.|+..+|++|.+-.++|.||++.
T Consensus 728 ------------kml~LdP~KRit~nqAL~HpFi~ 750 (752)
T KOG0670|consen 728 ------------KMLILDPEKRITVNQALKHPFIT 750 (752)
T ss_pred ------------HHhccChhhcCCHHHHhcCCccc
Confidence 67888999999999999999875
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=287.33 Aligned_cols=246 Identities=22% Similarity=0.319 Sum_probs=199.2
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
...|+..++||.|+||.||+|.+..++..||+|++..... ...+.+|+.+++.+.| ++++.+..++.+....++||
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCEEEEEE
Confidence 3568899999999999999999988899999998775432 2357789999998865 66777777777888999999
Q ss_pred ecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
||+ +++|.+++. ...++...+..++.|++.||+|||+.+++|+||+|+||++ +.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~i~--~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 82 EYLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred ecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE---cCCCCEEEcccccceeccCCcc
Confidence 999 778888876 3568999999999999999999999999999999999999 4788899999999976543221
Q ss_pred CccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhh
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~ 241 (414)
......++..|+|||++.+..++.++|+|||||++|||++|..||........ ...+ ..... +...
T Consensus 157 -------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~~-~~~~~---~~~~ 222 (277)
T cd06640 157 -------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV---LFLI-PKNNP---PTLT 222 (277)
T ss_pred -------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH---hhhh-hcCCC---CCCc
Confidence 11245678899999999988899999999999999999999999987543221 1111 11111 1222
Q ss_pred hcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 242 ~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+|..+.+++..||..+|++||++.++..
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 345788999999999999999999988755
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=289.38 Aligned_cols=258 Identities=20% Similarity=0.289 Sum_probs=200.1
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
.+|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+..|+.+++.+.| ++++.+...+....+.++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN-PFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCC-CCeeeeEEEEecCCEEEEE
Confidence 479999999999999999999999999999998765432 2346688899988875 5666776667777889999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++.. ...+++..+..++.|++.||.|||+.+|+||||||+||++ +..+.++|+|||+++......
T Consensus 80 ~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 80 MEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccCcCc
Confidence 9999 7789888865 4568999999999999999999999999999999999999 478899999999987422111
Q ss_pred CCcc--------ccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc
Q 015041 161 TNRH--------IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (414)
Q Consensus 161 ~~~~--------~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (414)
.... ..........++..|+|||.+.+..++.++|+|||||++|||++|..||.+.... +.+..+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---~~~~~~~~~~ 232 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFGQVISDD 232 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcc
Confidence 1000 0000112346788999999999889999999999999999999999999875432 2333333322
Q ss_pred cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 233 ~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
...+.. ...+|.++.+++.+||..+|++||+...+.+.+.
T Consensus 233 ~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 233 IEWPEG--DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred cCCCCc--cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 222221 1246889999999999999999999765555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=289.59 Aligned_cols=262 Identities=24% Similarity=0.261 Sum_probs=193.9
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeee-------
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV------- 73 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~------- 73 (414)
.-++|++.++||.|+||.||+|.+..+++.||||.+..... ...+.+|+++++.++|.+ +..+..+..
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPN-VVPLIDMAVERPDKSK 84 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCC-ccchhhheeccccccc
Confidence 35899999999999999999999999999999997754322 234678999999998754 444433322
Q ss_pred -eCCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecc
Q 015041 74 -DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (414)
Q Consensus 74 -~~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~ 152 (414)
.....++|++|+..++...+......+++..++.++.|++.||+|||++||+|+||||+||++ +.++.++|+|||+
T Consensus 85 ~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~ 161 (311)
T cd07866 85 RKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFGL 161 (311)
T ss_pred ccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcCcc
Confidence 233579999999988888877655679999999999999999999999999999999999999 5888999999999
Q ss_pred eeeecCCCCCccc----cccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHH
Q 015041 153 AKKYRDPTTNRHI----PYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (414)
Q Consensus 153 a~~~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~ 227 (414)
++........... .........++..|+|||++.+. .++.++|||||||++|||++|..||.+.......+.+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9765432221110 01112345678899999988754 489999999999999999999999987655433333222
Q ss_pred HHhhc----------------------cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 228 ICEKK----------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 228 i~~~~----------------------~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
..... .............+.+.+++.+|+..+|.+||++.++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell 306 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHh
Confidence 21110 00001111123446788899999999999999877653
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=288.85 Aligned_cols=247 Identities=21% Similarity=0.301 Sum_probs=198.2
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
....+|++.++||+|+||+||+|.+..+++.||+|.+..... ...+.+|+++++.+.| +++..+..++......
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~~~~~~~~~~~~ 90 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH-PNTIEYKGCYLREHTA 90 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEEeCCeE
Confidence 345789999999999999999999988999999998764321 1347789999999975 6666776777777889
Q ss_pred EEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 79 ~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
++|+||+.+++.+++......+++..+..++.|++.||.|||+.||+|+||+|+||++ +.++.++|+|||++.....
T Consensus 91 ~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 91 WLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASLVSP 167 (307)
T ss_pred EEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCcceecCC
Confidence 9999999999988887666779999999999999999999999999999999999999 5788999999999865322
Q ss_pred CCCCccccccCCCCCccCcCcccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
. ....++..|+|||++. ...++.++||||||+++|||++|..||.+..... ....+......
T Consensus 168 ~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~- 232 (307)
T cd06607 168 A-----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHIAQNDSP- 232 (307)
T ss_pred C-----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH---HHHHHhcCCCC-
Confidence 1 2456788999999985 3458899999999999999999999998754322 12222111111
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
......++.++.+++..||..+|++||++.++..
T Consensus 233 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 233 --TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred --CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 1111235788999999999999999999888754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=282.87 Aligned_cols=252 Identities=19% Similarity=0.285 Sum_probs=196.4
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--------chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
+|++.+.||.|+||+||+|.+ .+++.||+|.+..... ...+.+|+.+++.+.| .+++.+..++......+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH-VNIVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCC-CCEeeEeeEeecCCeEE
Confidence 588999999999999999986 4788999998764421 1347789999999976 56666767777778899
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
+++||+ +++|.+++.. ...++...+..++.|++.||+|||+.+|+|+||+|+||++ +.++.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 79 IFMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHhhhh
Confidence 999999 7899888865 3568899999999999999999999999999999999999 5788999999999875432
Q ss_pred CCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
...... .........|+..|+|||++.+..++.++|||||||++|+|++|..||........ ...+.... .+.+
T Consensus 155 ~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~~~~~~~--~~~~ 228 (265)
T cd06631 155 VGLHGT-HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA---MFYIGAHR--GLMP 228 (265)
T ss_pred cccccc-ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH---HHHhhhcc--CCCC
Confidence 111100 00112345689999999999998899999999999999999999999986543221 11111111 1112
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.....++.++.+++..||..+|++||++.++..
T Consensus 229 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 233456889999999999999999999887643
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=285.76 Aligned_cols=234 Identities=25% Similarity=0.337 Sum_probs=180.1
Q ss_pred ceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHc--CCCCCCeeEEeeeeCCeeEEEEecc-
Q 015041 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLVLDLL- 85 (414)
Q Consensus 14 ~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~--~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (414)
.||+|+||.||+|.+..++..||+|.+..... ......|..++..+. ++++++.+.......+..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999999999999998765321 122345555554443 3456666666666777899999999
Q ss_pred CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccc
Q 015041 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (414)
Q Consensus 86 ~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 165 (414)
+++|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+|||+ +.++.++|+|||++........
T Consensus 81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~~---- 152 (279)
T cd05633 81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP---- 152 (279)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceeccccCc----
Confidence 7888877764 4569999999999999999999999999999999999999 5788999999999875433211
Q ss_pred cccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcC
Q 015041 166 PYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (414)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 244 (414)
....||..|+|||.+.+ ..++.++|||||||++|+|++|..||......... ...... ...+ ..+...+
T Consensus 153 -----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~---~~~~-~~~~~~~ 222 (279)
T cd05633 153 -----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMT---LTVN-VELPDSF 222 (279)
T ss_pred -----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHh---hcCC-cCCcccc
Confidence 23468999999999874 56899999999999999999999999865433222 222211 1111 1123456
Q ss_pred hHHHHHHHHHHhcCCCCCCCC
Q 015041 245 PAEFASYFHYCQSLTFDQRPD 265 (414)
Q Consensus 245 p~~~~~l~~~c~~~~p~~RP~ 265 (414)
+.++.+++..||..+|.+||+
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~ 243 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLG 243 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcC
Confidence 789999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=288.46 Aligned_cols=254 Identities=22% Similarity=0.257 Sum_probs=196.0
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeC--CeeEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDG--EDNVL 80 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~--~~~~l 80 (414)
++|++.+.||.|+||.||+|.+..++..||+|.++..... ..+.+|+.++..+.| +++..+..+.... ...++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQH-PNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCC-CCEEEEEEEEEecCCCcEEE
Confidence 5799999999999999999999989999999987644322 235689999999985 6666666555544 78999
Q ss_pred EEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 81 v~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|+||+.++|.+++......+++..++.++.||+.||+|||++||+|+||||+||++ +.++.++|+|||++.......
T Consensus 84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceeeccCCc
Confidence 99999889999888756679999999999999999999999999999999999999 578899999999998765432
Q ss_pred CCccccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC-----
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS----- 234 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~----- 234 (414)
. ......++..|+|||.+.+.. ++.++|||||||++|+|++|..||...........+...+.....
T Consensus 161 ~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 161 K-------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred c-------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHH
Confidence 1 112345688999999987654 689999999999999999999999875543332222221110000
Q ss_pred --------------C---ch-HHhhhc-ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 235 --------------T---PI-EVLCKS-HPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 235 --------------~---p~-~~~~~~-~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
. .. ..+... .++.+.+++..||..+|++||++.++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 00 001111 3677889999999999999999877643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=284.43 Aligned_cols=252 Identities=21% Similarity=0.273 Sum_probs=196.1
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
+|++.++||.|++|.||+|++..++..||||.+..... ...+.+|+.+++.+.| ++++.+..++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKH-ENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcC-CCEeeeeeeEeeCCcEEEEEec
Confidence 58999999999999999999999999999998765432 3456789999999975 6777777777788889999999
Q ss_pred cCCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 85 LGPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 85 ~~~sL~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
+.++|.+++.... ..+++..+..++.|++.||+|||++||+|+||||+||++ +.++.++|+|||++........
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 80 MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred CCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCCcc-
Confidence 9889988877543 458999999999999999999999999999999999999 5788999999999875433211
Q ss_pred ccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC-------
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS------- 234 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~------- 234 (414)
......++..|++||++.+. .++.++|||||||++|+|++|..||.+....+....+.........
T Consensus 156 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 156 ------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred ------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence 11234568899999998764 5789999999999999999999999875443222222111100000
Q ss_pred --------C------chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 235 --------T------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 235 --------~------p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
. .........+..+.+++..|++.+|.+||++.++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l 279 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDAL 279 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHh
Confidence 0 00111224467888999999999999999987764
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=284.91 Aligned_cols=240 Identities=15% Similarity=0.185 Sum_probs=180.4
Q ss_pred cceeecCceeEEEEEECC------------CCceEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 13 RKIGSGSFGEIFLASHVD------------TNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~------------~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
+.||+|+||.||+|+... ....|++|++...... ..+..|+.++..+.| +++..+..++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~h-p~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSH-KHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCCC
Confidence 468999999999998542 2235889987654322 346778888888876 6677777777777788
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCC----CCCeEEEeeecce
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR----KANQVYIIDFGLA 153 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~----~~~~vkL~DFG~a 153 (414)
+++|||+ +++|..++......+++..++.++.||+.||+|||+++|+||||||+|||+.... ....++++|||++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 9999999 5667666655456689999999999999999999999999999999999995211 1123899999988
Q ss_pred eeecCCCCCccccccCCCCCccCcCcccccccc-CCCCCchhhHHHHHHHHHHHH-cCCCCCCCChhhchHHHHHHHHhh
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEK 231 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DiwSlG~il~el~-tG~~Pf~~~~~~~~~~~~~~i~~~ 231 (414)
...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||......... .....
T Consensus 160 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~----~~~~~ 224 (262)
T cd05077 160 ITVLSR-----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE----RFYEG 224 (262)
T ss_pred ccccCc-----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH----HHHhc
Confidence 654221 1345788999999887 466899999999999999998 589998764332211 11111
Q ss_pred ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 015041 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (414)
Q Consensus 232 ~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l 273 (414)
.... ....++++.+++.+||..+|++||++.+|.+.|
T Consensus 225 ~~~~-----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 QCML-----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CccC-----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1111 122357899999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=280.08 Aligned_cols=245 Identities=22% Similarity=0.334 Sum_probs=194.7
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-CCC
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~~s 88 (414)
++||.|+||.||+|.+.. ++.||+|....... ...+.+|+++++.+.| +++..+..++......++||||+ +++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDH-PNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 479999999999999877 89999998765443 2457889999999876 56667777777778899999998 788
Q ss_pred HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcccccc
Q 015041 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168 (414)
Q Consensus 89 L~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 168 (414)
|.+++......++...++.++.|++.||+|||+++++||||||+||++ +.++.++|+|||+++.........
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~----- 150 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTV----- 150 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCccee-----
Confidence 988887655678999999999999999999999999999999999999 578899999999987543211100
Q ss_pred CCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHH
Q 015041 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE 247 (414)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~ 247 (414)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+......... .......+. ....|.+
T Consensus 151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~----~~~~~~~~~---~~~~~~~ 223 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER----IESGYRMPA---PQLCPEE 223 (251)
T ss_pred ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH----HhcCCCCCC---CccCCHH
Confidence 0112233567999999998899999999999999999999 8999987654322222 222222221 1345789
Q ss_pred HHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 248 FASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 248 ~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
+.+++.+||..+|++||++.++.+.|+
T Consensus 224 ~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 224 IYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=286.46 Aligned_cols=240 Identities=18% Similarity=0.243 Sum_probs=183.5
Q ss_pred cceeecCceeEEEEEECCCCc-------eEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 13 RKIGSGSFGEIFLASHVDTNE-------IVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~-------~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
+.||.|+||.||+|.+...+. .||+|....... ...+..|+.+++.+.| +++..+..++..+...++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h-~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSH-KHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCC-CChhheeeEEEeCCCcEEEEe
Confidence 479999999999998865444 388887755432 2356778888888875 566667666677788999999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCC-----CCeEEEeeecceeeec
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK-----ANQVYIIDFGLAKKYR 157 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~-----~~~vkL~DFG~a~~~~ 157 (414)
|+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+||+++..+. ...++++|||++....
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 99 77898888765567899999999999999999999999999999999999962211 1237999999886433
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcC-CCCCCCChhhchHHHHHHHHhhccCC
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRG-SLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG-~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
.. ....++..|+|||++.+. .++.++|||||||++|||++| ..||......... .........
T Consensus 160 ~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~----~~~~~~~~~ 224 (258)
T cd05078 160 PK-----------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL----QFYEDRHQL 224 (258)
T ss_pred Cc-----------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH----HHHHccccC
Confidence 21 245678899999999874 589999999999999999998 4666654332211 122222222
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l 273 (414)
| ...+.++.+++..||+.+|++||++++|.+.|
T Consensus 225 ~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 225 P-----APKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred C-----CCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 2 23357899999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=279.66 Aligned_cols=249 Identities=20% Similarity=0.302 Sum_probs=197.0
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (414)
.+|++.+.||.|+||.||+|.+. ++..+|+|.+..... ...+..|+++++.+.| +++..+..++......++||||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSH-PKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCC-CCeeeEEEEEccCCceEEEEEcC
Confidence 58999999999999999999875 467899998775433 3568899999999976 55666666666777889999999
Q ss_pred -CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcc
Q 015041 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (414)
Q Consensus 86 -~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~ 164 (414)
+++|.+++......+++..++.++.|++.||+|||+.+++|+||||+||++ +.++.++|+|||+++........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~-- 156 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQYT-- 156 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecccCccc--
Confidence 788888887655678999999999999999999999999999999999999 47789999999998765332211
Q ss_pred ccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhhhc
Q 015041 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (414)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~ 243 (414)
......++..|+|||.+.+..++.++|||||||++|||++ |..||...... .....+.. ......+ ..
T Consensus 157 ----~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~-~~~~~~~---~~ 225 (256)
T cd05112 157 ----SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVETINA-GFRLYKP---RL 225 (256)
T ss_pred ----ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHhC-CCCCCCC---CC
Confidence 1122334678999999998889999999999999999998 99999864432 22222211 1111111 23
Q ss_pred ChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 015041 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (414)
Q Consensus 244 ~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l 273 (414)
.++.+.+++..||..+|++||++.++.+.|
T Consensus 226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 478999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=288.70 Aligned_cols=254 Identities=24% Similarity=0.285 Sum_probs=189.5
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeee--------
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVD-------- 74 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~-------- 74 (414)
++|++.++||+|+||.||+|.+..+++.||||.+..... ...+.+|+.+++.+.|.+.+ .+..++..
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVV-NLIEICRTKATPYNRY 90 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCcc-ceEEEEecccccccCC
Confidence 579999999999999999999999999999998754322 22356799999999875444 44433322
Q ss_pred CCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 75 ~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
....++||||++++|.+++......+++.+++.++.||+.||+|||+.|++|+||||+||++ +.++.+||+|||++.
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~ 167 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLADFGLAR 167 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEECcCCCcc
Confidence 23459999999999988887655578999999999999999999999999999999999999 578899999999998
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
.......... .......++..|+|||.+.+.. ++.++||||||+++|||++|..||.+.........+..++.
T Consensus 168 ~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~--- 241 (310)
T cd07865 168 AFSLSKNSKP---NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG--- 241 (310)
T ss_pred cccCCcccCC---CCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC---
Confidence 6644322110 1112446788999999887654 78999999999999999999999987654433333333221
Q ss_pred CCchHHh---------------------------hhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 234 STPIEVL---------------------------CKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 234 ~~p~~~~---------------------------~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
..+.+.. .......+.+++..||..+|.+||+++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l 305 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTAL 305 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHh
Confidence 1110000 001134566788888888888888876653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=292.92 Aligned_cols=259 Identities=20% Similarity=0.266 Sum_probs=198.4
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEee----eeCC
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYG----VDGE 76 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~----~~~~ 76 (414)
++.+|++.+.||.|+||.||+|.+..++..||+|.+.... ....+..|+.+++.+.| ++++.+..++ ....
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKH-DNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCC-CCccCHHHhccccCCCCc
Confidence 4689999999999999999999999999999999876542 22456789999999986 5555543322 2345
Q ss_pred eeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 77 DNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 77 ~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
..++||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 82 ~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 82 DVYVVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGL 157 (334)
T ss_pred eEEEEEehhhhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEecccccceee
Confidence 6899999998888888764 4558999999999999999999999999999999999999 58899999999999765
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHH--------
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK-------- 227 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~-------- 227 (414)
....... ........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.........+..
T Consensus 158 ~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 158 SSSPTEH---KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234 (334)
T ss_pred cccCcCC---CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence 4432211 011124578899999999866 4589999999999999999999999987543221111111
Q ss_pred ---------------HHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 228 ---------------ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 228 ---------------i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
........+........++++.+++..||+.+|++||++.++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 01111122223334556889999999999999999999887655
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=290.13 Aligned_cols=251 Identities=23% Similarity=0.258 Sum_probs=195.9
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEe-eeeCCeeE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWY-GVDGEDNV 79 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~-~~~~~~~~ 79 (414)
++++|++.+.||.|+||.||+|.+..+++.||||.+.... ....+..|+.+++.+.|+ ++..+..+ .......+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE-NIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCC-CeeeEeeeEecCCCcEE
Confidence 5789999999999999999999999999999999765422 234577899999999875 45555444 44466789
Q ss_pred EEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 80 lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
+++||++++|..++. ...++...+..++.|++.||.|||+++|+|+||+|+||++ +..+.++|+|||.+......
T Consensus 87 lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 87 FVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred EEeehhccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCccccccccCCC
Confidence 999999999888775 3468888999999999999999999999999999999999 57889999999998743221
Q ss_pred CCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHH----------
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI---------- 228 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i---------- 228 (414)
. ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.........+.+.
T Consensus 162 ~----------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 162 M----------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred c----------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 1 23467889999999876 56899999999999999999999999865432211111111
Q ss_pred -------------HhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 229 -------------CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 229 -------------~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.......+........++++.+++.+||..+|++||+++++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0111122333444566789999999999999999999887644
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=294.02 Aligned_cols=255 Identities=21% Similarity=0.236 Sum_probs=195.0
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeee-----C
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVD-----G 75 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~-----~ 75 (414)
++++|++.+.||.|+||+||+|.+..++..||||.+.... ....+..|+.+++.+.| +++..+..++.. .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDH-ENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCC-CCccchHHheeccccccc
Confidence 5689999999999999999999999999999999876432 22346789999999876 455544333322 1
Q ss_pred CeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 76 ~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
...++|+||++++|.+++.. ...++...+..++.|++.||.|||+++++||||||+||++ +.++.+||+|||+++.
T Consensus 82 ~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 82 NDVYIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLART 157 (337)
T ss_pred CcEEEEEeCCCCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcCccccc
Confidence 35799999999999888765 4569999999999999999999999999999999999999 5788999999999976
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHh----
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE---- 230 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~---- 230 (414)
...... ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 158 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (337)
T cd07858 158 TSEKGD-------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230 (337)
T ss_pred cCCCcc-------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 543221 1124567899999999875 4589999999999999999999999986533221111111110
Q ss_pred -------------------hccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 231 -------------------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 231 -------------------~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.....+.......++.++.+++.+||..+|.+||+++++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~ 290 (337)
T cd07858 231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290 (337)
T ss_pred HHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence 00111112223456788999999999999999999887765
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=283.03 Aligned_cols=255 Identities=21% Similarity=0.272 Sum_probs=201.1
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
++|++++.||.|+||+||+|.+..++..||+|++.... ....+.+|+++++.+.| ++++.+..........++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNH-PNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCC-CCEEEEEEEEeeCCEEEEEEe
Confidence 47999999999999999999998889999999886543 23457889999998876 556666666677888999999
Q ss_pred cc-CCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 84 LL-GPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
++ +++|.+++.... ..+++..+..++.|++.||+|||+.||+|+||+|+||++ ++++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccchHHHhccCc
Confidence 99 788998887542 468999999999999999999999999999999999999 477899999999987655433
Q ss_pred CCccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC-CchH
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS-TPIE 238 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~-~p~~ 238 (414)
... ........|+..|+|||++... .++.++|+|||||++|+|++|+.||...... +.+.++...... .+..
T Consensus 157 ~~~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~ 230 (267)
T cd06610 157 DRT---RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM---KVLMLTLQNDPPSLETG 230 (267)
T ss_pred ccc---ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh---hhHHHHhcCCCCCcCCc
Confidence 211 0122355789999999998877 7899999999999999999999999875443 222222222111 1111
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.....+++++.+++..||..+|++||++.+|.+
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111356789999999999999999999887654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=283.98 Aligned_cols=252 Identities=19% Similarity=0.241 Sum_probs=193.1
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
+|++++.||.|+||.||+|.+..++..||||.+..... ...+..|+++++.++| +++..+..++......++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-PNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCC-CCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999999999999998765432 2357889999999976 556666666667788999999
Q ss_pred ccCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 84 LLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 84 ~~~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
|+.++|..++.... ..+++..++.++.|++.||+|||+.+++|+||+|+||++ +.++.++|+|||++........
T Consensus 80 ~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 80 FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred ccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcccCcc-
Confidence 99888888876543 468999999999999999999999999999999999999 5788999999999875432211
Q ss_pred ccccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc---------
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK--------- 232 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (414)
......++..|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.........+.....
T Consensus 156 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 156 ------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred ------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence 112335678999999987654 6889999999999999999999998754332221111110000
Q ss_pred ------------cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 233 ------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 233 ------------~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
...........++.++.+++.+||..+|.+||+++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 279 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAAL 279 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 00001111234567788999999999999999987664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=282.84 Aligned_cols=251 Identities=21% Similarity=0.259 Sum_probs=194.5
Q ss_pred eEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHc--CCCCCCeeEEeeeeCCe-----
Q 015041 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQ--GGSGIPNIKWYGVDGED----- 77 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~--~~~~i~~l~~~~~~~~~----- 77 (414)
|++.+.||.|+||.||+|++..++..||+|.+...... ..+.+|+.+++.+. .|+++..+..++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 78999999999999999999888999999988754322 24567888888775 35667777666655554
Q ss_pred eEEEEeccCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 78 NVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 78 ~~lv~e~~~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
.+++||++.++|.+++.... ..+++..++.++.|++.||.|||+.+++|+||+|+||++ +.++.++|+|||++...
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE---ccCCCEEEeccCcceec
Confidence 89999999889988887643 358999999999999999999999999999999999999 47799999999998775
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHh------
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE------ 230 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~------ 230 (414)
..... .....++..|+|||++.+..++.++|||||||++|+|++|..||.+....+....+.....
T Consensus 158 ~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 158 SFEMA--------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229 (287)
T ss_pred cCCcc--------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHh
Confidence 43321 1133578899999999999999999999999999999999999987654433222221110
Q ss_pred -------------hccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 231 -------------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 231 -------------~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
.....+........+..+.+++..||..+|.+||++.++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il 282 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEAL 282 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHh
Confidence 0001111122234457889999999999999999988764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=286.78 Aligned_cols=248 Identities=21% Similarity=0.326 Sum_probs=198.5
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
++|++.+.||.|+||.||+|.+..+++.||+|.+..... ...+.+|+++++.+.| +++..+...+......++++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNS-PYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCC-CchhhhheeeecCCEEEEEEE
Confidence 468899999999999999999999999999998766532 2457889999999885 566666666666788999999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
++ +++|.+++......++...+..++.|++.||+|||+ .|++|+||||+||++ +.++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE---CCCCCEEEeecccchhhHHHHh
Confidence 99 589999888655778999999999999999999999 999999999999999 4788999999999865433211
Q ss_pred CccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChh--hchHHHHHHHHhhccCCchHH
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA--ATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~--~~~~~~~~~i~~~~~~~p~~~ 239 (414)
....++..|+|||.+.+..++.++|||||||++|+|++|..||..... ....+....+..... +.
T Consensus 157 ---------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~ 223 (265)
T cd06605 157 ---------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP----PR 223 (265)
T ss_pred ---------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC----CC
Confidence 125678899999999999999999999999999999999999976421 111222222222211 11
Q ss_pred hhhc-ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 240 LCKS-HPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 240 ~~~~-~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.... ++.++.+++..||..+|++||++.++..
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 1111 5788999999999999999999887754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=292.49 Aligned_cols=263 Identities=21% Similarity=0.279 Sum_probs=200.0
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeeEEeee--eC
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGV--DG 75 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~--~~ 75 (414)
+..+.++|++.+.||.|+||.||+|.+..+++.||+|.+... .....+..|+.++..+.+|+++..+..++. +.
T Consensus 2 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 2 DKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred CchhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 456779999999999999999999999888999999976432 222346789999999944566666655443 34
Q ss_pred CeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 76 ~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
...++||||+.++|..++.. ..+++..++.++.||+.||+|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 82 ~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 82 KDIYLVFEYMETDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARS 156 (337)
T ss_pred ceEEEEecccccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccchhc
Confidence 46899999998888887764 378899999999999999999999999999999999999 5889999999999986
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHH-----
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC----- 229 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~----- 229 (414)
........ .........||..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+....
T Consensus 157 ~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07852 157 LSELEENP--ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234 (337)
T ss_pred cccccccc--cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 54332211 0011234578999999998865 457899999999999999999999998654332222111110
Q ss_pred ------------------hhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 230 ------------------EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 230 ------------------~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
......+.....+.++.++.+++..||..+|++||++.++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 001111222333446889999999999999999999988765
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=285.77 Aligned_cols=246 Identities=21% Similarity=0.311 Sum_probs=196.0
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHc--CCCCCCeeEEeeeeCCeeEEEE
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~--~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
.|++.+.||.|+||.||+|.+..++..||+|.+..... ...+.+|+.+++.+. .++++..+..++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 58899999999999999999999999999998765432 245778999999997 3466666666667778899999
Q ss_pred ecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
||+ +++|.+++.. ..+++..++.++.|++.||.|||+.||+|+||+|+||+++ ..+.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT---NTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc---CCCCEEEccCCceeecCCCcc
Confidence 999 7788888753 4789999999999999999999999999999999999994 788999999999987654331
Q ss_pred CccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
......|+..|+|||.+.+. .++.++|+|||||++|+|++|..||.+..... ....+.. . .+....
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~~~~~-~--~~~~~~ 223 (277)
T cd06917 157 -------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR---AMMLIPK-S--KPPRLE 223 (277)
T ss_pred -------ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh---hhhcccc-C--CCCCCC
Confidence 12245688999999998754 57899999999999999999999998754321 1111111 1 111111
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...++.++.+++..||..+|++||++.++..
T Consensus 224 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 224 DNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1236789999999999999999999988755
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=281.06 Aligned_cols=247 Identities=23% Similarity=0.307 Sum_probs=193.5
Q ss_pred cceeecCceeEEEEEECC-CC--ceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-
Q 015041 13 RKIGSGSFGEIFLASHVD-TN--EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~-~~--~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (414)
++||+|+||.||+|.+.. .+ ..||||.+..... ...+.+|+.+++.+.|. ++..+...... ...++|+||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHE-NLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCC-CccceeEEEcC-CeEEEEEEecC
Confidence 478999999999999864 33 3689998876654 34578899999999874 55555554444 7889999999
Q ss_pred CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcc
Q 015041 86 GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (414)
Q Consensus 86 ~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~ 164 (414)
+++|.+.+.... ..+++..++.++.|++.||+|||++|++|+||||+||++ +.++.+||+|||+++........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~-- 153 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDH-- 153 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE---ecCCEEEeccccccccccccccc--
Confidence 889999887644 468999999999999999999999999999999999999 47799999999999876432211
Q ss_pred ccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhhhc
Q 015041 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (414)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~ 243 (414)
+.......++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ...+.......+ ....
T Consensus 154 --~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~~~~~~~~---~~~~ 225 (257)
T cd05040 154 --YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKKIDKEGERLE---RPEA 225 (257)
T ss_pred --eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHhcCCcCC---CCcc
Confidence 112224556788999999998899999999999999999998 9999987544332 222222111111 1234
Q ss_pred ChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 244 ~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
.|..+.+++..||..+|++||++.++.+.|.
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 226 CPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 5789999999999999999999999887664
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=284.49 Aligned_cols=253 Identities=19% Similarity=0.309 Sum_probs=200.7
Q ss_pred CCceEEecceeecCceeEEEEEECC-----CCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
.++|++++.||.|+||+||+|+... +...|++|........ ..+..|+++++.+.| +++..+..++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~ 82 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH-KNVVRLLGLCREAEP 82 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCC-cceeeeEEEECCCCc
Confidence 4789999999999999999999753 3467999987654433 457889999999976 566677777777778
Q ss_pred eEEEEecc-CCCHHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEe
Q 015041 78 NVLVLDLL-GPSLEDLFVYCR--------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~ 148 (414)
.++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+||++ +..+.++|+
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV---SSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE---eCCCcEEEc
Confidence 99999999 689999887543 158999999999999999999999999999999999999 478899999
Q ss_pred eecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHH
Q 015041 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDK 227 (414)
Q Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~ 227 (414)
|||++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.... ..+..
T Consensus 160 ~~~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~~ 230 (275)
T cd05046 160 LLSLSKDVYNSEY------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLNR 230 (275)
T ss_pred ccccccccCcccc------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHHH
Confidence 9999864432211 11224456778999999998889999999999999999998 88999765432 22333
Q ss_pred HHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 228 i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
+.......+.. ..+|..+.+++.+||..+|++||++.++...|.
T Consensus 231 ~~~~~~~~~~~---~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 LQAGKLELPVP---EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHcCCcCCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 32222222221 346889999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=303.51 Aligned_cols=252 Identities=20% Similarity=0.275 Sum_probs=203.9
Q ss_pred CCceEEecceeecCceeEEEEEEC---CCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
.++.++.++||+|.||.|++|.|. .+...||||.+..+... ..|++|+.++.+|+| +++..+++...+ ....
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H-~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQH-PHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccC-cceeEEeeeecc-chhh
Confidence 356778899999999999999997 33457999998876543 569999999999987 555566555444 7789
Q ss_pred EEEecc-CCCHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 80 LVLDLL-GPSLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
||+|++ .|+|.+.+.. ....|.......++.||+.||.||.++++|||||..+|+|+. ....|||+|||+.+...
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla---sprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA---SPRTVKICDFGLMRALG 263 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec---ccceeeeecccceeccC
Confidence 999999 8999999887 345688999999999999999999999999999999999995 68899999999998765
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCc
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTP 236 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p 236 (414)
..... |-......-...|.|||.+....++.++|||+|||++|||++ |+.||.|.......+.+ +.+...+
T Consensus 264 ~ned~----Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i----D~~erLp 335 (1039)
T KOG0199|consen 264 ENEDM----YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI----DAGERLP 335 (1039)
T ss_pred CCCcc----eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc----cccccCC
Confidence 43321 111112223567999999999999999999999999999998 99999998776444443 3444445
Q ss_pred hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 015041 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (414)
Q Consensus 237 ~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l 273 (414)
.+..| |+.+.+++..||..+|.+||+|..|++.+
T Consensus 336 RPk~c---sedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 336 RPKYC---SEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCCC---hHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 45444 89999999999999999999999997543
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=281.58 Aligned_cols=246 Identities=21% Similarity=0.235 Sum_probs=199.7
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
+|++.++||+|+||.||++++..+++.||+|.+.... ....+.+|+.+++.+.| +++..+..++......++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH-PNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCC-CCeeeeEeeecCCCeEEEEEe
Confidence 6999999999999999999999999999999876432 22457889999999986 566677777777788999999
Q ss_pred cc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 84 LL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
|+ +++|.+.+.... ..++..+++.++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcchh
Confidence 99 789988887533 357899999999999999999999999999999999999 4788899999999976543221
Q ss_pred CccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhh
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~ 241 (414)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||..... ...+.++....... ..
T Consensus 157 -------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~----~~ 222 (256)
T cd08218 157 -------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM---KNLVLKIIRGSYPP----VS 222 (256)
T ss_pred -------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH---HHHHHHHhcCCCCC----Cc
Confidence 11244678899999999988899999999999999999999999975432 23333333322211 12
Q ss_pred hcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 242 ~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..++.++.+++.+||+.+|++||++.++.+
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 355789999999999999999999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=302.23 Aligned_cols=248 Identities=17% Similarity=0.320 Sum_probs=201.0
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (414)
.|.|+..||.|+||.||+|....++...|.|++..... -..++-|+++|..+.| ++++.+.......+.++|.+|||
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdH-P~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDH-PVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCC-hHHHHHHHHHhccCceEEEEeec
Confidence 46788899999999999999998888888998765543 3457889999998875 66666644444556789999999
Q ss_pred -CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcc
Q 015041 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (414)
Q Consensus 86 -~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~ 164 (414)
||-...++...++.+.+.++..+++|++.||.|||+++|||||||..|||++ -+|.++|+|||.+.......
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T---ldGdirLADFGVSAKn~~t~---- 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT---LDGDIRLADFGVSAKNKSTR---- 184 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE---ecCcEeeecccccccchhHH----
Confidence 6666677778889999999999999999999999999999999999999995 88999999999875432211
Q ss_pred ccccCCCCCccCcCcccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 165 IPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
.....++||+.|||||+.. +.+|+.++||||||++|.||..+.+|-..++.. ..+.+|.. -.+|.-.
T Consensus 185 ---qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM---RVllKiaK--SePPTLl 256 (1187)
T KOG0579|consen 185 ---QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIAK--SEPPTLL 256 (1187)
T ss_pred ---hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH---HHHHHHhh--cCCCccc
Confidence 1235899999999999875 557999999999999999999999999877654 33333322 2333334
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+..+...|.+|+..||..||..||+..+|.+
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 44567889999999999999999999887754
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=281.69 Aligned_cols=249 Identities=24% Similarity=0.336 Sum_probs=190.8
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-------chhHHHHHHHHHHHcCCCCCCeeEEeeee--CCe
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-------HPQLLYEAKVYKILQGGSGIPNIKWYGVD--GED 77 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~--~~~ 77 (414)
.+|++.+.||+|+||.||+|.+..++..||+|.+..... ...+.+|+.+++.+.| +++..+..+... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH-ERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCC-CCeeeEEEEEEcCCCCE
Confidence 468999999999999999999999999999998754321 1246789999999976 555555444332 456
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
.++++||+ +++|.+.+.. ...++...++.++.|++.||+|||+++|+|+||||+||++ +.++.++|+|||+++..
T Consensus 81 ~~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCcccc
Confidence 78999999 6789888865 4468999999999999999999999999999999999999 57889999999998765
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCc
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p 236 (414)
....... .......++..|+|||++.+..++.++|||||||++|||++|+.||...... +.+..+......
T Consensus 157 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~---~~~~~~~~~~~~-- 227 (266)
T cd06651 157 QTICMSG----TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM---AAIFKIATQPTN-- 227 (266)
T ss_pred ccccccC----CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH---HHHHHHhcCCCC--
Confidence 3321110 0112356789999999999988999999999999999999999999865322 222222211111
Q ss_pred hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 237 ~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+......++.+.+++ .||..+|++||+++++.+
T Consensus 228 -~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 228 -PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 112234467888888 677789999999887744
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=289.40 Aligned_cols=257 Identities=19% Similarity=0.270 Sum_probs=194.5
Q ss_pred ceEEecceeecCceeEEEEEECCC--CceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeee----eCCe
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDT--NEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV----DGED 77 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~----~~~~ 77 (414)
+|++.+.||+|+||.||+|.+..+ +..||+|.+.... ....+..|+.+++.+.+|++++.+..++. ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999877 8899999876432 12456789999999976777777755432 2245
Q ss_pred eEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 78 ~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
.++++++++++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||+++...
T Consensus 81 ~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCceecc
Confidence 789999999999888764 4578999999999999999999999999999999999999 578899999999998654
Q ss_pred CCCCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHH---------
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK--------- 227 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~--------- 227 (414)
...... ........||..|+|||++.+ ..++.++|||||||++|++++|..||.+............
T Consensus 157 ~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 157 ENPGEN---AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred cccccc---cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 322110 011234578999999998876 4689999999999999999999999986442211111110
Q ss_pred ---HHh-----------hccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 228 ---ICE-----------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 228 ---i~~-----------~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+.. .....+........+..+.+++.+|++.+|.+||++.++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 00011122222345678999999999999999999887643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=286.90 Aligned_cols=260 Identities=22% Similarity=0.285 Sum_probs=200.1
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeC--
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDG-- 75 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~-- 75 (414)
|++...+|++.++||+|+||.||+|.+..+++.||+|.+..... ...+..|+.+++.++| +++..+..++...
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h-~~i~~~~~~~~~~~~ 80 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNH-RNIVNLKEIVTDKQD 80 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCC-CCeeeeeheecCcch
Confidence 45667899999999999999999999998999999998865432 2346789999999976 4555554443322
Q ss_pred --------CeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEE
Q 015041 76 --------EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 147 (414)
Q Consensus 76 --------~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL 147 (414)
...++|+||+.+++.+++......+++..++.++.||+.||+|||+.||+|+||||+||++ +..+.+||
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~kl 157 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIKL 157 (302)
T ss_pred hhhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcEEe
Confidence 3789999999888888877555578999999999999999999999999999999999999 58889999
Q ss_pred eeecceeeecCCCCCccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHH
Q 015041 148 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD 226 (414)
Q Consensus 148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~ 226 (414)
+|||++......... ......++..|+|||.+.+. .++.++|||||||++|+|++|+.||...........+.
T Consensus 158 ~dfg~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~ 231 (302)
T cd07864 158 ADFGLARLYNSEESR------PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231 (302)
T ss_pred CcccccccccCCccc------ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 999999765433211 11133457889999988654 47899999999999999999999998755443333333
Q ss_pred HHHhhccCC----------------------chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 227 KICEKKVST----------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 227 ~i~~~~~~~----------------------p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+.+...... .....+..+|..+.+++..||..+|.+||+++++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 332211100 011223356889999999999999999999887643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=284.41 Aligned_cols=249 Identities=20% Similarity=0.309 Sum_probs=190.4
Q ss_pred cceeecCceeEEEEEECCCC------ceEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 13 RKIGSGSFGEIFLASHVDTN------EIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~------~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
+.||+|+||.||+|++.... ..||+|.+.... ....+.+|+.+++.+.| +++..+..++......++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNH-PNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCC-CCeeeEeeeecCCCCeEEEEe
Confidence 46899999999999986443 679999776543 23457889999999976 556566666667778999999
Q ss_pred cc-CCCHHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCC--CCCeEEEeeeccee
Q 015041 84 LL-GPSLEDLFVYC------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR--KANQVYIIDFGLAK 154 (414)
Q Consensus 84 ~~-~~sL~~~~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~--~~~~vkL~DFG~a~ 154 (414)
|+ +++|.+++... ...+++..++.++.|++.||.|||+++++|+||||+||+++..+ ....++|+|||+++
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 98 78999888642 13378899999999999999999999999999999999995211 12379999999987
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhcc
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||......+ ....+ ....
T Consensus 160 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~-~~~~ 230 (269)
T cd05044 160 DIYKSDYY-----RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHV-TAGG 230 (269)
T ss_pred cccccccc-----ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHH-hcCC
Confidence 65432211 11223355788999999999999999999999999999998 999998654332 22222 1111
Q ss_pred CCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 234 ~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
... .....|..+.+++.+||..+|++||+++++.+.|+
T Consensus 231 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 RLQ---KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ccC---CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 111 11345789999999999999999999999988765
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=291.83 Aligned_cols=259 Identities=20% Similarity=0.225 Sum_probs=189.9
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeee--------
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVD-------- 74 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~-------- 74 (414)
++++|++.+.||.|+||.||+|.+..++..||+|.+..... ...+.+|+++++.++|.+.+..+..+...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 46899999999999999999999999999999998755432 34578899999999775444333222221
Q ss_pred -----CCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEee
Q 015041 75 -----GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149 (414)
Q Consensus 75 -----~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~D 149 (414)
....++||||+.++|.+++. ...+++..++.++.||+.||+|||+.||+||||||+||+++ ..+..++|+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~kl~d 158 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGD 158 (342)
T ss_pred ccccccceEEEEeecccccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceEEECC
Confidence 23578999999888887765 34689999999999999999999999999999999999995 3556789999
Q ss_pred ecceeeecCCCCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHH
Q 015041 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228 (414)
Q Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i 228 (414)
||+++......... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.............
T Consensus 159 fg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 159 FGLARIVDPHYSHK----GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred cccceecCCccccc----cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99997653321110 01123457889999998764 45889999999999999999999999865432221111100
Q ss_pred -------------------H---hhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 229 -------------------C---EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 229 -------------------~---~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+ ......+........+.++.+++..||..+|.+||++.++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0 001111122223345677888888888888888888776643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=281.25 Aligned_cols=236 Identities=18% Similarity=0.255 Sum_probs=184.4
Q ss_pred cceeecCceeEEEEEECCCC----------ceEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 13 RKIGSGSFGEIFLASHVDTN----------EIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~----------~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
+.||+|+||.||+|.+..++ ..|++|+...... ...+.+|+.+++.+.| +++..+..++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH-KHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCC-cchhheeeEEec-CCcEEE
Confidence 47999999999999997666 3588887765543 4568889999999976 555555555544 668999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCC-------eEEEeeecce
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-------QVYIIDFGLA 153 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~-------~vkL~DFG~a 153 (414)
|||+ +++|.+++......++...+..++.||+.||+|||++||+||||||+|||++ ..+ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~---~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVA---RYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEe---cCccccCCceeEEeCCCCcc
Confidence 9999 7888888876555789999999999999999999999999999999999995 444 7999999998
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccCC--CCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHh
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICE 230 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~ 230 (414)
...... ....++..|+|||++.+. .++.++|||||||++|+|++ |..||...........+.
T Consensus 156 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---- 220 (259)
T cd05037 156 ITVLSR-----------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---- 220 (259)
T ss_pred cccccc-----------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh----
Confidence 754331 134567789999999877 78999999999999999999 688887764332222221
Q ss_pred hccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 015041 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (414)
Q Consensus 231 ~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l 273 (414)
.....+.+ ....+.+++.+||..+|++||++.++.+.|
T Consensus 221 ~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 DQHRLPMP-----DCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred cCCCCCCC-----CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 11111111 126899999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=281.72 Aligned_cols=251 Identities=27% Similarity=0.401 Sum_probs=197.2
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC------------chhHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK------------HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 75 (414)
+|.+.+.||.|+||.||+|.+..+++.||+|.+..... .+.+..|+.+++.+.| ++++.+..++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH-LNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCC-CCcceEEEEeccC
Confidence 68999999999999999999988899999997653211 1236678899999976 6666777777778
Q ss_pred CeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
...++||||+ +++|.+++... ..++...+..++.|++.||.|||+++++|+||+|+||++ +.++.++|+|||+++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~~~~ 156 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGISK 156 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeeccccc
Confidence 8899999999 88999888764 578999999999999999999999999999999999999 578999999999987
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (414)
......... ......|+..|+|||.+.... ++.++|+||||+++|++++|..||...... ..+.++....
T Consensus 157 ~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~ 228 (272)
T cd06629 157 KSDDIYDND-----QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI---AAMFKLGNKR 228 (272)
T ss_pred ccccccccc-----ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH---HHHHHhhccc
Confidence 543221110 122456789999999988655 889999999999999999999999754322 2222222222
Q ss_pred cCCc-hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 233 VSTP-IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 233 ~~~p-~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.... .......++.++.+++..||..+|++||+++++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1111 12233456889999999999999999999887654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=289.97 Aligned_cols=247 Identities=19% Similarity=0.309 Sum_probs=193.3
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
..|.....||+|+||.||++.+..++..||||.+.... ....+.+|+.+++.+.| +++..+...+..+...++||||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHH-ENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCC-CcHHHHHHheecCCeEEEEEeC
Confidence 45666788999999999999998899999999876533 23457789999998876 5555555555677889999999
Q ss_pred c-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 85 ~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
+ +++|.+++. ...+++.++..++.||+.||+|||+++|+||||||+||++ +.++.++|+|||++........
T Consensus 101 ~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 101 LEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhhcccccc--
Confidence 9 667877764 3468999999999999999999999999999999999999 4778999999999875432221
Q ss_pred cccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhc
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~ 243 (414)
......|+..|+|||++.+..++.++|||||||++|||++|..||.+...... +..+.. ....... ....
T Consensus 174 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~~~~-~~~~~~~-~~~~ 243 (292)
T cd06658 174 -----KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---MRRIRD-NLPPRVK-DSHK 243 (292)
T ss_pred -----cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHh-cCCCccc-cccc
Confidence 11245688999999999988999999999999999999999999987543322 222211 1111111 1123
Q ss_pred ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 244 HPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 244 ~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+..+.+++..||..+|.+||+++++.+
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 4678999999999999999999987755
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=287.42 Aligned_cols=248 Identities=23% Similarity=0.302 Sum_probs=198.3
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
-+...|...+.||+|+||.||+|.+..++..||+|.+..... ...+..|+++++.+.| +++..+..++......
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~ 100 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH-PNSIEYKGCYLREHTA 100 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCC-CCEEEEEEEEeeCCeE
Confidence 344568899999999999999999998999999998764322 1347789999999975 5666666666777889
Q ss_pred EEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 79 ~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
++||||+.+++.+++......+++..+..++.|++.||.|||++||+||||+|+||++ +.++.++|+|||++.....
T Consensus 101 ~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 101 WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIASP 177 (317)
T ss_pred EEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCccccCC
Confidence 9999999889988887666779999999999999999999999999999999999999 5788999999998864322
Q ss_pred CCCCccccccCCCCCccCcCcccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
. ....|+..|+|||++. ...++.++|||||||++|+|++|..||...... ..+..+.......
T Consensus 178 ~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~~~~~~~~ 243 (317)
T cd06635 178 A-----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQNESPT 243 (317)
T ss_pred c-----------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHhccCCC
Confidence 1 2456788999999974 356889999999999999999999999865322 2222332222211
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHH
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~ 272 (414)
.. ...+++.+.+++.+||..+|.+||++.++.+.
T Consensus 244 ~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 277 (317)
T cd06635 244 LQ---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH 277 (317)
T ss_pred CC---CccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence 11 13456789999999999999999999887663
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=283.75 Aligned_cols=239 Identities=17% Similarity=0.240 Sum_probs=182.2
Q ss_pred ceeecCceeEEEEEECCC------------------------CceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCe
Q 015041 14 KIGSGSFGEIFLASHVDT------------------------NEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPN 67 (414)
Q Consensus 14 ~iG~G~~g~V~~~~~~~~------------------------~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~ 67 (414)
+||+|+||.||+|....+ ...|++|++..... ...+..|+.+++.+.| ++++.
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h-~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSH-IHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCC-CCeee
Confidence 699999999999975321 23588888765432 2346677888888775 77777
Q ss_pred eEEeeeeCCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccC----CCC
Q 015041 68 IKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG----RKA 142 (414)
Q Consensus 68 l~~~~~~~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~----~~~ 142 (414)
+..++......++||||+ +++|..++......+++..+..++.||+.||+|||+++|+||||||+|||++.. ...
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~ 160 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS 160 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence 878888888899999999 777877776656678999999999999999999999999999999999999521 112
Q ss_pred CeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHH-cCCCCCCCChhhc
Q 015041 143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAAT 220 (414)
Q Consensus 143 ~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~-tG~~Pf~~~~~~~ 220 (414)
..++|+|||++...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|..||.+.....
T Consensus 161 ~~~kl~d~g~~~~~~~~-----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 161 PFIKLSDPGVSFTALSR-----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ceeeecCCccccccccc-----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 35899999987643221 12356788999998875 56899999999999999995 6999998754432
Q ss_pred hHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 015041 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (414)
Q Consensus 221 ~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l 273 (414)
... ........+ ...+.++.+++.+||..+|++||++.++.+.|
T Consensus 230 ~~~----~~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 KER----FYEKKHRLP-----EPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHH----HHHhccCCC-----CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 222 222222222 12246899999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=279.11 Aligned_cols=245 Identities=25% Similarity=0.354 Sum_probs=196.9
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-------CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
+|+..+.||+|+||.||+|.+..++..|++|.+.... ....+..|+.+++.+.| +++..+..++..+...++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH-PNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCC-CCchheeeeEecCCeEEE
Confidence 5888999999999999999998889999999876533 22457889999999875 666677777777788999
Q ss_pred EEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 81 v~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
++||+ +++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||+|+||++ +.++.+||+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 80 FLELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceecccc
Confidence 99999 7789888875 3468999999999999999999999999999999999999 57889999999998765433
Q ss_pred CCCccccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
.. .....|+..|++||.+.... ++.++|+|||||++|+|++|..||...... ....++..... ..
T Consensus 156 ~~--------~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~---~~ 221 (258)
T cd06632 156 SF--------AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV---AAVFKIGRSKE---LP 221 (258)
T ss_pred cc--------ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH---HHHHHHHhccc---CC
Confidence 21 12456889999999998776 899999999999999999999999765422 22222211111 11
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.....+++.+.+++.+||..+|++||++.++..
T Consensus 222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 122455789999999999999999999887654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=307.17 Aligned_cols=264 Identities=18% Similarity=0.289 Sum_probs=222.4
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCC---ceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
+|-....+|.+.||.|.||+|+.|+.+..+ ..||||.++....+ ..|+.|..++-++.| ++|.++.......+
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdH-PNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDH-PNIIRLEGVVTKSK 703 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCC-CcEEEEEEEEecCc
Confidence 344567789999999999999999987444 57999999876543 348999999999986 66778888888999
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
..+||.||| .|+|..+++...+.|+..+..-+++.|+.||+||-++++|||||..+|||+ +.+-.+|++|||++|.
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRV 780 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceee
Confidence 999999999 999999999888889999999999999999999999999999999999999 6888999999999997
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccC
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
..+..... | ....-.-.++|.|||.|....++.++||||||+++||.+. |..||-++++++.. +-++..++
T Consensus 781 ledd~~~~---y-tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI----kaIe~gyR 852 (996)
T KOG0196|consen 781 LEDDPEAA---Y-TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI----KAIEQGYR 852 (996)
T ss_pred cccCCCcc---c-cccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH----HHHHhccC
Confidence 75543210 0 0011111479999999999999999999999999999886 99999998875433 34466667
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~ 281 (414)
.|.+.-| |..+.+||..||+++-.+||.|.+|+..|++++.+.+
T Consensus 853 LPpPmDC---P~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 853 LPPPMDC---PAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred CCCCCCC---cHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 7766545 9999999999999999999999999999999987553
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=282.69 Aligned_cols=249 Identities=21% Similarity=0.250 Sum_probs=194.8
Q ss_pred eEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
|++.++||.|++|.||+|.+..+|..||+|++..... ...+.+|+++++.++| ++++.+..++......+++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNH-PNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCC-CCccCHhheeccCCeEEEEEec
Confidence 6788999999999999999998999999998765432 2357789999999986 5666666666777889999999
Q ss_pred cCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 85 LGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 85 ~~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
++++|.+++.... ..+++..++.++.|++.||+|||+++++|+||+|+||+++ .++.++|+|||+++.......
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~-- 154 (283)
T cd07835 80 LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLARAFGVPVR-- 154 (283)
T ss_pred cCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCcEEEeecccccccCCCcc--
Confidence 9889998887543 3689999999999999999999999999999999999994 688999999999875432211
Q ss_pred cccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc----------
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK---------- 232 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~---------- 232 (414)
......++..|+|||++.+. .++.++|||||||++|+|++|..||......... .++....
T Consensus 155 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~ 226 (283)
T cd07835 155 -----TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL---FRIFRTLGTPDEDVWPG 226 (283)
T ss_pred -----ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChHHhhh
Confidence 11233568899999988764 4789999999999999999999999875432221 1111110
Q ss_pred --------------cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 233 --------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 233 --------------~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
............+..+.+++.+||..+|.+||+++++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 227 VTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 011112223456788999999999999999999877643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=296.01 Aligned_cols=265 Identities=18% Similarity=0.259 Sum_probs=215.2
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
.++-..+..+.++||+|-||+|-+|+-. .+..||||+++.... ...|..|+++|.+|+| ++|..+...+..++.+
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkh-PNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKH-PNIVELLGVCVQDDPL 610 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCC-CCeeEEEeeeecCCch
Confidence 3566788899999999999999999853 368999999887643 2469999999999965 6777787888888999
Q ss_pred EEEEecc-CCCHHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
|+++||+ .|+|..++.....+ ..-....+|+.||+.||+||.+.+||||||.+.|+|+ +.++++||+|||+++..
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNL 687 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCccccccc
Confidence 9999999 89999998865333 3555677899999999999999999999999999999 69999999999999966
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCChhhchHHHHHHHHhhccC
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR--GSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t--G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
..... |+.....+-.++|||+|.++-+++++++|+|+||+++||+++ ...||..+.+....+...........
T Consensus 688 ysg~y-----y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~ 762 (807)
T KOG1094|consen 688 YSGDY-----YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR 762 (807)
T ss_pred ccCCc-----eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc
Confidence 54443 222335566789999999999999999999999999999886 78999987766555544444433333
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
......+.-+|..+.++|-.||..+-.+||+|++|...|.+.
T Consensus 763 ~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 763 QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 222233345689999999999999999999999998877653
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=280.31 Aligned_cols=241 Identities=20% Similarity=0.294 Sum_probs=189.3
Q ss_pred CceEEecce--eecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 7 VKYKLGRKI--GSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 7 ~~y~i~~~i--G~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
++|.+.+.+ |.|+||.||++.+..++..+|+|+........ .|+.....+.+++++..+...+......++||||
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~ 90 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDY 90 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEc
Confidence 567777777 99999999999999999999999876543211 2344444455677888888777778899999999
Q ss_pred c-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCC-eEEEeeecceeeecCCCCC
Q 015041 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 85 ~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~-~vkL~DFG~a~~~~~~~~~ 162 (414)
+ +++|.+++... ..+++.+++.++.|++.||.|||+.|++||||||+||++. .++ .++|+|||++......
T Consensus 91 ~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~~l~dfg~~~~~~~~--- 163 (267)
T PHA03390 91 IKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---RAKDRIYLCDYGLCKIIGTP--- 163 (267)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---CCCCeEEEecCccceecCCC---
Confidence 9 78999988764 4799999999999999999999999999999999999994 555 8999999998754322
Q ss_pred ccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhch-HHHHHHHHhhccCCchHHhh
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK-KQKYDKICEKKVSTPIEVLC 241 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~-~~~~~~i~~~~~~~p~~~~~ 241 (414)
....++..|+|||++.+..++.++|||||||++|+|++|..||........ ...+..... .+. ...
T Consensus 164 --------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~-~~~ 230 (267)
T PHA03390 164 --------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ----KKL-PFI 230 (267)
T ss_pred --------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc----ccC-Ccc
Confidence 134678999999999999999999999999999999999999985433221 111111111 111 122
Q ss_pred hcChHHHHHHHHHHhcCCCCCCCC-hHHHH
Q 015041 242 KSHPAEFASYFHYCQSLTFDQRPD-YGFLK 270 (414)
Q Consensus 242 ~~~p~~~~~l~~~c~~~~p~~RP~-~~~l~ 270 (414)
+..++.+.+++..||+.+|.+||+ ++++.
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 231 KNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred cccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 356889999999999999999995 56553
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=282.78 Aligned_cols=242 Identities=28% Similarity=0.351 Sum_probs=197.0
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
+|++.++||.|+||.||+|.+..+++.||+|++.... ....+..|+++++.+.| +++..+..++..+...++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNH-PFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCC-CChHHHHHhhcCCCeEEEEE
Confidence 5899999999999999999999899999999886532 23457889999999976 56666666666778899999
Q ss_pred ecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
||+ +++|.+.+... ..++...+..++.||+.||.|||+++++|+||+|+||++ +.++.++|+|||++........
T Consensus 80 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 80 DLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred eCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCCCcc
Confidence 999 88898888753 578999999999999999999999999999999999999 5788999999999876543321
Q ss_pred CccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhh
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~ 241 (414)
.....|+..|+|||.+.+..++.++|+|||||++|+|++|..||.........+........ .....
T Consensus 156 --------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~ 222 (258)
T cd05578 156 --------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA-----DVLYP 222 (258)
T ss_pred --------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccc-----cccCc
Confidence 12456788999999999888999999999999999999999999876543222222221111 12222
Q ss_pred hcChHHHHHHHHHHhcCCCCCCCChH
Q 015041 242 KSHPAEFASYFHYCQSLTFDQRPDYG 267 (414)
Q Consensus 242 ~~~p~~~~~l~~~c~~~~p~~RP~~~ 267 (414)
...|..+.+++.+||..+|.+||++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~~~~ 248 (258)
T cd05578 223 ATWSTEAIDAINKLLERDPQKRLGDN 248 (258)
T ss_pred ccCcHHHHHHHHHHccCChhHcCCcc
Confidence 45689999999999999999999983
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=287.60 Aligned_cols=245 Identities=22% Similarity=0.297 Sum_probs=196.7
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
..|++.+.||+|+||.||+|.+..++..||+|.+..... ...+.+|+.+++.+.| ++++.+..++......++|+|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCC-CccHhhhcccccCCceEEEEE
Confidence 467888999999999999999988899999998774432 2347789999999875 666667666677788999999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
|+ +++|.+++. ...+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 83 YLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred ccCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE---eCCCCEEEccccccccccCcch-
Confidence 99 678887765 4568999999999999999999999999999999999999 4788999999999876543221
Q ss_pred ccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhh
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~ 242 (414)
......|+..|+|||.+.+..++.++|||||||++|||++|..||......... ..+.. ... .....
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~~~-~~~---~~~~~ 223 (277)
T cd06642 157 ------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---FLIPK-NSP---PTLEG 223 (277)
T ss_pred ------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---hhhhc-CCC---CCCCc
Confidence 112356788999999999989999999999999999999999999865432211 11111 111 11223
Q ss_pred cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 243 ~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+..+.+++..||..+|++||++.++..
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 224 QYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 45788999999999999999999998876
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=278.90 Aligned_cols=247 Identities=25% Similarity=0.391 Sum_probs=197.6
Q ss_pred eEEecceeecCceeEEEEEECCCC----ceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 9 YKLGRKIGSGSFGEIFLASHVDTN----EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
+++++.||.|+||.||+|.+...+ ..||+|.+..... ...+..|+.+++.+. ++++..+..++......+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLD-HPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcC-CCchheEEEEEcCCCeeEEE
Confidence 467899999999999999998766 8999999876553 346788999999995 56777777777777889999
Q ss_pred Eecc-CCCHHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 82 LDLL-GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
||++ +++|.+++...... +++..+..++.|++.||+|||+.+++|+||||+||++ +.++.++|+|||++......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceecccc
Confidence 9999 78999988764444 8999999999999999999999999999999999999 57789999999999876544
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
.... . ....++..|+|||.+.+..++.++|||||||++|+|++ |..||....... .+..+.. ....+..
T Consensus 157 ~~~~-----~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~~~-~~~~~~~ 226 (258)
T smart00219 157 DYYK-----K-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEYLKK-GYRLPKP 226 (258)
T ss_pred cccc-----c-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhc-CCCCCCC
Confidence 2211 0 12236789999999988889999999999999999998 889998744332 2222222 2222211
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~ 272 (414)
...+.++.+++.+||..+|++||++.++.+.
T Consensus 227 ---~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 227 ---ENCPPEIYKLMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred ---CcCCHHHHHHHHHHCcCChhhCcCHHHHHhh
Confidence 3368899999999999999999999988764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=277.98 Aligned_cols=249 Identities=26% Similarity=0.359 Sum_probs=204.8
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
.+|.+.+.||.|++|.||+|.+..+++.|+||++..... ...+..|+..+..++| +++..+..++......++|+|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCES-PYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCeeeEEEEEccCCeEEEEEE
Confidence 368999999999999999999999999999998876643 4568889999999985 667777777777788999999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
|+ +++|.+++.. ...++...++.++.|++.||+|||+ ++++|+||+|+||++ +.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 80 YMDGGSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred ecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceecccCCC
Confidence 99 6899988876 3678999999999999999999999 999999999999999 5789999999999876543322
Q ss_pred CccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhh
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~ 241 (414)
. .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.........+....+..... ....
T Consensus 156 ~-------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~ 224 (264)
T cd06623 156 Q-------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP----PSLP 224 (264)
T ss_pred c-------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC----CCCC
Confidence 1 1245678899999999998999999999999999999999999987643233344444432221 1122
Q ss_pred hc-ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 242 KS-HPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 242 ~~-~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.. ++..+.+++..||..+|++||++.++.+
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 33 6889999999999999999999988766
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=278.29 Aligned_cols=246 Identities=24% Similarity=0.295 Sum_probs=196.0
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEee--eeCCeeEEE
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYG--VDGEDNVLV 81 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~--~~~~~~~lv 81 (414)
+|++.+.||.|+||.||+|.+..++..||+|++..... ...+..|+.+++.+.|. ++..+..++ ..+...+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHP-NIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCC-ccceeeeeeecCCCCEEEEE
Confidence 58999999999999999999999999999998765432 23467889999999874 454444333 244567899
Q ss_pred Eecc-CCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHH-----hcCeeccccCCCceEEccCCCCCeEEEeeecc
Q 015041 82 LDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVH-----SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH-----~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~ 152 (414)
|||+ +++|.+++... ...+++..++.++.||+.||.||| +.+|+|+||||+||++ +.++.++|+|||+
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g~ 156 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFGL 156 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE---ecCCCEEEecccc
Confidence 9999 78999888754 456899999999999999999999 8899999999999999 4789999999999
Q ss_pred eeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc
Q 015041 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (414)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (414)
+........ ......++..|+|||++.+..++.++|+||||+++|+|++|..||...... +....+.. .
T Consensus 157 ~~~~~~~~~-------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~-~ 225 (265)
T cd08217 157 AKILGHDSS-------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKIKE-G 225 (265)
T ss_pred cccccCCcc-------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHHhc-C
Confidence 886543221 012456889999999999988999999999999999999999999875422 22222222 1
Q ss_pred cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 233 ~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.. +.....++..+.+++..|+..+|++||++.+|.+
T Consensus 226 ~~---~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 226 KF---RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred CC---CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11 1223456789999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=281.15 Aligned_cols=239 Identities=24% Similarity=0.296 Sum_probs=183.2
Q ss_pred ceeecCceeEEEEEECCCCceEEEEEecCCCCc-----hhHHHHHHHHHHHc--CCCCCCeeEEeeeeCCeeEEEEecc-
Q 015041 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLVLDLL- 85 (414)
Q Consensus 14 ~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~--~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (414)
.||+|+||.||+|.+..+++.||+|.+...... .....|..+++.++ +++++..+...+......++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999989999999987654211 12344544444443 3466666666777778899999999
Q ss_pred CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccc
Q 015041 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (414)
Q Consensus 86 ~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 165 (414)
+++|.+++.. ...+++..++.++.|++.||+|||+.+|+||||||+||++ +.++.++|+|||++.......
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~~----- 151 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK----- 151 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCccC-----
Confidence 7888877764 4568999999999999999999999999999999999999 578899999999987543221
Q ss_pred cccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcC
Q 015041 166 PYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (414)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 244 (414)
.....|+..|+|||++.+. .++.++|||||||++|+|++|..||.+............+...... .....
T Consensus 152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 222 (278)
T cd05606 152 ----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-----LPDSF 222 (278)
T ss_pred ----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC-----CCCcC
Confidence 1245789999999999754 6899999999999999999999999875332222222111111111 22345
Q ss_pred hHHHHHHHHHHhcCCCCCCC-----ChHHHH
Q 015041 245 PAEFASYFHYCQSLTFDQRP-----DYGFLK 270 (414)
Q Consensus 245 p~~~~~l~~~c~~~~p~~RP-----~~~~l~ 270 (414)
+.++.+++.+|+..+|.+|| ++.++.
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll 253 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 253 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHH
Confidence 78999999999999999999 666553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=278.18 Aligned_cols=249 Identities=24% Similarity=0.322 Sum_probs=191.4
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-------chhHHHHHHHHHHHcCCCCCCeeEEeeee--CCe
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-------HPQLLYEAKVYKILQGGSGIPNIKWYGVD--GED 77 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~--~~~ 77 (414)
.+|++.+.||+|+||.||+|.+..++..||||.+..... ...+.+|+.+++.+.| ++++.+..++.+ ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH-ERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCC-CCeeeEEeEeccCCCce
Confidence 579999999999999999999999999999998653221 1246779999999976 555555554443 345
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
.+++|||+ +++|.+++.. ...++...++.++.|++.||+|||+++|+|+||||+||++ +.++.++|+|||+++..
T Consensus 81 ~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCcccccc
Confidence 78999999 7789888765 3568899999999999999999999999999999999999 57889999999998765
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCc
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p 236 (414)
...... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ..+.++.......
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~- 228 (265)
T cd06652 157 QTICLS----GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM---AAIFKIATQPTNP- 228 (265)
T ss_pred cccccc----ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH---HHHHHHhcCCCCC-
Confidence 322111 01123456889999999999888999999999999999999999999865322 2222222211111
Q ss_pred hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 237 ~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
......+..+.+++..|| .+|++||+++++.+
T Consensus 229 --~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~ 260 (265)
T cd06652 229 --VLPPHVSDHCRDFLKRIF-VEAKLRPSADELLR 260 (265)
T ss_pred --CCchhhCHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence 112334678899999999 48999999887654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=287.58 Aligned_cols=247 Identities=19% Similarity=0.302 Sum_probs=195.7
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
..|....+||.|+||.||+|.+..++..||+|.+.... ....+.+|+.++..+.| +++..+..++..+...++++||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-p~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH-QNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCC-CchhhhhhheeeCCeEEEEEec
Confidence 45666778999999999999998889999999876432 33457789999988875 5666666666677889999999
Q ss_pred c-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 85 ~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
+ +++|..++. ...+++..++.++.|++.||+|||+.||+|+||||+||++ +.++.++|+|||++........
T Consensus 100 ~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~~-- 172 (297)
T cd06659 100 LQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP-- 172 (297)
T ss_pred CCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhcccccc--
Confidence 9 677877664 3568999999999999999999999999999999999999 5889999999999865432211
Q ss_pred cccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhc
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~ 243 (414)
......|+..|+|||++.+..++.++|||||||++|||++|..||....... .+..+.... .+.......
T Consensus 173 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~--~~~~~~~~~ 242 (297)
T cd06659 173 -----KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMKRLRDSP--PPKLKNAHK 242 (297)
T ss_pred -----cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhccC--CCCccccCC
Confidence 1124578999999999998899999999999999999999999998654322 222221111 111112245
Q ss_pred ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 244 HPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 244 ~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+..+.+++..||..+|++||++.++.+
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 6788999999999999999999887766
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=277.88 Aligned_cols=247 Identities=21% Similarity=0.261 Sum_probs=190.6
Q ss_pred EEecceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-C
Q 015041 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (414)
Q Consensus 10 ~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 86 (414)
.....||+|+||.||+|.+..++..||+|.+..... ...+.+|+.+++.++| +++..+..++..+...++++||+ +
T Consensus 11 ~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~ 89 (268)
T cd06624 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKH-RNIVQYLGSDSENGFFKIFMEQVPG 89 (268)
T ss_pred CceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCC-CCeeeeeeeeccCCEEEEEEecCCC
Confidence 344689999999999999988899999998765432 3457889999999976 55666666677778899999998 7
Q ss_pred CCHHHHHHHhCCCC--CHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcc
Q 015041 87 PSLEDLFVYCRRKF--SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (414)
Q Consensus 87 ~sL~~~~~~~~~~~--~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~ 164 (414)
++|.+++......+ +...+..++.||+.||+|||++||+||||||+||+++ ...+.++|+|||++........
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~--- 164 (268)
T cd06624 90 GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINP--- 164 (268)
T ss_pred CCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCC---
Confidence 89999887644445 8888999999999999999999999999999999994 2367899999999875432211
Q ss_pred ccccCCCCCccCcCccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhh
Q 015041 165 IPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (414)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~ 242 (414)
......|+..|+|||++.+.. ++.++||||||+++|+|++|..||........ ....+....... ....
T Consensus 165 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~---~~~~ 235 (268)
T cd06624 165 ----CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKVGMFKIHP---EIPE 235 (268)
T ss_pred ----ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHhhhhhhccCC---CCCc
Confidence 112346788999999987654 78999999999999999999999976432211 111111111111 1223
Q ss_pred cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 243 ~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+++++.+++.+||..+|.+||++.++..
T Consensus 236 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 236 SLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 45789999999999999999999987654
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=281.83 Aligned_cols=252 Identities=23% Similarity=0.276 Sum_probs=198.7
Q ss_pred eEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
|++.+.||.|++|.||+|.+..+++.+++|.+..... ...+..|+.+++.+.| +++..+..+...+...++++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNH-PNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcC-CCcchHHHhhccCCCEEEEEec
Confidence 6788999999999999999988999999998765433 2457789999999985 6666666666677889999999
Q ss_pred cCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcc
Q 015041 85 LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (414)
Q Consensus 85 ~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~ 164 (414)
+.+++.+++......+++..++.++.|++.||.|||+.+|+|+||||+||++ +.++.++|+|||.+........
T Consensus 80 ~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~--- 153 (283)
T cd05118 80 MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVR--- 153 (283)
T ss_pred cCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCcc---
Confidence 9889998888755679999999999999999999999999999999999999 4788999999999977654321
Q ss_pred ccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhh------------
Q 015041 165 IPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK------------ 231 (414)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~------------ 231 (414)
......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+..+...........
T Consensus 154 ----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 154 ----PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ----cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh
Confidence 11234578899999998877 7899999999999999999999999765432221111111000
Q ss_pred ----------ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 232 ----------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 232 ----------~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
............++.++.+++..||..+|.+||++.++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0011112233456789999999999999999999887654
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=280.85 Aligned_cols=251 Identities=22% Similarity=0.280 Sum_probs=193.2
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeee--eCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGV--DGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~--~~~~~~lv 81 (414)
++|...++||.|++|.||+|.+..+++.||+|.+..... ...+.+|+++++.+.| +++..+..++. .....++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKS-PYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCC-CCeeeeeeEEEccCCCeEEEE
Confidence 479999999999999999999998999999998875432 2457899999999976 55555544332 34468999
Q ss_pred Eecc-CCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 82 LDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
|||+ +++|.+++... ...++...+..++.||+.||.|||+.|++|+||+|+||++ +.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---ecCCeEEEeecccccccc
Confidence 9999 78998876542 3458899999999999999999999999999999999999 477889999999986543
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChh--hchHHHHHHHHhhccCC
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA--ATKKQKYDKICEKKVST 235 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~--~~~~~~~~~i~~~~~~~ 235 (414)
.... ....++..|+|||.+.+..++.++|||||||++|+|++|..||..... ....+....+..... .
T Consensus 157 ~~~~---------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~ 226 (287)
T cd06621 157 NSLA---------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN-P 226 (287)
T ss_pred cccc---------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc-h
Confidence 3221 234578899999999999999999999999999999999999986522 111222222221111 1
Q ss_pred chHHh---hhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 236 PIEVL---CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 236 p~~~~---~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..... ...+++.+.+++.+||..+|.+||++.++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 227 ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11000 0123578999999999999999999987755
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=296.68 Aligned_cols=245 Identities=24% Similarity=0.346 Sum_probs=207.5
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCch----hHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
-+.|.+.+.||+|.|+.|.+|++..++..||||++.+..... .+.+|+++++.|.| ++|+.+..+-......|+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~H-PnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNH-PNIVKLFSVIETEATLYLV 133 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCC-cceeeeeeeeeecceeEEE
Confidence 378999999999999999999999999999999988776443 36899999999987 6677777777778889999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ ++.+.+++...+ ...+.++..++.|++.|++|||+++|||||||++|||+ +.+.++||+|||++..+....
T Consensus 134 ~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred EEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceeecccc
Confidence 9999 888999888744 45559999999999999999999999999999999999 688889999999998776433
Q ss_pred CCccccccCCCCCccCcCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
. ..+++|++.|+|||++.+..| ++.+|+||+|+++|-|+.|.+||.|..-. ..-.+.+..++..|...
T Consensus 210 ~--------lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk---~Lr~rvl~gk~rIp~~m 278 (596)
T KOG0586|consen 210 M--------LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK---ELRPRVLRGKYRIPFYM 278 (596)
T ss_pred c--------ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc---cccchheeeeeccccee
Confidence 2 358899999999999999986 68899999999999999999999974322 22233455666666444
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..++.+++++.+-++|.+|++.+++.+
T Consensus 279 -----s~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 279 -----SCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred -----echhHHHHHHhhccCccccCCHHHhhh
Confidence 458899999999999999999988766
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=279.96 Aligned_cols=244 Identities=21% Similarity=0.304 Sum_probs=196.4
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
-|++.+.||.|+||.||+|.+..++..||||+...... ...+.+|+.++..+.| +++..+..++..+...++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCEeEEEEEEEeCCeEEEEEEe
Confidence 47889999999999999999988999999998764432 2357789999999876 5566676677778889999999
Q ss_pred c-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 85 ~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
+ +++|.+++. ...++...+..++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||++........
T Consensus 84 ~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06641 84 LGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecccchh--
Confidence 9 678887765 3568999999999999999999999999999999999999 4778899999999876543211
Q ss_pred cccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhc
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~ 243 (414)
......++..|+|||.+.+..++.++|+|||||++|+|++|..||...... .....+.... . +.....
T Consensus 157 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~-~---~~~~~~ 224 (277)
T cd06641 157 -----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM---KVLFLIPKNN-P---PTLEGN 224 (277)
T ss_pred -----hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH---HHHHHHhcCC-C---CCCCcc
Confidence 112456788999999999888999999999999999999999999865432 2222221111 1 112245
Q ss_pred ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 244 HPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 244 ~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+.++.+++..||..+|++||++.++.+
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 225 YSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 5789999999999999999999998877
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=279.03 Aligned_cols=250 Identities=20% Similarity=0.347 Sum_probs=196.6
Q ss_pred ceEEecceeecCceeEEEEEECC-CCceEEEEEecCCC---------C---chhHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGT---------K---HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~-~~~~vavK~~~~~~---------~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 74 (414)
.|++.+.||+|+||.||+|.+.. ++..||+|.+.... . ...+..|+.++.....|+++..+..++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 67899999765321 1 12355677777654455777777777777
Q ss_pred CCeeEEEEecc-CCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh-cCeeccccCCCceEEccCCCCCeEEEee
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIID 149 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDLkp~Nili~~~~~~~~vkL~D 149 (414)
....+++|||+ +++|.+++... ...++...++.++.|++.||.|||+ .+|+|+||+|+||++ +.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEEec
Confidence 88999999998 77998887532 3468999999999999999999996 689999999999999 4788999999
Q ss_pred ecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHH
Q 015041 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (414)
Q Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~ 229 (414)
||.+....... ......|+..|++||.+.+..++.++|+||||+++|+|++|..||...... .....+.
T Consensus 158 fg~~~~~~~~~--------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---~~~~~~~ 226 (269)
T cd08528 158 FGLAKQKQPES--------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---SLATKIV 226 (269)
T ss_pred ccceeeccccc--------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---HHHHHHh
Confidence 99997654322 112456889999999999888999999999999999999999999764332 2222333
Q ss_pred hhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 230 ~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
..... +.. ....++++.+++.+||..+|++||++.++...+.
T Consensus 227 ~~~~~-~~~--~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 227 EAVYE-PLP--EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hccCC-cCC--cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 32222 211 1245789999999999999999999999887764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=286.91 Aligned_cols=265 Identities=20% Similarity=0.251 Sum_probs=197.4
Q ss_pred CcccCCceEE-ecceeecCceeEEEEEECCCCceEEEEEecCCCCc----------------hhHHHHHHHHHHHcCCCC
Q 015041 2 ERIIGVKYKL-GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----------------PQLLYEAKVYKILQGGSG 64 (414)
Q Consensus 2 ~~i~~~~y~i-~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------~~~~~E~~~l~~l~~~~~ 64 (414)
.--+.++|.. .+.||.|+||+||+|.+..+++.||||.+...... ..+..|++++..+.| ++
T Consensus 3 ~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~ 81 (335)
T PTZ00024 3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKH-EN 81 (335)
T ss_pred ccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCC-cc
Confidence 3445678864 57799999999999999989999999987643221 146789999999976 56
Q ss_pred CCeeEEeeeeCCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCe
Q 015041 65 IPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 144 (414)
Q Consensus 65 i~~l~~~~~~~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~ 144 (414)
+..+..++......++||||+.++|.+++.. ...++...+..++.|++.||+|||++||+|+||+|+||++ +.++.
T Consensus 82 iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~~~ 157 (335)
T PTZ00024 82 IMGLVDVYVEGDFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKGI 157 (335)
T ss_pred eeeeeEEEecCCcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCCCC
Confidence 6666666677788999999999899988864 4568999999999999999999999999999999999999 57889
Q ss_pred EEEeeecceeeecCCCCCccc------c-ccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 015041 145 VYIIDFGLAKKYRDPTTNRHI------P-YRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGL 216 (414)
Q Consensus 145 vkL~DFG~a~~~~~~~~~~~~------~-~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~tG~~Pf~~~ 216 (414)
++|+|||++............ . ........++..|+|||.+.+.. ++.++|||||||++|+|++|..||.+.
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999865422111000 0 00112335688899999987654 799999999999999999999999876
Q ss_pred hhhchHHHHHHHHhhccC--------------------CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 217 KAATKKQKYDKICEKKVS--------------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~--------------------~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
........+......... ..........+.++.+++..||..+|++||+++++..
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 543322222211110000 0011112344678889999999999999999876643
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=278.35 Aligned_cols=244 Identities=22% Similarity=0.346 Sum_probs=191.8
Q ss_pred ecceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-
Q 015041 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (414)
++.||.|+||.||+|.+..+++.||+|++..... ...+..|..++....+++++..+..++......++++||+
T Consensus 1 ~~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred CccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 3679999999999999998999999998765421 1123445555544445677888877777888899999999
Q ss_pred CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccc
Q 015041 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (414)
Q Consensus 86 ~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 165 (414)
+++|.+++.. ...++...+..++.|++.||.|||+.+|+|+||+|+||++ +.++.++|+|||+++....
T Consensus 81 ~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~------- 149 (260)
T cd05611 81 GGDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE------- 149 (260)
T ss_pred CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc-------
Confidence 8899988875 3568999999999999999999999999999999999999 4788999999999875432
Q ss_pred cccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcCh
Q 015041 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (414)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p 245 (414)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||...... ..+..+.......+. .....++
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~-~~~~~~~ 221 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---AVFDNILSRRINWPE-EVKEFCS 221 (260)
T ss_pred ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhcccCCCC-cccccCC
Confidence 12456788999999999888999999999999999999999999865432 233333332222221 1223568
Q ss_pred HHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 246 AEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 246 ~~~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
.++.+++.+||..+|++||++..+.+.+.
T Consensus 222 ~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 222 PEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred HHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 89999999999999999998766655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=288.38 Aligned_cols=252 Identities=21% Similarity=0.258 Sum_probs=197.3
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeC-----Cee
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG-----EDN 78 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~-----~~~ 78 (414)
+|++.++||.|+||.||+|.+..+++.||||.+.... ....+..|+.+++.+.| +++..+..+.... ...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRH-ENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCC-cchhhhhhhhcccCcccccce
Confidence 6999999999999999999998889999999876533 23468889999999975 5555554444333 368
Q ss_pred EEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 79 ~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
+++|+|++++|.+++.. ...+++..++.++.||+.||+|||+.||+|+||||+|||+ +.++.++|+|||++.....
T Consensus 80 ~lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 80 YIVTELMETDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEEecchhhhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeecc
Confidence 99999998888887764 3479999999999999999999999999999999999999 5779999999999987655
Q ss_pred CCCCccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC--
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST-- 235 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~-- 235 (414)
..... .......++..|+|||++.+. .++.++|||||||++|+|++|..||.+...... +..+.......
T Consensus 156 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~ 228 (330)
T cd07834 156 DEDEK----GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ---LNLIVEVLGTPSE 228 (330)
T ss_pred ccccc----ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHhcCCCCh
Confidence 43110 012245678899999999988 799999999999999999999999987654322 22222211111
Q ss_pred ------------------------chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 236 ------------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 236 ------------------------p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+........+.++.+++..||..+|++||++.++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 111122345788999999999999999999887765
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=277.70 Aligned_cols=248 Identities=19% Similarity=0.267 Sum_probs=182.7
Q ss_pred cceeecCceeEEEEEECCC--CceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-C
Q 015041 13 RKIGSGSFGEIFLASHVDT--NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~--~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 86 (414)
++||+|+||.||+|+.... ...+++|....... ...+.+|+.++..++| +++..+...+......++||||+ +
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQH-PNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCC-cchhheEEEecCCCccEEEEecCCC
Confidence 4699999999999975432 33566776654332 3457888888988876 56666666666777889999999 6
Q ss_pred CCHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 87 PSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 87 ~sL~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
++|.+++.... ..++...++.++.||+.||+|||+++|+||||||+|||+ +.++.++|+|||++........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~-- 154 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDY-- 154 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcchh--
Confidence 89998887532 345677888999999999999999999999999999999 5788999999999753221110
Q ss_pred cccccCCCCCccCcCccccccccC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhh-ccC
Q 015041 164 HIPYRENKNLTGTARYASCNTHLG-------IEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEK-KVS 234 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~-~~~ 234 (414)
........++..|+|||++.. ..++.++|||||||++|||++ |..||....... .+..+... ...
T Consensus 155 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~~~~~~~~~ 228 (268)
T cd05086 155 ---IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---VLNHVIKDQQVK 228 (268)
T ss_pred ---hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHhhcccc
Confidence 011234567899999999753 346789999999999999997 678887654432 22222222 222
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l 273 (414)
.+.+.....+++.+.+++..|| .+|++||+++++.+.|
T Consensus 229 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 229 LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 2222333446788999999999 6799999999998765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=295.21 Aligned_cols=241 Identities=22% Similarity=0.331 Sum_probs=201.0
Q ss_pred ecceeecCceeEEEEEECCCCceEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEeccCC
Q 015041 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGP 87 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~~~ 87 (414)
.+.||+|-||+||-|++.++|+.||||++.+- ....++.+|+.+|+.+.| ++|+.+...+...+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~H-PGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHH-PGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCC-CCeeEEEEeecCCceEEEEehhhcc
Confidence 46899999999999999999999999987653 234568999999999965 8999999999999999999999988
Q ss_pred CHHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcccc
Q 015041 88 SLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (414)
Q Consensus 88 sL~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~ 166 (414)
+....+. ...+++++.....++.||+.||.|||.++|+|+||||+|||+...+.--++||||||+|+.......
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF----- 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF----- 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh-----
Confidence 7776665 4457799999999999999999999999999999999999997655556899999999998765543
Q ss_pred ccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChH
Q 015041 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (414)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~ 246 (414)
.+.++||+.|.|||++..+.|++.-|+||+|+|+|--+.|..||....+ .-++|.....-.|. .-++.++.
T Consensus 723 ---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----IndQIQNAaFMyPp-~PW~eis~ 793 (888)
T KOG4236|consen 723 ---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----INDQIQNAAFMYPP-NPWSEISP 793 (888)
T ss_pred ---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhHHhhccccccCC-CchhhcCH
Confidence 3588999999999999999999999999999999999999999986322 22233333333332 23355678
Q ss_pred HHHHHHHHHhcCCCCCCCChH
Q 015041 247 EFASYFHYCQSLTFDQRPDYG 267 (414)
Q Consensus 247 ~~~~l~~~c~~~~p~~RP~~~ 267 (414)
+..+||+..++..-.+|-+.+
T Consensus 794 ~AidlIn~LLqVkm~kRysvd 814 (888)
T KOG4236|consen 794 EAIDLINNLLQVKMRKRYSVD 814 (888)
T ss_pred HHHHHHHHHHHHHHHHhcchH
Confidence 899999999999888887654
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=286.83 Aligned_cols=248 Identities=21% Similarity=0.296 Sum_probs=191.0
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeee-eC----
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV-DG---- 75 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~-~~---- 75 (414)
+.++|++.+.||+|+||.||+|.+..++..||||.+..... ...+.+|+.+++.+.|.+ +..+..++. ..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHEN-VIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCC-ccceeeeecCCccccc
Confidence 56899999999999999999999999999999998754322 234778999999998754 444443332 22
Q ss_pred -CeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 76 -EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 76 -~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
...++||++++++|.+++. ...+++..++.++.||+.||+|||+.||+||||||+||++ +.++.++|+|||++.
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill---~~~~~~kl~dfg~~~ 166 (343)
T cd07880 92 FHDFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLAR 166 (343)
T ss_pred cceEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeccccc
Confidence 2468999999999988876 3568999999999999999999999999999999999999 478899999999987
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
...... ....++..|+|||.+.+ ..++.++|+|||||++|++++|..||.+..... .+.+++....
T Consensus 167 ~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~---~~~~~~~~~~ 233 (343)
T cd07880 167 QTDSEM----------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD---QLMEIMKVTG 233 (343)
T ss_pred ccccCc----------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcC
Confidence 543221 24467889999999876 358899999999999999999999998754322 2222221111
Q ss_pred CCc--------------------------hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 234 STP--------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 234 ~~p--------------------------~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+ ........+..+.+++..|+..+|.+||++.++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111 11122345677889999999999999999877654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=284.11 Aligned_cols=248 Identities=23% Similarity=0.317 Sum_probs=196.7
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
.++|++.+.||+|+||.||+|.+..++..||+|.+.... ....+.+|+.+++.+.| +++..+...+......++|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-p~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKH-PNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCC-CCeeehhheeeeCCcEEEEEe
Confidence 479999999999999999999988889999999876432 23457889999999875 666667666677788999999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
|+ +++|.+++.. ..++...+..++.|++.||.|||++|++|+||||+||++ +.++.++|+|||++........
T Consensus 97 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred cCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceeccccccc-
Confidence 99 7888888763 458899999999999999999999999999999999999 4788999999998875443221
Q ss_pred ccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhh
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~ 242 (414)
......|+..|+|||.+.+..++.++|+|||||++|++++|..||........ +..+... ..+......
T Consensus 171 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~---~~~~~~~--~~~~~~~~~ 239 (293)
T cd06647 171 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLIATN--GTPELQNPE 239 (293)
T ss_pred ------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh---eeehhcC--CCCCCCCcc
Confidence 11245688899999999988899999999999999999999999986433211 1111111 111111122
Q ss_pred cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 243 ~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+..+.+++..||..+|++||++.++..
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 34678999999999999999999987754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=299.43 Aligned_cols=244 Identities=21% Similarity=0.303 Sum_probs=197.0
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEe------cCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeee--CCeeE
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIE------NSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD--GEDNV 79 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~------~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~--~~~~~ 79 (414)
-.+...+||+|+|-+||+|.|..+|..||.--+ ......+.|..|+.+|+.|+| ++|..++..+.+ .+...
T Consensus 41 y~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H-~NIirfy~SW~d~~n~~in 119 (632)
T KOG0584|consen 41 YLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKH-PNIIRFYDSWVDTDNKTIN 119 (632)
T ss_pred eeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCC-CceeeeeeheecCCCceee
Confidence 346778999999999999999999999985422 222233568899999999987 455566544443 34477
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
+|+|++ .|+|..++.+ .+.++.+.++.|++||+.||.|||++. |||||||++||||+ ..-|.|||+|+|+|...
T Consensus 120 ~iTEL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeeecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHHh
Confidence 899999 9999988876 457899999999999999999999985 99999999999996 56789999999999877
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCc
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p 236 (414)
+.... +.++||+.|||||+.. ..|+..+||||||++++||+|+..||..-.. ..+.|.++.....+
T Consensus 197 r~s~a---------ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--~AQIYKKV~SGiKP-- 262 (632)
T KOG0584|consen 197 RKSHA---------KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--PAQIYKKVTSGIKP-- 262 (632)
T ss_pred hcccc---------ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC--HHHHHHHHHcCCCH--
Confidence 66543 3579999999999988 7899999999999999999999999986432 34666666554433
Q ss_pred hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 237 ~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+.+--.+++++||.+|+.. ..+||++.+|+.
T Consensus 263 -~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 263 -AALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -HHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 223333467999999999998 999999877654
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=277.76 Aligned_cols=247 Identities=23% Similarity=0.297 Sum_probs=196.8
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
+|.+.+.||.|+||.||+|.+..++..||+|.+... .....+.+|+.+++.++| +++..+...+......++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h-~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKH-PNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCC-CChhhhhheeccCCeEEEEEe
Confidence 689999999999999999999999999999987653 233457789999999976 556666666667788999999
Q ss_pred cc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 84 LL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
|+ +++|.+++.... ..+++..++.++.|++.||.|||+.+|+|+||||+||+++ +....++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc--CCCCeEEecccccchhccCCcc
Confidence 99 889988887533 3578999999999999999999999999999999999995 2334679999999876543221
Q ss_pred CccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhh
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~ 241 (414)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||...... +.+..+....... ..
T Consensus 158 -------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~----~~ 223 (257)
T cd08225 158 -------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH---QLVLKICQGYFAP----IS 223 (257)
T ss_pred -------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHhcccCCC----CC
Confidence 112346788999999998888999999999999999999999999864322 2233333322211 12
Q ss_pred hcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 242 ~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...+.++.+++.+||..+|++||++.++.+
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 224 PNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 345789999999999999999999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=286.48 Aligned_cols=249 Identities=21% Similarity=0.274 Sum_probs=186.9
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeee------
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV------ 73 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~------ 73 (414)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+|+.+++.++|.+ +..+..+..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~-iv~~~~~~~~~~~~~ 92 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN-VIGLLDVFTPARSLE 92 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCc-ccceeeeeeeccccc
Confidence 356899999999999999999999988999999998865321 234678999999998754 444433332
Q ss_pred eCCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 74 DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 74 ~~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
.....++++++++++|.+++. ...+++..++.++.|++.||+|||+.||+||||||+||++ +.++.++|+|||++
T Consensus 93 ~~~~~~lv~~~~~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~dfg~~ 167 (345)
T cd07877 93 EFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA 167 (345)
T ss_pred ccccEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCEEEeccccc
Confidence 123468999999999988775 3468999999999999999999999999999999999999 47889999999998
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (414)
+..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... .+..+....
T Consensus 168 ~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~ 234 (345)
T cd07877 168 RHTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLV 234 (345)
T ss_pred cccccc----------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHh
Confidence 754321 124567889999999876 468899999999999999999999997644322 222222211
Q ss_pred cCCchH--------------------------HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 233 VSTPIE--------------------------VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 233 ~~~p~~--------------------------~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...+.. ......+.++.+++..|+..+|.+||+..++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 111111 111123556777777777777777777665543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=291.96 Aligned_cols=264 Identities=22% Similarity=0.293 Sum_probs=208.6
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC---------CchhHHHHHHHHHHHcCCCCCCeeEEeee
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---------KHPQLLYEAKVYKILQGGSGIPNIKWYGV 73 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~ 73 (414)
+.+.++|-++..||.|+|++||+|-+...+.+||||+-.... ..+...+|..+.+.|.|+..+..+.++..
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 567889999999999999999999999999999999843322 12335688899999988665555556666
Q ss_pred eCCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc--CeeccccCCCceEEccCCCCCeEEEeeec
Q 015041 74 DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR--GFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (414)
Q Consensus 74 ~~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~iiHrDLkp~Nili~~~~~~~~vkL~DFG 151 (414)
+....|-|+|||.|+-.|++....+-+++++++.|+.||+.||.||.+. -|||-||||.|||+..+...|.+||+|||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 7788999999997777777776677899999999999999999999987 49999999999999888889999999999
Q ss_pred ceeeecCCCCCccccccCCCCCccCcCccccccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHH
Q 015041 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (414)
Q Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~ 227 (414)
+++.+.+...+............||.+|++||++.-+ ..+.++||||+|||+|.++.|+.||...-...+.-....
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 9999887776654444445678899999999998644 378899999999999999999999986433322222222
Q ss_pred HHh-hccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 228 ICE-KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 228 i~~-~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
|+. ....+|.. +....+.+.||++||.+.-++|.+..+|
T Consensus 699 IlkAtEVqFP~K---PvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 699 ILKATEVQFPPK---PVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred hhcceeccCCCC---CccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 222 22333322 2335789999999999999999775543
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=280.41 Aligned_cols=248 Identities=27% Similarity=0.401 Sum_probs=201.3
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|.+.+.||+|+||.||+|.+..+++.||+|+..... ....+..|+.++..+..+++++.+..++......++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999876532 2245778889999987467777776666777889999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||++ +++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccCCcc
Confidence 9999 9999998876 4479999999999999999999999999999999999999 478899999999987654332
Q ss_pred CCccc-------------cccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHH
Q 015041 161 TNRHI-------------PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (414)
Q Consensus 161 ~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~ 227 (414)
..... .........++..|+|||++.+..++.++|||||||+++++++|..||..... ...+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~ 233 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLTFQK 233 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHH
Confidence 21100 11223456788999999999988899999999999999999999999987542 233333
Q ss_pred HHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCCh
Q 015041 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 228 i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~ 266 (414)
+.......+ ..+++.+.+++..||+.+|++||++
T Consensus 234 ~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~R~~~ 267 (280)
T cd05581 234 ILKLEYSFP-----PNFPPDAKDLIEKLLVLDPQDRLGV 267 (280)
T ss_pred HHhcCCCCC-----CccCHHHHHHHHHHhcCCHhhCCCc
Confidence 333333333 3457899999999999999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=278.05 Aligned_cols=252 Identities=19% Similarity=0.333 Sum_probs=190.9
Q ss_pred eEEecceeecCceeEEEEEEC---CCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeC------
Q 015041 9 YKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDG------ 75 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~------ 75 (414)
|++.+.||+|+||.||+|.+. .+++.||||++..... ...+.+|+.+++.+.| +++..+..++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH-PNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCC-CCcceEEEEEccCCCCCcc
Confidence 678999999999999999864 4578999998865432 2347789999999976 5565565544322
Q ss_pred CeeEEEEecc-CCCHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEee
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYCR-----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~D 149 (414)
...+++++|+ +++|.+++.... ..++...++.++.|++.||+|||++||+||||||+||++ +.++.+||+|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEECc
Confidence 1236788888 788877764321 247889999999999999999999999999999999999 4788999999
Q ss_pred ecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHH
Q 015041 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKI 228 (414)
Q Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i 228 (414)
||+++....... +.......++..|++||.+.+..++.++|||||||++|+|++ |+.||.+..... ....+
T Consensus 157 fg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~ 228 (273)
T cd05074 157 FGLSKKIYSGDY-----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYL 228 (273)
T ss_pred ccccccccCCcc-----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHH
Confidence 999886533221 111123345678999999998899999999999999999999 899998754322 22222
Q ss_pred HhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 229 ~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
.... .... ....+..+.+++..||..+|++||++.++...|+.+
T Consensus 229 ~~~~-~~~~---~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 IKGN-RLKQ---PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HcCC-cCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2211 1111 124578999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=274.43 Aligned_cols=252 Identities=27% Similarity=0.423 Sum_probs=197.7
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
+|++.+.||+|+||.||+|.+..++..|++|.+..... ...+..|+.+++.+.| +++..+..........++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH-PNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCC-CChhheeeeEecCCEEEEEEe
Confidence 69999999999999999999988999999998776543 2457889999999976 566667666777788999999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
|+ +++|.+++.. ...+++..+..++.|++.||+|||+.||+|+||+|+||++ +..+.+||+|||++.........
T Consensus 80 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 80 YCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred cCCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEcccccccccCCCCCc
Confidence 99 7889888775 3458899999999999999999999999999999999999 47889999999998765443321
Q ss_pred ccccccCCCCCccCcCccccccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIE---QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
.. .......++..|+|||++.+.. .+.++|||||||++|++++|..||...... ......+.. ......+.
T Consensus 156 ~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~~~~~~~~-~~~~~~~~ 229 (264)
T cd06626 156 MG---EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQIMFHVGA-GHKPPIPD 229 (264)
T ss_pred cc---ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HHHHHHHhc-CCCCCCCc
Confidence 10 0012356788999999998776 889999999999999999999999865321 122222222 11111111
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
....+..+.+++..||..+|++||++.++..
T Consensus 230 -~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 230 -SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1234788999999999999999999887643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=286.50 Aligned_cols=250 Identities=21% Similarity=0.287 Sum_probs=188.9
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeee------
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVD------ 74 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~------ 74 (414)
+..+|.+.+.||+|+||.||+|.+..+++.||||.+..... ...+.+|+.+++.+.|. ++..+..++..
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE-NVIGLLDVFTSAVSGDE 91 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCC-CccchhheecccccCCC
Confidence 46799999999999999999999988999999998764321 23477899999999765 44444433322
Q ss_pred CCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 75 ~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
....++|++|+..+|..+. ...++...+..++.|++.||+|||+.+|+||||||+||++ +.++.++|+|||+++
T Consensus 92 ~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~kL~dfg~~~ 165 (342)
T cd07879 92 FQDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFGLAR 165 (342)
T ss_pred CceEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCCCCc
Confidence 2356899999987776553 4468999999999999999999999999999999999999 578899999999987
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHh---
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE--- 230 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~--- 230 (414)
..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+..+..
T Consensus 166 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (342)
T cd07879 166 HADAE----------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 235 (342)
T ss_pred CCCCC----------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 53221 124567889999999876 4589999999999999999999999987543221111111000
Q ss_pred -----------------hc---cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 231 -----------------KK---VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 231 -----------------~~---~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.. ............+.++.+++..||..+|++||++.++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 000111122345678899999999999999999887754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=275.70 Aligned_cols=249 Identities=24% Similarity=0.336 Sum_probs=193.1
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-------CchhHHHHHHHHHHHcCCCCCCeeEEeeee--CCe
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-------KHPQLLYEAKVYKILQGGSGIPNIKWYGVD--GED 77 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~--~~~ 77 (414)
.+|++.+.||+|+||.||+|.+..++..||+|.+.... ....+.+|+.+++.+.| +++..+..+... ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h-~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH-DRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCC-CCcceEEEEEEcCCCCE
Confidence 57999999999999999999999999999999865321 11346789999999986 445555444433 356
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
.++++||+ +++|.+.+.. ...++...++.++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||+++..
T Consensus 81 ~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcccccccc
Confidence 78999999 7789888765 3458899999999999999999999999999999999999 57888999999999865
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCc
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p 236 (414)
....... .......++..|+|||++.+..++.++|+|||||++|++++|+.||...... ..+.++... ..
T Consensus 157 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~---~~ 226 (264)
T cd06653 157 QTICMSG----TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---AAIFKIATQ---PT 226 (264)
T ss_pred ccccccC----ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---HHHHHHHcC---CC
Confidence 3321110 0112456889999999999888999999999999999999999999865322 222222221 11
Q ss_pred hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 237 ~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+..+..+++.+.+++.+||. ++..||+..++..
T Consensus 227 ~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 223345667899999999998 5799999886543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=282.10 Aligned_cols=244 Identities=24% Similarity=0.345 Sum_probs=195.2
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
..|...++||+|+||+||+|++..++..|++|.+..... ...+..|+.+++.++| ++++.+..++......++|
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv 99 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH-PNTIEYKGCYLKEHTAWLV 99 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCC-CCCccEEEEEEeCCEEEEE
Confidence 347778899999999999999999999999998764322 1346789999999975 6677777777778889999
Q ss_pred EeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 82 ~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
|||+.+++.+++......+++.+++.++.||+.||.|||++||+|+||+|+||++ +.++.++|+|||++.....
T Consensus 100 ~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 100 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCcccCC---
Confidence 9999889988887666678999999999999999999999999999999999999 4778999999998753211
Q ss_pred CccccccCCCCCccCcCcccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
.....|+..|+|||++. ...++.++|||||||++|+|++|..||........ ...+.....+ .
T Consensus 174 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~---~~~~~~~~~~---~ 239 (313)
T cd06633 174 --------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIAQNDSP---T 239 (313)
T ss_pred --------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhcCCC---C
Confidence 12457889999999985 35688999999999999999999999987543222 2222221111 1
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.....++..+.+++.+||+.+|.+||++.++..
T Consensus 240 ~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 240 LQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112345678999999999999999999887643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=280.04 Aligned_cols=250 Identities=23% Similarity=0.342 Sum_probs=202.5
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
.+.|++.+.||.|+||.||+|.+..++..|++|++..... ...+..|+++++.+.| +++..+...+......++++||
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKH-PNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCC-CCeeEEEEEEEECCEEEEEEec
Confidence 4679999999999999999999988899999998876543 4567889999999976 6677777777777889999999
Q ss_pred c-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 85 ~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
+ +++|.+++......++...+..++.|++.||.|||+.||+|+||+|+||++ +.++.++|+|||++........
T Consensus 97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~-- 171 (286)
T cd06614 97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFAAQLTKEKS-- 171 (286)
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchhhhhccchh--
Confidence 9 589999988654479999999999999999999999999999999999999 5788999999998765433221
Q ss_pred cccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhc
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~ 243 (414)
......++..|++||++.+..++.++|+|||||++|+|++|..||....... ....+..... .+.. ....
T Consensus 172 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~---~~~~~~~~~~-~~~~-~~~~ 241 (286)
T cd06614 172 -----KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR---ALFLITTKGI-PPLK-NPEK 241 (286)
T ss_pred -----hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhcCC-CCCc-chhh
Confidence 1124457889999999998889999999999999999999999998654332 2222222111 1111 1133
Q ss_pred ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 244 HPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 244 ~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
++..+.+++..||..+|.+||++.++.+
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 6789999999999999999999988755
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=278.99 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=194.7
Q ss_pred eEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc
Q 015041 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (414)
|++.+.||.|+||+||+|.+..+++.|+||.+..... .....+|+..+..+.+++++..+..++..+...++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 7889999999999999999988899999998765432 2234568888988884566777766666688899999999
Q ss_pred CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcc
Q 015041 86 GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (414)
Q Consensus 86 ~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~ 164 (414)
+++|.+.+.... ..+++..++.++.|++.+|.|||++|++|+||+|+||++ +..+.++|+|||++........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~--- 154 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPP--- 154 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccCCCC---
Confidence 999998887643 468999999999999999999999999999999999999 5789999999999876543221
Q ss_pred ccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc-----------
Q 015041 165 IPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK----------- 232 (414)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~----------- 232 (414)
.....++..|+|||++.+ ..++.++|+||||+++|+|++|..||..............+....
T Consensus 155 -----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 155 -----YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred -----cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 124567889999998854 457999999999999999999999998754332222211111100
Q ss_pred -----------cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 233 -----------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 233 -----------~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
............+..+.+++..||..+|++||++.++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000111112233678999999999999999999887644
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=278.55 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=193.3
Q ss_pred eEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeC--CeeEEEE
Q 015041 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG--EDNVLVL 82 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~--~~~~lv~ 82 (414)
|++.++||.|+||.||+|.+..+++.||+|.+.... ....+..|+.+++.+.| +++..+..+.... ...++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRH-PNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccC-CCeeeheeeEecCCCCcEEEEe
Confidence 788999999999999999999889999999887653 22347789999999986 4555555444444 7899999
Q ss_pred eccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 83 e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
||+.++|.+++......+++..++.++.||+.||+|||+.|++|+||||+||++ +.++.++|+|||++.........
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 80 EYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred ccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeeccCCCcc
Confidence 999889988887644579999999999999999999999999999999999999 57899999999999866544321
Q ss_pred ccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc--------
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV-------- 233 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 233 (414)
......++..|+|||.+.+. .++.++|||||||++|||++|..||...........+...+....
T Consensus 157 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 157 ------DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred ------cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccc
Confidence 11234567889999987754 579999999999999999999999987554322222221111000
Q ss_pred ----------CCc----hHHhhhc-ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 234 ----------STP----IEVLCKS-HPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 234 ----------~~p----~~~~~~~-~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+ ....... .+..+.+++..||..+|.+||++.++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 0011112 2778899999999999999999877644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=282.95 Aligned_cols=246 Identities=20% Similarity=0.300 Sum_probs=195.2
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
....|...+.||+|+||.||+|.+..+++.||+|.+..... ...+..|+++++.+.| +++..+..+.......+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH-PNTIQYRGCYLREHTAW 91 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCC-CCcccEEEEEEcCCeeE
Confidence 34568889999999999999999998999999998754211 2346789999999976 45555656666677889
Q ss_pred EEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 80 lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
+||||+.+++.+++......++..++..++.|++.||.|||+.+++||||||+||++ +.++.++|+|||++......
T Consensus 92 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCcccceeecCc
Confidence 999999889988887656678999999999999999999999999999999999999 47889999999998754321
Q ss_pred CCCccccccCCCCCccCcCcccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCc
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p 236 (414)
....++..|+|||.+. ...++.++|||||||++|+|++|..||......... ..+.......
T Consensus 169 -----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~~~~~- 233 (308)
T cd06634 169 -----------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHIAQNESPA- 233 (308)
T ss_pred -----------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH---HHHhhcCCCC-
Confidence 2456788999999985 345788999999999999999999999875433222 2222211111
Q ss_pred hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 237 ~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.....++..+.+++.+||..+|++||+++++.+
T Consensus 234 --~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 234 --LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred --cCcccccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence 112345788999999999999999999987765
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=271.79 Aligned_cols=247 Identities=25% Similarity=0.414 Sum_probs=199.9
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (414)
.|.+.+.||.|++|.||+|.+..++..|++|+..... ....+.+|+.+++.+.| +++..+..++......++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKH-PNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCC-CCEeEEEEEEecCCeEEEEEecC
Confidence 4889999999999999999998889999999987765 44568899999999984 66777777777778899999999
Q ss_pred -CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcc
Q 015041 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (414)
Q Consensus 86 -~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~ 164 (414)
+++|.+++......+++..+..++.|++.||.+||++|++|+||+|+||++ +.++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE---ccCCeEEEeecccccccccccc---
Confidence 589998887654679999999999999999999999999999999999999 4788999999999876543321
Q ss_pred ccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcC
Q 015041 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (414)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 244 (414)
.....++..|++||.+.+..++.++|+||||+++|+|++|..||........... +.... .+.......+
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~--~~~~~~~~~~ 223 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK---IATNG--PPGLRNPEKW 223 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HHhcC--CCCcCccccc
Confidence 1255778999999999988899999999999999999999999987543222211 11111 1111111123
Q ss_pred hHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 245 PAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 245 p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+..+.+++..||..+|++||++.++.+
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 788999999999999999999987654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=288.76 Aligned_cols=249 Identities=21% Similarity=0.301 Sum_probs=189.8
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeee-----C
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVD-----G 75 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~-----~ 75 (414)
+.++|++.+.||.|+||.||+|.+..++..||||++.... ....+.+|+.+++.+.|.+.+.....+... .
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 5689999999999999999999999999999999876432 223467899999999764444333322221 2
Q ss_pred CeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 76 ~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
...++|+||++++|.+++.. ..+++..++.++.|++.||+|||++||+|+||||+||++ +.++.++|+|||++..
T Consensus 93 ~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLARH 167 (343)
T ss_pred ccEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEcccccccc
Confidence 34899999999999988763 569999999999999999999999999999999999999 4788999999999875
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
.... .....++..|+|||.+.+. .++.++|||||||++|++++|+.||.+..... .+..+......
T Consensus 168 ~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~ 234 (343)
T cd07851 168 TDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGT 234 (343)
T ss_pred cccc----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCC
Confidence 4322 1244678899999998653 68899999999999999999999998654332 22222222111
Q ss_pred Cc--------------------------hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 235 TP--------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 235 ~p--------------------------~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+ ........++++.+++..||..+|++||++.+|..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 11 01111234677888888888888888888776643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=279.10 Aligned_cols=247 Identities=21% Similarity=0.297 Sum_probs=195.8
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
..|...++||.|++|.||+|.+..++..|++|.+.... ....+.+|+.+++.+.| +++..+..++......++++||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h-~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQH-PNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCC-CChheEEEEEEcCCeEEEEEec
Confidence 35677789999999999999998889999999876433 23347789999998875 5666676666777889999999
Q ss_pred c-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 85 ~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
+ +++|.+++.. ..++...+..++.|++.||+|||++||+||||+|+||++ +.++.++|+|||.+........
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 98 LEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhccCCc--
Confidence 9 7899888775 568999999999999999999999999999999999999 5788999999998765432211
Q ss_pred cccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhc
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~ 243 (414)
......|+..|+|||++.+..++.++|||||||++|+|++|..||...... ..+..+.... .+.......
T Consensus 171 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~---~~~~~~~~~~--~~~~~~~~~ 240 (285)
T cd06648 171 -----RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL---QAMKRIRDNL--PPKLKNLHK 240 (285)
T ss_pred -----ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH---HHHHHHHhcC--CCCCccccc
Confidence 112456889999999999888999999999999999999999999764332 2222222221 111111123
Q ss_pred ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 244 HPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 244 ~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+..+.+++.+||..+|++||++.++.+
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 5789999999999999999999877643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=273.46 Aligned_cols=246 Identities=23% Similarity=0.317 Sum_probs=199.8
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
+|++.+.||.|+||.||+|.+..++..||+|.+..... ...+..|+++++.++| +++..+..........++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNH-PNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCC-CChhheEEEEecCCEEEEEEE
Confidence 68999999999999999999998999999998876532 3457889999999985 556666555666688999999
Q ss_pred cc-CCCHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 84 LL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
++ +++|.+++.... ..++...+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE---cCCCcEEECCccceeecccC
Confidence 99 679999887643 679999999999999999999999999999999999999 47789999999999765443
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
.. ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...... +....+..... . .
T Consensus 157 ~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~~~~-~---~ 222 (258)
T cd08215 157 VD-------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---ELALKILKGQY-P---P 222 (258)
T ss_pred cc-------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---HHHHHHhcCCC-C---C
Confidence 21 112457889999999999989999999999999999999999999764422 22222222221 1 1
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+...++.++.+++..||..+|++||++.++.+
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 22356789999999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=275.73 Aligned_cols=234 Identities=21% Similarity=0.284 Sum_probs=188.6
Q ss_pred eeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-CCC
Q 015041 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (414)
Q Consensus 15 iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~~s 88 (414)
||.|+||.||+|.+..++..||+|++.... ....+.+|+.+++.+.| +++..+...+..+...++++||+ +++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNH-PFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCC-CCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 799999999999999889999999876533 22457889999999975 56666666667788899999998 789
Q ss_pred HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcccccc
Q 015041 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168 (414)
Q Consensus 89 L~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 168 (414)
|.+++.. ...++...+..++.||+.||+|||+++++|+||+|+||++ +.++.++|+|||++........
T Consensus 80 L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~------- 148 (262)
T cd05572 80 LWTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQK------- 148 (262)
T ss_pred HHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccc-------
Confidence 9988875 3468999999999999999999999999999999999999 4788999999999876543321
Q ss_pred CCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHH
Q 015041 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEF 248 (414)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~ 248 (414)
.....++..|++||.+.+..++.++|+||||+++|+|++|..||..... +..+.+.++.........+ ...++++
T Consensus 149 -~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~ 223 (262)
T cd05572 149 -TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-DPMEIYNDILKGNGKLEFP---NYIDKAA 223 (262)
T ss_pred -cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-CHHHHHHHHhccCCCCCCC---cccCHHH
Confidence 1245678899999999888899999999999999999999999987542 1233333433211222222 2337899
Q ss_pred HHHHHHHhcCCCCCCCC
Q 015041 249 ASYFHYCQSLTFDQRPD 265 (414)
Q Consensus 249 ~~l~~~c~~~~p~~RP~ 265 (414)
.+++.+||..+|++||+
T Consensus 224 ~~~i~~~l~~~p~~R~~ 240 (262)
T cd05572 224 KDLIKQLLRRNPEERLG 240 (262)
T ss_pred HHHHHHHccCChhhCcC
Confidence 99999999999999999
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=277.88 Aligned_cols=244 Identities=20% Similarity=0.336 Sum_probs=192.3
Q ss_pred ceEEecceeecCceeEEEEEEC---CCCceEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 8 KYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~---~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
.|++.+.||.|+||.||+|++. .+|..||+|++.... ....+..|+.++..+.++++++.+..++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999875 478999999876432 2245678999999998888998888777777888
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
++|+||+ +++|.+.+.. ...++...+..++.|++.||.|||+.|++||||+|+|||+ +.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceecc
Confidence 9999999 7789888775 4568899999999999999999999999999999999999 478899999999987654
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
..... ......|+..|+|||.+.+. .++.++|||||||++|+|++|..||...........+.+.+.... .
T Consensus 157 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~ 229 (290)
T cd05613 157 EDEVE------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-P 229 (290)
T ss_pred ccccc------ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC-C
Confidence 32211 11245688999999998764 468899999999999999999999975332222222222211111 1
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCC
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~ 265 (414)
+. ...++..+.+++.+||..+|++||+
T Consensus 230 ~~---~~~~~~~~~~ll~~~l~~~p~~R~~ 256 (290)
T cd05613 230 PY---PQEMSALAKDIIQRLLMKDPKKRLG 256 (290)
T ss_pred CC---CccCCHHHHHHHHHHhcCCHHHhcC
Confidence 11 2345788999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=279.32 Aligned_cols=252 Identities=21% Similarity=0.320 Sum_probs=197.5
Q ss_pred ceEEecceeecCceeEEEEEEC---CCCceEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 8 KYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~---~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
+|++.+.||+|+||.||+|++. .++..||||++.... ....+..|+.++..+.++++++.+...+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 467889999876432 2234678999999998888888887777777889
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
++||||+ +++|.+.+.. ...++...++.++.|++.||.|||+.+++|+||||+||++ +.++.++|+|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECccccccc
Confidence 9999999 6788887764 4568999999999999999999999999999999999999 477889999999987654
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHH-HHHHhhccC
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY-DKICEKKVS 234 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~-~~i~~~~~~ 234 (414)
..... ......|+..|+|||.+.+.. .+.++||||||+++|+|++|..||...........+ ..+......
T Consensus 157 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd05583 157 AEEEE------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP 230 (288)
T ss_pred ccccc------ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCC
Confidence 33211 112456889999999987765 788999999999999999999999753322211222 222222211
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
. ...++..+.+++.+||..+|++||++..+.+.|+
T Consensus 231 ~-----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 231 F-----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred C-----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 1 2345789999999999999999999887766554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=283.68 Aligned_cols=253 Identities=17% Similarity=0.195 Sum_probs=186.4
Q ss_pred ecceeec--CceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc
Q 015041 12 GRKIGSG--SFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (414)
Q Consensus 12 ~~~iG~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (414)
...||.| +||+||+|++..+++.||+|+....... ..+.+|+.+++.++| +++..+..++..+...++|+||+
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h-~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRH-PNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCcceEeeeEecCCceEEEEecc
Confidence 3567777 9999999999999999999998754322 346778888887775 66777777777888899999999
Q ss_pred -CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 86 -GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 86 -~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
++++.+++... ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++++||+.+..........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---eCCCcEEEechHHHhhhhccCccc
Confidence 67998888754 2458999999999999999999999999999999999999 477899999998654332211111
Q ss_pred cccccCCCCCccCcCccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCc-----
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP----- 236 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p----- 236 (414)
...+.......++..|+|||++.+. .++.++|||||||++|||++|..||.+...... +..........+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM---LLQKLKGPPYSPLDITT 235 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH---HHHHhcCCCCCCccccc
Confidence 1111112233456789999999764 478999999999999999999999987543211 111111000000
Q ss_pred -------------------------------------hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 237 -------------------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 237 -------------------------------------~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.......++..+.+++..||..+|++||+++++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00011234678999999999999999999988765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=276.47 Aligned_cols=238 Identities=22% Similarity=0.283 Sum_probs=186.6
Q ss_pred eeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-CCC
Q 015041 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (414)
Q Consensus 15 iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~~s 88 (414)
||+|+||+||+|.+..+|+.||+|++.... ....+..|+++++.++| +++..+..........++||||+ +++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS-RFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCC-CCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 699999999999999999999999876432 22345689999999974 66666766666777899999999 688
Q ss_pred HHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccccc
Q 015041 89 LEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167 (414)
Q Consensus 89 L~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 167 (414)
|.+++.... ..+++..++.++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~------- 149 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGK------- 149 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCC-------
Confidence 988876533 368999999999999999999999999999999999999 578899999999987543211
Q ss_pred cCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHH
Q 015041 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE 247 (414)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~ 247 (414)
......++..|+|||++.+..++.++|||||||++|+|++|+.||...........+... ....+. .....+++.
T Consensus 150 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~-~~~~~~~~~ 224 (277)
T cd05577 150 -KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR---TLEMAV-EYPDKFSPE 224 (277)
T ss_pred -ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc---cccccc-cCCccCCHH
Confidence 112446788999999999888999999999999999999999999875432222222111 111111 122345789
Q ss_pred HHHHHHHHhcCCCCCCCChHH
Q 015041 248 FASYFHYCQSLTFDQRPDYGF 268 (414)
Q Consensus 248 ~~~l~~~c~~~~p~~RP~~~~ 268 (414)
+.+++.+||..+|.+||++.+
T Consensus 225 ~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 225 AKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHHHHHHccCChhHccCCCc
Confidence 999999999999999995443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=277.25 Aligned_cols=245 Identities=19% Similarity=0.292 Sum_probs=193.1
Q ss_pred eEEecceeecCceeEEEEEECCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-
Q 015041 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (414)
|....+||+|+||.||+|....+++.||||.+.... ....+.+|+.+++.+.| ++++.+..++......++||||+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCC-cchhheeeEEEeCCEEEEEEecCC
Confidence 334568999999999999999999999999875433 23457889999999876 66767767777888999999999
Q ss_pred CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccc
Q 015041 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (414)
Q Consensus 86 ~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 165 (414)
+++|.+++. ...+++..+..++.|++.||+|||+.||+|+||+|+||++ +.++.++|+|||++........
T Consensus 101 ~~~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~---- 171 (292)
T cd06657 101 GGALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP---- 171 (292)
T ss_pred CCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceecccccc----
Confidence 667777654 3468999999999999999999999999999999999999 5778999999999875543221
Q ss_pred cccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcCh
Q 015041 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (414)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p 245 (414)
......|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+.........+ ....+.... .....+
T Consensus 172 ---~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~----~~~~~~~~~-~~~~~~ 243 (292)
T cd06657 172 ---RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI----RDNLPPKLK-NLHKVS 243 (292)
T ss_pred ---cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhhCCcccC-CcccCC
Confidence 123456889999999998888999999999999999999999999875433222221 111111111 113457
Q ss_pred HHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 246 AEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 246 ~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+.+++.+||..+|.+||++.++..
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 88999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=273.02 Aligned_cols=252 Identities=19% Similarity=0.295 Sum_probs=201.7
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
.+.+-+..||.|+||+|++..++.+|+..|||.++.... ..+++.|.+...+-..+++|+.+++....+...+|.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 445556789999999999999999999999998877654 34588888888777777888887776667788999999
Q ss_pred ccCCCHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhc-CeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 84 LLGPSLEDLFVYC----RRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 84 ~~~~sL~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
++..++..++.+. ...+++.-+-.|....+.||.||-.. .|||||+||+|||+ +..|.+||||||.+....+
T Consensus 144 LMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHHH
Confidence 9999999887643 35688888889999999999999965 89999999999999 6999999999999865544
Q ss_pred CCCCccccccCCCCCccCcCccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCc
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p 236 (414)
.-.. ..-.|...|||||.+.. ..|+.++|+||||++|||+.||..||++... ..+++..++....+.-
T Consensus 221 SiAk--------T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l 290 (361)
T KOG1006|consen 221 SIAK--------TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPIL 290 (361)
T ss_pred HHHh--------hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCee
Confidence 3221 24578899999999864 3589999999999999999999999998543 3344444433322211
Q ss_pred h-HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 237 I-EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 237 ~-~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
. +.-+-.+...+..+++.|+.+|-.+||.|.+|++
T Consensus 291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1 1122346788999999999999999999998876
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=275.86 Aligned_cols=252 Identities=21% Similarity=0.238 Sum_probs=196.3
Q ss_pred eEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
|++.++||+|+||.||+|++..+++.||+|++.... ....+..|+.+++.+.| +++..+..+.......++|+|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKH-PNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCC-CCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999887643 23456789999999875 5666666666666889999999
Q ss_pred cCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcc
Q 015041 85 LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (414)
Q Consensus 85 ~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~ 164 (414)
++++|.+++......+++..+..++.|++.||+|||+.||+|+||+|+||++ +.++.++|+|||.+........
T Consensus 80 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~--- 153 (282)
T cd07829 80 CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLR--- 153 (282)
T ss_pred cCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCCcc---
Confidence 9889999998754679999999999999999999999999999999999999 4789999999999876543221
Q ss_pred ccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhh------------
Q 015041 165 IPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK------------ 231 (414)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~------------ 231 (414)
......++..|+|||.+.+. .++.++|||||||++|||++|..||.+.........+......
T Consensus 154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 154 ----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred ----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccc
Confidence 11234457789999998877 7899999999999999999999999875543222222111110
Q ss_pred ---------ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 232 ---------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 232 ---------~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.............+..+.+++..||..+|++||+++++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000111122344678999999999999999999877643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=295.37 Aligned_cols=202 Identities=23% Similarity=0.360 Sum_probs=168.1
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCC---CCchhHHHHHHHHHHHcCCCCCCeeEEeee------eCC
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNIKWYGV------DGE 76 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~------~~~ 76 (414)
+.-+...+.||+|+||.||+|++..+|+.||||.++.. ...+..-+|++++++|+| ++|+.+..... ...
T Consensus 12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh-~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNH-PNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred CcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCc-hhhhhhcccCCccccCcccc
Confidence 34567788999999999999999999999999988763 334567899999999995 55555433222 234
Q ss_pred eeEEEEecc-CCCHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCe-EEEeeecc
Q 015041 77 DNVLVLDLL-GPSLEDLFVYC--RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ-VYIIDFGL 152 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~-vkL~DFG~ 152 (414)
..++||||| +|+|...++.. ...+++.+.+.++..++.||.|||++||+||||||.||++-.+.+... .||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 568999999 99999998743 346999999999999999999999999999999999999965543333 49999999
Q ss_pred eeeecCCCCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 015041 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGL 216 (414)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~ 216 (414)
|+...+... ...++||..|.+||+... ..|+..+|.|||||++|+++||..||...
T Consensus 171 Arel~d~s~--------~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 171 ARELDDNSL--------FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred cccCCCCCe--------eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 998766542 248899999999999994 78999999999999999999999999754
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=268.28 Aligned_cols=249 Identities=27% Similarity=0.372 Sum_probs=200.5
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeC--CeeEEE
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDG--EDNVLV 81 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~--~~~~lv 81 (414)
+|++.+.||+|++|.||+|.+..++..|++|++..... ...+.+|+.+++.+.| +++..+....... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQH-PNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCC-CCEeeEEEEEecCCCCeEEEE
Confidence 58899999999999999999998999999998876553 4457889999999986 5555565555555 778999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
+|++ +++|.+++... ..+++..+..++.|++.||+|||+.+++|+||+|+||+++ ..+.++|+|||.+.......
T Consensus 80 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 80 LEYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD---SDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEcccccEEeccccc
Confidence 9999 88999988764 3899999999999999999999999999999999999994 68899999999998765543
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
.. .......++..|+|||.+.+..++.++||||||+++|+|++|..||.... ........+....... ..
T Consensus 156 ~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~---~~ 225 (260)
T cd06606 156 TG-----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG--NPMAALYKIGSSGEPP---EI 225 (260)
T ss_pred cc-----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHhccccCCCc---CC
Confidence 21 01124567899999999998889999999999999999999999998755 1222222222211111 12
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
....+..+.+++.+|+..+|++||++.++..
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 2345789999999999999999999887654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=302.63 Aligned_cols=143 Identities=23% Similarity=0.465 Sum_probs=125.0
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|+++++||+|+||+||+|.+..+++.||||++..... ...+..|+.++..+.| ++++.+..++......++|
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS-PFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCC-CCcCeEEEEEEECCEEEEE
Confidence 689999999999999999999999999999999875432 1356788888888875 6677777777788899999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
|||+ +++|.+++.. ...+++..++.|+.||+.||+|||+++||||||||+|||+ +.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence 9999 8899998875 4568899999999999999999999999999999999999 478899999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=270.91 Aligned_cols=244 Identities=20% Similarity=0.307 Sum_probs=197.5
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
+|++.++||.|+||.||+|.+..+++.+|+|.+.... ....+..|+.+++.++| ++++.+..++......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNH-PNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCC-CCchhhhhhhccCCEEEEEeh
Confidence 5899999999999999999999999999999876532 22346788899999985 667777666667788999999
Q ss_pred cc-CCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 84 LL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 84 ~~-~~sL~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
|+ +++|.+++... ...+++..++.++.|++.||+|||+.|++|+||+|+||+++ ..+.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---ANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe---cCCcEEEeeccchhhhccC
Confidence 99 88898887642 35689999999999999999999999999999999999995 6788999999998765443
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
.. ....++..|++||.+.+..++.++|+||||+++|+|++|+.||....... ....+..... .+.
T Consensus 157 ~~---------~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~~~~~~~-~~~-- 221 (256)
T cd08530 157 MA---------KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRYKVQRGKY-PPI-- 221 (256)
T ss_pred Cc---------ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhcCCC-CCC--
Confidence 11 23467889999999999889999999999999999999999998754322 2222222222 122
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...++.++.+++.+||..+|++||++.++.+
T Consensus 222 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 222 -PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 2355789999999999999999999987754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=267.46 Aligned_cols=245 Identities=24% Similarity=0.362 Sum_probs=198.9
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
+|++.+.||+|++|.||+|.+..+++.|++|.+..... ...+.+|++++..+.| +++..+..++......+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKH-PNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCC-CCccEEEEEEEeCCEEEEEEe
Confidence 58999999999999999999988899999998776543 2457889999999976 566666666677788999999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
++ +++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++ .++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 80 YAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred cCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC---CCCCEEEeccccceecCCCccc
Confidence 99 67888888753 6789999999999999999999999999999999999994 6789999999999866543221
Q ss_pred ccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhh
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~ 242 (414)
.....++..|+|||...+..++.++||||||+++|+|++|..||...... ....++..... . ....
T Consensus 156 -------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~-~---~~~~ 221 (254)
T cd06627 156 -------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM---AALFRIVQDDH-P---PLPE 221 (254)
T ss_pred -------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHhccCC-C---CCCC
Confidence 12456789999999998888999999999999999999999999865432 22222221111 1 1224
Q ss_pred cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 243 ~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..++.+.+++..||..+|++||++.++..
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 55789999999999999999999887653
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=273.34 Aligned_cols=245 Identities=21% Similarity=0.264 Sum_probs=190.5
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-------CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
+|.+.++||+|+||.||+|.+..++..+++|+.+... ....+..|+.+++.++| +++..+..+.......++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH-PAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCC-CcHHHHHHHHhcCCceEE
Confidence 6999999999999999999998777777777654311 12245678888888876 555556555566678899
Q ss_pred EEecc-CCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 81 VLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 81 v~e~~-~~sL~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
|+||+ +++|.+++... ...+++..++.++.|++.||.|||++|++|+||||+||+++ ++.++|+|||++...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCceeec
Confidence 99999 77888877642 35689999999999999999999999999999999999993 456999999998765
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCc
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p 236 (414)
..... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... .....++.....
T Consensus 156 ~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~---~~~~~~~~~~~~--- 222 (260)
T cd08222 156 MGSCD-------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPT--- 222 (260)
T ss_pred CCCcc-------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHcCCC---
Confidence 43322 12245678899999999888899999999999999999999999975332 222223222211
Q ss_pred hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 237 ~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+.....++.++.+++..||..+|++||++.++.+
T Consensus 223 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 -PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1122455789999999999999999999987754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=289.86 Aligned_cols=241 Identities=21% Similarity=0.266 Sum_probs=199.1
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (414)
...|.+...+|.|+|+.|-.+.+..+++..++|++.... .+..+|+.++....+|+++..+.....++.+.++|||++
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~--~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l 398 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA--DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL 398 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc--cccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence 467899999999999999999999999999999988773 234578888888889999999988888999999999999
Q ss_pred -CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcc
Q 015041 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (414)
Q Consensus 86 -~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~ 164 (414)
++-+.+-+.+ .+.+. .++..|+.||+.|+.|||++|||||||||+|||+. +..++++|+|||.++......
T Consensus 399 ~g~ell~ri~~-~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~~---- 470 (612)
T KOG0603|consen 399 DGGELLRRIRS-KPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELERSC---- 470 (612)
T ss_pred cccHHHHHHHh-cchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCchhh----
Confidence 5555555543 22233 78889999999999999999999999999999994 478999999999998765541
Q ss_pred ccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcC
Q 015041 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (414)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 244 (414)
.+.+-|..|.|||++...+|+.++||||||++||+|++|+.||...... .+...++...+.. ...
T Consensus 471 ------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~~~~~s-------~~v 535 (612)
T KOG0603|consen 471 ------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQMPKFS-------ECV 535 (612)
T ss_pred ------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhcCCccc-------ccc
Confidence 1345689999999999999999999999999999999999999975443 2333333222211 456
Q ss_pred hHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 245 PAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 245 p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+++.++|+++||+.+|.+||++.++..
T Consensus 536 S~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 536 SDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred CHHHHHHHHHhccCChhhCcChhhhcc
Confidence 889999999999999999999987744
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=299.58 Aligned_cols=260 Identities=21% Similarity=0.302 Sum_probs=210.5
Q ss_pred ccCCceEEecceeecCceeEEEEEEC---C----CCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHV---D----TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV 73 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~---~----~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~ 73 (414)
+-..+..+.+.||+|.||.||+|... . ....||||..+..... ..+..|+++++.+.+|+++..+.+++.
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 34455678889999999999999743 1 1567999988765543 568899999999999999999988888
Q ss_pred eCCeeEEEEecc-CCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEc
Q 015041 74 DGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137 (414)
Q Consensus 74 ~~~~~~lv~e~~-~~sL~~~~~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~ 137 (414)
.....++|+||+ .|+|.++++.++ ..++..+.+.++.||+.|++||+++.+|||||.++|||++
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 888999999999 899999998766 3488999999999999999999999999999999999994
Q ss_pred cCCCCCeEEEeeecceeeecCCCCCccccccCCCCCc--cCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 015041 138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQ 214 (414)
Q Consensus 138 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~ 214 (414)
.+..+||+|||+|+......... .+.-. -...|||||.+....|+.++||||||++||||++ |..||.
T Consensus 453 ---~~~~~kIaDFGlar~~~~~~~y~------~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp 523 (609)
T KOG0200|consen 453 ---KNKVIKIADFGLARDHYNKDYYR------TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP 523 (609)
T ss_pred ---CCCEEEEccccceeccCCCCceE------ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence 77899999999998654433211 01111 2456999999999999999999999999999999 999999
Q ss_pred CChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 215 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 215 ~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
+..... ..+ +.+....+...+.. +++++.++|..||+.+|++||+|.++.+.|...+.
T Consensus 524 ~~~~~~--~l~-~~l~~G~r~~~P~~---c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 524 GIPPTE--ELL-EFLKEGNRMEQPEH---CSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCCcHH--HHH-HHHhcCCCCCCCCC---CCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 844221 112 23344444444444 48999999999999999999999999999998654
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=270.39 Aligned_cols=249 Identities=24% Similarity=0.374 Sum_probs=193.7
Q ss_pred eeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-CCC
Q 015041 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (414)
Q Consensus 15 iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~~s 88 (414)
||.|+||.||+|.+..+++.|++|++..... ...+.+|+.+++.+.| ++++.+..........++++|++ +++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQS-PYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCC-cchhHHHHheecCcEEEEEEecCCCCc
Confidence 6899999999999998899999998865432 2357788899999975 56666666666778899999999 779
Q ss_pred HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc-cccc
Q 015041 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR-HIPY 167 (414)
Q Consensus 89 L~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~-~~~~ 167 (414)
|.+++... ..+++..++.++.||+.||+|||+++++|+||+|+||++ +.++.++|+|||++.......... ....
T Consensus 80 L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 80 LASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCccccccccc
Confidence 98888763 478999999999999999999999999999999999999 578899999999987543321100 0000
Q ss_pred cCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHH
Q 015041 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE 247 (414)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~ 247 (414)
.......++..|++||.+.+..++.++||||||+++|++++|..||...... +.+..+.......+.. ...+..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~---~~~~~~ 229 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---EIFQNILNGKIEWPED---VEVSDE 229 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhcCCcCCCcc---ccCCHH
Confidence 1123456788999999999888999999999999999999999999865432 3333333323332221 124789
Q ss_pred HHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 248 FASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 248 ~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
+.+++..||..+|.+||++..+.+.++
T Consensus 230 ~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 230 AIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 999999999999999999966655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=268.50 Aligned_cols=270 Identities=20% Similarity=0.304 Sum_probs=217.5
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
..|.+++.||.|+|+.|.+++.++|.+.+|+|++++ +.+....+.|-.+.....+++.++-+..++......++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 579999999999999999999999999999998654 334445678888888887777777778888888999999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
.||. ||+|--.+.. .++++++.++.+..+|+.||.|||+.|||+||||.+|+|+ +..+.+||+|+|+++....+.
T Consensus 330 ieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCCCCC
Confidence 9999 7777655554 5679999999999999999999999999999999999999 699999999999998765554
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC--Chh--hch-HHHHHHHHhhccCC
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG--LKA--ATK-KQKYDKICEKKVST 235 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~--~~~--~~~-~~~~~~i~~~~~~~ 235 (414)
. ...+++||+.|.|||++.+.+|+..+|+|+||++++||+.|+.||.- +.+ .+. .-.++-|+++..++
T Consensus 406 d-------~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri 478 (593)
T KOG0695|consen 406 D-------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI 478 (593)
T ss_pred c-------ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc
Confidence 3 23589999999999999999999999999999999999999999972 222 122 22344566777776
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCccccccccccc
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQ 296 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l~~~ 296 (414)
|. +++.....+++..+.+||.+|....- ..-|.+ -.+..+....||.++...
T Consensus 479 pr-----slsvkas~vlkgflnkdp~erlgc~~-~~g~~d---ik~h~ffr~idwd~leqk 530 (593)
T KOG0695|consen 479 PR-----SLSVKASHVLKGFLNKDPKERLGCRP-QTGFSD---IKSHAFFRSIDWDLLEQK 530 (593)
T ss_pred cc-----eeehhhHHHHHHhhcCCcHHhcCCCc-ccchhh---hhcchhhhhCCHHHHhhc
Confidence 63 44677889999999999999975321 112222 234556667899876543
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=315.11 Aligned_cols=250 Identities=25% Similarity=0.369 Sum_probs=199.4
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
-++.-+.+||.|.||.||-|.+..+|+..|+|-++.... -+.+.+|..++..+.| ++++..++.....+..+|.|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnH-pNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNH-PNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccC-ccccccCceeecHHHHHHHH
Confidence 467778899999999999999999999999996654332 2457889999999986 56666767777788899999
Q ss_pred ecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
||| +|+|.+++.. ++..++.....+..|++.||.|||+.|||||||||+||++ +.++.+|++|||.|+...+...
T Consensus 1314 EyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccceeEecCchh
Confidence 999 9999999875 4556777778889999999999999999999999999999 5889999999999988765521
Q ss_pred CccccccCCCCCccCcCccccccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHH-HhhccCCch
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIE---QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI-CEKKVSTPI 237 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i-~~~~~~~p~ 237 (414)
. +| .+-....||+.|||||++.+-. -..++|||||||++.||+||+.||..++.. .+.+..+ ...+...|
T Consensus 1390 ~--~~-~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~aIMy~V~~gh~Pq~P- 1463 (1509)
T KOG4645|consen 1390 T--MP-GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WAIMYHVAAGHKPQIP- 1463 (1509)
T ss_pred c--CC-HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--hHHHhHHhccCCCCCc-
Confidence 1 11 2334778999999999998643 567899999999999999999999876532 2222232 23333333
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..++.+-.+|+..|+..||..|-++.+|++
T Consensus 1464 ----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1464 ----ERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ----hhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 335788999999999999999977665544
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=291.01 Aligned_cols=250 Identities=20% Similarity=0.340 Sum_probs=207.7
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeee-----eCCeeE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGV-----DGEDNV 79 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~-----~~~~~~ 79 (414)
...|.|.+.||.|.+|.||+++...+++.+|+||...... +.++..|.++++.+.+|++++.+++++. .++.++
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 4678999999999999999999999999999999887765 4557888999999999999999977665 356789
Q ss_pred EEEecc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 80 LVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
+||||| +|+.-|+.+.. +..+.+..+.+|++.++.||.+||...+||||||-.|||++ ..+.|||+|||++....
T Consensus 98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT---~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLD 174 (953)
T ss_pred EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe---ccCcEEEeeeeeeeeee
Confidence 999999 88999998754 46689999999999999999999999999999999999995 89999999999987655
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGI-----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (414)
..-. ...+.+||+.|||||++... .|+.++|+||||++..||.-|.+|+-++-.. ..+. ...
T Consensus 175 sT~g-------rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm---raLF---~Ip 241 (953)
T KOG0587|consen 175 STVG-------RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM---RALF---LIP 241 (953)
T ss_pred cccc-------cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh---hhhc---cCC
Confidence 4322 22478999999999999744 3788999999999999999999999887543 1222 222
Q ss_pred cCCchHH-hhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 233 VSTPIEV-LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 233 ~~~p~~~-~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+|+.. -++.+.++|.+||..|+.+|.+.||...++.+
T Consensus 242 RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 242 RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 2222222 24567899999999999999999999876643
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=274.68 Aligned_cols=247 Identities=18% Similarity=0.234 Sum_probs=180.2
Q ss_pred CceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-CCCHHHHH
Q 015041 19 SFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLF 93 (414)
Q Consensus 19 ~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~~sL~~~~ 93 (414)
+++.||+++...+++.||||++.... ....+..|+.+++.++| +++..+..++......+++|||+ +++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQH-PNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCC-cchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 44556666666789999999876542 22457899999999986 45555555666777899999999 68888888
Q ss_pred HHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccccccCCCC
Q 015041 94 VYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172 (414)
Q Consensus 94 ~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~ 172 (414)
... ...+++..+..++.|++.||+|||+++|+||||||+||++ +.++.++|+|||.+...................
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~ 167 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE---ecCCceEEecCccceeecccccccccccccccc
Confidence 753 3468999999999999999999999999999999999999 477899999999987654332211111112234
Q ss_pred CccCcCccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc---------------c--
Q 015041 173 LTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK---------------V-- 233 (414)
Q Consensus 173 ~~gt~~y~aPE~~~~~--~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~---------------~-- 233 (414)
..++..|+|||++.+. .++.++|||||||++|||++|..||....... ....++.... .
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (314)
T cd08216 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQ 245 (314)
T ss_pred ccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcCc
Confidence 5678899999998763 58899999999999999999999998653321 1111111000 0
Q ss_pred -----------CCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 234 -----------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 234 -----------~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..........++.++.+++..||..+|++||+++++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 246 SRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred ccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00000111233467889999999999999999887655
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=286.52 Aligned_cols=264 Identities=21% Similarity=0.296 Sum_probs=210.6
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
.+++++..||.|+||.|=+++.......+|+|++++.. ..+.+..|-.++.... .+.|+.++--+.+.++.||.
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhhhh
Confidence 45677888999999999999886655568999877643 2234677888888776 57788887777889999999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||-| ||.|...++. ++.|...++..++..++.|++|||++|||+|||||+|.|+ +.+|-+||.|||+|+......
T Consensus 499 mEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 499 MEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred HHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccCC
Confidence 9999 9999999876 6789999999999999999999999999999999999999 699999999999998766543
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
. ..+++||+.|.|||++++..-+..+|.||||+++||+++|++||.+.++. ..|..|+...-.. .+
T Consensus 575 K--------TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm---ktYn~ILkGid~i---~~ 640 (732)
T KOG0614|consen 575 K--------TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM---KTYNLILKGIDKI---EF 640 (732)
T ss_pred c--------eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH---HHHHHHHhhhhhh---hc
Confidence 2 34899999999999999999999999999999999999999999986554 3444443322111 12
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCccccccccc
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK 294 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l~ 294 (414)
++.++....++++.+-..+|.+|..+. ..-+.+ -..+.|...|||.-|.
T Consensus 641 Pr~I~k~a~~Lik~LCr~~P~ERLG~~--~~gI~D---IkkH~Wf~gfdweglr 689 (732)
T KOG0614|consen 641 PRRITKTATDLIKKLCRDNPTERLGYQ--KGGIND---IKKHRWFEGFDWEGLR 689 (732)
T ss_pred ccccchhHHHHHHHHHhcCcHhhhccc--cCChHH---HHhhhhhhcCChhhhh
Confidence 245577888999999999999998642 111122 2334677788997653
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=260.92 Aligned_cols=234 Identities=26% Similarity=0.376 Sum_probs=190.3
Q ss_pred eeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-CCC
Q 015041 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (414)
Q Consensus 15 iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~~s 88 (414)
||.|+||.||+|.+..+++.||+|++..... ...+..|+.+++.+.| +++..+...+..+...+++||++ +++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINH-PFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCC-CcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 6999999999999988899999998765432 2357889999999985 55666656666778899999999 899
Q ss_pred HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcccccc
Q 015041 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168 (414)
Q Consensus 89 L~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 168 (414)
|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||++ +..+.++|+|||++........
T Consensus 80 L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~------- 148 (250)
T cd05123 80 LFSHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGS------- 148 (250)
T ss_pred HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---cCCCcEEEeecCcceecccCCC-------
Confidence 9888875 3468999999999999999999999999999999999999 4788999999999876543321
Q ss_pred CCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHH
Q 015041 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEF 248 (414)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~ 248 (414)
......++..|+|||.+.+..++.++|+||||+++|++++|..||..... .+....+.......+ ...+..+
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~-----~~~~~~l 220 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILKDPLRFP-----EFLSPEA 220 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhcCCCCCC-----CCCCHHH
Confidence 11355678899999999988899999999999999999999999976433 233334433333222 3447899
Q ss_pred HHHHHHHhcCCCCCCCChHH
Q 015041 249 ASYFHYCQSLTFDQRPDYGF 268 (414)
Q Consensus 249 ~~l~~~c~~~~p~~RP~~~~ 268 (414)
.+++.+||..+|++||++.+
T Consensus 221 ~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 221 RDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHhcCCHhhCCCccc
Confidence 99999999999999999843
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=266.65 Aligned_cols=258 Identities=23% Similarity=0.289 Sum_probs=195.5
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHc-CCCCCCeeEEeeee----CCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ-GGSGIPNIKWYGVD----GEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~-~~~~i~~l~~~~~~----~~~~~lv 81 (414)
...++.+.||+|.||.||+|+. +++.||||++..... +.+.+|-+++.... .|++|..+.....- ...++||
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~k-qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEK-QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHH-HHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 3467788999999999999986 579999999877543 56888888876542 34556555444433 3478999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---------cCeeccccCCCceEEccCCCCCeEEEeeec
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS---------RGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---------~~iiHrDLkp~Nili~~~~~~~~vkL~DFG 151 (414)
++|. .|+|.+++. ...++|....+|+..|++||+|||+ ..|+|||||.+|||+ ..+.+..|+|||
T Consensus 287 t~fh~kGsL~dyL~--~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIaDFG 361 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLK--ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIADFG 361 (534)
T ss_pred eeeccCCcHHHHHH--hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEeeccc
Confidence 9998 999999998 4678999999999999999999995 359999999999999 689999999999
Q ss_pred ceeeecCCCCCccccccCCCCCccCcCccccccccCCC-CC-----chhhHHHHHHHHHHHHcCC------------CCC
Q 015041 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QS-----RRDDLESLGYVLLYFLRGS------------LPW 213 (414)
Q Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~~~DiwSlG~il~el~tG~------------~Pf 213 (414)
+|..+...... .....-+||.+|||||++.+.- +. .+.||||+|.++|||++.. +||
T Consensus 362 LAl~~~p~~~~-----~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf 436 (534)
T KOG3653|consen 362 LALRLEPGKPQ-----GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF 436 (534)
T ss_pred eeEEecCCCCC-----cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence 99887632211 1223468999999999998753 22 4689999999999999853 333
Q ss_pred CCC-h-hhchHHHHHHHHhhccCCchHHhhhc--ChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 015041 214 QGL-K-AATKKQKYDKICEKKVSTPIEVLCKS--HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (414)
Q Consensus 214 ~~~-~-~~~~~~~~~~i~~~~~~~p~~~~~~~--~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~ 277 (414)
+.. . .....+.-.-++.++.++-++..+.. ...-+.+.+..||+.|++.|.++.-+.+.+.++.
T Consensus 437 e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 437 EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 310 0 11122333345566666655554443 3466899999999999999999998888777654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=280.02 Aligned_cols=253 Identities=21% Similarity=0.260 Sum_probs=203.8
Q ss_pred eEEecceeecCceeEEEEEECCCCc----eEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 9 YKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
.+..++||+|+||+||+|.|.-.|+ .||+|++..... ..+++.|+-++..|.|.+.+ ++..++.... ..||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~-RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLL-RLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHH-HHhhhcccch-HHHH
Confidence 4557889999999999999975555 688887765543 45688999999999875544 4444433222 7789
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
++|+ .|.|.|+++..+.++..+..+.|..||++||.|||.++++||||..+|||+ .....+||.|||+|+......
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccCccc
Confidence 9999 999999999988899999999999999999999999999999999999999 588999999999998765443
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
..-+. ....-.+.|||-|.+....|+.++|||||||++||++| |..||++....+.... ++...+.+-+
T Consensus 853 ~ey~~-----~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl----le~geRLsqP- 922 (1177)
T KOG1025|consen 853 KEYSA-----PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL----LEKGERLSQP- 922 (1177)
T ss_pred ccccc-----cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH----HhccccCCCC-
Confidence 32111 12223578999999999999999999999999999999 9999999876544333 3333333333
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
+.++.++..++-+||..|++.||.|+++...|.+..+
T Consensus 923 --piCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 923 --PICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred --CCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 3448899999999999999999999999999887764
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=274.21 Aligned_cols=252 Identities=22% Similarity=0.309 Sum_probs=192.1
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
|-..-|..++.||-|+||+|.+++...|...+|+|.+.+... -.....|-.||.... .+-++.+++.+.+.+.+
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEEEEEeccCCce
Confidence 345678899999999999999999999999999997765431 112445666666543 36678888888999999
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
|+||+|. ||++-.++.+ -+-|.+..+++++.++.+|+++.|..|+|||||||+|||| |.+|++||+||||+..++
T Consensus 705 YFVMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EEEEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccce
Confidence 9999999 9998888876 4568999999999999999999999999999999999999 799999999999987544
Q ss_pred CCCCCccc---------------------------ccc--------CCCCCccCcCccccccccCCCCCchhhHHHHHHH
Q 015041 158 DPTTNRHI---------------------------PYR--------ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYV 202 (414)
Q Consensus 158 ~~~~~~~~---------------------------~~~--------~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~i 202 (414)
..+..... ..+ ..-.++||..|+|||++....|+..+|+||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 32221100 000 0124689999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCC
Q 015041 203 LLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265 (414)
Q Consensus 203 l~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~ 265 (414)
||||+.|++||..........++.. .+.-+.++ .|.+++.+..++|.++. ..++.|..
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~n-w~~~l~~~---~~~~ls~e~~~li~kLc-~sad~RLG 918 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVIN-WRNFLHIP---YQGNLSKEALDLIQKLC-CSADSRLG 918 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeeee-hhhccccc---cccccCHHHHHHHHHHh-cChhhhhc
Confidence 9999999999987654432222111 12222332 34566777777776544 36778864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=285.94 Aligned_cols=199 Identities=23% Similarity=0.279 Sum_probs=140.0
Q ss_pred CCceEEecceeecCceeEEEEEECCC----CceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEE----e-eeeCC
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDT----NEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKW----Y-GVDGE 76 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~----~-~~~~~ 76 (414)
.++|.+.++||+|+||.||+|++..+ +..||||.+...........|. +....+......+.. . .....
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~--l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNER--VRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHH--HHhhchhhHHHHHHhhhcccccccCC
Confidence 46899999999999999999999888 8999999876433222211111 111111111111111 1 23556
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCC-------------------CHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEE
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKF-------------------SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 136 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~-------------------~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili 136 (414)
..++|+||+ +++|.+++......+ ....+..++.||+.||+|||+++|+||||||+|||+
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl 288 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF 288 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEE
Confidence 789999999 778888876432111 123466899999999999999999999999999999
Q ss_pred ccCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCC----------------------CCCchh
Q 015041 137 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI----------------------EQSRRD 194 (414)
Q Consensus 137 ~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~~ 194 (414)
+ ++.+.+||+|||+|+........ ......+|+.|+|||.+... .++.++
T Consensus 289 ~--~~~~~~KL~DFGlA~~l~~~~~~------~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 289 S--EGSGSFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred e--CCCCcEEEEeCCCcccccccccc------CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 4 34578999999999765432211 12356789999999976432 234567
Q ss_pred hHHHHHHHHHHHHcCCCCCC
Q 015041 195 DLESLGYVLLYFLRGSLPWQ 214 (414)
Q Consensus 195 DiwSlG~il~el~tG~~Pf~ 214 (414)
|||||||++|||+++..++.
T Consensus 361 DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCc
Confidence 99999999999999877654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=255.18 Aligned_cols=220 Identities=17% Similarity=0.165 Sum_probs=172.3
Q ss_pred cCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-CCCHHHHHHHh
Q 015041 18 GSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC 96 (414)
Q Consensus 18 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~~sL~~~~~~~ 96 (414)
|.||.||+|++..+++.||+|.+..... ...|...+.... +++++.+..++......+++|||+ +++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~---~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~- 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE---YSRERLTIIPHC-VPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK- 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh---hhhHHHHHHhcC-CCceeehhhheecCCeEEEEEecCCCCCHHHHHHH-
Confidence 8999999999999999999998876532 233433333333 467777777777788899999999 7899888765
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccC
Q 015041 97 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176 (414)
Q Consensus 97 ~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt 176 (414)
...+++..+..++.|++.||+|||++||+||||||+||++ +.++.++|+|||.+....... ....++
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~~----------~~~~~~ 145 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDSC----------DGEAVE 145 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhcccccc----------ccCCcC
Confidence 3468999999999999999999999999999999999999 578889999999876543221 123456
Q ss_pred cCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHh
Q 015041 177 ARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQ 256 (414)
Q Consensus 177 ~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~ 256 (414)
..|+|||.+.+..++.++|+||+||++|||++|..||...... . ....... ....+++.+.+++.+|+
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~----~~~~~~~---~~~~~~~~~~~li~~~l 213 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I----NTHTTLN---IPEWVSEEARSLLQQLL 213 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c----ccccccC---CcccCCHHHHHHHHHHc
Confidence 7899999998888999999999999999999999888643211 0 0000111 11345788999999999
Q ss_pred cCCCCCCCChH
Q 015041 257 SLTFDQRPDYG 267 (414)
Q Consensus 257 ~~~p~~RP~~~ 267 (414)
+.||++||+..
T Consensus 214 ~~dp~~R~~~~ 224 (237)
T cd05576 214 QFNPTERLGAG 224 (237)
T ss_pred cCCHHHhcCCC
Confidence 99999999863
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=291.54 Aligned_cols=256 Identities=21% Similarity=0.264 Sum_probs=185.3
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEe------------
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWY------------ 71 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~------------ 71 (414)
.+|..++.||+||||.||+|+.+-+|+.||||.+..... ...+.+|+.++.+|+|++.+..+..+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 467888999999999999999999999999998776542 23478899999999874332111000
Q ss_pred ---------------------------------------------e--------------------------e-----e-
Q 015041 72 ---------------------------------------------G--------------------------V-----D- 74 (414)
Q Consensus 72 ---------------------------------------------~--------------------------~-----~- 74 (414)
. . +
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence 0 0 0
Q ss_pred ---------------------C--------CeeEEEEeccCCCHHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhcCe
Q 015041 75 ---------------------G--------EDNVLVLDLLGPSLEDLFVYCRRKF-SLKTVLMLADQMIARIEYVHSRGF 124 (414)
Q Consensus 75 ---------------------~--------~~~~lv~e~~~~sL~~~~~~~~~~~-~~~~~~~i~~qi~~aL~~LH~~~i 124 (414)
. ...||-||||..++...+....... .....+++++||+.||.|+|++||
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi 718 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI 718 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence 0 2247889999666665555423222 478899999999999999999999
Q ss_pred eccccCCCceEEccCCCCCeEEEeeecceeeec----------CCCCCccc-cccCCCCCccCcCccccccccCCC---C
Q 015041 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR----------DPTTNRHI-PYRENKNLTGTARYASCNTHLGIE---Q 190 (414)
Q Consensus 125 iHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~----------~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~---~ 190 (414)
|||||||.||++ +.++.|||+|||+|.... .+.....- ........+||.-|+|||++.+.. |
T Consensus 719 IHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 719 IHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred eeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 999999999999 699999999999998621 00111111 111234678999999999998765 9
Q ss_pred CchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 191 SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 191 s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
+.|+||||||+||+||+ .||.. ..+....+..+....++.+.......+ +.-+.+|..+++.||.+||++.+|.
T Consensus 796 n~KiDmYSLGIVlFEM~---yPF~T--sMERa~iL~~LR~g~iP~~~~f~~~~~-~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEML---YPFGT--SMERASILTNLRKGSIPEPADFFDPEH-PEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred cchhhhHHHHHHHHHHh---ccCCc--hHHHHHHHHhcccCCCCCCcccccccc-hHHHHHHHHHhcCCCccCCCHHHHh
Confidence 99999999999999999 46764 333444444444444444411122222 3567899999999999999998876
Q ss_pred H
Q 015041 271 R 271 (414)
Q Consensus 271 ~ 271 (414)
+
T Consensus 870 ~ 870 (1351)
T KOG1035|consen 870 N 870 (1351)
T ss_pred h
Confidence 5
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=300.65 Aligned_cols=249 Identities=13% Similarity=0.153 Sum_probs=187.1
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (414)
..|+..+.||+|+||.||+|++..++..||||.+..... ....|++++++++| ++|+.+..++......++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~l~~l~H-pnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--IPSSEIADMGKLQH-PNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--ccHHHHHHHhhCCC-CCcceEEEEEEcCCCCEEEEeCCC
Confidence 346667889999999999999988999999998765432 22456888888865 67777877777888899999999
Q ss_pred CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH---SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 86 ~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
+++|.+++. .+++..+..|+.|++.||+||| +.+|+||||||+||++ +..+..++. ||.+.....
T Consensus 767 ~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~---~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 767 GKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred CCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE---CCCCceEEE-ecccccccc----
Confidence 889998875 3789999999999999999999 6799999999999999 455666654 555432211
Q ss_pred ccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhh--chHHHHHH---------HHhh
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA--TKKQKYDK---------ICEK 231 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~--~~~~~~~~---------i~~~ 231 (414)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...... ...+.... +.+.
T Consensus 835 -------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (968)
T PLN00113 835 -------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDP 907 (968)
T ss_pred -------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCc
Confidence 11336789999999999999999999999999999999999999642211 11111110 0000
Q ss_pred ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 232 ~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
....... .......++.+++..||..+|++||++.++.+.|+.+..
T Consensus 908 ~~~~~~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 908 SIRGDVS-VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cccCCCC-ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 0000000 001113467889999999999999999999999987754
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=243.89 Aligned_cols=282 Identities=18% Similarity=0.301 Sum_probs=196.2
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeee--eCCeeEEEEe
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV--DGEDNVLVLD 83 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~--~~~~~~lv~e 83 (414)
..+|++.+++|.|-|++||.|....+++.++||+++.- +.+.+.+|+++|..|.++++|..+..... ..+-..+++|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 46899999999999999999999999999999998764 34568999999999998888877754433 3455679999
Q ss_pred ccC-CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 84 LLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 84 ~~~-~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
+.. .+...+ -..++..++..++.|++.||.|+|++||+|||+||.|+||+ .....++|+|+|+|..+.....
T Consensus 116 ~v~n~Dfk~l----y~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEFYHp~~e- 188 (338)
T KOG0668|consen 116 YVNNTDFKQL----YPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKE- 188 (338)
T ss_pred hhccccHHHH----hhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhhcCCCce-
Confidence 984 333333 34688899999999999999999999999999999999996 4667899999999987643321
Q ss_pred ccccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCC-CChhhchHHHHHHHHhhccCCc-hHH
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQ-GLKAATKKQKYDKICEKKVSTP-IEV 239 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~tG~~Pf~-~~~~~~~~~~~~~i~~~~~~~p-~~~ 239 (414)
....+.+..|-.||++.... |+..-|+|||||++..|+..+.||. |.++.++.-++.+++....-.. ...
T Consensus 189 -------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 189 -------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred -------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 12345567788999987654 8999999999999999999888875 5555544444444433210000 000
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCC--CCCccccc--cccccchhhhccccccCCCCccccC
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY--DFDFVFDW--TILKYQQTQKTKSQDLLPASRVTNS 315 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~--~~~~~~dw--~~l~~~~~~~~~~~~~l~~~~~~~~ 315 (414)
..-.+++++.+++..--.. .+..+...++. .-...+|. +.|.||..+|.+|++++.||+|...
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk-------------~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRK-------------PWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred HccCCChhHhhHhhccccc-------------cHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 0001223333333221111 11111111110 00111121 6688888899999999999998643
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=236.33 Aligned_cols=212 Identities=20% Similarity=0.279 Sum_probs=169.8
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
.....-+..||.|+||.|-+.++..+|...|+|.+..... ..++++|+.+..+...++.++.++..-......+|.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 3445557789999999999999999999999998776543 3446777777766666666666655444667789999
Q ss_pred eccCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc-CeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 83 DLLGPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 83 e~~~~sL~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
|.+..+|..+.... +..+++..+-+|+..++.||.|||++ .+||||+||+|||+ +..++||+||||.+....+
T Consensus 125 E~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccccceeehh
Confidence 99999999887632 56789999999999999999999987 89999999999999 6999999999999876655
Q ss_pred CCCCccccccCCCCCccCcCccccccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHh
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGI----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~ 230 (414)
.... ....|...|||||.+..+ .|+.++||||||+++.||.+++.||.... +..+.+.++++
T Consensus 202 SiAk--------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~--tpF~qLkqvVe 267 (282)
T KOG0984|consen 202 SIAK--------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG--TPFQQLKQVVE 267 (282)
T ss_pred hhHH--------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC--CHHHHHHHHhc
Confidence 4321 135788899999998643 68999999999999999999999998642 33455555544
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=253.62 Aligned_cols=207 Identities=20% Similarity=0.314 Sum_probs=164.4
Q ss_pred eEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeee----eCCeeEE
Q 015041 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV----DGEDNVL 80 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~----~~~~~~l 80 (414)
.+-.+.||.|+||.||-+++..+|+.||+|.+..-. .-+.+.+|++++.-++|.+.+..+..... .....|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 345678999999999999999999999999654321 23457899999999988665544332221 1234678
Q ss_pred EEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 81 v~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
++|++..+|..++.. ...++...++-++.||++||+|||+.+|+||||||.|.|+ +.+..+||||||+|+......
T Consensus 135 ~TELmQSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 135 LTELMQSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEecccccccccchhh
Confidence 889998888888765 6678999999999999999999999999999999999999 688999999999998765433
Q ss_pred CCccccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHH
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY 225 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~ 225 (414)
. .++ ..-+.|..|+|||++.|.. |+..+||||+|||+.|++..+..|+...+....+.+
T Consensus 211 ~-~hM-----TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lI 270 (449)
T KOG0664|consen 211 R-LNM-----THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMI 270 (449)
T ss_pred h-hhh-----HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHH
Confidence 2 111 1335588999999999875 999999999999999999999999976554444333
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=246.50 Aligned_cols=280 Identities=22% Similarity=0.320 Sum_probs=205.2
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeeEEeee-----eC
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGV-----DG 75 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~-----~~ 75 (414)
+-.||.-++.+|.|.- .|..|-+.-++..||+|..... ...++..+|..++..+.|.+.+..+..+.. ..
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 4578999999999998 7888888888999999965443 233567899999999988666555544433 23
Q ss_pred CeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 76 ~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
...|+|||++..+|...+.. .+.-.++.+|+.|++.|++|||+.||+||||||+||++ +.++.+||.|||+|+.
T Consensus 94 ~e~y~v~e~m~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 94 QEVYLVMELMDANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILDFGLART 167 (369)
T ss_pred HhHHHHHHhhhhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeeccchhhcc
Confidence 45799999999999888772 35678899999999999999999999999999999999 6899999999999975
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
-...- ....++.|..|+|||++.+..|...+||||+||++.||++|...|.|. +....+.++.+....
T Consensus 168 e~~~~--------~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~---d~idQ~~ki~~~lgt- 235 (369)
T KOG0665|consen 168 EDTDF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK---DHIDQWNKIIEQLGT- 235 (369)
T ss_pred cCccc--------ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc---hHHHHHHHHHHHhcC-
Confidence 43220 123567899999999999999999999999999999999999999974 344555566554433
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh---------cCCCCCc--cccccccccchhhhcccc
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR---------EGYDFDF--VFDWTILKYQQTQKTKSQ 304 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~---------~~~~~~~--~~dw~~l~~~~~~~~~~~ 304 (414)
|.+.+...+.+..+.++. .||.+.. ..+.+++.- ...+... .+-.+||..+|++|.+.+
T Consensus 236 pd~~F~~qL~~~~r~yv~--------~~~~y~~--~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~ 305 (369)
T KOG0665|consen 236 PDPSFMKQLQPTVRNYVE--------NRPQYQA--ISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVD 305 (369)
T ss_pred CCHHHHHHhhHHHHHHhh--------cChHhhc--cchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHH
Confidence 333333233333333333 2333222 122222211 1111111 122389999999999999
Q ss_pred ccCCCCccc
Q 015041 305 DLLPASRVT 313 (414)
Q Consensus 305 ~~l~~~~~~ 313 (414)
++|.||++.
T Consensus 306 daL~HPY~~ 314 (369)
T KOG0665|consen 306 DALRHPYIK 314 (369)
T ss_pred HHhcCCeee
Confidence 999999985
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-31 Score=238.97 Aligned_cols=236 Identities=25% Similarity=0.337 Sum_probs=186.9
Q ss_pred CceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEeccCC-CHHHHHH
Q 015041 19 SFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGP-SLEDLFV 94 (414)
Q Consensus 19 ~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~~~-sL~~~~~ 94 (414)
+||.||+|.+..+++.||+|++..... ...+..|++.++.++| +++..+..++......++++|++++ +|..++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKH-PNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCC-CcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 589999999988899999999876654 4578899999999854 6666666666667889999999955 9998887
Q ss_pred HhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccccccCCCCCc
Q 015041 95 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174 (414)
Q Consensus 95 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~ 174 (414)
... .++...++.++.+++.+|.+||+.+|+|+||+|+||++ +.++.++|+|||.+....... ......
T Consensus 80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~--------~~~~~~ 147 (244)
T smart00220 80 KRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL---DEDGHVKLADFGLARQLDPGG--------LLTTFV 147 (244)
T ss_pred hcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE---CCCCcEEEccccceeeecccc--------cccccc
Confidence 533 38999999999999999999999999999999999999 467899999999998765432 112456
Q ss_pred cCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHH
Q 015041 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHY 254 (414)
Q Consensus 175 gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~ 254 (414)
++..|++||.+.+..++.++||||||+++|++++|..||...... ......+...... . ......++.++.+++.+
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~i~~ 223 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIGKPKPP-F-PPPEWKISPEAKDLIRK 223 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHhccCCC-C-ccccccCCHHHHHHHHH
Confidence 788999999999888999999999999999999999999763221 1122222111111 1 11111157899999999
Q ss_pred HhcCCCCCCCChHHHHH
Q 015041 255 CQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 255 c~~~~p~~RP~~~~l~~ 271 (414)
||..+|++||++.++.+
T Consensus 224 ~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 224 LLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HccCCchhccCHHHHhh
Confidence 99999999999987754
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=253.72 Aligned_cols=293 Identities=23% Similarity=0.312 Sum_probs=216.2
Q ss_pred cCCceEEecceeecCceeEEEEEECC---CCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
+.+.|+++++||.|+|+.||++.+.. ..+.||+|.+........+.+|+++|..+.+..++..+..+...++..++|
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv 113 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV 113 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence 45789999999999999999999876 788999998888777778999999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
+||+ .....+++. .++..++..+++.++.||.++|.+|||||||||.|||.+ ..-+.-.|+|||+|.......
T Consensus 114 lp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n--~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 114 LPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN--RRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred ecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc--cccCCceEEechhHHHHHhhh
Confidence 9999 455555544 478999999999999999999999999999999999996 566777999999997211000
Q ss_pred ----------------CC------------------c---cccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHH
Q 015041 161 ----------------TN------------------R---HIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYV 202 (414)
Q Consensus 161 ----------------~~------------------~---~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~i 202 (414)
.+ . ...........||++|+|||++...+ +++++||||.|+|
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 00 0 00111223567999999999998876 8999999999999
Q ss_pred HHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH-HhcC
Q 015041 203 LLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF-SREG 281 (414)
Q Consensus 203 l~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~-~~~~ 281 (414)
+.-++++..||....+ +...+.+|+-......+. ..+.+..+.+-.++..+|+..++..-++.+. +.-.
T Consensus 268 ~Lslls~~~PFf~a~d--d~~al~ei~tifG~~~mr--------k~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKD--DADALAEIATIFGSAEMR--------KCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred eehhhccccccccCcc--ccchHHHHHHHhChHHHH--------HHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 9999999999975432 222333333322222222 1222223311222345777777766666552 1111
Q ss_pred ---------CCCCcccc-----c--cccccchhhhccccccCCCCccc
Q 015041 282 ---------YDFDFVFD-----W--TILKYQQTQKTKSQDLLPASRVT 313 (414)
Q Consensus 282 ---------~~~~~~~d-----w--~~l~~~~~~~~~~~~~l~~~~~~ 313 (414)
.++.+.++ . +.+..+|.+|++|.++|.||+|.
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~ 385 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD 385 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence 11112221 1 55888999999999999999987
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=241.76 Aligned_cols=260 Identities=18% Similarity=0.266 Sum_probs=196.8
Q ss_pred cCCceEEecceeecCceeEEEEEECCCC-----ceEEEEEecCCCCchh---HHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTN-----EIVAVKIENSGTKHPQ---LLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~---~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
-+.|+++...+-+|+||.||.|.|.+.. +.|-+|.++.....-+ ++.|--.+..+.|.+..+.......+..
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 4567888899999999999999876432 3455666555443322 4455555555555444444455555566
Q ss_pred eeEEEEecc-CCCHHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEe
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCR-------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~ 148 (414)
..+.++.+. -++|..++..|+ +.++-.+...++.|++.|++|||+.||||.||..+|++| ++.-+|||+
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqVklt 438 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQVKLT 438 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeEEec
Confidence 667778887 688888888654 236677889999999999999999999999999999999 688999999
Q ss_pred eecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHH
Q 015041 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDK 227 (414)
Q Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~ 227 (414)
|=.+++......... . ...-.....|||+|.+....|+..+|+||||+++|||+| |+.||...++.+....+
T Consensus 439 DsaLSRDLFP~DYhc-L----GDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl-- 511 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHC-L----GDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL-- 511 (563)
T ss_pred cchhccccCcccccc-c----CCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH--
Confidence 999998765443321 1 112233678999999999999999999999999999999 99999887665433332
Q ss_pred HHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 228 i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
....+..-+ -++|+++..+|..||...|++||+++++...|.++..+
T Consensus 512 --kdGyRlaQP---~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 512 --KDGYRLAQP---FNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred --hccceecCC---CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 233332222 46799999999999999999999999999998877654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=266.64 Aligned_cols=246 Identities=21% Similarity=0.196 Sum_probs=186.8
Q ss_pred ecceeecCcee-EEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEeccCCCHH
Q 015041 12 GRKIGSGSFGE-IFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLE 90 (414)
Q Consensus 12 ~~~iG~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~~~sL~ 90 (414)
.+.+|.|+-|+ ||+|.. .|+.||||.+-.... ....+|+..++.-..|++|..+++...+....||+.|+|..+|.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~-~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~ 590 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFF-DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQ 590 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhhHhH-HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHH
Confidence 35688998884 799987 688999997654432 34679999998888888887777777778889999999999999
Q ss_pred HHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCC--CCCeEEEeeecceeeecCCCCCccc
Q 015041 91 DLFVYCRRK---FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR--KANQVYIIDFGLAKKYRDPTTNRHI 165 (414)
Q Consensus 91 ~~~~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~--~~~~vkL~DFG~a~~~~~~~~~~~~ 165 (414)
+++...... ......+.++.|++.||++||+.+||||||||.||||...+ ....++|+|||+++........
T Consensus 591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS--- 667 (903)
T KOG1027|consen 591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS--- 667 (903)
T ss_pred HHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch---
Confidence 999863111 11244578889999999999999999999999999997543 3357799999999987643322
Q ss_pred cccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcC
Q 015041 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (414)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 244 (414)
++......||-+|+|||++.....+.++||+||||++|+.++ |..||......+ ..|+........ +....
T Consensus 668 -~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-----~NIl~~~~~L~~--L~~~~ 739 (903)
T KOG1027|consen 668 -FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-----ANILTGNYTLVH--LEPLP 739 (903)
T ss_pred -hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-----hhhhcCccceee--eccCc
Confidence 233567889999999999999988999999999999999999 499998643321 122222211110 00000
Q ss_pred hHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 245 PAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 245 p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+..+||..+++.+|..||++.++..
T Consensus 740 d~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 740 DCEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred hHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 127889999999999999999987754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=252.92 Aligned_cols=205 Identities=22% Similarity=0.242 Sum_probs=146.2
Q ss_pred cccCCceEEecceeecCceeEEEEEEC----------------CCCceEEEEEecCCCC----------------chhHH
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHV----------------DTNEIVAVKIENSGTK----------------HPQLL 50 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~----------------~~~~~ 50 (414)
++-.++|++.++||+|+||+||+|.+. ..+..||||.+..... .....
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 345679999999999999999999752 2346799998764321 11233
Q ss_pred HHHHHHHHHcCCCCC----CeeEEeee--------eCCeeEEEEecc-CCCHHHHHHHhC--------------------
Q 015041 51 YEAKVYKILQGGSGI----PNIKWYGV--------DGEDNVLVLDLL-GPSLEDLFVYCR-------------------- 97 (414)
Q Consensus 51 ~E~~~l~~l~~~~~i----~~l~~~~~--------~~~~~~lv~e~~-~~sL~~~~~~~~-------------------- 97 (414)
.|+.++..+.+++.+ ..+..++. .....++|+||+ +++|.+++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 466666677665432 22222221 234579999999 788988876321
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccccccCCCCCc
Q 015041 98 ---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174 (414)
Q Consensus 98 ---~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~ 174 (414)
..+++..++.++.|++.||.|||+++|+||||||+|||+ +.++.+||+|||+++........ ......
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~------~~~~g~ 371 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINF------NPLYGM 371 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCcc------CccccC
Confidence 123567788999999999999999999999999999999 47789999999999754322110 111234
Q ss_pred cCcCccccccccCCCC----------------------CchhhHHHHHHHHHHHHcCCC-CCCCC
Q 015041 175 GTARYASCNTHLGIEQ----------------------SRRDDLESLGYVLLYFLRGSL-PWQGL 216 (414)
Q Consensus 175 gt~~y~aPE~~~~~~~----------------------s~~~DiwSlG~il~el~tG~~-Pf~~~ 216 (414)
+|+.|+|||.+..... ..+.||||+||++|+|++|.+ ||.+.
T Consensus 372 ~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~ 436 (507)
T PLN03224 372 LDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANI 436 (507)
T ss_pred CCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccch
Confidence 4789999999864321 124799999999999999886 77653
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=253.43 Aligned_cols=195 Identities=23% Similarity=0.342 Sum_probs=166.7
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----------chhHHHHHHHHHHHcC--CCCCCeeEEeeeeC
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------HPQLLYEAKVYKILQG--GSGIPNIKWYGVDG 75 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~E~~~l~~l~~--~~~i~~l~~~~~~~ 75 (414)
.|+.++.+|.|+||.||+|.++++...|+||.+.+... -...-.|+.+|..|+. |++|.++..++.++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 49999999999999999999999999999998765431 1224579999999982 46677778888899
Q ss_pred CeeEEEEecc--CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 76 EDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 76 ~~~~lv~e~~--~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
+++||+||-- +-+|.+++.. ...+++.++..|+.|++.|+++||+.||||||||-+|+.+ +.+|-+||+|||.|
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfgsa 717 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFGSA 717 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeeccch
Confidence 9999999998 4556666664 5679999999999999999999999999999999999999 69999999999998
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCC
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQG 215 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlG~il~el~tG~~Pf~~ 215 (414)
....... ...++||..|+|||++.|..| +..-|||++|++||.++....||.+
T Consensus 718 a~~ksgp---------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYTKSGP---------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhcCCC---------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 6443321 247899999999999999886 7788999999999999999999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=231.85 Aligned_cols=253 Identities=20% Similarity=0.301 Sum_probs=186.3
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-CCchhHHHHHHHHHHHcCCCCCCee-EEeeeeCCeeEEEE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-TKHPQLLYEAKVYKILQGGSGIPNI-KWYGVDGEDNVLVL 82 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~~~~~i~~l-~~~~~~~~~~~lv~ 82 (414)
+...|.|.+.||+|.||.+-+|++..++..+|+|.+... .....|.+|...--.|.+|.+|..- ...+...+.+++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 347899999999999999999999999999999976654 3456688888766666666655433 44455666889999
Q ss_pred ecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
||+ .|+|..-.. ...+-+.....++.|++.||+|||++++||||||.+||||-.. +..+|||||||+.+.....-
T Consensus 102 E~aP~gdL~snv~--~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~-df~rvKlcDFG~t~k~g~tV- 177 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE--AAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA-DFYRVKLCDFGLTRKVGTTV- 177 (378)
T ss_pred ccCccchhhhhcC--cccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC-CccEEEeeecccccccCcee-
Confidence 999 777765543 3457888899999999999999999999999999999999643 34499999999986432111
Q ss_pred CccccccCCCCCccCcCccccccccCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCChhhc-hHHHHHHHHhhccCC
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGI-----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT-KKQKYDKICEKKVST 235 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~-~~~~~~~i~~~~~~~ 235 (414)
....-+..|.+||+.... ...+..|+|.||+++|.++||.+||+...-.+ ....+.+-.+.+. +
T Consensus 178 ---------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~-~ 247 (378)
T KOG1345|consen 178 ---------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN-P 247 (378)
T ss_pred ---------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC-c
Confidence 122335678899987543 24678999999999999999999999432111 1222223223222 2
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+....-+++....++++-+..++++|-...+..+
T Consensus 248 ~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 248 ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 334444566788999999999999999954444443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=215.77 Aligned_cols=207 Identities=29% Similarity=0.434 Sum_probs=178.3
Q ss_pred eeecCceeEEEEEECCCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEeccC-CCHH
Q 015041 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLG-PSLE 90 (414)
Q Consensus 15 iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~~-~sL~ 90 (414)
||.|.+|.||++....+++.+++|+....... ..+.+|+..++.+.+ .+++.+..++......++++|++. ++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH-PNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCC-CCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 68999999999999888999999998877653 678899999999987 677777777777788999999995 9999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCC-CCeEEEeeecceeeecCCCCCccccccC
Q 015041 91 DLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK-ANQVYIIDFGLAKKYRDPTTNRHIPYRE 169 (414)
Q Consensus 91 ~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~-~~~vkL~DFG~a~~~~~~~~~~~~~~~~ 169 (414)
+++......++...+..++.+++.+|.+||++|++|+||+|.||++. . .+.++|+|||.+........ .
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~---~~~~~~~l~d~~~~~~~~~~~~-------~ 149 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD---SDNGKVKLADFGLSKLLTSDKS-------L 149 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe---CCCCcEEEecCCceEEccCCcc-------h
Confidence 98876435689999999999999999999999999999999999994 5 68999999999986654321 1
Q ss_pred CCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHH
Q 015041 170 NKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEF 248 (414)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~ 248 (414)
.....+...|++||.+... .++.+.|+|+||++++++ ..+
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------~~~ 190 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------PEL 190 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------HHH
Confidence 1245568899999999887 788999999999999999 477
Q ss_pred HHHHHHHhcCCCCCCCChHHHHH
Q 015041 249 ASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 249 ~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+++..|+..+|++||++.++.+
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~ 213 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILE 213 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhh
Confidence 89999999999999999988765
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=252.23 Aligned_cols=250 Identities=18% Similarity=0.268 Sum_probs=200.4
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
..+|.++..+|+|+||.||+++++.+++..|+|+++... ...-+..|+-+++..+|.+.++.+..|- .....+++||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsyl-r~dklwicME 92 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYL-RRDKLWICME 92 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhh-hhcCcEEEEE
Confidence 468999999999999999999999999999999887654 3344678888888888877666554443 3345799999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
|| +++|.+.... ...+++.++.+.++..+.||+|||++|=+|||||-.||+++ +.+.+||.|||.+-.+.....
T Consensus 93 ycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt---d~gDvklaDfgvsaqitati~- 167 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT---DEGDVKLADFGVSAQITATIA- 167 (829)
T ss_pred ecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec---ccCceeecccCchhhhhhhhh-
Confidence 99 7788877654 56789999999999999999999999999999999999995 899999999999876544332
Q ss_pred ccccccCCCCCccCcCcccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 163 RHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
..+.+.||+.|||||+.. .+.|+..+|||++|++..|+..-++|....-.. +.+.-.-.....+|...
T Consensus 168 ------KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm---r~l~LmTkS~~qpp~lk 238 (829)
T KOG0576|consen 168 ------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM---RALFLMTKSGFQPPTLK 238 (829)
T ss_pred ------hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH---HHHHHhhccCCCCCccc
Confidence 346899999999999874 556999999999999999999999887765432 22222223334444333
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
-...+.+-|.+|++.|+..+|.+||+.+.+.
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 3445678899999999999999999987654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-27 Score=213.76 Aligned_cols=197 Identities=32% Similarity=0.476 Sum_probs=165.1
Q ss_pred eEEecceeecCceeEEEEEECCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc
Q 015041 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (414)
|.+.+.||.|++|.||+|.+..+++.+|+|.+.... ....+..|++.+..+.+ +++..+..+.......++++|++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~-~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKH-PNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCC-CChhhheeeeecCCceEEEEecc
Confidence 678899999999999999998889999999987654 24567889999999965 56666666666667889999999
Q ss_pred -CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcc
Q 015041 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (414)
Q Consensus 86 -~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~ 164 (414)
+++|.+++......++...+..++.|++.+|.+||+++++|+||+|.||++ +..+.++|+|||.+.........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~~~~-- 154 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL---GMDGLVKLADFGLARFIHRDLAA-- 154 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeCceeeEecCcccc--
Confidence 449999887643338999999999999999999999999999999999999 46789999999999876554310
Q ss_pred ccccCCCCCccCcCccccccc-cCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 015041 165 IPYRENKNLTGTARYASCNTH-LGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215 (414)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~-~~~~~s~~~DiwSlG~il~el~tG~~Pf~~ 215 (414)
......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 155 ----~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 ----LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ----cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 11245678889999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-27 Score=204.39 Aligned_cols=167 Identities=17% Similarity=0.184 Sum_probs=128.2
Q ss_pred CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcccc
Q 015041 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (414)
Q Consensus 87 ~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~ 166 (414)
|+|.+++...+..+++.+++.|+.||+.||.|||+.+ ||+|||+ +.++.+++ ||+++.....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPE------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeeccc-------
Confidence 5788888865667999999999999999999999998 9999999 57888898 9998765332
Q ss_pred ccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchH--HhhhcC
Q 015041 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE--VLCKSH 244 (414)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~--~~~~~~ 244 (414)
...||..|||||++.+..++.++|||||||++|||++|+.||....... ..+..+.......... ......
T Consensus 63 -----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 135 (176)
T smart00750 63 -----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPADDPRDRSNLESV 135 (176)
T ss_pred -----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccCCccccccHHHH
Confidence 2257899999999999999999999999999999999999997643221 2222222211111000 001122
Q ss_pred hH--HHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 245 PA--EFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 245 p~--~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
++ ++.+++..||..+|.+||++.++.+.+.....
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 33 69999999999999999999999887665543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=257.48 Aligned_cols=187 Identities=14% Similarity=0.188 Sum_probs=134.6
Q ss_pred CeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEcc----------------C
Q 015041 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL----------------G 139 (414)
Q Consensus 76 ~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~----------------~ 139 (414)
...++++|+++.+|.+++......++..+++.++.||+.||+|||++|||||||||+||||+. .
T Consensus 53 ~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~ 132 (793)
T PLN00181 53 DSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGS 132 (793)
T ss_pred chhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccc
Confidence 456788999999999999765566999999999999999999999999999999999999941 1
Q ss_pred CCCCeEEEeeecceeeecCCCC--------Ccccccc-CCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCC
Q 015041 140 RKANQVYIIDFGLAKKYRDPTT--------NRHIPYR-ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 210 (414)
Q Consensus 140 ~~~~~vkL~DFG~a~~~~~~~~--------~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~ 210 (414)
+..+.+||+|||+++....... ....++. .....+||..|||||++.+..++.++|||||||+||||++|.
T Consensus 133 ~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~ 212 (793)
T PLN00181 133 DEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPV 212 (793)
T ss_pred cccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCC
Confidence 2345667777777764221000 0000000 011246899999999999999999999999999999999998
Q ss_pred CCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 211 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 211 ~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.||.... ..+..+.....+ + . .... ......++..||..+|.+||++.++.+
T Consensus 213 ~~~~~~~-----~~~~~~~~~~~~-~-~-~~~~-~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 213 SSREEKS-----RTMSSLRHRVLP-P-Q-ILLN-WPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred CchhhHH-----HHHHHHHHhhcC-h-h-hhhc-CHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 8876421 111122111111 1 1 1111 245678899999999999999998865
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=213.67 Aligned_cols=171 Identities=19% Similarity=0.211 Sum_probs=131.6
Q ss_pred cccCCceEEecceeecCceeEEEEEECC-CCceEEEEEecCCC-------CchhHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGT-------KHPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~-~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 74 (414)
+.+.++|.+.+.||+|+||+||+|.+.. +++.||||...... ....+.+|+++++.+.|++.++.+..+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 5678999999999999999999999876 67778999765321 123478999999999988777766543
Q ss_pred CCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeecccc-CCCceEEccCCCCCeEEEeeecc
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI-KPDNFLMGLGRKANQVYIIDFGL 152 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDL-kp~Nili~~~~~~~~vkL~DFG~ 152 (414)
...++||||+ +++|. .+. ... ...++.|++.||.|||++||+|||| ||+|||+ +.++.+||+|||+
T Consensus 91 -~~~~LVmE~~~G~~L~-~~~----~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv---~~~~~ikLiDFGl 158 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLH-LAR----PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM---GPDGEAAVIDFQL 158 (365)
T ss_pred -CCcEEEEEccCCCCHH-HhC----ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE---cCCCCEEEEECcc
Confidence 3579999999 56664 221 111 2467899999999999999999999 9999999 4678899999999
Q ss_pred eeeecCCCCCccc-cccCCCCCccCcCccccccccCC
Q 015041 153 AKKYRDPTTNRHI-PYRENKNLTGTARYASCNTHLGI 188 (414)
Q Consensus 153 a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~ 188 (414)
|+.+........+ .+..-....++..|+|||++...
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9987655433222 12222467788999999998754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-23 Score=193.75 Aligned_cols=256 Identities=30% Similarity=0.430 Sum_probs=189.3
Q ss_pred eEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
|++.+.||.|+|+.||++.+. ..+++|.+..... ...+.+|+.++..+.+++++..+..++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 789999999999999999986 7789998776543 33578899999999887667667666666666799999
Q ss_pred cc-CCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCC-eEEEeeecceeeecCC
Q 015041 84 LL-GPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDP 159 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~-~vkL~DFG~a~~~~~~ 159 (414)
++ ++++.+++.... ..+.......++.|++.+++|+|+.+++|||+||+||++. ... .++++|||.++.....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~---~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD---RDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---CCCCeEEEeccCcceecCCC
Confidence 99 677776655433 2689999999999999999999999999999999999994 555 7999999999855443
Q ss_pred CCCccccccCCCCCccCcCccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCChhh-chHHHHHHHHhhccCC
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA-TKKQKYDKICEKKVST 235 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~-~~~~~~~~i~~~~~~~ 235 (414)
....... .......||..|++||.+.+ ..++...|+||+|++++++++|..||...... ........+.......
T Consensus 156 ~~~~~~~-~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 156 GSTSSIP-ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234 (384)
T ss_pred Ccccccc-ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence 3211000 12347789999999999998 57899999999999999999999998765431 0111222221211110
Q ss_pred chHHhhhc----ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 236 PIEVLCKS----HPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 236 p~~~~~~~----~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
........ ....+.+++..++..+|..|.+......
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 00001111 1257889999999999999998765443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-23 Score=189.45 Aligned_cols=231 Identities=23% Similarity=0.254 Sum_probs=147.9
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc-----hhHHHHHHHHHHHcC----------CC-CCCe----
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQG----------GS-GIPN---- 67 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~----------~~-~i~~---- 67 (414)
.+..++.||.|+|+.||.+++..|++.+|||++...... +++.+|.-....+.+ .. .+|.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 456788999999999999999999999999986554422 223333322221111 00 1111
Q ss_pred ------eEEeeeeCC-----eeEEEEeccCCCHHHHHHHh---CCC---CCHHHHHHHHHHHHHHHHHHHhcCeeccccC
Q 015041 68 ------IKWYGVDGE-----DNVLVLDLLGPSLEDLFVYC---RRK---FSLKTVLMLADQMIARIEYVHSRGFLHRDIK 130 (414)
Q Consensus 68 ------l~~~~~~~~-----~~~lv~e~~~~sL~~~~~~~---~~~---~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLk 130 (414)
+..-..... ..+++|+.+.++|.+++... ... +.....+.+..|+++.+++||+.||+|+|||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 111111111 23678888899998887632 111 2344456777999999999999999999999
Q ss_pred CCceEEccCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccC--------CCCCchhhHHHHHHH
Q 015041 131 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--------IEQSRRDDLESLGYV 202 (414)
Q Consensus 131 p~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~DiwSlG~i 202 (414)
|+||++ +.+|.++|+||+.......... ....+..|.+||.... ..++.+.|.|+||++
T Consensus 173 ~~nfll---~~~G~v~Lg~F~~~~r~g~~~~----------~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 173 PENFLL---DQDGGVFLGDFSSLVRAGTRYR----------CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp GGGEEE----TTS-EEE--GGGEEETTEEEE----------GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred eeeEEE---cCCCCEEEcChHHHeecCceee----------ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 999999 5899999999998765332111 0223467899997643 247889999999999
Q ss_pred HHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCC
Q 015041 203 LLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQR 263 (414)
Q Consensus 203 l~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~R 263 (414)
+|.|++|..||........... .-..|...|+.++.||..+++.+|.+|
T Consensus 240 ly~lWC~~lPf~~~~~~~~~~~------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPEADPEW------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGGGSTSGG------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCccccccc------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999999987544322211 122455778999999999999999887
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.7e-24 Score=214.23 Aligned_cols=254 Identities=20% Similarity=0.251 Sum_probs=179.2
Q ss_pred EEecceeecCceeEEEEEECCCCceEEEEEecC----CCCchh----HHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS----GTKHPQ----LLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 10 ~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~----~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
...+.+|.|++|.|+.+........++.|.+.. ...... +..|+-+-..|.|.+.+..+..+...... .-+
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~-~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI-LQS 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc-hhh
Confidence 567789999999888888776666666665442 111111 23344444445554444444332222222 223
Q ss_pred EeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 82 ~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
||||..+|..++.. ...+...++..++.|++.||.|||+.||.|||||++|+++ ...+.+||+|||.+..+..+..
T Consensus 400 mE~~~~Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~---~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 400 MEYCPYDLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV---TENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhcccHHHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE---ecCCceEEeecCcceeeccCcc
Confidence 99996677777664 2468999999999999999999999999999999999999 4788999999999987765543
Q ss_pred CccccccCCCCCccCcCccccccccCCCCCch-hhHHHHHHHHHHHHcCCCCCCCChhhchHH-HHHHHHhhccCCchHH
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRR-DDLESLGYVLLYFLRGSLPWQGLKAATKKQ-KYDKICEKKVSTPIEV 239 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-~DiwSlG~il~el~tG~~Pf~~~~~~~~~~-~~~~i~~~~~~~p~~~ 239 (414)
... ......+|+..|+|||++.+.+|.+. .||||.|++++.|.+|+.||......+... ........+.......
T Consensus 476 ~~~---~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~ 552 (601)
T KOG0590|consen 476 KNI---HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR 552 (601)
T ss_pred hhh---hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence 211 12357889999999999999998765 799999999999999999998643322110 0000112222223344
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+...+|.+.+.+|..+++.+|.+|-++++|.+
T Consensus 553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 553 LLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 45667889999999999999999999887755
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=177.31 Aligned_cols=136 Identities=21% Similarity=0.246 Sum_probs=102.4
Q ss_pred ecceeecCceeEEEEEECCCCceEEEEEecCCCC-----------chh-----------------HHHHHHHHHHHcCCC
Q 015041 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----------HPQ-----------------LLYEAKVYKILQGGS 63 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~-----------------~~~E~~~l~~l~~~~ 63 (414)
...||+|+||.||+|.+. +|+.||||+++.... ... ...|++.+..+.+.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~- 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA- 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC-
Confidence 578999999999999986 899999998865421 011 23488999999753
Q ss_pred CCCeeEEeeeeCCeeEEEEeccCCC-HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhcCeeccccCCCceEEccCCC
Q 015041 64 GIPNIKWYGVDGEDNVLVLDLLGPS-LEDLFVYCRRKFSLKTVLMLADQMIARIEYV-HSRGFLHRDIKPDNFLMGLGRK 141 (414)
Q Consensus 64 ~i~~l~~~~~~~~~~~lv~e~~~~s-L~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L-H~~~iiHrDLkp~Nili~~~~~ 141 (414)
+++....+.. ...+|||||++++ +...... ...++..+++.++.|++.+|.++ |+.||+||||||+|||++
T Consensus 80 ~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~---- 152 (190)
T cd05147 80 GIPCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH---- 152 (190)
T ss_pred CCCCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----
Confidence 3322211211 2348999999654 3333222 45789999999999999999999 799999999999999993
Q ss_pred CCeEEEeeecceeee
Q 015041 142 ANQVYIIDFGLAKKY 156 (414)
Q Consensus 142 ~~~vkL~DFG~a~~~ 156 (414)
.+.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=8e-23 Score=181.97 Aligned_cols=171 Identities=16% Similarity=0.229 Sum_probs=127.1
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchh-----------HHHHHHHHHHHcCCCCCCeeEE
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----------LLYEAKVYKILQGGSGIPNIKW 70 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~E~~~l~~l~~~~~i~~l~~ 70 (414)
.++++++|++.+.||.|+||.||++.. ++..+|||++.......+ +.+|+..+.++.| ++++.+..
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~-~GI~~~~d 102 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRS-EGLASLND 102 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHH-CCCCcceE
Confidence 467899999999999999999999765 466799999875432221 4688888999965 57776655
Q ss_pred eeee--------CCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCC
Q 015041 71 YGVD--------GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (414)
Q Consensus 71 ~~~~--------~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~ 141 (414)
++.. ....+++|||+ |.+|.++.. ++. ....+++.+|..||..|++|||+||+||+++ .
T Consensus 103 ~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~---~ 170 (232)
T PRK10359 103 FYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS---K 170 (232)
T ss_pred eeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe---C
Confidence 5332 23578999999 567766522 222 3456999999999999999999999999994 5
Q ss_pred CCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHH
Q 015041 142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 207 (414)
Q Consensus 142 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~ 207 (414)
++ ++|+|||..+....... ...+.+...|+.++|+|||||++..+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a-------------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKA-------------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhh-------------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 56 99999998765422111 011344455778999999999987654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.8e-22 Score=205.42 Aligned_cols=254 Identities=23% Similarity=0.321 Sum_probs=184.3
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHc--CCCCCCeeEEeeeeCCeeEEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~--~~~~i~~l~~~~~~~~~~~lv 81 (414)
+=+..|.|.+.||+|+||.||+|.... |+.||||+.+.....+ +.--.+++.+|+ -.+.+-.+...-...+--++|
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-eeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 446789999999999999999999876 9999999988776543 222233444444 012222222222344556899
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccC----CCCCeEEEeeecceeee
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG----RKANQVYIIDFGLAKKY 156 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~----~~~~~vkL~DFG~a~~~ 156 (414)
++|. .|+|.+++. ..+.+++..+..++.||+.-++.||..+|||+||||+|+|+... .....++|+|||.+..+
T Consensus 773 ~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 773 SEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM 851 (974)
T ss_pred eeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence 9999 999999998 35678999999999999999999999999999999999999731 23457899999999765
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCC--CCChhhchHHHHHHHHhhccC
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW--QGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf--~~~~~~~~~~~~~~i~~~~~~ 234 (414)
.-...+. ..+.+++|-.+-++|+..|..|++.+|.|.|+.+++-|+.|+.-= .|.. ....
T Consensus 852 ~lfp~~~-----~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~~g~~-------------~~~~ 913 (974)
T KOG1166|consen 852 KLFPDGT-----KFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVKNGSS-------------WMVK 913 (974)
T ss_pred eEcCCCc-----EEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhcCCcc-------------eecc
Confidence 4332221 234678899999999999999999999999999999999986421 1100 0000
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
...+.++. -+-+.+|+..+|..+-..-|...+|+..|+..+.+.
T Consensus 914 ~~~~Ry~~--~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 914 TNFPRYWK--RDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred ccchhhhh--HHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 00111111 133567888888877777788888888888877654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.3e-23 Score=207.67 Aligned_cols=235 Identities=24% Similarity=0.411 Sum_probs=159.9
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (414)
-..|..++.|..|+||.||++++..+.+.+|+|+- ++. -+++. ++. +... .+.|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~---lilRn--ilt-~a~n---------------pfvv---- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQN---LILRN--ILT-FAGN---------------PFVV---- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccc-ccc---hhhhc--ccc-ccCC---------------ccee----
Confidence 35789999999999999999999999999999642 211 11111 111 1110 1111
Q ss_pred CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC---
Q 015041 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN--- 162 (414)
Q Consensus 86 ~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~--- 162 (414)
++-.+++.. -+.++. +++.+++|||+.||+|||+||+|.+|+ .-+++|++|||+++...-....
T Consensus 136 -gDc~tllk~-~g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT---~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 -GDCATLLKN-IGPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLIT---SMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred -chhhhhccc-CCCCcc--------hhhHHhHhhccCCeecCCCCCCcceee---ecccccccchhhhhhhhhhccchhh
Confidence 222233222 122332 237899999999999999999999995 8899999999998753211111
Q ss_pred -ccc----cccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 163 -RHI----PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 163 -~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
.+| .--..+.++||+.|.|||+++...|++.+|||++|+|+||++.|..||.+.... +.+..++......|.
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe---elfg~visd~i~wpE 279 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFGQVISDDIEWPE 279 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH---HHHhhhhhhhccccc
Confidence 000 011246789999999999999999999999999999999999999999997554 334444443333333
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcccccc
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWT 291 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 291 (414)
. -...|.+.++++.++|+.+|-.|-... ..++-..+.+...+||+
T Consensus 280 ~--dea~p~Ea~dli~~LL~qnp~~Rlgt~-------ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 280 E--DEALPPEAQDLIEQLLRQNPLCRLGTG-------GALEVKQHGFFQLLDWK 324 (1205)
T ss_pred c--CcCCCHHHHHHHHHHHHhChHhhcccc-------hhhhhhhccceeecccc
Confidence 2 234578999999999999999996322 11222333455566665
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-22 Score=177.93 Aligned_cols=244 Identities=13% Similarity=0.148 Sum_probs=180.9
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
+...++.+|.....|+.|+|+|. |..+++|+++... ....|..|.-.++.+.|++.++.+..+. ...+..++.
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacn-sppnlv~is 266 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACN-SPPNLVIIS 266 (448)
T ss_pred hhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhcc-CCCCceEee
Confidence 34567788999999999999995 4557788877543 2345788888899998877777665544 446677888
Q ss_pred ecc-CCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcC--eeccccCCCceEEccCCCCCeEEEe--eecceeee
Q 015041 83 DLL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYII--DFGLAKKY 156 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDLkp~Nili~~~~~~~~vkL~--DFG~a~~~ 156 (414)
.|+ .++|..++..... ...-.++.+++.++++|++|||+.. |.---|....+++ |++.+.+|. |-.++-.
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kfsfq- 342 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFSFQ- 342 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheecccceeeee-
Confidence 888 8899998875332 2567889999999999999999874 4555788999999 566665543 4332211
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCC---chhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQS---RRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s---~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
+ ....-.+.||+||.+...+-+ +.+|+|||++++||+.|...||....+.+-.. +|.-..+
T Consensus 343 ---e----------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm---kialegl 406 (448)
T KOG0195|consen 343 ---E----------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM---KIALEGL 406 (448)
T ss_pred ---c----------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh---hhhhccc
Confidence 1 122336789999999887643 57899999999999999999999877654332 3322233
Q ss_pred CCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 234 ~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
+.-+ +++.+..+.++++-|+..||.+||.|+.+...|++.
T Consensus 407 rv~i---ppgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 407 RVHI---PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cccC---CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 2222 245678999999999999999999999999888754
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.2e-21 Score=169.89 Aligned_cols=139 Identities=22% Similarity=0.271 Sum_probs=104.7
Q ss_pred EecceeecCceeEEEEEECCCCceEEEEEecCCCCc----------------------------hhHHHHHHHHHHHcCC
Q 015041 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----------------------------PQLLYEAKVYKILQGG 62 (414)
Q Consensus 11 i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------------~~~~~E~~~l~~l~~~ 62 (414)
+.+.||+|+||+||+|.+. +|+.||||+++..... ..+..|...+..+.+.
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999986 8999999998764211 1134678888888764
Q ss_pred CCCCeeEEeeeeCCeeEEEEeccCCC-HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeccccCCCceEEccCC
Q 015041 63 SGIPNIKWYGVDGEDNVLVLDLLGPS-LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGR 140 (414)
Q Consensus 63 ~~i~~l~~~~~~~~~~~lv~e~~~~s-L~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDLkp~Nili~~~~ 140 (414)
+++....+... ..++||||+++. +...... ...++...+..++.|++.+|.+||+ +||+||||||+|||+ +
T Consensus 80 -~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll---~ 152 (190)
T cd05145 80 -GVPVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILY---H 152 (190)
T ss_pred -CCCCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEE---E
Confidence 33322222222 248999999554 3322221 3457888999999999999999999 999999999999999 3
Q ss_pred CCCeEEEeeecceeeecC
Q 015041 141 KANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 141 ~~~~vkL~DFG~a~~~~~ 158 (414)
++.++|+|||+|+....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 68899999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=167.63 Aligned_cols=191 Identities=16% Similarity=0.141 Sum_probs=135.6
Q ss_pred EEecceeecCceeEEEEEECCCCceEEEEEecCCCCch------hHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP------QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 10 ~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
.+...|++|+||+|+++.. .+..++.+.+....... .+.+|+++++.|.+++++|.+..+ ...+++|+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4577899999999998865 56777777665554321 367899999999988889998665 34699999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeecccc-CCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI-KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDL-kp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
|+ |.+|..... . ....++.|++.+|+++|++||+|||| ||+|||+ +.++.++|+|||+|........
T Consensus 79 yI~G~~L~~~~~-------~-~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv---~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 79 YLAGAAMYQRPP-------R-GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV---QEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eecCccHHhhhh-------h-hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE---cCCCCEEEEECCCceecCCcch
Confidence 98 555643221 1 12457889999999999999999999 7999999 4678899999999985443221
Q ss_pred C-ccccccC-----CCCCccCcCccccccccCC-CCC-chhhHHHHHHHHHHHHcCCCCCCCCh
Q 015041 162 N-RHIPYRE-----NKNLTGTARYASCNTHLGI-EQS-RRDDLESLGYVLLYFLRGSLPWQGLK 217 (414)
Q Consensus 162 ~-~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~s-~~~DiwSlG~il~el~tG~~Pf~~~~ 217 (414)
. ....++. ......++.|++|+...-. ..+ ...++++.|+.+|.++|+.+++-+..
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0000000 0011246677777754322 233 56799999999999999999886543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-22 Score=197.02 Aligned_cols=224 Identities=22% Similarity=0.324 Sum_probs=178.0
Q ss_pred ceeecCceeEEEEEEC---CCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-
Q 015041 14 KIGSGSFGEIFLASHV---DTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (414)
Q Consensus 14 ~iG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (414)
.+|.|+||.|++++-. ..+..+|+|+.++... ......|..++...+.++.+..+.+.+......++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 3799999999986532 4577889998765432 1234457777887777788888888888888888999998
Q ss_pred CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccc
Q 015041 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (414)
Q Consensus 86 ~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 165 (414)
++.+..... ....+....+..+...++.+++++|+.+|+|||+|++||++ +..|.+++.|||+++.......
T Consensus 81 gg~lft~l~-~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~---- 152 (612)
T KOG0603|consen 81 GGDLFTRLS-KEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKI---- 152 (612)
T ss_pred cchhhhccc-cCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhh----
Confidence 555544333 24567888899999999999999999999999999999999 6999999999999987655432
Q ss_pred cccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcCh
Q 015041 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (414)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p 245 (414)
.+||..|||||++. .....+|+||||++++||++|..||.+ +....|...+...|... .
T Consensus 153 -------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il~~~~~~p~~l-----~ 211 (612)
T KOG0603|consen 153 -------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRILKAELEMPREL-----S 211 (612)
T ss_pred -------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHHhhhccCCchhh-----h
Confidence 28999999999998 456789999999999999999999997 34455556566666433 5
Q ss_pred HHHHHHHHHHhcCCCCCCCCh
Q 015041 246 AEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 246 ~~~~~l~~~c~~~~p~~RP~~ 266 (414)
....+++.++...+|..|...
T Consensus 212 ~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 212 AEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHHHHHHhhCHHHHhcc
Confidence 688899999999999988754
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.3e-20 Score=168.43 Aligned_cols=188 Identities=19% Similarity=0.272 Sum_probs=137.8
Q ss_pred CeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCC-CCeEEEeeeccee
Q 015041 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK-ANQVYIIDFGLAK 154 (414)
Q Consensus 76 ~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~-~~~vkL~DFG~a~ 154 (414)
...|+||.-+..+|..++. .+..+......|+.|++.|+.|||.+||.|||||.+|||+.+.++ .-.+.|+|||.+-
T Consensus 316 ~tlylvMkrY~~tLr~yl~--~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 316 KTLYLVMKRYRQTLREYLW--TRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred ceEEEehhcchhhHHHHHh--cCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 3458999999999988876 455678888999999999999999999999999999999986543 3456899999875
Q ss_pred eecCCCCCccccccCC-CCCccCcCccccccccCCCC------CchhhHHHHHHHHHHHHcCCCCCCCChhhch-HHHHH
Q 015041 155 KYRDPTTNRHIPYREN-KNLTGTARYASCNTHLGIEQ------SRRDDLESLGYVLLYFLRGSLPWQGLKAATK-KQKYD 226 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~------s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~-~~~~~ 226 (414)
.-... +-..||..+ ...-|...-||||+....+- -.|+|.|+.|.+.||++....||.+..+... ...|+
T Consensus 394 Ad~~h--Glqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq 471 (598)
T KOG4158|consen 394 ADDNH--GLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ 471 (598)
T ss_pred ecccc--ccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh
Confidence 43222 223344332 24457888999999875431 2489999999999999999999987322211 11121
Q ss_pred HHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 227 KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 227 ~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
+.. .+.+...+|+.+.+++..+++.+|.+|++..-....++
T Consensus 472 ---e~q----LPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 472 ---ESQ----LPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred ---hhh----CCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 111 22334566899999999999999999998764444443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-20 Score=192.67 Aligned_cols=248 Identities=18% Similarity=0.116 Sum_probs=168.0
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc------hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH------PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
+|...+.||++.|=.|.+|++. .|. |+||++-+.... .+.+.|++ ..+...+++..+.......+..|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik--~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK--FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH--HHhhcCCcccchHHHHHhhHHHHHH
Confidence 7888999999999999999874 354 899987665422 23344444 3333444444444444556667888
Q ss_pred EeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 82 ~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
=+|...+|.|.+.- +.-+..-+.+-|+-|++.||..+|..||+|+|||.+||||+ .-+-+.|+||..-+...-++.
T Consensus 100 RqyvkhnLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT---SWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 100 RQYVKHNLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT---SWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHhhhhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe---eechhhhhcccccCCccCCCC
Confidence 89999999887762 33367778888999999999999999999999999999995 778899999976543322222
Q ss_pred Cccc-cccCCCCCccCcCccccccccCC----------C-CCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHH
Q 015041 162 NRHI-PYRENKNLTGTARYASCNTHLGI----------E-QSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKI 228 (414)
Q Consensus 162 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~----------~-~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i 228 (414)
+..- -|. ..+-..-..|.|||.+... . .+++=||||+||+++|+++ |++||.- ..+.+.
T Consensus 176 NPadf~fF-FDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-------SQL~aY 247 (1431)
T KOG1240|consen 176 NPADFTFF-FDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-------SQLLAY 247 (1431)
T ss_pred CcccceEE-EecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-------HHHHhH
Confidence 2110 000 0111122369999988542 1 5678899999999999998 8999862 111111
Q ss_pred HhhccCCchHHhhhc-ChHHHHHHHHHHhcCCCCCCCChHHHHHH
Q 015041 229 CEKKVSTPIEVLCKS-HPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (414)
Q Consensus 229 ~~~~~~~p~~~~~~~-~p~~~~~l~~~c~~~~p~~RP~~~~l~~~ 272 (414)
.... ....+..... -...++.++..+++.+|.+|.++++..+-
T Consensus 248 r~~~-~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 248 RSGN-ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hccC-ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1111 1111111111 13468899999999999999999876554
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=164.83 Aligned_cols=139 Identities=22% Similarity=0.265 Sum_probs=106.7
Q ss_pred ceEEecceeecCceeEEEEE-ECCCCceEEEEEecCCCCc--------------------------hhHHHHHHHHHHHc
Q 015041 8 KYKLGRKIGSGSFGEIFLAS-HVDTNEIVAVKIENSGTKH--------------------------PQLLYEAKVYKILQ 60 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~--------------------------~~~~~E~~~l~~l~ 60 (414)
-|.+.+.||+|+||.||+|. +..+|+.||||++...... ..+..|+..++.+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 6678999999987653210 12457999999997
Q ss_pred CC-CCCCeeEEeeeeCCeeEEEEeccCC-CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC-eeccccCCCceEEc
Q 015041 61 GG-SGIPNIKWYGVDGEDNVLVLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG-FLHRDIKPDNFLMG 137 (414)
Q Consensus 61 ~~-~~i~~l~~~~~~~~~~~lv~e~~~~-sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-iiHrDLkp~Nili~ 137 (414)
+. ..+|.+..+ ...++||||+++ ++...... ...+....+..++.||+.+|++||+.| |+||||||+||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli- 182 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV- 182 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE-
Confidence 52 223444332 235899999955 44443322 334566678899999999999999999 9999999999999
Q ss_pred cCCCCCeEEEeeecceee
Q 015041 138 LGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 138 ~~~~~~~vkL~DFG~a~~ 155 (414)
+ .+.++|+|||.|..
T Consensus 183 --~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 183 --H-DGKVVIIDVSQSVE 197 (237)
T ss_pred --E-CCCEEEEEChhhhc
Confidence 3 67899999999864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=7e-18 Score=149.74 Aligned_cols=136 Identities=17% Similarity=0.185 Sum_probs=101.6
Q ss_pred EecceeecCceeEEEEEECCCCceEEEEEecCCC--CchhHHHHHHHHHHHcC----CCCCCeeEEeeeeCC---e-eEE
Q 015041 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQG----GSGIPNIKWYGVDGE---D-NVL 80 (414)
Q Consensus 11 i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~----~~~i~~l~~~~~~~~---~-~~l 80 (414)
-.+.||+|+||.||. +..++.. +||+..... ....+.+|+.+++.+.| +++|+.++.+..... . ..+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 357899999999995 6667666 689876532 33568999999999954 567777766655442 3 337
Q ss_pred EEeccC---CCHHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhcCeeccccCCCceEEccCC-CCCeEEEeeecce
Q 015041 81 VLDLLG---PSLEDLFVYCRRKFSLKTVLMLADQMIARI-EYVHSRGFLHRDIKPDNFLMGLGR-KANQVYIIDFGLA 153 (414)
Q Consensus 81 v~e~~~---~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL-~~LH~~~iiHrDLkp~Nili~~~~-~~~~vkL~DFG~a 153 (414)
|+||.| ++|.+++.. ..+++. ..++.|++.++ +|||+++||||||||+|||++..+ ....++|+||+.+
T Consensus 83 I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 899965 799999864 345555 46678888888 999999999999999999996322 3458999995543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.6e-18 Score=150.92 Aligned_cols=132 Identities=25% Similarity=0.398 Sum_probs=103.8
Q ss_pred ecceeecCceeEEEEEECCCCceEEEEEecCCCC----------chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++.||+|++|.||+|.+ .+..|++|+...... ...+.+|+.++..+.+. +++....++......+++
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~-~i~~p~~~~~~~~~~~lv 77 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKA-GVNVPAVYFVDPENFIIV 77 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHC-CCCCCeEEEEeCCCCEEE
Confidence 36799999999999987 677899997654321 12366788899888764 344433344455678899
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
|||+ |.+|.+++.... . ....++.+++.+|.+||+.+++|+|++|+|||+. .+.++|+|||.+..
T Consensus 78 ~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence 9999 778988876422 2 7889999999999999999999999999999993 67899999998864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.2e-18 Score=165.27 Aligned_cols=210 Identities=14% Similarity=0.197 Sum_probs=157.1
Q ss_pred CCCCCeeEEeeeeCCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCe-eccccCCCceEEccC
Q 015041 62 GSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF-LHRDIKPDNFLMGLG 139 (414)
Q Consensus 62 ~~~i~~l~~~~~~~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i-iHrDLkp~Nili~~~ 139 (414)
|.++..+.+.+.++...++|.+|| .|+|.|.+......+++.-...++++|+.||+|||+-.| .|+.|+..|+++
T Consensus 6 h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClv--- 82 (484)
T KOG1023|consen 6 HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLV--- 82 (484)
T ss_pred hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccccee---
Confidence 366777777788888999999999 899999998766678888889999999999999998755 999999999999
Q ss_pred CCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCC-------CCchhhHHHHHHHHHHHHcCCCC
Q 015041 140 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-------QSRRDDLESLGYVLLYFLRGSLP 212 (414)
Q Consensus 140 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~s~~~DiwSlG~il~el~tG~~P 212 (414)
+....+||+|||+......... +.......-..-|.|||++.+.. .+.+.||||||++++|+++.+-|
T Consensus 83 d~~w~lklt~~Gl~~~~~~~~~-----~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 83 DSRWVLKLTDFGLNSLLEETAE-----PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred eeeEEEEechhhhccccccccc-----ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 6999999999999876532000 00111222345799999998642 36679999999999999999999
Q ss_pred CCCChhhc-hHHHHHHHHhhccCCchHHhh--hcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 213 WQGLKAAT-KKQKYDKICEKKVSTPIEVLC--KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 213 f~~~~~~~-~~~~~~~i~~~~~~~p~~~~~--~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
|....... ..+.+..+.+.......+... ...++++..++..||..+|..||+++.+...++.+...
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 98632222 123333332312211111111 14566899999999999999999999998888877654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.9e-17 Score=146.84 Aligned_cols=134 Identities=23% Similarity=0.323 Sum_probs=102.0
Q ss_pred eEEecceeecCceeEEEEEECCCCceEEEEEecCCCC------------------------chhHHHHHHHHHHHcCCC-
Q 015041 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK------------------------HPQLLYEAKVYKILQGGS- 63 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------------~~~~~~E~~~l~~l~~~~- 63 (414)
|.+.+.||.|+||.||+|.+. +|+.||||++..... ......|+.++..+.+..
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 889999999999999999874 799999998654320 012467788888886642
Q ss_pred CCCeeEEeeeeCCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCC
Q 015041 64 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 142 (414)
Q Consensus 64 ~i~~l~~~~~~~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~ 142 (414)
.++.... ....++||||+ +++|..+.. ......++.+++.++.++|+.||+|+||||+||++ +.+
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill---~~~ 161 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV---DDD 161 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE---cCC
Confidence 2333322 23458999999 556654321 13456788999999999999999999999999999 478
Q ss_pred CeEEEeeecceeeec
Q 015041 143 NQVYIIDFGLAKKYR 157 (414)
Q Consensus 143 ~~vkL~DFG~a~~~~ 157 (414)
+.++|+|||.+....
T Consensus 162 ~~~~liDfg~~~~~~ 176 (198)
T cd05144 162 EKIYIIDWPQMVSTD 176 (198)
T ss_pred CcEEEEECCccccCC
Confidence 899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.3e-17 Score=145.40 Aligned_cols=127 Identities=22% Similarity=0.399 Sum_probs=97.9
Q ss_pred ceeecCceeEEEEEECCCCceEEEEEecCCC-C---------chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGT-K---------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 14 ~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
.||+|+||.||+|.+ ++..|++|...... . ...+.+|++++..+.+.. ++....+.......+++||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAG-VNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCC-CCCCEEEEEECCCCEEEEE
Confidence 389999999999985 56789999754322 1 133567999999998643 3333334445566789999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
|+ |++|.+++.... . .++.|++.+|.+||+.|++|+|++|+||++ + .+.++++|||+++.
T Consensus 78 ~~~g~~l~~~~~~~~-----~---~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~---~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGN-----D---ELLREIGRLVGKLHKAGIVHGDLTTSNIIV---R-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcH-----H---HHHHHHHHHHHHHHHCCeecCCCCcceEEE---E-CCcEEEEECCCCcC
Confidence 99 788887765311 0 789999999999999999999999999999 3 68899999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.5e-18 Score=164.64 Aligned_cols=173 Identities=25% Similarity=0.333 Sum_probs=129.8
Q ss_pred CeeEEEEecc-CCCHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecc
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYC--RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~ 152 (414)
.+.+|.|++| ..+|.+++... ....++...+.++.|++.|++| ++.+|||+||.||++. .+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhhhhhhhhh
Confidence 3578999999 78899998632 2346888999999999999999 9999999999999994 666899999999
Q ss_pred eeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhh
Q 015041 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEK 231 (414)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~ 231 (414)
........+. ..++.....-+||..||+||.+.+..|+.++||||||++|+|++. -...|... ..+..+...
T Consensus 403 ~ts~~~~~~~-~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~------~t~~d~r~g 475 (516)
T KOG1033|consen 403 VTSQDKDETV-APAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI------ATLTDIRDG 475 (516)
T ss_pred eeecccCCcc-cchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH------HhhhhhhcC
Confidence 8766554411 112223446789999999999999999999999999999999997 44444321 222222222
Q ss_pred ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCC
Q 015041 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265 (414)
Q Consensus 232 ~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~ 265 (414)
. .| +......| +-..|+..++...|.+||.
T Consensus 476 ~--ip-~~~~~d~p-~e~~ll~~lls~~p~~RP~ 505 (516)
T KOG1033|consen 476 I--IP-PEFLQDYP-EEYTLLQQLLSPSPEERPS 505 (516)
T ss_pred C--CC-hHHhhcCc-HHHHHHHHhcCCCcccCch
Confidence 2 22 22223444 4468999999999999993
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=7e-17 Score=164.43 Aligned_cols=133 Identities=23% Similarity=0.420 Sum_probs=102.4
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCC-CC---------chhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-TK---------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~---------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
..|...++||+|+||+||+|.+.... +++|..... .. ...+.+|+++++.++++ +++....+.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~-~i~~p~~~~~~~~ 409 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRA-GVPTPVIYDVDPE 409 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhccc-CCCeeEEEEEeCC
Confidence 44566889999999999999875443 444432111 11 13467899999999864 4555555555666
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
..++||||+ +++|.+++. ....++.|++.+|.+||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl----~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV----RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE----ECCcEEEEeCccccc
Confidence 789999999 778887764 356789999999999999999999999999999 467899999999864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.8e-16 Score=138.01 Aligned_cols=136 Identities=27% Similarity=0.364 Sum_probs=95.8
Q ss_pred EecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hh----------------------HHHHHHHHHHHcCC-C
Q 015041 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQ----------------------LLYEAKVYKILQGG-S 63 (414)
Q Consensus 11 i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~----------------------~~~E~~~l~~l~~~-~ 63 (414)
+++.||+|+||+||+|.+. +++.||||++...... .. ...|...+..+.+. .
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999976 7899999987653211 00 12455556666543 2
Q ss_pred CCCeeEEeeeeCCeeEEEEeccCC-CHH-HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeccccCCCceEEccCC
Q 015041 64 GIPNIKWYGVDGEDNVLVLDLLGP-SLE-DLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGR 140 (414)
Q Consensus 64 ~i~~l~~~~~~~~~~~lv~e~~~~-sL~-~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDLkp~Nili~~~~ 140 (414)
.++....+ ...++||||+.+ .+. ..+..... ...+..++.+++.++.++|. .+|+|+||||+||++ +
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~---~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili---~ 149 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL---LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILV---D 149 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhhh---cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE---E
Confidence 23333332 245899999954 221 11111111 16778999999999999999 999999999999999 3
Q ss_pred CCCeEEEeeecceeeecC
Q 015041 141 KANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 141 ~~~~vkL~DFG~a~~~~~ 158 (414)
++.++|+|||.+.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 78899999999975544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.5e-15 Score=126.35 Aligned_cols=131 Identities=21% Similarity=0.281 Sum_probs=106.2
Q ss_pred EecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCC-CCCCeeEEeeeeCCeeEEEEeccCC-C
Q 015041 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG-SGIPNIKWYGVDGEDNVLVLDLLGP-S 88 (414)
Q Consensus 11 i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~-~~i~~l~~~~~~~~~~~lv~e~~~~-s 88 (414)
+.+.||.|.++.||++.... ..+++|..........+..|+..+..+.+. ..++.+..+.......+++|||+.+ .
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 46789999999999999743 679999876654445688999999999876 5677776666666789999999954 3
Q ss_pred HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR---GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 89 L~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
+..+ +......++.+++.+|.+||.. +++|+||+|+||+++ ..+.++++|||.+.
T Consensus 80 ~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~ 137 (155)
T cd05120 80 LDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYAG 137 (155)
T ss_pred cccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---CCcEEEEEeccccc
Confidence 3322 5566778899999999999985 699999999999994 57899999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=9.5e-15 Score=132.99 Aligned_cols=132 Identities=16% Similarity=0.214 Sum_probs=95.1
Q ss_pred ccee-ecCceeEEEEEECCCCceEEEEEecCC---------------CCchhHHHHHHHHHHHcCCCC-CCeeEEeee-e
Q 015041 13 RKIG-SGSFGEIFLASHVDTNEIVAVKIENSG---------------TKHPQLLYEAKVYKILQGGSG-IPNIKWYGV-D 74 (414)
Q Consensus 13 ~~iG-~G~~g~V~~~~~~~~~~~vavK~~~~~---------------~~~~~~~~E~~~l~~l~~~~~-i~~l~~~~~-~ 74 (414)
..|| .|+.|+||.+.. .+..++||.+... .....+.+|+.++..|.+... +|....+.. .
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 788889998876 3678999976431 112346789999999986432 344433322 2
Q ss_pred CCe---eEEEEeccC--CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEee
Q 015041 75 GED---NVLVLDLLG--PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149 (414)
Q Consensus 75 ~~~---~~lv~e~~~--~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~D 149 (414)
... .++|||++. .+|.+++.. ..++.. .+.||+.+|.+||++||+||||||+|||++ .++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~---~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLD---PDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEc---CCCCEEEEE
Confidence 222 359999994 478877653 345543 357899999999999999999999999994 567899999
Q ss_pred ecceee
Q 015041 150 FGLAKK 155 (414)
Q Consensus 150 FG~a~~ 155 (414)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.5e-17 Score=164.14 Aligned_cols=255 Identities=27% Similarity=0.301 Sum_probs=183.8
Q ss_pred CCceEEecceeecCceeEEEEEEC-CCCceEEEEEecCCCC-c---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHV-DTNEIVAVKIENSGTK-H---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~-~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
...|.+.+.||+|+|+.|-++... .....+|+|.+..... . .....|..+-+.+..|.++..+..........++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 356899999999999999988764 3345677776554431 1 1233466666777656777777777777888899
Q ss_pred EEecc-CCCHHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHHH-hcCeeccccCCCceEEccCCCCC-eEEEeeecceeee
Q 015041 81 VLDLL-GPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVH-SRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKY 156 (414)
Q Consensus 81 v~e~~-~~sL~~~~-~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~iiHrDLkp~Nili~~~~~~~-~vkL~DFG~a~~~ 156 (414)
+++|. ++++.+.+ .......+...+..++.|+..+|.|+| ..++.||||||+|.++ +..+ .+++.|||+|..+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l---~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLL---DESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchh---ccCCCcccCCCchhhccc
Confidence 99998 66666665 322225677888999999999999999 9999999999999999 4666 8999999999887
Q ss_pred cC-CCCCccccccCCCCCcc-CcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc
Q 015041 157 RD-PTTNRHIPYRENKNLTG-TARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 157 ~~-~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
.. ..... .....+| +..|+|||...+. ......|+||.|+++.-+++|..||....... ..+....+.+.
T Consensus 176 ~~~~g~~~-----~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~~ 248 (601)
T KOG0590|consen 176 RNKNGAER-----SLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSNKG 248 (601)
T ss_pred cccCCcce-----eeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--ccceeeccccc
Confidence 76 22221 2234567 9999999999985 45778999999999999999999998643222 22222222221
Q ss_pred CCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 234 ~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
. .-...+........+++..++..+++.|.+.+++..
T Consensus 249 ~-~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 R-FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred c-cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 1 112223455677788888888888888888766533
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.4e-13 Score=134.34 Aligned_cols=138 Identities=22% Similarity=0.352 Sum_probs=94.1
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCCCch------------------------------------------hHH
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP------------------------------------------QLL 50 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------------------------------------~~~ 50 (414)
+.||.|++|+||+|+. .+|+.||||+........ .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999986 478999999876542100 133
Q ss_pred HHHHHHHHHc----CCCCCCeeEEeeeeCCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHH-HHHHHHhcCe
Q 015041 51 YEAKVYKILQ----GGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIA-RIEYVHSRGF 124 (414)
Q Consensus 51 ~E~~~l~~l~----~~~~i~~l~~~~~~~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~-aL~~LH~~~i 124 (414)
+|...+..+. +.+.+..-..+.......++||||+ |.+|.++.......+. ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 3444444443 2233222223333345579999999 7777776553222232 3446666655 4788999999
Q ss_pred eccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 125 iHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
+|+|++|.||++ +.++.++|+|||++....
T Consensus 279 ~H~D~hPgNilv---~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFV---LKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEE---CCCCcEEEEeCCCeeECC
Confidence 999999999999 477899999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=6.8e-13 Score=115.85 Aligned_cols=136 Identities=16% Similarity=0.202 Sum_probs=98.7
Q ss_pred ecceeecCceeEEEEEECC------CCceEEEEEecCCC--------------C----------chh----HHHHHHHHH
Q 015041 12 GRKIGSGSFGEIFLASHVD------TNEIVAVKIENSGT--------------K----------HPQ----LLYEAKVYK 57 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~------~~~~vavK~~~~~~--------------~----------~~~----~~~E~~~l~ 57 (414)
...||.|--+.||.|.... .+..+|||+.+... . ... ..+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999998643 35789999754211 0 011 237888898
Q ss_pred HHcCC-CCCCeeEEeeeeCCeeEEEEeccCCC-HHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhcCeeccccCCCc
Q 015041 58 ILQGG-SGIPNIKWYGVDGEDNVLVLDLLGPS-LED-LFVYCRRKFSLKTVLMLADQMIARIEYV-HSRGFLHRDIKPDN 133 (414)
Q Consensus 58 ~l~~~-~~i~~l~~~~~~~~~~~lv~e~~~~s-L~~-~~~~~~~~~~~~~~~~i~~qi~~aL~~L-H~~~iiHrDLkp~N 133 (414)
++... -.+|....+ ...++||||++++ +.. .+. ...++..+...+..|++.+|..| |..||||+||++.|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 88753 356666544 5679999999754 211 111 22345566778889999999999 89999999999999
Q ss_pred eEEccCCCCCeEEEeeecceeeec
Q 015041 134 FLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 134 ili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
||+ .++.++|+|||.|....
T Consensus 156 IL~----~~~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLW----HDGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEE----ECCcEEEEECCCceeCC
Confidence 999 35789999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1e-13 Score=135.62 Aligned_cols=255 Identities=18% Similarity=0.155 Sum_probs=185.9
Q ss_pred ccCCceEEecceee--cCceeEEEEEE--CCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015041 4 IIGVKYKLGRKIGS--GSFGEIFLASH--VDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (414)
Q Consensus 4 i~~~~y~i~~~iG~--G~~g~V~~~~~--~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 75 (414)
.+...+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+... ....-.+|+....++..+.+...........
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence 45567788899999 99999999988 7888999999633322 2223456666666666555555555556677
Q ss_pred CeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHH----HHHHHHhcCeeccccCCCceEEccCCCC-CeEEEeee
Q 015041 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIA----RIEYVHSRGFLHRDIKPDNFLMGLGRKA-NQVYIIDF 150 (414)
Q Consensus 76 ~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~----aL~~LH~~~iiHrDLkp~Nili~~~~~~-~~vkL~DF 150 (414)
...++-+|+++.+|..+......-++...++.+..+... ||.++|+.+++|-|+||+||++. .+ ...+++||
T Consensus 191 ~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~---~~~~s~~~~df 267 (524)
T KOG0601|consen 191 GILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT---SDWTSCKLTDF 267 (524)
T ss_pred CcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc---cccceeecCCc
Confidence 889999999998888877654445788888888889888 99999999999999999999995 55 78899999
Q ss_pred cceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHh
Q 015041 151 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (414)
Q Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~ 230 (414)
|+...+.+...... +...+...|...|++||...+ -++..+|++|+|.++.+..++..+...-...... .+ .
T Consensus 268 ~~v~~i~~~~~~~~--~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~-~~----r 339 (524)
T KOG0601|consen 268 GLVSKISDGNFSSV--FKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWS-QL----R 339 (524)
T ss_pred ceeEEccCCccccc--eeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcc-cc----c
Confidence 99988776554322 112233467788999998765 4788999999999999999987666543111110 00 1
Q ss_pred hccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 231 ~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+ -..++|.+....+...+.++++.++-.|++...+..
T Consensus 340 ~~~--ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 340 QGY--IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccc--CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111 124455555667777888889888888888775544
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.1e-13 Score=114.69 Aligned_cols=126 Identities=21% Similarity=0.288 Sum_probs=95.3
Q ss_pred ecceeecCceeEEEEEECCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-CCCH
Q 015041 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSL 89 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~~sL 89 (414)
++.|+.|.++.||+++.. +..|++|+..... ....+..|+.+++.+.+...+|.+..+.. ...++|||++ +.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 467899999999999863 7789999876554 23346789999999977666777765543 3458999999 4444
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCe-----eccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 90 EDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF-----LHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i-----iHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
... ......++.+++.+|..||+.++ +|+|++|.||+++ .+.++++|||.+.
T Consensus 79 ~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTE---------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAG 135 (170)
T ss_pred ccc---------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEeccccc
Confidence 321 01123456799999999999885 9999999999993 5679999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.4e-12 Score=126.41 Aligned_cols=139 Identities=19% Similarity=0.301 Sum_probs=90.5
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc-----------------------------------------
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----------------------------------------- 46 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------------------------- 46 (414)
.|.. +.||+|++|+||+|+...+|+.||||+.......
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4555 7899999999999998877999999998654210
Q ss_pred -hhHHHHHHHHHHHc----CCCCCCeeEEeeeeCCeeEEEEecc-CCCHHHHHHHhCCCC-----CHHHHHHHHHHHHHH
Q 015041 47 -PQLLYEAKVYKILQ----GGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKF-----SLKTVLMLADQMIAR 115 (414)
Q Consensus 47 -~~~~~E~~~l~~l~----~~~~i~~l~~~~~~~~~~~lv~e~~-~~sL~~~~~~~~~~~-----~~~~~~~i~~qi~~a 115 (414)
-.+.+|...+.++. +.+.+..-..+.......+|||||+ |..+.++-....... ....+..++.|+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence 01334444444443 2222211133334456789999999 777766432112222 223333334443
Q ss_pred HHHHHhcCeeccccCCCceEEccCCCCC----eEEEeeecceeeec
Q 015041 116 IEYVHSRGFLHRDIKPDNFLMGLGRKAN----QVYIIDFGLAKKYR 157 (414)
Q Consensus 116 L~~LH~~~iiHrDLkp~Nili~~~~~~~----~vkL~DFG~a~~~~ 157 (414)
...|++|+|+||.||+++ .++ .++++|||++....
T Consensus 277 ----f~~GffHaDpHPGNIlv~---~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 ----FRDGFFHADMHPGNIFVS---YDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ----HhCCeeeCCCChHHeEEe---cCCCCCCeEEEEecceEEECC
Confidence 468999999999999995 444 89999999987653
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.5e-11 Score=103.55 Aligned_cols=146 Identities=20% Similarity=0.261 Sum_probs=107.6
Q ss_pred EecceeecCceeEEEEEECCCCceEEEEE-ecCCCCch---------hHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKI-ENSGTKHP---------QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 11 i~~~iG~G~~g~V~~~~~~~~~~~vavK~-~~~~~~~~---------~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
.+..|-+|+-+.|+++.+ .|+.++||. +.+...++ +..+|++.+.++.-- +|+.-..++.+.....|
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~-GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRAL-GIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHh-CCCCceEEEEecCCCeE
Confidence 577889999999999987 577778884 33433333 346788888887643 44433444555666789
Q ss_pred EEeccCC--CHHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 81 VLDLLGP--SLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 81 v~e~~~~--sL~~~~~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
+|||+.+ ++.+++...-.. ........++.+|-..+.-||..+|||+||..+||++........+.|+|||++....
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s~ 167 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVSR 167 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhccc
Confidence 9999976 888887754333 3333347888899999999999999999999999999755555566999999986544
Q ss_pred CC
Q 015041 158 DP 159 (414)
Q Consensus 158 ~~ 159 (414)
.+
T Consensus 168 ~~ 169 (229)
T KOG3087|consen 168 LP 169 (229)
T ss_pred Cc
Confidence 33
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.7e-11 Score=100.98 Aligned_cols=128 Identities=23% Similarity=0.392 Sum_probs=93.9
Q ss_pred cceeecCceeEEEEEECCCCceEEEEE-ecCCCCch---------hHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKI-ENSGTKHP---------QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~-~~~~~~~~---------~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
..|++|+-+.|+.+.+. |..+++|. +.+...++ .-.+|..++.++.. .+++.-..+..+.....|+|
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~-~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKARE-AGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHH-cCCCCCeEEEEcCCCCEEEE
Confidence 46789999999999773 44577884 33333333 24678888888865 35655555666777789999
Q ss_pred eccCC-CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 83 DLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 83 e~~~~-sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
||.+| .|.+.+... ...++..+-.-+.-||..||||+||.++||++ ..+.++++|||++..
T Consensus 79 e~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl----~~~~i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIIL----SGGRIYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEE----eCCcEEEEECCcccc
Confidence 99955 455566542 24566677777889999999999999999999 455599999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.1e-11 Score=127.71 Aligned_cols=270 Identities=21% Similarity=0.188 Sum_probs=182.3
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeeEEe---eeeCCe
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWY---GVDGED 77 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~l~~~---~~~~~~ 77 (414)
-..+.+.+-+-+|.++.++.++-..++...+.|+....... +....+-.+ ..++..|.+..+ ......
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~----~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNI----LITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCc----cccCCCCceecccCCCCCCCC
Confidence 35567788899999999999887777776676654332211 111111111 111222323211 235667
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee-
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK- 155 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~- 155 (414)
..++++|+ +++|...+.. ....+..-.......+..++++||+..++|||++|.|+++ ...+..++.|||....
T Consensus 879 ~~L~~~~~~~~~~~Skl~~-~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHN-SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred cchhhHHhccCCchhhhhc-CCCcccccccchhHHHHhhhhccccchhhcccccccchhh---cccCCcccCcccccccc
Confidence 88999999 6666666654 2345666667777889999999999999999999999999 5889999999984321
Q ss_pred ecC-CCCC-------------------ccc---cccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 015041 156 YRD-PTTN-------------------RHI---PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212 (414)
Q Consensus 156 ~~~-~~~~-------------------~~~---~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~P 212 (414)
... +.+. ... .-+......||..|.+||..++..-...+|+|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 110 0000 000 11223467899999999999999999999999999999999999999
Q ss_pred CCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCccccccc
Q 015041 213 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTI 292 (414)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 292 (414)
|...... +.+..|.....+.|. .....+.+..+++...+..++.+|-.+.. ..+..+..+....+|..
T Consensus 1035 ~na~tpq---~~f~ni~~~~~~~p~--g~~~~s~~aq~~~~~ll~~~~~qr~~a~~-------~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1035 FNAETPQ---QIFENILNRDIPWPE--GPEEGSYEAQDLINRLLTEEPTQRLGAKG-------AAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred CCCcchh---hhhhccccCCCCCCC--CccccChhhhhhhhhhhccCchhccCccc-------ccccccCCccCCCCccc
Confidence 9875443 444445444444432 22334678999999999999999987542 12345667777888876
Q ss_pred ccc
Q 015041 293 LKY 295 (414)
Q Consensus 293 l~~ 295 (414)
+..
T Consensus 1103 l~~ 1105 (1205)
T KOG0606|consen 1103 LAL 1105 (1205)
T ss_pred ccc
Confidence 543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1e-11 Score=121.69 Aligned_cols=242 Identities=18% Similarity=0.134 Sum_probs=163.7
Q ss_pred CCceEEecceeecCceeEEEEEEC-CCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHV-DTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~-~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
..+|.++..||.|.|+.|+.+... .++..+++|...... .+..-..|+.+...+.-+.+++.....+......++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 467889999999999999987755 678889999654432 112235667666666655555554334445556678
Q ss_pred EEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 81 v~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
-.|||.+....+.......+.....+++..|++.++.++|++.++|+|+||+||++. +..+..++.|||.+..+....
T Consensus 344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~--~~~~~~~~~~~~~~t~~~~~~ 421 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILIS--NDGFFSKLGDFGCWTRLAFSS 421 (524)
T ss_pred chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeec--cchhhhhccccccccccceec
Confidence 899994433334334456678888999999999999999999999999999999995 222777999999886422211
Q ss_pred CCccccccCCCCCccCcCcc--ccccccCCCCCchhhHHHHHHHHHHHHcCCCC-CCCChhhchHHHHHHHHhhccCCch
Q 015041 161 TNRHIPYRENKNLTGTARYA--SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP-WQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~~~DiwSlG~il~el~tG~~P-f~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
. ...++.+++ +++......+..++|++|||..+.+.++|... ..+. ....|........
T Consensus 422 ~----------~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------~~~~i~~~~~p~~- 483 (524)
T KOG0601|consen 422 G----------VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------QSLTIRSGDTPNL- 483 (524)
T ss_pred c----------cccccccccccchhhccccccccccccccccccccccccCcccCcccc-------cceeeecccccCC-
Confidence 1 223344555 45555566788999999999999999998643 2221 1111222222111
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+...++..+.+.....++..||.+.++..
T Consensus 484 ----~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 484 ----PGLKLQLQVLLKVMINPDRKRRPSAVELSL 513 (524)
T ss_pred ----CchHHhhhhhhhhhcCCccccchhhhhhcc
Confidence 122367778888888888888888765533
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.5e-11 Score=111.88 Aligned_cols=178 Identities=12% Similarity=0.177 Sum_probs=119.9
Q ss_pred CeeEEEEecc-CCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcC--eeccccCCCceEEccCCCCCeEEEee
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIID 149 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDLkp~Nili~~~~~~~~vkL~D 149 (414)
....++.||+ .+++..++++. ...+......+++.||+.||.|||+.. |+|+++..+-|++ ..++.+|+.-
T Consensus 145 ~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifi---q~ngLIkig~ 221 (458)
T KOG1266|consen 145 PRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFI---QHNGLIKIGS 221 (458)
T ss_pred cceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheee---cCCceEEecc
Confidence 3467889999 88998888743 456888999999999999999999985 9999999999999 4777777652
Q ss_pred ecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCC-CCCChhhchHHHHHHH
Q 015041 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP-WQGLKAATKKQKYDKI 228 (414)
Q Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~P-f~~~~~~~~~~~~~~i 228 (414)
-.-.. ..+... ..--.+.....+-++|.|||.-..-..+..+|||+||.+..||..|..- -.+.+.....+.+...
T Consensus 222 ~ap~s--~h~s~~-~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~ 298 (458)
T KOG1266|consen 222 VAPDS--THPSVN-STREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANV 298 (458)
T ss_pred cCccc--cchhhh-hhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhh
Confidence 11100 000000 0001112234556789999987777778899999999999999988653 3332222222222221
Q ss_pred HhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 229 ~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
.. .+. ...=++++..|++-.|..||++..+.
T Consensus 299 i~-~le----------n~lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 299 II-GLE----------NGLQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred ee-ecc----------CccccCcCcccccCCCCCCcchhhhh
Confidence 11 111 11234677889999999999987653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.8e-10 Score=100.28 Aligned_cols=136 Identities=21% Similarity=0.332 Sum_probs=95.8
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCC-CCCeeEEeeeeC---CeeEEEEecc
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGS-GIPNIKWYGVDG---EDNVLVLDLL 85 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~-~i~~l~~~~~~~---~~~~lv~e~~ 85 (414)
+.|+.|.++.||++... +|..+++|+...... ...+..|.++++.+.+.. .+|.+..+.... ...++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 57899999999999864 357899998765442 456889999999998643 366666655443 2568999999
Q ss_pred -CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 015041 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS------------------------------------------- 121 (414)
Q Consensus 86 -~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~------------------------------------------- 121 (414)
|.++.+.+. ...++......++.+++..|..||+
T Consensus 83 ~G~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLL--RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCC--CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 444443321 0234555556666666666666662
Q ss_pred -------------cCeeccccCCCceEEccCCC--CCeEEEeeeccee
Q 015041 122 -------------RGFLHRDIKPDNFLMGLGRK--ANQVYIIDFGLAK 154 (414)
Q Consensus 122 -------------~~iiHrDLkp~Nili~~~~~--~~~vkL~DFG~a~ 154 (414)
..++|+|+.+.||+++ . .+.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~---~~~~~~~~iID~e~~~ 205 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFH---PDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEc---CCCCcEEEEEeccccc
Confidence 2479999999999994 4 4668999998775
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.1e-09 Score=106.84 Aligned_cols=183 Identities=15% Similarity=0.136 Sum_probs=126.4
Q ss_pred ceEEecceeecCceeEE-EEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 8 KYKLGRKIGSGSFGEIF-LASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~-~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
-|++ ....-++.+ +| -|..+.++..|.|...+.... .....+-++-++.++|+..+..+ .........|+|+|-
T Consensus 14 pY~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL-~t~e~~~~~ylvTEr 90 (690)
T KOG1243|consen 14 PYDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYL-DTTEEEGTLYLVTER 90 (690)
T ss_pred Cccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhh-hhhcccCceEEEeec
Confidence 3555 444444444 44 456667788899888776555 33456777889999885544444 444455588999999
Q ss_pred cCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 85 LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH-SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 85 ~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
+.. |...+.. +....+...+.||+.||.||| .++++|++|.-+.|++ +..|..||++|.++..........
T Consensus 91 V~P-l~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~~ 162 (690)
T KOG1243|consen 91 VRP-LETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNAPA 162 (690)
T ss_pred ccc-HHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCccc
Confidence 843 4444443 236778888999999999998 5689999999999999 699999999999887554332211
Q ss_pred cccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCC
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 210 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~ 210 (414)
....--..|..|+.+.... -..|.|-|||+++|++.|.
T Consensus 163 -------~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 163 -------KSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred -------ccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 1112223456666554332 2469999999999999993
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=9e-09 Score=94.93 Aligned_cols=131 Identities=18% Similarity=0.139 Sum_probs=92.2
Q ss_pred eEEEEEECCCCceEEEEEecCCCC-----------c--hhHHHHHHHHHHHcCC-CCCCeeEEeeee-----CCeeEEEE
Q 015041 22 EIFLASHVDTNEIVAVKIENSGTK-----------H--PQLLYEAKVYKILQGG-SGIPNIKWYGVD-----GEDNVLVL 82 (414)
Q Consensus 22 ~V~~~~~~~~~~~vavK~~~~~~~-----------~--~~~~~E~~~l~~l~~~-~~i~~l~~~~~~-----~~~~~lv~ 82 (414)
.|.++.. .|+.|.||....... . ..+.+|...+..|... -..|....++.. ....++|+
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3555554 466788896533221 1 1367899988888542 223444444432 23478999
Q ss_pred eccCC--CHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEcc----CCCCCeEEEeeeccee
Q 015041 83 DLLGP--SLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL----GRKANQVYIIDFGLAK 154 (414)
Q Consensus 83 e~~~~--sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~----~~~~~~vkL~DFG~a~ 154 (414)
|++++ +|.+++... ....+......++.+++..+.-||..||+|+||++.|||+.. .+....+.|+||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99955 688887643 234566778899999999999999999999999999999952 1235789999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.05 E-value=8.4e-10 Score=96.07 Aligned_cols=125 Identities=27% Similarity=0.370 Sum_probs=80.0
Q ss_pred eEEEEEECCCCceEEEEEecCCC--------------C--------------chhHHHHHHHHHHHcCCC-CCCeeEEee
Q 015041 22 EIFLASHVDTNEIVAVKIENSGT--------------K--------------HPQLLYEAKVYKILQGGS-GIPNIKWYG 72 (414)
Q Consensus 22 ~V~~~~~~~~~~~vavK~~~~~~--------------~--------------~~~~~~E~~~l~~l~~~~-~i~~l~~~~ 72 (414)
.||.|.. ..|..||||+..... . .....+|.+.|.++.... .+|.+..+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3899986 457799999854321 0 012568999999988653 467765443
Q ss_pred eeCCeeEEEEeccC--CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhcCeeccccCCCceEEccCCCCCeEEEee
Q 015041 73 VDGEDNVLVLDLLG--PSLEDLFVYCRRKFSLKTVLMLADQMIARIEY-VHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149 (414)
Q Consensus 73 ~~~~~~~lv~e~~~--~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~-LH~~~iiHrDLkp~Nili~~~~~~~~vkL~D 149 (414)
..+|||||++ |.....+... .++......++.+++..+.. +|..||+|+||.+.|||++ .+.++|+|
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~----~~~~~iID 149 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD----DGKVYIID 149 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE----TTCEEE--
T ss_pred ----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee----cceEEEEe
Confidence 4689999997 5433333321 12234566777888885555 5799999999999999993 34999999
Q ss_pred ecceeeec
Q 015041 150 FGLAKKYR 157 (414)
Q Consensus 150 FG~a~~~~ 157 (414)
||.|....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1e-07 Score=90.17 Aligned_cols=256 Identities=13% Similarity=0.196 Sum_probs=156.9
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCe-e-----EEeeeeCC-ee
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN-I-----KWYGVDGE-DN 78 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~-l-----~~~~~~~~-~~ 78 (414)
+.-...++.||+|+-+.+|-.-. -+ ..+.|+........+. ..+..|...-.++.+.. + ..++.+.. ..
T Consensus 10 ge~i~~gr~LgqGgea~ly~l~e--~~-d~VAKIYh~Pppa~~a-qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 10 GEPIPPGRPLGQGGEADLYTLGE--VR-DQVAKIYHAPPPAAQA-QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CcccCCCccccCCccceeeecch--hh-chhheeecCCCchHHH-HHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 33445678899999999995432 22 2355887665432221 11222222222222211 1 12233333 35
Q ss_pred EEEEeccCC--CHHHHHHHh--C---CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeec
Q 015041 79 VLVLDLLGP--SLEDLFVYC--R---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (414)
Q Consensus 79 ~lv~e~~~~--sL~~~~~~~--~---~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG 151 (414)
-+.|..+.+ .+.+++.-. + ..+.|...++.++.++.+.+.||..|.+-+|+.++|||++ +...|.|.|=.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEEEccc
Confidence 677777733 344444311 1 2378999999999999999999999999999999999995 78888888743
Q ss_pred ceeeecCCCCCccccccCCCCCccCcCcccccccc-----CCCCCchhhHHHHHHHHHHHHcC-CCCCCCChhh----ch
Q 015041 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRG-SLPWQGLKAA----TK 221 (414)
Q Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DiwSlG~il~el~tG-~~Pf~~~~~~----~~ 221 (414)
.-..-.+. +.....+|...|.+||.-. +..-+...|.|.||+++++++.| +.||.|.... ..
T Consensus 163 sfqi~~ng--------~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p 234 (637)
T COG4248 163 SFQINANG--------TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNP 234 (637)
T ss_pred ceeeccCC--------ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCc
Confidence 22111111 1223668899999999754 33456788999999999999985 9999863211 11
Q ss_pred HH-HH-------H-HHHhhccCCchHHhhhcChHHHHHHHHHHhcCC--CCCCCChHHHHHHHHHH
Q 015041 222 KQ-KY-------D-KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLT--FDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 222 ~~-~~-------~-~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~--p~~RP~~~~l~~~l~~~ 276 (414)
.+ .+ . +......+.|...-+.-+|+.+.-++.+|+... +.-||+.+.-...|..+
T Consensus 235 ~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 235 LETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred chhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 11 10 0 111112223333333456789999999998764 56899987655555443
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.2e-09 Score=106.97 Aligned_cols=155 Identities=14% Similarity=0.190 Sum_probs=109.2
Q ss_pred HHHHHHHHHHHhc-CeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccccccCCC--CCccCcCcccccccc
Q 015041 110 DQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK--NLTGTARYASCNTHL 186 (414)
Q Consensus 110 ~qi~~aL~~LH~~-~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~--~~~gt~~y~aPE~~~ 186 (414)
.+++.||.|+|.. ++||++|.|++|.+ +..+..||+.|+.+.....+.......|...- ...-...|.|||++.
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hcccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3455999999965 89999999999999 69999999999988755443222222222111 223356799999999
Q ss_pred CCCCCchhhHHHHHHHHHHHH-cCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCC
Q 015041 187 GIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265 (414)
Q Consensus 187 ~~~~s~~~DiwSlG~il~el~-tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~ 265 (414)
+...+.++|++|+||.+|.+. .|+..+.......... ............+..++|.++.+-+.+.+..+..-||+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~----~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~ 258 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS----FSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT 258 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhh----hhhcccccccccccccCcHHHHHHHHHHhcCCcccCcc
Confidence 988899999999999999999 5666665433221111 11222222222333678999999999999999999997
Q ss_pred hHHHHH
Q 015041 266 YGFLKR 271 (414)
Q Consensus 266 ~~~l~~ 271 (414)
+..+..
T Consensus 259 ~~~l~~ 264 (700)
T KOG2137|consen 259 LDLLLS 264 (700)
T ss_pred hhhhhc
Confidence 665543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=7.1e-08 Score=81.26 Aligned_cols=128 Identities=24% Similarity=0.418 Sum_probs=97.5
Q ss_pred EEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-CCC
Q 015041 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (414)
Q Consensus 10 ~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~~s 88 (414)
++.+.|++|++|.||+|.+ .|..+|+|+-..+.....+..|.+++..+......|.++.++.+. +.|||. |..
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~me~i~G~~ 98 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRMEYIDGRP 98 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhh----hhhhhhcCcc
Confidence 4567799999999999998 566899999999988889999999999999988999999888653 459999 557
Q ss_pred HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCC--CceEEccCCCCCeEEEeeecceee
Q 015041 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP--DNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 89 L~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp--~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
|.+..... ....+ ..++.+---|-..||-|..|.- .||++ .++.+.|+||..|..
T Consensus 99 L~~~~~~~----~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG----DRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLV----NDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc----cHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEe----cCCcEEEEEccchhh
Confidence 77665421 22222 3344443445567999998874 56666 455899999998863
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.68 E-value=6.5e-07 Score=79.73 Aligned_cols=109 Identities=20% Similarity=0.268 Sum_probs=81.0
Q ss_pred chhHHHHHHHHHHHcCC-CCCCeeEEeeeeC----CeeEEEEeccCC--CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHH
Q 015041 46 HPQLLYEAKVYKILQGG-SGIPNIKWYGVDG----EDNVLVLDLLGP--SLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118 (414)
Q Consensus 46 ~~~~~~E~~~l~~l~~~-~~i~~l~~~~~~~----~~~~lv~e~~~~--sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~ 118 (414)
.....+|...+..|... -.+|....++... ...++|+|++.+ +|.+++..... .+......++.+++..+.-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence 34578898888888642 2344445555432 235899999944 68887775322 6777888999999999999
Q ss_pred HHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 119 LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
||..||+|+|+++.|||+...+....+.|+||+.++.
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999995333334899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.68 E-value=8.5e-07 Score=77.91 Aligned_cols=134 Identities=13% Similarity=0.115 Sum_probs=96.4
Q ss_pred eecCceeEEEEEECCCCceEEEEEec--------CCCCchhHHHHHHHHHHHcCCC-CCCeeEEeeee----CCeeEEEE
Q 015041 16 GSGSFGEIFLASHVDTNEIVAVKIEN--------SGTKHPQLLYEAKVYKILQGGS-GIPNIKWYGVD----GEDNVLVL 82 (414)
Q Consensus 16 G~G~~g~V~~~~~~~~~~~vavK~~~--------~~~~~~~~~~E~~~l~~l~~~~-~i~~l~~~~~~----~~~~~lv~ 82 (414)
|.||.+-|+..... |..+=+|.-. .....+.+.+|+..+..|.... .+|.+.++... .-..+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 56888889887653 3356677432 1234567999999999987532 24444433322 22357999
Q ss_pred eccC--CCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCe--EEEeeeccee
Q 015041 83 DLLG--PSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGLAK 154 (414)
Q Consensus 83 e~~~--~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~--vkL~DFG~a~ 154 (414)
|-++ .+|.+++... ..+.+......+..+++..+.-||+.|+.|+|+-+.||++. ..+. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~---~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVK---TEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeec---CCCCeeEEEEEhhccc
Confidence 9886 7888876542 23457777889999999999999999999999999999994 3344 9999997654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.4e-07 Score=83.41 Aligned_cols=132 Identities=20% Similarity=0.320 Sum_probs=93.4
Q ss_pred eEEecceeecCceeEEEEEECCCCceEEEEEecCCC----------------C--------chhHHHHHHHHHHHcCC-C
Q 015041 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----------------K--------HPQLLYEAKVYKILQGG-S 63 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------~--------~~~~~~E~~~l~~l~~~-~ 63 (414)
+.++.+||-|--+.||.|.+. .|..+|||.-+... . .....+|.++|.+|... -
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 567899999999999999975 68889999632110 0 11257889999998753 2
Q ss_pred CCCeeEEeeeeCCeeEEEEeccCCC-HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCC
Q 015041 64 GIPNIKWYGVDGEDNVLVLDLLGPS-LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 142 (414)
Q Consensus 64 ~i~~l~~~~~~~~~~~lv~e~~~~s-L~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~ 142 (414)
.+|.-. ..+.+++|||+..+- |..+ ++.......++..|+.-+.-.-..||||+|+.+=||++ +++
T Consensus 172 ~VP~P~----~~nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV---~~d 238 (304)
T COG0478 172 KVPKPI----AWNRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV---TED 238 (304)
T ss_pred CCCCcc----ccccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE---ecC
Confidence 444332 345689999999553 3221 12344445555666666666668999999999999999 488
Q ss_pred CeEEEeeeccee
Q 015041 143 NQVYIIDFGLAK 154 (414)
Q Consensus 143 ~~vkL~DFG~a~ 154 (414)
+.++++||-.+.
T Consensus 239 g~~~vIDwPQ~v 250 (304)
T COG0478 239 GDIVVIDWPQAV 250 (304)
T ss_pred CCEEEEeCcccc
Confidence 899999996543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.62 E-value=3e-07 Score=81.08 Aligned_cols=138 Identities=20% Similarity=0.274 Sum_probs=91.1
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCch-----------hHHHHHHHHHHHcC--CCCCCee
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP-----------QLLYEAKVYKILQG--GSGIPNI 68 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~E~~~l~~l~~--~~~i~~l 68 (414)
..++.++|++.+.+-......|.+..- +|..+++|......... ...+.+.....+.. ......+
T Consensus 26 ~~i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~ 103 (229)
T PF06176_consen 26 EKILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP 103 (229)
T ss_pred HHHHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence 357889999999999988888887764 57889999876654321 12333443444432 1222221
Q ss_pred EEee-----eeCCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCC
Q 015041 69 KWYG-----VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 142 (414)
Q Consensus 69 ~~~~-----~~~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~ 142 (414)
.... ......+++|||+ |..|.++.. +.. .+...+..++.-||+.|+.|+|..|.||++ .+
T Consensus 104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv----~~ 170 (229)
T PF06176_consen 104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLV----SN 170 (229)
T ss_pred eeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEE----EC
Confidence 1111 1224457899999 555554422 221 345667788999999999999999999999 45
Q ss_pred CeEEEeeeccee
Q 015041 143 NQVYIIDFGLAK 154 (414)
Q Consensus 143 ~~vkL~DFG~a~ 154 (414)
+.++++||+..+
T Consensus 171 ~~i~iID~~~k~ 182 (229)
T PF06176_consen 171 NGIRIIDTQGKR 182 (229)
T ss_pred CcEEEEECcccc
Confidence 669999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.60 E-value=5.4e-06 Score=80.68 Aligned_cols=209 Identities=17% Similarity=0.200 Sum_probs=136.1
Q ss_pred ceeEEEEEECCCCceEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeeEEee---eeCCeeEEEEecc--CCCHHHH
Q 015041 20 FGEIFLASHVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYG---VDGEDNVLVLDLL--GPSLEDL 92 (414)
Q Consensus 20 ~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~l~~~~---~~~~~~~lv~e~~--~~sL~~~ 92 (414)
-.+.|++....+|..|++|.+...... .....-++.++++.|.+.|+.-..+. ......++|++|+ .++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 347899999999999999988433211 11234467789998866554332222 2344578999998 6677776
Q ss_pred HHHh--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 93 FVYC--------------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 93 ~~~~--------------~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
+-.. +.+.++..++.++.|+..||.++|+.|+.-+-|.+.+||+. ...+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~---G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT---GKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee---CcceEEEecccceeeecC
Confidence 5421 12356789999999999999999999998899999999994 555889888876654332
Q ss_pred CCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCC-CCCChhhchHHHHHHHHhhccCCch
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP-WQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~P-f~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
..+ |.+. .-.+-|.=.||.+++.+.||..- +..... ....+.
T Consensus 446 d~~---------------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~--~~s~~~----------- 488 (655)
T KOG3741|consen 446 DPT---------------------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDST--QSSHLT----------- 488 (655)
T ss_pred CCC---------------------cchh---HHhhhhHHHHHHHHHHHhhcccccccccch--HHHHHH-----------
Confidence 211 1111 12357999999999999999532 221111 111111
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
.....++.++.+++.+....++.+ -+..+|.
T Consensus 489 -~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~ll 519 (655)
T KOG3741|consen 489 -RITTTYSTDLRNVVEYLESLNFRE-KSIQDLL 519 (655)
T ss_pred -HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHH
Confidence 111334567777888887777775 3444433
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.9e-06 Score=77.86 Aligned_cols=71 Identities=18% Similarity=0.141 Sum_probs=56.3
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCeeEEeeeeCCeeEEEEeccCC
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWYGVDGEDNVLVLDLLGP 87 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~l~~~~~~~~~~~lv~e~~~~ 87 (414)
..||+|..+.||+. .+..+++|+...........+|.+++..+..... +|.+..++.......+||+++.|
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 57899999999984 2446789998776656678999999999986544 67888888777778899999955
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=6.1e-07 Score=89.73 Aligned_cols=138 Identities=22% Similarity=0.334 Sum_probs=89.4
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCCCc----------------------------h--------------hHH
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----------------------------P--------------QLL 50 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------------~--------------~~~ 50 (414)
+.|+.++-|+||.|+.. +|+.||||+...+-.. . .+.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 56889999999999975 5999999986543210 0 133
Q ss_pred HHHHHHHHHcC----CCCCCeeEEeeeeCCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCee
Q 015041 51 YEAKVYKILQG----GSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125 (414)
Q Consensus 51 ~E~~~l~~l~~----~~~i~~l~~~~~~~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ii 125 (414)
+|..-+..++. .+.+..-..+.......+++|||+ |..+.++..-....++.+.+.....++. +..+-..|+.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff 287 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence 44444444432 222211133444456789999999 6666666433335566444444333332 2333347999
Q ss_pred ccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 126 HrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
|.|..|.||++ +.++.+.+.|||+....
T Consensus 288 HaDpHpGNi~v---~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 288 HADPHPGNILV---RSDGRIVLLDFGIVGRL 315 (517)
T ss_pred ccCCCccceEE---ecCCcEEEEcCcceecC
Confidence 99999999999 58899999999998654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.4e-06 Score=76.28 Aligned_cols=133 Identities=23% Similarity=0.301 Sum_probs=90.5
Q ss_pred ceeecCceeEEEEEECCCCceEEEEEecCCCC---------------------c-----hhHHHHHHHHHHHcCC-CCCC
Q 015041 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---------------------H-----PQLLYEAKVYKILQGG-SGIP 66 (414)
Q Consensus 14 ~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------------------~-----~~~~~E~~~l~~l~~~-~~i~ 66 (414)
.|+.|--+.||+|.. .++..||||++..... . .....|+.-|+++... -.+|
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 566677779999975 5688999998654321 0 0134677777776542 2233
Q ss_pred eeEEeeeeCCeeEEEEeccCCCHH--HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeccccCCCceEEccCCCCC
Q 015041 67 NIKWYGVDGEDNVLVLDLLGPSLE--DLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKAN 143 (414)
Q Consensus 67 ~l~~~~~~~~~~~lv~e~~~~sL~--~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDLkp~Nili~~~~~~~ 143 (414)
.-+.+ ..+++||||+|..-. -.+. .-.+...+...+..+++..+.-|-. .++||+||..=|||+ .++
T Consensus 134 ~Pi~~----~~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~----~~~ 203 (268)
T COG1718 134 EPIAF----RNNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV----HDG 203 (268)
T ss_pred Cceee----cCCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE----ECC
Confidence 32222 357899999965410 0011 1123334678888899999998887 899999999999999 588
Q ss_pred eEEEeeecceeeec
Q 015041 144 QVYIIDFGLAKKYR 157 (414)
Q Consensus 144 ~vkL~DFG~a~~~~ 157 (414)
.++|+|||.|....
T Consensus 204 ~p~iID~~QaV~~~ 217 (268)
T COG1718 204 EPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEECccccccC
Confidence 99999999886543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.36 E-value=7.5e-06 Score=74.88 Aligned_cols=74 Identities=23% Similarity=0.306 Sum_probs=53.2
Q ss_pred ceeecCc-eeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-CCCHH
Q 015041 14 KIGSGSF-GEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLE 90 (414)
Q Consensus 14 ~iG~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~~sL~ 90 (414)
.|-.|.+ +.||++... +..++||+..... ...+..|+++++.+.....+|.+..++......++||+++ |.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3444544 789998653 4678889876554 3457889999999986666778877776666688999998 44444
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.36 E-value=7.7e-06 Score=73.85 Aligned_cols=139 Identities=18% Similarity=0.243 Sum_probs=80.3
Q ss_pred ecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCeeEEeee---eCCeeEEEEecc-C
Q 015041 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWYGV---DGEDNVLVLDLL-G 86 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~l~~~~~---~~~~~~lv~e~~-~ 86 (414)
++.|+.|..+.||++.... ..+++|+.........+..|..++..|..... +|.+..+.. .....+++|+++ +
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 5689999999999998744 47899987665334567889999999876543 677765433 333468999998 4
Q ss_pred CCHHH----------------HHHHh---C-C--CCCHHH---------HH-----H-------HHHHHHH-HHHHHH--
Q 015041 87 PSLED----------------LFVYC---R-R--KFSLKT---------VL-----M-------LADQMIA-RIEYVH-- 120 (414)
Q Consensus 87 ~sL~~----------------~~~~~---~-~--~~~~~~---------~~-----~-------i~~qi~~-aL~~LH-- 120 (414)
..+.. .+... . . .+.... .. . ....+.. .++.++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 44444 11110 0 0 011000 00 0 0111222 233333
Q ss_pred -----hcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 121 -----SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 121 -----~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
...++|+|+.|.|||++ +.++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~--~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVD--PSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEE--SSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceee--eccceeEEEecccce
Confidence 24599999999999994 356777899998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.07 E-value=0.0002 Score=62.99 Aligned_cols=129 Identities=21% Similarity=0.297 Sum_probs=88.6
Q ss_pred ecceeecCceeEEEEEECCCCceEEEEEecCCC------------------CchhHHHHHHHHHHHc-CC----CCCCee
Q 015041 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT------------------KHPQLLYEAKVYKILQ-GG----SGIPNI 68 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~------------------~~~~~~~E~~~l~~l~-~~----~~i~~l 68 (414)
...||+|+.-.||.- .. ....+||+..... ...+..+|+..+..+. .. ..++.+
T Consensus 6 ~~~i~~G~~R~cy~H--P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 457999999999964 33 3446789877655 2356788888887776 32 446666
Q ss_pred EEeeeeCCeeEEEEecc-------CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCC
Q 015041 69 KWYGVDGEDNVLVLDLL-------GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (414)
Q Consensus 69 ~~~~~~~~~~~lv~e~~-------~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~ 141 (414)
+++.....-..+|+|.. ..+|.+++. ...++. .....+. .-..||-+.+|+.+||+|.||++...+.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~-~~~~~L~---~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK--EGGLTE-ELRQALD---EFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH--cCCccH-HHHHHHH---HHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 66666666677888887 235666664 334554 4344333 3356777889999999999999986555
Q ss_pred CC-eEEEee
Q 015041 142 AN-QVYIID 149 (414)
Q Consensus 142 ~~-~vkL~D 149 (414)
.. .+.|+|
T Consensus 157 ~~~~lvlID 165 (199)
T PF10707_consen 157 GEFRLVLID 165 (199)
T ss_pred CceEEEEEe
Confidence 45 788888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.02 E-value=5.3e-05 Score=75.83 Aligned_cols=139 Identities=24% Similarity=0.344 Sum_probs=88.4
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCCCc---------------------------------h------hHHHHH
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---------------------------------P------QLLYEA 53 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------------------------------~------~~~~E~ 53 (414)
+.||.-+.|+|++|+... |+.||||+-+.+-.. + .+.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 578999999999999754 999999985433211 0 133444
Q ss_pred HHHHH----HcCCC-----CCCeeEEeeeeCCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 015041 54 KVYKI----LQGGS-----GIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123 (414)
Q Consensus 54 ~~l~~----l~~~~-----~i~~l~~~~~~~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 123 (414)
+-..+ +.+.. .+|.+ +.......+++|||+ |..+.|+-.-....++...+..-+-++.. +-+=..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~V--y~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKV--YWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCee--hhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcC
Confidence 32222 22322 14444 333445679999999 55555554333456777765554444332 2233468
Q ss_pred eeccccCCCceEEccC-CCCCeEEEeeecceeee
Q 015041 124 FLHRDIKPDNFLMGLG-RKANQVYIIDFGLAKKY 156 (414)
Q Consensus 124 iiHrDLkp~Nili~~~-~~~~~vkL~DFG~a~~~ 156 (414)
++|+|=.|.||++... +.+..+.+.|||+....
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 9999999999999622 24678999999997643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.02 E-value=9.8e-05 Score=64.52 Aligned_cols=124 Identities=21% Similarity=0.308 Sum_probs=83.2
Q ss_pred CceEEecceeecCc-eeEEEEEECCCCceEEEEEecC---C--------C------------CchhHHHHHHHHHHHcCC
Q 015041 7 VKYKLGRKIGSGSF-GEIFLASHVDTNEIVAVKIENS---G--------T------------KHPQLLYEAKVYKILQGG 62 (414)
Q Consensus 7 ~~y~i~~~iG~G~~-g~V~~~~~~~~~~~vavK~~~~---~--------~------------~~~~~~~E~~~l~~l~~~ 62 (414)
..++.++.||.|.- |.||+++. .|..+|+|++.. . . ....|..|++.+.+|+..
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 99999986 677999998321 0 0 012367899988888753
Q ss_pred C--CC--CeeEEeee-e-----------------CCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015041 63 S--GI--PNIKWYGV-D-----------------GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120 (414)
Q Consensus 63 ~--~i--~~l~~~~~-~-----------------~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH 120 (414)
. ++ +..+.+.. . .....||.||....- .++. .-+.+|..-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence 2 33 22222211 1 112356777663211 1222 23456777889999
Q ss_pred hcCeeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 121 ~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
..||+-+|+++.|..=+ +|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~~G--------~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYRGG--------KLVDFSSS 206 (207)
T ss_pred HCCeeeccCccccccCC--------EEEecccC
Confidence 99999999999998632 79999865
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.98 E-value=8.2e-07 Score=88.22 Aligned_cols=183 Identities=10% Similarity=0.064 Sum_probs=129.2
Q ss_pred eEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeee--eCCeeEEEEeccC
Q 015041 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV--DGEDNVLVLDLLG 86 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~--~~~~~~lv~e~~~ 86 (414)
|.....+++|+++.+++.+...+...+ .+++... ....-++++|.++++++ +.+.+.+. .+.+.++++++++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---l~~rl~~eLLdK~n~P~--~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---LSRRLAIELLDKVNNPN--PVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---hhhHHHHHHHHHccCCC--CcccccccCCcccccchhhhhhc
Confidence 444556788999999998876665554 6655443 34556788899998866 34444433 3456789999994
Q ss_pred CC--HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcc
Q 015041 87 PS--LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (414)
Q Consensus 87 ~s--L~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~ 164 (414)
+. .........-.+-..+...+.+.-+.+|+++|+.-=+|+| ||+. ..+..++.||+.+..+....
T Consensus 318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~----s~~~~~~~~~~v~~~L~~~~---- 385 (829)
T KOG0576|consen 318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG----SEEEVKLLDFAVPPQLTRTM---- 385 (829)
T ss_pred CCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc----cccccccccccCCcccCccc----
Confidence 43 2222111111233444566777788999999988778998 8886 56788999999876544332
Q ss_pred ccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 015041 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213 (414)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf 213 (414)
......+|..++|||+.....+....|.|++|.-..++.-|-+|-
T Consensus 386 ----~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 ----KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ----ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 234778899999999999999999999999998777777776654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.92 E-value=8.1e-05 Score=67.70 Aligned_cols=68 Identities=18% Similarity=0.123 Sum_probs=44.8
Q ss_pred cceeecCce-eEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCC--CCCCeeEEeeeeC---CeeEEEEecc
Q 015041 13 RKIGSGSFG-EIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG--SGIPNIKWYGVDG---EDNVLVLDLL 85 (414)
Q Consensus 13 ~~iG~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~--~~i~~l~~~~~~~---~~~~lv~e~~ 85 (414)
+.|+.|+.. .||+.. ..+++|+.........+..|.+++..|... -.+|.+...+... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567766666 599752 347789866644455788999999998753 2355555544332 2347889998
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00021 Score=76.93 Aligned_cols=78 Identities=14% Similarity=0.215 Sum_probs=52.8
Q ss_pred EecceeecCceeEEEEEECCCC--ceEEEEEecCCC---CchhHHHHHHHHHHHcCCCC--CCeeEEeeeeC---CeeEE
Q 015041 11 LGRKIGSGSFGEIFLASHVDTN--EIVAVKIENSGT---KHPQLLYEAKVYKILQGGSG--IPNIKWYGVDG---EDNVL 80 (414)
Q Consensus 11 i~~~iG~G~~g~V~~~~~~~~~--~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~--i~~l~~~~~~~---~~~~l 80 (414)
-.+.|+.|.++.+|+......+ ..+++|+..... ....+.+|+++++.|..+.. +|.+..++.+. ...++
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 3577899999999998765332 367778654432 22457899999999964333 46665655443 35689
Q ss_pred EEeccCCC
Q 015041 81 VLDLLGPS 88 (414)
Q Consensus 81 v~e~~~~s 88 (414)
|||++.+.
T Consensus 122 VME~v~G~ 129 (822)
T PLN02876 122 IMEYLEGR 129 (822)
T ss_pred EEEecCCc
Confidence 99999543
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00038 Score=63.18 Aligned_cols=71 Identities=15% Similarity=0.164 Sum_probs=48.8
Q ss_pred ecceeecCceeEEEEEECC-CCceEEEEEecCCCCc-hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEeccC
Q 015041 12 GRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLG 86 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~-~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~~ 86 (414)
++.|..|-...+|++.... .+..|++|+....... ....+|+.+++.+......|.+..... ..++|||+.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeC
Confidence 4567888888999987532 2567889987654321 234579999999976666777754432 247999983
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00059 Score=64.44 Aligned_cols=138 Identities=21% Similarity=0.237 Sum_probs=93.3
Q ss_pred EecceeecCceeEEEEEECCCCceEEEEEecCCC---------------------C-c------hhHHHHHHHHHHHcCC
Q 015041 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---------------------K-H------PQLLYEAKVYKILQGG 62 (414)
Q Consensus 11 i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------------~-~------~~~~~E~~~l~~l~~~ 62 (414)
|-..|.-|--+.||.|.. .+|..+|||+++..- . . -....|++-|+++...
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 344677788889999974 568889999854210 0 0 1245788888888653
Q ss_pred CCCCeeEEeeeeCCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hcCeeccccCCCceEEccCCC
Q 015041 63 SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH-SRGFLHRDIKPDNFLMGLGRK 141 (414)
Q Consensus 63 ~~i~~l~~~~~~~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~iiHrDLkp~Nili~~~~~ 141 (414)
+||.-.-. .-...+|||+++|.+-.-.=.-....++...+..+-.|++.-|.-|. .+++||.||.-=|+|+ .
T Consensus 227 -GIP~PePI--lLk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly----h 299 (520)
T KOG2270|consen 227 -GIPCPEPI--LLKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY----H 299 (520)
T ss_pred -CCCCCCce--eeecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE----E
Confidence 34322100 11346899999965422111111234677778888888888888776 4689999999999999 8
Q ss_pred CCeEEEeeecceeee
Q 015041 142 ANQVYIIDFGLAKKY 156 (414)
Q Consensus 142 ~~~vkL~DFG~a~~~ 156 (414)
.|.++|+|.+-+...
T Consensus 300 dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEH 314 (520)
T ss_pred CCEEEEEEccccccC
Confidence 899999999877643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00031 Score=61.36 Aligned_cols=97 Identities=22% Similarity=0.263 Sum_probs=73.6
Q ss_pred HHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEeccC-CCHHHH----HHHhCCCCCHHHHHHHHHHHHHHHHHHHh---
Q 015041 50 LYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLG-PSLEDL----FVYCRRKFSLKTVLMLADQMIARIEYVHS--- 121 (414)
Q Consensus 50 ~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~~-~sL~~~----~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--- 121 (414)
..|.-+++.|.+.+.+|.+.+.+ + .++|.|+.+ +++... .. -...+|..+.+|+.+++..+++++.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C--G--~~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC--G--RFYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC--C--CEEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 35888899998877777775554 2 367888885 344321 11 1235899999999999999999997
Q ss_pred cCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 122 ~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
..+.-+|++++||-+ ++++.+|++|...+..
T Consensus 81 ~~~~lcDv~~~nfgv---~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGV---NDDGRLKLIDLDDVFV 111 (188)
T ss_pred CcEEEeecchHHeEE---eCCCcEEEEechhcch
Confidence 348889999999999 4778999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00078 Score=62.05 Aligned_cols=68 Identities=12% Similarity=0.066 Sum_probs=47.4
Q ss_pred ceeecCceeEEEEEECCCCceEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEeccCC
Q 015041 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGP 87 (414)
Q Consensus 14 ~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~~~ 87 (414)
.+..|-.+.+|+... ++..+++|+....... .....|..+++.+......|.+...+. .++|++++.|
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G 72 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEG 72 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccC
Confidence 355688889998873 5667889976544322 245789999999987656677765542 3689999844
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0022 Score=62.56 Aligned_cols=74 Identities=26% Similarity=0.282 Sum_probs=51.8
Q ss_pred ecceeecCceeEEEEEECCCCceEEEEEecCC---------CCchhHHHHHHHHHHHcCC--CCCCeeEEeeeeCCeeEE
Q 015041 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSG---------TKHPQLLYEAKVYKILQGG--SGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~~E~~~l~~l~~~--~~i~~l~~~~~~~~~~~l 80 (414)
.+.||.|.+..||++.....++.|+||.-... -.......|.+.|..+... ..+|.++.+.. ...++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence 46799999999999998543358999963311 1223467788888877532 45787777644 55789
Q ss_pred EEeccCC
Q 015041 81 VLDLLGP 87 (414)
Q Consensus 81 v~e~~~~ 87 (414)
|||++.+
T Consensus 109 VME~L~~ 115 (401)
T PRK09550 109 VMEDLSD 115 (401)
T ss_pred EEecCCC
Confidence 9999843
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0032 Score=59.96 Aligned_cols=73 Identities=11% Similarity=0.089 Sum_probs=45.4
Q ss_pred ecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCC-CCCeeEE------eeeeCCeeEEEEec
Q 015041 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS-GIPNIKW------YGVDGEDNVLVLDL 84 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~-~i~~l~~------~~~~~~~~~lv~e~ 84 (414)
.+.|+.|....+|+.... +| .+++|+.. ......+..|+.++..|.... .+|.+.. +.......++++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~-~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFE-RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred cchhccccccceEEEEeC-CC-cEEEEEec-cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 456777887899998753 33 68889876 333445667777787776432 2344322 12234556899999
Q ss_pred cCC
Q 015041 85 LGP 87 (414)
Q Consensus 85 ~~~ 87 (414)
+.|
T Consensus 104 l~G 106 (319)
T PRK05231 104 LEG 106 (319)
T ss_pred cCC
Confidence 844
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0014 Score=62.03 Aligned_cols=138 Identities=18% Similarity=0.292 Sum_probs=79.0
Q ss_pred EecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCC-CCCeeEEe------eeeCCeeEEEEe
Q 015041 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS-GIPNIKWY------GVDGEDNVLVLD 83 (414)
Q Consensus 11 i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~-~i~~l~~~------~~~~~~~~lv~e 83 (414)
-++.++.|....+|++.. .++ .+++|+.........+..|.+++..|.... .++.+... .......+++++
T Consensus 26 ~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred eccccCCccccceEEEEe-CCC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 356677787789999874 334 577898766444456677888888886422 13333221 122355689999
Q ss_pred ccCC-CH-----H------HHHHHh---CCCC--------CHHH---H--H----------HHHHHHHHHHHHHHh----
Q 015041 84 LLGP-SL-----E------DLFVYC---RRKF--------SLKT---V--L----------MLADQMIARIEYVHS---- 121 (414)
Q Consensus 84 ~~~~-sL-----~------~~~~~~---~~~~--------~~~~---~--~----------~i~~qi~~aL~~LH~---- 121 (414)
++.| .+ . ..+... ...+ .... . . .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9843 21 1 111100 0111 0010 0 0 011123344555542
Q ss_pred ---cCeeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 122 ---RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 122 ---~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
.+++|+|+.+.||+++ .++.+.|+||+.+
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~ 215 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFD---GDSVKGVIDFYFA 215 (307)
T ss_pred cCCCccCCCCCCcCcEEEE---CCceEEEeecccc
Confidence 5799999999999994 5555689999876
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00094 Score=63.11 Aligned_cols=70 Identities=14% Similarity=0.076 Sum_probs=48.9
Q ss_pred ecceeecCceeEEEEEECC------CCceEEEEEecCCCCc-hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 12 GRKIGSGSFGEIFLASHVD------TNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~-~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
++.|..|-...+|++.... +++.+++|+....... ....+|.+++..+......|.+..+... .+|+++
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 3556667777999987543 2578999997665322 4567899999999876667777666542 357888
Q ss_pred c
Q 015041 85 L 85 (414)
Q Consensus 85 ~ 85 (414)
+
T Consensus 79 i 79 (302)
T cd05156 79 I 79 (302)
T ss_pred e
Confidence 7
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0009 Score=63.01 Aligned_cols=137 Identities=14% Similarity=0.158 Sum_probs=78.9
Q ss_pred ecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCC-CCCeeEE------eeeeCCeeEEEEec
Q 015041 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS-GIPNIKW------YGVDGEDNVLVLDL 84 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~-~i~~l~~------~~~~~~~~~lv~e~ 84 (414)
.+.|..|....+|++.. .+..+++|+... .....+..|+.++..|.... .++.+.. +....+..++++++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK-VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC-CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 55677788789999865 334688998765 33456778899988886532 2333322 11233456889999
Q ss_pred cCC-CHH-----------HHHHH---hCCCC----------CHHHH----------HHHHHHHHHHHHHHHh-------c
Q 015041 85 LGP-SLE-----------DLFVY---CRRKF----------SLKTV----------LMLADQMIARIEYVHS-------R 122 (414)
Q Consensus 85 ~~~-sL~-----------~~~~~---~~~~~----------~~~~~----------~~i~~qi~~aL~~LH~-------~ 122 (414)
+.| .+. ..+.. ....+ .+... ......+..++.++.. .
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 843 321 11110 00011 10000 0011112333444442 4
Q ss_pred CeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 123 ~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
+++|+|+.|.|||+. .++.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~---~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFD---GDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEe---CCceEEEeehhhhc
Confidence 699999999999993 55556899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0075 Score=58.11 Aligned_cols=71 Identities=14% Similarity=0.090 Sum_probs=48.4
Q ss_pred EecceeecCceeEEEEEECC----CCceEEEEEecCCCCc-hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc
Q 015041 11 LGRKIGSGSFGEIFLASHVD----TNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (414)
Q Consensus 11 i~~~iG~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~-~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (414)
-++.|-.|-...+|++.... .++.|++|+....... -....|..+++.+.....-|.+..++..+ .|++|+
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 34456568888999987532 2467999987664321 12367999999998777777776665433 477787
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0058 Score=58.48 Aligned_cols=72 Identities=18% Similarity=0.207 Sum_probs=47.7
Q ss_pred cceeecCceeEEEEEECCCCceEEEEE----ecC-----CCCchhHHHHHHHHHHHcCC--CCCCeeEEeeeeCCeeEEE
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKI----ENS-----GTKHPQLLYEAKVYKILQGG--SGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~----~~~-----~~~~~~~~~E~~~l~~l~~~--~~i~~l~~~~~~~~~~~lv 81 (414)
+.||.|....||++.+...+..|+||- ++. .-...+...|...|+..... ..+|.++.+ +....++|
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v 78 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV 78 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence 358999999999999754336799993 111 11223456788888776532 346666554 45567899
Q ss_pred EeccC
Q 015041 82 LDLLG 86 (414)
Q Consensus 82 ~e~~~ 86 (414)
||++.
T Consensus 79 MEdL~ 83 (370)
T TIGR01767 79 MEDLS 83 (370)
T ss_pred HhhCc
Confidence 99984
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.00029 Score=65.45 Aligned_cols=132 Identities=20% Similarity=0.333 Sum_probs=89.3
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecC----------CC------C--------chhHHHHHHHHHHHcCC-
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS----------GT------K--------HPQLLYEAKVYKILQGG- 62 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~----------~~------~--------~~~~~~E~~~l~~l~~~- 62 (414)
-+.++++||-|--+.||.+-+ ..|...++|+-.. .. . .-...+|...++.|..+
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 366889999999999999986 4578889995221 10 0 01246788888888753
Q ss_pred CCCCeeEEeeeeCCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCC
Q 015041 63 SGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (414)
Q Consensus 63 ~~i~~l~~~~~~~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~ 141 (414)
.-+|... +....|+|||++ +..|.... ..-+..+ +...+..-+.-|-..|+||+|..-=||++ ++
T Consensus 172 fpVPkpi----D~~RH~Vvmelv~g~Pl~~v~----~v~d~~~---ly~~lm~~Iv~la~~GlIHgDFNEFNimv---~d 237 (465)
T KOG2268|consen 172 FPVPKPI----DHNRHCVVMELVDGYPLRQVR----HVEDPPT---LYDDLMGLIVRLANHGLIHGDFNEFNIMV---KD 237 (465)
T ss_pred CCCCCcc----cccceeeHHHhhcccceeeee----ecCChHH---HHHHHHHHHHHHHHcCceecccchheeEE---ec
Confidence 2333332 345679999998 54444332 1123333 33444445666778999999999999999 47
Q ss_pred CCeEEEeeeccee
Q 015041 142 ANQVYIIDFGLAK 154 (414)
Q Consensus 142 ~~~vkL~DFG~a~ 154 (414)
++.++++||--..
T Consensus 238 d~~i~vIDFPQmv 250 (465)
T KOG2268|consen 238 DDKIVVIDFPQMV 250 (465)
T ss_pred CCCEEEeechHhh
Confidence 8899999996543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0033 Score=58.56 Aligned_cols=46 Identities=13% Similarity=0.096 Sum_probs=30.3
Q ss_pred eecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCC
Q 015041 16 GSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG 62 (414)
Q Consensus 16 G~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~ 62 (414)
++|-...|+.+.. ..|..+++|.-........+.+|.+++..|..+
T Consensus 20 ~~g~~~~v~~i~~-~~g~~~VlR~p~~~~~~~~l~rE~~vL~~L~~~ 65 (276)
T cd05152 20 ESGLDFQVVFAKD-TDGVPWVLRIPRRPDVSERAAAEKRVLALVRKH 65 (276)
T ss_pred CCcceeEEEEEEc-CCCCeEEEEecCCHHHHHHHHHHHHHHHHHHhc
Confidence 3444445565532 346788899875544445688999999999764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0084 Score=57.45 Aligned_cols=70 Identities=14% Similarity=0.082 Sum_probs=45.8
Q ss_pred ecceeecCceeEEEEEECCC---CceEEEEEecCCCCc-hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc
Q 015041 12 GRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~-~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (414)
++.|..|-...+|++..... +..|++|+....... -.-.+|..+++.+.....-|.+.+++..+ +|.+|+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi 92 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFI 92 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCCc----Eeehhh
Confidence 34444477778998875432 237899987654321 12357899999998776667776665322 477777
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0025 Score=62.74 Aligned_cols=164 Identities=21% Similarity=0.217 Sum_probs=95.7
Q ss_pred chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCee
Q 015041 46 HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125 (414)
Q Consensus 46 ~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ii 125 (414)
..+++....+++.+.|.+....+..-........+|+|+++.+|++...... +-... + + ..++.
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~--l~~~s-------~---~----~~~~~ 89 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN--LKDES-------L---L----AHGVL 89 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcc--cchhh-------h---c----ccccc
Confidence 3456777888888887555544444434455688999999999999887422 11111 0 0 12222
Q ss_pred ccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHH
Q 015041 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY 205 (414)
Q Consensus 126 HrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~e 205 (414)
| - +.++.+| -++... ....| +|+||||+|.++.+
T Consensus 90 ~-----~----------~~~~~td-~~~t~~--------------~~~~~----------------pKsdVwsl~~i~~e 123 (725)
T KOG1093|consen 90 H-----L----------NIIYITD-HFLTKY--------------PSPIG----------------PKSDVWSLGFIILE 123 (725)
T ss_pred e-----e----------hhhhccc-cccccC--------------CCCCC----------------cchhhhhHHHHHHH
Confidence 2 1 2223334 111000 01111 38999999999999
Q ss_pred HHcCCCCCCCChhhchHHHHHHHHhhccCCc---hH-HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 206 FLRGSLPWQGLKAATKKQKYDKICEKKVSTP---IE-VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 206 l~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p---~~-~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+.-|...|......+..+.+.+........- .+ ..-..++..+.++.+.|+...|..||.+.++.+
T Consensus 124 l~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 124 LYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred HHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 9999888876555444333333211111100 00 111234678899999999999999997776654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0072 Score=64.94 Aligned_cols=195 Identities=16% Similarity=0.135 Sum_probs=113.8
Q ss_pred HHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE----Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCe
Q 015041 50 LYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV----LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124 (414)
Q Consensus 50 ~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv----~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 124 (414)
..|+..+.++.|.+ +..+..+.......-++ .+++ ..++..++.. ...++..+++.+..++..||.|+|+...
T Consensus 230 E~e~~~l~k~~~~n-~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~l 307 (1351)
T KOG1035|consen 230 EIELESLSKIAHDN-LGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLSL 307 (1351)
T ss_pred HHHHHHHHhhcccc-ccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence 34556666666644 43443443322211122 3444 4455554443 4567889999999999999999999855
Q ss_pred eccccCCCceEEccCCCCCeEEEe--eecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCc--hhhHHHHH
Q 015041 125 LHRDIKPDNFLMGLGRKANQVYII--DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSR--RDDLESLG 200 (414)
Q Consensus 125 iHrDLkp~Nili~~~~~~~~vkL~--DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--~~DiwSlG 200 (414)
.|.-|...-..-...+..+.+.++ ||+..+.+.+..... ....+.-+.++|......+.. ..|+|.+|
T Consensus 308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--------~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--------SDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred ceeEEecccccccccCccceeecchhhhcccccCCCcccch--------hhcCccccccccccccccchhhhhhHHHHHH
Confidence 555444331111112455566666 888877665443321 223355677888877666544 47999999
Q ss_pred HHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 201 YVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 201 ~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+..+..|..+=.. ...+...++........+....|+..+.++|+...++..
T Consensus 380 ll~~~~~~~~~i~~~-----------------~~~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEK-----------------SAVPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHhhhhhcCccccc-----------------ccchhhhhccccchhhhhhhhhhcchhhhhccchhhhhh
Confidence 999999887543211 011111222222235666777788777888887766554
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.015 Score=54.73 Aligned_cols=107 Identities=17% Similarity=0.097 Sum_probs=74.3
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCC--CCCeeEEeeee---CCeeEEEE
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS--GIPNIKWYGVD---GEDNVLVL 82 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~--~i~~l~~~~~~---~~~~~lv~ 82 (414)
...-.+.||.|..+.||..... +..+.+|+.+.......+..|...++.|.... .+|.+...+.. ....++||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDS--QGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hhheeeecCCccceeEEEEEcC--CCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 4455678999999999998642 23467788544334457899999999998643 56777765543 35589999
Q ss_pred ecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 015041 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 122 (414)
|++ +.++.+. ..+......+..+++.+|.-||..
T Consensus 93 E~i~G~~~~~~------~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 93 ERLRGVSVEAP------ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred eccCCEecCCC------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 999 4444431 123444566778888999999975
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.018 Score=55.83 Aligned_cols=73 Identities=21% Similarity=0.295 Sum_probs=49.7
Q ss_pred ecceeecCceeEEEEEECCCCceEEEEE----ecCCC----CchhHHHHHHHHHHHcC--CCCCCeeEEeeeeCCeeEEE
Q 015041 12 GRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGT----KHPQLLYEAKVYKILQG--GSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~~~~~vavK~----~~~~~----~~~~~~~E~~~l~~l~~--~~~i~~l~~~~~~~~~~~lv 81 (414)
.+.||.|.-..||++.+...+..|+||- ++... ...+...|.+.|+.+.. +..+|.++.+ +....++|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 6789999999999999743356799993 22211 22456778888877653 2357777665 44567889
Q ss_pred EeccC
Q 015041 82 LDLLG 86 (414)
Q Consensus 82 ~e~~~ 86 (414)
||++.
T Consensus 112 MEdL~ 116 (409)
T PRK12396 112 MEDLS 116 (409)
T ss_pred HHhCc
Confidence 99883
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.087 Score=51.50 Aligned_cols=73 Identities=12% Similarity=0.269 Sum_probs=48.9
Q ss_pred EecceeecCceeEEEEEECCCCceEEEEEec-----CCC----CchhHHHHHHHHHHHcC--CCCCCeeEEeeeeCCeeE
Q 015041 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGT----KHPQLLYEAKVYKILQG--GSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 11 i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~-----~~~----~~~~~~~E~~~l~~l~~--~~~i~~l~~~~~~~~~~~ 79 (414)
-.+.||.|....||++.+. +..|+||.-. ... ...+...|...|+.+.. +..+|.++.++. ...+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 4678899999999999863 4468899533 111 22344566666766642 246777777765 5578
Q ss_pred EEEeccCC
Q 015041 80 LVLDLLGP 87 (414)
Q Consensus 80 lv~e~~~~ 87 (414)
++||++.+
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 89999944
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.072 Score=52.00 Aligned_cols=72 Identities=17% Similarity=0.123 Sum_probs=45.9
Q ss_pred EecceeecCceeEEEEEECCCC-c-----eEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 11 LGRKIGSGSFGEIFLASHVDTN-E-----IVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 11 i~~~iG~G~~g~V~~~~~~~~~-~-----~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
.++.|..|-...+|++...... . .|++++..... ..-.-.+|+++++.|.....-|.+...+.. .++.|
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 3445656888899999754321 2 25555432221 111235789999999988888888777643 58888
Q ss_pred ccC
Q 015041 84 LLG 86 (414)
Q Consensus 84 ~~~ 86 (414)
|+.
T Consensus 130 fIe 132 (383)
T PTZ00384 130 WVE 132 (383)
T ss_pred Eec
Confidence 883
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.00054 Score=74.95 Aligned_cols=131 Identities=11% Similarity=-0.011 Sum_probs=95.6
Q ss_pred eCCeeEEEEecc-CCCHHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhc-C----eeccccCCCceEEccCCCCCe
Q 015041 74 DGEDNVLVLDLL-GPSLEDLFVYCRRK---FSLKTVLMLADQMIARIEYVHSR-G----FLHRDIKPDNFLMGLGRKANQ 144 (414)
Q Consensus 74 ~~~~~~lv~e~~-~~sL~~~~~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~-~----iiHrDLkp~Nili~~~~~~~~ 144 (414)
.....+.+++++ +|.+.+.+.+.... ....-+.....+.+.+..-+|+. + .+|++||+.|.+| ..+..
T Consensus 1302 ~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmI---Vtny~ 1378 (2724)
T KOG1826|consen 1302 ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMI---VTNYN 1378 (2724)
T ss_pred CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccce---ecCCc
Confidence 344557888888 78787777643222 22233333344447778887764 2 7899999999999 57888
Q ss_pred EEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 015041 145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 214 (414)
Q Consensus 145 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~ 214 (414)
+|++++|+.+...... .......+++-|+++++.....++.++|+|..|+-+|+...|..+|-
T Consensus 1379 v~~gk~gLdKIknp~~-------sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1379 VKLGKGGLDKIKNPVL-------SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred ccccccccccccCchH-------hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 9999999998221111 12345677888999999988899999999999999999999988774
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.17 Score=48.28 Aligned_cols=67 Identities=13% Similarity=0.072 Sum_probs=40.8
Q ss_pred CceeEEEEEECCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeE-------EeeeeCCeeEEEEeccCC
Q 015041 19 SFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIK-------WYGVDGEDNVLVLDLLGP 87 (414)
Q Consensus 19 ~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~-------~~~~~~~~~~lv~e~~~~ 87 (414)
.-..||++.. .++..+++|+..... ...++..|++.+..|... +++... .....+...+.++++++|
T Consensus 37 ~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~-gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 37 YENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEA-EIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred ccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHC-CCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 4457888864 346679999886543 345577888888888652 233111 112234456778888744
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.022 Score=50.72 Aligned_cols=50 Identities=24% Similarity=0.293 Sum_probs=32.4
Q ss_pred CceEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc
Q 015041 32 NEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (414)
Q Consensus 32 ~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (414)
++.|+||+...... .-....|..+++.+.....-|.+.+++.++ +|++|+
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i 52 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFI 52 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEe
Confidence 45788998877632 234567889999998767777777665433 566777
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.02 Score=54.40 Aligned_cols=73 Identities=21% Similarity=0.282 Sum_probs=59.5
Q ss_pred eCCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeccccCCCceEEccCCCCCeEEEeeecc
Q 015041 74 DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (414)
Q Consensus 74 ~~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDLkp~Nili~~~~~~~~vkL~DFG~ 152 (414)
++.+.|++|++-|+++.-. .....++++.++++.+.-+.-+..+ .+-||||.-.|||| +.|+|.|+||.+
T Consensus 297 e~~y~yl~~kdhgt~is~i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI----d~GnvtLIDfkl 367 (488)
T COG5072 297 ETLYLYLHFKDHGTPISII-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI----DEGNVTLIDFKL 367 (488)
T ss_pred CceEEEEEEecCCceeeee-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee----ecCceEEEEeee
Confidence 4556788999988877532 2246788999999988877777766 68999999999999 489999999999
Q ss_pred eee
Q 015041 153 AKK 155 (414)
Q Consensus 153 a~~ 155 (414)
+|.
T Consensus 368 sRl 370 (488)
T COG5072 368 SRL 370 (488)
T ss_pred eec
Confidence 984
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.051 Score=50.84 Aligned_cols=75 Identities=19% Similarity=0.249 Sum_probs=50.9
Q ss_pred eEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHc--CCCCCCeeEEeeeeCCeeEEEEeccC
Q 015041 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLVLDLLG 86 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~--~~~~i~~l~~~~~~~~~~~lv~e~~~ 86 (414)
.+-.+.|+.|....+|+.. .++..+-||+-. ......+..|.+-|+.|. ....+|.+..++......+++||++.
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS-ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEE-GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecC-hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 4456678999999999987 567788899876 333456889999999994 45568888888888778899999983
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.18 Score=48.14 Aligned_cols=134 Identities=19% Similarity=0.253 Sum_probs=75.4
Q ss_pred eeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCC-----CeeE--EeeeeCC--eeEEEEecc
Q 015041 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI-----PNIK--WYGVDGE--DNVLVLDLL 85 (414)
Q Consensus 15 iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i-----~~l~--~~~~~~~--~~~lv~e~~ 85 (414)
|.+ .-..+|+.... +|. +++|+........++..|+..+..|...... +.+. ....-.. ..+-+++|+
T Consensus 34 l~s-~eN~~f~~~~~-~g~-~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l 110 (331)
T COG2334 34 LNS-EENSNFRVQTE-DGR-YILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL 110 (331)
T ss_pred ccc-ccCceEEEEec-CCC-eEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence 444 45578888753 344 4999988875566788888888888754321 1111 1111223 677788888
Q ss_pred CC-CHHH-----HHH-------H---hCCCC-----------CHH----H---------HHHHHHHHHHHHHHHHh----
Q 015041 86 GP-SLED-----LFV-------Y---CRRKF-----------SLK----T---------VLMLADQMIARIEYVHS---- 121 (414)
Q Consensus 86 ~~-sL~~-----~~~-------~---~~~~~-----------~~~----~---------~~~i~~qi~~aL~~LH~---- 121 (414)
+| .+.. .+. . ..+.+ .+. . -.....++...++.+.+
T Consensus 111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~ 190 (331)
T COG2334 111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA 190 (331)
T ss_pred CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence 44 3331 110 0 01111 111 0 01123344444444442
Q ss_pred ----cC--eeccccCCCceEEccCCCCC-eEEEeeeccee
Q 015041 122 ----RG--FLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK 154 (414)
Q Consensus 122 ----~~--iiHrDLkp~Nili~~~~~~~-~vkL~DFG~a~ 154 (414)
.+ +||+|+.|.||++. ... .+.++||+-+.
T Consensus 191 ~lp~~~~~iIH~D~~~~NVl~d---~~~~~~g~iDFdDa~ 227 (331)
T COG2334 191 HLPALGDQIIHGDLHPDNVLFD---DDTDVSGFIDFDDAG 227 (331)
T ss_pred hCCcccceeeecCCCccceeEc---CCCCeeeEEEccccc
Confidence 23 99999999999994 444 47899998764
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.16 Score=47.95 Aligned_cols=30 Identities=23% Similarity=0.500 Sum_probs=25.0
Q ss_pred CeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 123 ~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
.++|+|+.+.|+++. ..+.+=+.||+++..
T Consensus 199 ~lvHGD~~~gNlii~---~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIID---PGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEe---CCCeeEEEecccccc
Confidence 489999999999995 555588999998864
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.14 E-value=0.35 Score=48.22 Aligned_cols=72 Identities=18% Similarity=0.075 Sum_probs=48.1
Q ss_pred EecceeecCceeEEEEEECC--------CCceEEEEEecCCCCc-hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 11 LGRKIGSGSFGEIFLASHVD--------TNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 11 i~~~iG~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~-~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
-++.|..|-...+|++.... .++.|++++....... -.-..|..+++.+.....-|.+...+. ...+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I 184 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRI 184 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence 45666677777899887542 1467999987655421 134568889998887777777765442 3457
Q ss_pred EeccC
Q 015041 82 LDLLG 86 (414)
Q Consensus 82 ~e~~~ 86 (414)
.+|+.
T Consensus 185 ~efi~ 189 (442)
T PTZ00296 185 EEWLY 189 (442)
T ss_pred EEeeC
Confidence 88873
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.07 E-value=0.53 Score=52.06 Aligned_cols=47 Identities=15% Similarity=0.140 Sum_probs=32.9
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcC
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~ 61 (414)
+.|+ |..-.+|+++. .+|..+++|+.+.......+..|.+.+..|..
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~ 77 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSEPRVESDFQTAALDHLAA 77 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCccchhHHHHHHHHHHHHHh
Confidence 4564 45677888874 45667999999876555556677778877754
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.076 Score=51.30 Aligned_cols=60 Identities=23% Similarity=0.282 Sum_probs=41.1
Q ss_pred CeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hcCeeccccCCCceEEc
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH-SRGFLHRDIKPDNFLMG 137 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~iiHrDLkp~Nili~ 137 (414)
...+++.+|. |.++..++.. ...++..+..++.=.+.||--|- --+++|.|+.|.||++.
T Consensus 318 ~~~vl~E~~~~Gl~v~~~v~~--~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 318 TDLVLVETYERGLSVLRFVKW--KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred ccceeeeeccccccHHhhhhc--ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 3456777787 7777777663 23344556666666666665544 34799999999999994
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.71 Score=43.69 Aligned_cols=29 Identities=24% Similarity=0.440 Sum_probs=25.4
Q ss_pred CeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 123 ~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
+++|+|+.+.|||+ +.++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLY---DETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEE---cCCCCEEEEEhhhcc
Confidence 69999999999999 466789999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.86 E-value=0.67 Score=42.94 Aligned_cols=44 Identities=23% Similarity=0.388 Sum_probs=32.7
Q ss_pred HHHHHHHHHHHHHhc--CeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 108 LADQMIARIEYVHSR--GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 108 i~~qi~~aL~~LH~~--~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
.+..+-.++.-.+.. -++|+|+.|+|++.+ +.+.++|+||..|.
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t---~~~~l~LIDWEyAg 182 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLT---DKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEc---CCCcEEEEecccCC
Confidence 444455555555543 489999999999993 56999999998764
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.74 E-value=0.43 Score=42.47 Aligned_cols=113 Identities=16% Similarity=0.166 Sum_probs=66.0
Q ss_pred cCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEeccCCCHHHHHHH
Q 015041 18 GSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY 95 (414)
Q Consensus 18 G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~~~sL~~~~~~ 95 (414)
|+.++.-.++... |..+.-|+...+.. ..-+.++..++.++.+ |.++. -.++..+-+++|.|...-.
T Consensus 73 ~gNsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~ArmhG---ilrL~--NDn~~~yGvIlE~Cy~~~i----- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMHG---ILRLK--NDNNYKYGVILERCYKIKI----- 141 (308)
T ss_pred CCceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhhh---eeEee--cCCCceeEEEEeeccCccc-----
Confidence 3444444444322 44444444444433 2335677777777643 44443 1144445688898843111
Q ss_pred hCCCCCHHHHHHHHHHHHHHHHHHHh--cCeeccccCCCceEEccCCCCCeEEEeeecc
Q 015041 96 CRRKFSLKTVLMLADQMIARIEYVHS--RGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (414)
Q Consensus 96 ~~~~~~~~~~~~i~~qi~~aL~~LH~--~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~ 152 (414)
...-.|.. =+.+|.-.|+ .+.+|+|..|+|||- |+.|.+||.|-+.
T Consensus 142 -------~~~N~i~a-gi~~L~~fH~~~~~~lHGD~np~NiM~---D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 -------NFSNFITA-GIKDLMDFHSENQHCLHGDCNPDNIMC---DKFGYLKLVDPVC 189 (308)
T ss_pred -------chhHHHHH-hHHHHHHhhccCCCeecCCCChhheee---cCCCCEEecChhh
Confidence 11111111 1356778884 379999999999999 7999999999874
|
The function of this family is unknown. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 414 | ||||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-146 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-127 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-127 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-127 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 6e-97 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 6e-97 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 2e-95 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 6e-95 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 7e-95 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 5e-94 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 1e-92 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 1e-26 | ||
| 2kty_A | 368 | Solution Structure Of Human Vaccinia Related Kinase | 1e-25 | ||
| 2lav_A | 361 | Nmr Solution Structure Of Human Vaccinia-Related Ki | 1e-25 | ||
| 3op5_A | 364 | Human Vaccinia-Related Kinase 1 Length = 364 | 1e-24 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 2jii_A | 352 | Structure Of Vaccinia Related Kinase 3 Length = 352 | 3e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 6e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 9e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-05 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-05 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-05 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-05 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-05 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-05 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 2e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-05 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 2e-05 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 2e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-05 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-05 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-05 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-05 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-05 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-05 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-05 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-05 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-05 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-05 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-05 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-05 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-05 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-05 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-05 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-05 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-05 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-05 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 9e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-04 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-04 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-04 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-04 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-04 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-04 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-04 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-04 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-04 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-04 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-04 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-04 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 9e-04 |
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368 | Back alignment and structure |
|
| >pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361 | Back alignment and structure |
|
| >pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2JII|A Chain A, Structure Of Vaccinia Related Kinase 3 Length = 352 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 545 bits (1405), Expect = 0.0
Identities = 246/422 (58%), Positives = 304/422 (72%), Gaps = 12/422 (2%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G K++LGRKIGSGSFGEI+L +++ TNE VA+K+EN TKHPQLLYE+K+Y+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG+GIPN++W+GV+G+ NVLV+DLLGPSLEDLF +C RK SLKTVLMLADQMI R+E+VH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ FLHRDIKPDNFLMGLGR+ANQVYIIDFGLAKKYRD +T++HIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YFLRGSLPWQGLKA TKKQKY+KI EKKV+T IE L
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
C+ +P EFASYFHYC+SL FD +PDY +LKRLF DLF REG+ FD+VFDWTILKYQQ+Q
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 301 TKSQDLLPASRVTNSRVMPMRTDKLKEVLECRG------SYNRTRPDADMQHRPSVAEKM 354
+ S + P ++ G S +R R + ++A K
Sbjct: 301 ASAPPRAVGHGAGPSGLAPPALQNDRQSGVDEGRTSGWSSMDRRRAPPPIASVGTLA-KQ 359
Query: 355 SSDHHFGKHSMGNASIPSASFVLPSTFN-----RNFQKPEGPDEAANIGRGHGNKTGASS 409
+ I +++F+ S+ + + + P + + R +
Sbjct: 360 KAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSRDVMPIDTSEPSRTRATDASPGA 419
Query: 410 SW 411
Sbjct: 420 FR 421
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 538 bits (1388), Expect = 0.0
Identities = 165/317 (52%), Positives = 226/317 (71%), Gaps = 3/317 (0%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
++G +++G+KIG G+FGE+ L ++ TNE VA+K+E ++ PQL E + YK L
Sbjct: 4 VLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGS 63
Query: 62 GSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
G GIP + ++G G+ N +VL+LLGPSLEDLF C R FSLKTVLM+A Q+I+R+EYVHS
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123
Query: 122 RGFLHRDIKPDNFLMGLG--RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
+ ++RD+KP+NFL+G + ++IIDF LAK+Y DP T +HIPYRE+K+LTGTARY
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239
S NTHLG EQSRRDDLE+LG++ +YFLRGSLPWQGLKA T K++Y KI + K +TPIEV
Sbjct: 184 MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV 243
Query: 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQ 299
LC++ P E A+Y Y + L F ++PDY +L++LF DLF R+GY FD+ +DW +
Sbjct: 244 LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPTPV 302
Query: 300 KTKSQDLLPASRVTNSR 316
QD +S +
Sbjct: 303 GAVQQDPALSSNREAHQ 319
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 536 bits (1382), Expect = 0.0
Identities = 205/294 (69%), Positives = 255/294 (86%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 62
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP I+W G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 63 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK 294
CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK
Sbjct: 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 532 bits (1372), Expect = 0.0
Identities = 166/295 (56%), Positives = 212/295 (71%), Gaps = 2/295 (0%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
++GV YK+GR+IG GSFG IF +++ N+ VA+K E + PQL E + YK+L
Sbjct: 4 QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA 63
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
G +GIPN+ ++G +G NVLV+DLLGPSLEDL C RKFS+KTV M A QM+AR++ +H
Sbjct: 64 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 121 SRGFLHRDIKPDNFLMGL--GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
+ ++RDIKPDNFL+G + AN +Y++DFG+ K YRDP T +HIPYRE KNL+GTAR
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
Y S NTHLG EQSRRDDLE+LG+V +YFLRGSLPWQGLKAAT KQKY++I EKK STP+
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243
Query: 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 293
LC P EF Y HY ++L FD PDY +L+ LF + R D FDW +L
Sbjct: 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 298
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 486 bits (1252), Expect = e-172
Identities = 83/330 (25%), Positives = 145/330 (43%), Gaps = 29/330 (8%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLAS-----HVDTNEIVAVKIENSGTKHPQLLYEAKV 55
+ + +K+G IG G FG I+LA V ++ VK+E S + L E K
Sbjct: 29 ITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPS--DNGPLFTELKF 86
Query: 56 YKILQ--------------GGSGIPNIKWYGVDGED----NVLVLDLLGPSLEDLFVYCR 97
Y+ G+P G+ ++ +++D G L+ ++
Sbjct: 87 YQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA 146
Query: 98 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
++FS KTVL L+ +++ +EY+H ++H DIK N L+ +QVY++D+GLA +Y
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK-NPDQVYLVDYGLAYRYC 205
Query: 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 217
++ + GT + S + H G+ SRR DLE LGY ++ +L G LPW+
Sbjct: 206 PEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265
Query: 218 AATKKQKYDKICEKKVSTPIEVLC---KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274
K + KI ++ + C + P E A Y + L + ++P Y L+ +
Sbjct: 266 KDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILL 325
Query: 275 DLFSREGYDFDFVFDWTILKYQQTQKTKSQ 304
G D D ++++ +
Sbjct: 326 QGLKAIGSKDDGKLDLSVVENGGLKAKTIT 355
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 465 bits (1198), Expect = e-164
Identities = 89/316 (28%), Positives = 142/316 (44%), Gaps = 33/316 (10%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHPQLLYEAKVYK 57
++ + G ++ LG+KIGSG FG I+LA + E A VK+E ++ L E K Y+
Sbjct: 31 LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY--QENGPLFSELKFYQ 88
Query: 58 ILQGGS--------------GIPNIKWYGV----DGEDNVLVLDLLGPSLEDLFVYCRRK 99
+ GIP G+ +V++ LG L+ +
Sbjct: 89 RVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-T 147
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
F TVL L +M+ +EY+H ++H DIK N L+G +QVY+ D+GL+ +Y
Sbjct: 148 FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-NPDQVYLADYGLSYRYCPN 206
Query: 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL--- 216
++ K GT + S + H G+ SRR D+E LGY +L +L G LPW+
Sbjct: 207 GNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266
Query: 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276
A + K + + E S S E A + SL +D++P+Y LK++ +
Sbjct: 267 PVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326
Query: 277 FSREGYDFDFVFDWTI 292
G D++
Sbjct: 327 GIPLGP-----LDFST 337
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 449 bits (1156), Expect = e-158
Identities = 68/317 (21%), Positives = 121/317 (38%), Gaps = 33/317 (10%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT--------NEIVAVKIENSGT----------- 44
G ++KL + G ++ A+ T + ++K++
Sbjct: 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQR 98
Query: 45 --KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED-NVLVLDLLGPSLEDLFVYC-RRKF 100
K Q+ K+Y IP +GV + LVL LG SL+ +
Sbjct: 99 AAKPLQVNKWKKLYST--PLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVL 156
Query: 101 SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
S ++VL +A +++ +E++H ++H ++ +N + + +QV + +G A +Y
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ-SQVTLAGYGFAFRYCP-- 213
Query: 161 TNRHIPYRENKN--LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218
+ +H+ Y E G + S + H G SRR DL+SLGY +L +L G LPW
Sbjct: 214 SGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273
Query: 219 ATKKQKYDKICEKKVSTPIEVLCK---SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275
T+ K P C Y +LT++++P Y L+
Sbjct: 274 NTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333
Query: 276 LFSREGYDFDFVFDWTI 292
L +
Sbjct: 334 LLQDLRVSPYDPIGLPM 350
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-30
Identities = 53/258 (20%), Positives = 92/258 (35%), Gaps = 43/258 (16%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKI 58
+ G Y + ++IGSG ++F + + +I A+K E E
Sbjct: 24 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 82
Query: 59 LQGGSGIPN---IKWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI 113
LQ + I+ Y + D +V++ L ++ M+
Sbjct: 83 LQQ----HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNML 137
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
+ +H G +H D+KP NFL+ G + +IDFG+A + + TT+ +
Sbjct: 138 EAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK-----DSQ 188
Query: 174 TGTARYAS-----------CNTHLGIEQSRRDDLESLG---YVLLYFLRGSLPWQGLKAA 219
GT Y N + S + D+ SLG Y + Y G P+Q +
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY---GKTPFQQI--I 243
Query: 220 TKKQKYDKICEKKVSTPI 237
+ K I +
Sbjct: 244 NQISKLHAIIDPNHEIEF 261
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-30
Identities = 53/256 (20%), Positives = 91/256 (35%), Gaps = 39/256 (15%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKI 58
+ G Y + ++IGSG ++F + + +I A+K E E
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 63
Query: 59 LQGGSGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
LQ S I + Y + D +V++ L ++ M+
Sbjct: 64 LQQHS--DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEA 120
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
+ +H G +H D+KP NFL+ + +IDFG+A + + TT+ + G
Sbjct: 121 VHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVK-----DSQVG 171
Query: 176 TARYAS-----------CNTHLGIEQSRRDDLESLG---YVLLYFLRGSLPWQGLKAATK 221
T Y N + S + D+ SLG Y + Y G P+Q + +
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY---GKTPFQQII--NQ 226
Query: 222 KQKYDKICEKKVSTPI 237
K I +
Sbjct: 227 ISKLHAIIDPNHEIEF 242
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-29
Identities = 51/258 (19%), Positives = 90/258 (34%), Gaps = 43/258 (16%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKI 58
+ G Y + ++IGSG ++F + + +I A+K E E
Sbjct: 52 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110
Query: 59 LQGGSGIPN---IKWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI 113
LQ + I+ Y + D +V++ L ++ M+
Sbjct: 111 LQQ----HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNML 165
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
+ +H G +H D+KP NFL+ + +IDFG+A + + TT+ +
Sbjct: 166 EAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVK-----DSQ 216
Query: 174 TGTARYAS-----------CNTHLGIEQSRRDDLESLG---YVLLYFLRGSLPWQGLKAA 219
G Y N + S + D+ SLG Y + Y G P+Q +
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY---GKTPFQQI--I 271
Query: 220 TKKQKYDKICEKKVSTPI 237
+ K I +
Sbjct: 272 NQISKLHAIIDPNHEIEF 289
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 35/272 (12%), Positives = 72/272 (26%), Gaps = 45/272 (16%)
Query: 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQ 60
G +G A+ +T E V + Q+ E ++L+
Sbjct: 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131
Query: 61 GG---------------------SGIPNIKWYGVDGEDN-----VLVLDLLGPSLEDLFV 94
G + +D D + + +L+
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191
Query: 95 Y------CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148
+ L L Q+I + +H G +H ++P + ++ + V++
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLT 248
Query: 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FL 207
F + + E L S + + D +LG +++Y
Sbjct: 249 GFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG-LVIYWIW 307
Query: 208 RGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239
LP + I + P V
Sbjct: 308 CADLPITK---DAALGGSEWIFRSCKNIPQPV 336
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 45/269 (16%), Positives = 76/269 (28%), Gaps = 52/269 (19%)
Query: 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQ 60
K KL + G +FL V+ E A+K+ ENS ++ +L L
Sbjct: 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLL 120
Query: 61 G--------------------GSGIPNIKWYGVDGEDN-----VLVLDLLGPSLEDLF-- 93
G P +D +L++ LE LF
Sbjct: 121 GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFST 180
Query: 94 ----VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149
R + + +L Q+I + S+G +H PDN + ++ + D
Sbjct: 181 LDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM---PDGRLMLGD 237
Query: 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYAS--CNTHLGIEQSRRDDLESLGYVLLYFL 207
K + YA + + LG +
Sbjct: 238 VSALWKVGTRGP----------ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
Query: 208 RGSLPWQGLKAATKKQKYDKICEKKVSTP 236
LP+ GL K + + + T
Sbjct: 288 CLFLPF-GLVTPGIKGSWKRPSLRVPGTD 315
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 61/305 (20%), Positives = 113/305 (37%), Gaps = 50/305 (16%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKI 58
+ + L +G G+ +F H T ++ A+K+ + + E +V K
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63
Query: 59 LQGGSGIPNI-KWYGVDGEDN----VLVLDLL-GPSLEDLFVYCRRKFSL--KTVLMLAD 110
L NI K + ++ E VL+++ SL + + L L++
Sbjct: 64 LNH----KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY-IIDFGLAKKYRDPTTNRHIPYRE 169
++ + ++ G +HR+IKP N + +G VY + DFG A++ D
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED----------- 168
Query: 170 NKNLT---GTARYAS--------CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLK 217
++ GT Y + DL S+G V Y GSLP++ +
Sbjct: 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFE 227
Query: 218 AA-TKKQKYDKICEKKVSTPIEVL--CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274
K+ KI K S I + ++ P +++ SL+ L+ L
Sbjct: 228 GPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS-------RGLQVLLT 280
Query: 275 DLFSR 279
+ +
Sbjct: 281 PVLAN 285
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 56/277 (20%), Positives = 102/277 (36%), Gaps = 41/277 (14%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKI 58
+ + L +G G+ +F H T ++ A+K+ + + E +V K
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63
Query: 59 LQGGSGIPNI-KWYGVDGEDN----VLVLDLL-GPSLEDLFVYCRRKFSL--KTVLMLAD 110
L NI K + ++ E VL+++ SL + + L L++
Sbjct: 64 LNH----KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY-IIDFGLAKKYRDPTTNRHIPYRE 169
++ + ++ G +HR+IKP N + +G VY + DFG A++ D
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED----------- 168
Query: 170 NKNLT---GTARYAS----CNTHLGIEQSRRDDLE----SLGYVLLY-FLRGSLPWQGLK 217
++ GT Y L + ++ S+G V Y GSLP++ +
Sbjct: 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFE 227
Query: 218 AA-TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFH 253
K+ KI K S I + K+
Sbjct: 228 GPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGD 264
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 8e-27
Identities = 34/286 (11%), Positives = 76/286 (26%), Gaps = 61/286 (21%)
Query: 1 MERIIGVKYKL---GRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYE 52
+E +G + + G +G A+ +T E V + Q+ E
Sbjct: 69 VESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEE 128
Query: 53 AKVYKILQG---------------------GSGIPNIKWYGVDGEDN-----VLVLDLLG 86
++L+G + +D D + +
Sbjct: 129 VLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ 188
Query: 87 PSLEDLFVYCRRK------FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 140
+L+ L L Q+I + +H G +H ++P + ++
Sbjct: 189 SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--- 245
Query: 141 KANQVYIIDFGLAKKYRDPT-TNRHIPYRENKNLTGTARYASCNTHLGIEQ-----SRRD 194
+ V++ F + + + + + +
Sbjct: 246 QRGGVFLTGFEHLVRDGASAVSPIGRGF-------APPETTAERMLPFGQHHPTLMTFAF 298
Query: 195 DLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239
D +LG + +Y+ LP + I + P V
Sbjct: 299 DTWTLG-LAIYWIWCADLPNTD---DAALGGSEWIFRSCKNIPQPV 340
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-26
Identities = 62/266 (23%), Positives = 102/266 (38%), Gaps = 70/266 (26%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEA 53
E +Y+LG +G G FG +F + VA+K+ + + E
Sbjct: 27 EAFEA-EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEV 85
Query: 54 KVYKILQGGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVY-----------CRRK 99
+ + G G P + + E +LVL+ P+ +DLF Y R
Sbjct: 86 ALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPA-QDLFDYITEKGPLGEGPSRCF 144
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
F Q++A I++ HSRG +HRDIK +N L + + +IDFG D
Sbjct: 145 FG---------QVVAAIQHCHSRGVVHRDIKDENIL--IDLRRGCAKLIDFGSGALLHD- 192
Query: 160 TTNRHIPYRENKNLT---GTARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLR-GS 210
+ T GT Y+ S + + + + SLG +LLY + G
Sbjct: 193 -----------EPYTDFDGTRVYSPPEWISRHQYHALPA----TVWSLG-ILLYDMVCGD 236
Query: 211 LPWQGLKAATKKQKYDKICEKKVSTP 236
+P++ +I E ++ P
Sbjct: 237 IPFER---------DQEILEAELHFP 253
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 44/199 (22%), Positives = 77/199 (38%), Gaps = 32/199 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIP 66
++ +G G+FG++ A + + A+K I ++ K +L E + L
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNH----Q 62
Query: 67 NI-KWYGVDGEDNV---------------LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLA 109
+ ++Y E + ++ +L DL L
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 110 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP--- 166
Q++ + Y+HS+G +HRD+KP N + ++ V I DFGLAK +
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFID---ESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 167 -YRENKNLT---GTARYAS 181
+ NLT GTA Y +
Sbjct: 180 LPGSSDNLTSAIGTAMYVA 198
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-25
Identities = 47/251 (18%), Positives = 89/251 (35%), Gaps = 29/251 (11%)
Query: 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGS 63
Y +K+G G F + L + A+K + + EA ++++
Sbjct: 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNH-- 85
Query: 64 GIPNI-KWYGV-----DGEDNV-LVLDL-LGPSLEDLFVYCRRK---FSLKTVLMLADQM 112
PNI + + L+L +L + + K + +L L +
Sbjct: 86 --PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH--IPYREN 170
+E +H++G+ HRD+KP N L+G Q ++D G + + ++
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLG---DEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 171 KNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYD 226
T Y + + R D+ SLG +LY + G P+ K
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLG-CVLYAMMFGEGPYDM--VFQKGDSVA 257
Query: 227 KICEKKVSTPI 237
+ ++S P
Sbjct: 258 LAVQNQLSIPQ 268
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 60/242 (24%), Positives = 97/242 (40%), Gaps = 34/242 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQG 61
+K+G +G GSF ++ A + T VA+K+ +G ++ E K++ L+
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQ-RVQNEVKIHCQLKH 70
Query: 62 GSGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
P+I + Y + + V LVL++ + + FS Q+I +
Sbjct: 71 ----PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--G 175
Y+HS G LHRD+ N L+ + + I DFGLA + + P + T G
Sbjct: 127 YLHSHGILHRDLTLSNLLLT---RNMNIKIADFGLATQLKMPHEKHY---------TLCG 174
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVS 234
T Y S D+ SLG + Y L G P+ T K +K+
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLG-CMFYTLLIGRPPFD---TDTVKNTLNKVVLADYE 230
Query: 235 TP 236
P
Sbjct: 231 MP 232
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 42/225 (18%), Positives = 84/225 (37%), Gaps = 20/225 (8%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
+ + + + +G G+ G I + N VAVK E + +L+
Sbjct: 18 VVIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILP-ECFSFADREVQ---LLR 72
Query: 61 GGSGIPNI-KWYGV-DGEDNV-LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
PN+ +++ + ++L +L++ + L Q + +
Sbjct: 73 ESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLA 132
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
++HS +HRD+KP N L+ + + I DFGL KK + + + G
Sbjct: 133 HLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS----FSRRSGVPG 188
Query: 176 TARYAS---CNTHLGIEQSRRDDLESLGYVLLYFL--RGSLPWQG 215
T + + + + D+ S G + Y++ GS P+
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAG-CVFYYVISEGSHPFGK 232
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 52/239 (21%), Positives = 90/239 (37%), Gaps = 37/239 (15%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
E+ + + +G GS G + VAVK L E K +L
Sbjct: 10 EQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-FCDIALMEIK---LLTE 64
Query: 62 GSGIPNI-KWYGV-DGEDNV-LVLDLLGPSLEDL------FVYCRRKFSLKTVLMLADQM 112
PN+ ++Y + + + L+L +L+DL + + L Q+
Sbjct: 65 SDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 113 IARIEYVHSRGFLHRDIKPDNFL----------MGLGRKANQVYIIDFGLAKKYRDPTTN 162
+ + ++HS +HRD+KP N L G + ++ I DFGL KK
Sbjct: 125 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS---G 181
Query: 163 RHIPYRENKNLTGTARYA-------SCNTHLGIEQSRRDDLESLGYVLLYFL--RGSLP 212
+ N +GT+ + S N +R D+ S+G + Y++ +G P
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG-CVFYYILSKGKHP 239
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 7e-24
Identities = 52/257 (20%), Positives = 93/257 (36%), Gaps = 39/257 (15%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKI 58
+ G +++ ++G+G FG + H DT E VA+K E S + E ++ K
Sbjct: 10 TQTCG-PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKK 68
Query: 59 LQGGSGIPNI---------KWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSL--KTVL 106
L PN+ + +L ++ G L L +
Sbjct: 69 LNH----PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR 124
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166
L + + + Y+H +HRD+KP+N ++ G + IID G AK+
Sbjct: 125 TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-------- 176
Query: 167 YRENKNLT---GTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKK 222
+ T GT +Y + + + D S G L + G P+ +
Sbjct: 177 ---GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFG-TLAFECITGFRPFLP---NWQP 229
Query: 223 QKYDKICEKKVSTPIEV 239
++ +K + I V
Sbjct: 230 VQWHGKVREKSNEHIVV 246
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 8e-24
Identities = 61/247 (24%), Positives = 99/247 (40%), Gaps = 45/247 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQG 61
+Y GR +G G F + F S DT E+ A KI + ++ E +++ L
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAH 74
Query: 62 GSGIPNI-KWYGV-DGEDNV-LVLDL-LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
++ ++G + D V +VL+L SL +L R+ + Q++ +
Sbjct: 75 ----QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQ 129
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--G 175
Y+H +HRD+K N L V I DFGLA K + G
Sbjct: 130 YLHRNRVIHRDLKLGNLF--LNEDLE-VKIGDFGLATKVEYDGERKK---------VLCG 177
Query: 176 TARYA-----SCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKIC 229
T Y S H S D+ S+G ++Y L G P++ + K+ Y +I
Sbjct: 178 TPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---TSCLKETYLRIK 228
Query: 230 EKKVSTP 236
+ + S P
Sbjct: 229 KNEYSIP 235
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 8e-24
Identities = 70/241 (29%), Positives = 112/241 (46%), Gaps = 35/241 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK------IENSGTKHPQLLYEAKVYKILQG 61
+++GR +G G FG ++LA + I+A+K +E +G +H QL E ++ L+
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH 68
Query: 62 GSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARI 116
PNI + YG D L+L+ L ++ ++ KF + ++ +
Sbjct: 69 ----PNILRLYGYFHDATRVYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
Y HS+ +HRDIKP+N L+G A ++ I DFG + H P +L GT
Sbjct: 123 SYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTDLCGT 170
Query: 177 ARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVST 235
Y G + DL SLG VL Y FL G P++ A T ++ Y +I + +
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLG-VLCYEFLVGKPPFE---ANTYQETYKRISRVEFTF 226
Query: 236 P 236
P
Sbjct: 227 P 227
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-23
Identities = 57/257 (22%), Positives = 102/257 (39%), Gaps = 54/257 (21%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEA 53
E + +Y++G +GSG FG ++ V N VA+K ++ E
Sbjct: 39 EPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 97
Query: 54 KVYKILQGGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVL--ML 108
+ K + SG + + + VL+L+ P +DLF + + +L+ L
Sbjct: 98 VLLKKVS--SGFSGVIRLLDWFERPDSFVLILERPEPV-QDLFDFITERGALQEELARSF 154
Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
Q++ + + H+ G LHRDIK +N L + ++ +IDFG +D
Sbjct: 155 FWQVLEAVRHCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKD---------- 202
Query: 169 ENKNLT---GTARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAA 219
T GT Y+ + + G + SLG +LLY + G +P++
Sbjct: 203 --TVYTDFDGTRVYSPPEWIRYHRYHGRSA----AVWSLG-ILLYDMVCGDIPFEH---- 251
Query: 220 TKKQKYDKICEKKVSTP 236
++I +V
Sbjct: 252 -----DEEIIRGQVFFR 263
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 68/248 (27%), Positives = 117/248 (47%), Gaps = 37/248 (14%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQ 60
+ Y+ +K+GSG++GE+ L T+ A+KI S + + +LL E V K+L
Sbjct: 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 61 GGSGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
PNI K Y + + N LV++ G L D ++ R KF+ ++ Q+++ +
Sbjct: 95 H----PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGV 149
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
Y+H +HRD+KP+N L+ K + I+DFGL+ + ++ K GT
Sbjct: 150 TYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--------NQKKMKERLGT 201
Query: 177 ARYASCNTHLGIEQSRRD-----DLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICE 230
A Y + E R+ D+ S+G V+L+ L G P+ G T ++ K+ +
Sbjct: 202 AYYIA------PEVLRKKYDEKCDVWSIG-VILFILLAGYPPFGG---QTDQEILRKVEK 251
Query: 231 KKVSTPIE 238
K +
Sbjct: 252 GKYTFDSP 259
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 61/249 (24%), Positives = 99/249 (39%), Gaps = 45/249 (18%)
Query: 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKIL 59
+Y GR +G G F + F S DT E+ A KI + ++ E +++ L
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSL 98
Query: 60 QGGSGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
++ ++G + D V +VL+L SL +L R+ + Q++
Sbjct: 99 AH----QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLG 153
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT- 174
+Y+H +HRD+K N L V I DFGLA K +
Sbjct: 154 CQYLHRNRVIHRDLKLGNLF--LNEDLE-VKIGDFGLATKVEYDGERKK---------VL 201
Query: 175 -GTARYA-----SCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDK 227
GT Y S H S D+ S+G ++Y L G P++ + K+ Y +
Sbjct: 202 CGTPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---TSCLKETYLR 252
Query: 228 ICEKKVSTP 236
I + + S P
Sbjct: 253 IKKNEYSIP 261
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-23
Identities = 35/161 (21%), Positives = 61/161 (37%), Gaps = 13/161 (8%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYKILQGGS 63
++ ++G GS+GE+F + + AVK S + P+ L E +
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVG---SHEKVG 114
Query: 64 GIPNI-KWYGVDGEDNVL--VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
P + E +L +L GPSL+ V + + ++H
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
S+G +H D+KP N +G + + DFGL +
Sbjct: 175 SQGLVHLDVKPANIFLG---PRGRCKLGDFGLLVELGTAGA 212
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 5e-23
Identities = 70/249 (28%), Positives = 108/249 (43%), Gaps = 38/249 (15%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKIL 59
+YK R +G GSFGE+ L T + AVK+ T LL E ++ K L
Sbjct: 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 60 QGGSGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
PNI K Y + + LV ++ G L D + R++FS + Q+++
Sbjct: 84 DH----PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSG 138
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
I Y+H +HRD+KP+N L+ K + IIDFGL+ + ++ K+ G
Sbjct: 139 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--------ASKKMKDKIG 190
Query: 176 TARYASCNTHLGIEQSRRD-----DLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKIC 229
TA Y + E D+ S G V+LY L G P+ G A + K+
Sbjct: 191 TAYYIA------PEVLHGTYDEKCDVWSTG-VILYILLSGCPPFNG---ANEYDILKKVE 240
Query: 230 EKKVSTPIE 238
+ K + +
Sbjct: 241 KGKYTFELP 249
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 8e-23
Identities = 63/243 (25%), Positives = 104/243 (42%), Gaps = 39/243 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK------IENSGTKHPQLLYEAKVYKILQG 61
+ +GR +G G FG ++LA I+A+K +E G +H QL E ++ L+
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH-QLRREIEIQSHLRH 73
Query: 62 GSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRR--KFSLKTVLMLADQMIA 114
PNI + Y D + L+L+ G +L+ ++ +F + +++
Sbjct: 74 ----PNILRMYNYFHDRKRIYLMLEFAPRG----ELYKELQKHGRFDEQRSATFMEELAD 125
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
+ Y H R +HRDIKP+N LMG ++ I DFG + H P + +
Sbjct: 126 ALHYCHERKVIHRDIKPENLLMG---YKGELKIADFGWSV---------HAPSLRRRTMC 173
Query: 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKV 233
GT Y G + DL G VL Y FL G P+ + + + + +I +
Sbjct: 174 GTLDYLPPEMIEGKTHDEKVDLWCAG-VLCYEFLVGMPPFD---SPSHTETHRRIVNVDL 229
Query: 234 STP 236
P
Sbjct: 230 KFP 232
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-22
Identities = 64/247 (25%), Positives = 105/247 (42%), Gaps = 48/247 (19%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQG 61
I + RK+GSG+FG++ L + +K + S Q+ E +V K L
Sbjct: 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH 79
Query: 62 GSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLF------VYCRRKFSLKTVLMLAD 110
PNI K + V D + +V++ G +L + S V L
Sbjct: 80 ----PNIIKIFEVFEDYHNMYIVMETCEGG----ELLERIVSAQARGKALSEGYVAELMK 131
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
QM+ + Y HS+ +H+D+KP+N L + + IIDFGLA+ ++ +
Sbjct: 132 QMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--------SDEHS 183
Query: 171 KNLTGTARYASCNTHLGIEQSRRD-----DLESLGYVLLYF-LRGSLP-W----QGLKAA 219
N GTA Y + E +RD D+ S G V++YF L G LP + ++
Sbjct: 184 TNAAGTALYMA------PEVFKRDVTFKCDIWSAG-VVMYFLLTGCLPFTGTSLEEVQQK 236
Query: 220 TKKQKYD 226
++ +
Sbjct: 237 ATYKEPN 243
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 44/167 (26%), Positives = 76/167 (45%), Gaps = 24/167 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----------ENSGTKHPQLLYEAKVYK 57
+Y + + +GSG+ GE+ LA T + VA+KI + E ++ K
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 58 ILQGGSGIPNI-KWYGVDGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQ 111
L P I K ++ +VL+L+ G +LF V ++ T + Q
Sbjct: 71 KLNH----PCIIKIKNFFDAEDYYIVLELMEGG----ELFDKVVGNKRLKEATCKLYFYQ 122
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
M+ ++Y+H G +HRD+KP+N L+ + + I DFG +K +
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 24/167 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----------ENSGTKHPQLLYEAKVYK 57
+Y + + +GSG+ GE+ LA T + VA++I + E ++ K
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 58 ILQGGSGIPNI-KWYGVDGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQ 111
L P I K ++ +VL+L+ G +LF V ++ T + Q
Sbjct: 196 KLNH----PCIIKIKNFFDAEDYYIVLELMEGG----ELFDKVVGNKRLKEATCKLYFYQ 247
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
M+ ++Y+H G +HRD+KP+N L+ + + I DFG +K +
Sbjct: 248 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 64/251 (25%), Positives = 106/251 (42%), Gaps = 43/251 (17%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQ 60
+Y + +G GSFGE+ T + AVK+ N +L E ++ K L
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 61 GGSGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
PNI K + + + + +V +L G L D + R++FS + Q+ + I
Sbjct: 80 H----PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGI 134
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT-- 174
Y+H +HRD+KP+N L+ K + IIDFGL+ +++N +
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC-----------FQQNTKMKDR 183
Query: 175 -GTARYASCNTHLGIEQSRRD-----DLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDK 227
GTA Y + E R D+ S G V+LY L G+ P+ G + +
Sbjct: 184 IGTAYYIA------PEVLRGTYDEKCDVWSAG-VILYILLSGTPPFYG---KNEYDILKR 233
Query: 228 ICEKKVSTPIE 238
+ K + +
Sbjct: 234 VETGKYAFDLP 244
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-22
Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 19/165 (11%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQ 60
+Y + +G GSFGE+ T + AVK+ N +L E ++ K L
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 61 GGSGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMI 113
PNI K + + + + +V +L G +LF + R++FS + Q+
Sbjct: 80 H----PNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIKQVF 131
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+ I Y+H +HRD+KP+N L+ K + IIDFGL+ ++
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 54/262 (20%), Positives = 90/262 (34%), Gaps = 75/262 (28%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----------SGTKHPQLLYEAKVYK 57
KY +GSG+FG ++ A + N+ V VK K ++ E +
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 58 ILQGGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVY-----------CRRKFSLK 103
++ NI K + + LV++ G L+ LF + F
Sbjct: 85 RVEH----ANIIKVLDIFENQGFFQLVMEKHGSGLD-LFAFIDRHPRLDEPLASYIFR-- 137
Query: 104 TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163
Q+++ + Y+ + +HRDIK +N + + + +IDFG A
Sbjct: 138 -------QLVSAVGYLRLKDIIHRDIKDENIV--IAEDFT-IKLIDFGSAAYLER----- 182
Query: 164 HIPYRENKNLT---GTARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQ 214
K GT Y N + G E ++ SLG V LY L P+
Sbjct: 183 ------GKLFYTFCGTIEYCAPEVLMGNPYRGPEL----EMWSLG-VTLYTLVFEENPFC 231
Query: 215 GLKAATKKQKYDKICEKKVSTP 236
++ E + P
Sbjct: 232 E---------LEETVEAAIHPP 244
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 4e-22
Identities = 45/206 (21%), Positives = 86/206 (41%), Gaps = 20/206 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
Y + ++G+G+FG + + T A K + + E + +L+
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH---- 213
Query: 66 PNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
P + + D + V++ + + G L + K S + Q+ + ++H
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
++H D+KP+N + +++N++ +IDFGL P + K TGTA +A+
Sbjct: 274 NNYVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLD--------PKQSVKVTTGTAEFAA 324
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFL 207
G D+ S+G VL Y L
Sbjct: 325 PEVAEGKPVGYYTDMWSVG-VLSYIL 349
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 8e-22
Identities = 33/182 (18%), Positives = 75/182 (41%), Gaps = 18/182 (9%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGS 63
+ KY + +G G FG + + + K ++ GT + E + I +
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH-- 60
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
NI + E+ V++ + + G + + + + + ++ Q+ ++++
Sbjct: 61 --RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
HS H DI+P+N + R+++ + II+FG A++ + P + L Y
Sbjct: 119 HSHNIGHFDIRPENIIY-QTRRSSTIKIIEFGQARQLK--------PGDNFRLLFTAPEY 169
Query: 180 AS 181
+
Sbjct: 170 YA 171
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 8e-22
Identities = 46/163 (28%), Positives = 73/163 (44%), Gaps = 17/163 (10%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLY-EAKVYKILQGG 62
I Y L IG GS+GE+ +A T A K I + E ++ K L
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH- 65
Query: 63 SGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIAR 115
PNI + Y + ++ LV++L G +LF V +R F + +++
Sbjct: 66 ---PNIIRLYETFEDNTDIYLVMELCTGG----ELFERVVHKRVFRESDAARIMKDVLSA 118
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+ Y H HRD+KP+NFL + + +IDFGLA +++
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 9e-22
Identities = 48/227 (21%), Positives = 84/227 (37%), Gaps = 32/227 (14%)
Query: 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGS 63
++ ++ R + G F ++ A V + A+K N K+ ++ E K L G
Sbjct: 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGH- 85
Query: 64 GIPNI----------KWYGVDGEDNVLVL-DLLGPSLEDLFVYCRRK--FSLKTVLMLAD 110
PNI K G+ L+L +L L + + S TVL +
Sbjct: 86 --PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143
Query: 111 QMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
Q ++++H + +HRD+K +N L+ + + DFG A R
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 169 -----ENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLYFL 207
E T Y + + + + D+ +LG +LY L
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG-CILYLL 246
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 9e-22
Identities = 53/256 (20%), Positives = 101/256 (39%), Gaps = 46/256 (17%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVY 56
++IG KY +G +G GS+G++ +T AVKI + E ++
Sbjct: 2 KLIG-KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 57 KILQGGSGIPNI-KWYGVDGEDN----VLVLDLLGPSLEDLFVY-CRRKFSLKTVLMLAD 110
+ L+ N+ + V + +V++ ++++ ++F +
Sbjct: 61 RRLRH----KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFC 116
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
Q+I +EY+HS+G +H+DIKP N L L + I G+A P+ +
Sbjct: 117 QLIDGLEYLHSQGIVHKDIKPGNLL--LTTGGT-LKISALGVA--------EALHPFAAD 165
Query: 171 KNLT---GTARYAS------CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAAT 220
G+ + +T G + D+ S G V LY G P++G
Sbjct: 166 DTCRTSQGSPAFQPPEIANGLDTFSGFKV----DIWSAG-VTLYNITTGLYPFEG---DN 217
Query: 221 KKQKYDKICEKKVSTP 236
+ ++ I + + P
Sbjct: 218 IYKLFENIGKGSYAIP 233
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-21
Identities = 49/162 (30%), Positives = 73/162 (45%), Gaps = 19/162 (11%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGS 63
Y + ++G G+F + H T A KI N S +L EA++ + LQ
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-- 64
Query: 64 GIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARI 116
PNI + + E LV DL+ G +LF + R +S Q++ I
Sbjct: 65 --PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCIQQILESI 118
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
Y HS G +HR++KP+N L+ K V + DFGLA + D
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 44/175 (25%), Positives = 64/175 (36%), Gaps = 22/175 (12%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSGI 65
++G GSFGE+ T AVK +E + E L
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE------ELVACAGLSS---- 109
Query: 66 PNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
P I YG E + ++LL G SL L L Q + +EY+H+
Sbjct: 110 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHT 168
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
R LH D+K DN L L ++ + DFG A + + + + GT
Sbjct: 169 RRILHGDVKADNVL--LSSDGSRAALCDFGHALCLQPDGLGKSLLTG--DYIPGT 219
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-21
Identities = 70/262 (26%), Positives = 102/262 (38%), Gaps = 62/262 (23%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY----EAKVYK 57
+ + L + +G G++GE+ LA + T E VAVKI + + E + K
Sbjct: 3 VPFVE-DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINK 60
Query: 58 ILQGGSGIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVY-----------CRRKF 100
+L N+ K+YG E N+ L LE +LF +R F
Sbjct: 61 MLNH----ENVVKFYGHRREGNIQYL-----FLEYCSGGELFDRIEPDIGMPEPDAQRFF 111
Query: 101 SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
Q++A + Y+H G HRDIKP+N L L + N + I DFGLA +R
Sbjct: 112 H---------QLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNN 159
Query: 161 TNRHIPYRENKNLTGTARYA-----SCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQ 214
R + + GT Y D+ S G ++L L G LPW
Sbjct: 160 RERLL-----NKMCGTLPYVAPELLKRREFHAEPV----DVWSCG-IVLTAMLAGELPWD 209
Query: 215 GLKAATKKQKYDKICEKKVSTP 236
+ Q+Y EKK
Sbjct: 210 Q--PSDSCQEYSDWKEKKTYLN 229
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 71/259 (27%), Positives = 114/259 (44%), Gaps = 57/259 (22%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVY 56
+ IG Y+L + IG G+F ++ LA H+ T VA+KI + + T +L E ++
Sbjct: 10 EQPHIG-NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIM 68
Query: 57 KILQGGSGIPNI-KWYGV-DGEDNV-LVLDLLGPSLEDLFVY-----------CRRKFSL 102
KIL PNI K + V + E + L+++ S ++F Y R KF
Sbjct: 69 KILNH----PNIVKLFEVIETEKTLYLIMEYA--SGGEVFDYLVAHGRMKEKEARSKFR- 121
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
Q+++ ++Y H + +HRD+K +N L L N + I DFG + ++
Sbjct: 122 --------QIVSAVQYCHQKRIVHRDLKAENLL--LDADMN-IKIADFGFSNEFTV---- 166
Query: 163 RHIPYRENKNLT---GTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLR-GSLPWQGLK 217
L G YA+ G + D+ SLG V+LY L GSLP+ G
Sbjct: 167 -------GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLG-VILYTLVSGSLPFDG-- 216
Query: 218 AATKKQKYDKICEKKVSTP 236
K+ +++ K P
Sbjct: 217 -QNLKELRERVLRGKYRIP 234
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-21
Identities = 41/200 (20%), Positives = 72/200 (36%), Gaps = 33/200 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSG 64
++ + +G G FG +F A + + A+K + N +++ E K L+
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH--- 62
Query: 65 IPNI-KWYGVDGEDNVLVLDLLGPSLEDLFV---YCRRK--------------FSLKTVL 106
P I +++ E N L++ CR++ L
Sbjct: 63 -PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-----YRDPTT 161
+ Q+ +E++HS+G +HRD+KP N + V + DFGL
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 162 NRHIPYRENKNLTGTARYAS 181
Y + GT Y S
Sbjct: 179 TPMPAYARHTGQVGTKLYMS 198
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 40/166 (24%), Positives = 66/166 (39%), Gaps = 22/166 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVY-------KIL 59
Y+ +G G + H T + AVK I+ +G ++ IL
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 60 QGGSGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQM 112
+ SG PNI + + LV DL+ G +LF + + S K + +
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG----ELFDYLTEKVTLSEKETRKIMRAL 133
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+ I +H +HRD+KP+N L L N + + DFG + +
Sbjct: 134 LEVICALHKLNIVHRDLKPENIL--LDDDMN-IKLTDFGFSCQLDP 176
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 43/164 (26%), Positives = 75/164 (45%), Gaps = 19/164 (11%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGS 63
+Y+L ++G G+F + V + A I N S H +L EA++ ++L+
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH-- 69
Query: 64 GIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARI 116
PNI + + E + L+ DL+ G +LF + R +S Q++ +
Sbjct: 70 --PNIVRLHDSISEEGHHYLIFDLVTGG----ELFEDIVAREYYSEADASHCIQQILEAV 123
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
+ H G +HR++KP+N L+ K V + DFGLA +
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 5e-21
Identities = 37/168 (22%), Positives = 61/168 (36%), Gaps = 21/168 (12%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVY---K 57
KY IG G + H T AVKI +
Sbjct: 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH 151
Query: 58 ILQGGSGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLAD 110
IL+ +G P+I + + LV DL+ G +LF + + S K +
Sbjct: 152 ILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG----ELFDYLTEKVALSEKETRSIMR 207
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
++ + ++H+ +HRD+KP+N L L + + DFG +
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENIL--LDDNMQ-IRLSDFGFSCHLEP 252
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-21
Identities = 49/165 (29%), Positives = 73/165 (44%), Gaps = 19/165 (11%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQ 60
Y + ++G G+F + H T A KI N S +L EA++ + LQ
Sbjct: 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 86
Query: 61 GGSGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMI 113
PNI + + E LV DL+ G +LF + R +S Q++
Sbjct: 87 H----PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCIQQIL 138
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
I Y HS G +HR++KP+N L+ K V + DFGLA + D
Sbjct: 139 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 6e-21
Identities = 63/255 (24%), Positives = 106/255 (41%), Gaps = 48/255 (18%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---------------ENSGTKHPQL 49
IG Y RK+GSG++GE+ L + + A+K+ +N H ++
Sbjct: 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 50 LYEAKVYKILQGGSGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTV 105
E + K L PNI K + V + + LV + G L + + R KF
Sbjct: 94 YNEISLLKSLDH----PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDA 148
Query: 106 LMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165
+ Q+++ I Y+H +HRDIKP+N L+ + I+DFGL+ +
Sbjct: 149 ANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS-------- 200
Query: 166 PYRENKNLTGTARYASCNTHLGIEQSRRD-----DLESLGYVLLYF-LRGSLPWQGLKAA 219
+ ++ GTA Y + E ++ D+ S G V++Y L G P+ G
Sbjct: 201 KDYKLRDRLGTAYYIA------PEVLKKKYNEKCDVWSCG-VIMYILLCGYPPFGG---Q 250
Query: 220 TKKQKYDKICEKKVS 234
+ K+ + K
Sbjct: 251 NDQDIIKKVEKGKYY 265
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 9e-21
Identities = 41/160 (25%), Positives = 80/160 (50%), Gaps = 17/160 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
+ +GSG+F E+FL T ++ A+K ++ + L E V K ++
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH---- 65
Query: 66 PNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARIEY 118
NI + + + LV+ L+ G +LF + R ++ K ++ Q+++ ++Y
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGG----ELFDRILERGVYTEKDASLVIQQVLSAVKY 121
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+H G +HRD+KP+N L + +++ I DFGL+K ++
Sbjct: 122 LHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 9e-21
Identities = 39/177 (22%), Positives = 74/177 (41%), Gaps = 21/177 (11%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
+ +G G++G ++ + +A+K E L E ++K L+
Sbjct: 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH---- 78
Query: 66 PNI-KWYGVDGEDNVL--VLDLL-GPSLEDL--FVYCRRKFSLKTVLMLADQMIARIEYV 119
NI ++ G E+ + ++ + G SL L + K + +T+ Q++ ++Y+
Sbjct: 79 KNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL 138
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
H +HRDIK DN L + + + I DFG +K+ + TGT
Sbjct: 139 HDNQIVHRDIKGDNVL--INTYSGVLKISDFGTSKRLAGINPCT-------ETFTGT 186
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 43/188 (22%), Positives = 77/188 (40%), Gaps = 32/188 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
Y +G ++GSG F + T A K G ++ E + + +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRRKFSL--KTVLMLADQM 112
N+ + V + D VL+L+L+ G +LF + +K SL + Q+
Sbjct: 73 LH----HNVITLHDVYENRTDVVLILELVSGG----ELFDFLAQKESLSEEEATSFIKQI 124
Query: 113 IARIEYVHSRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
+ + Y+H++ H D+KP+N ++ + +IDFGLA + E K
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--------DGVEFK 176
Query: 172 NLTGTARY 179
N+ GT +
Sbjct: 177 NIFGTPEF 184
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 70/262 (26%), Positives = 102/262 (38%), Gaps = 62/262 (23%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY----EAKVYK 57
+ + L + +G G++GE+ LA + T E VAVKI + + E + K
Sbjct: 3 VPFVE-DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINK 60
Query: 58 ILQGGSGIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVY-----------CRRKF 100
+L N+ K+YG E N+ L LE +LF +R F
Sbjct: 61 MLNH----ENVVKFYGHRREGNIQYL-----FLEYCSGGELFDRIEPDIGMPEPDAQRFF 111
Query: 101 SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
Q++A + Y+H G HRDIKP+N L L + N + I DFGLA +R
Sbjct: 112 H---------QLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNN 159
Query: 161 TNRHIPYRENKNLTGTARYA-----SCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQ 214
R + + GT Y D+ S G ++L L G LPW
Sbjct: 160 RERLL-----NKMCGTLPYVAPELLKRREFHAEPV----DVWSCG-IVLTAMLAGELPWD 209
Query: 215 GLKAATKKQKYDKICEKKVSTP 236
+ Q+Y EKK
Sbjct: 210 Q--PSDSCQEYSDWKEKKTYLN 229
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-20
Identities = 52/223 (23%), Positives = 83/223 (37%), Gaps = 45/223 (20%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
+K IGSG FG++F A H + +K + + E K L NI
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE--KAEREVKALAKLDH----VNI 66
Query: 69 -----KWYGVDGEDNVLVLDLLGPSLEDLFV---YC-------------RRKFSLKTVLM 107
W G D + + + LF+ +C K L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 108 LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167
L +Q+ ++Y+HS+ ++RD+KP N + QV I DFGL ++
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKNDG------- 176
Query: 168 RENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLYFL 207
+ GT RY S + + + DL +LG ++L L
Sbjct: 177 -KRTRSKGTLRYMSPEQIS---SQDYGKEVDLYALG-LILAEL 214
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 51/250 (20%), Positives = 90/250 (36%), Gaps = 47/250 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-------ENSGTKHPQLLYEAKVYKILQ 60
Y+L IG G F + + +T + AVKI + G L EA + +L+
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 61 GGSGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF------VYCRRKFSLKTVLMLA 109
P+I + + + +V + + DL +S
Sbjct: 85 H----PHIVELLETYSSDGMLYMVFEFMDGA----DLCFEIVKRADAGFVYSEAVASHYM 136
Query: 110 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
Q++ + Y H +HRD+KP L+ + V + FG+A + +
Sbjct: 137 RQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-------SGLV 189
Query: 170 NKNLTGTARYAS----CNTHLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQK 224
GT + + G D+ G V+L+ L G LP+ G TK++
Sbjct: 190 AGGRVGTPHFMAPEVVKREPYGKPV----DVWGCG-VILFILLSGCLPFYG----TKERL 240
Query: 225 YDKICEKKVS 234
++ I + K
Sbjct: 241 FEGIIKGKYK 250
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-20
Identities = 42/188 (22%), Positives = 79/188 (42%), Gaps = 32/188 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
Y++G ++GSG F + T + A K G ++ E + + +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYC--RRKFSLKTVLMLADQM 112
+ PNI + + + D VL+L+L+ G +LF + + + Q+
Sbjct: 66 RH----PNIITLHDIFENKTDVVLILELVSGG----ELFDFLAEKESLTEDEATQFLKQI 117
Query: 113 IARIEYVHSRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
+ + Y+HS+ H D+KP+N ++ ++ +IDFG+A K E K
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE--------AGNEFK 169
Query: 172 NLTGTARY 179
N+ GT +
Sbjct: 170 NIFGTPEF 177
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-20
Identities = 56/234 (23%), Positives = 95/234 (40%), Gaps = 47/234 (20%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY----------E 52
+II +YK+ K+G G ++LA N VA+K E
Sbjct: 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKA-----IFIPPREKEETLKRFERE 61
Query: 53 AKVYKILQGGSGIPNI-KWY--GVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLML 108
L NI + + LV++ + GP+L + + S+ T +
Sbjct: 62 VHNSSQLSH----QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEY-IESHGPLSVDTAINF 116
Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
+Q++ I++ H +HRDIKP N L+ + I DFG+AK + +
Sbjct: 117 TNQILDGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKALSETSLT------ 167
Query: 169 ENKNLTGTARYASCNTHLGIEQSR------RDDLESLGYVLLY-FLRGSLPWQG 215
+ ++ GT +Y S EQ++ D+ S+G ++LY L G P+ G
Sbjct: 168 QTNHVLGTVQYFS------PEQAKGEATDECTDIYSIG-IVLYEMLVGEPPFNG 214
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 6e-20
Identities = 67/274 (24%), Positives = 112/274 (40%), Gaps = 38/274 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHP----QLLYEAKVYKILQGG 62
+++ +KIG G F E++ A+ + VA+K ++ + E + K L
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH- 91
Query: 63 SGIPNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRK---FSLKTVLMLADQMIAR 115
PN+ K+Y EDN L VL+L L + + +++ +TV Q+ +
Sbjct: 92 ---PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 116 IEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
+E++HSR +HRDIKP N F+ V + D GL + + TT +L
Sbjct: 149 LEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTTAA-------HSLV 197
Query: 175 GTARYAS---CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231
GT Y S + + + D+ SLG +L P+ G KI +
Sbjct: 198 GTPYYMSPERIH---ENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLYSLCKKIEQC 253
Query: 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
P+ S E + C + ++RPD
Sbjct: 254 DYP-PLPSDHYS--EELRQLVNMCINPDPEKRPD 284
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 7e-20
Identities = 66/278 (23%), Positives = 115/278 (41%), Gaps = 29/278 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY----EAKVYKILQGGSGI 65
+G++IGSGSFG ++ + VAVK+ N PQ L E V + +
Sbjct: 27 TVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH---- 79
Query: 66 PNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVHS 121
NI + G + +V G SL KF +K ++ +A Q AR ++Y+H+
Sbjct: 80 VNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQ-TARGMDYLHA 138
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
+ +HRD+K +N + + N V I DFGLA +R + + L+G+ + +
Sbjct: 139 KSIIHRDLKSNNIFLH---EDNTVKIGDFGLAT-----EKSRWSGSHQFEQLSGSILWMA 190
Query: 182 ---CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
S + D+ + G VL + G LP+ + Q + + +S +
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVGRGSLSPDLS 248
Query: 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276
+ + P C D+RP + + +L
Sbjct: 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 8e-20
Identities = 46/275 (16%), Positives = 94/275 (34%), Gaps = 40/275 (14%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLL----YEAKVYKILQGGSGI 65
++G IG G FG+++ VA+++ + + L E Y+ +
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRH---- 88
Query: 66 PNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVH 120
N+ + G ++ L G +L + + + +A + I + + Y+H
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQE-IVKGMGYLH 147
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-KYRDPTTNRHIPYRENKNLTGTARY 179
++G LH+D+K N G+ V I DFGL R R G +
Sbjct: 148 AKGILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRREDKLRIQ---NGWLCH 200
Query: 180 ---------ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230
+ + S+ D+ +LG + P++ A ++
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AIIWQMGT 257
Query: 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
++ E + +C + ++RP
Sbjct: 258 GMKPNLSQIGM---GKEISDILLFCWAFEQEERPT 289
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 9e-20
Identities = 67/251 (26%), Positives = 97/251 (38%), Gaps = 56/251 (22%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
Y++ IG GS+ H TN AVKI + E +IL PN
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID--KSKRDPTEEI---EILLRYGQHPN 77
Query: 68 I-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARIEYVH 120
I V D V +V +L+ G +L + ++ FS + + + +EY+H
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGG----ELLDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 121 SRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT---GT 176
++G +HRD+KP N L + I DFG AK+ R EN L T
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA----------ENGLLMTPCYT 183
Query: 177 ARY------------ASCNTHLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQ 223
A + A+C D+ SLG VLLY L G P+ T ++
Sbjct: 184 ANFVAPEVLERQGYDAAC------------DIWSLG-VLLYTMLTGYTPFANGPDDTPEE 230
Query: 224 KYDKICEKKVS 234
+I K S
Sbjct: 231 ILARIGSGKFS 241
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 48/180 (26%), Positives = 73/180 (40%), Gaps = 19/180 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
Y + ++GSG+FG + T + K N + E + L
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH---- 107
Query: 66 PNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
P + + D + VL+L+ L G L D K S V+ Q ++++H
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
+H DIKP+N + +KA+ V IIDFGLA K P K T TA +A+
Sbjct: 168 HSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLN--------PDEIVKVTTATAEFAA 218
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 46/182 (25%), Positives = 76/182 (41%), Gaps = 16/182 (8%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHP-QLLYEAKVYKILQGGSGIPN 67
G +G G FG+ +H +T E++ +K + + L E KV + L+ PN
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH----PN 68
Query: 68 I-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVHSR 122
+ K+ GV +D L + + + G +L + ++ + A IA + Y+HS
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD-IASGMAYLHSM 127
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
+HRD+ N L+ + V + DFGLA+ D T R K RY
Sbjct: 128 NIIHRDLNSHNCLVR---ENKNVVVADFGLARLMVDEKTQPEGL-RSLKKPDRKKRYTVV 183
Query: 183 NT 184
Sbjct: 184 GN 185
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-19
Identities = 37/186 (19%), Positives = 66/186 (35%), Gaps = 31/186 (16%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY---------EAKVYKILQ 60
+ ++IG G FG + V +VA+K G + E + L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 61 GGSGIPNI-KWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IE 117
PNI K YG+ +V++ + L + L L IA IE
Sbjct: 82 H----PNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD-IALGIE 136
Query: 118 YVHSRG--FLHRDIKPDNFLMGLGRKANQVY--IIDFGLAKKYRDPTTNRHIPYRENKNL 173
Y+ ++ +HRD++ N + + V + DFGL+++ +
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGL---------- 186
Query: 174 TGTARY 179
G ++
Sbjct: 187 LGNFQW 192
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 54/231 (23%), Positives = 93/231 (40%), Gaps = 42/231 (18%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-TKHPQLLY----EAKVYK 57
G Y+L R +G G G+++ A IVA+K+ + + P EA+
Sbjct: 31 TQFG-PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAG 89
Query: 58 ILQGGSGIPNIKW---YGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMI 113
LQ P++ +G + + L+ G L + + + + + + Q+
Sbjct: 90 RLQE----PHVVPIHDFGEIDGQLYVDMRLINGVDLAAM-LRRQGPLAPPRAVAIVRQIG 144
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT---TNRHIPYREN 170
+ ++ H+ G HRD+KP+N L+ + Y++DFG+A D
Sbjct: 145 SALDAAHAAGATHRDVKPENILVS---ADDFAYLVDFGIASATTDEKLTQLG-------- 193
Query: 171 KNLTGTARYASCNTHLGIEQSR------RDDLESLGYVLLYFLRGSLPWQG 215
N GT Y + E+ R D+ +L VL L GS P+QG
Sbjct: 194 -NTVGTLYYMA------PERFSESHATYRADIYALTCVLYECLTGSPPYQG 237
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 41/201 (20%), Positives = 67/201 (33%), Gaps = 41/201 (20%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQ-LLYEAKVYKILQGGS 63
++ KIGSG FG +F I A+K +G+ Q L E + +L
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL---G 68
Query: 64 GIPNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRK---FSLKTVLMLADQMIARI 116
++ +++ ED+ + + G SL D R F + L Q+ +
Sbjct: 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 117 EYVHSRGFLHRDIKPDN-FLMGLGRKANQVYII---------------DFGLAKKYRDPT 160
Y+HS +H DIKP N F+ D G + P
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 161 TNRHIPYRENKNLTGTARYAS 181
G +R+ +
Sbjct: 189 V-----------EEGDSRFLA 198
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 59/273 (21%), Positives = 99/273 (36%), Gaps = 70/273 (25%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGI 65
+Y L +IG GS+G + LA + + N A+K+ + + G
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 66 ----------------------PNI-KWYGV---DGEDNV-LVLDLL-----------GP 87
PN+ K V ED++ +V +L+ P
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 88 SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 147
ED R F +I IEY+H + +HRDIKP N L+G + + I
Sbjct: 134 LSEDQ---ARFYFQ---------DLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKI 178
Query: 148 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLL 204
DFG++ +++ N GT + + + I + D+ ++G V L
Sbjct: 179 ADFGVSNEFKGSDALLS-------NTVGTPAFMAPESLSETRKIFSGKALDVWAMG-VTL 230
Query: 205 Y-FLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
Y F+ G P+ + KI + + P
Sbjct: 231 YCFVFGQCPFMD---ERIMCLHSKIKSQALEFP 260
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 71/252 (28%), Positives = 106/252 (42%), Gaps = 45/252 (17%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGTKHPQLLYEAKVY 56
+R IG Y + +G GSFG++ LA+H T + VA+K + H ++ E
Sbjct: 5 KRHIG-PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL 63
Query: 57 KILQGGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI 113
K+L+ P+I K Y V D V+V++ G L D V +++ + Q+I
Sbjct: 64 KLLRH----PHIIKLYDVITTPTDIVMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQII 118
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
IEY H +HRD+KP+N L L N V I DFGL+ D L
Sbjct: 119 CAIEYCHRHKIVHRDLKPENLL--LDDNLN-VKIADFGLSNIMTD-----------GNFL 164
Query: 174 T---GTARYA-----SCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQK 224
G+ YA + + G E D+ S G ++LY L G LP+
Sbjct: 165 KTSCGSPNYAAPEVINGKLYAGPEV----DVWSCG-IVLYVMLVGRLPFDD---EFIPNL 216
Query: 225 YDKICEKKVSTP 236
+ K+ P
Sbjct: 217 FKKVNSCVYVMP 228
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 8 KYKLGRK-IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIP 66
Y+L +G G+ + ++ T++ AVKI H + +V ++L G
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV-EMLYQCQGHR 71
Query: 67 NI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARIEYV 119
N+ + + ED LV + + G + ++ RR F+ ++ + + ++++
Sbjct: 72 NVLELIEFFEEEDRFYLVFEKMRGG----SILSHIHKRRHFNELEASVVVQDVASALDFL 127
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
H++G HRD+KP+N L + + V I DF L + I E G+A Y
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 180 AS-----CNTHLGIEQSRRDDLESLGYVLLYFL 207
+ + +R DL SLG V+LY L
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLG-VILYIL 219
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 45/188 (23%), Positives = 78/188 (41%), Gaps = 32/188 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
Y +G ++GSG F + T A K G ++ E + + +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRRKFSL--KTVLMLADQM 112
PNI + V + D VL+L+L+ G +LF + +K SL + Q+
Sbjct: 73 LH----PNIITLHDVYENRTDVVLILELVSGG----ELFDFLAQKESLSEEEATSFIKQI 124
Query: 113 IARIEYVHSRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
+ + Y+H++ H D+KP+N ++ + +IDFGLA + E K
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--------DGVEFK 176
Query: 172 NLTGTARY 179
N+ GT +
Sbjct: 177 NIFGTPEF 184
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 3e-19
Identities = 61/281 (21%), Positives = 103/281 (36%), Gaps = 69/281 (24%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-------ENSGTKHPQLLYEAKVYK 57
+ KY L IG GS+G + +A T I A+KI + + ++ E ++ K
Sbjct: 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83
Query: 58 ILQGGSGIPNIKW-YGV-DGEDNV-LVLDLL----------------------------- 85
L PNI Y V + E + LV++L
Sbjct: 84 KLHH----PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQI 139
Query: 86 -----------GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 134
S+ K + + Q+ + + Y+H++G HRDIKP+NF
Sbjct: 140 CPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENF 199
Query: 135 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS---CNTHLGIEQS 191
L K+ ++ ++DFGL+K++ + GT + + NT
Sbjct: 200 LF-STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT---KAGTPYFVAPEVLNT-TNESYG 254
Query: 192 RRDDLESLGYVLLYF-LRGSLP-W----QGLKAATKKQKYD 226
+ D S G VLL+ L G++P + +K
Sbjct: 255 PKCDAWSAG-VLLHLLLMGAVPFPGVNDADTISQVLNKKLC 294
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 4e-19
Identities = 36/175 (20%), Positives = 71/175 (40%), Gaps = 21/175 (12%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTN-----EIVAVKIENSGTKHPQLLYEAKVYK 57
++ + +G G+F +++ A+ D N + +K++ + ++ +
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW-EFYIGTQLME 119
Query: 58 ILQGGSGIPNIKWYGVDGEDN--VLVLDLL-GPSLEDLFVYCR----RKFSLKTVLMLAD 110
L+ +K+Y N VLV +L +L + + + V+ A
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ--------VYIIDFGLAKKYR 157
+M+ IE VH +H DIKPDNF++G G + +ID G + +
Sbjct: 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 4e-19
Identities = 45/188 (23%), Positives = 75/188 (39%), Gaps = 32/188 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
Y G ++GSG F + T A K G + E + K +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYC--RRKFSLKTVLMLADQM 112
Q PN+ + V + D +L+L+L+ G +LF + + + + Q+
Sbjct: 72 QH----PNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQI 123
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMG-LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
+ + Y+HS H D+KP+N ++ ++ IIDFGLA K E K
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--------FGNEFK 175
Query: 172 NLTGTARY 179
N+ GT +
Sbjct: 176 NIFGTPEF 183
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-19
Identities = 39/186 (20%), Positives = 74/186 (39%), Gaps = 29/186 (15%)
Query: 8 KYKL-GRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGG 62
Y L +++G G F + T + A K ++L+E +L+
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIA---VLELA 85
Query: 63 SGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRRK----FSLKTVLMLADQMI 113
P + + V + + +L+L+ G ++F C + S V+ L Q++
Sbjct: 86 KSCPRVINLHEVYENTSEIILILEYAAGG----EIFSLCLPELAEMVSENDVIRLIKQIL 141
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
+ Y+H +H D+KP N L+ + I+DFG+++K E + +
Sbjct: 142 EGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG--------HACELREI 193
Query: 174 TGTARY 179
GT Y
Sbjct: 194 MGTPEY 199
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 9e-19
Identities = 44/231 (19%), Positives = 85/231 (36%), Gaps = 46/231 (19%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKI-ENSGTKHPQ--LLYEAKVY 56
I+ +Y++ I G G I+LA +D N V +K +SG Q + E +
Sbjct: 76 DIVAGQYEVKGCIAHGGLGWIYLA--LDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFL 133
Query: 57 KILQGGSGIPNIKWYGVDGEDNV-----LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLAD 110
+ I I + + + +V++ + G SL+ +K + +
Sbjct: 134 AEVVH-PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLL 189
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
+++ + Y+HS G ++ D+KP+N ++ Q+ +ID G +
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLT----EEQLKLIDLGAVSRINSFGY--------- 236
Query: 171 KNLTGTARYASCNTHLGIEQSR-----RDDLESLGYVLLY-FLRGSLPWQG 215
L GT + + E R D+ ++G L G
Sbjct: 237 --LYGTPGFQA------PEIVRTGPTVATDIYTVG-RTLAALTLDLPTRNG 278
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 37/162 (22%), Positives = 65/162 (40%), Gaps = 15/162 (9%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
II + +G G G++ + T E A+K+ P+ E ++
Sbjct: 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARREV---ELHWR 66
Query: 62 GSGIPNI-KWYGV-----DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQM 112
S P+I + V G + +V++ L G + + F+ + + +
Sbjct: 67 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 126
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
I+Y+HS HRD+KP+N L R + + DFG AK
Sbjct: 127 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 62/256 (24%), Positives = 101/256 (39%), Gaps = 44/256 (17%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVY 56
M Y++ IG+GS+G +I+ K + G+ L+ E +
Sbjct: 1 MPSRAE-DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL 59
Query: 57 KILQGGSGIPNI-KWYG--VDGEDNVL--VLDLL-GPSLEDLFVYCRRK---FSLKTVLM 107
+ L+ PNI ++Y +D + L V++ G L + ++ + VL
Sbjct: 60 RELKH----PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115
Query: 108 LADQMIARIEYVHSRGF-----LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
+ Q+ ++ H R LHRD+KP N + V + DFGLA+ T+
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSF 172
Query: 163 RHIPYRENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKA 218
K GT Y S N + + + D+ SLG LLY L P+ A
Sbjct: 173 A-------KTFVGTPYYMSPEQMN---RMSYNEKSDIWSLG-CLLYELCALMPPFT---A 218
Query: 219 ATKKQKYDKICEKKVS 234
++K+ KI E K
Sbjct: 219 FSQKELAGKIREGKFR 234
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 43/160 (26%), Positives = 69/160 (43%), Gaps = 19/160 (11%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY-EAKVYKILQGGSGIP 66
+Y + IGSG+FG L T E+VAVK G + + E ++ L+ P
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH----P 76
Query: 67 NI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVY--CRRKFSLKTVLMLADQMIARIEY 118
NI ++ V L + +E +L+ +FS Q+++ + Y
Sbjct: 77 NIVRFKEVILTPTHLAI-----IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSY 131
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
HS HRD+K +N L+ G A ++ I DFG +K
Sbjct: 132 CHSMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVL 170
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 42/221 (19%)
Query: 5 IGVKYKLG---RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
Y L + +G GSF H +N+ AVKI + K + + ++ L+
Sbjct: 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEI-TALKL 61
Query: 62 GSGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIA 114
G PNI K + V + + LV++LL G +LF + ++ FS + ++++
Sbjct: 62 CEGHPNIVKLHEVFHDQLHTFLVMELLNGG----ELFERIKKKKHFSETEASYIMRKLVS 117
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
+ ++H G +HRD+KP+N L ++ IIDFG A+ +N+ L
Sbjct: 118 AVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP----------DNQPLK 167
Query: 175 ---GTARYAS-----CNTHLGIEQSRRDDLESLGYVLLYFL 207
T YA+ N + DL SLG V+LY +
Sbjct: 168 TPCFTLHYAAPELLNQNGY-----DESCDLWSLG-VILYTM 202
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 48/180 (26%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 8 KYKLGRK--IGSGSFGEIFLASHVDTNEIVAVK-IENSGTK-HPQLLYEAKVYKILQGGS 63
Y + + +G G FG++ T +A K I+ G K ++ E V L
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH-- 145
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
N+ + Y D VLV++ + G L D + + ++ Q+ I ++
Sbjct: 146 --ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
H LH D+KP+N L + R A Q+ IIDFGLA++Y+ P + K GT +
Sbjct: 204 HQMYILHLDLKPENILC-VNRDAKQIKIIDFGLARRYK--------PREKLKVNFGTPEF 254
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 41/162 (25%), Positives = 64/162 (39%), Gaps = 26/162 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGS 63
KY +KIG GSFG+ L + +K N + E V ++
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH-- 82
Query: 64 GIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVYCRRK----FSLKTVLMLADQMI 113
PNI ++ E+ L + ++ DLF + F +L Q+
Sbjct: 83 --PNIVQYRESFEENGSLYI-----VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQIC 135
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
+++VH R LHRDIK N + K V + DFG+A+
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARV 174
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 42/178 (23%), Positives = 71/178 (39%), Gaps = 27/178 (15%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI- 68
++ +G G+FG + A + VA+K S ++ + E + + PNI
Sbjct: 11 EVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNH----PNIV 64
Query: 69 KWYGVDGEDNVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIAR-IEYVHSR-- 122
K YG LV++ G SL ++ ++ + Q ++ + Y+HS
Sbjct: 65 KLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ-CSQGVAYLHSMQP 123
Query: 123 -GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
+HRD+KP N L L + I DFG A + TN G+A +
Sbjct: 124 KALIHRDLKPPNLL--LVAGGTVLKICDFGTACDIQTHMTNN----------KGSAAW 169
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 37/161 (22%), Positives = 69/161 (42%), Gaps = 15/161 (9%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG 64
+ +++ ++G G+ ++ T + A+K+ + E V L
Sbjct: 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH--- 107
Query: 65 IPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARIE 117
PNI K + + + LVL+L+ G +LF + + +S + Q++ +
Sbjct: 108 -PNIIKLKEIFETPTEISLVLELVTGG----ELFDRIVEKGYYSERDAADAVKQILEAVA 162
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
Y+H G +HRD+KP+N L + I DFGL+K
Sbjct: 163 YLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 7e-18
Identities = 35/162 (21%), Positives = 67/162 (41%), Gaps = 16/162 (9%)
Query: 8 KYKLGRK-IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIP 66
Y+L ++ +G G G++ H T + A+K+ P+ E SG P
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY---DSPKARQEVD---HHWQASGGP 82
Query: 67 NI-KWYGV-----DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
+I V G+ + ++++ + G + + F+ + + + I+
Sbjct: 83 HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
++HS HRD+KP+N L K + + DFG AK+
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN 184
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 7e-18
Identities = 52/299 (17%), Positives = 101/299 (33%), Gaps = 58/299 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-ENSGTKHPQLLYEAKVYKILQGGSGI- 65
Y++ R + G F +I L N+ A+K E S + + ++ KI
Sbjct: 32 DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 66 -------------PNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRR-------KFS 101
G+ D V ++ + + S+ Y
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 102 LKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
++ + + ++ Y+H+ + HRD+KP N LM K +V + DFG ++
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD---KNGRVKLSDFGESE------ 200
Query: 161 TNRHIPYRENKNLT---GTARYAS---CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPW 213
Y +K + GT + + + D+ SLG + LY +P+
Sbjct: 201 ------YMVDKKIKGSRGTYEFMPPEFFSNESSY-NGAKVDIWSLG-ICLYVMFYNVVPF 252
Query: 214 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272
+ + ++ I K + P++ +P L+ + FLK
Sbjct: 253 SL--KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDI---DFLKLF 306
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 8e-18
Identities = 42/161 (26%), Positives = 71/161 (44%), Gaps = 16/161 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
KY+ KIG GS+G +F + DT +IVA+K ++ K L E ++ K L+
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK-KIALREIRMLKQLKH- 61
Query: 63 SGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
PN+ V LV + ++ +R V + Q + + +
Sbjct: 62 ---PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
H +HRD+KP+N L+ K + + + DFG A+ P+
Sbjct: 119 HKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLTGPS 156
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 8e-18
Identities = 69/282 (24%), Positives = 107/282 (37%), Gaps = 53/282 (18%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
+R I L IG G FGE++ E VAVKI +S + EA++Y+ +
Sbjct: 37 QRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVML 93
Query: 62 GSGIPNI-KWYGVDGEDNV------LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMI 113
NI + D +DN LV D SL D R +++ ++ LA
Sbjct: 94 RH--ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALS-T 148
Query: 114 AR-IEYVHSR--------GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
A + ++H HRD+K N L+ +K I D GLA ++ T
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTID 205
Query: 165 IPYRENKNLTGTARY--------ASCNTHLGIEQSRRDDLESLGYVLLYFLRGS------ 210
I + GT RY + H E +R D+ ++G V R
Sbjct: 206 IA---PNHRVGTKRYMAPEVLDDSINMKHF--ESFKRADIYAMGLVFWEIARRCSIGGIH 260
Query: 211 ----LPWQGLKA--ATKKQKYDKICEKKVSTPIEVLCKSHPA 246
LP+ L + ++ +CE+K+ I +S A
Sbjct: 261 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEA 302
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 9e-18
Identities = 49/160 (30%), Positives = 72/160 (45%), Gaps = 23/160 (14%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGI 65
Y+L IGSG+ + A E VA+K E T +LL E +
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH---- 72
Query: 66 PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI----- 116
PNI +Y V ++ LV+ LL G S+ D+ + K K+ ++ IA I
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST-IATILREVL 131
Query: 117 ---EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
EY+H G +HRD+K N L+G + V I DFG++
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVS 168
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 46/164 (28%), Positives = 70/164 (42%), Gaps = 25/164 (15%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGTKHPQLLYEAKVYKILQGG 62
Y LG +G G+FG++ + H T VAVKI N S ++ E + K+ +
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH- 70
Query: 63 SGIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVYC--RRKFSLKTVLMLADQMIA 114
P+I K Y V + +E +LF Y + L Q+++
Sbjct: 71 ---PHIIKLYQVISTPTDFFM-----VMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
++Y H +HRD+KP+N L L N I DFGL+ D
Sbjct: 123 AVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSNMMSD 163
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 62/241 (25%), Positives = 97/241 (40%), Gaps = 55/241 (22%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDT--NEIVAVKIENSGTKHPQLLY--------- 51
+ +Y+LG +G G E+ LA D + VAVK+ L
Sbjct: 8 SHLSDRYELGEILGFGGMSEVHLA--RDLRDHRDVAVKV-----LRADLARDPSFYLRFR 60
Query: 52 -EAKVYKILQGGSGIPNI-KWYGVDGEDNV-------LVLDLL-GPSLEDLFVYCRRKFS 101
EA+ L P I Y GE +V++ + G +L D+ V+ +
Sbjct: 61 REAQNAAALNH----PAIVAVYDT-GEAETPAGPLPYIVMEYVDGVTLRDI-VHTEGPMT 114
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
K + + + + H G +HRD+KP N ++ N V ++DFG+A+ D
Sbjct: 115 PKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGN 171
Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSR------RDDLESLGYVLLY-FLRGSLPWQ 214
+ + GTA+Y S EQ+R R D+ SLG +LY L G P+
Sbjct: 172 ----SVTQTAAVIGTAQYLS------PEQARGDSVDARSDVYSLG-CVLYEVLTGEPPFT 220
Query: 215 G 215
G
Sbjct: 221 G 221
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 48/194 (24%), Positives = 80/194 (41%), Gaps = 29/194 (14%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
+R I + ++ ++IG G +GE+++ E VAVK+ + + E ++Y+ +
Sbjct: 32 QRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEA-SWFRETEIYQTVLM 88
Query: 62 GSGIPNI-KWYGVDGEDNV------LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMI 113
NI + D + L+ D SL D K++L LA +
Sbjct: 89 RH--ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSV 144
Query: 114 ARIEYVHSRGF--------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165
+ + ++H+ F HRD+K N L+ +K I D GLA K+ T I
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDI 201
Query: 166 PYRENKNLTGTARY 179
P GT RY
Sbjct: 202 P---PNTRVGTKRY 212
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 16/160 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
KY+ +G GS+G + + DT IVA+K ++ K + E K+ K L+
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK-KIAMREIKLLKQLRH- 83
Query: 63 SGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
N+ V + LV + + ++ D + V Q+I I +
Sbjct: 84 ---ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
HS +HRDIKP+N L+ ++ V + DFG A+ P
Sbjct: 141 HSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAP 177
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 37/166 (22%), Positives = 66/166 (39%), Gaps = 15/166 (9%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
II + +G G G++ + T E A+K+ P+ E ++
Sbjct: 57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARREV---ELHWR 110
Query: 62 GSGIPNI-KWYGV-----DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQM 112
S P+I + V G + +V++ L G + + F+ + + +
Sbjct: 111 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 170
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
I+Y+HS HRD+KP+N L R + + DFG AK+
Sbjct: 171 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 42/167 (25%), Positives = 75/167 (44%), Gaps = 40/167 (23%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
Y+L RK+G G + E+F A ++ NE V VKI K ++ E K+ + L+GG PN
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLRGG---PN 92
Query: 68 IKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD----------------- 110
I + + D++ + + + D
Sbjct: 93 I----------ITLADIVKDPVSRTPAL------VFEHVNNTDFKQLYQTLTDYDIRFYM 136
Query: 111 -QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
+++ ++Y HS G +HRD+KP N + + + ++ +ID+GLA+ Y
Sbjct: 137 YEILKALDYCHSMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEFY 181
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 51/182 (28%), Positives = 77/182 (42%), Gaps = 34/182 (18%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYK 57
+R V Y + IG+GSFG ++ A D+ E+VA+K K Q E ++ +
Sbjct: 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRFKNRELQIMR 102
Query: 58 ILQGGSGIPNI---KWY---GVDGEDNV---LVLDLLGPSLEDLFVYCRRKFSLKTVLML 108
L NI +++ + +D V LVLD + E ++ R K L +
Sbjct: 103 KLDH----CNIVRLRYFFYSSGEKKDEVYLNLVLDYVP---ETVYRVARHYSRAKQTLPV 155
Query: 109 AD------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
Q+ + Y+HS G HRDIKP N L L + + DFG AK+ N
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQLVRGEPN 213
Query: 163 RH 164
Sbjct: 214 VS 215
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 7e-17
Identities = 48/172 (27%), Positives = 75/172 (43%), Gaps = 20/172 (11%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-ENSGTKHPQLLYEAKVYKIL- 59
E +Y L RK+G G F ++LA + N VA+KI E K+ + +
Sbjct: 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 73
Query: 60 ------QGGSGIPNI-------KWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTV 105
+ G +I G +G V+V ++LG +L L R L V
Sbjct: 74 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 133
Query: 106 LMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRK---ANQVYIIDFGLA 153
++ Q++ ++Y+H R G +H DIKP+N LM + Q+ I D G A
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 8e-17
Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 16/161 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
KY+ KIG G++G +F A + +T+EIVA+K ++ G L E + K L+
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKELKH- 60
Query: 63 SGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
NI + + V D LV + L+ F C + V Q++ + +
Sbjct: 61 ---KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
HSR LHRD+KP N L+ + ++ + +FGLA+ + P
Sbjct: 118 HSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFGIPV 155
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 48/181 (26%), Positives = 71/181 (39%), Gaps = 34/181 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGT--------------KHPQ 48
KY+ KIG G+FGE+F A H T + VA+K E G KH
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 77
Query: 49 L--LYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVL 106
+ L E K +I Y LV D L L KF+L +
Sbjct: 78 VVNLIEICRTKASPYNRCKGSI--Y--------LVFDFCEHDLAGLLSNVLVKFTLSEIK 127
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166
+ ++ + Y+H LHRD+K N L+ + + + DFGLA+ + ++
Sbjct: 128 RVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 167 Y 167
Y
Sbjct: 185 Y 185
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 41/175 (23%), Positives = 81/175 (46%), Gaps = 32/175 (18%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPN 67
++L +G+G++G+++ HV T ++ A+K ++ +G + ++ E +L+ S N
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQE---INMLKKYSHHRN 82
Query: 68 I-KWYG------VDGEDNVL--VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI- 116
I +YG G D+ L V++ S+ DL + L ++ IA I
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-------TLKEEWIAYIC 135
Query: 117 -------EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
++H +HRDIK N L+ + +V ++DFG++ + R+
Sbjct: 136 REILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRN 187
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 50/176 (28%), Positives = 75/176 (42%), Gaps = 44/176 (25%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGTKHPQLLYEAKVYKIL 59
IG Y LG +G G+FG++ + H T VAVKI N S ++ E + K+
Sbjct: 15 IG-HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF 73
Query: 60 QGGSGIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVY-----------CRRKFSL 102
+ P+I K Y V + + + +E +LF Y RR F
Sbjct: 74 RH----PHIIKLYQVISTPSDIFM-----VMEYVSGGELFDYICKNGRLDEKESRRLFQ- 123
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
Q+++ ++Y H +HRD+KP+N L L N I DFGL+ D
Sbjct: 124 --------QILSGVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSNMMSD 168
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 3e-16
Identities = 42/223 (18%), Positives = 75/223 (33%), Gaps = 40/223 (17%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI--PN 67
KL IG G +G ++ S VAVK+ + + + E +Y++ + N
Sbjct: 16 KLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ-NFINEKNIYRV----PLMEHDN 68
Query: 68 I-KWYGVDGEDNV-------LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
I ++ D LV++ SL + LA + + Y
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSVTRGLAY 126
Query: 119 VHS---------RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY-RDPTTNRHIPYR 168
+H+ HRD+ N L+ + I DFGL+ + +
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 169 ENKNLTGTARY-------ASCNTHLGIEQSRRDDLESLGYVLL 204
+ GT RY + N ++ D+ +LG +
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-16
Identities = 60/258 (23%), Positives = 100/258 (38%), Gaps = 67/258 (25%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----------------EN---SGTKHP- 47
+K G+ +G GSF + LA + T+ A+KI E S HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 48 --QLLY----EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--K 99
+L + + K+Y L Y +GE L Y R+
Sbjct: 92 FVKLYFTFQDDEKLYFGLS----------YAKNGE---------------LLKYIRKIGS 126
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
F ++++ +EY+H +G +HRD+KP+N L+ + + I DFG AK
Sbjct: 127 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPE 183
Query: 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKA 218
+ + GTA+Y S + DL +LG ++Y + G P+ +A
Sbjct: 184 SKQ-----ARANSFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPF---RA 234
Query: 219 ATKKQKYDKICEKKVSTP 236
+ + KI + + P
Sbjct: 235 GNEYLIFQKIIKLEYDFP 252
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 61/259 (23%), Positives = 100/259 (38%), Gaps = 74/259 (28%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKI------------EN--------SGTKHP---QL 49
R IG GSFG++ + DT ++ A+K N G +HP L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 50 LY----EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRR--KFS 101
Y E ++ +V+DLL G DL + ++ F
Sbjct: 81 WYSFQDEEDMF-----------------------MVVDLLLGG----DLRYHLQQNVHFK 113
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
+TV + +++ ++Y+ ++ +HRD+KPDN L+ + V+I DF +A T
Sbjct: 114 EETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD---EHGHVHITDFNIAAMLPRETQ 170
Query: 162 NRHIPYRENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLK 217
+ GT Y + ++ G S D SLG V Y LRG P+
Sbjct: 171 --------ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLG-VTAYELLRGRRPYHIRS 221
Query: 218 AATKKQKYDKICEKKVSTP 236
+ + K+ V+ P
Sbjct: 222 STSSKEIVHTFETTVVTYP 240
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 15/154 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
+ R+IG GSFG ++ A V +E+VA+K + S K ++ E + + L+
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH- 113
Query: 63 SGIPNI-KWYG--VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
PN ++ G + LV++ S DL ++ + + + + Y+
Sbjct: 114 ---PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
HS +HRD+K N L+ + V + DFG A
Sbjct: 171 HSHNMIHRDVKAGNILLS---EPGLVKLGDFGSA 201
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 5e-16
Identities = 42/163 (25%), Positives = 70/163 (42%), Gaps = 17/163 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHPQL----LYEAKVYKILQ 60
+Y+ +G G F ++ A +TN+IVA +K+ + + L E K+ + L
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 61 GGSGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
PNI G + LV D + LE + + + + +E
Sbjct: 71 H----PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
Y+H LHRD+KP+N L+ + + + DFGLAK + P
Sbjct: 127 YLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGSPN 166
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-16
Identities = 46/195 (23%), Positives = 71/195 (36%), Gaps = 29/195 (14%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
M+R + L +G G +GE++ S E VAVKI +S + E ++Y +
Sbjct: 2 MQRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEK-SWFRETELYNTVM 58
Query: 61 GGSGIPNI-KWYGVDGEDNV------LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQM 112
NI + D L+ SL D + L + +
Sbjct: 59 LRH--ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSI 114
Query: 113 IARIEYVHSRGF--------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
+ + ++H F HRD+K N L+ +K Q I D GLA + T
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLD 171
Query: 165 IPYRENKNLTGTARY 179
+ N GT RY
Sbjct: 172 VG---NNPRVGTKRY 183
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 6e-16
Identities = 45/189 (23%), Positives = 71/189 (37%), Gaps = 37/189 (19%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP------QLLYEAKVYKILQGGS 63
L IG G FG+++ A + VAVK + EAK++ +L+
Sbjct: 10 TLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAMLKH-- 65
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEY 118
PNI GV + LV++ G L + ++ ++ A Q IAR + Y
Sbjct: 66 --PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQ-IARGMNY 120
Query: 119 VHSRG---FLHRDIKPDNFLMGLGRKANQVY-----IIDFGLAKKYRDPTTNRHIPYREN 170
+H +HRD+K N L+ + + I DFGLA R
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA---------REWHRTTK 171
Query: 171 KNLTGTARY 179
+ G +
Sbjct: 172 MSAAGAYAW 180
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 38/159 (23%), Positives = 70/159 (44%), Gaps = 13/159 (8%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSG 64
Y K+G G++ ++ T+ +VA+K +E+ + E + K L+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH--- 59
Query: 65 IPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
NI + + + LV + L L+ C ++ V + Q++ + Y H
Sbjct: 60 -ANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
+ LHRD+KP N L+ + ++ + DFGLA+ PT
Sbjct: 119 QKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT 154
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 37/209 (17%), Positives = 83/209 (39%), Gaps = 14/209 (6%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQ-- 60
+ +Y + RK+G G F ++L+ + + VA+K+ S + + L E ++ K ++
Sbjct: 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNS 93
Query: 61 -----GGSGIPNI----KWYGVDGEDNVLVLDLLGPSLEDL-FVYCRRKFSLKTVLMLAD 110
+ + K GV+G +V ++LG L + L V +
Sbjct: 94 DPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 111 QMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
Q++ ++Y+H++ +H DIKP+N L+ + + + + ++ P +
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 170 NKNLTGTARYASCNTHLGIEQSRRDDLES 198
+ + + DL +
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGN 242
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 66/278 (23%), Positives = 104/278 (37%), Gaps = 54/278 (19%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLL----YEAKVYKILQGGSGI 65
+ KIG+GSFG + A VAVKI H + + E + K L+
Sbjct: 40 NIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH---- 93
Query: 66 PNI-KWYGV--DGEDNVLVLDLL-GPSLEDLF--VYCRRKFSLKTVLMLADQMIAR-IEY 118
PNI + G + +V + L SL L R + + L +A +A+ + Y
Sbjct: 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD-VAKGMNY 152
Query: 119 VHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-KYRDPTTNRHIPYRENKNLTG 175
+H+R +HR++K N L+ K V + DFGL++ K + +K+ G
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVD---KKYTVKVCDFGLSRLKASTFLS--------SKSAAG 201
Query: 176 TARY--------ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227
T + N E+S D+ S G +L PW L A Q
Sbjct: 202 TPEWMAPEVLRDEPSN-----EKS---DVYSFGVILWELATLQQPWGNLNPA---QVVAA 250
Query: 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
+ K I + A+ C + +RP
Sbjct: 251 VGFKCKRLEIPRNL---NPQVAAIIEGCWTNEPWKRPS 285
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 37/159 (23%), Positives = 75/159 (47%), Gaps = 12/159 (7%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGG 62
+ +Y++ + IG GSFG++ A ++ VA+K + N H Q E ++ + L+
Sbjct: 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQ 153
Query: 63 SGIPNIKWYGVDGEDN-------VLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIA 114
+ + +N + +LL +L +L + + FSL V A ++
Sbjct: 154 D--KDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
++ +H +H D+KP+N L+ + + + +IDFG +
Sbjct: 212 CLDALHKNRIIHCDLKPENILL-KQQGRSGIKVIDFGSS 249
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 16/163 (9%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGI 65
+ KIG GSFGE+F T ++VA+KI E + + + E V
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS---- 79
Query: 66 PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
P + K+YG + ++++ L G S DL + + +++ ++Y+HS
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDL--LEPGPLDETQIATILREILKGLDYLHS 137
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
+HRDIK N L+ + +V + DFG+A + D R+
Sbjct: 138 EKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRN 177
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 4e-15
Identities = 56/234 (23%), Positives = 81/234 (34%), Gaps = 44/234 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI-- 65
+L G FG ++ A NE VAVKI K E +VY + G+
Sbjct: 25 PLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQ-SWQNEYEVYSL----PGMKH 77
Query: 66 PNI-KWYGVDGEDNVLVLDLL-------GPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
NI ++ G + + +DL SL D S + +A+ M +
Sbjct: 78 ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMARGLA 135
Query: 118 YVHSRGF----------LHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTNRHIP 166
Y+H HRDIK N L+ K N I DFGLA K+ +
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLL----KNNLTACIADFGLALKFEAGKS----- 186
Query: 167 YRENKNLTGTARY-----ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
+ GT RY + + R D+ ++G VL G
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 37/161 (22%), Positives = 73/161 (45%), Gaps = 11/161 (6%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
+ + K+G GS+G ++ A H +T +IVA+K + +++ E + + P+
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS----PH 85
Query: 68 I-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
+ K+YG D +V++ S+ D+ + + + + + +EY+H
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
+HRDIK N L+ + DFG+A + D R+
Sbjct: 146 KIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDTMAKRN 183
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 5e-15
Identities = 60/245 (24%), Positives = 92/245 (37%), Gaps = 46/245 (18%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSGI 65
R IG G FGE++ DT ++ A+K G L E + ++ G
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL--ALNERIMLSLVSTGDC- 251
Query: 66 PNIK--WYGVDGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARIEY 118
P I Y D + +LDL+ G DL + FS + A ++I +E+
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGG----DLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
+H+R ++RD+KP N L+ + V I D GLA + + GT
Sbjct: 308 MHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPH---------ASVGTHG 355
Query: 179 Y------ASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEK 231
Y + D SLG +L+ LRG P++ K K +
Sbjct: 356 YMAPEVLQKGVAY-----DSSADWFSLG-CMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409
Query: 232 KVSTP 236
V P
Sbjct: 410 AVELP 414
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 5e-15
Identities = 50/162 (30%), Positives = 72/162 (44%), Gaps = 19/162 (11%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHP-QLLYEAKVYKILQG 61
KY KIG G++G ++ A + + E A+K E+ G P + E + K L+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGI--PSTTIREISILKELKH 59
Query: 62 GSGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
NI K Y V VLV + L L+ L C T Q++ I Y
Sbjct: 60 ----SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
H R LHRD+KP N L+ + ++ I DFGLA+ + P
Sbjct: 116 CHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFGIPV 154
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 7e-15
Identities = 45/163 (27%), Positives = 70/163 (42%), Gaps = 19/163 (11%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHP-QLLYEAKVYKILQG 61
++ KIG G++G ++ A + T E+VA+K E G P + E + K L
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV--PSTAIREISLLKELNH 61
Query: 62 GSGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIE 117
PNI K V +N LV + L L+ L + Q++ +
Sbjct: 62 ----PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
+ HS LHRD+KP N L+ + + DFGLA+ + P
Sbjct: 118 FCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPV 157
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 8e-15
Identities = 33/163 (20%), Positives = 74/163 (45%), Gaps = 13/163 (7%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
+++ ++G G+FG+++ A + +T + A K+ S + + E ++
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDH---- 75
Query: 66 PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
P I K G ++++ G +++ + + R + + ++ QM+ + ++HS
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
+ +HRD+K N LM L + + DFG++ K R
Sbjct: 136 KRIIHRDLKAGNVLMTL---EGDIRLADFGVSAKNLKTLQKRD 175
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 8e-15
Identities = 39/161 (24%), Positives = 67/161 (41%), Gaps = 17/161 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
KY+ K+G G++G ++ A IVA+K E+ G + E + K L
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGI-PSTAIREISLLKELHH- 78
Query: 63 SGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
PNI V + LV + + L+ + + + + Q++ + +
Sbjct: 79 ---PNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
H LHRD+KP N L+ + + DFGLA+ + P
Sbjct: 136 HQHRILHRDLKPQNLLIN---SDGALKLADFGLARAFGIPV 173
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 8e-15
Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 18/164 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQ-LLYEAKVYKILQG 61
+Y+ K+G G++GE++ A TNE VA+K E G P + E + K LQ
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV--PGTAIREVSLLKELQH 92
Query: 62 GSGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
NI + V ++ L+ + L+ S++ + Q+I + +
Sbjct: 93 ----RNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNF 147
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKAN--QVYIIDFGLAKKYRDPT 160
HSR LHRD+KP N L+ + + + I DFGLA+ + P
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 38/189 (20%), Positives = 65/189 (34%), Gaps = 36/189 (19%)
Query: 8 KYKLGRKIGSG--SFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLY-EAKVYKILQG 61
Y+L IG G + LA + T E V V+ E + L E V K+
Sbjct: 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNH 85
Query: 62 GSGIPNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLM--LADQMIAR 115
PNI + + + +V + S +DL + T M + + IA
Sbjct: 86 ----PNIVPYRATFIADNELWVVTSFMAYGSAKDL---------ICTHFMDGMNELAIAY 132
Query: 116 I--------EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167
I +Y+H G++HR +K + L+ +VY+ + + +
Sbjct: 133 ILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVH 189
Query: 168 RENKNLTGT 176
K
Sbjct: 190 DFPKYSVKV 198
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 31/171 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
KY KIG G+ G ++ A V T + VA++ N K ++ E V + +
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN---- 76
Query: 66 PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI----- 116
PNI + + G++ +V++ L G SL D+ + + IA +
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECL 126
Query: 117 ---EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
E++HS +HRDIK DN L+G+ V + DFG + + R
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRS 174
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 40/170 (23%), Positives = 71/170 (41%), Gaps = 20/170 (11%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHPQL----LYEAKVYKILQ 60
+Y+ +IG G++G ++ A + VA V++ N G L + E + + L+
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 61 GGSGIPNI-------KWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK-FSLKTVLMLADQ 111
PN+ D E V LV + + L +T+ L Q
Sbjct: 70 AFEH-PNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
+ ++++H+ +HRD+KP+N L+ V + DFGLA+ Y
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILVT---SGGTVKLADFGLARIYSYQMA 175
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 24/159 (15%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKI--ENSGTKHPQ-LLYEAKVYKILQGG 62
K R +G G FG++ L ++ T E+VAVK ++G +H E + + L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH- 92
Query: 63 SGIPNI-KWYGV---DGEDNV-LVLDLLGPSLEDLFVYCRR-KFSLKTVLMLADQMIAR- 115
+I K+ G G ++ LV++ + L L Y R L +L+ A Q I
Sbjct: 93 ---EHIIKYKGCCEDAGAASLQLVMEYV--PLGSLRDYLPRHSIGLAQLLLFAQQ-ICEG 146
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+ Y+H++ ++HRD+ N L+ V I DFGLAK
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAK 182
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 56/239 (23%), Positives = 91/239 (38%), Gaps = 37/239 (15%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY------KILQGGSG--IP 66
IG G+FGE+ L H T ++ A+K+ +++ + I+ + +
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKL----LSKFEMIKRSDSAFFWEERDIMAFANSPWVV 132
Query: 67 NIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRG 123
+ + D +V++ + G DL K +++ ++ +HS G
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGG----DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG 188
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS-- 181
F+HRD+KPDN L+ K+ + + DFG K R GT Y S
Sbjct: 189 FIHRDVKPDNMLLD---KSGHLKLADFGTCMKMNKEGMVR------CDTAVGTPDYISPE 239
Query: 182 --CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
+ R D S+G V LY L G P+ A + Y KI K S
Sbjct: 240 VLKSQGGDGYYGRECDWWSVG-VFLYEMLVGDTPF---YADSLVGTYSKIMNHKNSLTF 294
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 34/196 (17%), Positives = 64/196 (32%), Gaps = 46/196 (23%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK----------------------------- 38
KY LG+ +G+GSFG + +++ + A+K
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVD 67
Query: 39 -----IENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV-LVLDLLGPSLEDL 92
+ K+ G + + ++++ + + L
Sbjct: 68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP---DTL 124
Query: 93 FVYCRRKFSLKTVLMLAD------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 146
+ + + Q+ + ++HS G HRDIKP N L + K N +
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL--VNSKDNTLK 182
Query: 147 IIDFGLAKKYRDPTTN 162
+ DFG AKK +
Sbjct: 183 LCDFGSAKKLIPSEPS 198
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 42/170 (24%), Positives = 71/170 (41%), Gaps = 27/170 (15%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSG 64
K +IG GSF ++ +T VA + + ++ + EA++ K LQ
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH--- 84
Query: 65 IPNI-----KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIA 114
PNI W + V +L+ +L+ Y +R +K + Q++
Sbjct: 85 -PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT---YLKRFKVMKIKVLRSWCRQILK 140
Query: 115 RIEYVHSRG--FLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTT 161
++++H+R +HRD+K DN F+ G V I D GLA R
Sbjct: 141 GLQFLHTRTPPIIHRDLKCDNIFITG---PTGSVKIGDLGLATLKRASFA 187
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 3e-14
Identities = 40/164 (24%), Positives = 71/164 (43%), Gaps = 18/164 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSG 64
++K K+G+G++ ++ + T VA+K +++ + E + K L+
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH--- 62
Query: 65 IPNI-KWYGVDGEDN--VLVLDLLGPSLEDL-----FVYCRRKFSLKTVLMLADQMIARI 116
NI + Y V +N LV + + L+ R L V Q++ +
Sbjct: 63 -ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
+ H LHRD+KP N L+ K Q+ + DFGLA+ + P
Sbjct: 122 AFCHENKILHRDLKPQNLLIN---KRGQLKLGDFGLARAFGIPV 162
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 19/171 (11%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL---LYEAKVYKILQGGSGIP 66
LG +IG G+FGE+F N +VAVK L EA++ K P
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH----P 172
Query: 67 NI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
NI + GV + +V++L+ G + +KT+L + A +EY+ S+
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH-----IPYR 168
+HRD+ N L+ + N + I DFG++++ D +P +
Sbjct: 233 CCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 42/171 (24%), Positives = 73/171 (42%), Gaps = 31/171 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
KIG GS G + LA + VAVK+ + + L E + + Q
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH---- 101
Query: 66 PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI----- 116
N+ + Y + GE+ ++++ L G +L D+ + + L ++ IA +
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIV----------SQVRLNEEQIATVCEAVL 151
Query: 117 ---EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
Y+H++G +HRDIK D+ L+ L +V + DFG + R
Sbjct: 152 QALAYLHAQGVIHRDIKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRK 199
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 52/177 (29%), Positives = 81/177 (45%), Gaps = 35/177 (19%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYKILQGG 62
+ Y + IG+GSFG +F A V+++E VA+K K Q E ++ +I++
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIK------KVLQDKRFKNRELQIMRIVKH- 91
Query: 63 SGIPNI---KWY---GVDGEDNV---LVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD--- 110
PN+ K + D +D V LVL+ + E ++ R LK + +
Sbjct: 92 ---PNVVDLKAFFYSNGDKKDEVFLNLVLEYVP---ETVYRASRHYAKLKQTMPMLLIKL 145
Query: 111 ---QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
Q++ + Y+HS G HRDIKP N L L + + +IDFG AK N
Sbjct: 146 YMYQLLRSLAYIHSIGICHRDIKPQNLL--LDPPSGVLKLIDFGSAKILIAGEPNVS 200
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-14
Identities = 53/160 (33%), Positives = 80/160 (50%), Gaps = 24/160 (15%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKI--ENSGTKHPQ-LLYEAKVYKILQGG 62
K R +G G FG++ L +T E VAVK SG H L E ++ + L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH- 82
Query: 63 SGIPNI-KWYGV---DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
NI K+ G+ DG + + L+++ L G SL++ + K +LK L A Q I +
Sbjct: 83 ---ENIVKYKGICTEDGGNGIKLIMEFLPSG-SLKEYLPKNKNKINLKQQLKYAVQ-ICK 137
Query: 116 -IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
++Y+ SR ++HRD+ N L+ +QV I DFGL K
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTK 174
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 7e-14
Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 22/175 (12%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVD--TNEIVAVK-IENSGTKHPQLLYEAKVYKI 58
ER+ + G K+G G++G ++ A D ++ A+K IE +G E + +
Sbjct: 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRE 74
Query: 59 LQGGSGIPNI-KWYGV---DGEDNV-LVLD--------LLGPSLEDLFVYCRRKFSLKTV 105
L+ PN+ V + V L+ D ++ + V
Sbjct: 75 LKH----PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMV 130
Query: 106 LMLADQMIARIEYVHSRGFLHRDIKPDNFL-MGLGRKANQVYIIDFGLAKKYRDP 159
L Q++ I Y+H+ LHRD+KP N L MG G + +V I D G A+ + P
Sbjct: 131 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 7e-14
Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 23/159 (14%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGS 63
K +++G G+FG + + +T E+VAVK ++ E ++ K LQ
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-- 70
Query: 64 GIPNI-KWYGV---DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIAR- 115
NI K+ GV G N+ L+++ L G SL D + + +L Q I +
Sbjct: 71 --DNIVKYKGVCYSAGRRNLKLIMEYLPYG-SLRDYLQKHKERIDHIKLLQYTSQ-ICKG 126
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+EY+ ++ ++HRD+ N L+ N+V I DFGL K
Sbjct: 127 MEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 162
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 23/159 (14%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKIENSGTKHPQ--LLYEAKVYKILQGGS 63
K +++G G+FG + + +T E+VAVK T+ E ++ K LQ
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-- 101
Query: 64 GIPNI-KWYGV---DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIAR- 115
NI K+ GV G N+ L+++ L G SL D + + +L Q I +
Sbjct: 102 --DNIVKYKGVCYSAGRRNLKLIMEYLPYG-SLRDYLQKHKERIDHIKLLQYTSQ-ICKG 157
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+EY+ ++ ++HRD+ N L+ N+V I DFGL K
Sbjct: 158 MEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 193
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 30/149 (20%), Positives = 70/149 (46%), Gaps = 13/149 (8%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIPNI-K 69
++GSG+ G+++ T ++AVK + ++ ++L + ++ P I +
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMD---LDVVLKSHDCPYIVQ 88
Query: 70 WYG--VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLH 126
+G + D + ++L+G E L + + + + ++ + Y+ G +H
Sbjct: 89 CFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIH 148
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
RD+KP N L+ + Q+ + DFG++ +
Sbjct: 149 RDVKPSNILLD---ERGQIKLCDFGISGR 174
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 59/242 (24%), Positives = 94/242 (38%), Gaps = 40/242 (16%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY------KILQGGSG--IP 66
IG G+FGE+ + + +++ A+KI ++L A+ +L G I
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKI----LNKWEMLKRAETACFREERDVLVNGDSKWIT 137
Query: 67 NIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRR---KFSLKTVLMLADQMIARIEYVHS 121
+ + D + LV+D G DL + + + +M+ I+ VH
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGG----DLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
++HRDIKPDN LM + + DFG K + T + + GT Y S
Sbjct: 194 LHYVHRDIKPDNILMD---MNGHIRLADFGSCLKLMEDGTVQ------SSVAVGTPDYIS 244
Query: 182 CNTHLGIEQSRRD-----DLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVST 235
+E + D SLG V +Y L G P+ A + + Y KI K
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLG-VCMYEMLYGETPFY---AESLVETYGKIMNHKERF 300
Query: 236 PI 237
Sbjct: 301 QF 302
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 48/159 (30%), Positives = 75/159 (47%), Gaps = 23/159 (14%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVK-IENSGTKHPQ-LLYEAKVYKILQGGS 63
K ++G G+FG + L +T +VAVK +++SG + E ++ K L
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS-- 83
Query: 64 GIPNI-KWYGV---DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIAR- 115
I K+ GV G ++ LV++ L G L D R + +L+ + Q I +
Sbjct: 84 --DFIVKYRGVSYGPGRQSLRLVMEYLPSG-CLRDFLQRHRARLDASRLLLYSSQ-ICKG 139
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+EY+ SR +HRD+ N L+ V I DFGLAK
Sbjct: 140 MEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAK 175
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 54/245 (22%), Positives = 86/245 (35%), Gaps = 44/245 (17%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSG--I 65
IG G+F E+ + T ++ A+K ++ E +L G I
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC--FREERD---VLVNGDRRWI 123
Query: 66 PNIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRR---KFSLKTVLMLADQMIARIEYVH 120
+ + D LV++ G DL + + + +++ I+ VH
Sbjct: 124 TQLHFAFQDENYLYLVMEYYVGG----DLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY- 179
G++HRDIKPDN L+ + + + DFG K R T R + GT Y
Sbjct: 180 RLGYVHRDIKPDNILLD---RCGHIRLADFGSCLKLRADGTVR------SLVAVGTPDYL 230
Query: 180 ------ASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKK 232
A D +LG V Y G P+ A + + Y KI K
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALG-VFAYEMFYGQTPFY---ADSTAETYGKIVHYK 286
Query: 233 VSTPI 237
+
Sbjct: 287 EHLSL 291
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 40/175 (22%), Positives = 68/175 (38%), Gaps = 40/175 (22%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYK-----ILQG 61
++++ R G G+FG + L T VA+K K + + ++ I+Q
Sbjct: 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK------K----VIQDPRFRNRELQIMQD 72
Query: 62 GSGI--PNI-------KWYGVDGEDNV---LVLDLLGPSLEDLFVYCRRKFSLKTVLMLA 109
+ + PNI G ++ +V++ + + L CR + +
Sbjct: 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRCCRNYYRRQVAPPPI 129
Query: 110 D------QMIARIEYVH--SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
Q+I I +H S HRDIKP N L + + + DFG AKK
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVL--VNEADGTLKLCDFGSAKKL 182
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 42/161 (26%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGG 62
+Y++ IG GSFG++ A E VA+K I+N Q E ++ +++
Sbjct: 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKH 110
Query: 63 SGIPNIKWYGVDGEDN-------VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIA 114
+K+Y V + + LV ++L +L DL R SL A QM
Sbjct: 111 D--TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 115 RIEYVHSR--GFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
+ ++ + +H D+KP+N L+ K + + I+DFG +
Sbjct: 169 ALLFLATPELSIIHCDLKPENILL-CNPKRSAIKIVDFGSS 208
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 60/258 (23%), Positives = 99/258 (38%), Gaps = 72/258 (27%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----------------EN---SGTKHP- 47
+ + +G+GSFG + L H ++ A+KI E P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 48 --QLLY----EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--K 99
+L + + +Y +++ +G GE +F + RR +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAG----------GE---------------MFSHLRRIGR 137
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
FS A Q++ EY+HS ++RD+KP+N L+ + + + DFG AK+ +
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGR 194
Query: 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKA 218
T L GT + L ++ D +LG VL+Y G P+ A
Sbjct: 195 T----------WTLCGTPEALAPEIILSKGYNKAVDWWALG-VLIYEMAAGYPPF---FA 240
Query: 219 ATKKQKYDKICEKKVSTP 236
Q Y+KI KV P
Sbjct: 241 DQPIQIYEKIVSGKVRFP 258
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 5e-13
Identities = 40/168 (23%), Positives = 68/168 (40%), Gaps = 21/168 (12%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI- 68
KL + IG G FG++ L + VAVK + L EA V L+ N+
Sbjct: 24 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASVMTQLRH----SNLV 77
Query: 69 KWYGV--DGEDNV-LVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIAR-IEYVH 120
+ GV + + + +V + + + L Y R +L + + +EY+
Sbjct: 78 QLLGVIVEEKGGLYIVTEYM--AKGSLVDYLRSRGRSVLGGDCLLKFSLD-VCEAMEYLE 134
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
F+HRD+ N L+ + N + DFGL K+ +P +
Sbjct: 135 GNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 179
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 6e-13
Identities = 34/178 (19%), Positives = 71/178 (39%), Gaps = 38/178 (21%)
Query: 8 KYKLGRKIGSGSFGEIFLASHV-DTNEIVA---VKIEN-------------------SGT 44
+Y+ +IG G++G++F A + + VA V+++
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 45 KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKF-SLK 103
+HP ++ +++ + K LV + + L +
Sbjct: 72 EHPNVV---RLFDVCTVSRTDRETKLT--------LVFEHVDQDLTTYLDKVPEPGVPTE 120
Query: 104 TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
T+ + Q++ ++++HS +HRD+KP N L+ + Q+ + DFGLA+ Y
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIYSFQMA 175
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 7e-13
Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 17/157 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPN- 67
+ K+G G +GE++ + VAVK T + L EA V K ++ PN
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNL 71
Query: 68 IKWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRRK-FSLKTVLMLADQMIAR-IEYVHS 121
++ GV ++ + + G +L D C R+ S +L +A Q I+ +EY+
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEK 129
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+ F+HRD+ N L+G + + V + DFGL++
Sbjct: 130 KNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTG 163
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 55/271 (20%), Positives = 95/271 (35%), Gaps = 98/271 (36%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----------------EN---SGTKHP- 47
+++ R +G+GSFG + L A+K+ E S HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 48 --QLLY----EAKVYKIL---QGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR 98
++ +++ I+ +GG +LF R+
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGG----------------------------ELFSLLRK 99
Query: 99 --KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
+F A ++ +EY+HS+ ++RD+KP+N L+ K + I DFG AK
Sbjct: 100 SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYV 156
Query: 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGY----------VLLY- 205
D T L GT Y + E + + Y +L+Y
Sbjct: 157 PDVT----------YTLCGTPDY------IAPEV-----VSTKPYNKSIDWWSFGILIYE 195
Query: 206 FLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
L G P+ + + Y+KI ++ P
Sbjct: 196 MLAGYTPFY---DSNTMKTYEKILNAELRFP 223
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 1e-12
Identities = 38/154 (24%), Positives = 69/154 (44%), Gaps = 13/154 (8%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
++IGSG FG + L ++ ++ VA+K G + + EA+V L P +
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSH----PKL 65
Query: 69 -KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
+ YGV + LV + + L D R F+ +T+L + + + Y+
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 125
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+HRD+ N L+G + + + DFG+ + D
Sbjct: 126 IHRDLAARNCLVG---ENQVIKVSDFGMTRFVLD 156
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 43/166 (25%), Positives = 68/166 (40%), Gaps = 17/166 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI- 68
KL + IG G FG++ L + VAVK + L EA V L+ N+
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASVMTQLRH----SNLV 249
Query: 69 KWYGV---DGEDNVLVLDLL--GPSLED-LFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
+ GV + +V + + G SL D L R +L + + +EY+
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKG-SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
F+HRD+ N L+ + N + DFGL K+ +P +
Sbjct: 309 NFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 351
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 44/203 (21%), Positives = 75/203 (36%), Gaps = 62/203 (30%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQL----LYEAKV 55
I ++L +G G++G + A+H T EIVA+K K P L E K+
Sbjct: 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------KIEPFDKPLFALRTLREIKI 62
Query: 56 YKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLMLAD--- 110
K + NI + + ++ P + F VY + LM D
Sbjct: 63 LKHFKH----ENI----------ITIFNIQRPDSFENFNEVY------IIQELMQTDLHR 102
Query: 111 -----------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGL 152
Q + ++ +H +HRD+KP N L+ +N + + DFGL
Sbjct: 103 VISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI----NSNCDLKVCDFGL 158
Query: 153 AKKYRDPTTNRHIPYRENKNLTG 175
A+ + + P + +
Sbjct: 159 ARIIDESAADNSEPTGQQSGMVE 181
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 38/168 (22%), Positives = 68/168 (40%), Gaps = 17/168 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
+++G+G FG + + VA+K+ G+ + EAKV L +
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSH----EKL 81
Query: 69 -KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
+ YGV ++ + + L + R +F + +L + + +EY+ S+ F
Sbjct: 82 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH----IPYR 168
LHRD+ N L+ V + DFGL++ D P R
Sbjct: 142 LHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 186
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 41/169 (24%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPN- 67
+ K+G G +GE++ + VAVK T + L EA V K ++ PN
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNL 278
Query: 68 IKWYGV--DGEDNVLVLDLL-GPSLED-LFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
++ GV ++ + + +L D L R++ S +L +A Q+ + +EY+ +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYR 168
F+HR++ N L+G + + V + DFGL++ P +
Sbjct: 339 FIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 384
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 32/153 (20%), Positives = 67/153 (43%), Gaps = 25/153 (16%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIPNI-K 69
+IG G++G + H + +I+AVK + QLL + ++ S P I +
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMD---LDVVMRSSDCPYIVQ 85
Query: 70 WYG--VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI--------EYV 119
+YG D + ++L+ S + + + ++ ++++ +I ++
Sbjct: 86 FYGALFREGDCWICMELMSTSFDKFY----KYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 120 HS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151
+HRDIKP N L+ ++ + + DFG
Sbjct: 142 KENLKIIHRDIKPSNILLD---RSGNIKLCDFG 171
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-12
Identities = 42/157 (26%), Positives = 66/157 (42%), Gaps = 21/157 (13%)
Query: 10 KLGRKIGSGSFGEIF---LASHVDTNEI-VAVKIENSGTKHPQ---LLYEAKVYKILQGG 62
K + +GSG+FG ++ + +I VA+K T +L EA V +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN- 76
Query: 63 SGIPNI-KWYGVDGEDNV-LVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IE 117
P++ + G+ V L+ L G L D + + +L Q IA+ +
Sbjct: 77 ---PHVCRLLGICLTSTVQLITQLMPFG-CLLDYVREHKDNIGSQYLLNWCVQ-IAKGMN 131
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Y+ R +HRD+ N L+ V I DFGLAK
Sbjct: 132 YLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 3e-12
Identities = 36/168 (21%), Positives = 65/168 (38%), Gaps = 17/168 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
L +++GSG FG + L + VAVK+ G+ EA+ L P +
Sbjct: 11 TLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSH----PKL 65
Query: 69 -KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
K+YGV +V + + L + + +L + + + ++ S F
Sbjct: 66 VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF 125
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH----IPYR 168
+HRD+ N L+ + V + DFG+ + D P +
Sbjct: 126 IHRDLAARNCLVD---RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK 170
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 27/219 (12%), Positives = 52/219 (23%), Gaps = 47/219 (21%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----LLYEAKVYK 57
RI +Y+L G + + A + VA+ + P L
Sbjct: 27 RIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLS 86
Query: 58 ILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
+ G+ + ++V + + G SL+++ S + + A
Sbjct: 87 RIDK-PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAA 142
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
+ H G P + V +
Sbjct: 143 DAAHRAGVALSIDHPSRVRVS---IDGDVVLAYPA----TMPDAN--------------- 180
Query: 177 ARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
+DD+ +G L L P
Sbjct: 181 ---------------PQDDIRGIGASLYALLVNRWPLPE 204
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 36/157 (22%), Positives = 69/157 (43%), Gaps = 26/157 (16%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIPNI-K 69
++G G++G + HV + +I+AVK + + +LL + I P
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMD---LDISMRTVDCPFTVT 70
Query: 70 WYG--VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI--------EYV 119
+YG D + ++L+ SL+ + K + + + ++ +I E++
Sbjct: 71 FYGALFREGDVWICMELMDTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 120 HS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
HS +HRD+KP N L+ QV + DFG++
Sbjct: 126 HSKLSVIHRDVKPSNVLIN---ALGQVKMCDFGISGY 159
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 45/185 (24%), Positives = 73/185 (39%), Gaps = 43/185 (23%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLY-EAKVYKILQGG 62
+G +Y + +G G G +F A D ++ VA+K I + + + E K+ + L
Sbjct: 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDH- 67
Query: 63 SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTV-----LMLAD------- 110
NI V V ++LGPS L L +V M D
Sbjct: 68 ---DNI----------VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ 114
Query: 111 -------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
Q++ ++Y+HS LHRD+KP N + + + I DFGLA+
Sbjct: 115 GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLF--INTEDLVLKIGDFGLARIMD 172
Query: 158 DPTTN 162
++
Sbjct: 173 PHYSH 177
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 5e-12
Identities = 19/184 (10%), Positives = 45/184 (24%), Gaps = 36/184 (19%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLL----YEAKVYKILQGGSGI 65
K+ GE++ + VK+ + E +I
Sbjct: 13 NFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH---- 66
Query: 66 PNI-KWYGV----DGEDNVLVLDLL-GPSLED-LFVYCRRKFSLKTVLMLADQMIAR-IE 117
PN+ G L+ + SL + L + A +AR +
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALD-MARGMA 125
Query: 118 YVHSRGF--LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
++H+ + + ++ + I + ++
Sbjct: 126 FLHTLEPLIPRHALNSRSVMID---EDMTARISMADVKF------------SFQSPGRMY 170
Query: 176 TARY 179
+
Sbjct: 171 APAW 174
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 34/181 (18%), Positives = 62/181 (34%), Gaps = 42/181 (23%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLAS-HVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQG 61
+ +Y++ +G G+FG++ H VA+K I N G E +L+
Sbjct: 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN---VLK- 71
Query: 62 GSGIPNIKWYGVDGEDNV--------------LVLDLLGPSLEDLFVYCRRK-FSLKTVL 106
IK + + + +LLG + + + + L V
Sbjct: 72 -----KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVR 126
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLM----------------GLGRKANQVYIIDF 150
+A Q+ + ++H H D+KP+N L K + + DF
Sbjct: 127 HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 151 G 151
G
Sbjct: 187 G 187
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 7e-12
Identities = 61/263 (23%), Positives = 98/263 (37%), Gaps = 84/263 (31%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
+G GSFG++FLA TN+ A+K E +HP +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 51 Y----EAKVYKILQ---GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFS 101
+ ++ +++ GG DL + KF
Sbjct: 85 CTFQTKENLFFVMEYLNGG----------------------------DLMYHIQSCHKFD 116
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDP 159
L A ++I ++++HS+G ++RD+K DN L+ K + I DFG+ K+ D
Sbjct: 117 LSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDA 173
Query: 160 TTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGL 216
TN T GT Y + LG + + D S G VLLY L G P+ G
Sbjct: 174 KTN-----------TFCGTPDYIAPEILLGQKYNHSVDWWSFG-VLLYEMLIGQSPFHG- 220
Query: 217 KAATKKQKYDKICEKKVSTPIEV 239
+++ + I P +
Sbjct: 221 --QDEEELFHSIRMDNPFYPRWL 241
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 7e-12
Identities = 38/157 (24%), Positives = 67/157 (42%), Gaps = 21/157 (13%)
Query: 10 KLGRKIGSGSFGEIF---LASHVDTNEI-VAVKI--ENSGTKHPQ-LLYEAKVYKILQGG 62
+ + +GSG FG + ++ +I V +K+ + SG + Q + L
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH- 74
Query: 63 SGIPNI-KWYGVDGEDNV-LVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IE 117
+I + G+ ++ LV LG SL D R + +L Q IA+ +
Sbjct: 75 ---AHIVRLLGLCPGSSLQLVTQYLPLG-SLLDHVRQHRGALGPQLLLNWGVQ-IAKGMY 129
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Y+ G +HR++ N L+ +QV + DFG+A
Sbjct: 130 YLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVAD 163
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 7e-12
Identities = 55/292 (18%), Positives = 107/292 (36%), Gaps = 38/292 (13%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGI 65
++ ++G+G+ G +F SH + ++A K+ E Q++ E +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS---- 90
Query: 66 PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
P I +YG + + ++ + G SL+ + R + + ++ +I + Y+
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE 149
Query: 122 RG-FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
+ +HRD+KP N L+ ++ + DFG++ + D N + GT Y
Sbjct: 150 KHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRSYM 197
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S G S + D+ S+G L+ G P A + + E +
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257
Query: 241 CKSHPAEFASYFHYCQSLTF--------DQRPDYGFLKRLFHDLFSREGYDF 284
+ ++ P +L +FS E DF
Sbjct: 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP-----PKLPSGVFSLEFQDF 304
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 9e-12
Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 18/159 (11%)
Query: 10 KLGRKIGSGSFGEIF---LASHVDTNEIVAVKIENSGTKHPQL---LYEAKVYKILQGGS 63
+LGR IG G FG++ S + VA+K + T L EA +
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-- 75
Query: 64 GIPNI-KWYGV-DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYV 119
P+I K GV ++++L L + L ++++ A Q ++ + Y+
Sbjct: 76 --PHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ-LSTALAYL 132
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
S+ F+HRDI N L+ + V + DFGL++ D
Sbjct: 133 ESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMED 168
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 56/259 (21%), Positives = 96/259 (37%), Gaps = 82/259 (31%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
+G GSFG++ L+ T+E+ AVKI E K P QL
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 51 Y----EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRR--KFSL 102
++Y V++ + G DL + ++ +F
Sbjct: 88 SCFQTMDRLY-----------------------FVMEYVNGG----DLMYHIQQVGRFKE 120
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPT 160
+ A ++ + ++ S+G ++RD+K DN ++ + I DFG+ K+ + T
Sbjct: 121 PHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENIWDGVT 177
Query: 161 TNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLK 217
T T GT Y + + D + G VLLY L G P++G
Sbjct: 178 TK-----------TFCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEMLAGQAPFEG-- 223
Query: 218 AATKKQKYDKICEKKVSTP 236
+ + + I E V+ P
Sbjct: 224 -EDEDELFQSIMEHNVAYP 241
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 54/263 (20%), Positives = 94/263 (35%), Gaps = 84/263 (31%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
+G GSFG++ LA +T ++ AVK+ E HP QL
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 51 Y----EAKVYKILQ---GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFS 101
+++ +++ GG DL + R+F
Sbjct: 91 CCFQTPDRLFFVMEFVNGG----------------------------DLMFHIQKSRRFD 122
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDP 159
A ++I+ + ++H +G ++RD+K DN L+ + DFG+ K+
Sbjct: 123 EARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD---HEGHCKLADFGMCKEGICNGV 179
Query: 160 TTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGL 216
TT T GT Y + + D ++G VLLY L G P++
Sbjct: 180 TTA-----------TFCGTPDYIAPEILQEMLYGPAVDWWAMG-VLLYEMLCGHAPFEA- 226
Query: 217 KAATKKQKYDKICEKKVSTPIEV 239
+ ++ I +V P +
Sbjct: 227 --ENEDDLFEAILNDEVVYPTWL 247
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 48/201 (23%), Positives = 79/201 (39%), Gaps = 61/201 (30%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVY------- 56
+ KY+L +K+G G++G ++ + T E+VAVK I + ++
Sbjct: 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD--------AFQNSTDAQRTFRE 58
Query: 57 -KILQGGSGIPNIKWYGVDGEDNVLVLDLLGP-SLEDLFVYCRRKFSLKTVLMLAD---- 110
IL SG NI V +L++L + D+++ M D
Sbjct: 59 IMILTELSGHENI----------VNLLNVLRADNDRDVYLV--------FDYMETDLHAV 100
Query: 111 ----------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLA 153
Q+I I+Y+HS G LHRD+KP N L+ A V + DFGL+
Sbjct: 101 IRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL----NAECHVKVADFGLS 156
Query: 154 KKYRDPTTNRHIPYRENKNLT 174
+ + + + T
Sbjct: 157 RSFVNIRRVTNNIPLSINENT 177
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 54/262 (20%), Positives = 97/262 (37%), Gaps = 83/262 (31%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------EN---SGTKHP---QLLY 51
+G G+FG++ L T A+KI E+ T+HP L Y
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 52 ----EAKVYKILQ---GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSL 102
++ +++ GG +LF + R F+
Sbjct: 73 AFQTHDRLCFVMEYANGG----------------------------ELFFHLSRERVFTE 104
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPT 160
+ ++++ +EY+HSR ++RDIK +N ++ K + I DFGL K+ T
Sbjct: 105 ERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGAT 161
Query: 161 TNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLK 217
T GT Y + + R D LG V++Y + G LP+
Sbjct: 162 MK-----------TFCGTPEYLAPEVLEDNDYGRAVDWWGLG-VVMYEMMCGRLPFYN-- 207
Query: 218 AATKKQKYDKICEKKVSTPIEV 239
++ ++ I +++ P +
Sbjct: 208 -QDHERLFELILMEEIRFPRTL 228
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 60/263 (22%), Positives = 91/263 (34%), Gaps = 84/263 (31%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
IG GSFG++ LA H AVK+ E + KHP L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 51 Y----EAKVYKILQ---GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFS 101
+ K+Y +L GG +LF + +R F
Sbjct: 106 FSFQTADKLYFVLDYINGG----------------------------ELFYHLQRERCFL 137
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDP 159
A ++ + + Y+HS ++RD+KP+N L+ + + DFGL K+ +
Sbjct: 138 EPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD---SQGHIVLTDFGLCKENIEHNS 194
Query: 160 TTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGL 216
TT+ T GT Y + R D LG +LY L G P+
Sbjct: 195 TTS-----------TFCGTPEYLAPEVLHKQPYDRTVDWWCLG-AVLYEMLYGLPPFYS- 241
Query: 217 KAATKKQKYDKICEKKVSTPIEV 239
+ YD I K + +
Sbjct: 242 --RNTAEMYDNILNKPLQLKPNI 262
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 25/104 (24%), Positives = 39/104 (37%), Gaps = 12/104 (11%)
Query: 86 GPSLEDLFVYCRRKFSL--KTVLMLADQMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKA 142
+L+D L + Q+ +E++HS+G +HRD+KP N F
Sbjct: 145 KENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT----MD 200
Query: 143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT-----GTARYAS 181
+ V + DFGL + + T GT Y S
Sbjct: 201 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 15/67 (22%), Positives = 28/67 (41%), Gaps = 7/67 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSG 64
++ + +G G FG +F A + + A+K + N +++ E K L+
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE---- 62
Query: 65 IPNIKWY 71
P I Y
Sbjct: 63 HPGIVRY 69
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 69/285 (24%), Positives = 118/285 (41%), Gaps = 43/285 (15%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
+L K+G G FGE+++ + T VA+K GT P+ L EA+V K L+ +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRH----EKL 241
Query: 69 -KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI----EYVHS 121
+ Y V E+ + +V + + SL D K+ L+ M A+I YV
Sbjct: 242 VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV---DMAAQIASGMAYVER 298
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYRENKNLTGTA 177
++HRD++ N L+G + + DFGLA+ D P + TA
Sbjct: 299 MNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTA 349
Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEKKVST 235
A+ + + D+ S G +LL +G +P+ G+ ++ D++ E+
Sbjct: 350 PEAALYGRF----TIKSDVWSFG-ILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRM 400
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
P C P C ++RP + +L+ D F+
Sbjct: 401 PCPPEC---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 41/170 (24%), Positives = 74/170 (43%), Gaps = 21/170 (12%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
KL ++G+G FGE+++ + + VAVK G+ P L EA + K LQ +
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQH----QRL 70
Query: 69 -KWYGV-DGEDNVLVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSR 122
+ Y V E ++ + + L + + K ++ +L +A Q+ + ++ R
Sbjct: 71 VRLYAVVTQEPIYIITEYM--ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH----IPYR 168
++HRD++ N L+ I DFGLA+ D P +
Sbjct: 129 NYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 52/250 (20%), Positives = 95/250 (38%), Gaps = 57/250 (22%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSG--I 65
+G G FGE+F T ++ A K + G + + E K IL I
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQG--AMVEKK---ILAKVHSRFI 247
Query: 66 PNIKWYGVDGEDNV-LVLDLL--GPSLEDLF------VYCRRKFSLKTVLMLADQMIARI 116
++ Y + + ++ LV+ ++ G D+ F + Q+++ +
Sbjct: 248 VSLA-YAFETKTDLCLVMTIMNGG----DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
E++H R ++RD+KP+N L+ V I D GLA + + + T
Sbjct: 303 EHLHQRNIIYRDLKPENVLLD---DDGNVRISDLGLAVE-----------LKAGQTKTKG 348
Query: 177 ARYASCNTH--------LGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQK-YD 226
T LG E D +LG V LY + P++ + ++
Sbjct: 349 ----YAGTPGFMAPELLLGEEYDFSVDYFALG-VTLYEMIAARGPFRARGEKVENKELKQ 403
Query: 227 KICEKKVSTP 236
++ E+ V+ P
Sbjct: 404 RVLEQAVTYP 413
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 52/269 (19%), Positives = 99/269 (36%), Gaps = 87/269 (32%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
IG GS+ ++ L T+ I A+K+ E + HP L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 51 Y----EAKVYKILQ---GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFS 101
E++++ +++ GG DL + +R K
Sbjct: 77 SCFQTESRLFFVIEYVNGG----------------------------DLMFHMQRQRKLP 108
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDP 159
+ + ++ + Y+H RG ++RD+K DN L+ + + D+G+ K+
Sbjct: 109 EEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGLRPGD 165
Query: 160 TTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGL 216
TT+ T GT Y + G + D +LG VL++ + G P+ +
Sbjct: 166 TTS-----------TFCGTPNYIAPEILRGEDYGFSVDWWALG-VLMFEMMAGRSPFDIV 213
Query: 217 KAA------TKKQKYDKICEKKVSTPIEV 239
++ T+ + I EK++ P +
Sbjct: 214 GSSDNPDQNTEDYLFQVILEKQIRIPRSL 242
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 69/285 (24%), Positives = 118/285 (41%), Gaps = 43/285 (15%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
+L K+G G FGE+++ + T VA+K GT P+ L EA+V K L+ +
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRH----EKL 324
Query: 69 -KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI----EYVHS 121
+ Y V E+ + +V + + SL D K+ L+ M A+I YV
Sbjct: 325 VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV---DMAAQIASGMAYVER 381
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYRENKNLTGTA 177
++HRD++ N L+G + + DFGLA+ D P + TA
Sbjct: 382 MNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTA 432
Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEKKVST 235
A+ + + D+ S G +LL +G +P+ G+ ++ D++ E+
Sbjct: 433 PEAALYGRF----TIKSDVWSFG-ILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRM 483
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
P C P C ++RP + +L+ D F+
Sbjct: 484 PCPPEC---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 51/239 (21%), Positives = 89/239 (37%), Gaps = 38/239 (15%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSG--I 65
+G G FGE+ T ++ A K + G L E + IL+ + +
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM--ALNEKQ---ILEKVNSRFV 246
Query: 66 PNIKWYGVDGEDNVLVLDLL--GPSLEDLFVY----CRRKFSLKTVLMLADQMIARIEYV 119
++ + + LVL L+ G DL + + F + A ++ +E +
Sbjct: 247 VSLAYAYETKDALCLVLTLMNGG----DLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
H ++RD+KP+N L+ + I D GLA + T + GT Y
Sbjct: 303 HRERIVYRDLKPENILLD---DHGHIRISDLGLAVHVPEGQTIK--------GRVGTVGY 351
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQK-YDKICEKKVSTP 236
+ + D +LG LLY + G P+Q K K+++ + E
Sbjct: 352 MAPEVVKNERYTFSPDWWALG-CLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS 409
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 25/172 (14%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN--SGTKHPQLLY-EAKVYKILQ 60
+ Y +GSG++G + A + E VA+K + + Y E + K +Q
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ 81
Query: 61 GGSGIPNI---------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQ 111
N+ + D LV+ + DL KFS + + L Q
Sbjct: 82 H----ENVIGLLDVFTPASSLRNFYDFYLVMPFMQ---TDLQKIMGLKFSEEKIQYLVYQ 134
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTN 162
M+ ++Y+HS G +HRD+KP N + + ++ I+DFGLA+ T
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAV----NEDCELKILDFGLARHADAEMTG 182
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 51/268 (19%), Positives = 99/268 (36%), Gaps = 85/268 (31%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
IG GS+ ++ L T+ I A+++ E + HP L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 51 Y----EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRR--KFSL 102
E++++ V++ + G DL + +R K
Sbjct: 120 SCFQTESRLF-----------------------FVIEYVNGG----DLMFHMQRQRKLPE 152
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPT 160
+ + ++ + Y+H RG ++RD+K DN L+ + + D+G+ K+ T
Sbjct: 153 EHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGLRPGDT 209
Query: 161 TNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLK 217
T+ T GT Y + G + D +LG VL++ + G P+ +
Sbjct: 210 TS-----------TFCGTPNYIAPEILRGEDYGFSVDWWALG-VLMFEMMAGRSPFDIVG 257
Query: 218 AA------TKKQKYDKICEKKVSTPIEV 239
++ T+ + I EK++ P +
Sbjct: 258 SSDNPDQNTEDYLFQVILEKQIRIPRSL 285
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 51/221 (23%), Positives = 85/221 (38%), Gaps = 50/221 (22%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN--SGTKHPQLLY-EAKVYKILQ 60
I +Y++ IG+GS+G + A +VA+K I + + E + L
Sbjct: 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN 110
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKF---SLKTVLM----LAD- 110
++ V VLD++ P + F +Y + K + L +
Sbjct: 111 H----DHV----------VKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTEL 156
Query: 111 -------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTN 162
++ ++YVHS G LHRD+KP N L+ + V + DFGLA
Sbjct: 157 HIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV----NQDCSVKVCDFGLA--------- 203
Query: 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESL-GYV 202
R + Y EN N + +L ++ L G+V
Sbjct: 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHV 244
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 4e-11
Identities = 34/160 (21%), Positives = 67/160 (41%), Gaps = 18/160 (11%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGG 62
+ IG+G FGE++ S VA+K +G Q L EA +
Sbjct: 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH- 105
Query: 63 SGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
NI + GV + +++ + + +L+ +FS+ ++ + + A ++Y
Sbjct: 106 ---HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 162
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+ + ++HRD+ N L+ + DFGL++ D
Sbjct: 163 LANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLED 199
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 42/157 (26%), Positives = 65/157 (41%), Gaps = 21/157 (13%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTKHPQ---LLYEAKVYKILQGG 62
K + +GSG+FG ++ + E VA+K T +L EA V +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN- 76
Query: 63 SGIPNI-KWYGVDGEDNV-LVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IE 117
P++ + G+ V L+ L G L D + + +L Q IA+ +
Sbjct: 77 ---PHVCRLLGICLTSTVQLITQLMPFG-CLLDYVREHKDNIGSQYLLNWCVQ-IAKGMN 131
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Y+ R +HRD+ N L+ V I DFGLAK
Sbjct: 132 YLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 37/159 (23%), Positives = 66/159 (41%), Gaps = 17/159 (10%)
Query: 10 KLGRKIGSGSFGEIFLA---SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGS 63
+ + IGSG GE+ + VA+K +G Q L EA +
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDH-- 109
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
PNI + GV G ++V + + SL+ +F++ ++ + + A + Y+
Sbjct: 110 --PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
G++HRD+ N L+ + DFGL++ D
Sbjct: 168 SDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVLED 203
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 6e-11
Identities = 38/187 (20%), Positives = 71/187 (37%), Gaps = 50/187 (26%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGG 62
++ + + RK+G G+FG + L H+D + AVK+ + K EA + K +Q
Sbjct: 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQND 91
Query: 63 SGIPNIKWYGVDGEDN---------------VLVLDLLGPSLEDLFVYCRRK-FSLKTVL 106
D +N L+ + LGPSL ++ F ++ +
Sbjct: 92 -----------DINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIK 140
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLM----------------------GLGRKANQ 144
+ +++ + Y+ H D+KP+N L+ K+
Sbjct: 141 LYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 145 VYIIDFG 151
+ +IDFG
Sbjct: 201 IKLIDFG 207
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 56/263 (21%), Positives = 97/263 (36%), Gaps = 84/263 (31%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
+G GSFG++ L+ T+E+ AVKI E K P QL
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 51 Y----EAKVYKILQ---GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFS 101
++Y +++ GG DL + ++ +F
Sbjct: 409 SCFQTMDRLYFVMEYVNGG----------------------------DLMYHIQQVGRFK 440
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDP 159
+ A ++ + ++ S+G ++RD+K DN ++ + I DFG+ K+ +
Sbjct: 441 EPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENIWDGV 497
Query: 160 TTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGL 216
TT T GT Y + + D + G VLLY L G P++G
Sbjct: 498 TTK-----------TFCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEMLAGQAPFEG- 544
Query: 217 KAATKKQKYDKICEKKVSTPIEV 239
+ + + I E V+ P +
Sbjct: 545 --EDEDELFQSIMEHNVAYPKSM 565
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 7e-11
Identities = 36/159 (22%), Positives = 67/159 (42%), Gaps = 17/159 (10%)
Query: 10 KLGRKIGSGSFGEIFLA--SHVDTNEI-VAVKIENSGTKHPQ---LLYEAKVYKILQGGS 63
+ + +G+G FGE+ EI VA+K G Q L EA +
Sbjct: 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH-- 105
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
PNI + GV + ++V + + SL+ +F++ ++ + + + ++Y+
Sbjct: 106 --PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
G++HRD+ N L+ + DFGL + D
Sbjct: 164 SDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLED 199
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 7e-11
Identities = 38/155 (24%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEI---VAVKIENSGTKHPQL---LYEAKVYKILQGGS 63
L R +G G FGE++ + + VAVK + EA + K L
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH-- 72
Query: 64 GIPNI-KWYGV-DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYV 119
P+I K G+ + E ++++L L + + T+++ + Q I + + Y+
Sbjct: 73 --PHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ-ICKAMAYL 129
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
S +HRDI N L+ V + DFGL++
Sbjct: 130 ESINCVHRDIAVRNILVA---SPECVKLGDFGLSR 161
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 8e-11
Identities = 36/177 (20%), Positives = 65/177 (36%), Gaps = 52/177 (29%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN--SGTKHPQLLY-EAKVYKILQ 60
+ Y + IG GS+G ++LA +T + VA+K + + + E + L+
Sbjct: 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK 83
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLMLAD-------- 110
I + + DL+ P F +Y + + +D
Sbjct: 84 S----DYI----------IRLYDLIIPDDLLKFDELY------IVLEIADSDLKKLFKTP 123
Query: 111 -------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLA 153
++ ++H G +HRD+KP N L+ + V + DFGLA
Sbjct: 124 IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL----NQDCSVKVCDFGLA 176
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 40/184 (21%), Positives = 65/184 (35%), Gaps = 50/184 (27%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN-SGTKHPQLLY-EAKVYKILQG 61
+G +Y IG G++G + A VA+K I + Q E K+ +
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 84
Query: 62 GSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLMLAD--------- 110
NI + + D++ + VY + LM D
Sbjct: 85 ----ENI----------IGINDIIRAPTIEQMKDVY------IVQDLMETDLYKLLKTQH 124
Query: 111 -----------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRD 158
Q++ ++Y+HS LHRD+KP N L+ + I DFGLA+
Sbjct: 125 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTTCDLKICDFGLARVADP 180
Query: 159 PTTN 162
+
Sbjct: 181 DHDH 184
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 35/181 (19%), Positives = 62/181 (34%), Gaps = 42/181 (23%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLA-SHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQG 61
++ +Y++ +G G+FG++ H VAVK ++N E +V + L
Sbjct: 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNT 70
Query: 62 GSGIPNIKWYGVDGEDNV--------------LVLDLLGPSLEDLF-VYCRRKFSLKTVL 106
+ +V +LLG S D F L +
Sbjct: 71 ---------TDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIR 121
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLM----------------GLGRKANQVYIIDF 150
+A Q+ + ++HS H D+KP+N L + ++DF
Sbjct: 122 KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
Query: 151 G 151
G
Sbjct: 182 G 182
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 43/172 (25%), Positives = 75/172 (43%), Gaps = 20/172 (11%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEI---VAVKIENSGTKHPQ---LLYEAKVYKILQGGS 63
+LGR IG G FG++ ++ VA+K + T L EA +
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-- 450
Query: 64 GIPNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
P+I K GV E+ V ++++L L + L ++++ A Q+ + Y+
Sbjct: 451 --PHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYR 168
S+ F+HRDI N L+ + V + DFGL++ D + +P +
Sbjct: 509 SKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 41/188 (21%), Positives = 74/188 (39%), Gaps = 56/188 (29%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL----LYEAKVYKILQ 60
+ +Y+ +GSG++G + A T VAVK + + E ++ K ++
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGP-----SLEDLFVYCRRKFSLKTVLMLAD----- 110
N+ + +LD+ P D+++ T LM AD
Sbjct: 87 H----ENV----------IGLLDVFTPARSLEEFNDVYLV--------THLMGADLNNIV 124
Query: 111 ---------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK 154
Q++ ++Y+HS +HRD+KP N + + ++ I+DFGLA+
Sbjct: 125 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV----NEDCELKILDFGLAR 180
Query: 155 KYRDPTTN 162
D T
Sbjct: 181 HTADEMTG 188
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 41/166 (24%), Positives = 77/166 (46%), Gaps = 25/166 (15%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN--SGTKHPQLLY-EAKVYKILQ 60
+ +Y+ + IGSG+ G + A + VA+K + H + Y E + K +
Sbjct: 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 119
Query: 61 GGSGIPNI---------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQ 111
NI + + +D LV++L+ +L + + + + L Q
Sbjct: 120 H----KNIISLLNVFTPQKTLEEFQDVYLVMELMD---ANLCQVIQMELDHERMSYLLYQ 172
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKY 156
M+ I+++HS G +HRD+KP N ++ K++ + I+DFGLA+
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLARTA 214
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 19/154 (12%)
Query: 11 LGRKIGSGSFGEIFLASHVDTNEI--VAVKIENSGTKHPQL----LYEAKVYKILQGGSG 64
+++GSG+FG + + + VAVKI + P L L EA V + L
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN--- 77
Query: 65 IPNI-KWYGV-DGEDNVLVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
P I + G+ + E +LV+++ LG L ++ R K ++ L Q+ ++Y+
Sbjct: 78 -PYIVRMIGICEAESWMLVMEMAELG-PLNK-YLQQNRHVKDKNIIELVHQVSMGMKYLE 134
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
F+HRD+ N L+ + I DFGL+K
Sbjct: 135 ESNFVHRDLAARNVLLV---TQHYAKISDFGLSK 165
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 2e-10
Identities = 59/261 (22%), Positives = 102/261 (39%), Gaps = 85/261 (32%)
Query: 15 IGSGSFGEIFLASHV---DTNEIVAVKI----------------EN---SGTKHP---QL 49
+G GSFG++FL + D ++ A+K+ E HP +L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 50 LY----EAKVYKIL---QGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKF 100
Y E K+Y IL +GG DLF + F
Sbjct: 92 HYAFQTEGKLYLILDFLRGG----------------------------DLFTRLSKEVMF 123
Query: 101 SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRD 158
+ + V ++ ++++HS G ++RD+KP+N L+ + + + DFGL+K+ +
Sbjct: 124 TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHE 180
Query: 159 PTTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQG 215
+ GT Y + ++ D S G VL++ L G+LP+QG
Sbjct: 181 KKAY-----------SFCGTVEYMAPEVVNRRGHTQSADWWSFG-VLMFEMLTGTLPFQG 228
Query: 216 LKAATKKQKYDKICEKKVSTP 236
+K+ I + K+ P
Sbjct: 229 ---KDRKETMTMILKAKLGMP 246
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 44/158 (27%), Positives = 65/158 (41%), Gaps = 22/158 (13%)
Query: 10 KLGRKIGSGSFGEIF---LASHVDTNEIVAVKIENSGTKHPQ-----LLYEAKVYKILQG 61
+L K+G GSFG + + VAVK + E L
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 62 GSGIPNI-KWYGVDGEDNV-LVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIAR-I 116
N+ + YGV + +V +L LG SL D + F L T+ A Q +A +
Sbjct: 81 ----RNLIRLYGVVLTPPMKMVTELAPLG-SLLDRLRKHQGHFLLGTLSRYAVQ-VAEGM 134
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Y+ S+ F+HRD+ N L+ + V I DFGL +
Sbjct: 135 GYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMR 169
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 17/168 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPN- 67
KL +K+G+G FGE+++A++ + VAVK G+ + L EA V K LQ
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQH----DKL 245
Query: 68 IKWYGVDGEDNVLVLDLLGP--SLED-LFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
+K + V ++ + ++ SL D L K L ++ + Q+ + ++ R +
Sbjct: 246 VKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 305
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH----IPYR 168
+HRD++ N L+ + I DFGLA+ D P +
Sbjct: 306 IHRDLRAANILVS---ASLVCKIADFGLARVIEDNEYTAREGAKFPIK 350
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 39/163 (23%), Positives = 70/163 (42%), Gaps = 32/163 (19%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNE---IVAVKI--ENSGTKHPQ-LLYEAKVYKILQGGS 63
R IG G FG ++ ++D + A+K + + + L E + + L
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNH-- 81
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLLGPSLE-----DLFVY---CRRKFSLKTVLMLADQM 112
PN+ G+ E VL L DL + +R ++K ++ Q
Sbjct: 82 --PNVLALIGIMLPPEGLPHVL------LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ- 132
Query: 113 IAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+AR +EY+ + F+HRD+ N ++ ++ V + DFGLA+
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLAR 172
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 50/176 (28%), Positives = 80/176 (45%), Gaps = 38/176 (21%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSGTKHPQ--LLYEAKVYKILQGG 62
L R++G G+FG++FLA + + +VAVK T + EA++ LQ
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH- 76
Query: 63 SGIPNI-KWYGV--DGEDNVLVL------DLL----------GPSLEDLFVYCRRKFSLK 103
+I K+YGV DG+ ++V DL ++ + + L
Sbjct: 77 ---EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133
Query: 104 TVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+L +A Q IA + Y+ S+ F+HRD+ N L+G V I DFG++ RD
Sbjct: 134 QMLHIASQ-IASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMS---RD 182
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 43/182 (23%), Positives = 70/182 (38%), Gaps = 27/182 (14%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKI--ENSGTKHPQ-LLYEAKVYKILQG 61
L R +G G+FGE++ + + VAVK E + L EA +
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92
Query: 62 GSGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQM----- 112
NI + GV ++++L+ G L+ R + S + L + D +
Sbjct: 93 ----QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 113 IAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-----YRDPTTNRHIP 166
IA +Y+ F+HRDI N L+ I DFG+A+ Y +P
Sbjct: 149 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 208
Query: 167 YR 168
+
Sbjct: 209 VK 210
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 51/261 (19%), Positives = 94/261 (36%), Gaps = 80/261 (30%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------EN---SGTKHP---QLLY 51
+G G+FG++ L T A+KI EN ++HP L Y
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 52 ----EAKVYKIL---QGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSL 102
++ ++ GG +LF + R FS
Sbjct: 216 SFQTHDRLCFVMEYANGG----------------------------ELFFHLSRERVFSE 247
Query: 103 KTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDP 159
++++ ++Y+HS + ++RD+K +N ++ K + I DFGL K+
Sbjct: 248 DRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGA 304
Query: 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKA 218
T GT Y + + R D LG V++Y + G LP+
Sbjct: 305 TMK---------TFCGTPEYLAPEVLEDNDYGRAVDWWGLG-VVMYEMMCGRLPFYN--- 351
Query: 219 ATKKQKYDKICEKKVSTPIEV 239
++ ++ I +++ P +
Sbjct: 352 QDHEKLFELILMEEIRFPRTL 372
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 6e-10
Identities = 43/184 (23%), Positives = 74/184 (40%), Gaps = 39/184 (21%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEI---VAVKIENSGTKHPQ---LLYEAKVYKILQGGS 63
IG G FG ++ + +D + AVK N T + L E + K
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-- 85
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLLGPSLE-----DLFVYCR---RKFSLKTVLMLADQM 112
PN+ G+ E + LV+ L DL + R ++K ++ Q
Sbjct: 86 --PNVLSLLGICLRSEGSPLVV------LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ- 136
Query: 113 IAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK------YR-DPTTNRH 164
+A+ ++Y+ S+ F+HRD+ N ++ + V + DFGLA+ Y T
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 165 IPYR 168
+P +
Sbjct: 194 LPVK 197
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 6e-10
Identities = 27/169 (15%), Positives = 61/169 (36%), Gaps = 26/169 (15%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEI-------VAVKIENSGTKHPQ--LLYEAKVYKILQ 60
+G G+F +IF + + V +K+ + ++ A + L
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 61 GGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRR---KFSLKTVLMLADQMIA 114
++ YGV G++N+LV + + L Y ++ ++ L +A Q+ A
Sbjct: 71 H----KHLVLNYGVCVCGDENILVQEFV--KFGSLDTYLKKNKNCINILWKLEVAKQLAA 124
Query: 115 RIEYVHSRGFLHRDIKPDNFL-----MGLGRKANQVYIIDFGLAKKYRD 158
+ ++ +H ++ N L + + D G++
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 6e-10
Identities = 61/266 (22%), Positives = 102/266 (38%), Gaps = 87/266 (32%)
Query: 15 IGSGSFGEIFLASHV---DTNEIVAVKI------------------ENS---GTKHP--- 47
+G G +G++F V +T +I A+K+ E + KHP
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 48 QLLY----EAKVYKIL---QGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR-- 98
L+Y K+Y IL GG +LF+ R
Sbjct: 85 DLIYAFQTGGKLYLILEYLSGG----------------------------ELFMQLEREG 116
Query: 99 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--Y 156
F T ++ + ++H +G ++RD+KP+N ++ V + DFGL K+ +
Sbjct: 117 IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN---HQGHVKLTDFGLCKESIH 173
Query: 157 RDPTTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPW 213
T+ T GT Y + + +R D SLG L+Y L G+ P+
Sbjct: 174 DGTVTH-----------TFCGTIEYMAPEILMRSGHNRAVDWWSLG-ALMYDMLTGAPPF 221
Query: 214 QGLKAATKKQKYDKICEKKVSTPIEV 239
G +K+ DKI + K++ P +
Sbjct: 222 TG---ENRKKTIDKILKCKLNLPPYL 244
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 38/188 (20%), Positives = 71/188 (37%), Gaps = 56/188 (29%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN--SGTKHPQLLY-EAKVYKILQ 60
+ Y+ + +GSG++G + A T VA+K + + Y E ++ K ++
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 82
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGP-----SLEDLFVYCRRKFSLKTVLMLAD----- 110
N+ + +LD+ P D ++ M D
Sbjct: 83 H----ENV----------IGLLDVFTPDETLDDFTDFYLV--------MPFMGTDLGKLM 120
Query: 111 ---------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK 154
QM+ + Y+H+ G +HRD+KP N + + ++ I+DFGLA+
Sbjct: 121 KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV----NEDCELKILDFGLAR 176
Query: 155 KYRDPTTN 162
+ T
Sbjct: 177 QADSEMTG 184
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 42/195 (21%), Positives = 73/195 (37%), Gaps = 44/195 (22%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKI--ENSGTKHPQ-LLYEAKVYKILQG 61
G+ +G+G+FG++ A D VAVK+ ++ + L+ E KV L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL-- 83
Query: 62 GSGIPNI-KWYGV--DGEDNVLVL------DLL------------GPSLEDLFVYCRRKF 100
NI G G +++ DLL + +
Sbjct: 84 -GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 101 SLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---- 155
L+ +L + Q +A+ + ++ S+ +HRD+ N L+ I DFGLA+
Sbjct: 143 DLEDLLSFSYQ-VAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIKND 198
Query: 156 --YRDPTTNRHIPYR 168
Y N +P +
Sbjct: 199 SNYV-VKGNARLPVK 212
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 47/191 (24%), Positives = 78/191 (40%), Gaps = 41/191 (21%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ--LLYEAKVYKILQGG 62
L ++G G+FG++FLA +VAVK ++ + EA++ +LQ
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQH- 102
Query: 63 SGIPNI-KWYGV--DGEDNVLVL------DLL---------GPSLEDLFVYCRRKFSLKT 104
+I +++GV +G ++V DL L L
Sbjct: 103 ---QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159
Query: 105 VLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK------YR 157
+L +A Q +A + Y+ F+HRD+ N L+G G V I DFG+++ YR
Sbjct: 160 LLAVASQ-VAAGMVYLAGLHFVHRDLATRNCLVGQGL---VVKIGDFGMSRDIYSTDYYR 215
Query: 158 DPTTNRHIPYR 168
+P R
Sbjct: 216 -VGGRTMLPIR 225
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 40/163 (24%), Positives = 75/163 (46%), Gaps = 25/163 (15%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN--SGTKHPQLLY-EAKVYKILQ 60
+ +Y+ + IGSG+ G + A VA+K + H + Y E + K +
Sbjct: 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 61 GGSGIPNI---------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQ 111
NI + + +D +V++L+ +L + + + + L Q
Sbjct: 83 H----KNIIGLLNVFTPQKSLEEFQDVYIVMELMD---ANLCQVIQMELDHERMSYLLYQ 135
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLA 153
M+ I+++HS G +HRD+KP N ++ K++ + I+DFGLA
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLA 174
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 40/177 (22%), Positives = 69/177 (38%), Gaps = 35/177 (19%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEI---VAVKIENSGTKHPQ---LLYEAKVYKILQGGS 63
IG G FG ++ + +D + AVK N T + L E + K
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-- 149
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLLGPSLE-----DLFVY---CRRKFSLKTVLMLADQM 112
PN+ G+ E + LV+ L DL + ++K ++ Q
Sbjct: 150 --PNVLSLLGICLRSEGSPLVV------LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ- 200
Query: 113 IAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
+A+ ++++ S+ F+HRD+ N ++ + V + DFGLA RD
Sbjct: 201 VAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA---RDMYDKEFDSVH 251
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 44/187 (23%), Positives = 70/187 (37%), Gaps = 37/187 (19%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKI--ENSGTKHPQ-LLYEAKVYKILQG 61
L R +G G+FGE++ + + VAVK E + L EA +
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133
Query: 62 GSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRR---------KFSLKTVLM 107
NI + GV ++L+L+ G DL + R ++ +L
Sbjct: 134 ----QNIVRCIGVSLQSLPRFILLELMAGG----DLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 108 LADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-----YRDPTT 161
+A IA +Y+ F+HRDI N L+ I DFG+A+ Y
Sbjct: 186 VARD-IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGG 244
Query: 162 NRHIPYR 168
+P +
Sbjct: 245 CAMLPVK 251
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 2e-09
Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 16/154 (10%)
Query: 10 KLGR-KIGSGSFGEIFLAS-HVDTNEI-VAVKI--ENSGTKHPQ-LLYEAKVYKILQGGS 63
+ ++G G+FG + + +I VA+K+ + + + ++ EA++ L
Sbjct: 12 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN-- 69
Query: 64 GIPNI-KWYGV-DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
P I + GV E +LV+++ G L V R + + V L Q+ ++Y+
Sbjct: 70 --PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 127
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+ F+HRD+ N L+ + I DFGL+K
Sbjct: 128 EKNFVHRDLAARNVLLV---NRHYAKISDFGLSK 158
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 38/188 (20%), Positives = 61/188 (32%), Gaps = 63/188 (33%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQL------------L 50
+ Y + R I SGS+G + VA+K + N+ + + L
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 51 YEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLML 108
E ++ PNI + + D+ E +Y L T LM
Sbjct: 78 REIRLLNHFHH----PNI----------LGLRDIFVHFEEPAMHKLY------LVTELMR 117
Query: 109 AD----------------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QV 145
D ++ + +H G +HRD+ P N L+ N +
Sbjct: 118 TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL----ADNNDI 173
Query: 146 YIIDFGLA 153
I DF LA
Sbjct: 174 TICDFNLA 181
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 15/152 (9%)
Query: 11 LGRKIGSGSFGEIFLAS-HVDTNEI-VAVKIENSGTKHPQ---LLYEAKVYKILQGGSGI 65
++G G+FG + + +I VA+K+ GT+ ++ EA++ L
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN---- 395
Query: 66 PNI-KWYGV-DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
P I + GV E +LV+++ G L V R + + V L Q+ ++Y+ +
Sbjct: 396 PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
F+HR++ N L+ + I DFGL+K
Sbjct: 456 NFVHRNLAARNVLLV---NRHYAKISDFGLSK 484
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 3e-09
Identities = 35/177 (19%), Positives = 61/177 (34%), Gaps = 39/177 (22%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
+ ++G FG+++ + + + VA+K + P +EA + LQ
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 62 GSGIPNI-KWYGV--DGEDNVLVL------DLL----------GPSLEDLFVYCRRKFSL 102
PN+ GV + ++ DL D +
Sbjct: 72 ----PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP 127
Query: 103 KTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+ L Q IA +EY+ S +H+D+ N L+ V I D GL R+
Sbjct: 128 PDFVHLVAQ-IAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLF---RE 177
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 42/189 (22%), Positives = 76/189 (40%), Gaps = 41/189 (21%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
+ R++G GSFG ++ + VA+K N + L EA V K
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 87
Query: 62 GSGIPNI-KWYGV--DGEDNVLVL------DLL------GPSLEDLFVYCRRKFSLKTVL 106
++ + GV G+ ++++ DL P++ + V SL ++
Sbjct: 88 ----HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV--LAPPSLSKMI 141
Query: 107 MLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK------YRDP 159
+A + IA + Y+++ F+HRD+ N ++ V I DFG+ + YR
Sbjct: 142 QMAGE-IADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYETDYYR-K 196
Query: 160 TTNRHIPYR 168
+P R
Sbjct: 197 GGKGLLPVR 205
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 6e-09
Identities = 44/194 (22%), Positives = 78/194 (40%), Gaps = 43/194 (22%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
KLG+ +G G+FG++ A T VAVK+ G H + L+ E K+ +
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI-- 87
Query: 62 GSGIPNI-KWYGV--DGEDNVLVL-------DLL----------GPSLEDLFVYCRRKFS 101
N+ G ++V+ +L P + +
Sbjct: 88 -GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 102 LKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK----- 155
L+ ++ + Q +A+ +E++ SR +HRD+ N L+ + N V I DFGLA+
Sbjct: 147 LEHLICYSFQ-VAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDP 202
Query: 156 -YRDPTTNRHIPYR 168
Y + +P +
Sbjct: 203 DYV-RKGDARLPLK 215
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 7e-09
Identities = 43/190 (22%), Positives = 76/190 (40%), Gaps = 38/190 (20%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
+ G+ +G+G+FG++ A+ + VAVK+ S + L+ E K+ L
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL-- 106
Query: 62 GSGIPNI-KWYGV--DGEDNVLVL------DLL--------GPSLEDLFVYCRRKFSLKT 104
NI G G +++ DLL + F S +
Sbjct: 107 -GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 105 VLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YRDP--- 159
+L + Q +A+ + ++ S+ +HRD+ N L+ G + I DFGLA+ D
Sbjct: 166 LLHFSSQ-VAQGMAFLASKNCIHRDVAARNVLLTNG---HVAKIGDFGLARDIMNDSNYI 221
Query: 160 -TTNRHIPYR 168
N +P +
Sbjct: 222 VKGNARLPVK 231
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 9e-09
Identities = 42/195 (21%), Positives = 75/195 (38%), Gaps = 44/195 (22%)
Query: 10 KLGRKIGSGSFGEIFLA-------SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
LG+ +G G+FG++ +A VAVK+ L+ E ++ K++
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVL------DLL----------GPSLEDLFVYCRRKF 100
NI G +++ +L D+ +
Sbjct: 98 ---GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 101 SLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---- 155
+ K ++ Q +AR +EY+ S+ +HRD+ N L+ + I DFGLA+
Sbjct: 155 TFKDLVSCTYQ-LARGMEYLASQKCIHRDLAARNVLVTENNV---MKIADFGLARDINNI 210
Query: 156 --YRDPTTNRHIPYR 168
Y+ TTN +P +
Sbjct: 211 DYYK-KTTNGRLPVK 224
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 57/271 (21%), Positives = 105/271 (38%), Gaps = 89/271 (32%)
Query: 15 IGSGSFGEIFLASHV---DTNEIVAVKI------------------EN----SGTKHP-- 47
+G+G++G++FL + DT ++ A+K+ E + P
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 48 -QLLY----EAKVYKIL---QGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCR 97
L Y E K++ IL GG +LF + R
Sbjct: 122 VTLHYAFQTETKLHLILDYINGG----------------------------ELFTHLSQR 153
Query: 98 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM---GLGRKANQVYIIDFGLAK 154
+F+ V + +++ +E++H G ++RDIK +N L+ G V + DFGL+K
Sbjct: 154 ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG------HVVLTDFGLSK 207
Query: 155 KYRDPTTNRHIPYRENKNLT--GTARYASCNTHLGIEQ--SRRDDLESLGYVLLY-FLRG 209
+ + GT Y + + G + + D SLG VL+Y L G
Sbjct: 208 --------EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG-VLMYELLTG 258
Query: 210 SLPWQGL-KAATKKQKYDKICEKKVSTPIEV 239
+ P+ + ++ + +I + + P E+
Sbjct: 259 ASPFTVDGEKNSQAEISRRILKSEPPYPQEM 289
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 41/187 (21%), Positives = 62/187 (33%), Gaps = 36/187 (19%)
Query: 10 KLGRKIGSGSFGEIFLA--SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGSG 64
K IG G+FG++ A A+K E +V L
Sbjct: 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH-- 85
Query: 65 IPNI-KWYGV--DGEDNVLVL------DLL----------GPSLEDLFVYCRRKFSLKTV 105
PNI G L + +LL + S + +
Sbjct: 86 -PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 106 LMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTT 161
L A +AR ++Y+ + F+HRD+ N L+G I DFGL++ Y T
Sbjct: 145 LHFAAD-VARGMDYLSQKQFIHRDLAARNILVGEN---YVAKIADFGLSRGQEVYV-KKT 199
Query: 162 NRHIPYR 168
+P R
Sbjct: 200 MGRLPVR 206
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 55.3 bits (132), Expect = 1e-08
Identities = 39/212 (18%), Positives = 61/212 (28%), Gaps = 59/212 (27%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---------------------------- 39
K + KIG G FGE+F + VA+KI
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 40 ------ENSGTKH----------------PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77
+ P LL +A + GS ++ D
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLM 136
VL + G LE + SL T + Q+ A + + F HRD+ N L+
Sbjct: 139 IVLEFEFGGIDLEQ---MRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 137 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
+K + + K P+ +
Sbjct: 196 ---KKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 45/195 (23%), Positives = 77/195 (39%), Gaps = 44/195 (22%)
Query: 10 KLGRKIGSGSFGEIFLA-------SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
LG+ +G G+FG++ LA + VAVK+ S L+ E ++ K++
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVL------DLL----------GPSLEDLFVYCRRKF 100
NI G +++ +L + +
Sbjct: 132 ---GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 101 SLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---- 155
S K ++ A Q +AR +EY+ S+ +HRD+ N L+ + I DFGLA+
Sbjct: 189 SSKDLVSCAYQ-VARGMEYLASKKCIHRDLAARNVLVTEDNV---MKIADFGLARDIHHI 244
Query: 156 --YRDPTTNRHIPYR 168
Y+ TTN +P +
Sbjct: 245 DYYK-KTTNGRLPVK 258
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 45/192 (23%), Positives = 70/192 (36%), Gaps = 46/192 (23%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTKHPQ----LLYEAKVYKILQGG 62
LGR +G G FG + A + VAVK+ + L EA K
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH- 84
Query: 63 SGIPNI-KWYGV--DGEDNVLVLDLL--------GPSLEDLFVYCR--------RKFSLK 103
P++ K GV + + G DL + L+
Sbjct: 85 ---PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHG----DLHAFLLASRIGENPFNLPLQ 137
Query: 104 TVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK------Y 156
T++ IA +EY+ SR F+HRD+ N ++ + V + DFGL++K Y
Sbjct: 138 TLVRFMVD-IACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLSRKIYSGDYY 193
Query: 157 RDPTTNRHIPYR 168
R +P +
Sbjct: 194 R-QGCASKLPVK 204
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 47/187 (25%), Positives = 70/187 (37%), Gaps = 37/187 (19%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEI---VAVKIENSGTKHPQ----LLYEAKVYKILQGG 62
LG+ +G G FG + + + VAVK + L EA K
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH- 95
Query: 63 SGIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVYCR--------RKFSLKTVLML 108
PN+ + GV E + + L DL Y + L+T+L
Sbjct: 96 ---PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152
Query: 109 ADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK------YRDPTT 161
IA +EY+ +R FLHRD+ N ++ V + DFGL+KK YR
Sbjct: 153 MVD-IALGMEYLSNRNFLHRDLAARNCMLR---DDMTVCVADFGLSKKIYSGDYYRQ-GR 207
Query: 162 NRHIPYR 168
+P +
Sbjct: 208 IAKMPVK 214
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 42/195 (21%), Positives = 74/195 (37%), Gaps = 44/195 (22%)
Query: 10 KLGRKIGSGSFGEIFLA-------SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
LG+ +G G FG++ +A VAVK+ L+ E ++ K++
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVL------DLL----------GPSLEDLFVYCRRKF 100
NI G +++ +L D+ +
Sbjct: 144 GKH---KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 101 SLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---- 155
+ K ++ Q +AR +EY+ S+ +HRD+ N L+ + I DFGLA+
Sbjct: 201 TFKDLVSCTYQ-LARGMEYLASQKCIHRDLAARNVLVTENNV---MKIADFGLARDINNI 256
Query: 156 --YRDPTTNRHIPYR 168
Y+ TTN +P +
Sbjct: 257 DYYK-KTTNGRLPVK 270
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 7e-08
Identities = 42/201 (20%), Positives = 73/201 (36%), Gaps = 51/201 (25%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
LG+ +G G FG++ A VAVK+ + LL E V K +
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 62 GSGIPNI-KWYGV--DGEDNVLVL------DLL------------------GPSLEDLFV 94
P++ K YG +L++ L + L
Sbjct: 86 ----PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 95 YCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
R ++ ++ A Q I++ ++Y+ +HRD+ N L+ G ++ I DFGL+
Sbjct: 142 PDERALTMGDLISFAWQ-ISQGMQYLAEMKLVHRDLAARNILVAEG---RKMKISDFGLS 197
Query: 154 KK------YRDPTTNRHIPYR 168
+ Y + IP +
Sbjct: 198 RDVYEEDSYV-KRSQGRIPVK 217
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 49/201 (24%), Positives = 70/201 (34%), Gaps = 51/201 (25%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
+ R IG G+FG +F A + +VAVK+ EA +
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 62 GSGIPNI-KWYGV--DGEDNVLVL------DLL------------------GPSLEDLFV 94
PNI K GV G+ L+ DL + +
Sbjct: 110 ----PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 95 YCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
S L +A Q +A + Y+ R F+HRD+ N L+G V I DFGL+
Sbjct: 166 PGPPPLSCAEQLCIARQ-VAAGMAYLSERKFVHRDLATRNCLVGENMV---VKIADFGLS 221
Query: 154 KK------YRDPTTNRHIPYR 168
+ Y+ N IP R
Sbjct: 222 RNIYSADYYK-ADGNDAIPIR 241
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 43/200 (21%), Positives = 70/200 (35%), Gaps = 49/200 (24%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
+ G+ +GSG+FG++ A S + VAVK+ + L+ E K+ L
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL-- 105
Query: 62 GSGIPNI-KWYGV--DGEDNVLVL------DLL-----------------GPSLEDLFVY 95
NI G L+ DLL
Sbjct: 106 -GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 96 CRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+ + +L A Q +A+ +E++ + +HRD+ N L+ V I DFGLA+
Sbjct: 165 DLNVLTFEDLLCFAYQ-VAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLAR 220
Query: 155 K------YRDPTTNRHIPYR 168
Y N +P +
Sbjct: 221 DIMSDSNYV-VRGNARLPVK 239
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 7e-07
Identities = 48/310 (15%), Positives = 96/310 (30%), Gaps = 106/310 (34%)
Query: 28 HVDT---NEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIP----NIKWYGVDGEDNVL 80
HV+ I+ + + +++ + + IP ++ W+ V D ++
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEYRKMFDRLS--VFPPSAHIPTILLSLIWFDVIKSDVMV 406
Query: 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI--KPDNFLMGL 138
V++ L K+SL + Q + S ++ ++ K +N L
Sbjct: 407 VVNKL------------HKYSL-----VEKQPKESTISIPS---IYLELKVKLEN-EYAL 445
Query: 139 GRKANQVYIID-FGLAKKY--RDPTTNR-------HIPYRENKNLTGTARYASCNTHL-G 187
R I+D + + K + D HI + HL
Sbjct: 446 HRS-----IVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH-----------------HLKN 483
Query: 188 IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE 247
IE R L + ++ FL +K ++D + + L +
Sbjct: 484 IEHPERMTLFRMVFLDFRFLE------------QKIRHDSTAWNASGSILNTL-----QQ 526
Query: 248 FASYFHYCQSLTFDQRPDY--------GFLKRLFHDLFSREGYDF---------DFVFDW 290
Y Y D P Y FL ++ +L + D + +F+
Sbjct: 527 LKFYKPY----ICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEE 582
Query: 291 TILKYQQTQK 300
++Q Q+
Sbjct: 583 A---HKQVQR 589
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 22/87 (25%), Positives = 40/87 (45%), Gaps = 8/87 (9%)
Query: 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 146
E + +L+ ++ + Q+ +E++ SR +HRD+ N L+ V
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVK 233
Query: 147 IIDFGLAKK-YRDP----TTNRHIPYR 168
I DFGLA+ Y+DP + +P +
Sbjct: 234 ICDFGLARDIYKDPDYVRKGDARLPLK 260
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 20/93 (21%), Positives = 39/93 (41%), Gaps = 15/93 (16%)
Query: 63 SGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
GIP + VD ++ +++ + G +D+ + +++ ++ H
Sbjct: 399 FGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIE------DNLDIAYKIGEIVGKL---HK 449
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+H D+ NF+ +YIIDFGL K
Sbjct: 450 NDVIHNDLTTSNFIFD-----KDLYIIDFGLGK 477
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 414 | |||
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.08 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.01 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.78 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.59 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.54 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.36 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.33 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.29 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.24 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.06 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.92 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.76 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.67 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.58 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.53 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.47 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.38 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.24 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.18 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.11 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.97 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.9 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.39 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.98 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.75 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.6 |
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-56 Score=446.21 Aligned_cols=300 Identities=78% Similarity=1.322 Sum_probs=275.8
Q ss_pred CCcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 1 ~~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
|+.+++++|+++++||+|+||.||+|++..+++.||||++........+..|+++++.|.++++++.+..++......+|
T Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp -CCEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCCCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 78899999999999999999999999999999999999988887777899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 81 v~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||||++++|.+++..+...+++..++.|+.||+.||+|||++|||||||||+|||++..+..+.+||+|||+++......
T Consensus 81 vme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 99999999999999878889999999999999999999999999999999999999655578899999999999888776
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
.....+++......||..|+|||++.+..++.++|||||||++|||++|+.||.+.......+.+.++.........+.+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence 66667777777889999999999999999999999999999999999999999998877778888888888888888888
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCccccccccccchhhh
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l~~~~~~~ 300 (414)
+..+|+++.+|+..||..+|++||++.+|.+.|++++...++.++..+||..+++...+.
T Consensus 241 ~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~~~~~ 300 (483)
T 3sv0_A 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300 (483)
T ss_dssp HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC-----
T ss_pred hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccccccc
Confidence 899999999999999999999999999999999999999999999999998887765543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-56 Score=420.43 Aligned_cols=259 Identities=22% Similarity=0.214 Sum_probs=213.1
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (414)
..|++.++||+|+||+||+|++..+|+.||||+++.... ..+|+.+++.|+| ++|+.++.++.+....|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---~~~E~~il~~l~H-pnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---RVEELVACAGLSS-PRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CTHHHHTTTTCCC-TTBCCEEEEEEETTEEEEEECCCT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---HHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEEeccC
Confidence 569999999999999999999999999999999876543 2479999999975 67778888888889999999999
Q ss_pred CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCC-eEEEeeecceeeecCCCCCcc
Q 015041 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTNRH 164 (414)
Q Consensus 86 ~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~-~vkL~DFG~a~~~~~~~~~~~ 164 (414)
+++|.+++.. .+.+++..++.|+.||+.||+|||++|||||||||+|||++ .++ .+||+|||+|+..........
T Consensus 134 gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 134 GGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS---SDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp TCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC---TTSCCEEECCCTTCEEC--------
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe---CCCCEEEEeeCCCCeEccCCCcccc
Confidence 8899999976 45799999999999999999999999999999999999994 555 699999999987654322111
Q ss_pred ccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcC
Q 015041 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (414)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 244 (414)
......++||+.|||||++.+..|+.++|||||||++|||++|+.||.+...... +.+|... ..+.......+
T Consensus 210 --~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~i~~~--~~~~~~~~~~~ 282 (336)
T 4g3f_A 210 --LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CLKIASE--PPPIREIPPSC 282 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HHHHHHS--CCGGGGSCTTS
T ss_pred --eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHHHHcC--CCCchhcCccC
Confidence 0112356899999999999999999999999999999999999999987654432 3334332 23334455678
Q ss_pred hHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 245 PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 245 p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
++++.+++.+||..||.+||++.+|.+.|...+...
T Consensus 283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 999999999999999999999999999888776543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-55 Score=418.71 Aligned_cols=245 Identities=19% Similarity=0.279 Sum_probs=207.3
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCC--CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
..|+++++||+|+||+||+|++..+|+.||||++... .....+.+|+.+++.|+| ++|+.++.++.+....||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H-pnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEEeC
Confidence 5699999999999999999999999999999987643 334568899999999975 7788888888888999999999
Q ss_pred c-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 85 ~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
| +++|.+++.. ..+++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.......
T Consensus 153 ~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~-- 225 (346)
T 4fih_A 153 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP-- 225 (346)
T ss_dssp CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSC--
T ss_pred CCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceecCCCCC--
Confidence 9 7899998874 569999999999999999999999999999999999999 5889999999999987654332
Q ss_pred cccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhc
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~ 243 (414)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+.. +.+..+... .... ......
T Consensus 226 -----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i~~~-~~~~-~~~~~~ 295 (346)
T 4fih_A 226 -----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDN-LPPR-LKNLHK 295 (346)
T ss_dssp -----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHS-SCCC-CSCGGG
T ss_pred -----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHcC-CCCC-CCcccc
Confidence 124679999999999999999999999999999999999999999875443 333444332 2211 112346
Q ss_pred ChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 244 HPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 244 ~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
+++++.+|+.+||..||++||+++++
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~ 321 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAEL 321 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 78999999999999999999998764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-56 Score=414.84 Aligned_cols=265 Identities=22% Similarity=0.330 Sum_probs=221.3
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
.+|++++.||+|+||+||+|++..+|+.||||++... .....+.+|+++++.|+| ++|+.++.++.+....|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCCEEEEE
Confidence 5699999999999999999999999999999998642 334568899999999975 7777888888888999999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||| +|+|.+++.. .+.+++.+++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+......
T Consensus 111 mEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 111 LSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp ECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCTTT
T ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCCCC
Confidence 9999 7899999876 4579999999999999999999999999999999999999 588999999999999765432
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+ ..+.+.+|.......|
T Consensus 187 ~~~-----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~~~~~~p---- 254 (311)
T 4aw0_A 187 KQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EGLIFAKIIKLEYDFP---- 254 (311)
T ss_dssp TCC-----CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCC----
T ss_pred Ccc-----cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCC----
Confidence 211 2246799999999999999999999999999999999999999998754 3455666766666555
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcccccccc
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 293 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l 293 (414)
..+++++.+|+.+||..||.+||+++++... ..+ ..+.|...+||..+
T Consensus 255 -~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~-~~i---~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 255 -EKFFPKARDLVEKLLVLDATKRLGCEEMEGY-GPL---KAHPFFESVTWENL 302 (311)
T ss_dssp -TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH-HHH---HTSGGGTTCCCTTG
T ss_pred -cccCHHHHHHHHHHccCCHhHCcChHHHcCC-HHH---HCCCCcCCCCHHHh
Confidence 4568899999999999999999998875331 111 23455556777654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-56 Score=421.80 Aligned_cols=247 Identities=21% Similarity=0.219 Sum_probs=203.8
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
++|+++++||+|+||+||+|++..+|+.||||++...... ..+.+|+.+++.|+| ++|+.++.++.+....||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH-PNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCC-CCCCcEEEEEEECCEEEEEE
Confidence 5899999999999999999999999999999998765432 357899999999975 67778888888889999999
Q ss_pred ecc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||| +++|.+++...+ ..+++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+......
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCCc
Confidence 999 789999997644 457999999999999999999999999999999999999 588999999999998653221
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+. .+.+.+++....+. .
T Consensus 180 ~-------~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i~~~~~~~----~ 245 (350)
T 4b9d_A 180 E-------LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM---KNLVLKIISGSFPP----V 245 (350)
T ss_dssp H-------HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHTCCCC----C
T ss_pred c-------cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHHcCCCCC----C
Confidence 1 11256899999999999999999999999999999999999999987543 34555565554432 1
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...+++++.+|+..||..||++||+++++.+
T Consensus 246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2456899999999999999999999887654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=421.44 Aligned_cols=245 Identities=19% Similarity=0.279 Sum_probs=207.4
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
++|+++++||+|+||.||+|++..+|+.||||++.... ....+.+|+.+++.|+| ++|+.++.++.+....||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H-pnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCC-CCCCceEEEEEECCEEEEEEeC
Confidence 57999999999999999999999999999999886543 34568899999999975 7777888888888999999999
Q ss_pred c-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 85 ~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
| +++|.+++.. ..+++..+..|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.......
T Consensus 230 ~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~~~-- 302 (423)
T 4fie_A 230 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP-- 302 (423)
T ss_dssp CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEECCSSCC--
T ss_pred CCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceECCCCCc--
Confidence 9 7899998864 469999999999999999999999999999999999999 5889999999999987654332
Q ss_pred cccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhc
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~ 243 (414)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.... +.+..|... .... ......
T Consensus 303 -----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i~~~-~~~~-~~~~~~ 372 (423)
T 4fie_A 303 -----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDN-LPPR-LKNLHK 372 (423)
T ss_dssp -----CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHS-CCCC-CSCTTS
T ss_pred -----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHcC-CCCC-Cccccc
Confidence 124679999999999999999999999999999999999999999875543 333344332 2111 112346
Q ss_pred ChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 244 HPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 244 ~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
+++++.+|+..||..||++||++.++
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~el 398 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAEL 398 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 68999999999999999999998764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=400.63 Aligned_cols=247 Identities=26% Similarity=0.333 Sum_probs=197.6
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
..+ ++|++++.||+|+||+||+|++..+|+.||||++.... ....+.+|+.+++.++| ++|+.+..++.+...
T Consensus 10 ~~i-g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~ 87 (275)
T 3hyh_A 10 AHI-GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH-PHIIKLYDVIKSKDE 87 (275)
T ss_dssp -----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSE
T ss_pred CEe-eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCC-CCCCeEEEEEEECCE
Confidence 344 58999999999999999999999999999999986542 23458899999999975 777788888888899
Q ss_pred eEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 78 ~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
.++||||++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+...
T Consensus 88 ~~ivmEy~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 88 IIMVIEYAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp EEEEEECCCEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC----
T ss_pred EEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecC
Confidence 999999999999999876 5679999999999999999999999999999999999999 588999999999998654
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCc
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p 236 (414)
.... ....+||+.|||||++.+..| +.++|||||||++|+|++|+.||.+.+. .+.+..+.......|
T Consensus 164 ~~~~--------~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~---~~~~~~i~~~~~~~p 232 (275)
T 3hyh_A 164 DGNF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI---PVLFKNISNGVYTLP 232 (275)
T ss_dssp -------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCCCC
T ss_pred CCCc--------cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHcCCCCCC
Confidence 3321 236789999999999998886 6899999999999999999999987543 344555555555444
Q ss_pred hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 237 ~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+++++.+|+.+||..||++||+++++.+
T Consensus 233 -----~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 233 -----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 456899999999999999999999988765
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=407.97 Aligned_cols=263 Identities=23% Similarity=0.331 Sum_probs=215.0
Q ss_pred CcccCCceEEecceeecCceeEEEEEEC-----CCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 74 (414)
..|-..+|.+.++||+|+||+||+|++. .++..||||+++.... ...+.+|+++++.|+| ++|+.++.++.+
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H-pnIV~l~g~~~~ 86 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQH-EHIVKFYGVCVE 86 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECS
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCC-CCCccEEEEEee
Confidence 3455678999999999999999999875 3578899999876543 2458899999999975 778888888888
Q ss_pred CCeeEEEEecc-CCCHHHHHHHhC------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCC
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYCR------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~ 141 (414)
....+|||||| +|+|.+++...+ ..+++.+++.|+.||+.||+|||+++||||||||+|||+ +.
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~ 163 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GE 163 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CC
Confidence 88999999999 899999997532 468999999999999999999999999999999999999 58
Q ss_pred CCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhc
Q 015041 142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT 220 (414)
Q Consensus 142 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~ 220 (414)
++.+||+|||+|+........ .......||++|||||++.+..|+.++|||||||++|||+| |+.||.+.+..
T Consensus 164 ~~~~Ki~DFGla~~~~~~~~~-----~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~- 237 (299)
T 4asz_A 164 NLLVKIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN- 237 (299)
T ss_dssp GGCEEECCCSCHHHHTGGGCE-----EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-
T ss_pred CCcEEECCcccceecCCCCce-----eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence 899999999999865432211 11234578999999999999999999999999999999998 99999987544
Q ss_pred hHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 221 ~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
+.+..+..... .+.+ ..+|+++.+|+..||+.||++||++.+|.+.|+++.+..
T Consensus 238 --~~~~~i~~~~~-~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 238 --EVIECITQGRV-LQRP---RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp --HHHHHHHHTCC-CCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred --HHHHHHHcCCC-CCCC---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 33444443332 2222 456899999999999999999999999999998876543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=398.77 Aligned_cols=294 Identities=70% Similarity=1.243 Sum_probs=258.8
Q ss_pred CCcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 1 ~~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
|+..++++|++++.||+|+||+||+|++..+++.||||++........+..|+.+++.+.|+++++.+..++......++
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp --------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 45568899999999999999999999999999999999988777777899999999999999999999998889999999
Q ss_pred EEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 81 v~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+...+..+.+||+|||+++......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 99999999999998777789999999999999999999999999999999999999544578899999999999877666
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
.....++.......||..|+|||++.+..++.++|||||||++|+|++|+.||.+.......+.+..+.......+.+..
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh
Confidence 55555566667789999999999999999999999999999999999999999987666666667777777778888888
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCccccccccc
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK 294 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l~ 294 (414)
+..+|+++.+++..||..+|++||++.++.+.|++++.+.+...++.+||+.++
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 296 (296)
T 4hgt_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGCC
T ss_pred hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhcC
Confidence 888999999999999999999999999999999999999999999999998763
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-53 Score=396.35 Aligned_cols=294 Identities=70% Similarity=1.243 Sum_probs=264.5
Q ss_pred CCcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 1 ~~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
|+..++++|++++.||+|+||.||+|++..+++.||||++........+.+|+.+++.+.|+++++.+..++......++
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp --CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 45668899999999999999999999999999999999988877777899999999999999999999888888999999
Q ss_pred EEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 81 v~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||||++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++..+.++.+||+|||+++......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 99999999999998777789999999999999999999999999999999999999644578899999999999877665
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
.....++.......||..|+|||++.+..++.++|||||||++|+|++|+.||.+.......+.+..+.......+.+..
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH
Confidence 55555555566788999999999999999999999999999999999999999987665555666677777777888888
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCccccccccc
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK 294 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l~ 294 (414)
+..+|+++.+++..||..+|.+||++.++.+.|++++...+...+..+||+.++
T Consensus 243 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 296 (296)
T 3uzp_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGGCC
T ss_pred HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 888999999999999999999999999999999999999999999999998753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=403.76 Aligned_cols=285 Identities=57% Similarity=1.033 Sum_probs=259.6
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
-+++++|++++.||+|+||+||+|++..+++.||||++........+..|+.+++.|.+|++++.+..++......++||
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 36789999999999999999999999999999999999877767789999999999977789999998998999999999
Q ss_pred eccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCe-----EEEeeecceeeec
Q 015041 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ-----VYIIDFGLAKKYR 157 (414)
Q Consensus 83 e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~-----vkL~DFG~a~~~~ 157 (414)
||++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++ .++. +||+|||+|+...
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~---~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 85 ELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIG---RPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---CGGGTCTTSEEECCCTTCEESB
T ss_pred EeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---cCCCCCCceEEEEEcccceeee
Confidence 9999999999998777899999999999999999999999999999999999994 4554 9999999999887
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
........+++......||..|+|||++.+..++.++|||||||++|||++|..||.+.......+.+..+...+...+.
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 76666666666667889999999999999999999999999999999999999999987777777777788777878888
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcccccc
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWT 291 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 291 (414)
+..+..+| ++.+++..||..+|.+||++++|.+.|++++.+.+...+..+||.
T Consensus 242 ~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 242 EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 88888888 999999999999999999999999999999999999999999996
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=406.07 Aligned_cols=259 Identities=22% Similarity=0.302 Sum_probs=207.0
Q ss_pred ccCCceEEecceeecCceeEEEEEEC-----CCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
+-..+|.+.++||+|+||+||+|++. .++..||||+++.... ...+.+|+++++.|+| ++|+.++.++.+..
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H-pnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQH-QHIVRFFGVCTEGR 116 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSSS
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECC
Confidence 44568999999999999999999875 3688999999876543 2458899999999975 77778888888888
Q ss_pred eeEEEEecc-CCCHHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCC
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCR--------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~--------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~ 141 (414)
..+|||||| +|+|.+++.... ..+++.+++.|+.||+.||+|||+++||||||||+|||+ +.
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl---~~ 193 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---GQ 193 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ET
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE---CC
Confidence 999999999 899999986432 358999999999999999999999999999999999999 58
Q ss_pred CCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhc
Q 015041 142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT 220 (414)
Q Consensus 142 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~ 220 (414)
++.+||+|||+|+........ .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~-----~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~- 267 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYY-----RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT- 267 (329)
T ss_dssp TTEEEECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH-
T ss_pred CCcEEEcccccceeccCCCcc-----eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH-
Confidence 899999999999865433221 12235679999999999999999999999999999999999 99999986554
Q ss_pred hHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 221 ~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
+.+..+... ...+.+ ..+|+++.+|+..||+.||++||++.+|.+.|+.+.+
T Consensus 268 --~~~~~i~~g-~~~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 268 --EAIDCITQG-RELERP---RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp --HHHHHHHHT-CCCCCC---TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --HHHHHHHcC-CCCCCc---ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 333344332 222222 4568999999999999999999999999999988764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=393.73 Aligned_cols=292 Identities=57% Similarity=0.994 Sum_probs=261.0
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
+.+++++|++++.||+|+||.||+|.+..+++.||||++........+.+|+.+++.+.++++++.+..++......++|
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 57899999999999999999999999999999999999887777778999999999998889999999999999999999
Q ss_pred EeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccC--CCCCeEEEeeecceeeecCC
Q 015041 82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG--RKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 82 ~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~--~~~~~vkL~DFG~a~~~~~~ 159 (414)
|||++++|.+++......++...++.++.||+.||+|||++||+||||||+|||++.. +....+||+|||+++.....
T Consensus 85 ~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 85 IDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred EEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 9999999999998877779999999999999999999999999999999999999521 12234999999999987766
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
......++.......||..|+|||++.+..++.++|||||||++|||++|+.||.+.......+.+..+.......+...
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 244 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHH
Confidence 55555555556678899999999999999999999999999999999999999998766666677777777777777788
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcccccccc
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 293 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l 293 (414)
.+..+|+++.+++..||..+|++||++.+|.+.|++++.+.+...+..+||..+
T Consensus 245 ~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l 298 (298)
T 1csn_A 245 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 298 (298)
T ss_dssp HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGCC
T ss_pred HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCCC
Confidence 888899999999999999999999999999999999999999999999999753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-54 Score=402.62 Aligned_cols=257 Identities=23% Similarity=0.315 Sum_probs=204.1
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
|-.++|+++++||+|+||+||+|++. ..||||+++..... ..+.+|+.+++.++| ++|+.+..++.. ...+
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~H-pNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRH-VNILLFMGYMTK-DNLA 107 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECS-SSCE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEC-CeEE
Confidence 44578899999999999999999863 35999998754332 357899999999986 556666666544 5689
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
|||||| +++|.+++......+++..++.|+.||+.||+|||+++||||||||+|||+ +.++.+||+|||+|+....
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC---
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE---CCCCcEEEeeccCceeccc
Confidence 999999 899999998666789999999999999999999999999999999999999 5889999999999986543
Q ss_pred CCCCccccccCCCCCccCcCccccccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
..... .....+||+.|||||++.+. .|+.++|||||||++|||+||+.||.+.+.. ..+..++......
T Consensus 185 ~~~~~-----~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~---~~~~~~~~~~~~~ 256 (307)
T 3omv_A 185 WSGSQ-----QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR---DQIIFMVGRGYAS 256 (307)
T ss_dssp --------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHHHHHHHTTCCC
T ss_pred CCcce-----eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH---HHHHHHHhcCCCC
Confidence 22211 12367899999999999743 5899999999999999999999999876543 2233333333333
Q ss_pred c-hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 236 P-IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 236 p-~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
| .......+|+++.+|+..||+.+|++||++.+|.+.|+.+
T Consensus 257 p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 257 PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2 3444567799999999999999999999999999888755
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=402.41 Aligned_cols=257 Identities=18% Similarity=0.223 Sum_probs=211.0
Q ss_pred cccCCceEEecceeecCceeEEEEEEC-----CCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 74 (414)
++--..++++++||+|+||+||+|.+. .+++.||||+++.... ...+.+|+.+++.|+| ++|+.+..++..
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~H-pNIV~l~g~~~~ 100 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH-PNVVCLLGVVTK 100 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCC-TTBCCEEEEECS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCC-CCCCCcceEEEE
Confidence 455578999999999999999999864 4678999999875432 3568999999999976 677778787878
Q ss_pred CCeeEEEEecc-CCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEcc
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 138 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~ 138 (414)
....+|||||| +|+|.+++.... ..+++..++.|+.||+.||+|||+++||||||||+|||+
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl-- 178 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV-- 178 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE--
Confidence 88899999999 899999986431 358999999999999999999999999999999999999
Q ss_pred CCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCh
Q 015041 139 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLK 217 (414)
Q Consensus 139 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~ 217 (414)
++++.+||+|||+|+........ ......+||++|||||++.+..|+.++|||||||++|||+| |..||.+.+
T Consensus 179 -~~~~~~Ki~DFGlar~~~~~~~~-----~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 179 -YDKLNVKISDLGLFREVYAADYY-----KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp -CGGGCEEECCSCCBCGGGGGGCB-----CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred -CCCCCEEECCcccceeccCCCce-----eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 58899999999999865432221 12235689999999999999999999999999999999998 899999876
Q ss_pred hhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 015041 218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (414)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~ 275 (414)
.. +.+..+.. ....|.+ ..+|+++.+++..||+.+|++||++.+|.+.|+.
T Consensus 253 ~~---~~~~~i~~-~~~~~~p---~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 253 NQ---DVVEMIRN-RQVLPCP---DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp HH---HHHHHHHT-TCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HH---HHHHHHHc-CCCCCCc---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 54 33333333 3333332 4568999999999999999999999999888873
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=409.20 Aligned_cols=263 Identities=21% Similarity=0.309 Sum_probs=216.6
Q ss_pred ccCCceEEecceeecCceeEEEEEECCC-----CceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeee-
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD- 74 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~- 74 (414)
|-.++|+++++||+|+||+||+|.+..+ ++.||||.+...... ..+.+|++++..+.||++|+.+..++..
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 4457899999999999999999998654 357999998765543 3588999999999998888888776644
Q ss_pred CCeeEEEEecc-CCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEcc
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 138 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~ 138 (414)
+...+|||||| +|+|.+++.... ..+++..++.|+.||+.||+|||+++||||||||+|||+
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl-- 218 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-- 218 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee--
Confidence 56789999999 899999997532 347899999999999999999999999999999999999
Q ss_pred CCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCh
Q 015041 139 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLK 217 (414)
Q Consensus 139 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~ 217 (414)
+.++.+||+|||+|+........ ......+||+.|||||++.+..|+.++|||||||++|||+| |..||.+..
T Consensus 219 -~~~~~vKi~DFGlar~~~~~~~~-----~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 219 -SEKNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp -CGGGCEEECCCGGGSCTTTCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred -CCCCCEEECcchhhhhcccCCCc-----eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 58899999999999865433221 12235678999999999999999999999999999999998 999999865
Q ss_pred hhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
.. +.+.+++......+.+ ..+|+++.+++..||+.||++||++.+|.+.|+++++..
T Consensus 293 ~~---~~~~~~i~~g~~~~~p---~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 293 ID---EEFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp CS---HHHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HH---HHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 33 2233333443333333 345899999999999999999999999999999887654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=396.46 Aligned_cols=247 Identities=22% Similarity=0.263 Sum_probs=197.4
Q ss_pred cCCce-EEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeee----C
Q 015041 5 IGVKY-KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVD----G 75 (414)
Q Consensus 5 ~~~~y-~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~----~ 75 (414)
..++| ++.++||+|+||+||+|.+..++..||+|++..... ...+.+|+.+++.|+| ++|+.++.++.. .
T Consensus 23 ~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIV~~~~~~~~~~~~~ 101 (290)
T 3fpq_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PNIVRFYDSWESTVKGK 101 (290)
T ss_dssp TTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEEEEETTE
T ss_pred CCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEeeccCCC
Confidence 34555 889999999999999999999999999998765432 2357899999999986 556666554432 3
Q ss_pred CeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeccccCCCceEEccCCCCCeEEEeeecc
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDLkp~Nili~~~~~~~~vkL~DFG~ 152 (414)
...+|||||| +++|.+++.. ...+++..++.|+.||+.||+|||+++ ||||||||+|||++ +.++.+||+|||+
T Consensus 102 ~~~~lvmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGl 178 (290)
T 3fpq_A 102 KCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTG
T ss_pred cEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeCcC
Confidence 4579999999 8899999876 467999999999999999999999998 99999999999994 2468999999999
Q ss_pred eeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc
Q 015041 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (414)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (414)
|+..... .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.... ...+..+...
T Consensus 179 a~~~~~~---------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~~~~i~~~- 245 (290)
T 3fpq_A 179 ATLKRAS---------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVTSG- 245 (290)
T ss_dssp GGGCCTT---------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHTTT-
T ss_pred CEeCCCC---------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HHHHHHHHcC-
Confidence 9753322 1236789999999999875 6999999999999999999999999864332 2233333332
Q ss_pred cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 233 ~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
..+ .......++++.+|+..||..||++||++.++.
T Consensus 246 ~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l 281 (290)
T 3fpq_A 246 VKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp CCC--GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCC--CCCCccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 221 223345678999999999999999999988763
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-54 Score=402.79 Aligned_cols=241 Identities=23% Similarity=0.367 Sum_probs=199.0
Q ss_pred CCceEEecceeecCceeEEEEEEC---CCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
-++|++++.||+|+||+||+|++. .+++.||||+++... ....+.+|+.+++.++| ++|+.++.++.+....
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH-PFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCC-TTEECEEEEEEETTEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCC-CCCCeEEEEEEECCEE
Confidence 357999999999999999999984 467899999886532 22357889999998875 6777788888888999
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
||||||| |++|.+++.. ...+++.+++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+...
T Consensus 102 ~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC--
T ss_pred EEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceecc
Confidence 9999999 8899999876 4579999999999999999999999999999999999999 588999999999998654
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
.... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+. .+.+..|.......|
T Consensus 178 ~~~~-------~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i~~~~~~~p- 246 (304)
T 3ubd_A 178 DHEK-------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR---KETMTMILKAKLGMP- 246 (304)
T ss_dssp ---C-------CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCC-
T ss_pred CCCc-------cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH---HHHHHHHHcCCCCCC-
Confidence 4322 12367899999999999999999999999999999999999999997544 345556666655544
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCCh
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~ 266 (414)
..+++++.+|+.+||..||++||++
T Consensus 247 ----~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 247 ----QFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ----CcCCHHHHHHHHHHcccCHHHCCCC
Confidence 4568999999999999999999985
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-52 Score=403.82 Aligned_cols=255 Identities=21% Similarity=0.250 Sum_probs=200.9
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeee------e
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGV------D 74 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~------~ 74 (414)
++++|+++++||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.|+| ++|+.++.++. +
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKH-DNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCC-TTBCCEEEECCCSSCTTT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCC-CCcceEeeeeeccccccc
Confidence 567899999999999999999999999999999998765432 347789999999976 56666655543 2
Q ss_pred CCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 75 ~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
....|||||||+++|.+++.. .+.+++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+
T Consensus 131 ~~~~~ivmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 131 FKSVYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMAR 206 (398)
T ss_dssp CCCEEEEEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCB
T ss_pred CCEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEeecceee
Confidence 357899999999999888865 5679999999999999999999999999999999999999 588999999999998
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
.+....... .......+||+.|||||++.+.. |+.++||||+||++|||++|+.||.+.+.... +..|.....
T Consensus 207 ~~~~~~~~~---~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~---l~~I~~~~g 280 (398)
T 4b99_A 207 GLCTSPAEH---QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ---LQLIMMVLG 280 (398)
T ss_dssp CC----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH---HHHHHHHHC
T ss_pred ecccCcccc---ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhcC
Confidence 654322111 11234679999999999998864 69999999999999999999999998655433 333333322
Q ss_pred CCc--------------------------hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 234 STP--------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 234 ~~p--------------------------~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
.++ ........++++.+|+.+||..||.+||++.++.
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 343 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAAL 343 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 222 2233345567788888888888888888876653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=387.30 Aligned_cols=265 Identities=23% Similarity=0.249 Sum_probs=198.0
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHH--HHHHHHHcCCCCCCeeEEeeeeC----Cee
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYE--AKVYKILQGGSGIPNIKWYGVDG----EDN 78 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E--~~~l~~l~~~~~i~~l~~~~~~~----~~~ 78 (414)
|+++|.+.++||+|+||+||+|++ +|+.||||+++.... ..+..| +..+..++| ++|+.+..++... ...
T Consensus 1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~H-pNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRH-ENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCC-TTBCCEEEEEEEECSSSEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hhHHHHHHHHHHhcCCC-CCCCcEEEEEEecCCCceEE
Confidence 467899999999999999999998 688999999875432 234444 444455665 5666665555432 257
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc--------CeeccccCCCceEEccCCCCCeEEEee
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR--------GFLHRDIKPDNFLMGLGRKANQVYIID 149 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~iiHrDLkp~Nili~~~~~~~~vkL~D 149 (414)
+|||||+ +++|.+++.. ..+++..++.++.|++.||+|||++ +||||||||+|||+ +.++.+||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~D 151 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIAD 151 (303)
T ss_dssp EEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECC
T ss_pred EEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEEe
Confidence 9999999 7999999874 5689999999999999999999987 89999999999999 5889999999
Q ss_pred ecceeeecCCCCCccccccCCCCCccCcCccccccccCC------CCCchhhHHHHHHHHHHHHcCCCCCCC--------
Q 015041 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI------EQSRRDDLESLGYVLLYFLRGSLPWQG-------- 215 (414)
Q Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~~DiwSlG~il~el~tG~~Pf~~-------- 215 (414)
||+|+.......... ......+||+.|||||++.+. .++.++|||||||++|||+||..||..
T Consensus 152 FGla~~~~~~~~~~~---~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~ 228 (303)
T 3hmm_A 152 LGLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp CTTCEEEETTTTEES---CC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred CCCCccccCCCCcee---eecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence 999987654432111 112356899999999999765 367899999999999999999776542
Q ss_pred --Chh--hchHHHHHHHHhhccCCchHHhhh--cChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 015041 216 --LKA--ATKKQKYDKICEKKVSTPIEVLCK--SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (414)
Q Consensus 216 --~~~--~~~~~~~~~i~~~~~~~p~~~~~~--~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~ 281 (414)
... ....+....+.....+++++.... ..++.+.+++..||..||++||++.+|.+.|+++.+.++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~ 300 (303)
T 3hmm_A 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred hhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence 211 112233333445555444333222 235689999999999999999999999999998876654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=387.41 Aligned_cols=206 Identities=23% Similarity=0.381 Sum_probs=173.5
Q ss_pred cCCceEEecceeecCceeEEEEEEC---CCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
+.++|+++++||+|+||+||+|++. .+++.||||.+........+.+|+++++.+.+|++|+.+..++.+..+.++|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv 98 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA 98 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence 4678999999999999999999874 4678999999887776677899999999998888999998888889999999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++ +.+++.+++.++.||+.||+|||++|||||||||+|||++ .+.+.+||+|||+|+......
T Consensus 99 mE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~--~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 99 MPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN--RRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECTTCS
T ss_pred EeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe--CCCCeEEECcCCCCcccCCcc
Confidence 9999 78898877 3589999999999999999999999999999999999995 344799999999998654432
Q ss_pred CCcc---------------------ccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 015041 161 TNRH---------------------IPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGL 216 (414)
Q Consensus 161 ~~~~---------------------~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~tG~~Pf~~~ 216 (414)
.... .........+||+.|||||++.+.. |+.++||||+||++|||++|+.||...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 1100 0001123568999999999998864 899999999999999999999999653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=379.75 Aligned_cols=255 Identities=21% Similarity=0.257 Sum_probs=184.3
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeee-C---
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD-G--- 75 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~-~--- 75 (414)
|.+ ++|++++.||+|+||+||+|++..+|+.||||++...... ..+.+|+.+++.|+| ++|+.++.++.+ .
T Consensus 2 R~l-~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~H-pnIV~~~~~~~~~~~~~ 79 (299)
T 4g31_A 2 RYL-TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH-PGIVRYFNAWLEKNTTE 79 (299)
T ss_dssp HHH-HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEEEC---
T ss_pred Ccc-hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEecCccc
Confidence 344 4699999999999999999999999999999988654432 357899999999976 556566544332 2
Q ss_pred --------CeeEEEEecc-CCCHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCe
Q 015041 76 --------EDNVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 144 (414)
Q Consensus 76 --------~~~~lv~e~~-~~sL~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~ 144 (414)
.+.||||||| +++|.+++..... ......++.|+.||+.||+|||++|||||||||+|||+ +.++.
T Consensus 80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~ 156 (299)
T 4g31_A 80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDV 156 (299)
T ss_dssp -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCC
T ss_pred cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCc
Confidence 2468999999 8899999875321 24567789999999999999999999999999999999 57889
Q ss_pred EEEeeecceeeecCCCCCcc-----ccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhh
Q 015041 145 VYIIDFGLAKKYRDPTTNRH-----IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219 (414)
Q Consensus 145 vkL~DFG~a~~~~~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~ 219 (414)
+||+|||+|+.......... .........+||+.|||||++.+..|+.++|||||||++|||++ ||.+..
T Consensus 157 vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-- 231 (299)
T 4g31_A 157 VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-- 231 (299)
T ss_dssp EEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred EEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--
Confidence 99999999987654322111 01112235689999999999999999999999999999999996 887532
Q ss_pred chHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 220 TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 220 ~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+....+..+.... .|. . ....++...+|+..||..||.+||++.++.+
T Consensus 232 ~~~~~~~~~~~~~--~p~-~-~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 ERVRTLTDVRNLK--FPP-L-FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHHHHTTC--CCH-H-HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHhcCC--CCC-C-CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2223333333322 221 1 1222456789999999999999999887644
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=405.02 Aligned_cols=259 Identities=24% Similarity=0.330 Sum_probs=214.4
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHc--CCCCCCeeEEeeeeCCeeE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~--~~~~i~~l~~~~~~~~~~~ 79 (414)
++|++++.||+|+||+||+|++..+|+.||||++.+. ........|..++..+. +|++|+.++..+.+....|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 6899999999999999999999999999999988642 22334556666666654 4678888888888999999
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
|||||+ ||+|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+....
T Consensus 269 lVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSS
T ss_pred EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceeeecCC
Confidence 999999 8999999876 4679999999999999999999999999999999999999 5889999999999987654
Q ss_pred CCCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
... .+.+||+.|||||++.+ ..|+.++|||||||++|||++|..||.+.......+....+.......|
T Consensus 345 ~~~---------~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p- 414 (689)
T 3v5w_A 345 KKP---------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP- 414 (689)
T ss_dssp CCC---------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC-
T ss_pred CCC---------CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC-
Confidence 322 36799999999999975 5799999999999999999999999987655444455555555555544
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCC-----hHHHHHHHHHHHHhcCCCCCcccccccc
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKRLFHDLFSREGYDFDFVFDWTIL 293 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~-----~~~l~~~l~~~~~~~~~~~~~~~dw~~l 293 (414)
..+++++.+|+..||..||.+|++ +++|. .+.|...+||..+
T Consensus 415 ----~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~----------~HpfF~~idW~~l 461 (689)
T 3v5w_A 415 ----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK----------ESPFFRSLDWQMV 461 (689)
T ss_dssp ----TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT----------TSGGGTTCCHHHH
T ss_pred ----ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh----------cCccccCCCHHHH
Confidence 456899999999999999999997 34443 3455566777543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=381.81 Aligned_cols=285 Identities=29% Similarity=0.531 Sum_probs=223.4
Q ss_pred ccCCceEEecceeecCceeEEEEEECCC-----CceEEEEEecCCCCchhHHHHHHHHHHHcC--------------CCC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTKHPQLLYEAKVYKILQG--------------GSG 64 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~E~~~l~~l~~--------------~~~ 64 (414)
+..++|+++++||+|+||+||+|.+..+ ++.||||++.... ..+..|+++++.+.+ |++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN--GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC--HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc--hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence 4456999999999999999999998754 5789999987654 356677777766654 677
Q ss_pred CCeeEEeeeeC----CeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCC
Q 015041 65 IPNIKWYGVDG----EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 140 (414)
Q Consensus 65 i~~l~~~~~~~----~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~ 140 (414)
|+.+..++... ...++||||++++|.+++......+++..++.|+.||+.||+|||++||+||||||+|||++. +
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~ 188 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-K 188 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-S
T ss_pred CCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-C
Confidence 77776665543 457999999999999999886678999999999999999999999999999999999999942 1
Q ss_pred CCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhc
Q 015041 141 KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT 220 (414)
Q Consensus 141 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~ 220 (414)
..+.+||+|||+|+....................||..|+|||++.+..++.++|||||||++|||++|+.||.+.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 67899999999998765433222211222345679999999999999999999999999999999999999998643222
Q ss_pred hHHHHHHHHhhccCCchHHh---h---hcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCccccccccc
Q 015041 221 KKQKYDKICEKKVSTPIEVL---C---KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK 294 (414)
Q Consensus 221 ~~~~~~~i~~~~~~~p~~~~---~---~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l~ 294 (414)
..... ...........+ | ..+|+++.+++..||..+|.+||++.+|.+.|++++...+...+..+||....
T Consensus 269 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 345 (364)
T 3op5_A 269 KYVRD---SKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVE 345 (364)
T ss_dssp HHHHH---HHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC----
T ss_pred HHHHH---HHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEecc
Confidence 11111 111111112211 1 46689999999999999999999999999999999999999999999997644
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=395.85 Aligned_cols=251 Identities=18% Similarity=0.252 Sum_probs=212.5
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
++|++++.||+|+||+||+|.+..+|+.||||++..... ...+.+|+.+|+.|+| ++|..++.++.+....+|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCC-TTBCCEEEEEECSSEEEEEEEC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEEEEEEee
Confidence 689999999999999999999999999999998876542 3457899999999975 6777888888888999999999
Q ss_pred c-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 85 ~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
| +++|.+++......+++.++..++.||+.||+|||++||+||||||+|||++. +..+.+||+|||+|+.......
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~~~~~~~-- 312 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQS-- 312 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCSSCEECCTTSE--
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC-CCCCCEEEeeccceeEccCCCc--
Confidence 9 78999888655567999999999999999999999999999999999999942 2347899999999987643321
Q ss_pred cccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhc
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~ 243 (414)
....+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+.. +.+..|.......+. .....
T Consensus 313 ------~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~---~~~~~i~~~~~~~~~-~~~~~ 382 (573)
T 3uto_A 313 ------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNVKSCDWNMDD-SAFSG 382 (573)
T ss_dssp ------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHTTCCCCCS-GGGTT
T ss_pred ------eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHhCCCCCCc-ccccC
Confidence 13568999999999999999999999999999999999999999986543 445555555544443 33456
Q ss_pred ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 244 HPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 244 ~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+++++.+|+..||..||.+||++.++.+
T Consensus 383 ~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 383 ISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 7899999999999999999999887654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=356.77 Aligned_cols=281 Identities=22% Similarity=0.361 Sum_probs=220.4
Q ss_pred CCceEEecceeecCceeEEEEEECC--------CCceEEEEEecCCCCchhHHHHHHHHHHHcCC--------------C
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVD--------TNEIVAVKIENSGTKHPQLLYEAKVYKILQGG--------------S 63 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~--------------~ 63 (414)
+++|++++.||+|+||.||+|++.. .++.||||++... ..+.+|+.+++.+.|. .
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 6899999999999999999999987 3889999998765 4678899999998763 2
Q ss_pred CCCeeEEeeee-CCeeEEEEeccCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCC
Q 015041 64 GIPNIKWYGVD-GEDNVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (414)
Q Consensus 64 ~i~~l~~~~~~-~~~~~lv~e~~~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~ 141 (414)
+++.+..++.. ....++||||++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++ .
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~---~ 194 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD---P 194 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE---T
T ss_pred CccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc---C
Confidence 34445555554 7788999999999999999864 36799999999999999999999999999999999999994 5
Q ss_pred CC--eEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhh
Q 015041 142 AN--QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219 (414)
Q Consensus 142 ~~--~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~ 219 (414)
++ .+||+|||+++....................||..|+|||++.+..++.++|||||||++|||++|..||.+....
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 66 8999999999865543221111111223568999999999999999999999999999999999999999875321
Q ss_pred c-h-HHHHHHHHhhccCCch-HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCccccccc
Q 015041 220 T-K-KQKYDKICEKKVSTPI-EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTI 292 (414)
Q Consensus 220 ~-~-~~~~~~i~~~~~~~p~-~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 292 (414)
. . ......+.......+. ......+++++.+++..||..+|.+||++.++.+.|+.++...+...+..+||..
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw~~ 350 (352)
T 2jii_A 275 TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLPM 350 (352)
T ss_dssp HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCCCC
T ss_pred HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccCcC
Confidence 1 1 1111111111111000 0011245899999999999999999999999999999999999999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=348.66 Aligned_cols=264 Identities=23% Similarity=0.338 Sum_probs=213.9
Q ss_pred CCcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015041 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (414)
Q Consensus 1 ~~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 75 (414)
+|++++++|++++.||+|+||.||+|++..++..||+|++...... ..+.+|+.++..+.| ++++.+..++...
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~ 83 (294)
T 4eqm_A 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH-QNIVSMIDVDEED 83 (294)
T ss_dssp CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCB-TTBCCEEEEEECS
T ss_pred hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCC-CCCceEEEeeeeC
Confidence 5889999999999999999999999999999999999987554322 346789999988875 6777777788888
Q ss_pred CeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
...++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~ 159 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAK 159 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCSSST
T ss_pred CeEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCCCcc
Confidence 8999999999 7799998876 4579999999999999999999999999999999999999 578899999999997
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
........ ......||..|+|||++.+..++.++|||||||++|+|++|+.||.+.... ....+.......
T Consensus 160 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~---~~~~~~~~~~~~ 230 (294)
T 4eqm_A 160 ALSETSLT------QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV---SIAIKHIQDSVP 230 (294)
T ss_dssp TC-------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH---HHHHHHHSSCCC
T ss_pred cccccccc------ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHhhccCC
Confidence 54332211 123567899999999999999999999999999999999999999875433 223333344444
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCC-ChHHHHHHHHHHHH
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRP-DYGFLKRLFHDLFS 278 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP-~~~~l~~~l~~~~~ 278 (414)
.........+|+.+.+++.+||..+|.+|| +++++.+.|..++.
T Consensus 231 ~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 231 NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 444455567899999999999999999999 78888777775543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=356.80 Aligned_cols=265 Identities=20% Similarity=0.299 Sum_probs=215.8
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
-++|+++++||+|+||+||+|++..+++.||||+++... ....+..|..++..+.+|++|+.+..++......++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999999999999999886432 234578899999988777889999888888899999
Q ss_pred EEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 81 v~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.....
T Consensus 131 V~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCT
T ss_pred EEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeecccC
Confidence 99999 7799888876 4579999999999999999999999999999999999999 58899999999999853332
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhh------chHHHHHHHHhhcc
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA------TKKQKYDKICEKKV 233 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~------~~~~~~~~i~~~~~ 233 (414)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.... ........+.....
T Consensus 207 ~~-------~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~ 279 (396)
T 4dc2_A 207 GD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 279 (396)
T ss_dssp TC-------CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC
T ss_pred CC-------ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc
Confidence 21 224678999999999999999999999999999999999999999753211 12234445555555
Q ss_pred CCchHHhhhcChHHHHHHHHHHhcCCCCCCCChH---HHHHHHHHHHHhcCCCCCcccccccc
Q 015041 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG---FLKRLFHDLFSREGYDFDFVFDWTIL 293 (414)
Q Consensus 234 ~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~---~l~~~l~~~~~~~~~~~~~~~dw~~l 293 (414)
..| ..++.++.+++..||..||.+||++. .+.+.++ +.|...+||..+
T Consensus 280 ~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~-------Hpff~~i~w~~l 330 (396)
T 4dc2_A 280 RIP-----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG-------HPFFRNVDWDMM 330 (396)
T ss_dssp CCC-----TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH-------STTTTTCCHHHH
T ss_pred CCC-----CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc-------CccccCCCHHHH
Confidence 544 34688999999999999999999862 2222222 355566778654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=343.49 Aligned_cols=246 Identities=22% Similarity=0.313 Sum_probs=204.1
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCC--CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
.++|++.++||+|+||+||+|.+..+++.||||++... .....+.+|+.+++.+.| ++|+.+..++......++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCC-CCCCeEeEEEEECCEEEEEEE
Confidence 47899999999999999999999999999999987543 334557899999999876 677777777778889999999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
|+ +++|.+++.. ..++...++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 98 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCceecCCccc-
Confidence 99 8899998874 468999999999999999999999999999999999999 5788999999999987654332
Q ss_pred ccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhh
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~ 242 (414)
......||..|+|||++.+..++.++|||||||++|+|++|..||.+...... ...+....... .....
T Consensus 172 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~--~~~~~ 240 (297)
T 3fxz_A 172 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA---LYLIATNGTPE--LQNPE 240 (297)
T ss_dssp ------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHHCSCC--CSCGG
T ss_pred ------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhCCCCC--CCCcc
Confidence 12356899999999999999999999999999999999999999987554322 22222222111 11124
Q ss_pred cChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 243 SHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 243 ~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
.+++.+.+++..||..||.+||++.++
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~el 267 (297)
T 3fxz_A 241 KLSAIFRDFLNRCLEMDVEKRGSAKEL 267 (297)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHH
Confidence 568899999999999999999998765
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=351.20 Aligned_cols=262 Identities=19% Similarity=0.311 Sum_probs=214.5
Q ss_pred ccCCceEEecceeecCceeEEEEEEC-------CCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHV-------DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV 73 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~ 73 (414)
+..++|++++.||+|+||.||+|++. .++..||||++...... ..+.+|+.+++.+.+|++|+.+..++.
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 44578999999999999999999975 34567999998765432 347899999999966688888888888
Q ss_pred eCCeeEEEEecc-CCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEc
Q 015041 74 DGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137 (414)
Q Consensus 74 ~~~~~~lv~e~~-~~sL~~~~~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~ 137 (414)
.....++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll- 236 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV- 236 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE-
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE-
Confidence 888899999999 779999988643 247899999999999999999999999999999999999
Q ss_pred cCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 015041 138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 216 (414)
Q Consensus 138 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~ 216 (414)
+.++.+||+|||+++........ .......+|..|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 237 --~~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 237 --TENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp --CTTCCEEECCCSSCEETTCCCTT-----CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred --CCCCCEEEccccCCcccCcccce-----ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 58899999999999865443221 12234567889999999999999999999999999999999 99999886
Q ss_pred hhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
..... +..+ ......+. ...++.++.+++..||..+|.+||++.++.+.|+.++...
T Consensus 310 ~~~~~---~~~~-~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 310 PVEEL---FKLL-KEGHRMDK---PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp CGGGH---HHHH-HTTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CHHHH---HHHH-hcCCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 54332 2222 22222222 2356889999999999999999999999999999887643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=342.73 Aligned_cols=259 Identities=17% Similarity=0.231 Sum_probs=201.1
Q ss_pred CCcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-------CchhHHHHHHHHHHHc--CCCCCCeeEEe
Q 015041 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-------KHPQLLYEAKVYKILQ--GGSGIPNIKWY 71 (414)
Q Consensus 1 ~~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~--~~~~i~~l~~~ 71 (414)
+|.++.++|+++++||+|+||+||+|++..+++.||||++.... ....+.+|+.+++.+. .|++++.+..+
T Consensus 3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 47789999999999999999999999999999999999876322 2345778998888887 35667666655
Q ss_pred eeeCC-----eeEEEEeccCCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeE
Q 015041 72 GVDGE-----DNVLVLDLLGPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 145 (414)
Q Consensus 72 ~~~~~-----~~~lv~e~~~~sL~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~v 145 (414)
+.... ..++|||+++++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~~~ 159 (308)
T 3g33_A 83 CATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTV 159 (308)
T ss_dssp EEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTSCE
T ss_pred eeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCE
Confidence 54433 5799999999999999875432 38999999999999999999999999999999999999 578899
Q ss_pred EEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHH
Q 015041 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY 225 (414)
Q Consensus 146 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~ 225 (414)
||+|||+++....... .....||..|+|||++.+..++.++|||||||++|+|++|..||.+.........+
T Consensus 160 kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i 231 (308)
T 3g33_A 160 KLADFGLARIYSYQMA--------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231 (308)
T ss_dssp EECSCSCTTTSTTCCC--------SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHH
T ss_pred EEeeCccccccCCCcc--------cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999975433221 23567899999999999999999999999999999999999999986654433333
Q ss_pred HHHHhh-------------------ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 226 DKICEK-------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 226 ~~i~~~-------------------~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
...... ....+.......+++++.+++..||..||.+||++.++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 295 (308)
T 3g33_A 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295 (308)
T ss_dssp HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHh
Confidence 322211 111122333446778999999999999999999987653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=352.99 Aligned_cols=244 Identities=18% Similarity=0.282 Sum_probs=204.2
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
+--++|++++.||+|+||+||+|++..+++.||||++... .....+..|..++..+.+|++++.+..++......
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 3457899999999999999999999999999999988643 23345778999999887788999998888888999
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+...
T Consensus 100 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSC
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeecc
Confidence 9999999 7899888876 4579999999999999999999999999999999999999 588999999999997533
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+. .+.+..+.......|
T Consensus 176 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~~~~~~p- 244 (353)
T 3txo_A 176 CNGV-------TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE---DDLFEAILNDEVVYP- 244 (353)
T ss_dssp C----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCC-
T ss_pred cCCc-------cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCC-
Confidence 2221 12367899999999999998999999999999999999999999987544 345556666665554
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCCh
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~ 266 (414)
..+++++.+++..||..+|.+||++
T Consensus 245 ----~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 245 ----TWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred ----CCCCHHHHHHHHHHhhhCHHHccCC
Confidence 3457899999999999999999997
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=348.93 Aligned_cols=252 Identities=20% Similarity=0.278 Sum_probs=212.0
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--------chhHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 74 (414)
.-+.++|++++.||+|+||.||+|.+..+|+.||+|++..... ...+.+|+.+++.+.| ++|+.+..++..
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~ 86 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH-PNIITLHDVYEN 86 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCC-TTBCCEEEEEEC
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCC-cCCCcEEEEEEe
Confidence 3467899999999999999999999999999999998875432 2458899999999975 677778777788
Q ss_pred CCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCC----eEEEee
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN----QVYIID 149 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~----~vkL~D 149 (414)
....++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+. ..+ .+||+|
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~---~~~~~~~~vkl~D 162 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL---DKNIPIPHIKLID 162 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES---CTTSSSCCEEECC
T ss_pred CCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe---CCCCCccCEEEEe
Confidence 88999999999 8899998864 45799999999999999999999999999999999999995 333 799999
Q ss_pred ecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHH
Q 015041 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (414)
Q Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~ 229 (414)
||+++....... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... +.+..+.
T Consensus 163 FG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~~~~~i~ 231 (361)
T 2yab_A 163 FGLAHEIEDGVE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANIT 231 (361)
T ss_dssp CSSCEECCTTCC--------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHH
T ss_pred cCCceEcCCCCc--------cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH
Confidence 999987654321 23567999999999999999999999999999999999999999875433 4455555
Q ss_pred hhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 230 ~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
......+. ..+...++++.+|+..||..||.+||++.++.+
T Consensus 232 ~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 232 AVSYDFDE-EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp TTCCCCCH-HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcCCCCCc-hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 55555443 344677899999999999999999999887643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=346.72 Aligned_cols=246 Identities=23% Similarity=0.347 Sum_probs=207.1
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
.-++|++++.||+|+||.||+|.+..+|+.||||++...... ..+.+|+++++.++| ++++.+..++......++
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH-PNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCEEEE
Confidence 347899999999999999999999999999999988654322 347789999999975 677777777778889999
Q ss_pred EEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 81 v~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 92 v~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EECCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSSS
T ss_pred EEECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCceecCCC
Confidence 99999 7899998876 4579999999999999999999999999999999999999 58899999999999754432
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQS-RRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
.. ....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+.. +....+.......|
T Consensus 168 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~p-- 234 (328)
T 3fe3_A 168 GK--------LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK---ELRERVLRGKYRIP-- 234 (328)
T ss_dssp CG--------GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC--
T ss_pred Cc--------cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC--
Confidence 21 2356899999999999988875 8999999999999999999999986543 34444555555544
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...+.++.+++..||..||.+||+++++.+
T Consensus 235 ---~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 235 ---FYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ---TTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ---CCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 245789999999999999999999887644
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=341.70 Aligned_cols=256 Identities=19% Similarity=0.247 Sum_probs=205.8
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
+.+.++|+++++||+|+||+||+|++. +++.||||++...... ..+.+|+.+++.++| ++|+.+..++......
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~ 94 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHH-PNIVSLIDVIHSERCL 94 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCC-TTBCCEEEEECCSSCE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCC-CCEeeeeeEEccCCEE
Confidence 456799999999999999999999985 5899999988754322 357899999999975 6777777777788889
Q ss_pred EEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 79 ~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
++||||+.++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 95 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 95 TLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEETTS
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCcCceecCC
Confidence 9999999999999888766679999999999999999999999999999999999999 5788999999999987543
Q ss_pred CCCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC---
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS--- 234 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~--- 234 (414)
... ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+..+......
T Consensus 172 ~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 172 PVR-------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244 (311)
T ss_dssp CCC----------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred Ccc-------cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence 322 1234578999999999987 46899999999999999999999999987665554444443322111
Q ss_pred -------------------CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 235 -------------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 235 -------------------~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
.+.......+++++.+|+..||..||.+||++.++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 299 (311)
T 3niz_A 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM 299 (311)
T ss_dssp GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 112223345678899999999999999999987653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=340.40 Aligned_cols=249 Identities=19% Similarity=0.203 Sum_probs=204.1
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
++++.++|+++++||+|+||+||+|.+..+++.||||++...... .....|+..+..+.++++++.+..++.....
T Consensus 52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~ 131 (311)
T 3p1a_A 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131 (311)
T ss_dssp SCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence 456678999999999999999999999999999999987654332 2345666666677677888888888889999
Q ss_pred eEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 78 ~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
.++||||++++|.+++......+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+++...
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccceeeeecc
Confidence 99999999999999998877789999999999999999999999999999999999999 578899999999998654
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
.... .....||..|+|||++.+ .++.++|||||||++|||++|..||.+.. ....+.... ..
T Consensus 209 ~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~------~~~~~~~~~---~~ 270 (311)
T 3p1a_A 209 TAGA--------GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE------GWQQLRQGY---LP 270 (311)
T ss_dssp --------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH------HHHHHTTTC---CC
T ss_pred cCCC--------CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHhccC---CC
Confidence 3322 124568999999999886 79999999999999999999977766522 122222222 12
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
......+++++.+++..||..+|++||++.++.+
T Consensus 271 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 271 PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 3344667899999999999999999999987643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=345.11 Aligned_cols=247 Identities=21% Similarity=0.302 Sum_probs=207.1
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
--++|++++.||+|+||+||+|++..+++.||||++... .....+..|+.+++.+.| ++++.+..++......+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCC-TTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCC-CcCcceEEEEEeCCEEE
Confidence 347899999999999999999999999999999988642 233457889999998865 67778888888888999
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
+||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 82 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhccc
Confidence 999999 7799888875 4579999999999999999999999999999999999999 5889999999999975432
Q ss_pred CCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+.......|
T Consensus 158 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~~~~~~~p-- 225 (337)
T 1o6l_A 158 DGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELILMEEIRFP-- 225 (337)
T ss_dssp TTC-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCC--
T ss_pred CCC-------cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCCCC--
Confidence 221 12367899999999999999999999999999999999999999987543 344445555555444
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP-----~~~~l~~ 271 (414)
..+++++.+++..||..+|.+|| +++++.+
T Consensus 226 ---~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 226 ---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 35688999999999999999999 6665543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=348.63 Aligned_cols=209 Identities=24% Similarity=0.388 Sum_probs=180.5
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHc----CCCCCCeeEEeeeeCC
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQ----GGSGIPNIKWYGVDGE 76 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~----~~~~i~~l~~~~~~~~ 76 (414)
+.+++++|+++++||+|+||+||+|++..+++.||||++..... ...+..|+.+++.+. .|++++.+..++....
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 67889999999999999999999999999999999999875332 234678999999997 3577888888888888
Q ss_pred eeEEEEeccCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccC----------------
Q 015041 77 DNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG---------------- 139 (414)
Q Consensus 77 ~~~lv~e~~~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~---------------- 139 (414)
..++||||++++|.+++.... ..++...++.++.||+.||+|||++||+||||||+|||+...
T Consensus 110 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 110 HMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp EEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred eeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccc
Confidence 999999999999999998654 359999999999999999999999999999999999999421
Q ss_pred ------CCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 015041 140 ------RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213 (414)
Q Consensus 140 ------~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf 213 (414)
...+.+||+|||+|+...... ....||..|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 190 ~~~~~~~~~~~~kl~DFG~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 190 KIQIYRTKSTGIKLIDFGCATFKSDYH----------GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp EEEEEEESCCCEEECCCTTCEETTSCC----------CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccCCCCEEEEeccCceecCCCC----------cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence 127889999999998643322 2567899999999999999999999999999999999999999
Q ss_pred CCChhhc
Q 015041 214 QGLKAAT 220 (414)
Q Consensus 214 ~~~~~~~ 220 (414)
.+.....
T Consensus 260 ~~~~~~~ 266 (360)
T 3llt_A 260 RTHEHME 266 (360)
T ss_dssp CCSSHHH
T ss_pred CCCcHHH
Confidence 8865443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=346.80 Aligned_cols=264 Identities=19% Similarity=0.279 Sum_probs=213.9
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCc---eEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 75 (414)
.++..++|++.+.||+|+||+||+|.+..+++ .||||++...... ..+.+|+.+++.++| ++|+.+..++...
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~ 122 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDH-PNIIRLEGVVTRG 122 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECGG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEeC
Confidence 35677899999999999999999999986555 4999998765432 347889999999975 6777777777788
Q ss_pred CeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
...++||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSR 199 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSCE
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCccc
Confidence 8899999999 779999987666789999999999999999999999999999999999999 588999999999998
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhcc
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
.......... ......+|..|+|||++.+..++.++|||||||++|||++ |..||.+..... ....+ ....
T Consensus 200 ~~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~-~~~~ 271 (325)
T 3kul_A 200 VLEDDPDAAY----TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---VISSV-EEGY 271 (325)
T ss_dssp ECC----CCE----ECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHH-HTTC
T ss_pred ccccCcccee----eccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHH-HcCC
Confidence 7654322111 1123456788999999999999999999999999999999 999998765433 22222 2222
Q ss_pred CCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 234 ~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
..+.+ ..+|+.+.+++..||..+|.+||++.++.+.|+.++...
T Consensus 272 ~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 272 RLPAP---MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp CCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred CCCCC---CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 22222 456899999999999999999999999999999887643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=340.74 Aligned_cols=242 Identities=23% Similarity=0.324 Sum_probs=205.9
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
-++|++++.||+|+||.||+|++..+|+.||+|++... .....+.+|+.+++.+.| ++++.+..++.+....++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH-PFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCB-TTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCC-CCCceEeEEEEeCCEEEE
Confidence 47899999999999999999999999999999987643 233457789999988865 677778777888889999
Q ss_pred EEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 81 v~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 84 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC
T ss_pred EEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceecCCc
Confidence 99999 7899998876 5579999999999999999999999999999999999999 58899999999999865432
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
. ...+||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+.+.++.......|
T Consensus 160 ~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~p--- 223 (318)
T 1fot_A 160 T----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MKTYEKILNAELRFP--- 223 (318)
T ss_dssp B----------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHCCCCCC---
T ss_pred c----------ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCC---
Confidence 1 256899999999999999999999999999999999999999987543 345556666555544
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCC-----ChHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLK 270 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP-----~~~~l~ 270 (414)
..+++++.+++..||..+|.+|| +++++.
T Consensus 224 --~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~ 257 (318)
T 1fot_A 224 --PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 257 (318)
T ss_dssp --TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred --CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHh
Confidence 35678999999999999999999 555543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=347.89 Aligned_cols=256 Identities=19% Similarity=0.217 Sum_probs=210.9
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-------CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-------TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 75 (414)
.++.++|++++.||+|+||+||+|.+..+++.||||++... .....+.+|+.+++.++| ++|+.+..++...
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~ 98 (351)
T 3c0i_A 20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH-PHIVELLETYSSD 98 (351)
T ss_dssp CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCC-TTBCCEEEEEEET
T ss_pred CccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCC-CCCCcEEEEEEeC
Confidence 35678999999999999999999999999999999987531 134568899999999975 6777777777788
Q ss_pred CeeEEEEecc-CCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeec
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG 151 (414)
...++||||+ +++|.+.+... ...+++..++.++.||+.||+|||++||+||||||+|||++..+....+||+|||
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 8999999999 68998777643 2358999999999999999999999999999999999999643345569999999
Q ss_pred ceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhh
Q 015041 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (414)
Q Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~ 231 (414)
+++....... .....+||..|+|||++.+..++.++|||||||++|+|++|..||.+... +.+..+...
T Consensus 179 ~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~i~~~ 247 (351)
T 3c0i_A 179 VAIQLGESGL-------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEGIIKG 247 (351)
T ss_dssp TCEECCTTSC-------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHHHHHHT
T ss_pred ceeEecCCCe-------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHHHHHcC
Confidence 9987654322 12356799999999999999999999999999999999999999987432 344445555
Q ss_pred ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 232 ~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
....+. ..+..+++++.+++..||..||.+||++.++.+
T Consensus 248 ~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 248 KYKMNP-RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCCCCH-HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCc-cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 544443 334567899999999999999999999987755
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=353.38 Aligned_cols=206 Identities=22% Similarity=0.323 Sum_probs=177.2
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCC-----CCCCeeEEeeeeC
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGG-----SGIPNIKWYGVDG 75 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~-----~~i~~l~~~~~~~ 75 (414)
++.+..+|+++++||+|+||+||+|.+..+++.||||++..... ...+..|+.+++.+.+. .++..+..++...
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred CCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 35678899999999999999999999999999999999876432 24577899999998753 3666677777788
Q ss_pred CeeEEEEeccCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCe--EEEeeecc
Q 015041 76 EDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGL 152 (414)
Q Consensus 76 ~~~~lv~e~~~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~--vkL~DFG~ 152 (414)
...++||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++. +||+|||+
T Consensus 172 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~---~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 172 NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK---QQGRSGIKVIDFGS 248 (429)
T ss_dssp TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEES---STTSCCEEECCCTT
T ss_pred CeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc---cCCCcceEEeeccc
Confidence 8999999999999999988654 4599999999999999999999999999999999999994 5555 99999999
Q ss_pred eeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhc
Q 015041 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT 220 (414)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~ 220 (414)
|+...... ...+||..|+|||++.+..++.++|||||||++|||++|..||.+.....
T Consensus 249 a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 306 (429)
T 3kvw_A 249 SCYEHQRV----------YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306 (429)
T ss_dssp CEETTCCC----------CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ceecCCcc----------cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 97543321 25688999999999999999999999999999999999999999865543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=347.47 Aligned_cols=244 Identities=20% Similarity=0.289 Sum_probs=208.0
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
+--++|++++.||+|+||.||+|++..+++.||||++... .....+..|..++..+.+|++++.+..++......
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 4457999999999999999999999999999999987643 23345778888888887788999998888888999
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+...
T Consensus 97 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCcccccc
Confidence 9999999 7899998876 3569999999999999999999999999999999999999 588999999999997543
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+. .+.+..+.......|
T Consensus 173 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~~~~~~p- 241 (353)
T 2i0e_A 173 WDGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIMEHNVAYP- 241 (353)
T ss_dssp CTTC-------CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCC-
T ss_pred cCCc-------ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH---HHHHHHHHhCCCCCC-
Confidence 2221 12367899999999999999999999999999999999999999987543 345556666655554
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCCh
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~ 266 (414)
..++.++.+++..||..+|.+||+.
T Consensus 242 ----~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 242 ----KSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp ----TTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred ----CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 4568999999999999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=351.80 Aligned_cols=216 Identities=26% Similarity=0.368 Sum_probs=168.2
Q ss_pred CCcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeee--
Q 015041 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVD-- 74 (414)
Q Consensus 1 ~~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~-- 74 (414)
|++.+.++|+++++||+|+||.||+|.+..+++.||||++..... ...+.+|+.++..+.+|++++.+..++..
T Consensus 3 v~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 3 VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp -CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred ccCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 456677999999999999999999999999999999998765432 23467899999999867778777666543
Q ss_pred CCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 75 ~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
....++||||++++|..++.. ..++...+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+
T Consensus 83 ~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 83 DRDVYLVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSR 157 (388)
T ss_dssp SSCEEEEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred CCEEEEEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCcccc
Confidence 346899999999999988874 578999999999999999999999999999999999999 588999999999998
Q ss_pred eecCCCCCc-cc-------------cccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhh
Q 015041 155 KYRDPTTNR-HI-------------PYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219 (414)
Q Consensus 155 ~~~~~~~~~-~~-------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~ 219 (414)
......... .. ........+||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 764321110 00 0111235689999999999987 57999999999999999999999999986554
Q ss_pred ch
Q 015041 220 TK 221 (414)
Q Consensus 220 ~~ 221 (414)
..
T Consensus 238 ~~ 239 (388)
T 3oz6_A 238 NQ 239 (388)
T ss_dssp HH
T ss_pred HH
Confidence 33
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=343.73 Aligned_cols=253 Identities=17% Similarity=0.232 Sum_probs=212.5
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
+.++|++++.||+|+||+||+|.+..+++.||+|++..... ...+.+|+.+++.+.| ++++.+..++.+....++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH-RNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCC-TTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCC-CCCCeEeEEEecCCEEEEEEE
Confidence 56899999999999999999999999999999998875543 2347789999999975 667777777788889999999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
|+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++. +.++.+||+|||+++.......
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~-~~~~~~kl~Dfg~a~~~~~~~~- 159 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDN- 159 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCE-
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc-CCCCCEEEEECCCCeECCCCCc-
Confidence 99 67999988754557999999999999999999999999999999999999952 1278999999999987643221
Q ss_pred ccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhh
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~ 242 (414)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... +.+..+.......+. ..+.
T Consensus 160 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~-~~~~ 228 (321)
T 1tki_A 160 -------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIENIMNAEYTFDE-EAFK 228 (321)
T ss_dssp -------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHTCCCCCH-HHHT
T ss_pred -------cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHHHHHHcCCCCCCh-hhhc
Confidence 12457899999999999988999999999999999999999999875433 445555555555443 3445
Q ss_pred cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 243 ~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.++.++.+++..||..||.+||++.++.+
T Consensus 229 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 229 EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 77899999999999999999999988766
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=343.42 Aligned_cols=254 Identities=26% Similarity=0.314 Sum_probs=204.0
Q ss_pred CCcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 1 ~~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
|..-+-++|++++.||+|+||+||+|.+..+++.||||++..... ...+.+|+.+++.+.| ++|+.+..++.....
T Consensus 1 m~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~ 79 (323)
T 3tki_A 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-ENVVKFYGHRREGNI 79 (323)
T ss_dssp -CCTTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCC-TTBCCEEEEEECSSE
T ss_pred CCCcHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCC-CCCCeEEEEEecCCe
Confidence 444566899999999999999999999999999999998865432 3458899999999975 677778778888889
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
.++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 80 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVF 155 (323)
T ss_dssp EEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeecccee
Confidence 99999999 6788887753 4469999999999999999999999999999999999999 57889999999999865
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
....... ......||..|+|||++.+..+ +.++|||||||++|+|++|..||.+..... ..+..........
T Consensus 156 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~~~~~ 228 (323)
T 3tki_A 156 RYNNRER-----LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWKEKKTYL 228 (323)
T ss_dssp EETTEEC-----CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS--HHHHHHHTTCTTS
T ss_pred ccCCccc-----ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHHhcccccC
Confidence 4322111 1235689999999999988775 789999999999999999999998754432 2222222222222
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
+. ...++.++.+++..||..||.+||++.++
T Consensus 229 ~~---~~~~~~~~~~li~~~L~~dP~~R~t~~ei 259 (323)
T 3tki_A 229 NP---WKKIDSAPLALLHKILVENPSARITIPDI 259 (323)
T ss_dssp TT---GGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred Cc---cccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 21 24568899999999999999999998765
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=341.78 Aligned_cols=263 Identities=19% Similarity=0.276 Sum_probs=211.4
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
.++|+++++||+|+||+||+|.+..+++.||+|++..... ...+.+|+.+++.++| ++++.+..++.+....++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH-PNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCC-cCcccEEEEEecCCeeEEEEE
Confidence 4799999999999999999999999999999998755432 2457899999999975 677778777888889999999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
|+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC-----
T ss_pred ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceeccccccc
Confidence 99 779999998767789999999999999999999999999999999999999 58889999999999876443321
Q ss_pred ccc-------cccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchH--HHHHHHHhhcc
Q 015041 163 RHI-------PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK--QKYDKICEKKV 233 (414)
Q Consensus 163 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~--~~~~~i~~~~~ 233 (414)
... .........||..|+|||++.+..++.++|||||||++|||++|..||......... ..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~- 243 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY- 243 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT-
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc-
Confidence 100 001112568999999999999999999999999999999999999999764322111 1111111111
Q ss_pred CCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 234 ~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
....+|+.+.+++..||..+|++||++.++.+.|+.+...
T Consensus 244 ------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 244 ------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp ------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1245678999999999999999999999999999887643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=346.35 Aligned_cols=245 Identities=23% Similarity=0.326 Sum_probs=207.2
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
+--++|++++.||+|+||.||+|++..+++.||||+++.. .....+..|..++..+.+|++++.+..++.+....
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 4458999999999999999999999999999999988643 23445778999998886778888888888888899
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+...
T Consensus 94 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhcc
Confidence 9999999 8899998876 3579999999999999999999999999999999999999 588999999999997543
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.. +.+..+.......|
T Consensus 170 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~p- 238 (345)
T 1xjd_A 170 LGDA-------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIRMDNPFYP- 238 (345)
T ss_dssp CTTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC-
T ss_pred cCCC-------cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHhCCCCCC-
Confidence 2211 123678999999999999999999999999999999999999999875433 44445545444433
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChH
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYG 267 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~ 267 (414)
..+++++.+++..||..+|.+||++.
T Consensus 239 ----~~~s~~~~~li~~lL~~dp~~R~~~~ 264 (345)
T 1xjd_A 239 ----RWLEKEAKDLLVKLFVREPEKRLGVR 264 (345)
T ss_dssp ----TTSCHHHHHHHHHHSCSSGGGSBTTB
T ss_pred ----cccCHHHHHHHHHHhcCCHhHcCCCh
Confidence 34688999999999999999999975
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=341.26 Aligned_cols=258 Identities=23% Similarity=0.299 Sum_probs=203.1
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
++..++|++.++||+|+||+||+|++ ++..||||++...... ..+.+|+.+++.++| ++++.+..++......
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH-PNIVLFMGAVTQPPNL 109 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCC-TTBCCEEEEECSTTCC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCce
Confidence 45678999999999999999999987 6888999998765433 247789999999975 6677777777788889
Q ss_pred EEEEecc-CCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC--eeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 79 VLVLDLL-GPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||++
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLS 186 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEEECCCC--
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEEECCCCCC
Confidence 9999999 779999887432 13899999999999999999999999 9999999999999 58889999999999
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
+....... ......||..|+|||++.+..++.++|||||||++|+|++|..||.+..... ....+.....
T Consensus 187 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~~~~~~~~~ 256 (309)
T 3p86_A 187 RLKASTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VVAAVGFKCK 256 (309)
T ss_dssp ----------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHHHHHHSCC
T ss_pred cccccccc-------ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhcCC
Confidence 75433221 1235678999999999999999999999999999999999999998765432 2222222222
Q ss_pred CCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 234 ~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
... ....+++++.+++..||..+|.+||++.++.+.|+.++..
T Consensus 257 ~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 257 RLE---IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 222 2245689999999999999999999999999999988754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=347.76 Aligned_cols=256 Identities=23% Similarity=0.243 Sum_probs=213.2
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
+.++|++++.||+|+||.||+|.+..+++.||||++..... ....|++++..+.+|++|+.+..++.+....++||||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 45789999999999999999999999999999999876543 3467899999997778898998888888999999999
Q ss_pred c-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCC-CCCeEEEeeecceeeecCCCCC
Q 015041 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR-KANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 85 ~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~-~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
+ +++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||+...+ ..+.+||+|||+++........
T Consensus 98 ~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 176 (342)
T 2qr7_A 98 MKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176 (342)
T ss_dssp CCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCC
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCc
Confidence 9 7899988865 45699999999999999999999999999999999999985221 2246999999999876543221
Q ss_pred ccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhh
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~ 242 (414)
....+||..|+|||++.+..++.++|||||||++|||++|..||.+.......+.+..+.......+. ..+.
T Consensus 177 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-~~~~ 248 (342)
T 2qr7_A 177 -------LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG-GYWN 248 (342)
T ss_dssp -------BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCS-TTTT
T ss_pred -------eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCc-cccc
Confidence 23567899999999999888999999999999999999999999875544555556666555544332 2335
Q ss_pred cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 243 ~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+++++.+++..||..||.+||++.++.+
T Consensus 249 ~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 67899999999999999999999887654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=335.41 Aligned_cols=249 Identities=23% Similarity=0.289 Sum_probs=200.7
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
++|+++++||+|+||+||+|++..+++.||||++...... ..+.+|+.+++.++| ++++.+..++......++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCC-CCEeeEEeEEEeCCEEEEEE
Confidence 5899999999999999999999999999999988754432 457789999999975 67777777788888999999
Q ss_pred eccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 83 e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
||+.+++.+.+......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~- 156 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCCS-
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecCCccc-
Confidence 999999999888777889999999999999999999999999999999999999 5888999999999987643322
Q ss_pred ccccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCC-CChhhchHHHHHHHHhhccCCchH--
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQ-GLKAATKKQKYDKICEKKVSTPIE-- 238 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~tG~~Pf~-~~~~~~~~~~~~~i~~~~~~~p~~-- 238 (414)
......||..|+|||++.+.. ++.++|||||||++|+|++|..||. +.... ..+..+.......+..
T Consensus 157 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~---~~~~~i~~~~~~~~~~~~ 227 (292)
T 3o0g_A 157 ------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---DQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp ------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH---HHHHHHHHHHCCCCTTTC
T ss_pred ------cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHHhCCCChhhh
Confidence 223567899999999998776 8999999999999999999887754 43322 2333333222111111
Q ss_pred ----------------------HhhhcChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 239 ----------------------VLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 239 ----------------------~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
......++++.+++..||..||.+||+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 280 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHH
Confidence 1112456788889999999999999987765
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=358.94 Aligned_cols=267 Identities=22% Similarity=0.279 Sum_probs=216.5
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
+..++|+++++||+|+||+||+|++..+++.||||++... .....+..|+.++..+. |++++.+..++.+....
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQDDNNL 149 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCEE
Confidence 4567999999999999999999999999999999987642 22334788999998885 57788888888888999
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
++||||+ +++|.+++......+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+...
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhhcc
Confidence 9999999 899999998656789999999999999999999999999999999999999 588999999999998765
Q ss_pred CCCCCccccccCCCCCccCcCcccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (414)
..... .....+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+.. +.+.+++...
T Consensus 227 ~~~~~------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~~ 297 (437)
T 4aw2_A 227 EDGTV------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHK 297 (437)
T ss_dssp TTSCE------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTHH
T ss_pred cCCCc------ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh---HHHHhhhhcc
Confidence 43221 123468999999999997 556999999999999999999999999975443 4444554433
Q ss_pred cCCchHHhhhcChHHHHHHHHHHhcCCCCC--CCChHHHHHHHHHHHHhcCCCCCcccccccc
Q 015041 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 293 (414)
Q Consensus 233 ~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~--RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l 293 (414)
.....+.....+++++.+|+..||..+|++ ||+++++.+ +.|...+||..+
T Consensus 298 ~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~----------Hpff~~i~w~~l 350 (437)
T 4aw2_A 298 ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK----------HPFFSGIDWDNI 350 (437)
T ss_dssp HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT----------SGGGTTCCTTTG
T ss_pred ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC----------CCccCCCCHHHH
Confidence 222222222456899999999999888887 898877644 345556778665
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=342.93 Aligned_cols=249 Identities=20% Similarity=0.298 Sum_probs=207.1
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
..+--++|++++.||+|+||.||+|++..+++.||||++..... ...+..|..++..+.+|++++.+..++....
T Consensus 4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 34556789999999999999999999999999999999875432 1236789999988867788888888888889
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
..++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKE 159 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCBC
T ss_pred EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEecccccc
Confidence 999999999 7899888875 4579999999999999999999999999999999999999 5889999999999975
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChh------hchHHHHHHHH
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA------ATKKQKYDKIC 229 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~------~~~~~~~~~i~ 229 (414)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|..||..... .........+.
T Consensus 160 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~ 232 (345)
T 3a8x_A 160 GLRPGD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 232 (345)
T ss_dssp SCCTTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH
T ss_pred ccCCCC-------cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH
Confidence 432221 12367899999999999999999999999999999999999999975321 11223344455
Q ss_pred hhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCCh
Q 015041 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 230 ~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~ 266 (414)
......| ..++.++.+++..||..+|.+||++
T Consensus 233 ~~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 233 EKQIRIP-----RSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HCCCCCC-----TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred cCCCCCC-----CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 5544444 3568899999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=352.98 Aligned_cols=260 Identities=22% Similarity=0.325 Sum_probs=214.1
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
+-.++|+++++||+|+||+||+|.+..+++.||||++...... ..+.+|+.+++.+.| ++++.+..++......++
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH-PNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCC-TTBCCEEEEECSSSSCEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEecCCCcEE
Confidence 3457899999999999999999999989999999998765332 347789999999975 667777777777788999
Q ss_pred EEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 81 v~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
||||+ +++|.+++......++...++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCEECTTS
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCceecCCC
Confidence 99999 789999998766679999999999999999999999999999999999999 57889999999999864332
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+....... ..+......+.+
T Consensus 267 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~----~~~~~~~~~~~~ 337 (377)
T 3cbl_A 267 VYA-----ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR----EFVEKGGRLPCP 337 (377)
T ss_dssp EEE-----CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH----HHHHTTCCCCCC
T ss_pred cee-----ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHcCCCCCCC
Confidence 110 01112345778999999998899999999999999999998 99999987554322 222333333332
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
..+|+++.+++..||..+|++||++.++.+.|+.+..+
T Consensus 338 ---~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 338 ---ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 34589999999999999999999999999999987654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=349.81 Aligned_cols=270 Identities=30% Similarity=0.490 Sum_probs=197.9
Q ss_pred CcccCCceEEecceeecCceeEEEEEECC---CCceEEEEEecCCCCc-------------hhHHHHHHHHHHHcCCCCC
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTKH-------------PQLLYEAKVYKILQGGSGI 65 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-------------~~~~~E~~~l~~l~~~~~i 65 (414)
+++.+++|++++.||+|+||.||+|.+.. ++..||||+....... ..+.+|+..++.+.| +++
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h-~ni 110 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDY-LGI 110 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSC-CCC
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccc-cCc
Confidence 34567899999999999999999999987 7889999988765421 123445555555554 667
Q ss_pred CeeEEeeee----CCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCC
Q 015041 66 PNIKWYGVD----GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (414)
Q Consensus 66 ~~l~~~~~~----~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~ 141 (414)
+.+..++.. ....++||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++ .
T Consensus 111 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~ 186 (345)
T 2v62_A 111 PLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLG---Y 186 (345)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---S
T ss_pred ceeecccccccCCCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEc---c
Confidence 777666555 67889999999999999886533 799999999999999999999999999999999999995 4
Q ss_pred CC--eEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhh
Q 015041 142 AN--QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219 (414)
Q Consensus 142 ~~--~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~ 219 (414)
++ .+||+|||+|+....................||..|+|||++.+..++.++|||||||++|||++|..||.+....
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 44 9999999999876533221111111124568999999999999999999999999999999999999999653221
Q ss_pred c-hHHHHHHHHhhccCCchHHhhh--cChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 220 T-KKQKYDKICEKKVSTPIEVLCK--SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 220 ~-~~~~~~~i~~~~~~~p~~~~~~--~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
. .............+........ .+|+++.+++..||..+|++||++.+|.+.|+.+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 267 PVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred cHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 1 1111111111111111111111 6788999999999999999999999998887643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=346.96 Aligned_cols=254 Identities=24% Similarity=0.295 Sum_probs=210.9
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
.+.++|++++.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.+.| ++|+.+..++.+....+
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCCEEE
Confidence 3456899999999999999999999999999999998765432 347789999999975 67777877788888999
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
+||||+ +++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.....+.+||+|||++.....
T Consensus 105 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp EEECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 999999 7789887764 45689999999999999999999999999999999999996444456799999999976543
Q ss_pred CCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... +.+..+.......+.+
T Consensus 184 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~i~~~~~~~~~~ 252 (362)
T 2bdw_A 184 SEA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIKAGAYDYPSP 252 (362)
T ss_dssp CCS--------CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCCCCTT
T ss_pred Ccc--------cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhCCCCCCcc
Confidence 221 23568999999999999999999999999999999999999999875432 3444455555544433
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+..+++++.+++..||..||.+||++.++.+
T Consensus 253 -~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 253 -EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp -GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -cccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 23467899999999999999999999887654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=354.86 Aligned_cols=255 Identities=22% Similarity=0.264 Sum_probs=212.4
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
.+.++|++++.||+|+||+||+|.+..+|+.||+|++..... ...+.+|+.+++.+.| ++|+.+..++.+....+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH-PNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCB-TTBCCEEEEEECSSEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-cCCCeEEEEEEECCEEE
Confidence 456789999999999999999999999999999999876543 2347899999999975 67777777788888999
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
+||||+ +++|.+.+.. ...+++..+..++.||+.||+|||++||+||||||+|||++....++.+||+|||+|+....
T Consensus 87 lv~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp EEECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 999999 7899888876 56799999999999999999999999999999999999996444568899999999976544
Q ss_pred CCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .+.+..+.......+.+
T Consensus 166 ~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~ 235 (444)
T 3soa_A 166 EQQ-------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---HRLYQQIKAGAYDFPSP 235 (444)
T ss_dssp TCC-------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHTCCCCCTT
T ss_pred CCc-------eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHhCCCCCCcc
Confidence 322 12356899999999999999999999999999999999999999987543 34445555555554433
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+..+++++.+++..||..||.+||++.++.+
T Consensus 236 -~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 236 -EWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 23466899999999999999999999988766
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=347.49 Aligned_cols=250 Identities=25% Similarity=0.344 Sum_probs=209.3
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
+.+.-++|++++.||+|+||.||+|.+..+++.||+|++... .....+.+|+.+++.+.| ++|+.+..++.+..
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH-PFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEeCC
Confidence 355668999999999999999999999999999999987542 233467889999999965 67777878888888
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
..++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~ 164 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAM 164 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred EEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeee
Confidence 999999999 8889888764 5579999999999999999999999999999999999999 5889999999999987
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (414)
...... ....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.......+.+..+....
T Consensus 165 ~~~~~~--------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 236 (384)
T 4fr4_A 165 LPRETQ--------ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV 236 (384)
T ss_dssp CCTTCC--------BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC
T ss_pred ccCCCc--------eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc
Confidence 543321 236789999999999974 458999999999999999999999998765555555555555544
Q ss_pred cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCC-hHHH
Q 015041 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD-YGFL 269 (414)
Q Consensus 233 ~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~-~~~l 269 (414)
...| ..++.++.+++..||..+|.+||+ ++++
T Consensus 237 ~~~p-----~~~s~~~~~li~~lL~~dP~~R~s~~~~l 269 (384)
T 4fr4_A 237 VTYP-----SAWSQEMVSLLKKLLEPNPDQRFSQLSDV 269 (384)
T ss_dssp CCCC-----TTSCHHHHHHHHHHSCSSGGGSCCSHHHH
T ss_pred cCCC-----CcCCHHHHHHHHHHhcCCHhHhcccHHHH
Confidence 4444 356889999999999999999998 4444
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=350.09 Aligned_cols=264 Identities=18% Similarity=0.255 Sum_probs=211.5
Q ss_pred CcccCCceEEecceeecCceeEEEEEE-----CCCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeee
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV 73 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~ 73 (414)
.++..++|+++++||+|+||+||+|++ ..++..||||++...... ..+.+|+.+++.++| ++|+.+..++.
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~ 144 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH-QNIVRCIGVSL 144 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEC
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCC-CCCCeEEEEEe
Confidence 356678999999999999999999994 456789999998754332 347789999999975 66777777777
Q ss_pred eCCeeEEEEecc-CCCHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEE
Q 015041 74 DGEDNVLVLDLL-GPSLEDLFVYCR------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 146 (414)
Q Consensus 74 ~~~~~~lv~e~~-~~sL~~~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vk 146 (414)
.....++||||+ +++|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|||++.......+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 788889999999 789999998654 3589999999999999999999999999999999999995333455799
Q ss_pred EeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHH
Q 015041 147 IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKY 225 (414)
Q Consensus 147 L~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~ 225 (414)
|+|||+|+........ .......||..|+|||++.+..++.++|||||||++|||++ |..||.+.... +.+
T Consensus 225 L~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~ 296 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYY-----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVL 296 (367)
T ss_dssp ECCCHHHHHHHHHSSC-----TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHH
T ss_pred ECCCcccccccccccc-----ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH
Confidence 9999999754322111 12235577999999999999999999999999999999998 99999875543 223
Q ss_pred HHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 226 DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 226 ~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
..+.... ..+. ...+|..+.+++..||..+|.+||++.++.+.|+.+..
T Consensus 297 ~~i~~~~-~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 297 EFVTSGG-RMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HHHHTTC-CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCC-CCCC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 3332222 2221 24568899999999999999999999999999887754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=355.05 Aligned_cols=266 Identities=23% Similarity=0.308 Sum_probs=213.0
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
+..++|++++.||+|+||+||+|++..+++.||||+++... ....+..|..++..+.| ++++.+..++.+....
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~h-p~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR-RWITQLHFAFQDENYL 136 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCT-TTBCCEEEEEECSSEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCC-CCeeeEEEEEeeCCEE
Confidence 45678999999999999999999999999999999886421 22347889999988764 7788888888888999
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
++||||+ +++|.+++...+..+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+...
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhheecc
Confidence 9999999 899999998766789999999999999999999999999999999999999 588999999999998765
Q ss_pred CCCCCccccccCCCCCccCcCcccccccc-------CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHh
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHL-------GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~ 230 (414)
..... .....+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+.. +.+.++..
T Consensus 214 ~~~~~------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~~ 284 (412)
T 2vd5_A 214 ADGTV------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA---ETYGKIVH 284 (412)
T ss_dssp TTSCE------ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHT
T ss_pred CCCcc------ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH---HHHHHHHh
Confidence 43221 113568999999999997 456899999999999999999999999875443 34445544
Q ss_pred hccCCchHHhhhcChHHHHHHHHHHhcCCCCCCC---ChHHHHHHHHHHHHhcCCCCCcccccccc
Q 015041 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP---DYGFLKRLFHDLFSREGYDFDFVFDWTIL 293 (414)
Q Consensus 231 ~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP---~~~~l~~~l~~~~~~~~~~~~~~~dw~~l 293 (414)
.+.....+.....+++++.+++.+||. +|.+|+ +++++.+ +.|...+||..+
T Consensus 285 ~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~----------Hpff~~i~w~~l 339 (412)
T 2vd5_A 285 YKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT----------HPFFFGLDWDGL 339 (412)
T ss_dssp HHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT----------SGGGTTCCSTTS
T ss_pred cccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc----------CCCcCCCCHHHH
Confidence 322121222235678999999999998 999985 6655532 345556778655
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=339.38 Aligned_cols=252 Identities=20% Similarity=0.261 Sum_probs=209.5
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--------chhHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 74 (414)
+.+.++|++++.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.+.| ++++.+..++..
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~ 85 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH-PNVITLHEVYEN 85 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEEC
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCC-CCCCcEEEEEEe
Confidence 3456789999999999999999999999999999998765432 3458899999999975 667777777778
Q ss_pred CCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCC----eEEEee
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN----QVYIID 149 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~----~vkL~D 149 (414)
....++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+. ..+ .+||+|
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~---~~~~~~~~~kl~D 161 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL---DRNVPKPRIKIID 161 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES---CSSSSSCCEEECC
T ss_pred CCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEe---cCCCCCCCEEEEE
Confidence 88999999999 7899998864 45799999999999999999999999999999999999995 444 899999
Q ss_pred ecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHH
Q 015041 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (414)
Q Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~ 229 (414)
||+++....... .....||..|+|||++.+..++.++|||||||++|+|++|..||.+.... +.+..+.
T Consensus 162 fg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~ 230 (326)
T 2y0a_A 162 FGLAHKIDFGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANVS 230 (326)
T ss_dssp CTTCEECCTTSC--------CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHH
T ss_pred CCCCeECCCCCc--------cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHHH
Confidence 999987643221 13567999999999999999999999999999999999999999875443 3334444
Q ss_pred hhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 230 ~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
......+ .......+..+.+++..||..+|.+||++.++.+
T Consensus 231 ~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 231 AVNYEFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HTCCCCC-HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hcCCCcC-ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 4444444 3344567899999999999999999999887644
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=336.22 Aligned_cols=252 Identities=24% Similarity=0.310 Sum_probs=201.1
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
++|+++++||+|+||+||+|++ .+++.||+|++..... ...+.+|+.+++.+.| ++++.+..++......++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH-SNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCC-TTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCC-CCEeeeeeEEccCCeEEEEE
Confidence 5899999999999999999998 6789999998865432 3457899999999975 67777777777888999999
Q ss_pred eccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 83 e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
||+.++|.+++......++...++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC----
T ss_pred EecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccCcccc-
Confidence 999889999988766789999999999999999999999999999999999999 5888999999999976543211
Q ss_pred ccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc--------
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV-------- 233 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 233 (414)
......||..|+|||++.+. .++.++|||||||++|+|++|..||.+.........+.+......
T Consensus 156 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 156 ------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ------ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence 11245789999999999764 589999999999999999999999998655443333332221110
Q ss_pred -------------CCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 234 -------------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 234 -------------~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
..+.......+++++.+++..||..||.+||++.++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 279 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0111223345788999999999999999999987664
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=347.89 Aligned_cols=263 Identities=21% Similarity=0.312 Sum_probs=211.6
Q ss_pred cccCCceEEecceeecCceeEEEEE-----ECCCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLAS-----HVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 74 (414)
++..++|+++++||+|+||.||+|+ +..+++.||||++...... ..+.+|++++..+.+|++++.+..++..
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 3557899999999999999999998 4456789999999765543 3488999999999877888888766554
Q ss_pred -CCeeEEEEecc-CCCHHHHHHHhCC------------------------------------------------------
Q 015041 75 -GEDNVLVLDLL-GPSLEDLFVYCRR------------------------------------------------------ 98 (414)
Q Consensus 75 -~~~~~lv~e~~-~~sL~~~~~~~~~------------------------------------------------------ 98 (414)
+...++||||+ +++|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 45589999999 7799999875322
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccccc
Q 015041 99 -----------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167 (414)
Q Consensus 99 -----------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 167 (414)
.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++........
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~----- 249 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDY----- 249 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCTTC-----
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccceeeecccccc-----
Confidence 18899999999999999999999999999999999999 47889999999999765332221
Q ss_pred cCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChH
Q 015041 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (414)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~ 246 (414)
.......||..|+|||++.+..++.++|||||||++|||++ |..||.+..... .+..........+.+ ..+++
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~~~~~~~~~~---~~~~~ 323 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFCRRLKEGTRMRAP---DYTTP 323 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH---HHHHHHHHTCCCCCC---TTCCH
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH---HHHHHHHcCCCCCCC---CCCCH
Confidence 12235678899999999999999999999999999999998 999998754332 222222222222222 34578
Q ss_pred HHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 247 EFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 247 ~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
++.+++..||..+|.+||++.++.+.|+.++..
T Consensus 324 ~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 324 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 999999999999999999999999999988764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=353.59 Aligned_cols=253 Identities=21% Similarity=0.306 Sum_probs=208.5
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeee-eCCeeEEEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV-DGEDNVLVL 82 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~-~~~~~~lv~ 82 (414)
+..++|+++++||+|+||+||+|.+. ++.||||+++.......+.+|+.+++.++| +++..+..++. .....++||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRH-SNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCCC-TTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhccC-CCEEEEEEEEEcCCCceEEEE
Confidence 44578999999999999999999984 779999999887777789999999999986 45555555444 444789999
Q ss_pred ecc-CCCHHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 83 DLL-GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||+ +++|.+++...... ++...++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTCEECC---
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCcccccccc
Confidence 999 78999999875543 7999999999999999999999999999999999999 578899999999998543221
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
....++..|+|||++.+..++.++|||||||++|||++ |..||.+......... + ......+.+
T Consensus 344 ----------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~---i-~~~~~~~~p- 408 (450)
T 1k9a_A 344 ----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---V-EKGYKMDAP- 408 (450)
T ss_dssp -------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH---H-HTTCCCCCC-
T ss_pred ----------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---H-HcCCCCCCC-
Confidence 13356889999999999999999999999999999998 9999998765433322 2 222222222
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
..+|+++.+++..||..+|.+||++.+|.+.|+++...
T Consensus 409 --~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 409 --DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 45689999999999999999999999999999988654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=345.95 Aligned_cols=255 Identities=20% Similarity=0.234 Sum_probs=195.7
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
.+.++|++.+.||+|+||.||+|++..+++.||||++........+.+|+.+++.+.| ++++.+..++......++|||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH-PNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCC-TTBCCEEEEEECSSEEEEEEC
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCC-CCCcceeeeEecCCeEEEEEE
Confidence 4567899999999999999999999999999999999877666678899999999976 667777777778888999999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
|+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++..+.++.+||+|||+++.......
T Consensus 129 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~- 206 (349)
T 2w4o_A 129 LVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL- 206 (349)
T ss_dssp CCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc-
Confidence 99 7899888764 45689999999999999999999999999999999999996444588999999999986543221
Q ss_pred ccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhh
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~ 242 (414)
.....||..|+|||++.+..++.++|||||||++|||++|..||.+.... ...+..+.......+ .....
T Consensus 207 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~i~~~~~~~~-~~~~~ 276 (349)
T 2w4o_A 207 -------MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFMFRRILNCEYYFI-SPWWD 276 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHHHHHHHTTCCCCC-TTTTT
T ss_pred -------cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHHHHHHHhCCCccC-Cchhh
Confidence 13567899999999999999999999999999999999999999865432 223444444443332 22335
Q ss_pred cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 243 ~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.++.++.+++..||..||++||++.++.+
T Consensus 277 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 277 EVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 67889999999999999999999877644
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=343.57 Aligned_cols=238 Identities=22% Similarity=0.347 Sum_probs=204.9
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
.-++|++++.||+|+||.||+|++..+|+.||||++... .....+.+|+.+++.+.| ++++.+..++.+....+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEcCCEEE
Confidence 347899999999999999999999999999999987543 233457889999988864 77777878888888999
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
+||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 118 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSS
T ss_pred EEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceeccC
Confidence 999999 8899998876 3569999999999999999999999999999999999999 5889999999999986543
Q ss_pred CCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
.. ...+||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+.......|
T Consensus 194 ~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~~~~~~~p-- 258 (350)
T 1rdq_E 194 RT----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFP-- 258 (350)
T ss_dssp CB----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCC--
T ss_pred Cc----------ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH---HHHHHHHHcCCCCCC--
Confidence 21 256899999999999999999999999999999999999999987543 345555666555544
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCC
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPD 265 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~ 265 (414)
..++.++.+++..||..+|.+||+
T Consensus 259 ---~~~~~~~~~li~~lL~~dp~~R~~ 282 (350)
T 1rdq_E 259 ---SHFSSDLKDLLRNLLQVDLTKRFG 282 (350)
T ss_dssp ---TTCCHHHHHHHHHHSCSCTTTCTT
T ss_pred ---CCCCHHHHHHHHHHhhcCHHhccC
Confidence 456899999999999999999998
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=345.51 Aligned_cols=264 Identities=20% Similarity=0.305 Sum_probs=217.3
Q ss_pred cccCCceEEecceeecCceeEEEEEECCC-------CceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEee
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDT-------NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYG 72 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~ 72 (414)
++..++|+++++||+|+||+||+|++..+ +..||||++...... ..+.+|+++++.+..|++|+.+..++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 46678999999999999999999997543 357999998776543 34789999999996678888888888
Q ss_pred eeCCeeEEEEecc-CCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEE
Q 015041 73 VDGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 136 (414)
Q Consensus 73 ~~~~~~~lv~e~~-~~sL~~~~~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili 136 (414)
......++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 8888899999999 779999998653 348999999999999999999999999999999999999
Q ss_pred ccCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 015041 137 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQG 215 (414)
Q Consensus 137 ~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~ 215 (414)
+.++.+||+|||+|+........ .......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 225 ---~~~~~~kL~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 225 ---TEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp ---CTTCCEEECSCSCCCCSSCCCTT-----CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ---cCCCcEEEcccCccccccccccc-----ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 57889999999999865433221 12234567889999999999999999999999999999999 9999987
Q ss_pred ChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 015041 216 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (414)
Q Consensus 216 ~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~ 281 (414)
..... ....+ ........ ...+++++.+++..||..+|.+||++.++.+.|+.++....
T Consensus 297 ~~~~~---~~~~~-~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 297 VPVEE---LFKLL-KEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp CCHHH---HHHHH-HTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred CCHHH---HHHHH-HcCCCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 65432 22222 22222222 24568999999999999999999999999999999987654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=350.97 Aligned_cols=253 Identities=19% Similarity=0.183 Sum_probs=197.6
Q ss_pred CceEEe-cceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeee----CCeeEEE
Q 015041 7 VKYKLG-RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD----GEDNVLV 81 (414)
Q Consensus 7 ~~y~i~-~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~----~~~~~lv 81 (414)
++|.+. +.||.|+||+||+|.+..+++.||||++.. ...+.+|+.++.++.+|++|+.+..++.. ....++|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv 137 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 137 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc---chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEE
Confidence 456665 799999999999999999999999999863 34678899988777777888877665543 5568999
Q ss_pred Eecc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 82 LDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
|||+ +++|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+|||++..+.++.+||+|||+++.....
T Consensus 138 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~ 217 (400)
T 1nxk_A 138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217 (400)
T ss_dssp EECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred EEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence 9999 779999987532 35999999999999999999999999999999999999963333789999999999865432
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhch-HHHHHHHHhhccCCchH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK-KQKYDKICEKKVSTPIE 238 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~-~~~~~~i~~~~~~~p~~ 238 (414)
.. ....+||..|+|||++.+..++.++|||||||++|||++|..||.+...... ......+.......+.+
T Consensus 218 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 289 (400)
T 1nxk_A 218 NS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289 (400)
T ss_dssp -----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred Cc--------cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence 21 1356789999999999999999999999999999999999999987543321 11223333444444432
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+..+++++.+|+..||..||.+||++.++.+
T Consensus 290 -~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 290 -EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp -TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 22456899999999999999999999988766
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=343.71 Aligned_cols=253 Identities=21% Similarity=0.307 Sum_probs=201.5
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCC-CCCCeeEEeeeeCCe
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGG-SGIPNIKWYGVDGED 77 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~-~~i~~l~~~~~~~~~ 77 (414)
.+.+++|++++.||+|+||.||+|.+ .+++.||||++...... ..+.+|+.+++.+.|+ ++++.+..++.....
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 35688999999999999999999987 56889999998765433 3477899999999864 788888888888899
Q ss_pred eEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 78 ~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
.++|||+.+++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ .++.+||+|||+++...
T Consensus 84 ~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll----~~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 84 IYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEEEECCCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----ETTEEEECCCSSSCCC-
T ss_pred EEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE----ECCcEEEeecccccccC
Confidence 999999889999999886 5679999999999999999999999999999999999999 35789999999997654
Q ss_pred CCCCCccccccCCCCCccCcCccccccccC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHH
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLG-----------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD 226 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~ 226 (414)
...... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+... ....+.
T Consensus 159 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~ 231 (343)
T 3dbq_A 159 PDTTSV-----VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLH 231 (343)
T ss_dssp ----------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHH
T ss_pred cccccc-----cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh--HHHHHH
Confidence 332211 1235679999999999875 6789999999999999999999999986432 223333
Q ss_pred HHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 227 KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 227 ~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+.........+ ...+.++.+++..||..+|.+||++.++.+
T Consensus 232 ~~~~~~~~~~~~---~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 232 AIIDPNHEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp HHHCTTSCCCCC---CCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhcCCcccCCc---ccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 333333322222 334678999999999999999999988755
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=355.64 Aligned_cols=249 Identities=20% Similarity=0.249 Sum_probs=189.9
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeee------
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVD------ 74 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~------ 74 (414)
+.++|+++++||+|+||+||+|.+..+++.||||++..... ...+.+|+.+++.++| ++|+.+..++..
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH-KNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCC-TTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCC-CCCCcEEEEEccCCcccc
Confidence 45899999999999999999999999999999999875422 2457789999999976 455555444332
Q ss_pred CCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 75 ~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
....++||||+.+++.+.+. ..++...++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+
T Consensus 139 ~~~~~lv~E~~~~~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 139 FQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 212 (464)
T ss_dssp CCEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCCC-
T ss_pred CCeEEEEEeCCCCCHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEEEEEeee
Confidence 24579999999888777663 458999999999999999999999999999999999999 588899999999998
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
....... ....+||..|+|||++.+..|+.++|||||||++|||++|+.||.+.+... .+.+++.....
T Consensus 213 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~---~~~~i~~~lg~ 281 (464)
T 3ttj_A 213 TAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGT 281 (464)
T ss_dssp ----CCC--------C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCS
T ss_pred ecCCCcc--------cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCC
Confidence 6543221 235689999999999999999999999999999999999999999865443 33333332222
Q ss_pred CchHHh-------------------------h------------hcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 235 TPIEVL-------------------------C------------KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 235 ~p~~~~-------------------------~------------~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+.+.. . ...++++.+|+.+||..||.+||+++++.+
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 211111 0 001456788888888888888888776644
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=350.23 Aligned_cols=207 Identities=21% Similarity=0.338 Sum_probs=173.5
Q ss_pred CCcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcC-------CCCCCeeEEee
Q 015041 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQG-------GSGIPNIKWYG 72 (414)
Q Consensus 1 ~~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~-------~~~i~~l~~~~ 72 (414)
+|+++.++|+++++||+|+||+||+|++..+++.||||++..... ...+.+|+.+++.+.+ ++++..+..++
T Consensus 31 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 31 IGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred hhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 467889999999999999999999999999999999999875432 2457889999999974 34455555444
Q ss_pred e----eCCeeEEEEeccCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhc-CeeccccCCCceEEccCC------
Q 015041 73 V----DGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGR------ 140 (414)
Q Consensus 73 ~----~~~~~~lv~e~~~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDLkp~Nili~~~~------ 140 (414)
. .....++||||+++++.+.+.... ..+++..++.++.||+.||+|||++ ||+||||||+|||++...
T Consensus 111 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 111 KISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp EEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred eecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhh
Confidence 3 456789999999999988887643 5699999999999999999999998 999999999999995211
Q ss_pred ----------------------------------------CCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCcc
Q 015041 141 ----------------------------------------KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180 (414)
Q Consensus 141 ----------------------------------------~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~ 180 (414)
....+||+|||+|+...... ....||..|+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----------~~~~gt~~y~ 260 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----------TEDIQTRQYR 260 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----------CSCCSCGGGC
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----------ccCCCCCccc
Confidence 11379999999998654322 2457899999
Q ss_pred ccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCh
Q 015041 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 217 (414)
Q Consensus 181 aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~ 217 (414)
|||++.+..++.++|||||||++|||++|..||.+..
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 9999999999999999999999999999999998654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=348.85 Aligned_cols=252 Identities=21% Similarity=0.303 Sum_probs=202.2
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcC-CCCCCeeEEeeeeCCee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQG-GSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~-~~~i~~l~~~~~~~~~~ 78 (414)
+.+++|++++.||+|+||.||+|.+.. ++.||||++...... ..+.+|+.+++.+.+ +++|+.+..++......
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 345679999999999999999999764 889999998765432 357899999999986 68888888888888899
Q ss_pred EEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 79 ~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
++|||+.+++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ .++.+||+|||+++....
T Consensus 132 ~lv~E~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll----~~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 132 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEEEECCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEE----SSSCEEECCCSSSCCC--
T ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE----ECCeEEEEecCccccccC
Confidence 99999889999999876 4578999999999999999999999999999999999999 357899999999986543
Q ss_pred CCCCccccccCCCCCccCcCccccccccC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHH
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLG-----------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~ 227 (414)
..... .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+... ....+..
T Consensus 207 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~~~~~ 279 (390)
T 2zmd_A 207 DTTSV-----VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHA 279 (390)
T ss_dssp ------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHH
T ss_pred CCccc-----cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH--HHHHHHH
Confidence 22111 1235679999999999976 3689999999999999999999999986432 2233444
Q ss_pred HHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 228 i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
++......+.+ ...+.++.+++..||..+|.+||++.++.+
T Consensus 280 ~~~~~~~~~~~---~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 280 IIDPNHEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HHCTTSCCCCC---CCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhCccccCCCC---ccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 44433333222 233688999999999999999999988755
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=338.46 Aligned_cols=253 Identities=20% Similarity=0.262 Sum_probs=185.9
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
.++|+++++||+|+||+||+|.+..+++.||||++.... ....+.+|+.+++.+.| ++|+.+..++......++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH-ENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCB-TTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCC-CCcceEEEEEEECCeEEEEE
Confidence 478999999999999999999999999999999886543 23568899999999975 67777777777888999999
Q ss_pred eccCCCHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 83 DLLGPSLEDLFVYCR-----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 83 e~~~~sL~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
||+.++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 83 e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp ECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCSSCEETT
T ss_pred EecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCccceecC
Confidence 999999999887542 458999999999999999999999999999999999999 578899999999998754
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC-
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST- 235 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~- 235 (414)
.... ......||..|+|||++.+. .++.++|||||||++|||++|..||.+.........+..........
T Consensus 160 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 160 IPVN-------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp SCCC-------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred CCcc-------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence 3321 12355789999999999874 68999999999999999999999999866544333333322111000
Q ss_pred --------------------ch-----HHhhhcChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 236 --------------------PI-----EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 236 --------------------p~-----~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
.. ......++.++.+|+..||..||.+||++.++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~ 291 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHH
Confidence 00 00112356778888888888888888887654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=338.13 Aligned_cols=266 Identities=20% Similarity=0.258 Sum_probs=208.8
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeeeC--C
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG--E 76 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~--~ 76 (414)
+.+++++|++.++||+|+||+||+|.+..+++.||||++.... ....+.+|+++++.++| ++++.+..++... .
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~ 82 (319)
T 4euu_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-KNIVKLFAIEEETTTR 82 (319)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCC-TTBCCEEEEEECTTTC
T ss_pred ccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCC-CCcceEEEEeecCCCc
Confidence 3567899999999999999999999999999999999986532 23457799999999986 5666665555443 3
Q ss_pred eeEEEEecc-CCCHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccC-CCCCeEEEeeecc
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG-RKANQVYIIDFGL 152 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~-~~~~~vkL~DFG~ 152 (414)
..++||||+ +++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||+... +..+.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 779999999 7899999875432 38999999999999999999999999999999999998322 3567799999999
Q ss_pred eeeecCCCCCccccccCCCCCccCcCcccccccc--------CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhh-chHH
Q 015041 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL--------GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA-TKKQ 223 (414)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~-~~~~ 223 (414)
++....... .....||..|+|||++. +..++.++|||||||++|||++|..||...... ...+
T Consensus 163 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 234 (319)
T 4euu_A 163 ARELEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234 (319)
T ss_dssp CEECCTTCC--------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHH
T ss_pred ceecCCCCc--------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHH
Confidence 987654332 12567899999999986 567899999999999999999999999764432 2334
Q ss_pred HHHHHHhhccCC-------------------ch-HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 224 KYDKICEKKVST-------------------PI-EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 224 ~~~~i~~~~~~~-------------------p~-~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
.+.++....... +. ..+...++..+.+++..||..||++||+++++.+...+.
T Consensus 235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 444444433211 10 112234467899999999999999999999888766544
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=335.67 Aligned_cols=266 Identities=21% Similarity=0.257 Sum_probs=205.7
Q ss_pred ccCCceEEe-cceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 4 IIGVKYKLG-RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 4 i~~~~y~i~-~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
-+.++|++. +.||+|+||+||+|.+..+++.||||++..... ...+.+|+.++..+.+|++++.+..++......++
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 356889995 789999999999999999999999999876532 35688999999987777888888888888899999
Q ss_pred EEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 81 v~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++..+....+||+|||+++.....
T Consensus 89 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999 6899999876 457899999999999999999999999999999999999963333345999999998765422
Q ss_pred CCCccccccCCCCCccCcCccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhc------------hH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT------------KK 222 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~------------~~ 222 (414)
..............+||..|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ..
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 2111111111234569999999999975 458899999999999999999999998753221 22
Q ss_pred HHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 223 QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 223 ~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+..+.......+.. ....++.++.+++..||..||.+||++.++.+
T Consensus 248 ~~~~~i~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 248 MLFESIQEGKYEFPDK-DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHCCCCCCHH-HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhccCcccCch-hcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 3344455555555433 33467889999999999999999999887644
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=337.21 Aligned_cols=267 Identities=21% Similarity=0.254 Sum_probs=207.4
Q ss_pred CcccCCceEEecceeecCceeEEEEE----ECCCCceEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeeEEeee--
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLAS----HVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGV-- 73 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~l~~~~~-- 73 (414)
+++..++|+++++||+|+||+||+|+ +..+++.||||++...... ..+.+|+.+++.++| ++++.+..++.
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-DNIVKYKGVCYSA 83 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECHH
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEecC
Confidence 46788999999999999999999998 4568899999998765432 457899999999986 55555554443
Q ss_pred eCCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecc
Q 015041 74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (414)
Q Consensus 74 ~~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~ 152 (414)
.....++||||+ +++|.+++......+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGL 160 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCCS
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEE---cCCCeEEEccCcc
Confidence 345689999999 889999998766679999999999999999999999999999999999999 4788999999999
Q ss_pred eeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhc------------
Q 015041 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT------------ 220 (414)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~------------ 220 (414)
++........ ........+|..|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 161 ~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T 3ugc_A 161 TKVLPQDKEF----FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236 (295)
T ss_dssp CC-----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHH
T ss_pred cccccCCcce----eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccch
Confidence 9865433211 111234457888999999999999999999999999999999999997532210
Q ss_pred hHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 221 ~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
...............+. ...+|+++.+++..||..+|++||++.++.+.|+.+...
T Consensus 237 ~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 237 IVFHLIELLKNNGRLPR---PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHhccCcCCC---CcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 00011122222222222 245689999999999999999999999999999988653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=338.76 Aligned_cols=253 Identities=24% Similarity=0.288 Sum_probs=189.6
Q ss_pred CceEEe---cceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 7 VKYKLG---RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 7 ~~y~i~---~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
.+|.+. ++||+|+||+||+|.+..+++.||||++... ....+.+|+.+++.+.+|++|+.+..++.+....++|||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 86 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVME 86 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEE
Confidence 578886 7899999999999999999999999998654 234678899999999877889999888888899999999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
|+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++..+....+||+|||+++.......
T Consensus 87 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~- 164 (325)
T 3kn6_A 87 LLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ- 164 (325)
T ss_dssp CCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-
Confidence 99 7799998876 56799999999999999999999999999999999999996333344899999999986543322
Q ss_pred ccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhh----chHHHHHHHHhhccCCchH
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA----TKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~----~~~~~~~~i~~~~~~~p~~ 238 (414)
.....+||..|+|||++.+..++.++|||||||++|+|++|..||.+.... ...+.+..+.......+.
T Consensus 165 ------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~- 237 (325)
T 3kn6_A 165 ------PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG- 237 (325)
T ss_dssp -------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS-
T ss_pred ------cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc-
Confidence 123557899999999999999999999999999999999999999875331 223444455444444333
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
..+..+++++.+++..||..||.+||++.++
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~el 268 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL 268 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTS
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHH
Confidence 3335678999999999999999999997654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=370.40 Aligned_cols=266 Identities=21% Similarity=0.291 Sum_probs=219.7
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
+--++|++++.||+|+||.||+|++..+++.||||++... .....+..|..++..+.++++++.+..++......
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 3457899999999999999999999999999999987642 33455788999998888889999999888888999
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
+|||||+ +++|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+...
T Consensus 418 ~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEECC
T ss_pred EEEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeeccc
Confidence 9999999 7899988876 3579999999999999999999999999999999999999 588999999999998644
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
.... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+. .+.+..|.......|
T Consensus 494 ~~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~~~~~~p- 562 (674)
T 3pfq_A 494 WDGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIMEHNVAYP- 562 (674)
T ss_dssp CTTC-------CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHSSCCCCC-
T ss_pred cCCc-------ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH---HHHHHHHHhCCCCCC-
Confidence 3322 12467899999999999999999999999999999999999999998543 455666767666655
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcccccccc
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 293 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l 293 (414)
..+++++.+|+..||..||.+||++.. ...+++ ..+.|...+||..+
T Consensus 563 ----~~~s~~~~~li~~lL~~dP~~R~~~~~--~~~~ei---~~h~ff~~i~w~~l 609 (674)
T 3pfq_A 563 ----KSMSKEAVAICKGLMTKHPGKRLGCGP--EGERDI---KEHAFFRYIDWEKL 609 (674)
T ss_dssp ----TTSCHHHHHHHHHHSCSSSTTCTTCST--THHHHH---HSSGGGSSCCHHHH
T ss_pred ----ccCCHHHHHHHHHHccCCHHHCCCCCC--CcHHHH---hcCccccCCCHHHH
Confidence 456899999999999999999998721 011111 12355556778654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=335.70 Aligned_cols=264 Identities=22% Similarity=0.275 Sum_probs=202.6
Q ss_pred CCcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHH--HcCCCCCCeeEEeee----e
Q 015041 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKI--LQGGSGIPNIKWYGV----D 74 (414)
Q Consensus 1 ~~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~--l~~~~~i~~l~~~~~----~ 74 (414)
|++++.++|++++.||+|+||+||+|++ +++.||||++.... ...+..|.+++.. +.| +++..+..++. .
T Consensus 2 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~e~~~~~~~~l~h-~niv~~~~~~~~~~~~ 77 (301)
T 3q4u_A 2 MQRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-EKSWFRETELYNTVMLRH-ENILGFIASDMTSRHS 77 (301)
T ss_dssp --CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHHHTCCCC-TTBCCEEEEEEEEETT
T ss_pred ccccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc-chhhHHHHHHHHHhhccC-cCeeeEEEeeccccCC
Confidence 6889999999999999999999999988 68899999986542 3456678877777 444 56666654432 2
Q ss_pred CCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hcCeeccccCCCceEEccCCCCCeE
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH--------SRGFLHRDIKPDNFLMGLGRKANQV 145 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--------~~~iiHrDLkp~Nili~~~~~~~~v 145 (414)
....++||||+ +++|.+++. ...+++..++.++.||+.||+||| +++|+||||||+|||+ +.++.+
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~~ 152 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQC 152 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTSCE
T ss_pred CceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCCCE
Confidence 34578999999 779999885 457999999999999999999999 9999999999999999 578899
Q ss_pred EEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCC------CCCchhhHHHHHHHHHHHHcC----------
Q 015041 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI------EQSRRDDLESLGYVLLYFLRG---------- 209 (414)
Q Consensus 146 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~~DiwSlG~il~el~tG---------- 209 (414)
||+|||+|+.......... .......||..|+|||++.+. .++.++|||||||++|||++|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~ 229 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLD---VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229 (301)
T ss_dssp EECCCTTCEEEETTTTEEE---CCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred EEeeCCCeeeccccccccc---ccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence 9999999987655433211 112345799999999999877 455799999999999999999
Q ss_pred CCCCCCChhhc-hHHHHHHHHh-h--ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 210 SLPWQGLKAAT-KKQKYDKICE-K--KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 210 ~~Pf~~~~~~~-~~~~~~~i~~-~--~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
..||....... ....+..... . ....+........++++.+++..||..+|.+||++.++.+.|+.+
T Consensus 230 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 88987643221 2222222221 1 122222223334568899999999999999999999999988764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=342.32 Aligned_cols=251 Identities=23% Similarity=0.285 Sum_probs=198.4
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
..++|+++++||+|+||+||+|++..+++.||||++.... ....+.+|+.+++.++| ++|+.+..++......++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCC-CCCCcEEEEEeeCCEEEEEEE
Confidence 4589999999999999999999999999999999887644 34568899999999975 677778777788889999999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCC--eEEEeeecceeeecCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN--QVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~--~vkL~DFG~a~~~~~~~ 160 (414)
|+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++ ..+ .+||+|||+|+......
T Consensus 97 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~---~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 97 YASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLD---GSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEEC---SSSSCCEEECCCCCC-------
T ss_pred eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc---CCCCceEEEeecCccccccccC
Confidence 99 8899988875 45699999999999999999999999999999999999994 444 59999999987433221
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCch-hhHHHHHHHHHHHHcCCCCCCCChhhc-hHHHHHHHHhhccCCchH
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRR-DDLESLGYVLLYFLRGSLPWQGLKAAT-KKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-~DiwSlG~il~el~tG~~Pf~~~~~~~-~~~~~~~i~~~~~~~p~~ 238 (414)
......||..|+|||++.+..++.+ +|||||||++|+|++|+.||.+..... ....+..+.......+..
T Consensus 173 --------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (361)
T 3uc3_A 173 --------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD 244 (361)
T ss_dssp ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTT
T ss_pred --------CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCc
Confidence 1235679999999999998888665 899999999999999999998754432 334444555555444432
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+++++.+|+.+||..+|.+||++.++.+
T Consensus 245 ---~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 245 ---IRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp ---SCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ---CCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 245789999999999999999999988765
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=340.77 Aligned_cols=252 Identities=19% Similarity=0.252 Sum_probs=194.8
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
++|+++++||+|+||+||+|++..+++.||||++...... ..+.+|+.+++.++| ++++.+..++......++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH-ANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCC-TTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCC-CCCCeeeeEEeeCCEEEEEec
Confidence 5899999999999999999999999999999988654322 235579999999875 677777777778888999999
Q ss_pred ccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 84 ~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
|+.++|.+++......++...++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~-- 155 (324)
T 3mtl_A 81 YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTK-- 155 (324)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC-------
T ss_pred ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCcccccccCCcc--
Confidence 99999999998877789999999999999999999999999999999999999 5788999999999975443221
Q ss_pred cccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCc------
Q 015041 164 HIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP------ 236 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p------ 236 (414)
......||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.++........
T Consensus 156 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 156 -----TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -----ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhc
Confidence 1234578999999999987 5689999999999999999999999998765544444433322111110
Q ss_pred ----------------hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 237 ----------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 237 ----------------~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
.......+++++.+|+..||..||.+||++.++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 279 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA 279 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHH
Confidence 011122456677788888888888888887654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=344.82 Aligned_cols=248 Identities=26% Similarity=0.289 Sum_probs=204.3
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
...-++|++++.||+|+||.||+|.+..+++.||||++... .....+.+|+.+++.++| ++|+.+..++.....
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~ 83 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH-PHIIKLYDVITTPTD 83 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCC-TTBCCEEEEEECSSE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCCE
Confidence 33448999999999999999999999999999999987532 334568899999999975 677777777778889
Q ss_pred eEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 78 ~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
.++||||++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 84 ~~lv~E~~~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 84 IVMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp EEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTBTTT
T ss_pred EEEEEECCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccceecc
Confidence 999999999999998876 4579999999999999999999999999999999999999 588899999999987543
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCc
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p 236 (414)
... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+........ ++.......
T Consensus 160 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~---~i~~~~~~~- 227 (336)
T 3h4j_B 160 DGN--------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK---KVNSCVYVM- 227 (336)
T ss_dssp TSB--------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC---CCCSSCCCC-
T ss_pred CCc--------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH---HHHcCCCCC-
Confidence 322 1235679999999999998876 789999999999999999999998753322111 111111111
Q ss_pred hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 237 ~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...+++++.+++..||..||.+||++.++.+
T Consensus 228 ----p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 228 ----PDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp ----CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred ----cccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 2345789999999999999999999988765
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=329.75 Aligned_cols=257 Identities=16% Similarity=0.214 Sum_probs=211.9
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++..++|++++.||+|+||.||+|.+. ++..||||++.... ....+.+|+.+++.++| ++++.+..++......++|
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSH-PKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSEEEE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCC-CCEeeEEEEEccCCceEEE
Confidence 456789999999999999999999875 56789999987654 34568899999999985 6777777777788889999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++......+++..++.++.|++.||+|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEECCTTC
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCccceecchhh
Confidence 9999 788999998766779999999999999999999999999999999999999 588899999999998654432
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
.. ......+|..|+|||++.+..++.++|||||||++|+|++ |..||....... ....+.... ....+
T Consensus 159 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~~-~~~~~- 227 (268)
T 3sxs_A 159 YV------SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE---VVLKVSQGH-RLYRP- 227 (268)
T ss_dssp EE------ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHHHHTTC-CCCCC-
T ss_pred hh------cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH---HHHHHHcCC-CCCCC-
Confidence 21 1124456788999999999899999999999999999999 999998765432 222232222 11111
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~ 277 (414)
...++.+.+++..||..+|.+||++.++.+.|+.+.
T Consensus 228 --~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 228 --HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp --TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred --CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 345789999999999999999999999999887654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=347.29 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=207.2
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
+..++|+++++||+|+||+||+|++..+++.||+|++.. ......+..|+.+++.+.| ++|+.+..++.+....
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQLFYAFQDDRYL 144 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCC-TTBCCEEEEEECSSEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEE
Confidence 445789999999999999999999999999999998754 2233457889999998865 7777888888888899
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
++||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+...
T Consensus 145 ~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp EEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEeec
Confidence 9999999 8899998864 469999999999999999999999999999999999999 588999999999998754
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc-
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIE----QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK- 232 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~- 232 (414)
..... .....+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+.. ..+.++....
T Consensus 220 ~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~~ 290 (410)
T 3v8s_A 220 KEGMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIMNHKN 290 (410)
T ss_dssp TTSEE------ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTHHH
T ss_pred cCCcc------cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh---hHHHHHHhccc
Confidence 33211 123678999999999998765 889999999999999999999999875443 4444554432
Q ss_pred -cCCchHHhhhcChHHHHHHHHHHhcCCCCC--CCChHHHHH
Q 015041 233 -VSTPIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKR 271 (414)
Q Consensus 233 -~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~--RP~~~~l~~ 271 (414)
...|.. ..+++++.+|+..||..+|.+ ||++++|.+
T Consensus 291 ~~~~p~~---~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 291 SLTFPDD---NDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HCCCCTT---CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred cccCCCc---ccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 333321 356889999999999988888 999887754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=333.54 Aligned_cols=264 Identities=21% Similarity=0.327 Sum_probs=216.9
Q ss_pred ccCCceEEecceeecCceeEEEEEE-----CCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 75 (414)
+..++|++++.||+|+||.||+|.+ ..+++.||||++..... ...+.+|+.+++.+.+|++++.+..++...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 4568999999999999999999985 35678999999876543 245789999999996668888888888888
Q ss_pred CeeEEEEecc-CCCHHHHHHHhCC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEc
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYCRR-----------------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~~~-----------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~ 137 (414)
...++||||+ +++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~- 178 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL- 178 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE-
Confidence 8899999999 6799999886443 48999999999999999999999999999999999999
Q ss_pred cCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 015041 138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 216 (414)
Q Consensus 138 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~ 216 (414)
+.++.+||+|||+++........ .......||..|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 179 --~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 179 --THGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp --ETTTEEEECCCGGGSCTTSCTTS-----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred --cCCCCEEEccccccccccccccc-----eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 47889999999999765443221 11234567889999999999999999999999999999999 99999876
Q ss_pred hhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 015041 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (414)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~ 281 (414)
.... .+..+.......+.+ ...|.++.+++..||..+|.+||++.++.+.|++++....
T Consensus 252 ~~~~---~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 252 PVDS---KFYKMIKEGFRMLSP---EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp CSSH---HHHHHHHHTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred cchh---HHHHHhccCCCCCCc---ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 4332 222333333332222 3568899999999999999999999999999999887543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=334.65 Aligned_cols=261 Identities=23% Similarity=0.352 Sum_probs=199.3
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
++|.+++|++.++||+|+||+||+|++. ..||||+++..... ..+.+|+.+++.++| +++..+..+. ....
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH-VNILLFMGYS-TAPQ 93 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEE-CSSS
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCC-CcEEEEEeec-cCCc
Confidence 5889999999999999999999999863 35999998765433 347889999999986 4555555544 4556
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
.++||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEK 170 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTEEEECCCC-----
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE---CCCCCEEEccceecccc
Confidence 89999999 788988886656679999999999999999999999999999999999999 47889999999999754
Q ss_pred cCCCCCccccccCCCCCccCcCcccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
....... ......||..|+|||++. +..++.++|||||||++|+|++|..||.+..... .....+.....
T Consensus 171 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~~~ 243 (289)
T 3og7_A 171 SRWSGSH-----QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVGRGSL 243 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHHHHHTSC
T ss_pred ccccccc-----cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHHhccccc
Confidence 4322111 123567899999999987 5678999999999999999999999998754332 22233333444
Q ss_pred CCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 015041 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (414)
Q Consensus 234 ~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~ 277 (414)
..+.......+|+++.+++..||..+|.+||++.++.+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 244 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 44444455677899999999999999999999999999988754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=329.18 Aligned_cols=260 Identities=22% Similarity=0.317 Sum_probs=200.2
Q ss_pred cccCCceEEecceeecCceeEEEEEECCC---CceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
++..++|++++.||+|+||.||+|.+..+ +..||+|+....... ..+.+|+.+++.+.| ++++.+..+. ...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~-~~~ 88 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-PHIVKLIGVI-TEN 88 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEE-CSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CccceEEEEE-ccC
Confidence 46678999999999999999999998653 457999987764432 347789999999976 5566665554 345
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
..++||||+ +++|.+++......+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRY 165 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC---CCCCEEECccccccc
Confidence 689999999 6799999987666799999999999999999999999999999999999994 788999999999986
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccC
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
....... ......+|..|+|||++.+..++.++|||||||++|||++ |..||.+...... +..+.... .
T Consensus 166 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~i~~~~-~ 235 (281)
T 1mp8_A 166 MEDSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIENGE-R 235 (281)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHHTTC-C
T ss_pred cCccccc------ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHHHHcCC-C
Confidence 5433211 1124456789999999999999999999999999999997 9999987654432 23332222 2
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
.+ ....+|+.+.+++..||..+|++||++.++.+.|++++..+
T Consensus 236 ~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 236 LP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 22 22456899999999999999999999999999999887654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=339.61 Aligned_cols=262 Identities=19% Similarity=0.271 Sum_probs=212.2
Q ss_pred ccCCceEEecceeecCceeEEEEEEC-----CCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 75 (414)
+..++|++++.||+|+||.||+|.+. .++..||||++.... ....+.+|+.+++.+..|++++.+..++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 45679999999999999999999973 456789999987543 3356889999999996668888888888888
Q ss_pred CeeEEEEecc-CCCHHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCC
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYCRR----------------------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 132 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~~~----------------------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~ 132 (414)
...++||||+ +++|.+++..... .+++..++.++.||+.||+|||++||+||||||+
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 201 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence 8899999999 7899999875432 3789999999999999999999999999999999
Q ss_pred ceEEccCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCC
Q 015041 133 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSL 211 (414)
Q Consensus 133 Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~ 211 (414)
|||+ +.++.+||+|||++.......... ......||..|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 202 NIll---~~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 202 NVLV---THGKVVKICDFGLARDIMSDSNYV-----VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp GEEE---ETTTEEEECCCGGGSCGGGCTTSE-----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred hEEE---cCCCcEEeCCCccCcccccCccce-----eccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCC
Confidence 9999 478899999999998654432211 1234567889999999999999999999999999999998 999
Q ss_pred CCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 212 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 212 Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
||.+.... ..+..++......+.+ ...++++.+++..||..+|.+||++.++.+.|+.++..
T Consensus 274 p~~~~~~~---~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 274 PYPGIPVD---ANFYKLIQNGFKMDQP---FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp SSTTCCCS---HHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CcccCCcH---HHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 99876433 2233333433333322 34589999999999999999999999999999987654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=329.44 Aligned_cols=257 Identities=19% Similarity=0.286 Sum_probs=211.6
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
+-.++|++.+.||+|+||+||+|.+. ++..||+|++.... ....+.+|+.+++.++| ++++.+..++.+....++||
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSSEEEEE
T ss_pred eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCceEEEE
Confidence 34579999999999999999999986 47789999987654 34568899999999985 67777777777888899999
Q ss_pred ecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
||+ +++|.+++......++...++.++.|++.||+|||++||+||||||+||++ +.++.+||+|||+++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGBCCHHH
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEecccccccccccccc
Confidence 999 779999987666679999999999999999999999999999999999999 4778999999999975432211
Q ss_pred CccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
.......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+.... +....+... .....+
T Consensus 162 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~~~~~~~-~~~~~~-- 229 (269)
T 4hcu_A 162 ------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDISTG-FRLYKP-- 229 (269)
T ss_dssp ------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTT-CCCCCC--
T ss_pred ------ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHhcC-ccCCCC--
Confidence 11234556888999999999999999999999999999999 99999875543 223333222 122111
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
...++++.+++..||..+|.+||++.++.+.|+++.+
T Consensus 230 -~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 230 -RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 3457899999999999999999999999999998765
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=346.33 Aligned_cols=264 Identities=21% Similarity=0.287 Sum_probs=205.8
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
+..++|++++.||+|+||.||+|++..+++.||||++.... ....+..|..++....+|++++.+..++......
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 34478999999999999999999999999999999886542 1223455655532223457788888888888899
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 115 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGGB
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCccccccc
Confidence 9999999 7799888876 4578999999999999999999999999999999999999 588999999999997543
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+. .+.+..+.......+
T Consensus 191 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~~~~~~~- 259 (373)
T 2r5t_A 191 EHNS-------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYDNILNKPLQLK- 259 (373)
T ss_dssp CCCC-------CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH---HHHHHHHHHSCCCCC-
T ss_pred cCCC-------ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcccCCC-
Confidence 3221 12467899999999999999999999999999999999999999987543 345556666555444
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCccccccc
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTI 292 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 292 (414)
..++.++.+++..||..+|.+||+..+. +.++ ..+.+...+||..
T Consensus 260 ----~~~~~~~~~li~~lL~~dp~~R~~~~~~---~~~i---~~h~~f~~~~w~~ 304 (373)
T 2r5t_A 260 ----PNITNSARHLLEGLLQKDRTKRLGAKDD---FMEI---KSHVFFSLINWDD 304 (373)
T ss_dssp ----SSSCHHHHHHHHHHTCSSGGGSTTTTTT---HHHH---HTSGGGTTCCHHH
T ss_pred ----CCCCHHHHHHHHHHcccCHHhCCCCCCC---HHHH---hCCccccCCCHHH
Confidence 4568899999999999999999997421 1222 2234555567754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=332.09 Aligned_cols=259 Identities=19% Similarity=0.300 Sum_probs=210.9
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
+-.++|++++.||+|+||+||+|.+. ++..||||++.... ....+.+|+++++.+.| ++++.+..++......++||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-EKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSSEEEEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCC-CCEeeEEEEEecCCCeEEEE
Confidence 55679999999999999999999875 57789999987654 34568899999999975 66777777777888899999
Q ss_pred ecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
||+ +++|.+++......+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGGBCCHHH
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEcccccccccccccc
Confidence 999 889999988656779999999999999999999999999999999999999 5888999999999975432211
Q ss_pred CccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
.......+|..|+|||++.+..++.++|||||||++|+|++ |+.||....... ....+... .....+
T Consensus 176 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~~-~~~~~~-- 243 (283)
T 3gen_A 176 ------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAEHIAQG-LRLYRP-- 243 (283)
T ss_dssp ------HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHHHHTT-CCCCCC--
T ss_pred ------ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH---HHHHHhcc-cCCCCC--
Confidence 11224456888999999999999999999999999999998 999998765433 22233222 222211
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
...++.+.+++..||..+|.+||++.++.+.|.+++.++
T Consensus 244 -~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 244 -HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp -TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 345789999999999999999999999999999888654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=330.61 Aligned_cols=254 Identities=18% Similarity=0.283 Sum_probs=203.8
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc---------hhHHHHHHHHHHHcCCCCCCeeEEee
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---------PQLLYEAKVYKILQGGSGIPNIKWYG 72 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~E~~~l~~l~~~~~i~~l~~~~ 72 (414)
..+..++|++.+.||+|+||+||+|++..+++.||||++...... ..+.+|+.+++.++| ++++.+..++
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~ 92 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH-PNIVKLYGLM 92 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCC-TTBCCEEEEE
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCC-CCchhhheee
Confidence 356789999999999999999999999999999999988654321 457889999999975 5666665554
Q ss_pred eeCCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeccccCCCceEEccCCCCC-----e
Q 015041 73 VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKAN-----Q 144 (414)
Q Consensus 73 ~~~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDLkp~Nili~~~~~~~-----~ 144 (414)
.. ..++||||+ +++|.+.+......+++..++.++.|++.||+|||++| |+||||||+|||++ ..+ .
T Consensus 93 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~---~~~~~~~~~ 167 (287)
T 4f0f_A 93 HN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQ---SLDENAPVC 167 (287)
T ss_dssp TT--TTEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEES---CCCTTCSCC
T ss_pred cC--CCeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEe---ccCCCCcee
Confidence 33 337999999 68998888765667999999999999999999999999 99999999999995 333 3
Q ss_pred EEEeeecceeeecCCCCCccccccCCCCCccCcCcccccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchH
Q 015041 145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL--GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK 222 (414)
Q Consensus 145 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~ 222 (414)
+||+|||+++..... .....||..|+|||++. ...++.++|||||||++|+|++|..||....... .
T Consensus 168 ~kl~Dfg~~~~~~~~----------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~ 236 (287)
T 4f0f_A 168 AKVADFGLSQQSVHS----------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-I 236 (287)
T ss_dssp EEECCCTTCBCCSSC----------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH-H
T ss_pred EEeCCCCcccccccc----------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH-H
Confidence 999999999743321 12567899999999984 4568899999999999999999999998754332 2
Q ss_pred HHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 015041 223 QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (414)
Q Consensus 223 ~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~ 275 (414)
.....+......... ...+|+++.+++..||..+|.+||++.++.+.|++
T Consensus 237 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 237 KFINMIREEGLRPTI---PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHHHHSCCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHHhccCCCCCC---CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 223333333333222 24568999999999999999999999999988764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=325.57 Aligned_cols=255 Identities=24% Similarity=0.294 Sum_probs=210.1
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
..+.++|++.++||+|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.++| ++++.+..++......
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESFH 80 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEE
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCC-CCcCeEEEEEEcCCEE
Confidence 34679999999999999999999999999999999988654322 347789999999975 6777777777888889
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
++||||+ +++|.+.+.. ...++...++.++.|++.||+|||++||+||||||+||+++.....+.+||+|||++....
T Consensus 81 ~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999 7788887765 4569999999999999999999999999999999999999644445569999999997654
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
.... .....||..|+|||++.+..++.++|||||||++|+|++|..||.+.... .....+.......+.
T Consensus 160 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~ 228 (284)
T 3kk8_A 160 DSEA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIKAGAYDYPS 228 (284)
T ss_dssp SSCB--------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCCCCT
T ss_pred cCcc--------ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHHHHHHhccccCCc
Confidence 4322 13567899999999999999999999999999999999999999875443 333344444444443
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+ ....+++++.+++..||..+|.+||++.++.+
T Consensus 229 ~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 229 P-EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp T-TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred h-hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 2 22456889999999999999999999987754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=334.33 Aligned_cols=244 Identities=23% Similarity=0.327 Sum_probs=196.4
Q ss_pred cccCCceEEecceeecCceeEEEEEEC---CCCceEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCeeEEeee
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT------KHPQLLYEAKVYKILQGGSGIPNIKWYGV 73 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~---~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~ 73 (414)
.+..++|++++.||+|+||.||+|++. .+++.||+|++.... ....+.+|+.+++.+.| ++++.+..++.
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~ 91 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKH-PFIVDLIYAFQ 91 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCC-TTBCCEEEEEE
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCC-CCccceeEEEE
Confidence 456789999999999999999999985 688999999987542 22346789999999975 66777777777
Q ss_pred eCCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecc
Q 015041 74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (414)
Q Consensus 74 ~~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~ 152 (414)
.....++||||+ +++|.+++.. ...++...++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGL 167 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSC
T ss_pred cCCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCc
Confidence 888999999999 7899888875 4568999999999999999999999999999999999999 5788999999999
Q ss_pred eeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc
Q 015041 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (414)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (414)
++....... .....+||..|+|||++.+..++.++|||||||++|+|++|..||.+.... +.+..+....
T Consensus 168 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~ 237 (327)
T 3a62_A 168 CKESIHDGT-------VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KTIDKILKCK 237 (327)
T ss_dssp C-----------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHTC
T ss_pred ccccccCCc-------cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhCC
Confidence 875433221 123567999999999999999999999999999999999999999875433 3445555555
Q ss_pred cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCCh
Q 015041 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 233 ~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~ 266 (414)
...| ..++.++.+++..||..+|.+||++
T Consensus 238 ~~~p-----~~~~~~~~~li~~~L~~dp~~R~~~ 266 (327)
T 3a62_A 238 LNLP-----PYLTQEARDLLKKLLKRNAASRLGA 266 (327)
T ss_dssp CCCC-----TTSCHHHHHHHHHHSCSCGGGSTTS
T ss_pred CCCC-----CCCCHHHHHHHHHHHhcCHhhccCC
Confidence 5444 3457899999999999999999943
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=343.46 Aligned_cols=259 Identities=18% Similarity=0.227 Sum_probs=201.4
Q ss_pred cCCceEEecceeec--CceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 5 IGVKYKLGRKIGSG--SFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 5 ~~~~y~i~~~iG~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
.+++|+++++||+| +||+||+|++..+++.||||++...... ..+.+|+.+++.++| ++|+.+..++......
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNH-PNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCC-CCCCcEeEEEEECCEE
Confidence 46899999999999 9999999999999999999998754322 346779999999976 6677777777888899
Q ss_pred EEEEecc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 79 VLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
++||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||.+...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGCEEC
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccccceee
Confidence 9999999 78999998764 2569999999999999999999999999999999999999 58889999999998765
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc-
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV- 233 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~- 233 (414)
..................||..|+|||++.+ ..++.++|||||||++|||++|+.||.+......... +.....
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---~~~~~~~ 255 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE---KLNGTVP 255 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH---C------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH---HhcCCCC
Confidence 4332222111222345688999999999988 5799999999999999999999999987544322111 111000
Q ss_pred ----------------------------------------CCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 234 ----------------------------------------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 234 ----------------------------------------~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
..+.......+++++.+|+..||..||.+||++.++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 0001112345678899999999999999999987653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=332.97 Aligned_cols=256 Identities=19% Similarity=0.251 Sum_probs=203.7
Q ss_pred CCcccCCceEEecceeecCceeEEEEEE-CCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCC-----CCCeeEEeee
Q 015041 1 MERIIGVKYKLGRKIGSGSFGEIFLASH-VDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGS-----GIPNIKWYGV 73 (414)
Q Consensus 1 ~~~i~~~~y~i~~~iG~G~~g~V~~~~~-~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~-----~i~~l~~~~~ 73 (414)
.|+++.++|++++.||+|+||+||+|.+ ..+++.||||++..... ...+.+|+.+++.+.|.+ +++.+..++.
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 3788999999999999999999999998 56789999999875432 245788999999987644 3566677777
Q ss_pred eCCeeEEEEeccCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCC-----------
Q 015041 74 DGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK----------- 141 (414)
Q Consensus 74 ~~~~~~lv~e~~~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~----------- 141 (414)
.....++||||++++|.+++.... ..++...++.++.||+.||+|||++||+||||||+|||++..+.
T Consensus 88 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 88 HHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp ETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred cCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 888999999999999999988644 36899999999999999999999999999999999999952111
Q ss_pred -----CCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 015041 142 -----ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 216 (414)
Q Consensus 142 -----~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~ 216 (414)
++.+||+|||+++...... ....||..|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEHH----------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSCC----------CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCCCceEeeCcccccCcccc----------ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 5679999999997643321 2567899999999999999999999999999999999999999986
Q ss_pred hhhchHHHHHHHHhhccCCchHHh---------------------------------------hhcChHHHHHHHHHHhc
Q 015041 217 KAATKKQKYDKICEKKVSTPIEVL---------------------------------------CKSHPAEFASYFHYCQS 257 (414)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~p~~~~---------------------------------------~~~~p~~~~~l~~~c~~ 257 (414)
........+..+. ...|.... ....++++.+++..||.
T Consensus 238 ~~~~~~~~~~~~~---~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 238 DSKEHLAMMERIL---GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp CHHHHHHHHHHHH---CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred ChHHHHHHHHHHh---CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence 5544333333322 12221110 01124678889999999
Q ss_pred CCCCCCCChHHH
Q 015041 258 LTFDQRPDYGFL 269 (414)
Q Consensus 258 ~~p~~RP~~~~l 269 (414)
.||.+||++.++
T Consensus 315 ~dP~~Rpt~~el 326 (339)
T 1z57_A 315 YDPAKRITLREA 326 (339)
T ss_dssp SSTTTSCCHHHH
T ss_pred cCcccccCHHHH
Confidence 999999987765
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=336.33 Aligned_cols=254 Identities=22% Similarity=0.330 Sum_probs=196.2
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCC-
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDGE- 76 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~- 76 (414)
..+.++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.+.| ++|+.+..++....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~ 86 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH-PAIVAVYDTGEAETP 86 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCC-TTBCCEEEEEEEEET
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCC-CCcceEEEeeeccCC
Confidence 45789999999999999999999999999999999998765332 246788888888876 55666655444332
Q ss_pred ---eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecc
Q 015041 77 ---DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (414)
Q Consensus 77 ---~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~ 152 (414)
..++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGI 162 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---ETTSCEEECCCSC
T ss_pred CCcccEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE---cCCCCEEEeeccC
Confidence 349999999 7899998876 4579999999999999999999999999999999999999 4788999999999
Q ss_pred eeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc
Q 015041 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (414)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (414)
++........ ........||..|+|||++.+..++.++|||||||++|+|++|+.||.+..... ....+...
T Consensus 163 a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~---~~~~~~~~- 234 (311)
T 3ork_A 163 ARAIADSGNS----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS---VAYQHVRE- 234 (311)
T ss_dssp C----------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHC-
T ss_pred cccccccccc----cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHhcC-
Confidence 9865433221 112235678999999999999999999999999999999999999998765432 22223232
Q ss_pred cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 233 ~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
...+.......++.++.+++..||..||.+||+..++
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~ 271 (311)
T 3ork_A 235 DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAE 271 (311)
T ss_dssp CCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred CCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHH
Confidence 3344445556789999999999999999999976543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=351.61 Aligned_cols=263 Identities=20% Similarity=0.249 Sum_probs=187.1
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeee-----e
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGV-----D 74 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~-----~ 74 (414)
.+.++|++++.||+|+||+||+|.+..+++.||||++...... ..+.+|+.+++.++| ++|+.+..++. .
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNH-DHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCC-TTBCCEEEECCCSCTTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCC-CCCCceEEEEecCCccc
Confidence 3568999999999999999999999999999999988654322 357889999999976 55666655542 2
Q ss_pred CCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 75 ~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
....++||||++++|.+++.. ...+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+
T Consensus 129 ~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 129 FDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLAR 204 (458)
T ss_dssp CCCEEEEECCCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCB
T ss_pred CceEEEEEeccccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeecccccch
Confidence 356899999999999988864 4569999999999999999999999999999999999999 588899999999998
Q ss_pred eecCCCCCccc-c-------------------ccCCCCCccCcCcccccccc-CCCCCchhhHHHHHHHHHHHHc-----
Q 015041 155 KYRDPTTNRHI-P-------------------YRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLR----- 208 (414)
Q Consensus 155 ~~~~~~~~~~~-~-------------------~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DiwSlG~il~el~t----- 208 (414)
........... + .......+||..|+|||++. +..++.++|||||||++|||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 76433211100 0 01223568899999999874 5569999999999999999999
Q ss_pred ------CCCCCCCChhh-----------------chHHHHHHHHhhccCCch--------------------------HH
Q 015041 209 ------GSLPWQGLKAA-----------------TKKQKYDKICEKKVSTPI--------------------------EV 239 (414)
Q Consensus 209 ------G~~Pf~~~~~~-----------------~~~~~~~~i~~~~~~~p~--------------------------~~ 239 (414)
|.++|.+.... .....+..+.......+. ..
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 77777664310 011222233222222221 12
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.....++++.+|+.+||..||.+||+++++.+
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 22345788999999999999999999887655
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=335.09 Aligned_cols=256 Identities=18% Similarity=0.244 Sum_probs=203.3
Q ss_pred CCcccCCceEEecceeecCceeEEEEEECCCC-ceEEEEEecCCCC-chhHHHHHHHHHHHcCCCC-----CCeeEEeee
Q 015041 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTN-EIVAVKIENSGTK-HPQLLYEAKVYKILQGGSG-----IPNIKWYGV 73 (414)
Q Consensus 1 ~~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~-~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~-----i~~l~~~~~ 73 (414)
+|+++.++|++++.||+|+||+||+|.+..++ ..||||++..... ...+.+|+.+++.+.|.+. +..+..++.
T Consensus 13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 47889999999999999999999999998776 7899999875432 3457789999999986442 455566677
Q ss_pred eCCeeEEEEeccCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccC-------------
Q 015041 74 DGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG------------- 139 (414)
Q Consensus 74 ~~~~~~lv~e~~~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~------------- 139 (414)
.....++||||+++++.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||+...
T Consensus 93 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 93 FHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp ETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred eCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 788999999999999998887644 469999999999999999999999999999999999999422
Q ss_pred ---CCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 015041 140 ---RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 216 (414)
Q Consensus 140 ---~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~ 216 (414)
+..+.+||+|||+++...... ....||..|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEHH----------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSCC----------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccCCCcEEEeecCccccccccc----------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 257889999999998643322 2567899999999999999999999999999999999999999986
Q ss_pred hhhchHHHHHHHHhhccCCchHHhh---------------------------------------hcChHHHHHHHHHHhc
Q 015041 217 KAATKKQKYDKICEKKVSTPIEVLC---------------------------------------KSHPAEFASYFHYCQS 257 (414)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~p~~~~~---------------------------------------~~~p~~~~~l~~~c~~ 257 (414)
........+.++. ...|..... ...+.++.+|+..||.
T Consensus 243 ~~~~~~~~~~~~~---~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 243 ENREHLVMMEKIL---GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp SHHHHHHHHHHHH---CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CHHHHHHHHHHHc---CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 5544333333322 222221100 0113577888888888
Q ss_pred CCCCCCCChHHH
Q 015041 258 LTFDQRPDYGFL 269 (414)
Q Consensus 258 ~~p~~RP~~~~l 269 (414)
.||.+||++.++
T Consensus 320 ~dP~~Rpt~~e~ 331 (355)
T 2eu9_A 320 FDPAQRITLAEA 331 (355)
T ss_dssp SSTTTSCCHHHH
T ss_pred CChhhCcCHHHH
Confidence 888888887654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=339.01 Aligned_cols=207 Identities=25% Similarity=0.322 Sum_probs=177.4
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCC-----CCeeEEeeeeC
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSG-----IPNIKWYGVDG 75 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~-----i~~l~~~~~~~ 75 (414)
++.+.++|++++.||+|+||+||+|.+..+++.||||++..... ...+..|+.+++.+.++++ ++.+..++...
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 45677899999999999999999999999999999999875432 2446778999999876654 66777777788
Q ss_pred CeeEEEEeccCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH--hcCeeccccCCCceEEccCCCCCeEEEeeecc
Q 015041 76 EDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVH--SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (414)
Q Consensus 76 ~~~~lv~e~~~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH--~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~ 152 (414)
...++||||++++|.+++.... ..+++..++.++.||+.||.||| +.||+||||||+|||++. +..+.+||+|||+
T Consensus 129 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 129 NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGS 207 (382)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSCCEEECCCTT
T ss_pred CceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCCcEEEEeccC
Confidence 8999999999999999998654 56999999999999999999999 479999999999999941 2467899999999
Q ss_pred eeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhh
Q 015041 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219 (414)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~ 219 (414)
|+...... ....||..|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 208 a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 264 (382)
T 2vx3_A 208 SCQLGQRI----------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264 (382)
T ss_dssp CEETTCCC----------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ceeccccc----------ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 98754321 2567899999999999999999999999999999999999999986544
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=337.33 Aligned_cols=254 Identities=23% Similarity=0.230 Sum_probs=195.4
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
.-++|+++++||+|+||+||+|.+..+++.||||++...... ..+.+|+.+++.++| ++++.+..++......++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH-RNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCC-TTBCCEEEEEEETTEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCC-CCcceEEEEEecCCEEEE
Confidence 347899999999999999999999999999999998754332 346789999999965 677778778888899999
Q ss_pred EEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccC--CCCCeEEEeeecceeeecC
Q 015041 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG--RKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 81 v~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~--~~~~~vkL~DFG~a~~~~~ 158 (414)
||||+.++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.. +..+.+||+|||+++....
T Consensus 111 v~e~~~~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 111 IFEYAENDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp EEECCSEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred EEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 999999999998876 4569999999999999999999999999999999999999532 2455699999999976543
Q ss_pred CCCCccccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCc-
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP- 236 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p- 236 (414)
... ......||..|+|||++.+.. ++.++|||||||++|+|++|..||.+....... ..+.......+
T Consensus 190 ~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~~~~~~~~~~~ 259 (329)
T 3gbz_A 190 PIR-------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL---FKIFEVLGLPDD 259 (329)
T ss_dssp -----------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCT
T ss_pred ccc-------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH---HHHHHHhCCCch
Confidence 221 123457899999999998754 899999999999999999999999886544333 23322211111
Q ss_pred ------------------------hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 237 ------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 237 ------------------------~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
.......+++++.+|+..||..||.+||++.++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 317 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 1112223578888999999999999999987653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=338.07 Aligned_cols=248 Identities=21% Similarity=0.308 Sum_probs=194.8
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeC-----
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDG----- 75 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~----- 75 (414)
+.++|++++.||+|+||.||+|.+..+|+.||||++...... ..+.+|+.+++.++| +++..+..++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH-ENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCB-TTBCCCSEEECSCSSTTT
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCC-cCCCCceeeEecCCcccc
Confidence 568999999999999999999999999999999998654332 346789999999986 5555554444332
Q ss_pred -CeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 76 -EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 76 -~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
...++||||++++|.+++.. ..++...+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 102 ~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 102 FTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLAR 176 (367)
T ss_dssp CCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred CceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEEEeeeccc
Confidence 34699999999999998875 569999999999999999999999999999999999999 578899999999998
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
...... ...+||..|+|||++.+ ..++.++|||||||++|||++|+.||.+..... .+..+.....
T Consensus 177 ~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g 243 (367)
T 1cm8_A 177 QADSEM----------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEIMKVTG 243 (367)
T ss_dssp ECCSSC----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHC
T ss_pred cccccc----------CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcC
Confidence 754321 25678999999999987 679999999999999999999999999865443 3333333222
Q ss_pred CCch--------------------------HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 234 STPI--------------------------EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 234 ~~p~--------------------------~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+. .......++++.+|+.+||..||.+||++.++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 2221 1222455788999999999999999999887655
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=333.86 Aligned_cols=263 Identities=19% Similarity=0.308 Sum_probs=213.4
Q ss_pred ccCCceEEecceeecCceeEEEEEEC-------CCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHV-------DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV 73 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~ 73 (414)
+..++|++++.||+|+||.||+|++. .++..||||++...... ..+.+|+.+++.+..|++++.+..++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 45689999999999999999999986 45678999998765433 347889999999966788888888888
Q ss_pred eCCeeEEEEecc-CCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEc
Q 015041 74 DGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137 (414)
Q Consensus 74 ~~~~~~lv~e~~-~~sL~~~~~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~ 137 (414)
.....++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll- 190 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV- 190 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE-
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE-
Confidence 888899999999 779999987543 238999999999999999999999999999999999999
Q ss_pred cCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 015041 138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 216 (414)
Q Consensus 138 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~ 216 (414)
+.++.+||+|||+++........ .......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 191 --~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 191 --TENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp --CTTCCEEECCCTTCEECTTTSSE-----ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred --cCCCCEEEccccccccccccccc-----cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 57889999999999876543221 11234567889999999999899999999999999999999 99999876
Q ss_pred hhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 015041 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (414)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~ 281 (414)
.... ....+.. ....+. ...++.++.+++..||..+|.+||++.++.+.|+.++....
T Consensus 264 ~~~~---~~~~~~~-~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 264 PVEE---LFKLLKE-GHRMDK---PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp CHHH---HHHHHHH-TCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CHHH---HHHHHhc-CCCCCC---CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 4432 2222222 222221 24568899999999999999999999999999999886543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=323.75 Aligned_cols=252 Identities=24% Similarity=0.275 Sum_probs=210.3
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC--CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
+.++|++.+.||+|+||+||+|.+..++..||+|.+... .....+.+|+.+++.+.| ++++.+..++......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH-PNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCeEEEEE
Confidence 457899999999999999999999999999999987653 334568899999999965 67777777788888999999
Q ss_pred ecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
||+ +++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||+...+.++.+||+|||++........
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 86 ELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp ECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred eccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 999 7799888776 45699999999999999999999999999999999999996545778999999999987654322
Q ss_pred CccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhh
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~ 241 (414)
.....||..|+|||++.+. ++.++|||||||++|+|++|..||.+.... +....+.......+.. ..
T Consensus 165 --------~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~-~~ 231 (277)
T 3f3z_A 165 --------MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS---EVMLKIREGTFTFPEK-DW 231 (277)
T ss_dssp --------BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCCHH-HH
T ss_pred --------hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhCCCCCCch-hh
Confidence 2356789999999998765 899999999999999999999999875443 3444444555444433 33
Q ss_pred hcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 242 ~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+++++.+++..||..+|.+||++.++.+
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 232 LNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 467899999999999999999999887654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=327.86 Aligned_cols=255 Identities=22% Similarity=0.278 Sum_probs=197.7
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
-++|+++++||+|+||+||+|.+..+++.||||++...... ..+.+|+.+++.++| ++++.+..++......++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH-PNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCC-CCccchhheeecCCeEEEE
Confidence 37899999999999999999999999999999988665443 346789999999975 6677777777888899999
Q ss_pred EeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 82 ~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
|||+.+.+...+......++...+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC----
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCccc
Confidence 9999655444444446679999999999999999999999999999999999999 5788999999999987653322
Q ss_pred CccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc--------
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK-------- 232 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~-------- 232 (414)
. .....||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.+.....
T Consensus 158 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
T 4agu_A 158 Y-------YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF 230 (311)
T ss_dssp ---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred c-------cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccc
Confidence 1 124578999999999986 568999999999999999999999999866544333333221110
Q ss_pred ---------------cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 233 ---------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 233 ---------------~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...+........+.++.+++..||..||.+||+++++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 001122233467888999999999999999999887643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=331.46 Aligned_cols=252 Identities=20% Similarity=0.284 Sum_probs=209.5
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--------chhHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 74 (414)
..+.++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+.| ++++.+..++..
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~ 86 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH-HNVITLHDVYEN 86 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEEC
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCC-CCcceEEEEEec
Confidence 3456789999999999999999999999999999998765432 3458899999999976 567777777778
Q ss_pred CCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCC----eEEEee
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN----QVYIID 149 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~----~vkL~D 149 (414)
....++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++ .++ .+||+|
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~---~~~~~~~~~kl~D 162 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL---DKNIPIPHIKLID 162 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES---CTTSSSCCEEECC
T ss_pred CCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEe---cCCCCcCCEEEcc
Confidence 88999999999 7899998865 55789999999999999999999999999999999999994 444 799999
Q ss_pred ecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHH
Q 015041 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (414)
Q Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~ 229 (414)
||+++....... .....||..|+|||++.+..++.++|||||||++|+|++|..||.+.... +.+..+.
T Consensus 163 fg~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~ 231 (321)
T 2a2a_A 163 FGLAHEIEDGVE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANIT 231 (321)
T ss_dssp CTTCEECCTTCC--------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHH
T ss_pred CccceecCcccc--------ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH
Confidence 999987654321 13557899999999999999999999999999999999999999875443 3344444
Q ss_pred hhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 230 ~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
......+ .......++.+.+++..||..+|.+||++.++.+
T Consensus 232 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 232 SVSYDFD-EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp TTCCCCC-HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred hcccccC-hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 4444333 3344567899999999999999999999887654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=332.32 Aligned_cols=261 Identities=18% Similarity=0.280 Sum_probs=212.8
Q ss_pred cccCCceEEecceeecCceeEEEEEEC-----CCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 74 (414)
++..++|++++.||+|+||.||+|.+. .++..||||++...... ..+.+|+.+++.+.| ++++.+..++..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~ 97 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH-PHVIKLYGACSQ 97 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCC-CceeeEEEEEec
Confidence 456789999999999999999999983 45588999998765432 347789999999965 677777777777
Q ss_pred CCeeEEEEecc-CCCHHHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccC
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYCR-----------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 130 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~~-----------------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLk 130 (414)
....++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+|||||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 177 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence 88899999999 689999988643 238899999999999999999999999999999
Q ss_pred CCceEEccCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-C
Q 015041 131 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-G 209 (414)
Q Consensus 131 p~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G 209 (414)
|+|||+ +.++.+||+|||+++........ .......+|..|+|||++.+..++.++|||||||++|+|++ |
T Consensus 178 p~NIli---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 249 (314)
T 2ivs_A 178 ARNILV---AEGRKMKISDFGLSRDVYEEDSY-----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249 (314)
T ss_dssp GGGEEE---ETTTEEEECCCTTCEECTTTSCE-----ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred hheEEE---cCCCCEEEccccccccccccccc-----eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCC
Confidence 999999 47889999999999876443221 12234567889999999999999999999999999999999 9
Q ss_pred CCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 210 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 210 ~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
..||.+........ .+ ......+ ....+++++.+++..||..+|.+||++.++.+.|+.++.+
T Consensus 250 ~~p~~~~~~~~~~~---~~-~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 250 GNPYPGIPPERLFN---LL-KTGHRME---RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CCSSTTCCGGGHHH---HH-HTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCCHHHHHH---Hh-hcCCcCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 99998765443222 22 2222221 1245689999999999999999999999999999988764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=345.18 Aligned_cols=262 Identities=18% Similarity=0.250 Sum_probs=196.0
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeC-----
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDG----- 75 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~----- 75 (414)
+.++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++| ++|..+..++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS-DYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCC-TTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCC-CCcceEEEEEecCCCCcC
Confidence 678999999999999999999999999999999998764332 457899999999986 5555565554433
Q ss_pred CeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 76 ~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
...++||||++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.
T Consensus 103 ~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 103 DELYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLART 178 (432)
T ss_dssp CCEEEEEECCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred CeEEEEEecCCcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEccCCCccc
Confidence 56899999999999998864 4569999999999999999999999999999999999999 5888999999999987
Q ss_pred ecCCCCCccc---------------cccCCCCCccCcCcccccccc-CCCCCchhhHHHHHHHHHHHHcC----------
Q 015041 156 YRDPTTNRHI---------------PYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRG---------- 209 (414)
Q Consensus 156 ~~~~~~~~~~---------------~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DiwSlG~il~el~tG---------- 209 (414)
.......... ........+||..|+|||++. +..++.++|||||||++|||++|
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 6543211000 001124678999999999864 55699999999999999999984
Q ss_pred -CCCCCCChh--------------hchHHHHHHHHhhccCCc--------------------------hHHhhhcChHHH
Q 015041 210 -SLPWQGLKA--------------ATKKQKYDKICEKKVSTP--------------------------IEVLCKSHPAEF 248 (414)
Q Consensus 210 -~~Pf~~~~~--------------~~~~~~~~~i~~~~~~~p--------------------------~~~~~~~~p~~~ 248 (414)
.++|.+... ......+..+.+....++ .......+++++
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 338 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG 338 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence 444443220 011222223322222222 222334578899
Q ss_pred HHHHHHHhcCCCCCCCChHHHHH
Q 015041 249 ASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 249 ~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+|+..||..||.+||+++++.+
T Consensus 339 ~dLl~~mL~~dP~~R~ta~e~L~ 361 (432)
T 3n9x_A 339 INLLESMLKFNPNKRITIDQALD 361 (432)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhcCCcccCCCHHHHhc
Confidence 99999999999999999877654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=330.53 Aligned_cols=249 Identities=20% Similarity=0.288 Sum_probs=197.0
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----------------------------chhHHHHHHH
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------------------------HPQLLYEAKV 55 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------------------------~~~~~~E~~~ 55 (414)
+.-++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 445899999999999999999999999999999998765421 2457899999
Q ss_pred HHHHcCCCCCCeeEEeeee--CCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCC
Q 015041 56 YKILQGGSGIPNIKWYGVD--GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 132 (414)
Q Consensus 56 l~~l~~~~~i~~l~~~~~~--~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~ 132 (414)
++.+.| ++++.+..++.. ....++||||+ +++|.++.. ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 90 l~~l~h-~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 90 LKKLDH-PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HHTCCC-TTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HHhCCC-CCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 999976 556666555543 56789999999 667766532 456999999999999999999999999999999999
Q ss_pred ceEEccCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCC---CCchhhHHHHHHHHHHHHcC
Q 015041 133 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE---QSRRDDLESLGYVLLYFLRG 209 (414)
Q Consensus 133 Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DiwSlG~il~el~tG 209 (414)
|||+ +.++.+||+|||+++........ .....||..|+|||++.+.. ++.++|||||||++|+|++|
T Consensus 167 Nil~---~~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g 236 (298)
T 2zv2_A 167 NLLV---GEDGHIKIADFGVSNEFKGSDAL-------LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236 (298)
T ss_dssp GEEE---CTTSCEEECCCTTCEECSSSSCE-------ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred HEEE---CCCCCEEEecCCCcccccccccc-------ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence 9999 57889999999999876543221 12457899999999998765 47899999999999999999
Q ss_pred CCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 210 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 210 ~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..||.+.... .....+.......+. ...+++++.+++..||..||.+||++.++.+
T Consensus 237 ~~pf~~~~~~---~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 237 QCPFMDERIM---CLHSKIKSQALEFPD---QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SCSSCCSSHH---HHHHHHHHCCCCCCS---SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCCCccHH---HHHHHHhcccCCCCC---ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 9999875432 233333333333332 1356889999999999999999999887643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=350.77 Aligned_cols=247 Identities=21% Similarity=0.302 Sum_probs=198.1
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
+..++|+++++||+|+||.||+|.+..+++.||||++... .....+..|+.+++.+.| ++++.+..++......
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH-PFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSC-TTSCCEEEEEEETTEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCC-CeEeeEEEEEeeCCEE
Confidence 4457899999999999999999999999999999987632 223456778888888875 6777888888888899
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
++||||+ +++|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||+ +.++.+||+|||+|+..
T Consensus 224 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EEEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCCTT
T ss_pred EEEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCceec
Confidence 9999999 7788888765 4579999999999999999999998 999999999999999 57889999999999753
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCc
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p 236 (414)
..... .....+||..|+|||++.+..++.++|||||||++|||++|..||.+.... +.+..+.......|
T Consensus 300 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~p 369 (446)
T 4ejn_A 300 IKDGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILMEEIRFP 369 (446)
T ss_dssp CC------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC
T ss_pred cCCCc-------ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHHHHhCCCCCC
Confidence 32221 123678999999999999999999999999999999999999999875433 34444555554444
Q ss_pred hHHhhhcChHHHHHHHHHHhcCCCCCCC-----ChHHHH
Q 015041 237 IEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLK 270 (414)
Q Consensus 237 ~~~~~~~~p~~~~~l~~~c~~~~p~~RP-----~~~~l~ 270 (414)
..+++++.+++..||..||.+|| ++.++.
T Consensus 370 -----~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell 403 (446)
T 4ejn_A 370 -----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIM 403 (446)
T ss_dssp -----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHH
T ss_pred -----ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHH
Confidence 35688999999999999999999 766553
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=336.77 Aligned_cols=245 Identities=20% Similarity=0.304 Sum_probs=204.5
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
.++|++++.||+|+||+||+|++..+++.||||++...... ..+.+|+.+++.++| ++++.+..++......++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH-PNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCeEEE
Confidence 35699999999999999999999999999999998754322 347789999999975 667777777778889999
Q ss_pred EEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 81 v~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||||+.++|.+++......+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 132 v~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 132 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSSB-
T ss_pred EEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEeeccCceecCCC-
Confidence 99999999999988767889999999999999999999999999999999999999 47899999999999754321
Q ss_pred CCccccccCCCCCccCcCcccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
....||..|+|||++. +..++.++|||||||++|||++|..||.+.... ..+..+........
T Consensus 208 ----------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~---~~~~~~~~~~~~~~- 273 (348)
T 1u5q_A 208 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQNESPAL- 273 (348)
T ss_dssp ----------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHSCCCCC-
T ss_pred ----------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcCCCCC-
Confidence 2467899999999985 467899999999999999999999999876443 22333333332221
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
....+++.+.+++..||..+|.+||++.++.+
T Consensus 274 --~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 274 --QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 12456889999999999999999999987754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=338.84 Aligned_cols=261 Identities=21% Similarity=0.323 Sum_probs=211.5
Q ss_pred cccCCceEEecceeecCceeEEEEEEC-----CCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 74 (414)
++..++|++++.||+|+||.||+|++. .++..||||++...... ..+.+|+.+++.++| ++++.+..++..
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~ 121 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN-PNIVKLLGVCAV 121 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEcc
Confidence 355689999999999999999999987 34589999998765432 347889999999965 677777777778
Q ss_pred CCeeEEEEecc-CCCHHHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccC
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYCR-----------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 130 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~~-----------------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLk 130 (414)
....++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+|||||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 88899999999 779999987642 568999999999999999999999999999999
Q ss_pred CCceEEccCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-C
Q 015041 131 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-G 209 (414)
Q Consensus 131 p~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G 209 (414)
|+|||+ +.++.+||+|||+++....... +.......+|..|+|||++.+..++.++|||||||++|+|++ |
T Consensus 202 p~NIl~---~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 273 (343)
T 1luf_A 202 TRNCLV---GENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273 (343)
T ss_dssp GGGEEE---CGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred cceEEE---CCCCeEEEeecCCCcccccCcc-----ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence 999999 5788999999999976533211 112235567899999999999999999999999999999999 9
Q ss_pred CCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 210 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 210 ~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
..||.+.... +....+...... + ....+|.++.+++..||..+|.+||++.++.+.|+++...
T Consensus 274 ~~p~~~~~~~---~~~~~~~~~~~~-~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 274 LQPYYGMAHE---EVIYYVRDGNIL-A---CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp CCTTTTSCHH---HHHHHHHTTCCC-C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCcCCCCChH---HHHHHHhCCCcC-C---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 9999876543 233333333221 1 1245689999999999999999999999999999877543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=344.94 Aligned_cols=263 Identities=17% Similarity=0.288 Sum_probs=202.4
Q ss_pred cccCCceEEecceeecCceeEEEEEEC---CCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
++...+|++.+.||+|+||+||+|++. .++..||||++...... ..+.+|+.+++.+.| ++++.+..++....
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~ 119 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH-PNIIRLEGVVTKSK 119 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEeeCC
Confidence 455678999999999999999999876 46778999998765432 357889999999965 67777877777888
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
..++||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRV 196 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC-----
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCccccc
Confidence 899999999 889999998666679999999999999999999999999999999999999 5788999999999986
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccC
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
......... ......+|..|+|||++.+..++.++|||||||++|||++ |..||.+..... ....+ .....
T Consensus 197 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~~~~i-~~~~~ 268 (373)
T 2qol_A 197 LEDDPEAAY----TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---VIKAV-DEGYR 268 (373)
T ss_dssp ---------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---HHHHH-HTTEE
T ss_pred cccCCccce----eccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH-HcCCC
Confidence 543321110 1123345778999999999999999999999999999998 999998765432 22222 22222
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
.+.+ ..+|..+.+++..||..+|.+||++.++.+.|+.++...
T Consensus 269 ~~~~---~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 269 LPPP---MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp CCCC---TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred CCCC---ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 2222 356889999999999999999999999999999887643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=335.29 Aligned_cols=256 Identities=23% Similarity=0.268 Sum_probs=195.5
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeee--------
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVD-------- 74 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~-------- 74 (414)
++|+++++||+|+||+||+|++..+++.||||++..... ...+.+|+.+++.++| ++++.+..++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH-ENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCC-TTBCCEEEEEEEC-------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccC-CCcccHhheeeccccccccC
Confidence 789999999999999999999999999999998765432 2357899999999986 555555544433
Q ss_pred CCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 75 ~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
....++||||+.++|.+.+......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLAR 172 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEccchhcc
Confidence 45689999999999998888666779999999999999999999999999999999999999 578899999999998
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
.......... .......||..|+|||++.+. .++.++|||||||++|+|++|..||.+.........+...+....
T Consensus 173 ~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 173 AFSLAKNSQP---NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp ECCCCSSSSC---CCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccccc---cccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 7653322211 122356789999999999864 589999999999999999999999998665544444433322111
Q ss_pred CCchHHh------------------------hhcChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 234 STPIEVL------------------------CKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 234 ~~p~~~~------------------------~~~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
....+.. ....++.+.+|+..||..||.+||++.++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 309 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 309 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHH
Confidence 1100000 00124566777777777777777776544
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=344.41 Aligned_cols=252 Identities=23% Similarity=0.227 Sum_probs=207.4
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
.++|++++.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.+.| ++++.+..++......++|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-PKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCS-TTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCC-cCCCeEEEEEEeCCEEEEEEE
Confidence 3689999999999999999999999999999999876532 2357889999999975 667777777778889999999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
|+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++. +..+.+||+|||+++.......
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~- 206 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEI- 206 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSC-
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-CCCCceEEEecccceecCCCcc-
Confidence 99 78998888754557999999999999999999999999999999999999941 1356899999999987643321
Q ss_pred ccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhh
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~ 242 (414)
.....||..|+|||++.+..++.++|||||||++|||++|..||.+.... +.+..+.......+ .....
T Consensus 207 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~i~~~~~~~~-~~~~~ 275 (387)
T 1kob_A 207 -------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNVKRCDWEFD-EDAFS 275 (387)
T ss_dssp -------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHHCCCCCC-SSTTT
T ss_pred -------eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-ccccc
Confidence 12457899999999999999999999999999999999999999985443 33334433333322 22334
Q ss_pred cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 243 ~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+++++.+++..||..||.+||++.++.+
T Consensus 276 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 276 SVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 66899999999999999999999887654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=330.68 Aligned_cols=246 Identities=19% Similarity=0.282 Sum_probs=202.1
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (414)
.|...++||+|+||+||+|++..+|+.||||++..... ...+.+|+.+++.++| ++++.+..++......++||||+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH-FNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEECCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC-CCcceEEEEEEECCEEEEEEecC
Confidence 48899999999999999999998999999999875433 3457899999999976 66667777777788999999999
Q ss_pred -CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcc
Q 015041 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (414)
Q Consensus 86 -~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~ 164 (414)
+++|.+++. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 125 ~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~--- 196 (321)
T 2c30_A 125 QGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP--- 196 (321)
T ss_dssp CSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSC---
T ss_pred CCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCcc---
Confidence 788988775 4569999999999999999999999999999999999999 5788999999999987544322
Q ss_pred ccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcC
Q 015041 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (414)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 244 (414)
......||..|+|||++.+..++.++|||||||++|+|++|..||.+..... .+..+...... .......+
T Consensus 197 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~--~~~~~~~~ 267 (321)
T 2c30_A 197 ----KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMKRLRDSPPP--KLKNSHKV 267 (321)
T ss_dssp ----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHSSCC--CCTTGGGS
T ss_pred ----ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhcCCCC--CcCccccC
Confidence 1235679999999999999999999999999999999999999998754432 23333222211 11122456
Q ss_pred hHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 245 PAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 245 p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
++++.+++..||..+|.+||++.++.+
T Consensus 268 ~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 268 SPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 889999999999999999999887643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=336.34 Aligned_cols=258 Identities=21% Similarity=0.295 Sum_probs=201.9
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCce----EEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEI----VAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~----vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
+..++|+++++||+|+||+||+|++..+++. ||+|.+.... ....+.+|+.+++.++| ++++.+..++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN-PHVCRLLGICLTST 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCB-TTBCCEEEEEESSS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEecCC
Confidence 4568999999999999999999999877765 4777765432 33568899999999976 66666766665544
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
.++|++++ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 166 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTHHHH
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE---CCCCCEEEccCcceeE
Confidence 66777777 899999998777789999999999999999999999999999999999999 4788999999999986
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccC
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
........ ......+|..|+|||++.+..++.++|||||||++|||++ |..||.+....... .++.....
T Consensus 167 ~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~----~~~~~~~~ 237 (327)
T 3poz_A 167 LGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGER 237 (327)
T ss_dssp HTTTCC------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----HHHHTTCC
T ss_pred ccCCcccc-----cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH----HHHHcCCC
Confidence 64433211 1124456889999999999999999999999999999999 99999886554322 22333333
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
.+.+ ..++.++.+++..||..+|.+||++.++.+.|+.+..
T Consensus 238 ~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 238 LPQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCC---TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CCCC---ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 3322 3457899999999999999999999999999887753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=333.66 Aligned_cols=262 Identities=19% Similarity=0.298 Sum_probs=214.2
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCc-----eEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 75 (414)
+..++|++++.||+|+||.||+|.+..++. .||+|++...... ..+.+|+.+++.+..|++++.+..++...
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 456889999999999999999999976654 7999998765432 34789999999996668888888888888
Q ss_pred CeeEEEEecc-CCCHHHHHHHh-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCC
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYC-------------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~-------------~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~ 141 (414)
...++||||+ +++|.+++... ...++...++.++.||+.||+|||++||+||||||+|||+ +.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL---TN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE---EG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE---CC
Confidence 8899999999 67999998753 2357999999999999999999999999999999999999 47
Q ss_pred CCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhc
Q 015041 142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT 220 (414)
Q Consensus 142 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~ 220 (414)
++.+||+|||+++........ .......||..|+|||++.+..++.++|||||||++|+|++ |..||.+.....
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNY-----IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTS-----EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred CCeEEECccccccccccccce-----eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 889999999999865433221 11234567889999999999999999999999999999998 999998754332
Q ss_pred hHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 221 ~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
.+..+.......+.+ ...|+.+.+++..||..+|.+||++.++.+.|+++...
T Consensus 275 ---~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 275 ---KFYKLVKDGYQMAQP---AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp ---HHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHHHHhcCCCCCCC---CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 223333333333222 34588999999999999999999999999999887654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=335.12 Aligned_cols=256 Identities=21% Similarity=0.236 Sum_probs=202.3
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeC-----Ce
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG-----ED 77 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~-----~~ 77 (414)
+++|++++.||+|+||.||+|.+..++..||||++...... ..+.+|+++++.++| ++++.+..++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH-ENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCC-TTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCccceeEEecCCccccce
Confidence 48999999999999999999999999999999998754432 457789999999986 4555554443322 46
Q ss_pred eEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 78 ~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
.++||||++++|.+++.. ..++...++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 105 ~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 105 VYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred EEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEeCcceEecC
Confidence 899999999999998864 569999999999999999999999999999999999999 588899999999998654
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhh-----
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK----- 231 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~----- 231 (414)
...... .......||..|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+..+...
T Consensus 180 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 180 PDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp GGGCBC----CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred CCCCcc----ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 322111 112356899999999987654 5899999999999999999999999986655443333222111
Q ss_pred ------------------ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 232 ------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 232 ------------------~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
....+........+.++.+|+..||..||.+||++.++.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1112233344566889999999999999999999887654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=328.98 Aligned_cols=261 Identities=20% Similarity=0.324 Sum_probs=216.8
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc-hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++..++|++.++||+|+||+||+|.+..++..||+|++...... ..+.+|+.+++.++| ++++.+..++......++|
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEccCCCEEEE
Confidence 56778999999999999999999999999999999998765443 458899999999985 6677777777788889999
Q ss_pred Eecc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 82 LDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
|||+ +++|.+++.... ..++...++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCGGGTSCSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCccceeccCC
Confidence 9999 689999987643 458999999999999999999999999999999999999 47789999999999755432
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
... ......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+.......+. +......+.+
T Consensus 165 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~----~~~~~~~~~~ 234 (288)
T 3kfa_A 165 TYT------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL----LEKDYRMERP 234 (288)
T ss_dssp SSE------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH----HHTTCCCCCC
T ss_pred ccc------cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HhccCCCCCC
Confidence 211 1224566889999999999999999999999999999999 9999987654433222 2222222222
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
..+|+.+.+++..||..+|.+||++.++.+.|+.++...
T Consensus 235 ---~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 235 ---EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 456899999999999999999999999999999888654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=354.90 Aligned_cols=257 Identities=19% Similarity=0.330 Sum_probs=213.9
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
+-..+|++.++||+|+||+||+|.+..++..||||++.... ....+.+|+.+++.++| ++++.+..++......++||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCC-CCEeeEEEEEecCCcEEEEE
Confidence 44568999999999999999999999889999999987654 34568899999999975 66777777777788899999
Q ss_pred ecc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||+ +++|.+++.... ..++...++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEECCTTCC
T ss_pred EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccceeccCCc
Confidence 999 789999998643 458999999999999999999999999999999999999 478899999999998654322
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
. .......++..|+|||++.+..++.++|||||||++|||++ |..||.+.......+ .+......+.+
T Consensus 373 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~----~~~~~~~~~~~- 441 (495)
T 1opk_A 373 Y------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE----LLEKDYRMERP- 441 (495)
T ss_dssp E------ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH----HHHTTCCCCCC-
T ss_pred e------eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHcCCCCCCC-
Confidence 1 12234456789999999999999999999999999999999 999999876543322 22333333222
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~ 277 (414)
..+|+++.+++..||..+|.+||++.+|.+.|+.++
T Consensus 442 --~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 442 --EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 456899999999999999999999999999888664
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=325.87 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=200.2
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
+.++|++.++||+|+||.||+|.+..++..||+|++.... ....+.+|+++++.++| ++++.+..++......++|
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH-PNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCC-chHHhHHHheecCCeEEEE
Confidence 4578999999999999999999999999999999876543 23568899999999976 6677777777788889999
Q ss_pred Eecc-CCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 82 LDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
|||+ +++|.+.+... ...+++..++.++.||+.||+|||++||+||||||+|||+...+..+.+||+|||++....
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999 77998888643 4679999999999999999999999999999999999999644456889999999997654
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
.... .....||..|+|||++. ..++.++|||||||++|+|++|..||.+...... ...+.......+
T Consensus 179 ~~~~--------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~---~~~~~~~~~~~~- 245 (285)
T 3is5_A 179 SDEH--------STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV---QQKATYKEPNYA- 245 (285)
T ss_dssp ----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHCCCCCC-
T ss_pred Cccc--------CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH---HhhhccCCcccc-
Confidence 3221 13567899999999876 5689999999999999999999999998654322 222222222222
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+...++++.+++..||..+|.+||++.++.+
T Consensus 246 -~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 246 -VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 122346789999999999999999999887643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=328.35 Aligned_cols=265 Identities=22% Similarity=0.257 Sum_probs=209.1
Q ss_pred CcccCCceEEecceeecCceeEEEEE----ECCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLAS----HVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~----~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 74 (414)
+.+..++|+++++||+|+||.||+|+ +..+++.||||++.... ....+.+|+.+++.++| ++++.+..++..
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~ 94 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH-ENIVKYKGICTE 94 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCC-TTBCCEEEEEEC
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCC-CCeeeeeeEEec
Confidence 34566789999999999999999999 46789999999987543 23568899999999976 556666555544
Q ss_pred C--CeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeec
Q 015041 75 G--EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (414)
Q Consensus 75 ~--~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG 151 (414)
. ...++||||+ +++|.+++......++...++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg 171 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFG 171 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCT
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEE---cCCCCEEECccc
Confidence 3 5689999999 779999997777789999999999999999999999999999999999999 478899999999
Q ss_pred ceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChh-----------hc
Q 015041 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA-----------AT 220 (414)
Q Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~-----------~~ 220 (414)
+++........ ........||..|+|||++.+..++.++|||||||++|+|++|..||..... ..
T Consensus 172 ~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (302)
T 4e5w_A 172 LTKAIETDKEY----YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM 247 (302)
T ss_dssp TCEECCTTCCE----EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGG
T ss_pred ccccccCCCcc----eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccccc
Confidence 99876543321 1122355788899999999999999999999999999999999998753211 11
Q ss_pred hHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 015041 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (414)
Q Consensus 221 ~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~ 277 (414)
....+..........+. ...+|+++.+++..||..+|.+||++.++.+.|+.++
T Consensus 248 ~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 248 TVTRLVNTLKEGKRLPC---PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHhccCCCCC---CCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11222222222222222 2456899999999999999999999999999998875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=333.81 Aligned_cols=260 Identities=20% Similarity=0.330 Sum_probs=191.1
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCc---eEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 75 (414)
.+..++|++++.||+|+||+||+|++..++. .||||++..... ...+.+|+.+++.++| ++++.+..++...
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~ 97 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH-PHVAKLVGVSLRS 97 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCC-TTBCCCCEEEECC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCC-Cceehhhceeecc
Confidence 3567899999999999999999999876664 899999875432 2457899999999965 5666665555444
Q ss_pred Cee------EEEEecc-CCCHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCC
Q 015041 76 EDN------VLVLDLL-GPSLEDLFVYCR-----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN 143 (414)
Q Consensus 76 ~~~------~lv~e~~-~~sL~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~ 143 (414)
... ++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---cCCC
Confidence 333 8999999 779999886432 258999999999999999999999999999999999999 5788
Q ss_pred eEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchH
Q 015041 144 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKK 222 (414)
Q Consensus 144 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~ 222 (414)
.+||+|||+|+........ .......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+......
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~- 248 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYY-----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI- 248 (323)
T ss_dssp CEEECCCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-
T ss_pred CEEEeeccccccccccccc-----cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH-
Confidence 9999999999865433221 11224456789999999999999999999999999999999 9999998655432
Q ss_pred HHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 223 QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 223 ~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
...+...... + ....+++++.+++..||..+|.+||++.++.+.|++++.
T Consensus 249 --~~~~~~~~~~-~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 249 --YNYLIGGNRL-K---QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp --HHHHHTTCCC-C---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHhcCCCC-C---CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 2333332211 1 124568899999999999999999999999999998865
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=327.93 Aligned_cols=253 Identities=19% Similarity=0.289 Sum_probs=203.4
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
+....+|++++.||+|+||.||+|.+..+|+.||||++........+.+|+.+++.+.| ++++.+..++......++||
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS-PHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCC-CCCccEEEEEEeCCEEEEEe
Confidence 44578999999999999999999999999999999999887777789999999999965 66777777777788899999
Q ss_pred ecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
||+ +++|.+++......++...++.++.||+.||.|||++||+|+||||+||++ +.++.+||+|||++........
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECBTTBS
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccchhhhhhcc
Confidence 999 669999988667789999999999999999999999999999999999999 5788999999999987654322
Q ss_pred CccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhh
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~ 241 (414)
......||..|+|||++.+..++.++|||||||++|+|++|..||.+..... ....+.... . +.....
T Consensus 181 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~-~-~~~~~~ 248 (314)
T 3com_A 181 -------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR---AIFMIPTNP-P-PTFRKP 248 (314)
T ss_dssp -------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHSC-C-CCCSSG
T ss_pred -------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHhcCC-C-cccCCc
Confidence 1235678999999999999999999999999999999999999998754332 222221111 1 111112
Q ss_pred hcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 242 ~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..++..+.+++..||..+|.+||++.++.+
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 446889999999999999999999887644
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=348.89 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=209.7
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
+++..++|.+++.||+|+||.||+|++..+|+.||||++... .....+.+|+.+++.+.| ++|..+..++....
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~~~~ 89 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH-PHIIKLYQVISTPS 89 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCC-TTBCCEEEEEECSS
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECC
Confidence 456678999999999999999999999999999999987643 223467899999998875 66777777777888
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
..++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNM 165 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCEE
T ss_pred EEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchhh
Confidence 999999999 8899888764 4569999999999999999999999999999999999999 5788999999999987
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
...... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.... ..+.++......
T Consensus 166 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~~~~ 234 (476)
T 2y94_A 166 MSDGEF--------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLFKKICDGIFY 234 (476)
T ss_dssp CCTTCC--------BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHHHHHHTTCCC
T ss_pred cccccc--------ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHHHHHhcCCcC
Confidence 644321 235689999999999998875 78999999999999999999999875433 344455555444
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.| ..+++++.+++..||..||.+||++.++.+
T Consensus 235 ~p-----~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 TP-----QYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CC-----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC-----ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 33 345789999999999999999999998876
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=337.93 Aligned_cols=252 Identities=21% Similarity=0.276 Sum_probs=197.4
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEee-----------
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG----------- 72 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~----------- 72 (414)
...++|++++.||+|+||+||+|.+..+|+.||||++...... ..+|+.+++.+.| ++|+.+..++
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~--~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY--KNRELDIMKVLDH-VNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS--CCHHHHHHTTCCC-TTBCCEEEEEEEC--------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch--HHHHHHHHHHcCC-CCccchhheeeecCccccccc
Confidence 4678999999999999999999999999999999988665432 3479999999976 4555554433
Q ss_pred ---------------------------eeCCeeEEEEeccCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 015041 73 ---------------------------VDGEDNVLVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSR 122 (414)
Q Consensus 73 ---------------------------~~~~~~~lv~e~~~~sL~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~ 122 (414)
......++||||+.++|.+.+.. ....+++..++.++.||+.||+|||++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp -----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 22334789999999898887763 246799999999999999999999999
Q ss_pred CeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCC-CCchhhHHHHHH
Q 015041 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGY 201 (414)
Q Consensus 123 ~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~ 201 (414)
||+||||||+|||++ ..++.+||+|||+|+....... .....||..|+|||++.+.. ++.++|||||||
T Consensus 161 gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 161 GICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEP--------SVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp TEECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSC--------CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred cCccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCC--------CcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 999999999999994 2578999999999987644322 13567899999999998764 999999999999
Q ss_pred HHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch------------------------HHhhhcChHHHHHHHHHHhc
Q 015041 202 VLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI------------------------EVLCKSHPAEFASYFHYCQS 257 (414)
Q Consensus 202 il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~------------------------~~~~~~~p~~~~~l~~~c~~ 257 (414)
++|||++|+.||.+........ .++......+. ..+....|+++.+|+..||.
T Consensus 231 il~ell~g~~pf~~~~~~~~~~---~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQLV---RIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHH---HHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 9999999999999865543333 33222221111 11233467889999999999
Q ss_pred CCCCCCCChHHHHH
Q 015041 258 LTFDQRPDYGFLKR 271 (414)
Q Consensus 258 ~~p~~RP~~~~l~~ 271 (414)
.+|.+||++.++.+
T Consensus 308 ~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 308 YEPDLRINPYEAMA 321 (383)
T ss_dssp SSGGGSCCHHHHHT
T ss_pred CChhhCCCHHHHhc
Confidence 99999999988765
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=331.62 Aligned_cols=264 Identities=21% Similarity=0.313 Sum_probs=211.8
Q ss_pred ccCCceEEecceeecCceeEEEEEE-----CCCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeee-
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD- 74 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~- 74 (414)
+..++|++++.||+|+||+||+|.+ ..+++.||||++...... ..+.+|+.++..+.+|++++.+..++..
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 4568999999999999999999985 356789999998766543 3478899999999777888777666544
Q ss_pred CCeeEEEEecc-CCCHHHHHHHhCCC---------------CCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEcc
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYCRRK---------------FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 138 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~~~~---------------~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~ 138 (414)
+...++||||+ +++|.+++...... +++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~-- 181 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-- 181 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE--
Confidence 45689999999 67999998754322 7899999999999999999999999999999999999
Q ss_pred CCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCh
Q 015041 139 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLK 217 (414)
Q Consensus 139 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~ 217 (414)
+.++.+||+|||+++........ .......||..|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 182 -~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 182 -SEKNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp -CGGGCEEECCCGGGSCTTTCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred -CCCCCEEECCCccccccccCccc-----eeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 47889999999999765432221 11234567889999999999999999999999999999998 999998754
Q ss_pred hhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 015041 218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (414)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~ 281 (414)
... .+...+......+. ....++++.+++..||..+|.+||++.++.+.|+.++....
T Consensus 256 ~~~---~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 256 IDE---EFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp CSH---HHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hhH---HHHHHhccCccCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 322 22222222222221 13457899999999999999999999999999999886543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=335.09 Aligned_cols=257 Identities=18% Similarity=0.229 Sum_probs=203.3
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCce----EEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEI----VAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~----vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
+-.++|++++.||+|+||+||+|.+..+++. ||+|.+.... ....+.+|+.+++.+.| ++|+.+..++. +.
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH-AHIVRLLGLCP-GS 87 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCC-TTBCCEEEEEC-BS
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCC-CCcCeEEEEEc-CC
Confidence 3467999999999999999999999888776 7777765433 22456789999998875 56666666554 45
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
..++||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADL 164 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCcccc
Confidence 688999999 789999887655679999999999999999999999999999999999999 5788999999999986
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccC
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
........ ......||..|+|||++.+..++.++|||||||++|+|++ |..||.+......... +.....
T Consensus 165 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~----~~~~~~ 235 (325)
T 3kex_A 165 LPPDDKQL-----LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL----LEKGER 235 (325)
T ss_dssp SCCCTTCC-----C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH----HHTTCB
T ss_pred cCcccccc-----cccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH----HHcCCC
Confidence 54432211 1234567889999999999999999999999999999999 9999998654332222 222222
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~ 277 (414)
.+.+ ..++.++.+++..||..+|.+||++.++.+.|+.+.
T Consensus 236 ~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 236 LAQP---QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp CCCC---TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CCCC---CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2211 234678999999999999999999999999988764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=336.35 Aligned_cols=255 Identities=18% Similarity=0.261 Sum_probs=207.4
Q ss_pred cccCCceEEe-cceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 3 RIIGVKYKLG-RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 3 ~i~~~~y~i~-~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
+.+.++|.+. +.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.++++++.+..++.....
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3567889998 89999999999999999999999999877543 234688999999999988999999888888899
Q ss_pred eEEEEecc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 78 NVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
.++||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.....+.+||+|||+++.
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 99999999 67888876532 35689999999999999999999999999999999999995322368999999999987
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
...... .....||..|+|||++.+..++.++|||||||++|+|++|..||.+.... +.+..+.......
T Consensus 184 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~ 252 (327)
T 3lm5_A 184 IGHACE--------LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ---ETYLNISQVNVDY 252 (327)
T ss_dssp C-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCCC
T ss_pred cCCccc--------cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHHHhccccc
Confidence 643321 12467899999999999999999999999999999999999999875543 3333343433333
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
+. .....+++.+.+++..||..+|.+||+++++
T Consensus 253 ~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~l 285 (327)
T 3lm5_A 253 SE-ETFSSVSQLATDFIQSLLVKNPEKRPTAEIC 285 (327)
T ss_dssp CT-TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred Cc-hhhcccCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 32 2334668899999999999999999998765
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=334.07 Aligned_cols=263 Identities=22% Similarity=0.253 Sum_probs=201.2
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc-hhHHHHHHHHHHHcCCCCCCeeEEeeeeC----CeeE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGVDG----EDNV 79 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~E~~~l~~l~~~~~i~~l~~~~~~~----~~~~ 79 (414)
-.++|+++++||+|+||+||+|++. ++.||||++...... .....|+.++..++| ++|+.+..++... ...+
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKH-ENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCC-TTBCCEEEEEEEECSSSEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCC-CCchhhcceeccCCCCCceEE
Confidence 4578999999999999999999874 789999998654322 234567777888876 5565665554442 3479
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc----------CeeccccCCCceEEccCCCCCeEEEe
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR----------GFLHRDIKPDNFLMGLGRKANQVYII 148 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----------~iiHrDLkp~Nili~~~~~~~~vkL~ 148 (414)
+||||+ +++|.+++.. ..+++..++.++.||+.||+|||+. ||+||||||+|||+ +.++.+||+
T Consensus 99 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~kL~ 173 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIA 173 (322)
T ss_dssp EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEEEC
T ss_pred EEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeEEEc
Confidence 999999 7799999874 4599999999999999999999999 99999999999999 578899999
Q ss_pred eecceeeecCCCCCccccccCCCCCccCcCccccccccCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCChhh----
Q 015041 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAA---- 219 (414)
Q Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~---- 219 (414)
|||+|+......... ......||..|+|||++.+. .++.++|||||||++|||++|+.||.+....
T Consensus 174 DFg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 248 (322)
T 3soc_A 174 DFGLALKFEAGKSAG-----DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248 (322)
T ss_dssp CCTTCEEECTTSCCC-----CCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred cCCcccccccccCcc-----ccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence 999998765433211 12346799999999999874 4667889999999999999999999764321
Q ss_pred ---------chHHHHHHHHhhccCCchHHhh--hcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 220 ---------TKKQKYDKICEKKVSTPIEVLC--KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 220 ---------~~~~~~~~i~~~~~~~p~~~~~--~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
........+............+ ...++++.+++..||..||++||++.++.+.|+.+.+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111222222222222222211 123567999999999999999999999999999886544
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=346.00 Aligned_cols=269 Identities=19% Similarity=0.244 Sum_probs=210.6
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeeeC--C
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG--E 76 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~--~ 76 (414)
+.+++++|++.++||+|+||+||+|.+..+++.||||++.... ....+.+|+++++.++| ++++.+..++... .
T Consensus 4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~ 82 (396)
T 4eut_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-KNIVKLFAIEEETTTR 82 (396)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCC-TTBCCEEEEEECTTTC
T ss_pred CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCC-CCCCeEEEeeccCCCC
Confidence 3567899999999999999999999999999999999986532 23457799999999986 5566665555443 3
Q ss_pred eeEEEEecc-CCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccC-CCCCeEEEeeecc
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG-RKANQVYIIDFGL 152 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~-~~~~~vkL~DFG~ 152 (414)
..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+..+ +..+.+||+|||+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 679999999 789999887433 238999999999999999999999999999999999998322 3566799999999
Q ss_pred eeeecCCCCCccccccCCCCCccCcCccccccccC--------CCCCchhhHHHHHHHHHHHHcCCCCCCCChh-hchHH
Q 015041 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKA-ATKKQ 223 (414)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~-~~~~~ 223 (414)
|+....... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||..... ....+
T Consensus 163 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~ 234 (396)
T 4eut_A 163 ARELEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234 (396)
T ss_dssp CEECCCGGG--------SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHH
T ss_pred ceEccCCCc--------cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHH
Confidence 987543221 135678999999999875 4678899999999999999999999976443 22334
Q ss_pred HHHHHHhhccCCc--------------------hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 224 KYDKICEKKVSTP--------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 224 ~~~~i~~~~~~~p--------------------~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
.+.++........ ...+....+..+.+++..||..||++||++.++.+.+.+++.+
T Consensus 235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 4444444322110 0011234467899999999999999999999999988888754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=322.08 Aligned_cols=254 Identities=19% Similarity=0.281 Sum_probs=207.1
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC--------CchhHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 75 (414)
++.++|++++.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.+++.+.| ++++.+..++...
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~ 80 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH-PNIITLHDIFENK 80 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEECS
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCC-CCeeehhheecCC
Confidence 56789999999999999999999999999999999876542 23458899999999975 6777777777788
Q ss_pred CeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCC-CCCeEEEeeecce
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR-KANQVYIIDFGLA 153 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~-~~~~vkL~DFG~a 153 (414)
...++||||+ +++|.+++.. ...++...++.++.||+.||+|||++||+||||||+||++.... ....+||+|||++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CeEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 8899999999 7899998875 45799999999999999999999999999999999999995211 1238999999999
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
........ .....||..|+|||++.+..++.++|||||||++|+|++|..||.+.... +.+..+.....
T Consensus 160 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~ 228 (283)
T 3bhy_A 160 HKIEAGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ---ETLTNISAVNY 228 (283)
T ss_dssp EECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTTCC
T ss_pred eeccCCCc--------ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH---HHHHHhHhccc
Confidence 86543221 12456899999999999999999999999999999999999999875443 33333433333
Q ss_pred CCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 234 ~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+ .......++.+.+++..||..+|.+||++.++.+
T Consensus 229 ~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 DFD-EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCC-HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCc-chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 333 3344577899999999999999999999988876
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=348.16 Aligned_cols=252 Identities=24% Similarity=0.342 Sum_probs=209.3
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecC----CCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
+.++|+++++||+|+||+||+|.+..+++.||||++.. ......+.+|+.+++.+.| ++|+.+..++......++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH-PNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCC-CCcCeEEEEEEcCCEEEE
Confidence 45789999999999999999999999999999998753 2334568899999999975 677777777788889999
Q ss_pred EEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 81 v~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
||||+ +++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||+...+..+.+||+|||+|+.....
T Consensus 99 v~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 99 VGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp EECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 99999 7899888876 457999999999999999999999999999999999999965456678999999998754332
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
.. ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.... +.+..+.......+.+.
T Consensus 178 ~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~ 245 (486)
T 3mwu_A 178 TK--------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKRVETGKYAFDLPQ 245 (486)
T ss_dssp ------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCCSCSGG
T ss_pred Cc--------cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCCCcc
Confidence 21 235679999999999876 5999999999999999999999999886443 34445555554444332
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+..+++++.+++..||..+|.+||++.++.+
T Consensus 246 -~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 246 -WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp -GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -cCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 3567899999999999999999999988766
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=330.06 Aligned_cols=263 Identities=17% Similarity=0.257 Sum_probs=206.6
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCC----ceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTN----EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 75 (414)
++...+|++.+.||+|+||+||+|.+..++ ..||||++...... ..+.+|+.+++.+.| ++++.+..++...
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH-HNIIRLEGVISKY 118 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEecC
Confidence 567789999999999999999999986543 35999998765432 347789999999975 6677777777778
Q ss_pred CeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
...++||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSR 195 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC--
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCCCcch
Confidence 8899999999 669999998766789999999999999999999999999999999999999 578899999999998
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhcc
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
......... .......+|..|+|||++.+..++.++|||||||++|||++ |..||.+..... ....+.. ..
T Consensus 196 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~~~~~-~~ 267 (333)
T 1mqb_A 196 VLEDDPEAT----YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMKAIND-GF 267 (333)
T ss_dssp -------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHT-TC
T ss_pred hhccccccc----cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHC-CC
Confidence 654332111 01123456789999999999999999999999999999999 999998765432 2223322 22
Q ss_pred CCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 234 ~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
..+.+ ..+|..+.+++..||..+|.+||++.++.+.|+.++...
T Consensus 268 ~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 268 RLPTP---MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp CCCCC---TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred cCCCc---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 22222 356899999999999999999999999999999887643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=346.84 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=208.3
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC---------------CchhHHHHHHHHHHHcCCCCCCee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---------------KHPQLLYEAKVYKILQGGSGIPNI 68 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~E~~~l~~l~~~~~i~~l 68 (414)
.++++|+++++||+|+||+||+|.+..++..||||++.... ....+.+|+.+++.+.| ++|+.+
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~ 111 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH-PNIIKL 111 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCC-TTBCCE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCC-CCCCeE
Confidence 46789999999999999999999999999999999876542 23457899999999975 677788
Q ss_pred EEeeeeCCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEE
Q 015041 69 KWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 147 (414)
Q Consensus 69 ~~~~~~~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL 147 (414)
..++......++||||+ +++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||+........+||
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 78888888999999999 7799888876 457999999999999999999999999999999999999963333347999
Q ss_pred eeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHH
Q 015041 148 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (414)
Q Consensus 148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~ 227 (414)
+|||+|+....... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.... +.+..
T Consensus 191 ~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~ 258 (504)
T 3q5i_A 191 VDFGLSSFFSKDYK--------LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DIIKK 258 (504)
T ss_dssp CCCTTCEECCTTSC--------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH
T ss_pred EECCCCEEcCCCCc--------cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH
Confidence 99999987654321 135679999999999874 6999999999999999999999999986543 44455
Q ss_pred HHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 228 i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+.......+.+ .+..+++++.+++..||..+|.+||++.++.+
T Consensus 259 i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 259 VEKGKYYFDFN-DWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHCCCCCCHH-HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHcCCCCCCcc-ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 55555554443 34567899999999999999999999988765
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=332.97 Aligned_cols=258 Identities=21% Similarity=0.299 Sum_probs=200.6
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceE----EEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIV----AVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~v----avK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
+..++|+++++||+|+||+||+|.+..+++.| |+|.+.... ....+.+|+.+++.+.| ++++.+..++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN-PHVCRLLGICLTST 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCB-TTBCCCCEEEESSS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCC-CCeeEEEEEEecCC
Confidence 45789999999999999999999998887765 666654332 34568899999999976 55656655555444
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
.+++++++ +++|.+++......++...++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 166 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTC---
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEE---cCCCCEEEccCcceeE
Confidence 66777777 889999998877789999999999999999999999999999999999999 4788999999999986
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccC
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
........ ......+|..|+|||++.+..++.++|||||||++|||++ |..||.+........ ++.....
T Consensus 167 ~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~----~~~~~~~ 237 (327)
T 3lzb_A 167 LGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS----ILEKGER 237 (327)
T ss_dssp ------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH----HHHTTCC
T ss_pred ccCccccc-----cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH----HHHcCCC
Confidence 54332211 1124456889999999999999999999999999999999 999999865543322 2233333
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
.+.+ ..++.++.+++..||..+|.+||++.++.+.|..+..
T Consensus 238 ~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 238 LPQP---PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCCC---ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 3322 3457899999999999999999999999999988763
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=337.91 Aligned_cols=252 Identities=22% Similarity=0.242 Sum_probs=204.0
Q ss_pred CCceEE--ecceeecCceeEEEEEECCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 6 GVKYKL--GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 6 ~~~y~i--~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
+..|.+ .+.||+|+||.||+|.+..+|+.||+|++.... ....+.+|+.+++.+.| ++|+.+..++......++|
T Consensus 86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH-ANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEEEEE
Confidence 445666 678999999999999999999999999987654 23458899999999975 6777777777888899999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+.. +..+.+||+|||+++......
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCceecCCcc
Confidence 9999 78998888765667999999999999999999999999999999999999842 256789999999998764332
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
. .....||..|+|||++.+..++.++|||||||++|||++|..||.+.... +.+..+.......+.. .
T Consensus 244 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~i~~~~~~~~~~-~ 311 (373)
T 2x4f_A 244 K--------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---ETLNNILACRWDLEDE-E 311 (373)
T ss_dssp B--------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHTCCCSCSG-G
T ss_pred c--------cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccCCCChh-h
Confidence 1 12457999999999999999999999999999999999999999886543 3444555544444322 2
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...+++++.+|+..||..+|.+||++.++.+
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 3467899999999999999999999988765
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=334.72 Aligned_cols=253 Identities=21% Similarity=0.249 Sum_probs=200.3
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-------chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
..++|++++.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+++.+.| ++++.+..++.....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH-PNIIGLLDAFGHKSN 86 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCC-TTBCCEEEEECCTTC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCC-CCCCeEEEEEeeCCc
Confidence 34789999999999999999999999999999998864321 2457899999999975 667777777777888
Q ss_pred eEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 78 ~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
.++||||+.++|.+++......+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 87 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 87 ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFG 163 (346)
T ss_dssp CEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTT
T ss_pred eEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEecccceecc
Confidence 99999999889988887655678999999999999999999999999999999999999 578899999999997654
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC--
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS-- 234 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~-- 234 (414)
.... ......||..|+|||++.+. .++.++|||||||++|+|++|..||.+...... +..+......
T Consensus 164 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~~~~~~~ 233 (346)
T 1ua2_A 164 SPNR-------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPT 233 (346)
T ss_dssp SCCC-------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCC
T ss_pred CCcc-------cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHcCCCC
Confidence 3321 12356789999999999765 489999999999999999999999988654433 3333332111
Q ss_pred ---------------------CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 235 ---------------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 235 ---------------------~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+........++++.+++..||..||.+||++.++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 1222334566789999999999999999999887644
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=325.54 Aligned_cols=253 Identities=20% Similarity=0.282 Sum_probs=199.1
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEe-eeeCCeeEEEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWY-GVDGEDNVLVL 82 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~-~~~~~~~~lv~ 82 (414)
+..++|++.+.||+|+||.||+|++ +++.||||++........+.+|+.+++.++|. ++..+..+ .......++||
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHS-NLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCT-TBCCEEEEECCC--CCEEEE
T ss_pred CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCC-CEeeEEEEEEcCCCceEEEE
Confidence 4458999999999999999999987 48899999998877777789999999999864 45455444 44555789999
Q ss_pred ecc-CCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 83 DLL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||+ +++|.+++..... .++...++.++.|++.||+|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC--------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeeccccccccccc
Confidence 999 5699999875432 38999999999999999999999999999999999999 578899999999987543322
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
....++..|+|||++.+..++.++|||||||++|+|++ |..||........ ...+.. .....
T Consensus 172 ----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~~~~-~~~~~--- 234 (278)
T 1byg_A 172 ----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVEK-GYKMD--- 234 (278)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHHTT-TCCCC---
T ss_pred ----------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHhc-CCCCC---
Confidence 13456889999999999999999999999999999998 9999987644322 222222 22221
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
....+|+.+.+++..||..+|.+||++.++.+.|+.+...
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 2245689999999999999999999999999999987654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=341.87 Aligned_cols=251 Identities=23% Similarity=0.261 Sum_probs=195.4
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEee-ee-----CCee
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG-VD-----GEDN 78 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~-~~-----~~~~ 78 (414)
...+|++++.||+|+||.||+|++..+++.||||++..... ...+|+++++.+.|. +|+.+..++ .. ..+.
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~E~~il~~l~hp-niv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--FKNRELQIMRKLDHC-NIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--SCCHHHHHHHTCCCT-TBCCEEEEEEEEETTTTEEEE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHcCCC-CccceeeEEeccCCCCcceeE
Confidence 34579999999999999999999999999999998865432 235799999999864 455554333 21 2236
Q ss_pred EEEEeccCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 79 VLVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 79 ~lv~e~~~~sL~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
++||||+.+++.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++ .+.+.+||+|||+|+.
T Consensus 129 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEE
T ss_pred EeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe--CCCCeEEeccchhhhh
Confidence 79999998888877653 246799999999999999999999999999999999999994 2456789999999987
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
...... ....+||..|+|||++.+. .++.++|||||||++|||++|+.||.+....... .+++.....
T Consensus 207 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l---~~i~~~lg~ 275 (420)
T 1j1b_A 207 LVRGEP--------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL---VEIIKVLGT 275 (420)
T ss_dssp CCTTCC--------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCS
T ss_pred cccCCC--------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCC
Confidence 643322 1356789999999999875 6999999999999999999999999986544333 233222111
Q ss_pred Cch------------------------HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 235 TPI------------------------EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 235 ~p~------------------------~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
... ..+....++++.+|+.+||..||.+||++.++.+
T Consensus 276 p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 111 1122345789999999999999999999887654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=335.53 Aligned_cols=260 Identities=16% Similarity=0.194 Sum_probs=204.6
Q ss_pred ccCCceEEecceeecCceeEEEE-----EECCCCceEEEEEecCCCCchhHHHHHHHHHHHcC--CCCCCeeEEeeeeCC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG--GSGIPNIKWYGVDGE 76 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~-----~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~--~~~i~~l~~~~~~~~ 76 (414)
+.+++|++.++||+|+||+||+| .+..+++.||||++.... ...+..|+.+++.+.+ ++++..+..++....
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 45688999999999999999999 466789999999987653 4567888988888873 355667777777888
Q ss_pred eeEEEEecc-CCCHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEcc--------CCCCC
Q 015041 77 DNVLVLDLL-GPSLEDLFVYC----RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL--------GRKAN 143 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~--------~~~~~ 143 (414)
..++||||+ +++|.+++... ...+++..++.|+.||+.||+|||++|||||||||+|||++. .+..+
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence 899999999 79999999753 456999999999999999999999999999999999999952 11178
Q ss_pred eEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHH
Q 015041 144 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ 223 (414)
Q Consensus 144 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~ 223 (414)
.+||+|||+|+......... .....+||..|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 221 ~~kl~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~- 294 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPKGT-----IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK- 294 (365)
T ss_dssp TEEECCCTTCEEGGGSCTTE-----EECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-
T ss_pred CEEEeeCchhhhhhccCCCc-----eeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-
Confidence 99999999998654322211 123567999999999999999999999999999999999999999753321100
Q ss_pred HHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCC-CChHHHHHHHHHHHHhcC
Q 015041 224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQR-PDYGFLKRLFHDLFSREG 281 (414)
Q Consensus 224 ~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~R-P~~~~l~~~l~~~~~~~~ 281 (414)
....... ...++.+.+++..|+..+|.+| |++.++.+.|++++....
T Consensus 295 ---------~~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 295 ---------PEGLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp ---------ECSCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ---------echhccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 0000000 0125788999999999999999 578889999998887643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=337.53 Aligned_cols=251 Identities=20% Similarity=0.272 Sum_probs=181.5
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeee------
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVD------ 74 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~------ 74 (414)
+.++|++++.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+++.++| +++..+..++..
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH-ENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCC-TTBCCCSEEECSCSSGGG
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEecCCcccc
Confidence 56899999999999999999999999999999999865432 2357789999999986 455555443322
Q ss_pred CCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 75 ~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
....++|+|+++++|.+++.. ..++...++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 106 ~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 106 FNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLAR 180 (367)
T ss_dssp CCCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECC-----
T ss_pred CCeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEEeeccccc
Confidence 256799999999999988864 579999999999999999999999999999999999999 578899999999998
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhh--
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK-- 231 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~-- 231 (414)
...... ...+||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+.+.+..
T Consensus 181 ~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 250 (367)
T 2fst_X 181 HTADEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 250 (367)
T ss_dssp --------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred cccccC----------CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 644321 25678999999999987 67999999999999999999999999986554333332222111
Q ss_pred ---------------------ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 232 ---------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 232 ---------------------~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
....+........++.+.+|+.+||..||.+||++.++.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0011122233455778888999999999999998876644
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=322.10 Aligned_cols=253 Identities=23% Similarity=0.366 Sum_probs=197.1
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC------chhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
++-.++|++.+.||+|+||.||+|.+ ++..||||++..... ...+.+|+++++.++| ++++.+..++....
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 79 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH-PNIIALRGVCLKEP 79 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCC-TTBCCEEEEECCC-
T ss_pred ccchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCC-CCEeeEEEEEecCC
Confidence 45678999999999999999999998 488999998765422 2457889999999975 67777777777788
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeccccCCCceEEccCC-----CCCeEEE
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG---FLHRDIKPDNFLMGLGR-----KANQVYI 147 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---iiHrDLkp~Nili~~~~-----~~~~vkL 147 (414)
..++||||+ +++|.+++. ...+++..++.++.|++.||+|||++| |+||||||+|||++... ..+.+||
T Consensus 80 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp -CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred ceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 899999999 788888774 567999999999999999999999999 99999999999995211 2678999
Q ss_pred eeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHH
Q 015041 148 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (414)
Q Consensus 148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~ 227 (414)
+|||+++....... ....||..|+|||++.+..++.++|||||||++|+|++|+.||.+.... .....
T Consensus 158 ~Dfg~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~ 225 (271)
T 3dtc_A 158 TDFGLAREWHRTTK---------MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL---AVAYG 225 (271)
T ss_dssp CCCCC----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH---HHHHH
T ss_pred ccCCcccccccccc---------cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHh
Confidence 99999976543322 2457899999999999999999999999999999999999999876543 22233
Q ss_pred HHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 015041 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (414)
Q Consensus 228 i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~ 275 (414)
+.......+.+ ..+|+.+.+++..||..+|.+||++.++.+.|++
T Consensus 226 ~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 226 VAMNKLALPIP---STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHTSCCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred hhcCCCCCCCC---cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 33333333322 4568999999999999999999999999988764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=333.09 Aligned_cols=264 Identities=17% Similarity=0.257 Sum_probs=207.6
Q ss_pred CcccCCceEEecceeecCceeEEEEE-----ECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeee
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLAS-----HVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGV 73 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~ 73 (414)
.++..++|++++.||+|+||.||+|+ +..++..||||++..... ...+.+|+.+++.+.| +++..+..++.
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~ 103 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH-QNIVRCIGVSL 103 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEC
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCC-CCCCeEEEEEc
Confidence 56788999999999999999999999 456788999999865433 2347889999999965 67777777777
Q ss_pred eCCeeEEEEecc-CCCHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEE
Q 015041 74 DGEDNVLVLDLL-GPSLEDLFVYCR------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 146 (414)
Q Consensus 74 ~~~~~~lv~e~~-~~sL~~~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vk 146 (414)
.....++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.......+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 788889999999 889999998754 3489999999999999999999999999999999999995433566799
Q ss_pred EeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHH
Q 015041 147 IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKY 225 (414)
Q Consensus 147 L~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~ 225 (414)
|+|||+++........ .......||..|+|||++.+..++.++|||||||++|+|++ |..||.+.... +..
T Consensus 184 l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~ 255 (327)
T 2yfx_A 184 IGDFGMARDIYRASYY-----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVL 255 (327)
T ss_dssp ECCCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHH
T ss_pred ECcccccccccccccc-----ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHH
Confidence 9999998754432221 11234567899999999999999999999999999999998 99999875433 222
Q ss_pred HHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 226 DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 226 ~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
..+...... .. ...++..+.+++..||..+|.+||++.++.+.|+.+..
T Consensus 256 ~~~~~~~~~-~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 256 EFVTSGGRM-DP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHHTTCCC-CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcCCCC-CC---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 223222221 11 24568899999999999999999999999999887654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=347.71 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=206.2
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
.++|+++++||+|+||+||+|++..++..||||++.... ....+.+|+.+++.+.| ++|+.+..++......++|
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH-PNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCCEEEEE
Confidence 457999999999999999999999999999999886542 34568899999999975 6777777777888899999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+..+.+||+|||+|+......
T Consensus 115 ~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 115 MECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred EecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 9999 7799888765 4569999999999999999999999999999999999999644456779999999998765432
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
. ....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.... +.+..+.......+.+ .
T Consensus 194 ~--------~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~-~ 260 (494)
T 3lij_A 194 K--------MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EILRKVEKGKYTFDSP-E 260 (494)
T ss_dssp C--------BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCCCCSG-G
T ss_pred c--------ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCCch-h
Confidence 2 23567999999999876 46999999999999999999999999986543 3444555555444433 2
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+..+++++.+++..||..+|.+||++.++.+
T Consensus 261 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 261 WKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 3567899999999999999999999998876
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=332.61 Aligned_cols=266 Identities=18% Similarity=0.239 Sum_probs=192.7
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEee--------e
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYG--------V 73 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~--------~ 73 (414)
+.+.+|++.++||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.+.+|+++..+..++ .
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 446689999999999999999999999999999998754432 345788999999998667777776555 2
Q ss_pred eCCeeEEEEeccCCCHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC--eeccccCCCceEEccCCCCCeEEEee
Q 015041 74 DGEDNVLVLDLLGPSLEDLFVYC--RRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIID 149 (414)
Q Consensus 74 ~~~~~~lv~e~~~~sL~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDLkp~Nili~~~~~~~~vkL~D 149 (414)
.....++||||++++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|
T Consensus 105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~~~kl~D 181 (337)
T 3ll6_A 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCD 181 (337)
T ss_dssp SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTSCEEBCC
T ss_pred CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE---CCCCCEEEec
Confidence 34457999999999999988753 456999999999999999999999999 9999999999999 5788999999
Q ss_pred ecceeeecCCCCCccc-----cccCCCCCccCcCccccccc---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhch
Q 015041 150 FGLAKKYRDPTTNRHI-----PYRENKNLTGTARYASCNTH---LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK 221 (414)
Q Consensus 150 FG~a~~~~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~---~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~ 221 (414)
||+++........... .........||..|+|||++ .+..++.++|||||||++|+|++|..||.+....
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-- 259 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-- 259 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH--
Confidence 9999865433221100 00112245689999999998 5667899999999999999999999999764321
Q ss_pred HHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCC
Q 015041 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY 282 (414)
Q Consensus 222 ~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~ 282 (414)
.+.......+.. ...+..+.+++..||..+|.+||++.++.+.|+.+....+.
T Consensus 260 -----~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 260 -----RIVNGKYSIPPH---DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp -----------CCCCTT---CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred -----HhhcCcccCCcc---cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 122223333322 34467899999999999999999999999999988766543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=348.03 Aligned_cols=247 Identities=21% Similarity=0.298 Sum_probs=206.5
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
+-.++|++++.||+|+||+||+|++..+|+.||||++... .....+..|+.+++.+.| ++++.+..++......
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS-RFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCC-CCEeeEEEEEeeCCEE
Confidence 4457899999999999999999999999999999987643 233457889999999865 6777777777788899
Q ss_pred EEEEecc-CCCHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 79 VLVLDLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAV 337 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeecceee
Confidence 9999999 789988887532 369999999999999999999999999999999999999 588999999999998
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhh-chHHHHHHHHhhcc
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA-TKKQKYDKICEKKV 233 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~-~~~~~~~~i~~~~~ 233 (414)
........ ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.... ...+....+.....
T Consensus 338 ~~~~~~~~-------~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~ 410 (543)
T 3c4z_A 338 ELKAGQTK-------TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV 410 (543)
T ss_dssp ECCTTCCC-------BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC
T ss_pred eccCCCcc-------cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc
Confidence 76543221 23568999999999999999999999999999999999999999875432 22344445555444
Q ss_pred CCchHHhhhcChHHHHHHHHHHhcCCCCCCCCh
Q 015041 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 234 ~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~ 266 (414)
..| ..++.++.+++..||..+|.+||++
T Consensus 411 ~~p-----~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 411 TYP-----DKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CCC-----TTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred CCC-----cccCHHHHHHHHHhccCCHhHCCCC
Confidence 444 4568999999999999999999976
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=334.22 Aligned_cols=250 Identities=21% Similarity=0.331 Sum_probs=202.1
Q ss_pred CCceEEecceeecCceeEEEEEEC---CCCceEEEEEecCC------CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSG------TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~---~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
-++|+++++||+|+||+||+|++. .+++.||||++... .....+.+|+.+++.+.++++++.+..++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 379999999999999999999985 58899999987643 223456789999999988888999988888888
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
..++||||+ +++|.+++.. ...++...++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCee
Confidence 999999999 7799998876 4579999999999999999999999999999999999999 5888999999999987
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchH-HHHHHHHhhc
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK-QKYDKICEKK 232 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~-~~~~~i~~~~ 232 (414)
....... .....+||..|+|||++.+. .++.++|||||||++|||++|..||......... .....+....
T Consensus 209 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 282 (355)
T 1vzo_A 209 FVADETE------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282 (355)
T ss_dssp CCGGGGG------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC
T ss_pred cccCCCC------cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC
Confidence 5432221 12246799999999999863 4789999999999999999999999865433222 2223333332
Q ss_pred cCCchHHhhhcChHHHHHHHHHHhcCCCCCCC-----ChHHHH
Q 015041 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLK 270 (414)
Q Consensus 233 ~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP-----~~~~l~ 270 (414)
...+ ..++..+.+++..||..||.+|| +++++.
T Consensus 283 ~~~~-----~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell 320 (355)
T 1vzo_A 283 PPYP-----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 320 (355)
T ss_dssp CCCC-----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred CCCC-----cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHH
Confidence 2222 45678999999999999999999 655543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=325.84 Aligned_cols=253 Identities=22% Similarity=0.293 Sum_probs=207.4
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
.+.++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+|+.+++.+.| +++..+..++......++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH-ENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCC-CCeeehhhhcccCCEEEEE
Confidence 45689999999999999999999999999999999887543 33458899999999975 6677777777788899999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++.. ...++...++.++.||+.||+|||++||+||||||+||++...+..+.+||+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 163 (304)
T 2jam_A 85 MQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163 (304)
T ss_dssp ECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred EEcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence 9999 7899988875 4568999999999999999999999999999999999999544577899999999986432211
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
.....||..|+|||++.+..++.++|||||||++|+|++|..||.+.... .....+.......+. ..
T Consensus 164 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~-~~ 230 (304)
T 2jam_A 164 ---------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFEKIKEGYYEFES-PF 230 (304)
T ss_dssp ---------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHCCCCCCT-TT
T ss_pred ---------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHcCCCCCCc-cc
Confidence 12456899999999999999999999999999999999999999875433 333444444333322 23
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...+++++.+++..||..+|.+||++.++.+
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 231 WDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 3466899999999999999999999987654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=350.85 Aligned_cols=254 Identities=26% Similarity=0.349 Sum_probs=212.0
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
.++.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.+.| ++|+.+..++.....
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~ 100 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH-PNIMKLYEFFEDKGY 100 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCC-CCCCcEEEEEEeCCE
Confidence 456789999999999999999999999999999999986432 33458899999999965 677777777788889
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
.++||||+ +++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||+...+..+.+||+|||+|+..
T Consensus 101 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999 7889888765 567999999999999999999999999999999999999965456789999999999765
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCc
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p 236 (414)
..... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.... +.+..+.......+
T Consensus 180 ~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~ 247 (484)
T 3nyv_A 180 EASKK--------MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DILKKVEKGKYTFE 247 (484)
T ss_dssp CCCCS--------HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC
T ss_pred ccccc--------cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHcCCCCCC
Confidence 43321 124578999999999876 6999999999999999999999999986543 34445555554444
Q ss_pred hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 237 ~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+. +..+++++.+++..||..+|.+||++.++.+
T Consensus 248 ~~~-~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 248 LPQ-WKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp SGG-GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Ccc-cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 332 3467899999999999999999999988766
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=329.30 Aligned_cols=250 Identities=20% Similarity=0.222 Sum_probs=208.3
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----------chhHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 75 (414)
.++|++.+.||+|+||+||+|.+..+|+.||||++..... ...+.+|+.+++.+.++++++.+..++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 3689999999999999999999988999999999876542 234678999999996678888888888888
Q ss_pred CeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
...++||||+ +++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFSC 248 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEEecCccc
Confidence 8999999999 6799998875 4579999999999999999999999999999999999999 588899999999998
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccC------CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHH
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLG------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i 228 (414)
....... .....||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.... ..+..+
T Consensus 249 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~i 317 (365)
T 2y7j_A 249 HLEPGEK--------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---LMLRMI 317 (365)
T ss_dssp ECCTTCC--------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH
T ss_pred ccCCCcc--------cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---HHHHHH
Confidence 7653321 135689999999999863 35889999999999999999999999875432 334444
Q ss_pred HhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 229 ~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.......+.+. +...+..+.+++..||..+|.+||++.++.+
T Consensus 318 ~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 318 MEGQYQFSSPE-WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHTCCCCCHHH-HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhCCCCCCCcc-cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 45554444332 3466889999999999999999999987754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=331.44 Aligned_cols=266 Identities=23% Similarity=0.280 Sum_probs=210.4
Q ss_pred ccc-CCceEEecceeecCceeEEEEE----ECCCCceEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeeEEeee--
Q 015041 3 RII-GVKYKLGRKIGSGSFGEIFLAS----HVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGV-- 73 (414)
Q Consensus 3 ~i~-~~~y~i~~~iG~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~l~~~~~-- 73 (414)
+++ .++|+++++||+|+||.||+|+ +..+++.||||++...... ..+.+|+++++.+.| ++++.+..++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS-DFIVKYRGVSYGP 96 (327)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEECS
T ss_pred hhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCC-CceeEEEEEEecC
Confidence 344 4799999999999999999999 4578899999998765432 347899999999965 56666654443
Q ss_pred eCCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecc
Q 015041 74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (414)
Q Consensus 74 ~~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~ 152 (414)
.....++||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIADFGL 173 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCGGG
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEE---CCCCCEEEccccc
Confidence 556789999999 889999998766679999999999999999999999999999999999999 4788999999999
Q ss_pred eeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhc-----------h
Q 015041 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT-----------K 221 (414)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~-----------~ 221 (414)
++........ ........||..|+|||++.+..++.++|||||||++|+|++|..||....... .
T Consensus 174 ~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 249 (327)
T 3lxl_A 174 AKLLPLDKDY----YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA 249 (327)
T ss_dssp CEECCTTCSE----EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCH
T ss_pred ceecccCCcc----ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccccccc
Confidence 9876443221 112234568889999999999999999999999999999999999997643211 1
Q ss_pred HHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 222 ~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
...+..........+. ...+++++.+++..||..+|.+||++.++.+.|+.+...
T Consensus 250 ~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 250 LSRLLELLEEGQRLPA---PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred HHHHHHHhhcccCCCC---CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 1122222233322222 245689999999999999999999999999999877543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=334.54 Aligned_cols=260 Identities=20% Similarity=0.306 Sum_probs=210.1
Q ss_pred cccCCceEEecceeecCceeEEEEEEC-----CCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 74 (414)
++..++|++.+.||+|+||.||+|.+. .++..||||++...... ..+.+|+.+++.+.| +++..+..++..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~ 99 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC-HHVVRLLGVVSQ 99 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCC-TTBCCEEEEECS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCC-CCEeeeEEEEcc
Confidence 567789999999999999999999876 35788999998765432 247789999999876 567777777777
Q ss_pred CCeeEEEEecc-CCCHHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCe
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYCR---------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 144 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~ 144 (414)
....++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---~~~~~ 176 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFT 176 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCC
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE---cCCCe
Confidence 88899999999 679999987532 457999999999999999999999999999999999999 57889
Q ss_pred EEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHH
Q 015041 145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQ 223 (414)
Q Consensus 145 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~ 223 (414)
+||+|||+++....... ........+|..|+|||++.+..++.++|||||||++|+|++ |..||.+.... +
T Consensus 177 ~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~ 248 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---Q 248 (322)
T ss_dssp EEECCTTCCCGGGGGGC-----EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---H
T ss_pred EEECcCccccccccccc-----cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---H
Confidence 99999999975433221 111234567889999999999999999999999999999999 89999876543 2
Q ss_pred HHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 224 ~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
....+....... ....+|..+.+++..||..+|.+||++.++.+.|++.+.
T Consensus 249 ~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 249 VLRFVMEGGLLD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHcCCcCC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 233333322221 124568999999999999999999999999998876543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=329.31 Aligned_cols=255 Identities=22% Similarity=0.272 Sum_probs=198.2
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
-++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.+.| ++++.+..++......++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH-ENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCC-CCEeeEEEEeecCCEEEEE
Confidence 37899999999999999999999999999999987655433 236689999999985 6777777778888899999
Q ss_pred EeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 82 ~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
|||+.+.+.+.+......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC--------
T ss_pred EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCceeecCCcc
Confidence 9999766666555556779999999999999999999999999999999999999 5788999999999976543322
Q ss_pred CccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhh---------
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK--------- 231 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~--------- 231 (414)
......||..|+|||++.+. .++.++|||||||++|+|++|..||.+.........+......
T Consensus 180 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 180 -------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred -------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence 11245789999999999876 6899999999999999999999999886544332222211110
Q ss_pred --------------ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 232 --------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 232 --------------~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
....+.......+++.+.+++..||..||.+||++.++.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0111222333456788999999999999999999876644
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=348.71 Aligned_cols=257 Identities=23% Similarity=0.400 Sum_probs=208.0
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++..++|++.++||+|+||+||+|.+. ++..||||+++... ....+.+|+.+++.++| ++++.+..++. ....++|
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQH-DKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCC-TTBCCEEEEEC-SSSCEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCC-CCEeeEEEEEe-CCccEEE
Confidence 355678999999999999999999985 46789999987654 34568899999999976 55666655554 5678999
Q ss_pred Eecc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 82 LDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
|||+ +++|.+++... ...++...++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGGGGBCCH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCceEcCCC
Confidence 9999 78999998743 2468999999999999999999999999999999999999 57889999999999764321
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
. +.......+|..|+|||++.+..++.++|||||||++|||++ |+.||.+........ .+ ......+.+
T Consensus 338 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~---~i-~~~~~~~~~ 407 (454)
T 1qcf_A 338 E------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR---AL-ERGYRMPRP 407 (454)
T ss_dssp H------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH---HH-HHTCCCCCC
T ss_pred c------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHH---HH-HcCCCCCCC
Confidence 1 111223456789999999998999999999999999999999 999999865543322 22 223333332
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
..+|+++.+++..||..+|++||++.+|.+.|++++.
T Consensus 408 ---~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 408 ---ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred ---CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 4568999999999999999999999999999887654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=350.15 Aligned_cols=246 Identities=20% Similarity=0.247 Sum_probs=203.8
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
.+..++|++++.||+|+||.||+|++..+|+.||||++... .....+.+|+.+++.+.| ++++.+..++.+...
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-RFVVSLAYAYETKDA 258 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCC-CCEeeEEEEEeeCCE
Confidence 35568899999999999999999999999999999987542 233457889999999975 677777777778889
Q ss_pred eEEEEecc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
.++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVH 335 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEeccccee
Confidence 99999999 889998887533 349999999999999999999999999999999999999 5889999999999987
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHH-HHHHHhhccC
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK-YDKICEKKVS 234 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~-~~~i~~~~~~ 234 (414)
...... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+......... ...+......
T Consensus 336 ~~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~ 407 (576)
T 2acx_A 336 VPEGQT--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE 407 (576)
T ss_dssp CCTTCC--------EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCC
T ss_pred cccCcc--------ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccccc
Confidence 643321 1245899999999999999999999999999999999999999987644322222 3333333322
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCCC
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~ 265 (414)
.+ ..+++++.+|+..||..||.+||+
T Consensus 408 ~p-----~~~s~~~~dLI~~lL~~dP~~R~g 433 (576)
T 2acx_A 408 YS-----ERFSPQARSLCSQLLCKDPAERLG 433 (576)
T ss_dssp CC-----TTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred CC-----ccCCHHHHHHHHHhccCCHHHcCC
Confidence 22 456899999999999999999994
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=327.26 Aligned_cols=257 Identities=22% Similarity=0.330 Sum_probs=201.5
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+.| +++..+..++......++|
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE-PHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCC-CCeeEEEEEEeeCCeEEEE
Confidence 789999999999999999999999999999999875432 1457789999999875 6677777777888899999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 113 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 113 MRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC--------
T ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCccccccc
Confidence 9999 6699998876 4569999999999999999999999999999999999999 578899999999987654332
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
.. ......||..|+|||++.+..++.++|||||||++|+|++|..||.+.... .+...+..... .....
T Consensus 189 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~-~~~~~ 257 (309)
T 2h34_A 189 LT------QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----VMGAHINQAIP-RPSTV 257 (309)
T ss_dssp --------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----HHHHHHHSCCC-CGGGT
T ss_pred cc------cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----HHHHHhccCCC-Ccccc
Confidence 11 123457899999999999999999999999999999999999999875432 22222232222 22334
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCC-ChHHHHHHHHHHHHh
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRP-DYGFLKRLFHDLFSR 279 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP-~~~~l~~~l~~~~~~ 279 (414)
...+|.++.+++..||..+|++|| +++++.+.|+..+..
T Consensus 258 ~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 258 RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 467789999999999999999999 899999988876543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=325.28 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=198.0
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
.+-.++|++.+.||+|+||+||+|++ .++.||||++........+.+|+.+++.++| +++..+..++. ...++||
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~--~~~~lv~ 78 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNH-PNIVKLYGACL--NPVCLVM 78 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCC-TTBCCEEEBCT--TTTEEEE
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCC-CCcCeEEEEEc--CCcEEEE
Confidence 45568999999999999999999998 4788999999876666678999999999976 55656655443 4589999
Q ss_pred ecc-CCCHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHh---cCeeccccCCCceEEccCCCCC-eEEEeeecceee
Q 015041 83 DLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHS---RGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKK 155 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~iiHrDLkp~Nili~~~~~~~-~vkL~DFG~a~~ 155 (414)
||+ +++|.+++..... .++...++.++.|++.||+|||+ +||+||||||+|||++ .++ .+||+|||++..
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV---AGGTVLKICDFGTACD 155 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE---TTTTEEEECCCCC---
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe---CCCCEEEEcccccccc
Confidence 999 7899999875332 47899999999999999999999 8999999999999995 444 489999999975
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
..... ....||..|+|||++.+..++.++|||||||++|||++|+.||........ .....+.. ....
T Consensus 156 ~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~-~~~~ 223 (307)
T 2eva_A 156 IQTHM----------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-RIMWAVHN-GTRP 223 (307)
T ss_dssp -------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-HHHHHHHT-TCCC
T ss_pred ccccc----------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-HHHHHHhc-CCCC
Confidence 43321 234689999999999999999999999999999999999999986433221 11212212 1111
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
+ ....+|+.+.+++..||..+|.+||++.++.+.|+.+..
T Consensus 224 ~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 224 P---LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp C---CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred C---cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1 224668999999999999999999999999999988754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=329.66 Aligned_cols=256 Identities=18% Similarity=0.257 Sum_probs=204.4
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCC-------ceEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEee
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTN-------EIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYG 72 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~-------~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~ 72 (414)
.++..++|++.+.||+|+||+||+|.+..++ ..||+|++.... ....+.+|+.+++.++| ++++.+..++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~ 81 (289)
T 4fvq_A 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH-KHLVLNYGVC 81 (289)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCC-TTBCCEEEEE
T ss_pred EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCC-CCEeEEEEEE
Confidence 5678899999999999999999999988776 469999886543 23458899999999975 6777777777
Q ss_pred eeCCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCe-------
Q 015041 73 VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ------- 144 (414)
Q Consensus 73 ~~~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~------- 144 (414)
......++||||+ +++|.+++......++...++.++.||+.||.|||++||+||||||+|||++ .++.
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~~~~~~~ 158 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLI---REEDRKTGNPP 158 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---ECCBGGGTBCC
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEe---cCCcccccccc
Confidence 7788899999999 6899999987666699999999999999999999999999999999999995 4443
Q ss_pred -EEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcC-CCCCCCChhhch
Q 015041 145 -VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRG-SLPWQGLKAATK 221 (414)
Q Consensus 145 -vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG-~~Pf~~~~~~~~ 221 (414)
+||+|||++...... ....||..|+|||++.+ ..++.++|||||||++|||++| ..||.......
T Consensus 159 ~~kl~Dfg~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~- 226 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK-----------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR- 226 (289)
T ss_dssp EEEECCCCSCTTTSCH-----------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-
T ss_pred eeeeccCcccccccCc-----------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-
Confidence 999999998543211 23467889999999988 6799999999999999999995 55555543321
Q ss_pred HHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 015041 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (414)
Q Consensus 222 ~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~ 281 (414)
...........+ ...++++.+++..||..+|.+||++.++.+.|+.++...+
T Consensus 227 ---~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 227 ---KLQFYEDRHQLP-----APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp ---HHHHHHTTCCCC-----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred ---HHHHhhccCCCC-----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 122222222222 2346789999999999999999999999999987765443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=342.82 Aligned_cols=253 Identities=26% Similarity=0.338 Sum_probs=195.0
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----------CchhHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----------KHPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 74 (414)
+.++|++.++||+|+||+||+|.+..+++.||||++.... ....+.+|+.+++.+.| ++++.+..++ .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~-~ 210 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH-PCIIKIKNFF-D 210 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCC-TTBCCCCEEE-E
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCC-CCEeeEEEEE-e
Confidence 4688999999999999999999999999999999876421 12347899999999976 5555565554 3
Q ss_pred CCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
....++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++..+....+||+|||+|
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred cCceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 45679999999 7788777653 457999999999999999999999999999999999999964445567999999999
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHh
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~ 230 (414)
+....... ....+||..|+|||++.+ ..++.++|||||||++|+|++|..||.+...... ....+..
T Consensus 290 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i~~ 359 (419)
T 3i6u_A 290 KILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITS 359 (419)
T ss_dssp TSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHHHT
T ss_pred eecCCCcc--------ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHHhc
Confidence 76543221 235689999999999864 5688999999999999999999999987543221 2222333
Q ss_pred hccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 231 ~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..... .+..+..+++.+.+++..||..+|.+||++.++.+
T Consensus 360 ~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 360 GKYNF-IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TCCCC-CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCC-CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 33333 34445677899999999999999999999887644
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=320.13 Aligned_cols=256 Identities=19% Similarity=0.286 Sum_probs=210.7
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
-.++|++.+.||+|+||.||+|.+. ++..||+|++.... ....+.+|+.+++.++| ++++.+..++......++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSSCEEEEC
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCC-CCEeeEEEEEccCCCeEEEEe
Confidence 3578999999999999999999986 57789999987654 34568899999999975 667777777777788999999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
|+ +++|.+++......++...++.++.|++.||+|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~-- 158 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ-- 158 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCHH--
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEccccccccccccc--
Confidence 99 789999998766779999999999999999999999999999999999999 578899999999987543211
Q ss_pred ccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhh
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~ 241 (414)
........+|..|+|||++.+..++.++|||||||++|+|++ |..||.+.... +....+... ..... .
T Consensus 159 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~i~~~-~~~~~---~ 227 (267)
T 3t9t_A 159 ----YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDISTG-FRLYK---P 227 (267)
T ss_dssp ----HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTT-CCCCC---C
T ss_pred ----ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HHHHHHhcC-CcCCC---C
Confidence 111224566889999999998899999999999999999999 89999875433 223333222 11111 1
Q ss_pred hcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 242 ~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
...+..+.+++..||..+|.+||++.++.+.|+++.+
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3457899999999999999999999999999998765
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=320.34 Aligned_cols=246 Identities=24% Similarity=0.329 Sum_probs=202.9
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
+.-++|++++.||+|+||+||+|.+..++..||||++... .....+.+|+.+++.+.| ++++.+..++.+....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH-PNILRLYGYFHDATRV 84 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCC-CCCcchhheEecCCEE
Confidence 4457999999999999999999999999999999987542 233457889999998875 6777787788888899
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
++||||+ +++|.+++.. ...++...++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++....
T Consensus 85 ~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESCC-
T ss_pred EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEeccccccCC
Confidence 9999999 6788888876 3569999999999999999999999999999999999999 588899999999985433
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
... .....||..|+|||++.+..++.++|||||||++|+|++|..||.+.... +....+.......|
T Consensus 161 ~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~- 227 (279)
T 3fdn_A 161 SSR---------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETYKRISRVEFTFP- 227 (279)
T ss_dssp ----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHTCCCCC-
T ss_pred ccc---------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH---HHHHHHHhCCCCCC-
Confidence 221 13567899999999999999999999999999999999999999875443 33333434333333
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...++.+.+++..||..+|.+||++.++.+
T Consensus 228 ----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 228 ----DFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp ----TTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ----CcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 345789999999999999999999988765
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=322.51 Aligned_cols=264 Identities=22% Similarity=0.275 Sum_probs=201.1
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
....++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++| ++++.+..++.....
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH-PNVIKYYASFIEDNE 106 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEEETTE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCc
Confidence 3455789999999999999999999999999999998875321 2347789999999975 667777777778889
Q ss_pred eEEEEecc-CCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 78 NVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
.++||||+ +++|.+++... ...++...++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLG 183 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC---
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEeccce
Confidence 99999999 66999988742 4568999999999999999999999999999999999999 57889999999998
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
+....... ......||..|+|||++.+..++.++|||||||++|+|++|..||.+... ........+.....
T Consensus 184 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~ 255 (310)
T 2wqm_A 184 RFFSSKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDY 255 (310)
T ss_dssp ----------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-CHHHHHHHHHTTCS
T ss_pred eeecCCCc-------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-hHHHHHHHhhcccC
Confidence 76543221 11245789999999999999999999999999999999999999986432 12222223322222
Q ss_pred CCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 015041 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (414)
Q Consensus 234 ~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~ 281 (414)
... ....+++++.+++..||..||.+||++.++.+.|+++.....
T Consensus 256 ~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 256 PPL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp CCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CCC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 211 124568899999999999999999999999999998876543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=326.36 Aligned_cols=196 Identities=24% Similarity=0.395 Sum_probs=168.7
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeee--CCeeEEEE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD--GEDNVLVL 82 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~--~~~~~lv~ 82 (414)
..++|+++++||+|+||+||+|.+..+++.||||++... ....+.+|+.+++.+.++++++.+..++.. ....++||
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 457899999999999999999999999999999998754 346688999999999977888888777665 66789999
Q ss_pred ecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
||+ +++|.+++. .++...++.++.||+.||+|||++||+||||||+|||++ .+...+||+|||+|+.......
T Consensus 113 e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~ 186 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQE 186 (330)
T ss_dssp ECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCC
T ss_pred eccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCceEcCCCCc
Confidence 999 677777653 489999999999999999999999999999999999995 2334899999999986544322
Q ss_pred CccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQG 215 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~ 215 (414)
.....||..|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 187 --------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 187 --------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp --------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred --------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 135578999999999987 5699999999999999999999999954
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=317.77 Aligned_cols=259 Identities=20% Similarity=0.232 Sum_probs=205.8
Q ss_pred cccCCceEEecceeecCceeEEEEEECC---CCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
.+..++|++.+.||+|+||+||+|.+.. ++..||+|++..... ...+.+|+.+++.++| +++..+..+.. ..
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~-~~ 85 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH-PHIVKLIGIIE-EE 85 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCC-TTBCCEEEEEC-SS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCC-CCcceEEEEEc-CC
Confidence 3556899999999999999999998753 344699999876543 2457889999999976 55666655544 34
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
..++||||+ +++|.+++......++...++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLSRY 162 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---ETTEEEECCCCGGGC
T ss_pred CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC---CCCcEEeCccCCCcc
Confidence 568999999 6899999987677799999999999999999999999999999999999994 788999999999976
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccC
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
....... ......+|..|+|||++.+..++.++|||||||++|+|++ |+.||...........+ .....
T Consensus 163 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~----~~~~~ 232 (281)
T 3cc6_A 163 IEDEDYY------KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL----EKGDR 232 (281)
T ss_dssp C---------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH----HHTCC
T ss_pred ccccccc------ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH----hcCCC
Confidence 5432211 1224456889999999998899999999999999999998 99999876544333222 22222
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
.+.+ ..+++.+.+++..||..+|++||++.++.+.|++++..
T Consensus 233 ~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 233 LPKP---DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp CCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCC---CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 2222 34588999999999999999999999999999988754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=335.78 Aligned_cols=261 Identities=18% Similarity=0.248 Sum_probs=196.4
Q ss_pred CceEEecceeecCceeEEEEEECCC---CceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEE-eeeeCCeeE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKW-YGVDGEDNV 79 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~-~~~~~~~~~ 79 (414)
..|++.+.||+|+||+||+|++..+ +..||||.++..... ..+.+|+.+++.++|+ ++..+.. +.......+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hp-nIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP-NVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCT-TBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCC-CcceEEEEEEcCCCCeE
Confidence 3588999999999999999997533 346899988654332 3578899999999764 4555544 445566789
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
+||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC--------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeeccccccccc
Confidence 999999 779999998656678999999999999999999999999999999999999 5788999999999986543
Q ss_pred CCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
..... ........+|..|+|||++.+..++.++|||||||++|||++ |.+||.+........ .+..... .+.
T Consensus 245 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~---~~~~~~~-~~~ 317 (373)
T 3c1x_A 245 KEFDS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLLQGRR-LLQ 317 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH---HHHTTCC-CCC
T ss_pred ccccc---ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH---HHHcCCC-CCC
Confidence 32111 011224467889999999999999999999999999999999 788888765443322 2222221 111
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~ 281 (414)
...+|..+.+++..||..+|++||++.++.+.|+.++....
T Consensus 318 ---p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 318 ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 13568999999999999999999999999999999886543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=345.60 Aligned_cols=257 Identities=23% Similarity=0.374 Sum_probs=203.7
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
+..++|++.++||+|+||+||+|.+.. +..||||++..... ...+.+|+.+++.++| ++++.+..++.. ...++||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH-EKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCC-TTBCCEEEEECS-SSCEEEE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCC-CCEeeEEEEEcC-CceEEEe
Confidence 456789999999999999999999864 46799999886543 3568999999999986 556566555544 6789999
Q ss_pred ecc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 83 e~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCccceecCCCc
Confidence 999 78999998753 3568999999999999999999999999999999999999 478899999999998654322
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
. .......+|..|+|||++.+..++.++|||||||++|||++ |..||.+...... +..+ ......+.+
T Consensus 335 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~~i-~~~~~~~~~- 403 (452)
T 1fmk_A 335 Y------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQV-ERGYRMPCP- 403 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHH-HTTCCCCCC-
T ss_pred e------ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHHH-HcCCCCCCC-
Confidence 1 11224456789999999999999999999999999999999 9999998654432 2222 223333322
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
..+|+.+.+++..||..+|++||++++|.+.|++++..
T Consensus 404 --~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 404 --PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred --CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 35689999999999999999999999999998877643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=322.48 Aligned_cols=253 Identities=20% Similarity=0.276 Sum_probs=189.6
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCch---hHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP---QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
++..++|+++++||+|+||+||+|++..+++.||||++....... ....|...+....+|++++.+..++......+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 467799999999999999999999999999999999987654332 23333333333335677888888888888999
Q ss_pred EEEeccCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 80 LVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 80 lv~e~~~~sL~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
+||||+.++|.+++.. ....+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||+++.
T Consensus 83 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC-----
T ss_pred EEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecCCccc
Confidence 9999999899888764 346799999999999999999999998 99999999999999 5788999999999976
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccc----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhh
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTH----LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~ 231 (414)
...... .....||..|+|||++ .+..++.++|||||||++|+|++|..||...... ...+......
T Consensus 160 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~ 229 (290)
T 3fme_A 160 LVDDVA--------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP--FQQLKQVVEE 229 (290)
T ss_dssp ------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH--HHHHHHHHHS
T ss_pred cccccc--------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch--HHHHHHHhcc
Confidence 544322 1244789999999996 5667899999999999999999999999864322 2223333333
Q ss_pred ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 232 ~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...... ...+++++.+++..||..+|.+||++.++.+
T Consensus 230 ~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 230 PSPQLP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCCCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCcc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 222211 1356889999999999999999999988755
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=328.74 Aligned_cols=264 Identities=20% Similarity=0.228 Sum_probs=202.7
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeee----
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD---- 74 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~---- 74 (414)
+..+.++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+.+|+.+++.++| ++++.+..++..
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKH-ENIITIFNIQRPDSFE 84 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCC-TTBCCEEEECCCSCST
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcC-CCcCCeeeeecccccC
Confidence 345789999999999999999999999999999999998654332 346789999999976 556555554433
Q ss_pred -CCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 75 -GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 75 -~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
....++||||+.++|.+++.. ..++...++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 85 ~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 85 NFNEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLA 159 (353)
T ss_dssp TCCCEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred ccceEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEEecccc
Confidence 267899999999999988874 569999999999999999999999999999999999999 57889999999999
Q ss_pred eeecCCCCCcccc---ccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHH
Q 015041 154 KKYRDPTTNRHIP---YRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (414)
Q Consensus 154 ~~~~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~ 229 (414)
+...........+ ........||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 239 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 8765332211100 011234678999999998865 679999999999999999999999999865443322222221
Q ss_pred hhc------------------------cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 230 EKK------------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 230 ~~~------------------------~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
... ...+.......+++++.+++..||..||.+||++.++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 110 111233344567889999999999999999999887644
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=331.31 Aligned_cols=268 Identities=22% Similarity=0.320 Sum_probs=202.9
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHc-CCCCCCeeEEeeeeC----Ce
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ-GGSGIPNIKWYGVDG----ED 77 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~-~~~~i~~l~~~~~~~----~~ 77 (414)
+.+.++|+++++||+|+||.||+|++. ++.||||++.... ......|.+++..+. +|+++..+..++... ..
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc-cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 456789999999999999999999984 8899999886443 234455666655442 456777776666555 67
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc--------CeeccccCCCceEEccCCCCCeEEEe
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR--------GFLHRDIKPDNFLMGLGRKANQVYII 148 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~iiHrDLkp~Nili~~~~~~~~vkL~ 148 (414)
.++||||+ +++|.+++.. ..+++..++.++.|++.||+|||++ ||+||||||+|||+ +.++.+||+
T Consensus 110 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kl~ 184 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIA 184 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEEC
T ss_pred eEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCCCEEEE
Confidence 89999999 7799999864 4699999999999999999999998 99999999999999 578899999
Q ss_pred eecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCch------hhHHHHHHHHHHHHcC----------CCC
Q 015041 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRR------DDLESLGYVLLYFLRG----------SLP 212 (414)
Q Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~------~DiwSlG~il~el~tG----------~~P 212 (414)
|||+|+........... ......||..|+|||++.+..++.. +|||||||++|||++| ..|
T Consensus 185 Dfg~a~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDI---PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp CCTTCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred eCCCceeeccccccccC---CCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 99999876543322111 1235679999999999988776654 9999999999999999 778
Q ss_pred CCCChhhc-hHHHHHHHH-hhccCC--chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 015041 213 WQGLKAAT-KKQKYDKIC-EKKVST--PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (414)
Q Consensus 213 f~~~~~~~-~~~~~~~i~-~~~~~~--p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~ 281 (414)
|....... ......... ...... +.......+++++.+++..||..+|.+||++.++.+.|+.+.+..+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred HhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 86543221 112222222 222222 2221223457889999999999999999999999999999887654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=323.73 Aligned_cols=262 Identities=18% Similarity=0.254 Sum_probs=204.6
Q ss_pred CCceEEecceeecCceeEEEEEECCC---CceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
..+|++.+.||+|+||+||+|.+..+ ...||+|.+...... ..+.+|+.+++.++|.+.+..+..+.......+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 35799999999999999999997543 346899988765432 347789999999987554444454556667889
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
+||||+ +++|.+++......++...++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECcccccccccc
Confidence 999999 669999997656678999999999999999999999999999999999999 5888999999999976543
Q ss_pred CCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
.... .........||..|+|||++.+..++.++|||||||++|+|++ |.+||.+........ .+........
T Consensus 181 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~~- 253 (298)
T 3f66_A 181 KEYY---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLLQGRRLLQ- 253 (298)
T ss_dssp GGGC---BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH---HHHTTCCCCC-
T ss_pred cchh---ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH---HHhcCCCCCC-
Confidence 2211 1112235567889999999999999999999999999999999 677777654433222 2222222111
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
...+|+.+.+++..||..+|.+||++.++.+.|+.++...
T Consensus 254 ---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 254 ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred ---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1345889999999999999999999999999999988643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=334.70 Aligned_cols=254 Identities=20% Similarity=0.295 Sum_probs=203.9
Q ss_pred CCcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 1 ~~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
++++..++|+++++||+|+||+||+|.+..++..||+|++...... ..+.+|+.+++.+.| ++++.+..++.....
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGE 105 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCC-TTBCCEEEEEEETTE
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCC-CCEEEEeEEEEECCE
Confidence 4678889999999999999999999999999999999998765432 347789999988865 677777777788889
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
.++||||+ +++|.+++.. ...++...+..++.|++.||+|||++ ||+||||||+|||+ +.++.+||+|||++..
T Consensus 106 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp EEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHH
T ss_pred EEEEEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECCCCcc
Confidence 99999999 7799999876 35689999999999999999999996 99999999999999 5788999999999865
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHH----------
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY---------- 225 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~---------- 225 (414)
..... .....||..|+|||++.+..++.++|||||||++|+|++|..||...........+
T Consensus 182 ~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3eqc_A 182 LIDSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252 (360)
T ss_dssp HHHHC-------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------
T ss_pred ccccc---------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCC
Confidence 43221 12457899999999999999999999999999999999999999875433221111
Q ss_pred -----------------------------HHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 226 -----------------------------DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 226 -----------------------------~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+...... ......++.++.+|+..||..+|.+||++.++.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP---KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---------------------CCCHHHHHHHHHHSCCC---CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCcccCCCcccccccCCCCcccchhhhhHHhccCCC---CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 111111100 0011235778999999999999999999887755
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=331.40 Aligned_cols=249 Identities=20% Similarity=0.268 Sum_probs=187.7
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeC-----
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDG----- 75 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~----- 75 (414)
+.++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.+.| +++..+..++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH-KNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCC-TTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCC-CCccceEEeecccccccc
Confidence 458999999999999999999999999999999998764332 346789999999976 5555555544333
Q ss_pred -CeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 76 -EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 76 -~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
...++||||+.++|.+.+. ..++...+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+
T Consensus 102 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 102 FQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 175 (371)
T ss_dssp CCEEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC--
T ss_pred ccceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEEeeccc
Confidence 3689999999988888774 458999999999999999999999999999999999999 578899999999997
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
....... .....||..|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+.+++.....
T Consensus 176 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~ 244 (371)
T 2xrw_A 176 TAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQWNKVIEQLGT 244 (371)
T ss_dssp ----------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHC-CCC
T ss_pred ccccccc--------cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCC
Confidence 6543211 12567899999999999999999999999999999999999999986543 233333332211
Q ss_pred CchHHh-------------------------------------hhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 235 TPIEVL-------------------------------------CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 235 ~p~~~~-------------------------------------~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...+.. ....+.++.+|+..||..||.+||+++++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 111100 0111567888999999999999999877655
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=328.20 Aligned_cols=258 Identities=19% Similarity=0.238 Sum_probs=209.3
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceE--EEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIV--AVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~v--avK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
-++|++.+.||+|+||.||+|++..++..+ |+|.+.... ....+.+|+.+++.+.+|++++.+..++......++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 478999999999999999999998888755 899876432 334588999999999667888888888888899999
Q ss_pred EEecc-CCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCe
Q 015041 81 VLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 144 (414)
Q Consensus 81 v~e~~-~~sL~~~~~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~ 144 (414)
||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE---cCCCe
Confidence 99999 779999987532 368999999999999999999999999999999999999 47889
Q ss_pred EEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHH
Q 015041 145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQ 223 (414)
Q Consensus 145 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~ 223 (414)
+||+|||+++...... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.... +
T Consensus 181 ~kL~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~ 249 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---E 249 (327)
T ss_dssp EEECCTTCEESSCEEC--------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---H
T ss_pred EEEcccCcCccccccc--------cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH---H
Confidence 9999999997432211 1124456889999999998889999999999999999998 99999876443 2
Q ss_pred HHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 015041 224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (414)
Q Consensus 224 ~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~ 281 (414)
....+ ........ ...+++++.+++..||..+|.+||++.++.+.|+.++....
T Consensus 250 ~~~~~-~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 250 LYEKL-PQGYRLEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp HHHHG-GGTCCCCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHHh-hcCCCCCC---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 22222 22222221 13557899999999999999999999999999999987654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=325.20 Aligned_cols=255 Identities=20% Similarity=0.258 Sum_probs=202.2
Q ss_pred cCCceEEecceeecCceeEEEEEEC-CCCceEEEEEecCCC----CchhHHHHHHHHHHHc--CCCCCCeeEEeee----
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHV-DTNEIVAVKIENSGT----KHPQLLYEAKVYKILQ--GGSGIPNIKWYGV---- 73 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~-~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~--~~~~i~~l~~~~~---- 73 (414)
..++|++++.||+|+||.||+|.+. .+++.||||++.... ....+.+|+.+++.+. .|+++..+..++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4589999999999999999999995 678899999875432 2345788999888885 4567777765544
Q ss_pred -eCCeeEEEEeccCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeec
Q 015041 74 -DGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (414)
Q Consensus 74 -~~~~~~lv~e~~~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG 151 (414)
.....++||||+.++|.+++.... ..++...++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl~Dfg 165 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG 165 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCC
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEEecCc
Confidence 456689999999999999988654 348999999999999999999999999999999999999 578899999999
Q ss_pred ceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhh
Q 015041 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (414)
Q Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~ 231 (414)
+++...... ......||..|+|||++.+..++.++|||||||++|+|++|..||.+.........+......
T Consensus 166 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (326)
T 1blx_A 166 LARIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 237 (326)
T ss_dssp SCCCCCGGG--------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred ccccccCCC--------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence 987543211 123567899999999999999999999999999999999999999986544333222221110
Q ss_pred -------------------ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 232 -------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 232 -------------------~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
....+.......+++.+.+++..||..+|.+||++.++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 295 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 001122333456789999999999999999999987663
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=322.64 Aligned_cols=260 Identities=22% Similarity=0.321 Sum_probs=205.7
Q ss_pred ccCCceEEec-ceeecCceeEEEEEE--CCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 4 IIGVKYKLGR-KIGSGSFGEIFLASH--VDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 4 i~~~~y~i~~-~iG~G~~g~V~~~~~--~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
+-.++|++.+ .||+|+||+||+|.+ ..+++.||||++..... ...+.+|+.+++.+.| ++++.+..++ ...
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIVRMIGIC-EAE 90 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCC-TTBCCEEEEE-ESS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEE-CCC
Confidence 3457899999 999999999999954 46678999999876533 2457889999999975 5666665555 566
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
..++||||+ +++|.+++.. ...++...++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKA 166 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEE
T ss_pred CcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe---CCCcEEEccCCccee
Confidence 789999999 6899998876 55699999999999999999999999999999999999994 788999999999987
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccC
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
....... ........+|..|+|||++.+..++.++|||||||++|+|++ |..||.+...... ...+ .....
T Consensus 167 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~-~~~~~ 238 (291)
T 1xbb_A 167 LRADENY----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TAML-EKGER 238 (291)
T ss_dssp CCTTCSE----EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHH-HTTCC
T ss_pred eccCCCc----ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH-HcCCC
Confidence 6543221 111223456789999999998889999999999999999999 9999998654322 2222 22222
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
.+ ....+|+++.+++..||..+|.+||++.++.+.|+.++...
T Consensus 239 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 239 MG---CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp CC---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 21 12456899999999999999999999999999999988643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=334.77 Aligned_cols=253 Identities=21% Similarity=0.260 Sum_probs=195.4
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeee-e-----C
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV-D-----G 75 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~-~-----~ 75 (414)
++....+|++++.||+|+||+||+|++..+++ ||+|.+..... ...+|+.+++.++| ++++.+..++. . .
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~--~~~~E~~il~~l~h-~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR--FKNRELQIMRIVKH-PNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT--SCCHHHHHHHTCCC-TTBCCEEEEEEEESSSSSC
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc--hHHHHHHHHHhCCC-CCcceEEEEEEecCCCCCc
Confidence 45667899999999999999999999977666 78886654432 23479999999976 55555544442 2 2
Q ss_pred CeeEEEEeccCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecc
Q 015041 76 EDNVLVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (414)
Q Consensus 76 ~~~~lv~e~~~~sL~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~ 152 (414)
...++||||+.+++...+.. ....+++..++.++.||+.||+|||++||+||||||+|||++ ..++.+||+|||+
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSGVLKLIDFGS 188 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTT
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCCcEEEeeCCC
Confidence 23789999998887766543 256799999999999999999999999999999999999994 2688999999999
Q ss_pred eeeecCCCCCccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhh
Q 015041 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (414)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~ 231 (414)
|+....... .....||..|+|||++.+. .++.++|||||||++|||++|+.||.+.+....... +...
T Consensus 189 a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~---i~~~ 257 (394)
T 4e7w_A 189 AKILIAGEP--------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVE---IIKV 257 (394)
T ss_dssp CEECCTTCC--------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHH
T ss_pred cccccCCCC--------CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHH
Confidence 987644322 1356789999999999876 499999999999999999999999998655433333 2222
Q ss_pred ccCCch------------------------HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 232 KVSTPI------------------------EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 232 ~~~~p~------------------------~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
....+. ..+....++++.+|+.+||..||.+||++.++.+
T Consensus 258 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 111111 1122346789999999999999999999877654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=333.16 Aligned_cols=240 Identities=20% Similarity=0.237 Sum_probs=200.0
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----------CchhHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----------KHPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 74 (414)
+.++|++++.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++| ++|+.+..++..
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~~~~~~~~ 100 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH-ANIIKVLDIFEN 100 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCC-TTBCCEEEEEEC
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCC-CCEeeEEEEEee
Confidence 3478999999999999999999999999999999887653 22356789999999965 677777777788
Q ss_pred CCeeEEEEecc-CC-CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecc
Q 015041 75 GEDNVLVLDLL-GP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (414)
Q Consensus 75 ~~~~~lv~e~~-~~-sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~ 152 (414)
....++||||+ ++ +|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGS 176 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTT
T ss_pred CCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEeeccc
Confidence 88999999998 33 88887764 4579999999999999999999999999999999999999 5788999999999
Q ss_pred eeeecCCCCCccccccCCCCCccCcCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhh
Q 015041 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (414)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~ 231 (414)
++....... .....||..|+|||++.+..+ +.++|||||||++|+|++|..||...... ...
T Consensus 177 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~~~ 239 (335)
T 3dls_A 177 AAYLERGKL--------FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------VEA 239 (335)
T ss_dssp CEECCTTCC--------BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------TTT
T ss_pred ceECCCCCc--------eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------Hhh
Confidence 987654322 124678999999999998876 88999999999999999999999864321 122
Q ss_pred ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 232 ~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
....+ ..+++++.+++..||..+|.+||++.++.+
T Consensus 240 ~~~~~-----~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 240 AIHPP-----YLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp CCCCS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCC-----cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 22222 235789999999999999999999887655
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=319.56 Aligned_cols=259 Identities=21% Similarity=0.352 Sum_probs=209.0
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++..++|++++.||+|+||.||+|.+. ++..||||++.... ....+.+|+++++.+.| +++..+..+.. ....++|
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~-~~~~~~v 85 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH-QRLVRLYAVVT-QEPIYII 85 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCC-TTBCCEEEEEC-SSSCEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCC-cCcceEEEEEc-CCCcEEE
Confidence 456789999999999999999999975 56789999887654 34568899999999976 55556655544 4568999
Q ss_pred Eecc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 82 LDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
|||+ +++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSS
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCcccccccCc
Confidence 9999 789999886322 368999999999999999999999999999999999999 57889999999999876443
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
.. .......++..|+|||++.+..++.++|||||||++|||++ |..||.+..... .+..+.. .....
T Consensus 163 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~~~-~~~~~-- 230 (279)
T 1qpc_A 163 EY------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQNLER-GYRMV-- 230 (279)
T ss_dssp CE------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHT-TCCCC--
T ss_pred cc------ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---HHHHHhc-ccCCC--
Confidence 21 11224456889999999998889999999999999999999 999998765432 2222222 22221
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
....+|+++.+++..||..+|++||++.++.+.|++++...
T Consensus 231 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 231 -RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 12456899999999999999999999999999999988654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=354.61 Aligned_cols=264 Identities=20% Similarity=0.287 Sum_probs=206.0
Q ss_pred cCCceEEec-ceeecCceeEEEEEEC--CCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 5 IGVKYKLGR-KIGSGSFGEIFLASHV--DTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 5 ~~~~y~i~~-~iG~G~~g~V~~~~~~--~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
...+|.+.+ +||+|+||.||+|.+. .++..||||+++... ....+.+|+++++.++| ++|+.+..++.. ...
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~h-pniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN-PYIVRLIGVCQA-EAL 410 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCC-TTBCCEEEEEES-SSE
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCC-CCEeeEEEEecc-CCe
Confidence 345667666 8999999999999875 356679999987653 23568899999999976 566666666544 568
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
++||||+ +++|.+++......+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+...
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL---VNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCSTTTTCC
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE---cCCCcEEEeeccCccccc
Confidence 9999999 789999887656679999999999999999999999999999999999999 478899999999997653
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCc
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTP 236 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p 236 (414)
..... +.......+|..|+|||++.+..++.++|||||||++|||++ |+.||.+....+. +..+.. ....+
T Consensus 488 ~~~~~----~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~---~~~i~~-~~~~~ 559 (613)
T 2ozo_A 488 ADDSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MAFIEQ-GKRME 559 (613)
T ss_dssp ------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH---HHHHHT-TCCCC
T ss_pred CCCce----eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HHHHHc-CCCCC
Confidence 22111 111123445789999999999999999999999999999998 9999998765432 222322 22222
Q ss_pred hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCC
Q 015041 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDF 284 (414)
Q Consensus 237 ~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 284 (414)
.+ ..+|+++.+++..||..+|++||++.+|.+.|+.++...+...
T Consensus 560 ~p---~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~ 604 (613)
T 2ozo_A 560 CP---PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 604 (613)
T ss_dssp CC---TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred CC---CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence 22 4568999999999999999999999999999999887665433
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=328.98 Aligned_cols=248 Identities=25% Similarity=0.309 Sum_probs=206.2
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
...++|++++.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.+++.+.| ++++.+..++......
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH-QHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEecCCeE
Confidence 34679999999999999999999999999999999876542 12347789999999865 6677777777788899
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 117 ~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCceecc
Confidence 9999999 6889888765 4679999999999999999999999999999999999999 578899999999998764
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
.... ......||..|+|||++.+..++.++|||||||++|+|++|..||.+.... +.+..+.......+
T Consensus 193 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~- 261 (335)
T 2owb_A 193 YDGE-------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK---ETYLRIKKNEYSIP- 261 (335)
T ss_dssp STTC-------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHTCCCCC-
T ss_pred cCcc-------cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHHhcCCCCCC-
Confidence 3322 123567899999999999999999999999999999999999999875433 33334434333333
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..++.++.+++..||..||.+||++.++.+
T Consensus 262 ----~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 262 ----KHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ----ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 345789999999999999999999887644
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=318.82 Aligned_cols=251 Identities=21% Similarity=0.266 Sum_probs=205.0
Q ss_pred CCcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeee-------
Q 015041 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV------- 73 (414)
Q Consensus 1 ~~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~------- 73 (414)
++..++++|++++.||+|+||.||+|.+..+++.||+|++.... ..+.+|+++++.+.| +++..+..++.
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--EKAEREVKALAKLDH-VNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp CCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--GGGHHHHHHHHHCCC-TTBCCEEEEEEEEEEC--
T ss_pred ccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHhCCC-CCEEEEeeeEeccccCcc
Confidence 35667889999999999999999999999899999999987653 467899999999986 45555544332
Q ss_pred ---------eCCeeEEEEecc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCC
Q 015041 74 ---------DGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 142 (414)
Q Consensus 74 ---------~~~~~~lv~e~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~ 142 (414)
.....++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~ 158 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL---VDT 158 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EET
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE---cCC
Confidence 244579999999 56999999764 3579999999999999999999999999999999999999 478
Q ss_pred CeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchH
Q 015041 143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK 222 (414)
Q Consensus 143 ~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~ 222 (414)
+.+||+|||++........ .....||..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----- 225 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGK--------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----- 225 (284)
T ss_dssp TEEEECCCTTCEESSCCSC--------CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----
T ss_pred CCEEECcchhheecccccc--------ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----
Confidence 8999999999987654322 124568999999999999999999999999999999999998885321
Q ss_pred HHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 015041 223 QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (414)
Q Consensus 223 ~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~ 277 (414)
.....+..... ...++.++.+++..||..+|.+||++.++.+.|..+.
T Consensus 226 ~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 226 KFFTDLRDGII-------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHHHHTTCC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHHHhhcccc-------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 12222222211 1345789999999999999999999999999887653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=331.36 Aligned_cols=247 Identities=21% Similarity=0.292 Sum_probs=193.7
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe---
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGED--- 77 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~--- 77 (414)
+.++|++.+.||+|+||+||+|.+..+|+.||||++...... ..+.+|+.+++.++| ++++.+..++.....
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH-ENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCC-TTBCCCSEEECSCSSSTT
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCC-CCchhhhhheeccCCccc
Confidence 568999999999999999999999999999999998765432 347789999999986 455555444443333
Q ss_pred ---eEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 78 ---NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 78 ---~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
.++||||+.++|.+++ ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 119 ~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 119 FYDFYLVMPFMQTDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLAR 192 (371)
T ss_dssp CCCCEEEEECCCEEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECSTTCC-
T ss_pred ceeEEEEEccccccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEEEecCccc
Confidence 3999999998887665 4569999999999999999999999999999999999999 588899999999997
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
...... ....||..|+|||++.+ ..++.++|||||||++|+|++|..||.+......... +.....
T Consensus 193 ~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~~~~ 259 (371)
T 4exu_A 193 HADAEM----------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ---ILKVTG 259 (371)
T ss_dssp -----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHC
T ss_pred ccccCc----------CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhC
Confidence 543322 25678999999999987 6799999999999999999999999998654433222 222111
Q ss_pred CC--------------------------chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 234 ST--------------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 234 ~~--------------------------p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.. .........++++.+|+..||..+|.+||++.++.+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 11 112223456788999999999999999999876644
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=327.87 Aligned_cols=264 Identities=23% Similarity=0.305 Sum_probs=207.7
Q ss_pred cccCCce-EEecceeecCceeEEEEEEC----CCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015041 3 RIIGVKY-KLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (414)
Q Consensus 3 ~i~~~~y-~i~~~iG~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 74 (414)
.++.++| +++++||+|+||+||+|.+. .+++.||||++...... ..+.+|+.+++.++| ++++.+..++.+
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~ 104 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH-EHIIKYKGCCED 104 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCC-cchhhEEEEEec
Confidence 3566777 99999999999999888653 57889999998876432 347899999999986 566666555554
Q ss_pred --CCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeec
Q 015041 75 --GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (414)
Q Consensus 75 --~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG 151 (414)
....++||||+ +++|.+++. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg 179 (318)
T 3lxp_A 105 AGAASLQLVMEYVPLGSLRDYLP--RHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFG 179 (318)
T ss_dssp TTTTEEEEEECCCTTCBHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGG
T ss_pred CCCceEEEEEecccCCcHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECCcc
Confidence 46789999999 779998886 3459999999999999999999999999999999999999 578899999999
Q ss_pred ceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhh-----------c
Q 015041 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA-----------T 220 (414)
Q Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~-----------~ 220 (414)
+++........ ........+|..|+|||++.+..++.++|||||||++|+|++|..||...... .
T Consensus 180 ~a~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 255 (318)
T 3lxp_A 180 LAKAVPEGHEY----YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255 (318)
T ss_dssp GCEECCTTCSE----EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHH
T ss_pred ccccccccccc----cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccch
Confidence 99876543221 11223556788999999999999999999999999999999999999763221 0
Q ss_pred hHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 221 ~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
....+..........+. ...+|.++.+++..||..+|.+||++.++.+.|+.+.+.
T Consensus 256 ~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 256 TVLRLTELLERGERLPR---PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp HHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccCCCC---CccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 11122223333333322 245689999999999999999999999999999988654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=319.49 Aligned_cols=262 Identities=21% Similarity=0.304 Sum_probs=209.9
Q ss_pred ccCCceEEec-ceeecCceeEEEEEEC--CCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 4 IIGVKYKLGR-KIGSGSFGEIFLASHV--DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 4 i~~~~y~i~~-~iG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
+-.++|.+.+ .||+|+||.||+|.+. .++..||||++...... ..+.+|+.+++.+.| ++++.+..++ ....
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~-~~~~ 83 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN-PYIVRLIGVC-QAEA 83 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEE-ESSS
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCC-CCEeEEEEEe-cCCC
Confidence 3467888887 9999999999999864 46788999998775432 347889999999975 5666665555 4566
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
.++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc---CCCCEEECcccceeee
Confidence 89999999 6799998875566799999999999999999999999999999999999994 7889999999999876
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
...... ........+|..|+|||++.+..++.++|||||||++|+|++ |..||.+..... ....+.... ..
T Consensus 161 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~i~~~~-~~ 232 (287)
T 1u59_A 161 GADDSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQGK-RM 232 (287)
T ss_dssp TTCSCE----ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHHHTTC-CC
T ss_pred ccCcce----eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHhcCC-cC
Confidence 433221 111234567899999999998889999999999999999998 999998765432 222222221 11
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~ 281 (414)
+ ....+|+++.+++..||..+|.+||++.++.+.|+.++...+
T Consensus 233 ~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 233 E---CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp C---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred C---CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 1 124668999999999999999999999999999999886554
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=326.72 Aligned_cols=252 Identities=20% Similarity=0.253 Sum_probs=190.8
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeC--------
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG-------- 75 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~-------- 75 (414)
++|++++.||+|+||+||+|++..+++.||||++..... ...+.+|+.+++.++| ++++.+..++.+.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH-PGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCC-TTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCC-CCEeeEEEEEEEeccchhhhh
Confidence 689999999999999999999999999999999875432 2458899999999976 5555554443222
Q ss_pred -------------------------------------------------CeeEEEEecc-CCCHHHHHHHhC--CCCCHH
Q 015041 76 -------------------------------------------------EDNVLVLDLL-GPSLEDLFVYCR--RKFSLK 103 (414)
Q Consensus 76 -------------------------------------------------~~~~lv~e~~-~~sL~~~~~~~~--~~~~~~ 103 (414)
...++||||+ +++|.+++.... ......
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 2379999999 779999887532 235667
Q ss_pred HHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccc-----cccCCCCCccCcC
Q 015041 104 TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI-----PYRENKNLTGTAR 178 (414)
Q Consensus 104 ~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~-----~~~~~~~~~gt~~ 178 (414)
.++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++........... .+.......||..
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 789999999999999999999999999999999 57889999999999876544321110 0122345679999
Q ss_pred ccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcC
Q 015041 179 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSL 258 (414)
Q Consensus 179 y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~ 258 (414)
|+|||++.+..++.++|||||||++|||++|..|+.. .......+... ..+ ......++++.+++..||..
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~--~~~--~~~~~~~~~~~~li~~~l~~ 312 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNL--KFP--LLFTQKYPQEHMMVQDMLSP 312 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTT--CCC--HHHHHHCHHHHHHHHHHHCS
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhcc--CCC--cccccCChhHHHHHHHHccC
Confidence 9999999999999999999999999999998766532 11222222222 222 22233467889999999999
Q ss_pred CCCCCCChHHHHH
Q 015041 259 TFDQRPDYGFLKR 271 (414)
Q Consensus 259 ~p~~RP~~~~l~~ 271 (414)
+|.+||++.++.+
T Consensus 313 ~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 313 SPTERPEATDIIE 325 (332)
T ss_dssp SGGGSCCHHHHHH
T ss_pred CCCcCCCHHHHhh
Confidence 9999999887654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=330.10 Aligned_cols=255 Identities=18% Similarity=0.205 Sum_probs=176.0
Q ss_pred ccCCceEEec-ceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeee----CCee
Q 015041 4 IIGVKYKLGR-KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD----GEDN 78 (414)
Q Consensus 4 i~~~~y~i~~-~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~----~~~~ 78 (414)
.+.++|.+.+ .||+|+||+||+|.+..+++.||||++... .....|+..+..+..+++++.+..++.. ....
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 4678999966 599999999999999999999999998653 3445565555455556777776555443 4457
Q ss_pred EEEEecc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 79 VLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++..+..+.+||+|||+++..
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 9999999 669999987543 36999999999999999999999999999999999999964445677999999999865
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHH-HHHHHhhccCC
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK-YDKICEKKVST 235 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~-~~~i~~~~~~~ 235 (414)
..... ....||..|+|||++.+..++.++|||||||++|+|++|..||.+......... ...+.......
T Consensus 182 ~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (336)
T 3fhr_A 182 TQNAL---------QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252 (336)
T ss_dssp -------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CC
T ss_pred ccccc---------ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc
Confidence 43221 255789999999999988899999999999999999999999987544322111 11122222222
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+. .....+++++.+++..||..+|.+||++.++.+
T Consensus 253 ~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 253 PN-PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp CT-TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred Cc-hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 22 122456899999999999999999999988765
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=321.26 Aligned_cols=249 Identities=25% Similarity=0.302 Sum_probs=206.5
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
....++|++++.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.+.| ++++.+..++.....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~ 89 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH-QHVVGFHGFFEDNDF 89 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSE
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCC-CCEeeeeeeeccCCE
Confidence 3456899999999999999999999999999999998765421 2347789999999865 677777777778888
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
.++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 90 VFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCceec
Confidence 99999999 6888887765 4579999999999999999999999999999999999999 57889999999999875
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCc
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p 236 (414)
...... .....||..|+|||++.+..++.++|||||||++|+|++|..||.+.... +.+..+.......+
T Consensus 166 ~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~ 235 (294)
T 2rku_A 166 EYDGER-------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK---ETYLRIKKNEYSIP 235 (294)
T ss_dssp CSTTCC-------BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTTCCCCC
T ss_pred ccCccc-------cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhhccCCCc
Confidence 433221 23567899999999999999999999999999999999999999875433 33334434333333
Q ss_pred hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 237 ~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..++..+.+++..||..+|.+||++.++.+
T Consensus 236 -----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 236 -----KHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp -----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -----cccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 355789999999999999999999887654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=330.98 Aligned_cols=256 Identities=24% Similarity=0.329 Sum_probs=202.2
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-------CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-------TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
+.++|++++.||+|+||+||+|.+..++..||+|++... .....+.+|+.+++.++| ++|+.+..++.+...
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~ 102 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH-PNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCC-CCcceeehhhccCCe
Confidence 457899999999999999999999999999999987532 223468899999999975 677778777888889
Q ss_pred eEEEEecc-CCCHHHHHHHh---------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 015041 78 NVLVLDLL-GPSLEDLFVYC---------------------------------------RRKFSLKTVLMLADQMIARIE 117 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~---------------------------------------~~~~~~~~~~~i~~qi~~aL~ 117 (414)
.++||||+ +++|.+++... ...+++..++.++.||+.||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 99999999 88998877310 011356778899999999999
Q ss_pred HHHhcCeeccccCCCceEEccCCCCC--eEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccC--CCCCch
Q 015041 118 YVHSRGFLHRDIKPDNFLMGLGRKAN--QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRR 193 (414)
Q Consensus 118 ~LH~~~iiHrDLkp~Nili~~~~~~~--~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~ 193 (414)
|||++||+||||||+|||++ .++ .+||+|||+++......... ........||..|+|||++.+ ..++.+
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~---~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFS---TNKSFEIKLVDFGLSKEFYKLNNGE---YYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHTTEECCCCCGGGEEES---CSSSCCEEECCCTTCEEGGGTTCC-----------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHCCccccCCChhhEEEe---cCCCceEEEeeccccccccccCccc---cccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999999999999994 344 89999999998765433221 112235678999999999975 678999
Q ss_pred hhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 194 DDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 194 ~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+|||||||++|||++|..||.+.... +.+..+.......+.+. ...+++++.+++..||..+|.+||++.++.+
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDA---DTISQVLNKKLCFENPN-YNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCTTSGG-GGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChH---HHHHHHHhcccccCCcc-cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 99999999999999999999886543 34444445444443322 2456889999999999999999999988755
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=317.01 Aligned_cols=249 Identities=18% Similarity=0.198 Sum_probs=201.7
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
...+.++|++++.||+|+||+||+|.+..+++.||||++..... ...+.+|+..+..+.+|++++.+..++.....
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~ 85 (289)
T 1x8b_A 6 KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH 85 (289)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE
T ss_pred cccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence 34456899999999999999999999999999999998876432 23477888888888667888888888888899
Q ss_pred eEEEEecc-CCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCC-------------
Q 015041 78 NVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR------------- 140 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~------------- 140 (414)
.++||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++...
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999 77999998754 25689999999999999999999999999999999999995221
Q ss_pred ---CCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 015041 141 ---KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGL 216 (414)
Q Consensus 141 ---~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~ 216 (414)
....+||+|||++....... ...||..|+|||++.+. .++.++|||||||++|+|++|..++...
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred ccCCceEEEEcccccccccCCcc-----------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 44579999999998654322 34589999999999876 5678999999999999999998877653
Q ss_pred hhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
. ....+....... ....+++++.+++..||..+|.+||++.++.+
T Consensus 235 ~------~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 235 D------QWHEIRQGRLPR----IPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp H------HHHHHHTTCCCC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred h------HHHHHHcCCCCC----CCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 2 122233332221 22456899999999999999999999887643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=317.17 Aligned_cols=246 Identities=22% Similarity=0.296 Sum_probs=206.3
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
+.-++|++++.||+|+||.||+|++..++..||||++... .....+.+|+.+++.+.| ++++.+..++......
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH-PNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCC-CCEeeEEEEEEcCCEE
Confidence 4457999999999999999999999999999999987532 233568899999999975 6677777777788899
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
++||||+ +++|.+++... ..++...++.++.||+.||+|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECS
T ss_pred EEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccccCc
Confidence 9999999 67999988763 568999999999999999999999999999999999999 578899999999987654
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
... .....||..|+|||++.+..++.++|||||||++|+|++|..||...... .....+.......+
T Consensus 166 ~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~- 232 (284)
T 2vgo_A 166 SLR---------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT---ETHRRIVNVDLKFP- 232 (284)
T ss_dssp SSC---------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTTCCCCC-
T ss_pred ccc---------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh---HHHHHHhccccCCC-
Confidence 321 13567899999999999999999999999999999999999999875433 33334444443333
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..++.++.+++..||..+|.+||++.++.+
T Consensus 233 ----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 233 ----PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 345789999999999999999999988755
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=321.42 Aligned_cols=248 Identities=24% Similarity=0.333 Sum_probs=181.7
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
|+.+ ++|++.+.||+|+||.||+|++..+++.||||++... .....+.+|+.+++.+.| ++++.+..++....
T Consensus 7 g~~~-~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 84 (278)
T 3cok_A 7 GEKI-EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH-PSILELYNYFEDSN 84 (278)
T ss_dssp CSSG-GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCC-TTBCCEEEEEECSS
T ss_pred cccc-ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCC-CCeEeEEEEEccCC
Confidence 3444 5799999999999999999999999999999987543 223567889999998875 66777777777888
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
..++||||+ +++|.+++......+++..++.++.|++.||+|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQ 161 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceee
Confidence 899999999 779998887655679999999999999999999999999999999999999 5788999999999987
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
....... .....||..|+|||++.+..++.++|||||||++|+|++|..||....... .+.++.......
T Consensus 162 ~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~ 231 (278)
T 3cok_A 162 LKMPHEK-------HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN---TLNKVVLADYEM 231 (278)
T ss_dssp CC-----------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------CCSSCCCC
T ss_pred ccCCCCc-------ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH---HHHHHhhcccCC
Confidence 5433221 124578999999999999999999999999999999999999998754322 222222222222
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
| ..++.++.+++..||..+|.+||++.++
T Consensus 232 ~-----~~~~~~~~~li~~~l~~dp~~Rps~~~~ 260 (278)
T 3cok_A 232 P-----SFLSIEAKDLIHQLLRRNPADRLSLSSV 260 (278)
T ss_dssp C-----TTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred c-----cccCHHHHHHHHHHcccCHhhCCCHHHH
Confidence 2 3457899999999999999999998765
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=316.53 Aligned_cols=250 Identities=19% Similarity=0.177 Sum_probs=207.8
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-----------chhHHHHHHHHHHHcCCCCCCeeEEeee
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----------HPQLLYEAKVYKILQGGSGIPNIKWYGV 73 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~E~~~l~~l~~~~~i~~l~~~~~ 73 (414)
+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+.+|++++.+..++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 45899999999999999999999999999999999875431 2346789999999986788888888888
Q ss_pred eCCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecc
Q 015041 74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (414)
Q Consensus 74 ~~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~ 152 (414)
.....++||||+ +++|.+++.. ...++...++.++.||+.||+|||++||+|+||||+||++ +.++.+||+|||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~ 170 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGF 170 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred cCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEecccc
Confidence 888999999999 6899998876 4579999999999999999999999999999999999999 5788999999999
Q ss_pred eeeecCCCCCccccccCCCCCccCcCcccccccc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHH
Q 015041 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL------GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD 226 (414)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~ 226 (414)
+........ .....||..|+|||++. ...++.++|||||||++|+|++|..||.+.... ....
T Consensus 171 ~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~ 239 (298)
T 1phk_A 171 SCQLDPGEK--------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LMLR 239 (298)
T ss_dssp CEECCTTCC--------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH
T ss_pred hhhcCCCcc--------cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---HHHH
Confidence 987543221 13567899999999985 456899999999999999999999999875433 3333
Q ss_pred HHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 227 KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 227 ~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
.+.......+.+ ....++..+.+++..||..+|.+||++.++.
T Consensus 240 ~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 282 (298)
T 1phk_A 240 MIMSGNYQFGSP-EWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 282 (298)
T ss_dssp HHHHTCCCCCTT-TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred HHhcCCcccCcc-cccccCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 444444443332 2246689999999999999999999987763
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=320.10 Aligned_cols=260 Identities=17% Similarity=0.251 Sum_probs=202.7
Q ss_pred ceEEecceeecCceeEEEEEECCCCc---eEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeee-eCCeeEE
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV-DGEDNVL 80 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~-~~~~~~l 80 (414)
.|++.++||+|+||+||+|.+..++. .||+|++...... ..+.+|+.+++.++| +++..+..++. .....++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNH-PNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCC-TTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEecCCCCcEE
Confidence 57778999999999999999765544 7999998765443 347789999999976 45555544444 4445589
Q ss_pred EEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 81 v~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
||||+ +++|.+++......+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDILDR 177 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCTTTTG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCcccccCC
Confidence 99998 899999988656779999999999999999999999999999999999999 57889999999999754332
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCC-CCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS-LPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~-~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
.. ..........+|..|+|||.+.+..++.++|||||||++|+|++|. +||......... ..+ ......+.+
T Consensus 178 ~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~---~~~-~~~~~~~~~ 250 (298)
T 3pls_A 178 EY---YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT---HFL-AQGRRLPQP 250 (298)
T ss_dssp GG---GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHH---HHH-HTTCCCCCC
T ss_pred cc---cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHH---HHh-hcCCCCCCC
Confidence 11 1111233567789999999999999999999999999999999954 555544333222 222 222222222
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~ 281 (414)
..+++.+.+++..||..+|.+||++.++.+.|++++....
T Consensus 251 ---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 251 ---EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred ---ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 3458899999999999999999999999999999987653
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=327.68 Aligned_cols=253 Identities=25% Similarity=0.310 Sum_probs=198.3
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----------CchhHHHHHHHHHHHcCCCCCCeeEEeee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----------KHPQLLYEAKVYKILQGGSGIPNIKWYGV 73 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~ 73 (414)
.+.++|++++.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.| +++..+..+..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~ 85 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH-PCIIKIKNFFD 85 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCC-TTBCCEEEEEE
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCC-CCCceEeeEEc
Confidence 45689999999999999999999999999999999876432 12347899999999976 55666655554
Q ss_pred eCCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecc
Q 015041 74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (414)
Q Consensus 74 ~~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~ 152 (414)
.. ..++||||+ +++|.+++.. ...++...++.++.||+.||+|||++||+||||||+|||++..+....+||+|||+
T Consensus 86 ~~-~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 86 AE-DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp SS-SEEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred CC-ceEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 43 489999999 6788887754 45799999999999999999999999999999999999996433445699999999
Q ss_pred eeeecCCCCCccccccCCCCCccCcCcccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHH
Q 015041 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (414)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~ 229 (414)
++....... .....||..|+|||++. ...++.++|||||||++|+|++|..||........ ....+.
T Consensus 164 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~ 233 (322)
T 2ycf_A 164 SKILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQIT 233 (322)
T ss_dssp CEECCCCHH--------HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHH
T ss_pred ceecccccc--------cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHH
Confidence 986543211 12456899999999974 45689999999999999999999999986543321 122222
Q ss_pred hhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 230 ~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
..... ..+..+..+++++.+++..||..+|.+||++.++.
T Consensus 234 ~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l 273 (322)
T 2ycf_A 234 SGKYN-FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273 (322)
T ss_dssp HTCCC-CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred hCccc-cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 33332 23444567789999999999999999999988764
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=322.80 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=199.6
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcC-CCCCCeeEEeeeeCCe
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQG-GSGIPNIKWYGVDGED 77 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~-~~~i~~l~~~~~~~~~ 77 (414)
.+.+++|++++.||+|+||.||+|.+. +++.||||++...... ..+.+|+.+++.+.+ ++++..+..++.....
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 356788999999999999999999975 5889999998765432 357889999999986 6788888888888889
Q ss_pred eEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 78 ~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
.++|||+.+++|.+++.. ...++...++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++...
T Consensus 103 ~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~----~~~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 103 IYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEEEECCCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----ETTEEEECCCSSSCC--
T ss_pred EEEEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE----ECCeEEEeecccccccc
Confidence 999999889999999886 5578999999999999999999999999999999999999 34899999999997654
Q ss_pred CCCCCccccccCCCCCccCcCccccccccC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHH
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLG-----------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD 226 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~ 226 (414)
...... ......||..|+|||++.+ ..++.++|||||||++|+|++|..||...... ...+.
T Consensus 178 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~ 250 (313)
T 3cek_A 178 PDTTSV-----VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLH 250 (313)
T ss_dssp -----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHH
T ss_pred Cccccc-----cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH--HHHHH
Confidence 332211 1124578999999999876 46889999999999999999999999865322 22333
Q ss_pred HHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 227 KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 227 ~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+.........+ ...++++.+++..||..+|.+||++.++.+
T Consensus 251 ~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 251 AIIDPNHEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHCTTSCCCCC---CCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhcccccCCc---ccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 333333222221 344789999999999999999999987755
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=323.57 Aligned_cols=252 Identities=19% Similarity=0.314 Sum_probs=198.1
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeee------CC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVD------GE 76 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~------~~ 76 (414)
...++|++++.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.+.+|++++.+..++.. ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 35689999999999999999999999999999999886543 345688999999999767778777666554 46
Q ss_pred eeEEEEecc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
..++||||+ +++|.+++.... ..++...++.++.||+.||.|||++||+|+||||+|||+ +.++.+||+|||++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSA 177 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCTTTC
T ss_pred eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCEEEeeCcCce
Confidence 789999999 569999988643 568999999999999999999999999999999999999 578899999999987
Q ss_pred eecCCCCCccccccCCCCCccCcCcccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHH
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~ 229 (414)
....... ......||..|+|||++. +..++.++|||||||++|+|++|..||.+.... ..+..+.
T Consensus 178 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~ 247 (326)
T 2x7f_A 178 QLDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---RALFLIP 247 (326)
T ss_dssp --------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHH
T ss_pred ecCcCcc-------ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHhh
Confidence 6543211 123557899999999997 566899999999999999999999999875433 2222222
Q ss_pred hhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 230 ~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...... .....++..+.+++..||..+|.+||++.++.+
T Consensus 248 ~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 248 RNPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HSCCCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCcccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 222211 112456889999999999999999999987755
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=329.24 Aligned_cols=266 Identities=16% Similarity=0.220 Sum_probs=208.6
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
..++|++.+.||+|+||.||+|.+ .+++.||||++...... ..+.+|+.+++.+.| ++++.+..++......++||
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRH-PHLVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCC-TTBCCEEEECCCTTCCEEEE
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCC-CCEeeEEEEEcCCCeEEEEE
Confidence 457999999999999999999996 46889999987765432 457889999988875 66777777777888899999
Q ss_pred ecc-CCCHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 83 DLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTE 191 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCTTCEECSS
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeeccccccccc
Confidence 999 779988875432 248999999999999999999999999999999999999 5888999999999986543
Q ss_pred CCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHH---H-HHhhccC
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD---K-ICEKKVS 234 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~---~-i~~~~~~ 234 (414)
..... ......||..|+|||++.+..++.++|||||||++|||++|+.||.+........... . .......
T Consensus 192 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 192 LDQTH-----LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp SSCCC-----CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred ccccc-----cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 22211 1234568999999999999999999999999999999999999998654322111111 0 0000000
Q ss_pred ----C-chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 235 ----T-PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 235 ----~-p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
. .........+..+.+++..||..+|++||++.++.+.|+.++...
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 0 011112334678999999999999999999999999999887643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=323.97 Aligned_cols=258 Identities=20% Similarity=0.227 Sum_probs=196.0
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEee-------
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYG------- 72 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~------- 72 (414)
|..++++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+.|+ ++..+..+.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHD-NIVKVFEILGPSGSQL 84 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCT-TBCCEEEEECTTSCBC
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCC-CeeEEEEecccccccc
Confidence 45688999999999999999999999999999999998875532 24578899999999765 444443332
Q ss_pred -------eeCCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeE
Q 015041 73 -------VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 145 (414)
Q Consensus 73 -------~~~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~v 145 (414)
......++||||+.++|.+++. ...++...++.++.||+.||+|||++||+||||||+|||++ ..++.+
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~ 160 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN--TEDLVL 160 (320)
T ss_dssp CC----CCSCSEEEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTTTEE
T ss_pred ccccccccccCceeEEeeccCCCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc--CCCCeE
Confidence 2346789999999989998875 45799999999999999999999999999999999999994 356799
Q ss_pred EEeeecceeeecCCCCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHH
Q 015041 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK 224 (414)
Q Consensus 146 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~ 224 (414)
||+|||+++......... .......+|..|+|||++.+ ..++.++|||||||++|||++|+.||.+........
T Consensus 161 kl~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~- 235 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHK----GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ- 235 (320)
T ss_dssp EECCCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-
T ss_pred EEccCccccccCCCcccc----cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHH-
Confidence 999999998654321110 11234567899999999876 679999999999999999999999999865433222
Q ss_pred HHHHHhhc-------------------------cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 225 YDKICEKK-------------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 225 ~~~i~~~~-------------------------~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+.... ...+.......++.++.+++..||..||.+||++.++.+
T Consensus 236 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 236 --LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp --HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred --HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 222211 112233444567899999999999999999999887754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=321.86 Aligned_cols=260 Identities=20% Similarity=0.310 Sum_probs=196.8
Q ss_pred ccCCceEEecceeecCceeEEEEEECC---CCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
+..++|++++.||+|+||.||+|.+.. ++..||||++...... ..+.+|+.+++.++| +++..+..++....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH-PNVIRLLGVCIEMS 109 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCC-TTBCCCCEEEEC--
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCC-CCeeeeeEEEeecc
Confidence 456899999999999999999998764 4568999998765432 347889999999986 45555544443322
Q ss_pred -----eeEEEEecc-CCCHHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeE
Q 015041 77 -----DNVLVLDLL-GPSLEDLFVYC-----RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 145 (414)
Q Consensus 77 -----~~~lv~e~~-~~sL~~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~v 145 (414)
..++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE---CTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcE
Confidence 459999999 77999988643 2468999999999999999999999999999999999999 578899
Q ss_pred EEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHH
Q 015041 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQK 224 (414)
Q Consensus 146 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~ 224 (414)
||+|||+++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.......
T Consensus 187 kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-- 259 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY-- 259 (313)
T ss_dssp EECSCSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH--
T ss_pred EEeecCcceeccccccc-----CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH--
Confidence 99999999765433211 12234567889999999999999999999999999999999 99999876544322
Q ss_pred HHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 225 ~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
..+..... .+ ....+++++.+++..||..+|.+||++.++.+.|+.++..
T Consensus 260 -~~~~~~~~-~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 260 -DYLLHGHR-LK---QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp -HHHHTTCC-CC---CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHcCCC-CC---CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 22322221 11 1245688999999999999999999999999999988764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=339.19 Aligned_cols=249 Identities=16% Similarity=0.110 Sum_probs=186.7
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcC-CCCCCe-eE------Eeee
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQG-GSGIPN-IK------WYGV 73 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~-~~~i~~-l~------~~~~ 73 (414)
..|+++++||+|+||+||+|++..+++.||||++..... ...+..|+.+++.|.+ |+++.. +. ....
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 359999999999999999999999999999999887653 2346678777777763 344332 21 1111
Q ss_pred e-C----------------CeeEEEEeccCCCHHHHHHHhCCCCCHHHH------HHHHHHHHHHHHHHHhcCeeccccC
Q 015041 74 D-G----------------EDNVLVLDLLGPSLEDLFVYCRRKFSLKTV------LMLADQMIARIEYVHSRGFLHRDIK 130 (414)
Q Consensus 74 ~-~----------------~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~------~~i~~qi~~aL~~LH~~~iiHrDLk 130 (414)
. + ...++||||+.++|.+++......+....+ +.++.||+.||+|||++||+|||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 1 1 347999999999999999876555565566 7888999999999999999999999
Q ss_pred CCceEEccCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccC--CCCCchhhHHHHHHHHHHHHc
Q 015041 131 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLR 208 (414)
Q Consensus 131 p~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DiwSlG~il~el~t 208 (414)
|+|||+ +.++.+||+|||+|+...... ....+|..|+|||++.+ ..++.++|||||||++|||++
T Consensus 222 p~NIll---~~~~~~kL~DFG~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 222 PDNLFI---MPDGRLMLGDVSALWKVGTRG----------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp GGGEEE---CTTSCEEECCGGGEEETTCEE----------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred HHHEEE---CCCCCEEEEecceeeecCCCc----------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 999999 578899999999998653211 13456799999999987 679999999999999999999
Q ss_pred CCCCCCCChhhchHHHH----HHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 209 GSLPWQGLKAATKKQKY----DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 209 G~~Pf~~~~~~~~~~~~----~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
|+.||.+.......... ..........+ .+..+++++.+++..||..||++||++.++.+
T Consensus 289 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFG---SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCT---TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCCcCcccccchhhhhhhhccccccchh---hccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99999875332111000 00000111111 22467899999999999999999999987754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=314.67 Aligned_cols=249 Identities=23% Similarity=0.309 Sum_probs=198.2
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
+++..++|++++.||+|+||.||+|.+..+++.||||++... .....+.+|+.+++.+.| ++++.+..++....
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH-PHIIKLYQVISTPT 84 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSS
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCC-CCEeEEEEEEecCC
Confidence 567789999999999999999999999989999999987542 223467889999999875 66777777777888
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
..++||||+ +++|.+++.. ...++...++.++.||+.||+|||++||+|+||||+||++ +.++.+||+|||++..
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNM 160 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGGGC
T ss_pred eEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeecccccc
Confidence 999999999 7899998876 3568999999999999999999999999999999999999 5788999999999876
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
...... .....||..|+|||++.+..+ +.++|||||||++|+|++|..||.+.... ..+..+......
T Consensus 161 ~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~ 229 (276)
T 2h6d_A 161 MSDGEF--------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLFKKIRGGVFY 229 (276)
T ss_dssp CCC---------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCC
T ss_pred cCCCcc--------eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHhhcCccc
Confidence 543221 124578999999999988775 68999999999999999999999875432 233333333322
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.| ..++..+.+++..||..+|.+||++.++.+
T Consensus 230 ~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 230 IP-----EYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp CC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cc-----hhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 22 345789999999999999999999988766
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=331.89 Aligned_cols=256 Identities=25% Similarity=0.328 Sum_probs=194.3
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcC----------CCCCCeeEEee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQG----------GSGIPNIKWYG 72 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~----------~~~i~~l~~~~ 72 (414)
+..++|++++.||+|+||+||+|++..+++.||||++..... ...+.+|+.+++.+.+ +++++.+..++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 456899999999999999999999999999999999875432 3457789999998874 34565554444
Q ss_pred eeC----CeeEEEEeccCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhc-CeeccccCCCceEEccC---CCCC
Q 015041 73 VDG----EDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLG---RKAN 143 (414)
Q Consensus 73 ~~~----~~~~lv~e~~~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDLkp~Nili~~~---~~~~ 143 (414)
... ...++|||+++++|.+++.... ..++...++.++.||+.||+|||++ ||+||||||+|||++.. +..+
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred hccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence 332 3789999999999999998643 4599999999999999999999998 99999999999999522 2344
Q ss_pred eEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhh---c
Q 015041 144 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA---T 220 (414)
Q Consensus 144 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~---~ 220 (414)
.+||+|||+++...... ....||..|+|||++.+..++.++|||||||++|||++|..||.+.... .
T Consensus 176 ~~kl~Dfg~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 176 QIKIADLGNACWYDEHY----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp EEEECCCTTCEETTBCC----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred eEEEcccccccccCCCC----------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 89999999998654322 2457899999999999999999999999999999999999999865421 1
Q ss_pred hHHHHHHHHhhccCCchHHh-------------------------------------hhcChHHHHHHHHHHhcCCCCCC
Q 015041 221 KKQKYDKICEKKVSTPIEVL-------------------------------------CKSHPAEFASYFHYCQSLTFDQR 263 (414)
Q Consensus 221 ~~~~~~~i~~~~~~~p~~~~-------------------------------------~~~~p~~~~~l~~~c~~~~p~~R 263 (414)
....+..+.......|.... ....++++.+|+..||..||.+|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 22333333333222222110 12235677888888888888888
Q ss_pred CChHHH
Q 015041 264 PDYGFL 269 (414)
Q Consensus 264 P~~~~l 269 (414)
|++.++
T Consensus 326 pt~~el 331 (373)
T 1q8y_A 326 ADAGGL 331 (373)
T ss_dssp BCHHHH
T ss_pred CCHHHH
Confidence 887765
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=325.32 Aligned_cols=244 Identities=23% Similarity=0.332 Sum_probs=202.6
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC--------CchhHHHHHHHHHHHcC-CCCCCeeEEee
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQG-GSGIPNIKWYG 72 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~~-~~~i~~l~~~~ 72 (414)
++.+.++|++++.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.+ +++++.+..++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 4578899999999999999999999999999999999876542 22456789999999985 67888888888
Q ss_pred eeCCeeEEEEeccC--CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeee
Q 015041 73 VDGEDNVLVLDLLG--PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 150 (414)
Q Consensus 73 ~~~~~~~lv~e~~~--~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DF 150 (414)
......++|||++. ++|.+++.. ...++...++.++.||+.||+|||++||+||||||+|||++ ...+.+||+||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~~kL~Df 194 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDF 194 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--CCCCCEEEeeC
Confidence 88889999999994 789988876 46789999999999999999999999999999999999994 26789999999
Q ss_pred cceeeecCCCCCccccccCCCCCccCcCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHH
Q 015041 151 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (414)
Q Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~ 229 (414)
|+++....... ....||..|+|||++.+..+ +.++|||||||++|||++|..||..... +.
T Consensus 195 g~~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---------~~ 256 (320)
T 3a99_A 195 GSGALLKDTVY---------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------II 256 (320)
T ss_dssp TTCEECCSSCB---------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------HH
T ss_pred ccccccccccc---------cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh---------hh
Confidence 99987653321 24578999999999987765 7889999999999999999999986321 11
Q ss_pred hhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 230 ~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...... ...+++++.+++..||..+|.+||++.++.+
T Consensus 257 ~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 257 RGQVFF-----RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HCCCCC-----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cccccc-----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 222222 2456889999999999999999999887643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=318.74 Aligned_cols=247 Identities=21% Similarity=0.295 Sum_probs=204.7
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
...+|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+.| +++..+..++......++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEecCCeEEEE
Confidence 34679999999999999999999999999999999875532 3557899999999865 6677777777788899999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++. ...++...++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 99 ~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 99 MEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp EECCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECBTTB
T ss_pred EEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeecccceecCccc
Confidence 9999 668888875 4579999999999999999999999999999999999999 578899999999998765432
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
. ......||..|+|||++.+..++.++|||||||++|+|++|..||....... ....+.... .. ..
T Consensus 174 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~-~~---~~ 239 (303)
T 3a7i_A 174 I-------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---VLFLIPKNN-PP---TL 239 (303)
T ss_dssp C-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHSC-CC---CC
T ss_pred c-------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---HHHHhhcCC-CC---CC
Confidence 2 1235678999999999999999999999999999999999999998754432 222222221 11 12
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...++..+.+++..||..+|.+||++.++.+
T Consensus 240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 3466889999999999999999999988765
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=327.69 Aligned_cols=252 Identities=17% Similarity=0.209 Sum_probs=191.3
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc-------------hhHHHHHHHHHHHcCCCCCCeeEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-------------PQLLYEAKVYKILQGGSGIPNIKW 70 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~E~~~l~~l~~~~~i~~l~~ 70 (414)
.+.++|++++.||+|+||.||+|.+.. +..||||++...... ..+.+|+.+++.++| ++++.+..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~ 96 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH-PNILGLRD 96 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCC-TTBCCCSE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCC-cCccceee
Confidence 467899999999999999999999754 899999987543221 457899999999986 45555543
Q ss_pred ee-e----eCCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeE
Q 015041 71 YG-V----DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 145 (414)
Q Consensus 71 ~~-~----~~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~v 145 (414)
++ . .....++||||+.++|.+.+......++...++.++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~~~~ 173 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDI 173 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCE
T ss_pred eEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---cCCCCE
Confidence 33 2 234679999999999999988656679999999999999999999999999999999999999 578899
Q ss_pred EEeeecceeeecCCCCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHH
Q 015041 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK 224 (414)
Q Consensus 146 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~ 224 (414)
||+|||+++....... .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........
T Consensus 174 kl~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 245 (362)
T 3pg1_A 174 TICDFNLAREDTADAN--------KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245 (362)
T ss_dssp EECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred EEEecCcccccccccc--------cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999975433221 124578999999999987 6799999999999999999999999998654433332
Q ss_pred HHHHHhhccCCc---------------------------hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 225 YDKICEKKVSTP---------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 225 ~~~i~~~~~~~p---------------------------~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+.......+ ........++.+.+++..||..+|.+||++.++.+
T Consensus 246 ---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 246 ---IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp ---HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 222211111 12233455778999999999999999999877644
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=350.80 Aligned_cols=256 Identities=23% Similarity=0.388 Sum_probs=207.3
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
+..++|++.++||+|+||+||+|.+.. +..||||++..... ...+.+|+.+++.|+| ++|+.+..++.. ...+|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH-EKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCC-TTBCCEEEEECS-SSCEEEE
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCC-CCEeeEEEEEee-ccceEee
Confidence 556789999999999999999999865 46799999886543 3568999999999986 555566555544 6789999
Q ss_pred ecc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 83 e~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||+ +++|.+++... ...+++..++.|+.||+.||+|||+++||||||||+|||+ +.++.+||+|||+++......
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTSTTTCCCHH
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEcccccceecCCCc
Confidence 999 77999998753 3568999999999999999999999999999999999999 478899999999997543211
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
+.......++..|+|||++.+..++.++|||||||++|||++ |..||.+...... +..+ ......+.+
T Consensus 418 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~---~~~i-~~~~~~~~~- 486 (535)
T 2h8h_A 418 ------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQV-ERGYRMPCP- 486 (535)
T ss_dssp ------HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH---HHHH-HTTCCCCCC-
T ss_pred ------eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH-HcCCCCCCC-
Confidence 111224456889999999999999999999999999999999 9999998654332 2222 223333322
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
..+|+++.+||..||..+|++||++.+|.+.|++++.
T Consensus 487 --~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 487 --PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred --CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 3568999999999999999999999999999887654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=317.67 Aligned_cols=254 Identities=26% Similarity=0.314 Sum_probs=202.7
Q ss_pred CCcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 1 ~~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
|..-+.++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+.| ++++.+..++.....
T Consensus 1 M~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~ 79 (276)
T 2yex_A 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-ENVVKFYGHRREGNI 79 (276)
T ss_dssp -CHHHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCC-TTBCCEEEEEEETTE
T ss_pred CCCceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCC-CCceeeeeEEEcCCE
Confidence 333455789999999999999999999999999999998764332 2457889999998865 667777777788889
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
.++||||+ +++|.+++.. ...++...++.++.|++.||+|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVF 155 (276)
T ss_dssp EEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCcccc
Confidence 99999999 6688887653 3468999999999999999999999999999999999999 47889999999999865
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
....... ......||..|+|||++.+..+ +.++|||||||++|+|++|..||.+..... ..+..+.......
T Consensus 156 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~ 228 (276)
T 2yex_A 156 RYNNRER-----LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWKEKKTYL 228 (276)
T ss_dssp EETTEEC-----CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS--HHHHHHHTTCTTS
T ss_pred CCCcchh-----cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHhhhccccc
Confidence 4322111 1235678999999999988775 789999999999999999999998754332 1222222222221
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
+ ....+++.+.+++..||..+|.+||++.++
T Consensus 229 ~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 259 (276)
T 2yex_A 229 N---PWKKIDSAPLALLHKILVENPSARITIPDI 259 (276)
T ss_dssp T---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred C---chhhcCHHHHHHHHHHCCCCchhCCCHHHH
Confidence 1 124568899999999999999999998765
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=336.51 Aligned_cols=209 Identities=20% Similarity=0.280 Sum_probs=159.4
Q ss_pred ccCCceEE-ecceeecCceeEEEEEEC--CCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEee--eeCCee
Q 015041 4 IIGVKYKL-GRKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG--VDGEDN 78 (414)
Q Consensus 4 i~~~~y~i-~~~iG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~--~~~~~~ 78 (414)
.+.+.|.+ +++||+|+||+||+|++. .+++.||||++........+.+|+.+++.++| ++|+.+..++ ......
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKH-PNVISLQKVFLSHADRKV 95 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCC-TTBCCCCEEEEETTTTEE
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCC-CCeeeEeeEEecCCCCeE
Confidence 34567888 568999999999999976 57889999999877767788999999999986 4555554444 346788
Q ss_pred EEEEeccCCCHHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccC-CCCCeEEEee
Q 015041 79 VLVLDLLGPSLEDLFVYCR--------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG-RKANQVYIID 149 (414)
Q Consensus 79 ~lv~e~~~~sL~~~~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~-~~~~~vkL~D 149 (414)
++||||++++|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+|||+... +..+.+||+|
T Consensus 96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9999999999998886432 248999999999999999999999999999999999999532 3668999999
Q ss_pred ecceeeecCCCCCccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCh
Q 015041 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLK 217 (414)
Q Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~ 217 (414)
||+|+........ .......+||..|+|||++.+. .++.++|||||||++|+|++|..||.+..
T Consensus 176 fg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 176 MGFARLFNSPLKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp TTCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred CCCceecCCCCcc----cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 9999865432211 1122356899999999999885 49999999999999999999999997643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=320.98 Aligned_cols=250 Identities=18% Similarity=0.306 Sum_probs=198.4
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
-..++|++++.||+|+||.||+|.+..++..||+|++.... ....+.+|+.+++.+.| ++++.+..++......++|
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDH-PYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCC-TTBCCEEEEEECC-CEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCC-CCEeeeeeeeeeCCeEEEE
Confidence 35689999999999999999999999999999999876543 33568899999999965 6677777777777889999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++......++...++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCccccccc
Confidence 9999 778888887767789999999999999999999999999999999999999 578899999999875322111
Q ss_pred CCccccccCCCCCccCcCcccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
. ......||..|+|||++. +..++.++|||||||++|+|++|..||....... .+..+.......
T Consensus 172 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~ 241 (302)
T 2j7t_A 172 Q-------KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VLLKIAKSDPPT 241 (302)
T ss_dssp H-------C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHSCCCC
T ss_pred c-------ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHHHHhccCCcc
Confidence 0 112457899999999984 6678999999999999999999999998765432 222332222111
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
......++.++.+++..||..+|.+||++.++
T Consensus 242 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 273 (302)
T 2j7t_A 242 --LLTPSKWSVEFRDFLKIALDKNPETRPSAAQL 273 (302)
T ss_dssp --CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred --cCCccccCHHHHHHHHHHcccChhhCCCHHHH
Confidence 11224568899999999999999999998765
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=323.60 Aligned_cols=266 Identities=21% Similarity=0.246 Sum_probs=208.4
Q ss_pred cccCCceEEecceeecCceeEEEEEE----CCCCceEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeeEEeeee--
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASH----VDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGVD-- 74 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~l~~~~~~-- 74 (414)
.+..++|++++.||+|+||.||+|++ ..+++.||||++...... ..+.+|+.+++.++| ++++.+..++..
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-DNIVKYKGVCYSAG 115 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCC-TTBCCEEEEECC--
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEEecC
Confidence 45667899999999999999999984 568999999998765432 357899999999976 555555444332
Q ss_pred CCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
....++||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLT 192 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTC
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---cCCCcEEEecCcch
Confidence 34689999999 779999998766679999999999999999999999999999999999999 47889999999999
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhc------------h
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT------------K 221 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~------------~ 221 (414)
+......... .......++..|+|||++.+..++.++|||||||++|+|++|..||....... .
T Consensus 193 ~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 268 (326)
T 2w1i_A 193 KVLPQDKEYY----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268 (326)
T ss_dssp EECCSSCSEE----ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH
T ss_pred hhcccccccc----ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh
Confidence 8765432210 11224467888999999999889999999999999999999999987532110 0
Q ss_pred HHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 222 ~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
...+...+......+. ...+|+++.+++..||..+|.+||++.++.+.|+.+..+
T Consensus 269 ~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 269 VFHLIELLKNNGRLPR---PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhhcCCCCCC---CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1112222222222222 245689999999999999999999999999999887643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=342.23 Aligned_cols=240 Identities=14% Similarity=0.109 Sum_probs=183.7
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-----CchhHHHHHHHHHHHc--CCCCCCeeE-------Ee
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQ--GGSGIPNIK-------WY 71 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~--~~~~i~~l~-------~~ 71 (414)
.++|++.+.||+|+||+||+|++..+|+.||||++.... ....+.+|+.+++.+. .|++|..+. .+
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 578999999999999999999998899999999976332 2245778996666664 334443332 22
Q ss_pred eeeCC-----------------eeEEEEeccCCCHHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhcCeeccc
Q 015041 72 GVDGE-----------------DNVLVLDLLGPSLEDLFVYCRR------KFSLKTVLMLADQMIARIEYVHSRGFLHRD 128 (414)
Q Consensus 72 ~~~~~-----------------~~~lv~e~~~~sL~~~~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~iiHrD 128 (414)
..... ..++||||++++|.+++..... .+++..++.|+.||+.||+|||++||+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 22221 3789999999999999986421 123478889999999999999999999999
Q ss_pred cCCCceEEccCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCC-----------CCCchhhHH
Q 015041 129 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-----------EQSRRDDLE 197 (414)
Q Consensus 129 Lkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~~Diw 197 (414)
|||+|||+ +.++.+||+|||+|+..... .....| ..|+|||++.+. .++.++|||
T Consensus 232 ikp~NIll---~~~~~~kL~DFG~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw 297 (377)
T 3byv_A 232 LRPVDIVL---DQRGGVFLTGFEHLVRDGAR----------VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW 297 (377)
T ss_dssp CCGGGEEE---CTTCCEEECCGGGCEETTCE----------EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred CCHHHEEE---cCCCCEEEEechhheecCCc----------ccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence 99999999 57889999999999853221 124567 999999999988 899999999
Q ss_pred HHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 198 SLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 198 SlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
||||++|||++|+.||.+......... + .. .+..+|+++.+++..||..||.+||++.++.+
T Consensus 298 SlG~il~elltg~~Pf~~~~~~~~~~~---~----~~-----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 298 ALGLVIYWIWCADLPITKDAALGGSEW---I----FR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHHHHHSSCCC------CCSGG---G----GS-----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHHHHHCCCCCcccccccchhh---h----hh-----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999999999986543221111 1 11 12466899999999999999999999998765
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=315.44 Aligned_cols=253 Identities=24% Similarity=0.340 Sum_probs=206.5
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
.+.++|++++.||+|+||.||+|++..+++.||||++... .....+.+|+.+++.+.| +++..+..++......+
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH-PNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccC-CCccEEEEEEeCCCeEE
Confidence 4568999999999999999999999999999999987543 233568899999999965 66777777777888899
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
+|||++ +++|.+.+.. ...++...++.++.||+.||+|||++||+||||||+||+++..+....+||+|||++.....
T Consensus 98 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 999999 7899888765 45799999999999999999999999999999999999996444456899999999875433
Q ss_pred CCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
... .....||..|+|||++.+ .++.++|||||||++|+|++|..||.+.... +....+.......+.+
T Consensus 177 ~~~--------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~ 244 (287)
T 2wei_A 177 NTK--------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKRVETGKYAFDLP 244 (287)
T ss_dssp CSS--------CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCCSG
T ss_pred CCc--------cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCCCCch
Confidence 221 124568999999999876 4899999999999999999999999876543 3333444444433332
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
. ...+++++.+++..||..+|.+||++.++.+
T Consensus 245 ~-~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 245 Q-WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp G-GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred h-hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 2 2466899999999999999999999988866
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=319.32 Aligned_cols=249 Identities=20% Similarity=0.328 Sum_probs=183.6
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCch---hHHHHHH-HHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP---QLLYEAK-VYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~E~~-~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
++|++++.||+|+||.||+|.+..+++.||||++....... ....|.. +++.+ .|+++..+..++......++||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEEE
Confidence 68999999999999999999999999999999987654432 2333443 34444 5577888888888888999999
Q ss_pred eccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 83 e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
||++..+..+.......+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||++........
T Consensus 104 e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~ 180 (318)
T 2dyl_A 104 ELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDDKA 180 (318)
T ss_dssp CCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCCTTC--------
T ss_pred eccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEECCCchhccCCcc
Confidence 9998777777776677899999999999999999999996 99999999999999 5788999999999976543221
Q ss_pred CccccccCCCCCccCcCcccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCc
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p 236 (414)
.....||..|+|||++. +..++.++|||||||++|+|++|..||..... ..+.+..+........
T Consensus 181 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~ 250 (318)
T 2dyl_A 181 --------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLTKVLQEEPPLL 250 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHHHSCCCCC
T ss_pred --------ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHHHHHHhccCCCCC
Confidence 12457899999999994 45689999999999999999999999986432 2233333333322111
Q ss_pred hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 237 ~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.....++.++.+++..||..+|.+||++.++.+
T Consensus 251 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 251 --PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp --CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111346889999999999999999999988765
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=326.17 Aligned_cols=268 Identities=24% Similarity=0.295 Sum_probs=208.2
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHH-cCCCCCCeeEEeeeeCC----e
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL-QGGSGIPNIKWYGVDGE----D 77 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~~~~~i~~l~~~~~~~~----~ 77 (414)
+.+.++|++.+.||+|+||.||+|++ +++.||||++.... ...+.+|.+++..+ ..|+++..+..++.... .
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh-HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 45678999999999999999999998 58899999986543 34577888888874 24566666666655443 7
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hcCeeccccCCCceEEccCCCCCeEEEe
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH--------SRGFLHRDIKPDNFLMGLGRKANQVYII 148 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--------~~~iiHrDLkp~Nili~~~~~~~~vkL~ 148 (414)
.++||||+ +++|.+++.. ..+++..++.++.|++.||+||| ++||+||||||+|||+ +.++.+||+
T Consensus 115 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~ 189 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIA 189 (342)
T ss_dssp EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTSCEEEC
T ss_pred eEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCCCEEEE
Confidence 89999999 6699999874 46899999999999999999999 8999999999999999 578899999
Q ss_pred eecceeeecCCCCCccccccCCCCCccCcCccccccccCCC------CCchhhHHHHHHHHHHHHcC----------CCC
Q 015041 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE------QSRRDDLESLGYVLLYFLRG----------SLP 212 (414)
Q Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~s~~~DiwSlG~il~el~tG----------~~P 212 (414)
|||+++.......... .......||..|+|||++.+.. ++.++|||||||++|||++| ..|
T Consensus 190 Dfg~~~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 190 DLGLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp CCTTCEEEETTTTEEE---ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred ECCCceeccccccccc---cccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 9999987655432110 0123567899999999998763 34789999999999999999 889
Q ss_pred CCCChhh--chHHHHHHHHhhccCCchHH--hhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 015041 213 WQGLKAA--TKKQKYDKICEKKVSTPIEV--LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (414)
Q Consensus 213 f~~~~~~--~~~~~~~~i~~~~~~~p~~~--~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~ 281 (414)
|...... ........+.........+. .....++.+.+++..||..+|++||++.++.+.|+.+..+.+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred ccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 9765322 12222233333333332221 122346789999999999999999999999999999987665
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=321.89 Aligned_cols=251 Identities=20% Similarity=0.204 Sum_probs=182.7
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeee-C------Cee
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVD-G------EDN 78 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~-~------~~~ 78 (414)
++|++.+.||+|+||+||+|++..+++.||||++.... .......|++.+..+.| ++++.+..++.. + ...
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHH-PNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCC-TTBCCEEEEEEEECSSCTTCEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCC-CCcccHHHhhhccccccccceeE
Confidence 68999999999999999999999999999999876543 23456777788888876 455555444332 2 137
Q ss_pred EEEEeccCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHH--hcCeeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 79 VLVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVH--SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 79 ~lv~e~~~~sL~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH--~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
++||||+.++|.+.+.. ....++...++.++.|++.||.||| ++||+||||||+|||++ ..++.+||+|||++
T Consensus 102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGSA 179 (360)
T ss_dssp EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE--TTTTEEEECCCTTC
T ss_pred EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe--CCCCcEEEeeCCCc
Confidence 89999998888776653 2456899999999999999999999 99999999999999995 23789999999999
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (414)
+....... .....||..|+|||++.+.. ++.++|||||||++|+|++|+.||.+........ .+....
T Consensus 180 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~---~~~~~~ 248 (360)
T 3e3p_A 180 KKLSPSEP--------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH---EIVRVL 248 (360)
T ss_dssp BCCCTTSC--------CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHH
T ss_pred eecCCCCC--------cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH---HHHHHc
Confidence 86543322 13567899999999997655 8999999999999999999999999865443333 332222
Q ss_pred cCCchHHh-----------------------h----hcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 233 VSTPIEVL-----------------------C----KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 233 ~~~p~~~~-----------------------~----~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...+.... . ...++++.+|+..||..||.+||++.++.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 22221111 0 114678999999999999999999876643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=317.14 Aligned_cols=250 Identities=18% Similarity=0.285 Sum_probs=199.1
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCC------CCchhHHHHHHHHHHHcCCCCCCeeEEee--eeCC
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG------TKHPQLLYEAKVYKILQGGSGIPNIKWYG--VDGE 76 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~~~~~i~~l~~~~--~~~~ 76 (414)
+.++|++++.||+|+||.||+|.+..+++.||+|++... .....+.+|+.+++.++| +++..+..++ ....
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH-KNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCC-TTBCCEEEEEECC---
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCC-CCeeEEEEEEEcCCCC
Confidence 448999999999999999999999999999999987643 223568899999999976 5565565544 3456
Q ss_pred eeEEEEeccCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 77 DNVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 77 ~~~lv~e~~~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
..++||||+.++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 82 KMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAEA 158 (305)
T ss_dssp CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred eEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeeccccccc
Confidence 78999999988888887754 3569999999999999999999999999999999999999 5788999999999987
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
........ ......||..|+|||++.+.. ++.++|||||||++|+|++|..||.+.... +.+..+.....
T Consensus 159 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~i~~~~~ 230 (305)
T 2wtk_C 159 LHPFAADD-----TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY---KLFENIGKGSY 230 (305)
T ss_dssp CCTTCSSC-----EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHCCC
T ss_pred cCcccccc-----ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---HHHHHHhcCCC
Confidence 64322211 112556899999999998754 478999999999999999999999875432 33333433333
Q ss_pred CCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 234 ~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+ ..+++.+.+++..||..||.+||++.++.+
T Consensus 231 ~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 231 AIP-----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp CCC-----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCC-----CccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 322 456889999999999999999999988765
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=318.85 Aligned_cols=260 Identities=22% Similarity=0.260 Sum_probs=198.3
Q ss_pred cccCCceEEecceeecCceeEEEEEECC-CC--ceEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVD-TN--EIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~-~~--~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 74 (414)
.+..++|++++.||+|+||+||+|++.. ++ ..||||++.... ....+.+|+.+++.+.| ++++.+..+...
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~ 92 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH-RNLIRLYGVVLT 92 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCC-TTBCCEEEEECS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCC-CCcccEEEEEcc
Confidence 3456899999999999999999998643 33 368999876542 12457889999999975 566666555544
Q ss_pred CCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
. ..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 93 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 93 P-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLM 168 (291)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTC
T ss_pred C-CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---cCCCCEEEcccccc
Confidence 4 488999999 789999998766779999999999999999999999999999999999999 47889999999999
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhc
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKK 232 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~ 232 (414)
.......... .......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+.... +.+..+....
T Consensus 169 ~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~~~ 241 (291)
T 1u46_A 169 RALPQNDDHY----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHKIDKEG 241 (291)
T ss_dssp EECCC-CCEE----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTSC
T ss_pred ccccccccch----hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HHHHHHHccC
Confidence 8764432211 11234567889999999999889999999999999999999 99999876543 3333343333
Q ss_pred cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 015041 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (414)
Q Consensus 233 ~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~ 277 (414)
...+. ...+|+++.+++..||..+|.+||++.++.+.|+++.
T Consensus 242 ~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 242 ERLPR---PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCC---CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 33332 2456899999999999999999999999999888664
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=313.72 Aligned_cols=250 Identities=10% Similarity=0.120 Sum_probs=201.5
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeC--Ce
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDG--ED 77 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~--~~ 77 (414)
+.-++|++.+.||+|+||+||+|++ ++..||||++...... ..+.+|+.+++.++| +++..+..++... ..
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH-PNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSC-TTEECEEEEECTTTSSS
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCC-CchhheEEEEccCCCCC
Confidence 4558999999999999999999998 4888999998765432 347788888888865 5666666655544 67
Q ss_pred eEEEEecc-CCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcC--eeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
.++||||+ +++|.+++..... .+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.++|+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVK 160 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSC
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEeccce
Confidence 89999999 6799999875433 4899999999999999999999999 9999999999999 57889999998886
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccCCCCCc---hhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHh
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSR---RDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~ 230 (414)
..... ....||..|+|||++.+..++. ++|||||||++|||++|+.||.+..... ....+..
T Consensus 161 ~~~~~------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~ 225 (271)
T 3kmu_A 161 FSFQS------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME---IGMKVAL 225 (271)
T ss_dssp CTTSC------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH---HHHHHHH
T ss_pred eeecc------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH---HHHHHHh
Confidence 53211 2457899999999998876544 8999999999999999999998765432 2233333
Q ss_pred hccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 015041 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (414)
Q Consensus 231 ~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~ 277 (414)
....... ...+++++.+++..||..+|.+||++.++.+.|+.+.
T Consensus 226 ~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 226 EGLRPTI---PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp SCCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cCCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 3333222 2456899999999999999999999999999988763
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=349.24 Aligned_cols=254 Identities=22% Similarity=0.336 Sum_probs=199.3
Q ss_pred ceEEe-cceeecCceeEEEEEE--CCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 8 KYKLG-RKIGSGSFGEIFLASH--VDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 8 ~y~i~-~~iG~G~~g~V~~~~~--~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
.+.+. ++||+|+||+||+|.+ ..+++.||||+++.... ...+.+|+.+++.++| ++|+.+..++. ....++
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~-~~~~~l 446 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIVRMIGICE-AESWML 446 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCC-TTBCCEEEEEE-SSSEEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEe-cCCEEE
Confidence 34443 4899999999999965 35678999999875432 2468899999999986 56666666554 456889
Q ss_pred EEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 81 v~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
||||+ +++|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.....
T Consensus 447 v~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl---~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp EEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCTTHHHHTTC-
T ss_pred EEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE---eCCCCEEEEEcCCccccccC
Confidence 99999 7899998865 5679999999999999999999999999999999999999 47889999999999865433
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
... +.......+|..|+|||++.+..++.++|||||||++|||++ |+.||.+.......+ . +......+.+
T Consensus 523 ~~~----~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~---~-i~~~~~~~~p 594 (635)
T 4fl3_A 523 ENY----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA---M-LEKGERMGCP 594 (635)
T ss_dssp ----------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---H-HHTTCCCCCC
T ss_pred ccc----cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---H-HHcCCCCCCC
Confidence 211 111224456889999999999999999999999999999998 999999876543222 2 2222222222
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
..+|+++.+++..||..+|++||++.+|.+.|++++.
T Consensus 595 ---~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 595 ---AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp ---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 4568999999999999999999999999999998875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=313.33 Aligned_cols=248 Identities=22% Similarity=0.255 Sum_probs=195.8
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeee----eCC
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV----DGE 76 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~----~~~ 76 (414)
-+..|++.+.||+|+||.||+|.+..++..||+|++..... ...+.+|+.+++.++| ++++.+..++. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEEESSSCE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCC-CCeeeeeeeeccccCCCc
Confidence 45679999999999999999999999999999998765432 2347889999999976 45555544333 245
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
..++||||+ +++|.+++.. ...++...++.++.||+.||.|||+++ |+||||||+|||++ ...+.+||+|||++
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGG
T ss_pred eEEEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCc
Confidence 689999999 7799999876 356899999999999999999999999 99999999999994 36789999999998
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
....... .....||..|+|||++.+ .++.++|||||||++|+|++|..||.+.... ...+..+... .
T Consensus 180 ~~~~~~~---------~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~-~ 246 (290)
T 1t4h_A 180 TLKRASF---------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVTSG-V 246 (290)
T ss_dssp GGCCTTS---------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHTTT-C
T ss_pred ccccccc---------cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH--HHHHHHHhcc-C
Confidence 6433221 124578999999998874 5999999999999999999999999874332 2222222222 1
Q ss_pred CCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 234 ~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
. ........++++.+++..||..+|.+||++.++.+
T Consensus 247 ~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 247 K--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp C--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C--ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1 12233455789999999999999999999887643
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=328.92 Aligned_cols=261 Identities=16% Similarity=0.221 Sum_probs=201.9
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
+..++|++.+.||+|+||.||+|.+ .+++.||||++.... ....+.+|+.+++.+.| ++++.+..++......++
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~l 104 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTERLL 104 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCC-TTBCCCCEEECCSSCCEE
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccC-CCccceEEEEecCCceEE
Confidence 5678999999999999999999985 468899999887643 23368899999998875 667777777777888899
Q ss_pred EEecc-CCCHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhc---CeeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 81 VLDLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSR---GFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 81 v~e~~-~~sL~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
||||+ +++|.+++.... ..+++..++.++.|++.||+|||++ ||+||||||+|||+ +.++.+||+|||++
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~~ 181 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLA 181 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCEEECCCSSC
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCEEeccCccc
Confidence 99999 779999887532 3489999999999999999999999 99999999999999 57889999999999
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhh-----chHHHHHHH
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA-----TKKQKYDKI 228 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~-----~~~~~~~~i 228 (414)
+........ ......||..|+|||++.+..++.++|||||||++|+|++|..||...... .........
T Consensus 182 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 182 KLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp EECCSSSSC------EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cccCccccc------ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 876433221 123456899999999999889999999999999999999999999632111 111111100
Q ss_pred Hhhc-cCC-----chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 015041 229 CEKK-VST-----PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (414)
Q Consensus 229 ~~~~-~~~-----p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~ 275 (414)
.... ... .........+..+.+++..||..+|.+||++.++.+.|+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 0000 000 0001112235789999999999999999999999888874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=322.48 Aligned_cols=264 Identities=19% Similarity=0.254 Sum_probs=198.4
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeee----eCCe
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGV----DGED 77 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~----~~~~ 77 (414)
+.+++|++++.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.| ++++.+..++. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNH-PNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCC-TTBCCCCEEEEEEETTEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCC-CCeeeEEEEEEeccCCCce
Confidence 45679999999999999999999999999999999875433 23457889999999976 45555544333 2346
Q ss_pred eEEEEecc-CCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 78 NVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
.++||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecCcc
Confidence 78999999 66999988763 4569999999999999999999999999999999999999 57889999999998
Q ss_pred eeecCCCCCcc--ccccCCCCCccCcCccccccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHH
Q 015041 154 KKYRDPTTNRH--IPYRENKNLTGTARYASCNTHLGIE---QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228 (414)
Q Consensus 154 ~~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i 228 (414)
........... ..........||..|+|||++.+.. ++.++|||||||++|+|++|..||........ .....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~ 259 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--SVALA 259 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--CHHHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc--hhhHH
Confidence 75432111000 0000011345789999999998654 68999999999999999999999965322111 11111
Q ss_pred HhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 229 ~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
.......+. ...++.++.+++..||..+|.+||++.++.+.|+.+
T Consensus 260 ~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 260 VQNQLSIPQ---SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp HHCC--CCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred hhccCCCCc---cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 222222222 135688999999999999999999999999988754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=323.29 Aligned_cols=247 Identities=22% Similarity=0.300 Sum_probs=192.2
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCC----
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGE---- 76 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~---- 76 (414)
+.++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+.+|+.+++.++| +++..+..++....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH-ENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCC-TTBCCCSEEECSCSSGGG
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCC-CCcccHhheEeccccccc
Confidence 458999999999999999999999999999999998765432 346789999999986 45555544443332
Q ss_pred --eeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 77 --DNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 77 --~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
..++||||+.++|.+++ ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 101 ~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 101 FYDFYLVMPFMQTDLQKIM---GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLAR 174 (353)
T ss_dssp CCCCEEEEECCSEEGGGTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEECSTTCTT
T ss_pred ceeEEEEeccccCCHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEeeccccc
Confidence 35999999998887765 3469999999999999999999999999999999999999 578899999999987
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
...... ....||..|+|||++.+ ..++.++|||||||++|+|++|..||.+........ .+.....
T Consensus 175 ~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~---~i~~~~~ 241 (353)
T 3coi_A 175 HADAEM----------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT---QILKVTG 241 (353)
T ss_dssp C------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHH---HHHHHHC
T ss_pred CCCCCc----------cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhC
Confidence 543221 24578999999999987 678999999999999999999999998765433222 2222111
Q ss_pred CC--------------------------chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 234 ST--------------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 234 ~~--------------------------p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.. .........++++.+++..||..||.+||++.++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp BCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11 111222356789999999999999999999876643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=313.85 Aligned_cols=256 Identities=24% Similarity=0.300 Sum_probs=199.9
Q ss_pred eEEecceeecCceeEEEEEECCCCceEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
|..+++||+|+||.||+|.+ ++..||||++.... ....+.+|+.+++.++| ++++.+..++......++||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH-ENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC-CCeEEEEEEEecCCceEEEE
Confidence 34458999999999999986 67899999876532 12457899999999975 67777777777788899999
Q ss_pred ecc-CCCHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 83 DLL-GPSLEDLFVYC--RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 83 e~~-~~sL~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+||++ +.++.+||+|||+++.....
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKF 186 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeecccccccccc
Confidence 999 88999988743 3458999999999999999999999999999999999999 57889999999999865443
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCC----
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST---- 235 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~---- 235 (414)
.... ......||..|+|||++.+ .++.++|||||||++|+|++|..||.+.........+..........
T Consensus 187 ~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (307)
T 2nru_A 187 AQTV-----MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY 260 (307)
T ss_dssp SSCE-----ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH
T ss_pred cccc-----cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh
Confidence 2211 1234678999999998875 58999999999999999999999998755433222222211111100
Q ss_pred ---chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 236 ---PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 236 ---p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
.........++.+.+++..||..+|.+||++.++.+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 261 IDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp SCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 00011123367899999999999999999999999998876
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=314.40 Aligned_cols=248 Identities=22% Similarity=0.263 Sum_probs=198.0
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEee--eeCCeeE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYG--VDGEDNV 79 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~--~~~~~~~ 79 (414)
.++|++++.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.++| +++..+..++ ......+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH-PNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCC-CCCCeEEEEEecCCCceEE
Confidence 37999999999999999999999999999999998765432 347889999999976 5565665443 3456789
Q ss_pred EEEecc-CCCHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhcC-----eeccccCCCceEEccCCCCCeEEEeee
Q 015041 80 LVLDLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRG-----FLHRDIKPDNFLMGLGRKANQVYIIDF 150 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~-----iiHrDLkp~Nili~~~~~~~~vkL~DF 150 (414)
+||||+ +++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~df 160 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDF 160 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEEECCC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEecC
Confidence 999999 679999987532 34899999999999999999999999 9999999999999 57889999999
Q ss_pred cceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHh
Q 015041 151 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (414)
Q Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~ 230 (414)
|+++....... ......||..|+|||++.+..++.++|||||||++|+|++|..||...... +....+..
T Consensus 161 g~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~i~~ 230 (279)
T 2w5a_A 161 GLARILNHDTS-------FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKIRE 230 (279)
T ss_dssp CHHHHC---CH-------HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH
T ss_pred chheeeccccc-------cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHHHHHhh
Confidence 99875433211 012346899999999999999999999999999999999999999876543 22333333
Q ss_pred hccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 231 ~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.... + ....+++++.+++..||..+|.+||++.++.+
T Consensus 231 ~~~~-~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 267 (279)
T 2w5a_A 231 GKFR-R---IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267 (279)
T ss_dssp TCCC-C---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cccc-c---CCcccCHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 3221 1 12456899999999999999999999987755
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=321.69 Aligned_cols=255 Identities=19% Similarity=0.290 Sum_probs=180.6
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
+..++|++++.||+|+||.||+|.+..+++.||||++...... ..+..|+..+....+|+++..+..++......++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 4568999999999999999999999999999999998765433 2345555534333456788888888888889999
Q ss_pred EEeccCCCHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhc-CeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 81 VLDLLGPSLEDLFVYC----RRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 81 v~e~~~~sL~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
||||+.++|.+++... ...++...+..++.|++.||.|||+. ||+||||||+|||+ +.++.+||+|||+++.
T Consensus 99 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 99 CMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDFGISGQ 175 (327)
T ss_dssp EECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE---ETTTEEEECCCSSSCC
T ss_pred EEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE---cCCCCEEEccCCCcee
Confidence 9999998998888742 46789999999999999999999998 99999999999999 4888999999999976
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccc----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhh
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTH----LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~ 231 (414)
...... .....||..|+|||++ .+..++.++|||||||++|+|++|..||.+.... .+.+..+...
T Consensus 176 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~ 245 (327)
T 3aln_A 176 LVDSIA--------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--FDQLTQVVKG 245 (327)
T ss_dssp --------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCCS
T ss_pred cccccc--------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--HHHHHHHhcC
Confidence 543221 1234789999999998 4567899999999999999999999999864321 1111111111
Q ss_pred ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 232 ~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
............+++.+.+++..||..+|.+||++.++.+
T Consensus 246 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 1111111122356889999999999999999999988765
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=322.62 Aligned_cols=267 Identities=17% Similarity=0.226 Sum_probs=191.3
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHH--HHcCCCCCCeeEEee-----eeCC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYK--ILQGGSGIPNIKWYG-----VDGE 76 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~--~l~~~~~i~~l~~~~-----~~~~ 76 (414)
+--++|++++.||+|+||.||+|++ +++.||||++..... ..+..|.+++. .+.| +++..+...+ ....
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~e~~~~~~~~~~h-~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR-QNFINEKNIYRVPLMEH-DNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH-HHHHHHHHHHTSTTCCC-TTBCCEEEEEEEECTTSCE
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch-hhHHHHHHHHHHHhccC-cchhhheecccccccCCCc
Confidence 4568999999999999999999987 688999999865432 33444544433 3444 5555554322 1233
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---------CeeccccCCCceEEccCCCCCeEE
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR---------GFLHRDIKPDNFLMGLGRKANQVY 146 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---------~iiHrDLkp~Nili~~~~~~~~vk 146 (414)
..++||||+ +++|.+++.. ...++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+|
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~k 160 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCV 160 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSCEE
T ss_pred eEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---cCCCcEE
Confidence 568999999 8899999874 4468999999999999999999999 99999999999999 5788999
Q ss_pred EeeecceeeecCCCCCcc-ccccCCCCCccCcCccccccccC-------CCCCchhhHHHHHHHHHHHHcCCCCCCCChh
Q 015041 147 IIDFGLAKKYRDPTTNRH-IPYRENKNLTGTARYASCNTHLG-------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218 (414)
Q Consensus 147 L~DFG~a~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~ 218 (414)
|+|||+++.......... ..........||..|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987654322110 00112235579999999999987 4567899999999999999999776643211
Q ss_pred hc--------------hHHHHHHHH-hhccCCchHHhh---hcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 219 AT--------------KKQKYDKIC-EKKVSTPIEVLC---KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 219 ~~--------------~~~~~~~i~-~~~~~~p~~~~~---~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
.. ......... ........+..+ ...++++.+++..||..+|.+||++.++.+.|+.++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 10 011111111 111111111111 11356899999999999999999999999999998753
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=315.59 Aligned_cols=243 Identities=23% Similarity=0.330 Sum_probs=192.3
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--------chhHHHHHHHHHHHc---CCCCCCeeEEe
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------HPQLLYEAKVYKILQ---GGSGIPNIKWY 71 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~---~~~~i~~l~~~ 71 (414)
+.+.++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+.++..+. .|+++..+..+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 5678899999999999999999999999999999999865432 234567999999984 45777777777
Q ss_pred eeeCCeeEEEEec-c-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEee
Q 015041 72 GVDGEDNVLVLDL-L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149 (414)
Q Consensus 72 ~~~~~~~~lv~e~-~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~D 149 (414)
+......++|||+ + +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||+++ ..++.+||+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~d 183 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID--LRRGCAKLID 183 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--TTTTEEEECC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--CCCCeEEEEE
Confidence 7777888999998 4 7899998876 45699999999999999999999999999999999999994 2678999999
Q ss_pred ecceeeecCCCCCccccccCCCCCccCcCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHH
Q 015041 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228 (414)
Q Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i 228 (414)
||+++....... ....||..|+|||++.+..+ +.++|||||||++|+|++|+.||.... .+
T Consensus 184 fg~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------~~ 245 (312)
T 2iwi_A 184 FGSGALLHDEPY---------TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------EI 245 (312)
T ss_dssp CSSCEECCSSCB---------CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HH
T ss_pred cchhhhcccCcc---------cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---------HH
Confidence 999987654321 25578999999999987765 458999999999999999999998632 12
Q ss_pred HhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 229 ~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.......+ ..++.++.+++..||..+|++||++.++.+
T Consensus 246 ~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 246 LEAELHFP-----AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHTCCCCC-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hhhccCCc-----ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 23333322 456789999999999999999999987754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=343.23 Aligned_cols=260 Identities=22% Similarity=0.311 Sum_probs=206.8
Q ss_pred cccCCceEEecceeecCceeEEEEEECCC---CceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
++..++|++++.||+|+||.||+|.+..+ +..||||........ ..+.+|+.+++.+.| ++|+.+..++. ..
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-PHIVKLIGVIT-EN 463 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEC-SS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEe-cC
Confidence 35567899999999999999999998643 457999987754432 457889999999976 55666655553 45
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
..++||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl---~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRY 540 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCCCCCS
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE---eCCCCEEEEecCCCee
Confidence 689999999 789999998766679999999999999999999999999999999999999 4788999999999986
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccC
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
....... ......+|..|+|||++.+..++.++|||||||++|||++ |..||.+..... .+..+... ..
T Consensus 541 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~~i~~~-~~ 610 (656)
T 2j0j_A 541 MEDSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIENG-ER 610 (656)
T ss_dssp CCC----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHHT-CC
T ss_pred cCCCcce------eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHcC-CC
Confidence 5433211 1124456789999999999999999999999999999997 999999865433 23333222 22
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
.+. ...+|+.+.+++..||..+|.+||++.++.+.|+.++..+
T Consensus 611 ~~~---~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 611 LPM---PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCC---CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 222 2456899999999999999999999999999999887654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=319.09 Aligned_cols=260 Identities=22% Similarity=0.249 Sum_probs=184.5
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
.+..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.| ++++.+..++......+
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH-PNIVSYYTSFVVKDELW 89 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCC-TTBCCEEEEEESSSCEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCC-CCEeeEEEEEeecCCcE
Confidence 356789999999999999999999998899999999876532 23457788888888865 66777777777788899
Q ss_pred EEEecc-CCCHHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeec
Q 015041 80 LVLDLL-GPSLEDLFVYC-------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG 151 (414)
+||||+ +++|.+++... ...++...++.++.||+.||+|||++||+||||||+||++ +.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEEEEecc
Confidence 999999 88999988752 3458999999999999999999999999999999999999 578899999999
Q ss_pred ceeeecCCCCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHh
Q 015041 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (414)
Q Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~ 230 (414)
++.......... .........||..|+|||++.+ ..++.++|||||||++|+|++|..||.+....... .....
T Consensus 167 ~~~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~ 241 (303)
T 2vwi_A 167 VSAFLATGGDIT--RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---MLTLQ 241 (303)
T ss_dssp HHHHCC-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---HHHHT
T ss_pred chheeccCCCcc--chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH---HHHhc
Confidence 987543321100 0111235678999999999876 46899999999999999999999999876543222 22222
Q ss_pred hccCCc-----hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 231 KKVSTP-----IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 231 ~~~~~p-----~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...... .......++.++.+++..||..+|.+||++.++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 211111 11223456889999999999999999999887654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=310.29 Aligned_cols=244 Identities=22% Similarity=0.250 Sum_probs=192.9
Q ss_pred cceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-CCCH
Q 015041 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSL 89 (414)
Q Consensus 13 ~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~~sL 89 (414)
..||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+.| ++++.+..++......++||||+ +++|
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH-KNIVQYLGSFSENGFIKIFMEQVPGGSL 106 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCC-TTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCC-CCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence 389999999999999999999999998876432 3558899999999975 66777777777888999999999 7899
Q ss_pred HHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccccc
Q 015041 90 EDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167 (414)
Q Consensus 90 ~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 167 (414)
.+++..... .++...++.++.||+.||+|||++||+|+||||+||+++ ..++.+||+|||+++.......
T Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~------ 178 (295)
T 2clq_A 107 SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRLAGINP------ 178 (295)
T ss_dssp HHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTCCEEECCTTTCEESCC---------
T ss_pred HHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEE--CCCCCEEEeecccccccCCCCC------
Confidence 999886533 467889999999999999999999999999999999995 2378999999999986543221
Q ss_pred cCCCCCccCcCccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcCh
Q 015041 168 RENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (414)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~--~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p 245 (414)
......||..|+|||++.+.. ++.++|||||||++|+|++|..||........ ............. ....++
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~---~~~~~~ 252 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--AMFKVGMFKVHPE---IPESMS 252 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH--HHHHHHHHCCCCC---CCTTSC
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH--HHHhhcccccccc---ccccCC
Confidence 113567899999999997654 89999999999999999999999976432211 1111111121111 224568
Q ss_pred HHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 246 AEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 246 ~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+++.+++..||..+|++||++.++.+
T Consensus 253 ~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 253 AEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 89999999999999999999887643
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=320.71 Aligned_cols=263 Identities=17% Similarity=0.244 Sum_probs=199.1
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
++..++|++++.||+|+||.||+|.+.. .||+|++.... ....+.+|+.+++.++| +++..+..++......
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRH-ENVVLFMGACMSPPHL 104 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCC-TTBCCCCEEEECSSCE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCC-CCEeEEEEEEecCCce
Confidence 4567899999999999999999999853 49999876542 22446789999998876 5666676777777889
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
++||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +++.+||+|||+++...
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~----~~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY----DNGKVVITDFGLFSISG 180 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEE----C--CCEECCCSCCC---
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEE----eCCCEEEeecCCccccc
Confidence 9999999 789999887655579999999999999999999999999999999999999 35789999999987543
Q ss_pred CCCCCccccccCCCCCccCcCccccccccC---------CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHH
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLG---------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i 228 (414)
...... .........||..|+|||++.+ ..++.++|||||||++|||++|..||.+.... .....+
T Consensus 181 ~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~ 255 (319)
T 2y4i_B 181 VLQAGR--REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AIIWQM 255 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---HHHHHH
T ss_pred cccccc--cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHh
Confidence 221110 0112234568999999999875 35789999999999999999999999875443 222233
Q ss_pred HhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 015041 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (414)
Q Consensus 229 ~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~ 281 (414)
........ ....+|.++.+++..||..+|.+||++.++.+.|+.+..+..
T Consensus 256 ~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 256 GTGMKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp HTTCCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred ccCCCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 22222111 113467899999999999999999999999999887765543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=309.50 Aligned_cols=257 Identities=19% Similarity=0.228 Sum_probs=190.6
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeee----------
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGV---------- 73 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~---------- 73 (414)
+.++|++++.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.+.| +++..+..++.
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNH-QYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCc-hHHHHHHHHHHhhcchhhhhc
Confidence 3478999999999999999999999999999999886432 22457889999999976 45555544332
Q ss_pred ---eCCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEee
Q 015041 74 ---DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149 (414)
Q Consensus 74 ---~~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~D 149 (414)
.....++||||+ +++|.+++......++...++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCEEEee
Confidence 245679999999 779999998766678899999999999999999999999999999999999 5788999999
Q ss_pred ecceeeecCCCCCcc-------ccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhch
Q 015041 150 FGLAKKYRDPTTNRH-------IPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK 221 (414)
Q Consensus 150 FG~a~~~~~~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~ 221 (414)
||++........... ..........||..|+|||++.+. .++.++|||||||++|+|++ ||.... ..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~~ 234 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--ER 234 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--HH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--hH
Confidence 999976542211000 001112356789999999999865 68999999999999999998 665422 12
Q ss_pred HHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 222 ~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
......+.......+ +......++.+.+++..||..||.+||++.++.+
T Consensus 235 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 VNILKKLRSVSIEFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHHSTTCCCC-TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccccccccC-ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 223333333333322 2233456788999999999999999999887644
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=318.53 Aligned_cols=253 Identities=16% Similarity=0.231 Sum_probs=201.9
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc-------------------hhHHHHHHHHHHHcCC
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-------------------PQLLYEAKVYKILQGG 62 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------------------~~~~~E~~~l~~l~~~ 62 (414)
+++..++|++++.||+|+||.||+|.+ +++.||||++...... ..+.+|+.+++.++|
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h- 102 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN- 102 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC-
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC-
Confidence 345668999999999999999999998 8999999987543110 678899999999975
Q ss_pred CCCCeeEEeeeeCCeeEEEEecc-CCCHHHH------HHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-cCeeccccCCCc
Q 015041 63 SGIPNIKWYGVDGEDNVLVLDLL-GPSLEDL------FVYC-RRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDN 133 (414)
Q Consensus 63 ~~i~~l~~~~~~~~~~~lv~e~~-~~sL~~~------~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDLkp~N 133 (414)
++++.+..++......++||||+ +++|.++ +... ...+++..++.++.||+.||.|||+ +||+||||||+|
T Consensus 103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 66777777777788999999999 5688887 4322 4568999999999999999999999 999999999999
Q ss_pred eEEccCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCC-CCCc-hhhHHHHHHHHHHHHcCCC
Q 015041 134 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSR-RDDLESLGYVLLYFLRGSL 211 (414)
Q Consensus 134 ili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~~DiwSlG~il~el~tG~~ 211 (414)
||+ +.++.+||+|||++....... .....||..|+|||++.+. .++. ++|||||||++|+|++|..
T Consensus 183 il~---~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 250 (348)
T 2pml_X 183 ILM---DKNGRVKLSDFGESEYMVDKK---------IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250 (348)
T ss_dssp EEE---CTTSCEEECCCTTCEECBTTE---------ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSC
T ss_pred EEE---cCCCcEEEecccccccccccc---------ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCC
Confidence 999 588899999999998754431 1356789999999999987 5666 9999999999999999999
Q ss_pred CCCCChhhchHHHHHHHHhhccCCchH--------------HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 212 PWQGLKAATKKQKYDKICEKKVSTPIE--------------VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 212 Pf~~~~~~~~~~~~~~i~~~~~~~p~~--------------~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
||.+.... .+....+.......+.. .....++.++.+++..||..+|.+||++.++.+
T Consensus 251 pf~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 251 PFSLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SSCCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 99875431 23334444433333311 111456889999999999999999999887644
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=323.30 Aligned_cols=260 Identities=21% Similarity=0.189 Sum_probs=192.7
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++.+++.|.+.+.||+|+||+||.+. ..+|+.||||++.... ...+.+|+.++..+.+|++|+.+..++......++|
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~-~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF-CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG-HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH-HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 56778899999999999999998754 4579999999876543 245788999999886678888888888888899999
Q ss_pred EeccCCCHHHHHHHhCCC------CCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccC----------CCCCeE
Q 015041 82 LDLLGPSLEDLFVYCRRK------FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG----------RKANQV 145 (414)
Q Consensus 82 ~e~~~~sL~~~~~~~~~~------~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~----------~~~~~v 145 (414)
|||++++|.+++...... .+...++.++.||+.||+|||++||+||||||+|||++.. +....+
T Consensus 88 ~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 88 LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp ECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred EecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 999998999998743211 1233457899999999999999999999999999999522 235689
Q ss_pred EEeeecceeeecCCCCCccccccCCCCCccCcCccccccccC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCh
Q 015041 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-------IEQSRRDDLESLGYVLLYFLR-GSLPWQGLK 217 (414)
Q Consensus 146 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~ 217 (414)
||+|||+++.......... .......||..|+|||++.+ ..++.++|||||||++|||++ |..||.+..
T Consensus 168 kL~DFG~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFR---TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp EECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred EEcccccceecCCCCccce---eeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 9999999987654321100 01234579999999999976 568999999999999999999 999997643
Q ss_pred hhchHHHHHHHHhhccCCch--HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 218 AATKKQKYDKICEKKVSTPI--EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~p~--~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
... ..+.......+. ......+++++.+++..||..+|.+||++.++.+
T Consensus 245 ~~~-----~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 245 SRE-----SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp THH-----HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhH-----HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 221 122222222211 1111234678999999999999999999988754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=327.71 Aligned_cols=239 Identities=15% Similarity=0.127 Sum_probs=185.3
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCC----------------
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGI---------------- 65 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i---------------- 65 (414)
..|++.+.||+|+||+||+|++..+|+.||||++..... ...+.+|+.+++.+.|..+.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 358899999999999999999999999999999874322 34578899888887653211
Q ss_pred -----CeeEEeee-----eCCeeEEEEeccCCCHHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhcCeecccc
Q 015041 66 -----PNIKWYGV-----DGEDNVLVLDLLGPSLEDLFVYC------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129 (414)
Q Consensus 66 -----~~l~~~~~-----~~~~~~lv~e~~~~sL~~~~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDL 129 (414)
+.+..+.. .....+++|++++++|.+++... ...+++..++.++.||+.||+|||++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 11101111 12346889999999999998643 234678889999999999999999999999999
Q ss_pred CCCceEEccCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccc----------cCCCCCchhhHHHH
Q 015041 130 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH----------LGIEQSRRDDLESL 199 (414)
Q Consensus 130 kp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~~DiwSl 199 (414)
||+|||+ +.++.+||+|||+++..... ....+| ..|+|||++ .+..++.++|||||
T Consensus 238 Kp~NILl---~~~~~~kL~DFG~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 238 RPVDIVL---DQRGGVFLTGFEHLVRDGAS----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp CGGGEEE---CTTCCEEECCGGGCEETTEE----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred ccceEEE---ecCCeEEEEeccceeecCCc----------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 9999999 57888999999998764332 125577 999999999 55568999999999
Q ss_pred HHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 200 GYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 200 G~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
||++|||++|+.||.+........ .+.. .+..+|+++.+++..||..+|++||++.++.+
T Consensus 304 Gvil~elltg~~Pf~~~~~~~~~~---~~~~---------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALGGSE---WIFR---------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGSCSG---GGGS---------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHCCCCCCCcchhhhHH---HHHh---------hcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999999998754332111 1111 12356889999999999999999999877654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=325.32 Aligned_cols=254 Identities=18% Similarity=0.182 Sum_probs=189.8
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEeccC
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLG 86 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~~ 86 (414)
.+|.+.+.||+|+||+||.. ...+++.||||++.... ...+.+|+.+++.+..|++|+.+..++.+....++||||++
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~-~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPEC-FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTT-EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHH-HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 46999999999999997643 34678999999886543 23467899999999667888888888888889999999999
Q ss_pred CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCC--CCCeEEEeeecceeeecCCCCCcc
Q 015041 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR--KANQVYIIDFGLAKKYRDPTTNRH 164 (414)
Q Consensus 87 ~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~--~~~~vkL~DFG~a~~~~~~~~~~~ 164 (414)
++|.+++......+....++.++.||+.||+|||++||+||||||+|||++..+ ....+||+|||+|+........
T Consensus 102 g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~-- 179 (432)
T 3p23_A 102 ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS-- 179 (432)
T ss_dssp EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--------
T ss_pred CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc--
Confidence 999999886555566667789999999999999999999999999999995322 2346889999999865433211
Q ss_pred ccccCCCCCccCcCcccccccc---CCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 165 IPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
+......+||..|+|||++. +..++.++|||||||++|||++ |..||...... ....+.. .........
T Consensus 180 --~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~----~~~~~~~-~~~~~~~~~ 252 (432)
T 3p23_A 180 --FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR----QANILLG-ACSLDCLHP 252 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH----HHHHHTT-CCCCTTSCT
T ss_pred --eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH----HHHHHhc-cCCccccCc
Confidence 11223567999999999998 4567889999999999999999 99999653321 1111111 111111111
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
....+..+.+++..||..||.+||++.++.+
T Consensus 253 ~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 253 EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1222566899999999999999999988764
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=303.58 Aligned_cols=234 Identities=12% Similarity=0.076 Sum_probs=189.4
Q ss_pred Cc-ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015041 2 ER-IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (414)
Q Consensus 2 ~~-i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 75 (414)
|+ +++++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.++..+.| ++++.+..++...
T Consensus 25 g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~ 103 (286)
T 3uqc_A 25 GARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK-PGVARVLDVVHTR 103 (286)
T ss_dssp TCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEEET
T ss_pred CCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCC-CCcceeeEEEEEC
Confidence 55 8899999999999999999999999999999999998866432 457889999988865 6677888888888
Q ss_pred CeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
...++||||+ +++|.+++. ......++..|+.||+.||+|||++||+||||||+|||++ .++.+||+++|
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~---~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~---~~g~~kl~~~~--- 174 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVAD---TSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS---IDGDVVLAYPA--- 174 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHT---TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---TTSCEEECSCC---
T ss_pred CcEEEEEEecCCCCHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc---CCCCEEEEecc---
Confidence 8999999999 689998874 2356678899999999999999999999999999999994 78889988543
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
|++ .++.++|||||||++|||++|+.||.+...........+... ...
T Consensus 175 ------------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~ 222 (286)
T 3uqc_A 175 ------------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA-GQP 222 (286)
T ss_dssp ------------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTT-SCB
T ss_pred ------------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhc-cCC
Confidence 222 368899999999999999999999987654321100001111 112
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
.+.......+|+++.+++.+||..||.+| ++.++.+.|+.+..
T Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 223 IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 23344556789999999999999999999 99999999887653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=302.80 Aligned_cols=236 Identities=21% Similarity=0.236 Sum_probs=182.1
Q ss_pred CcccCCceEEe-cceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeee----CC
Q 015041 2 ERIIGVKYKLG-RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD----GE 76 (414)
Q Consensus 2 ~~i~~~~y~i~-~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~----~~ 76 (414)
+.++ ++|.+. +.||+|+||.||+|.+..+++.||||++.. ...+.+|+.++..+.+|++++.+..++.. ..
T Consensus 13 ~~~~-~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 13 NAII-DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp SCGG-GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccc-cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc---cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 3455 456665 889999999999999999999999999864 34678899998777777888877666554 56
Q ss_pred eeEEEEecc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++..+.++.+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 789999999 679999998643 369999999999999999999999999999999999999633337899999999986
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHH-HHHHhhcc
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY-DKICEKKV 233 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~-~~i~~~~~ 233 (414)
... +..++.++|||||||++|||++|..||.+.......... ..+.....
T Consensus 169 ~~~-----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 219 (299)
T 3m2w_A 169 ETT-----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 219 (299)
T ss_dssp ECT-----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCC
T ss_pred ccc-----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccc
Confidence 432 134677999999999999999999999865432111000 01111122
Q ss_pred CCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 234 ~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+ ......+++++.+++..||..+|.+||++.++.+
T Consensus 220 ~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 220 EFP-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SSC-HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCC-chhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 222 2223467899999999999999999999987755
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=332.54 Aligned_cols=242 Identities=17% Similarity=0.212 Sum_probs=190.2
Q ss_pred CcccCCceEEecceeecCceeEEEEEECC-CCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
|+++.++|+++++||+|+||+||+|.+.. +++.||||++...... ..+.+|+.++..++| ++|+.+..++.....
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~ 153 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVH-PSIVQIFNFVEHTDR 153 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCC-TTBCCEEEEEEEECT
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCC-CCcCeEeeeEeecCC
Confidence 57888999999999999999999999975 7899999988654332 346789999999876 566666665554433
Q ss_pred -----eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeec
Q 015041 78 -----NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (414)
Q Consensus 78 -----~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG 151 (414)
.++||||+ +++|.+++. ..+++..++.|+.||+.||+|||++|||||||||+|||++ . +.+||+|||
T Consensus 154 ~~~~~~~lv~E~~~g~~L~~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~---~-~~~kl~DFG 226 (681)
T 2pzi_A 154 HGDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT---E-EQLKLIDLG 226 (681)
T ss_dssp TSCEEEEEEEECCCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---S-SCEEECCCT
T ss_pred CCCceeEEEEEeCCCCcHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe---C-CcEEEEecc
Confidence 69999999 678877653 3799999999999999999999999999999999999994 3 489999999
Q ss_pred ceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhh
Q 015041 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (414)
Q Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~ 231 (414)
+++..... ....||..|+|||++.+.. +.++|||||||++|+|++|..||.+.....
T Consensus 227 ~a~~~~~~-----------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------- 283 (681)
T 2pzi_A 227 AVSRINSF-----------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------- 283 (681)
T ss_dssp TCEETTCC-----------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------
T ss_pred cchhcccC-----------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-----------
Confidence 99865432 2567899999999987654 899999999999999999999987632111
Q ss_pred ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCC-hHHHHHHHHHHH
Q 015041 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD-YGFLKRLFHDLF 277 (414)
Q Consensus 232 ~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~-~~~l~~~l~~~~ 277 (414)
....... ...++.+.+++.+||..+|.+||+ .+.+...|..++
T Consensus 284 -~~~~~~~--~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 284 -LPEDDPV--LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp -CCTTCHH--HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -ccccccc--cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0000011 122578999999999999999995 666666666554
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=327.69 Aligned_cols=255 Identities=18% Similarity=0.237 Sum_probs=190.8
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeee------CC
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD------GE 76 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~------~~ 76 (414)
.++|++.++||+|+||+||+|.+..+|+.||||++...... ..+.+|+.+++.+.| +++..+..+... ..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~H-pnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNH-PNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCB-TTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCC-CCCCceeeeecccccccCCC
Confidence 38999999999999999999999999999999988765332 347889999999976 556666555433 56
Q ss_pred eeEEEEecc-CCCHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
..++||||+ +++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++.++....+||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 779999999 8899999875432 5899999999999999999999999999999999999964434456999999999
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchH------HHHHH
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK------QKYDK 227 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~------~~~~~ 227 (414)
........ .....||..|+|||++.+..++.++|||||||++|+|++|..||.+....... .....
T Consensus 172 ~~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 172 KELDQGEL--------CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243 (676)
T ss_dssp CBTTSCCC--------CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------
T ss_pred cccccccc--------cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchh
Confidence 86543322 13567899999999999999999999999999999999999999763211000 00000
Q ss_pred H-----HhhccCC----c-hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 228 I-----CEKKVST----P-IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 228 i-----~~~~~~~----p-~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
+ ....... + ...+...+++.+.+++..||..||.+||++.++
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 0 0000000 0 111233467899999999999999999998763
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=299.42 Aligned_cols=233 Identities=21% Similarity=0.179 Sum_probs=176.3
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----------hhHHHHHHHHHHHc--------CCCCCC
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----------PQLLYEAKVYKILQ--------GGSGIP 66 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~E~~~l~~l~--------~~~~i~ 66 (414)
..++|+++++||+|+||+||+|++ +|+.||||++...... ..+.+|+.+++.++ .|+++.
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 347899999999999999999998 6899999988754321 56889999999997 355555
Q ss_pred eeEEeee------------------------------eCCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHH
Q 015041 67 NIKWYGV------------------------------DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115 (414)
Q Consensus 67 ~l~~~~~------------------------------~~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~a 115 (414)
.+..... .....++||||+ ++++.+.+. ...+++..++.++.||+.|
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHHH
Confidence 5543221 267899999998 665555543 3568999999999999999
Q ss_pred HHHHH-hcCeeccccCCCceEEccCCCCC--------------------eEEEeeecceeeecCCCCCccccccCCCCCc
Q 015041 116 IEYVH-SRGFLHRDIKPDNFLMGLGRKAN--------------------QVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174 (414)
Q Consensus 116 L~~LH-~~~iiHrDLkp~Nili~~~~~~~--------------------~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~ 174 (414)
|+||| ++||+||||||+|||++ ..+ .+||+|||+|+..... ..+
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~---~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------~~~ 238 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLK---KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------IVV 238 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEE---ECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------------EEE
T ss_pred HHHHHHhCCEeECCCCHHHEEEe---ccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------------cEE
Confidence 99999 99999999999999995 443 8999999999876532 347
Q ss_pred cCcCccccccccCCCCCchhhHHHHHHH-HHHHHcCCCCCCCChhhchHHHHHHHHhhc--cCCchHHhhhcChHHHHHH
Q 015041 175 GTARYASCNTHLGIEQSRRDDLESLGYV-LLYFLRGSLPWQGLKAATKKQKYDKICEKK--VSTPIEVLCKSHPAEFASY 251 (414)
Q Consensus 175 gt~~y~aPE~~~~~~~s~~~DiwSlG~i-l~el~tG~~Pf~~~~~~~~~~~~~~i~~~~--~~~p~~~~~~~~p~~~~~l 251 (414)
||..|+|||++.+.. +.++||||||++ .++++.|..||.+.... ......+.... ...+.......+++++.+|
T Consensus 239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dl 315 (336)
T 2vuw_A 239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL--HYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEF 315 (336)
T ss_dssp CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH--HHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHH
T ss_pred EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh--hHHHHhhhhhhccCcccchhhhhhcCHHHHHH
Confidence 899999999999776 899999998877 77888999999642110 11122222111 1111222334567899999
Q ss_pred HHHHhcCC
Q 015041 252 FHYCQSLT 259 (414)
Q Consensus 252 ~~~c~~~~ 259 (414)
+.+||..+
T Consensus 316 i~~~L~~d 323 (336)
T 2vuw_A 316 HRTMLNFS 323 (336)
T ss_dssp HHHGGGSS
T ss_pred HHHHhccC
Confidence 99999865
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-32 Score=274.67 Aligned_cols=183 Identities=16% Similarity=0.114 Sum_probs=129.2
Q ss_pred ceeecCceeEEEEEECCCCceEEEEEecCCCC------------chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTK------------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 14 ~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
.++.|++|.+..++....|+.|+||++..... ..++.+|+++|+++.++++++.+..++.+....|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35667777777666667899999998875421 134889999999998889999999999999999999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ |++|.+++.. ...++.. .|+.||+.||+|+|++|||||||||+|||+ +.++.+||+|||+|+......
T Consensus 321 MEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCCCCC
Confidence 9999 8899999875 4556654 588999999999999999999999999999 588999999999998665433
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCC
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 211 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~ 211 (414)
. .....+||+.|||||++.+. +..++|+||+|++++++.++..
T Consensus 394 ~-------~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 394 S-------WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp C-------CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred c-------cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccc
Confidence 2 12357899999999999764 6778999999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-27 Score=239.98 Aligned_cols=188 Identities=19% Similarity=0.173 Sum_probs=138.7
Q ss_pred EEecceeecCceeEEEEEECCCCceEEEEEecCCCC----------chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 10 ~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
...+.||+|+||+||+|.. .+..+++|....... ...+.+|+++++.++| ++++.+..++......+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKD-FGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGG-GTCCCCCEEEEETTTTE
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCC-CCcCceEEEEEeCCccE
Confidence 3456899999999999954 577899997554322 1236899999999976 55664445555677789
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
+||||+ +++|.+++.. ++.++.|++.||+|||++||+||||||+|||++ . .+||+|||+|+....
T Consensus 416 lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~---~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD---K--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---S--SEEECCCTTCEECCC
T ss_pred EEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---C--eEEEEECccCEECCC
Confidence 999999 6899888653 678999999999999999999999999999994 4 999999999987644
Q ss_pred CCCCccccccCCCCCccCcCccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCC
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQ 214 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DiwSlG~il~el~tG~~Pf~ 214 (414)
........+.....+.||+.|||||++.+ ..|+..+|+||..+-..+-+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 32111000001235689999999999987 568888999999998888888777664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=201.75 Aligned_cols=142 Identities=20% Similarity=0.301 Sum_probs=111.3
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--------------------chhHHHHHHHHHHHcCCCCCC
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------------------HPQLLYEAKVYKILQGGSGIP 66 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------------~~~~~~E~~~l~~l~~~~~i~ 66 (414)
..|.+++.||+|+||.||+|.+ .+|+.||||++..... ...+.+|+.+++.+.+ ..++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~-~~v~ 167 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG-LAVP 167 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-SSSC
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-CCcC
Confidence 4566779999999999999999 8899999999864321 2347899999999983 3333
Q ss_pred eeEEeeeeCCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeE
Q 015041 67 NIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 145 (414)
Q Consensus 67 ~l~~~~~~~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~v 145 (414)
. .+. ....++||||+ +++|.+ + .......++.|++.||.|||++||+||||||+|||+ + ++.+
T Consensus 168 ~--~~~--~~~~~lvmE~~~g~~L~~-l-------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl---~-~~~v 231 (282)
T 1zar_A 168 K--VYA--WEGNAVLMELIDAKELYR-V-------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV---S-EEGI 231 (282)
T ss_dssp C--EEE--EETTEEEEECCCCEEGGG-C-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---E-TTEE
T ss_pred e--EEe--ccceEEEEEecCCCcHHH-c-------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE---E-CCcE
Confidence 3 222 24569999999 668876 2 123456799999999999999999999999999999 4 7899
Q ss_pred EEeeecceeeecCCCCCccccccCCCCCccCcCcccccccc
Q 015041 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186 (414)
Q Consensus 146 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 186 (414)
||+|||+|+. +..++|||++.
T Consensus 232 kl~DFG~a~~--------------------~~~~~a~e~l~ 252 (282)
T 1zar_A 232 WIIDFPQSVE--------------------VGEEGWREILE 252 (282)
T ss_dssp EECCCTTCEE--------------------TTSTTHHHHHH
T ss_pred EEEECCCCeE--------------------CCCCCHHHHHH
Confidence 9999999863 34578898874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=6.6e-22 Score=181.69 Aligned_cols=136 Identities=22% Similarity=0.291 Sum_probs=106.4
Q ss_pred ceEEecceeecCceeEEEEEECCCCce--EEEEEecCCCCc--------------------------hhHHHHHHHHHHH
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEI--VAVKIENSGTKH--------------------------PQLLYEAKVYKIL 59 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~--------------------------~~~~~E~~~l~~l 59 (414)
-|.+.+.||+|+||.||+|.+..+|+. ||||+++..... ..+.+|+.++..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999998778888 999986543111 1477899999999
Q ss_pred cCCC-CCCeeEEeeeeCCeeEEEEeccCC------CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hcCeeccccCC
Q 015041 60 QGGS-GIPNIKWYGVDGEDNVLVLDLLGP------SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH-SRGFLHRDIKP 131 (414)
Q Consensus 60 ~~~~-~i~~l~~~~~~~~~~~lv~e~~~~------sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~iiHrDLkp 131 (414)
.+.. .+|.+..+ ...++||||+++ +|.++.. ..+...+..++.|++.||.||| ++||+||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR----ELKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG----GGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh----ccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 8753 34544432 357899999952 5655432 1234567899999999999999 99999999999
Q ss_pred CceEEccCCCCCeEEEeeecceeee
Q 015041 132 DNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 132 ~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
+|||++ . .++|+|||+|...
T Consensus 200 ~NILl~---~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYI---D--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEES---S--SEEECCCTTCEET
T ss_pred HHEEEc---C--cEEEEECcccccC
Confidence 999994 4 8999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1.8e-17 Score=158.71 Aligned_cols=136 Identities=21% Similarity=0.308 Sum_probs=95.9
Q ss_pred eEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----------------chh--------HHHHHHHHHHHcCCCC
Q 015041 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------------HPQ--------LLYEAKVYKILQGGSG 64 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------------~~~--------~~~E~~~l~~l~~~~~ 64 (414)
|+++++||.|+||.||+|.+ .+|+.||||+++.... ... ...|...+.++.+ .+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~-~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE-EG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh-cC
Confidence 99999999999999999997 4689999998653210 001 2356777777754 33
Q ss_pred CCeeEEeeeeCCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCC--
Q 015041 65 IPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK-- 141 (414)
Q Consensus 65 i~~l~~~~~~~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~-- 141 (414)
++....+.. ...+|||||+ |.+|..+ ........++.||+.+|.+||++|||||||||.|||++.+.+
T Consensus 175 v~vp~p~~~--~~~~LVME~i~G~~L~~l-------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 175 FPVPEPIAQ--SRHTIVMSLVDALPMRQV-------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp CSCCCEEEE--ETTEEEEECCSCEEGGGC-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCCeeeec--cCceEEEEecCCccHhhh-------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 333222222 2358999999 4444332 122345678899999999999999999999999999952211
Q ss_pred -----CCeEEEeeecceee
Q 015041 142 -----ANQVYIIDFGLAKK 155 (414)
Q Consensus 142 -----~~~vkL~DFG~a~~ 155 (414)
...+.|+||+-+..
T Consensus 246 d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CTTSEEEEEEECCCTTCEE
T ss_pred cccccccceEEEEeCCccc
Confidence 01489999998764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=5.5e-12 Score=115.40 Aligned_cols=137 Identities=17% Similarity=0.200 Sum_probs=107.3
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCC--CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
..|++...++.|+.+.||++.. .+..+++|+.... .....+.+|+.+++.|..+..+|.+..++......++|||+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 4599999999999999999974 3678999987642 22346889999999997766788888888888889999999
Q ss_pred c-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 015041 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS------------------------------------------ 121 (414)
Q Consensus 85 ~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~------------------------------------------ 121 (414)
+ |.++.+.+ . +......++.+++.+|..||+
T Consensus 92 i~G~~l~~~~---~---~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 92 ADGVLCSEEY---E---DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHC---C---TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred cCCeehhhcc---C---CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 9 55665431 1 122345788899999999998
Q ss_pred -----------------cCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 122 -----------------RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 122 -----------------~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
..++|+|++|.|||+. ....+.|+||+.+.
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhcc
Confidence 4589999999999993 44455799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.26 E-value=8.4e-11 Score=106.98 Aligned_cols=134 Identities=18% Similarity=0.130 Sum_probs=96.6
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCeeEEeeeeCCeeEEEEecc
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWYGVDGEDNVLVLDLL 85 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~l~~~~~~~~~~~lv~e~~ 85 (414)
..|.+....+.|..+.||++.. .+|..+++|+.... ....+..|+.+++.+.++.. +|.+..++......++|||++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 3466655555667799999964 45678999987654 33568899999999987643 677777777777789999999
Q ss_pred -CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 015041 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG----------------------------------------- 123 (414)
Q Consensus 86 -~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----------------------------------------- 123 (414)
|.++ + . . ... ...++.+++..|..||+..
T Consensus 98 ~G~~l-~-~---~-~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 98 PGQDL-L-S---S-HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp SSEET-T-T---S-CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred CCccc-C-c---C-cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 4444 2 1 1 111 2356677777777777643
Q ss_pred -----------------eeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 124 -----------------FLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 124 -----------------iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
++|+|++|.|||+. ..+.+.|+||+.+.
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhcc
Confidence 99999999999993 44455799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.08 E-value=7.9e-10 Score=105.87 Aligned_cols=137 Identities=15% Similarity=0.197 Sum_probs=99.5
Q ss_pred EecceeecCceeEEEEEECCCCceEEEEEec--CCC---CchhHHHHHHHHHHHcCCC-CCCeeEEeeeeC---CeeEEE
Q 015041 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGT---KHPQLLYEAKVYKILQGGS-GIPNIKWYGVDG---EDNVLV 81 (414)
Q Consensus 11 i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~--~~~---~~~~~~~E~~~l~~l~~~~-~i~~l~~~~~~~---~~~~lv 81 (414)
-.+.|+.|.++.||++... +..+++|+.. ... ....+.+|+.+++.|.... .+|.+..++.+. ...++|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 4677899999999998753 4578889776 332 2346889999999998632 367777666554 347899
Q ss_pred EeccCC-CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 015041 82 LDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS--------------------------------------- 121 (414)
Q Consensus 82 ~e~~~~-sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--------------------------------------- 121 (414)
||++.| .+.+. ....++......++.+++..|..||+
T Consensus 120 me~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 120 MEFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999944 44221 12346788888999999999999997
Q ss_pred -------------------cCeeccccCCCceEEccCCCC--CeEEEeeecceee
Q 015041 122 -------------------RGFLHRDIKPDNFLMGLGRKA--NQVYIIDFGLAKK 155 (414)
Q Consensus 122 -------------------~~iiHrDLkp~Nili~~~~~~--~~vkL~DFG~a~~ 155 (414)
..++|+|+++.|||+. .+ ..+.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~---~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFH---PTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEEC---SSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEe---CCCCcEEEEECcccccc
Confidence 3599999999999994 33 3468999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.01 E-value=2.6e-10 Score=106.67 Aligned_cols=189 Identities=15% Similarity=0.179 Sum_probs=117.7
Q ss_pred ecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCC--CCeeEEeeeeCC---eeEEEEecc-
Q 015041 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG--IPNIKWYGVDGE---DNVLVLDLL- 85 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~--i~~l~~~~~~~~---~~~lv~e~~- 85 (414)
++.++.|....||++. ..+++|+.........+.+|..+++.+..... +|.+...+.... ..++||+++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4568999999999863 45889986544233568899999999855433 455555543332 347899999
Q ss_pred CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 015041 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-------------------------------------------- 121 (414)
Q Consensus 86 ~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-------------------------------------------- 121 (414)
|.++.+... ..++..+...++.|++..|..||+
T Consensus 100 G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 100 GVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 545543221 246777777888888888888885
Q ss_pred --------------cCeeccccCCCceEEccCCC--CCeEEEeeecceeeecCCCCCccccccC---C-----CCCccCc
Q 015041 122 --------------RGFLHRDIKPDNFLMGLGRK--ANQVYIIDFGLAKKYRDPTTNRHIPYRE---N-----KNLTGTA 177 (414)
Q Consensus 122 --------------~~iiHrDLkp~Nili~~~~~--~~~vkL~DFG~a~~~~~~~~~~~~~~~~---~-----~~~~gt~ 177 (414)
..++|+|++|.||+++ . ...+.|+||+.+...... ..-..-... . ..+....
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~---~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFD---TEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEE---TTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEe---CCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHHHHHHHc
Confidence 1379999999999995 3 456789999998754221 100000000 0 0000000
Q ss_pred Cccc-cccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 015041 178 RYAS-CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 214 (414)
Q Consensus 178 ~y~a-PE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~ 214 (414)
.... |+.... .....+.|+++.++|.+.+|..+|.
T Consensus 253 ~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 253 KHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp TCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 0111 111110 1123689999999999999987763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.59 E-value=5.1e-07 Score=84.26 Aligned_cols=136 Identities=22% Similarity=0.255 Sum_probs=86.9
Q ss_pred ecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCC--CCCeeEEeee-eCCeeEEEEecc-CC
Q 015041 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS--GIPNIKWYGV-DGEDNVLVLDLL-GP 87 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~--~i~~l~~~~~-~~~~~~lv~e~~-~~ 87 (414)
++.++.|....||+. +..+++|+.........+..|..++..|.++. .+|.+..++. .....++||+++ |.
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 456788988999987 45688998543222346789999999998642 3667666664 345578999999 44
Q ss_pred CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 015041 88 SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS---------------------------------------------- 121 (414)
Q Consensus 88 sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---------------------------------------------- 121 (414)
.+.+.. -..++......++.++...|..||+
T Consensus 99 ~l~~~~---~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 99 ILGEDG---MAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp ECHHHH---HTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred ECchhh---hhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 444321 1123333444444444444444442
Q ss_pred --------------cCeeccccCCCceEEccCCCCCe-EEEeeecceee
Q 015041 122 --------------RGFLHRDIKPDNFLMGLGRKANQ-VYIIDFGLAKK 155 (414)
Q Consensus 122 --------------~~iiHrDLkp~Nili~~~~~~~~-vkL~DFG~a~~ 155 (414)
..++|+|+++.|||++..+..+. +.|+||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 14699999999999952111344 58999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=1.1e-06 Score=80.19 Aligned_cols=131 Identities=17% Similarity=0.156 Sum_probs=89.1
Q ss_pred eeecCce-eEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-CCCHHHH
Q 015041 15 IGSGSFG-EIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDL 92 (414)
Q Consensus 15 iG~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~~sL~~~ 92 (414)
+..|..+ .||+......+..+++|+.... ....+..|...++.|...--+|.+..++.+....++||+++ |.++.+.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~ 110 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV 110 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH-HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC-CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence 4445444 6898877666778999986543 23457889999999987656788888888888899999999 5455444
Q ss_pred HHHhCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------------------
Q 015041 93 FVYCRRKFSLKTVLMLADQMIARIEYVHS--------------------------------------------------- 121 (414)
Q Consensus 93 ~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--------------------------------------------------- 121 (414)
... .......++.++...|..||.
T Consensus 111 ~~~-----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 185 (272)
T 4gkh_A 111 LEE-----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHK 185 (272)
T ss_dssp HHH-----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHT
T ss_pred ccC-----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHh
Confidence 322 111222334444444444442
Q ss_pred -------cCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 122 -------RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 122 -------~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
..++|+|+.+.|||+. ..+.+-|+||+.+.
T Consensus 186 ~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 186 LLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVG 222 (272)
T ss_dssp TCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred cccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECcccc
Confidence 1278999999999993 55556799998775
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=4.2e-06 Score=80.90 Aligned_cols=75 Identities=16% Similarity=0.177 Sum_probs=51.0
Q ss_pred EecceeecCceeEEEEEECCCCceEEEEEecCCC---------CchhHHHHHHHHHHHcCC--CCCCeeEEeeeeCCeeE
Q 015041 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---------KHPQLLYEAKVYKILQGG--SGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 11 i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~E~~~l~~l~~~--~~i~~l~~~~~~~~~~~ 79 (414)
-.+.||.|..+.||++....++..|+||...... ....+..|.++++.+... ..+|.++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 3568999999999999765556789999754321 223467899999988653 356666554 345578
Q ss_pred EEEeccCC
Q 015041 80 LVLDLLGP 87 (414)
Q Consensus 80 lv~e~~~~ 87 (414)
+|||++.+
T Consensus 112 lvmE~l~g 119 (397)
T 2olc_A 112 TVMEDLSH 119 (397)
T ss_dssp EEECCCTT
T ss_pred EEEEeCCC
Confidence 99999954
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=2.2e-06 Score=81.56 Aligned_cols=79 Identities=10% Similarity=0.264 Sum_probs=54.8
Q ss_pred eEEecce-eecCceeEEEEEEC--C----CCceEEEEEecCCC-----CchhHHHHHHHHHHHcCC--CCCCeeEEeeee
Q 015041 9 YKLGRKI-GSGSFGEIFLASHV--D----TNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGG--SGIPNIKWYGVD 74 (414)
Q Consensus 9 y~i~~~i-G~G~~g~V~~~~~~--~----~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~~--~~i~~l~~~~~~ 74 (414)
....+.| +.|....+|++... . ++..+++|+..... ....+..|+.+++.|... -.+|.+..++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 4456778 88889999988753 0 15678999865432 124678999999998754 346777666554
Q ss_pred C---CeeEEEEeccCC
Q 015041 75 G---EDNVLVLDLLGP 87 (414)
Q Consensus 75 ~---~~~~lv~e~~~~ 87 (414)
. ...++|||++.|
T Consensus 102 ~~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEG 117 (357)
T ss_dssp STTTSSCEEEEECCCC
T ss_pred CCccCCceEEEEecCC
Confidence 4 346899999943
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.06 E-value=7.8e-05 Score=70.04 Aligned_cols=72 Identities=15% Similarity=0.134 Sum_probs=42.8
Q ss_pred ecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCC-CCCCeeEE------eeeeCCeeEEEEec
Q 015041 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG-SGIPNIKW------YGVDGEDNVLVLDL 84 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~-~~i~~l~~------~~~~~~~~~lv~e~ 84 (414)
.+.|+.|..+.||++... +..+++|+.... ...+..|..+++.|... -.+|.+.. +.......+++|++
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~--~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP--EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSC--HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCC--HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 345666788999998763 335889988752 34455677777777632 23444432 12345667899999
Q ss_pred cCC
Q 015041 85 LGP 87 (414)
Q Consensus 85 ~~~ 87 (414)
+.|
T Consensus 113 i~G 115 (346)
T 2q83_A 113 IEG 115 (346)
T ss_dssp CCC
T ss_pred ecC
Confidence 944
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.92 E-value=0.0001 Score=68.20 Aligned_cols=68 Identities=18% Similarity=0.142 Sum_probs=47.7
Q ss_pred ecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc-CC
Q 015041 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GP 87 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 87 (414)
++.|+.|....+|++ ..+++|+...... ......|..+++.+......|.+..+. ....+++++++ ++
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence 678899999999998 4588998765422 123467998898887655557776543 33457899999 54
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.0002 Score=69.69 Aligned_cols=73 Identities=12% Similarity=0.297 Sum_probs=45.7
Q ss_pred EecceeecCceeEEEEEECCCCceEEEEEec-------CC--CCchhHHHHHHHHHHHc--CCCCCCeeEEeeeeCCeeE
Q 015041 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-------SG--TKHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 11 i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~-------~~--~~~~~~~~E~~~l~~l~--~~~~i~~l~~~~~~~~~~~ 79 (414)
-.+.||.|..+.||++.. ++..++||... .. ........|.+++..+. .+..+|.+..++ ....+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 356789999999999964 46779999321 11 01123334544444332 234567776665 46679
Q ss_pred EEEecc-CC
Q 015041 80 LVLDLL-GP 87 (414)
Q Consensus 80 lv~e~~-~~ 87 (414)
+|||++ .+
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 76
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00067 Score=62.19 Aligned_cols=78 Identities=14% Similarity=0.149 Sum_probs=57.5
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCC--CCeeEEeeeeCCee
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSG--IPNIKWYGVDGEDN 78 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~--i~~l~~~~~~~~~~ 78 (414)
++.|.+..-.+.+|.|..+.||+++. .+|+.|++|+...... ...+..|...|+.|..... +|.+...+ ..
T Consensus 11 ~l~G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~ 85 (288)
T 3f7w_A 11 ELTGREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DR 85 (288)
T ss_dssp HHHCCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TT
T ss_pred HhcCCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----Cc
Confidence 45677888899999999999999985 5688899998654432 2357889999999975433 44444432 24
Q ss_pred EEEEecc
Q 015041 79 VLVLDLL 85 (414)
Q Consensus 79 ~lv~e~~ 85 (414)
++|||++
T Consensus 86 ~lv~e~l 92 (288)
T 3f7w_A 86 TLAMEWV 92 (288)
T ss_dssp EEEEECC
T ss_pred eEEEEee
Confidence 7889998
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00091 Score=62.20 Aligned_cols=140 Identities=17% Similarity=0.196 Sum_probs=78.1
Q ss_pred EEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCeeEEe------eeeCCeeEEEE
Q 015041 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWY------GVDGEDNVLVL 82 (414)
Q Consensus 10 ~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~l~~~------~~~~~~~~lv~ 82 (414)
.-.+.|+.|....+|++... ++ .+++|+.........+..|+.++..|..... +|.+... .......++++
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEEEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 34566778888999998763 23 6889988764344567789999888875422 4444321 12235568999
Q ss_pred eccCC-CH-----H------HHH---HHhCCCC--------CHHHHHH---------------HHHHHHHHHHHHHh---
Q 015041 83 DLLGP-SL-----E------DLF---VYCRRKF--------SLKTVLM---------------LADQMIARIEYVHS--- 121 (414)
Q Consensus 83 e~~~~-sL-----~------~~~---~~~~~~~--------~~~~~~~---------------i~~qi~~aL~~LH~--- 121 (414)
+++.| .+ . ..+ ......+ ....... +...+...++.+..
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 99844 21 1 111 1111111 1111000 01113344555542
Q ss_pred ----cCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 122 ----RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 122 ----~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
.+++|+|+.+.|||+. .+..+.|+||+.+.
T Consensus 183 ~~~~~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFL---GDELSGLIDFYFAC 216 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred ccCCcccCCCCCCccCEEEe---CCceEEEecchhcc
Confidence 3699999999999993 44445799998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00044 Score=64.34 Aligned_cols=75 Identities=25% Similarity=0.306 Sum_probs=57.5
Q ss_pred EEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCC--CCCCeeEEeeeeCCeeEEEEeccCC
Q 015041 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG--SGIPNIKWYGVDGEDNVLVLDLLGP 87 (414)
Q Consensus 10 ~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~--~~i~~l~~~~~~~~~~~lv~e~~~~ 87 (414)
.-.+.|+.|....+|+... .+..++||+.... ....+..|...++.|... ..+|.+..++......++|||++.+
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS-YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 3456789999999999874 4667889986543 234578899999998753 5678888787777789999999943
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00054 Score=66.80 Aligned_cols=73 Identities=12% Similarity=0.112 Sum_probs=51.3
Q ss_pred EecceeecCceeEEEEEECC-------CCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 11 LGRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 11 i~~~iG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
-++.|+.|....||++.... ++..|++|+.........+..|..++..|......|.+...+.+ .+|++
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 35678888889999998653 25789999984422214667899999999876666777654432 38899
Q ss_pred ccCC
Q 015041 84 LLGP 87 (414)
Q Consensus 84 ~~~~ 87 (414)
|+.|
T Consensus 153 ~l~G 156 (429)
T 1nw1_A 153 YIPS 156 (429)
T ss_dssp CCCE
T ss_pred EeCC
Confidence 9843
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.0013 Score=61.50 Aligned_cols=72 Identities=10% Similarity=-0.008 Sum_probs=38.7
Q ss_pred ecceeecCcee-EEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCC-CCCeeEEeeeeCCeeEEEEeccCC
Q 015041 12 GRKIGSGSFGE-IFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS-GIPNIKWYGVDGEDNVLVLDLLGP 87 (414)
Q Consensus 12 ~~~iG~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~-~i~~l~~~~~~~~~~~lv~e~~~~ 87 (414)
.+.|+.|.... +|+... .++..+++|...... ...+..|+.+++.|.... .+|.+..+... ..+++||.+++
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~-~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~l~~ 96 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE-GGDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIEDLGD 96 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTT-TCCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECCCCS
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC-CccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEeeCCC
Confidence 44566665444 677653 225667788654432 134567888888887543 35666655332 23789999854
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0012 Score=62.75 Aligned_cols=72 Identities=17% Similarity=0.093 Sum_probs=45.2
Q ss_pred ecceeecCceeEEEEEECC--------CCceEEEEEecCCCCc-hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 12 GRKIGSGSFGEIFLASHVD--------TNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~-~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
.+.|+.|....+|++.... .+..+++|+....... .....|..+++.|......|.+.... ..++||
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 4567888888999998643 1267899987553221 12468899999887655566665433 237899
Q ss_pred eccCC
Q 015041 83 DLLGP 87 (414)
Q Consensus 83 e~~~~ 87 (414)
+++.|
T Consensus 114 e~i~G 118 (369)
T 3c5i_A 114 EWLYG 118 (369)
T ss_dssp ECCCS
T ss_pred EEecC
Confidence 99844
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0029 Score=60.44 Aligned_cols=139 Identities=17% Similarity=0.174 Sum_probs=79.9
Q ss_pred ecceeecCceeEEEEEECC-------CCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 12 GRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
++.|..|-...+|++.... ++..|++|+..... ......+|..+++.|......|.+..++.+ .+|||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 3467778888999988642 35789999864322 234467899999999876667888665543 28999
Q ss_pred ccCC-CHH--------------HHHHHhC-------CCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 015041 84 LLGP-SLE--------------DLFVYCR-------RKFS--LKTVLMLADQMIA-------------------RIEYVH 120 (414)
Q Consensus 84 ~~~~-sL~--------------~~~~~~~-------~~~~--~~~~~~i~~qi~~-------------------aL~~LH 120 (414)
|+.| .+. +.+.... +... +..+.++..++.. .++.|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9843 211 1111111 1122 3444555444322 233332
Q ss_pred ----h----cCeeccccCCCceEEccC-CCCCeEEEeeeccee
Q 015041 121 ----S----RGFLHRDIKPDNFLMGLG-RKANQVYIIDFGLAK 154 (414)
Q Consensus 121 ----~----~~iiHrDLkp~Nili~~~-~~~~~vkL~DFG~a~ 154 (414)
. ..++|+|+.+.|||+... +..+.+.|+||..|.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 248999999999999521 113689999998775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0064 Score=56.51 Aligned_cols=72 Identities=11% Similarity=0.019 Sum_probs=46.0
Q ss_pred ceeecCceeEEEEEECCCCceEEEEEecCC-CCchhHHHHHHHHHHHcCCCC-CCeeEEe-----eeeCCeeEEEEeccC
Q 015041 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSG-TKHPQLLYEAKVYKILQGGSG-IPNIKWY-----GVDGEDNVLVLDLLG 86 (414)
Q Consensus 14 ~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~~~~~-i~~l~~~-----~~~~~~~~lv~e~~~ 86 (414)
.|+ |....||++.. .+|+.+++|+.... .....+..|..++..|..... +|.+... ....+..+++|+++.
T Consensus 33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 455 77789998764 34667899998744 234567789988888875321 3333222 112345678999995
Q ss_pred C
Q 015041 87 P 87 (414)
Q Consensus 87 ~ 87 (414)
|
T Consensus 111 G 111 (328)
T 1zyl_A 111 G 111 (328)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0086 Score=58.66 Aligned_cols=72 Identities=13% Similarity=0.045 Sum_probs=48.7
Q ss_pred EecceeecCceeEEEEEECCCCceEEEEEecCCCCc-hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEeccC
Q 015041 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLG 86 (414)
Q Consensus 11 i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~~ 86 (414)
-++.|+.|-...+|++.....+..+++|+....... .....|..++..|......|.+...+. ..+||+|+.
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~----~G~v~e~I~ 184 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT----NGRIEEFMD 184 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET----TEEEEECCC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC----CeEEEEeeC
Confidence 356788898999999987544578999987543211 123689999999987666677766553 235999984
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.39 E-value=0.089 Score=45.61 Aligned_cols=98 Identities=14% Similarity=0.143 Sum_probs=63.4
Q ss_pred CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCccc
Q 015041 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (414)
Q Consensus 87 ~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 165 (414)
.+|.+++...+.++++++++-++.|.+.+|.-+-. +.-..+=+-|..|++ ..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l---~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV---WRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE---ETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE---ecCCceeccc-cccc-----------
Confidence 47999999889999999999999999999887621 111122234577777 4677766553 1110
Q ss_pred cccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc
Q 015041 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR 208 (414)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t 208 (414)
.....+.+||... ...+.+.=|||||+++|..+-
T Consensus 98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -----------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123456777653 345678899999999999885
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.98 E-value=0.026 Score=52.83 Aligned_cols=66 Identities=8% Similarity=0.061 Sum_probs=40.4
Q ss_pred eecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCC-C-CCeeEEe------eeeCCeeEEEEeccCC
Q 015041 16 GSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS-G-IPNIKWY------GVDGEDNVLVLDLLGP 87 (414)
Q Consensus 16 G~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~-~-i~~l~~~------~~~~~~~~lv~e~~~~ 87 (414)
|.|....||++.. .+| .+++|+...... ..|+.++..|.... . +|.+... .......+++|+++.|
T Consensus 32 G~g~~N~vy~v~~-~~g-~~vLK~~~~~~~----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 32 GADTNAFAYQADS-ESK-SYFIKLKYGYHD----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp TSCSSCEEEEEEC-SSC-EEEEEEEECSSC----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred cCccccceEEEEe-CCC-CEEEEEecCccc----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 3344678999874 344 789998766542 46777777775431 1 3333221 2234667899999943
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.75 E-value=0.055 Score=52.31 Aligned_cols=72 Identities=18% Similarity=0.136 Sum_probs=49.9
Q ss_pred ecceeecCceeEEEEEECCC-------CceEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 12 GRKIGSGSFGEIFLASHVDT-------NEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
++.|..|-...+|++..... +..|++|+...... .-...+|..+++.|......|.+...+. .++|++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 45677788889999987521 57799998655432 1234689999999986666777765332 378999
Q ss_pred ccCC
Q 015041 84 LLGP 87 (414)
Q Consensus 84 ~~~~ 87 (414)
|+.|
T Consensus 151 fI~G 154 (424)
T 3mes_A 151 FIDG 154 (424)
T ss_dssp CCCS
T ss_pred EeCC
Confidence 9944
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.60 E-value=0.063 Score=51.52 Aligned_cols=31 Identities=26% Similarity=0.480 Sum_probs=25.3
Q ss_pred eeccccCCCceEEcc---CCCCCeEEEeeeccee
Q 015041 124 FLHRDIKPDNFLMGL---GRKANQVYIIDFGLAK 154 (414)
Q Consensus 124 iiHrDLkp~Nili~~---~~~~~~vkL~DFG~a~ 154 (414)
++|+|+.+.|||+.. .++...++++||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 689999999999942 1356789999998875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 414 | ||||
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-89 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-89 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-33 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-32 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-32 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-32 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-32 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-31 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-30 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-30 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-30 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-30 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-29 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-29 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-29 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-28 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-28 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-28 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-27 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-27 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-26 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-26 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-26 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-26 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-26 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-26 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-25 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-25 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-25 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-25 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-25 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-24 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-24 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-24 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-24 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-24 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-24 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-23 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-23 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-23 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-23 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-22 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-22 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-22 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-22 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-21 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-21 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-21 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-21 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-20 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-20 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-20 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-19 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-18 |
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 271 bits (693), Expect = 1e-89
Identities = 166/292 (56%), Positives = 212/292 (72%), Gaps = 2/292 (0%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS 63
++GV YK+GR+IG GSFG IF +++ N+ VA+K E + PQL E + YK+L G +
Sbjct: 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT 61
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
GIPN+ ++G +G NVLV+DLLGPSLEDL C RKFS+KTV M A QM+AR++ +H +
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 124 FLHRDIKPDNFLMGLG--RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
++RDIKPDNFL+G + AN +Y++DFG+ K YRDP T +HIPYRE KNL+GTARY S
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241
NTHLG EQSRRDDLE+LG+V +YFLRGSLPWQGLKAAT KQKY++I EKK STP+ LC
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 293
P EF Y HY ++L FD PDY +L+ LF + R D FDW +L
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 270 bits (690), Expect = 3e-89
Identities = 205/299 (68%), Positives = 258/299 (86%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP I+W G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQ 299
CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+ ++
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASR 299
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 5e-33
Identities = 53/287 (18%), Positives = 105/287 (36%), Gaps = 26/287 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSG 64
++ ++G+G+ G +F SH + ++A K+ E Q++ E +V
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS--- 63
Query: 65 IPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
P I +YG + + ++ + D + + + + ++ +I + Y+
Sbjct: 64 -PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 122 R-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
+ +HRD+KP N L+ ++ + DFG++ + D N + GT Y
Sbjct: 123 KHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRSYM 170
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S G S + D+ S+G L+ G P A + + E +
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDY---GFLKRLFHDLFSREGYDF 284
+ + + DY +L +FS E DF
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 277
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (311), Expect = 6e-33
Identities = 47/259 (18%), Positives = 98/259 (37%), Gaps = 16/259 (6%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIP 66
KY + +G G FG + + + K ++ GT + E + I + I
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-HRNIL 64
Query: 67 NIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
++ E+ V++ + + G + + + + + ++ Q+ ++++HS
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH 185
H DI+P+N + R+++ + II+FG A++ + R + Y + H
Sbjct: 125 HFDIRPENIIYQ-TRRSSTIKIIEFGQARQLKPGDNFRLLF--------TAPEYYAPEVH 175
Query: 186 LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245
S D+ SLG ++ L G P+ T +Q + I + + E K
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLA---ETNQQIIENIMNAEYTFDEEAF-KEIS 231
Query: 246 AEFASYFHYCQSLTFDQRP 264
E + R
Sbjct: 232 IEAMDFVDRLLVKERKSRM 250
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 122 bits (308), Expect = 3e-32
Identities = 44/260 (16%), Positives = 94/260 (36%), Gaps = 17/260 (6%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
Y + ++G+G+FG + + T A K + + E + +L+ +
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPTL 85
Query: 66 PNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
N+ D + V++ + + G L + K S + Q+ + ++H +
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 145
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
+H D+KP+N + +++N++ +IDFGL + + TGTA +A+
Sbjct: 146 VHLDLKPENIMF-TTKRSNELKLIDFGLTAHLDPKQSVKVT--------TGTAEFAAPEV 196
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244
G D+ S+G + L G P+ G + + +
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGG---ENDDETLRNVKSCDWNMDDSAF-SGI 252
Query: 245 PAEFASYFHYCQSLTFDQRP 264
+ + + R
Sbjct: 253 SEDGKDFIRKLLLADPNTRM 272
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 122 bits (307), Expect = 4e-32
Identities = 54/260 (20%), Positives = 90/260 (34%), Gaps = 17/260 (6%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
Y + ++GSG+FG + T + K + E + L +
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH-HPKL 88
Query: 66 PNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
N+ D + VL+L+ L G L D K S V+ Q ++++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 148
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
+H DIKP+N + +KA+ V IIDFGLA K + T TA +A+
Sbjct: 149 VHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIVKVT--------TATAEFAAPEI 199
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244
D+ ++G + L G P+ G + + + S
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAG---EDDLETLQNVKRCDWEFDEDAF-SSV 255
Query: 245 PAEFASYFHYCQSLTFDQRP 264
E + +R
Sbjct: 256 SPEAKDFIKNLLQKEPRKRL 275
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 7e-32
Identities = 51/284 (17%), Positives = 105/284 (36%), Gaps = 32/284 (11%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
+++ ++G G+FG+++ A + +T+ + A K+ S + + E + P
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH----P 69
Query: 67 NI-KWYGVDGEDN--VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
NI K +N ++++ G +++ + + R + + ++ Q + + Y+H
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS- 181
+HRD+K N L + + DFG++ K R + GT + +
Sbjct: 130 KIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRD-------SFIGTPYWMAP 179
Query: 182 ----CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
C T + D+ SLG L+ P L + KI + + P
Sbjct: 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL---NPMRVLLKIAKSE--PPT 234
Query: 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
+ F + C D R L + H + +
Sbjct: 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ--HPFVTVDS 276
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 7e-32
Identities = 63/262 (24%), Positives = 100/262 (38%), Gaps = 26/262 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
+++GR +G G FG ++LA + I+A+K+ QL E ++ L+
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH- 65
Query: 63 SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
I + Y D L+L+ + KF + ++ + Y HS+
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
+HRDIKP+N L+G A ++ I DFG + H P L GT Y
Sbjct: 126 RVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTTLCGTLDYLPP 173
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
G + DL SLG + FL G P++ T ++ Y +I + + P V
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA---NTYQETYKRISRVEFTFPDFV--- 227
Query: 243 SHPAEFASYFHYCQSLTFDQRP 264
QRP
Sbjct: 228 --TEGARDLISRLLKHNPSQRP 247
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (298), Expect = 2e-31
Identities = 59/268 (22%), Positives = 105/268 (39%), Gaps = 27/268 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYKILQGGS 63
+ +G++IGSGSFG ++ VAVK+ N PQ E V + +
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH-- 63
Query: 64 GIPNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
NI + G + +V G SL KF + ++ +A Q ++Y+H
Sbjct: 64 --VNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
++ +HRD+K +N + + V I DFGLA + + + L+G+ +
Sbjct: 122 AKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQF-----EQLSGSILWM 173
Query: 181 S---CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
+ S + D+ + G VL + G LP+ + + Q + +S +
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIFMVGRGYLSPDL 231
Query: 238 EVLCKSHPAEFASYFHYCQSLTFDQRPD 265
+ + P C D+RP
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPL 259
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 1e-30
Identities = 53/238 (22%), Positives = 93/238 (39%), Gaps = 19/238 (7%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
+K G+ +G GSF + LA + T+ A+KI K P + E V L
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-H 67
Query: 63 SGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
+ + D E L L ++ F ++++ +EY+H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLK-YIRKIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
+G +HRD+KP+N L+ + + I DFG AK + + GTA+Y S
Sbjct: 127 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARA-----NSFVGTAQYVS 178
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239
+ DL +LG ++ + G P++ + + KI + + P +
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA---GNEYLIFQKIIKLEYDFPEKF 233
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 5e-30
Identities = 67/248 (27%), Positives = 101/248 (40%), Gaps = 21/248 (8%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSG 64
+ L + +G G++GE+ LA + T E VAVKI + + + E + K+L
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH--- 62
Query: 65 IPNI-KWYGVDGEDNV--LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
N+ K+YG E N+ L L+ + Q++A + Y+H
Sbjct: 63 -ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
G HRDIKP+N L+ + + + I DFGLA +R R + + GT Y +
Sbjct: 122 IGITHRDIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLL-----NKMCGTLPYVA 173
Query: 182 CNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
E + D+ S G VL L G LPW + Q+Y EKK
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ--PSDSCQEYSDWKEKKTYLNPWKK 231
Query: 241 CKSHPAEF 248
S P
Sbjct: 232 IDSAPLAL 239
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 114 bits (287), Expect = 7e-30
Identities = 56/269 (20%), Positives = 100/269 (37%), Gaps = 27/269 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
+Y+LG +G G E+ LA + + VAVK+ + + + EA+ L
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH- 66
Query: 63 SGIPNI-KWYGVDGEDN------VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
P I Y + +V++ + V+ + K + +
Sbjct: 67 ---PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
+ + H G +HRD+KP N ++ N V ++DFG+A+ D + + + G
Sbjct: 124 LNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVT----QTAAVIG 176
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
TA+Y S G R D+ SLG VL L G P+ G + + +
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG---DSPVSVAYQHVREDP-I 232
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
P + A+ + + + R
Sbjct: 233 PPSARHEGLSADLDAVVLKALAKNPENRY 261
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 115 bits (288), Expect = 8e-30
Identities = 55/284 (19%), Positives = 97/284 (34%), Gaps = 37/284 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
+ R+IG GSFG ++ A V +E+VA+K + S K ++ E + + L+
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH- 74
Query: 63 SGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
PN ++ G LV++ S DL ++ + + + + Y+
Sbjct: 75 ---PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
HS +HRD+K N L+ + V + DFG A + GT +
Sbjct: 132 HSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPANS-----------FVGTPYW 177
Query: 180 AS---CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
+ + + D+ SLG + P + I + +
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNESPAL 234
Query: 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
F ++ C RP L + H RE
Sbjct: 235 QSGHW---SEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVLRE 273
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 113 bits (283), Expect = 2e-29
Identities = 47/269 (17%), Positives = 84/269 (31%), Gaps = 22/269 (8%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----------ENSGTKHPQLLYEAKVY 56
Y+ +G G + H T + AVKI E L E +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 57 KILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
+ + G I +K LV DL+ L D ++ + S K + ++
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD-YLTEKVTLSEKETRKIMRALLEV 122
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
I +H +HRD+KP+N L+ + + DFG + + R + +
Sbjct: 123 ICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
+ + H G + D+ S G ++ L GS P+ + I
Sbjct: 180 IIECSMNDNHPGY--GKEVDMWSTGVIMYTLLAGSPPFWH---RKQMLMLRMIMSGNYQF 234
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
+ + +R
Sbjct: 235 GSPEW-DDYSDTVKDLVSRFLVVQPQKRY 262
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 3e-29
Identities = 54/277 (19%), Positives = 112/277 (40%), Gaps = 27/277 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIP 66
KL ++G+G FGE+++ + + + VAVK ++ L EA + K LQ
Sbjct: 14 TLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH----Q 68
Query: 67 NI-KWYGVDGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
+ + Y V ++ + ++ + + G ++ L K ++ +L +A Q+ + ++ R
Sbjct: 69 RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
++HRD++ N L+ I DFGLA+ D + ++ +
Sbjct: 129 NYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAR------EGAKFPIKWTAP 179
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241
+ + D+ S G +L + G +P+ G ++ + V
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-------MTNPEVIQNLERGYRMVRP 232
Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
+ P E C + RP + +L+ + D F+
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 3e-29
Identities = 49/227 (21%), Positives = 89/227 (39%), Gaps = 22/227 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
+Y++G +GSG FG ++ V N VA+K ++ E + K +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 60 QGG-SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK-FSLKTVLMLADQMIARIE 117
G SG+ + + + VL+L+ P + R + Q++ +
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
+ H+ G LHRDIK +N L + ++ +IDFG +D + GT
Sbjct: 125 HCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKDTVYT---------DFDGTR 173
Query: 178 RYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ 223
Y+ R + SLG +L + G +P++ + + Q
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 220
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 5e-29
Identities = 64/289 (22%), Positives = 99/289 (34%), Gaps = 27/289 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQG-- 61
KY+ KIG G+FGE+F A H T + VA+K L E K+ ++L+
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 62 -----GSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
Y LV D L L KF+L + + ++ +
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 130
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
Y+H LHRD+K N L+ + + + DFGLA+ + ++ Y N T
Sbjct: 131 YYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRY---TNRVVT 184
Query: 177 ARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
Y LG DL G ++ S QG T++ + I + S
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG---NTEQHQLALISQLCGSI 241
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDF 284
EV + + L + RL + D
Sbjct: 242 TPEVW------PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL 284
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 7e-29
Identities = 47/237 (19%), Positives = 95/237 (40%), Gaps = 25/237 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
+ + +G G+FG++ L T A+KI + + + E++V + +
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH- 64
Query: 63 SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYV 119
P + + L + + +LF + R+ F+ + ++++ +EY+
Sbjct: 65 ---PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
HSR ++RDIK +N ++ K + I DFGL K+ GT Y
Sbjct: 122 HSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMK-------TFCGTPEY 171
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
+ + R D LG V+ + G LP+ ++ ++ I +++ P
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELILMEEIRFP 225
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 1e-28
Identities = 51/245 (20%), Positives = 92/245 (37%), Gaps = 22/245 (8%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
KY KIG G+ G ++ A V T + VA++ K ++ E V + + I
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNI 79
Query: 66 PNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
N + G++ +V++ L G SL D+ + + + + +E++HS
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
+HRDIK DN L+ V + DFG + + R + GT + +
Sbjct: 138 IHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRS-------TMVGTPYWMAPEV 187
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG------LKAATKKQKYDKICEKKVSTPIE 238
+ D+ SLG + + + G P+ L + +K+S
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247
Query: 239 VLCKS 243
Sbjct: 248 DFLNR 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 3e-28
Identities = 51/268 (19%), Positives = 89/268 (33%), Gaps = 19/268 (7%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS 63
II + +G G G++ + T E A+K+ P+ E +++
Sbjct: 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARREVELHWRASQCP 65
Query: 64 GIPNIKWYGVDGEDN----VLVLDLL-GPSLEDLFV-YCRRKFSLKTVLMLADQMIARIE 117
I I + ++V++ L G L + F+ + + + I+
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
Y+HS HRD+KP+N L R + + DFG AK+ + Y T
Sbjct: 126 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--------TP 177
Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL-KAATKKQKYDKICEKKVSTP 236
Y + + + D+ SLG ++ L G P+ A +I + P
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237
Query: 237 IEVLCKSHPAEFASYFHYCQSLTFDQRP 264
E QR
Sbjct: 238 NP-EWSEVSEEVKMLIRNLLKTEPTQRM 264
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 3e-28
Identities = 53/234 (22%), Positives = 93/234 (39%), Gaps = 20/234 (8%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
+ L + +G GSFG++FLA TN+ A+K ++ + ++L P
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 67 NI-KWYGVDGEDNVLVLDL---LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
+ + L + G L + KF L A ++I ++++HS+
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYH-IQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
G ++RD+K DN L+ K + I DFG+ K+ + GT Y +
Sbjct: 123 GIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTN-------TFCGTPDYIAP 172
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
LG + + D S G +L L G P+ G +++ + I P
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG---QDEEELFHSIRMDNPFYP 223
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 110 bits (276), Expect = 6e-28
Identities = 56/278 (20%), Positives = 105/278 (37%), Gaps = 16/278 (5%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
Y+L RK+G G + E+F A ++ NE V VKI K ++ E K+ + L+GG I
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLRGGPNIIT 94
Query: 68 IKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 127
+ D L + D + + + +++ ++Y HS G +HR
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLYQT-LTDYDIRFYMYEILKALDYCHSMGIMHR 153
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
D+KP N + + + ++ +ID+GLA+ Y + + +
Sbjct: 154 DVKPHNVM--IDHEHRKLRLIDWGLAEFYHPGQEYNVR--------VASRYFKGPELLVD 203
Query: 188 IEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246
+ D+ SLG +L + P+ + +I + + + +
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFH--GHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 247 EFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDF 284
E F+ +R + H + S E DF
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLV-SPEALDF 298
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (273), Expect = 9e-28
Identities = 51/261 (19%), Positives = 100/261 (38%), Gaps = 18/261 (6%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSG 64
Y +G+G+F E+ LA T ++VA+K + K + E V ++
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK-HPN 68
Query: 65 IPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
I + G L++ L+ G L D + + ++ + L Q++ ++Y+H G
Sbjct: 69 IVALDDIYESGGHLYLIMQLVSGGELFD-RIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
+HRD+KP+N L + +++ I DFGL+K + GT Y +
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--------CGTPGYVAPE 179
Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
S+ D S+G + L G P+ + +++I + +
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD---ENDAKLFEQILKAEYEFDSPYW-DD 235
Query: 244 HPAEFASYFHYCQSLTFDQRP 264
+ + ++R
Sbjct: 236 ISDSAKDFIRHLMEKDPEKRF 256
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 2e-27
Identities = 55/273 (20%), Positives = 95/273 (34%), Gaps = 33/273 (12%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
Y++ IG+GS+G +I+ K + + L+ E + + L+
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HP 63
Query: 64 GIPNIKWYGVDGEDNV--LVLDLL-GPSLEDLFVYCRRK---FSLKTVLMLADQMIARIE 117
I +D + +V++ G L + ++ + VL + Q+ ++
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 118 YVHSRG-----FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
H R LHRD+KP N + V + DFGLA+ T+ K
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFA-------KA 173
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
GT Y S + + + D+ SLG +L P+ ++K+ KI E K
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIREGK 230
Query: 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
E +L RP
Sbjct: 231 FRRIPYRY----SDELNEIITRMLNLKDYHRPS 259
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 3e-27
Identities = 64/277 (23%), Positives = 119/277 (42%), Gaps = 27/277 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIP 66
+L K+G G FGE+++ + T VA+K GT P+ L EA+V K L+
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRH----E 72
Query: 67 NI-KWYGVDGEDNVLVL--DLLGPSLEDLFVYCRRKF-SLKTVLMLADQMIARIEYVHSR 122
+ + Y V E+ + ++ + SL D K+ L ++ +A Q+ + + YV
Sbjct: 73 KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
++HRD++ N L+G + + DFGLA+ D Y + ++ +
Sbjct: 133 NYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE------YTARQGAKFPIKWTAP 183
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241
L + + D+ S G +L +G +P+ G+ ++ D++ E+ P C
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC 239
Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
P C ++RP + +L+ D F+
Sbjct: 240 ---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 107 bits (269), Expect = 1e-26
Identities = 54/239 (22%), Positives = 91/239 (38%), Gaps = 20/239 (8%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGGS 63
+ + R IG G FGE++ DT ++ A+K L E + ++ G
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 64 --GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
I + + + +LDL+ + FS + A ++I +E++H+
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
R ++RD+KP N L+ + V I D GLA + + + GT Y +
Sbjct: 126 RFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGYMA 173
Query: 182 CNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239
G+ D SLG +L LRG P++ K K + V P
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 2e-26
Identities = 49/266 (18%), Positives = 94/266 (35%), Gaps = 26/266 (9%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSG 64
K +IG GSF ++ +T VA + + ++ + EA++ K LQ +
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 65 IPNIKWYGVDGEDN---VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
+ + + VLV +L+ ++ + +K + Q++ ++++H+
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 122 RG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
R +HRD+K DN + V I D GLA R K + GT +
Sbjct: 131 RTPPIIHRDLKCDNIF--ITGPTGSVKIGDLGLATLKRASFA---------KAVIGTPEF 179
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239
+ + + D+ + G +L P+ Q Y ++ +
Sbjct: 180 MAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE--CQNAAQIYRRVTSGVKPASFD- 235
Query: 240 LCKSHPAEFASYFHYCQSLTFDQRPD 265
K E C D+R
Sbjct: 236 --KVAIPEVKEIIEGCIRQNKDERYS 259
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 3e-26
Identities = 63/274 (22%), Positives = 98/274 (35%), Gaps = 30/274 (10%)
Query: 4 IIGVK-YKLGRKIGSGSFGEIFLASHVDTN---EIVAVKI-----ENSGTKHPQLLYEAK 54
+IG K +L K+G GSFG + + VAVK + + E
Sbjct: 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63
Query: 55 VYKILQGGSGIPNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQ 111
L N+ + YGV + +V +L SL D + F L T+ A Q
Sbjct: 64 AMHSLDH----RNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
+ + Y+ S+ F+HRD+ N L+ + V I DFGL + + Y +
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDH----YVMQE 172
Query: 172 NLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICE 230
+ + + + S D G L G PW GL Q KI +
Sbjct: 173 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQILHKIDK 229
Query: 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
+ P C P + + C + + RP
Sbjct: 230 EGERLPRPEDC---PQDIYNVMVQCWAHKPEDRP 260
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 4e-26
Identities = 63/295 (21%), Positives = 108/295 (36%), Gaps = 39/295 (13%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
+R V Y + IG+GSFG ++ A D+ E+VA+K + E ++ + L
Sbjct: 15 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--FKNRELQIMRKLDH 72
Query: 62 GSGIPNIKWYGVDGEDN-----VLVLDLLGPS-LEDLFVYCRRK--FSLKTVLMLADQMI 113
+ + ++ GE LVLD + + Y R K + V + Q+
Sbjct: 73 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYRE 169
+ Y+HS G HRDIKP N L + + DFG AK+ + YR
Sbjct: 133 RSLAYIHSFGICHRDIKPQNL--LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 190
Query: 170 NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229
+ + G Y + D+ S G VL L G + G + + +I
Sbjct: 191 PELIFGATDY-----------TSSIDVWSAGCVLAELLLGQPIFPG---DSGVDQLVEII 236
Query: 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDF 284
+ + E + + +P F ++ + ++F E
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPW---------TKVFRPRTPPEAIAL 282
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 9e-26
Identities = 57/274 (20%), Positives = 114/274 (41%), Gaps = 27/274 (9%)
Query: 13 RKIGSGSFGEIFLASHVD--TNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIP 66
+++GSG+FG + + + VAVKI + P +LL EA V + L P
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN----P 68
Query: 67 NI-KWYGV-DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
I + G+ + E +LV+++ + ++ R K ++ L Q+ ++Y+ F
Sbjct: 69 YIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
+HRD+ N L+ + I DFGL+K R Y+ + ++ +
Sbjct: 129 VHRDLAARNVLLV---TQHYAKISDFGLSKALRADENY----YKAQTHGKWPVKWYAPEC 181
Query: 185 HLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
+ S + D+ S G ++ G P++G+K + +K +++ P
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK--GERMGCPAGC---- 235
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277
P E + C + + RP + ++ + +
Sbjct: 236 -PREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 104 bits (259), Expect = 9e-26
Identities = 51/236 (21%), Positives = 94/236 (39%), Gaps = 28/236 (11%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGGS 63
+++ R +G+GSFG + L A+K+ + E + I+
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH-- 63
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
P I + +G D + +++D + + ++F A ++ +EY+H
Sbjct: 64 --PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ ++RD+KP+N L+ K + I DFG AK D T L GT Y
Sbjct: 122 SKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVPDVTY----------TLCGTPDYI 168
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
+ ++ D S G ++ L G P+ + + Y+KI ++ P
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD---SNTMKTYEKILNAELRFP 221
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 104 bits (261), Expect = 9e-26
Identities = 57/297 (19%), Positives = 114/297 (38%), Gaps = 32/297 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
++ + +G+GSFG + L H ++ A+KI + L E ++ + +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-F 100
Query: 63 SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
+ +++ D + +V++ + + +FS A Q++ EY+HS
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
++RD+KP+N L+ + + DFG AK+ + T GT +
Sbjct: 161 DLIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWTLC----------GTPEALAP 207
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
L ++ D +LG ++ G P+ Q Y+KI KV P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA---DQPIQIYEKIVSGKVRFPSHF--- 261
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQ 299
++ L D +G LK +D+ + + + DW + ++ +
Sbjct: 262 --SSDLKDLLRNL--LQVDLTKRFGNLKNGVNDIKNHK---WFATTDWIAIYQRKVE 311
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 3e-25
Identities = 56/281 (19%), Positives = 109/281 (38%), Gaps = 31/281 (11%)
Query: 13 RKIGSGSFGEIFLASHVDTNE--IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPN 67
++G G+FG + + + VA+K+ GT+ +++ EA++ L P
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN----PY 70
Query: 68 I-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
I + GV + + LV+++ G L V R + + V L Q+ ++Y+ + F
Sbjct: 71 IVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 130
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
+HRD+ N L+ + I DFGL+K + ++ +
Sbjct: 131 VHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTA----RSAGKWPLKWYAPEC 183
Query: 185 HLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
+ S R D+ S G + L G P++ + + I + K
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---KGPEVMAFIEQGKRMECPPEC--- 237
Query: 244 HPAEFASYFHYCQSLTFDQRPDYG----FLKRLFHDLFSRE 280
P E + C ++ RPD+ ++ ++ L S+
Sbjct: 238 -PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 3e-25
Identities = 53/289 (18%), Positives = 99/289 (34%), Gaps = 46/289 (15%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEI-----VAVKI---ENSGTKHPQLLYEAKVYKIL 59
+ G+ +GSG+FG++ A+ ++ VAVK+ + ++ L+ E K+ L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 60 QGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFS----------------- 101
I N+ L+ + L + R KFS
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 102 -----LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
+ +L A Q+ +E++ + +HRD+ N L+ V I DFGLA+
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARDI 214
Query: 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQG 215
+ Y N ++ + + + + D+ S G +L G P+ G
Sbjct: 215 MSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269
Query: 216 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
+ + K+ + E C + +RP
Sbjct: 270 I---PVDANFYKLIQNGFKMDQPFYA---TEEIYIIMQSCWAFDSRKRP 312
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 3e-25
Identities = 57/280 (20%), Positives = 99/280 (35%), Gaps = 33/280 (11%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
+ KL + IG G FG++ L + VAVK + L EA V L+ N
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH----SN 61
Query: 68 I-KWYGVDGEDN---VLVLDLL-GPSLED-LFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
+ + GV E+ +V + + SL D L R +L + + +EY+
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
F+HRD+ N L+ + N + DFGL K+ ++ +
Sbjct: 122 NNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGK----------LPVKWTA 168
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
+ S + D+ S G +L G +P+ + K ++ + +
Sbjct: 169 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEKGYKMDAPDGC 225
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
P C L RP + L+ + + E
Sbjct: 226 ----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 6e-25
Identities = 60/283 (21%), Positives = 111/283 (39%), Gaps = 30/283 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKI---ENSGTKHPQLLYEAKVYKILQG 61
+ +LGR IG G FG++ ++ VA+K S + + L EA +
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 62 GSGIPNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
P+I K GV E+ V ++++L L + L ++++ A Q+ + Y
Sbjct: 68 ----PHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
+ S+ F+HRDI N L+ + V + DFGL++ D T Y + +
Sbjct: 124 LESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDST------YYKASKGKLPIK 174
Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
+ + + + D+ G + L G P+QG+ K + + + +
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-------KNNDVIGRIENGER 227
Query: 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
+ + P S C + +RP + LK + E
Sbjct: 228 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 100 bits (251), Expect = 7e-25
Identities = 55/277 (19%), Positives = 108/277 (38%), Gaps = 25/277 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIP 66
+ K+G G +GE++ + VAVK ++ + + L EA V K ++ P
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----P 73
Query: 67 NI-KWYGVDGEDNVLVLDL----LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
N+ + GV + + G L+ L R++ S +L +A Q+ + +EY+
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
+ F+HRD+ N L+G + + V + DFGL++ T H + ++ +
Sbjct: 134 KNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAK------FPIKWTA 184
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241
+ + S + D+ + G +L + + ++ EK C
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP---GIDLSQVYELLEKDYRMERPEGC 241
Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
P + C RP + + + F +F
Sbjct: 242 ---PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 1e-24
Identities = 53/269 (19%), Positives = 95/269 (35%), Gaps = 28/269 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
Y G ++GSG F + T A K G + E + K +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
Q PN+ + V + D +L+L+L+ F+ + + + Q++ +
Sbjct: 71 QH----PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 117 EYVHSRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
Y+HS H D+KP+N ++ ++ IIDFGLA K ++I G
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI--------FG 178
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
T + + D+ S+G + L G+ P+ G TK++ +
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG---DTKQETLANVSAVNYEF 235
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
E + A + +R
Sbjct: 236 EDEYF-SNTSALAKDFIRRLLVKDPKKRM 263
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 1e-24
Identities = 53/285 (18%), Positives = 101/285 (35%), Gaps = 30/285 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHV-DTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGG 62
+Y+ +IG G++G++F A + + VA+K + E V + L+
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 63 SGIPNIKWYGVDGEDNVLVLDLL--------GPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
++ + V L L +T+ + Q++
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
++++HS +HRD+KP N L+ + Q+ + DFGLA+ Y +
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIYSFQMALTSV--------V 176
Query: 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234
T Y + L + DL S+G + R ++G ++ + KI +
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG---SSDVDQLGKIL-DVIG 232
Query: 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
P E A FH + ++ + L DL +
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD--IDELGKDLLLK 275
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 2e-24
Identities = 59/291 (20%), Positives = 94/291 (32%), Gaps = 33/291 (11%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQG 61
+G +Y IG G++G + A VA+K T + L E K+ +
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65
Query: 62 GSGIPNI-KWYGV-------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI 113
NI + +D LV L+G L L + S + Q++
Sbjct: 66 ----ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL--KTQHLSNDHICYFLYQIL 119
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
++Y+HS LHRD+KP N L+ + I DFGLA+ +
Sbjct: 120 RGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVADPDHDHTGFLTEYVATR 176
Query: 174 TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233
A N ++ D+ S+G +L L + G + + I
Sbjct: 177 WYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLSNRPIFPG---KHYLDQLNHILGILG 230
Query: 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDF 284
S E L L + RLF + + D
Sbjct: 231 SPSQEDL------NCIINLKARNYLLSLPHKNKVPWNRLFPNA-DSKALDL 274
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 99.4 bits (247), Expect = 3e-24
Identities = 45/272 (16%), Positives = 98/272 (36%), Gaps = 21/272 (7%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKI---ENSGTKHPQLLYEAKV 55
+ I K+ + IG+G FGE+ + VA+K + + L EA +
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 80
Query: 56 YKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
+ +++ +++ + + SL+ +F++ ++ + + A
Sbjct: 81 MGQFDH-PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
++Y+ ++HRD+ N L+ + DFGL++ D T++ Y
Sbjct: 140 GMKYLADMNYVHRDLAARNILVN---SNLVCKVSDFGLSRFLEDDTSDPT--YTSALGGK 194
Query: 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKV 233
R+ + + + D+ S G V+ + G P+ + T + + I +
Sbjct: 195 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---TNQDVINAIEQDYR 251
Query: 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
P P+ C + RP
Sbjct: 252 LPPPM----DCPSALHQLMLDCWQKDRNHRPK 279
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 98.8 bits (245), Expect = 5e-24
Identities = 62/281 (22%), Positives = 105/281 (37%), Gaps = 29/281 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
KY KIG G++G ++ A + + E A+K + + E + K L+ S
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH-S 60
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
I + + VLV + L L+ L C T Q++ I Y H R
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH-----IPYRENKNLTGTAR 178
LHRD+KP N L+ + ++ I DFGLA+ + P + YR L G+ +
Sbjct: 121 VLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
Y S D+ S+G + + G+ + G ++ + +I + + TP
Sbjct: 178 Y-----------STTIDIWSVGCIFAEMVNGTPLFPG---VSEADQLMRIF-RILGTPNS 222
Query: 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
+ ++ L DL S+
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSK 263
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 5e-24
Identities = 51/265 (19%), Positives = 95/265 (35%), Gaps = 24/265 (9%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-------ENSGTKHPQLLYEAKVYKILQG 61
+K + +GSG+FG ++ + E V + + S + ++L EA V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 62 GSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
+ + + ++ + L D + + +L Q+ + Y+
Sbjct: 71 -PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
R +HRD+ N L+ V I DFGLAK H + ++ +
Sbjct: 130 RRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHA-----EGGKVPIKWMA 181
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
+ L + + D+ S G + + GS P+ G+ A + I EK P +
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SEISSILEKGERLPQPPI 237
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPD 265
C + C + D RP
Sbjct: 238 C---TIDVYMIMVKCWMIDADSRPK 259
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.1 bits (241), Expect = 1e-23
Identities = 49/263 (18%), Positives = 99/263 (37%), Gaps = 27/263 (10%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPN 67
+++G+G FG + VA+K I+ + + EAKV L
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH----EK 60
Query: 68 I-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
+ + YGV ++ + + L + R +F + +L + + +EY+ S+
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
FLHRD+ N L+ V + DFGL++ D Y + R++
Sbjct: 121 FLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE------YTSSVGSKFPVRWSPPE 171
Query: 184 THLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
+ + S + D+ + G ++ G +P++ T + + I + +
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF---TNSETAEHIAQGLRLYRPHLA-- 226
Query: 243 SHPAEFASYFHYCQSLTFDQRPD 265
+ + + C D+RP
Sbjct: 227 --SEKVYTIMYSCWHEKADERPT 247
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 2e-23
Identities = 49/248 (19%), Positives = 106/248 (42%), Gaps = 23/248 (9%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKI------ENSGTKHPQLLYE 52
E++ ++L + +G+G++G++FL + DT ++ A+K+ E
Sbjct: 19 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE 78
Query: 53 AKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQM 112
+V + ++ + + + L+LD + + R +F+ V + ++
Sbjct: 79 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 138
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
+ +E++H G ++RDIK +N L+ V + DFGL+K++ T R +
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFC---- 191
Query: 173 LTGTARYASCNTHLGIEQ--SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230
GT Y + + G + + D SLG ++ L G+ P+ +K +I
Sbjct: 192 --GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV---DGEKNSQAEISR 246
Query: 231 KKVSTPIE 238
+ + +
Sbjct: 247 RILKSEPP 254
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 96.5 bits (239), Expect = 4e-23
Identities = 58/302 (19%), Positives = 102/302 (33%), Gaps = 53/302 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKI---ENSGTKHPQLLYEAKVYKIL 59
+ R IG G+FG +F A + +VAVK+ E S EA +
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 60 QGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDL-----------------------FVY 95
+ + + G+ L+ + + L +
Sbjct: 74 DNPNIVKLL-GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 96 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
S L +A Q+ A + Y+ R F+HRD+ N L+G + V I DFGL++
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLSRN 189
Query: 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQ 214
Y+ + N R+ + + D+ + G VL G P+
Sbjct: 190 IYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244
Query: 215 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG----FLK 270
G+ ++ + + + E + P E + C S RP + L+
Sbjct: 245 GM---AHEEVIYYVRDGNILACPE----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297
Query: 271 RL 272
R+
Sbjct: 298 RM 299
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 97.4 bits (241), Expect = 5e-23
Identities = 64/310 (20%), Positives = 106/310 (34%), Gaps = 37/310 (11%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQ 60
E +Y L RK+G G F ++LA + N VA+K + E K+ + +
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67
Query: 61 ----------GGSGIPNIKWYGVDGEDNVLVLDLLG-----PSLEDLFVYCRRKFSLKTV 105
G + I + + N + + ++ L + Y R L V
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 106 LMLADQMIARIEYV-HSRGFLHRDIKPDNFLM---GLGRKANQVYIIDFGLAKKYRDPTT 161
++ Q++ ++Y+ G +H DIKP+N LM Q+ I D G A Y + T
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK 221
N T Y S LG D+ S ++ + G ++ + +
Sbjct: 188 NSI----------QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237
Query: 222 KQKYD---KICEKKVSTPIEVLCKSHPAEF----ASYFHYCQSLTFDQRPDYGFLKRLFH 274
+ D +I E P +L L F D K F
Sbjct: 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS 297
Query: 275 DLFSREGYDF 284
++E DF
Sbjct: 298 KDEAKEISDF 307
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.4 bits (239), Expect = 5e-23
Identities = 50/284 (17%), Positives = 92/284 (32%), Gaps = 39/284 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKIL 59
+ G+ +G+G+FG++ A D VAVK+ T+ L+ E KV L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 60 QGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDL-----------------FVYCRRKFS 101
I N+ G +++ + L +
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
L+ +L + Q+ + ++ S+ +HRD+ N L+ I DFGLA+ ++ +
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSN 200
Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK 221
Y N ++ + + + D+ S G L
Sbjct: 201 -----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY--PGMPV 253
Query: 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
K+ K+ ++ PAE C +RP
Sbjct: 254 DSKFYKMIKEGFRMLSPEHA---PAEMYDIMKTCWDADPLKRPT 294
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.8 bits (237), Expect = 6e-23
Identities = 59/282 (20%), Positives = 101/282 (35%), Gaps = 27/282 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
KY+ KIG G++G +F A + +T+EIVA+K ++ L E + K L+
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HK 61
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
I + + LV + L+ F C + V Q++ + + HSR
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
LHRD+KP N L+ + ++ + +FGLA+ + P T Y +
Sbjct: 122 VLHRDLKPQNLLIN---RNGELKLANFGLARAFGIPVRCYS-------AEVVTLWYRPPD 171
Query: 184 THLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
G + S D+ S G + P + +I + E
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPL--FPGNDVDDQLKRIFRLLGTPTEE---- 225
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDF 284
++ S + P L + L + G D
Sbjct: 226 ----QWPSMTKLPDYKPYPMYPATTSLVNVVPKL-NATGRDL 262
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.7 bits (237), Expect = 1e-22
Identities = 55/261 (21%), Positives = 103/261 (39%), Gaps = 38/261 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
Y+ + +GSG++G + A T VA+K S + E ++ K ++
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH-- 76
Query: 64 GIPNI-KWYGVDGEDN--------VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
N+ V D LV+ +G L L K + L QM+
Sbjct: 77 --ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM--KHEKLGEDRIQFLVYQMLK 132
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR--HIPYRENKN 172
+ Y+H+ G +HRD+KP N + + ++ I+DFGLA++ T YR +
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQADSEMTGYVVTRWYRAPEV 189
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
+ RY ++ D+ S+G ++ + G ++G + + +I +
Sbjct: 190 ILNWMRY-----------TQTVDIWSVGCIMAEMITGKTLFKG---SDHLDQLKEIMKVT 235
Query: 233 VSTPIEVLCKSHPAEFASYFH 253
+ P E + + E +Y
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMK 256
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 2e-22
Identities = 60/291 (20%), Positives = 105/291 (36%), Gaps = 43/291 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
+Y+ +GSG++G + A T VAVK S + E ++ K ++
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH-- 76
Query: 64 GIPNI---------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
N+ + D LV L+G L ++ +K + V L Q++
Sbjct: 77 --ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI--VKCQKLTDDHVQFLIYQILR 132
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
++Y+HS +HRD+KP N + + ++ I+DFGLA+ D T
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGYVA--------- 180
Query: 175 GTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233
T Y + L ++ D+ S+G ++ L G + G + I
Sbjct: 181 -TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG---TDHIDQLKLILRLVG 236
Query: 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDF 284
+ E+L K +Y + Q P F + D
Sbjct: 237 TPGAELLKKISSESARNYIQ-----SLTQMPKMNFANVFIG--ANPLAVDL 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.2 bits (233), Expect = 2e-22
Identities = 53/277 (19%), Positives = 95/277 (34%), Gaps = 19/277 (6%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
++ KIG G++G ++ A + T E+VA+K + + E + K L
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HP 61
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSR 122
I + LV + L L+ L + Q++ + + HS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
LHRD+KP N L+ + + DFGLA+ + P + A
Sbjct: 122 RVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPE 172
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
S D+ SLG + + + G ++ + +I + + TP EV+
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIF-RTLGTPDEVVWP 228
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
+ + + D L L S+
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQ 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.6 bits (232), Expect = 2e-22
Identities = 51/263 (19%), Positives = 99/263 (37%), Gaps = 27/263 (10%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPN 67
++IGSG FG + L ++ ++ VA+K I + EA+V L P
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSH----PK 61
Query: 68 I-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
+ + YGV + LV + + L D R F+ +T+L + + + Y+
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
+HRD+ N L+ + + + DFG+ + D + ++AS
Sbjct: 122 VIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTK------FPVKWASPE 172
Query: 184 THLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
S + D+ S G ++ G +P++ + + + I L
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDI-STGFRLYKPRLAS 228
Query: 243 SHPAEFASYFHYCQSLTFDQRPD 265
+H + + +C + RP
Sbjct: 229 THVYQIMN---HCWKERPEDRPA 248
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.5 bits (231), Expect = 1e-21
Identities = 56/290 (19%), Positives = 113/290 (38%), Gaps = 30/290 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
+Y+ + IGSG+ G + A + VA+K + T + E + K + +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 64 -----GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
+ + + +D LV++L+ +L + + + + L QM+ I++
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKH 134
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
+HS G +HRD+KP N ++ + + I+DFGLA+ T
Sbjct: 135 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPY--------VVTRY 183
Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
Y + LG+ D+ S+G ++ +R + + G +++K+ E+ + E
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG---RDYIDQWNKVIEQLGTPCPE 240
Query: 239 VLCKSHPA--EFASYFHYCQSLTFDQRPDYGFLK--RLFHDLFSREGYDF 284
+ K P + LTF + + L + + D
Sbjct: 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.8 bits (227), Expect = 1e-21
Identities = 56/278 (20%), Positives = 91/278 (32%), Gaps = 30/278 (10%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKI-------ENSGTKHPQLLYEAKVYKILQGGSGI 65
+G G F ++ A +TN+IVA+K E + L E K+ + L
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH---- 59
Query: 66 PNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
PNI G + LV D + LE + + + + +EY+H
Sbjct: 60 PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
LHRD+KP+N L+ + + + DFGLAK + P + T Y +
Sbjct: 120 WILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYT-------HQVVTRWYRAP 169
Query: 183 NTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241
G D+ ++G +L L G + + +I E + E
Sbjct: 170 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG---DSDLDQLTRIFETLGTPTEEQWP 226
Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
F + DL
Sbjct: 227 DMCSLPDYVTFKSFPGIPLHHIFSA--AGDDLLDLIQG 262
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.7 bits (224), Expect = 3e-21
Identities = 44/280 (15%), Positives = 98/280 (35%), Gaps = 30/280 (10%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNE----IVAVKI---ENSGTKHPQLLYEAKVYKILQG 61
+ IG+G FGE++ ++ VA+K + + L EA +
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 62 GSGIPNI-KWYGVDGEDNVLVLDL---LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
NI + GV + +++ +L+ +FS+ ++ + + A ++
Sbjct: 69 ----HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
Y+ + ++HRD+ N L+ + DFGL++ D +
Sbjct: 125 YLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYT----TSGGKIPI 177
Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK-KVSTP 236
R+ + + + D+ S G V+ + + + I + ++ TP
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW--ELSNHEVMKAINDGFRLPTP 235
Query: 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276
++ P+ C +RP + + + L
Sbjct: 236 MDC-----PSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.6 bits (224), Expect = 5e-21
Identities = 49/279 (17%), Positives = 85/279 (30%), Gaps = 40/279 (14%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGGS 63
K IG G+FG++ A + I S H E +V L
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 64 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDL---------------FVYCRRKFSLKTVLM 107
I N+ L ++ +L D S + +L
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 108 LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167
A + ++Y+ + F+HRD+ N L+G + I DFGL++
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYVKKTMG-- 186
Query: 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYD 226
R+ + + + D+ S G +L + G P+ G+ T + Y+
Sbjct: 187 ------RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAELYE 237
Query: 227 KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
K+ + E C +RP
Sbjct: 238 KLPQGYRLEKPLNC----DDEVYDLMRQCWREKPYERPS 272
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.3 bits (218), Expect = 3e-20
Identities = 49/282 (17%), Positives = 101/282 (35%), Gaps = 23/282 (8%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTKHP---QLLYEAKVYKILQ 60
+ IG G FG ++ + +D + AVK N T Q L E + K
Sbjct: 27 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 86
Query: 61 GGSGIPNIKWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
+ ++ + E + +VL + L + ++K ++ Q+ +++
Sbjct: 87 H-PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 145
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
+ S+ F+HRD+ N ++ + V + DFGLA+ D + +
Sbjct: 146 LASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEFDSV---HNKTGAKLPVK 199
Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
+ + + + + + D+ S G +L + RG+ P+ + + + +
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---NTFDITVYLLQGRRLLQP 256
Query: 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
E P C + RP + L +FS
Sbjct: 257 EYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.6 bits (216), Expect = 4e-20
Identities = 52/285 (18%), Positives = 103/285 (36%), Gaps = 42/285 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVKI---ENSGTKHPQLLYEAKVYK 57
+ LG+ +G G+FG++ LA + ++ VAVK+ + + L+ E ++ K
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 58 ILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFS 101
++ I N+ ++++ +L + R + S
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
K ++ A Q+ +EY+ S+ +HRD+ N L+ + N + I DFGLA+
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDY 190
Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAAT 220
+ N ++ + + + D+ S G +L G P+ G+
Sbjct: 191 YKK-----TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV---P 242
Query: 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
++ + + E E C QRP
Sbjct: 243 VEELFKLLKEGHRMDKPSNC----TNELYMMMRDCWHAVPSQRPT 283
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.6 bits (216), Expect = 5e-20
Identities = 72/311 (23%), Positives = 105/311 (33%), Gaps = 45/311 (14%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG 64
I L IG G FGE++ E VAVKI +S + EA++Y+ +
Sbjct: 1 IARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS-REERSWFREAEIYQTVMLRH- 56
Query: 65 IPNI-KWYGVDGEDNV------LVLDLL-GPSLED------LFVYCRRKFSLKTVLMLAD 110
NI + D +DN LV D SL D + V K +L T LA
Sbjct: 57 -ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAH 115
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
+ + HRD+K N L+ K I D GLA ++ T I
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTCCIADLGLAVRHDSATDTIDIAP--- 169
Query: 171 KNLTGTARY------ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG--------- 215
+ GT RY E +R D+ ++G V R
Sbjct: 170 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229
Query: 216 ---LKAATKKQKYDKICEKKVSTPIEVLCKSHPA--EFASYFHYCQSLTFDQRPDYGFLK 270
+ ++ +CE+K+ I +S A A C R +K
Sbjct: 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
Query: 271 RLFHDLFSREG 281
+ L +EG
Sbjct: 290 KTLSQLSQQEG 300
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.7 bits (211), Expect = 2e-19
Identities = 58/295 (19%), Positives = 104/295 (35%), Gaps = 40/295 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG 62
+ KLG+ +G G+FG++ A T VAVK+ G H + KIL
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 63 SGIPNIK--WYGVDGEDNVLVLDLLGPSLEDLFVYCRRK------------------FSL 102
N+ L++ + +L Y R K +L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
+ ++ + Q+ +E++ SR +HRD+ N L+ + N V I DFGLA+
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD- 189
Query: 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG-SLPWQGLKAATK 221
Y + ++ + T + + D+ S G +L + P+ G+K
Sbjct: 190 ----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-- 243
Query: 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276
+++ + ++ E C QRP + L +L
Sbjct: 244 -EEFCRRLKEGTRMRAPDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.3 bits (210), Expect = 3e-19
Identities = 55/301 (18%), Positives = 106/301 (35%), Gaps = 39/301 (12%)
Query: 8 KYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKI---ENSGTKHPQLLYEAKVYKIL 59
K + R++G GSFG ++ + VA+K S + + L EA V K
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 60 QGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRR---------KFSLKTVLMLA 109
+ + G+ +++++L+ L+ R SL ++ +A
Sbjct: 81 N-CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 110 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
++ + Y+++ F+HRD+ N ++ + V I DFG+ + + YR+
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDY-----YRK 191
Query: 170 NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKI 228
R+ S + + D+ S G VL P+QGL + +Q +
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLRFV 248
Query: 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG----FLKRLFHDLFSREGYDF 284
E + + P C RP + +K F + +
Sbjct: 249 MEGGLLDKPDNC----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYY 304
Query: 285 D 285
Sbjct: 305 S 305
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.4 bits (195), Expect = 6e-18
Identities = 28/183 (15%), Positives = 61/183 (33%), Gaps = 32/183 (17%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT------------KHPQLLYEAKV- 55
+G+ +G G +F + VK G A
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 56 ----YKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQ 111
++ LQ G+ K Y + N +++ E + + ++ + D
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWE--GNAVLM-------ELIDAKELYRVRVENPDEVLDM 111
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
++ + + RG +H D+ N L+ ++IIDF + + + + R+ +
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWIIDFPQSVEVGEEGWREIL-ERDVR 166
Query: 172 NLT 174
N+
Sbjct: 167 NII 169
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 414 | |||
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.44 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.12 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.92 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.48 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.13 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.96 |
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-60 Score=448.66 Aligned_cols=298 Identities=69% Similarity=1.232 Sum_probs=267.4
Q ss_pred CCcccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 1 ~~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
|+--+|++|+++++||+|+||+||+|++..+|+.||||++.......++..|+++++.+.|+++++.+..++......++
T Consensus 1 ~~~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp CCCEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CCCeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 67778999999999999999999999999999999999988877777899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 81 v~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||||+++++.+.+......+++..++.++.|++.||+|||++|||||||||+|||+...+.+..+||+|||+|+......
T Consensus 81 vme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 81 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 99999999999888878889999999999999999999999999999999999999766677889999999999887766
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
.....+++.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+.+....+...+.+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence 66666666677889999999999999999999999999999999999999999987766666666666677777788888
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCccccccccccchh
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQT 298 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l~~~~~ 298 (414)
+.++|+++.+++..||..+|++||++.+|.+.|++++.+.++..++.+||..+++.+.
T Consensus 241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~~~~~~~ 298 (299)
T d1ckia_ 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298 (299)
T ss_dssp TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHHGGGTCC
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchhhcCCCC
Confidence 8899999999999999999999999999999999999999999999999998887654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.9e-60 Score=441.87 Aligned_cols=291 Identities=57% Similarity=0.996 Sum_probs=266.7
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
+|++++|+++++||+|+||+||+|++..+|+.||||++........+.+|+++++.|.++++++.+..++......++||
T Consensus 1 ~vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 58899999999999999999999999999999999998877777789999999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccC--CCCCeEEEeeecceeeecCCC
Q 015041 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG--RKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 83 e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~--~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||++++|.+++......++..++..++.|++.||+|||++|||||||||+|||++.. ...+.+||+|||+|+......
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 81 DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred EecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 999999999998877789999999999999999999999999999999999999632 235789999999999987776
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
.....+.+.....+||+.|||||++.+..++.++|||||||++|||++|+.||.+.........+.++...+...+.+.+
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHh
Confidence 66666666677889999999999999999999999999999999999999999987777777777777777777788888
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcccccccc
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 293 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l 293 (414)
++.+|+++.+++..||..+|++||+|+.+.+.|++++.+.+...++.|||.+|
T Consensus 241 ~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~~~ 293 (293)
T d1csna_ 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293 (293)
T ss_dssp TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGCC
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCCcC
Confidence 88999999999999999999999999999999999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-53 Score=394.53 Aligned_cols=246 Identities=22% Similarity=0.316 Sum_probs=205.7
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCC--CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
.++|+++++||+|+||+||+|++..+|+.||||++... ...+.+.+|+.+++.++| ++|+.+..++.+....++|||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCC-CCEeeEeEEEEECCEEEEEEE
Confidence 35899999999999999999999999999999987643 234568899999999976 667788888888889999999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
|+ +++|.+++.. ..+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.......
T Consensus 98 y~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTC-
T ss_pred ecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheeeccccc-
Confidence 99 7888887653 569999999999999999999999999999999999999 4788999999999987654322
Q ss_pred ccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhh
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~ 242 (414)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.... +.+..+........ ....
T Consensus 172 ------~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~~~~~~~~~~--~~~~ 240 (293)
T d1yhwa1 172 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALYLIATNGTPEL--QNPE 240 (293)
T ss_dssp ------CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHHCSCCC--SSGG
T ss_pred ------cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH---HHHHHHHhCCCCCC--CCcc
Confidence 123568999999999999999999999999999999999999999875443 23333333322111 1224
Q ss_pred cChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 243 SHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 243 ~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
.+++++.+|+.+||..||++||+++++
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~ei 267 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKEL 267 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 668999999999999999999998765
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-53 Score=388.43 Aligned_cols=243 Identities=24% Similarity=0.340 Sum_probs=208.2
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|++++.||+|+||+||+|++..+++.||||++.. ......+.+|+.+++.++| ++|..+..++.+....++|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH-PNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCC-CCCCeEEEEEEECCEEEEE
Confidence 579999999999999999999999999999998753 2334568899999999975 6777888888888899999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++.. ...+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+......
T Consensus 85 mEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCCC
T ss_pred EeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeecCCCc
Confidence 9999 7899988876 4579999999999999999999999999999999999999 578899999999997554322
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
. ....||+.|||||++.+..++.++|||||||++|||++|+.||.+.+.. +.+..+.......|
T Consensus 161 ~---------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~~~~p---- 224 (263)
T d2j4za1 161 R---------TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETYKRISRVEFTFP---- 224 (263)
T ss_dssp C---------EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTTCCCCC----
T ss_pred c---------cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCCCCC----
Confidence 1 3568999999999999999999999999999999999999999875433 44455555554444
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+++++.+|+..||..||++||+++++.+
T Consensus 225 -~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 225 -DFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 356899999999999999999999887644
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=391.18 Aligned_cols=249 Identities=27% Similarity=0.316 Sum_probs=203.0
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
-++|+++++||+|+||+||+|++..+|+.||||++.... ....+.+|+.+++.++| ++|..+..++.+....++||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-ENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCC-CCEeeEeeeeccCceeEEEE
Confidence 368999999999999999999999999999999986543 23458899999999976 67778888888889999999
Q ss_pred ecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
||+ +++|.+++.. ...+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.......
T Consensus 83 Ey~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 83 EYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp ECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECEETTE
T ss_pred eccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhheeeccCCc
Confidence 999 7799888754 4579999999999999999999999999999999999999 5788999999999987643322
Q ss_pred CccccccCCCCCccCcCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
. ......+||+.|||||++.+..+ +.++|||||||++|||++|+.||.+..... ..+..+.......+ .
T Consensus 159 ~-----~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~~~~~~~~~~~---~ 228 (271)
T d1nvra_ 159 E-----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWKEKKTYLN---P 228 (271)
T ss_dssp E-----CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHHHHHHTTCTTST---T
T ss_pred c-----ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--HHHHHHhcCCCCCC---c
Confidence 1 12246789999999999998876 678999999999999999999998754332 22222222222221 1
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
...+++++.+|+..||..||++||+++++
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~~ei 257 (271)
T d1nvra_ 229 WKKIDSAPLALLHKILVENPSARITIPDI 257 (271)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 24568899999999999999999998765
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-53 Score=393.34 Aligned_cols=247 Identities=17% Similarity=0.300 Sum_probs=206.1
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
+.|+++++||+|+||+||+|++..+++.||||++..... ...+.+|+++++.++| ++|..+..++.+....++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH-PNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEeeCCeEEEEEec
Confidence 469999999999999999999999999999999876543 3568899999999976 6777888888888999999999
Q ss_pred c-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 85 ~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.......
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~~~-- 165 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQ-- 165 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHHHH--
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhccCCCcc--
Confidence 9 789988877767789999999999999999999999999999999999999 5788999999999976533211
Q ss_pred cccccCCCCCccCcCcccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchH
Q 015041 164 HIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~ 238 (414)
.....+||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.+.. +.+.++....... .
T Consensus 166 -----~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---~~~~~i~~~~~~~--~ 235 (288)
T d2jfla1 166 -----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---RVLLKIAKSEPPT--L 235 (288)
T ss_dssp -----HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHHHHHHHSCCCC--C
T ss_pred -----cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---HHHHHHHcCCCCC--C
Confidence 113568999999999984 445899999999999999999999999886544 3344444433221 1
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
.....+++++.+|+..||..||++||++.++
T Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~el 266 (288)
T d2jfla1 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266 (288)
T ss_dssp SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 1224668999999999999999999998765
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-53 Score=393.55 Aligned_cols=266 Identities=22% Similarity=0.326 Sum_probs=215.7
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 80 (414)
-.+|++++.||+|+||+||+|++..+++.||||++.. ......+.+|+++++.++| ++|..++.++.+....++
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCS-TTBCCEEEEEECSSEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCC-CCeeEEEEEEEECCEEEE
Confidence 3579999999999999999999999999999998763 2334568899999999976 677788888888889999
Q ss_pred EEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 81 v~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
||||+ +++|.+++.. .+.+++..++.++.|++.||+|||++|||||||||+|||+ +.++.+||+|||+|+.....
T Consensus 86 vmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC--
T ss_pred EEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceecccC
Confidence 99999 7799888775 4679999999999999999999999999999999999999 58889999999999876533
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+. .+.+.++.......|
T Consensus 162 ~~~~-----~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~~i~~~~~~~p--- 230 (288)
T d1uu3a_ 162 SKQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKIIKLEYDFP--- 230 (288)
T ss_dssp -------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHTTCCCCC---
T ss_pred Cccc-----ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH---HHHHHHHHcCCCCCC---
Confidence 2211 12356899999999999999999999999999999999999999987543 345556666555544
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcccccccc
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 293 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l 293 (414)
..+++++.+|+..||..||.+||+++++... ..+ ..+.|...+||..+
T Consensus 231 --~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~-~~i---~~Hpff~~i~w~~l 278 (288)
T d1uu3a_ 231 --EKFFPKARDLVEKLLVLDATKRLGCEEMEGY-GPL---KAHPFFESVTWENL 278 (288)
T ss_dssp --TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH-HHH---HTSGGGTTCCCTTG
T ss_pred --ccCCHHHHHHHHHHccCCHhHCcCHHHHcCC-HHH---HcCCccCCCCHHHh
Confidence 4568899999999999999999999876442 111 12344555677543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-52 Score=392.48 Aligned_cols=253 Identities=21% Similarity=0.282 Sum_probs=199.7
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
+.++|++++.||+|+||+||+|++..+++.||||++.... ....+.+|+.+++.++| ++|+.+..++.+....++|
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKH-PNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEE
Confidence 4678999999999999999999999999999999886543 23457789999999975 6788888888888999999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++.. ...+++..+..++.||+.||+|||++|||||||||+|||+...+.++.+||+|||+|+......
T Consensus 86 mE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp ECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 9999 7899998865 5679999999999999999999999999999999999999755678899999999998654322
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
. ....+||+.|||||++.+..|+.++|||||||++|||++|..||.+.... +....+.......+.+ .
T Consensus 165 ~--------~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~~~~~~~~~~-~ 232 (307)
T d1a06a_ 165 V--------LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLFEQILKAEYEFDSP-Y 232 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHTTCCCCCTT-T
T ss_pred e--------eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHhccCCCCCCc-c
Confidence 1 13568999999999999999999999999999999999999999875433 3445555555444432 3
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
...+|+++.+|+..||..||++||+++++.+
T Consensus 233 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 3567899999999999999999999887643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=387.24 Aligned_cols=260 Identities=22% Similarity=0.319 Sum_probs=205.9
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCee
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 78 (414)
+|-.++|+++++||+|+||+||+|++ +..||||+++.... ...+.+|+.++..++| ++|..+..++. ....
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~~~~~-~~~~ 78 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH-VNILLFMGYST-APQL 78 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCC-TTBCCEEEEEC-SSSC
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCEeeeeEEEe-ccEE
Confidence 35568999999999999999999985 33599999865432 2457889999999976 56666666654 4568
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
++||||+ +++|.+++......+++..++.|+.||+.||+|||+++||||||||+|||+ +.++.+||+|||+|+...
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC--
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE---cCCCCEEEccccceeecc
Confidence 9999999 689999987666779999999999999999999999999999999999999 588999999999997654
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc-c
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK-V 233 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~-~ 233 (414)
..... .......||+.|||||++.+. .|+.++|||||||++|||+||+.||.+..... .+..++... .
T Consensus 156 ~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~---~~~~~~~~~~~ 227 (276)
T d1uwha_ 156 RWSGS-----HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIFMVGRGYL 227 (276)
T ss_dssp ---------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHHTSC
T ss_pred ccCCc-----ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH---HHHHHHhcCCC
Confidence 32221 122356899999999999754 48999999999999999999999998765432 222333333 3
Q ss_pred CCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 234 ~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
.+........+|+++.+++..||..+|++||++.+|.+.|+.+.+
T Consensus 228 ~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 228 SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 333444556789999999999999999999999999999887654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=377.12 Aligned_cols=255 Identities=18% Similarity=0.289 Sum_probs=202.4
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
.++|+++++||+|+||+||+|.+. +++.||||+++... ...++.+|+++++.++| ++|..+..++......++||||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEEEC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCC-CCcccccceeccCCceEEEEEe
Confidence 478999999999999999999985 56789999987654 34568999999999975 7787888888788889999999
Q ss_pred c-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 85 ~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
+ +++|.+++......+++..++.|+.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+|+........
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheeccCCCce-
Confidence 9 889999887666779999999999999999999999999999999999999 58899999999999865443221
Q ss_pred cccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhhh
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~ 242 (414)
......||..|+|||++.+..++.++|||||||++|||+| |.+||...... +.+..+.. ....+.+ .
T Consensus 158 -----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~---~~~~~i~~-~~~~~~p---~ 225 (263)
T d1sm2a_ 158 -----SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDIST-GFRLYKP---R 225 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH---HHHHHHHH-TCCCCCC---T
T ss_pred -----eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH---HHHHHHHh-cCCCCCc---c
Confidence 1224578999999999999999999999999999999999 56666654332 33333322 2233222 3
Q ss_pred cChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 243 ~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
.+++++.+++..||+.+|++||++++|.+.|+++.+
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 458899999999999999999999999999998754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-51 Score=385.83 Aligned_cols=263 Identities=18% Similarity=0.293 Sum_probs=203.0
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCc---eEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
+-.++|++.+.||+|+||+||+|++..+++ .||||.+...... ..+.+|+++++.++| ++|+.+..++.....
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH-PNVIHLEGVVTKSTP 101 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSSSS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC-CCCccEEEEEeeCCE
Confidence 445789999999999999999999876654 5889987655433 358899999999975 677778788888889
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
.++||||+ +++|.+++......+++.+++.++.||+.||+|||+++||||||||+|||+ +.++.+||+|||+|+..
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceEc
Confidence 99999999 788988887666679999999999999999999999999999999999999 58899999999999865
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
........ ........||+.|||||++.+..++.++|||||||++|||+| |..||.+.... +.+..+. .....
T Consensus 179 ~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~i~-~~~~~ 252 (299)
T d1jpaa_ 179 EDDTSDPT--YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINAIE-QDYRL 252 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH-TTCCC
T ss_pred cCCCCcce--eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHHHHH-cCCCC
Confidence 54322111 111223467999999999999999999999999999999998 89999986543 2333333 23333
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
+.+ ..+|+++.+++..||+.+|++||++.+|.+.|+++++.
T Consensus 253 ~~~---~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 253 PPP---MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp CCC---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCC---ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 322 35689999999999999999999999999999988753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-52 Score=387.13 Aligned_cols=259 Identities=19% Similarity=0.283 Sum_probs=212.9
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
|-.++|+++++||+|+||+||+|.+..+++.||||+++.+.. .+++.+|+.+++.++| ++|..+..++.+....++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCC-CCEecCCccEeeCCeeEEEe
Confidence 455789999999999999999999999999999999876544 3568999999999976 67777877778888999999
Q ss_pred ecc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 83 e~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||+ +++|.+++... ...+++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+......
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTTCCSSS
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceeecCCCC
Confidence 999 78999888754 3568999999999999999999999999999999999999 588999999999997654332
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
.. ......||..|+|||++.+..|+.++|||||||++|||++|..||...... ..+.+++......+.+
T Consensus 170 ~~------~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~---~~~~~~i~~~~~~~~~-- 238 (287)
T d1opja_ 170 YT------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKDYRMERP-- 238 (287)
T ss_dssp SE------EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHTTCCCCCC--
T ss_pred ce------eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH---HHHHHHHhcCCCCCCC--
Confidence 21 112446889999999999999999999999999999999976665432221 2233334444443332
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
..+|+++.+|+..||..||++||++.++.+.|+.++.
T Consensus 239 -~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 239 -EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred -ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 4568999999999999999999999999988887653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.7e-51 Score=392.59 Aligned_cols=251 Identities=18% Similarity=0.253 Sum_probs=212.1
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+.+++.|+| ++|+.+..++.+....+|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCC-TTBCCEEEEEEETTEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEEEc
Confidence 589999999999999999999999999999999876543 2457899999999975 6777887888888999999999
Q ss_pred c-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 85 ~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
+ +++|.+++......+++..++.|+.||+.||+|||++|||||||||+|||+.. +.++.+||+|||+|+.......
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~-- 181 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQS-- 181 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTSCCEEECCCTTCEECCTTSC--
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-CCCCeEEEeecchheecccccc--
Confidence 9 78999988655667999999999999999999999999999999999999942 2357899999999987654322
Q ss_pred cccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhc
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~ 243 (414)
.....||+.|||||++.+..++.++|||||||++|||++|+.||.+.+. .+.+..+.......+. .....
T Consensus 182 ------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~~~~~~-~~~~~ 251 (350)
T d1koaa2 182 ------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLRNVKSCDWNMDD-SAFSG 251 (350)
T ss_dssp ------EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCCSCC-GGGGG
T ss_pred ------cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCCc-ccccC
Confidence 1356899999999999999999999999999999999999999987543 3445555555544442 33456
Q ss_pred ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 244 HPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 244 ~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
+++++.+|+.+||..||.+||+++++.+
T Consensus 252 ~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 252 ISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 7899999999999999999999887644
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=396.46 Aligned_cols=201 Identities=20% Similarity=0.318 Sum_probs=175.7
Q ss_pred cccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 3 ~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
++..++|+++++||+|+||+||+|++..+|+.||+|+++.... ...+.+|+.+++.++| ++|+.+..++.+....+
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCC-TTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEE
Confidence 4667899999999999999999999999999999999875533 2457899999999976 67778888888888999
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||+|+...
T Consensus 81 iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHH
T ss_pred EEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCccccC
Confidence 999999 6799998876 45699999999999999999999985 99999999999999 588999999999998654
Q ss_pred CCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCh
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 217 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~ 217 (414)
... ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+
T Consensus 157 ~~~---------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 157 DSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp HHT---------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred CCc---------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 322 136789999999999999999999999999999999999999998754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-51 Score=377.45 Aligned_cols=251 Identities=22% Similarity=0.256 Sum_probs=199.3
Q ss_pred CcccCCce-EEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeee--
Q 015041 2 ERIIGVKY-KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVD-- 74 (414)
Q Consensus 2 ~~i~~~~y-~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~-- 74 (414)
|...+++| ++.++||+|+||+||+|.+..+++.||+|.+..... ...+.+|+++++.++| ++|+.++.++..
T Consensus 3 g~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~ 81 (270)
T d1t4ha_ 3 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PNIVRFYDSWESTV 81 (270)
T ss_dssp EECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEEES
T ss_pred CcCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEeecc
Confidence 44556666 788999999999999999999999999998765432 2347899999999986 556666554432
Q ss_pred --CCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeccccCCCceEEccCCCCCeEEEee
Q 015041 75 --GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIID 149 (414)
Q Consensus 75 --~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--iiHrDLkp~Nili~~~~~~~~vkL~D 149 (414)
....++||||+ +++|.+++.. ...+++..++.++.||+.||+|||+++ ||||||||+|||++ ++++.+||+|
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~D 158 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGD 158 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECC
T ss_pred ccCCEEEEEEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEee
Confidence 34579999999 8899998876 457999999999999999999999998 99999999999994 3578999999
Q ss_pred ecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHH
Q 015041 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (414)
Q Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~ 229 (414)
||+|+...... ....+||+.|||||++.+ .++.++|||||||++|||++|+.||.+.... .+.+..+.
T Consensus 159 FGla~~~~~~~---------~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~~~~~i~ 226 (270)
T d1t4ha_ 159 LGLATLKRASF---------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVT 226 (270)
T ss_dssp TTGGGGCCTTS---------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHT
T ss_pred cCcceeccCCc---------cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--HHHHHHHH
Confidence 99997433221 235689999999999876 5999999999999999999999999864322 23333333
Q ss_pred hhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 230 ~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.. ... .......++++.+++.+||..||++||+++++.+
T Consensus 227 ~~-~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 227 SG-VKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TT-CCC--GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cC-CCC--cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 32 221 2233556789999999999999999999887643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=388.47 Aligned_cols=256 Identities=20% Similarity=0.283 Sum_probs=211.3
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCc-----eEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
-.++|+++++||+|+||+||+|++..+++ .||+|.+.... ....+.+|+.++..+.+|++|+.+..++.+..
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 34689999999999999999999875543 69999875432 33458899999999977788989988888888
Q ss_pred eeEEEEecc-CCCHHHHHHHhC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCc
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCR----------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 133 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~----------------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~N 133 (414)
..++||||+ +++|.+++.... ..+++..++.|+.||+.||+|||+++||||||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 999999999 889999987532 247889999999999999999999999999999999
Q ss_pred eEEccCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCC
Q 015041 134 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLP 212 (414)
Q Consensus 134 ili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~P 212 (414)
||+ +.++.+||+|||+|+......... ......||+.|||||++.+..++.++|||||||++|||++ |..|
T Consensus 195 ill---~~~~~~Kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 195 VLV---THGKVVKICDFGLARDIMSDSNYV-----VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp EEE---ETTTEEEECCCGGGSCGGGCTTSE-----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred ccc---ccCCeEEEeeccccccccCCCcee-----eeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCC
Confidence 999 588999999999998655443221 1235678999999999999999999999999999999998 8999
Q ss_pred CCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 213 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
|.+.... +.+.+++......+.+ ..+|+++.+|+..||+.+|++||++++|.+.|.
T Consensus 267 f~~~~~~---~~~~~~~~~~~~~~~p---~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 267 YPGIPVD---ANFYKLIQNGFKMDQP---FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp STTCCCS---HHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCHH---HHHHHHHhcCCCCCCC---CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 9876543 3344555555554433 355899999999999999999999999988775
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=378.76 Aligned_cols=253 Identities=19% Similarity=0.241 Sum_probs=211.5
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC--------CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
+.++|++++.||+|+||+||+|++..+|+.||||++.... ....+.+|+.+++.++| ++|+.+..++.+..
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~ 86 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH-PNVITLHEVYENKT 86 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSS
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECC
Confidence 5678999999999999999999999999999999876432 12458899999999976 67778888888889
Q ss_pred eeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCC-CCCeEEEeeeccee
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR-KANQVYIIDFGLAK 154 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~-~~~~vkL~DFG~a~ 154 (414)
..+|||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+...+ ....+||+|||+|+
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 999999999 7899998876 45799999999999999999999999999999999999995221 22369999999998
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.. +.+..+......
T Consensus 166 ~~~~~~~--------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~~~~~~ 234 (293)
T d1jksa_ 166 KIDFGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANVSAVNYE 234 (293)
T ss_dssp ECTTSCB--------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHTTCCC
T ss_pred hcCCCcc--------ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH---HHHHHHHhcCCC
Confidence 7643321 23568899999999999999999999999999999999999999985443 444555555554
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
.+. ......++++.+|+..||..||++||+++++.+
T Consensus 235 ~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 FED-EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCH-HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCc-hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 443 344567899999999999999999999887643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-51 Score=384.42 Aligned_cols=243 Identities=21% Similarity=0.311 Sum_probs=203.0
Q ss_pred ceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 8 ~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
.|+++++||+|+||+||+|++..+++.||||++...... ..+.+|+++++.++| ++|..+..++.+....++||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH-PNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCC-CCEeeEEEEEEECCEEEEEE
Confidence 599999999999999999999999999999998765432 347889999999975 67778877788888999999
Q ss_pred eccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 83 e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
|||.+++.+.+......+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS----
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---CCCCCEEEeecccccccCC----
Confidence 999655555555557789999999999999999999999999999999999999 4889999999999975432
Q ss_pred ccccccCCCCCccCcCccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
....+||+.|||||++.+ ..|+.++|||||||++|||++|..||.+.... +.+.++.......+..
T Consensus 168 -------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~---~~~~~i~~~~~~~~~~- 236 (309)
T d1u5ra_ 168 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQNESPALQS- 236 (309)
T ss_dssp -------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHSCCCCCSC-
T ss_pred -------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhCCCCCCCC-
Confidence 125689999999999864 35899999999999999999999999875433 3444555544433322
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+++++.+|+..||..||.+||+++++.+
T Consensus 237 --~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 237 --GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 456899999999999999999999987644
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=378.12 Aligned_cols=246 Identities=22% Similarity=0.277 Sum_probs=192.6
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeee--eCCeeEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGV--DGEDNVL 80 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~--~~~~~~l 80 (414)
++|++++.||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.++| ++|..+..++. .....++
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH-PNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCC-TTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCC-CCEeeEEEEEEeCCCCEEEE
Confidence 6899999999999999999999999999999998765432 347789999999976 55666655443 3456899
Q ss_pred EEecc-CCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcC-----eeccccCCCceEEccCCCCCeEEEeeec
Q 015041 81 VLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRG-----FLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (414)
Q Consensus 81 v~e~~-~~sL~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~-----iiHrDLkp~Nili~~~~~~~~vkL~DFG 151 (414)
||||+ +++|.+++... ...+++..++.++.||+.||+|||+++ ||||||||+|||+ +.++.+||+|||
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DFG 159 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFG 159 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEEECCHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeecc
Confidence 99999 78999988643 467999999999999999999999976 9999999999999 578999999999
Q ss_pred ceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhh
Q 015041 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (414)
Q Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~ 231 (414)
+|+....... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+.. +.+.++...
T Consensus 160 ~a~~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~~~i~~~ 229 (269)
T d2java1 160 LARILNHDTS-------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKIREG 229 (269)
T ss_dssp HHHHC------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHT
T ss_pred ceeecccCCC-------ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHHHHHHcC
Confidence 9986543222 123578999999999999999999999999999999999999999876543 344444444
Q ss_pred ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 232 ~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
.... ....+++++.+++.+||..||.+||++.++.
T Consensus 230 ~~~~----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell 264 (269)
T d2java1 230 KFRR----IPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264 (269)
T ss_dssp CCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 3332 2245689999999999999999999988764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=384.25 Aligned_cols=239 Identities=22% Similarity=0.321 Sum_probs=206.6
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|++++.||+|+||.||+|++..+|+.||||+++.. .....+.+|+.+++.++| ++|+.++..+.+....++|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCC-TTBCCEEEEEECSSEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCC-CCEEEEEeeeccccccccc
Confidence 6899999999999999999999999999999987642 234568899999999975 7788888888889999999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++.. ...+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+......
T Consensus 84 ~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTT
T ss_pred eeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeecccccccccCC
Confidence 9999 8889888776 5679999999999999999999999999999999999999 588999999999998654432
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
. .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+. .+.+..+.......|
T Consensus 160 ~-------~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~~~i~~~~~~~p---- 225 (337)
T d1o6la_ 160 A-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELILMEEIRFP---- 225 (337)
T ss_dssp C-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCC----
T ss_pred c-------ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---HHHHHHHhcCCCCCC----
Confidence 2 12367899999999999999999999999999999999999999998654 344555555555544
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCC
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPD 265 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~ 265 (414)
..+++++.+|+..||..||.+|++
T Consensus 226 -~~~s~~~~dli~~~L~~dP~~R~~ 249 (337)
T d1o6la_ 226 -RTLSPEAKSLLAGLLKKDPKQRLG 249 (337)
T ss_dssp -TTSCHHHHHHHHHHTCSSTTTSTT
T ss_pred -ccCCHHHHHHHHhhccCCchhhcc
Confidence 456889999999999999999996
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-51 Score=375.17 Aligned_cols=257 Identities=21% Similarity=0.352 Sum_probs=207.3
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
|-.++|+++++||+|+||+||+|.+. ++..||||+++... ....+.+|+.++..++| ++|+.+..++. ....++||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~g~~~-~~~~~iv~ 86 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH-QRLVRLYAVVT-QEPIYIIT 86 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCC-TTBCCEEEEEC-SSSCEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCC-CCEeEEEeeec-cCCeEEEE
Confidence 55679999999999999999999975 57789999987654 34568999999999976 56666666554 35678999
Q ss_pred ecc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 83 e~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||+ +++|.+++... ...+++..++.|+.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+|+......
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSC
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccceEEccCCc
Confidence 999 78888866532 3469999999999999999999999999999999999999 588999999999998765432
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG-SLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG-~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
.. ......||..|+|||++.+..++.++|||||||++|||+|| .+||...... +.+..+. .....+.+
T Consensus 164 ~~------~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~---~~~~~i~-~~~~~~~p- 232 (272)
T d1qpca_ 164 YT------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNLE-RGYRMVRP- 232 (272)
T ss_dssp EE------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHH-TTCCCCCC-
T ss_pred cc------cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH---HHHHHHH-hcCCCCCc-
Confidence 11 12356789999999999999999999999999999999995 5555543332 3333332 23333322
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
..+|+++.+++..||+.+|++||++++|.+.|++++..
T Consensus 233 --~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 233 --DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 45689999999999999999999999999999988764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.3e-51 Score=390.96 Aligned_cols=250 Identities=23% Similarity=0.234 Sum_probs=210.1
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
++|+++++||+|+||+||+|++..+|+.||||++..... ...+.+|+.+++.|.| ++|..++.++.+....+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-PKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCS-TTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEEEc
Confidence 579999999999999999999999999999999876542 2347789999999975 6777888888888999999999
Q ss_pred c-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 85 ~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
| +++|.+.+.....++++.+++.|+.||+.||+|||++|||||||||+|||++. ...+.+||+|||+|+.......
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~~~~~-- 184 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEI-- 184 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSC--
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceecCCCCc--
Confidence 9 78998877655567999999999999999999999999999999999999942 2467999999999987654322
Q ss_pred cccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhc
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~ 243 (414)
.....||+.|+|||++.+..++.++|||||||++|||++|..||.+.... +.+..+.......+ ......
T Consensus 185 ------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~~~~~~~~-~~~~~~ 254 (352)
T d1koba_ 185 ------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNVKRCDWEFD-EDAFSS 254 (352)
T ss_dssp ------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHHCCCCCC-SSTTTT
T ss_pred ------eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-cccccC
Confidence 12567899999999999999999999999999999999999999876543 34445555444433 233456
Q ss_pred ChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 244 HPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 244 ~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
+++++.+|+..||..||.+||++.++.
T Consensus 255 ~s~~~~~li~~~L~~dp~~R~s~~eil 281 (352)
T d1koba_ 255 VSPEAKDFIKNLLQKEPRKRLTVHDAL 281 (352)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 789999999999999999999988764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=376.38 Aligned_cols=257 Identities=20% Similarity=0.288 Sum_probs=207.8
Q ss_pred CCceEEec-ceeecCceeEEEEEECC--CCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeE
Q 015041 6 GVKYKLGR-KIGSGSFGEIFLASHVD--TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 6 ~~~y~i~~-~iG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 79 (414)
..+|.+.+ +||+|+||+||+|.+.. ++..||||+++..... ..+.+|+++++.++| ++|+.+..++. .+..+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~g~~~-~~~~~ 84 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN-PYIVRLIGVCQ-AEALM 84 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEE-SSSEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCC-CCEeeEeeeec-cCeEE
Confidence 35688888 59999999999998753 4557999998765433 358899999999976 56666766654 35689
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
+||||+ +++|.+++...+..+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+....
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEECTT
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee---ccCCceeeccchhhhcccc
Confidence 999999 679998876656679999999999999999999999999999999999999 4788999999999987654
Q ss_pred CCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
..... .......||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+..+ .+..+.. ....+.
T Consensus 162 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~~~i~~-~~~~~~ 233 (285)
T d1u59a_ 162 DDSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQ-GKRMEC 233 (285)
T ss_dssp CSCEE----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHHHT-TCCCCC
T ss_pred ccccc----ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HHHHHHc-CCCCCC
Confidence 32211 12235678999999999999999999999999999999998 999999865432 3333332 222222
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
...+|+++.+|+..||..+|++||++.+|.+.|+..+.
T Consensus 234 ---p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 234 ---PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp ---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 24668999999999999999999999999999987764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-50 Score=379.40 Aligned_cols=236 Identities=23% Similarity=0.343 Sum_probs=202.6
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|++++.||+|+||+||+|++..+|+.||||++... .....+.+|+.+++.++| ++|+.+..++.+....++|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH-PFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCB-TTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccC-cChhheeeeEeeCCeeeeE
Confidence 5799999999999999999999999999999987532 334568899999999976 6777888888888999999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|..++.. ...++...++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+......
T Consensus 83 mE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp ECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSCB
T ss_pred eeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEecccc
Confidence 9999 6677766654 6678999999999999999999999999999999999999 588999999999998764432
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+.. +.+.++.......|
T Consensus 159 ----------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~i~~~~~~~p---- 221 (316)
T d1fota_ 159 ----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KTYEKILNAELRFP---- 221 (316)
T ss_dssp ----------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHCCCCCC----
T ss_pred ----------ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH---HHHHHHHcCCCCCC----
Confidence 2578999999999999999999999999999999999999999875443 44555655555444
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCC
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPD 265 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~ 265 (414)
..+++++.+++.+||..+|.+|+.
T Consensus 222 -~~~s~~~~~li~~~L~~dp~~R~~ 245 (316)
T d1fota_ 222 -PFFNEDVKDLLSRLITRDLSQRLG 245 (316)
T ss_dssp -TTSCHHHHHHHHHHTCSCTTTCTT
T ss_pred -CCCCHHHHHHHHHHhhhCHHhccc
Confidence 456889999999999999999973
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=371.54 Aligned_cols=251 Identities=18% Similarity=0.294 Sum_probs=210.6
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
.++|+++++||+|+||+||+|++. ++..||||+++... ....+.+|+.++..++| ++|..+..++.+....++||||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~H-pnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-EKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCC-TTBCCEEEEECCSSSEEEEEEC
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCC-CceeeEEEEEeeCCceEEEEEc
Confidence 478999999999999999999984 77889999987654 44668999999999975 6677777777788889999999
Q ss_pred c-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 85 ~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
+ +++|.+++......+++..+++++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+........
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSSCC-
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCCce-
Confidence 9 688888877666789999999999999999999999999999999999999 58899999999999765443221
Q ss_pred cccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhhh
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~ 242 (414)
......||..|+|||++.+..++.++|||||||++|||+| |+.||.+....+ ...++.. ....+.+ .
T Consensus 157 -----~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~~~i~~-~~~~~~p---~ 224 (258)
T d1k2pa_ 157 -----SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAEHIAQ-GLRLYRP---H 224 (258)
T ss_dssp -----CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHHHT-TCCCCCC---T
T ss_pred -----eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---HHHHHHh-CCCCCCc---c
Confidence 2234678999999999999999999999999999999998 899999876543 3334433 2233322 4
Q ss_pred cChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 015041 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (414)
Q Consensus 243 ~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~ 274 (414)
..|+++.+|+..||+.+|++||++++|.+.|.
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred cccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 56899999999999999999999999888765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=385.18 Aligned_cols=253 Identities=19% Similarity=0.185 Sum_probs=203.6
Q ss_pred CceEEec-ceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeee----CCeeEEE
Q 015041 7 VKYKLGR-KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD----GEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~-~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~----~~~~~lv 81 (414)
++|.+.+ .||+|+||+||+|++..+++.||||+++. ...+.+|+.++.++.+|++|+.++.++.+ ....|+|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~---~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv 87 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 87 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC---cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence 6798875 59999999999999999999999999864 35678899998877777888877665543 4568999
Q ss_pred Eecc-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCC
Q 015041 82 LDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~ 159 (414)
|||| +++|.+++.... ..+++.+++.|+.||+.||+|||++||+||||||+|||+...+..+.+||+|||+|+.....
T Consensus 88 mEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~ 167 (335)
T d2ozaa1 88 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167 (335)
T ss_dssp EECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred EECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCC
Confidence 9999 789999987543 46999999999999999999999999999999999999965445678999999999876543
Q ss_pred CCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHH-HHHHhhccCCchH
Q 015041 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY-DKICEKKVSTPIE 238 (414)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~-~~i~~~~~~~p~~ 238 (414)
.. ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.........+ ..+.......|.+
T Consensus 168 ~~--------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (335)
T d2ozaa1 168 NS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239 (335)
T ss_dssp CC--------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTT
T ss_pred Cc--------cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCc
Confidence 32 23568999999999999999999999999999999999999999875443322222 2222223333322
Q ss_pred HhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 239 ~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
....+++++.+|+..||..||++||++.++.+
T Consensus 240 -~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 240 -EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 23456889999999999999999999988755
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-50 Score=371.91 Aligned_cols=262 Identities=16% Similarity=0.232 Sum_probs=204.4
Q ss_pred CcccCCceEEecceeecCceeEEEEEECCCC----ceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015041 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTN----EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (414)
Q Consensus 2 ~~i~~~~y~i~~~iG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 74 (414)
.+|-...|++.+.||+|+||+||+|.+..++ ..||||.+...... ..+.+|+.++..++| ++|..+..++..
T Consensus 2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H-~nIv~~~g~~~~ 80 (283)
T d1mqba_ 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH-HNIIRLEGVISK 80 (283)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECS
T ss_pred CcCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCC-CCEeeeeEEEec
Confidence 4667788999999999999999999987554 46999998765433 347899999999975 677788788878
Q ss_pred CCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
....++||||+ ++++.+++......+++..++.++.||+.||+|||+++||||||||+|||+ +.++.+||+|||+|
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla 157 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLS 157 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC-
T ss_pred CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchh
Confidence 88899999999 677777777666789999999999999999999999999999999999999 58899999999999
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCC-CCCChhhchHHHHHHHHhhc
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP-WQGLKAATKKQKYDKICEKK 232 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~P-f~~~~~~~~~~~~~~i~~~~ 232 (414)
+.......... ......||..|+|||++.+..++.++|||||||++|||++|..| |.+... .+.+.. +...
T Consensus 158 ~~~~~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~---~~~~~~-i~~~ 229 (283)
T d1mqba_ 158 RVLEDDPEATY----TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKA-INDG 229 (283)
T ss_dssp --------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHH-HHTT
T ss_pred hcccCCCccce----EeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH---HHHHHH-Hhcc
Confidence 86544322111 11245689999999999999999999999999999999996555 444332 223333 3333
Q ss_pred cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 233 ~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
...+.+ ..+|.++.+++..||+.+|++||++.+|.+.|+.+++
T Consensus 230 ~~~~~~---~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 230 FRLPTP---MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp CCCCCC---TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCc---hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 343333 3568999999999999999999999999999988765
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-49 Score=367.97 Aligned_cols=249 Identities=19% Similarity=0.177 Sum_probs=210.8
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc-----------hhHHHHHHHHHHHcCCCCCCeeEEeee
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----------PQLLYEAKVYKILQGGSGIPNIKWYGV 73 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~E~~~l~~l~~~~~i~~l~~~~~ 73 (414)
+.++|++++.||+|+||+||+|++..+++.||||++...... ..+.+|+.+++.+..|++|+.+..++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 357999999999999999999999999999999998764321 247789999999987788888888888
Q ss_pred eCCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecc
Q 015041 74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (414)
Q Consensus 74 ~~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~ 152 (414)
+....+|||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~ 156 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGF 156 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred cCcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccchh
Confidence 999999999999 7899999876 5579999999999999999999999999999999999999 5889999999999
Q ss_pred eeeecCCCCCccccccCCCCCccCcCccccccccC------CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHH
Q 015041 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD 226 (414)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~ 226 (414)
|+....... ....+||..|+|||.+.+ ..++.++||||+||++|||++|+.||.+.+.. ..+.
T Consensus 157 a~~~~~~~~--------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~---~~~~ 225 (277)
T d1phka_ 157 SCQLDPGEK--------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LMLR 225 (277)
T ss_dssp CEECCTTCC--------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH
T ss_pred eeEccCCCc--------eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH---HHHH
Confidence 987644322 235689999999999863 34688999999999999999999999986543 3444
Q ss_pred HHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 227 KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 227 ~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
.+.......+.+ ...++++++.+|+.+||..+|.+||+++++
T Consensus 226 ~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~~p~~R~s~~ei 267 (277)
T d1phka_ 226 MIMSGNYQFGSP-EWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267 (277)
T ss_dssp HHHHTCCCCCTT-TGGGSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred HHHhCCCCCCCc-ccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 555555444332 234678999999999999999999998765
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-50 Score=382.82 Aligned_cols=235 Identities=22% Similarity=0.360 Sum_probs=202.9
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|+++++||+|+||+||+|++..+|+.||||++... .....+.+|+++++.+.| ++|+.+..++......++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCC-CcEeecccccccccccccc
Confidence 6899999999999999999999999999999987532 233457899999999975 6777787778888889999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+.+.. ...+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+......
T Consensus 120 ~e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp EECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSCB
T ss_pred cccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeeccccc
Confidence 9999 7888888765 4579999999999999999999999999999999999999 578899999999998765332
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
...+||+.|||||++.+..++.++|||||||++|||++|..||.+.+. ...+.++.......|
T Consensus 196 ----------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~i~~~~~~~p---- 258 (350)
T d1rdqe_ 196 ----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFP---- 258 (350)
T ss_dssp ----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCC----
T ss_pred ----------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH---HHHHHHHhcCCCCCC----
Confidence 257899999999999999999999999999999999999999987543 345556666555544
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCC
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRP 264 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP 264 (414)
..+++++.+++..||..||.+|+
T Consensus 259 -~~~s~~~~~li~~~L~~dP~kR~ 281 (350)
T d1rdqe_ 259 -SHFSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp -TTCCHHHHHHHHHHSCSCTTTCT
T ss_pred -ccCCHHHHHHHHHHhhhCHHhcc
Confidence 45688999999999999999995
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=372.47 Aligned_cols=253 Identities=22% Similarity=0.331 Sum_probs=199.7
Q ss_pred eEEe-cceeecCceeEEEEEEC--CCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 9 YKLG-RKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 9 y~i~-~~iG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
+.+. ++||+|+||+||+|.+. .+++.||||+++.... ...+.+|+++++.++| ++|+.+..++. .+..++|
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~g~~~-~~~~~lv 85 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIVRMIGICE-AESWMLV 85 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCC-TTBCCEEEEEE-SSSEEEE
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCC-CCCceEEEEec-cCCEEEE
Confidence 3444 47999999999999864 4567899999865432 2358899999999976 56666666654 4467899
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++.. ...+++..++.|+.||+.||+|||+++||||||||+|||+ +.++.+||+|||+|+......
T Consensus 86 mE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~ 161 (277)
T d1xbba_ 86 MEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADE 161 (277)
T ss_dssp EECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECCTTC
T ss_pred EEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc---cccCcccccchhhhhhccccc
Confidence 9999 7899988775 5679999999999999999999999999999999999999 488999999999998765433
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHH
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+ ....+ ......+.+
T Consensus 162 ~~~----~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~~~~i-~~~~~~~~p- 232 (277)
T d1xbba_ 162 NYY----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAML-EKGERMGCP- 232 (277)
T ss_dssp SEE----EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHH-HTTCCCCCC-
T ss_pred ccc----ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---HHHHH-HcCCCCCCC-
Confidence 221 12235678999999999999999999999999999999998 999999865432 22233 222222222
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~ 278 (414)
..+|+++.+|+..||..+|++||++.+|.+.|+..+.
T Consensus 233 --~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 233 --AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp --TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 4568999999999999999999999999988887653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=375.85 Aligned_cols=262 Identities=21% Similarity=0.298 Sum_probs=203.5
Q ss_pred ccCCceEEecceeecCceeEEEEEECC-----CCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeee-e
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV-D 74 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~-~ 74 (414)
+-.++|+++++||+|+||+||+|.+.. +++.||||+++..... ..+..|..++..+.||+++..+..+.. .
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 445789999999999999999999754 3468999998765433 346788888989988888877765544 4
Q ss_pred CCeeEEEEecc-CCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEcc
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 138 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~ 138 (414)
....++||||+ +++|.+++.... ..+++..++.++.||+.||+|||+++||||||||+|||+
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl-- 167 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-- 167 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE--
Confidence 55789999999 899999987532 247899999999999999999999999999999999999
Q ss_pred CCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCh
Q 015041 139 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG-SLPWQGLK 217 (414)
Q Consensus 139 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG-~~Pf~~~~ 217 (414)
+.++.+||+|||+|+......... ......||+.|+|||++.+..++.++|||||||++|||++| ..||.+..
T Consensus 168 -~~~~~~Kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 168 -SEKNVVKICDFGLARDIYKDPDYV-----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp -CGGGCEEECC------CCSCTTSC-----CTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred -CCCCcEEEccCcchhhcccccccc-----ccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 588999999999998654433211 22356899999999999999999999999999999999986 56887654
Q ss_pred hhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
.. +.+..++......+.+ ..+++++.+++..||..||++||++.++.+.|+++++.
T Consensus 242 ~~---~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 242 ID---EEFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CS---HHHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH---HHHHHHHhcCCCCCCC---ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 33 2333333443333332 45588999999999999999999999999999988754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1e-49 Score=369.49 Aligned_cols=261 Identities=21% Similarity=0.306 Sum_probs=202.1
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeeEEeeeeC---
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDG--- 75 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~--- 75 (414)
.++++|++++.||+|+||+||+|++..+|+.||||++...... ..+.+|+.+++.++|++.+..+..+....
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 4678999999999999999999999999999999998764322 24788999999988754444444443332
Q ss_pred CeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
...++||||+ +++|.+++.. .+.+++.+++.++.||+.||+|||++|||||||||+|||+ +.++.++|+|||.+.
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll---~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTSCEEECCCTTCE
T ss_pred ceEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc---Cccccceeehhhhhh
Confidence 3478999999 6788877765 4679999999999999999999999999999999999999 488999999999987
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
......... ......+||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+.. +.+.+++.....
T Consensus 160 ~~~~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 160 AIADSGNSV----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV---SVAYQHVREDPI 232 (277)
T ss_dssp ECC--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHCCCC
T ss_pred hhccccccc----cccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH---HHHHHHHhcCCC
Confidence 654332211 1234678999999999999999999999999999999999999999875443 334444443333
Q ss_pred CchHHhhhcChHHHHHHHHHHhcCCCCCCC-ChHHHHHHHHHH
Q 015041 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRP-DYGFLKRLFHDL 276 (414)
Q Consensus 235 ~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP-~~~~l~~~l~~~ 276 (414)
+.......+|+++.+++.+||..||.+|| +++++...|..+
T Consensus 233 -~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 233 -PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp -CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 33444567899999999999999999999 788887766654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=378.69 Aligned_cols=251 Identities=18% Similarity=0.242 Sum_probs=213.2
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc-hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEecc
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (414)
++|++++.||+|+||+||+|.+..+++.||||+++..... ..+.+|+++++.++| ++|+.+..++.+....+||||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH-RNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCC-TTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEEEEEEecC
Confidence 7899999999999999999999999999999998776533 347799999999986 67778888888889999999999
Q ss_pred -CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCcc
Q 015041 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (414)
Q Consensus 86 -~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~ 164 (414)
+++|.+++......+++.+++.|+.||+.||+|||++||+||||||+|||++. +....+||+|||+++.......
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~~~~~--- 159 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDN--- 159 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCE---
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-CCceEEEEcccchhhccccCCc---
Confidence 67999988765557999999999999999999999999999999999999942 2456899999999987543221
Q ss_pred ccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhhhcC
Q 015041 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (414)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 244 (414)
.....||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+.. +.+..|.......+.. ....+
T Consensus 160 -----~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~-~~~~~ 230 (321)
T d1tkia_ 160 -----FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIENIMNAEYTFDEE-AFKEI 230 (321)
T ss_dssp -----EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHTCCCCCHH-HHTTS
T ss_pred -----ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCChh-hccCC
Confidence 12567899999999999999999999999999999999999999875443 4555666666555543 34567
Q ss_pred hHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 245 PAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 245 p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
++++.+|+..||..||++||+++++.+
T Consensus 231 s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 231 SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 899999999999999999999988755
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-49 Score=382.10 Aligned_cols=242 Identities=24% Similarity=0.320 Sum_probs=199.5
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCC-----CCchhHHHHHHHHHHHc--CCCCCCeeEEeeeeCCeeE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNV 79 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~--~~~~i~~l~~~~~~~~~~~ 79 (414)
++|++++.||+|+||+||+|++..+|+.||||++... .....+.+|..+++.+. +|++|+.+..++......+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5799999999999999999999999999999987532 22334566766666665 3577888888888888999
Q ss_pred EEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecC
Q 015041 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (414)
Q Consensus 80 lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~ 158 (414)
+||||+ +++|.+++.. ...+++..++.++.||+.||+|||++|||||||||+|||+ +..+.+||+|||+|+....
T Consensus 84 ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceeeecCC
Confidence 999999 7899998876 4678999999999999999999999999999999999999 5889999999999987654
Q ss_pred CCCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCch
Q 015041 159 PTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (414)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~ 237 (414)
... ...+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+............+......
T Consensus 160 ~~~---------~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~--- 227 (364)
T d1omwa3 160 KKP---------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE--- 227 (364)
T ss_dssp SCC---------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCC---
T ss_pred Ccc---------cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC---
Confidence 322 35689999999999975 56999999999999999999999999876544433333222222222
Q ss_pred HHhhhcChHHHHHHHHHHhcCCCCCCCCh
Q 015041 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 238 ~~~~~~~p~~~~~l~~~c~~~~p~~RP~~ 266 (414)
....+++++.+|+..||..||.+||+.
T Consensus 228 --~~~~~s~~~~~li~~~L~~dP~~R~t~ 254 (364)
T d1omwa3 228 --LPDSFSPELRSLLEGLLQRDVNRRLGC 254 (364)
T ss_dssp --CCSSSCHHHHHHHHHHTCSSTTTSTTT
T ss_pred --CCCCCCHHHHHHHHHHcccCHHHhCCC
Confidence 224678999999999999999999983
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=373.40 Aligned_cols=242 Identities=24% Similarity=0.336 Sum_probs=204.6
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
.+|+++++||+|+||+||+|++..+++.||||++.. ......+..|..++....+|++|+.+..++.+....+||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 579999999999999999999999999999999863 223345677877776555668888888888899999999
Q ss_pred Eecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
|||+ +++|.+++.. ...+++..++.++.||+.||+|||++|||||||||+|||+ +..+.+||+|||+|+......
T Consensus 82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhccccc
Confidence 9999 7899998875 5578999999999999999999999999999999999999 588999999999998654332
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHh
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~ 240 (414)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.. +.+.++.......|
T Consensus 158 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i~~~~~~~p---- 223 (320)
T d1xjda_ 158 A-------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIRMDNPFYP---- 223 (320)
T ss_dssp C-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC----
T ss_pred c-------cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCCCC----
Confidence 2 123568999999999999999999999999999999999999999986543 34444544444333
Q ss_pred hhcChHHHHHHHHHHhcCCCCCCCChH
Q 015041 241 CKSHPAEFASYFHYCQSLTFDQRPDYG 267 (414)
Q Consensus 241 ~~~~p~~~~~l~~~c~~~~p~~RP~~~ 267 (414)
+.+++++.+|+.+||..||++||++.
T Consensus 224 -~~~s~~~~dli~~~L~~dP~~R~s~~ 249 (320)
T d1xjda_ 224 -RWLEKEAKDLLVKLFVREPEKRLGVR 249 (320)
T ss_dssp -TTSCHHHHHHHHHHSCSSGGGSBTTB
T ss_pred -ccCCHHHHHHHHHhcccCCCCCcCHH
Confidence 45689999999999999999999974
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=367.65 Aligned_cols=259 Identities=22% Similarity=0.318 Sum_probs=200.5
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCC---ceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
|-..+|++++.||+|+||+||+|.+..++ ..||||.+...... ..+.+|+.+++.++| ++|..++.++. ...
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-PHIVKLIGVIT-ENP 81 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEC-SSS
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEe-cCe
Confidence 45679999999999999999999987543 46888887654433 347899999999976 66666666654 467
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
.++||||+ +++|.+++......+++..++.++.||+.||+|||+++||||||||+||++ +.++.+||+|||+|+..
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll---~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC-------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee---cCCCcEEEccchhheec
Confidence 89999999 788888877767789999999999999999999999999999999999999 47889999999999865
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
...... ......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+... .+.++.... ..
T Consensus 159 ~~~~~~------~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i~~~~-~~ 228 (273)
T d1mp8a_ 159 EDSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIENGE-RL 228 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHTTC-CC
T ss_pred cCCcce------eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCC-CC
Confidence 433221 1235578999999999999999999999999999999998 899999866543 333333322 22
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
+. ..++|+++.+|+..||..||++||++.+|.+.|+.+++.+
T Consensus 229 ~~---~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 229 PM---PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CC---CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 22 2567899999999999999999999999999999887543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=368.30 Aligned_cols=240 Identities=23% Similarity=0.343 Sum_probs=199.5
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCC--------CchhHHHHHHHHHHHcC-CCCCCeeEEeeeeC
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQG-GSGIPNIKWYGVDG 75 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~~-~~~i~~l~~~~~~~ 75 (414)
+.++|++++.||+|+||+||+|++..+|+.||||++.... ....+.+|+.+++.+.+ |++|+.+..++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 5789999999999999999999999999999999876432 12346789999999974 67888888888888
Q ss_pred CeeEEEEeccC--CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 76 EDNVLVLDLLG--PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 76 ~~~~lv~e~~~--~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
...++||||+. +++.+++.. ...+++.+++.++.||+.||+|||++|||||||||+|||++ .+.+.+||+|||+|
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~--~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSG 158 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTC
T ss_pred CeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe--cCCCeEEECccccc
Confidence 99999999993 466666655 56799999999999999999999999999999999999994 24579999999999
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (414)
+...... .....||..|+|||++.+..+ +.++|||||||++|||++|+.||.+.. .+....
T Consensus 159 ~~~~~~~---------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---------~i~~~~ 220 (273)
T d1xwsa_ 159 ALLKDTV---------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIRGQ 220 (273)
T ss_dssp EECCSSC---------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHHHCC
T ss_pred eeccccc---------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch---------HHhhcc
Confidence 8654322 235789999999999987764 678999999999999999999998632 122333
Q ss_pred cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 233 ~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
...+ ..+|+++.+|+.+||..||.+||+++++.
T Consensus 221 ~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~eil 253 (273)
T d1xwsa_ 221 VFFR-----QRVSSECQHLIRWCLALRPSDRPTFEEIQ 253 (273)
T ss_dssp CCCS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCCC-----CCCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 3322 45689999999999999999999988763
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=372.75 Aligned_cols=258 Identities=22% Similarity=0.308 Sum_probs=202.1
Q ss_pred cccC-CceEEecceeecCceeEEEEEECCCCc----eEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeee
Q 015041 3 RIIG-VKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (414)
Q Consensus 3 ~i~~-~~y~i~~~iG~G~~g~V~~~~~~~~~~----~vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 74 (414)
+++. .+|+++++||+|+||+||+|.+..+|+ .||+|.+.... ....+.+|+.+++.++| ++|+.+..++.+
T Consensus 4 ~~~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~g~~~~ 82 (317)
T d1xkka_ 4 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN-PHVCRLLGICLT 82 (317)
T ss_dssp EECCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCC-TTBCCEEEEEES
T ss_pred ccCCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEec
Confidence 3443 469999999999999999999987776 58888775432 23468999999999976 667777777766
Q ss_pred CCeeEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecce
Q 015041 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (414)
Q Consensus 75 ~~~~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a 153 (414)
... +++++++ +++|.+.+......+++..++.++.||+.||+|||+++||||||||+|||+ +.++.+||+|||+|
T Consensus 83 ~~~-~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll---~~~~~~kl~DFGla 158 (317)
T d1xkka_ 83 STV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLA 158 (317)
T ss_dssp SSE-EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCCSHH
T ss_pred CCe-eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee---CCCCCeEeeccccc
Confidence 554 4555555 899999888777889999999999999999999999999999999999999 48889999999999
Q ss_pred eeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhc
Q 015041 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKK 232 (414)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~ 232 (414)
+......... ......||..|+|||++.+..++.++|||||||++|||+| |..||.+.+..... .++...
T Consensus 159 ~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~----~~i~~~ 229 (317)
T d1xkka_ 159 KLLGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKG 229 (317)
T ss_dssp HHTTTTCC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH----HHHHHT
T ss_pred eecccccccc-----cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH----HHHHcC
Confidence 8654332211 1224568999999999999999999999999999999998 89999886654332 223333
Q ss_pred cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 015041 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (414)
Q Consensus 233 ~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~ 277 (414)
...+.+ ..+|+++.+++..||..+|.+||++.+|.+.|..+.
T Consensus 230 ~~~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 230 ERLPQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp CCCCCC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCC---cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 333333 345899999999999999999999999988877654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=368.29 Aligned_cols=248 Identities=20% Similarity=0.226 Sum_probs=197.0
Q ss_pred EecceeecCceeEEEEEECCCCceEEEEEecCCCC-------chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEe
Q 015041 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (414)
Q Consensus 11 i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (414)
.+++||+|+||+||+|++..+|+.||||+++.... ...+.+|+.+++.++| ++|+.++.++......++|||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH-PNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCC-TTBCCEEEEECCTTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCC-CCEeEEEeeeccCCceeehhh
Confidence 46889999999999999999999999998764321 2457899999999976 667777777888889999999
Q ss_pred ccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCCc
Q 015041 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (414)
Q Consensus 84 ~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~ 163 (414)
|+.+++...+......+++..+..++.||+.||+|||++||+||||||+|||+ +..+.+||+|||+|+.......
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~-- 155 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNR-- 155 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCC--
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCCcc--
Confidence 99777666665546679999999999999999999999999999999999999 5889999999999976544322
Q ss_pred cccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc---------
Q 015041 164 HIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV--------- 233 (414)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~--------- 233 (414)
.....+||..|+|||++.+. .|+.++|||||||++|||++|..||.+....+....+.+.+....
T Consensus 156 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 156 -----AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp -----CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred -----cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhc
Confidence 12356899999999998755 589999999999999999999999998665443333333221100
Q ss_pred -----------CCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 234 -----------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 234 -----------~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
..+........++++.+|+..||..||++||+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~ 277 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 112233344567889999999999999999998765
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=364.11 Aligned_cols=253 Identities=20% Similarity=0.231 Sum_probs=202.3
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
.+|+++++||+|+||+||+|++..+|+.||||++.... ....+.+|+++++.+.| ++|+.++.++.+....++||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H-p~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-PNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCC-CcEEEeccccccccceeEEE
Confidence 48999999999999999999999999999999886543 24568899999999875 67778888888899999999
Q ss_pred eccCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 83 DLLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 83 e~~~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
||+++++.+++... ...+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.......
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCCSB
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceeccCCcc
Confidence 99988887777543 4569999999999999999999999999999999999999 5888999999999976543322
Q ss_pred CccccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhh---------
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK--------- 231 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~--------- 231 (414)
......||..|+|||++.... ++.++|||||||++|+|++|+.||.+.+.......+.+....
T Consensus 158 -------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 158 -------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp -------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred -------cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence 223568999999999987766 589999999999999999999999876543322222211111
Q ss_pred ------------ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 232 ------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 232 ------------~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
....+.......+++++.+|+.+||..||.+||++.++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell 281 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 001111223345568899999999999999999988763
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-49 Score=359.93 Aligned_cols=249 Identities=20% Similarity=0.285 Sum_probs=199.9
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeee-eCCeeEEEEec
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV-DGEDNVLVLDL 84 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~-~~~~~~lv~e~ 84 (414)
-++|+++++||+|+||.||+|++ +|..||||+++.+...+.+.+|+++++.++| ++|..+..++. .....++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~H-pnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH-SNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCC-TTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEecCCcEEEEEec
Confidence 46799999999999999999998 4778999999887777889999999999975 66777766554 34567999999
Q ss_pred c-CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 85 L-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 85 ~-~~sL~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
+ +++|.+++.... ..+++..++.|+.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~~~~-- 157 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ-- 157 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccceecCCCC--
Confidence 9 889999986533 358999999999999999999999999999999999999 588999999999998644322
Q ss_pred ccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCCchHHhh
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~ 241 (414)
....+|..|+|||++.+..++.++|||||||++|||++ |++||....... .+..+.. ....+. .
T Consensus 158 --------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i~~-~~~~~~---~ 222 (262)
T d1byga_ 158 --------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEK-GYKMDA---P 222 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTT-TCCCCC---C
T ss_pred --------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHc-CCCCCC---C
Confidence 24567899999999999999999999999999999998 799998765443 3333333 222222 2
Q ss_pred hcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 015041 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (414)
Q Consensus 242 ~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~ 277 (414)
..+++++.+++..||..||.+||++.+|.+.|+.+-
T Consensus 223 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 456889999999999999999999999999988764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=363.88 Aligned_cols=256 Identities=21% Similarity=0.271 Sum_probs=199.6
Q ss_pred CCceEEecceeecCceeEEEEEECCC---CceEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
.++|++++.||+|+||+||+|++..+ ...||||+++.... ...+.+|+.+++.++| ++|..++.++.+ ..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH-RNLIRLYGVVLT-PP 84 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCC-TTBCCEEEEECS-SS
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEee-cc
Confidence 46799999999999999999987532 24689998765421 2358899999999965 677777766654 46
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
.++||||+ ++++.+.+......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll---~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEEC
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcc---ccccceeeccchhhhhc
Confidence 78999999 788888887767789999999999999999999999999999999999999 47889999999999876
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCChhhchHHHHHHHHhhccCC
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (414)
....... .......||..|+|||++.+..++.++|||||||++|||++ |..||.+.+.. +.+..+.......
T Consensus 162 ~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---~~~~~i~~~~~~~ 234 (273)
T d1u46a_ 162 PQNDDHY----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHKIDKEGERL 234 (273)
T ss_dssp CC-CCEE----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTSCCCC
T ss_pred ccCCCcc----eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH---HHHHHHHhCCCCC
Confidence 5443221 12234567889999999999999999999999999999998 89999986544 3445555555444
Q ss_pred chHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 236 p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
+.+ ..+|.++.+++..||..||++||++.+|.+.|++.
T Consensus 235 ~~~---~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 PRP---EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCc---ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 433 45689999999999999999999999998887753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-49 Score=364.01 Aligned_cols=255 Identities=22% Similarity=0.344 Sum_probs=198.5
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
|-.++|+++++||+|+||+||+|++..+ ..||||++..... .+.+.+|+.+++.++|+ +|+.+..++. .+..++||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~-nIv~~~g~~~-~~~~~lv~ 90 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE-KLVQLYAVVS-EEPIYIVT 90 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCT-TBCCEEEEEC-SSSCEEEE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccC-CEeEEEEEEe-cCCeEEEE
Confidence 4457899999999999999999998654 5799999876543 45699999999999875 5666666654 45678999
Q ss_pred ecc-CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCC
Q 015041 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (414)
Q Consensus 83 e~~-~~sL~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~ 160 (414)
||+ +++|..++... ...+++..++.|+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+......
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC------
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhhccCCC
Confidence 999 77788776533 4569999999999999999999999999999999999999 578899999999998654322
Q ss_pred CCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCC-CCCChhhchHHHHHHHHhhccCCchHH
Q 015041 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP-WQGLKAATKKQKYDKICEKKVSTPIEV 239 (414)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~P-f~~~~~~~~~~~~~~i~~~~~~~p~~~ 239 (414)
.. ......||..|+|||++.+..++.++|||||||++|||++|..| |.+... .+.+..+. .....+.+
T Consensus 168 ~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~---~~~~~~i~-~~~~~~~~- 236 (285)
T d1fmka3 168 YT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVE-RGYRMPCP- 236 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHH-TTCCCCCC-
T ss_pred ce------eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH---HHHHHHHH-hcCCCCCC-
Confidence 11 12245789999999999999999999999999999999996544 554332 23333332 33333333
Q ss_pred hhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 015041 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (414)
Q Consensus 240 ~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~ 277 (414)
..+|+++.+++.+||+.+|++||++++|.+.|++.+
T Consensus 237 --~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 237 --PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred --cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 456899999999999999999999999988888654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=363.39 Aligned_cols=261 Identities=20% Similarity=0.311 Sum_probs=211.3
Q ss_pred ccCCceEEecceeecCceeEEEEEECCCC-------ceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeee
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTN-------EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV 73 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~ 73 (414)
|-.++|++++.||+|+||.||+|++..++ ..||||+++.+... ..+.+|...+..+.+|++|..+..++.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 34579999999999999999999976544 47999998776543 347788899999977788989988888
Q ss_pred eCCeeEEEEecc-CCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEc
Q 015041 74 DGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137 (414)
Q Consensus 74 ~~~~~~lv~e~~-~~sL~~~~~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~ 137 (414)
+....++||||+ +++|.+++.... ..+++.+++.++.||+.||+|||+++||||||||+|||+
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl- 168 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV- 168 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee-
Confidence 888999999999 889999986432 358999999999999999999999999999999999999
Q ss_pred cCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 015041 138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 216 (414)
Q Consensus 138 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~ 216 (414)
+.++.+||+|||+++......... ......||+.|+|||++.+..|+.++|||||||++|||++ |..||.+.
T Consensus 169 --~~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 169 --TEDNVMKIADFGLARDIHHIDYYK-----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp --CTTCCEEECSTTCCCCGGGCCTTC-----CCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred --cCCCCeEeccchhhcccccccccc-----ccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence 588899999999998765543321 2245678999999999999999999999999999999998 79999876
Q ss_pred hhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
.... .+.. +......+.+ ..+++++.+|+..||+.+|.+||++.+|.+.|+.++..
T Consensus 242 ~~~~---~~~~-i~~~~~~~~p---~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 242 PVEE---LFKL-LKEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp CHHH---HHHH-HHTTCCCCCC---SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHH---HHHH-HHcCCCCCCC---ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 5432 2222 2333333322 46689999999999999999999999999999988653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=364.64 Aligned_cols=253 Identities=20% Similarity=0.257 Sum_probs=197.6
Q ss_pred CCceEEecceeecCceeEEEEEECCC-CceEEEEEecCC----CCchhHHHHHHHHHHHc--CCCCCCeeEEeee-----
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDT-NEIVAVKIENSG----TKHPQLLYEAKVYKILQ--GGSGIPNIKWYGV----- 73 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~--~~~~i~~l~~~~~----- 73 (414)
.++|+++++||+|+||+||+|++..+ ++.||||++... .....+.+|+.+++.|. +|++|..+..++.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47999999999999999999999765 667999987542 22345778999988885 4566766654442
Q ss_pred eCCeeEEEEeccCCCHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecc
Q 015041 74 DGEDNVLVLDLLGPSLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (414)
Q Consensus 74 ~~~~~~lv~e~~~~sL~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~ 152 (414)
.....+++||++.+++..+... ....+++..++.++.||+.||+|||++|||||||||+|||+ +..+.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecchhh
Confidence 2346799999997776655543 34568999999999999999999999999999999999999 5889999999999
Q ss_pred eeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhh-
Q 015041 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK- 231 (414)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~- 231 (414)
++...... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.......+......
T Consensus 163 ~~~~~~~~--------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 163 ARIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234 (305)
T ss_dssp CCCCCGGG--------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhhhcccc--------cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence 87543221 224678999999999999999999999999999999999999999986654433333222111
Q ss_pred ------------------ccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 232 ------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 232 ------------------~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
....+........++.+.+|+.+||..||++||++.++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~ 290 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 11112233344567889999999999999999998765
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-48 Score=366.80 Aligned_cols=257 Identities=20% Similarity=0.301 Sum_probs=207.3
Q ss_pred cCCceEEecceeecCceeEEEEEEC-----CCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeCC
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 76 (414)
-.++|+++++||+|+||+||+|++. .++..||||+++..... ..+.+|+.+++.++| +++..+..++....
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h-~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN-PNIVKLLGVCAVGK 89 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCC-CCcccceeeeccCC
Confidence 3568999999999999999999975 35678999998765433 358899999999976 55666666677788
Q ss_pred eeEEEEecc-CCCHHHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCC
Q 015041 77 DNVLVLDLL-GPSLEDLFVYCR-----------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 132 (414)
Q Consensus 77 ~~~lv~e~~-~~sL~~~~~~~~-----------------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~ 132 (414)
..+++|||+ +++|.+++.... ..+++..++.|+.||+.||+|||+++||||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 899999999 889999886432 24788999999999999999999999999999999
Q ss_pred ceEEccCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCC-C
Q 015041 133 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS-L 211 (414)
Q Consensus 133 Nili~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~-~ 211 (414)
|||+ +.++.+||+|||+|+........ .......||+.|+|||.+.+..++.++|||||||++|||++|. .
T Consensus 170 NILl---d~~~~~Kl~DFGls~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 170 NCLV---GENMVVKIADFGLSRNIYSADYY-----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp GEEE---CGGGCEEECCCSCHHHHTGGGCB-----C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ceEE---CCCCcEEEccchhheeccCCccc-----cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 9999 57899999999999765433221 1123567899999999999999999999999999999999985 6
Q ss_pred CCCCChhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 015041 212 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (414)
Q Consensus 212 Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~ 277 (414)
||.+.... +.+..+..... .+. ...+|+++.+++..||+.+|++||++.+|.+.|+++.
T Consensus 242 p~~~~~~~---e~~~~v~~~~~-~~~---p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMAHE---EVIYYVRDGNI-LAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSCHH---HHHHHHHTTCC-CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCHH---HHHHHHHcCCC-CCC---CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 78876443 33444444332 222 2466899999999999999999999999999888653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=363.88 Aligned_cols=262 Identities=21% Similarity=0.323 Sum_probs=217.2
Q ss_pred ccCCceEEecceeecCceeEEEEEEC-----CCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 75 (414)
+-.++|+++++||+|+||.||+|++. .++..||||+++..... ..+.+|+.+++.+.+|++|..++.++...
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 34579999999999999999999863 45678999998765433 34788999999998789999998888888
Q ss_pred CeeEEEEecc-CCCHHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEc
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYCR-----------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~~-----------------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~ 137 (414)
...++||||+ +++|.+++.... ..+++..++.++.||+.||+|||+++||||||||+|||+
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~- 178 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL- 178 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc-
Confidence 8899999999 789998887532 258899999999999999999999999999999999999
Q ss_pred cCCCCCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 015041 138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 216 (414)
Q Consensus 138 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~t-G~~Pf~~~ 216 (414)
+..+.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.
T Consensus 179 --~~~~~~ki~DfG~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 179 --THGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp --ETTTEEEECCCGGGSCTTSCTTS-----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred --cccCcccccccchheeccCCCcc-----eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 58899999999999865443321 12345688999999999999999999999999999999998 66667665
Q ss_pred hhhchHHHHHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
... ..+.+++........+ ..+|+++.+|+..||+.||.+||++++|.+.|++.+..
T Consensus 252 ~~~---~~~~~~i~~~~~~~~~---~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 252 PVD---SKFYKMIKEGFRMLSP---EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp CSS---HHHHHHHHHTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHH---HHHHHHHhcCCCCCCc---ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 433 3344455555544433 34589999999999999999999999999999887654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-48 Score=362.71 Aligned_cols=256 Identities=18% Similarity=0.222 Sum_probs=208.3
Q ss_pred CceEEecceeecCceeEEEEEECCCCce--EEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEI--VAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~--vavK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 81 (414)
++|+++++||+|+||+||+|++..++.. ||||.+.... ....+.+|++++..+.+|++|..+..++.+....++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 5899999999999999999999888764 6677654332 3346899999999997678888898888899999999
Q ss_pred Eecc-CCCHHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeE
Q 015041 82 LDLL-GPSLEDLFVYC---------------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 145 (414)
Q Consensus 82 ~e~~-~~sL~~~~~~~---------------~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~v 145 (414)
|||+ +++|.+++... ...+++..++.++.||+.||.|||+++||||||||+|||+ +.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---cCCCce
Confidence 9999 89999988632 2568999999999999999999999999999999999999 588899
Q ss_pred EEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCC-CCCCCChhhchHHH
Q 015041 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS-LPWQGLKAATKKQK 224 (414)
Q Consensus 146 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~-~Pf~~~~~~~~~~~ 224 (414)
||+|||+|+....... .....||..|+|||.+.+..++.++|||||||++|||++|. +||.+.+.. +.
T Consensus 167 kl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~---~~ 235 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---EL 235 (309)
T ss_dssp EECCTTCEESSCEECC--------C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH
T ss_pred EEcccccccccccccc--------ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH---HH
Confidence 9999999975433221 12557899999999999999999999999999999999965 678765433 33
Q ss_pred HHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 015041 225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (414)
Q Consensus 225 ~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~ 280 (414)
+..+.. ....+.+ ..+|+++.+|+.+||..+|++||++.++.+.|+++++..
T Consensus 236 ~~~i~~-~~~~~~~---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 236 YEKLPQ-GYRLEKP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp HHHGGG-TCCCCCC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHHh-cCCCCCC---ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 344333 2222222 456899999999999999999999999999999887644
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-47 Score=355.82 Aligned_cols=252 Identities=24% Similarity=0.300 Sum_probs=200.6
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
++|+++++||+|+||+||+|++. +|+.||||++.... ....+.+|+.+++.++| ++|+.++.++......+++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH-SNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCC-TTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCC-CcEEeeeeecccCCceeEEE
Confidence 58999999999999999999985 78999999986543 23568899999999975 67778888888888999999
Q ss_pred eccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 83 e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
+++++++...+....+.+++..+..++.||+.||+|||++|||||||||+|||+ +.++.+||+|||.|.....+...
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC----
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecccCccc
Confidence 999888888887767789999999999999999999999999999999999999 58899999999999765443221
Q ss_pred ccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhc---------
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK--------- 232 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (414)
.....|++.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+.+.....
T Consensus 157 -------~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 157 -------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred -------cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh
Confidence 1345789999999999765 47999999999999999999999998865443333322211110
Q ss_pred ------------cCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 233 ------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 233 ------------~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
...+.......+++++.+|+..||..||++||++.++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 01111222345678899999999999999999988764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=362.40 Aligned_cols=248 Identities=20% Similarity=0.297 Sum_probs=193.1
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeeeC-----
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDG----- 75 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~----- 75 (414)
+.++|+++++||+|+||+||+|.+..+|+.||||+++..... ..+.+|+++++.++|+ +++.+..++...
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hp-niv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE-NVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBT-TBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCC-CeeEEEEEeccCccccc
Confidence 679999999999999999999999999999999998765432 3477899999999765 555554444322
Q ss_pred -CeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeeccee
Q 015041 76 -EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (414)
Q Consensus 76 -~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~ 154 (414)
...++||||++.+|..+.. ...+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+
T Consensus 95 ~~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 95 FTDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLAR 169 (346)
T ss_dssp CCCCEEEEECCSEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred cceEEEEEecccccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---cccccccccccccee
Confidence 3579999999888888776 3579999999999999999999999999999999999999 588999999999998
Q ss_pred eecCCCCCccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhcc
Q 015041 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (414)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (414)
...... ...+||..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+......... ....
T Consensus 170 ~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~---~~~~ 236 (346)
T d1cm8a_ 170 QADSEM----------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM---KVTG 236 (346)
T ss_dssp ECCSSC----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HHHC
T ss_pred ccCCcc----------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHH---hccC
Confidence 764432 256889999999999875 47999999999999999999999998865433322222 2121
Q ss_pred CCc--------------------------hHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 234 STP--------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 234 ~~p--------------------------~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
..+ ........++++.+|+..||..||.+||++.++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 111 12222345678899999999999999999887754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-47 Score=361.35 Aligned_cols=258 Identities=21% Similarity=0.236 Sum_probs=197.0
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeee----CCe
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD----GED 77 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~----~~~ 77 (414)
++.+|+++++||+|+||+||+|.+..+|+.||||++...... ..+.+|+.+++.|+|++.+..+..+... ...
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 348999999999999999999999999999999998765432 3577899999999875444333333322 234
Q ss_pred eEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeec
Q 015041 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (414)
Q Consensus 78 ~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~ 157 (414)
.++++++++++|.+++.. ..+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+...
T Consensus 86 ~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred EEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccCceeecc
Confidence 677777779999999874 479999999999999999999999999999999999999 588999999999998754
Q ss_pred CCCCCccccccCCCCCccCcCccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHH-------
Q 015041 158 DPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC------- 229 (414)
Q Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~------- 229 (414)
...... ......+||..|+|||++.. ..++.++||||+||++|+|++|+.||.+............+.
T Consensus 161 ~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 161 PDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp GGGCBC----CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred CCCccc----eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence 432211 11245679999999999854 468999999999999999999999998765433222221110
Q ss_pred ----------------hhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 015041 230 ----------------EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (414)
Q Consensus 230 ----------------~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~ 271 (414)
......+........+.++.+|+..||..||.+||++.++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111122233444566788999999999999999999887754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-47 Score=356.54 Aligned_cols=254 Identities=24% Similarity=0.274 Sum_probs=190.4
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeee-------eC
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV-------DG 75 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~-------~~ 75 (414)
++|+++++||+|+||+||+|++..+|+.||||++.... ....+.+|+.+++.++|++.+..+..+.. ..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 79999999999999999999999999999999875432 23458899999999987554444433322 23
Q ss_pred CeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 76 ~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
...++|||++.+.+...+......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARA 166 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEE
T ss_pred ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEeeecceeee
Confidence 4679999999888877776656789999999999999999999999999999999999999 5889999999999987
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
........ .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+.++.. .
T Consensus 167 ~~~~~~~~---~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~---~ 240 (318)
T d3blha1 167 FSLAKNSQ---PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG---S 240 (318)
T ss_dssp CCC--------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC---C
T ss_pred cccccccc---cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC---C
Confidence 65433221 1123356899999999999866 689999999999999999999999998665544444433322 1
Q ss_pred CchHHh---------------------------hhcChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 235 TPIEVL---------------------------CKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 235 ~p~~~~---------------------------~~~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
.+.... ....++++.+|+.+||..||++||+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~el 302 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 111100 01123456667777777777777776654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=353.14 Aligned_cols=257 Identities=18% Similarity=0.240 Sum_probs=201.0
Q ss_pred EEecceeecCceeEEEEEECCCC---ceEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeee-eCCeeEEEE
Q 015041 10 KLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV-DGEDNVLVL 82 (414)
Q Consensus 10 ~i~~~iG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~-~~~~~~lv~ 82 (414)
.+.++||+|+||+||+|++..++ ..||||.++..... .++.+|++++.+++| ++|..+..++. .....++||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCC-TTBCCCCEEEEETTTEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC-CCEeEEeEEEEecCCceEEEE
Confidence 34678999999999999986543 36899988754332 458899999999986 55666655544 456789999
Q ss_pred ecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCC
Q 015041 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (414)
Q Consensus 83 e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~ 161 (414)
||+ +++|.+++......+++..++.++.|++.||.|||+++|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTTC
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhcccccc
Confidence 999 788888887656678899999999999999999999999999999999999 5889999999999987654332
Q ss_pred CccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccCCchHHhh
Q 015041 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (414)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~~p~~~~~ 241 (414)
... .......||..|+|||++.+..++.++|||||||++|||++|..||...... .+....+...+ ..+.+
T Consensus 186 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i~~g~-~~~~p--- 256 (311)
T d1r0pa_ 186 DSV---HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQGR-RLLQP--- 256 (311)
T ss_dssp CCT---TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTC-CCCCC---
T ss_pred ccc---eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCC-CCCCc---
Confidence 211 1223467899999999999999999999999999999999988877653221 22223333322 22222
Q ss_pred hcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 015041 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (414)
Q Consensus 242 ~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~ 279 (414)
..+|+++.+++..||..||++||++.++.+.|+.++..
T Consensus 257 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 257 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 45689999999999999999999999999999988754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=358.81 Aligned_cols=247 Identities=23% Similarity=0.276 Sum_probs=188.3
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeee------eCCeeE
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV------DGEDNV 79 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~------~~~~~~ 79 (414)
.-+|+.+++||+|+||+||+|++..+|+.||||++..... ...+|+++++.++|. +++.+..++. +..+.+
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~Ei~il~~l~h~-niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--FKNRELQIMRKLDHC-NIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--SCCHHHHHHHHCCCT-TBCCEEEEEEEC--CCSCCEEE
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--HHHHHHHHHHhcCCC-CCCcEEEEEEecCccCCceEEE
Confidence 3479999999999999999999999999999999876543 335799999999765 4555544332 234578
Q ss_pred EEEeccCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCC-CeEEEeeecceee
Q 015041 80 LVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA-NQVYIIDFGLAKK 155 (414)
Q Consensus 80 lv~e~~~~sL~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~-~~vkL~DFG~a~~ 155 (414)
|||||+++++.+.+.. ....+++..++.++.||+.||+|||++||+||||||+|||+. .+ ..+||+|||+|+.
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~---~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD---PDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC---TTTCCEEECCCTTCEE
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEe---cCCCceeEecccchhh
Confidence 9999998877666542 345699999999999999999999999999999999999994 44 5899999999987
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
...... ....+||..|+|||.+.+. .++.++|||||||++|||++|+.||.+..... .+.++......
T Consensus 173 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~---~l~~i~~~~g~ 241 (350)
T d1q5ka_ 173 LVRGEP--------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVEIIKVLGT 241 (350)
T ss_dssp CCTTSC--------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHHHHHCC
T ss_pred ccCCcc--------cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH---HHHHHHHHhCC
Confidence 644322 2356899999999998764 68999999999999999999999998765443 33333332222
Q ss_pred CchHH------------------------hhhcChHHHHHHHHHHhcCCCCCCCChHHH
Q 015041 235 TPIEV------------------------LCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (414)
Q Consensus 235 ~p~~~------------------------~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l 269 (414)
.+... .....++++.+|+.+||..||++||++.++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~ 300 (350)
T d1q5ka_ 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300 (350)
T ss_dssp CCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred ChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 21111 112345667777777777777777776654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-47 Score=355.39 Aligned_cols=257 Identities=20% Similarity=0.291 Sum_probs=208.6
Q ss_pred ccCCceEEecceeecCceeEEEEEECC-----CCceEEEEEecCCCCch---hHHHHHHHHHHHcCCCCCCeeEEeeeeC
Q 015041 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKHP---QLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (414)
Q Consensus 4 i~~~~y~i~~~iG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~---~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 75 (414)
|-.++|+++++||+|+||+||+|.+.. ++..||||+++...... .+.+|+.+++.++| ++|..+..++...
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC-HHVVRLLGVVSQG 95 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCC-TTBCCEEEEECSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCC-CCEeeeeeEEecC
Confidence 455899999999999999999998752 35789999987654433 37899999999976 5677777777778
Q ss_pred CeeEEEEecc-CCCHHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeE
Q 015041 76 EDNVLVLDLL-GPSLEDLFVYCR---------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 145 (414)
Q Consensus 76 ~~~~lv~e~~-~~sL~~~~~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~v 145 (414)
...++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||+ +.++.+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cCCceE
Confidence 8899999999 889998876432 346899999999999999999999999999999999999 688999
Q ss_pred EEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCChhhchHHH
Q 015041 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG-SLPWQGLKAATKKQK 224 (414)
Q Consensus 146 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG-~~Pf~~~~~~~~~~~ 224 (414)
||+|||+|+......... ......||+.|+|||.+.+..++.++|||||||++|||+|| .+||.+.+.. +.
T Consensus 173 Kl~DFGla~~~~~~~~~~-----~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~---~~ 244 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYR-----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QV 244 (308)
T ss_dssp EECCTTCCCGGGGGGCEE-----GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HH
T ss_pred EEeecccceeccCCccee-----eccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH---HH
Confidence 999999998654432211 12345789999999999999999999999999999999997 5888875443 34
Q ss_pred HHHHHhhccCCchHHhhhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 015041 225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (414)
Q Consensus 225 ~~~i~~~~~~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~ 276 (414)
+..+..... .+.+ ..+|+.+.+++..||+.+|++||++.+|.+.|++.
T Consensus 245 ~~~i~~~~~-~~~p---~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 245 LRFVMEGGL-LDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHHHTTCC-CCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHhCCC-CCCc---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 444444332 2222 45689999999999999999999999998887654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-46 Score=345.31 Aligned_cols=198 Identities=26% Similarity=0.377 Sum_probs=169.7
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEE
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (414)
++|+++++||+|+||+||+|++..+++.||||+++.... ..++.+|+.+++.++| +++..+..++......++|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h-~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCc-CCEEeeccccccccceeEEe
Confidence 589999999999999999999999999999999865433 2457899999999876 56777778888888999999
Q ss_pred eccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 83 e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
+++.+.....+....+.+++..+..++.|++.||+|||++|||||||||+|||+ +..+.+||+|||.|+........
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCSC
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhcccCCCcc
Confidence 999666666666667789999999999999999999999999999999999999 57889999999999876544321
Q ss_pred ccccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCC
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQG 215 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~tG~~Pf~~ 215 (414)
.....++..|+|||++.+.. ++.++|||||||++|||++|..||..
T Consensus 158 -------~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 158 -------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp -------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred -------ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 22456788999999988765 69999999999999999999999754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=352.37 Aligned_cols=266 Identities=24% Similarity=0.263 Sum_probs=199.5
Q ss_pred cCCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHH--HHHcCCCCCCeeEEeeeeC----Cee
Q 015041 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY--KILQGGSGIPNIKWYGVDG----EDN 78 (414)
Q Consensus 5 ~~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l--~~l~~~~~i~~l~~~~~~~----~~~ 78 (414)
++.+|.+.++||+|+||+||+|++ +|+.||||++..... .....|.+++ ..++| ++|..+..++... ...
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~H-pnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRH-ENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCC-TTBCCEEEEEEEECSSSEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hHHHHHHHHHHHhhCCC-CcCcceEEEEEeCCCcceEE
Confidence 467899999999999999999987 688999999865432 3344555444 34554 5666665555432 257
Q ss_pred EEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--------cCeeccccCCCceEEccCCCCCeEEEee
Q 015041 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS--------RGFLHRDIKPDNFLMGLGRKANQVYIID 149 (414)
Q Consensus 79 ~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--------~~iiHrDLkp~Nili~~~~~~~~vkL~D 149 (414)
++||||+ +++|.+++.. ..+++..++.++.|++.||+|||+ +|||||||||+|||+ +.++.+||+|
T Consensus 77 ~lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~D 151 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIAD 151 (303)
T ss_dssp EEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECC
T ss_pred EEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEEe
Confidence 9999999 8899999874 468999999999999999999996 599999999999999 5889999999
Q ss_pred ecceeeecCCCCCccccccCCCCCccCcCccccccccCCC------CCchhhHHHHHHHHHHHHcCCCCCCCChh-----
Q 015041 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE------QSRRDDLESLGYVLLYFLRGSLPWQGLKA----- 218 (414)
Q Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~s~~~DiwSlG~il~el~tG~~Pf~~~~~----- 218 (414)
||+++........... ......||+.|+|||++.+.. ++.++|||||||++|||+||..||.....
T Consensus 152 FGl~~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~ 228 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDI---APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp CTTCEEEETTTTEECC-------CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred cCccccccCCCcceec---cccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence 9999877554322111 123568999999999987653 57789999999999999999887743211
Q ss_pred -------hchHHHHHHHHhhccCCchHHh--hhcChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCC
Q 015041 219 -------ATKKQKYDKICEKKVSTPIEVL--CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY 282 (414)
Q Consensus 219 -------~~~~~~~~~i~~~~~~~p~~~~--~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~~~l~~~~~~~~~ 282 (414)
.........+......++.+.. ....+..+.+++..||..||.+||++.+|.+.|+++..+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~ 301 (303)
T d1vjya_ 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCC
T ss_pred hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCC
Confidence 1112222233333443332221 223356799999999999999999999999999999887764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-46 Score=352.05 Aligned_cols=245 Identities=20% Similarity=0.338 Sum_probs=202.3
Q ss_pred CceEEecceeecCceeEEEEEEC---CCCceEEEEEecCC------CCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCe
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSG------TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~---~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 77 (414)
++|+++++||+|+||+||+|++. .+|+.||||+++.. .....+.+|++++++++|+++|..+..+..+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999974 46899999987543 2334578999999999999999999888888999
Q ss_pred eEEEEecc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 78 ~~lv~e~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
.+++|||+ +++|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+|+..
T Consensus 104 ~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhhh
Confidence 99999999 7899888876 4567899999999999999999999999999999999999 57889999999999876
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHH-hhcc
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC-EKKV 233 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~-~~~~ 233 (414)
...... ......|++.|+|||.+.+.. ++.++|||||||++|||++|+.||.+.........+.+.. ....
T Consensus 180 ~~~~~~------~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~ 253 (322)
T d1vzoa_ 180 VADETE------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 253 (322)
T ss_dssp CGGGGG------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC
T ss_pred cccccc------cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC
Confidence 443222 123567899999999998654 7889999999999999999999998876555444443322 2222
Q ss_pred CCchHHhhhcChHHHHHHHHHHhcCCCCCCCCh
Q 015041 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (414)
Q Consensus 234 ~~p~~~~~~~~p~~~~~l~~~c~~~~p~~RP~~ 266 (414)
..| ..+++++.+++.+||..||++||+.
T Consensus 254 ~~~-----~~~s~~~~~li~~~l~~dP~~R~s~ 281 (322)
T d1vzoa_ 254 PYP-----QEMSALAKDLIQRLLMKDPKKRLGC 281 (322)
T ss_dssp CCC-----TTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred CCc-----ccCCHHHHHHHHHHcccCHHHcCCC
Confidence 222 3568999999999999999999963
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-45 Score=350.61 Aligned_cols=197 Identities=24% Similarity=0.380 Sum_probs=167.8
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeee--eCCeeEEEEe
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV--DGEDNVLVLD 83 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~--~~~~~~lv~e 83 (414)
.++|+++++||+|+||+||+|++..+|+.||||+++.. ...++.+|+.+++.+.+|++|+.+..++. .....++|||
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 36799999999999999999999999999999998754 34568899999999987788888876655 3456899999
Q ss_pred cc-CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeeecCCCCC
Q 015041 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (414)
Q Consensus 84 ~~-~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~~~~~~~ 162 (414)
|+ +++|..+ .+.+++..++.++.||+.||+|||++|||||||||+|||++ .+++.+||+|||+|+.......
T Consensus 113 ~~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~~~~- 185 (328)
T d3bqca1 113 HVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQE- 185 (328)
T ss_dssp CCCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCTTCC-
T ss_pred ecCCCcHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc--CCCCeeeecccccceeccCCCc-
Confidence 99 5566543 45799999999999999999999999999999999999995 3455799999999987654322
Q ss_pred ccccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCh
Q 015041 163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLK 217 (414)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~tG~~Pf~~~~ 217 (414)
....+||..|+|||.+.+.. ++.++|||||||++|||++|+.||....
T Consensus 186 -------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 186 -------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp -------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred -------ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 23567899999999988765 7999999999999999999999997643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=351.24 Aligned_cols=198 Identities=23% Similarity=0.315 Sum_probs=158.8
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeee------eCC
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGV------DGE 76 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~------~~~ 76 (414)
++|+++++||+|+||+||+|++..+|+.||||++...... ..+.+|+.+++.++| ++|+.+...+. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH-KNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCC-TTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCC-CCeeEEEEEEecccccccCc
Confidence 7899999999999999999999999999999998765433 247799999999975 56655544442 336
Q ss_pred eeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceeee
Q 015041 77 DNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (414)
Q Consensus 77 ~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~~ 156 (414)
+.|+||||+.+++.+.+ ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+|++|||+++..
T Consensus 96 ~~~iv~Ey~~~~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEEECCSEEHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC----
T ss_pred eeEEEEeccchHHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeechhhhhcc
Confidence 78999999988876655 4568999999999999999999999999999999999999 57889999999998765
Q ss_pred cCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCChhh
Q 015041 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219 (414)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~~~~ 219 (414)
..... ....+||..|+|||++.+..++.++||||+||++|+|++|+.||.+.+..
T Consensus 170 ~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~ 224 (355)
T d2b1pa1 170 GTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224 (355)
T ss_dssp -------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ccccc--------cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH
Confidence 44322 23567899999999999999999999999999999999999999876544
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=350.67 Aligned_cols=246 Identities=21% Similarity=0.263 Sum_probs=188.4
Q ss_pred CCceEEecceeecCceeEEEEEECCCCceEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeee------eC
Q 015041 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGV------DG 75 (414)
Q Consensus 6 ~~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~------~~ 75 (414)
.++|+++++||+|+||+||+|++..+|+.||||++...... ..+.+|+.+++.++|.+ ++.+..++. +.
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~-iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN-VIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTT-BCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCC-eeeEEEEEeeccccccC
Confidence 47899999999999999999999999999999998765432 34779999999998754 444433332 23
Q ss_pred CeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEeeecceee
Q 015041 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (414)
Q Consensus 76 ~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~DFG~a~~ 155 (414)
...++++++.+++|.+++. .+++++..++.++.||+.||+|||++||+||||||+|||+ +.++.+|++|||+|..
T Consensus 96 ~~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH 170 (348)
T ss_dssp CCCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC----C
T ss_pred ceEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---cccccccccccchhcc
Confidence 3466777767999998875 4679999999999999999999999999999999999999 5889999999999875
Q ss_pred ecCCCCCccccccCCCCCccCcCccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCChhhchHHHHHHHHhhccC
Q 015041 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (414)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlG~il~el~tG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (414)
.... .....||..|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+...... .+......
T Consensus 171 ~~~~----------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~---~i~~~~~~ 237 (348)
T d2gfsa1 171 TDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK---LILRLVGT 237 (348)
T ss_dssp CTGG----------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCC
T ss_pred cCcc----------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCC
Confidence 4332 23568899999999987765 6899999999999999999999999865443332 23222222
Q ss_pred Cch--------------------------HHhhhcChHHHHHHHHHHhcCCCCCCCChHHHH
Q 015041 235 TPI--------------------------EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (414)
Q Consensus 235 ~p~--------------------------~~~~~~~p~~~~~l~~~c~~~~p~~RP~~~~l~ 270 (414)
.+. .....+.++++.+|+..||..||.+||++.++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL 299 (348)
T d2gfsa1 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299 (348)
T ss_dssp CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHh
Confidence 221 112234567778888888888888888876654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-41 Score=325.17 Aligned_cols=206 Identities=25% Similarity=0.299 Sum_probs=160.2
Q ss_pred CCcccC-CceEEecceeecCceeEEEEEECCCCceEEEEEecCCCC-chhHHHHHHHHHHHcCC----------CCCCee
Q 015041 1 MERIIG-VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGG----------SGIPNI 68 (414)
Q Consensus 1 ~~~i~~-~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~~----------~~i~~l 68 (414)
+|+++. +||+++++||+|+||+||+|++..+|+.||||+++.... ...+.+|+.+++.+.|. ++++.+
T Consensus 6 ~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 6 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp TTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence 467665 679999999999999999999999999999999876532 24567899999988753 345444
Q ss_pred EEeee--eCCeeEEEEecc--CCCHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeccccCCCceEEccCCC-
Q 015041 69 KWYGV--DGEDNVLVLDLL--GPSLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRK- 141 (414)
Q Consensus 69 ~~~~~--~~~~~~lv~e~~--~~sL~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iiHrDLkp~Nili~~~~~- 141 (414)
..++. .....+++++++ ++........ ....+++..++.++.||+.||+|||+ .||+||||||+|||+...+.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence 43332 334556666665 4444443333 24568999999999999999999998 89999999999999952211
Q ss_pred --CCeEEEeeecceeeecCCCCCccccccCCCCCccCcCccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 015041 142 --ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 216 (414)
Q Consensus 142 --~~~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlG~il~el~tG~~Pf~~~ 216 (414)
...++|+|||.|....... ...+||..|+|||++.+..++.++||||+||++++|++|+.||...
T Consensus 166 ~~~~~~kl~dfg~s~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDEHY----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp TTEEEEEECCCTTCEETTBCC----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred cccceeeEeeccccccccccc----------ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 1258999999998654332 2567999999999999999999999999999999999999999754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=7.9e-25 Score=189.83 Aligned_cols=163 Identities=17% Similarity=0.258 Sum_probs=113.2
Q ss_pred eEEecceeecCceeEEEEEECCCCceEEEEEecCCCC------------c--------hhHHHHHHHHHHHcCCCCCCee
Q 015041 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK------------H--------PQLLYEAKVYKILQGGSGIPNI 68 (414)
Q Consensus 9 y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------~--------~~~~~E~~~l~~l~~~~~i~~l 68 (414)
|.++++||+|+||+||+|.+. +|+.||||+++.... . .....|...+..+.+. +++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGL-AVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTS-SSCCE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCC-CcceE
Confidence 568999999999999999974 689999998653210 0 1134566777777653 44444
Q ss_pred EEeeeeCCeeEEEEeccCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCeeccccCCCceEEccCCCCCeEEEe
Q 015041 69 KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148 (414)
Q Consensus 69 ~~~~~~~~~~~lv~e~~~~sL~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iiHrDLkp~Nili~~~~~~~~vkL~ 148 (414)
..+. ..+++|||+++... ..++...+..++.|++.+|.|||++||+||||||+|||++ ++.++|+
T Consensus 80 ~~~~----~~~lvme~~~~~~~-------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~~~~~li 144 (191)
T d1zara2 80 YAWE----GNAVLMELIDAKEL-------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWII 144 (191)
T ss_dssp EEEE----TTEEEEECCCCEEG-------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEEEC
T ss_pred EEec----CCEEEEEeeccccc-------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee----CCCEEEE
Confidence 3332 24799999965322 2245566778999999999999999999999999999994 4569999
Q ss_pred eecceeeecCCCCCccccccCCCCCccCcCccc--cc---cccCCCCCchhhHHHHHHHH
Q 015041 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS--CN---THLGIEQSRRDDLESLGYVL 203 (414)
Q Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~a--PE---~~~~~~~s~~~DiwSlG~il 203 (414)
|||+|+....+... .|.. .+ .+....|+.++|+||+.--+
T Consensus 145 DFG~a~~~~~~~~~---------------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWR---------------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHH---------------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcH---------------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 99999764332210 1111 00 11235678899999976444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.44 E-value=9.7e-07 Score=77.90 Aligned_cols=79 Identities=15% Similarity=0.152 Sum_probs=58.8
Q ss_pred CceEEecceeecCceeEEEEEECCCCceEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 7 ~~y~i~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
..|++.+..+.++.+.||++.. ++..++||+..... ....+..|...+..|...-.+|.+..++......++||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 4677777766666789998863 55667888765432 2335788999999887665678888888888888999999
Q ss_pred cCC
Q 015041 85 LGP 87 (414)
Q Consensus 85 ~~~ 87 (414)
+.+
T Consensus 92 l~G 94 (263)
T d1j7la_ 92 ADG 94 (263)
T ss_dssp CSS
T ss_pred ccc
Confidence 944
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.12 E-value=9.3e-06 Score=76.10 Aligned_cols=74 Identities=16% Similarity=0.191 Sum_probs=48.9
Q ss_pred ecceeecCceeEEEEEECCCCceEEEEEecC------C---CCchhHHHHHHHHHHHcCC--CCCCeeEEeeeeCCeeEE
Q 015041 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENS------G---TKHPQLLYEAKVYKILQGG--SGIPNIKWYGVDGEDNVL 80 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~------~---~~~~~~~~E~~~l~~l~~~--~~i~~l~~~~~~~~~~~l 80 (414)
.+.||.|....||++.+..+++.|+||.-.. . ....+...|.+.+..+... ..+|.++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4578999999999998777778899995321 1 1123456788888887643 346666554 4556789
Q ss_pred EEeccCC
Q 015041 81 VLDLLGP 87 (414)
Q Consensus 81 v~e~~~~ 87 (414)
|||++++
T Consensus 109 vmE~L~~ 115 (392)
T d2pula1 109 VMEDLSH 115 (392)
T ss_dssp EECCCTT
T ss_pred EEeccCC
Confidence 9999944
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.92 E-value=5.7e-05 Score=65.69 Aligned_cols=71 Identities=18% Similarity=0.111 Sum_probs=51.2
Q ss_pred ceeecC-ceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCeeEEeeeeCCeeEEEEeccC
Q 015041 14 KIGSGS-FGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWYGVDGEDNVLVLDLLG 86 (414)
Q Consensus 14 ~iG~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~l~~~~~~~~~~~lv~e~~~ 86 (414)
.+..|. -+.||+... ..+..+++|...... ...+..|...++.|..... +|.+..++.+....++||+++.
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~-~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC-HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 334454 468999874 456678899866543 3457889999998876543 6777777777778899999993
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.48 E-value=0.00031 Score=65.41 Aligned_cols=72 Identities=13% Similarity=0.123 Sum_probs=53.4
Q ss_pred ecceeecCceeEEEEEECC-------CCceEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeeeCCeeEEEEec
Q 015041 12 GRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (414)
++.|+.|-.-.+|++.... ....|++++...........+|..+++.+......|.+.+++.+ .+|++|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 4678889999999998753 24568888876444444567899999999877778888777643 688998
Q ss_pred cCC
Q 015041 85 LGP 87 (414)
Q Consensus 85 ~~~ 87 (414)
+.+
T Consensus 123 i~g 125 (395)
T d1nw1a_ 123 IPS 125 (395)
T ss_dssp CCE
T ss_pred ecc
Confidence 843
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.13 E-value=0.0009 Score=59.89 Aligned_cols=49 Identities=12% Similarity=0.140 Sum_probs=31.0
Q ss_pred ecceeecCceeEEEEEECCCCceEEEEEecCCCCchhHHHHHHHHHHHcCC
Q 015041 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG 62 (414)
Q Consensus 12 ~~~iG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~~ 62 (414)
.+.|..|---+.|+++.. +| .+++|+.........+..|++++..|...
T Consensus 23 ~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~~~~~l~~~~~~l~~L~~~ 71 (316)
T d2ppqa1 23 YKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAK 71 (316)
T ss_dssp EEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHT
T ss_pred eecCCCCcccCeEEEEEC-CC-cEEEEEcCCCCCHHHHHHHHHHHHhhhhc
Confidence 344556766788998864 34 58899987665556778888888888753
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.96 E-value=0.0024 Score=57.42 Aligned_cols=66 Identities=14% Similarity=0.070 Sum_probs=44.0
Q ss_pred ceeEEEEEECCCCceEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCee-------EEeeeeCCeeEEEEeccCC
Q 015041 20 FGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNI-------KWYGVDGEDNVLVLDLLGP 87 (414)
Q Consensus 20 ~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l-------~~~~~~~~~~~lv~e~~~~ 87 (414)
-..||+++. .+|..|++|+..... ...++..|...+..|... +++.. ......+...+.+++++.|
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~-gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVND-EVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHT-TCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhc-CCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 357999975 568889999987654 345688899998888753 23221 1112345567888888854
|